abstract_id,title,abstract,label,label_encoded,combined_text
30872385,comparison of methodology for the detection of braf mutation in bone marrow trephine specimen,aim braf ve detection assist in the diagnosis of hairy cell leukaemia hcl however testing practice vary we evaluated the clinical utility of braf mutation testing strategy for use on bone marrow trephine bmt method hcl hcl mimic treated hcl and normal bmt specimen were tested for mutant braf comparing sanger sequencing pyrosequencing ampliconbased next generation sequencing ng automated idylla pcr and immunohistochemistry ihc result pcr and ihc were cheaper and identified ve in of hcl case pyrosequencing detected the mutation in ng in of case and sanger sequencing in all assay gave wildtype braf result in hcl mimic and normal bmt sample conclusion pcr and ihc were most sensitive and costeffective but these have limited scope for multiplexing and are likely to be replaced by ng gene panel or whole genome sequencing in the medium to long term,Cancer,0,comparison of methodology for the detection of braf mutation in bone marrow trephine specimen aim braf ve detection assist in the diagnosis of hairy cell leukaemia hcl however testing practice vary we evaluated the clinical utility of braf mutation testing strategy for use on bone marrow trephine bmt method hcl hcl mimic treated hcl and normal bmt specimen were tested for mutant braf comparing sanger sequencing pyrosequencing ampliconbased next generation sequencing ng automated idylla pcr and immunohistochemistry ihc result pcr and ihc were cheaper and identified ve in of hcl case pyrosequencing detected the mutation in ng in of case and sanger sequencing in all assay gave wildtype braf result in hcl mimic and normal bmt sample conclusion pcr and ihc were most sensitive and costeffective but these have limited scope for multiplexing and are likely to be replaced by ng gene panel or whole genome sequencing in the medium to long term
30873683,tumour biomarkerstracing the molecular function and clinical implication,in recent year with the increase in cancer mortality caused by metastasis and with the development of individualized and precise medical treatment early diagnosis with precision becomes the key to decrease the death rate since detecting tumour biomarkers in body fluid is the most noninvasive way to identify the status of tumour development it ha been widely investigated for the usage in clinic these biomarkers include different expression or mutation in micrornas mirnas circulating tumour dna ctdnas protein exosomes and circulating tumour cell ctc in the present article we summarized and discussed some updated research on these biomarkers we overviewed their biological function and evaluated their multiple role in human and small animal clinical treatment including diagnosis of cancer classification of cancer prognostic and predictive value for therapy response monitor for therapy efficacy and anticancer therapeutic biomarkers including different expression or mutation in mirnas ctdnas protein exosomes and ctc provide more choice for early diagnosis of tumour detection at early stage before metastasis combination detection of these tumour biomarkers may provide higher accuracy at the lowest molecule combination number for tumour early detection moreover tumour biomarkers can provide valuable suggestion for clinical anticancer treatment and execute monitoring of treatment efficiency,Cancer,0,tumour biomarkerstracing the molecular function and clinical implication in recent year with the increase in cancer mortality caused by metastasis and with the development of individualized and precise medical treatment early diagnosis with precision becomes the key to decrease the death rate since detecting tumour biomarkers in body fluid is the most noninvasive way to identify the status of tumour development it ha been widely investigated for the usage in clinic these biomarkers include different expression or mutation in micrornas mirnas circulating tumour dna ctdnas protein exosomes and circulating tumour cell ctc in the present article we summarized and discussed some updated research on these biomarkers we overviewed their biological function and evaluated their multiple role in human and small animal clinical treatment including diagnosis of cancer classification of cancer prognostic and predictive value for therapy response monitor for therapy efficacy and anticancer therapeutic biomarkers including different expression or mutation in mirnas ctdnas protein exosomes and ctc provide more choice for early diagnosis of tumour detection at early stage before metastasis combination detection of these tumour biomarkers may provide higher accuracy at the lowest molecule combination number for tumour early detection moreover tumour biomarkers can provide valuable suggestion for clinical anticancer treatment and execute monitoring of treatment efficiency
30874851,pomalidomide cyclophosphamide and dexamethasone for relapsedrefractory multiple myeloma patient in a reallife setting a singlecenter retrospective study,pomalidomide dexamethasone is a standard of care for relapsed multiple myeloma mm patient who received at least two prior line of therapy including both lenalidomide and proteasome inhibitor pi we report here a reallife singlecenter series of consecutive patient with relapsed and refractory mm treated with the triplet pomalidomide cyclophosphamide dexamethasone pcd combination the median of prior line of therapy wa and all patient were previously exposed to proteasome inhibitor and lenalidomide the overall response rate wa including very good partial response or better with a median followup of month the median progressionfree survival pfs wa month and the median overall survival wa not reached regarding safety most frequent toxicity wa hematologic including grade cytopenia nine patient discontinued therapy due to adverse event our study confirms that pcd combination is feasible and result in favorable response rate and pfs in comparison with pomalidomide dexamethasone alone,Cancer,0,pomalidomide cyclophosphamide and dexamethasone for relapsedrefractory multiple myeloma patient in a reallife setting a singlecenter retrospective study pomalidomide dexamethasone is a standard of care for relapsed multiple myeloma mm patient who received at least two prior line of therapy including both lenalidomide and proteasome inhibitor pi we report here a reallife singlecenter series of consecutive patient with relapsed and refractory mm treated with the triplet pomalidomide cyclophosphamide dexamethasone pcd combination the median of prior line of therapy wa and all patient were previously exposed to proteasome inhibitor and lenalidomide the overall response rate wa including very good partial response or better with a median followup of month the median progressionfree survival pfs wa month and the median overall survival wa not reached regarding safety most frequent toxicity wa hematologic including grade cytopenia nine patient discontinued therapy due to adverse event our study confirms that pcd combination is feasible and result in favorable response rate and pfs in comparison with pomalidomide dexamethasone alone
30875581,aggressive variant of prostate cancer are we ready to apply specific treatment right now,recently adoption of novel drug for systemic treatment of metastatic prostate cancer ha led to a striking improvement of response rate and survival in both hormonesensitive and castrationresistant disease in most case prostate cancer essentially depends on androgen receptor signaling axis even in castrationresistant setting and hence may be targeted by second generation hormonal therapy however a subset of patient bear androgenindependent cancer biology with a shortterm response to hormonal treatment early and extensive visceral metastasis low psa level and poor outcome identification and specific management of these rapidly fatal malignancy is of an unmet medical need since their classification and utilized therapeutic regimen vary significantly unfortunately molecular pathway have not been sufficiently elucidated yet in order to provide an effective targeted treatment with a prolonged response lack of diagnostic and predictive biomarkers for these cancer make successful counteraction against them even more sophisticated in this comprehensive review we aimed at summarizing the current body of literature reporting on causal molecular machinery a well a diagnostic and therapeutic concept of aggressive prostate tumor and draw clinically relevant conclusion for the uptodate sensible disease management,Cancer,0,aggressive variant of prostate cancer are we ready to apply specific treatment right now recently adoption of novel drug for systemic treatment of metastatic prostate cancer ha led to a striking improvement of response rate and survival in both hormonesensitive and castrationresistant disease in most case prostate cancer essentially depends on androgen receptor signaling axis even in castrationresistant setting and hence may be targeted by second generation hormonal therapy however a subset of patient bear androgenindependent cancer biology with a shortterm response to hormonal treatment early and extensive visceral metastasis low psa level and poor outcome identification and specific management of these rapidly fatal malignancy is of an unmet medical need since their classification and utilized therapeutic regimen vary significantly unfortunately molecular pathway have not been sufficiently elucidated yet in order to provide an effective targeted treatment with a prolonged response lack of diagnostic and predictive biomarkers for these cancer make successful counteraction against them even more sophisticated in this comprehensive review we aimed at summarizing the current body of literature reporting on causal molecular machinery a well a diagnostic and therapeutic concept of aggressive prostate tumor and draw clinically relevant conclusion for the uptodate sensible disease management
30875950,circulating tumour cell ctc head and neck cancer and radiotherapy future perspective,head and neck cancer is the seventh most common cancer in australia and globally despite the current improved treatment modality there is still up to local regional recurrence and or distant metastasis highresolution medical imaging technology such a petct and mri do not currently detect the early spread of tumour cell thus limiting the potential for effective minimal residual detection and early diagnosis circulating tumour cell ctc are a rare subset of cell that escape from the primary tumour and enter into the bloodstream to form metastatic deposit or even reestablish themselves in the primary site of the cancer these cell are more aggressive and accumulate gene alteration by somatic mutation that are the same or even greater than the primary tumour because of additional feature acquired in the circulation the potential application of ctc in clinical use is to acquire a liquid biopsy by taking a reliable minimally invasive venous blood sample for cell genotyping during radiotherapy treatment to monitor the decline in ctc detectability and mutational change in response to radiation resistance and radiation sensitivity currently very little ha been published on radiation therapy ctc and circulating cancer stem cell ccscs the prognostic value of ctc in cancer management and personalised medicine for head and neck cancer radiotherapy patient requires a deeper understanding at the cellular level along with other advanced technology with this goal this review summarises the current research of head and neck cancer ctc ccsc and the molecular target for personalised radiotherapy response,Cancer,0,circulating tumour cell ctc head and neck cancer and radiotherapy future perspective head and neck cancer is the seventh most common cancer in australia and globally despite the current improved treatment modality there is still up to local regional recurrence and or distant metastasis highresolution medical imaging technology such a petct and mri do not currently detect the early spread of tumour cell thus limiting the potential for effective minimal residual detection and early diagnosis circulating tumour cell ctc are a rare subset of cell that escape from the primary tumour and enter into the bloodstream to form metastatic deposit or even reestablish themselves in the primary site of the cancer these cell are more aggressive and accumulate gene alteration by somatic mutation that are the same or even greater than the primary tumour because of additional feature acquired in the circulation the potential application of ctc in clinical use is to acquire a liquid biopsy by taking a reliable minimally invasive venous blood sample for cell genotyping during radiotherapy treatment to monitor the decline in ctc detectability and mutational change in response to radiation resistance and radiation sensitivity currently very little ha been published on radiation therapy ctc and circulating cancer stem cell ccscs the prognostic value of ctc in cancer management and personalised medicine for head and neck cancer radiotherapy patient requires a deeper understanding at the cellular level along with other advanced technology with this goal this review summarises the current research of head and neck cancer ctc ccsc and the molecular target for personalised radiotherapy response
30878128,alk rearrangement biology detection and opportunity of therapy in nonsmall cell lung cancer,the alk receptor tyrosine kinase alk gene encodes a transmembrane protein rearranged in of nonsmall cell lung cancer nsclc case this gene ha become the second most studied therapeutic target after egfr due to the implied therapeutic opportunity while the diagnostic of alk rearrangement is well established small molecule targeting alk are in constant evolution because tumor cell eventually will develop mechanism of resistance in this review we describe the biology of the alk gene alteration epidemiology diagnostic test a well a strategy of treatment,Cancer,0,alk rearrangement biology detection and opportunity of therapy in nonsmall cell lung cancer the alk receptor tyrosine kinase alk gene encodes a transmembrane protein rearranged in of nonsmall cell lung cancer nsclc case this gene ha become the second most studied therapeutic target after egfr due to the implied therapeutic opportunity while the diagnostic of alk rearrangement is well established small molecule targeting alk are in constant evolution because tumor cell eventually will develop mechanism of resistance in this review we describe the biology of the alk gene alteration epidemiology diagnostic test a well a strategy of treatment
30878469,aga clinical practice update on interaction between oral directacting antiviral for chronic hepatitis c infection and hepatocellular carcinoma expert review,description the purpose of this clinical practice update is to evaluate the evidence describing the interaction between directacting antiviral daa therapy for hepatitis and hepatocellular carcinoma hcc with regard to hcc incidence hcc recurrence and daa efficacy and to summarize best practice advice regarding hcc surveillance and timing of daa therapy method the recommendation outlined in this expert review are based on available published evidence including observational study and systematic review and incorporates expert opinion where applicable best practice advice daa treatment is associated with a reduction in the risk of incident hcc the relative risk reduction is similar in patient with and without cirrhosis best practice advice patient with advanced liver fibrosis f or cirrhosis should receive surveillance imaging before initiating daa treatment best practice advice patient with advanced liver fibrosis f or cirrhosis at the time of daa treatment represent the highestrisk group for hcc after daainduced sustained virologic response these patient should stay in hcc surveillance best practice advice hcc surveillance should be performed using ultrasound with or without alphafetoprotein every month current data do not support shorter surveillance interval or the use of alternative surveillance modality best practice advice future study may show a reduction in hcc risk over time after daainduced sustained virologic response however in the interim hcc surveillance should continue indefinitely if patient are otherwise eligible for potentially curative therapy best practice advice the presence of active hcc is associated with a small but statistically significant decrease in sustained virologic response with daa therapy best practice advice patient with hcc who are eligible for potentially curative therapy with liver resection or ablation should defer daa therapy until after hcc treatment is completed best practice advice timing of daa therapy for patient with hcc who are listed for liver transplantation should be determined with consideration of median wait time availability of hepatitis c viruspositive organ and degree of liver dysfunction best practice advice there are insufficient data evaluating benefit and costeffectiveness of daa therapy in patient with active intermediate or advanced hcc decision regarding daa treatment in these patient should be considered in light of hcc tumor burden degree of liver dysfunction life expectancy and patient preference best practice advice there are no conclusive data that daa therapy is associated with increased or decreased risk differential time to recurrence or aggressiveness of recurrent hcc in patient with complete response to hcc therapy best practice advice daa therapy should not be withheld from patient with complete response to hcc therapy however daa therapy can be deferred month to confirm response to hcc therapy best practice advice patient with complete response to hcc therapy who are treated with daas have a continued risk of hcc recurrence and require hcc surveillance which should be conducted indefinitely with dynamic contrastenhanced computed tomography or magnetic resonance imaging every month current data do not support more frequent surveillance in these patient this clinical practice update wa produced by the aga institute,Cancer,0,aga clinical practice update on interaction between oral directacting antiviral for chronic hepatitis c infection and hepatocellular carcinoma expert review description the purpose of this clinical practice update is to evaluate the evidence describing the interaction between directacting antiviral daa therapy for hepatitis and hepatocellular carcinoma hcc with regard to hcc incidence hcc recurrence and daa efficacy and to summarize best practice advice regarding hcc surveillance and timing of daa therapy method the recommendation outlined in this expert review are based on available published evidence including observational study and systematic review and incorporates expert opinion where applicable best practice advice daa treatment is associated with a reduction in the risk of incident hcc the relative risk reduction is similar in patient with and without cirrhosis best practice advice patient with advanced liver fibrosis f or cirrhosis should receive surveillance imaging before initiating daa treatment best practice advice patient with advanced liver fibrosis f or cirrhosis at the time of daa treatment represent the highestrisk group for hcc after daainduced sustained virologic response these patient should stay in hcc surveillance best practice advice hcc surveillance should be performed using ultrasound with or without alphafetoprotein every month current data do not support shorter surveillance interval or the use of alternative surveillance modality best practice advice future study may show a reduction in hcc risk over time after daainduced sustained virologic response however in the interim hcc surveillance should continue indefinitely if patient are otherwise eligible for potentially curative therapy best practice advice the presence of active hcc is associated with a small but statistically significant decrease in sustained virologic response with daa therapy best practice advice patient with hcc who are eligible for potentially curative therapy with liver resection or ablation should defer daa therapy until after hcc treatment is completed best practice advice timing of daa therapy for patient with hcc who are listed for liver transplantation should be determined with consideration of median wait time availability of hepatitis c viruspositive organ and degree of liver dysfunction best practice advice there are insufficient data evaluating benefit and costeffectiveness of daa therapy in patient with active intermediate or advanced hcc decision regarding daa treatment in these patient should be considered in light of hcc tumor burden degree of liver dysfunction life expectancy and patient preference best practice advice there are no conclusive data that daa therapy is associated with increased or decreased risk differential time to recurrence or aggressiveness of recurrent hcc in patient with complete response to hcc therapy best practice advice daa therapy should not be withheld from patient with complete response to hcc therapy however daa therapy can be deferred month to confirm response to hcc therapy best practice advice patient with complete response to hcc therapy who are treated with daas have a continued risk of hcc recurrence and require hcc surveillance which should be conducted indefinitely with dynamic contrastenhanced computed tomography or magnetic resonance imaging every month current data do not support more frequent surveillance in these patient this clinical practice update wa produced by the aga institute
30878600,concurrent driver gene mutation a negative predictive factor in epidermal growth factor receptorpositive nonsmall cell lung cancer,background tyrosine kinase inhibitor tkis are clinically effective in nonsmall cell lung cancer nsclc patient harbouring epidermal growth factor receptor egfr oncogene mutation genetic factor other than egfr sensitive mutation that allow prognosis of tki treatment remain undefined method we retrospectively screened consecutive patient with advanced nsclc and egfr del or lr mutation a total of patient whose progressionfree survival pfs were shorter than month or longer than month were included and stratified into separate group genetic background discrepancy wa analysed in the two group using next generation sequencing ng finding sensitive egfr mutation of del or lr were detected by ng in all patient the lr mutation wa the major type the most frequent accompanying somatic mutation were tp rb mapk alk fusion met amplification and braf ve were found only in the short pfs group concurrent pretreament t m mutation wa found in both group but wa proportionally higher in the short pfs group in the short pfs group patient had significantly more driver gene mutation than in long pfs group p the number of concomitant somatic mutation egfr pathwayrelated mutation and tumor mutation burden tmb were not significantly different between the two group interpretation cooccuring driver gene mutation were negative predictive factor of tki therapy in egfrmutated patient this study highlight the importance of exploring cooccuring genomic alteration before initiation of egfrtkis,Cancer,0,concurrent driver gene mutation a negative predictive factor in epidermal growth factor receptorpositive nonsmall cell lung cancer background tyrosine kinase inhibitor tkis are clinically effective in nonsmall cell lung cancer nsclc patient harbouring epidermal growth factor receptor egfr oncogene mutation genetic factor other than egfr sensitive mutation that allow prognosis of tki treatment remain undefined method we retrospectively screened consecutive patient with advanced nsclc and egfr del or lr mutation a total of patient whose progressionfree survival pfs were shorter than month or longer than month were included and stratified into separate group genetic background discrepancy wa analysed in the two group using next generation sequencing ng finding sensitive egfr mutation of del or lr were detected by ng in all patient the lr mutation wa the major type the most frequent accompanying somatic mutation were tp rb mapk alk fusion met amplification and braf ve were found only in the short pfs group concurrent pretreament t m mutation wa found in both group but wa proportionally higher in the short pfs group in the short pfs group patient had significantly more driver gene mutation than in long pfs group p the number of concomitant somatic mutation egfr pathwayrelated mutation and tumor mutation burden tmb were not significantly different between the two group interpretation cooccuring driver gene mutation were negative predictive factor of tki therapy in egfrmutated patient this study highlight the importance of exploring cooccuring genomic alteration before initiation of egfrtkis
30879681,inhibition of tumor growth by betaglucans through promoting cd t cell immunomodulation and neutrophilkilling in mouse,betaglucans are polysaccharide comprising betadglucoses with various bioactivities herein we extracted three betaglucans from lentinus edodes with different source and assessed their antitumor activity on a mouse model with intragastric intraperitoneal and intratumoral injection three polysaccharide were shown to have the same chemical structure of betaglucan with beta branch and exhibited s tumorsuppressing ability with good safety it wa found that betaglucans upregulated cd t cell level in lymphoid organ decreased by tumorburden indicating promotion of immunomodulation betaglucans targeted tumor in vivo even after oral or intraperitoneal injection furthermore betaglucans not only targeted to lymphoid organ and increased cd t cell number but also enhanced cd t cell and neutrophil population in tumor it wa proposed that betaglucans promoted cd t cell immunomodulation and neutrophil infiltration into tumor leading to tumor growth inhibition these finding reveal that betaglucans can be used a an effective agent for cancer immunotherapy,Cancer,0,inhibition of tumor growth by betaglucans through promoting cd t cell immunomodulation and neutrophilkilling in mouse betaglucans are polysaccharide comprising betadglucoses with various bioactivities herein we extracted three betaglucans from lentinus edodes with different source and assessed their antitumor activity on a mouse model with intragastric intraperitoneal and intratumoral injection three polysaccharide were shown to have the same chemical structure of betaglucan with beta branch and exhibited s tumorsuppressing ability with good safety it wa found that betaglucans upregulated cd t cell level in lymphoid organ decreased by tumorburden indicating promotion of immunomodulation betaglucans targeted tumor in vivo even after oral or intraperitoneal injection furthermore betaglucans not only targeted to lymphoid organ and increased cd t cell number but also enhanced cd t cell and neutrophil population in tumor it wa proposed that betaglucans promoted cd t cell immunomodulation and neutrophil infiltration into tumor leading to tumor growth inhibition these finding reveal that betaglucans can be used a an effective agent for cancer immunotherapy
30880225,a comprehensive study of epigenetic alteration in hepatocellular carcinoma identifies potential therapeutic target,background aim a causal link ha recently been established between epigenetic alteration and hepatocarcinogenesis indicating that epigenetic inhibition may have therapeutic potential we aimed to identify and target epigenetic modifier that show molecular alteration in hepatocellular carcinoma hcc method we studied the molecularclinical correlation of epigenetic modifier including bromodomains histone acetyltransferases lysine methyltransferases and lysine demethylases in hcc using the cancer genome atlas tcga data of patient with hcc the therapeutic potential of epigenetic inhibitor wa evaluated in vitro and in vivo rna sequencing analysis and it correlation with expression and clinical data in the tcga dataset were used to identify expression program normalized by jumonji lysine demethylase jmjc inhibitor result genetic alteration aberrant expression and correlation between tumor expression and poor patient prognosis of epigenetic enzyme are common event in hcc epigenetic inhibitor that target bromodomain jq lysine methyltransferases bix and lly and jmjc lysine demethylases jib gskj and sd reduce hcc aggressiveness the panjmjc inhibitor jib had a potent antitumor effect in tumor bearing mouse hcc cell treated with jmjc inhibitor showed overlapping change in expression program related with inhibition of cell proliferation and induction of cell death jmjc inhibition revers an aggressive hcc gene expression program that is also altered in patient with hcc several gene downregulated by jmjc inhibitor are highly expressed in tumor v nontumor parenchyma and their high expression correlate with a poor prognosis we identified and validated a gene expression prognostic signature consisting of cenpa kifa plk and ncapg conclusion the epigenetic alteration identified in hcc can be used to predict prognosis and to define a subgroup of highrisk patient that would potentially benefit from jmjc inhibitor therapy lay summary in this study we found that mutation and change in expression of epigenetic modifier are common event in human hepatocellular carcinoma leading to an aggressive gene expression program and poor clinical prognosis the transcriptional program can be reversed by pharmacological inhibition of jumonji enzyme this inhibition block hepatocellular carcinoma progression providing a novel potential therapeutic strategy,Cancer,0,a comprehensive study of epigenetic alteration in hepatocellular carcinoma identifies potential therapeutic target background aim a causal link ha recently been established between epigenetic alteration and hepatocarcinogenesis indicating that epigenetic inhibition may have therapeutic potential we aimed to identify and target epigenetic modifier that show molecular alteration in hepatocellular carcinoma hcc method we studied the molecularclinical correlation of epigenetic modifier including bromodomains histone acetyltransferases lysine methyltransferases and lysine demethylases in hcc using the cancer genome atlas tcga data of patient with hcc the therapeutic potential of epigenetic inhibitor wa evaluated in vitro and in vivo rna sequencing analysis and it correlation with expression and clinical data in the tcga dataset were used to identify expression program normalized by jumonji lysine demethylase jmjc inhibitor result genetic alteration aberrant expression and correlation between tumor expression and poor patient prognosis of epigenetic enzyme are common event in hcc epigenetic inhibitor that target bromodomain jq lysine methyltransferases bix and lly and jmjc lysine demethylases jib gskj and sd reduce hcc aggressiveness the panjmjc inhibitor jib had a potent antitumor effect in tumor bearing mouse hcc cell treated with jmjc inhibitor showed overlapping change in expression program related with inhibition of cell proliferation and induction of cell death jmjc inhibition revers an aggressive hcc gene expression program that is also altered in patient with hcc several gene downregulated by jmjc inhibitor are highly expressed in tumor v nontumor parenchyma and their high expression correlate with a poor prognosis we identified and validated a gene expression prognostic signature consisting of cenpa kifa plk and ncapg conclusion the epigenetic alteration identified in hcc can be used to predict prognosis and to define a subgroup of highrisk patient that would potentially benefit from jmjc inhibitor therapy lay summary in this study we found that mutation and change in expression of epigenetic modifier are common event in human hepatocellular carcinoma leading to an aggressive gene expression program and poor clinical prognosis the transcriptional program can be reversed by pharmacological inhibition of jumonji enzyme this inhibition block hepatocellular carcinoma progression providing a novel potential therapeutic strategy
30882153,the singlebasepair deletion msh cdelc affecting intron splicing can be a cause of lynch syndrome,the proband wa a yearold man with ureter cancer he had a history of metachronous colorectal and gastric cancer immunohistochemical staining showed the absence of both msh and msh protein in the ureter cancer and other available cancer tissue specimen genetic testing wa conducted to identify the causative gene of hereditary gastrointestinal cancer syndrome including mismatch repair gene we detected a germline variant cdelc within the splice acceptor site of exon in the msh gene to investigate whether this variant affected splicing of the gene rna sequencing wa performed using blood sample we observed a substantial amount of the transcript that lacked proper splicing of intron in the indexed case whereas a very low amount of such aberrant transcript wa detected in the control strongly indicating an association between the variant and splicing defect these result indicate that msh cdelc affect normal splicing and might be a cause of lynch syndrome,Cancer,0,the singlebasepair deletion msh cdelc affecting intron splicing can be a cause of lynch syndrome the proband wa a yearold man with ureter cancer he had a history of metachronous colorectal and gastric cancer immunohistochemical staining showed the absence of both msh and msh protein in the ureter cancer and other available cancer tissue specimen genetic testing wa conducted to identify the causative gene of hereditary gastrointestinal cancer syndrome including mismatch repair gene we detected a germline variant cdelc within the splice acceptor site of exon in the msh gene to investigate whether this variant affected splicing of the gene rna sequencing wa performed using blood sample we observed a substantial amount of the transcript that lacked proper splicing of intron in the indexed case whereas a very low amount of such aberrant transcript wa detected in the control strongly indicating an association between the variant and splicing defect these result indicate that msh cdelc affect normal splicing and might be a cause of lynch syndrome
30883505,circulating cellfree dnadiagnostic and prognostic application in personalized cancer therapy,genomic analysis in oncologic care allow for the development of more precise clinical laboratory test that will be critical for personalized pharmacotherapy traditional biopsybased approach are limited by the availability of sequential tissue specimen to detect resistance bloodbased genomic profiling liquid biopsy is useful for longitudinal monitoring of tumor genome and can complement biopsy tumorassociated mutation can be identified in cellfree tumor dna ctdna from patient blood sample and used for monitoring disease activity the u food and drug administration approved a liquid biopsy test for egfractivating mutation in patient with nonsmallcell lung cancer a a companion diagnostic for therapy selection ctdna also allows for the identification of mutation selected by treatment such a egfr tm in nonsmallcell lung cancer ctdna can also detect mutation such a kras gv in colorectal cancer and braf vevk in melanoma chromosomal aberration pattern analysis by lowcoverage whole genome sequencing is a new broader approach genomic imbalance detected in cellfree dna cfdna can be used to compute a copy number instability cni score in clinical study it wa demonstrated that the change in cni score can serve a an early predictor of therapeutic response to chemotherapyimmunotherapy of many cancer type in multivariable model it could be shown that the cni score wa superior to clinical parameter for prediction of overall survival in patient with head and neck cancer there is emerging evidence for the clinical validity of ctdna testing regarding identification of candidate for targeted therapy prediction of therapeutic response early detection of recurrence resistance mutation detection measuring genetic heterogeneity tumor burden monitoring and risk stratification improvement of sensitivity to detect tumor at very early stage is difficult due to insufficient mutant dna fraction of further development will include validation in prospective multicenter interventional outcome study and the development of digital platform to integrate diagnostic data,Cancer,0,circulating cellfree dnadiagnostic and prognostic application in personalized cancer therapy genomic analysis in oncologic care allow for the development of more precise clinical laboratory test that will be critical for personalized pharmacotherapy traditional biopsybased approach are limited by the availability of sequential tissue specimen to detect resistance bloodbased genomic profiling liquid biopsy is useful for longitudinal monitoring of tumor genome and can complement biopsy tumorassociated mutation can be identified in cellfree tumor dna ctdna from patient blood sample and used for monitoring disease activity the u food and drug administration approved a liquid biopsy test for egfractivating mutation in patient with nonsmallcell lung cancer a a companion diagnostic for therapy selection ctdna also allows for the identification of mutation selected by treatment such a egfr tm in nonsmallcell lung cancer ctdna can also detect mutation such a kras gv in colorectal cancer and braf vevk in melanoma chromosomal aberration pattern analysis by lowcoverage whole genome sequencing is a new broader approach genomic imbalance detected in cellfree dna cfdna can be used to compute a copy number instability cni score in clinical study it wa demonstrated that the change in cni score can serve a an early predictor of therapeutic response to chemotherapyimmunotherapy of many cancer type in multivariable model it could be shown that the cni score wa superior to clinical parameter for prediction of overall survival in patient with head and neck cancer there is emerging evidence for the clinical validity of ctdna testing regarding identification of candidate for targeted therapy prediction of therapeutic response early detection of recurrence resistance mutation detection measuring genetic heterogeneity tumor burden monitoring and risk stratification improvement of sensitivity to detect tumor at very early stage is difficult due to insufficient mutant dna fraction of further development will include validation in prospective multicenter interventional outcome study and the development of digital platform to integrate diagnostic data
30884806,telomere and telomerase in cutaneous squamous cell carcinoma,the role of telomere biology and telomerase activation in skin cancer ha been investigated in melanoma and basal cell carcinoma but limited evidence is available for cutaneous squamous cell carcinoma cscc we will review the current knowledge on the role of telomere and telomerase pathway in cscc pathogenesis at the somatic level both long and short telomere length have been described in cscc this telomere dichotomy is probably related to two different mechanism of tumour initiation which determines two tumour subtypes telomere shortening is observed during the invasive progression from in situ form of cscc such a bowens disease bd and actinic keratosis ak to invasive cscc at the germline level controversial result have been reported on the association between constitutive telomere length and risk of cscc approximately of cscc tumour are characterized by a high level of telomerase activity telomerase activation ha been also reported in ak and bd and in sundamaged skin thus supporting the hypothesis that uv modulates telomerase activity in the skin activating tert promoter mutation have been identified in of csccs with the majority showing the uvsignature no significant correlation wa observed between tert promoter mutation and cscc clinicopathological feature however tert promoter mutation have been recently suggested to be independent predictor of an adverse outcome the attention on telomere biology and telomerase activity in cscc is increasing for the potential implication in the development of effective tool for prognostic assessment and of therapeutic strategy in patient with cutaneous cscc,Cancer,0,telomere and telomerase in cutaneous squamous cell carcinoma the role of telomere biology and telomerase activation in skin cancer ha been investigated in melanoma and basal cell carcinoma but limited evidence is available for cutaneous squamous cell carcinoma cscc we will review the current knowledge on the role of telomere and telomerase pathway in cscc pathogenesis at the somatic level both long and short telomere length have been described in cscc this telomere dichotomy is probably related to two different mechanism of tumour initiation which determines two tumour subtypes telomere shortening is observed during the invasive progression from in situ form of cscc such a bowens disease bd and actinic keratosis ak to invasive cscc at the germline level controversial result have been reported on the association between constitutive telomere length and risk of cscc approximately of cscc tumour are characterized by a high level of telomerase activity telomerase activation ha been also reported in ak and bd and in sundamaged skin thus supporting the hypothesis that uv modulates telomerase activity in the skin activating tert promoter mutation have been identified in of csccs with the majority showing the uvsignature no significant correlation wa observed between tert promoter mutation and cscc clinicopathological feature however tert promoter mutation have been recently suggested to be independent predictor of an adverse outcome the attention on telomere biology and telomerase activity in cscc is increasing for the potential implication in the development of effective tool for prognostic assessment and of therapeutic strategy in patient with cutaneous cscc
30884810,pfkfb promoter hypomethylation a recurrence predictive marker in welldifferentiated thyroid carcinoma,despite the low mortality rate welldifferentiated thyroid carcinoma wdtc frequently relapse braf and tert mutation have been extensively related to prognosis in thyroid cancer in this study the methylation level of selected cpgs cytosinephosphateguanine comprising a classifier previously reported by our group were assessed in combination with braf and tert mutation we evaluated wdtc three poorlydifferentiatedanaplastic thyroid carcinoma pdtcatc benign thyroid lesion btl and nonneoplastic thyroid nt tissue braf ve and tert promoter ct and ct mutation were tested by pyrosequencing and sanger sequencing respectively three cpgs mapped in pfkfb atpvc and cxxc were evaluated by bisulfite pyrosequencing atpvc hypermethylation and pfkfb hypomethylation were detected in poorprognosis pdtcatc and relapsed wdtc compared with goodprognosis no relapsed wdtc and nonmalignant case ntbtl cxxc wa hypomethylated in both poor and goodprognosis case shorter diseasefree survival wa observed in wdtc patient presenting lower pfkfb methylation level p no association wa observed on comparing braf and tert mutation and prognosis lower pfkfb methylation level wa an independent factor of high relapse risk hazard ratio ci pfkfb promoter methylation analysis ha potential applicability to better stratify wdtc patient according to the recurrence risk independently of braf and tert mutation,Cancer,0,pfkfb promoter hypomethylation a recurrence predictive marker in welldifferentiated thyroid carcinoma despite the low mortality rate welldifferentiated thyroid carcinoma wdtc frequently relapse braf and tert mutation have been extensively related to prognosis in thyroid cancer in this study the methylation level of selected cpgs cytosinephosphateguanine comprising a classifier previously reported by our group were assessed in combination with braf and tert mutation we evaluated wdtc three poorlydifferentiatedanaplastic thyroid carcinoma pdtcatc benign thyroid lesion btl and nonneoplastic thyroid nt tissue braf ve and tert promoter ct and ct mutation were tested by pyrosequencing and sanger sequencing respectively three cpgs mapped in pfkfb atpvc and cxxc were evaluated by bisulfite pyrosequencing atpvc hypermethylation and pfkfb hypomethylation were detected in poorprognosis pdtcatc and relapsed wdtc compared with goodprognosis no relapsed wdtc and nonmalignant case ntbtl cxxc wa hypomethylated in both poor and goodprognosis case shorter diseasefree survival wa observed in wdtc patient presenting lower pfkfb methylation level p no association wa observed on comparing braf and tert mutation and prognosis lower pfkfb methylation level wa an independent factor of high relapse risk hazard ratio ci pfkfb promoter methylation analysis ha potential applicability to better stratify wdtc patient according to the recurrence risk independently of braf and tert mutation
30885150,the small molecule bclmcl inhibitor tw show singleagent cytotoxicity in neuroblastoma cell line,background highrisk neuroblastoma with nmyc amplification remains a therapeutic challenge in paediatric oncology antagonism of prodeath bcl homology bh protein to prosurvival bh member such a mcl and bcl ha become a treatment approach but previous study suggest that a combined inhibition of bcl and mcl is necessary tw inhibits mcl and bcl with almost the same affinity however singleagent cytotoxicity of tw in neuroblastoma cell line ha not been investigated method cell viability apoptosis proliferation and change in growth property were determined in sknas imr syy and kelly cell after treatment with tw after transfection with mcl or bcl sirna apoptosis and proliferation were investigated in kelly cell mouse with kelly cell line xenograft were treated with tw and tumor growth survival and apoptosis were determined result cell line with nmyc amplification were more sensitive to tw treatment ic value for imr and kelly cell being mum and mum compared to syy cell and sknas cell ic mum and mum treatment with tw resulted in increased apoptosis and reduced proliferation rate especially in imr and kelly cell bcl a well a mcl knockdown induced apoptosis in kelly cell tw led to a decrease in tumor growth and a favorable survival p in a kelly neuroblastoma xenograft mouse model conclusion tw ha strong singleagent cytotoxicity in vitro and in vivo therefore combined inhibition of bclmcl by tw in nmyc amplified neuroblastoma may represent an interesting therapeutic strategy,Cancer,0,the small molecule bclmcl inhibitor tw show singleagent cytotoxicity in neuroblastoma cell line background highrisk neuroblastoma with nmyc amplification remains a therapeutic challenge in paediatric oncology antagonism of prodeath bcl homology bh protein to prosurvival bh member such a mcl and bcl ha become a treatment approach but previous study suggest that a combined inhibition of bcl and mcl is necessary tw inhibits mcl and bcl with almost the same affinity however singleagent cytotoxicity of tw in neuroblastoma cell line ha not been investigated method cell viability apoptosis proliferation and change in growth property were determined in sknas imr syy and kelly cell after treatment with tw after transfection with mcl or bcl sirna apoptosis and proliferation were investigated in kelly cell mouse with kelly cell line xenograft were treated with tw and tumor growth survival and apoptosis were determined result cell line with nmyc amplification were more sensitive to tw treatment ic value for imr and kelly cell being mum and mum compared to syy cell and sknas cell ic mum and mum treatment with tw resulted in increased apoptosis and reduced proliferation rate especially in imr and kelly cell bcl a well a mcl knockdown induced apoptosis in kelly cell tw led to a decrease in tumor growth and a favorable survival p in a kelly neuroblastoma xenograft mouse model conclusion tw ha strong singleagent cytotoxicity in vitro and in vivo therefore combined inhibition of bclmcl by tw in nmyc amplified neuroblastoma may represent an interesting therapeutic strategy
30885334,a study of alkpositive pulmonary squamouscell carcinoma from diagnostic methodology to clinical efficacy,background high concordance ha been observed between ventana df alk immunohistochemistry ihc and fluorescence insitu hybridization fish in lung adenocarcinoma ladc however whether a similar conclusion can be applied to lung squamouscell carcinoma lscc ha remained unclear we therefore evaluated the alk anaplastic lymphoma kinase status and the therapeutic effect of an alk tyrosine kinase inhibitor tki in ihc or fishpositive lscc material and method a total of lscc patient from three institution were screened for alk aberration by ihc all ihcpositive case were subjected to fish with an approximately equal number of negative case a a control group and nextgeneration sequencing ng clinical efficacy wa evaluated for the patient who received tki therapy result in case of lscc case were identified a alkpositive by ihc after quality control case were succeeded by fish six with insufficient tissue three with lack of signal and by ng failed due to insufficient sample or poor dna quality the percentage of nondiagnostic test wa and respectively four case analyzed by fish were determined a alkpositive for the control group alk ihc fish demonstrated no sample with alk gene fusion the concordance between alk ihc and alk fishpositive result wa in the case studied by ng two case showed alkeml fusion consistent with two fishpositive result and two case were interpreted a harboring an alkassociation gene mutation among four patient two fishpositive and two ihcpositive only case receiving tki therapy two patient had stable disease and the other two had progressive disease conclusion the positive concordance rate of alk ihc and fish in lscc is far less than that reported for ladc therefore alk ihc detection in lscc can not be used a a diagnostic method for alk rearrangement,Cancer,0,a study of alkpositive pulmonary squamouscell carcinoma from diagnostic methodology to clinical efficacy background high concordance ha been observed between ventana df alk immunohistochemistry ihc and fluorescence insitu hybridization fish in lung adenocarcinoma ladc however whether a similar conclusion can be applied to lung squamouscell carcinoma lscc ha remained unclear we therefore evaluated the alk anaplastic lymphoma kinase status and the therapeutic effect of an alk tyrosine kinase inhibitor tki in ihc or fishpositive lscc material and method a total of lscc patient from three institution were screened for alk aberration by ihc all ihcpositive case were subjected to fish with an approximately equal number of negative case a a control group and nextgeneration sequencing ng clinical efficacy wa evaluated for the patient who received tki therapy result in case of lscc case were identified a alkpositive by ihc after quality control case were succeeded by fish six with insufficient tissue three with lack of signal and by ng failed due to insufficient sample or poor dna quality the percentage of nondiagnostic test wa and respectively four case analyzed by fish were determined a alkpositive for the control group alk ihc fish demonstrated no sample with alk gene fusion the concordance between alk ihc and alk fishpositive result wa in the case studied by ng two case showed alkeml fusion consistent with two fishpositive result and two case were interpreted a harboring an alkassociation gene mutation among four patient two fishpositive and two ihcpositive only case receiving tki therapy two patient had stable disease and the other two had progressive disease conclusion the positive concordance rate of alk ihc and fish in lscc is far less than that reported for ladc therefore alk ihc detection in lscc can not be used a a diagnostic method for alk rearrangement
30886395,immunotherapy in colorectal cancer rationale challenge and potential,following initial success in melanoma treatment immunotherapy ha rapidly become established a a major treatment modality for multiple type of solid cancer including a subset of colorectal cancer crcs two programmed cell death pdblocking antibody pembrolizumab and nivolumab have shown efficacy in patient with metastatic crc that is mismatchrepairdeficient and microsatellite instabilityhigh dmmrmsih and have been granted accelerated fda approval in contrast to most other treatment for metastatic cancer immunotherapy achieves longterm durable remission in a subset of patient highlighting the tremendous promise of immunotherapy in treating dmmrmsih metastatic crc here we review the clinical development of immune checkpoint inhibition in crc leading to regulatory approval for the treatment of dmmrmsih crc we focus on new advance in expanding the efficacy of immunotherapy to earlystage crc and crc that is mismatchrepairproficient and ha low microsatellite instability pmmrmsil and discus emerging approach for targeting the immune microenvironment which might complement immune checkpoint inhibition,Cancer,0,immunotherapy in colorectal cancer rationale challenge and potential following initial success in melanoma treatment immunotherapy ha rapidly become established a a major treatment modality for multiple type of solid cancer including a subset of colorectal cancer crcs two programmed cell death pdblocking antibody pembrolizumab and nivolumab have shown efficacy in patient with metastatic crc that is mismatchrepairdeficient and microsatellite instabilityhigh dmmrmsih and have been granted accelerated fda approval in contrast to most other treatment for metastatic cancer immunotherapy achieves longterm durable remission in a subset of patient highlighting the tremendous promise of immunotherapy in treating dmmrmsih metastatic crc here we review the clinical development of immune checkpoint inhibition in crc leading to regulatory approval for the treatment of dmmrmsih crc we focus on new advance in expanding the efficacy of immunotherapy to earlystage crc and crc that is mismatchrepairproficient and ha low microsatellite instability pmmrmsil and discus emerging approach for targeting the immune microenvironment which might complement immune checkpoint inhibition
30887763,immunotherapy in endometrial cancer new scenario on the horizon,this extensive review summarizes clinical evidence on immunotherapy and targeted therapy currently available for endometrial cancer ec and report the result of the clinical trial and ongoing study the research wa carried out collecting preclinical and clinical finding using keywords such a immune environment tumor infiltrating lymphocyte programmed death pdprogrammed deathligand pdl expression immune checkpoint inhibitor antipdpdl antibody and others on pubmed finally we looked for the ongoing immunotherapy trial on clinicaltrialsgov ec is the fourth most common malignancy in woman in developed country despite medical and surgical treatment survival ha not improved in the last decade and death rate have increased for uterine cancer in woman therefore identification of clinically significant prognostic risk factor and formulation of new rational therapeutic regimen have great significance for enhancing the survival rate and improving the outcome in patient with advanced or metastatic disease the identification of genetic alteration including somatic mutation and microsatellite instability and the definition of intracellular signaling pathway alteration that have a major role in in tumorigenesis is leading to the development of new therapeutic option for immunotherapy and targeted therapy,Cancer,0,immunotherapy in endometrial cancer new scenario on the horizon this extensive review summarizes clinical evidence on immunotherapy and targeted therapy currently available for endometrial cancer ec and report the result of the clinical trial and ongoing study the research wa carried out collecting preclinical and clinical finding using keywords such a immune environment tumor infiltrating lymphocyte programmed death pdprogrammed deathligand pdl expression immune checkpoint inhibitor antipdpdl antibody and others on pubmed finally we looked for the ongoing immunotherapy trial on clinicaltrialsgov ec is the fourth most common malignancy in woman in developed country despite medical and surgical treatment survival ha not improved in the last decade and death rate have increased for uterine cancer in woman therefore identification of clinically significant prognostic risk factor and formulation of new rational therapeutic regimen have great significance for enhancing the survival rate and improving the outcome in patient with advanced or metastatic disease the identification of genetic alteration including somatic mutation and microsatellite instability and the definition of intracellular signaling pathway alteration that have a major role in in tumorigenesis is leading to the development of new therapeutic option for immunotherapy and targeted therapy
30888062,two novel variant in the atm gene causing ataxiatelangiectasia including a duplication of kb utility of targeted nextgeneration sequencing in detection of copy number variation,ataxiatelangiectasia at is a rare autosomal recessive neurodegenerative disorder characterized by progressive cerebellar ataxia ocular apraxia immunodeficiency telangiectasia elevated serum alphafetoprotein concentration radiosensitivity and cancer predisposition classical at is caused by biallelic variant on atm ataxia telangiectasia mutated gene leading to a loss of function of the protein kinase atm involved in dna damage repair atypical presentation can be found in atlike disease or in nijmegen breakage syndrome caused by deficiency of mre or nibrin protein respectively in this report we present the genetic characterization of a yearold female with clinical diagnosis of at nextgeneration sequencing ng revealed two novel heterozygous mutation in the atm gene a singlenucleotide variant snv at exon nmcg c ptrpser and kb genomic duplication spanning exon nggdup these finding were validated by sanger sequencing and mlpa multiplex ligationdependent probe amplification analysis respectively familial segregation study confirmed that the two variant are inherited and the infant is a compound heterozygote thus our study expands the spectrum of atm pathogenic variant and demonstrates the utility of targeted ng in the detection of copy number variation,Cancer,0,two novel variant in the atm gene causing ataxiatelangiectasia including a duplication of kb utility of targeted nextgeneration sequencing in detection of copy number variation ataxiatelangiectasia at is a rare autosomal recessive neurodegenerative disorder characterized by progressive cerebellar ataxia ocular apraxia immunodeficiency telangiectasia elevated serum alphafetoprotein concentration radiosensitivity and cancer predisposition classical at is caused by biallelic variant on atm ataxia telangiectasia mutated gene leading to a loss of function of the protein kinase atm involved in dna damage repair atypical presentation can be found in atlike disease or in nijmegen breakage syndrome caused by deficiency of mre or nibrin protein respectively in this report we present the genetic characterization of a yearold female with clinical diagnosis of at nextgeneration sequencing ng revealed two novel heterozygous mutation in the atm gene a singlenucleotide variant snv at exon nmcg c ptrpser and kb genomic duplication spanning exon nggdup these finding were validated by sanger sequencing and mlpa multiplex ligationdependent probe amplification analysis respectively familial segregation study confirmed that the two variant are inherited and the infant is a compound heterozygote thus our study expands the spectrum of atm pathogenic variant and demonstrates the utility of targeted ng in the detection of copy number variation
30889379,the proteogenomic landscape of curable prostate cancer,dna sequencing ha identified recurrent mutation that drive the aggressiveness of prostate cancer surprisingly the influence of genomic epigenomic and transcriptomic dysregulation on the tumor proteome remains poorly understood we profiled the genome epigenomes transcriptomes and proteome of localized intermediaterisk prostate cancer we discovered that the genomic subtypes of prostate cancer converge on five proteomic subtypes with distinct clinical trajectory ets fusion the most common alteration in prostate tumor affect different gene and pathway in the proteome and transcriptome globally mrna abundance change explain only of protein abundance variability a a result prognostic biomarkers combining genomic or epigenomic feature with proteomic one significantly outperform biomarkers comprised of a single data type,Cancer,0,the proteogenomic landscape of curable prostate cancer dna sequencing ha identified recurrent mutation that drive the aggressiveness of prostate cancer surprisingly the influence of genomic epigenomic and transcriptomic dysregulation on the tumor proteome remains poorly understood we profiled the genome epigenomes transcriptomes and proteome of localized intermediaterisk prostate cancer we discovered that the genomic subtypes of prostate cancer converge on five proteomic subtypes with distinct clinical trajectory ets fusion the most common alteration in prostate tumor affect different gene and pathway in the proteome and transcriptome globally mrna abundance change explain only of protein abundance variability a a result prognostic biomarkers combining genomic or epigenomic feature with proteomic one significantly outperform biomarkers comprised of a single data type
30890403,braf ve mutation and micrornas are helpful in distinguishing papillary thyroid malignant lesion tissue and fine needle aspiration cytology case,aim mutation of braf oncogene are considered to contribute in the invasiveness and poor clinicopathologic feature of papillary thyroid cancer ptc a a step towards understanding the underlying molecular mechanism of this contribution we aimed to examine the association of four micrornas mir b level with brafve and clinicopathological feature in ptc tissue and fine needle aspiration fna specimen method in total ptc and benign with multinodular goiter tissue sample fna sample and bcpap and hek cell line were examined brafve mutation wa examined in ptc tissue and fna sample expression of micrornas wa assessed by realtime quantitative reverse transcriptionpcr key finding the frequency of brafve in ptc tissue and fna sample suspicious for ptc wa and respectively mir and b were significantly upregulated in ptc tumor p and in bcpap cell line p in fna the expression of mir b and were significantly elevated in patient suspected for ptc p while there wa no significant difference in mir after adjustment for age and sex mirb wa associated with an increased risk of bearing brafve mutation or ci p and risk of lymphovascular invasion or ci p mir wa associated with the risk of larger tumor size or ci p mir wa related to increase in extracapsular invasion or ci p significance upregulation of mir and b ha been confirmed in ptc tumor fna sample and cell line mir upregulation ha been confirmed in ptc tumor and cell line but not in fna sample mir and b showed an association with the degree of malignancy in ptc tumor,Cancer,0,braf ve mutation and micrornas are helpful in distinguishing papillary thyroid malignant lesion tissue and fine needle aspiration cytology case aim mutation of braf oncogene are considered to contribute in the invasiveness and poor clinicopathologic feature of papillary thyroid cancer ptc a a step towards understanding the underlying molecular mechanism of this contribution we aimed to examine the association of four micrornas mir b level with brafve and clinicopathological feature in ptc tissue and fine needle aspiration fna specimen method in total ptc and benign with multinodular goiter tissue sample fna sample and bcpap and hek cell line were examined brafve mutation wa examined in ptc tissue and fna sample expression of micrornas wa assessed by realtime quantitative reverse transcriptionpcr key finding the frequency of brafve in ptc tissue and fna sample suspicious for ptc wa and respectively mir and b were significantly upregulated in ptc tumor p and in bcpap cell line p in fna the expression of mir b and were significantly elevated in patient suspected for ptc p while there wa no significant difference in mir after adjustment for age and sex mirb wa associated with an increased risk of bearing brafve mutation or ci p and risk of lymphovascular invasion or ci p mir wa associated with the risk of larger tumor size or ci p mir wa related to increase in extracapsular invasion or ci p significance upregulation of mir and b ha been confirmed in ptc tumor fna sample and cell line mir upregulation ha been confirmed in ptc tumor and cell line but not in fna sample mir and b showed an association with the degree of malignancy in ptc tumor
30893213,measurement of ffdg pet tumor heterogeneity improves early assessment of response to bevacizumab compared with the standard size and uptake metric in a colorectal cancer model,purpose treatment of metastatic colorectal cancer frequently includes antiangiogenic agent such a bevacizumab size measurement are inadequate to assess treatment response to these agent and newer response assessment criterion are needed we aimed to evaluate ffdg petderived texture parameter in a preclinical colorectal cancer model a alternative metric of response to treatment with bevacizumab material and method fourteen cd athymic mouse injected in the flank with x lst cell human colorectal carcinoma were either untreated control n or bevacizumab treated n after week mouse underwent ffdg petct callipermeasured tumor growth deltavol and final tumor volume volcal ffdg pet metabolically active volume volmet mean metabolism metmean and maximum metabolism metmax were measured twentyfour texture feature were compared between treated and untreated mouse immunohistochemical mean tumor vascular density wa estimated by anticd staining after tumor resection result treated mouse had significantly lower tumor vascular density p confirming the antiangiogenic therapeutic effect of bevacizumab none of the conventional measure were different between the two group deltavol p volcal p volmet p metmax p or metmean p one texture parameter glszmszv visually indicating that the ffdg pet image of treated mouse comprise uniformly sized cluster of different activity had significantly different mean between the two group of mouse p conclusion ffdg pet derived texture parameter particularly glszmszv may be valid biomarkers of tumor response to treatment with bevacizumab before change in volume,Cancer,0,measurement of ffdg pet tumor heterogeneity improves early assessment of response to bevacizumab compared with the standard size and uptake metric in a colorectal cancer model purpose treatment of metastatic colorectal cancer frequently includes antiangiogenic agent such a bevacizumab size measurement are inadequate to assess treatment response to these agent and newer response assessment criterion are needed we aimed to evaluate ffdg petderived texture parameter in a preclinical colorectal cancer model a alternative metric of response to treatment with bevacizumab material and method fourteen cd athymic mouse injected in the flank with x lst cell human colorectal carcinoma were either untreated control n or bevacizumab treated n after week mouse underwent ffdg petct callipermeasured tumor growth deltavol and final tumor volume volcal ffdg pet metabolically active volume volmet mean metabolism metmean and maximum metabolism metmax were measured twentyfour texture feature were compared between treated and untreated mouse immunohistochemical mean tumor vascular density wa estimated by anticd staining after tumor resection result treated mouse had significantly lower tumor vascular density p confirming the antiangiogenic therapeutic effect of bevacizumab none of the conventional measure were different between the two group deltavol p volcal p volmet p metmax p or metmean p one texture parameter glszmszv visually indicating that the ffdg pet image of treated mouse comprise uniformly sized cluster of different activity had significantly different mean between the two group of mouse p conclusion ffdg pet derived texture parameter particularly glszmszv may be valid biomarkers of tumor response to treatment with bevacizumab before change in volume
30895378,dna methylation profiling distinguishes ewinglike sarcoma with ewsrnfatc fusion from ewing sarcoma,purpose recent study revealed divergent gene expression pattern in ewing sarcoma ew with canonical ewsrets gene fusion and undifferentiated round cell sarcoma urcs with ewsr rearrangement fused to the nonets gene nfatc thus the question arises whether the latter tumor really belong to ew method we collected five case matching the group of urcs with ewsrnfatc fusion and performed dna methylation and copy number profiling result were compared to methylation data of ew with various ewsrets fusion and one ew with fuserg fusion urcs with cic rearrangement and urcs with bcor alteration and a total of ewsrassociated soft tissue sarcoma including angiomatoid fibrous histiocytomas clear cell sarcoma of the soft tissue desmoplastic small round cell tumor extraskeletal myxoid chondrosarcoma and myxoid liposarcoma result unsupervised hierarchical clustering and tdistributed stochastic neighbor embedding analysis of dna methylation data revealed a homogeneous methylation cluster for urcs with ewsrnfatc fusion which clearly segregated from ew and the other subtypes copy number profile of ewsrnfatc case showed recurrent loss on chromosome q and segmental gain on q and q involving the ewsr and nfatc locus respectively conclusion in summary urcs with ewsrnfatc fusion share a distinct dna methylation signature and carry characteristic copy number alteration which emphasizes that these sarcoma should be considered separately from ew,Cancer,0,dna methylation profiling distinguishes ewinglike sarcoma with ewsrnfatc fusion from ewing sarcoma purpose recent study revealed divergent gene expression pattern in ewing sarcoma ew with canonical ewsrets gene fusion and undifferentiated round cell sarcoma urcs with ewsr rearrangement fused to the nonets gene nfatc thus the question arises whether the latter tumor really belong to ew method we collected five case matching the group of urcs with ewsrnfatc fusion and performed dna methylation and copy number profiling result were compared to methylation data of ew with various ewsrets fusion and one ew with fuserg fusion urcs with cic rearrangement and urcs with bcor alteration and a total of ewsrassociated soft tissue sarcoma including angiomatoid fibrous histiocytomas clear cell sarcoma of the soft tissue desmoplastic small round cell tumor extraskeletal myxoid chondrosarcoma and myxoid liposarcoma result unsupervised hierarchical clustering and tdistributed stochastic neighbor embedding analysis of dna methylation data revealed a homogeneous methylation cluster for urcs with ewsrnfatc fusion which clearly segregated from ew and the other subtypes copy number profile of ewsrnfatc case showed recurrent loss on chromosome q and segmental gain on q and q involving the ewsr and nfatc locus respectively conclusion in summary urcs with ewsrnfatc fusion share a distinct dna methylation signature and carry characteristic copy number alteration which emphasizes that these sarcoma should be considered separately from ew
30895567,fulminant essential thrombocythemia associated with acquired von willebrand syndrome and bleeding episode in a yearold girl,background essential thrombocythemia is a chronic myeloproliferative neoplasm it is extremely rare in child below year of age with an estimated annual incidence of only per million usually clinical symptom associated with essential thrombocythemia are mild or absent case here we present the case of a yearold female patient fulminantly presenting with acute symptom comprising visual impairment palmar and plantar stabbing pain blood count revealed massive thrombocytosis of x l bone marrow morphology showed elevated number of mature megakaryocyte von willebrand factor activityantigen ratio wa significantly reduced compatible with an acquired von willebrand syndrome associated with high platelet count molecular analysis for driver mutation of myeloproliferative neoplasm including jakvf calr and mpl were negative acute therapy comprising hyperhydration and oxygen supply complemented by acetylsalicylic acid led to amelioration of symptom medication with hydroxycarbamide maintained a significant reduction of platelet count but had to be reduced or withheld several time due to neutropenia repeated bleeding episode observed in the course were clearly associated with increase in platelet count above x l explained by acquired von willebrand syndrome sixteen month after diagnosis therapy wa switched to pegylated interferon and platelet count could be stabilized without significant side effect,Cancer,0,fulminant essential thrombocythemia associated with acquired von willebrand syndrome and bleeding episode in a yearold girl background essential thrombocythemia is a chronic myeloproliferative neoplasm it is extremely rare in child below year of age with an estimated annual incidence of only per million usually clinical symptom associated with essential thrombocythemia are mild or absent case here we present the case of a yearold female patient fulminantly presenting with acute symptom comprising visual impairment palmar and plantar stabbing pain blood count revealed massive thrombocytosis of x l bone marrow morphology showed elevated number of mature megakaryocyte von willebrand factor activityantigen ratio wa significantly reduced compatible with an acquired von willebrand syndrome associated with high platelet count molecular analysis for driver mutation of myeloproliferative neoplasm including jakvf calr and mpl were negative acute therapy comprising hyperhydration and oxygen supply complemented by acetylsalicylic acid led to amelioration of symptom medication with hydroxycarbamide maintained a significant reduction of platelet count but had to be reduced or withheld several time due to neutropenia repeated bleeding episode observed in the course were clearly associated with increase in platelet count above x l explained by acquired von willebrand syndrome sixteen month after diagnosis therapy wa switched to pegylated interferon and platelet count could be stabilized without significant side effect
30896620,association between kras gd mutation and anastomotic recurrence in colorectal cancer two case report,rationale the prevalence of anastomotic recurrence ar in colorectal cancer crc after resection of the primary tumor pt is to however no association ha been observed between specific somatic genetic alteration and ar such association may shed light on the mechanism of ar patient concern we experienced patient with ar of crc the first patient wa a yearold woman who underwent resection of an ar of rectal cancer time within month after resection of the pt the second patient wa a yearold woman who underwent resection of an ar of ascending colon cancer twice within month after resection of the pt diagnosis both case were diagnosed a repetitive ar intervention loss of heterozygosity analysis microsatellite instability msi study of microsatellite locus and mutational analysis of kras braf apc tp and smad were performed outcome all the lesion except harbored mutation in apc kras and tp without msi after neoadjuvant chemoradiotherapy the apc kras and tp mutation were pathogenic or likely pathogenic in the pt and ar both woman harbored the same kras gd mutation which account for of all kras mutation in sporadic crc s the probability of the incidental occurrence of kras gd mutation in both case is provided that the mutation were independent of ar lesson our finding may shed light on the mechanism of ar in crc namely that the pt harbored the same mutation a the ar and the lesion in both case harbored the kras gd mutation,Cancer,0,association between kras gd mutation and anastomotic recurrence in colorectal cancer two case report rationale the prevalence of anastomotic recurrence ar in colorectal cancer crc after resection of the primary tumor pt is to however no association ha been observed between specific somatic genetic alteration and ar such association may shed light on the mechanism of ar patient concern we experienced patient with ar of crc the first patient wa a yearold woman who underwent resection of an ar of rectal cancer time within month after resection of the pt the second patient wa a yearold woman who underwent resection of an ar of ascending colon cancer twice within month after resection of the pt diagnosis both case were diagnosed a repetitive ar intervention loss of heterozygosity analysis microsatellite instability msi study of microsatellite locus and mutational analysis of kras braf apc tp and smad were performed outcome all the lesion except harbored mutation in apc kras and tp without msi after neoadjuvant chemoradiotherapy the apc kras and tp mutation were pathogenic or likely pathogenic in the pt and ar both woman harbored the same kras gd mutation which account for of all kras mutation in sporadic crc s the probability of the incidental occurrence of kras gd mutation in both case is provided that the mutation were independent of ar lesson our finding may shed light on the mechanism of ar in crc namely that the pt harbored the same mutation a the ar and the lesion in both case harbored the kras gd mutation
30897307,genotypephenotype correlation in familial adenomatous polyposis patient a prospective prevention protocol,background familial adenomatous polyposis fap is a syndrome caused by germline pathogenic variant in the tumor suppressor gene adenomatous polyposis coli apc identification of apc pathogenic variant site and the genotypephenotype correlation are important for characterizing monitoring and treating member of affected family the aim of this study wa to correlate genotypephenotype of brazilian individual carrying apc pathogenic germline variant and that have fap method the polyposis phenotype of individual from family between july and december were prospectively evaluated based on the insight polyposis staging classification seven extracolonic manifestation were assessed and the clinical manifestation correlated with the apc genotype result the age of the study participant ranged from to year median of year twentysix apc pathogenic variant were identified fiftyfive case harbored nonsense pathogenic variant frameshift alteration were noted in case aberrant splicing wa noted in case rearrangement were observed in case an association between nonsense variant and rearrangement wa noted in case the genotypephenotype correlation analysis led the identification of classic fap in case profuse polyposis wa identified in case thirtysix case were diagnosed with cancer of which case were colorectal cancer case wa brain cancer case were papillary thyroid cancer and case were stomach cancer the extracolonic manifestation included individual with desmoids tumor with osteoma and with congenital hypertrophy of the retinal pigment epithelium conclusion the genotypephenotype correlation in brazilian individual with fap revealed specific finding not previously reported for other cohort demonstrating the relevance of knowledge regarding the variable pathogenic variant and clinical presentation in different population for adequate individual clinical management of patient harboring this medical condition,Cancer,0,genotypephenotype correlation in familial adenomatous polyposis patient a prospective prevention protocol background familial adenomatous polyposis fap is a syndrome caused by germline pathogenic variant in the tumor suppressor gene adenomatous polyposis coli apc identification of apc pathogenic variant site and the genotypephenotype correlation are important for characterizing monitoring and treating member of affected family the aim of this study wa to correlate genotypephenotype of brazilian individual carrying apc pathogenic germline variant and that have fap method the polyposis phenotype of individual from family between july and december were prospectively evaluated based on the insight polyposis staging classification seven extracolonic manifestation were assessed and the clinical manifestation correlated with the apc genotype result the age of the study participant ranged from to year median of year twentysix apc pathogenic variant were identified fiftyfive case harbored nonsense pathogenic variant frameshift alteration were noted in case aberrant splicing wa noted in case rearrangement were observed in case an association between nonsense variant and rearrangement wa noted in case the genotypephenotype correlation analysis led the identification of classic fap in case profuse polyposis wa identified in case thirtysix case were diagnosed with cancer of which case were colorectal cancer case wa brain cancer case were papillary thyroid cancer and case were stomach cancer the extracolonic manifestation included individual with desmoids tumor with osteoma and with congenital hypertrophy of the retinal pigment epithelium conclusion the genotypephenotype correlation in brazilian individual with fap revealed specific finding not previously reported for other cohort demonstrating the relevance of knowledge regarding the variable pathogenic variant and clinical presentation in different population for adequate individual clinical management of patient harboring this medical condition
30897768,breast cancer and mirsnps the importance of mir germline genetics,recent study in cancer diagnostics have identified micrornas mirnas a promising cancer biomarkers single nucleotide polymorphism snp in mirna binding site seed region and coding sequence can help predict breast cancer risk aggressiveness response to stimulus and prognosis this review also document significant known mirsnps in mirna biogenesis gene and their effect on gene regulation in breast cancer taking into account the genetic background and ethnicity of the sampled population when applicable mirsnps are evaluated in the context of other patient factor including mutation hormonal status and demographic given the power of mirsnps to predict patient cancer risk prognosis and outcome further study of mirsnps is warranted to improve effort towards personalized medicine,Cancer,0,breast cancer and mirsnps the importance of mir germline genetics recent study in cancer diagnostics have identified micrornas mirnas a promising cancer biomarkers single nucleotide polymorphism snp in mirna binding site seed region and coding sequence can help predict breast cancer risk aggressiveness response to stimulus and prognosis this review also document significant known mirsnps in mirna biogenesis gene and their effect on gene regulation in breast cancer taking into account the genetic background and ethnicity of the sampled population when applicable mirsnps are evaluated in the context of other patient factor including mutation hormonal status and demographic given the power of mirsnps to predict patient cancer risk prognosis and outcome further study of mirsnps is warranted to improve effort towards personalized medicine
30898933,highfructose corn syrup enhances intestinal tumor growth in mouse,excessive consumption of beverage sweetened with highfructose corn syrup hfc is associated with obesity and with an increased risk of colorectal cancer whether hfc contributes directly to tumorigenesis is unclear we investigated the effect of daily oral administration of hfc in adenomatous polyposis coli apc mutant mouse which are predisposed to develop intestinal tumor the hfcstreated mouse showed a substantial increase in tumor size and tumor grade in the absence of obesity and metabolic syndrome hfc increased the concentration of fructose and glucose in the intestinal lumen and serum respectively and the tumor transported both sugar within the tumor fructose wa converted to fructosephosphate leading to activation of glycolysis and increased synthesis of fatty acid that support tumor growth these mouse study support the hypothesis that the combination of dietary glucose and fructose even at a moderate dose can enhance tumorigenesis,Cancer,0,highfructose corn syrup enhances intestinal tumor growth in mouse excessive consumption of beverage sweetened with highfructose corn syrup hfc is associated with obesity and with an increased risk of colorectal cancer whether hfc contributes directly to tumorigenesis is unclear we investigated the effect of daily oral administration of hfc in adenomatous polyposis coli apc mutant mouse which are predisposed to develop intestinal tumor the hfcstreated mouse showed a substantial increase in tumor size and tumor grade in the absence of obesity and metabolic syndrome hfc increased the concentration of fructose and glucose in the intestinal lumen and serum respectively and the tumor transported both sugar within the tumor fructose wa converted to fructosephosphate leading to activation of glycolysis and increased synthesis of fatty acid that support tumor growth these mouse study support the hypothesis that the combination of dietary glucose and fructose even at a moderate dose can enhance tumorigenesis
30900388,measurable residual disease monitoring using wilms tumor gene expression in childhood acute myeloid leukemia based on childspecific reference value,background measurableminimal residual disease mrd monitoring can predict imminent hematological relapse in acute myeloid leukemia aml the majority of childhood aml patient do not harbor fusion gene or mutation applicable a mrd marker and overexpression of wilms tumor gene wt may constitute a useful monitoring target however agespecific reference value in healthy hematopoiesis and standardization of wt assessment are prerequisite for clinical utility procedure we investigated wt expression across age in hematologically healthy control n during suspected infection n and bone marrow bm regeneration n wt expression in aml at diagnosis n and during followup n wa compared with agespecific reference value result wt expression correlated with age and showed higher level in both bm and peripheral blood pb in child compared with adult p and p wt expression from healthy hematopoiesis wa lower in pb compared with bm wtbm wtpb ci and not influenced by infection nor bm regeneration at aml diagnosis had more than fold wt overexpression in pb or bm pb bm wt wa quantified in pb sample during followup all patient with pb sampling within month of disease recurrence displayed wt overexpression by a median of month range before hematological relapse conclusion this study defines childspecific reference value for wt expression in healthy hematopoiesis and demonstrates that wt expression in pb is a useful posttreatment monitoring tool in childhood aml based on these observation we propose definition for childhood aml molecular relapse using wt overexpression,Cancer,0,measurable residual disease monitoring using wilms tumor gene expression in childhood acute myeloid leukemia based on childspecific reference value background measurableminimal residual disease mrd monitoring can predict imminent hematological relapse in acute myeloid leukemia aml the majority of childhood aml patient do not harbor fusion gene or mutation applicable a mrd marker and overexpression of wilms tumor gene wt may constitute a useful monitoring target however agespecific reference value in healthy hematopoiesis and standardization of wt assessment are prerequisite for clinical utility procedure we investigated wt expression across age in hematologically healthy control n during suspected infection n and bone marrow bm regeneration n wt expression in aml at diagnosis n and during followup n wa compared with agespecific reference value result wt expression correlated with age and showed higher level in both bm and peripheral blood pb in child compared with adult p and p wt expression from healthy hematopoiesis wa lower in pb compared with bm wtbm wtpb ci and not influenced by infection nor bm regeneration at aml diagnosis had more than fold wt overexpression in pb or bm pb bm wt wa quantified in pb sample during followup all patient with pb sampling within month of disease recurrence displayed wt overexpression by a median of month range before hematological relapse conclusion this study defines childspecific reference value for wt expression in healthy hematopoiesis and demonstrates that wt expression in pb is a useful posttreatment monitoring tool in childhood aml based on these observation we propose definition for childhood aml molecular relapse using wt overexpression
30900517,successful role of adjuvant radiotherapy in a rare case of tracheal inflammatory myofibroblastic tumor a case report,background inflammatory myofibroblastic tumor imt is a rare benign cancer that can express a more aggressive phenotype related to the genetic mutation of the anaplastic lymphoma kinase receptor alk involvement of trachea is extremely rare and due to the clinical and radiologic nonspecificity the definitive diagnosis is based on the histologic evaluation of tissue specimen total surgical excision is curative and chemotherapy or radiotherapy ha been employed in the treatment of unresectable tumor or a adjuvant therapy case presentation the case described here is being reported because of the rare tracheal location and the atypical treatment approach used for an alkpositive imt a week pregnant woman voluntary interrupted pregnancy and underwent total surgical excision that resulted to have close margin although alkpositive expression indicated the use of alk inhibitor she refused any type of adjuvant therapy that could affect ovarian function thus d conformational external beam radiotherapy wa performed with a daily dose of cgy time per week up to gy at the level of trachea a total of month of followup showed and no sign of disease recurrence or late radiation therapyrelated toxicity conclusion this report describes an extremely rare case of a tracheal imt underlying the key role of radiotherapy a adjuvant treatment able to definitively cure imt limiting systemic chemotherapyrelated toxicity,Cancer,0,successful role of adjuvant radiotherapy in a rare case of tracheal inflammatory myofibroblastic tumor a case report background inflammatory myofibroblastic tumor imt is a rare benign cancer that can express a more aggressive phenotype related to the genetic mutation of the anaplastic lymphoma kinase receptor alk involvement of trachea is extremely rare and due to the clinical and radiologic nonspecificity the definitive diagnosis is based on the histologic evaluation of tissue specimen total surgical excision is curative and chemotherapy or radiotherapy ha been employed in the treatment of unresectable tumor or a adjuvant therapy case presentation the case described here is being reported because of the rare tracheal location and the atypical treatment approach used for an alkpositive imt a week pregnant woman voluntary interrupted pregnancy and underwent total surgical excision that resulted to have close margin although alkpositive expression indicated the use of alk inhibitor she refused any type of adjuvant therapy that could affect ovarian function thus d conformational external beam radiotherapy wa performed with a daily dose of cgy time per week up to gy at the level of trachea a total of month of followup showed and no sign of disease recurrence or late radiation therapyrelated toxicity conclusion this report describes an extremely rare case of a tracheal imt underlying the key role of radiotherapy a adjuvant treatment able to definitively cure imt limiting systemic chemotherapyrelated toxicity
30902384,an integral view of cancer i the study classification and reprogramming of the tumoral microclimate,the group of disease that we call cancer share a biological structure formed by a complex ecosystem with altered intercellular communication information field development and tissue function beyond the genetic alteration of the tumor cell the demonstration of an altered ecosystem with interconnection at systemic level open up a new perspective on cancer biology and behavior different tumor facet such a morphology classification clinical aggressiveness prognosis and response to treatment now appear under a comprehensive vision that offer a new horizon of study research and clinical management the somatic mutation theory in cancer in force for more than one hundred year is now completed by the study of the tumor microenvironment the extracellular matrix the stromal cell the immune response the innervation the nutrition the mitochondrion the metabolism the interstitial fluid the mechanical and electromagnetic property of the tissue and many other area of emerging knowledge thus opening the door to a reprogramming exercise of the tumor phenotype through the modification of the key offered by this new paradigm it recognition make it possible to go from considering the oncological process a a cellular problem to a supracellular alteration based on the disorganization of tissue immersed in the relationship of the complex system of the living being,Cancer,0,an integral view of cancer i the study classification and reprogramming of the tumoral microclimate the group of disease that we call cancer share a biological structure formed by a complex ecosystem with altered intercellular communication information field development and tissue function beyond the genetic alteration of the tumor cell the demonstration of an altered ecosystem with interconnection at systemic level open up a new perspective on cancer biology and behavior different tumor facet such a morphology classification clinical aggressiveness prognosis and response to treatment now appear under a comprehensive vision that offer a new horizon of study research and clinical management the somatic mutation theory in cancer in force for more than one hundred year is now completed by the study of the tumor microenvironment the extracellular matrix the stromal cell the immune response the innervation the nutrition the mitochondrion the metabolism the interstitial fluid the mechanical and electromagnetic property of the tissue and many other area of emerging knowledge thus opening the door to a reprogramming exercise of the tumor phenotype through the modification of the key offered by this new paradigm it recognition make it possible to go from considering the oncological process a a cellular problem to a supracellular alteration based on the disorganization of tissue immersed in the relationship of the complex system of the living being
30904095,the role of inherited genetic variant in colorectal polyposis syndrome,colorectal carcinoma crc is the third most common cancer in men and the second most common cancer in woman across the world most crcs occur sporadically but in of case hereditary factor are important some patient with an inherited predisposition to crc will be diagnosed with a genetic polyposis syndrome such a familial adenomatous polyposis fap mutyhassociated polyposis map polymerase proofreading associated polyposis ppap nthlassociated polyposis mshassociated polyposis or a hamartomatous polyposis syndrome individual with colorectal polyp have traditionally been referred for genetic diagnostic testing to identify apc and mutyh mutation which cause fap and map respectively mutation are found in most patient with adenoma but in only a minority of those with adenoma the reason that diagnostic laboratory are not identifying pathogenic variant include mutation occurring outside of the open reading frame of gene individual exhibiting generalized mosaicism and the involvement of additional gene it is important to identify patient with an inherited polyposis syndrome and to define the mutation causing their polyposis so that the individual and their relative can be managed appropriately,Cancer,0,the role of inherited genetic variant in colorectal polyposis syndrome colorectal carcinoma crc is the third most common cancer in men and the second most common cancer in woman across the world most crcs occur sporadically but in of case hereditary factor are important some patient with an inherited predisposition to crc will be diagnosed with a genetic polyposis syndrome such a familial adenomatous polyposis fap mutyhassociated polyposis map polymerase proofreading associated polyposis ppap nthlassociated polyposis mshassociated polyposis or a hamartomatous polyposis syndrome individual with colorectal polyp have traditionally been referred for genetic diagnostic testing to identify apc and mutyh mutation which cause fap and map respectively mutation are found in most patient with adenoma but in only a minority of those with adenoma the reason that diagnostic laboratory are not identifying pathogenic variant include mutation occurring outside of the open reading frame of gene individual exhibiting generalized mosaicism and the involvement of additional gene it is important to identify patient with an inherited polyposis syndrome and to define the mutation causing their polyposis so that the individual and their relative can be managed appropriately
30904619,metabolomics of neonatal blood spot reveal distinct phenotype of pediatric acute lymphoblastic leukemia and potential effect of earlylife nutrition,earlylife exposure are believed to influence the incidence of pediatric acute lymphoblastic leukemia all archived neonatal blood spot nb collected within the first day of life offer a mean to investigate small molecule that reflect earlylife exposure using untargeted metabolomics we compared abundance of smallmolecule feature in extract of nb punch from child that later developed all and healthy control subject were stratified by early y and late y diagnosis mutuallyexclusive set of metabolic feature representing putative lipid and fatty acid were associated with all including and metabolite in the early and latediagnosis group respectively in the latediagnosis group a prominent cluster of feature with apparent fattyacid chain suggested that newborn exposure to the essential nutrient linoleic acid increased all risk interestingly abundance of these putative lipid were greater in infant who were fed formula rather than breast milk colostrum and increased with the mother prepregnancy body mass index these result suggest possible etiologic role of newborn nutrition in latediagnosis all,Cancer,0,metabolomics of neonatal blood spot reveal distinct phenotype of pediatric acute lymphoblastic leukemia and potential effect of earlylife nutrition earlylife exposure are believed to influence the incidence of pediatric acute lymphoblastic leukemia all archived neonatal blood spot nb collected within the first day of life offer a mean to investigate small molecule that reflect earlylife exposure using untargeted metabolomics we compared abundance of smallmolecule feature in extract of nb punch from child that later developed all and healthy control subject were stratified by early y and late y diagnosis mutuallyexclusive set of metabolic feature representing putative lipid and fatty acid were associated with all including and metabolite in the early and latediagnosis group respectively in the latediagnosis group a prominent cluster of feature with apparent fattyacid chain suggested that newborn exposure to the essential nutrient linoleic acid increased all risk interestingly abundance of these putative lipid were greater in infant who were fed formula rather than breast milk colostrum and increased with the mother prepregnancy body mass index these result suggest possible etiologic role of newborn nutrition in latediagnosis all
30906574,firstinhuman phase study of inchxadtpa trastuzumab for her tumor imaging,introduction tumor overexpressing the human epithelial receptor her or exhibiting amplification or mutation of it protooncogene have a poorer prognosis using trastuzumab andor other her targeted therapy can increase overall survival in patient with her tumor making it critical to accurately identify patient who may benefit we report on a phase study of the imaging agent inchxadtpa trastuzumab in patient with known her status to evaluate it safety and biodistribution and to obtain preliminary data regarding it ability to provide an accurate wholebody noninvasive mean to determine her status method inchxadtpa trastuzumab wa radiolabeled onsite and slowly infused into patient who underwent single n or multiple n gammacamera n andor spect n imaging session result no safety issue were identified visual and semiquantitative imaging data were concordant with tissue her expression profiling in all but patient the biodistribution showed intense peak liver activity at the initial imaging timepoint h and a singlephase clearance fit of the average timeactivity curve tac estimated th r ci to h this wa followed by high gastrointestinal gi tract activity peaking by h linear regression predicted gi clearance by h r ci to h blood pool had lower activity with it maximum on the initial image nonlinear regression fit projected a th r ci to h assuming linear wholebody clearance linear regression projected complete elimination xintercept at hr r ci to h conclusion inchxadtpa trastuzumab can be safely imaged in human the biodistribution allowed for visual and semiquantitative analysis with result concordant with tissue expression profiling in of patient advance in knowledge and implication for patient care using readily available component and onsite radiolabeling inchxadtpa trastuzumab spect imaging may provide an economical noninvasive mean to detect her overexpression,Cancer,0,firstinhuman phase study of inchxadtpa trastuzumab for her tumor imaging introduction tumor overexpressing the human epithelial receptor her or exhibiting amplification or mutation of it protooncogene have a poorer prognosis using trastuzumab andor other her targeted therapy can increase overall survival in patient with her tumor making it critical to accurately identify patient who may benefit we report on a phase study of the imaging agent inchxadtpa trastuzumab in patient with known her status to evaluate it safety and biodistribution and to obtain preliminary data regarding it ability to provide an accurate wholebody noninvasive mean to determine her status method inchxadtpa trastuzumab wa radiolabeled onsite and slowly infused into patient who underwent single n or multiple n gammacamera n andor spect n imaging session result no safety issue were identified visual and semiquantitative imaging data were concordant with tissue her expression profiling in all but patient the biodistribution showed intense peak liver activity at the initial imaging timepoint h and a singlephase clearance fit of the average timeactivity curve tac estimated th r ci to h this wa followed by high gastrointestinal gi tract activity peaking by h linear regression predicted gi clearance by h r ci to h blood pool had lower activity with it maximum on the initial image nonlinear regression fit projected a th r ci to h assuming linear wholebody clearance linear regression projected complete elimination xintercept at hr r ci to h conclusion inchxadtpa trastuzumab can be safely imaged in human the biodistribution allowed for visual and semiquantitative analysis with result concordant with tissue expression profiling in of patient advance in knowledge and implication for patient care using readily available component and onsite radiolabeling inchxadtpa trastuzumab spect imaging may provide an economical noninvasive mean to detect her overexpression
30907473,expandable immunotherapeutic nanoplatforms engineered from cytomembrane of hybrid cell derived from cancer and dendritic cell,using the cytomembrane fm of hybrid cell acquired from the fusion of cancer and dendritic cell dc this study offer a biologically derived platform for the combination of immunotherapy and traditional oncotherapy approach due to the immunoactivation implicated in the cellular fusion fm can effectively express whole cancer antigen and immunological costimulatory molecule for robust immunotherapy fm share the tumor selftargeting character with the parent cancer cell in bilateral tumorbearing mouse model the fmcoated nanophotosensitizer cause durable immunoresponse to inhibit the rebound of primary tumor postnanophotosensitizerinduced photodynamic therapy pdt the fminduced immunotherapy display ultrahigh antitumor effect even comparable to that of pdt on the other hand pdt toward primary tumor enhances the immunotherapycaused regression of the irradiationfree distant tumor consequently both the primary and the distant tumor are almost completely eliminated this tumorspecific immunotherapybased nanoplatform is potentially expandable to multiple tumor type and readily equipped with diverse function owing to the flexible nanoparticle option,Cancer,0,expandable immunotherapeutic nanoplatforms engineered from cytomembrane of hybrid cell derived from cancer and dendritic cell using the cytomembrane fm of hybrid cell acquired from the fusion of cancer and dendritic cell dc this study offer a biologically derived platform for the combination of immunotherapy and traditional oncotherapy approach due to the immunoactivation implicated in the cellular fusion fm can effectively express whole cancer antigen and immunological costimulatory molecule for robust immunotherapy fm share the tumor selftargeting character with the parent cancer cell in bilateral tumorbearing mouse model the fmcoated nanophotosensitizer cause durable immunoresponse to inhibit the rebound of primary tumor postnanophotosensitizerinduced photodynamic therapy pdt the fminduced immunotherapy display ultrahigh antitumor effect even comparable to that of pdt on the other hand pdt toward primary tumor enhances the immunotherapycaused regression of the irradiationfree distant tumor consequently both the primary and the distant tumor are almost completely eliminated this tumorspecific immunotherapybased nanoplatform is potentially expandable to multiple tumor type and readily equipped with diverse function owing to the flexible nanoparticle option
30908656,highlevel expression of prss correlate with metastasis and poor prognosis in patient with gastric cancer,background and objective serine protease prss is a known contributor to the genesis and development of malignant tumor although it role in gastric cancer gc is still unclear method prss expression in gc tissue sample and it relationship with clinicopathological feature were analyzed effect of gc cellular response to the introduction of small interfering rna sirnamediated and short hairpin rna shrnamediated interference with tumor prss expression were also assessed result prss wa significantly upregulated in gc tissue and prss protein level were higher in tumor that developed metastasis soon after the surgery compared with those that remained metastasisfree high expression of prss wa associated with tumor n staging and independently predictive of postoperative prognosis in patient with gc the v variant of prss wa primarily detected in gc tissue and cell line the others vv being scarcely detectable methylation and demethylation drug had no impact on expression level of any prss transcriptional variant the downregulated prss expression suppressed gc cell growth migration and invasion in vitro and in vivo conclusion prss appears to act a an oncogene of gc high prss expression portends postoperative metastasis serving a an effective biomarker of poor therapeutic outcome,Cancer,0,highlevel expression of prss correlate with metastasis and poor prognosis in patient with gastric cancer background and objective serine protease prss is a known contributor to the genesis and development of malignant tumor although it role in gastric cancer gc is still unclear method prss expression in gc tissue sample and it relationship with clinicopathological feature were analyzed effect of gc cellular response to the introduction of small interfering rna sirnamediated and short hairpin rna shrnamediated interference with tumor prss expression were also assessed result prss wa significantly upregulated in gc tissue and prss protein level were higher in tumor that developed metastasis soon after the surgery compared with those that remained metastasisfree high expression of prss wa associated with tumor n staging and independently predictive of postoperative prognosis in patient with gc the v variant of prss wa primarily detected in gc tissue and cell line the others vv being scarcely detectable methylation and demethylation drug had no impact on expression level of any prss transcriptional variant the downregulated prss expression suppressed gc cell growth migration and invasion in vitro and in vivo conclusion prss appears to act a an oncogene of gc high prss expression portends postoperative metastasis serving a an effective biomarker of poor therapeutic outcome
30908670,somatic alteration detected in diagnostic prostate biopsy provide an inadequate representation of multifocal prostate cancer,background the majority of clinical prostate cancer are multifocal with morphological and molecular heterogeneity adequate tissue representation is crucial for the clinical utility of multigene panel sequencing of core needle biopsy the aim of this study wa to evaluate the genomic heterogeneity in multifocal prostate cancer and to analyze how representative preoperative biopsy are of spatially separated tumor focus method we analyzed at least tumor focus and to preoperative biopsy core from patient diagnostic biopsy a well a fresh frozen and formalinfixed paraffinembedded sample from major tumor focus of radical prostatectomy specimen were macrodissected for the enrichment of tumor tissue dna wa extracted and sequenced we analyzed structural alteration mutation and copy number variation and compared the genomic profile of tumor focus with those of preoperative biopsy result alteration were rarely shared between focus indicating a high degree of genomic heterogeneity in of men at least tumor focus wa represented by the biopsy defined a harboring at least common clonal somatic event in only one case somatic alteration from two spatially separate tumor were identified in the biopsy of the mutation and structural variant detected in fresh frozen or formalinfixed paraffinembedded prostatectomy material only an average of range and range respectively were found in preoperative biopsy where a common somatic origin wa established conclusion multifocal prostate cancer is a somatically heterogeneous disease in which systematic needle biopsy do not provide sufficient molecular representation of the somatic alteration detected in spatially distinct tumor area targeted biopsy directed at separate tumor focus could potentially improve tissue representation of these heterogeneous focus in preoperative biopsy,Cancer,0,somatic alteration detected in diagnostic prostate biopsy provide an inadequate representation of multifocal prostate cancer background the majority of clinical prostate cancer are multifocal with morphological and molecular heterogeneity adequate tissue representation is crucial for the clinical utility of multigene panel sequencing of core needle biopsy the aim of this study wa to evaluate the genomic heterogeneity in multifocal prostate cancer and to analyze how representative preoperative biopsy are of spatially separated tumor focus method we analyzed at least tumor focus and to preoperative biopsy core from patient diagnostic biopsy a well a fresh frozen and formalinfixed paraffinembedded sample from major tumor focus of radical prostatectomy specimen were macrodissected for the enrichment of tumor tissue dna wa extracted and sequenced we analyzed structural alteration mutation and copy number variation and compared the genomic profile of tumor focus with those of preoperative biopsy result alteration were rarely shared between focus indicating a high degree of genomic heterogeneity in of men at least tumor focus wa represented by the biopsy defined a harboring at least common clonal somatic event in only one case somatic alteration from two spatially separate tumor were identified in the biopsy of the mutation and structural variant detected in fresh frozen or formalinfixed paraffinembedded prostatectomy material only an average of range and range respectively were found in preoperative biopsy where a common somatic origin wa established conclusion multifocal prostate cancer is a somatically heterogeneous disease in which systematic needle biopsy do not provide sufficient molecular representation of the somatic alteration detected in spatially distinct tumor area targeted biopsy directed at separate tumor focus could potentially improve tissue representation of these heterogeneous focus in preoperative biopsy
30909992,association between the her gene status and the efficacy of firstline pemetrexed combined with platinum chemotherapy in patient with advanced lung adenocarcinoma,background human epidermal growth factor receptor her is one of the driver gene of nonsmall cell lung cancer nsclc several study have shown that the efficacy of pemetrexed in hermutant nsclc is controversial the aim of this study is to investigate the efficacy of pemetrexed combined with platinum chemotherapy in patient with hermutant and her wildtype lung adenocarcinoma method the clinical data of case of egfr alk ro kras braf ret and metnegative patient with advanced lung adenocarcinoma patient who diagnosed by histopathology in the first affiliated hospital of zhengzhou university were retrospectively reviewed the relationship between her gene status clinical characteristic and response and progressionfree survival pfs were analyzed result all of the patient her status were determined her mutation occurred in case no mutation in case her mutation were common in young nonsmoking and female patient all patient received firstline pemetrexed and platinumbased chemotherapy the objective response rate orr and disease control rate dcr of patient with hermutant lung adenocarcinoma were significantly higher than those without her mutation v chi p v chi p and the difference wa statistically significant according to univariate analysis the pfs wa significantly associated with the brain metastasis maintenance chemotherapy and her gene status p cox multivariate analysis indicated that her mutation wa an independent positive prognostic factor of pfs p conclusion hermutant lung adenocarcinoma patient with firstline pemetrexed combined with platinum chemotherapy have greater clinical benefit than her wildtype patient,Cancer,0,association between the her gene status and the efficacy of firstline pemetrexed combined with platinum chemotherapy in patient with advanced lung adenocarcinoma background human epidermal growth factor receptor her is one of the driver gene of nonsmall cell lung cancer nsclc several study have shown that the efficacy of pemetrexed in hermutant nsclc is controversial the aim of this study is to investigate the efficacy of pemetrexed combined with platinum chemotherapy in patient with hermutant and her wildtype lung adenocarcinoma method the clinical data of case of egfr alk ro kras braf ret and metnegative patient with advanced lung adenocarcinoma patient who diagnosed by histopathology in the first affiliated hospital of zhengzhou university were retrospectively reviewed the relationship between her gene status clinical characteristic and response and progressionfree survival pfs were analyzed result all of the patient her status were determined her mutation occurred in case no mutation in case her mutation were common in young nonsmoking and female patient all patient received firstline pemetrexed and platinumbased chemotherapy the objective response rate orr and disease control rate dcr of patient with hermutant lung adenocarcinoma were significantly higher than those without her mutation v chi p v chi p and the difference wa statistically significant according to univariate analysis the pfs wa significantly associated with the brain metastasis maintenance chemotherapy and her gene status p cox multivariate analysis indicated that her mutation wa an independent positive prognostic factor of pfs p conclusion hermutant lung adenocarcinoma patient with firstline pemetrexed combined with platinum chemotherapy have greater clinical benefit than her wildtype patient
30910249,molecular marker in recurrent stage i grade endometrioid endometrial cancer,objective stage i grade endometrial cancer have low recurrence rate and often do not receive adjuvant therapy we compared recurrent case to matched nonrecurrent control to evaluate for molecular marker associated with higher risk of recurrence method a casecontrol study including all case of recurrent stage i grade endometrioid endometrial cancer at one institution in a tenyear period case were matched to control by age bmi weight and stage molecular testing and immunohistochemistry were performed on archival tumor specimen microsatellite instability msih mismatch repair status pole mutational status and nextgeneration sequencing result stage i grade endometrial cancer case with recurrent disease and available tumor specimen were identified ctnnb and msih were present at significantly higher rate in case than control ctnnb v or ci p and msih v or ci p pole mutation were found in of case v of control p among specimen demonstrating microsatellite stability ms of case v of control had ctnnb mutation p ctnnb wild type tumor were msih in of case v of control p conclusion compared to control ctnnb mutation is present at significantly higher rate in recurrent stage i grade endometrial cancer and is found most commonly in ms tumor msih is also present at significantly higher rate in recurrent case these marker may be useful for prognostic risk stratification and adjuvant therapy decisionmaking in this otherwise lowrisk population,Cancer,0,molecular marker in recurrent stage i grade endometrioid endometrial cancer objective stage i grade endometrial cancer have low recurrence rate and often do not receive adjuvant therapy we compared recurrent case to matched nonrecurrent control to evaluate for molecular marker associated with higher risk of recurrence method a casecontrol study including all case of recurrent stage i grade endometrioid endometrial cancer at one institution in a tenyear period case were matched to control by age bmi weight and stage molecular testing and immunohistochemistry were performed on archival tumor specimen microsatellite instability msih mismatch repair status pole mutational status and nextgeneration sequencing result stage i grade endometrial cancer case with recurrent disease and available tumor specimen were identified ctnnb and msih were present at significantly higher rate in case than control ctnnb v or ci p and msih v or ci p pole mutation were found in of case v of control p among specimen demonstrating microsatellite stability ms of case v of control had ctnnb mutation p ctnnb wild type tumor were msih in of case v of control p conclusion compared to control ctnnb mutation is present at significantly higher rate in recurrent stage i grade endometrial cancer and is found most commonly in ms tumor msih is also present at significantly higher rate in recurrent case these marker may be useful for prognostic risk stratification and adjuvant therapy decisionmaking in this otherwise lowrisk population
30911841,comprehensive analysis of the characteristic and treatment outcome of patient with nonsmall cell lung cancer treated with antipd therapy in realworld practice,purpose immune checkpoint inhibitor ici have shown marked response in patient with nonsmall cell lung cancer nsclc in clinical trial however because such trial comprise cohort selected based on specific criterion it is unclear if their result represent routine clinical practice method we examined patient with advanced nsclc who were administered either nivolumab or pembrolizumab at yonsei cancer center korea between march and january patient characteristic egfralk mutation status metastatic location response to icis and adverse event were retrospectively analyzed result the median age wa year and of patient were male former or current smoker constituted of the subject adenocarcinoma wa predominant and of the patient underwent previous treatment twentythree patient were egfr mutation or alk rearrangementpositive the objective response rate orr wa confidence interval ci the median progressionfree survival pfs and overall survival o were ci and ci month respectively multivariate analysis identified ecog performance status egfr mutationalk rearrangement status liver metastasis and pdl proportion a independent predictor of o furthermore of the patient had adverse event of any grade had immunerelated adverse event that were associated with pfs and o on multivariate analysis conclusion the realworld orr pfs o and adverse event profile were comparable to previous clinical trial despite the patient different baseline characteristic our finding can aid in establishing effective immunotherapeutic management of nsclc in routine clinical practice,Cancer,0,comprehensive analysis of the characteristic and treatment outcome of patient with nonsmall cell lung cancer treated with antipd therapy in realworld practice purpose immune checkpoint inhibitor ici have shown marked response in patient with nonsmall cell lung cancer nsclc in clinical trial however because such trial comprise cohort selected based on specific criterion it is unclear if their result represent routine clinical practice method we examined patient with advanced nsclc who were administered either nivolumab or pembrolizumab at yonsei cancer center korea between march and january patient characteristic egfralk mutation status metastatic location response to icis and adverse event were retrospectively analyzed result the median age wa year and of patient were male former or current smoker constituted of the subject adenocarcinoma wa predominant and of the patient underwent previous treatment twentythree patient were egfr mutation or alk rearrangementpositive the objective response rate orr wa confidence interval ci the median progressionfree survival pfs and overall survival o were ci and ci month respectively multivariate analysis identified ecog performance status egfr mutationalk rearrangement status liver metastasis and pdl proportion a independent predictor of o furthermore of the patient had adverse event of any grade had immunerelated adverse event that were associated with pfs and o on multivariate analysis conclusion the realworld orr pfs o and adverse event profile were comparable to previous clinical trial despite the patient different baseline characteristic our finding can aid in establishing effective immunotherapeutic management of nsclc in routine clinical practice
30914778,a combined gene expression tool for parallel histological prediction and gene fusion detection in nonsmall cell lung cancer,accurate histological classification and identification of fusion gene represent two cornerstone of clinical diagnostics in nonsmall cell lung cancer nsclc here we present a nanostring gene expression platform and a novel platformindependent single sample predictor ssp of nsclc histology for combined simultaneous histological classification and fusion gene detection in minimal formalin fixed paraffin embedded ffpe tissue the ssp wa developed in nsclc tumor of adenocarcinoma ac squamous cell carcinoma sqcc and largecell neuroendocrine carcinoma lcnec histology based on nanostring expression of chga syp cd sftpg napsa ttf tpl krta krt krt krt relevant gene for ihcbased nsclc histology classification the ssp wa combined with a gene fusion detection module analyzing alk ret ro met nrg and ntrk into a multicomponent nanostring assay the histological ssp wa validated in six cohort varying in size n tissue origin early or advanced disease histological composition including undifferentiated cancer and gene expression platform fusion gene detection revealed five emlalk fusion four kifbret fusion two cdnrg fusion and three met exon skipping event among tested case the histological ssp wa successfully trained and tested in the development cohort mean auc in iterated test set the ssp proved successful in predicting histology of nsclc tumor of welldefined subgroup and difficult undifferentiated morphology irrespective of gene expression data platform discrepancy between gene expression prediction and histologic diagnosis included case with mixed histology true large cell carcinoma or poorly differentiated adenocarcinoma with mucin expression in summary we present a proofofconcept multicomponent assay for parallel histological classification and multiplexed fusion gene detection in archival tissue including a novel platformindependent histological ssp classifier the assay and ssp could serve a a promising complement in the routine evaluation of diagnostic lung cancer biopsy,Cancer,0,a combined gene expression tool for parallel histological prediction and gene fusion detection in nonsmall cell lung cancer accurate histological classification and identification of fusion gene represent two cornerstone of clinical diagnostics in nonsmall cell lung cancer nsclc here we present a nanostring gene expression platform and a novel platformindependent single sample predictor ssp of nsclc histology for combined simultaneous histological classification and fusion gene detection in minimal formalin fixed paraffin embedded ffpe tissue the ssp wa developed in nsclc tumor of adenocarcinoma ac squamous cell carcinoma sqcc and largecell neuroendocrine carcinoma lcnec histology based on nanostring expression of chga syp cd sftpg napsa ttf tpl krta krt krt krt relevant gene for ihcbased nsclc histology classification the ssp wa combined with a gene fusion detection module analyzing alk ret ro met nrg and ntrk into a multicomponent nanostring assay the histological ssp wa validated in six cohort varying in size n tissue origin early or advanced disease histological composition including undifferentiated cancer and gene expression platform fusion gene detection revealed five emlalk fusion four kifbret fusion two cdnrg fusion and three met exon skipping event among tested case the histological ssp wa successfully trained and tested in the development cohort mean auc in iterated test set the ssp proved successful in predicting histology of nsclc tumor of welldefined subgroup and difficult undifferentiated morphology irrespective of gene expression data platform discrepancy between gene expression prediction and histologic diagnosis included case with mixed histology true large cell carcinoma or poorly differentiated adenocarcinoma with mucin expression in summary we present a proofofconcept multicomponent assay for parallel histological classification and multiplexed fusion gene detection in archival tissue including a novel platformindependent histological ssp classifier the assay and ssp could serve a a promising complement in the routine evaluation of diagnostic lung cancer biopsy
30917048,clear cell sarcoma of the kidney,clear cell sarcoma of the kidney is an uncommon malignant pediatric renal neoplasm that typically present in the to year age group and ha a propensity for aggressive behavior and late relapse histologically this tumor exhibit a great diversity of morphologic pattern that can mimic most other pediatric renal neoplasm often leading to confusion and misdiagnosis until recently adjunct immunohistochemical and molecular genetic test to support the diagnosis were lacking the presence of internal tandem duplication in bcl coreceptor bcor and a translocation t creating the fusion gene ywhaenutmbe have now been well accepted immunohistochemistry for bcor ha also been shown to be a sensitive and specific marker for clear cell sarcoma of the kidney in the context of pediatric renal tumor improved intensive chemotherapy regimen have influenced the clinical course of the disease with late relapse now being less frequent and the brain having overtaken bone a the most common site of relapse,Cancer,0,clear cell sarcoma of the kidney clear cell sarcoma of the kidney is an uncommon malignant pediatric renal neoplasm that typically present in the to year age group and ha a propensity for aggressive behavior and late relapse histologically this tumor exhibit a great diversity of morphologic pattern that can mimic most other pediatric renal neoplasm often leading to confusion and misdiagnosis until recently adjunct immunohistochemical and molecular genetic test to support the diagnosis were lacking the presence of internal tandem duplication in bcl coreceptor bcor and a translocation t creating the fusion gene ywhaenutmbe have now been well accepted immunohistochemistry for bcor ha also been shown to be a sensitive and specific marker for clear cell sarcoma of the kidney in the context of pediatric renal tumor improved intensive chemotherapy regimen have influenced the clinical course of the disease with late relapse now being less frequent and the brain having overtaken bone a the most common site of relapse
30918505,senecavirus a c protease mediates host cell apoptosis late in infection,senecavirus a sva an oncolytic picornavirus used for cancer treatment in human ha recently emerged a a vesicular disease vdcausing agent in swine worldwide notably svainduced vd is indistinguishable from footandmouth disease fmd and other highconsequence vd of pig here we investigated the role of apoptosis on infection and replication of sva given the critical role of the nuclear factorkappa b nfkappab signaling pathway on modulation of cell death we first assessed activation of nfkappab during sva infection result here show that while early during infection sva induces activation of nfkappab a evidenced by nuclear translocation of nfkappabp and nfkappabmediated transcription late in infection a cleaved product corresponding to the cterminus of nfkappabp is detected in infected cell resulting in lower nfkappab transcriptional activity additionally we assessed the potential role of sva c protease cpro in svainduced hostcell apoptosis and cleavage of nfkappabp transient expression of sva cpro wa associated with cleavage of nfkappabp and poly adpribose polymerase parp suggesting it involvement in virusinduced apoptosis most importantly we showed that while cleavage of nfkappabp is secondary to caspase activation the proteolytic activity of sva cpro is essential for induction of apoptosis experiment using the pancaspase inhibitor zvadfmk confirmed the relevance of late apoptosis for sva infection indicating that sva induces apoptosis presumably a a mechanism to facilitate virus release andor spread from infected cell together these result suggest an important role of apoptosis for sva infection biology,Cancer,0,senecavirus a c protease mediates host cell apoptosis late in infection senecavirus a sva an oncolytic picornavirus used for cancer treatment in human ha recently emerged a a vesicular disease vdcausing agent in swine worldwide notably svainduced vd is indistinguishable from footandmouth disease fmd and other highconsequence vd of pig here we investigated the role of apoptosis on infection and replication of sva given the critical role of the nuclear factorkappa b nfkappab signaling pathway on modulation of cell death we first assessed activation of nfkappab during sva infection result here show that while early during infection sva induces activation of nfkappab a evidenced by nuclear translocation of nfkappabp and nfkappabmediated transcription late in infection a cleaved product corresponding to the cterminus of nfkappabp is detected in infected cell resulting in lower nfkappab transcriptional activity additionally we assessed the potential role of sva c protease cpro in svainduced hostcell apoptosis and cleavage of nfkappabp transient expression of sva cpro wa associated with cleavage of nfkappabp and poly adpribose polymerase parp suggesting it involvement in virusinduced apoptosis most importantly we showed that while cleavage of nfkappabp is secondary to caspase activation the proteolytic activity of sva cpro is essential for induction of apoptosis experiment using the pancaspase inhibitor zvadfmk confirmed the relevance of late apoptosis for sva infection indicating that sva induces apoptosis presumably a a mechanism to facilitate virus release andor spread from infected cell together these result suggest an important role of apoptosis for sva infection biology
30919552,clinical implication of the genetics of sporadic colorectal cancer,colorectal cancer crc is common and at least of case are sporadic without any significant family history prognostication and treatment have been relatively empirical for what ha become increasingly identified a a genetically heterogeneous disease there are three main genetic pathway in sporadic crc the chromosomal instability pathway the microsatellite instability pathway and the cpg island methylator phenotype pathway there is significant overlap between these complex molecular pathway and this limit the clinical application of crc genetics recent australian and new zealand guideline recommend routine testing of mismatch repair mmr status for new case of crc and selective kras and braf testing on the basis of diagnostic prognostic and therapeutic implication it is important that all clinician treating crc have an understanding of the importance of and basis for identifying key genetic feature of crc it is likely that in the future better molecular characterization such a that allowed by the consensus molecular subtype classification will allow improved prognostication and targeted therapy in order to deliver more personalized treatment for crc,Cancer,0,clinical implication of the genetics of sporadic colorectal cancer colorectal cancer crc is common and at least of case are sporadic without any significant family history prognostication and treatment have been relatively empirical for what ha become increasingly identified a a genetically heterogeneous disease there are three main genetic pathway in sporadic crc the chromosomal instability pathway the microsatellite instability pathway and the cpg island methylator phenotype pathway there is significant overlap between these complex molecular pathway and this limit the clinical application of crc genetics recent australian and new zealand guideline recommend routine testing of mismatch repair mmr status for new case of crc and selective kras and braf testing on the basis of diagnostic prognostic and therapeutic implication it is important that all clinician treating crc have an understanding of the importance of and basis for identifying key genetic feature of crc it is likely that in the future better molecular characterization such a that allowed by the consensus molecular subtype classification will allow improved prognostication and targeted therapy in order to deliver more personalized treatment for crc
30921238,prognostic value of ffdg petct metabolic parameter and clinical figure in locally advanced pancreatic cancer underwent chemotherapy combined with stereotactic body radiation therapy,stereotactic body radiation therapy sbrt ha emerged to be a preference treatment for locally advanced pancreatic cancer lapc patient in this study we aimed to investigate the prognostic role of ffdg petct metabolic parameter and clinical figure in lapc patient underwent chemosbrt combined therapyduring january to january lapc patient who underwent ffdg petct within week before treatment were recruited and retrospectively analyzed maximum standardized uptake value suvmax suvmean metabolic tumor volume mtv total lesion glycolysis tlg chemoradiotherapy crt sequence and relevant clinical figure were grouped upon the median value then analyzed by kaplanmeier method and cox proportional hazard model for their prognostic evaluationthe median overall survival o and progressionfree survival pfs of all patient were month and month respectively according to the statistic result the longest diameter of tumor ldt mtv tlg and crt sequence were associated with o all p among which ldt and mtv were proved to be the independent prognostic factor for o hazard ratio hr both p additionally ldt and crt sequence were found associated with pfs both p and crt sequence wa the independent prognostic factor for pfs in chemosbrt treated lapc patient hr p for lapc patient received chemotherapy and sbrt combined therapy mtv and ldt showed independent prognostic value for o meanwhile crt sequence wa an independent pfs prediction factor,Cancer,0,prognostic value of ffdg petct metabolic parameter and clinical figure in locally advanced pancreatic cancer underwent chemotherapy combined with stereotactic body radiation therapy stereotactic body radiation therapy sbrt ha emerged to be a preference treatment for locally advanced pancreatic cancer lapc patient in this study we aimed to investigate the prognostic role of ffdg petct metabolic parameter and clinical figure in lapc patient underwent chemosbrt combined therapyduring january to january lapc patient who underwent ffdg petct within week before treatment were recruited and retrospectively analyzed maximum standardized uptake value suvmax suvmean metabolic tumor volume mtv total lesion glycolysis tlg chemoradiotherapy crt sequence and relevant clinical figure were grouped upon the median value then analyzed by kaplanmeier method and cox proportional hazard model for their prognostic evaluationthe median overall survival o and progressionfree survival pfs of all patient were month and month respectively according to the statistic result the longest diameter of tumor ldt mtv tlg and crt sequence were associated with o all p among which ldt and mtv were proved to be the independent prognostic factor for o hazard ratio hr both p additionally ldt and crt sequence were found associated with pfs both p and crt sequence wa the independent prognostic factor for pfs in chemosbrt treated lapc patient hr p for lapc patient received chemotherapy and sbrt combined therapy mtv and ldt showed independent prognostic value for o meanwhile crt sequence wa an independent pfs prediction factor
30922401,mucinous colorectal adenocarcinoma clinical pathology and treatment option,mucinous colorectal adenocarcinoma is a distinct subtype of colorectal cancer crc characterized by the presence of abundant extracellular mucin which account for at least of the tumor volume mucinous colorectal adenocarcinoma is found in of crc patient and occurs more commonly in female and younger patient moreover mucinous colorectal adenocarcinoma is more frequently located in the proximal colon and diagnosed at an advanced stage based on it molecular context mucinous colorectal adenocarcinoma is associated with the overexpression of mucin muc and mucin ac mucac protein at the same time it show higher mutation rate in the fundamental gene of the rasmapk and pikaktmtor pathway mucinous colorectal adenocarcinoma also show higher rate of microsatellite instability msi than nonmucinous colorectal adenocarcinoma which might correlate it with lynch syndrome and the cpg island methylator phenotype the prognosis of mucinous colorectal adenocarcinoma a to nonmucinous colorectal adenocarcinoma is debatable further the impaired response of mucinous colorectal adenocarcinoma to palliative or adjuvant chemotherapy warrant more study to be performed for a specialized treatment for these patient in this review we discus the molecular background and histopathology of mucinous colorectal adenocarcinoma and provide an update on it prognosis and therapeutic from recent literature,Cancer,0,mucinous colorectal adenocarcinoma clinical pathology and treatment option mucinous colorectal adenocarcinoma is a distinct subtype of colorectal cancer crc characterized by the presence of abundant extracellular mucin which account for at least of the tumor volume mucinous colorectal adenocarcinoma is found in of crc patient and occurs more commonly in female and younger patient moreover mucinous colorectal adenocarcinoma is more frequently located in the proximal colon and diagnosed at an advanced stage based on it molecular context mucinous colorectal adenocarcinoma is associated with the overexpression of mucin muc and mucin ac mucac protein at the same time it show higher mutation rate in the fundamental gene of the rasmapk and pikaktmtor pathway mucinous colorectal adenocarcinoma also show higher rate of microsatellite instability msi than nonmucinous colorectal adenocarcinoma which might correlate it with lynch syndrome and the cpg island methylator phenotype the prognosis of mucinous colorectal adenocarcinoma a to nonmucinous colorectal adenocarcinoma is debatable further the impaired response of mucinous colorectal adenocarcinoma to palliative or adjuvant chemotherapy warrant more study to be performed for a specialized treatment for these patient in this review we discus the molecular background and histopathology of mucinous colorectal adenocarcinoma and provide an update on it prognosis and therapeutic from recent literature
30923916,genetic variant in rpa associated with the response to oxaliplatinbased chemotherapy in colorectal cancer,background oxaliplatin lohp is a commonly used firstline chemotherapy for colorectal cancer genetic variant in nucleotide excision repair ner pathway gene may alter genomic integrity and the efficacy of oxaliplatinbased chemotherapy in colorectal cancer method we investigated the association between genetic variant in ner pathway gene and the disease control rate dcr and progressionfree survival pfs among colorectal cancer patient who received oxaliplatinbased chemotherapy expression quantitative trait locus eqtl analysis wa performed using the genotypetissue expression gtex portal gene harboring significant snp wa overexpressed or knocked down to demonstrate the effect on cell phenotype with or without oxaliplatin treatment result we found that r located in the untranslated region utr of rpa wa associated with dcr or p x and pfs hr p x the c allele wa significantly associated with higher rpa mrna expression level according to eqtl analysis p for sigmoid colon and p for transverse colon the c allele of r disrupted letep binding to enhance rpa expression functionally rpa knockdown inhibited cell proliferation and promoted cell apoptosis whereas rpa overexpression promoted proliferation and suppressed apoptosis furthermore low rpa expression increased sensitivity to oxaliplatin in colon cancer cell and inhibited proliferation after oxaliplatin treatment conclusion our finding demonstrate an association between r and the dcr and pfs of colorectal cancer patient rpa function a a putative oncogene in tumorigenesis by reducing sensitivity to oxaliplatin and could serve a a potential prognostic biomarker in colorectal cancer,Cancer,0,genetic variant in rpa associated with the response to oxaliplatinbased chemotherapy in colorectal cancer background oxaliplatin lohp is a commonly used firstline chemotherapy for colorectal cancer genetic variant in nucleotide excision repair ner pathway gene may alter genomic integrity and the efficacy of oxaliplatinbased chemotherapy in colorectal cancer method we investigated the association between genetic variant in ner pathway gene and the disease control rate dcr and progressionfree survival pfs among colorectal cancer patient who received oxaliplatinbased chemotherapy expression quantitative trait locus eqtl analysis wa performed using the genotypetissue expression gtex portal gene harboring significant snp wa overexpressed or knocked down to demonstrate the effect on cell phenotype with or without oxaliplatin treatment result we found that r located in the untranslated region utr of rpa wa associated with dcr or p x and pfs hr p x the c allele wa significantly associated with higher rpa mrna expression level according to eqtl analysis p for sigmoid colon and p for transverse colon the c allele of r disrupted letep binding to enhance rpa expression functionally rpa knockdown inhibited cell proliferation and promoted cell apoptosis whereas rpa overexpression promoted proliferation and suppressed apoptosis furthermore low rpa expression increased sensitivity to oxaliplatin in colon cancer cell and inhibited proliferation after oxaliplatin treatment conclusion our finding demonstrate an association between r and the dcr and pfs of colorectal cancer patient rpa function a a putative oncogene in tumorigenesis by reducing sensitivity to oxaliplatin and could serve a a potential prognostic biomarker in colorectal cancer
30923996,mucosaassociated lymphoid tissue lymphoma with tqq translocation longterm followup result,translocation qq is found in mucosaassociated lymphoid tissue malt lymphoma resulting in apimalt gene fusion it is known that tpositive malt lymphoma show a tendency to disseminate and be resistant to helicobacter pylorus eradication by antibiotic however the prognostic feature including recurrence and histological transformation ht remain unknown we conducted a singleinstitute retrospective analysis of patient with newly diagnosed malt lymphoma evaluating the impact of t on clinical outcome one hundred and six patient were screened for the translocation by fluorescence in situ hybridization andor reverse transcriptasepolymerase chain reaction of these patient patient were diagnosed a malt lymphoma with t the patient had a significantly shortened progressionfree survival pfs at year v p compared to those without t however this did not translate into overall survival or incidence of ht we confirmed previous report stating that tpositive malt lymphoma showed disseminated disease and refractoriness to h pylorus eradication therapy patient with t had more frequent monoclonal gammopathy especially of igm subtype v p some of which developed class switch these finding characterize the feature of tpositive malt lymphoma suggesting that it comprises a distinct clinical entity of malt lymphoma,Cancer,0,mucosaassociated lymphoid tissue lymphoma with tqq translocation longterm followup result translocation qq is found in mucosaassociated lymphoid tissue malt lymphoma resulting in apimalt gene fusion it is known that tpositive malt lymphoma show a tendency to disseminate and be resistant to helicobacter pylorus eradication by antibiotic however the prognostic feature including recurrence and histological transformation ht remain unknown we conducted a singleinstitute retrospective analysis of patient with newly diagnosed malt lymphoma evaluating the impact of t on clinical outcome one hundred and six patient were screened for the translocation by fluorescence in situ hybridization andor reverse transcriptasepolymerase chain reaction of these patient patient were diagnosed a malt lymphoma with t the patient had a significantly shortened progressionfree survival pfs at year v p compared to those without t however this did not translate into overall survival or incidence of ht we confirmed previous report stating that tpositive malt lymphoma showed disseminated disease and refractoriness to h pylorus eradication therapy patient with t had more frequent monoclonal gammopathy especially of igm subtype v p some of which developed class switch these finding characterize the feature of tpositive malt lymphoma suggesting that it comprises a distinct clinical entity of malt lymphoma
30925542,comparison of the volumetric and radiomics finding of ffdg petct image with immunohistochemical prognostic factor in locallocally advanced breast cancer,objective the aim of this study wa to determine the change in volumetric and radiomics parameter of fluorine fluorodeoxyglucose ffdg petcomputed tomography ct imaging in locallocally advanced cancer patient according to immunohistochemical finding patient and method a total of patient who were diagnosed with locallocally advanced breast cancer and then examined by ffdg petct for staging were included in this study immunohistochemical prognostic factor estrogen receptor er progesterone receptor pr human epidermal growth factor receptor her p mutation ki proliferation index and histological grade were determined standardized uptake value suvbased volumebased and radiomics finding were obtained from ffdg petct image result in case of er and pr negativity her positivity presence of the p mutation and ki index of at least patient total volumetric parameter were significantly higher in paired comparison the result of the ernegative group were significantly higher than those of erpositive patient in glrlmglnu glrlmrlnu glzlmglnu and glzlmzlnu comparison in grade patient mean suv maximum suv and glrlmlrhge value were higher than those of grade patient suv and volumetric parameter were significantly higher in patient with ki index of at least than those with less than maximum suv breast tumor lesion glycolysis value and entropy in nuclear polymorphism in the patient group were found to be higher compared with the patient group moreover patient with mitosis had significantly higher breast metabolic tumor volume breast tumor lesion glycolysis and kurtosis value than the group conclusion er negativity triple negativity high tumor grade and high nuclear polymorphism were associated with tumor heterogeneity with respect to er negativity pr negativity high tumor grade high mitosis number high ki index her positivity and the presence of p mutation an increased tumor load were observed in addition to immunohistochemical parameter the use of radiomics data is believed to contribute to breast cancer management,Cancer,0,comparison of the volumetric and radiomics finding of ffdg petct image with immunohistochemical prognostic factor in locallocally advanced breast cancer objective the aim of this study wa to determine the change in volumetric and radiomics parameter of fluorine fluorodeoxyglucose ffdg petcomputed tomography ct imaging in locallocally advanced cancer patient according to immunohistochemical finding patient and method a total of patient who were diagnosed with locallocally advanced breast cancer and then examined by ffdg petct for staging were included in this study immunohistochemical prognostic factor estrogen receptor er progesterone receptor pr human epidermal growth factor receptor her p mutation ki proliferation index and histological grade were determined standardized uptake value suvbased volumebased and radiomics finding were obtained from ffdg petct image result in case of er and pr negativity her positivity presence of the p mutation and ki index of at least patient total volumetric parameter were significantly higher in paired comparison the result of the ernegative group were significantly higher than those of erpositive patient in glrlmglnu glrlmrlnu glzlmglnu and glzlmzlnu comparison in grade patient mean suv maximum suv and glrlmlrhge value were higher than those of grade patient suv and volumetric parameter were significantly higher in patient with ki index of at least than those with less than maximum suv breast tumor lesion glycolysis value and entropy in nuclear polymorphism in the patient group were found to be higher compared with the patient group moreover patient with mitosis had significantly higher breast metabolic tumor volume breast tumor lesion glycolysis and kurtosis value than the group conclusion er negativity triple negativity high tumor grade and high nuclear polymorphism were associated with tumor heterogeneity with respect to er negativity pr negativity high tumor grade high mitosis number high ki index her positivity and the presence of p mutation an increased tumor load were observed in addition to immunohistochemical parameter the use of radiomics data is believed to contribute to breast cancer management
30926971,genomic subtyping and therapeutic targeting of acute erythroleukemia,acute erythroid leukemia ael is a highrisk leukemia of poorly understood genetic basis with controversy regarding diagnosis in the spectrum of myelodysplasia and myeloid leukemia we compared genomic feature of childhood and adult ael case with nonael myeloid disorder and defined five agerelated subgroup with distinct transcriptional profile adult tp mutated npm mutated kmta mutatedrearranged adult ddx mutated and pediatric nup rearranged genomic feature influenced outcome with npm mutation and hoxb overexpression being associated with a favorable prognosis and tp flt or rb alteration associated with poor survival targetable signaling mutation were present in of case and included recurrent mutation of alk and ntrk the latter of which drive erythroid leukemogenesis sensitive to trk inhibition this genomic landscape of ael provides the framework for accurate diagnosis and risk stratification of this disease and the rationale for testing targeted therapy in this highrisk leukemia,Cancer,0,genomic subtyping and therapeutic targeting of acute erythroleukemia acute erythroid leukemia ael is a highrisk leukemia of poorly understood genetic basis with controversy regarding diagnosis in the spectrum of myelodysplasia and myeloid leukemia we compared genomic feature of childhood and adult ael case with nonael myeloid disorder and defined five agerelated subgroup with distinct transcriptional profile adult tp mutated npm mutated kmta mutatedrearranged adult ddx mutated and pediatric nup rearranged genomic feature influenced outcome with npm mutation and hoxb overexpression being associated with a favorable prognosis and tp flt or rb alteration associated with poor survival targetable signaling mutation were present in of case and included recurrent mutation of alk and ntrk the latter of which drive erythroid leukemogenesis sensitive to trk inhibition this genomic landscape of ael provides the framework for accurate diagnosis and risk stratification of this disease and the rationale for testing targeted therapy in this highrisk leukemia
30927944,radiogenomics of rectal adenocarcinoma in the era of precision medicine a pilot study of association between qualitative and quantitative mri imaging feature and genetic mutation,objective to investigate association between genetic mutation and qualitative a well a quantitative feature on mri in rectal adenocarcinoma at primary staging method in this retrospective study patient with rectal adenocarcinoma genome sequencing and pretreatment rectal mri were included statistical analysis wa performed to evaluate association between qualitative feature obtained from subjective evaluation of rectal mri and gene mutation a well a between quantitative textural feature and gene mutation for the qualitative evaluation fisher exact test wa used to analyze categorical association and wilcoxon rank sum test wa used for continuous clinical variable for the quantitative evaluation we performed manual segmentation of tweighted image for radiomicsbased quantitative image analysis thirtyfour texture feature consisting of first order intensity histogrambased feature n second order haralick texture n and gaboredge based haralick texture were computed at two different orientation consensus clustering wa performed with computed texture feature using the kmeans algorithm with euclidean distance between the texture feature the cluster resulting from the algorithm were then used to enumerate the prevalence of gene mutation in those cluster result in patient gene were mutated in more than patient and were included in the statistical analysis regarding qualitative imaging feature on univariate analysis tumor location wa significantly associated with apc p and rasa mutation p crm status wa significantly associated with atm mutation p and lymph node metastasis wa significantly associated with brca p mutation however these association were not significant after adjusting for multiple comparison regarding quantitative imaging feature cluster c had tumor with higher mean gabor edge intensity compared with cluster c theta p theta p theta p cluster c theta p theta p theta p and cluster c theta p theta p theta p suggesting that the cluster c had tumor with more distinct edge or heterogeneous appearance compared with other cluster conclusion although this preliminary study showed promising association between quantitative feature and genetic mutation it did not show any correlation between qualitative feature and genetic mutation further study with larger sample size are warranted to validate our preliminary data,Cancer,0,radiogenomics of rectal adenocarcinoma in the era of precision medicine a pilot study of association between qualitative and quantitative mri imaging feature and genetic mutation objective to investigate association between genetic mutation and qualitative a well a quantitative feature on mri in rectal adenocarcinoma at primary staging method in this retrospective study patient with rectal adenocarcinoma genome sequencing and pretreatment rectal mri were included statistical analysis wa performed to evaluate association between qualitative feature obtained from subjective evaluation of rectal mri and gene mutation a well a between quantitative textural feature and gene mutation for the qualitative evaluation fisher exact test wa used to analyze categorical association and wilcoxon rank sum test wa used for continuous clinical variable for the quantitative evaluation we performed manual segmentation of tweighted image for radiomicsbased quantitative image analysis thirtyfour texture feature consisting of first order intensity histogrambased feature n second order haralick texture n and gaboredge based haralick texture were computed at two different orientation consensus clustering wa performed with computed texture feature using the kmeans algorithm with euclidean distance between the texture feature the cluster resulting from the algorithm were then used to enumerate the prevalence of gene mutation in those cluster result in patient gene were mutated in more than patient and were included in the statistical analysis regarding qualitative imaging feature on univariate analysis tumor location wa significantly associated with apc p and rasa mutation p crm status wa significantly associated with atm mutation p and lymph node metastasis wa significantly associated with brca p mutation however these association were not significant after adjusting for multiple comparison regarding quantitative imaging feature cluster c had tumor with higher mean gabor edge intensity compared with cluster c theta p theta p theta p cluster c theta p theta p theta p and cluster c theta p theta p theta p suggesting that the cluster c had tumor with more distinct edge or heterogeneous appearance compared with other cluster conclusion although this preliminary study showed promising association between quantitative feature and genetic mutation it did not show any correlation between qualitative feature and genetic mutation further study with larger sample size are warranted to validate our preliminary data
30928887,ring sideroblast in chronic phase of polycythemia vera identifies a subset of patient with an increased risk of progression to blast phase,blast phase of pv is often associated with a complex karyotype ck and bilineage dysplasia we hypothesized that bm morphologic abnormality detected in the chronic phase cp can identify patient with an increased risk of developing blast phase bp we also compared case of bp pv to a group of acute myeloid leukemia case with jak mutation amljakmut we collected morphological cytogenetics cg and molecular information at the time of diagnosis and at time of diagnosis of bp we evaluate the presence of splicing factor mutation at bp a total of patient with diagnosis of bp of pv were identified of them had bm sample available during cp ten patient with pv cp were used a control group we found that dyserythropoiesis during evolution were more frequent in patient who develop bp than in patient who remain in cp v p similarly ring sideroblast r increase during cp were more frequent in patient who develop bp v p by eln risk stratification for cg risk in bp all patient had adverse or intermediate risk in amljakmut patient had favorable a risk category tp mutation were significantly more frequent in bp than in amljakmut v p mutation analysis for splicing factor at bp wa performed on patient only patient with r had srsf patient and sfb patient mutation the other patient were wild type dyserythropoiesis and the acquisition of r precede other marker of disease progression to bp ck and tp mutation are more frequent in bp than in amljakmut sfb mutation are rare in bp,Cancer,0,ring sideroblast in chronic phase of polycythemia vera identifies a subset of patient with an increased risk of progression to blast phase blast phase of pv is often associated with a complex karyotype ck and bilineage dysplasia we hypothesized that bm morphologic abnormality detected in the chronic phase cp can identify patient with an increased risk of developing blast phase bp we also compared case of bp pv to a group of acute myeloid leukemia case with jak mutation amljakmut we collected morphological cytogenetics cg and molecular information at the time of diagnosis and at time of diagnosis of bp we evaluate the presence of splicing factor mutation at bp a total of patient with diagnosis of bp of pv were identified of them had bm sample available during cp ten patient with pv cp were used a control group we found that dyserythropoiesis during evolution were more frequent in patient who develop bp than in patient who remain in cp v p similarly ring sideroblast r increase during cp were more frequent in patient who develop bp v p by eln risk stratification for cg risk in bp all patient had adverse or intermediate risk in amljakmut patient had favorable a risk category tp mutation were significantly more frequent in bp than in amljakmut v p mutation analysis for splicing factor at bp wa performed on patient only patient with r had srsf patient and sfb patient mutation the other patient were wild type dyserythropoiesis and the acquisition of r precede other marker of disease progression to bp ck and tp mutation are more frequent in bp than in amljakmut sfb mutation are rare in bp
30929114,review of ependymomas assessment of consensus in pathological diagnosis and correlation with genetic profile and outcome,we focused on histological and immunohistochemical characteristic of ependymoma epn with molecular profile to develop more reproducible criterion of the diagnosis three expert neuropathologists reviewed the pathology of sample from the japan pediatric molecular neurooncology group study confirmed case were assessed for histology surrogate marker molecular subgrouping and survival data we reached a consensus regarding the diagnosis of epns in of spinal cord tumor and of posterior fossa pf tumor that had been diagnosed a epns by local pathologist whereas we reached a consensus regarding only of the local diagnosis of supratentorial st epns among the pfepns most of anaplastic ependymomas aepns were defined a epna by methylation profiling which wa significantly correlated with the subgroup assignment regarding prognosis the overall survival of patient with pfepn wa significantly better than that of patient with pf aepn p histologically all ependymoma rela fusionpositive epnrela qualified a grade iii both l cell adhesion molecule and nuclear factor kappab p antibody showed good sensitivity for detecting epnrela this study indicated that the expert consensus pathological diagnosis could correlate well with the molecular classification in epns st epns should be diagnosed more carefully by histological and molecular analysis,Cancer,0,review of ependymomas assessment of consensus in pathological diagnosis and correlation with genetic profile and outcome we focused on histological and immunohistochemical characteristic of ependymoma epn with molecular profile to develop more reproducible criterion of the diagnosis three expert neuropathologists reviewed the pathology of sample from the japan pediatric molecular neurooncology group study confirmed case were assessed for histology surrogate marker molecular subgrouping and survival data we reached a consensus regarding the diagnosis of epns in of spinal cord tumor and of posterior fossa pf tumor that had been diagnosed a epns by local pathologist whereas we reached a consensus regarding only of the local diagnosis of supratentorial st epns among the pfepns most of anaplastic ependymomas aepns were defined a epna by methylation profiling which wa significantly correlated with the subgroup assignment regarding prognosis the overall survival of patient with pfepn wa significantly better than that of patient with pf aepn p histologically all ependymoma rela fusionpositive epnrela qualified a grade iii both l cell adhesion molecule and nuclear factor kappab p antibody showed good sensitivity for detecting epnrela this study indicated that the expert consensus pathological diagnosis could correlate well with the molecular classification in epns st epns should be diagnosed more carefully by histological and molecular analysis
30931661,clear cell variant of papillary thyroid carcinoma with associated anaplastic thyroid carcinoma description of an extraordinary case,clear cell change is a rare observation in thyroid cancer resulting from aberrant cytoplasmic accumulation of lipid glycogen or thyroglobulin in the tumor cell the phenomenon is most common for follicular thyroid neoplasia with no definite coupling to patient outcome the clear cell variant of papillary thyroid carcinoma ccptc is even more infrequentmaking conclusion regarding prognosis difficult single report describe distant metastasis of ccptcs a well a cooccurrence with anaplastic thyroid carcinoma atc in this report a case of a therapyresistant ccptc dedifferentiating into an atc is characterized from morphological and immunohistochemical standpoint the patient wa a yearold female presenting with a mm nodule in her right thyroid lobe a first round of cytology raised the suspicion of ptc but a repeated biopsy verified an atc diagnosis neoadjuvant doxorubicin and external irradiation therapy wa administered and the patient developed lung metastasis concomitantly a palliative lobectomy wa performed and the final diagnosis wa a ccptc with focal dedifferentiation into an atc intriguingly the ccptc component wa viable and dominated the lesion the clear cell morphology stemmed from an accumulation of glycogen while the anaplastic component wa devoid of evident clear cell change the case is one of exceedingly few description of a ccptc that dedifferentiates to an atc suggesting that this ptc subtype is not without potential for development of a highly lethal tumor component moreover the partial lack of response to neoadjuvant therapy suggests a possible underlying resistance to aggressive treatment modality in this particular case,Cancer,0,clear cell variant of papillary thyroid carcinoma with associated anaplastic thyroid carcinoma description of an extraordinary case clear cell change is a rare observation in thyroid cancer resulting from aberrant cytoplasmic accumulation of lipid glycogen or thyroglobulin in the tumor cell the phenomenon is most common for follicular thyroid neoplasia with no definite coupling to patient outcome the clear cell variant of papillary thyroid carcinoma ccptc is even more infrequentmaking conclusion regarding prognosis difficult single report describe distant metastasis of ccptcs a well a cooccurrence with anaplastic thyroid carcinoma atc in this report a case of a therapyresistant ccptc dedifferentiating into an atc is characterized from morphological and immunohistochemical standpoint the patient wa a yearold female presenting with a mm nodule in her right thyroid lobe a first round of cytology raised the suspicion of ptc but a repeated biopsy verified an atc diagnosis neoadjuvant doxorubicin and external irradiation therapy wa administered and the patient developed lung metastasis concomitantly a palliative lobectomy wa performed and the final diagnosis wa a ccptc with focal dedifferentiation into an atc intriguingly the ccptc component wa viable and dominated the lesion the clear cell morphology stemmed from an accumulation of glycogen while the anaplastic component wa devoid of evident clear cell change the case is one of exceedingly few description of a ccptc that dedifferentiates to an atc suggesting that this ptc subtype is not without potential for development of a highly lethal tumor component moreover the partial lack of response to neoadjuvant therapy suggests a possible underlying resistance to aggressive treatment modality in this particular case
30932419,analysis of lpl gene expression in patient with chronic lymphocytic leukemia,aim the ighv mutational status is one of the most important marker for chronic lymphocytic leukemia cll prognostication lipoprotein lipase lpl gene expression wa found to correlate with ighv status and wa suggested a it surrogate marker recent data reported that lpl expression might be influenced by pivotal signalling pathway in cll this study aimed to assess lpl gene expression in relation to key immunogenetic and molecular marker of cll including ighv mutational status bcell receptor bcr stereotypy tp notch and sfb gene mutation material and method expression of lpl mrna wa measured in peripheral blood mononuclear cell of cll patient by realtime quantitative reverse transcription polymerase chain reaction rtqpcr ighv notch tp and sfb gene mutation analysis wa performed by pcr amplification and direct sequencing result of cll case were categorized a lplpositive based on the cutoff value established by roc receiver operating characteristic curve analysis lpl expression wa significantly associated with ighv mutation status r p and tended to correlate with presence of notch gene mutation p bcr stereotyped case showed higher lpl expression value in comparison to unstereotyped case in the lplpositive group of patient p lpl expression wa associated with a shorter overall survival in the entire sll group median v p a well a in binet a patient albeit with borderline significance median v not reached p conclusion lpl expression wa found to be closely correlated with ighv gene mutational status and overall survival proving lpl a prognostic marker in cll our result also indicate a possible relationship between aberrant expression of lpl and bcr and notchdependent signalling pathway,Cancer,0,analysis of lpl gene expression in patient with chronic lymphocytic leukemia aim the ighv mutational status is one of the most important marker for chronic lymphocytic leukemia cll prognostication lipoprotein lipase lpl gene expression wa found to correlate with ighv status and wa suggested a it surrogate marker recent data reported that lpl expression might be influenced by pivotal signalling pathway in cll this study aimed to assess lpl gene expression in relation to key immunogenetic and molecular marker of cll including ighv mutational status bcell receptor bcr stereotypy tp notch and sfb gene mutation material and method expression of lpl mrna wa measured in peripheral blood mononuclear cell of cll patient by realtime quantitative reverse transcription polymerase chain reaction rtqpcr ighv notch tp and sfb gene mutation analysis wa performed by pcr amplification and direct sequencing result of cll case were categorized a lplpositive based on the cutoff value established by roc receiver operating characteristic curve analysis lpl expression wa significantly associated with ighv mutation status r p and tended to correlate with presence of notch gene mutation p bcr stereotyped case showed higher lpl expression value in comparison to unstereotyped case in the lplpositive group of patient p lpl expression wa associated with a shorter overall survival in the entire sll group median v p a well a in binet a patient albeit with borderline significance median v not reached p conclusion lpl expression wa found to be closely correlated with ighv gene mutational status and overall survival proving lpl a prognostic marker in cll our result also indicate a possible relationship between aberrant expression of lpl and bcr and notchdependent signalling pathway
30933052,detection of a circulating microrna custom panel in patient with metastatic colorectal cancer,there is increasing interest in liquid biopsy for cancer diagnosis prognosis and therapeutic monitoring creating the need for reliable and useful biomarkers for clinical practice here we present a protocol to extract reverse transcribe and evaluate the expression level of circulating mirnas from plasma sample of patient with colorectal cancer crc micrornas mirnas are a class of noncoding rna of nucleotide in length that regulate the expression of target gene at the translational level and play an important role including that of pro and antiangiogenic function in the physiopathology of various organ mirnas are stable in biological fluid such a serum and plasma which render them ideal circulating biomarkers for cancer diagnosis prognosis and treatment decisionmaking and monitoring circulating mirna extraction wa performed using a rapid and effective method that involves both organic and columnbased methodology for mirna retrotranscription we used a multistep procedure that considers polyadenylation at and the ligation of an adapter at of the mature mirnas followed by random mirna preamplification we selected a mirna custom panel to be tested by quantitative realtime polymerase chain reaction qrtpcr and spotted the mirna probe on array custom plate we performed qrtpcr plate run on a realtime pcr system housekeeping mirnas for normalization were selected using genorm software v data were analyzed using expression suite software v and statistical analysis were performed the method proved to be reliable and technically robust and could be useful to evaluate biomarker level in liquid sample such a plasma andor serum,Cancer,0,detection of a circulating microrna custom panel in patient with metastatic colorectal cancer there is increasing interest in liquid biopsy for cancer diagnosis prognosis and therapeutic monitoring creating the need for reliable and useful biomarkers for clinical practice here we present a protocol to extract reverse transcribe and evaluate the expression level of circulating mirnas from plasma sample of patient with colorectal cancer crc micrornas mirnas are a class of noncoding rna of nucleotide in length that regulate the expression of target gene at the translational level and play an important role including that of pro and antiangiogenic function in the physiopathology of various organ mirnas are stable in biological fluid such a serum and plasma which render them ideal circulating biomarkers for cancer diagnosis prognosis and treatment decisionmaking and monitoring circulating mirna extraction wa performed using a rapid and effective method that involves both organic and columnbased methodology for mirna retrotranscription we used a multistep procedure that considers polyadenylation at and the ligation of an adapter at of the mature mirnas followed by random mirna preamplification we selected a mirna custom panel to be tested by quantitative realtime polymerase chain reaction qrtpcr and spotted the mirna probe on array custom plate we performed qrtpcr plate run on a realtime pcr system housekeeping mirnas for normalization were selected using genorm software v data were analyzed using expression suite software v and statistical analysis were performed the method proved to be reliable and technically robust and could be useful to evaluate biomarker level in liquid sample such a plasma andor serum
30935717,diagnosis and management of a recurrent polymeraseepsilon polemutated endometrial cancer,polymeraseepsilon polemutated carcinoma are a rare but wellknown subtype of endometrial cancer while typically associated with good prognosis recurrence are documented here we present a case of recurrent polemutated endometrial cancer discus pathologic feature current method of molecular classification and explore therapeutic implication for the polemutation phenotype,Cancer,0,diagnosis and management of a recurrent polymeraseepsilon polemutated endometrial cancer polymeraseepsilon polemutated carcinoma are a rare but wellknown subtype of endometrial cancer while typically associated with good prognosis recurrence are documented here we present a case of recurrent polemutated endometrial cancer discus pathologic feature current method of molecular classification and explore therapeutic implication for the polemutation phenotype
30936351,ocular infiltration a initial presentation of acute monocytic leukaemia transformed from chronic myelomonocytic leukaemia associated with braf ve mutation,acute monocytic leukaemia frenchbritishamerican classification amlmb is characterised by a predominance of cell of the monocytic lineage on bone marrow examination furthermore a discerning feature is it tendency for tissue infiltration while gum hypertrophy and hepatosplenomegaly are common ocular involvement is rare here we present a case of a yearold man referred with proptosis and monocytosissubsequently diagnosed a amlmb whose disease course wa distinguished by extensive tissue invasion ocular pulmonary liver spleen cytogenetics and molecular test were consistent with blastic transformation of previously undiagnosed chronic myelomonocytic leukaemia supported by the presence of longstanding lowgrade monocytosis notably a braf ve mutation wa also detectedan oncogenic driver previously reported in de novo and therapyrelated but not chronic myelomonocytic leukaemiatransformed amlmb while an initial response to cytoreductive treatment wa observed his tissueinvasive disease soon progressed with worsening pulmonary infiltrates disseminated intravascular coagulation and renal failure resulting in death,Cancer,0,ocular infiltration a initial presentation of acute monocytic leukaemia transformed from chronic myelomonocytic leukaemia associated with braf ve mutation acute monocytic leukaemia frenchbritishamerican classification amlmb is characterised by a predominance of cell of the monocytic lineage on bone marrow examination furthermore a discerning feature is it tendency for tissue infiltration while gum hypertrophy and hepatosplenomegaly are common ocular involvement is rare here we present a case of a yearold man referred with proptosis and monocytosissubsequently diagnosed a amlmb whose disease course wa distinguished by extensive tissue invasion ocular pulmonary liver spleen cytogenetics and molecular test were consistent with blastic transformation of previously undiagnosed chronic myelomonocytic leukaemia supported by the presence of longstanding lowgrade monocytosis notably a braf ve mutation wa also detectedan oncogenic driver previously reported in de novo and therapyrelated but not chronic myelomonocytic leukaemiatransformed amlmb while an initial response to cytoreductive treatment wa observed his tissueinvasive disease soon progressed with worsening pulmonary infiltrates disseminated intravascular coagulation and renal failure resulting in death
30937513,bronchoalveolar lavage in hairy cell leukemia with pulmonary infiltration,we report a yearold male patient suffering from hairy cell leukemia presenting clinically mainly with dyspnea radiology exhibited bilateral groundglass shadow in order to prevent pneumonia a a possible side effect due to conventional chemotherapy it wa decided to first treat the patient with rituximab however dyspnea persisted therefore bronchoscopy wa performed and specimen were sampled for both histological examination and bronchoalveolar lavage bal analysis bal showed lymphocytosis and by mean of immunocytochemistry a few cda blymphocytes a well a lymphoid cell positive for the hairy cell marker dba were observed in addition molecular study revealed the braf ve mutation thus the finding of bal were interpreted a lung infiltration by hairy cell leukemia this result wa confirmed by histology following a therapy switch to cladribine a significant improvement wa reached pulmonary infiltrates by hairy cell leukemia were rarely described this case represents the first report of hairy cell leukemia diagnosed by mean of bal it may be difficult to clearly separate between lymphoma infiltration of the lung and medicamentous pneumonitis but this differential diagnosis can be supported by morphological method,Cancer,0,bronchoalveolar lavage in hairy cell leukemia with pulmonary infiltration we report a yearold male patient suffering from hairy cell leukemia presenting clinically mainly with dyspnea radiology exhibited bilateral groundglass shadow in order to prevent pneumonia a a possible side effect due to conventional chemotherapy it wa decided to first treat the patient with rituximab however dyspnea persisted therefore bronchoscopy wa performed and specimen were sampled for both histological examination and bronchoalveolar lavage bal analysis bal showed lymphocytosis and by mean of immunocytochemistry a few cda blymphocytes a well a lymphoid cell positive for the hairy cell marker dba were observed in addition molecular study revealed the braf ve mutation thus the finding of bal were interpreted a lung infiltration by hairy cell leukemia this result wa confirmed by histology following a therapy switch to cladribine a significant improvement wa reached pulmonary infiltrates by hairy cell leukemia were rarely described this case represents the first report of hairy cell leukemia diagnosed by mean of bal it may be difficult to clearly separate between lymphoma infiltration of the lung and medicamentous pneumonitis but this differential diagnosis can be supported by morphological method
30938815,metachronous contralateral male breast cancer case report and literature review,male breast cancer mbc is rare and consequently understudied here we present the case of contralateral breast cancer in a male patient nearly a quarter century following his initial breast cancer diagnosis and treatment the epidemiology risk factor diagnosis characterization treatment and prognosis of male breast cancer are reviewed mbc account for in lifetime risk of breast cancer and is present in of mbc patient while brca is present in an estimated of mbc patient the risk of contralateral breast cancer developing in a male with a unilateral lesion is much higher than for a primary male breast cancer in the general population men tend to be diagnosed at a later age and stage than female prognosis for male and female breast cancer is similar considering both age of patient and stage of the tumor at diagnosis and similar treatment paradigm have resulted in similar outcome although lumpectomy with radiation therapy may have the same prognosis a mastectomy the standard of care for male breast cancer continues to be simple mastectomy with sentinel lymph node biopsy,Cancer,0,metachronous contralateral male breast cancer case report and literature review male breast cancer mbc is rare and consequently understudied here we present the case of contralateral breast cancer in a male patient nearly a quarter century following his initial breast cancer diagnosis and treatment the epidemiology risk factor diagnosis characterization treatment and prognosis of male breast cancer are reviewed mbc account for in lifetime risk of breast cancer and is present in of mbc patient while brca is present in an estimated of mbc patient the risk of contralateral breast cancer developing in a male with a unilateral lesion is much higher than for a primary male breast cancer in the general population men tend to be diagnosed at a later age and stage than female prognosis for male and female breast cancer is similar considering both age of patient and stage of the tumor at diagnosis and similar treatment paradigm have resulted in similar outcome although lumpectomy with radiation therapy may have the same prognosis a mastectomy the standard of care for male breast cancer continues to be simple mastectomy with sentinel lymph node biopsy
30940785,a case of meningeal solitary fibrous tumourhaemangiopericytoma who grade iii metastasized to the spleen shortly after tumor resection,revision of who guideline in led to the classification of solitary fibrous tumourssftsand haemangiopericytomashpcsas a single tumor entity characterized by nabstat fusion standardofcare treatment involves surgery but local recurrence and distant metastasis sometimes occur the average latency to metastasis after surgery is month a yearold female patient presented with a complaint of headache an xxcm lesion showing gdt enhancement wa detected near the superior sagittal sinus pathological assessment following resection revealed proliferating polymorphic atypical tumor cell with distinct nucleolus in a patternless pattern cellularity wa moderate to high and mitotic figure were observed in high power field immunohistochemically tumor cell tested positive for stat and rtpcr revealed a nabstat fusion geneexons and respectively supporting a diagnosis of sfthpc who grade iii despite postoperative radiotherapy multiple metastasis to the spleen were detected month after surgery and distal pancreatectomy with splenectomy wa performed the pathology of the splenic tumor wa similar to that of the intracranial tumor recurrent disease in a lymph node wa detected month later and local radiation therapy wa administered the patient died of cancerous peritonitis month later in this case exceedingly rapid metastasis to the spleen occurred despite the administration of vigorous treatment here we review sfthpc incidence treatment and outcome to better understand this rare malignancy,Cancer,0,a case of meningeal solitary fibrous tumourhaemangiopericytoma who grade iii metastasized to the spleen shortly after tumor resection revision of who guideline in led to the classification of solitary fibrous tumourssftsand haemangiopericytomashpcsas a single tumor entity characterized by nabstat fusion standardofcare treatment involves surgery but local recurrence and distant metastasis sometimes occur the average latency to metastasis after surgery is month a yearold female patient presented with a complaint of headache an xxcm lesion showing gdt enhancement wa detected near the superior sagittal sinus pathological assessment following resection revealed proliferating polymorphic atypical tumor cell with distinct nucleolus in a patternless pattern cellularity wa moderate to high and mitotic figure were observed in high power field immunohistochemically tumor cell tested positive for stat and rtpcr revealed a nabstat fusion geneexons and respectively supporting a diagnosis of sfthpc who grade iii despite postoperative radiotherapy multiple metastasis to the spleen were detected month after surgery and distal pancreatectomy with splenectomy wa performed the pathology of the splenic tumor wa similar to that of the intracranial tumor recurrent disease in a lymph node wa detected month later and local radiation therapy wa administered the patient died of cancerous peritonitis month later in this case exceedingly rapid metastasis to the spleen occurred despite the administration of vigorous treatment here we review sfthpc incidence treatment and outcome to better understand this rare malignancy
30941953,firstline treatment choice of turkish medical oncologist in metastatic colorectal cancer a survey study,purpose colorectal cancer is one of the most common malignancy in the world rasbraf mutational status and primary tumor location are also important factor for the selection of optimal combination therapy in this study we aimed to evaluate the turkish oncologist treatment decision depending on tumor location and mutational status in metastatic colorectal cancer method an online survey link wa sent to the medical oncologist who are registered to turkish society of medical oncology via email and mobile application result ninetyfour oncologist reported that tumor localization affect their treatment modality in rasbraf wild type left colon tumor turkish oncologist mostly use chemotherapy and antiegfr therapy for the firstline treatment while on the right side oncologist favored antivegf therapy in combination with chemotherapy brafmutant tumor in left colon had nearly the same rate of treatment tendency with both antivegf and antiegfr antibody in combination with chemotherapy while in rightsided tumor the main treatment selection of the participant wa antivegfbased treatment in rasmutant patient a great number of oncologist selected antivegfbased treatment on the right and left colon tumor antivegf treatment option ratio were and respectively maintenance treatment is usually preferred by oncologist in both antivegf and antiegfrbased treatment conclusion turkish oncologist are considering tumor sidedness a an indicator for treatment individualization of patient the selection of monoclonal antibody is being affected by tumor localization and mutation status,Cancer,0,firstline treatment choice of turkish medical oncologist in metastatic colorectal cancer a survey study purpose colorectal cancer is one of the most common malignancy in the world rasbraf mutational status and primary tumor location are also important factor for the selection of optimal combination therapy in this study we aimed to evaluate the turkish oncologist treatment decision depending on tumor location and mutational status in metastatic colorectal cancer method an online survey link wa sent to the medical oncologist who are registered to turkish society of medical oncology via email and mobile application result ninetyfour oncologist reported that tumor localization affect their treatment modality in rasbraf wild type left colon tumor turkish oncologist mostly use chemotherapy and antiegfr therapy for the firstline treatment while on the right side oncologist favored antivegf therapy in combination with chemotherapy brafmutant tumor in left colon had nearly the same rate of treatment tendency with both antivegf and antiegfr antibody in combination with chemotherapy while in rightsided tumor the main treatment selection of the participant wa antivegfbased treatment in rasmutant patient a great number of oncologist selected antivegfbased treatment on the right and left colon tumor antivegf treatment option ratio were and respectively maintenance treatment is usually preferred by oncologist in both antivegf and antiegfrbased treatment conclusion turkish oncologist are considering tumor sidedness a an indicator for treatment individualization of patient the selection of monoclonal antibody is being affected by tumor localization and mutation status
30942566,labelfree electrochemical sensor for cd by ligandprotein interaction,detection of biomarkers in biosystems play a key role in advanced biodiagnostics for research and clinical use design of new analytical platform is challenging and in demand addressing molecular capture and subsequent quantitation herein we developed a labelfree electrochemical sensor for cd by ligandprotein interaction we assembled carbon nanotube composite on the electrode to enhance electronic conductivity by fold and reduce overpotential with a shift of mv we conjugated hyaluronic acid ha to the surface of carbon nanotube via electrostatic interaction between ha and polydiallyldimethylammonium chloride pdda consequently we performed direct electrochemical sensing of cd with a dynamic range of ngml and detection limit of pgml without any postlabeling for amplification comparable to the best current result the sensor also displayed high selectivity reproducibility with relative standard deviation rsd n of and longterm stability for day we demonstrated application of the sensor in detection of human serum and cancer cell our work guide the development of more sensor type by ligandprotein interaction and contributes to design of interface in given biosystems for diagnosis,Cancer,0,labelfree electrochemical sensor for cd by ligandprotein interaction detection of biomarkers in biosystems play a key role in advanced biodiagnostics for research and clinical use design of new analytical platform is challenging and in demand addressing molecular capture and subsequent quantitation herein we developed a labelfree electrochemical sensor for cd by ligandprotein interaction we assembled carbon nanotube composite on the electrode to enhance electronic conductivity by fold and reduce overpotential with a shift of mv we conjugated hyaluronic acid ha to the surface of carbon nanotube via electrostatic interaction between ha and polydiallyldimethylammonium chloride pdda consequently we performed direct electrochemical sensing of cd with a dynamic range of ngml and detection limit of pgml without any postlabeling for amplification comparable to the best current result the sensor also displayed high selectivity reproducibility with relative standard deviation rsd n of and longterm stability for day we demonstrated application of the sensor in detection of human serum and cancer cell our work guide the development of more sensor type by ligandprotein interaction and contributes to design of interface in given biosystems for diagnosis
30943439,the prognostic significance of the long noncoding rna ccat pvt in t associated acute myeloid leukemia,long noncoding rna lncrna is recently linked to various type of cancer ccat and pvt are two lncrnas linked to t associated acute myeloid leukemia the interplay between ccat pvt and the myc protooncogene implicated in t could present an opportunity for using lncrna a prognostic biomarker or a target for therapy we investigated the expression level of lncrnas in patient with t positive aml and with t negative aml we found that ccat and pvt are expressed in higher level in t positive aml by fold compared to t negative group the expression value were significantly associated with highrisk clinical criterion moreover they are associated with lower overall survival o rate and leukemiafree survival lf however we didnt find a statistically significant cutoff value of lncrnas using the cox regression analysis for lncpvt except with lf we conclude that high expression level of ccat and pvt are associated with poor prognosis while being poor prognostic biomarkers in t associated aml,Cancer,0,the prognostic significance of the long noncoding rna ccat pvt in t associated acute myeloid leukemia long noncoding rna lncrna is recently linked to various type of cancer ccat and pvt are two lncrnas linked to t associated acute myeloid leukemia the interplay between ccat pvt and the myc protooncogene implicated in t could present an opportunity for using lncrna a prognostic biomarker or a target for therapy we investigated the expression level of lncrnas in patient with t positive aml and with t negative aml we found that ccat and pvt are expressed in higher level in t positive aml by fold compared to t negative group the expression value were significantly associated with highrisk clinical criterion moreover they are associated with lower overall survival o rate and leukemiafree survival lf however we didnt find a statistically significant cutoff value of lncrnas using the cox regression analysis for lncpvt except with lf we conclude that high expression level of ccat and pvt are associated with poor prognosis while being poor prognostic biomarkers in t associated aml
30943982,long noncoding rna hotair promotes exosome secretion by regulating rab and snap in hepatocellular carcinoma,background emerging evidence indicates that tumor cell release a large amount of exosomes loaded with cargo during tumorigenesis exosome secretion is a multistep process regulated by certain related molecule long noncoding rna lncrnas play an important role in hepatocellular carcinoma hcc progression however the role of lncrna hotair in regulating exosome secretion in hcc cell remains unclear method we analyzed the relationship between hotair expression and exosome secretionrelated gene using gene set enrichment analysis gsea nanoparticle tracking analysis wa performed to validate the effect of hotair on exosome secretion the transport of multivesicular body mvbs after overexpression of hotair wa detected by transmission electron microscopy and confocal microscopy analysis of cluster determinant cd with synaptosome associated protein snap the mechanism of hotairs regulation of rasrelated protein rab rab vesicle associated membrane protein vamp and snap wa assessed using confocal colocalization analysis phosphorylation assay and rescue experiment result we found an enrichment of exosome secretionrelated gene in the hotair high expression group hotair promoted the release of exosomes by inducing mvb transport to the plasma membrane hotair regulated rab expression and localization which controlled the docking process moreover hotair facilitated the final step of fusion by influencing vamp and snap colocalization in addition we validated that hotair induced the phosphorylation of snap via mammalian target of rapamycin mtor signaling conclusion our study demonstrated a novel function of lncrna hotair in promoting exosome secretion from hcc cell and provided a new understanding of lncrnas in tumor cell biology,Cancer,0,long noncoding rna hotair promotes exosome secretion by regulating rab and snap in hepatocellular carcinoma background emerging evidence indicates that tumor cell release a large amount of exosomes loaded with cargo during tumorigenesis exosome secretion is a multistep process regulated by certain related molecule long noncoding rna lncrnas play an important role in hepatocellular carcinoma hcc progression however the role of lncrna hotair in regulating exosome secretion in hcc cell remains unclear method we analyzed the relationship between hotair expression and exosome secretionrelated gene using gene set enrichment analysis gsea nanoparticle tracking analysis wa performed to validate the effect of hotair on exosome secretion the transport of multivesicular body mvbs after overexpression of hotair wa detected by transmission electron microscopy and confocal microscopy analysis of cluster determinant cd with synaptosome associated protein snap the mechanism of hotairs regulation of rasrelated protein rab rab vesicle associated membrane protein vamp and snap wa assessed using confocal colocalization analysis phosphorylation assay and rescue experiment result we found an enrichment of exosome secretionrelated gene in the hotair high expression group hotair promoted the release of exosomes by inducing mvb transport to the plasma membrane hotair regulated rab expression and localization which controlled the docking process moreover hotair facilitated the final step of fusion by influencing vamp and snap colocalization in addition we validated that hotair induced the phosphorylation of snap via mammalian target of rapamycin mtor signaling conclusion our study demonstrated a novel function of lncrna hotair in promoting exosome secretion from hcc cell and provided a new understanding of lncrnas in tumor cell biology
30948335,the role of p isoforms expression and p mutation status in renal cell cancer prognosis,objective to analyze p mutation and gene expression of p p and p isoforms in renal cell cancer rcc tissue and normal adjacent tissue nat and to associate them to clinical feature and outcome patient and method fortyone randomly selected patient with primary previously untreated rcc with complete clinicopathohistological data were analyzed nat sample were available for case expression of p p and p wa determined using rtqpcr a functional yeastbased assay wa performed to analyze p mutation result more than half of patient harbored functional p mutation and they were significantly younger than those with wild type wt p p expression of p p and p wa upregulated in mutant mt p rcc compared to wt p rcc tissue however there wa no difference in expression of these isoforms between mt p rcc tissue and nat expression of p wa significantly downregulated in wt p tissue compared to nat p patient that harbored functional p mutation had better overall survival hazard ratio confidence interval p multivariate analysis demonstrated that tumor stage and p mutation might be used a independent prognostic marker for overall survival in rcc patient conclusion our finding support the specific event in the carcinogenesis of rcc p isoforms can be differentially expressed depending on p mutational status,Cancer,0,the role of p isoforms expression and p mutation status in renal cell cancer prognosis objective to analyze p mutation and gene expression of p p and p isoforms in renal cell cancer rcc tissue and normal adjacent tissue nat and to associate them to clinical feature and outcome patient and method fortyone randomly selected patient with primary previously untreated rcc with complete clinicopathohistological data were analyzed nat sample were available for case expression of p p and p wa determined using rtqpcr a functional yeastbased assay wa performed to analyze p mutation result more than half of patient harbored functional p mutation and they were significantly younger than those with wild type wt p p expression of p p and p wa upregulated in mutant mt p rcc compared to wt p rcc tissue however there wa no difference in expression of these isoforms between mt p rcc tissue and nat expression of p wa significantly downregulated in wt p tissue compared to nat p patient that harbored functional p mutation had better overall survival hazard ratio confidence interval p multivariate analysis demonstrated that tumor stage and p mutation might be used a independent prognostic marker for overall survival in rcc patient conclusion our finding support the specific event in the carcinogenesis of rcc p isoforms can be differentially expressed depending on p mutational status
30952820,the impact of brain metastasis and associated neurocognitive aspect on health utility score in egfr mutated and alk rearranged nsclc a real world evidence analysis,background in lung cancer brain metastasis bm and their treatment are associated with high economic burden and inferior healthrelated quality of life in the era of targeted therapy real world evidence through health utility score hus is critical for economic analysis material and method in a prospective observational cohort study outpatient with stage iv lung cancer completed demographic and eqdl survey to derive hus health state and clinicopathologic variable were obtained from chart abstraction patient were categorized by the presence or absence of bm regression analysis identified factor that were associated with hus a subset of patient prospectively completed neurocognitive function ncf test andor the factbrain factbr questionnaire which were then correlated with hus spearman coefficient regression analysis result of patient with eqdlderived hus completed ncf test and completed factbr never developed bm developed first bm during study period and had bm at study entry the sample wa enriched for egfr mutation egfrm and alkrearrangements alkr there were no hus difference by bm status overall and in subset by demographic in multivariable analysis superior hus wa associated with having egfrmalkr p no prior radiation for extracranial disease p and both intracranial p and extracranial disease control p hus correlated with multiple element of the factbr and test of ncf conclusion having bm in lung cancer is not associated with inferior hus in a population enriched for egfrm and alkr patient exhibiting disease control and those with oncogeneaddicted tumor have superior hus implication for practice in the setting of egfr mutation or alk rearrangement nonsmall cell lung cancer nsclc a diagnosis of brain metastasis no longer consigns the patient to an inferior health state suggesting that new economic analysis in nsclc are needed in the era of targeted therapy additionally the eqd questionnaire is associated with measure of healthrelated quality of life and neurocognitive score suggesting this tool should be further explored in prospective clinical study,Cancer,0,the impact of brain metastasis and associated neurocognitive aspect on health utility score in egfr mutated and alk rearranged nsclc a real world evidence analysis background in lung cancer brain metastasis bm and their treatment are associated with high economic burden and inferior healthrelated quality of life in the era of targeted therapy real world evidence through health utility score hus is critical for economic analysis material and method in a prospective observational cohort study outpatient with stage iv lung cancer completed demographic and eqdl survey to derive hus health state and clinicopathologic variable were obtained from chart abstraction patient were categorized by the presence or absence of bm regression analysis identified factor that were associated with hus a subset of patient prospectively completed neurocognitive function ncf test andor the factbrain factbr questionnaire which were then correlated with hus spearman coefficient regression analysis result of patient with eqdlderived hus completed ncf test and completed factbr never developed bm developed first bm during study period and had bm at study entry the sample wa enriched for egfr mutation egfrm and alkrearrangements alkr there were no hus difference by bm status overall and in subset by demographic in multivariable analysis superior hus wa associated with having egfrmalkr p no prior radiation for extracranial disease p and both intracranial p and extracranial disease control p hus correlated with multiple element of the factbr and test of ncf conclusion having bm in lung cancer is not associated with inferior hus in a population enriched for egfrm and alkr patient exhibiting disease control and those with oncogeneaddicted tumor have superior hus implication for practice in the setting of egfr mutation or alk rearrangement nonsmall cell lung cancer nsclc a diagnosis of brain metastasis no longer consigns the patient to an inferior health state suggesting that new economic analysis in nsclc are needed in the era of targeted therapy additionally the eqd questionnaire is associated with measure of healthrelated quality of life and neurocognitive score suggesting this tool should be further explored in prospective clinical study
30953094,the expression of circulating mir in plasma is associated with egfr mutation status in nonsmallcell lung carcinoma patient,micrornas mirnas key regulator of gene expression at the posttranscriptional level are grossly misregulated in some human cancer including nonsmallcell lung carcinoma nsclc the aberrant expression of specific mirnas result in the abnormal regulation of key component of signalling pathway in tumour cell mirna level and the activity of the gene target including oncogene and tumour suppressor produce feedback that change mirna expression level and indicates the cell genetic activity in this study we measured the expression of five circulating mirnas mir mir mir mirb and mir and evaluated their association with epidermal growth factor receptor egfr mutation status in nsclc patient moreover we examined the discriminative power of circulating mirnas for egfr mutantpositive and negative nsclc patient using two different data normalisation approach we extracted total rna from the plasma of nonsquamous nsclc patient of whom had tumour with egfr mutation and measured circulating mirna level using quantitative reverse transcription polymerase chain reaction rtqpcr the mirna expression level were normalised using two endogenous control mir and mir we found significant association between the expression of circulating mir and egfractivating mutation in nsclc patient regardless of the normalisation approach used p and for mir and mir normalisation respectively the greatest discriminative power of circulating mir wa observed in patient with egfr exon deletion versus wildtype egfr normalised to mir area under the curve auc p interestingly circulating mir level were significantly reduced in the vkiras kirsten rat sarcoma viral oncogene homolog krasmutated subgroup compared to egfrmutated patient p and those with egfrkras wildtype tumour p our study demonstrated the feasibility and potential diagnostic value of plasma mir expression analysis to distinguish between egfrmutated and wildtype nsclc patient however quality control and normalisation strategy are very important and have a major impact on the outcome of circulating mirna analysis,Cancer,0,the expression of circulating mir in plasma is associated with egfr mutation status in nonsmallcell lung carcinoma patient micrornas mirnas key regulator of gene expression at the posttranscriptional level are grossly misregulated in some human cancer including nonsmallcell lung carcinoma nsclc the aberrant expression of specific mirnas result in the abnormal regulation of key component of signalling pathway in tumour cell mirna level and the activity of the gene target including oncogene and tumour suppressor produce feedback that change mirna expression level and indicates the cell genetic activity in this study we measured the expression of five circulating mirnas mir mir mir mirb and mir and evaluated their association with epidermal growth factor receptor egfr mutation status in nsclc patient moreover we examined the discriminative power of circulating mirnas for egfr mutantpositive and negative nsclc patient using two different data normalisation approach we extracted total rna from the plasma of nonsquamous nsclc patient of whom had tumour with egfr mutation and measured circulating mirna level using quantitative reverse transcription polymerase chain reaction rtqpcr the mirna expression level were normalised using two endogenous control mir and mir we found significant association between the expression of circulating mir and egfractivating mutation in nsclc patient regardless of the normalisation approach used p and for mir and mir normalisation respectively the greatest discriminative power of circulating mir wa observed in patient with egfr exon deletion versus wildtype egfr normalised to mir area under the curve auc p interestingly circulating mir level were significantly reduced in the vkiras kirsten rat sarcoma viral oncogene homolog krasmutated subgroup compared to egfrmutated patient p and those with egfrkras wildtype tumour p our study demonstrated the feasibility and potential diagnostic value of plasma mir expression analysis to distinguish between egfrmutated and wildtype nsclc patient however quality control and normalisation strategy are very important and have a major impact on the outcome of circulating mirna analysis
30953289,noninvasive follicular thyroid neoplasm with papillarylike nuclear feature niftp update and diagnostic considerationsa review,advance in our understanding of thyroid lesion especially those entity with an indolent behavior ha led clinician to question the most appropriate surgical management of such thyroid nodule several study have shown that the noninvasive encapsulated follicular variant of papillary thyroid carcinoma niefvpc exhibit poor histopathologic diagnostic reproducibility and have been overtreated a conventional thyroid cancer in an international thyroid working group reevaluated niefvpc and it diagnostic criterion the new terminology of noninvasive follicular thyroid neoplasm with papillarylike nuclear feature niftp wa accordingly introduced to replace niefvpc the literature ha emphasized that niftps are biologically similar to follicular adenoma lacking lymph node metastasis andor recurrence while the definition of niftp is based on specific morphological parameter recent study have questioned whether the criterion allowing less than of true papilla should be revised to a total absence of papilla the motivation for this revision is the rare finding in some study of lymph node with metastatic niftp this review evaluates the existing published series of niftp case clinical consequence of niftp and emerging change in the diagnostic criterion for niftp the introduction of niftp ha resulted in significant impact on the clinical management of thyroid nodule recent revision in the morphological criterion for niftp emphasize the need to adhere to very stringent histomorphologic criterion when making a diagnosis of niftp the adoption of niftp terminology instead of niefvpc is associated with conservative lobectomy without radioactive iodine treatment in the majority of case,Cancer,0,noninvasive follicular thyroid neoplasm with papillarylike nuclear feature niftp update and diagnostic considerationsa review advance in our understanding of thyroid lesion especially those entity with an indolent behavior ha led clinician to question the most appropriate surgical management of such thyroid nodule several study have shown that the noninvasive encapsulated follicular variant of papillary thyroid carcinoma niefvpc exhibit poor histopathologic diagnostic reproducibility and have been overtreated a conventional thyroid cancer in an international thyroid working group reevaluated niefvpc and it diagnostic criterion the new terminology of noninvasive follicular thyroid neoplasm with papillarylike nuclear feature niftp wa accordingly introduced to replace niefvpc the literature ha emphasized that niftps are biologically similar to follicular adenoma lacking lymph node metastasis andor recurrence while the definition of niftp is based on specific morphological parameter recent study have questioned whether the criterion allowing less than of true papilla should be revised to a total absence of papilla the motivation for this revision is the rare finding in some study of lymph node with metastatic niftp this review evaluates the existing published series of niftp case clinical consequence of niftp and emerging change in the diagnostic criterion for niftp the introduction of niftp ha resulted in significant impact on the clinical management of thyroid nodule recent revision in the morphological criterion for niftp emphasize the need to adhere to very stringent histomorphologic criterion when making a diagnosis of niftp the adoption of niftp terminology instead of niefvpc is associated with conservative lobectomy without radioactive iodine treatment in the majority of case
30953464,intussusception reveals mutyhassociated polyposis syndrome and colorectal cancer a case report,background we are reporting a rare case of mutyhassociated polyposis a colorectal cancer hereditary syndrome diagnosticated after an intussusception colorectal cancer is an important cause of cancer related mortality that can be manifested by an intussusception a rare occurrence in adult and almost always related to tumor approximately of colorectal cancer can be attributed to syndrome known to cause hereditary colorectal cancer such a mutyhassociated polyposis autosomal genetic syndrome associated with this disease case presentation we present the case of a year old male that sought medical consultation with a complaint of abdominal discomfort that after five day changed it characteristic the patient wa sent to the emergency department were a ctscan revealed intestinal subocclusion by ileocolic invagination right colectomy wa carried out the anatomicpathological examination revealed a moderately differentiated mucinous adenocarcinoma and multiple sessile polyp which led to the suspicion of a genetic syndrome in the genetics analysis two mutation were observed in the mutyh gene and mutyhassociated polyposis wa diagnosticated conclusion this case demonstrates the importance of meticulous analysis of the patient examination result to identify possible discrete alteration that can lead to improved understanding of disease,Cancer,0,intussusception reveals mutyhassociated polyposis syndrome and colorectal cancer a case report background we are reporting a rare case of mutyhassociated polyposis a colorectal cancer hereditary syndrome diagnosticated after an intussusception colorectal cancer is an important cause of cancer related mortality that can be manifested by an intussusception a rare occurrence in adult and almost always related to tumor approximately of colorectal cancer can be attributed to syndrome known to cause hereditary colorectal cancer such a mutyhassociated polyposis autosomal genetic syndrome associated with this disease case presentation we present the case of a year old male that sought medical consultation with a complaint of abdominal discomfort that after five day changed it characteristic the patient wa sent to the emergency department were a ctscan revealed intestinal subocclusion by ileocolic invagination right colectomy wa carried out the anatomicpathological examination revealed a moderately differentiated mucinous adenocarcinoma and multiple sessile polyp which led to the suspicion of a genetic syndrome in the genetics analysis two mutation were observed in the mutyh gene and mutyhassociated polyposis wa diagnosticated conclusion this case demonstrates the importance of meticulous analysis of the patient examination result to identify possible discrete alteration that can lead to improved understanding of disease
30955261,diagnosis of lung biopsy employing the who criterion and detection of related oncogenic driver mutation,objective the diagnostic criterion of lung biopsy specimen by who lung tumor classification were used to evaluate lung biopsy specimen along with detection of genetic alteration of major tumor driving gene including epidermal growth factor receptor egfr method the clinical data histological slide immunohistochemical stain and special stain of lung biopsy specimen at beijing hospital from july to july were retrospectively analyzed diagnosis of lung cancer wa reclassified according to the who lung tumor classification and related gene mutation data were analyzed result during a threeyear period the total number of lung cancer diagnosis wa case including female and male patient with age ranging from to year median age of year there were case of small cell carcinoma case of large cell neuroendocrine carcinoma case of combined neuroendocrine carcinoma case of atypical carcinoid case of adenocarcinoma case of nonsmall cell carcinoma favor adenocarcinoma case of squamous cell carcinoma case of nonsmall cell carcinoma favor squamous cell carcinoma case of nonsmall cell carcinoma not otherwise specified and case of nonsmall cell carcinoma possible adenosquamous carcinoma among case tested case showed egfr mutation including of case of adenocarcinoma and of case of nonsmall cell carcinoma favor adenocarcinoma twenty two case were found to have tm mutation among patient after egfr tki targeted drug therapy immunohistochemical staining of alk df wa positive in of case of nonsmall cell lung cancer confirmed by emlalk fusion gene fluorescence pcr ro gene fusion wa found in of case splicing mutation in exon of met gene were seen in one case of nonsmall cell carcinoma with spindle cell differentiation conclusion the new diagnostic criterion by the who lung tumor classification is better suited for diagnosing lung biopsy specimen and providing accurate treatment guidance and improving the patient outcome,Cancer,0,diagnosis of lung biopsy employing the who criterion and detection of related oncogenic driver mutation objective the diagnostic criterion of lung biopsy specimen by who lung tumor classification were used to evaluate lung biopsy specimen along with detection of genetic alteration of major tumor driving gene including epidermal growth factor receptor egfr method the clinical data histological slide immunohistochemical stain and special stain of lung biopsy specimen at beijing hospital from july to july were retrospectively analyzed diagnosis of lung cancer wa reclassified according to the who lung tumor classification and related gene mutation data were analyzed result during a threeyear period the total number of lung cancer diagnosis wa case including female and male patient with age ranging from to year median age of year there were case of small cell carcinoma case of large cell neuroendocrine carcinoma case of combined neuroendocrine carcinoma case of atypical carcinoid case of adenocarcinoma case of nonsmall cell carcinoma favor adenocarcinoma case of squamous cell carcinoma case of nonsmall cell carcinoma favor squamous cell carcinoma case of nonsmall cell carcinoma not otherwise specified and case of nonsmall cell carcinoma possible adenosquamous carcinoma among case tested case showed egfr mutation including of case of adenocarcinoma and of case of nonsmall cell carcinoma favor adenocarcinoma twenty two case were found to have tm mutation among patient after egfr tki targeted drug therapy immunohistochemical staining of alk df wa positive in of case of nonsmall cell lung cancer confirmed by emlalk fusion gene fluorescence pcr ro gene fusion wa found in of case splicing mutation in exon of met gene were seen in one case of nonsmall cell carcinoma with spindle cell differentiation conclusion the new diagnostic criterion by the who lung tumor classification is better suited for diagnosing lung biopsy specimen and providing accurate treatment guidance and improving the patient outcome
30955263,dedifferentiated liposarcoma with inflammatory myofibroblastic tumorlike feature a clinicopathological analysis of five case,objective to investigate the clinicopathological feature diagnosis and differential diagnosis of dedifferentiated liposarcoma ddlps with inflammatory myofibroblastic tumor imtlike feature method five case of ddlps with imtlike feature were collected from the first affiliated hospital of nanjing medical university the affiliated hospital of nanjing university of traditional chinese medicine and the first people hospital of qinzhou between and envision method and fluorescence in situ hybridization fish were used to detect the immunophenotype of the tumor cell and the profile of mdm gene amplification respectively result all five case were male and the median age wa range to year the clinical symptom were mainly related to the spaceoccupying lesion the tumor were located in duodenal mesentery two case intestinal wall one case retroperitoneum one case and spermatic cord one case grossly the tumor were not well encapsulated ranging from to cm median cm in diameter with tan to gray and firm cut surface histologically the dedifferentiated component closely resembled inflammatory myofibroblastic tumor imt with spindlepolygonalstellateshaped cell arranged in storiform sheetlike or random pattern with varying degree of chronic inflammation and fibrosis all three major pattern seen in imt myxoid cellular and hypocellular fibrous were observed the hypocellular fibrous pattern wa the most common welldifferentiated liposarcomatous component wa found in the peripheral area of all the tumor one case had high grade dedifferentiated component four case were strongly positive for mdm and p two case were positive for sma and one case wa focally positive for desmin and one for cd none of the case stained for alk fish demonstrated mdm gene amplification in all five case clinical followup were available in all five case and the interval ranged from to month median month two patient developed recurrence and one patient had metastasis the remaining two patient were alive with no evidence of tumor recurrence at and month after surgery respectively conclusion ddlps with imtlike feature is a more aggressive neoplasm than it histological mimic imt and should not be misdiagnosed a other intermediate or lowgrade malignant tumor such a imt sclerosing liposarcoma inflammatory liposarcoma aggressive fibromatosis solitary fibrous tumor lowgrade myofibroblastic sarcoma and lowgrade fibrosarcoma,Cancer,0,dedifferentiated liposarcoma with inflammatory myofibroblastic tumorlike feature a clinicopathological analysis of five case objective to investigate the clinicopathological feature diagnosis and differential diagnosis of dedifferentiated liposarcoma ddlps with inflammatory myofibroblastic tumor imtlike feature method five case of ddlps with imtlike feature were collected from the first affiliated hospital of nanjing medical university the affiliated hospital of nanjing university of traditional chinese medicine and the first people hospital of qinzhou between and envision method and fluorescence in situ hybridization fish were used to detect the immunophenotype of the tumor cell and the profile of mdm gene amplification respectively result all five case were male and the median age wa range to year the clinical symptom were mainly related to the spaceoccupying lesion the tumor were located in duodenal mesentery two case intestinal wall one case retroperitoneum one case and spermatic cord one case grossly the tumor were not well encapsulated ranging from to cm median cm in diameter with tan to gray and firm cut surface histologically the dedifferentiated component closely resembled inflammatory myofibroblastic tumor imt with spindlepolygonalstellateshaped cell arranged in storiform sheetlike or random pattern with varying degree of chronic inflammation and fibrosis all three major pattern seen in imt myxoid cellular and hypocellular fibrous were observed the hypocellular fibrous pattern wa the most common welldifferentiated liposarcomatous component wa found in the peripheral area of all the tumor one case had high grade dedifferentiated component four case were strongly positive for mdm and p two case were positive for sma and one case wa focally positive for desmin and one for cd none of the case stained for alk fish demonstrated mdm gene amplification in all five case clinical followup were available in all five case and the interval ranged from to month median month two patient developed recurrence and one patient had metastasis the remaining two patient were alive with no evidence of tumor recurrence at and month after surgery respectively conclusion ddlps with imtlike feature is a more aggressive neoplasm than it histological mimic imt and should not be misdiagnosed a other intermediate or lowgrade malignant tumor such a imt sclerosing liposarcoma inflammatory liposarcoma aggressive fibromatosis solitary fibrous tumor lowgrade myofibroblastic sarcoma and lowgrade fibrosarcoma
30955977,pembrolizumab versus chemotherapy for previously untreated pdlexpressing locally advanced or metastatic nonsmallcell lung cancer keynote a randomised openlabel controlled phase trial,background firstline pembrolizumab monotherapy improves overall and progressionfree survival in patient with untreated metastatic nonsmallcell lung cancer with a programmed death ligand pdl tumour proportion score tps of or greater we investigated overall survival after treatment with pembrolizumab monotherapy in patient with a pdl tps of or greater method this randomised openlabel phase study wa done in medical centre in country eligible patient were adult year with previously untreated locally advanced or metastatic nonsmallcell lung cancer without a sensitising egfr mutation or alk translocation and with an eastern cooperative oncology group ecog performance status score of or life expectancy month or longer and a pdl tps of or greater randomisation wa computer generated accessed via an interactive voiceresponse and integrated webresponse system and stratified by region of enrolment east asia v rest of world ecog performance status score v histology squamous v nonsquamous and pdl tps v enrolled patient were randomly assigned in block of four per stratum to receive pembrolizumab mg every week for up to cycle or the investigator choice of platinumbased chemotherapy for four to six cycle primary endpoint were overall survival in patient with a tps of or greater or greater and or greater onesided significance threshold p p and p respectively in the intentiontotreat population assessed sequentially if the previous finding were significant this study is registered at clinicaltrialsgov number nct finding from dec to march patient men woman median age year iqr with a pdl tps of or greater were allocated to pembrolizumab n or chemotherapy n and included in the intentiontotreat population had a tps of or greater and patient had a tps of or greater a of feb median followup wa month overall survival wa significantly longer in the pembrolizumab group than in the chemotherapy group in all three tps population hazard ratio ci p p and p the median surival value by tps population were month ci for pembrolizumab versus month for chemotherapy month versus month and month versus month respectively treatmentrelated adverse event of grade or worse occurred in of treated patient in the pembrolizumab group and in of in the chemotherapy group and led to death in and patient respectively interpretation the benefittorisk profile suggests that pembrolizumab monotherapy can be extended a firstline therapy to patient with locally advanced or metastatic nonsmallcell lung cancer without sensitising egfr or alk alteration and with low pdl tps funding merck sharp dohme,Cancer,0,pembrolizumab versus chemotherapy for previously untreated pdlexpressing locally advanced or metastatic nonsmallcell lung cancer keynote a randomised openlabel controlled phase trial background firstline pembrolizumab monotherapy improves overall and progressionfree survival in patient with untreated metastatic nonsmallcell lung cancer with a programmed death ligand pdl tumour proportion score tps of or greater we investigated overall survival after treatment with pembrolizumab monotherapy in patient with a pdl tps of or greater method this randomised openlabel phase study wa done in medical centre in country eligible patient were adult year with previously untreated locally advanced or metastatic nonsmallcell lung cancer without a sensitising egfr mutation or alk translocation and with an eastern cooperative oncology group ecog performance status score of or life expectancy month or longer and a pdl tps of or greater randomisation wa computer generated accessed via an interactive voiceresponse and integrated webresponse system and stratified by region of enrolment east asia v rest of world ecog performance status score v histology squamous v nonsquamous and pdl tps v enrolled patient were randomly assigned in block of four per stratum to receive pembrolizumab mg every week for up to cycle or the investigator choice of platinumbased chemotherapy for four to six cycle primary endpoint were overall survival in patient with a tps of or greater or greater and or greater onesided significance threshold p p and p respectively in the intentiontotreat population assessed sequentially if the previous finding were significant this study is registered at clinicaltrialsgov number nct finding from dec to march patient men woman median age year iqr with a pdl tps of or greater were allocated to pembrolizumab n or chemotherapy n and included in the intentiontotreat population had a tps of or greater and patient had a tps of or greater a of feb median followup wa month overall survival wa significantly longer in the pembrolizumab group than in the chemotherapy group in all three tps population hazard ratio ci p p and p the median surival value by tps population were month ci for pembrolizumab versus month for chemotherapy month versus month and month versus month respectively treatmentrelated adverse event of grade or worse occurred in of treated patient in the pembrolizumab group and in of in the chemotherapy group and led to death in and patient respectively interpretation the benefittorisk profile suggests that pembrolizumab monotherapy can be extended a firstline therapy to patient with locally advanced or metastatic nonsmallcell lung cancer without sensitising egfr or alk alteration and with low pdl tps funding merck sharp dohme
30956778,specific allelic variant of snp in the mdm and mdmx gene are associated with earlier tumor onset and progression in caucasian breast cancer patient,background genetic factor play a substantial role in breast cancer etiology gene encoding protein that have key function in the dna damage response such a p and it inhibitor mdm and mdmx are most likely candidate to harbor allelic variant that influence breast cancer susceptibility the aim of our study wa to comprehensively analyze the impact of snp in the tp mdm and mdmx gene in conjunction with tp mutational status regarding the onset and progression of breast cancer method in specimen from breast cancer patient five snp within the selected gene were analyzed tp argpro r mdm snp r snp r mdmx snp r and snp r classification of the tumor wa evaluated by histomorphology subtyping according hormone receptor status herstatus and proliferation rate enabled provision of the clinicopathological surrogate of intrinsic subtypes result the homozygous callele of mdm snp wa significantly associated with a younger ageatdiagnosis of year in contrast to gg and gcpatients yr respectively p logranktest in contrast there wa no difference regarding the ageatdiagnosis for patient with the respective genotype of mdm snp p logranktest in patient with estrogen receptor erpositive and tpmutated tumor however the ttgenotype of the mdm snp wa significantly associated with an earlier average ageatdiagnosis compared with tgggpatients v yr p logranktest in the triplenegative subgroup the ggpatients had an average ageatdiagnosis of year compared with year for snpt carrier p logranktest indicating a susceptibility of the gg genotype for the development of triple negative breast cancer patient with the aagenotype of mdmx snp with ernegative tumor were diagnosed year earlier compared with patient and erpositive tumor v yr p logranktest furthermore in luminal blike patient herindependent the ccgenotype of mdmx snp wa significantly correlated with a decreased eventfree survival compared with the aagenotype p logranktest conclusion we showed that snp in the mdm and mdmx gene affect at least in part the onset and progression of breast cancer dependent on the erstatus our finding provide further evidence for the distinct etiological pathway in ernegative and erpositive breast cancer,Cancer,0,specific allelic variant of snp in the mdm and mdmx gene are associated with earlier tumor onset and progression in caucasian breast cancer patient background genetic factor play a substantial role in breast cancer etiology gene encoding protein that have key function in the dna damage response such a p and it inhibitor mdm and mdmx are most likely candidate to harbor allelic variant that influence breast cancer susceptibility the aim of our study wa to comprehensively analyze the impact of snp in the tp mdm and mdmx gene in conjunction with tp mutational status regarding the onset and progression of breast cancer method in specimen from breast cancer patient five snp within the selected gene were analyzed tp argpro r mdm snp r snp r mdmx snp r and snp r classification of the tumor wa evaluated by histomorphology subtyping according hormone receptor status herstatus and proliferation rate enabled provision of the clinicopathological surrogate of intrinsic subtypes result the homozygous callele of mdm snp wa significantly associated with a younger ageatdiagnosis of year in contrast to gg and gcpatients yr respectively p logranktest in contrast there wa no difference regarding the ageatdiagnosis for patient with the respective genotype of mdm snp p logranktest in patient with estrogen receptor erpositive and tpmutated tumor however the ttgenotype of the mdm snp wa significantly associated with an earlier average ageatdiagnosis compared with tgggpatients v yr p logranktest in the triplenegative subgroup the ggpatients had an average ageatdiagnosis of year compared with year for snpt carrier p logranktest indicating a susceptibility of the gg genotype for the development of triple negative breast cancer patient with the aagenotype of mdmx snp with ernegative tumor were diagnosed year earlier compared with patient and erpositive tumor v yr p logranktest furthermore in luminal blike patient herindependent the ccgenotype of mdmx snp wa significantly correlated with a decreased eventfree survival compared with the aagenotype p logranktest conclusion we showed that snp in the mdm and mdmx gene affect at least in part the onset and progression of breast cancer dependent on the erstatus our finding provide further evidence for the distinct etiological pathway in ernegative and erpositive breast cancer
30957187,mirbp and mir cooperatively regulate blm gene expression by directly targeting the utr in pc cell,blm recq like helicase blm ha a pivotal role in genetic recombination transcription dna replication and dna repair which present the possibility of using blm a an anticancer target for treatment however the posttranscriptional control regulation of blm gene expression is not fully understood and limit the application of drug targeting blm for carcinoma therapy in the future micrornas mirnas inhibit gene expression through interaction with the untranslated region utr of mrna at the posttranscriptional stage therefore the current study screened for mirnas that regulate blm gene expression with software predicting that mirna mirbp mir mirp mirp and mirp blm gene expression level in the pc prostate cancer cell line and rwpe normal prostate epithelium cell line were detected by reverse transcriptionquantitative pcr additionally blm mrna level were following mirna overexpression for and h for further mirna filtration and validation a dualluciferase reporter system and western blot analysis were performed which demonstrated that mirbp and mir reduce blm gene expression by directly targeting the blm mrna utr a boxbehnken design experiment suggested that mirbp and mir have synergetic mutual effect on blm gene expression finally the suppressive effect of mirbp and mir on pc cell proliferation colony formation migration and invasion indicated the benefit of studying blm a a drug target in cancer in conclusion the finding of the current provide evidence that mirbp and mir have an oncosuppressive function in pc cell and cooperatively downregulate blm expression at the posttranscriptional level,Cancer,0,mirbp and mir cooperatively regulate blm gene expression by directly targeting the utr in pc cell blm recq like helicase blm ha a pivotal role in genetic recombination transcription dna replication and dna repair which present the possibility of using blm a an anticancer target for treatment however the posttranscriptional control regulation of blm gene expression is not fully understood and limit the application of drug targeting blm for carcinoma therapy in the future micrornas mirnas inhibit gene expression through interaction with the untranslated region utr of mrna at the posttranscriptional stage therefore the current study screened for mirnas that regulate blm gene expression with software predicting that mirna mirbp mir mirp mirp and mirp blm gene expression level in the pc prostate cancer cell line and rwpe normal prostate epithelium cell line were detected by reverse transcriptionquantitative pcr additionally blm mrna level were following mirna overexpression for and h for further mirna filtration and validation a dualluciferase reporter system and western blot analysis were performed which demonstrated that mirbp and mir reduce blm gene expression by directly targeting the blm mrna utr a boxbehnken design experiment suggested that mirbp and mir have synergetic mutual effect on blm gene expression finally the suppressive effect of mirbp and mir on pc cell proliferation colony formation migration and invasion indicated the benefit of studying blm a a drug target in cancer in conclusion the finding of the current provide evidence that mirbp and mir have an oncosuppressive function in pc cell and cooperatively downregulate blm expression at the posttranscriptional level
30961661,gtse is involved in breast cancer progression in p mutationdependent manner,background with the rapid development of the high throughput detection technique tumorrelated omics data ha become an important source for studying the mechanism of tumor progression including breast cancer one of the major malignancy worldwide a previous study ha shown that the g and s phaseexpressed gtse can act a an oncogene in several human cancer however it functional role in breast cancer remain elusive method in this study we analyzed breast cancer data downloaded from the cancer genome atlas tcga database and other online database including the oncomine bcgenexminer and proggenev database to identify the molecule contributing to the progression of breast cancer the gtse expression level were investigated using qrtpcr immunoblotting and ihc the biological function of gtse in the growth migration and invasion of breast cancer wa examined in mdamb mdamb and mcf cell line the in vitro cell proliferative migratory and invasive ability were evaluated by mt colony formation and transwell assay respectively the role of gtse in the growth and metastasis of breast cancer were revealed by in vivo investigation using balbc nude mouse result we showed that the expression level of gtse wa upregulated in breast cancer specimen and cell line especially in triple negative breast cancer tnbc and p mutated breast cancer cell line importantly high gtse expression wa positively correlated with histological grade and poor survival we demonstrated that gtse could promote breast cancer cell growth by activating the akt pathway and enhance metastasis by regulating the epithelialmesenchymal transition emt pathway furthermore it could cause multidrug resistance in breast cancer cell interestingly we found that gtse could regulate the p function to alter the cell cycle distribution dependent on the mutation state of p conclusion our result reveal that gtse played a key role in the progression of breast cancer indicating that gtse could serve a a novel biomarker to aid in the assessment of the prognosis of breast cancer,Cancer,0,gtse is involved in breast cancer progression in p mutationdependent manner background with the rapid development of the high throughput detection technique tumorrelated omics data ha become an important source for studying the mechanism of tumor progression including breast cancer one of the major malignancy worldwide a previous study ha shown that the g and s phaseexpressed gtse can act a an oncogene in several human cancer however it functional role in breast cancer remain elusive method in this study we analyzed breast cancer data downloaded from the cancer genome atlas tcga database and other online database including the oncomine bcgenexminer and proggenev database to identify the molecule contributing to the progression of breast cancer the gtse expression level were investigated using qrtpcr immunoblotting and ihc the biological function of gtse in the growth migration and invasion of breast cancer wa examined in mdamb mdamb and mcf cell line the in vitro cell proliferative migratory and invasive ability were evaluated by mt colony formation and transwell assay respectively the role of gtse in the growth and metastasis of breast cancer were revealed by in vivo investigation using balbc nude mouse result we showed that the expression level of gtse wa upregulated in breast cancer specimen and cell line especially in triple negative breast cancer tnbc and p mutated breast cancer cell line importantly high gtse expression wa positively correlated with histological grade and poor survival we demonstrated that gtse could promote breast cancer cell growth by activating the akt pathway and enhance metastasis by regulating the epithelialmesenchymal transition emt pathway furthermore it could cause multidrug resistance in breast cancer cell interestingly we found that gtse could regulate the p function to alter the cell cycle distribution dependent on the mutation state of p conclusion our result reveal that gtse played a key role in the progression of breast cancer indicating that gtse could serve a a novel biomarker to aid in the assessment of the prognosis of breast cancer
30962859,increased breast cancer risk in woman with neurofibromatosis type a metaanalysis and systematic review of the literature,background neurofibromatosis type nf is a cancer predisposing syndrome study suggest that woman v stage iiiiv respectively p median survival for the entire cohort wa year v the reported median bc survival of over year in the general population using the seer database median age at bc death wa year of deceased patient were yo conclusion this systematic literature review and metaanalysis suggests that woman with nf yo have a fivefold increased risk of bc present with more advanced disease and may have an increased bc related mortality increased awareness and implementation of recent national comprehensive cancer network early bc screening guideline for this highrisk patient population is essential additional evaluation on the influence of nf gene mutation identified in patient undergoing hereditary cancer genetic testing on breast cancer risk in individual without clinical evidence of nf is needed,Cancer,0,increased breast cancer risk in woman with neurofibromatosis type a metaanalysis and systematic review of the literature background neurofibromatosis type nf is a cancer predisposing syndrome study suggest that woman v stage iiiiv respectively p median survival for the entire cohort wa year v the reported median bc survival of over year in the general population using the seer database median age at bc death wa year of deceased patient were yo conclusion this systematic literature review and metaanalysis suggests that woman with nf yo have a fivefold increased risk of bc present with more advanced disease and may have an increased bc related mortality increased awareness and implementation of recent national comprehensive cancer network early bc screening guideline for this highrisk patient population is essential additional evaluation on the influence of nf gene mutation identified in patient undergoing hereditary cancer genetic testing on breast cancer risk in individual without clinical evidence of nf is needed
30963251,an update on the central nervous system manifestation of neurofibromatosis type,neurofibromatosis nf is an autosomal dominant genetic disorder that present with variable phenotype a a result of mutation in the neurofibromatosis type nf gene and subsequently abnormal function of the protein product neurofibromin patient with nf are at increased risk for central nervous system cns manifestation including structural functional and neoplastic disease the mechanism underlying the varied manifestation of nf are incompletely understood but the loss of functional neurofibromin resulting in sustained activation of the oncoprotein ra is responsible for tumorigenesis throughout the body including the cns much of our understanding of nfrelated cns manifestation is from a combination of data from animal model and natural history study of people with nf and cns disease data from animal model suggest the importance of both nf mutation and somatic genetic alteration such a tp loss for development of neoplasm a well a the role of the timing of the acquisition of such alteration on the variability of cns manifestation a variety of nonneoplastic structural macrocephaly hydrocephalus aqueductal stenosis and vasculopathy and functional epilepsy impaired cognition attention deficit and autism spectrum disorder abnormality occur with variable frequency in individual with nf in addition there is increasing evidence that similar appearing cns neoplasm in people with and without the nf syndrome are due to distinct oncogenic pathway glioma in people with nf show alteration in the rasmapk pathway generally in the absence of braf alteration common to sporadic pilocytic astrocytomas or idh or histone h mutation common to diffuse glioma subset a subset of lowgrade astrocytomas in these patient remain difficult to classify using standard criterion and occasionally demonstrate morphologic feature resembling subependymal giant cell astrocytomas that afflict patient with tuberous sclerosis complex segalike astrocytomas there is also emerging evidence that nfassociated highgrade astrocytomas have frequent coexisting alteration such a atrx mutation and an alternative lengthening of telomere alt phenotype responsible for unique biologic property ongoing effort are seeking to improve diagnostic accuracy for cns neoplasm in the setting of nf versus sporadic tumor in addition mek inhibitor which act on the rasmapk pathway continue to be studied a rational target for the treatment of nfassociated tumor including cns tumor,Cancer,0,an update on the central nervous system manifestation of neurofibromatosis type neurofibromatosis nf is an autosomal dominant genetic disorder that present with variable phenotype a a result of mutation in the neurofibromatosis type nf gene and subsequently abnormal function of the protein product neurofibromin patient with nf are at increased risk for central nervous system cns manifestation including structural functional and neoplastic disease the mechanism underlying the varied manifestation of nf are incompletely understood but the loss of functional neurofibromin resulting in sustained activation of the oncoprotein ra is responsible for tumorigenesis throughout the body including the cns much of our understanding of nfrelated cns manifestation is from a combination of data from animal model and natural history study of people with nf and cns disease data from animal model suggest the importance of both nf mutation and somatic genetic alteration such a tp loss for development of neoplasm a well a the role of the timing of the acquisition of such alteration on the variability of cns manifestation a variety of nonneoplastic structural macrocephaly hydrocephalus aqueductal stenosis and vasculopathy and functional epilepsy impaired cognition attention deficit and autism spectrum disorder abnormality occur with variable frequency in individual with nf in addition there is increasing evidence that similar appearing cns neoplasm in people with and without the nf syndrome are due to distinct oncogenic pathway glioma in people with nf show alteration in the rasmapk pathway generally in the absence of braf alteration common to sporadic pilocytic astrocytomas or idh or histone h mutation common to diffuse glioma subset a subset of lowgrade astrocytomas in these patient remain difficult to classify using standard criterion and occasionally demonstrate morphologic feature resembling subependymal giant cell astrocytomas that afflict patient with tuberous sclerosis complex segalike astrocytomas there is also emerging evidence that nfassociated highgrade astrocytomas have frequent coexisting alteration such a atrx mutation and an alternative lengthening of telomere alt phenotype responsible for unique biologic property ongoing effort are seeking to improve diagnostic accuracy for cns neoplasm in the setting of nf versus sporadic tumor in addition mek inhibitor which act on the rasmapk pathway continue to be studied a rational target for the treatment of nfassociated tumor including cns tumor
30963570,nonve braf mutation and egfr signaling pathway in colorectal cancer,the raf murine sarcoma viral oncogene homolog b brafve mutation mt in metastatic colorectal cancer crc is a wellknown prognostic indicator and a negative predictive biomarker for antiepidermal growth factor receptor egfr treatment however the clinical characteristic and significance of brafnonve mt remain unclear here we evaluated the clinical characteristic of brafnonve mt v those of other mt in the egfr signaling pathway including brafve consecutive crc patient in our institute from june to november were enrolled in our study multiplex genotyping of the egfr pathway wa performed with archival sample using a luminex assay for brafve brafnonve krasnras exon and phosphatidylinositolbisphosphate kinase catalytic subunit alpha pikca we analyzed correlation among the mt profile clinical data and primary tumor location in crc all statistical analysis were performed using r software crc sample from male and female patient were analyzed of which or had stage i ii iii or iv or recurrent crc respectively the frequency of brafve brafnonve kras including exon nra and pikca mt were and respectively the characteristic of patient with the brafve mt were an age of year old a rightsided primary tumor location poorly differentiated histology and an advanced disease stage in contrast the characteristic of patient with brafnonve mt were a leftsided primary tumor location and welldifferentiated histology brafnonve mt were relatively rare and showed different characteristic compared to the brafve mt these result may contribute to future precision medicine,Cancer,0,nonve braf mutation and egfr signaling pathway in colorectal cancer the raf murine sarcoma viral oncogene homolog b brafve mutation mt in metastatic colorectal cancer crc is a wellknown prognostic indicator and a negative predictive biomarker for antiepidermal growth factor receptor egfr treatment however the clinical characteristic and significance of brafnonve mt remain unclear here we evaluated the clinical characteristic of brafnonve mt v those of other mt in the egfr signaling pathway including brafve consecutive crc patient in our institute from june to november were enrolled in our study multiplex genotyping of the egfr pathway wa performed with archival sample using a luminex assay for brafve brafnonve krasnras exon and phosphatidylinositolbisphosphate kinase catalytic subunit alpha pikca we analyzed correlation among the mt profile clinical data and primary tumor location in crc all statistical analysis were performed using r software crc sample from male and female patient were analyzed of which or had stage i ii iii or iv or recurrent crc respectively the frequency of brafve brafnonve kras including exon nra and pikca mt were and respectively the characteristic of patient with the brafve mt were an age of year old a rightsided primary tumor location poorly differentiated histology and an advanced disease stage in contrast the characteristic of patient with brafnonve mt were a leftsided primary tumor location and welldifferentiated histology brafnonve mt were relatively rare and showed different characteristic compared to the brafve mt these result may contribute to future precision medicine
30964475,endosomal escape by photoactivated fusion of liposome containing a malachite green derivative a novel class of photoresponsive liposome for drug delivery vehicle,we conducted photoactivated delivery of drug based on the fusion of liposome with endocytic membrane thus allowing the direct release of encapsulated drug inside the cytoplasm a described in our earlier work liposome can be photoresponsive and fusogenic following the incorporation of a malachite green derivative carrying a long alkyl chain mgl into the lipid membrane we prepared mgl liposome using palmitoyloleoylsnglycerophosphatidylcholine and encapsulated doxorubicin dox though the shape of mgl liposome became elliptical after encapsulating dox uv irradiation did not enhance dox leakage from mgl liposome we demonstrated the cellular uptake of mgl liposome into murine cell derived from colon cancer colon cell using flow cytometry and we found that the uptake wa governed by a clathrindependent endocytosis pathway confocal fluorescence microscopic observation of colon cell treated with mgl liposome encapsulating dox revealed that dox wa localized in endosomes under dark condition while dox wa observed in the cytosol and nucleus after uv irradiation the viability of colon cell treated with mgl liposome encapsulating dox wa reduced by uv irradiation indicating photoinduced enhancement of anticancer efficacy,Cancer,0,endosomal escape by photoactivated fusion of liposome containing a malachite green derivative a novel class of photoresponsive liposome for drug delivery vehicle we conducted photoactivated delivery of drug based on the fusion of liposome with endocytic membrane thus allowing the direct release of encapsulated drug inside the cytoplasm a described in our earlier work liposome can be photoresponsive and fusogenic following the incorporation of a malachite green derivative carrying a long alkyl chain mgl into the lipid membrane we prepared mgl liposome using palmitoyloleoylsnglycerophosphatidylcholine and encapsulated doxorubicin dox though the shape of mgl liposome became elliptical after encapsulating dox uv irradiation did not enhance dox leakage from mgl liposome we demonstrated the cellular uptake of mgl liposome into murine cell derived from colon cancer colon cell using flow cytometry and we found that the uptake wa governed by a clathrindependent endocytosis pathway confocal fluorescence microscopic observation of colon cell treated with mgl liposome encapsulating dox revealed that dox wa localized in endosomes under dark condition while dox wa observed in the cytosol and nucleus after uv irradiation the viability of colon cell treated with mgl liposome encapsulating dox wa reduced by uv irradiation indicating photoinduced enhancement of anticancer efficacy
30967556,defective homologous recombination dna repair a therapeutic target in advanced chordoma,chordomas are rare bone tumor with few therapeutic option here we show using wholeexome and genome sequencing within a precision oncology program that advanced chordomas n may be characterized by genomic pattern indicative of defective homologous recombination hr dna repair and alteration affecting hrrelated gene including for example deletion and pathogenic germline variant of brca nbn and chek a mutational signature associated with hr deficiency wa significantly enriched in of sample and cooccurred with genomic instability the polyadpribose polymerase parp inhibitor olaparib which is preferentially toxic to hrincompetent cell led to prolonged clinical benefit in a patient with refractory chordoma and wholegenome analysis at progression revealed a parp pta mutation predicted to disrupt the autoinhibitory parp helical domain these finding uncover a therapeutic opportunity in chordoma that warrant further exploration and provide insight into the mechanism underlying parp inhibitor resistance,Cancer,0,defective homologous recombination dna repair a therapeutic target in advanced chordoma chordomas are rare bone tumor with few therapeutic option here we show using wholeexome and genome sequencing within a precision oncology program that advanced chordomas n may be characterized by genomic pattern indicative of defective homologous recombination hr dna repair and alteration affecting hrrelated gene including for example deletion and pathogenic germline variant of brca nbn and chek a mutational signature associated with hr deficiency wa significantly enriched in of sample and cooccurred with genomic instability the polyadpribose polymerase parp inhibitor olaparib which is preferentially toxic to hrincompetent cell led to prolonged clinical benefit in a patient with refractory chordoma and wholegenome analysis at progression revealed a parp pta mutation predicted to disrupt the autoinhibitory parp helical domain these finding uncover a therapeutic opportunity in chordoma that warrant further exploration and provide insight into the mechanism underlying parp inhibitor resistance
30968154,diverse and cancer typespecific role of the p rq gainoffunction mutation in cancer migration and invasiveness,gainoffunction gof mutation in the tp gene lead to acquisition of new function by the mutated tumor suppressor p protein a number of the overrepresented hot spot mutation including the one in codon or convey gof phenotype such phenotype may include resistance to chemotherapeutics or change in motility and invasiveness whereas the prevalent notion is that the acquisition of the p gof phenotype translates into poorer prognosis for the patient the analysis of a human somatic p mutation dataset demonstrated earlier tumor onset but decreased frequency and altered location of metastasis in patient with the prq allele therefore the gof activity of prq and pdg were analyzed in triple negative breast cancer mdamb and lung adenocarcinoma h cell line with regard to invasive and metastatic trait the expression of pdg increased the motility and invasiveness of the lung cancer cell but not those of the breast cancer cell in contrast the expression of prq decreased the motility and invasiveness of the breast and lung cancer cell in a p transactivationdependent manner the intravenous xenotransplantation of mdamb cell expressing prq into zebrafish embryo resulted in an alteration of the distribution of cancer cell in the body of the fish in prqexpressing h cell a decrease in the expression of tcfzeb and ncadherin wa observed suggesting partial mesenchymaltoepithelial transition in the two cell line expressing prq a decrease wa noted in the expression of myosin light chain a protein involved in actomyosinbased motility to the best of our knowledge the present study is one of only few report demonstrating the mutated p gof activity resulting in a decrease of a malignant trait in human cancer,Cancer,0,diverse and cancer typespecific role of the p rq gainoffunction mutation in cancer migration and invasiveness gainoffunction gof mutation in the tp gene lead to acquisition of new function by the mutated tumor suppressor p protein a number of the overrepresented hot spot mutation including the one in codon or convey gof phenotype such phenotype may include resistance to chemotherapeutics or change in motility and invasiveness whereas the prevalent notion is that the acquisition of the p gof phenotype translates into poorer prognosis for the patient the analysis of a human somatic p mutation dataset demonstrated earlier tumor onset but decreased frequency and altered location of metastasis in patient with the prq allele therefore the gof activity of prq and pdg were analyzed in triple negative breast cancer mdamb and lung adenocarcinoma h cell line with regard to invasive and metastatic trait the expression of pdg increased the motility and invasiveness of the lung cancer cell but not those of the breast cancer cell in contrast the expression of prq decreased the motility and invasiveness of the breast and lung cancer cell in a p transactivationdependent manner the intravenous xenotransplantation of mdamb cell expressing prq into zebrafish embryo resulted in an alteration of the distribution of cancer cell in the body of the fish in prqexpressing h cell a decrease in the expression of tcfzeb and ncadherin wa observed suggesting partial mesenchymaltoepithelial transition in the two cell line expressing prq a decrease wa noted in the expression of myosin light chain a protein involved in actomyosinbased motility to the best of our knowledge the present study is one of only few report demonstrating the mutated p gof activity resulting in a decrease of a malignant trait in human cancer
30970592,different clinical presentation and management in complete androgen insensitivity syndrome cais,complete androgen insensitivity syndrome cais is an xlinked recessive genetic disorder resulting from maternally inherited or de novo mutation involving the androgen receptor gene situated in the xqq region the diagnosis is based on the presence of female external genitalia in a xy human individual with normally developed but undescended testis and complete unresponsiveness of target tissue to androgen subsequently pelvic ultrasound or magnetic resonance imaging mri could be helpful in confirming the absence of mullerian structure revealing the presence of a blindending vagina and identifying testis cais management still represents a unique challenge throughout childhood and adolescence particularly regarding timing of gonadectomy type of hormonal therapy and psychological concern indeed this condition is associated with an increased risk of testicular germ cell tumour tgct although tgct result less frequently than in other disorder of sex development dsd furthermore the majority of detected tumoral lesion are noninvasive and with a low probability of progression into aggressive form therefore histological epidemiological and prognostic feature of testicular cancer in cais allow postponing of the gonadectomy until after pubertal age in order to guarantee the initial spontaneous pubertal development and avoid the necessity of hormonal replacement therapy hrt induction however hrt is necessary after gonadectomy in order to prevent symptom of hypoestrogenism and to maintain secondary sexual feature this article present differential clinical presentation and management in patient with cais to emphasize the continued importance of standardizing the clinical and surgical approach to this disorder,Cancer,0,different clinical presentation and management in complete androgen insensitivity syndrome cais complete androgen insensitivity syndrome cais is an xlinked recessive genetic disorder resulting from maternally inherited or de novo mutation involving the androgen receptor gene situated in the xqq region the diagnosis is based on the presence of female external genitalia in a xy human individual with normally developed but undescended testis and complete unresponsiveness of target tissue to androgen subsequently pelvic ultrasound or magnetic resonance imaging mri could be helpful in confirming the absence of mullerian structure revealing the presence of a blindending vagina and identifying testis cais management still represents a unique challenge throughout childhood and adolescence particularly regarding timing of gonadectomy type of hormonal therapy and psychological concern indeed this condition is associated with an increased risk of testicular germ cell tumour tgct although tgct result less frequently than in other disorder of sex development dsd furthermore the majority of detected tumoral lesion are noninvasive and with a low probability of progression into aggressive form therefore histological epidemiological and prognostic feature of testicular cancer in cais allow postponing of the gonadectomy until after pubertal age in order to guarantee the initial spontaneous pubertal development and avoid the necessity of hormonal replacement therapy hrt induction however hrt is necessary after gonadectomy in order to prevent symptom of hypoestrogenism and to maintain secondary sexual feature this article present differential clinical presentation and management in patient with cais to emphasize the continued importance of standardizing the clinical and surgical approach to this disorder
30971355,prevalence and prognostic value of ckit and tp mutation in canine mast cell tumour,cutaneous mast cell tumour mct are among the most frequent malignancy in dog their clinical behaviour is highly variable and with the exception of mutation in the ckit gene little is known about their genetic aetiology the mutational status of the ckit exon and and exon of the tp gene wa analysed to find marker for molecular stratification of mcts and predictor of clinical outcome mutation in the ckit gene were detected in n sample and their presence wa significantly associated with the high histopathological grade p mutation in the dna binding domain of the tp gene were found in n of the analysed mcts and their frequency wa similar in low and high grade mcts p tp mutation were not useful prognostic factor in this sample of canine cutaneous mcts,Cancer,0,prevalence and prognostic value of ckit and tp mutation in canine mast cell tumour cutaneous mast cell tumour mct are among the most frequent malignancy in dog their clinical behaviour is highly variable and with the exception of mutation in the ckit gene little is known about their genetic aetiology the mutational status of the ckit exon and and exon of the tp gene wa analysed to find marker for molecular stratification of mcts and predictor of clinical outcome mutation in the ckit gene were detected in n sample and their presence wa significantly associated with the high histopathological grade p mutation in the dna binding domain of the tp gene were found in n of the analysed mcts and their frequency wa similar in low and high grade mcts p tp mutation were not useful prognostic factor in this sample of canine cutaneous mcts
30971541,the diagnostic significance of trophoblast cellsurface antigen expression in benign and malignant thyroid lesion,context thyroid cancer are the most common malignancy of the endocrine system overexpression of trophoblast cellsurface antigen trop in various tumor ha been found to correlate with poor prognosis and aggressive tumor behavior aim the aim of this study wa to evaluatetrop expression in thyroid neoplasm subject and method this study contained case including follicular nodular disease fnd follicular adenoma fa papillary thyroid carcinoma ptc follicular thyroid carcinoma ftc medullary thyroid carcinoma mtc poorly differentiated thyroid carcinoma pdtc and undifferentiated thyroid carcinoma udtc trop expression wa investigated via immunohistochemistry in section prepared from paraffin block of the case result the case comprised male and female with a mean age of year range year trop expression wa observed in of the malignant lesion of the thyroid except for medullary carcinoma poorly differentiated and undifferentiated thyroid carcinoma immunoreactivity wa in fa of case with ftc and in ptc follicular variant ptc fv the difference between faftc and faptc follicular variant were both significant p p respectively there wa no difference between ftcptc fv p conclusion trop can be considered a useful marker for distinguishing ptc fv case from follicular nodular disease and follicular adenoma case because of it high sensitivity in the identification of papillary carcinoma of the thyroid,Cancer,0,the diagnostic significance of trophoblast cellsurface antigen expression in benign and malignant thyroid lesion context thyroid cancer are the most common malignancy of the endocrine system overexpression of trophoblast cellsurface antigen trop in various tumor ha been found to correlate with poor prognosis and aggressive tumor behavior aim the aim of this study wa to evaluatetrop expression in thyroid neoplasm subject and method this study contained case including follicular nodular disease fnd follicular adenoma fa papillary thyroid carcinoma ptc follicular thyroid carcinoma ftc medullary thyroid carcinoma mtc poorly differentiated thyroid carcinoma pdtc and undifferentiated thyroid carcinoma udtc trop expression wa investigated via immunohistochemistry in section prepared from paraffin block of the case result the case comprised male and female with a mean age of year range year trop expression wa observed in of the malignant lesion of the thyroid except for medullary carcinoma poorly differentiated and undifferentiated thyroid carcinoma immunoreactivity wa in fa of case with ftc and in ptc follicular variant ptc fv the difference between faftc and faptc follicular variant were both significant p p respectively there wa no difference between ftcptc fv p conclusion trop can be considered a useful marker for distinguishing ptc fv case from follicular nodular disease and follicular adenoma case because of it high sensitivity in the identification of papillary carcinoma of the thyroid
30971562,posttransplant epithelioid inflammatory myofibroblastic sarcoma a case report,epithelioid inflammatory myofibroblastic sarcoma eims is a rare entity and a novel variant of inflammatory myofibroblastic tumor imt usually seen in child and nonsmoking young adult their occurrence in a posttransplant setting is still rare these tumor are characterized by prominent epithelioid morphology large histiocytoid reed sternberglike cell unique pattern of alk immunoreactivity and aggressive clinical behavior their etiology and metastatic potential is controversial in a posttransplant setting many factor such a trauma infection with ebv hiv hepatitis c mycobacteria fungus and chemotherapyinduced immunosuppression have been implicated in their etiology we present the case of a yearold female child who developed multiple omental and mesenteric tumor nodule month post liver transplant for progressive familial intrahepatic cholestasis pfic following a histopathological diagnosis of mesenchymal neoplasm of possible malignant nature on a trucut biopsy and frozen section tumor debulking wa performed a final histological diagnosis of emis wa made on the completely resected tumor the patient remains in remission nearly month after presentation without any followup systemic chemotherapy imt after a solid organ transplant is rare only case have been reported in the literature until now similar phenomenon ha also been noted with hematopoietic stem cell transplant however to our knowledge this case of emis in a post liver transplant patient is first of it kind,Cancer,0,posttransplant epithelioid inflammatory myofibroblastic sarcoma a case report epithelioid inflammatory myofibroblastic sarcoma eims is a rare entity and a novel variant of inflammatory myofibroblastic tumor imt usually seen in child and nonsmoking young adult their occurrence in a posttransplant setting is still rare these tumor are characterized by prominent epithelioid morphology large histiocytoid reed sternberglike cell unique pattern of alk immunoreactivity and aggressive clinical behavior their etiology and metastatic potential is controversial in a posttransplant setting many factor such a trauma infection with ebv hiv hepatitis c mycobacteria fungus and chemotherapyinduced immunosuppression have been implicated in their etiology we present the case of a yearold female child who developed multiple omental and mesenteric tumor nodule month post liver transplant for progressive familial intrahepatic cholestasis pfic following a histopathological diagnosis of mesenchymal neoplasm of possible malignant nature on a trucut biopsy and frozen section tumor debulking wa performed a final histological diagnosis of emis wa made on the completely resected tumor the patient remains in remission nearly month after presentation without any followup systemic chemotherapy imt after a solid organ transplant is rare only case have been reported in the literature until now similar phenomenon ha also been noted with hematopoietic stem cell transplant however to our knowledge this case of emis in a post liver transplant patient is first of it kind
30971563,epithelioid sarcoma of paratesticular region a case report of an unusual case,primary tumor of the paratesticular region are rare with sarcoma constituting a major proportion particularly in the old age the paratesticular region consists of mesothelial various epithelial and mesenchymal cell and may therefore give rise to a variety of tumor epithelioid sarcoma usually occurs at the distal extremity of young adult the proximaltype variant is characterized by a more aggressive course and resistance to treatment we herein report a case of year male with scrotal swelling diagnosed a proximaltype epithelioid sarcoma of paratesticular region after histopathological examination and immunohistochemistry to the best of our knowledge this is only the second case of proximal epithelioid sarcoma of paratesticular region in the english literature a these tumor are rare it ha been difficult to establish their optimal treatment also these can be easily misdiagnosed a other epithelioid lesion,Cancer,0,epithelioid sarcoma of paratesticular region a case report of an unusual case primary tumor of the paratesticular region are rare with sarcoma constituting a major proportion particularly in the old age the paratesticular region consists of mesothelial various epithelial and mesenchymal cell and may therefore give rise to a variety of tumor epithelioid sarcoma usually occurs at the distal extremity of young adult the proximaltype variant is characterized by a more aggressive course and resistance to treatment we herein report a case of year male with scrotal swelling diagnosed a proximaltype epithelioid sarcoma of paratesticular region after histopathological examination and immunohistochemistry to the best of our knowledge this is only the second case of proximal epithelioid sarcoma of paratesticular region in the english literature a these tumor are rare it ha been difficult to establish their optimal treatment also these can be easily misdiagnosed a other epithelioid lesion
30973434,the effect of inhaler aromatherapy on invasive pain procedure adherence vital sign and saturation during port catheterization in oncology patient,the study wa conducted to evaluate the effect of inhaler aromatherapy on invasive pain procedure adherence vital sign and saturation during port catheter insertion among patient diagnosed with cancer the study wa conducted in a nonrandomized controlled trial sixty patient including patient in the intervention group and patient in the control group who were subjected with the same local anesthetic protocol were included in the study aromatic mixture prepared by diluting orange chamomile and lavender oil in ml distilled water wa inhaled by the intervention group during the procedure the data of the study were collected by using questionnaire vital followup form and visual analog scale the patient in the intervention and control group were similar in term of sociodemographic and disease characteristic p it wa determined that inhaler aromatherapy applied to patient in the intervention group decreased pain experienced during the procedure and facilitated the procedure adherence p it can be recommended to administer inhaler aromatherapy with pharmacological therapy during catheterization procedure since it decrease invasive pain and facilitates the procedure adherence,Cancer,0,the effect of inhaler aromatherapy on invasive pain procedure adherence vital sign and saturation during port catheterization in oncology patient the study wa conducted to evaluate the effect of inhaler aromatherapy on invasive pain procedure adherence vital sign and saturation during port catheter insertion among patient diagnosed with cancer the study wa conducted in a nonrandomized controlled trial sixty patient including patient in the intervention group and patient in the control group who were subjected with the same local anesthetic protocol were included in the study aromatic mixture prepared by diluting orange chamomile and lavender oil in ml distilled water wa inhaled by the intervention group during the procedure the data of the study were collected by using questionnaire vital followup form and visual analog scale the patient in the intervention and control group were similar in term of sociodemographic and disease characteristic p it wa determined that inhaler aromatherapy applied to patient in the intervention group decreased pain experienced during the procedure and facilitated the procedure adherence p it can be recommended to administer inhaler aromatherapy with pharmacological therapy during catheterization procedure since it decrease invasive pain and facilitates the procedure adherence
30974190,clinical spectrum of lifraumeni syndromelifraumenilike syndrome in brazilian individual with the tp prh mutation,background the tp prh germline mutation is highly prevalent among child with adrenocortical tumor act from south and southeast brazil however the prevalence of other tumor of the lifraumeni syndrome lf and lifraumenilike syndrome lfl spectrum the clinical outcome and the potential tumor occurrence in relative carrying this distinct tp mutation were not fully investigated patient and method we investigated tumor profile data and outcome of individual and their close relative with the tp prh germline mutation a questionnaire and the toronto protocol were used for evaluation of asymptomatic carrier of this tp mutation result the cohort of this study comprised patient from different family were female all but one harbored the tp prh mutation in heterozygous state only one child wa homozygous for this variant maternal allele inheritance occurred in of the case p in pediatric group act wa the most common primary tumor at the diagnosis median age year no patient of the pediatric group who initially presented with act developed a second primary tumor and n died due to complication related to the primary tumor median followup time of month range month in adult group the main tumor at diagnosis were adrenocortical carcinoma acc median age year breast cancer median age year soft tissue sarcoma median age year and choroid plexus carcinoma cpc median age year among adult patient who were diagnosed with acc a the first primary tumor all presented with aggressive disease a per histologic and clinical criterion at diagnosis and of patient died median followup time of month range month five adult patient had a second primary tumor including bronchoalveolar lung cancer case acc uterine cervical carcinoma and fibrosarcoma the diagnosis of these tumor wa established from to month after the first primary tumor three family presented more than one case of act nine malignant neoplasm were diagnosed in asymptomatic carrier using toronto protocol conclusion this study confirms a high frequency of tp prh mutation in pediatric group with act in addition we observed the occurrence of other tumor of lfslfl spectrum and a difference in the aggressiveness of act depending on the age group in which they were diagnosed the predominance of maternal mutated allele inheritance wa first demonstrated in the affected brazilian family,Cancer,0,clinical spectrum of lifraumeni syndromelifraumenilike syndrome in brazilian individual with the tp prh mutation background the tp prh germline mutation is highly prevalent among child with adrenocortical tumor act from south and southeast brazil however the prevalence of other tumor of the lifraumeni syndrome lf and lifraumenilike syndrome lfl spectrum the clinical outcome and the potential tumor occurrence in relative carrying this distinct tp mutation were not fully investigated patient and method we investigated tumor profile data and outcome of individual and their close relative with the tp prh germline mutation a questionnaire and the toronto protocol were used for evaluation of asymptomatic carrier of this tp mutation result the cohort of this study comprised patient from different family were female all but one harbored the tp prh mutation in heterozygous state only one child wa homozygous for this variant maternal allele inheritance occurred in of the case p in pediatric group act wa the most common primary tumor at the diagnosis median age year no patient of the pediatric group who initially presented with act developed a second primary tumor and n died due to complication related to the primary tumor median followup time of month range month in adult group the main tumor at diagnosis were adrenocortical carcinoma acc median age year breast cancer median age year soft tissue sarcoma median age year and choroid plexus carcinoma cpc median age year among adult patient who were diagnosed with acc a the first primary tumor all presented with aggressive disease a per histologic and clinical criterion at diagnosis and of patient died median followup time of month range month five adult patient had a second primary tumor including bronchoalveolar lung cancer case acc uterine cervical carcinoma and fibrosarcoma the diagnosis of these tumor wa established from to month after the first primary tumor three family presented more than one case of act nine malignant neoplasm were diagnosed in asymptomatic carrier using toronto protocol conclusion this study confirms a high frequency of tp prh mutation in pediatric group with act in addition we observed the occurrence of other tumor of lfslfl spectrum and a difference in the aggressiveness of act depending on the age group in which they were diagnosed the predominance of maternal mutated allele inheritance wa first demonstrated in the affected brazilian family
30975761,inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy,survival from malignant mesothelioma particularly pleural mesothelioma is very poor for patient with breast ovarian or prostate cancer overall survival is associated with increased sensitivity to platinum chemotherapy due to lossoffunction mutation in dna repair gene the goal of this project wa to evaluate in patient with malignant mesothelioma the relationship between inherited lossoffunction mutation in dna repair and other tumor suppressor gene and overall survival following platinum chemotherapy patient with histologically confirmed malignant mesothelioma were evaluated for inherited mutation in tumor suppressor gene survival wa evaluated with respect to genotype and site of mesothelioma among patient treated with platinum chemotherapy median overall survival wa significantly longer for patient with lossoffunction mutation in any of the targeted gene compared with patient with no such mutation p the effect of genotype wa highly significant for patient with pleural mesothelioma median survival y versus y p but not for patient with peritoneal mesothelioma median survival y versus y p effect of patient genotype on overall survival measured at y remained independently significant after adjusting for gender and age at diagnosis two other known prognostic factor patient with pleural mesothelioma with inherited mutation in dna repair and other tumor suppressor gene appear to particularly benefit from platinum chemotherapy compared with patient without inherited mutation these patient may also benefit from other dna repair targeted therapy such a polyadp ribose polymerase parp inhibitor,Cancer,0,inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy survival from malignant mesothelioma particularly pleural mesothelioma is very poor for patient with breast ovarian or prostate cancer overall survival is associated with increased sensitivity to platinum chemotherapy due to lossoffunction mutation in dna repair gene the goal of this project wa to evaluate in patient with malignant mesothelioma the relationship between inherited lossoffunction mutation in dna repair and other tumor suppressor gene and overall survival following platinum chemotherapy patient with histologically confirmed malignant mesothelioma were evaluated for inherited mutation in tumor suppressor gene survival wa evaluated with respect to genotype and site of mesothelioma among patient treated with platinum chemotherapy median overall survival wa significantly longer for patient with lossoffunction mutation in any of the targeted gene compared with patient with no such mutation p the effect of genotype wa highly significant for patient with pleural mesothelioma median survival y versus y p but not for patient with peritoneal mesothelioma median survival y versus y p effect of patient genotype on overall survival measured at y remained independently significant after adjusting for gender and age at diagnosis two other known prognostic factor patient with pleural mesothelioma with inherited mutation in dna repair and other tumor suppressor gene appear to particularly benefit from platinum chemotherapy compared with patient without inherited mutation these patient may also benefit from other dna repair targeted therapy such a polyadp ribose polymerase parp inhibitor
30975996,a requirement for stag in replication fork progression creates a targetable synthetic lethality in cohesinmutant cancer,cohesin is a multiprotein ring that is responsible for cohesion of sister chromatid and formation of dna loop to regulate gene expression genomic analysis have identified that the cohesin subunit stag is frequently inactivated by mutation in cancer however the reason stag mutation are selected during tumorigenesis and strategy for therapeutically targeting mutant cancer cell are largely unknown here we show that stag is essential for dna replication fork progression whereby stag inactivation in nontransformed cell lead to replication fork stalling and collapse with disruption of interaction between the cohesin ring and the replication machinery a well a failure to establish smc acetylation a a consequence stag mutation confers synthetic lethality with dna doublestrand break repair gene and increased sensitivity to select cytotoxic chemotherapeutic agent and parp or atr inhibitor these study identify a critical role for stag in replication fork procession and elucidate a potential therapeutic strategy for cohesinmutant cancer,Cancer,0,a requirement for stag in replication fork progression creates a targetable synthetic lethality in cohesinmutant cancer cohesin is a multiprotein ring that is responsible for cohesion of sister chromatid and formation of dna loop to regulate gene expression genomic analysis have identified that the cohesin subunit stag is frequently inactivated by mutation in cancer however the reason stag mutation are selected during tumorigenesis and strategy for therapeutically targeting mutant cancer cell are largely unknown here we show that stag is essential for dna replication fork progression whereby stag inactivation in nontransformed cell lead to replication fork stalling and collapse with disruption of interaction between the cohesin ring and the replication machinery a well a failure to establish smc acetylation a a consequence stag mutation confers synthetic lethality with dna doublestrand break repair gene and increased sensitivity to select cytotoxic chemotherapeutic agent and parp or atr inhibitor these study identify a critical role for stag in replication fork procession and elucidate a potential therapeutic strategy for cohesinmutant cancer
30980196,molecular carcinogenesis of gastric cancer lauren classification mucin phenotype expression and cancer stem cell,gastric cancer gc one of the most common human cancer is a heterogeneous disease with different phenotype prognosis and response to treatment understanding the pathogenesis of gc at the molecular level is important for prognosis prediction and determining treatment microsatellite instability msi silencing of mlh mgmt and cdkna gene by dna hypermethylation kras mutation apc mutation and erbb amplification are frequently found in intestinal type gc inactivation of cdh and rarb by dna hypermethylation and amplification of fgfr and met are frequently detected in diffuse type gc in addition bst and pcdhb gene are overexpressed in intestinal type gc both gene are associated with gc progression gc can be divided into gastricintestinal mucin phenotype according to mucin expression msi alteration of tp cdh mutation and dna methylation of mlh are detected frequently in the gastric mucin phenotype tp mutation deletion of apc and dna methylation of mgmt are detected frequently in the intestinal mucin phenotype fktn is overexpressed in the intestinal mucin phenotype and iqgap is overexpressed in the gastric mucin phenotype these gene are involved in gc progression to characterize cancer stem cell a useful method is spheroid colony formation kifc and kif gene show more than twofold higher expression in spheroidforming cell than that in parental cell both kif gene are overexpressed in gc and knockdown of these gene inhibits spheroid formation alteration of these molecule may be useful to understand gastric carcinogenesis specific inhibitor of these molecule may also be promising anticancer drug,Cancer,0,molecular carcinogenesis of gastric cancer lauren classification mucin phenotype expression and cancer stem cell gastric cancer gc one of the most common human cancer is a heterogeneous disease with different phenotype prognosis and response to treatment understanding the pathogenesis of gc at the molecular level is important for prognosis prediction and determining treatment microsatellite instability msi silencing of mlh mgmt and cdkna gene by dna hypermethylation kras mutation apc mutation and erbb amplification are frequently found in intestinal type gc inactivation of cdh and rarb by dna hypermethylation and amplification of fgfr and met are frequently detected in diffuse type gc in addition bst and pcdhb gene are overexpressed in intestinal type gc both gene are associated with gc progression gc can be divided into gastricintestinal mucin phenotype according to mucin expression msi alteration of tp cdh mutation and dna methylation of mlh are detected frequently in the gastric mucin phenotype tp mutation deletion of apc and dna methylation of mgmt are detected frequently in the intestinal mucin phenotype fktn is overexpressed in the intestinal mucin phenotype and iqgap is overexpressed in the gastric mucin phenotype these gene are involved in gc progression to characterize cancer stem cell a useful method is spheroid colony formation kifc and kif gene show more than twofold higher expression in spheroidforming cell than that in parental cell both kif gene are overexpressed in gc and knockdown of these gene inhibits spheroid formation alteration of these molecule may be useful to understand gastric carcinogenesis specific inhibitor of these molecule may also be promising anticancer drug
30985412,comparison of lmethylcmethionine pet with magnetic resonance spectroscopy in detecting newly diagnosed glioma,aim amino acid pet and magnetic resonance spectroscopy mr are at the forefront of noninvasive imaging technique used for detection and subtyping of gliomasuspicious lesion in this pilot study we compare lmethylcmethionine pet and mr for their ability to predict glioma subtypes method nineteen patient with histologically confirmed newly diagnosed glioma underwent preoperative lmethylcmethionine pet and mr in diagnostic session according to the molecular portfolio and histopathologic diagnosis patient were subdivided in isocitrate dehydrogenase idh wildtype glioblastoma idh wildtype grade iiiii glioma idhmutant grade iiiii glioma without pq codeletion and with pq codeletion subgroup maximum tumortobrain ratio tbrmax creatine choline and nacetyl aspartate peak were correlated with postoperative histopathologic tumor diagnosis result maximum tumortobrain ratio wa highest in glioblastoma patient followed by patient with idh wildtype grade ii and iii glioma the latter tbrmax value were higher compared with those in patient with idhmutant grade iiiii glioma without pq codeletion and in patient with idhmutant pq codeleted grade ii and iii glioma magnetic resonance spectroscopy marker distribution showed no clear trend receiver operating characteristic analysis revealed tbrmax to be the best performing parameter in identifying idh status area under the curve and all spectroscopy marker combined in identifying glioma subgroup area under the curve respectively conclusion lmethylcmethionine pet and mr bear limited potential in glioma subgrouping lmethylcmethionine pet appears to be superior in differentiating idh status whereas mr is more helpful in glioma subgrouping,Cancer,0,comparison of lmethylcmethionine pet with magnetic resonance spectroscopy in detecting newly diagnosed glioma aim amino acid pet and magnetic resonance spectroscopy mr are at the forefront of noninvasive imaging technique used for detection and subtyping of gliomasuspicious lesion in this pilot study we compare lmethylcmethionine pet and mr for their ability to predict glioma subtypes method nineteen patient with histologically confirmed newly diagnosed glioma underwent preoperative lmethylcmethionine pet and mr in diagnostic session according to the molecular portfolio and histopathologic diagnosis patient were subdivided in isocitrate dehydrogenase idh wildtype glioblastoma idh wildtype grade iiiii glioma idhmutant grade iiiii glioma without pq codeletion and with pq codeletion subgroup maximum tumortobrain ratio tbrmax creatine choline and nacetyl aspartate peak were correlated with postoperative histopathologic tumor diagnosis result maximum tumortobrain ratio wa highest in glioblastoma patient followed by patient with idh wildtype grade ii and iii glioma the latter tbrmax value were higher compared with those in patient with idhmutant grade iiiii glioma without pq codeletion and in patient with idhmutant pq codeleted grade ii and iii glioma magnetic resonance spectroscopy marker distribution showed no clear trend receiver operating characteristic analysis revealed tbrmax to be the best performing parameter in identifying idh status area under the curve and all spectroscopy marker combined in identifying glioma subgroup area under the curve respectively conclusion lmethylcmethionine pet and mr bear limited potential in glioma subgrouping lmethylcmethionine pet appears to be superior in differentiating idh status whereas mr is more helpful in glioma subgrouping
30987226,pathological and molecular feature of glioblastoma and it peritumoral tissue,glioblastoma gbm is one of the most aggressive and lethal human brain tumor at present gbms are divided in primary and secondary on the basis of the mutational status of the isocitrate dehydrogenase idh gene in addition idh and idh mutation are considered crucial to better define the prognosis although primary and secondary gbms are histologically indistinguishable they retain distinct genetic alteration that account for different evolution of the tumor the high invasiveness the propensity to disperse throughout the brain parenchyma and the elevated vascularity make these tumor extremely recidivist resulting in a short patient median survival even after surgical resection and chemoradiotherapy furthermore gbm is considered an immunologically cold tumor several study highlight a highly immunosuppressive tumor microenvironment that promotes recurrence and poor prognosis deeper insight into the tumor immune microenvironment together with the recent discovery of a conventional lymphatic system in the central nervous system cns led to new immunotherapeutic strategy in the last two decade experimental evidence from different group proved the existence of cancer stem cell cscs also known a tumorinitiating cell that may play an active role in tumor development and progression recent finding also indicated the presence of highly infiltrative cscs in the peritumoral region of gbm this region appears to play a key role in tumor growing and recurrence however until recently few study investigated the biomolecular characteristic of the peritumoral tissue the aim of this review is to recapitulate the pathological feature of gbm and of the peritumoral region associated with progression and recurrence,Cancer,0,pathological and molecular feature of glioblastoma and it peritumoral tissue glioblastoma gbm is one of the most aggressive and lethal human brain tumor at present gbms are divided in primary and secondary on the basis of the mutational status of the isocitrate dehydrogenase idh gene in addition idh and idh mutation are considered crucial to better define the prognosis although primary and secondary gbms are histologically indistinguishable they retain distinct genetic alteration that account for different evolution of the tumor the high invasiveness the propensity to disperse throughout the brain parenchyma and the elevated vascularity make these tumor extremely recidivist resulting in a short patient median survival even after surgical resection and chemoradiotherapy furthermore gbm is considered an immunologically cold tumor several study highlight a highly immunosuppressive tumor microenvironment that promotes recurrence and poor prognosis deeper insight into the tumor immune microenvironment together with the recent discovery of a conventional lymphatic system in the central nervous system cns led to new immunotherapeutic strategy in the last two decade experimental evidence from different group proved the existence of cancer stem cell cscs also known a tumorinitiating cell that may play an active role in tumor development and progression recent finding also indicated the presence of highly infiltrative cscs in the peritumoral region of gbm this region appears to play a key role in tumor growing and recurrence however until recently few study investigated the biomolecular characteristic of the peritumoral tissue the aim of this review is to recapitulate the pathological feature of gbm and of the peritumoral region associated with progression and recurrence
30987669,linc interacting with hnrnpd contributes to the proliferation and metastasis in colorectal cancer through activating wntbetacatenin signaling pathway,background long noncoding rna lncrnas have been identified to play an important role in the development and progression of various tumor including colorectal cancer crc however the regulatory molecular mechanism by lncrna in crc initiation and progression ha not been fully clarified method tcga database wa used to identify the involvement of linc in crc qrtpcr and western blot were used to determine rna and protein expression the gain and lossoffunction assay were conducted to explore the function of linc in the progression of crc in order to investigate the lincmediated mrna in crc tumorigenesis we applied the profiling analysis a well a go and kegg analysis pulldown and rip assay were applied to detect the interaction of hnrnpd with linc and betacatenin result the upregulation of linc in crc and it prognostic significance were identified by tcga database and confirmed in crc tissue functionally forced expression of linc promoted while knockdown of linc inhibited cell proliferation migration and emt phenotype formation of crc cell a significant enrichment of the wntbetacatenin signaling pathway gene under linc overexpression in addition linc modulated the mrna stability of betacatenin through interacting with hnrnpd thereby activating wntbetacatenin signaling pathway conclusion our investigation proposed novel regulatory axis of linchnrnpdwntbetacatenin which might be in favor of exploring novel therapeutic regimen for the clinical treatment of crc,Cancer,0,linc interacting with hnrnpd contributes to the proliferation and metastasis in colorectal cancer through activating wntbetacatenin signaling pathway background long noncoding rna lncrnas have been identified to play an important role in the development and progression of various tumor including colorectal cancer crc however the regulatory molecular mechanism by lncrna in crc initiation and progression ha not been fully clarified method tcga database wa used to identify the involvement of linc in crc qrtpcr and western blot were used to determine rna and protein expression the gain and lossoffunction assay were conducted to explore the function of linc in the progression of crc in order to investigate the lincmediated mrna in crc tumorigenesis we applied the profiling analysis a well a go and kegg analysis pulldown and rip assay were applied to detect the interaction of hnrnpd with linc and betacatenin result the upregulation of linc in crc and it prognostic significance were identified by tcga database and confirmed in crc tissue functionally forced expression of linc promoted while knockdown of linc inhibited cell proliferation migration and emt phenotype formation of crc cell a significant enrichment of the wntbetacatenin signaling pathway gene under linc overexpression in addition linc modulated the mrna stability of betacatenin through interacting with hnrnpd thereby activating wntbetacatenin signaling pathway conclusion our investigation proposed novel regulatory axis of linchnrnpdwntbetacatenin which might be in favor of exploring novel therapeutic regimen for the clinical treatment of crc
30989185,isolated bone marrow nonlangerhans cell histiocytosis preceding runxmutated acute myeloid leukemia case report and literature review,objective the prevalence of concomitant myeloid neoplasm wa recently reported to be unexpectedly high among adult without nonlangerhans cell histiocytosis nonlch however the coexistence of nonlch with runx genetic aberration ha not been reported previously method herein we report a yearold woman with severe pancytopenia diagnosed with nonlch following presentation with pancytopenia and marrow examination showing histiocytosis positive for cd cd cd and lysozyme but negative for cda langerin and s result wholeexome sequencing showed runx mutation and nf mutation in the ensuing month she developed hepatosplenomegaly and repeat bone marrow evaluation wa diagnostic of acute myeloid leukemia aml repeat mutational analysis showed again presence of runx mutation she underwent induction therapy but died of septic shock conclusion the demonstration of runx mutation in both nonlch and aml bone marrow specimen at differing time point is suggestive of a biologic association of both distinct disease entity,Cancer,0,isolated bone marrow nonlangerhans cell histiocytosis preceding runxmutated acute myeloid leukemia case report and literature review objective the prevalence of concomitant myeloid neoplasm wa recently reported to be unexpectedly high among adult without nonlangerhans cell histiocytosis nonlch however the coexistence of nonlch with runx genetic aberration ha not been reported previously method herein we report a yearold woman with severe pancytopenia diagnosed with nonlch following presentation with pancytopenia and marrow examination showing histiocytosis positive for cd cd cd and lysozyme but negative for cda langerin and s result wholeexome sequencing showed runx mutation and nf mutation in the ensuing month she developed hepatosplenomegaly and repeat bone marrow evaluation wa diagnostic of acute myeloid leukemia aml repeat mutational analysis showed again presence of runx mutation she underwent induction therapy but died of septic shock conclusion the demonstration of runx mutation in both nonlch and aml bone marrow specimen at differing time point is suggestive of a biologic association of both distinct disease entity
30989623,survival and prognostic factor in surgically treated brain metastasis,purpose while surgery and radiation remain the mainstay of therapy for all patient with brain metastasis bm the management is moving to a more individualized approach based on the underlying tumor we sought to identify prognostic factor of both intracranial progression icpfs and overall survival o in a surgical cohort method we retrospectively reviewed the record of patient treated surgically for bm at brigham and womens hospital kaplanmeier curve were used for o and icpfs and cox proportional hazard model were built to assess for predictive factor result common origin were lung breast and melanoma median o for the cohort wa month confidence interval ci breast cancer month ci and colorectal cancer month ci had the longest and shortest o respectively on multivariable cox regression significant prognostic factor of shorter o were age hr ci number of lesion hr ci extracranial spread at bm diagnosis hr ci and kp hr ci regarding molecular factor all driver mutation in lung adenocarcinoma had a favorable effect egfr hr ci alk hr ci kras hr ci triple negative status predicted poor prognosis in breast adenocarcinoma hr ci while no effect of brafnras mutation wa demonstrated in melanoma bm conclusion our result corroborate the role of tumor origin and systemic a well a intracranial spread in o heterogeneity within histology wa further explained by molecular alteration,Cancer,0,survival and prognostic factor in surgically treated brain metastasis purpose while surgery and radiation remain the mainstay of therapy for all patient with brain metastasis bm the management is moving to a more individualized approach based on the underlying tumor we sought to identify prognostic factor of both intracranial progression icpfs and overall survival o in a surgical cohort method we retrospectively reviewed the record of patient treated surgically for bm at brigham and womens hospital kaplanmeier curve were used for o and icpfs and cox proportional hazard model were built to assess for predictive factor result common origin were lung breast and melanoma median o for the cohort wa month confidence interval ci breast cancer month ci and colorectal cancer month ci had the longest and shortest o respectively on multivariable cox regression significant prognostic factor of shorter o were age hr ci number of lesion hr ci extracranial spread at bm diagnosis hr ci and kp hr ci regarding molecular factor all driver mutation in lung adenocarcinoma had a favorable effect egfr hr ci alk hr ci kras hr ci triple negative status predicted poor prognosis in breast adenocarcinoma hr ci while no effect of brafnras mutation wa demonstrated in melanoma bm conclusion our result corroborate the role of tumor origin and systemic a well a intracranial spread in o heterogeneity within histology wa further explained by molecular alteration
30990879,differential expression of wilms tumor protein in diffuse intrinsic pontine glioma,diffuse intrinsic pontine glioma dipgs are deadly tumor comprising of all childhood cns cancer standard treatment is considered palliative and prognosis is near universal mortality dipgs have been classified into genomic subtypes based on histone variant with the lysine to methionine mutation on position of histone tail km given the increasing promise of immunotherapy there have been ongoing effort to identify tumorspecific antigen to serve a immunologic target we evaluated a large cohort of cns specimen for wilms tumor protein wt expression these specimen include primary pediatric cns tumor n midline glioma and n nonmidline glioma n dipg n lowgrade glioma n highgrade glioma and dipg primary cell here we report the validation of wt a a tumorassociated antigen in dipgs we further report that wt expression is significantly correlated with specific oncohistone variant with the highest expression detected in the hkm subgroup wt expression wa absent in all control specimen n western blot assay using dipg primary cell n showed a trend of higher wt expression in hkm cell when compared with h km cell and h wildtype cell our data are the first indication of the association between wt and dipg with specific upregulation in those harboring oncohistone hkm,Cancer,0,differential expression of wilms tumor protein in diffuse intrinsic pontine glioma diffuse intrinsic pontine glioma dipgs are deadly tumor comprising of all childhood cns cancer standard treatment is considered palliative and prognosis is near universal mortality dipgs have been classified into genomic subtypes based on histone variant with the lysine to methionine mutation on position of histone tail km given the increasing promise of immunotherapy there have been ongoing effort to identify tumorspecific antigen to serve a immunologic target we evaluated a large cohort of cns specimen for wilms tumor protein wt expression these specimen include primary pediatric cns tumor n midline glioma and n nonmidline glioma n dipg n lowgrade glioma n highgrade glioma and dipg primary cell here we report the validation of wt a a tumorassociated antigen in dipgs we further report that wt expression is significantly correlated with specific oncohistone variant with the highest expression detected in the hkm subgroup wt expression wa absent in all control specimen n western blot assay using dipg primary cell n showed a trend of higher wt expression in hkm cell when compared with h km cell and h wildtype cell our data are the first indication of the association between wt and dipg with specific upregulation in those harboring oncohistone hkm
30992265,recommendation for the management of hemophagocytic lymphohistiocytosis in adult,hemophagocytic lymphohistiocytosis hlh is a severe hyperinflammatory syndrome induced by aberrantly activated macrophage and cytotoxic t cell the primary genetic form caused by mutation affecting lymphocyte cytotoxicity and immune regulation is most common in child whereas the secondary acquired form is most frequent in adult secondary hlh is commonly triggered by infection or malignancy but may also be induced by autoinflammatoryautoimmune disorder in which case it is called macrophage activation syndrome ma or mashlh most information on the diagnosis and treatment of hlh come from the pediatric literature although helpful in some adult case this raise several challenge for example the hlh diagnostic criterion developed for child are commonly applied but are not validated for adult another challenge in hlh diagnosis is that patient may present with a phenotype indistinguishable from sepsis or multiple organ dysfunction syndrome treatment algorithm targeting hyperinflammation are frequently based on pediatric protocol such a hlh and hlh which may result in overtreatment and unnecessary toxicity in adult therefore dose reduction individualized tailoring of treatment duration and an agedependent modified diagnostic approach are to be considered here we present expert opinion derived from an interdisciplinary working group on adult hlh sponsored by the histiocyte society to facilitate knowledge transfer between physician caring for pediatric and adult patient with hlh with the aim to improve the outcome for adult patient affected by hlh,Cancer,0,recommendation for the management of hemophagocytic lymphohistiocytosis in adult hemophagocytic lymphohistiocytosis hlh is a severe hyperinflammatory syndrome induced by aberrantly activated macrophage and cytotoxic t cell the primary genetic form caused by mutation affecting lymphocyte cytotoxicity and immune regulation is most common in child whereas the secondary acquired form is most frequent in adult secondary hlh is commonly triggered by infection or malignancy but may also be induced by autoinflammatoryautoimmune disorder in which case it is called macrophage activation syndrome ma or mashlh most information on the diagnosis and treatment of hlh come from the pediatric literature although helpful in some adult case this raise several challenge for example the hlh diagnostic criterion developed for child are commonly applied but are not validated for adult another challenge in hlh diagnosis is that patient may present with a phenotype indistinguishable from sepsis or multiple organ dysfunction syndrome treatment algorithm targeting hyperinflammation are frequently based on pediatric protocol such a hlh and hlh which may result in overtreatment and unnecessary toxicity in adult therefore dose reduction individualized tailoring of treatment duration and an agedependent modified diagnostic approach are to be considered here we present expert opinion derived from an interdisciplinary working group on adult hlh sponsored by the histiocyte society to facilitate knowledge transfer between physician caring for pediatric and adult patient with hlh with the aim to improve the outcome for adult patient affected by hlh
30996350,targeting lifmediated paracrine interaction for pancreatic cancer therapy and monitoring,pancreatic ductal adenocarcinoma pdac ha a dismal prognosis largely owing to inefficient diagnosis and tenacious drug resistance activation of pancreatic stellate cell pscs and consequent development of dense stroma are prominent feature accounting for this aggressive biology the reciprocal interplay between pscs and pancreatic cancer cell pccs not only enhances tumour progression and metastasis but also sustains their own activation facilitating a vicious cycle to exacerbate tumorigenesis and drug resistance furthermore psc activation occurs very early during pdac tumorigenesis and activated pscs comprise a substantial fraction of the tumour mass providing a rich source of readily detectable factor therefore we hypothesized that the communication between pscs and pccs could be an exploitable target to develop effective strategy for pdac therapy and diagnosis here starting with a systematic proteomic investigation of secreted disease mediator and underlying molecular mechanism we reveal that leukaemia inhibitory factor lif is a key paracrine factor from activated pscs acting on cancer cell both pharmacologic lif blockade and genetic lifr deletion markedly slow tumour progression and augment the efficacy of chemotherapy to prolong survival of pdac mouse model mainly by modulating cancer cell differentiation and epithelialmesenchymal transition status moreover in both mouse model and human pdac aberrant production of lif in the pancreas is restricted to pathological condition and correlate with pdac pathogenesis and change in the level of circulating lif correlate well with tumour response to therapy collectively these finding reveal a function of lif in pdac tumorigenesis and suggest it translational potential a an attractive therapeutic target and circulating marker our study underscore how a better understanding of cellcell communication within the tumour microenvironment can suggest novel strategy for cancer therapy,Cancer,0,targeting lifmediated paracrine interaction for pancreatic cancer therapy and monitoring pancreatic ductal adenocarcinoma pdac ha a dismal prognosis largely owing to inefficient diagnosis and tenacious drug resistance activation of pancreatic stellate cell pscs and consequent development of dense stroma are prominent feature accounting for this aggressive biology the reciprocal interplay between pscs and pancreatic cancer cell pccs not only enhances tumour progression and metastasis but also sustains their own activation facilitating a vicious cycle to exacerbate tumorigenesis and drug resistance furthermore psc activation occurs very early during pdac tumorigenesis and activated pscs comprise a substantial fraction of the tumour mass providing a rich source of readily detectable factor therefore we hypothesized that the communication between pscs and pccs could be an exploitable target to develop effective strategy for pdac therapy and diagnosis here starting with a systematic proteomic investigation of secreted disease mediator and underlying molecular mechanism we reveal that leukaemia inhibitory factor lif is a key paracrine factor from activated pscs acting on cancer cell both pharmacologic lif blockade and genetic lifr deletion markedly slow tumour progression and augment the efficacy of chemotherapy to prolong survival of pdac mouse model mainly by modulating cancer cell differentiation and epithelialmesenchymal transition status moreover in both mouse model and human pdac aberrant production of lif in the pancreas is restricted to pathological condition and correlate with pdac pathogenesis and change in the level of circulating lif correlate well with tumour response to therapy collectively these finding reveal a function of lif in pdac tumorigenesis and suggest it translational potential a an attractive therapeutic target and circulating marker our study underscore how a better understanding of cellcell communication within the tumour microenvironment can suggest novel strategy for cancer therapy
30997549,pituitary adenoma,despite characteristic symptom the diagnosis of clinically relevant pituitary adenoma is often delayed until an advanced stage due to the rarity of the disease the typical clinical manifestation are presented in this review article the recent discovery of the usp mutation in cushing disease and of xlinked acrogigantism xlag syndrome in early onset gigantism were milestone in the search for the molecular etiology of pituitary adenoma the triad of endocrinological radiological and ophthalmological diagnostics are the main pillar for the diagnostic workup of pituitary adenoma the standard treatment modality which include surgery medical treatment and irradiation have been further developed and refined for transsphenoidal excision of pituitary adenoma microsurgery and endoscopy are two equivalent surgical technique with relatively few complication surgery represents the firstline treatment of pituitary adenoma prolactinomas are an exception a the medical treatment with dopamine agonist is highly efficient nowadays new medical treatment option are available for acromegaly and cushing disease and are used for secondline treatment the alkylating chemotherapeutic agent temozolomide is used for the firstline chemotherapy of rare aggressively growing pituitary adenoma irradiation is indicated if surgical and medical treatment option are insufficiently successful stereotactic onestage irradiation radiosurgery is especially suitable for welldemarcated invasive residual or recurrent adenoma in the cavernous sinus a new development is hypofractionated radiosurgery for protection of structure at risk fractionated irradiation is necessary with large radiation volume and for pituitary adenoma with a close proximity to the optic tract,Cancer,0,pituitary adenoma despite characteristic symptom the diagnosis of clinically relevant pituitary adenoma is often delayed until an advanced stage due to the rarity of the disease the typical clinical manifestation are presented in this review article the recent discovery of the usp mutation in cushing disease and of xlinked acrogigantism xlag syndrome in early onset gigantism were milestone in the search for the molecular etiology of pituitary adenoma the triad of endocrinological radiological and ophthalmological diagnostics are the main pillar for the diagnostic workup of pituitary adenoma the standard treatment modality which include surgery medical treatment and irradiation have been further developed and refined for transsphenoidal excision of pituitary adenoma microsurgery and endoscopy are two equivalent surgical technique with relatively few complication surgery represents the firstline treatment of pituitary adenoma prolactinomas are an exception a the medical treatment with dopamine agonist is highly efficient nowadays new medical treatment option are available for acromegaly and cushing disease and are used for secondline treatment the alkylating chemotherapeutic agent temozolomide is used for the firstline chemotherapy of rare aggressively growing pituitary adenoma irradiation is indicated if surgical and medical treatment option are insufficiently successful stereotactic onestage irradiation radiosurgery is especially suitable for welldemarcated invasive residual or recurrent adenoma in the cavernous sinus a new development is hypofractionated radiosurgery for protection of structure at risk fractionated irradiation is necessary with large radiation volume and for pituitary adenoma with a close proximity to the optic tract
30998136,mutation spectrum of fancj gene in adult acute myeloid leukemia,objective to detect and analyze the mutation status of fancj gene in adult aml patient so a to provide the basis for studying the mechanism of fancj driven aml and guiding the preventim and treatment of deseese method the cdna were extracted and transeripted from bone marrow cell and normal skin cell in newly diagnosed aml patient the primer were designed for fancj gene coding region the mutation of fancj gene coding region in aml patient a well a the mutation of fancj gene in mucous membrane epethelia in patient were detected by pcr and sanger seguencing the evolutionary conservation of fancj mutation in different organism wa analyzed by ncbi blast online bioinformaties software result the sequencing analysis showed that the mutation of fancj gene happened in site of fancj gene coding region which were a followed exoncgapat exoncagpns exoncctprw exoncgapgd exonccgplv exoncctppl exoncctprc exoncctphy exoncagpiv exonccgpqe exoncgapdn among them the repeatability existed in mutation of at n rc iv and qe beside the mutation site of a r g l p h q and d were highly conserved in different organism conclusion among adult aml patient the mutation of fancj gene have been found in patient moreover the mutation site are relatively conserved in different organism and possess important fanction the result of this study provide the basis for exploring the mexhanism of fancj gene driven aml and for guiding the prevantion and treatment of aml,Cancer,0,mutation spectrum of fancj gene in adult acute myeloid leukemia objective to detect and analyze the mutation status of fancj gene in adult aml patient so a to provide the basis for studying the mechanism of fancj driven aml and guiding the preventim and treatment of deseese method the cdna were extracted and transeripted from bone marrow cell and normal skin cell in newly diagnosed aml patient the primer were designed for fancj gene coding region the mutation of fancj gene coding region in aml patient a well a the mutation of fancj gene in mucous membrane epethelia in patient were detected by pcr and sanger seguencing the evolutionary conservation of fancj mutation in different organism wa analyzed by ncbi blast online bioinformaties software result the sequencing analysis showed that the mutation of fancj gene happened in site of fancj gene coding region which were a followed exoncgapat exoncagpns exoncctprw exoncgapgd exonccgplv exoncctppl exoncctprc exoncctphy exoncagpiv exonccgpqe exoncgapdn among them the repeatability existed in mutation of at n rc iv and qe beside the mutation site of a r g l p h q and d were highly conserved in different organism conclusion among adult aml patient the mutation of fancj gene have been found in patient moreover the mutation site are relatively conserved in different organism and possess important fanction the result of this study provide the basis for exploring the mexhanism of fancj gene driven aml and for guiding the prevantion and treatment of aml
31000705,aurkb a a target in nonsmall cell lung cancer with acquired resistance to antiegfr therapy,nonsmall cell lung cancer nsclc tumor harboring mutation in egfr ultimately relapse to therapy with egfr tyrosine kinase inhibitor egfr tkis here we show that resistant cell without the ptm or other acquired mutation are sensitive to the aurora b aurkb inhibitor barasertib and s phosphohistone h ph a major product of aurkb is increased in most resistant cell and treatment with aurkb inhibitor reduces the level of ph triggering g arrest and polyploidy senescence is subsequently induced in cell with acquired mutation while in their absence polyploidy is followed by cell death finally in nsclc patient ph level are increased after progression on egfr tkis and high ph baseline correlate with shorter survival our result reveal that aurkb activation is associated with acquired resistance to egfr tkis and that aurkb constitutes a potential target in nsclc progressing to antiegfr therapy and not carrying resistance mutation,Cancer,0,aurkb a a target in nonsmall cell lung cancer with acquired resistance to antiegfr therapy nonsmall cell lung cancer nsclc tumor harboring mutation in egfr ultimately relapse to therapy with egfr tyrosine kinase inhibitor egfr tkis here we show that resistant cell without the ptm or other acquired mutation are sensitive to the aurora b aurkb inhibitor barasertib and s phosphohistone h ph a major product of aurkb is increased in most resistant cell and treatment with aurkb inhibitor reduces the level of ph triggering g arrest and polyploidy senescence is subsequently induced in cell with acquired mutation while in their absence polyploidy is followed by cell death finally in nsclc patient ph level are increased after progression on egfr tkis and high ph baseline correlate with shorter survival our result reveal that aurkb activation is associated with acquired resistance to egfr tkis and that aurkb constitutes a potential target in nsclc progressing to antiegfr therapy and not carrying resistance mutation
31002019,pancreatic acinar cell carcinoma is associated with brca germline mutation a case report and literature review,acinar cell carcinoma acc is a rare pancreatic neoplasm with dismal prognosis insight into the molecular basis of acc can pave the way for the application of more effective personalized therapy and detection of patient with hereditary predisposition molecular analysis revealed a germline brca and chek mutation in a patient with a rare pancreatic acc with extensive intraductal growth somatic loss of the wildtype brca allele in the tumor indicated the causal relationship of acc with the germline defect a thorough literature review identified another nine acc associated with germline brca mutation and two acc associated with germline brca mutation resulting in a prevalence of brca germline mutation in almost of acc moreover somatic brca alteration are reported in of sporadic acc overall about one fifth of all pancreatic acc exhibit brca deficiency this study underscore the important role of brca mutation in pancreatic acc all acc patient should undergo genetic testing for brca mutation to identify carrier of pathogenic variant this will allow to select patient that can benefit from targeted therapy directed against brcadeficient tumor and is also crucial a a referral to genetic screening for the relative of affected individual carrying germline brca alteration abbreviation acc acinar cell carcinoma hboc hereditary breast and ovarian cancer loh loss of heterozygosity parp poly adpribose polymerase pdac pancreatic ductal adenocarcinoma pp pancreatic panniculitis sd standard deviation wes wholeexome sequencing,Cancer,0,pancreatic acinar cell carcinoma is associated with brca germline mutation a case report and literature review acinar cell carcinoma acc is a rare pancreatic neoplasm with dismal prognosis insight into the molecular basis of acc can pave the way for the application of more effective personalized therapy and detection of patient with hereditary predisposition molecular analysis revealed a germline brca and chek mutation in a patient with a rare pancreatic acc with extensive intraductal growth somatic loss of the wildtype brca allele in the tumor indicated the causal relationship of acc with the germline defect a thorough literature review identified another nine acc associated with germline brca mutation and two acc associated with germline brca mutation resulting in a prevalence of brca germline mutation in almost of acc moreover somatic brca alteration are reported in of sporadic acc overall about one fifth of all pancreatic acc exhibit brca deficiency this study underscore the important role of brca mutation in pancreatic acc all acc patient should undergo genetic testing for brca mutation to identify carrier of pathogenic variant this will allow to select patient that can benefit from targeted therapy directed against brcadeficient tumor and is also crucial a a referral to genetic screening for the relative of affected individual carrying germline brca alteration abbreviation acc acinar cell carcinoma hboc hereditary breast and ovarian cancer loh loss of heterozygosity parp poly adpribose polymerase pdac pancreatic ductal adenocarcinoma pp pancreatic panniculitis sd standard deviation wes wholeexome sequencing
31002364,jakstat oncogenic pathway and prdm expression stratify clinicopathologic feature of extranodal nktcell lymphoma nasal type,the inactivation of tumor suppressor gene positive regulatory domain containing i prdm and activation of signal transducer and activator of transcription stat have been detected in the majority of extranodal nktcell lymphoma nasal type ennktnt case in the present study their association with and effect on the clinicopathologic feature of ennktnt are described prdm wa revealed to be expressed in out of patient with ennktnt and phosphorylated stat wa overexpressed in out of oncogenic pathway were investigated by nanostring encounter technology in prdm and prdm ennktnt specimen multiple oncogenic pathway involved in cell apoptosis cellcycle cc and angiogenesis were discriminately activated in ennktnt case and in prdm case in particular the sustained activation of the janus kinase jakstat pathway wa more pronounced in addition missense mutation in the src homology domain of stat were detected in out of ennktnt case and the acquired mutation wa related to the activation of the jakstat pathway the downregulation of prdm and upregulation of phosphostat tyr were associated with angiocentric infiltration of ennktnt p notably the prognosis of patient in the prdmstat mutated mut group wa considerably improved than that of patient in the statmutprdm group p in addition the inhibition of nkt cell lymphoma cell line by stattic and tofacitinib could suppress cell proliferation by inducing cell apoptosis or arresting the cc the present result revealed that the jakstat oncogenic pathway and prdm expression could stratify clinicopathologic feature of ennktnt the inhibition of the jakstat pathway may serve a a treatment option for ennktnt,Cancer,0,jakstat oncogenic pathway and prdm expression stratify clinicopathologic feature of extranodal nktcell lymphoma nasal type the inactivation of tumor suppressor gene positive regulatory domain containing i prdm and activation of signal transducer and activator of transcription stat have been detected in the majority of extranodal nktcell lymphoma nasal type ennktnt case in the present study their association with and effect on the clinicopathologic feature of ennktnt are described prdm wa revealed to be expressed in out of patient with ennktnt and phosphorylated stat wa overexpressed in out of oncogenic pathway were investigated by nanostring encounter technology in prdm and prdm ennktnt specimen multiple oncogenic pathway involved in cell apoptosis cellcycle cc and angiogenesis were discriminately activated in ennktnt case and in prdm case in particular the sustained activation of the janus kinase jakstat pathway wa more pronounced in addition missense mutation in the src homology domain of stat were detected in out of ennktnt case and the acquired mutation wa related to the activation of the jakstat pathway the downregulation of prdm and upregulation of phosphostat tyr were associated with angiocentric infiltration of ennktnt p notably the prognosis of patient in the prdmstat mutated mut group wa considerably improved than that of patient in the statmutprdm group p in addition the inhibition of nkt cell lymphoma cell line by stattic and tofacitinib could suppress cell proliferation by inducing cell apoptosis or arresting the cc the present result revealed that the jakstat oncogenic pathway and prdm expression could stratify clinicopathologic feature of ennktnt the inhibition of the jakstat pathway may serve a a treatment option for ennktnt
31006323,magnetic resonance imagingtransrectal ultrasound image fusion guidance of prostate biopsy current status challenge and future perspective,the use of multiparametric magnetic resonance imaging mpmri in prostate cancer pca diagnosis is rapidly evolving to try to overcome the limitation of the current diagnostic pathway using systematic transrectal ultrasoundguided biopsy trusbx for all men with clinical suspicion of pca prostate mpmri allows for high quality lesion detection and characterization and ha been shown to improve detection of significant pca with a more accurate gleason score grading suspicious lesion can be stratified by suspicion and sampled by selective mriguided targeted biopsy tbx for improved diagnostic accuracy several tbx method have been established and include mritrus image fusion biopsy cognitive or softwareassisted and inbore biopsy but none have yet proven superior in clinical practice however while mri inbore biopsy is not routinely used due to it cost and limited availability mritrus image fusion is rapidly embraced a it allows skilled urologist to perform tbx in an outpatient clinic furthermore it give the operator the advantage of adding tbx to the systematic standard biopsy scheme which is the currently recommended approach with the anticipated increased future use of prebiopsy mpmri a more widespread implementation of mritrus image fusion platform is concurrently expected in clinical practice therefore the objective of this review is to assess the current status challenge and future perspective of prostate mritrus image fusion biopsy,Cancer,0,magnetic resonance imagingtransrectal ultrasound image fusion guidance of prostate biopsy current status challenge and future perspective the use of multiparametric magnetic resonance imaging mpmri in prostate cancer pca diagnosis is rapidly evolving to try to overcome the limitation of the current diagnostic pathway using systematic transrectal ultrasoundguided biopsy trusbx for all men with clinical suspicion of pca prostate mpmri allows for high quality lesion detection and characterization and ha been shown to improve detection of significant pca with a more accurate gleason score grading suspicious lesion can be stratified by suspicion and sampled by selective mriguided targeted biopsy tbx for improved diagnostic accuracy several tbx method have been established and include mritrus image fusion biopsy cognitive or softwareassisted and inbore biopsy but none have yet proven superior in clinical practice however while mri inbore biopsy is not routinely used due to it cost and limited availability mritrus image fusion is rapidly embraced a it allows skilled urologist to perform tbx in an outpatient clinic furthermore it give the operator the advantage of adding tbx to the systematic standard biopsy scheme which is the currently recommended approach with the anticipated increased future use of prebiopsy mpmri a more widespread implementation of mritrus image fusion platform is concurrently expected in clinical practice therefore the objective of this review is to assess the current status challenge and future perspective of prostate mritrus image fusion biopsy
31008966,spontaneous rotational dislocation of the lumbar spine in type neurofibromatosis a case report and literature review,rationale scoliosis is the most common form of dystrophic spinal deformity in type neurofibromatosis whereas a spontaneous rotational dislocation of the lumbar spine is a rare entity former researcher had advocated the use of circumferential fusion performed through combined anteriorposterior approach a the mode of treatment of this situation but we managed to achieve a solid circumferential fusion equally using posterior approach alone patient concern a yearold lady presented with severe back pain and no history of trauma fever or loss of weight on examination she showed several cafeaulait spot on her body and no neurologic deficit diagnosis the imageology revealed a rotational dislocation of the l to l the diagnosis of neurofibroma wa confirmed by biopsy intervention the patient underwent posterior reduction combined intervertebralposterolateral fusion and internal fixation with screw and rod outcome the patient wa satisfied with the back pain relief after surgery and able to live a normal life at followup the imageology showed a good correction of the deformity with a solid bony fusion lesson special attention must be paid to patient who have neurofibromatosis and unexplained back pain for early diagnosis early circumferential fusion to reconstruct a stable spine is the key to treatment given the result of this case the prognosis is promising following posterior surgery alone,Cancer,0,spontaneous rotational dislocation of the lumbar spine in type neurofibromatosis a case report and literature review rationale scoliosis is the most common form of dystrophic spinal deformity in type neurofibromatosis whereas a spontaneous rotational dislocation of the lumbar spine is a rare entity former researcher had advocated the use of circumferential fusion performed through combined anteriorposterior approach a the mode of treatment of this situation but we managed to achieve a solid circumferential fusion equally using posterior approach alone patient concern a yearold lady presented with severe back pain and no history of trauma fever or loss of weight on examination she showed several cafeaulait spot on her body and no neurologic deficit diagnosis the imageology revealed a rotational dislocation of the l to l the diagnosis of neurofibroma wa confirmed by biopsy intervention the patient underwent posterior reduction combined intervertebralposterolateral fusion and internal fixation with screw and rod outcome the patient wa satisfied with the back pain relief after surgery and able to live a normal life at followup the imageology showed a good correction of the deformity with a solid bony fusion lesson special attention must be paid to patient who have neurofibromatosis and unexplained back pain for early diagnosis early circumferential fusion to reconstruct a stable spine is the key to treatment given the result of this case the prognosis is promising following posterior surgery alone
31009688,hepatic complication of oral contraceptive pill and estrogen on mri controversy and update adenoma and beyond,hepatic complication of oral contraceptive pill and exogenous estrogen include intrahepatic canalicular cholestasis neoplasm formation and vascular pathology while it remains controversial a to whether estrogen play a role in focal nodular hyperplasia hemangioma or hamartoma exposure to oral contraceptive pill and estrogen ha a strong association with hepatic adenoma four different subgroup of adenoma have been described inflammatory hnfalphamutated betacateninmutated and unclassified vascular complication may include buddchiari syndrome vascular thrombosis dilated sinusoid and peliosis,Cancer,0,hepatic complication of oral contraceptive pill and estrogen on mri controversy and update adenoma and beyond hepatic complication of oral contraceptive pill and exogenous estrogen include intrahepatic canalicular cholestasis neoplasm formation and vascular pathology while it remains controversial a to whether estrogen play a role in focal nodular hyperplasia hemangioma or hamartoma exposure to oral contraceptive pill and estrogen ha a strong association with hepatic adenoma four different subgroup of adenoma have been described inflammatory hnfalphamutated betacateninmutated and unclassified vascular complication may include buddchiari syndrome vascular thrombosis dilated sinusoid and peliosis
31013001,clinical impact of testing for mutation and micrornas in thyroid nodule,background we report result of a multicenter clinical experience study examining the likelihood of patient with indeterminate thyroid nodule to undergo surgery or have malignant outcome based on multiplatform combination mutation and microrna testing mpt method mpt assessed mutation in braf hras kras nra and pikca gene paxppargamma retptc and retptc gene rearrangement and the expression of micrornas baseline clinical information at the time of mpt and clinical followup record were reviewed for patient of which had negative mpt result kaplan meier analysis for cumulative probability of survival without having a surgical procedure or malignant diagnosis over the course of patient followup wa determined for mpt result of patient among which only had malignancy result a negative mpt result in nodule with bethesda iii or iv conferred a high probability of nonsurgical treatment with only expected to undergo surgery and a high probability of survival without malignancy for up to year follow up a positive mpt result conferred a probability of malignancy and wa an independent risk factor for undergoing surgical treatment hazard ratio hr confidence interval p and for malignancy hr confidence interval p for nodule with weak driver mutation positive microrna test result supported high risk of cancer while negative result downgraded cancer risk conclusion mpt result are predictive of realworld decision to surgically treat indeterminate thyroid nodule with those decision being appropriately aligned with a patient risk of malignancy over time,Cancer,0,clinical impact of testing for mutation and micrornas in thyroid nodule background we report result of a multicenter clinical experience study examining the likelihood of patient with indeterminate thyroid nodule to undergo surgery or have malignant outcome based on multiplatform combination mutation and microrna testing mpt method mpt assessed mutation in braf hras kras nra and pikca gene paxppargamma retptc and retptc gene rearrangement and the expression of micrornas baseline clinical information at the time of mpt and clinical followup record were reviewed for patient of which had negative mpt result kaplan meier analysis for cumulative probability of survival without having a surgical procedure or malignant diagnosis over the course of patient followup wa determined for mpt result of patient among which only had malignancy result a negative mpt result in nodule with bethesda iii or iv conferred a high probability of nonsurgical treatment with only expected to undergo surgery and a high probability of survival without malignancy for up to year follow up a positive mpt result conferred a probability of malignancy and wa an independent risk factor for undergoing surgical treatment hazard ratio hr confidence interval p and for malignancy hr confidence interval p for nodule with weak driver mutation positive microrna test result supported high risk of cancer while negative result downgraded cancer risk conclusion mpt result are predictive of realworld decision to surgically treat indeterminate thyroid nodule with those decision being appropriately aligned with a patient risk of malignancy over time
31016433,the composition of t cell infiltrates varies in primary invasive breast cancer of different molecular subtypes a well a according to tumor size and nodal status,t lymphocyte are the most numerous immune cell in tumorassociated infiltrates and include several subpopulation of either anticancer or protumorigenic function however the association between level of different t cell subset and breast cancer molecular subtypes a well a other prognostic factor have not been fully established yet we performed immunohistochemistry for cd cytotoxic t cell ctl foxp regulatory t cell tregs and gata th cell in formalinfixed paraffinembedded invasive breast cancer tissue sample and analyzed both the number and percentage of investigated cell in tumorassociated infiltrates we observed that triplenegative breast cancer tnbc and her nonluminal breast tumor were associated with more numerous ctls and tregs and a higher tregth cell ratio a compared with luminal a subtype a higher treg percentage wa related to a decreased hormone receptor expression an increase in the ki level a greater tumor size of luminal tumor and the presence of lymph node metastasis moreover difference in the composition of t cell infiltrates were associated with her status and histologic grade and type and a distinct immune pattern wa observed in tumor of different phenotype regarding pt stage and nodal status the result of our work show the diversity of t cell infiltrates in primary invasive breast cancer of different phenotype and suggest that progression of luminal or nonluminal tumor is related to distinct tumorassociated t cell composition,Cancer,0,the composition of t cell infiltrates varies in primary invasive breast cancer of different molecular subtypes a well a according to tumor size and nodal status t lymphocyte are the most numerous immune cell in tumorassociated infiltrates and include several subpopulation of either anticancer or protumorigenic function however the association between level of different t cell subset and breast cancer molecular subtypes a well a other prognostic factor have not been fully established yet we performed immunohistochemistry for cd cytotoxic t cell ctl foxp regulatory t cell tregs and gata th cell in formalinfixed paraffinembedded invasive breast cancer tissue sample and analyzed both the number and percentage of investigated cell in tumorassociated infiltrates we observed that triplenegative breast cancer tnbc and her nonluminal breast tumor were associated with more numerous ctls and tregs and a higher tregth cell ratio a compared with luminal a subtype a higher treg percentage wa related to a decreased hormone receptor expression an increase in the ki level a greater tumor size of luminal tumor and the presence of lymph node metastasis moreover difference in the composition of t cell infiltrates were associated with her status and histologic grade and type and a distinct immune pattern wa observed in tumor of different phenotype regarding pt stage and nodal status the result of our work show the diversity of t cell infiltrates in primary invasive breast cancer of different phenotype and suggest that progression of luminal or nonluminal tumor is related to distinct tumorassociated t cell composition
31019896,genetic profile and clinical implication of hepatoblastoma and neuroblastoma coexistence in a child,the aim of the following case report is to provide a description of the coexistence of two independent tumor in a child a monthold male wa referred to department of pediatric oncology and hematology with hepatic tumor present on ultrasound imaging and symptom of enlarged abdominal circumference physical examination revealed a palpable epigastric mass and the imaging technique showed a tumor of the left hepatic lobe measuring x x cm with pancreas infiltration distant metastasis in both lung and abnormal lesion in the left adrenal gland basing on histopathological examination after a coreneedle biopsy hepatoblastoma hbl mixed epithelialmesenchymal subtype wa diagnosed the alphafetoprotein level wa ngml elevated value of normetanephrine methoxytyramine a well a neuronspecific enolase were observed due to the clinical picture and diagnosis the patient wa qualified to preoperative chemotherapy according to the siopel protocol followed by siopel protocol for the highrisk patient after undergoing preoperative chemotherapy imaging test revealed regression of hepatic tumor and no focal pulmonary mass while regression of adrenal gland mass wa not completed the patient wa qualified for left hemihepatectomy with left adrenalectomy histopathological examination of liver specimen confirmed the hbl diagnosis however in left adrenal gland and paraaortic lymph node the residual neuroblastoma nbl cell were detected whole exome sequencing wes wa utilized to identify diseaseassociated germline mutation wes revealed a novel germline insertion variant in twist pglydup along with the potentially pathogenic nonsynonymous variant in nf pvalile raf pleuarg and whsc pserasn gene currently month after completion of treatment according to the siopel protocol the patient is in good general condition without any sign and symptom of relapse of both neoplasm the coexistence of two different primary childhood malignancy is rarely seen so far only one case of synchronous hbl and nbl ha been reported however for the first time therapeutic process wa successful a specific signature of rare germline mutation can be proposed a a predisposing factor to synchronous hbl and nbl occurrence,Cancer,0,genetic profile and clinical implication of hepatoblastoma and neuroblastoma coexistence in a child the aim of the following case report is to provide a description of the coexistence of two independent tumor in a child a monthold male wa referred to department of pediatric oncology and hematology with hepatic tumor present on ultrasound imaging and symptom of enlarged abdominal circumference physical examination revealed a palpable epigastric mass and the imaging technique showed a tumor of the left hepatic lobe measuring x x cm with pancreas infiltration distant metastasis in both lung and abnormal lesion in the left adrenal gland basing on histopathological examination after a coreneedle biopsy hepatoblastoma hbl mixed epithelialmesenchymal subtype wa diagnosed the alphafetoprotein level wa ngml elevated value of normetanephrine methoxytyramine a well a neuronspecific enolase were observed due to the clinical picture and diagnosis the patient wa qualified to preoperative chemotherapy according to the siopel protocol followed by siopel protocol for the highrisk patient after undergoing preoperative chemotherapy imaging test revealed regression of hepatic tumor and no focal pulmonary mass while regression of adrenal gland mass wa not completed the patient wa qualified for left hemihepatectomy with left adrenalectomy histopathological examination of liver specimen confirmed the hbl diagnosis however in left adrenal gland and paraaortic lymph node the residual neuroblastoma nbl cell were detected whole exome sequencing wes wa utilized to identify diseaseassociated germline mutation wes revealed a novel germline insertion variant in twist pglydup along with the potentially pathogenic nonsynonymous variant in nf pvalile raf pleuarg and whsc pserasn gene currently month after completion of treatment according to the siopel protocol the patient is in good general condition without any sign and symptom of relapse of both neoplasm the coexistence of two different primary childhood malignancy is rarely seen so far only one case of synchronous hbl and nbl ha been reported however for the first time therapeutic process wa successful a specific signature of rare germline mutation can be proposed a a predisposing factor to synchronous hbl and nbl occurrence
31023294,a case report of revision occipitalcervical fusion after atlantoaxial instrumentation failure for neurofibromatosis type i,background neurofibromatosis type is an autosomal dominant genetic disease with characteristic cafeaulait spot neurofibroma and dystrophic change in the bone however complication involving atlantoaxial dislocation are rare case presentation we report a case of neurofibromatosis with atlantoaxial dislocation the chief complaint were numbness of the upper limb and gait disturbance we performed short fusion using the brook method however recurrence of the dislocation wa found after month recovery and the patient underwent posterior fusion from the occipital bone to c thereafter she had a good postoperative course conclusion neurofibromatosis patient often exhibit a low bone mineral density because of dystrophic change and are prone to fragile bone in the present case the use of long fusion at the first surgery may have helped to form a strong fusion of fragile bone,Cancer,0,a case report of revision occipitalcervical fusion after atlantoaxial instrumentation failure for neurofibromatosis type i background neurofibromatosis type is an autosomal dominant genetic disease with characteristic cafeaulait spot neurofibroma and dystrophic change in the bone however complication involving atlantoaxial dislocation are rare case presentation we report a case of neurofibromatosis with atlantoaxial dislocation the chief complaint were numbness of the upper limb and gait disturbance we performed short fusion using the brook method however recurrence of the dislocation wa found after month recovery and the patient underwent posterior fusion from the occipital bone to c thereafter she had a good postoperative course conclusion neurofibromatosis patient often exhibit a low bone mineral density because of dystrophic change and are prone to fragile bone in the present case the use of long fusion at the first surgery may have helped to form a strong fusion of fragile bone
31025086,integrated diagnostics of diffuse astrocytic and oligodendroglial tumor,background diffuse astrocytic and oligodendroglial glioma are the most common neuroepithelial tumor their classification is based on the integration of histological and molecular finding according to the classification of tumor of the central nervous system published by the world health organization who in objective this review describes the different entity and variant of diffuse glioma and summarizes the current diagnostic criterion for these tumor material and method based on the who classification and selected other publication the histomolecular diagnostics of diffuse glioma is presented and illustrated result diffuse glioma are divided into isocitrate dehydrogenase idhmutant or idhwildtype glioma by detection of mutation in the idh or idh gene among the idhmutant glioma oligodendroglial tumor are characterized by combined loss of chromosome arm p and q loss of nuclear expression of the atrx protein is a marker of idh mutant astrocytic glioma glioblastoma idhwildtype is the most common diffuse glioma diffuse and anaplastic astrocytic glioma without idh mutation should be further evaluated for molecular feature of glioblastoma idhwildtype diffuse glioma in the thalamus brainstem or spinal cord carrying a histone hkm mutation are classified a diffuse midline glioma hkmmutant by determining the idh and pq status oligoastrocytomas can be stratified into either astrocytic or oligodendroglial glioma gliomatosis cerebri is no longer regarded a a distinct glioma entity conclusion diffuse glioma can today be classified accurately and reproducibly by mean of histological immunohistochemical and molecular analysis,Cancer,0,integrated diagnostics of diffuse astrocytic and oligodendroglial tumor background diffuse astrocytic and oligodendroglial glioma are the most common neuroepithelial tumor their classification is based on the integration of histological and molecular finding according to the classification of tumor of the central nervous system published by the world health organization who in objective this review describes the different entity and variant of diffuse glioma and summarizes the current diagnostic criterion for these tumor material and method based on the who classification and selected other publication the histomolecular diagnostics of diffuse glioma is presented and illustrated result diffuse glioma are divided into isocitrate dehydrogenase idhmutant or idhwildtype glioma by detection of mutation in the idh or idh gene among the idhmutant glioma oligodendroglial tumor are characterized by combined loss of chromosome arm p and q loss of nuclear expression of the atrx protein is a marker of idh mutant astrocytic glioma glioblastoma idhwildtype is the most common diffuse glioma diffuse and anaplastic astrocytic glioma without idh mutation should be further evaluated for molecular feature of glioblastoma idhwildtype diffuse glioma in the thalamus brainstem or spinal cord carrying a histone hkm mutation are classified a diffuse midline glioma hkmmutant by determining the idh and pq status oligoastrocytomas can be stratified into either astrocytic or oligodendroglial glioma gliomatosis cerebri is no longer regarded a a distinct glioma entity conclusion diffuse glioma can today be classified accurately and reproducibly by mean of histological immunohistochemical and molecular analysis
31026246,impact of initial stage on metastatic melanoma survival,patient diagnosed with metastatic melanoma have varied clinical course even in patient with similar disease characteristic we examine the impact of initial stage of melanoma diagnosis braf status of primary melanoma and receiving adjuvant therapy on postmetastatic overall survival pmos we studied melanoma patient presenting to perlmutter cancer center at new york university and prospectively enrolled in new york university melanoma biospecimen database and followed up on protocoldriven schedule patient were stratified by stage at initial melanoma diagnosis a per ajcc th ed guideline pmos wa determined using the kaplanmeier method and cox proportional hazard model were used to assess hazard ratio hr three hundred and four out of patient developed metastatic disease over the time of followup median followup year range year patient diagnosed with stage i n melanoma had longer pmos month than those diagnosed with stage ii n pmos month or stage iii n pmos month melanoma p initial stage of diagnosis remained significant in multivariate analysis when controlling for lactate dehydrogenase and site of metastasis primary diagnosis stage ii hr p stage iii hr p adjuvant treatment wa associated with better survival but braf mutation status did not show an association our data challenge the general assumption that primary melanoma converge upon diagnosis of metastatic disease and behave uniformly primary stage of melanoma at the time of diagnosis may be prognostic of outcome similar to lactate dehydrogenase and metastatic disease site,Cancer,0,impact of initial stage on metastatic melanoma survival patient diagnosed with metastatic melanoma have varied clinical course even in patient with similar disease characteristic we examine the impact of initial stage of melanoma diagnosis braf status of primary melanoma and receiving adjuvant therapy on postmetastatic overall survival pmos we studied melanoma patient presenting to perlmutter cancer center at new york university and prospectively enrolled in new york university melanoma biospecimen database and followed up on protocoldriven schedule patient were stratified by stage at initial melanoma diagnosis a per ajcc th ed guideline pmos wa determined using the kaplanmeier method and cox proportional hazard model were used to assess hazard ratio hr three hundred and four out of patient developed metastatic disease over the time of followup median followup year range year patient diagnosed with stage i n melanoma had longer pmos month than those diagnosed with stage ii n pmos month or stage iii n pmos month melanoma p initial stage of diagnosis remained significant in multivariate analysis when controlling for lactate dehydrogenase and site of metastasis primary diagnosis stage ii hr p stage iii hr p adjuvant treatment wa associated with better survival but braf mutation status did not show an association our data challenge the general assumption that primary melanoma converge upon diagnosis of metastatic disease and behave uniformly primary stage of melanoma at the time of diagnosis may be prognostic of outcome similar to lactate dehydrogenase and metastatic disease site
31027701,improvement in the survival of patient with stage iv nonsmallcell lung cancer experience in a single institutional,objective in the past two decade several antineoplastic agent have been approved for the treatment of advanced nonsmallcell lung cancer nsclc and the management of these patient ha drastically changed however there is limited information regarding the impact of these advance on patient survival in clinical practice material and method we analyzed the survival of patient with stage iv nsclc who received any treatment in the cancer institute hospital of the japanese foundation for cancer research jfcr between january and march a total of consecutive patient were included in this case series in this analysis five diagnostic period were evaluated period a period b period c period d and period e we compared overall survival o between the period before and after propensity score matching psm and in patient with egfr mutation with alk fusion gene or without driver mutation result in the past two decade the o of patient with stage iv nsclc improved the median os for period a b c d and e were month and not reached respectively after psm with known baseline characteristic the trend of improvement in o wa similar however the o of patient with egfr mutation or alk fusion gene did not improve between period despite the availability of several tyrosine kinase inhibitor in japan the o of patient without a driver mutation wa slightly longer in the period e conclusion the introduction of new class of drug ha significantly improved the survival of patient with stage iv nsclc however the approval of similar type of drug may not be associated with further improvement in survival,Cancer,0,improvement in the survival of patient with stage iv nonsmallcell lung cancer experience in a single institutional objective in the past two decade several antineoplastic agent have been approved for the treatment of advanced nonsmallcell lung cancer nsclc and the management of these patient ha drastically changed however there is limited information regarding the impact of these advance on patient survival in clinical practice material and method we analyzed the survival of patient with stage iv nsclc who received any treatment in the cancer institute hospital of the japanese foundation for cancer research jfcr between january and march a total of consecutive patient were included in this case series in this analysis five diagnostic period were evaluated period a period b period c period d and period e we compared overall survival o between the period before and after propensity score matching psm and in patient with egfr mutation with alk fusion gene or without driver mutation result in the past two decade the o of patient with stage iv nsclc improved the median os for period a b c d and e were month and not reached respectively after psm with known baseline characteristic the trend of improvement in o wa similar however the o of patient with egfr mutation or alk fusion gene did not improve between period despite the availability of several tyrosine kinase inhibitor in japan the o of patient without a driver mutation wa slightly longer in the period e conclusion the introduction of new class of drug ha significantly improved the survival of patient with stage iv nsclc however the approval of similar type of drug may not be associated with further improvement in survival
31027705,a retrospective cohort study of pdl prevalence molecular association and clinical outcome in patient with nsclc result from the european thoracic oncology platform etop lungscape project,introduction the pdl biomarker is an important factor in selecting patient with nonsmall cell lung cancer for immunotherapy while several report suggest that pdl positivity is linked to a poor prognosis others suggest that pdl positive status portends a good prognosis method pdl positivity prevalence assessed via immunohistochemistry ihc on tissue microarrays tmas and it association with clinicopathological characteristic molecular profile and patient outcome relapsefree survival rf timetorelapse ttr and overall survival o is explored in the etop lungscape cohort of stage iiii nonsmall cell lung cancer nsclc tumor are considered positive if they have neoplastic cell membrane staining result pdl expression wa assessed in nsclc case evaluable median followup year still alive from etop center adenocarcinoma represent of the cohort squamous cell former smoker are current never pdl positivity prevalence is present in more than one third of the lungscape cohort cutoff it doesnt differ between adenocarcinoma and squamous cell histology but is more frequently detected in higher stage never smoker larger tumor cutoff with cutoff it is significantly associated with ihc met overexpression expression of pten egfr and kras mutation only for adenocarcinoma result for and cutoff were similar with met being significantly associated with pdl positivity both for ac p cutoff and scc p cutoff and p for when adjusting for clinicopathological characteristic a significant prognostic effect wa identified in adenocarcinoma adjusted pvalues for rfsttros cutoff analogous for but not for similar result obtained for the model including all histology but no effect wa found for the squamous cell carcinoma conclusion pdl positivity when adjusted for clinicopathological characteristic is associated with a better prognosis for nonmetastatic adenocarcinoma patient,Cancer,0,a retrospective cohort study of pdl prevalence molecular association and clinical outcome in patient with nsclc result from the european thoracic oncology platform etop lungscape project introduction the pdl biomarker is an important factor in selecting patient with nonsmall cell lung cancer for immunotherapy while several report suggest that pdl positivity is linked to a poor prognosis others suggest that pdl positive status portends a good prognosis method pdl positivity prevalence assessed via immunohistochemistry ihc on tissue microarrays tmas and it association with clinicopathological characteristic molecular profile and patient outcome relapsefree survival rf timetorelapse ttr and overall survival o is explored in the etop lungscape cohort of stage iiii nonsmall cell lung cancer nsclc tumor are considered positive if they have neoplastic cell membrane staining result pdl expression wa assessed in nsclc case evaluable median followup year still alive from etop center adenocarcinoma represent of the cohort squamous cell former smoker are current never pdl positivity prevalence is present in more than one third of the lungscape cohort cutoff it doesnt differ between adenocarcinoma and squamous cell histology but is more frequently detected in higher stage never smoker larger tumor cutoff with cutoff it is significantly associated with ihc met overexpression expression of pten egfr and kras mutation only for adenocarcinoma result for and cutoff were similar with met being significantly associated with pdl positivity both for ac p cutoff and scc p cutoff and p for when adjusting for clinicopathological characteristic a significant prognostic effect wa identified in adenocarcinoma adjusted pvalues for rfsttros cutoff analogous for but not for similar result obtained for the model including all histology but no effect wa found for the squamous cell carcinoma conclusion pdl positivity when adjusted for clinicopathological characteristic is associated with a better prognosis for nonmetastatic adenocarcinoma patient
31028214,early second round targeted biopsy of pirads score or in men with persistent suspicion of prostate cancer,backgroundaim the aim of the study wa to determine the rate of clinically significant prostate cancer cspca case in men submitted to early second round mpmritrus multiparametric magnetic resonance imagingtransrectal ultrasound fusion biopsy tpbx material and method from january to december men with a pirads prostate imagingreporting and data system score case or case and negative repeat transperineal saturation biopsy plus tpbx underwent a new tpbx four core for the persistent clinical suspicion of cancer the accuracy of mpmri adc apparent diffusion coefficient value in the diagnosis of cspca were evaluated result overall detection rate of cspca wa equal to case versus had a pirads score equal to versus respectively the presence of cspca wa significantly correlated with an adc value of x mmsec conclusion a negative tbpx missed a cspca in of pirads score that wa diagnosed by an early second round tbpx the evaluation of adc map could select mpmri lesion deserving a repeat tpbx,Cancer,0,early second round targeted biopsy of pirads score or in men with persistent suspicion of prostate cancer backgroundaim the aim of the study wa to determine the rate of clinically significant prostate cancer cspca case in men submitted to early second round mpmritrus multiparametric magnetic resonance imagingtransrectal ultrasound fusion biopsy tpbx material and method from january to december men with a pirads prostate imagingreporting and data system score case or case and negative repeat transperineal saturation biopsy plus tpbx underwent a new tpbx four core for the persistent clinical suspicion of cancer the accuracy of mpmri adc apparent diffusion coefficient value in the diagnosis of cspca were evaluated result overall detection rate of cspca wa equal to case versus had a pirads score equal to versus respectively the presence of cspca wa significantly correlated with an adc value of x mmsec conclusion a negative tbpx missed a cspca in of pirads score that wa diagnosed by an early second round tbpx the evaluation of adc map could select mpmri lesion deserving a repeat tpbx
31029168,targeted capturebased ng is superior to multiplex pcrbased ng for hereditary brca and brca gene analysis in ffpe tumor sample,background with the introduction of olaparib treatment for brcadeficient recurrent ovarian cancer testing for somatic andor germline mutation in brca gene in tumor tissue became essential for treatment decision in most case only formalinfixed paraffinembedded ffpe sample containing fragmented and chemically modified dna of minor quality are available thus multiplex pcrbased sequencing is most commonly applied in routine molecular testing which is predominantly focused on the identification of known hot spot mutation in oncogene method we compared the overall performance of an adjusted targeted capturebased enrichment protocol and a multiplex pcrbased approach for calling of pathogenic snvs and indels using dna extracted from ffpe tissue sample we further applied both strategy to seven blood sample and five matched ffpe tumor tissue of patient with known germline exonspanning deletion and genewide duplication in brca to evaluate cnv detection based solely on panel ng data finally we analyzed dna from ffpe tissue of index patient from family suspected of having hereditary breast and ovarian cancer of whom no blood sample were available for testing in order to identify underlying pathogenic germline brca mutation result the multiplex pcrbased protocol produced inhomogeneous coverage among target of each sample and between sample a well a sporadic amplicon drop out leading to insufficiently or noncovered nucleotide which subsequently hindered variant detection this protocol further led to detection of pcrartifacts that could easily have been misinterpreted a pathogenic mutation no such limitation were observed by application of an adjusted targeted capturebased protocol which allowed for cnv calling with sensitivity and specificity all pathogenic cnvs were confirmed in the five matched ffpe tumor sample from patient carrying known pathogenic germline mutation and we additionally identified somatic loss of the second allele in brca furthermore we detected pathogenic brca variant in four the eleven ffpe sample from patient of whom no blood wa available for analysis conclusion we demonstrate that an adjusted targeted capturebased enrichment protocol is superior to commonly applied multiplex pcrbased protocol for reliable brca variant detection including cnvdetection using ffpe tumor sample,Cancer,0,targeted capturebased ng is superior to multiplex pcrbased ng for hereditary brca and brca gene analysis in ffpe tumor sample background with the introduction of olaparib treatment for brcadeficient recurrent ovarian cancer testing for somatic andor germline mutation in brca gene in tumor tissue became essential for treatment decision in most case only formalinfixed paraffinembedded ffpe sample containing fragmented and chemically modified dna of minor quality are available thus multiplex pcrbased sequencing is most commonly applied in routine molecular testing which is predominantly focused on the identification of known hot spot mutation in oncogene method we compared the overall performance of an adjusted targeted capturebased enrichment protocol and a multiplex pcrbased approach for calling of pathogenic snvs and indels using dna extracted from ffpe tissue sample we further applied both strategy to seven blood sample and five matched ffpe tumor tissue of patient with known germline exonspanning deletion and genewide duplication in brca to evaluate cnv detection based solely on panel ng data finally we analyzed dna from ffpe tissue of index patient from family suspected of having hereditary breast and ovarian cancer of whom no blood sample were available for testing in order to identify underlying pathogenic germline brca mutation result the multiplex pcrbased protocol produced inhomogeneous coverage among target of each sample and between sample a well a sporadic amplicon drop out leading to insufficiently or noncovered nucleotide which subsequently hindered variant detection this protocol further led to detection of pcrartifacts that could easily have been misinterpreted a pathogenic mutation no such limitation were observed by application of an adjusted targeted capturebased protocol which allowed for cnv calling with sensitivity and specificity all pathogenic cnvs were confirmed in the five matched ffpe tumor sample from patient carrying known pathogenic germline mutation and we additionally identified somatic loss of the second allele in brca furthermore we detected pathogenic brca variant in four the eleven ffpe sample from patient of whom no blood wa available for analysis conclusion we demonstrate that an adjusted targeted capturebased enrichment protocol is superior to commonly applied multiplex pcrbased protocol for reliable brca variant detection including cnvdetection using ffpe tumor sample
31029439,study of anogenital distance a a diagnostic tool for prostate cancer,introduction and objective the distance from the genitals to the anus anogenital distance agd reflects androgen concentration during prenatal development in mammal at the present time there is only one study suggesting the relationship between agd and risk of prostate cancer cap the goal of this study wa to assess the performance and clinical utility of agd a a biomarker of prenatal androgenic milieu and risk of cap in a larger population in cap diagnosis material and method a casecontrol study wa conducted on men seen in a hospital outpatient clinic where underwent a physical and andrological examination and completed a brief questionnaire cap patient were confirmed by biopsy of the tumor control were men without cap seen in the urology outpatient clinic for routine examination two variant of agd from the anus to the posterior base of the scrotum agdas and to the cephalad insertion of the penis agdap were measured parametric and nonparametric test and receiver operating characteristic cor analysis were used to determine relationship between agd and presence of cap result the highest area under the curve ci to and ci to wa obtained for the gleason subgroup with the agdas and agdap measurement with a sensitivity and specificity of and and and the predictive positive value of and and negative value of and respectively conclusion agd may be a useful clinical tool for the cap diagnosis,Cancer,0,study of anogenital distance a a diagnostic tool for prostate cancer introduction and objective the distance from the genitals to the anus anogenital distance agd reflects androgen concentration during prenatal development in mammal at the present time there is only one study suggesting the relationship between agd and risk of prostate cancer cap the goal of this study wa to assess the performance and clinical utility of agd a a biomarker of prenatal androgenic milieu and risk of cap in a larger population in cap diagnosis material and method a casecontrol study wa conducted on men seen in a hospital outpatient clinic where underwent a physical and andrological examination and completed a brief questionnaire cap patient were confirmed by biopsy of the tumor control were men without cap seen in the urology outpatient clinic for routine examination two variant of agd from the anus to the posterior base of the scrotum agdas and to the cephalad insertion of the penis agdap were measured parametric and nonparametric test and receiver operating characteristic cor analysis were used to determine relationship between agd and presence of cap result the highest area under the curve ci to and ci to wa obtained for the gleason subgroup with the agdas and agdap measurement with a sensitivity and specificity of and and and the predictive positive value of and and negative value of and respectively conclusion agd may be a useful clinical tool for the cap diagnosis
31032226,a novel approach to preoperative risk stratification in endometrial cancer the added value of immunohistochemical marker,background the current model used to preoperatively stratify endometrial cancer ec patient into low and highrisk group is based on histotype grade and imaging method and is not optimal our study aim to prove whether a new model incorporating immunohistochemical marker lcam er pr p obtained from preoperative biopsy could help refine stratification and thus the choice of adequate surgical extent and appropriate adjuvant treatment material and method the following data were prospectively collected from patient operated for ec from january through august age pre and postoperative histology grade lymphovascular space invasion lcam er pr p imaging parameter obtained from ultrasound ct chestabdomen final figo stage and current decision model based on histology grade imaging method result in total patient were enrolled the current model revealed sensitivity and specificity for highrisk group determination in myometrial invasion lower level of er p pr and higher level of lcam p were observed in cervical involvement a higher expression of lcam p lower pr p in tumor with positive lvsi higher lcam p in case with positive ln lower expression of erpr p p the positive predictive value ppv for er pr and lcam were the negative predictive value npv for each marker were a follows and mutation of p revealed ppv and npv when immunohistochemical marker were included into the current diagnostic model sensitivity improved v p ppv wa similar for both method while npv ie the probability of extremely low risk in negative test case wa improved v p conclusion we proved superiority of new proposed model using immunohistochemical marker over standard clinical practice and that new proposed model increase accuracy of prognosis prediction we propose wider implementation and validation of the proposed model,Cancer,0,a novel approach to preoperative risk stratification in endometrial cancer the added value of immunohistochemical marker background the current model used to preoperatively stratify endometrial cancer ec patient into low and highrisk group is based on histotype grade and imaging method and is not optimal our study aim to prove whether a new model incorporating immunohistochemical marker lcam er pr p obtained from preoperative biopsy could help refine stratification and thus the choice of adequate surgical extent and appropriate adjuvant treatment material and method the following data were prospectively collected from patient operated for ec from january through august age pre and postoperative histology grade lymphovascular space invasion lcam er pr p imaging parameter obtained from ultrasound ct chestabdomen final figo stage and current decision model based on histology grade imaging method result in total patient were enrolled the current model revealed sensitivity and specificity for highrisk group determination in myometrial invasion lower level of er p pr and higher level of lcam p were observed in cervical involvement a higher expression of lcam p lower pr p in tumor with positive lvsi higher lcam p in case with positive ln lower expression of erpr p p the positive predictive value ppv for er pr and lcam were the negative predictive value npv for each marker were a follows and mutation of p revealed ppv and npv when immunohistochemical marker were included into the current diagnostic model sensitivity improved v p ppv wa similar for both method while npv ie the probability of extremely low risk in negative test case wa improved v p conclusion we proved superiority of new proposed model using immunohistochemical marker over standard clinical practice and that new proposed model increase accuracy of prognosis prediction we propose wider implementation and validation of the proposed model
31032472,genomic assessment of bloodderived circulating tumor dna in patient with colorectal cancer correlation with tissue sequencing therapeutic response and survival,purpose genomic alteration in bloodderived circulating tumor dna ctdna from patient with colorectal cancer were correlated with clinical outcome patient and method nextgeneration sequencing of ctdna to gene panel wa performed in patient with colorectal cancer result most patient had metastatic or recurrent disease at the time of blood draw the median number of nonsynonymous alteration per patient wa three range zero to the most frequently aberrant gene were tp of patient kras and apc concordance between tissue and blood nextgeneration sequencing ranged from apc to braf altogether patient had one or more nonsynonymous alteration had one or more potentially actionable alteration and had an alteration actionable by a drug approved by the u food and drug administration on or off label lung metastasis correlated with improved survival from diagnosis in univariable analysis ctdna of or more from blood test a well a egfr and erbb her nonsynonymous alteration correlated with worse survival but only erbb remained significant in multivariable analysis no two patient had identical molecular portfolio overall versus of patient treated with matched n versus unmatched therapy n after ctdna testing achieved stable disease for month or more partial response or complete response p progressionfree survival versus month p and survival not reached versus month p all by multivariable analysis conclusion patient with colorectal cancer have heterogeneous ctdna profile and most harbor potentially actionable ctdna alteration matched therapy yielded higher rate of stable disease for month or more partial response or complete response ctdna assessment may have clinical utility and merit further investigation,Cancer,0,genomic assessment of bloodderived circulating tumor dna in patient with colorectal cancer correlation with tissue sequencing therapeutic response and survival purpose genomic alteration in bloodderived circulating tumor dna ctdna from patient with colorectal cancer were correlated with clinical outcome patient and method nextgeneration sequencing of ctdna to gene panel wa performed in patient with colorectal cancer result most patient had metastatic or recurrent disease at the time of blood draw the median number of nonsynonymous alteration per patient wa three range zero to the most frequently aberrant gene were tp of patient kras and apc concordance between tissue and blood nextgeneration sequencing ranged from apc to braf altogether patient had one or more nonsynonymous alteration had one or more potentially actionable alteration and had an alteration actionable by a drug approved by the u food and drug administration on or off label lung metastasis correlated with improved survival from diagnosis in univariable analysis ctdna of or more from blood test a well a egfr and erbb her nonsynonymous alteration correlated with worse survival but only erbb remained significant in multivariable analysis no two patient had identical molecular portfolio overall versus of patient treated with matched n versus unmatched therapy n after ctdna testing achieved stable disease for month or more partial response or complete response p progressionfree survival versus month p and survival not reached versus month p all by multivariable analysis conclusion patient with colorectal cancer have heterogeneous ctdna profile and most harbor potentially actionable ctdna alteration matched therapy yielded higher rate of stable disease for month or more partial response or complete response ctdna assessment may have clinical utility and merit further investigation
31032708,thyroidlike follicular carcinoma of the kidney with extensive sarcomatoid differentiation a case report and review of the literature,thyroidlike follicular carcinoma of the kidney tlfck is an extremely rare primary renal malignancy that typically ha an indolent course and good prognosis histologically this tumor mimic follicular carcinoma of the thyroid however typical thyroid marker are negative there are fewer than case reported in the literature and thus the prognosis and course of disease is not well understood sarcomatoid differentiation ha never been reported in a case of tlfck we present a case of a yearold woman with an aggressive tlfck with extensive sarcomatoid differentiation and metastatic disease at presentation we performed targeted nextgeneration sequencing of both the thyroidlike component and the poorly differentiated sarcomatoid component using our solid tumor panel to evaluate for any diseaseassociated mutation and to better understand the molecular profile of these tumor,Cancer,0,thyroidlike follicular carcinoma of the kidney with extensive sarcomatoid differentiation a case report and review of the literature thyroidlike follicular carcinoma of the kidney tlfck is an extremely rare primary renal malignancy that typically ha an indolent course and good prognosis histologically this tumor mimic follicular carcinoma of the thyroid however typical thyroid marker are negative there are fewer than case reported in the literature and thus the prognosis and course of disease is not well understood sarcomatoid differentiation ha never been reported in a case of tlfck we present a case of a yearold woman with an aggressive tlfck with extensive sarcomatoid differentiation and metastatic disease at presentation we performed targeted nextgeneration sequencing of both the thyroidlike component and the poorly differentiated sarcomatoid component using our solid tumor panel to evaluate for any diseaseassociated mutation and to better understand the molecular profile of these tumor
31032785,an update on mucosal melanoma future direction,by definition mucosal melanoma are malignant primary tumor originating from melanocyte located in the mucosal membrane of the nasal cavity and accessory sinus oral cavity lip and pharynx and vulvar vaginal or uterus anorectal or basically any other part of the mucosal surface lining these malignant melanoma usually occur in occult site which in combination with the lack of early specific sign contributes to the delay in diagnosis and poor prognosis of the disease given the rarity of mucosal melanoma knowledge about their pathogenesis and risk factor is insufficient and when compared with cutaneous and ocular melanoma they have the lowest fiveyear survival rate surgical resection is frequently the first approach to primary tumor even though the utility of lymph node surgery and radiation therapy is not well established novel molecular technique such a whole exome sequencing have become routine in order to aid patient care they show great promise in the treatment of rare and usually fatal disease such a mucosal melanoma target therapy against ckit activating mutation frequently seen in mucosal melanoma and the immunotherapy have emerged a a promising treatment modality for these aggressive tumor,Cancer,0,an update on mucosal melanoma future direction by definition mucosal melanoma are malignant primary tumor originating from melanocyte located in the mucosal membrane of the nasal cavity and accessory sinus oral cavity lip and pharynx and vulvar vaginal or uterus anorectal or basically any other part of the mucosal surface lining these malignant melanoma usually occur in occult site which in combination with the lack of early specific sign contributes to the delay in diagnosis and poor prognosis of the disease given the rarity of mucosal melanoma knowledge about their pathogenesis and risk factor is insufficient and when compared with cutaneous and ocular melanoma they have the lowest fiveyear survival rate surgical resection is frequently the first approach to primary tumor even though the utility of lymph node surgery and radiation therapy is not well established novel molecular technique such a whole exome sequencing have become routine in order to aid patient care they show great promise in the treatment of rare and usually fatal disease such a mucosal melanoma target therapy against ckit activating mutation frequently seen in mucosal melanoma and the immunotherapy have emerged a a promising treatment modality for these aggressive tumor
31033100,association between certain nonsmall cell lung cancer driver mutation and predictive marker for chemotherapy or programmed deathligand inhibition,this study aimed to analyze the association between driver mutation and predictive marker for some antitumor agent in nonsmall cell lung cancer nsclc a cohort of chinese patient with nsclc who underwent resection from march to november in the first affiliated hospital of guangzhou medical university wa investigated the specimen were subjected to hybridization capture and sequence of important nsclcrelated driver gene in addition the slide were tested for pdl excision repair crosscomplementation group ercc ribonucleotide reductase subunit m rrm thymidylate synthase t and betatubulin iii by immunohistochemical staining a total of patient had at least driver gene alteration wildtype egfr rare mutation mut alk fusion fus ra mut ret fus and met mut had relatively higher proportion of lower ercc expression egfr del egfr lr egfr rare mut alk fus her mut ro fus and met mut were more likely to have t low expression wildtype egfr lr egfr rare mut and braf mut were associated with lower betatubulin iii expression in addition wildtype ra mut ro fus braf and met mut had higher proportion of pdl high expression a a pilot validation wildtype patient with advanced nsclc showed better depth of response and response rate to taxanes compared with pemetrexedgemcitabine v our study may aid in selecting the optimal salvage regimen after targeted therapy failure or the chemoregimen where targeted therapy ha not been a routine option further validation is warranted,Cancer,0,association between certain nonsmall cell lung cancer driver mutation and predictive marker for chemotherapy or programmed deathligand inhibition this study aimed to analyze the association between driver mutation and predictive marker for some antitumor agent in nonsmall cell lung cancer nsclc a cohort of chinese patient with nsclc who underwent resection from march to november in the first affiliated hospital of guangzhou medical university wa investigated the specimen were subjected to hybridization capture and sequence of important nsclcrelated driver gene in addition the slide were tested for pdl excision repair crosscomplementation group ercc ribonucleotide reductase subunit m rrm thymidylate synthase t and betatubulin iii by immunohistochemical staining a total of patient had at least driver gene alteration wildtype egfr rare mutation mut alk fusion fus ra mut ret fus and met mut had relatively higher proportion of lower ercc expression egfr del egfr lr egfr rare mut alk fus her mut ro fus and met mut were more likely to have t low expression wildtype egfr lr egfr rare mut and braf mut were associated with lower betatubulin iii expression in addition wildtype ra mut ro fus braf and met mut had higher proportion of pdl high expression a a pilot validation wildtype patient with advanced nsclc showed better depth of response and response rate to taxanes compared with pemetrexedgemcitabine v our study may aid in selecting the optimal salvage regimen after targeted therapy failure or the chemoregimen where targeted therapy ha not been a routine option further validation is warranted
31037912,galectin expression and it clinical significance in acute myeloid leukemia with positive amleto fusion gene,objective to investigate the mrna expression of galectin and it clinical significance in acute myeloid leukemia aml patient carrying amletofusion gene method rqpcr method wa used to detect the expression of galectin mrna in bone marrow mononuclear cell of aml patient with amleto elisa wa used to detect the expression of galectin protein in peripheral blood and the correlation of galectin expression with clinical and laboratory feature and outcome were analyzed result the mrna and protein level of galectin were significantly higher in newly diagnosed amleto aml patient compared with the control p but there wa significant difference in recurrence rate between the two group p the median overall survival o rate and diseasefree survival dfs rate were shortened in the highexpression group p p and the cumulative incidence of relapse wa increased p but there wa no significant difference in the cumulative incidence of cmmmmortality p cox regression analysis suggested galectin mrna level an independent indicator of o and dfs in amleto aml patient conclusion bone marrow galectin mrna level may be an important reference index for evaluating the prognosis and guiding the treatment of amleto aml patient,Cancer,0,galectin expression and it clinical significance in acute myeloid leukemia with positive amleto fusion gene objective to investigate the mrna expression of galectin and it clinical significance in acute myeloid leukemia aml patient carrying amletofusion gene method rqpcr method wa used to detect the expression of galectin mrna in bone marrow mononuclear cell of aml patient with amleto elisa wa used to detect the expression of galectin protein in peripheral blood and the correlation of galectin expression with clinical and laboratory feature and outcome were analyzed result the mrna and protein level of galectin were significantly higher in newly diagnosed amleto aml patient compared with the control p but there wa significant difference in recurrence rate between the two group p the median overall survival o rate and diseasefree survival dfs rate were shortened in the highexpression group p p and the cumulative incidence of relapse wa increased p but there wa no significant difference in the cumulative incidence of cmmmmortality p cox regression analysis suggested galectin mrna level an independent indicator of o and dfs in amleto aml patient conclusion bone marrow galectin mrna level may be an important reference index for evaluating the prognosis and guiding the treatment of amleto aml patient
31038558,evaluating mmp and tgfssri expression in circulating tumor cell of pancreatic cancer patient and their correlation with clinical evolution,background metastasis is common in the diagnosis of pancreatic cancer and the presence of epithelialmesenchymal transition marker in circulating tumor cell may suggest worse prognosis aim to correlate the number of circulating tumor cell ctc in the peripheral blood of patient with a locally advanced or metastatic pancreatic tumor and the protein expression involved in epithelialmesenchymal transition emt in ctc with clinical characteristic progressionfree survival pfs and overall survival o method this wa a prospective study conducted using peripheral blood sample collected at three different time ctc were quantified by the iset test and analyzed by immunocytochemistry protein involved in emt vimentin tgfssri and mmp were analyzed in all ctc result twentyone patient were included median ctc detected were and ctc ml blood at baseline first and second followup respectively no statistically significant correlation wa found in correlating the number of ctc and the evaluated clinical characteristic pfs or o there wa no difference in pfs and o among the emt marker in the group with and without marker conclusion ctc analysis wa not relevant in this sample for comparing clinical finding pfs and o in patient with pancreatic cancer however marker analysis in ctc could be useful for the mmp andor tgfssri expression a observed by the separate pfs curve,Cancer,0,evaluating mmp and tgfssri expression in circulating tumor cell of pancreatic cancer patient and their correlation with clinical evolution background metastasis is common in the diagnosis of pancreatic cancer and the presence of epithelialmesenchymal transition marker in circulating tumor cell may suggest worse prognosis aim to correlate the number of circulating tumor cell ctc in the peripheral blood of patient with a locally advanced or metastatic pancreatic tumor and the protein expression involved in epithelialmesenchymal transition emt in ctc with clinical characteristic progressionfree survival pfs and overall survival o method this wa a prospective study conducted using peripheral blood sample collected at three different time ctc were quantified by the iset test and analyzed by immunocytochemistry protein involved in emt vimentin tgfssri and mmp were analyzed in all ctc result twentyone patient were included median ctc detected were and ctc ml blood at baseline first and second followup respectively no statistically significant correlation wa found in correlating the number of ctc and the evaluated clinical characteristic pfs or o there wa no difference in pfs and o among the emt marker in the group with and without marker conclusion ctc analysis wa not relevant in this sample for comparing clinical finding pfs and o in patient with pancreatic cancer however marker analysis in ctc could be useful for the mmp andor tgfssri expression a observed by the separate pfs curve
31041634,primary cardiac malignant peripheral nerve sheath tumor a case report,malignant peripheral nerve sheath tumor are rare sarcoma of child and adolescent and they are aggressive tumor with a high rate of local recurrence here we report a case of a primary cardiac malignant peripheral nerve sheath tumor without neurofibromatosis type i a year old woman presented having had cough expectoration and dyspnea for day and wa found to have a heartinvolving tumor diagnosed a a malignant peripheral nerve sheath tumor a rare cardiac sarcoma of x x cm in size the patient underwent a successful resection of the tumor but died month postoperative we report this case for it rarity and peculiar mode of morphologic and immunohistochemical presentation,Cancer,0,primary cardiac malignant peripheral nerve sheath tumor a case report malignant peripheral nerve sheath tumor are rare sarcoma of child and adolescent and they are aggressive tumor with a high rate of local recurrence here we report a case of a primary cardiac malignant peripheral nerve sheath tumor without neurofibromatosis type i a year old woman presented having had cough expectoration and dyspnea for day and wa found to have a heartinvolving tumor diagnosed a a malignant peripheral nerve sheath tumor a rare cardiac sarcoma of x x cm in size the patient underwent a successful resection of the tumor but died month postoperative we report this case for it rarity and peculiar mode of morphologic and immunohistochemical presentation
31043167,snw is a prognostic biomarker in prostate cancer,background snw is a nuclear receptor coactivator involved in splicing and transcription control including androgen receptor signaling overexpression of snw ha been linked to adverse prognosis in different cancer type but study on the role of snw in prostate cancer are lacking method using immunohistochemistry we analyzed snw expression in prostate cancer in a tissue microarray tma with attached clinical and molecular data result the comparison with normal prostate tissue revealed an up regulation of snw in a subset of cancer sample snw staining wa considered weak in moderate in and strong in of cancer strong snw expression wa markedly more frequent in prostate cancer harboring the tmprsserg fusion than in erg negative cancer p significant association with gleason grade stage nodal status and early biochemical recurrence were observed in the erg negative and positive subset multivariable modeling revealed that the prognostic value of snw up regulation wa independent from the established preoperative histopathological and clinical parameter conclusion these result demonstrate that snw overexpression is an independent prognostic marker in prostate cancer with potential clinical utility,Cancer,0,snw is a prognostic biomarker in prostate cancer background snw is a nuclear receptor coactivator involved in splicing and transcription control including androgen receptor signaling overexpression of snw ha been linked to adverse prognosis in different cancer type but study on the role of snw in prostate cancer are lacking method using immunohistochemistry we analyzed snw expression in prostate cancer in a tissue microarray tma with attached clinical and molecular data result the comparison with normal prostate tissue revealed an up regulation of snw in a subset of cancer sample snw staining wa considered weak in moderate in and strong in of cancer strong snw expression wa markedly more frequent in prostate cancer harboring the tmprsserg fusion than in erg negative cancer p significant association with gleason grade stage nodal status and early biochemical recurrence were observed in the erg negative and positive subset multivariable modeling revealed that the prognostic value of snw up regulation wa independent from the established preoperative histopathological and clinical parameter conclusion these result demonstrate that snw overexpression is an independent prognostic marker in prostate cancer with potential clinical utility
31043608,capicua regulates neural stem cell proliferation and lineage specification through control of ets factor,capicua cic is a transcriptional repressor mutated in the brain cancer oligodendroglioma despite it cancer link little is known of cics function in the brain we show that nuclear cic expression is strongest in astrocyte and neuron but weaker in stem cell and oligodendroglial lineage cell using a new conditional cic knockout mouse we demonstrate that forebrainspecific cic deletion increase proliferation and selfrenewal of neural stem cell furthermore cic loss bias neural stem cell toward glial lineage selection expanding the pool of oligodendrocyte precursor cell opcs these proliferation and lineage effect are dependent on derepression of ets transcription factor in patientderived oligodendroglioma cell cic reexpression or etv blockade decrease lineage bias proliferation selfrenewal and tumorigenicity our result identify cic a an important regulator of cell fate in neurodevelopment and oligodendroglioma and suggest that it loss contributes to oligodendroglioma by promoting proliferation and an opclike identity via ets overactivity,Cancer,0,capicua regulates neural stem cell proliferation and lineage specification through control of ets factor capicua cic is a transcriptional repressor mutated in the brain cancer oligodendroglioma despite it cancer link little is known of cics function in the brain we show that nuclear cic expression is strongest in astrocyte and neuron but weaker in stem cell and oligodendroglial lineage cell using a new conditional cic knockout mouse we demonstrate that forebrainspecific cic deletion increase proliferation and selfrenewal of neural stem cell furthermore cic loss bias neural stem cell toward glial lineage selection expanding the pool of oligodendrocyte precursor cell opcs these proliferation and lineage effect are dependent on derepression of ets transcription factor in patientderived oligodendroglioma cell cic reexpression or etv blockade decrease lineage bias proliferation selfrenewal and tumorigenicity our result identify cic a an important regulator of cell fate in neurodevelopment and oligodendroglioma and suggest that it loss contributes to oligodendroglioma by promoting proliferation and an opclike identity via ets overactivity
31046485,circulating cellfree nucleic acid a biomarkers in colorectal cancer screening and diagnosis an update,introduction screening method for one of the most frequently diagnosed malignancy colorectal cancer crc have limitation circulating cellfree nucleic acid cfna hold clinical relevance a screening prognostic and therapy monitoring marker area covered in this review we summarize potential crcspecific cfna biomarkers the recently developed sample preparation technique their application and pitfall expert opinion automated extraction of cfdna is highly reproducible however cfdna yield is less compared to manual isolation quantitative and highly sensitive detection technique eg digital pcr ng can be applied to analyze genetic and epigenetic change detection of dna mutation or methylation in cfdna and related altered level of mrna mirna and lncrna may improve early cancer recognition based on specific crcrelated pattern detection of cfdna mutation eg tp kras apc ha limited diagnostic sensitivity however methylated dna including sept sfrp sdc can be applied with higher sensitivity up to for crc circulating mirnas eg mir mir mir provide comparably high sensitivity for crc a the circulating tumor cell mrna marker eg egfr ck ck cea automation of cfna isolation coupled with quantitative analysis of crcrelated highly sensitive biomarkers may enhance crc screening and early detection in the future,Cancer,0,circulating cellfree nucleic acid a biomarkers in colorectal cancer screening and diagnosis an update introduction screening method for one of the most frequently diagnosed malignancy colorectal cancer crc have limitation circulating cellfree nucleic acid cfna hold clinical relevance a screening prognostic and therapy monitoring marker area covered in this review we summarize potential crcspecific cfna biomarkers the recently developed sample preparation technique their application and pitfall expert opinion automated extraction of cfdna is highly reproducible however cfdna yield is less compared to manual isolation quantitative and highly sensitive detection technique eg digital pcr ng can be applied to analyze genetic and epigenetic change detection of dna mutation or methylation in cfdna and related altered level of mrna mirna and lncrna may improve early cancer recognition based on specific crcrelated pattern detection of cfdna mutation eg tp kras apc ha limited diagnostic sensitivity however methylated dna including sept sfrp sdc can be applied with higher sensitivity up to for crc circulating mirnas eg mir mir mir provide comparably high sensitivity for crc a the circulating tumor cell mrna marker eg egfr ck ck cea automation of cfna isolation coupled with quantitative analysis of crcrelated highly sensitive biomarkers may enhance crc screening and early detection in the future
31047032,the molecular biologic basis of esophageal and gastric cancer,esophageal cancer and gastric cancer are leading cause of cancerrelated mortality worldwide in this article the author discus the molecular biology of esophageal and gastric cancer with a focus on esophageal adenocarcinoma they review data from the cancer genome atlas project and advance in the molecular stratification and classification of esophageal carcinoma and gastric cancer they also summarize advance in microrna molecular staging gene expression profiling tumor microenvironment and detection of circulating tumor dna finally the author summarize some of the implication of understanding the molecular basis of esophageal cancer and future direction in the management of esophageal cancer,Cancer,0,the molecular biologic basis of esophageal and gastric cancer esophageal cancer and gastric cancer are leading cause of cancerrelated mortality worldwide in this article the author discus the molecular biology of esophageal and gastric cancer with a focus on esophageal adenocarcinoma they review data from the cancer genome atlas project and advance in the molecular stratification and classification of esophageal carcinoma and gastric cancer they also summarize advance in microrna molecular staging gene expression profiling tumor microenvironment and detection of circulating tumor dna finally the author summarize some of the implication of understanding the molecular basis of esophageal cancer and future direction in the management of esophageal cancer
31048353,proposed diagnostic criterion for classical chronic myelomonocytic leukemia cmml cmml variant and precmml condition,chronic myelomonocytic leukemia cmml is a myeloid neoplasm characterized by dysplasia abnormal production and accumulation of monocytic cell and an elevated risk of transforming into acute leukemia over the past two decade our knowledge about the pathogenesis and molecular mechanism in cmml ha increased substantially in parallel better diagnostic criterion and therapeutic strategy have been developed however many question remain regarding prognostication and optimal therapy in addition there is a need to define potential prephases of cmml and special cmml variant and to separate these entity from each other and from condition mimicking cmml to address these unmet need an international consensus group met in a working conference in august and discussed open question and issue around cmml it variant and precmml condition the outcome of this meeting are summarized herein and include diag nostic criterion and a proposed classification of precmml condition a well a refined minimal diagnostic criterion for classical cmml and special cmml variant including oligomonocytic cmml and cmml associated with systemic mastocytosis moreover we propose diagnostic standard and tool to distinguish between normal precmml and cmml entity these criterion and standard should facilitate diagnostic and prognostic evaluation in daily practice and clinical study in applied hematology,Cancer,0,proposed diagnostic criterion for classical chronic myelomonocytic leukemia cmml cmml variant and precmml condition chronic myelomonocytic leukemia cmml is a myeloid neoplasm characterized by dysplasia abnormal production and accumulation of monocytic cell and an elevated risk of transforming into acute leukemia over the past two decade our knowledge about the pathogenesis and molecular mechanism in cmml ha increased substantially in parallel better diagnostic criterion and therapeutic strategy have been developed however many question remain regarding prognostication and optimal therapy in addition there is a need to define potential prephases of cmml and special cmml variant and to separate these entity from each other and from condition mimicking cmml to address these unmet need an international consensus group met in a working conference in august and discussed open question and issue around cmml it variant and precmml condition the outcome of this meeting are summarized herein and include diag nostic criterion and a proposed classification of precmml condition a well a refined minimal diagnostic criterion for classical cmml and special cmml variant including oligomonocytic cmml and cmml associated with systemic mastocytosis moreover we propose diagnostic standard and tool to distinguish between normal precmml and cmml entity these criterion and standard should facilitate diagnostic and prognostic evaluation in daily practice and clinical study in applied hematology
31048490,genetic diversity of tumor with mismatch repair deficiency influence antipd immunotherapy response,tumor with mismatch repair deficiency mmrd are characterized by sequence alteration in microsatellites and can accumulate thousand of mutation this high mutational burden render tumor immunogenic and sensitive to programmed cell death pd immune checkpoint inhibitor yet despite their tumor immunogenicity patient with mmrdeficient tumor experience highly variable response and roughly half are refractory to treatment we present experimental and clinical evidence showing that the degree of microsatellite instability msi and resultant mutational load in part underlies the variable response to pd blockade immunotherapy in mmrd human and mouse tumor the extent of response is particularly associated with the accumulation of insertiondeletion indel mutational load this study provides a rationale for the genomewide characterization of msi intensity and mutational load to better profile response to antipd immunotherapy across mmrdeficient human cancer,Cancer,0,genetic diversity of tumor with mismatch repair deficiency influence antipd immunotherapy response tumor with mismatch repair deficiency mmrd are characterized by sequence alteration in microsatellites and can accumulate thousand of mutation this high mutational burden render tumor immunogenic and sensitive to programmed cell death pd immune checkpoint inhibitor yet despite their tumor immunogenicity patient with mmrdeficient tumor experience highly variable response and roughly half are refractory to treatment we present experimental and clinical evidence showing that the degree of microsatellite instability msi and resultant mutational load in part underlies the variable response to pd blockade immunotherapy in mmrd human and mouse tumor the extent of response is particularly associated with the accumulation of insertiondeletion indel mutational load this study provides a rationale for the genomewide characterization of msi intensity and mutational load to better profile response to antipd immunotherapy across mmrdeficient human cancer
31049933,advancedstage mycosis fungoides role of the signal transducer and activator of transcription nuclear factorkappab and nuclear factor of activated t cell pathway,background the malignant mechanism that control the development of cutaneous tcell lymphoma ctcl are beginning to be identified recent evidence suggests that disturbance in specific intracellular signalling pathway such a rasmitogenactivated protein kinase tcell receptor tcrphospholipase c gamma plcgnuclear factor of activated t cell nfat and janus kinase jaksignal transducer and activator of transcription stat may play an essential role in the pathogenesis of ctcl objective to investigate the mechanism controlling disease development and progression in mycosis fungoides mf the most common form of ctcl method we collected sample that were submitted for diagnosis of or a second opinion regarding mf between and of which were in the early clinical stage of the disease formalinfixed paraffinembedded tissue were used for histological review and to measure the expression by immunohistochemistry of surrogate marker of activation of the tcrplcgnfat jakstat and nfkappab pathway folliculotropism and largecell transformation were also examined result nfat and nuclear factor kappa b nfkappab marker showed a comparable activation status in early and advanced stage while stat activation wa more frequent in advanced stage and wa associated with largecell transformation consistently with this observation stat activation occurred in parallel with mf progression in two initially mfnegative case a significant association of nfat with nfkappab marker wa also found reflecting a common mechanism of activation in the two pathway genomic study identified nine mutation in seven gene known to play a potential role in tumorigenesis in tcell leukaemialymphoma including plcg jak and stat which underlies the activation of these key cellsurvival pathway a higher mutational allele frequency wa detected in advanced stage conclusion our result show that stat is activated in advanced case and is associated with largecell transformation while the activation of nfat and nfkappab is maintained throughout the disease these finding could have important diagnostic and therapeutic implication whats already known about this topic mycosis fungoides is characterized by a clonal expansion of t cell in the skin the mechanism controlling disease development and progression are not fully understood what doe this study add an association of the nuclear factor of activated t cell and nuclear factor kappa b pathway wa found which could reflect a common mechanism of activation these pathway were activated in early and advanced stage at the same level signal transducer and activator of transcription activation wa associated with largecell transformation and wa more frequent in advanced stage a genomic analysis of cutaneous tcell lymphomaassociated gene wa performed nine mutation were detected what is the translational message these result could have important implication for the treatment of mf in the near future,Cancer,0,advancedstage mycosis fungoides role of the signal transducer and activator of transcription nuclear factorkappab and nuclear factor of activated t cell pathway background the malignant mechanism that control the development of cutaneous tcell lymphoma ctcl are beginning to be identified recent evidence suggests that disturbance in specific intracellular signalling pathway such a rasmitogenactivated protein kinase tcell receptor tcrphospholipase c gamma plcgnuclear factor of activated t cell nfat and janus kinase jaksignal transducer and activator of transcription stat may play an essential role in the pathogenesis of ctcl objective to investigate the mechanism controlling disease development and progression in mycosis fungoides mf the most common form of ctcl method we collected sample that were submitted for diagnosis of or a second opinion regarding mf between and of which were in the early clinical stage of the disease formalinfixed paraffinembedded tissue were used for histological review and to measure the expression by immunohistochemistry of surrogate marker of activation of the tcrplcgnfat jakstat and nfkappab pathway folliculotropism and largecell transformation were also examined result nfat and nuclear factor kappa b nfkappab marker showed a comparable activation status in early and advanced stage while stat activation wa more frequent in advanced stage and wa associated with largecell transformation consistently with this observation stat activation occurred in parallel with mf progression in two initially mfnegative case a significant association of nfat with nfkappab marker wa also found reflecting a common mechanism of activation in the two pathway genomic study identified nine mutation in seven gene known to play a potential role in tumorigenesis in tcell leukaemialymphoma including plcg jak and stat which underlies the activation of these key cellsurvival pathway a higher mutational allele frequency wa detected in advanced stage conclusion our result show that stat is activated in advanced case and is associated with largecell transformation while the activation of nfat and nfkappab is maintained throughout the disease these finding could have important diagnostic and therapeutic implication whats already known about this topic mycosis fungoides is characterized by a clonal expansion of t cell in the skin the mechanism controlling disease development and progression are not fully understood what doe this study add an association of the nuclear factor of activated t cell and nuclear factor kappa b pathway wa found which could reflect a common mechanism of activation these pathway were activated in early and advanced stage at the same level signal transducer and activator of transcription activation wa associated with largecell transformation and wa more frequent in advanced stage a genomic analysis of cutaneous tcell lymphomaassociated gene wa performed nine mutation were detected what is the translational message these result could have important implication for the treatment of mf in the near future
31050834,six regulates leukemia stem cell maintenance in acute myeloid leukemia,molecular genetic change in acute myeloid leukemia aml play crucial role in leukemogenesis including recurrent chromosome translocation epigeneticspliceosome mutation and transcription factor aberration six a transcription factor of the sine oculis homeobox six family ha been shown to transform normal hematopoietic progenitor into leukemia in cooperation with eya however the specific role and the underlying mechanism of six in leukemia maintenance remain unexplored here we showed increased expression of six in aml patient and murine leukemia stem cell ckit cell lscs importantly we also observed that a higher level of six in human patient predicts a worse prognosis notably knockdown of six significantly prolonged the survival of mllafinduced aml mouse with reduced peripheral infiltration and tumor burden aml cell from sixknockdown kd mouse displayed a significantly decreased number and function of lsc a assessed by the immunophenotype colonyforming ability and limiting dilution assay further analysis revealed the augmented apoptosis of lsc and decreased expression of glycolytic gene in six kd mouse overall our data showed that six is essential for the progression of mllafinduced aml via maintaining the pool of lsc,Cancer,0,six regulates leukemia stem cell maintenance in acute myeloid leukemia molecular genetic change in acute myeloid leukemia aml play crucial role in leukemogenesis including recurrent chromosome translocation epigeneticspliceosome mutation and transcription factor aberration six a transcription factor of the sine oculis homeobox six family ha been shown to transform normal hematopoietic progenitor into leukemia in cooperation with eya however the specific role and the underlying mechanism of six in leukemia maintenance remain unexplored here we showed increased expression of six in aml patient and murine leukemia stem cell ckit cell lscs importantly we also observed that a higher level of six in human patient predicts a worse prognosis notably knockdown of six significantly prolonged the survival of mllafinduced aml mouse with reduced peripheral infiltration and tumor burden aml cell from sixknockdown kd mouse displayed a significantly decreased number and function of lsc a assessed by the immunophenotype colonyforming ability and limiting dilution assay further analysis revealed the augmented apoptosis of lsc and decreased expression of glycolytic gene in six kd mouse overall our data showed that six is essential for the progression of mllafinduced aml via maintaining the pool of lsc
31053248,receptor radionuclide targeting for neuroendocrine tumor net diagnostic and therapy,neuroendocrine tumor net represent a heterogeneous group of tumor originating from cell of neuroendocrine origin which express somatostatin receptor sstr this property allowed the successful development of radionuclides for diagnostic and peptide radionuclide radiation therapy prrt this is the paradigm for the theragnostic concept in net personalized medicine the only phase iii study to date netter clearly demonstrated the ability of lutetiumbased prrt to improve progressionfree survival in advanced intestinal net in clinical practice the indication are limited to gg welldifferentiated net with high expression of sstr net with a low tumor burden and slow progression are probably the optimal indication this treatment is now available in france however it precise position in the treatment algorithm remains to be explored we provide an overview of receptor radionuclide utilization and mechanism in diagnostic and pretherapeutic imaging and we focus on prrt for endocrine tumor,Cancer,0,receptor radionuclide targeting for neuroendocrine tumor net diagnostic and therapy neuroendocrine tumor net represent a heterogeneous group of tumor originating from cell of neuroendocrine origin which express somatostatin receptor sstr this property allowed the successful development of radionuclides for diagnostic and peptide radionuclide radiation therapy prrt this is the paradigm for the theragnostic concept in net personalized medicine the only phase iii study to date netter clearly demonstrated the ability of lutetiumbased prrt to improve progressionfree survival in advanced intestinal net in clinical practice the indication are limited to gg welldifferentiated net with high expression of sstr net with a low tumor burden and slow progression are probably the optimal indication this treatment is now available in france however it precise position in the treatment algorithm remains to be explored we provide an overview of receptor radionuclide utilization and mechanism in diagnostic and pretherapeutic imaging and we focus on prrt for endocrine tumor
31054046,osteosarcoma and second malignant neoplasm a case series,background the overall survival of patient with localised osteosarcoma ha dramatically improved with the introduction of multidrug chemotherapeutic regimen into the treatment paradigm however despite optimal treatment allcause mortality remains higher among osteosarcoma survivor than in the general population the development of second malignant neoplasm contributes to this higher mortality rate case series we present three case of patient definitively treated for osteosarcoma who subsequently developed a second malignant neoplasm the first case describes a yearold female with osteosarcoma of her right femur treated with surgical resection and perioperative chemotherapy ten year later she wa diagnosed with metastatic herpositive breast cancer genetic testing identified a germline tp mutation confirming the presence of lifraumeni syndrome the second case detail an yearold male with osteosarcoma of his right humerus treated with definitive resection and perioperative chemotherapy he wa diagnosed with appendiceal adenocarcinoma after presenting with acute abdominal pain year later the third case reviewed is of a yearold male with osteosarcoma of his right femur treated with definitive resection and adjuvant chemotherapy a diagnosis of leiomyosarcoma wa made year later following surveillance imaging discussion the risk of second malignant neoplasm in osteosarcoma may relate to previous oncological treatment an inherited cancer predisposition syndrome or a spontaneous new neoplasm although screening for a second malignancy is not routinely recommended for osteosarcoma survivor a high degree of clinical suspicion should be maintained during surveillance,Cancer,0,osteosarcoma and second malignant neoplasm a case series background the overall survival of patient with localised osteosarcoma ha dramatically improved with the introduction of multidrug chemotherapeutic regimen into the treatment paradigm however despite optimal treatment allcause mortality remains higher among osteosarcoma survivor than in the general population the development of second malignant neoplasm contributes to this higher mortality rate case series we present three case of patient definitively treated for osteosarcoma who subsequently developed a second malignant neoplasm the first case describes a yearold female with osteosarcoma of her right femur treated with surgical resection and perioperative chemotherapy ten year later she wa diagnosed with metastatic herpositive breast cancer genetic testing identified a germline tp mutation confirming the presence of lifraumeni syndrome the second case detail an yearold male with osteosarcoma of his right humerus treated with definitive resection and perioperative chemotherapy he wa diagnosed with appendiceal adenocarcinoma after presenting with acute abdominal pain year later the third case reviewed is of a yearold male with osteosarcoma of his right femur treated with definitive resection and adjuvant chemotherapy a diagnosis of leiomyosarcoma wa made year later following surveillance imaging discussion the risk of second malignant neoplasm in osteosarcoma may relate to previous oncological treatment an inherited cancer predisposition syndrome or a spontaneous new neoplasm although screening for a second malignancy is not routinely recommended for osteosarcoma survivor a high degree of clinical suspicion should be maintained during surveillance
31055803,analysis of agespecific cytogenetic change among patient withacute myeloid leukemia,objective to characterize cytogenetic change and prognosis of patient with acute myeloid leukemia aml from different age group method the karyotype of aml patient were analyzed by using shortterm culture of bone marrow cell and rbanding technique combined with fab typing and genetic testing cytogenetic change and prognosis of different age group were analyzed result the abnormal cloning rate wa among the patient the abnormal cloning rate and adverse risk karyotype proportion of those with myeloproliferative syndrome md and secondary aml were higher than those with de novo aml p pyearold group wa lower than the yearsold group and karyotype of poor prognosis is low patient with md with secondary aml have a poor prognosis,Cancer,0,analysis of agespecific cytogenetic change among patient withacute myeloid leukemia objective to characterize cytogenetic change and prognosis of patient with acute myeloid leukemia aml from different age group method the karyotype of aml patient were analyzed by using shortterm culture of bone marrow cell and rbanding technique combined with fab typing and genetic testing cytogenetic change and prognosis of different age group were analyzed result the abnormal cloning rate wa among the patient the abnormal cloning rate and adverse risk karyotype proportion of those with myeloproliferative syndrome md and secondary aml were higher than those with de novo aml p pyearold group wa lower than the yearsold group and karyotype of poor prognosis is low patient with md with secondary aml have a poor prognosis
31055804,characterizing the molecular cytogenetics in acute monocytic leukemia,objective to characterize the molecular genetics of patient with acute monocytic leukemia aml method fluorescence in situ hybridization fish wa employed to detect mll gene rearrangement combined mutation of gene were detected by dnabased pcr and sanger sequencing result sixty seven patient were found to harbor at least one mutation the most commonly mutated gene wa npm n which wa followed by fltitd n nra n dnmta n tet n runx n and kras n based on the function of mutated gene the most frequently involved gene were those involved in dna methylation tyrosine kinase receptor signaling transcription regulation and ra pathway single gene mutation predominated in patient with cytogenetic abnormality while coexistence of mutation have predominated in patient with normal cytogenetic finding stratified by cytogenetic finding patient with single gene mutation intermediaterisk group had significantly higher complete remission cr rate than those with gene mutation unfavorablerisk group v v p respectively conclusion over of aml patient were found to harbor at least one mutation their clinical phenotype and prognosis may be impacted by the synergy of mll gene rearrangement and multiple mutation for patient under the same risk stratification the number of mutation is reversely correlated with the cr rate,Cancer,0,characterizing the molecular cytogenetics in acute monocytic leukemia objective to characterize the molecular genetics of patient with acute monocytic leukemia aml method fluorescence in situ hybridization fish wa employed to detect mll gene rearrangement combined mutation of gene were detected by dnabased pcr and sanger sequencing result sixty seven patient were found to harbor at least one mutation the most commonly mutated gene wa npm n which wa followed by fltitd n nra n dnmta n tet n runx n and kras n based on the function of mutated gene the most frequently involved gene were those involved in dna methylation tyrosine kinase receptor signaling transcription regulation and ra pathway single gene mutation predominated in patient with cytogenetic abnormality while coexistence of mutation have predominated in patient with normal cytogenetic finding stratified by cytogenetic finding patient with single gene mutation intermediaterisk group had significantly higher complete remission cr rate than those with gene mutation unfavorablerisk group v v p respectively conclusion over of aml patient were found to harbor at least one mutation their clinical phenotype and prognosis may be impacted by the synergy of mll gene rearrangement and multiple mutation for patient under the same risk stratification the number of mutation is reversely correlated with the cr rate
31055940,a pilot lowinflammatory dietary intervention to reduce inflammation and improve quality of life in patient with familial adenomatous polyposis protocol description and preliminary result,patient with familial adenomatous polyposis fap depend on a lifelong endoscopic surveillance programme and prophylactic surgery and usually suffer nutritional problem intestinal inflammation ha been linked to both fap and colorectal cancer epidemiological study show a relationship between diet and inflammation preventive dietary recommendation for fap patient are so far lacking we have designed a nonrandomized prospective pilot study on fap patient to assess whether a lowinflammatory diet based on the mediterranean diet principle and recipe by interacting with the microbiota reduces gastrointestinal marker of inflammation and improves quality of life this report describes the scientific protocol of the study and report the participant adherence to the proposed dietary recommendation thirtyfour fap patient older than year bearing the apc pathogenic variant who underwent prophylactic total colectomy with ileorectal anastomosis were eligible into the study during the month dietary intervention they reported improvement in their consumption of mediterranean food vegetable fruit fish and legume and a reduction in proinflammatory food redprocessed meat and sweet this led to a significant increase in their adherence to the mediterranean diet the improvement wa accompanied by a decrease in the number of diarrhoeal discharge these preliminary result are encouraging with regard to feasibility dietary outcome measure and safety,Cancer,0,a pilot lowinflammatory dietary intervention to reduce inflammation and improve quality of life in patient with familial adenomatous polyposis protocol description and preliminary result patient with familial adenomatous polyposis fap depend on a lifelong endoscopic surveillance programme and prophylactic surgery and usually suffer nutritional problem intestinal inflammation ha been linked to both fap and colorectal cancer epidemiological study show a relationship between diet and inflammation preventive dietary recommendation for fap patient are so far lacking we have designed a nonrandomized prospective pilot study on fap patient to assess whether a lowinflammatory diet based on the mediterranean diet principle and recipe by interacting with the microbiota reduces gastrointestinal marker of inflammation and improves quality of life this report describes the scientific protocol of the study and report the participant adherence to the proposed dietary recommendation thirtyfour fap patient older than year bearing the apc pathogenic variant who underwent prophylactic total colectomy with ileorectal anastomosis were eligible into the study during the month dietary intervention they reported improvement in their consumption of mediterranean food vegetable fruit fish and legume and a reduction in proinflammatory food redprocessed meat and sweet this led to a significant increase in their adherence to the mediterranean diet the improvement wa accompanied by a decrease in the number of diarrhoeal discharge these preliminary result are encouraging with regard to feasibility dietary outcome measure and safety
31062729,fish and herneu equivocal immunohistochemistry in breast carcinoma,aim the aim of this study wa to validate the role of fluorescence in situ hybridization fish in investigating herneu gene amplification human epidermal growth factor receptor in patient with herneu equivocal breast cancer diagnosed on immunohistochemistry ihc material and method this wa a retrospective study conducted from january to october a total of patient diagnosed with invasive breast carcinoma and herneu equivocal status on ihc were analyzed also the case for the year and formed a subgroup that wa analyzed further to study the impact of preanalytical factor on ihc and fish result result a total of woman with herneu ihc equivocal breast cancer were included in the study with a median age of year range herneu amplification by fish wa noted in case whereas it wa nonamplified in case ten case were reported a equivocal even on fish ascocap guideline polysomy wa noted in case of which patient were year of age twenty of these case showed herneu amplification whereas case were nonamplified and case were reported a equivocal on fish also more than half of the polysomy case were hormone receptor negative conclusion ihc is a good screening tool for negative and positive result any patient targeted for trastuzumab therapy should undergo confirmation of herneu equivocal status by fish analysis we also suggest that if a nonclassical fish pattern is seen the test should be repeated with a noncentromeric chromosome reference locus probe for better treatment planning,Cancer,0,fish and herneu equivocal immunohistochemistry in breast carcinoma aim the aim of this study wa to validate the role of fluorescence in situ hybridization fish in investigating herneu gene amplification human epidermal growth factor receptor in patient with herneu equivocal breast cancer diagnosed on immunohistochemistry ihc material and method this wa a retrospective study conducted from january to october a total of patient diagnosed with invasive breast carcinoma and herneu equivocal status on ihc were analyzed also the case for the year and formed a subgroup that wa analyzed further to study the impact of preanalytical factor on ihc and fish result result a total of woman with herneu ihc equivocal breast cancer were included in the study with a median age of year range herneu amplification by fish wa noted in case whereas it wa nonamplified in case ten case were reported a equivocal even on fish ascocap guideline polysomy wa noted in case of which patient were year of age twenty of these case showed herneu amplification whereas case were nonamplified and case were reported a equivocal on fish also more than half of the polysomy case were hormone receptor negative conclusion ihc is a good screening tool for negative and positive result any patient targeted for trastuzumab therapy should undergo confirmation of herneu equivocal status by fish analysis we also suggest that if a nonclassical fish pattern is seen the test should be repeated with a noncentromeric chromosome reference locus probe for better treatment planning
31065274,a potential antitumor effect of dendritic cell fused with cancer stem cell in hepatocellular carcinoma,hcc stem cell were reported a posttreatment residual tumor cell that play a pivotal role in tumor relapse fusing dendritic cell dc with tumor cell represents an ideal approach to effectively activate the antitumor immunity in vivo dchcc stem cell vaccine provides a potential strategy to generate polyclonal immune response to multiple tumor stem cell antigen including those yet to be unidentified to assess the potential capacity of dchcc stem cell vaccine against hcc cdhepg cell were sorted from the hcc cell line hepg dc and cdhepg and dc and hepg fused cell were induced by polyethylene glycol peg the influence of fusion cell on proliferation and immunological function transformation of lymphocyte wa assessed by fcm and elisa assay respectively the cytotoxicity assay of specific fusion cellinduced ctls against hepg wa conducted by cytotox nonradioactive cytotoxicity assay kit in vitro at last the prevention of hcc formation in vivo wa described in a mouse model the result of fcm analysis showed that the proportion of cdhepg cell in the spheral cdhepg enriched by suspension sphere culture wa ranging from to and cdhepgdc fused cell were successfully constructed the fusion cell expressed a higher level of costimulatory molecule cd cd cd and mhci and mhcii molecule hlaabc and hladr than did immature dc p and the functional analysis of fusion cellinduced ctls also illustrated that cdhepgdc fusion cell showed a greater capacity to activate proliferation of lymphocyte in vitro p the cdhepgdcactivated ctls had a specific killing ability against cdhepg cell in vivo these result suggested that cdhepgdc fusion cell could efficiently stimulate t lymphocyte to generate specific ctls targeting cdhepg cell it might be a promising strategy of immunotherapy for hcc,Cancer,0,a potential antitumor effect of dendritic cell fused with cancer stem cell in hepatocellular carcinoma hcc stem cell were reported a posttreatment residual tumor cell that play a pivotal role in tumor relapse fusing dendritic cell dc with tumor cell represents an ideal approach to effectively activate the antitumor immunity in vivo dchcc stem cell vaccine provides a potential strategy to generate polyclonal immune response to multiple tumor stem cell antigen including those yet to be unidentified to assess the potential capacity of dchcc stem cell vaccine against hcc cdhepg cell were sorted from the hcc cell line hepg dc and cdhepg and dc and hepg fused cell were induced by polyethylene glycol peg the influence of fusion cell on proliferation and immunological function transformation of lymphocyte wa assessed by fcm and elisa assay respectively the cytotoxicity assay of specific fusion cellinduced ctls against hepg wa conducted by cytotox nonradioactive cytotoxicity assay kit in vitro at last the prevention of hcc formation in vivo wa described in a mouse model the result of fcm analysis showed that the proportion of cdhepg cell in the spheral cdhepg enriched by suspension sphere culture wa ranging from to and cdhepgdc fused cell were successfully constructed the fusion cell expressed a higher level of costimulatory molecule cd cd cd and mhci and mhcii molecule hlaabc and hladr than did immature dc p and the functional analysis of fusion cellinduced ctls also illustrated that cdhepgdc fusion cell showed a greater capacity to activate proliferation of lymphocyte in vitro p the cdhepgdcactivated ctls had a specific killing ability against cdhepg cell in vivo these result suggested that cdhepgdc fusion cell could efficiently stimulate t lymphocyte to generate specific ctls targeting cdhepg cell it might be a promising strategy of immunotherapy for hcc
31068555,heterogeneity of genomic alteration and clinical aspect in peripheral tcell lymphoma future perspective,peripheral tcell lymphoma ptcl is a heterogeneous group of lymphoid malignancy several recent comprehensive genomic study characterize the genomic alteration of each ptcl type and reveal the complexity and heterogeneity the updated world health organization classification ha precisely distinguished lymphoma from lymphoproliferative disorder and ha included a new entity based on the tumor phenotype although establishing the classification based on genomic alteration ha been difficult because of heterogeneity the genomic alteration may support the diagnosis establishing genomic alteration that act a predictive marker for clinical course andor therapeutic target is needed in future study using genomic alteration information since patient with ptcl generally have poor prognosis establishing the target and standard therapy is one of the major issue to be addressed in addition to clinicopathological and genomic analysis patientderived xenograft model can provide these therapeutic strategy integration of analyzed data is considered to promote future ptcl study leading to improved ptcl prognosis,Cancer,0,heterogeneity of genomic alteration and clinical aspect in peripheral tcell lymphoma future perspective peripheral tcell lymphoma ptcl is a heterogeneous group of lymphoid malignancy several recent comprehensive genomic study characterize the genomic alteration of each ptcl type and reveal the complexity and heterogeneity the updated world health organization classification ha precisely distinguished lymphoma from lymphoproliferative disorder and ha included a new entity based on the tumor phenotype although establishing the classification based on genomic alteration ha been difficult because of heterogeneity the genomic alteration may support the diagnosis establishing genomic alteration that act a predictive marker for clinical course andor therapeutic target is needed in future study using genomic alteration information since patient with ptcl generally have poor prognosis establishing the target and standard therapy is one of the major issue to be addressed in addition to clinicopathological and genomic analysis patientderived xenograft model can provide these therapeutic strategy integration of analyzed data is considered to promote future ptcl study leading to improved ptcl prognosis
31069152,apc germline hepatoblastomas demonstrate cisplatininduced intratumor tertiary lymphoid structure,hepatoblastoma hb is the most common liver cancer in child we aimed to characterize hb related to apc adenomatous polyposis coli germline mutation apchb this french multicentric retrospective study included apchb patient under at diagnosis clinical feature of apchb were compared to the french siopel cohort of hb patient molecular and histopathological analysis of apchb were compared to consecutive sporadic hb treated at bicetre hospital from to nonapchb apchb patient have a peculiar spectrum of germline apc mutation with no event in the main hotspot of classical apc mutation at codon p compared to sporadic hb they have similar clinical feature including good prognosis since all patient are alive in complete remission at last followup apchb are mostly welllimited tumor with fetal predominance and few mesenchymal component all apchb have an activated wntbetacatenin pathway without ctnnb mutation confirming that germline apc and somatic ctnnb mutation are mutually exclusive p pathological reviewing identified massive intratumor tertiary lymphoid structure tl containing both lymphocyte and antigenpresenting cell in all apchb case who received cisplatinbased neoadjuvant chemotherapy but not in five prechemotherapy sample four paired biopsy and one patient resected without chemotherapy indicating that these tl are induced by chemotherapy p conclusion apchb show a good prognosis they are all infiltrated by cisplatininduced tl a feature only retrieved in a minority of nonapchb this suggests that apc inactivation can synergize with cisplatin to induce an immunogenic cell death that initiate an antitumor immune response,Cancer,0,apc germline hepatoblastomas demonstrate cisplatininduced intratumor tertiary lymphoid structure hepatoblastoma hb is the most common liver cancer in child we aimed to characterize hb related to apc adenomatous polyposis coli germline mutation apchb this french multicentric retrospective study included apchb patient under at diagnosis clinical feature of apchb were compared to the french siopel cohort of hb patient molecular and histopathological analysis of apchb were compared to consecutive sporadic hb treated at bicetre hospital from to nonapchb apchb patient have a peculiar spectrum of germline apc mutation with no event in the main hotspot of classical apc mutation at codon p compared to sporadic hb they have similar clinical feature including good prognosis since all patient are alive in complete remission at last followup apchb are mostly welllimited tumor with fetal predominance and few mesenchymal component all apchb have an activated wntbetacatenin pathway without ctnnb mutation confirming that germline apc and somatic ctnnb mutation are mutually exclusive p pathological reviewing identified massive intratumor tertiary lymphoid structure tl containing both lymphocyte and antigenpresenting cell in all apchb case who received cisplatinbased neoadjuvant chemotherapy but not in five prechemotherapy sample four paired biopsy and one patient resected without chemotherapy indicating that these tl are induced by chemotherapy p conclusion apchb show a good prognosis they are all infiltrated by cisplatininduced tl a feature only retrieved in a minority of nonapchb this suggests that apc inactivation can synergize with cisplatin to induce an immunogenic cell death that initiate an antitumor immune response
31069978,inherited thrombocytopenia and platelet disorder with germline predisposition to myeloid neoplasia,advance in molecular genetic sequencing technique have contributed to the elucidation of previously unknown germline mutation responsible for inherited thrombocytopenia it regardless of age of presentation and severity of symptom related to thrombocytopenia andor platelet dysfunction a subset of patient with it are at increased risk of developing myeloid neoplasm during their life time particularly those with germline autosomal dominant mutation in runx ankrd and etv patient may present with isolated thrombocytopenia and megakaryocytic dysmorphia or atypia on baseline bone marrow evaluation without constituting myelodysplasia md bone marrow feature may overlap with idiopathic thrombocytopenic purpura itp or sporadic md leading to misdiagnosis progression to myelodysplastic syndrome acute myeloid leukemia mdsaml may be accompanied by progressive bi or pancytopenia multilineage dysplasia increased blast cytogenetic abnormality acquisition of biallelic mutation in the underlying gene with germline mutation or additional somatic mutation in gene associated with myeloid malignancy a subset of patient may present with mdsaml at a young age underscoring the growing concern for evaluating young patient with mdsaml for germline mutation predisposing to myeloid neoplasm early recognition of germline mutation and predisposition to myeloid malignancy permit appropriate treatment adequate monitoring for disease progression proper donor selection for hematopoietic stem cell transplantation a well a genetic counseling of the affected patient and their family member herein we describe the clinical and diagnostic feature of it with germline mutation predisposing to myeloid neoplasm focusing on mutation involving runx ankrd and etv,Cancer,0,inherited thrombocytopenia and platelet disorder with germline predisposition to myeloid neoplasia advance in molecular genetic sequencing technique have contributed to the elucidation of previously unknown germline mutation responsible for inherited thrombocytopenia it regardless of age of presentation and severity of symptom related to thrombocytopenia andor platelet dysfunction a subset of patient with it are at increased risk of developing myeloid neoplasm during their life time particularly those with germline autosomal dominant mutation in runx ankrd and etv patient may present with isolated thrombocytopenia and megakaryocytic dysmorphia or atypia on baseline bone marrow evaluation without constituting myelodysplasia md bone marrow feature may overlap with idiopathic thrombocytopenic purpura itp or sporadic md leading to misdiagnosis progression to myelodysplastic syndrome acute myeloid leukemia mdsaml may be accompanied by progressive bi or pancytopenia multilineage dysplasia increased blast cytogenetic abnormality acquisition of biallelic mutation in the underlying gene with germline mutation or additional somatic mutation in gene associated with myeloid malignancy a subset of patient may present with mdsaml at a young age underscoring the growing concern for evaluating young patient with mdsaml for germline mutation predisposing to myeloid neoplasm early recognition of germline mutation and predisposition to myeloid malignancy permit appropriate treatment adequate monitoring for disease progression proper donor selection for hematopoietic stem cell transplantation a well a genetic counseling of the affected patient and their family member herein we describe the clinical and diagnostic feature of it with germline mutation predisposing to myeloid neoplasm focusing on mutation involving runx ankrd and etv
31074748,controlling trapping state on selective theranostic coreshell nayfybtmtiozro nanocomplexes for enhanced niractivated photodynamic therapy against breast cancer cell,photodynamic and immune therapy are innovative medical strategy against cancer and their integration with upconversion nanoparticles ucnps can improve the diagnosis and treatment of the disease the ucnps convert the deep penetrating nearinfrared nir light into higher energy emission allowing the imaging and detection of malignant cell and the simultaneous energy transfer for activation of the photosensitizers in this work the ucnps were coated with a photocatalytic tiozro shell and an increase of oxygen defect vo wa observed a a result of the partial substitution of ti by zr ion in the crystalline lattice of tio such defect act a trapping state improving charge separation and then reducing the recombination rate of the electronhole pair eh generated upon resonant energy transfer from the donor ucnps to acceptor shell the overall result are the enhancement of both ro production and the emission band centered at nm which is useful for tracking cell at the deep tissue level however an excess of those defect produce deleterious effect on both process a a result of charge migration the specificity against her positive breast cancer wa provided by bioconjugation with the monoclonal antibody trastuzumab after administration of the synthesized nayfybtmtiozrotrastuzumab theranostic nanocomplex doped with an optimal zro molar concentration and subsequent exposure to nm light w cm during minute herpositive skbr breast cancer cell were suppressed with drop of the cell viability higher than ucnps decorated with a pure tio shell,Cancer,0,controlling trapping state on selective theranostic coreshell nayfybtmtiozro nanocomplexes for enhanced niractivated photodynamic therapy against breast cancer cell photodynamic and immune therapy are innovative medical strategy against cancer and their integration with upconversion nanoparticles ucnps can improve the diagnosis and treatment of the disease the ucnps convert the deep penetrating nearinfrared nir light into higher energy emission allowing the imaging and detection of malignant cell and the simultaneous energy transfer for activation of the photosensitizers in this work the ucnps were coated with a photocatalytic tiozro shell and an increase of oxygen defect vo wa observed a a result of the partial substitution of ti by zr ion in the crystalline lattice of tio such defect act a trapping state improving charge separation and then reducing the recombination rate of the electronhole pair eh generated upon resonant energy transfer from the donor ucnps to acceptor shell the overall result are the enhancement of both ro production and the emission band centered at nm which is useful for tracking cell at the deep tissue level however an excess of those defect produce deleterious effect on both process a a result of charge migration the specificity against her positive breast cancer wa provided by bioconjugation with the monoclonal antibody trastuzumab after administration of the synthesized nayfybtmtiozrotrastuzumab theranostic nanocomplex doped with an optimal zro molar concentration and subsequent exposure to nm light w cm during minute herpositive skbr breast cancer cell were suppressed with drop of the cell viability higher than ucnps decorated with a pure tio shell
31076661,going to extreme determinant of extraordinary response and survival in patient with cancer,research into factor affecting treatment response or survival in patient with cancer frequently involves cohort that span the most common range of clinical outcome a such patient are most readily available for study however attention ha turned to highly unusual patient who have exceptionally favourable or atypically poor response to treatment andor overall survival with the expectation that patient at the extreme may provide insight that could ultimately improve the outcome of individual with more typical disease trajectory while clinician can often recount surprising patient whose clinical journey wa very unusual given known clinical characteristic and prognostic indicator there is a lack of consensus among researcher on how best to define exceptional patient and little ha been proposed for the optimal design of study to identify factor that dictate unusual outcome in this opinion article we review different approach to identifying exceptional patient with cancer and possible study design to investigate extraordinary clinical outcome we discus pitfall with finding these rare patient including challenge associated with accrual of patient across different treatment centre and time period we describe recent molecular and immunological factor that have been identified a contributing to unusual patient outcome and make recommendation for future study on these intriguing patient,Cancer,0,going to extreme determinant of extraordinary response and survival in patient with cancer research into factor affecting treatment response or survival in patient with cancer frequently involves cohort that span the most common range of clinical outcome a such patient are most readily available for study however attention ha turned to highly unusual patient who have exceptionally favourable or atypically poor response to treatment andor overall survival with the expectation that patient at the extreme may provide insight that could ultimately improve the outcome of individual with more typical disease trajectory while clinician can often recount surprising patient whose clinical journey wa very unusual given known clinical characteristic and prognostic indicator there is a lack of consensus among researcher on how best to define exceptional patient and little ha been proposed for the optimal design of study to identify factor that dictate unusual outcome in this opinion article we review different approach to identifying exceptional patient with cancer and possible study design to investigate extraordinary clinical outcome we discus pitfall with finding these rare patient including challenge associated with accrual of patient across different treatment centre and time period we describe recent molecular and immunological factor that have been identified a contributing to unusual patient outcome and make recommendation for future study on these intriguing patient
31077215,low expression of acly associate with favorable prognosis in acute myeloid leukemia,background aberrant metabolism is a hallmark of cancer cell recently atp citratelyase acly expression wa demonstrated a an independent predictor of clinical outcome in solid tumor however no systematic study wa conducted to explore the prognostic impact of acly on acute myeloid leukemia aml method to assess the prognostic value of acly transcript we conducted a study with a discovery and validation design we measured acly transcript by realtime quantitative pcr in aml patient and validated the prognostic value in the two independent cohort using published data metaanalysis of geneexpression profile and inhibition acly expression in leukemia cell line were conducted to help u understand the biological insight of low acly expression result low acly expression is less common amongst amls with dnmta mutation but coexisted in double allele cebpa mutation moreover low acly expression is associated with favorable overall survival in aml patient and is involved in multiple pathway these result are also validated in two independent cohort of aml patient moreover acly silencing induces proliferation arrest in thp and molm leukemia cell line conclusion we found low acly expression is associated with favorable overall survival in aml patient,Cancer,0,low expression of acly associate with favorable prognosis in acute myeloid leukemia background aberrant metabolism is a hallmark of cancer cell recently atp citratelyase acly expression wa demonstrated a an independent predictor of clinical outcome in solid tumor however no systematic study wa conducted to explore the prognostic impact of acly on acute myeloid leukemia aml method to assess the prognostic value of acly transcript we conducted a study with a discovery and validation design we measured acly transcript by realtime quantitative pcr in aml patient and validated the prognostic value in the two independent cohort using published data metaanalysis of geneexpression profile and inhibition acly expression in leukemia cell line were conducted to help u understand the biological insight of low acly expression result low acly expression is less common amongst amls with dnmta mutation but coexisted in double allele cebpa mutation moreover low acly expression is associated with favorable overall survival in aml patient and is involved in multiple pathway these result are also validated in two independent cohort of aml patient moreover acly silencing induces proliferation arrest in thp and molm leukemia cell line conclusion we found low acly expression is associated with favorable overall survival in aml patient
31077683,classification of acute myeloid leukemia by the revised fourth edition world health organization criterion a retrospective singleinstitution study with appraisal of the new entity of acute myeloid leukemia with gene mutation in npm and biallelic cebpa,the world health organization who classification for acute myeloid leukemia aml includes new entity with gene mutation in npm amlnpmmut and biallelic cebpa amlbicebpamut to retrospectively identify and study these new molecularly defined whoentities we reviewed clinicopathologic data and pretherapy archived pathologic material at diagnosis for consecutive aml case male median age range year and classified all case by the who who and revised who criterion by who case included with recurrent genetic abnormality male median age range year with myelodysplasiarelated change male median age range year therapy related male median age range year and not otherwise specified male median age range year twentytwo case aml not otherwise specified aml with myelodysplasiarelated change by who reclassified by who a amlnpmmut showed female predominance and median range value were a follows age year hemoglobin gdl total leucocyte x l monocyte x l neutrophil x l platelet x l blast peripheral blood bone marrow with myeloblastscdneg cytogeneticsnormal fltitdpos fltitdnegflttkdpos fltitdnegflttkdneg and extramedullary involvement including novel cutaneous presentation notably presenting feature among amlnpmmut included those of anemia and thrombocytopenia this is also the first report of amlnpmmut including nonsmoker with a family history of leukemia and one yearold with familial amlbicebpamut this study validates the application of the who classification criterion by retrospectively identifying amlnpmmut and amlbicebpamut case using singlegene molecular analysis additional study are needed to characterize the complete spectrum of whodefined amlbicebpamut and for familial aml including amlnpmmut,Cancer,0,classification of acute myeloid leukemia by the revised fourth edition world health organization criterion a retrospective singleinstitution study with appraisal of the new entity of acute myeloid leukemia with gene mutation in npm and biallelic cebpa the world health organization who classification for acute myeloid leukemia aml includes new entity with gene mutation in npm amlnpmmut and biallelic cebpa amlbicebpamut to retrospectively identify and study these new molecularly defined whoentities we reviewed clinicopathologic data and pretherapy archived pathologic material at diagnosis for consecutive aml case male median age range year and classified all case by the who who and revised who criterion by who case included with recurrent genetic abnormality male median age range year with myelodysplasiarelated change male median age range year therapy related male median age range year and not otherwise specified male median age range year twentytwo case aml not otherwise specified aml with myelodysplasiarelated change by who reclassified by who a amlnpmmut showed female predominance and median range value were a follows age year hemoglobin gdl total leucocyte x l monocyte x l neutrophil x l platelet x l blast peripheral blood bone marrow with myeloblastscdneg cytogeneticsnormal fltitdpos fltitdnegflttkdpos fltitdnegflttkdneg and extramedullary involvement including novel cutaneous presentation notably presenting feature among amlnpmmut included those of anemia and thrombocytopenia this is also the first report of amlnpmmut including nonsmoker with a family history of leukemia and one yearold with familial amlbicebpamut this study validates the application of the who classification criterion by retrospectively identifying amlnpmmut and amlbicebpamut case using singlegene molecular analysis additional study are needed to characterize the complete spectrum of whodefined amlbicebpamut and for familial aml including amlnpmmut
31083180,concurrent lymphoma and hemophilia b in a pediatric patient a case report,introduction lymphoma is the third most common cancer among child in the united state and europe hemophilia is a congenital bleeding disorder characterized by deficiency of coagulation factor viii or ix hemophilia b is a consequence of factor ix deficiency and ha an incidence of in male birth a concurrence of these uncommon disease is rare except in patient infected with the human immunodeficiency virus hiv we report a case of a patient with both burkitt lymphoma and hemophilia b this is only such report in china since patient concern a yearold boy wa admitted to our hospital because of melena and jaundice for several day his older brother had died due to hemophilia b and ventricular septal defect the patient had not experienced any previous episode of severe bleeding gradual abdominal distention wa observed after admission the patient superficial lymph node were not enlarged result of blood routine and bone marrow examination showed no abnormality he wa diagnosed with sclerosing cholangitis abdominal infection and hepatitis however after treatment of reducing enzyme activity and eliminating jaundice the patient condition deteriorated hydrops abdominis wa detected on abdominal ultrasonography tumor cell were found by pathological examination of peritoneal effusion both a cmyc gene translocation and a cmycigh gene fusion were detected diagnosis burkitt lymphoma and hemophilia b intervention the patient wa transferred to the pediatric hematology department of our hospital and treated with a modified bnhlbfm protocol during chemotherapy platelet change were monitored regularly and blood product were infused timely outcome the patient died of infection and bleeding after chemotherapy conclusion concurrent hemophilia and lymphoma are rare especially in child when encountering a patient with unexplained obstructive jaundice and massive ascites the possibility of a tumor should be considered early diagnosis and adequate treatment of such tumor may improve prognosis,Cancer,0,concurrent lymphoma and hemophilia b in a pediatric patient a case report introduction lymphoma is the third most common cancer among child in the united state and europe hemophilia is a congenital bleeding disorder characterized by deficiency of coagulation factor viii or ix hemophilia b is a consequence of factor ix deficiency and ha an incidence of in male birth a concurrence of these uncommon disease is rare except in patient infected with the human immunodeficiency virus hiv we report a case of a patient with both burkitt lymphoma and hemophilia b this is only such report in china since patient concern a yearold boy wa admitted to our hospital because of melena and jaundice for several day his older brother had died due to hemophilia b and ventricular septal defect the patient had not experienced any previous episode of severe bleeding gradual abdominal distention wa observed after admission the patient superficial lymph node were not enlarged result of blood routine and bone marrow examination showed no abnormality he wa diagnosed with sclerosing cholangitis abdominal infection and hepatitis however after treatment of reducing enzyme activity and eliminating jaundice the patient condition deteriorated hydrops abdominis wa detected on abdominal ultrasonography tumor cell were found by pathological examination of peritoneal effusion both a cmyc gene translocation and a cmycigh gene fusion were detected diagnosis burkitt lymphoma and hemophilia b intervention the patient wa transferred to the pediatric hematology department of our hospital and treated with a modified bnhlbfm protocol during chemotherapy platelet change were monitored regularly and blood product were infused timely outcome the patient died of infection and bleeding after chemotherapy conclusion concurrent hemophilia and lymphoma are rare especially in child when encountering a patient with unexplained obstructive jaundice and massive ascites the possibility of a tumor should be considered early diagnosis and adequate treatment of such tumor may improve prognosis
31083279,oncogenic effect of the novel fusion gene vaparab in lung adenocarcinoma,fusion gene have been identified a oncogene in several solid tumor including lung colorectal and stomach cancer here we characterized the fusion gene vaparab discovered from rnasequencing data of a patient with lung adenocarcinoma who did not harbor activating mutation in egfr kras and alk this fusion gene encodes a protein comprising the nterminal region of vesicleassociated membrane protein vampassociated protein a vapa fused to the cterminal region of rasrelated protein rab exogenous expression of vaparab in immortalized normal bronchial epithelial cell demonstrated the potential transforming effect of this fusion gene including increased colony formation and cell proliferation in vitro also enhanced tumorigenicity upon vaparab wa confirmed in vivo using a mouse xenograft model metastatic tumor were also detected in the liver and lung of xenografted mouse overexpression of vaparab upregulated antiapoptotic protein bcl and phosphorylated creb both in cell and xenograft tumor reduced apoptosis and increased phosphorylation of creb and erk were observed in vaparaboverexpressing cell after bortezomib treatment elevated bcl level via activated creb contributed to the resistance to the bortezomibinduced apoptosis our data suggest the oncogenic function of the novel fusion gene vaparab via upregulated bcl and activated creb in lung cancer,Cancer,0,oncogenic effect of the novel fusion gene vaparab in lung adenocarcinoma fusion gene have been identified a oncogene in several solid tumor including lung colorectal and stomach cancer here we characterized the fusion gene vaparab discovered from rnasequencing data of a patient with lung adenocarcinoma who did not harbor activating mutation in egfr kras and alk this fusion gene encodes a protein comprising the nterminal region of vesicleassociated membrane protein vampassociated protein a vapa fused to the cterminal region of rasrelated protein rab exogenous expression of vaparab in immortalized normal bronchial epithelial cell demonstrated the potential transforming effect of this fusion gene including increased colony formation and cell proliferation in vitro also enhanced tumorigenicity upon vaparab wa confirmed in vivo using a mouse xenograft model metastatic tumor were also detected in the liver and lung of xenografted mouse overexpression of vaparab upregulated antiapoptotic protein bcl and phosphorylated creb both in cell and xenograft tumor reduced apoptosis and increased phosphorylation of creb and erk were observed in vaparaboverexpressing cell after bortezomib treatment elevated bcl level via activated creb contributed to the resistance to the bortezomibinduced apoptosis our data suggest the oncogenic function of the novel fusion gene vaparab via upregulated bcl and activated creb in lung cancer
31086113,a comparison of dna mutation and copy number profile of primary breast cancer and paired brain metastasis for identifying clinically relevant genetic alteration in brain metastasis,improving the systemic treatment of brain metastasis bm in primary breast cancer pbc is impaired by the lack of genomic characterization of bm to estimate the concordance of dna copynumberalterations cnas mutation and actionable genetic alteration aga between paired sample we performed wholegenome arraycomparativegenomichybridization and targetednextgenerationsequencing on clinical pbcbm pair we found more cnas more mutation and higher tumor mutational burden and more aga in bm than in pbc of the pair harbored at least one aga in the bm not observed in the paired pbc this concerned various therapeutic class including tyrosinekinasereceptorinhibitors phosphatidylinositol kinaseakt mammalian target of rapamycin pikaktmtorinhibitors poly adp ribose polymerase parpinhibitors or cyclindependent kinase cdkinhibitors with regard to the parpinhibitors the homologous recombination defect score wa positive in of bm compared to of pbc discordant in out of pair and positive in the bm in out of case cdkinhibitors were associated with the largest percentage of discordant aga appearing in the bm when considering the aga with the highest clinicalevidence level for each sample of the pair harbored an aga in the bm not detected or not retained from the analysis of the paired pbc thus the profiling of bm provided a more reliable opportunity than that of pbc for diagnostic decisionmaking based on genomic analysis patient with bm deserve an investigation of several targeted therapy,Cancer,0,a comparison of dna mutation and copy number profile of primary breast cancer and paired brain metastasis for identifying clinically relevant genetic alteration in brain metastasis improving the systemic treatment of brain metastasis bm in primary breast cancer pbc is impaired by the lack of genomic characterization of bm to estimate the concordance of dna copynumberalterations cnas mutation and actionable genetic alteration aga between paired sample we performed wholegenome arraycomparativegenomichybridization and targetednextgenerationsequencing on clinical pbcbm pair we found more cnas more mutation and higher tumor mutational burden and more aga in bm than in pbc of the pair harbored at least one aga in the bm not observed in the paired pbc this concerned various therapeutic class including tyrosinekinasereceptorinhibitors phosphatidylinositol kinaseakt mammalian target of rapamycin pikaktmtorinhibitors poly adp ribose polymerase parpinhibitors or cyclindependent kinase cdkinhibitors with regard to the parpinhibitors the homologous recombination defect score wa positive in of bm compared to of pbc discordant in out of pair and positive in the bm in out of case cdkinhibitors were associated with the largest percentage of discordant aga appearing in the bm when considering the aga with the highest clinicalevidence level for each sample of the pair harbored an aga in the bm not detected or not retained from the analysis of the paired pbc thus the profiling of bm provided a more reliable opportunity than that of pbc for diagnostic decisionmaking based on genomic analysis patient with bm deserve an investigation of several targeted therapy
31092450,role of amino acid transporter expression a a prognostic marker in patient with surgically resected colorectal cancer,backgroundaim ltype amino acid transporter lat is highly expressed in various human cancer however the clinicopathological significance of lat and f cell surface antigen fhc in patient with colorectal cancer crc is unknown the aim of this study wa to clarify the prognostic significance of lat expression in crc patient who underwent surgical resection material and method sample from one hundred and fortyseven patient were examined by immunohistochemistry the expression of lat and fhc and the ki labeling index were assessed using resected tumor specimen result the positive expression of lat and fc wa and p respectively the expression of lat wa identified a an independent significant marker linked to worse prognosis in patient with crc and wa correlated with tumor cell proliferation tumor aggressiveness and metastasis moreover lat wa closely associated with the expression of fhc and phosphorylation of the mtor pathway conclusion lat is a significant molecular marker used to predict prognosis after surgical resection of crc patient,Cancer,0,role of amino acid transporter expression a a prognostic marker in patient with surgically resected colorectal cancer backgroundaim ltype amino acid transporter lat is highly expressed in various human cancer however the clinicopathological significance of lat and f cell surface antigen fhc in patient with colorectal cancer crc is unknown the aim of this study wa to clarify the prognostic significance of lat expression in crc patient who underwent surgical resection material and method sample from one hundred and fortyseven patient were examined by immunohistochemistry the expression of lat and fhc and the ki labeling index were assessed using resected tumor specimen result the positive expression of lat and fc wa and p respectively the expression of lat wa identified a an independent significant marker linked to worse prognosis in patient with crc and wa correlated with tumor cell proliferation tumor aggressiveness and metastasis moreover lat wa closely associated with the expression of fhc and phosphorylation of the mtor pathway conclusion lat is a significant molecular marker used to predict prognosis after surgical resection of crc patient
31094133,epicardial fat mimicking pericardial tumour case series and review of literature,advance in imaging modality have improved diagnosis of disease in patient allowing physician to make earlier and accurate diagnosis with resultant improved overall outcome for patient sometimes however this come at a cost of over estimation of normal variant leading to further unnecessary investigation or in extreme case intervention in this article we demonstrate three case where epicardial fat is misdiagnosed a pericardial mass which are an example of misinterpretation of normal finding correct identification of pericardial fat on transthoracic echocardiogram is important in reducing misdiagnosis and also anxiety for both physician and patient knowledge about normal variant not only improves patient care but also reduce unnecessary investigation that are subsequently ordered for clarification,Cancer,0,epicardial fat mimicking pericardial tumour case series and review of literature advance in imaging modality have improved diagnosis of disease in patient allowing physician to make earlier and accurate diagnosis with resultant improved overall outcome for patient sometimes however this come at a cost of over estimation of normal variant leading to further unnecessary investigation or in extreme case intervention in this article we demonstrate three case where epicardial fat is misdiagnosed a pericardial mass which are an example of misinterpretation of normal finding correct identification of pericardial fat on transthoracic echocardiogram is important in reducing misdiagnosis and also anxiety for both physician and patient knowledge about normal variant not only improves patient care but also reduce unnecessary investigation that are subsequently ordered for clarification
31094179,mutyhassociated polyposis,mutyhassociated polyposis is the only polyposis syndrome with an autosomal recessive type of inheritance often phenotypically similar to a weakened form of familial adenomatous polyposis for the development of the disease mutation in both allele of the gene are required but an increased risk of developing colorectal cancer in carrier of monoallelic mutation is noted the diagnosis of mutyhassociated polyposis should be suspected in a patient with colorectal cancer over year old on the background of polyp in the colon the review present modern algorithm for diagnostic and treatment of the disease,Cancer,0,mutyhassociated polyposis mutyhassociated polyposis is the only polyposis syndrome with an autosomal recessive type of inheritance often phenotypically similar to a weakened form of familial adenomatous polyposis for the development of the disease mutation in both allele of the gene are required but an increased risk of developing colorectal cancer in carrier of monoallelic mutation is noted the diagnosis of mutyhassociated polyposis should be suspected in a patient with colorectal cancer over year old on the background of polyp in the colon the review present modern algorithm for diagnostic and treatment of the disease
31094905,mycn amplified relapse following resolution of mycn nonamplified s neuroblastoma with placental involvement a case report and review of the literature,congenital neuroblastoma with placental involvement is exceptionally rare but mortality is high detailed examination of placenta including mycn amplification and segmental chromosomal aberration should be performed in all suspected case a it is noninvasive and readily available maternal dissemination ha not been reported in this manuscript we describe an infant with placental diagnosis of mycn nonamplified congenital neuroblastoma this is the first report of a recurrence of congenital s neuroblastoma following resolution in which mycn amplification is only detected in the recurrence germline sequencing using a large comprehensive cancer panel did not reveal variant in candidate cancer predisposition gene,Cancer,0,mycn amplified relapse following resolution of mycn nonamplified s neuroblastoma with placental involvement a case report and review of the literature congenital neuroblastoma with placental involvement is exceptionally rare but mortality is high detailed examination of placenta including mycn amplification and segmental chromosomal aberration should be performed in all suspected case a it is noninvasive and readily available maternal dissemination ha not been reported in this manuscript we describe an infant with placental diagnosis of mycn nonamplified congenital neuroblastoma this is the first report of a recurrence of congenital s neuroblastoma following resolution in which mycn amplification is only detected in the recurrence germline sequencing using a large comprehensive cancer panel did not reveal variant in candidate cancer predisposition gene
31095042,the programmed cell death proteinprogrammed cell death ligand expression cd t cell infiltration nyeso expression and microsatellite instability phenotype in primary cutaneous melanoma and mucosal melanoma and their clinical significance and prognostic value a study of consecutive case,we evaluated the expression of programmed cell death protein pd programmed cell death ligand pdl and nyeso antigen the infiltration of cd t cell and the microsatellite instability msi phenotype a well a the relationship of each factor to survival in malignant melanoma patient malignant melanoma sample from patient were stained by immunohistochemistry to evaluate pd pdl cd tumorinfiltrating lymphocyte tils nyeso and msi pd and pdl were expressed in and of the sample respectively there wa a significant correlation between pd and pdl expression r p high infiltration of cd t cell wa observed in of the sample and increased cell infiltration wa associated with increased pd expression p nyeso antigen wa detected in of all sample and the expression of nyeso wa positively correlated with the expression of pd p in our research msi wa detected in sample survival analysis showed that a high infiltration of cd t cell wa related to longer progressionfree survival pfs month confidence interval ci v month ci p similarly the median overall survival o of the cd t cell highinfiltration patient wa also longer v month but with no statistical significance p the result for the immune marker mentioned above provide a theoretical basis for the prognosis and immunotherapy selection of malignant melanoma patient,Cancer,0,the programmed cell death proteinprogrammed cell death ligand expression cd t cell infiltration nyeso expression and microsatellite instability phenotype in primary cutaneous melanoma and mucosal melanoma and their clinical significance and prognostic value a study of consecutive case we evaluated the expression of programmed cell death protein pd programmed cell death ligand pdl and nyeso antigen the infiltration of cd t cell and the microsatellite instability msi phenotype a well a the relationship of each factor to survival in malignant melanoma patient malignant melanoma sample from patient were stained by immunohistochemistry to evaluate pd pdl cd tumorinfiltrating lymphocyte tils nyeso and msi pd and pdl were expressed in and of the sample respectively there wa a significant correlation between pd and pdl expression r p high infiltration of cd t cell wa observed in of the sample and increased cell infiltration wa associated with increased pd expression p nyeso antigen wa detected in of all sample and the expression of nyeso wa positively correlated with the expression of pd p in our research msi wa detected in sample survival analysis showed that a high infiltration of cd t cell wa related to longer progressionfree survival pfs month confidence interval ci v month ci p similarly the median overall survival o of the cd t cell highinfiltration patient wa also longer v month but with no statistical significance p the result for the immune marker mentioned above provide a theoretical basis for the prognosis and immunotherapy selection of malignant melanoma patient
31097693,mek inhibitor activate wnt signalling and induce stem cell plasticity in colorectal cancer,in colorectal cancer crc aberrant wnt signalling is essential for tumorigenesis and maintenance of cancer stem cell however how other oncogenic pathway converge on wnt signalling to modulate stem cell homeostasis in crc currently remains poorly understood using largescale compound screen in crc we identify mek inhibitor a potent activator of wntbetacatenin signalling targeting mek increase wnt activity in different crc cell line and murine intestine in vivo truncating mutation of apc generated by crisprcas strongly synergize with mek inhibitor in enhancing wnt response in isogenic crc model mechanistically we demonstrate that mek inhibition induces a rapid downregulation of axin using patientderived crc organoids we show that mek inhibition lead to increased wnt activity elevated lgr level and enrichment of gene signature associated with stemness and cancer relapse our study demonstrates that clinically used mek inhibitor inadvertently induce stem cell plasticity revealing an unknown side effect of ra pathway inhibition,Cancer,0,mek inhibitor activate wnt signalling and induce stem cell plasticity in colorectal cancer in colorectal cancer crc aberrant wnt signalling is essential for tumorigenesis and maintenance of cancer stem cell however how other oncogenic pathway converge on wnt signalling to modulate stem cell homeostasis in crc currently remains poorly understood using largescale compound screen in crc we identify mek inhibitor a potent activator of wntbetacatenin signalling targeting mek increase wnt activity in different crc cell line and murine intestine in vivo truncating mutation of apc generated by crisprcas strongly synergize with mek inhibitor in enhancing wnt response in isogenic crc model mechanistically we demonstrate that mek inhibition induces a rapid downregulation of axin using patientderived crc organoids we show that mek inhibition lead to increased wnt activity elevated lgr level and enrichment of gene signature associated with stemness and cancer relapse our study demonstrates that clinically used mek inhibitor inadvertently induce stem cell plasticity revealing an unknown side effect of ra pathway inhibition
31097696,functional linkage of gene fusion to cancer cell fitness assessed by pharmacological and crisprcas screening,many gene fusion are reported in tumour and for most their role remains unknown a fusion are used for diagnostic and prognostic purpose and are target for treatment it is crucial to assess their function in cancer to systematically investigate the role of fusion in tumour cell fitness we utilized rnasequencing data from human cancer cell line to functionally link fusion event with genomic data sensitivity to anticancer drug and crisprcas lossoffitness effect established clinicallyrelevant fusion were identified overall detection of functional fusion wa rare including those involving cancer driver gene suggesting that many fusion are dispensable for tumour fitness therapeutically actionable fusion involving raf brd and ro were verified in new histology in addition recurrent yapmaml fusion were identified a activator of hippopathway signaling in multiple cancer type our approach discriminates functional fusion identifying new driver of carcinogenesis and fusion that could have clinical implication,Cancer,0,functional linkage of gene fusion to cancer cell fitness assessed by pharmacological and crisprcas screening many gene fusion are reported in tumour and for most their role remains unknown a fusion are used for diagnostic and prognostic purpose and are target for treatment it is crucial to assess their function in cancer to systematically investigate the role of fusion in tumour cell fitness we utilized rnasequencing data from human cancer cell line to functionally link fusion event with genomic data sensitivity to anticancer drug and crisprcas lossoffitness effect established clinicallyrelevant fusion were identified overall detection of functional fusion wa rare including those involving cancer driver gene suggesting that many fusion are dispensable for tumour fitness therapeutically actionable fusion involving raf brd and ro were verified in new histology in addition recurrent yapmaml fusion were identified a activator of hippopathway signaling in multiple cancer type our approach discriminates functional fusion identifying new driver of carcinogenesis and fusion that could have clinical implication
31100224,feature and prognostic significance of intraductal carcinoma of the prostate,context intraductal carcinoma of the prostate idcp is an intraglandularductal neoplastic growth of glandular epithelial cell characterized by marked abnormality of the glandular architecture andor cytological atypia that exceeds what is typically seen in highgrade prostatic intraepithelial neoplasia hpgin it ha been shown that idcp is a strong independent indicator of poor prognosis for prostate carcinoma pca objective to review the pathological and genetic feature diagnostic criterion and differential diagnosis and clinical significance of idcp evidence acquisition pubmed wa searched using keywords including prostate carcinoma intraductal carcinoma idc histology diagnostic criterion and prognosis the reference in relevant article were also reviewed evidence synthesis idcp is a distinct entity with characteristic morphological and genetic feature it is strongly associated with aggressive pca with high gleason scoregrade group and large tumor volume and portends unfavorable clinical outcome morphological diagnostic criterion have been established to distinguish it from other lesion with similar histological feature idcp is an uncommon finding in prostate biopsy and is even rarer a an isolated finding without concomitant pca however patient with isolated idcp in biopsy specimen are recommended to have either definitive treatment or immediate repeat biopsy conclusion it is critical to recognize and report idcp especially in prostate biopsy where the clinical impact of such a diagnosis is greatest patient summary intraductal carcinoma is a unique form of aggressive prostate cancer in this report we review it pathological and genetic feature and poor prognostic significance it is critical for pathologist to recognize and report this lesion in prostate specimen especially in prostate biopsy for patient management,Cancer,0,feature and prognostic significance of intraductal carcinoma of the prostate context intraductal carcinoma of the prostate idcp is an intraglandularductal neoplastic growth of glandular epithelial cell characterized by marked abnormality of the glandular architecture andor cytological atypia that exceeds what is typically seen in highgrade prostatic intraepithelial neoplasia hpgin it ha been shown that idcp is a strong independent indicator of poor prognosis for prostate carcinoma pca objective to review the pathological and genetic feature diagnostic criterion and differential diagnosis and clinical significance of idcp evidence acquisition pubmed wa searched using keywords including prostate carcinoma intraductal carcinoma idc histology diagnostic criterion and prognosis the reference in relevant article were also reviewed evidence synthesis idcp is a distinct entity with characteristic morphological and genetic feature it is strongly associated with aggressive pca with high gleason scoregrade group and large tumor volume and portends unfavorable clinical outcome morphological diagnostic criterion have been established to distinguish it from other lesion with similar histological feature idcp is an uncommon finding in prostate biopsy and is even rarer a an isolated finding without concomitant pca however patient with isolated idcp in biopsy specimen are recommended to have either definitive treatment or immediate repeat biopsy conclusion it is critical to recognize and report idcp especially in prostate biopsy where the clinical impact of such a diagnosis is greatest patient summary intraductal carcinoma is a unique form of aggressive prostate cancer in this report we review it pathological and genetic feature and poor prognostic significance it is critical for pathologist to recognize and report this lesion in prostate specimen especially in prostate biopsy for patient management
31100235,not all multiparametric magnetic resonance imagingtargeted biopsy are equal the impact of the type of approach and operator expertise on the detection of clinically significant prostate cancer,background the extensive use of multiparametric magnetic resonance imaging mpmri ha led to an even more widespread use of different targeted biopsy technique and approach the best way of performing targeted biopsy and the effect of operator expertise have still to be defined objective to compare the rate of detection of clinically significant prostate cancer cspca of different mpmri targeted approach and to assess the role of operator expertise in the detection of cspca design setting and participant we included consecutive patient who underwent both core transrectal ultrasound trus biopsy and mpmri targeted biopsy with either a cognitive biopsy cb or fusion biopsy fb approach during the same session between and at a single tertiary referral centre intervention all men underwent t mpmri with an endorectal coil all biopsy were performed by three operator a their first case of targeted biopsy lesion with a prostate imaging recording and data system pirads v score of detected at mpmri were targeted outcome measurement and statistical analysis cspca wa defined a disease with a gleason score at biopsy of operator expertise wa coded a the progressive number of targeted biopsy performed by each physician multivariable logistic regression analysis mva were used to assess the association between the targeted biopsy technique fb v cb and operator expertise for detection of cspca covariates consisted of prostatespecific antigen prostate volume pirads v v number of targeted core per mri lesion and digital rectal examination negative v positive the same analysis were performed for patient undergoing fb only after accounting for the fb approach transrectal v transperineal a lowess smoothing weighted function wa used to graphically assess the effect of operator expertise on the probability of detecting cspca after accounting for all confounders result and limitation overall patient underwent fb and underwent cb the overall cspca detection rate wa for fb and for cb p a significantly higher rate of cspca detection in targeted sample wa observed for fb compared to cb v p on mva fb and operator expertise were significantly associated with a higher probability of cspca detection in targeted sample odds ratio or and respectively both p when the same analysis were repeated for patient undergoing fb operator expertise remained an independent predictor of cspca detection or p an increase in the probability of detecting cspca with the number of procedure performed wa observed after accounting for all confounders conclusion we demonstrated that fb had higher detection rate than cb for cspca moreover operator expertise wa significantly associated with higher detection rate for cspca patient summary when different targeted biopsy technique were compared fusion biopsy provided a higher detection rate compared to cognitive biopsy for clinically significant prostate cancer cspca moreover we found that operator expertise wa an important predictor of the detection of cspca regardless of the procedure used,Cancer,0,not all multiparametric magnetic resonance imagingtargeted biopsy are equal the impact of the type of approach and operator expertise on the detection of clinically significant prostate cancer background the extensive use of multiparametric magnetic resonance imaging mpmri ha led to an even more widespread use of different targeted biopsy technique and approach the best way of performing targeted biopsy and the effect of operator expertise have still to be defined objective to compare the rate of detection of clinically significant prostate cancer cspca of different mpmri targeted approach and to assess the role of operator expertise in the detection of cspca design setting and participant we included consecutive patient who underwent both core transrectal ultrasound trus biopsy and mpmri targeted biopsy with either a cognitive biopsy cb or fusion biopsy fb approach during the same session between and at a single tertiary referral centre intervention all men underwent t mpmri with an endorectal coil all biopsy were performed by three operator a their first case of targeted biopsy lesion with a prostate imaging recording and data system pirads v score of detected at mpmri were targeted outcome measurement and statistical analysis cspca wa defined a disease with a gleason score at biopsy of operator expertise wa coded a the progressive number of targeted biopsy performed by each physician multivariable logistic regression analysis mva were used to assess the association between the targeted biopsy technique fb v cb and operator expertise for detection of cspca covariates consisted of prostatespecific antigen prostate volume pirads v v number of targeted core per mri lesion and digital rectal examination negative v positive the same analysis were performed for patient undergoing fb only after accounting for the fb approach transrectal v transperineal a lowess smoothing weighted function wa used to graphically assess the effect of operator expertise on the probability of detecting cspca after accounting for all confounders result and limitation overall patient underwent fb and underwent cb the overall cspca detection rate wa for fb and for cb p a significantly higher rate of cspca detection in targeted sample wa observed for fb compared to cb v p on mva fb and operator expertise were significantly associated with a higher probability of cspca detection in targeted sample odds ratio or and respectively both p when the same analysis were repeated for patient undergoing fb operator expertise remained an independent predictor of cspca detection or p an increase in the probability of detecting cspca with the number of procedure performed wa observed after accounting for all confounders conclusion we demonstrated that fb had higher detection rate than cb for cspca moreover operator expertise wa significantly associated with higher detection rate for cspca patient summary when different targeted biopsy technique were compared fusion biopsy provided a higher detection rate compared to cognitive biopsy for clinically significant prostate cancer cspca moreover we found that operator expertise wa an important predictor of the detection of cspca regardless of the procedure used
31101557,outcome of diseasespecific nextgeneration sequencing gene panel testing in adolescent and young adult with colorectal cancer,purpose adolescent and young adult with colorectal cancer crc have attracted recent attention with a hereditary syndrome identified in onethird of patient diagnosed we aimed to study this population to determine if a crcspecific gene panel increased the yield of testing method patient with crc evaluated from were identified from the genetic counseling database record were reviewed for personalfamily history and genetic counseling outcome result one hundred fortythree patient with crc were included one hundred four underwent crc panel testing thirtynine had syndromedirected testing declined or were lost to followup fortytwo patient had a genetic syndrome twentyfour of the hereditary patient were identified via syndromedirected testing mutation identified via panel testing were consistent with patient personalfamily history thirtythree patient had at least one variant of uncertain significance conclusion hereditary syndrome were identified in of patient panel testing in patient without a phenotype did not increase diagnostic yield but identified variant in onethird diseasespecific panel testing is of low yield in young patient without a suggestive personalfamily history testing broader panel may increase the yield of mutation pickup in this population although at the expense of identifying variant,Cancer,0,outcome of diseasespecific nextgeneration sequencing gene panel testing in adolescent and young adult with colorectal cancer purpose adolescent and young adult with colorectal cancer crc have attracted recent attention with a hereditary syndrome identified in onethird of patient diagnosed we aimed to study this population to determine if a crcspecific gene panel increased the yield of testing method patient with crc evaluated from were identified from the genetic counseling database record were reviewed for personalfamily history and genetic counseling outcome result one hundred fortythree patient with crc were included one hundred four underwent crc panel testing thirtynine had syndromedirected testing declined or were lost to followup fortytwo patient had a genetic syndrome twentyfour of the hereditary patient were identified via syndromedirected testing mutation identified via panel testing were consistent with patient personalfamily history thirtythree patient had at least one variant of uncertain significance conclusion hereditary syndrome were identified in of patient panel testing in patient without a phenotype did not increase diagnostic yield but identified variant in onethird diseasespecific panel testing is of low yield in young patient without a suggestive personalfamily history testing broader panel may increase the yield of mutation pickup in this population although at the expense of identifying variant
31102358,expression of wt gene and it prognostic value in patient with acute myeloid leukemia,objective to investigate the expression of wilmstumor wt gene in patient with acute myeloid leukemia aml and to explore it application in predicting prognosis of aml in patient with wild or mutated nucleophosmin npm and fmslike tyrosine kinase internal tandem duplication fltitd method one hundred and sixtyseven newly diagnosed aml patientsexclued m type were enrolled in this study the survival of patient were analyzed with kaplanmeier method the clinical data laboratory finding and the survival of patient were analyzed and compared between patient with high wt expression highwt group and those with low wt expression lowwt group a well a among the patient with npm or fltitd wild type and mutant result the overall response rate orr in highwt and lowwt group were and respectively p log wa associated with higher orr and y o rate all p in patient with npm wild type the highwt group had inferior orr and y o rate all p conclusion wt gene overexpression indicated poor prognosis of aml patient the patient with decreased wt gene expression log after the first induction therapy show better prognosis than those with log the wt gene expression level at diagnosis can be used a an unfavorable prognostic factor for aml patient with npm or fltitd wild type,Cancer,0,expression of wt gene and it prognostic value in patient with acute myeloid leukemia objective to investigate the expression of wilmstumor wt gene in patient with acute myeloid leukemia aml and to explore it application in predicting prognosis of aml in patient with wild or mutated nucleophosmin npm and fmslike tyrosine kinase internal tandem duplication fltitd method one hundred and sixtyseven newly diagnosed aml patientsexclued m type were enrolled in this study the survival of patient were analyzed with kaplanmeier method the clinical data laboratory finding and the survival of patient were analyzed and compared between patient with high wt expression highwt group and those with low wt expression lowwt group a well a among the patient with npm or fltitd wild type and mutant result the overall response rate orr in highwt and lowwt group were and respectively p log wa associated with higher orr and y o rate all p in patient with npm wild type the highwt group had inferior orr and y o rate all p conclusion wt gene overexpression indicated poor prognosis of aml patient the patient with decreased wt gene expression log after the first induction therapy show better prognosis than those with log the wt gene expression level at diagnosis can be used a an unfavorable prognostic factor for aml patient with npm or fltitd wild type
31103372,reactivity with the epcamspecific antibody moc and berep in plasma cell neoplasm a potential diagnostic pitfall in cytology sample,objective epithelial cell adhesion molecule epcam is a protein expressed on surface of healthy epithelium and is overexpressed in dysplasia and carcinoma immunohistochemistry ihc utilizing antibody that react with epcam such a moc and berep distinguish reactive mesothelial cell from carcinoma in serous effusion ihc is crucial in effusion with singly dispersed atypical cell a scenario with a broad differential including hematopoietic malignancy plasma cell neoplasm pcn are the second most common hematopoietic malignancy manifesting a multiple myeloma or plasmacytoma with of case developing serous cavity involvement most pcns are readily recognizable however variant that deviate from the classic cytomorphology risk erroneous diagnosis this study demonstrates epcam expression in a subset of pcns highlighting a potential diagnostic pitfall in serous effusion cytology method a year retrospective search for cytology specimen with a diagnosis of pcn wa performed all case demonstrating cdcd and monoclonal immunoglobulin expression and adequately cellular cell block were included ihc analysis for moc and berep wa performed using ventana benchmark ultra scoring wa performed a follows total ihc score equal the positive proportion no positive tumor cell wa considered positive result of pcns demonstrated positivity for moc and berep conclusion a subset of pcns in cytology sample show positivity for moc and berep which could result in misinterpretation a carcinoma,Cancer,0,reactivity with the epcamspecific antibody moc and berep in plasma cell neoplasm a potential diagnostic pitfall in cytology sample objective epithelial cell adhesion molecule epcam is a protein expressed on surface of healthy epithelium and is overexpressed in dysplasia and carcinoma immunohistochemistry ihc utilizing antibody that react with epcam such a moc and berep distinguish reactive mesothelial cell from carcinoma in serous effusion ihc is crucial in effusion with singly dispersed atypical cell a scenario with a broad differential including hematopoietic malignancy plasma cell neoplasm pcn are the second most common hematopoietic malignancy manifesting a multiple myeloma or plasmacytoma with of case developing serous cavity involvement most pcns are readily recognizable however variant that deviate from the classic cytomorphology risk erroneous diagnosis this study demonstrates epcam expression in a subset of pcns highlighting a potential diagnostic pitfall in serous effusion cytology method a year retrospective search for cytology specimen with a diagnosis of pcn wa performed all case demonstrating cdcd and monoclonal immunoglobulin expression and adequately cellular cell block were included ihc analysis for moc and berep wa performed using ventana benchmark ultra scoring wa performed a follows total ihc score equal the positive proportion no positive tumor cell wa considered positive result of pcns demonstrated positivity for moc and berep conclusion a subset of pcns in cytology sample show positivity for moc and berep which could result in misinterpretation a carcinoma
31103629,hnfa inhibition induces the resistance of pancreatic cancer cell to gemcitabine by targeting abcb,background pancreatic ductal adenocarcinoma pdac is an aggressive disease with poor prognosis and gemcitabinebased chemotherapy remains an effective option for the majority of pdac patient hepatocyte nuclear factor alpha hnfa is a tumorsuppressor in pdac but it role in gemcitabine chemoresistance of pdac ha not been clarified method the function of hnfa in gemcitabine wa detected by overexpression and knockdown of hnfa in vitro and in vitro the regulatory network between hnfa and abcb wa further demonstrated by luciferase assay deletionmutation reporter construct assay and chip assay finding here we found that hnfa expression is significantly associated with gemcitabine sensitivity in pdac cell line moreover we identified that hnfa overexpression enhanced gemcitabine sensitivity of pdac both in vitro and in vitro while inhibition of hnfa had the opposite effect furthermore by inhibiting and overexpressing hnfa we revealed that hnfa regulates the expression of mdr gene abcb and abcc in pdac cell mechanistically we demonstrated that hnfa regulates abcb expression through binding to it specific promoter region and suppressing it transcription level finally the survival analysis revealed the clinical value of hnfa in stratification of gemcitabine sensitive pancreatic cancer patient interpretation our study paved the road for finding novel treatment combination using conventional cytotoxic agent with functional restoration of the hnfa protein individualized treatment through hnfa staining and improvement of the prognosis of pdac patient fund national natural science foundation of china and national natural science foundation of guangdong province,Cancer,0,hnfa inhibition induces the resistance of pancreatic cancer cell to gemcitabine by targeting abcb background pancreatic ductal adenocarcinoma pdac is an aggressive disease with poor prognosis and gemcitabinebased chemotherapy remains an effective option for the majority of pdac patient hepatocyte nuclear factor alpha hnfa is a tumorsuppressor in pdac but it role in gemcitabine chemoresistance of pdac ha not been clarified method the function of hnfa in gemcitabine wa detected by overexpression and knockdown of hnfa in vitro and in vitro the regulatory network between hnfa and abcb wa further demonstrated by luciferase assay deletionmutation reporter construct assay and chip assay finding here we found that hnfa expression is significantly associated with gemcitabine sensitivity in pdac cell line moreover we identified that hnfa overexpression enhanced gemcitabine sensitivity of pdac both in vitro and in vitro while inhibition of hnfa had the opposite effect furthermore by inhibiting and overexpressing hnfa we revealed that hnfa regulates the expression of mdr gene abcb and abcc in pdac cell mechanistically we demonstrated that hnfa regulates abcb expression through binding to it specific promoter region and suppressing it transcription level finally the survival analysis revealed the clinical value of hnfa in stratification of gemcitabine sensitive pancreatic cancer patient interpretation our study paved the road for finding novel treatment combination using conventional cytotoxic agent with functional restoration of the hnfa protein individualized treatment through hnfa staining and improvement of the prognosis of pdac patient fund national natural science foundation of china and national natural science foundation of guangdong province
31105705,functional antibody response following allogeneic stem cell transplantation for tp mutant preball in a patient with xlinked agammaglobulinemia,patient with xlinked agammaglobulinemia xla have failure of bcell development with lack of immunoglobulin ig production while immunoglobulin replacement therapy igrt is beneficial xla patient remain at risk for infection structural lung damage and rarely neoplasia allogeneic stem cell transplantation allosct may offer a potential cure but is associated with significant lifethreatening complication here we present a year old xla patient who developed preb acute lymphocytic leukemia all with somatic tp mutation and treatment for this highrisk malignancy involved full myeloablative conditioning and a hlamatched sibling allosct full donor chimerism wa achieved for cd and cd cell fraction the patient remains in morphological and flow cytometric remission month posttransplant with lateonset oral gvhd requiring low dose prednisolone and cyclosporin following igrt discontinuation at month posttransplantation humoral immunity wa established within month a reflected by normal number of total b cell memory b cell serum igg igm and iga and production of specific igg response to prevenar vaccination this is only the second reported case of an xla patient with preball and the most detailed report of engraftment following allosct in xla together with the two previous xla case treated with allosct our report provides evidence for the potential for successful humoral reconstitution with allosct in patient with bcell intrinsic antibody deficiency these observation may be relevant given igrt while beneficial remains an imperfect solution to longterm infectious complication,Cancer,0,functional antibody response following allogeneic stem cell transplantation for tp mutant preball in a patient with xlinked agammaglobulinemia patient with xlinked agammaglobulinemia xla have failure of bcell development with lack of immunoglobulin ig production while immunoglobulin replacement therapy igrt is beneficial xla patient remain at risk for infection structural lung damage and rarely neoplasia allogeneic stem cell transplantation allosct may offer a potential cure but is associated with significant lifethreatening complication here we present a year old xla patient who developed preb acute lymphocytic leukemia all with somatic tp mutation and treatment for this highrisk malignancy involved full myeloablative conditioning and a hlamatched sibling allosct full donor chimerism wa achieved for cd and cd cell fraction the patient remains in morphological and flow cytometric remission month posttransplant with lateonset oral gvhd requiring low dose prednisolone and cyclosporin following igrt discontinuation at month posttransplantation humoral immunity wa established within month a reflected by normal number of total b cell memory b cell serum igg igm and iga and production of specific igg response to prevenar vaccination this is only the second reported case of an xla patient with preball and the most detailed report of engraftment following allosct in xla together with the two previous xla case treated with allosct our report provides evidence for the potential for successful humoral reconstitution with allosct in patient with bcell intrinsic antibody deficiency these observation may be relevant given igrt while beneficial remains an imperfect solution to longterm infectious complication
31108964,future option of moleculartargeted therapy in small cell lung cancer,lung cancer is the leading cause of cancerrelated death worldwide with a focus on histology there are two major subtypes nonsmall cell lung cancer nsclc the more frequent subtype and small cell lung cancer sclc the more aggressive one even though sclc in general is a chemosensitive malignancy relapse following induction therapy are frequent the standard of care treatment of sclc consists of platinumbased chemotherapy in combination with etoposide that is subsequently enhanced by pdlinhibiting atezolizumab in the extensivestage disease a the addition of immunecheckpoint inhibition yielded improved overall survival although there are promising molecular pathway with potential therapeutic impact targeted therapy are still not an integral part of routine treatment against this background we evaluated current literature for potential new molecular candidate such a surface marker eg dll trop or cd apoptotic factor eg bcl bet genetic alteration eg crebbp notch or pten or vascular marker eg vegf fgfr or cd apart from these factor the application of socalled polyadpribose polymerase parp inhibitor can influence tumor repair mechanism and thus offer new perspective for future treatment another promising therapeutic concept is the inhibition of enhancer of zeste homolog ezh in the loss of function of tumor suppressor or amplification of proto oncogene considering the poor prognosis of sclc patient new molecular pathway require further investigation to augment our therapeutic armamentarium in the future,Cancer,0,future option of moleculartargeted therapy in small cell lung cancer lung cancer is the leading cause of cancerrelated death worldwide with a focus on histology there are two major subtypes nonsmall cell lung cancer nsclc the more frequent subtype and small cell lung cancer sclc the more aggressive one even though sclc in general is a chemosensitive malignancy relapse following induction therapy are frequent the standard of care treatment of sclc consists of platinumbased chemotherapy in combination with etoposide that is subsequently enhanced by pdlinhibiting atezolizumab in the extensivestage disease a the addition of immunecheckpoint inhibition yielded improved overall survival although there are promising molecular pathway with potential therapeutic impact targeted therapy are still not an integral part of routine treatment against this background we evaluated current literature for potential new molecular candidate such a surface marker eg dll trop or cd apoptotic factor eg bcl bet genetic alteration eg crebbp notch or pten or vascular marker eg vegf fgfr or cd apart from these factor the application of socalled polyadpribose polymerase parp inhibitor can influence tumor repair mechanism and thus offer new perspective for future treatment another promising therapeutic concept is the inhibition of enhancer of zeste homolog ezh in the loss of function of tumor suppressor or amplification of proto oncogene considering the poor prognosis of sclc patient new molecular pathway require further investigation to augment our therapeutic armamentarium in the future
31109278,a computer aided drug designing for pharmacological inhibition of mutant alk for the treatment of nonsmall cell lung cancer,background lung cancer is the most common among all the type of cancer worldwide with million people diagnosed every year leading to million death every year according to the american cancer society the involvement of mutated anaplasic lymphoma kinase alk positive fusion protein in the progression of nsclc ha made a propitious target to inhibit and treat nsclc in the present study the main motif is to screen the most effective inhibitor against alk protein with the potential pharmacological profile the ligand selected were docked with molegro virtual docker mvd and cep pubchem cid wa the best docked preestablished compound with a permissible pharmacological profile method the selected ligand were docked with molegro virtual docker mvd with reference to the obtained compound with the lowest rerank score pubchem database wa virtually screened to retrieve a large set of similar compound which were docked to find the compound with higher affinity further comparative study and in silico prediction included pharmacophore study proximity energy parameter admet and boiledegg plot analysis result cep pubchem cid wa the best docked preestablished compound with preferable pharmacological profile and pubchem compound cid came out a the most efficient virtually screened inhibitor interestingly the contour of the virtual screened compound pubchem cid fall within our desired high volume cavity of protein having admirable property to control the alk regulation to prevent carcinogenesis in nsclc boiledegg plot analysis depicts that both the compound have analogous characteristic in the divergent aspect moreover in the evaluation of blood brain barrier human intestinal absorption ames toxicity and ld the virtually screened compound pubchem cid wa found within high optimization conclusion these investigation denote that the virtually screened compound pubchem cid is more efficient to be a better prospective candidate for nsclc treatment having good pharmacological profile than the preestablished compound cep pubchem cid with low rerank score the identified virtually screened compound ha high potential to act a an alk inhibitor and can show promising result in the research of nonsmall cell lung cancer nsclc,Cancer,0,a computer aided drug designing for pharmacological inhibition of mutant alk for the treatment of nonsmall cell lung cancer background lung cancer is the most common among all the type of cancer worldwide with million people diagnosed every year leading to million death every year according to the american cancer society the involvement of mutated anaplasic lymphoma kinase alk positive fusion protein in the progression of nsclc ha made a propitious target to inhibit and treat nsclc in the present study the main motif is to screen the most effective inhibitor against alk protein with the potential pharmacological profile the ligand selected were docked with molegro virtual docker mvd and cep pubchem cid wa the best docked preestablished compound with a permissible pharmacological profile method the selected ligand were docked with molegro virtual docker mvd with reference to the obtained compound with the lowest rerank score pubchem database wa virtually screened to retrieve a large set of similar compound which were docked to find the compound with higher affinity further comparative study and in silico prediction included pharmacophore study proximity energy parameter admet and boiledegg plot analysis result cep pubchem cid wa the best docked preestablished compound with preferable pharmacological profile and pubchem compound cid came out a the most efficient virtually screened inhibitor interestingly the contour of the virtual screened compound pubchem cid fall within our desired high volume cavity of protein having admirable property to control the alk regulation to prevent carcinogenesis in nsclc boiledegg plot analysis depicts that both the compound have analogous characteristic in the divergent aspect moreover in the evaluation of blood brain barrier human intestinal absorption ames toxicity and ld the virtually screened compound pubchem cid wa found within high optimization conclusion these investigation denote that the virtually screened compound pubchem cid is more efficient to be a better prospective candidate for nsclc treatment having good pharmacological profile than the preestablished compound cep pubchem cid with low rerank score the identified virtually screened compound ha high potential to act a an alk inhibitor and can show promising result in the research of nonsmall cell lung cancer nsclc
31109360,rare case of primary central nervous system anaplastic variant of diffuse large bcell lymphoma,background primary central nervous system cns diffuse large bcell lymphoma dlbcl is a rare intracranial tumor defined a dlbcl arising from the brain spinal cord leptomeninges and eye with an overall annual incidence of case per million the primary cns anaplastic variant of dlbcl adlbcl is even less common to our knowledge there are only two other case report in the literature the aim of this report is to present rare case of primary cns adlbcl and study their clinicopathologic and genetic feature case presentation we report patient two men and one woman aged and year old with primary cns adlbcl all patient had a high international extranodal lymphoma study group ielsg score although the patient were treated with methotrexatebased regimen andor with radiation therapy the overall survival wa only and month all patient presented with characteristic feature of perivascular space infiltration with bizarreshaped tumor cell leading to the diagnosis of primary cns adlbcl concurrent of myc and bcl andor bcl abnormality and mycbcl doubleexpressor dlbcl occurred in all patient two patient had mycbclbcl triple extra copy and one patient had myc extra copy and bcl translocation all patient displayed mutation in myd lp and nuclear positivity for rela relb andor crel indicating constitutive activation of the nfkappab pathway conclusion these case shed light on the unique genetic alteration and biological feature of primary cns adlbcl patient with primary cns adlbcl may often have a mycbcl doubleexpressor and concurrent myc and bcl andor bcl genetic abnormality a well a constitutive activation of the nfkappab pathway primary cns adlbcl follows a very aggressive disease course and poor prognosis in the future a large number of case should be analyzed and the evaluation of molecular genetic characteristic could help with practical and therapeutic implication for primary cns adlbcl,Cancer,0,rare case of primary central nervous system anaplastic variant of diffuse large bcell lymphoma background primary central nervous system cns diffuse large bcell lymphoma dlbcl is a rare intracranial tumor defined a dlbcl arising from the brain spinal cord leptomeninges and eye with an overall annual incidence of case per million the primary cns anaplastic variant of dlbcl adlbcl is even less common to our knowledge there are only two other case report in the literature the aim of this report is to present rare case of primary cns adlbcl and study their clinicopathologic and genetic feature case presentation we report patient two men and one woman aged and year old with primary cns adlbcl all patient had a high international extranodal lymphoma study group ielsg score although the patient were treated with methotrexatebased regimen andor with radiation therapy the overall survival wa only and month all patient presented with characteristic feature of perivascular space infiltration with bizarreshaped tumor cell leading to the diagnosis of primary cns adlbcl concurrent of myc and bcl andor bcl abnormality and mycbcl doubleexpressor dlbcl occurred in all patient two patient had mycbclbcl triple extra copy and one patient had myc extra copy and bcl translocation all patient displayed mutation in myd lp and nuclear positivity for rela relb andor crel indicating constitutive activation of the nfkappab pathway conclusion these case shed light on the unique genetic alteration and biological feature of primary cns adlbcl patient with primary cns adlbcl may often have a mycbcl doubleexpressor and concurrent myc and bcl andor bcl genetic abnormality a well a constitutive activation of the nfkappab pathway primary cns adlbcl follows a very aggressive disease course and poor prognosis in the future a large number of case should be analyzed and the evaluation of molecular genetic characteristic could help with practical and therapeutic implication for primary cns adlbcl
31110352,release of paused rna polymerase ii at specific locus favor dna doublestrandbreak formation and promotes cancer translocation,it is not clear how spontaneous dna doublestrand break dsbs form and are processed in normal cell and whether they predispose to cancerassociated translocation we show that dsbs in normal mammary cell form upon release of paused rna polymerase ii pol ii at promoter splice site and active enhancer and are processed by endjoining in the absence of a canonical dnadamage response logistic and causalassociation model showed that pol ii pausing at long gene is the main predictor and determinant of dsbs damaged intron with paused pol iips topb and xrcc are enriched in translocation breakpoints and map at topologically associating domain boundaryflanking region showing high interaction frequency with distal locus thus in unperturbed growth condition release of paused pol ii at specific locus and chromatin territory favor dsb formation leading to chromosomal translocation,Cancer,0,release of paused rna polymerase ii at specific locus favor dna doublestrandbreak formation and promotes cancer translocation it is not clear how spontaneous dna doublestrand break dsbs form and are processed in normal cell and whether they predispose to cancerassociated translocation we show that dsbs in normal mammary cell form upon release of paused rna polymerase ii pol ii at promoter splice site and active enhancer and are processed by endjoining in the absence of a canonical dnadamage response logistic and causalassociation model showed that pol ii pausing at long gene is the main predictor and determinant of dsbs damaged intron with paused pol iips topb and xrcc are enriched in translocation breakpoints and map at topologically associating domain boundaryflanking region showing high interaction frequency with distal locus thus in unperturbed growth condition release of paused pol ii at specific locus and chromatin territory favor dsb formation leading to chromosomal translocation
31115156,comprehensive evaluation of context dependence of the prognostic impact of mycn amplification in neuroblastoma a report from the international neuroblastoma risk group inrg project,background mycn amplification mycna is an established adverse prognostic factor in neuroblastoma the extent to which the prognostic impact of mycna depends on other factor ha not been fully characterized patient and method using the international neuroblastoma risk group database we constructed cox model of overall survival o to obtain hazard ratio of the effect of mycna within subgroup defined by other prognostic factor cox model assessed the degree to which the prognostic impact of mycna wa modulated by each other covariate we used absolute hazard ratio hr difference to construct classification tree to identify subgroup with greatest differential prognostic effect of mycna result in a cohort of patient with known mycn status the o hazard ratio associated with mycna wa confidence interval p month mycna remained significantly prognostic of o after controlling for other factor abrogating their prognostic strength patient whose outcome wa most impacted by mycn status were those who were month had high mitosis karrhyohexis index mki and low ferritin conclusion the prognostic strength of mycna varies depending on which patient subgroup defined by other neuroblastoma risk factor is examined with greatest strength in patient with otherwise favorable feature mycna ha little effect within some subgroup aiding clinical decisionmaking if mycn status can not be assessed subgroup where mycna ha large effect may be prioritized for agent targeting myc family protein,Cancer,0,comprehensive evaluation of context dependence of the prognostic impact of mycn amplification in neuroblastoma a report from the international neuroblastoma risk group inrg project background mycn amplification mycna is an established adverse prognostic factor in neuroblastoma the extent to which the prognostic impact of mycna depends on other factor ha not been fully characterized patient and method using the international neuroblastoma risk group database we constructed cox model of overall survival o to obtain hazard ratio of the effect of mycna within subgroup defined by other prognostic factor cox model assessed the degree to which the prognostic impact of mycna wa modulated by each other covariate we used absolute hazard ratio hr difference to construct classification tree to identify subgroup with greatest differential prognostic effect of mycna result in a cohort of patient with known mycn status the o hazard ratio associated with mycna wa confidence interval p month mycna remained significantly prognostic of o after controlling for other factor abrogating their prognostic strength patient whose outcome wa most impacted by mycn status were those who were month had high mitosis karrhyohexis index mki and low ferritin conclusion the prognostic strength of mycna varies depending on which patient subgroup defined by other neuroblastoma risk factor is examined with greatest strength in patient with otherwise favorable feature mycna ha little effect within some subgroup aiding clinical decisionmaking if mycn status can not be assessed subgroup where mycna ha large effect may be prioritized for agent targeting myc family protein
31115855,papillary thyroid cancer with focal tall cell change are a aggressive a tall cell variant and should not be considered a lowrisk disease,background the tall cell variant of papillary thyroid carcinoma ptc is a an aggressive histological variant the proportion of tall cell needed to influence prognosis is debated method patient with ptc and tall cell defined a having a heighttowidth ratio of seen at a highvolume center between and were reviewed specimen were classified a focal tall cell change containing of tall cell and control case selected from infiltrative classical ptcs without adverse cytologic feature univariate sensitivity and multivariate analysis were performed with persistentrecurrent disease a the primary outcome result we identified ptcs with focal tall cell change with the tall cell variant and control case factor associated with poor clinical prognosis were significantly greater in those with focal tall cell change and tall cell variant regarding primary outcome hazard ratio were confidence interval ci for focal tall cell change and ci for tall cell variant compared with control fiveyear diseasefree survival wa higher for the control group ci compared with focal tall cell change ci and the tall cell variant ci when stratified in group consisting of tall cell proportion identification of tall cell change wa associated with worse outcome p conclusion ptcs with tall cell change have worse prognosis than those without tall cell our data indicate that thyroid cancer management guideline should consider ptcs with focal tall cell change outside of the lowrisk classification,Cancer,0,papillary thyroid cancer with focal tall cell change are a aggressive a tall cell variant and should not be considered a lowrisk disease background the tall cell variant of papillary thyroid carcinoma ptc is a an aggressive histological variant the proportion of tall cell needed to influence prognosis is debated method patient with ptc and tall cell defined a having a heighttowidth ratio of seen at a highvolume center between and were reviewed specimen were classified a focal tall cell change containing of tall cell and control case selected from infiltrative classical ptcs without adverse cytologic feature univariate sensitivity and multivariate analysis were performed with persistentrecurrent disease a the primary outcome result we identified ptcs with focal tall cell change with the tall cell variant and control case factor associated with poor clinical prognosis were significantly greater in those with focal tall cell change and tall cell variant regarding primary outcome hazard ratio were confidence interval ci for focal tall cell change and ci for tall cell variant compared with control fiveyear diseasefree survival wa higher for the control group ci compared with focal tall cell change ci and the tall cell variant ci when stratified in group consisting of tall cell proportion identification of tall cell change wa associated with worse outcome p conclusion ptcs with tall cell change have worse prognosis than those without tall cell our data indicate that thyroid cancer management guideline should consider ptcs with focal tall cell change outside of the lowrisk classification
31119365,microsatellite instability review of method and application,after introduction of the bethesda microsatellite test panel demonstration of microsatellite instability msi andor loss of mismatch repair protein mmrd wa primarily used a a marker for cancer predisposition of lynch syndrome l previous hnpcc nowadays msimmrd ha become an important biomarker to predict therapy response to checkpoint immunotherapy msi can be determined either by polymerase chain reaction pcrbased technology with or without specification of fragment size or next generation sequencing ng method depending on the individual tumor entity these test method are used differently currently msimmrd is a tumor biomarker which cover a broad spectrum of indication in tumor pathology especially in colorectal endometrial and gastric cancer in advanced carcinoma msi is an established predictor of therapy response to checkpointdirected immunotherapy,Cancer,0,microsatellite instability review of method and application after introduction of the bethesda microsatellite test panel demonstration of microsatellite instability msi andor loss of mismatch repair protein mmrd wa primarily used a a marker for cancer predisposition of lynch syndrome l previous hnpcc nowadays msimmrd ha become an important biomarker to predict therapy response to checkpoint immunotherapy msi can be determined either by polymerase chain reaction pcrbased technology with or without specification of fragment size or next generation sequencing ng method depending on the individual tumor entity these test method are used differently currently msimmrd is a tumor biomarker which cover a broad spectrum of indication in tumor pathology especially in colorectal endometrial and gastric cancer in advanced carcinoma msi is an established predictor of therapy response to checkpointdirected immunotherapy
31124195,kit mutation in a naive succinate dehydrogenasedeficient gastric gist,up to of gastrointestinal stromal tumor gist harbor mutually exclusive mutation in the kit or the pdgfra gene among others known a wild type gist succinate dehydrogenase sdhdeficient tumor develop due to genetic or epigenetic alteration in any of four sdh gene herein we present a unique case of sdhdeficient gist with an unusual heterogeneous sdha and sdhb staining pattern and mutation detected in the sdha and kit gene a yearold patient presented with a cm large gastric tumor with a multinodularplexiform growth pattern mixed epithelioid and spindle cell morphology and focal pronounced nuclear atypia with hyperchromasia and high mitotic activity immunohistochemically cd and dog were positive sdhb and sdha stain showed loss of expression in some of the nodule whereas others presented with an unusually weak patchy positivity molecular analysis revealed a point mutation in exon of the sdha gene and a mutation in exon of the kit gene we hypothesize that based on the allele frequency of sdha and kit mutation the tumor is best regarded a sdhdeficient gist in which the sdha mutation represents the most likely driver mutation the identified kit mutation raise the distinct possibility that the kit mutation is a secondary event reflecting clonal evolution this is the first case of a treatment naive gist harboring a somatic sdha and a kit mutation challenging the dogma that oncogenic mutation in treatment naive gist are mutually exclusive,Cancer,0,kit mutation in a naive succinate dehydrogenasedeficient gastric gist up to of gastrointestinal stromal tumor gist harbor mutually exclusive mutation in the kit or the pdgfra gene among others known a wild type gist succinate dehydrogenase sdhdeficient tumor develop due to genetic or epigenetic alteration in any of four sdh gene herein we present a unique case of sdhdeficient gist with an unusual heterogeneous sdha and sdhb staining pattern and mutation detected in the sdha and kit gene a yearold patient presented with a cm large gastric tumor with a multinodularplexiform growth pattern mixed epithelioid and spindle cell morphology and focal pronounced nuclear atypia with hyperchromasia and high mitotic activity immunohistochemically cd and dog were positive sdhb and sdha stain showed loss of expression in some of the nodule whereas others presented with an unusually weak patchy positivity molecular analysis revealed a point mutation in exon of the sdha gene and a mutation in exon of the kit gene we hypothesize that based on the allele frequency of sdha and kit mutation the tumor is best regarded a sdhdeficient gist in which the sdha mutation represents the most likely driver mutation the identified kit mutation raise the distinct possibility that the kit mutation is a secondary event reflecting clonal evolution this is the first case of a treatment naive gist harboring a somatic sdha and a kit mutation challenging the dogma that oncogenic mutation in treatment naive gist are mutually exclusive
31137165,difference in circrna expression profile between herpositive breast cancer cell and normal mammary epithelial cell,objective to investigate the differential expression profile of circular rna circrna in human epidermal growth factor receptor her positive breast cancer cell and normal mammary epithelial cell and to develop novel diagnostic and therapeutic marker for her positive breast cancer method total rna were extracted from her positive breast cancer cell skbr and normal mammary epithelial cell mcfa rna quality wa detected using nanodrop nd rnase r wa applied to remove linear rna and enrich circrnas after amplification and reverse transcription into fluorescent complementary rna crna using random primer the labeled crnas were hybridized onto the arraystar human circrna array the raw data were extracted and the acquired array image were subjected to quantile normalization followed by heat map and volcano plot analysis the expression of circrnas with large fold change wa verified by realtime quantitative polymerase chain reaction rtqpcr finally gene ontology go and kyoto encyclopedia of gene and genome kegg enrichment analysis were performed in the differentially expressed circrnas and circrnamicrorna mirna network wa constructed result the total rna extracted from skbr and mcfa had high integrity and quality the expression profile of circrna in skbr and mcfa cell were significantly different shown by fluorescent expression signal compared with mcfa cell there were upregulated circrnas and downregulated circrnas in skbr cell there were circrnas with logfc of which were upregulated and were downregulated moreover circrnas with logfc among them were upregulated in skbr cell including hsacircrna logfc hsacircrna logfc hsacircrna logfc hsacircrna logfc and hsacircrna logfc a well a were downregulated including hsacircrna logfc hsacircrna logfc and hsacircrna logfc the expression level of hsacircrna hsacircrna and hsacircrna were further validated by rtqpcr in consistent with the result of microarray go analysis showed that differentially expressed circrnas were significantly enriched in the biological process of heart development p cellular component in the cell adhesionrelated component p molecular function in protein serinethreonine kinase activity p kegg analysis revealed that differentially expressed circrnas were significantly enriched in the pikakt signaling pathway conclusion the expression profile of circrna in her positive breast cancer cell is significantly different from that in normal mammary epithelial cell the differentially expressed circrnas may be served a potential diagnostic or therapeutic target for her positive breast cancer,Cancer,0,difference in circrna expression profile between herpositive breast cancer cell and normal mammary epithelial cell objective to investigate the differential expression profile of circular rna circrna in human epidermal growth factor receptor her positive breast cancer cell and normal mammary epithelial cell and to develop novel diagnostic and therapeutic marker for her positive breast cancer method total rna were extracted from her positive breast cancer cell skbr and normal mammary epithelial cell mcfa rna quality wa detected using nanodrop nd rnase r wa applied to remove linear rna and enrich circrnas after amplification and reverse transcription into fluorescent complementary rna crna using random primer the labeled crnas were hybridized onto the arraystar human circrna array the raw data were extracted and the acquired array image were subjected to quantile normalization followed by heat map and volcano plot analysis the expression of circrnas with large fold change wa verified by realtime quantitative polymerase chain reaction rtqpcr finally gene ontology go and kyoto encyclopedia of gene and genome kegg enrichment analysis were performed in the differentially expressed circrnas and circrnamicrorna mirna network wa constructed result the total rna extracted from skbr and mcfa had high integrity and quality the expression profile of circrna in skbr and mcfa cell were significantly different shown by fluorescent expression signal compared with mcfa cell there were upregulated circrnas and downregulated circrnas in skbr cell there were circrnas with logfc of which were upregulated and were downregulated moreover circrnas with logfc among them were upregulated in skbr cell including hsacircrna logfc hsacircrna logfc hsacircrna logfc hsacircrna logfc and hsacircrna logfc a well a were downregulated including hsacircrna logfc hsacircrna logfc and hsacircrna logfc the expression level of hsacircrna hsacircrna and hsacircrna were further validated by rtqpcr in consistent with the result of microarray go analysis showed that differentially expressed circrnas were significantly enriched in the biological process of heart development p cellular component in the cell adhesionrelated component p molecular function in protein serinethreonine kinase activity p kegg analysis revealed that differentially expressed circrnas were significantly enriched in the pikakt signaling pathway conclusion the expression profile of circrna in her positive breast cancer cell is significantly different from that in normal mammary epithelial cell the differentially expressed circrnas may be served a potential diagnostic or therapeutic target for her positive breast cancer
31138334,prognostic value of b cell in cutaneous melanoma,background measure of the adaptive immune response have prognostic and predictive association in melanoma and other cancer type specifically intratumoral t cell density and function have considerable prognostic and predictive value in skin cutaneous melanoma skcm less is known about the significance of tumorinfiltrating b cell in skcm our goal wa to understand the prognostic and predictive value of b cell phenotypic subset in skcm using rna sequencing method we used our previously published algorithm vdjer to assemble b cell receptor bcr repertoire and estimate diversity from shortread rna sequencing rnaseq we applied machine learningbased cellular phenotype classifier to measure relative similarity of bulk tumor sample gene expression profile and different b cell phenotype we assessed these aspect of b cell biology in skcm from the cancer genome atlas project tcga a well a in rnaseq data corresponding to tumor sample procured from patient who received ctla and pd inhibitor for metastatic skcm result we found that the bcr repertoire wa associated with different clinical factor such a tumor tissue site and sex however increased clonality of the bcr repertoire wa favorably prognostic in skcm and wa prognostic even after first conditioning on various clinical factor mutation burden wa not correlated with any bcr measurement and no specific mutation had an altered bcr repertoire lack of an assembled bcr in pretreatment tumor tissue wa associated with a lack of antitumor response to a ctla inhibitor in metastatic skcm conclusion these finding suggest an important prognostic and predictive role for b cell characteristic in skcm this ha implication for melanoma immunobiology and potential development of immunogenomics feature to predict survival and response to immunotherapy,Cancer,0,prognostic value of b cell in cutaneous melanoma background measure of the adaptive immune response have prognostic and predictive association in melanoma and other cancer type specifically intratumoral t cell density and function have considerable prognostic and predictive value in skin cutaneous melanoma skcm less is known about the significance of tumorinfiltrating b cell in skcm our goal wa to understand the prognostic and predictive value of b cell phenotypic subset in skcm using rna sequencing method we used our previously published algorithm vdjer to assemble b cell receptor bcr repertoire and estimate diversity from shortread rna sequencing rnaseq we applied machine learningbased cellular phenotype classifier to measure relative similarity of bulk tumor sample gene expression profile and different b cell phenotype we assessed these aspect of b cell biology in skcm from the cancer genome atlas project tcga a well a in rnaseq data corresponding to tumor sample procured from patient who received ctla and pd inhibitor for metastatic skcm result we found that the bcr repertoire wa associated with different clinical factor such a tumor tissue site and sex however increased clonality of the bcr repertoire wa favorably prognostic in skcm and wa prognostic even after first conditioning on various clinical factor mutation burden wa not correlated with any bcr measurement and no specific mutation had an altered bcr repertoire lack of an assembled bcr in pretreatment tumor tissue wa associated with a lack of antitumor response to a ctla inhibitor in metastatic skcm conclusion these finding suggest an important prognostic and predictive role for b cell characteristic in skcm this ha implication for melanoma immunobiology and potential development of immunogenomics feature to predict survival and response to immunotherapy
31138587,tumorlocalized costimulatory tcell engagement by the bbher bispecific antibodyanticalin fusion pr,purpose bb cd is a key costimulatory immunoreceptor and promising therapeutic target in cancer to overcome limitation of current bbtargeting antibody we have developed pr a bbher bispecific molecule pr is designed to facilitate tcell costimulation by tumorlocalized herdependent bb clustering and activation experimental design pr wa generated by the genetic fusion of bbspecific anticalin protein to a variant of trastuzumab with an engineered igg isotype it activity wa characterized using a panel of in vitro assay and humanized mouse model the safety wa assessed using ex vivo human cell assay and a toxicity study in cynomolgus monkey result pr target bb and her with high affinity and bind both target simultaneously bbexpressing t cell are efficiently costimulated when incubated with pr in the presence of cancer cell expressing her a evidenced by increased production of proinflammatory cytokine il gmcsf tnfalpha and ifngamma in a humanized mouse model engrafted with herpositive skov tumor cell and human peripheral blood mononuclear cell pr lead to tumor growth inhibition and a dosedependent increase of tumorinfiltrating lymphocyte in indenabling study pr wa found to be well tolerated with no overt toxicity and no relevant drugrelated toxicologic finding conclusion pr facilitates tumorlocalized targeting of t cell by bispecific engagement of her and bb this approach ha the potential to provide a more localized activation of the immune system with higher efficacy and reduced peripheral toxicity compared with current monospecific approach the reported data led to initiation of a phase i clinical trial with this firstinclass moleculesee related commentary by su et al p,Cancer,0,tumorlocalized costimulatory tcell engagement by the bbher bispecific antibodyanticalin fusion pr purpose bb cd is a key costimulatory immunoreceptor and promising therapeutic target in cancer to overcome limitation of current bbtargeting antibody we have developed pr a bbher bispecific molecule pr is designed to facilitate tcell costimulation by tumorlocalized herdependent bb clustering and activation experimental design pr wa generated by the genetic fusion of bbspecific anticalin protein to a variant of trastuzumab with an engineered igg isotype it activity wa characterized using a panel of in vitro assay and humanized mouse model the safety wa assessed using ex vivo human cell assay and a toxicity study in cynomolgus monkey result pr target bb and her with high affinity and bind both target simultaneously bbexpressing t cell are efficiently costimulated when incubated with pr in the presence of cancer cell expressing her a evidenced by increased production of proinflammatory cytokine il gmcsf tnfalpha and ifngamma in a humanized mouse model engrafted with herpositive skov tumor cell and human peripheral blood mononuclear cell pr lead to tumor growth inhibition and a dosedependent increase of tumorinfiltrating lymphocyte in indenabling study pr wa found to be well tolerated with no overt toxicity and no relevant drugrelated toxicologic finding conclusion pr facilitates tumorlocalized targeting of t cell by bispecific engagement of her and bb this approach ha the potential to provide a more localized activation of the immune system with higher efficacy and reduced peripheral toxicity compared with current monospecific approach the reported data led to initiation of a phase i clinical trial with this firstinclass moleculesee related commentary by su et al p
31148183,a noncoding regulatory rna network driven by circcdyl act specifically in the early stage hepatocellular carcinoma,hepatocellular carcinoma hcc is one of the fastestrising cause of cancerrelated death worldwide but it deficiency of specific biomarkers and therapeutic target in the early stage lead to severe inadequacy in the early diagnosis and treatment of hcc covalently closed circular rna circrna which wa once considered an aberrant splicing byproduct is now drawing new interest in cancer research because of it remarkable functionality beneath the surface of the dominant functional protein event a hidden circrnacentric noncoding regulatory rna network active in the very early stage of hcc is here revealed by a genomewide analysis of mrna circrna and microrna mirna expression profile circcdyl chromodomain y like is specifically upregulated in the early stage of hcc and therefore contributes to the property of epithelial cell adhesion molecule epcampositive liver tumorinitiating cell circcdyl interacts with mrna encoding hepatomaderived growth factor hdgf and hypoxiainducible factor asparagine hydroxylase hifan by acting a the sponge of mira and mirp respectively subsequently activation of the phosphoinositide kinase pikakt serinethreonine kinasemechanistic target of rapamycin kinase complex betacatenin and notch pathway which promote the expression of the effect protein baculoviral iap repeat containing birc or survivin and myc protooncogene is influenced by circcdyl a treatment incorporating circcdyl interference and traditional enzyme inhibitor targeting pik and hifan demonstrated highly effective inhibition of stemlike characteristic and tumor growth in hcc finally we demonstrated that circcdyl expression or which combined with hdgf and hifan are both independent marker for discrimination of early stage of hcc with the odds ratio of confidence interval ci and ci respectively conclusion these finding uncover a circrnacentric noncoding regulatory rna network in the early stage of hcc and thus provide a possibility for surveillance and early treatment of hcc,Cancer,0,a noncoding regulatory rna network driven by circcdyl act specifically in the early stage hepatocellular carcinoma hepatocellular carcinoma hcc is one of the fastestrising cause of cancerrelated death worldwide but it deficiency of specific biomarkers and therapeutic target in the early stage lead to severe inadequacy in the early diagnosis and treatment of hcc covalently closed circular rna circrna which wa once considered an aberrant splicing byproduct is now drawing new interest in cancer research because of it remarkable functionality beneath the surface of the dominant functional protein event a hidden circrnacentric noncoding regulatory rna network active in the very early stage of hcc is here revealed by a genomewide analysis of mrna circrna and microrna mirna expression profile circcdyl chromodomain y like is specifically upregulated in the early stage of hcc and therefore contributes to the property of epithelial cell adhesion molecule epcampositive liver tumorinitiating cell circcdyl interacts with mrna encoding hepatomaderived growth factor hdgf and hypoxiainducible factor asparagine hydroxylase hifan by acting a the sponge of mira and mirp respectively subsequently activation of the phosphoinositide kinase pikakt serinethreonine kinasemechanistic target of rapamycin kinase complex betacatenin and notch pathway which promote the expression of the effect protein baculoviral iap repeat containing birc or survivin and myc protooncogene is influenced by circcdyl a treatment incorporating circcdyl interference and traditional enzyme inhibitor targeting pik and hifan demonstrated highly effective inhibition of stemlike characteristic and tumor growth in hcc finally we demonstrated that circcdyl expression or which combined with hdgf and hifan are both independent marker for discrimination of early stage of hcc with the odds ratio of confidence interval ci and ci respectively conclusion these finding uncover a circrnacentric noncoding regulatory rna network in the early stage of hcc and thus provide a possibility for surveillance and early treatment of hcc
31152596,the role of gene fusion in melanocytic neoplasm,recent advance in next generation sequencing ng have allowed for efficient whole transcriptome sequencing leading to the identification of important kinase fusion a the primary driver in some melanocytic neoplasm these fusion typically occur mutually exclusively of one another and other wellknown initiating mutation such a braf nra nf kit and gnaq fusion are found in over of spitz neoplasm including alk braf ntrk ntrk ro met mapk and ret familiarity with the typical morphologic feature of certain fusiondriven melanocytic neoplasm can help with classification diagnosis and identification of targeted molecular therapy in malignant case spitz tumor with alk ntrk and ntrk fusion have characteristic morphologic feature braf and mapk fusion in particular tend to be epithelioid high grade and more frequent in spitz melanoma than other fusion subtypes sporadic case of pigmented epithelioid melanocytoma may have prkca fusion and sheet of monomorphic epithelioid melanocyte fusion event are also enriched among melanoma without the key mutation braf nra or nf although ng is the most reliable method to detect fusion immunohistochemistry and fluorescence in situ hybridization are costeffective alternative in some case we describe recent discovery regarding the role of kinase fusion in melanocytic neoplasm and their associated morphology,Cancer,0,the role of gene fusion in melanocytic neoplasm recent advance in next generation sequencing ng have allowed for efficient whole transcriptome sequencing leading to the identification of important kinase fusion a the primary driver in some melanocytic neoplasm these fusion typically occur mutually exclusively of one another and other wellknown initiating mutation such a braf nra nf kit and gnaq fusion are found in over of spitz neoplasm including alk braf ntrk ntrk ro met mapk and ret familiarity with the typical morphologic feature of certain fusiondriven melanocytic neoplasm can help with classification diagnosis and identification of targeted molecular therapy in malignant case spitz tumor with alk ntrk and ntrk fusion have characteristic morphologic feature braf and mapk fusion in particular tend to be epithelioid high grade and more frequent in spitz melanoma than other fusion subtypes sporadic case of pigmented epithelioid melanocytoma may have prkca fusion and sheet of monomorphic epithelioid melanocyte fusion event are also enriched among melanoma without the key mutation braf nra or nf although ng is the most reliable method to detect fusion immunohistochemistry and fluorescence in situ hybridization are costeffective alternative in some case we describe recent discovery regarding the role of kinase fusion in melanocytic neoplasm and their associated morphology
31157977,analysis of fusobacterium nucleatum and streptococcus gallolyticus in saliva of colorectal cancer patient,aim the aim of the study wa to examine the prevalence and amount of fusobacterium nucleatum fn porphyromonas gingivalis pg and streptococcus gallolyticus sg in the saliva of colorectal cancer crc patient and control method pcr analysis performed in crc patient and control result saliva sample of patient had higher amount of fn p and sg p compared with control amount of fn and sg were lower in the microsatellite instability group evaluation of salivary sg amount by receiver operating characteristic analysis found to have diagnostic value for crc auc ci conclusion we found higher amount of fn and sg in the saliva of crc patient salivary sg could helpful in distinction of crc,Cancer,0,analysis of fusobacterium nucleatum and streptococcus gallolyticus in saliva of colorectal cancer patient aim the aim of the study wa to examine the prevalence and amount of fusobacterium nucleatum fn porphyromonas gingivalis pg and streptococcus gallolyticus sg in the saliva of colorectal cancer crc patient and control method pcr analysis performed in crc patient and control result saliva sample of patient had higher amount of fn p and sg p compared with control amount of fn and sg were lower in the microsatellite instability group evaluation of salivary sg amount by receiver operating characteristic analysis found to have diagnostic value for crc auc ci conclusion we found higher amount of fn and sg in the saliva of crc patient salivary sg could helpful in distinction of crc
31158106,clinical implication of genetic aberration in metastatic prostate cancer,purpose of review the utility of tumor genetic testing in metastatic prostate cancer is rapidly evolving especially in respect to finding prognostic and predictive biomarkers in this review we describe genomic aberration in clinically relevant pathway in metastatic castrationresistant prostate cancer mcrpc for which therapeutic targeting is possible recent finding recognizing the diverse array of genetic feature within prostate cancer the goal of testing in mcrpc is to match an individual patient tumor with the best therapy approximately of mcrpc patient have defect in dna repair which may be exploited with polyadpribose polymerase inhibitor platinumbased chemotherapy andor immunotherapy choosing between the secondgeneration androgen inhibitor and chemotherapy may be informed through testing for androgen receptor splice variant or androgen receptor amplification but technology and outcome are still being clarified genetic testing for mismatch repair deficiency of mcrpc patient is a standard of care but may be expanded a other subpopulation that could respond to immunotherapy are found summary the era of precision medicine for prostate cancer is here but is being refined further study with newer technology and standardized analytical platform are needed and must be matched with improvement in clinical care infrastructure,Cancer,0,clinical implication of genetic aberration in metastatic prostate cancer purpose of review the utility of tumor genetic testing in metastatic prostate cancer is rapidly evolving especially in respect to finding prognostic and predictive biomarkers in this review we describe genomic aberration in clinically relevant pathway in metastatic castrationresistant prostate cancer mcrpc for which therapeutic targeting is possible recent finding recognizing the diverse array of genetic feature within prostate cancer the goal of testing in mcrpc is to match an individual patient tumor with the best therapy approximately of mcrpc patient have defect in dna repair which may be exploited with polyadpribose polymerase inhibitor platinumbased chemotherapy andor immunotherapy choosing between the secondgeneration androgen inhibitor and chemotherapy may be informed through testing for androgen receptor splice variant or androgen receptor amplification but technology and outcome are still being clarified genetic testing for mismatch repair deficiency of mcrpc patient is a standard of care but may be expanded a other subpopulation that could respond to immunotherapy are found summary the era of precision medicine for prostate cancer is here but is being refined further study with newer technology and standardized analytical platform are needed and must be matched with improvement in clinical care infrastructure
31158302,clinicopathological feature diagnosis and treatment of sessile serrated adenomapolyp with dysplasiacarcinoma,sessile serrated adenomapolyps ssaps are early precursor lesion in the serrated neoplasia pathway which result in brafmutated colorectal carcinoma with not only high level of microsatellite instability but also microsatellite stable ssaps with advanced histology including cytological dysplasia or minimally invasive carcinoma are important lesion because ssaps are considered major contributor to interval cancer and these lesion can rapidly become dysplastic or invasive carcinoma clinicopathologically ssaps with dysplasia or invasive carcinoma were associated with advanced age female sex and proximal colon although ssaps with submucosal invasive carcinoma were smaller and invaded less deeply into the submucosal layer than conventional tubular adenoma with submucosal invasive carcinoma ssaps with submucosal invasive carcinoma frequently had a mucinous component and exhibited a higher potential for lymphatic invasion and lymph node metastasis in an ssap series endoscopic characteristic including semipedunculated morphology double elevation central depression and reddishness may help accurately diagnose ssaps with advanced histology removal of ssaps with dysplasia or invasive carcinoma wa recommended endoscopic treatment such a endoscopic mucosal resection or endoscopic submucosal dissection is useful for those lesion however surgical resection with lymph node dissection might be indicated when ssaps with invasive carcinoma are endoscopically suspected because these have the high risk of lymph node metastasis greater awareness may promote further research into improving the detection recognition and complete resection rate of ssaps with dysplasia or invasive carcinoma and reduce the interval cancer rate,Cancer,0,clinicopathological feature diagnosis and treatment of sessile serrated adenomapolyp with dysplasiacarcinoma sessile serrated adenomapolyps ssaps are early precursor lesion in the serrated neoplasia pathway which result in brafmutated colorectal carcinoma with not only high level of microsatellite instability but also microsatellite stable ssaps with advanced histology including cytological dysplasia or minimally invasive carcinoma are important lesion because ssaps are considered major contributor to interval cancer and these lesion can rapidly become dysplastic or invasive carcinoma clinicopathologically ssaps with dysplasia or invasive carcinoma were associated with advanced age female sex and proximal colon although ssaps with submucosal invasive carcinoma were smaller and invaded less deeply into the submucosal layer than conventional tubular adenoma with submucosal invasive carcinoma ssaps with submucosal invasive carcinoma frequently had a mucinous component and exhibited a higher potential for lymphatic invasion and lymph node metastasis in an ssap series endoscopic characteristic including semipedunculated morphology double elevation central depression and reddishness may help accurately diagnose ssaps with advanced histology removal of ssaps with dysplasia or invasive carcinoma wa recommended endoscopic treatment such a endoscopic mucosal resection or endoscopic submucosal dissection is useful for those lesion however surgical resection with lymph node dissection might be indicated when ssaps with invasive carcinoma are endoscopically suspected because these have the high risk of lymph node metastasis greater awareness may promote further research into improving the detection recognition and complete resection rate of ssaps with dysplasia or invasive carcinoma and reduce the interval cancer rate
31160360,elucidating a falsenegative myc breakapart fluorescence in situ hybridization probe study by nextgeneration sequencing in a patient with highgrade bcell lymphoma with ighmyc and ighbcl rearrangement,the identification of myc rearrangement in several mature bcell neoplasm is critical for diagnostic and prognostic purpose commercially available fluorescence in situ hybridization fish probe set including ighmyc dualcolor dualfusion dfish and myc breakapart probe bap serve a the primary methodology utilized to detect myc rearrangement however performing either ighmyc dfish or myc bap fish study in isolation ha been reported to result in falsenegative result because of the complex nature of q rearrangement involving the myc gene region we report a yrold male with newly diagnosed highgrade bcell lymphoma with a negative myc bap study but with positive bcl and bcl bap study per our current laboratory algorithm to concurrently interrogate the myc gene region with both myc bap and ighmyc dfish probe set we performed ighmyc dfish study and detected an ighmyc fusion to further characterize the discrepant myc result obtained by fish a nextgeneration sequencing strategy matepair sequencing mpseq wa performed and revealed a small insertion kb of the igh locus downstream from the myc gene that wa undetectable by myc bap study this case highlight the importance of utilizing both ighmyc dfish and myc bap set to detect potential cryptic myc rearrangement and also demonstrates the power of mpseq to characterize complex structural rearrangement and copynumber abnormality unappreciable by fish,Cancer,0,elucidating a falsenegative myc breakapart fluorescence in situ hybridization probe study by nextgeneration sequencing in a patient with highgrade bcell lymphoma with ighmyc and ighbcl rearrangement the identification of myc rearrangement in several mature bcell neoplasm is critical for diagnostic and prognostic purpose commercially available fluorescence in situ hybridization fish probe set including ighmyc dualcolor dualfusion dfish and myc breakapart probe bap serve a the primary methodology utilized to detect myc rearrangement however performing either ighmyc dfish or myc bap fish study in isolation ha been reported to result in falsenegative result because of the complex nature of q rearrangement involving the myc gene region we report a yrold male with newly diagnosed highgrade bcell lymphoma with a negative myc bap study but with positive bcl and bcl bap study per our current laboratory algorithm to concurrently interrogate the myc gene region with both myc bap and ighmyc dfish probe set we performed ighmyc dfish study and detected an ighmyc fusion to further characterize the discrepant myc result obtained by fish a nextgeneration sequencing strategy matepair sequencing mpseq wa performed and revealed a small insertion kb of the igh locus downstream from the myc gene that wa undetectable by myc bap study this case highlight the importance of utilizing both ighmyc dfish and myc bap set to detect potential cryptic myc rearrangement and also demonstrates the power of mpseq to characterize complex structural rearrangement and copynumber abnormality unappreciable by fish
31163629,prostaglandin emajor urinary metabolite pgemum a a tumor marker for lung adenocarcinoma,background prostaglandin e pge is metabolized to prostaglandin emajor urinary metabolite pgemum enhanced cyclooxygenase cox expression demonstrated in lung adenocarcinoma indicates increased pgemum level in patient with lung adenocarcinoma objective we aimed to elucidate the clinical usefulness of measuring pgemum a an indicator of tumor burden in patient with lung adenocarcinoma method pgemum wa measured by a radioimmunoassay in control healthy volunteer n and patient with lung adenocarcinoma n association between pgemum level and clinical characteristic of the patient including lung cancer stage and tnm factor t tumor n node m metastasis were examined result pgemum level were significantly elevated in patient with lung adenocarcinoma a pgemum level of mugg cr showed sensitivity and specificity for the diagnosis of lung adenocarcinoma pgemum level tended to be positively correlated with cancer progression a determined by the tnm staging system advanced stage stage iii stage iv and recurrence wa significantly associated with high pgemum level by logistic regression analysis no apparent correlation wa demonstrated between pgemum and carcinoma embryonic antigen cea level conclusion pgemum can be a promising biomarker reflecting the systemic tumor burden of lung adenocarcinoma,Cancer,0,prostaglandin emajor urinary metabolite pgemum a a tumor marker for lung adenocarcinoma background prostaglandin e pge is metabolized to prostaglandin emajor urinary metabolite pgemum enhanced cyclooxygenase cox expression demonstrated in lung adenocarcinoma indicates increased pgemum level in patient with lung adenocarcinoma objective we aimed to elucidate the clinical usefulness of measuring pgemum a an indicator of tumor burden in patient with lung adenocarcinoma method pgemum wa measured by a radioimmunoassay in control healthy volunteer n and patient with lung adenocarcinoma n association between pgemum level and clinical characteristic of the patient including lung cancer stage and tnm factor t tumor n node m metastasis were examined result pgemum level were significantly elevated in patient with lung adenocarcinoma a pgemum level of mugg cr showed sensitivity and specificity for the diagnosis of lung adenocarcinoma pgemum level tended to be positively correlated with cancer progression a determined by the tnm staging system advanced stage stage iii stage iv and recurrence wa significantly associated with high pgemum level by logistic regression analysis no apparent correlation wa demonstrated between pgemum and carcinoma embryonic antigen cea level conclusion pgemum can be a promising biomarker reflecting the systemic tumor burden of lung adenocarcinoma
31164383,idiopathic myelofibrosis causing inflammatory central retinal vein occlusion mimicking frosted branch angiitis,primary idiopathic myelofibrosis is a clonal disorder arising from the neoplastic transformation of early haematopoietic stem cell leading to abnormal fibrous tissue within bone marrow we present a yearold man complaining of sudden loss of vision in the right eye along with multiple superficial retinal haemorrhage and perivascular infiltration fundus fluorescein angiography and optical coherence tomography confirmed the diagnosis of inflammatory central retinal vein occlusion with macular oedema which mimicked frosted branch angiitis laboratory test and bone marrow biopsy confirmed underlying systemic disease to be janus kinase mutation positive primary idiopathic myelofibrosis he received one intravitreal injection of antivascular endothelial growth factor along with dexamethasone for his ocular condition in view of his systemic disease he wa started on systemic chemotherapy and oral corticosteroid which helped in stabilising the eye condition,Cancer,0,idiopathic myelofibrosis causing inflammatory central retinal vein occlusion mimicking frosted branch angiitis primary idiopathic myelofibrosis is a clonal disorder arising from the neoplastic transformation of early haematopoietic stem cell leading to abnormal fibrous tissue within bone marrow we present a yearold man complaining of sudden loss of vision in the right eye along with multiple superficial retinal haemorrhage and perivascular infiltration fundus fluorescein angiography and optical coherence tomography confirmed the diagnosis of inflammatory central retinal vein occlusion with macular oedema which mimicked frosted branch angiitis laboratory test and bone marrow biopsy confirmed underlying systemic disease to be janus kinase mutation positive primary idiopathic myelofibrosis he received one intravitreal injection of antivascular endothelial growth factor along with dexamethasone for his ocular condition in view of his systemic disease he wa started on systemic chemotherapy and oral corticosteroid which helped in stabilising the eye condition
31164412,tcell deletion of myd connects il and ikappabzeta to ra oncogenesis,cancer development requires a favorable tissue microenvironment by deleting myd in keratinocytes or specific bone marrow subpopulation in oncogenic rasmediated skin carcinogenesis we show that il from infiltrating t cell and ikappabzeta signaling in keratinocytes are essential to produce a permissive microenvironment and tumor formation both normal and rastransformed keratinocytes respond to tumor promoter by activating canonical nfkappab and ikappabzeta signaling releasing specific cytokine and chemokines that attract th cell through myddependent signaling in t cell the release of il into the microenvironment elevates ikappabzeta in normal and rastransformed keratinocytes activation of ikappabzeta signaling is required for the expression of specific promoting factor induced by il in normal keratinocytes and constitutively expressed in rasinitiated keratinocytes deletion of nfkbiz in keratinocytes impairs rasmediated benign tumor formation transcriptional profiling and gene set enrichment analysis of ikappabzetadeficient rasinitiated keratinocytes indicate that ikappabzeta signaling is common for ra transformation of multiple epithelial cancer probing the cancer genome atlas datasets using this transcriptional profile indicates that reduction of ikappabzeta signaling during cancer progression associate with poor prognosis in rasdriven human cancer implication the paradox that elevation of ikappabzeta and stimulation of ikappabzeta signaling through tumor extrinsic factor is required for rasmediated benign tumor formation while relative ikappabzeta expression is reduced in advanced cancer with poor prognosis implies that tumor cell switch from microenvironmental dependency early in carcinogenesis to cellautonomous pathway during cancer progression,Cancer,0,tcell deletion of myd connects il and ikappabzeta to ra oncogenesis cancer development requires a favorable tissue microenvironment by deleting myd in keratinocytes or specific bone marrow subpopulation in oncogenic rasmediated skin carcinogenesis we show that il from infiltrating t cell and ikappabzeta signaling in keratinocytes are essential to produce a permissive microenvironment and tumor formation both normal and rastransformed keratinocytes respond to tumor promoter by activating canonical nfkappab and ikappabzeta signaling releasing specific cytokine and chemokines that attract th cell through myddependent signaling in t cell the release of il into the microenvironment elevates ikappabzeta in normal and rastransformed keratinocytes activation of ikappabzeta signaling is required for the expression of specific promoting factor induced by il in normal keratinocytes and constitutively expressed in rasinitiated keratinocytes deletion of nfkbiz in keratinocytes impairs rasmediated benign tumor formation transcriptional profiling and gene set enrichment analysis of ikappabzetadeficient rasinitiated keratinocytes indicate that ikappabzeta signaling is common for ra transformation of multiple epithelial cancer probing the cancer genome atlas datasets using this transcriptional profile indicates that reduction of ikappabzeta signaling during cancer progression associate with poor prognosis in rasdriven human cancer implication the paradox that elevation of ikappabzeta and stimulation of ikappabzeta signaling through tumor extrinsic factor is required for rasmediated benign tumor formation while relative ikappabzeta expression is reduced in advanced cancer with poor prognosis implies that tumor cell switch from microenvironmental dependency early in carcinogenesis to cellautonomous pathway during cancer progression
31165234,complexity of pecomas diagnostic approach molecular background clinical management german version,perivascular epithelioid cell neoplasm pecomas are a family of mesenchymal neoplasm with feature of both melanotic and smooth muscle differentiation pecoma morphology is highly variable and encompasses epithelioid to spindle cell often with clear cytoplasm and prominent nucleolus molecularly most pecomas are defined by a loss of function of the tsctsc complex additionally a distinct small subset of pecomas harboring rearrangement of the tfe xp gene locus ha been identified by presenting a series of three case report with distinct feature we demonstrate diagnostic pitfall a well a the importance of molecular workup of pecomas because of important therapeutic consequence,Cancer,0,complexity of pecomas diagnostic approach molecular background clinical management german version perivascular epithelioid cell neoplasm pecomas are a family of mesenchymal neoplasm with feature of both melanotic and smooth muscle differentiation pecoma morphology is highly variable and encompasses epithelioid to spindle cell often with clear cytoplasm and prominent nucleolus molecularly most pecomas are defined by a loss of function of the tsctsc complex additionally a distinct small subset of pecomas harboring rearrangement of the tfe xp gene locus ha been identified by presenting a series of three case report with distinct feature we demonstrate diagnostic pitfall a well a the importance of molecular workup of pecomas because of important therapeutic consequence
31167492,liquid biopsy for ovarian carcinoma how blood test may improve the clinical management of a deadly disease,ovarian cancer ovc are frequent with more than new case each year for death in the united state except for patient with brca or brca mutation diagnostic method prognostic tool and therapeutic strategy have not much improved in the last two decade high throughput tumor molecular analysis have identified important alteration involved in ovarian carcinoma growth and spreading however these data have not modified the clinical management of most of patient moreover tumor sample collection requires invasive procedure not adapted to objective such a the screening prediction or assessment of treatment efficacy monitoring of residual disease and early diagnosis of relapse in recent year circulating tumor biomarkers also known a liquid biopsy such a circulating tumor cell circulating nucleotide dna or mirna or extracellular vesicle have been massively explored through various indication platform and goal but their use ha not yet been validated in routine practice this review describes the method of analysis and result related to liquid biopsy for ovarian epithelial cancer the different setting that a patient can go through during her journey with ovc are explored screening and early diagnosis prognosis prediction of response to systemic therapy for advanced stage and monitoring of residual subclinical disease,Cancer,0,liquid biopsy for ovarian carcinoma how blood test may improve the clinical management of a deadly disease ovarian cancer ovc are frequent with more than new case each year for death in the united state except for patient with brca or brca mutation diagnostic method prognostic tool and therapeutic strategy have not much improved in the last two decade high throughput tumor molecular analysis have identified important alteration involved in ovarian carcinoma growth and spreading however these data have not modified the clinical management of most of patient moreover tumor sample collection requires invasive procedure not adapted to objective such a the screening prediction or assessment of treatment efficacy monitoring of residual disease and early diagnosis of relapse in recent year circulating tumor biomarkers also known a liquid biopsy such a circulating tumor cell circulating nucleotide dna or mirna or extracellular vesicle have been massively explored through various indication platform and goal but their use ha not yet been validated in routine practice this review describes the method of analysis and result related to liquid biopsy for ovarian epithelial cancer the different setting that a patient can go through during her journey with ovc are explored screening and early diagnosis prognosis prediction of response to systemic therapy for advanced stage and monitoring of residual subclinical disease
31167998,acute myeloid leukemia evolving from kit dmutated systemic mastocytosis relapsing two month after completion of chemotherapy,here we report the case of a yearold girl with acute myeloid leukemia aml developed from systemic mastocytosis sm she experienced bladder and rectal disturbance due to an extramedullary nodule in the paraspinal region of the sacrum cytogenetic and genetic analysis of leukemic cell revealed the kit dy mutation besides t qq runxrunxt despite receiving proton beam therapy after conventional chemotherapy the patient relapsed after month a smaml with the kit d mutation in adult exhibit a poor prognosis hematopoietic stem cell transplantation is recommended owing to a few report of smaml in child the standard therapy for pediatric case ha not been established to date based on our experience and the related literature the prognosis of childhood smaml could be a poor a in adult hence further investigation including mutational analysis of the kit gene is warranted to establish a riskoriented strategy for managing childhood smaml,Cancer,0,acute myeloid leukemia evolving from kit dmutated systemic mastocytosis relapsing two month after completion of chemotherapy here we report the case of a yearold girl with acute myeloid leukemia aml developed from systemic mastocytosis sm she experienced bladder and rectal disturbance due to an extramedullary nodule in the paraspinal region of the sacrum cytogenetic and genetic analysis of leukemic cell revealed the kit dy mutation besides t qq runxrunxt despite receiving proton beam therapy after conventional chemotherapy the patient relapsed after month a smaml with the kit d mutation in adult exhibit a poor prognosis hematopoietic stem cell transplantation is recommended owing to a few report of smaml in child the standard therapy for pediatric case ha not been established to date based on our experience and the related literature the prognosis of childhood smaml could be a poor a in adult hence further investigation including mutational analysis of the kit gene is warranted to establish a riskoriented strategy for managing childhood smaml
31168000,latent essential thrombocythemia becoming perceptible after splenectomy,a yearold male wa admitted to our hospital because of left hypochondrium part pain and wa diagnosed with splenomegaly with splenic infarction in may his complete blood cell count wa almost within normal limit and a bone marrow biopsy revealed normal cellularity with no fibrosis in addition no abnormal uptake wa noted on fdg petct in august he underwent splenectomy for splenomegaly the histological examination revealed fibrotic stenosis of the blood vessel in the spleen after splenectomy his platelet count elevated and remained at xl month later finally he wa diagnosed with latent essential thrombocythemia et because the jakvf mutation wa positive accordingly oral hydroxyurea wa initiated thrombosis could be a complication in myeloproliferative neoplasm mpn in our case et wa masked perhaps because of hypersplenism and splenomegaly because of splenic vein thrombosis hence examination of the jakvf mutation in patient with splanchnic vein thrombosis is recommended because of the possibility of latent mpn,Cancer,0,latent essential thrombocythemia becoming perceptible after splenectomy a yearold male wa admitted to our hospital because of left hypochondrium part pain and wa diagnosed with splenomegaly with splenic infarction in may his complete blood cell count wa almost within normal limit and a bone marrow biopsy revealed normal cellularity with no fibrosis in addition no abnormal uptake wa noted on fdg petct in august he underwent splenectomy for splenomegaly the histological examination revealed fibrotic stenosis of the blood vessel in the spleen after splenectomy his platelet count elevated and remained at xl month later finally he wa diagnosed with latent essential thrombocythemia et because the jakvf mutation wa positive accordingly oral hydroxyurea wa initiated thrombosis could be a complication in myeloproliferative neoplasm mpn in our case et wa masked perhaps because of hypersplenism and splenomegaly because of splenic vein thrombosis hence examination of the jakvf mutation in patient with splanchnic vein thrombosis is recommended because of the possibility of latent mpn
31168257,surgical management of carcinoma vulvacase series and review of literature,the objective of this study wa to study the risk factor management protocol and the outcome of vulvar cancer case over a period of year in a tertiary care hospital this is a case series of earlystage vulvar cancer in the department of surgical oncology in bl kapur superspeciality hospital from jan to date five patient with histologically proven diagnosis of earlystage vulvar cancer were included the mean age for the diagnosis of vulvar cancer wa year and the peak incidence wa seen in postmenopausal age group all of the case were squamous cell carcinoma in stage ib except one which wa a basisquamous variant all case were treated primarily with surgery and vulvar flap reconstruction adjuvant therapy wa not given in any case case were followed from month to date and no recurrence noted the limitation of the study were rarity of disease and less number of case a all the case in our study were in early stage of disease stage i and ii surgical treatment in the form of modified radical vulvectomy with bl inguinofemoral lymph node dissection and oncoplastic procedure wa the treatment modality chosen for all the patient,Cancer,0,surgical management of carcinoma vulvacase series and review of literature the objective of this study wa to study the risk factor management protocol and the outcome of vulvar cancer case over a period of year in a tertiary care hospital this is a case series of earlystage vulvar cancer in the department of surgical oncology in bl kapur superspeciality hospital from jan to date five patient with histologically proven diagnosis of earlystage vulvar cancer were included the mean age for the diagnosis of vulvar cancer wa year and the peak incidence wa seen in postmenopausal age group all of the case were squamous cell carcinoma in stage ib except one which wa a basisquamous variant all case were treated primarily with surgery and vulvar flap reconstruction adjuvant therapy wa not given in any case case were followed from month to date and no recurrence noted the limitation of the study were rarity of disease and less number of case a all the case in our study were in early stage of disease stage i and ii surgical treatment in the form of modified radical vulvectomy with bl inguinofemoral lymph node dissection and oncoplastic procedure wa the treatment modality chosen for all the patient
31169702,intrahepatic adrenocortical adenoma arising from adrenohepatic fusion mimicking hepatic malignancy two case report,rationale intrahepatic adrenocortical adenoma iaa arising from adrenohepatic fusion ahf is rare and it imaging finding are not well established moreover it is easily misdiagnosed a malignant hepatic tumor in patient at risk of malignancy it key finding is the connection between the tumor and adrenal gland when iaa from ahf is suspected biopsy should be considered to avoid unnecessary surgery herein we report case of iaa from ahf patient concern a yearold woman wa admitted due to a cm hypoechoic nodule in the right hepatic lobe detected on ultrasound for hepatocellular carcinoma hcc surveillance due to chronic hepatitis b contrastenhanced computed tomography ct and gadoxetic acidenhanced magnetic resonance imaging mri were performed to evaluate the hepatic mass another yearold woman wa admitted due to rectal adenocarcinoma detected on colonoscopy contrastenhanced ct depicted a cm mass in the right hepatic lobe diagnosis in case ct and mri showed a cm subcapsular mass in the right hepatic lobe with typical finding of hcc in a patient with chronic hepatitis b the mass wa confirmed a iaa from ahf after the laparoscopic surgery in case ct showed advanced rectal malignancy and a cm poorly enhancing mass in the right hepatic lobe the tentative diagnosis wa hepatic metastasis however based on the connection between the tumor and adrenal gland during preoperative review the presumed diagnosis wa changed to iaa from ahf which wa confirmed on biopsy intervention the hepatic mass connected with the right adrenal gland wa laparoscopically resected in case laparoscopic lower anterior resection for rectal malignancy and percutaneous biopsy for the hepatic mass were performed in case outcome the first patient had an uneventful recovery without recurrence on the year followup ct the second patient had an uneventful postoperative course and ha been alive for month postoperatively without pathologically proven iaa change on followup ct lesson when hepatic mass is found adjacent to the right adrenal gland on imaging the connection between the tumor and adrenal gland should be investigated when iaa arising from ahf is suspected biopsy should be considered to avoid unnecessary surgery,Cancer,0,intrahepatic adrenocortical adenoma arising from adrenohepatic fusion mimicking hepatic malignancy two case report rationale intrahepatic adrenocortical adenoma iaa arising from adrenohepatic fusion ahf is rare and it imaging finding are not well established moreover it is easily misdiagnosed a malignant hepatic tumor in patient at risk of malignancy it key finding is the connection between the tumor and adrenal gland when iaa from ahf is suspected biopsy should be considered to avoid unnecessary surgery herein we report case of iaa from ahf patient concern a yearold woman wa admitted due to a cm hypoechoic nodule in the right hepatic lobe detected on ultrasound for hepatocellular carcinoma hcc surveillance due to chronic hepatitis b contrastenhanced computed tomography ct and gadoxetic acidenhanced magnetic resonance imaging mri were performed to evaluate the hepatic mass another yearold woman wa admitted due to rectal adenocarcinoma detected on colonoscopy contrastenhanced ct depicted a cm mass in the right hepatic lobe diagnosis in case ct and mri showed a cm subcapsular mass in the right hepatic lobe with typical finding of hcc in a patient with chronic hepatitis b the mass wa confirmed a iaa from ahf after the laparoscopic surgery in case ct showed advanced rectal malignancy and a cm poorly enhancing mass in the right hepatic lobe the tentative diagnosis wa hepatic metastasis however based on the connection between the tumor and adrenal gland during preoperative review the presumed diagnosis wa changed to iaa from ahf which wa confirmed on biopsy intervention the hepatic mass connected with the right adrenal gland wa laparoscopically resected in case laparoscopic lower anterior resection for rectal malignancy and percutaneous biopsy for the hepatic mass were performed in case outcome the first patient had an uneventful recovery without recurrence on the year followup ct the second patient had an uneventful postoperative course and ha been alive for month postoperatively without pathologically proven iaa change on followup ct lesson when hepatic mass is found adjacent to the right adrenal gland on imaging the connection between the tumor and adrenal gland should be investigated when iaa arising from ahf is suspected biopsy should be considered to avoid unnecessary surgery
31171119,hereditary cancer syndromesa primer on diagnosis and management part breastovarian cancer syndrome,cancer is the second leading cause of death in both men and woman in the united state with colorectal cancer and breast cancer being two of the most frequent cancer type hereditary cause occurring due to pathogenic sequence variant and defect in certain gene make up roughly of all colorectal cancer and breastovarian cancer highrisk hereditary predisposition syndrome have been associated with a substantially increased lifetime risk for the development of colorectal cancer and breastovarian cancer depending on the genetic syndrome and many people also carry an increased risk of several other cancer compared with the general population the aim of this review wa to provide comprehensive literature on the most commonly encountered hereditary predisposition syndrome including lynch syndrome familial adenomatous polyposis mutyhassociated polyposis hamartomatous polyposis and breastovarian cancer condition this will be presented a a part series the first part will cover the breastovarian cancer syndrome and the second will focus on the inherited colorectal cancer and polyposis condition,Cancer,0,hereditary cancer syndromesa primer on diagnosis and management part breastovarian cancer syndrome cancer is the second leading cause of death in both men and woman in the united state with colorectal cancer and breast cancer being two of the most frequent cancer type hereditary cause occurring due to pathogenic sequence variant and defect in certain gene make up roughly of all colorectal cancer and breastovarian cancer highrisk hereditary predisposition syndrome have been associated with a substantially increased lifetime risk for the development of colorectal cancer and breastovarian cancer depending on the genetic syndrome and many people also carry an increased risk of several other cancer compared with the general population the aim of this review wa to provide comprehensive literature on the most commonly encountered hereditary predisposition syndrome including lynch syndrome familial adenomatous polyposis mutyhassociated polyposis hamartomatous polyposis and breastovarian cancer condition this will be presented a a part series the first part will cover the breastovarian cancer syndrome and the second will focus on the inherited colorectal cancer and polyposis condition
31171120,hereditary cancer syndromesa primer on diagnosis and management part gastrointestinal cancer syndrome,hereditary cause due to mutation and defect in certain gene account for roughly to of all colorectal cancer these inherited syndrome have been associated with a to lifetime risk for development of colorectal cancer depending on the genetic syndrome and many also carry an increased risk for multiple extracolonic malignancy in this second part of a review series on hereditary cancer syndrome the focus will be to provide guidance on the feature and management of the most commonly encountered hereditary colorectal cancer and polyposis condition including lynch syndrome familial adenomatous polyposis mutyhassociated polyposis and hamartomatous polyposis,Cancer,0,hereditary cancer syndromesa primer on diagnosis and management part gastrointestinal cancer syndrome hereditary cause due to mutation and defect in certain gene account for roughly to of all colorectal cancer these inherited syndrome have been associated with a to lifetime risk for development of colorectal cancer depending on the genetic syndrome and many also carry an increased risk for multiple extracolonic malignancy in this second part of a review series on hereditary cancer syndrome the focus will be to provide guidance on the feature and management of the most commonly encountered hereditary colorectal cancer and polyposis condition including lynch syndrome familial adenomatous polyposis mutyhassociated polyposis and hamartomatous polyposis
31177117,overexpression of galectin in chronic lymphocytic leukemia is associated with p deletion a short report,backgroundaim galectins belong to the family of galactosebinding protein known to play an important role in the process of cell proliferation differentiation migration and neoplastic progression herein we studied the expression of galectin gal in chronic lymphocytic leukemia cll material and method the expression of gal wa analyzed by mean of multiparametric flow cytometry in normal and pathological bcells from peripheral blood and bone marrow sample of patient with cll result pathological bcells expressed significantly higher level of cytoplasmic gal than normal bcells moreover overexpression of cytoplasmic gal wa observed in the prognostically poorest subgroup of cll patient namely those with p deletion conclusion our result indicate a possible role of galectin in cll pathophysiology and it potential value a a prognostic marker and therapeutic target,Cancer,0,overexpression of galectin in chronic lymphocytic leukemia is associated with p deletion a short report backgroundaim galectins belong to the family of galactosebinding protein known to play an important role in the process of cell proliferation differentiation migration and neoplastic progression herein we studied the expression of galectin gal in chronic lymphocytic leukemia cll material and method the expression of gal wa analyzed by mean of multiparametric flow cytometry in normal and pathological bcells from peripheral blood and bone marrow sample of patient with cll result pathological bcells expressed significantly higher level of cytoplasmic gal than normal bcells moreover overexpression of cytoplasmic gal wa observed in the prognostically poorest subgroup of cll patient namely those with p deletion conclusion our result indicate a possible role of galectin in cll pathophysiology and it potential value a a prognostic marker and therapeutic target
31177124,paraoxonase pon qr and lm polymorphism a potential predisposition factor for chronic lymphocytic leukemia,backgroundaim pon gene ha an executive role in antioxidant defense protecting cell from genotoxic factor qr and lm pon polymorphism reduce catalytic activity of the encoded protein these polymorphism were studied in chronic lymphocytic leukemia cll patient and healthy donor they were also associated with patient cytogenetic finding to investigate their possible implication in cll pathogenesis material and method snp genotyping wa performed using polymerase chain reactionrestriction fragment length polymorphism pcrrflp assay karyotypic analysis wa also performed by chromosome gbanding analysis and fluorescence in situ hybridization result genotypic and allelic distribution of qr polymorphism showed a statistically significant higher frequency of mutant genotype and mutant allele in patient compared to control the same observation wa noted in patient with abnormal karyotype and those carrying abnq and delq a statistically increased frequency for the mutant allele wa also revealed in patient with delq on the contrary lm polymorphism showed a similar distribution between patient and control conclusion qr polymorphism play a role in cll predisposition and the formation of specific chromosomal aberration,Cancer,0,paraoxonase pon qr and lm polymorphism a potential predisposition factor for chronic lymphocytic leukemia backgroundaim pon gene ha an executive role in antioxidant defense protecting cell from genotoxic factor qr and lm pon polymorphism reduce catalytic activity of the encoded protein these polymorphism were studied in chronic lymphocytic leukemia cll patient and healthy donor they were also associated with patient cytogenetic finding to investigate their possible implication in cll pathogenesis material and method snp genotyping wa performed using polymerase chain reactionrestriction fragment length polymorphism pcrrflp assay karyotypic analysis wa also performed by chromosome gbanding analysis and fluorescence in situ hybridization result genotypic and allelic distribution of qr polymorphism showed a statistically significant higher frequency of mutant genotype and mutant allele in patient compared to control the same observation wa noted in patient with abnormal karyotype and those carrying abnq and delq a statistically increased frequency for the mutant allele wa also revealed in patient with delq on the contrary lm polymorphism showed a similar distribution between patient and control conclusion qr polymorphism play a role in cll predisposition and the formation of specific chromosomal aberration
31177126,targeted genomic sequencing reveals novel tp inframe deletion mutation leading to p overexpression in highgrade serous tuboovarian carcinoma,backgroundaim highgrade serous carcinoma hgsc is the most common histological subtype of ovarian carcinoma somatic mutation of tumor protein tp is a hallmark of tuboovarian hgsc and is observed in almost all such case highly sensitive targeted genomic sequencing can be used to identify novel mutation that may become potential druggable target and aid in therapeutic decision the aim of this study wa to describe the clinicopathological and molecular characteristic of hgscs with novel somatic tp mutation identified by nextgeneration sequencing ng material and method a commercial ng panel comprising gene including tp wa used to analyze the genetic profile of ovarian carcinoma case the clinicopathological characteristic and p immunostaining result of two hgscs exhibiting novel tp mutation were investigated result eightyeight out of ovarian carcinoma case were diagnosed a hgsc novel tp inframe deletion mutation cdelgttcctgca p psercysdel and cdeltttcgacat p pfhdel were detected in a single case of hgsc each both patient were postmenopausal woman imaging and laboratory study revealed peritoneal carcinomatosis and elevated level of serum tumor marker the patient underwent primary debulking surgery and were diagnosed a having stage iiic hgsc in both case p immunostaining revealed uniform nuclear immunoreactivity in or more of tumor cell at a very strong intensity conclusion targeted genomic sequencing revealed novel inframe deletion mutation of tp leading to p overexpression in tuboovarian hgsc this discovery of previously unreported somatic tp mutation provides insight into the translation of ng technology into personalized medicine and identifies new potential target for therapeutic application,Cancer,0,targeted genomic sequencing reveals novel tp inframe deletion mutation leading to p overexpression in highgrade serous tuboovarian carcinoma backgroundaim highgrade serous carcinoma hgsc is the most common histological subtype of ovarian carcinoma somatic mutation of tumor protein tp is a hallmark of tuboovarian hgsc and is observed in almost all such case highly sensitive targeted genomic sequencing can be used to identify novel mutation that may become potential druggable target and aid in therapeutic decision the aim of this study wa to describe the clinicopathological and molecular characteristic of hgscs with novel somatic tp mutation identified by nextgeneration sequencing ng material and method a commercial ng panel comprising gene including tp wa used to analyze the genetic profile of ovarian carcinoma case the clinicopathological characteristic and p immunostaining result of two hgscs exhibiting novel tp mutation were investigated result eightyeight out of ovarian carcinoma case were diagnosed a hgsc novel tp inframe deletion mutation cdelgttcctgca p psercysdel and cdeltttcgacat p pfhdel were detected in a single case of hgsc each both patient were postmenopausal woman imaging and laboratory study revealed peritoneal carcinomatosis and elevated level of serum tumor marker the patient underwent primary debulking surgery and were diagnosed a having stage iiic hgsc in both case p immunostaining revealed uniform nuclear immunoreactivity in or more of tumor cell at a very strong intensity conclusion targeted genomic sequencing revealed novel inframe deletion mutation of tp leading to p overexpression in tuboovarian hgsc this discovery of previously unreported somatic tp mutation provides insight into the translation of ng technology into personalized medicine and identifies new potential target for therapeutic application
31178200,diagnosis and prognosis of canine cutaneous mast cell tumor,canine cutaneous mast cell tumor mcts are among the most common canine cutaneous tumor with highly variable biological behavior this review describes in detail current approach for cytologic and histologic diagnosis and prognosis including advantage and limitation of cytologic and histologic grading and utilization of molecular marker for example ki agnors kit expression and ckit mutation for a more accurate detection of aggressive mcts furthermore the current approach to evaluate surgical margin and spread to local lymph node is discussed,Cancer,0,diagnosis and prognosis of canine cutaneous mast cell tumor canine cutaneous mast cell tumor mcts are among the most common canine cutaneous tumor with highly variable biological behavior this review describes in detail current approach for cytologic and histologic diagnosis and prognosis including advantage and limitation of cytologic and histologic grading and utilization of molecular marker for example ki agnors kit expression and ckit mutation for a more accurate detection of aggressive mcts furthermore the current approach to evaluate surgical margin and spread to local lymph node is discussed
31181727,zbtb spdef and etv novel potential biomarkers and therapeutic target in castrationresistant prostate cancer,prostate cancer pca is the second most common killer among men in western country targeting androgen receptor ar signaling by androgen deprivation therapy adt is the current therapeutic regime for patient newly diagnosed with metastatic pca however most patient relapse and become resistant to adt leading to metastatic castrationresistant pca crpc and eventually death several proposed mechanism have been proposed for crpc however the exact mechanism through which crpc develops is still unclear one possible pathway is that the ar remains active in crpc case therefore understanding ar signaling network a primary pca change into metastatic crpc is key to developing future biomarkers and therapeutic strategy for pca and crpc in the current review we focused on three novel biomarkers zbtb spdef and etv that were demonstrated to play critical role in crpc progression epidermal growth factor receptor tyrosine kinase inhibitor egfr tki drug resistance and the epithelialtomesenchymal transition emt for patient treated with adt or ar inhibition in addition we summarize how these potential biomarkers can be used in the clinic for diagnosis and a therapeutic target of pca,Cancer,0,zbtb spdef and etv novel potential biomarkers and therapeutic target in castrationresistant prostate cancer prostate cancer pca is the second most common killer among men in western country targeting androgen receptor ar signaling by androgen deprivation therapy adt is the current therapeutic regime for patient newly diagnosed with metastatic pca however most patient relapse and become resistant to adt leading to metastatic castrationresistant pca crpc and eventually death several proposed mechanism have been proposed for crpc however the exact mechanism through which crpc develops is still unclear one possible pathway is that the ar remains active in crpc case therefore understanding ar signaling network a primary pca change into metastatic crpc is key to developing future biomarkers and therapeutic strategy for pca and crpc in the current review we focused on three novel biomarkers zbtb spdef and etv that were demonstrated to play critical role in crpc progression epidermal growth factor receptor tyrosine kinase inhibitor egfr tki drug resistance and the epithelialtomesenchymal transition emt for patient treated with adt or ar inhibition in addition we summarize how these potential biomarkers can be used in the clinic for diagnosis and a therapeutic target of pca
31182807,the deubiquitinase otub control the activation of cd t cell and nk cell by regulating ilmediated priming,cd t cell and natural killer nk cell are central cellular component of immune response against pathogen and cancer which rely on interleukin il for homeostasis here we show that il also mediates homeostatic priming of cd t cell for antigenstimulated activation which is controlled by a deubiquitinase otub il mediates membrane recruitment of otub which inhibits ubiquitindependent activation of akt a kinase that is pivotal for t cell activation and metabolism otub deficiency in mouse cause aberrant response of cd t cell to il rendering naive cd t cell hypersensitive to antigen stimulation characterized by enhanced metabolic reprograming and effector function otub also control the maturation and activation of nk cell deletion of otub profoundly enhances anticancer immunity by unleashing the activity of cd t cell and nk cell these finding suggest that otub control the activation of cd t cell and nk cell by functioning a a checkpoint of ilmediated priming,Cancer,0,the deubiquitinase otub control the activation of cd t cell and nk cell by regulating ilmediated priming cd t cell and natural killer nk cell are central cellular component of immune response against pathogen and cancer which rely on interleukin il for homeostasis here we show that il also mediates homeostatic priming of cd t cell for antigenstimulated activation which is controlled by a deubiquitinase otub il mediates membrane recruitment of otub which inhibits ubiquitindependent activation of akt a kinase that is pivotal for t cell activation and metabolism otub deficiency in mouse cause aberrant response of cd t cell to il rendering naive cd t cell hypersensitive to antigen stimulation characterized by enhanced metabolic reprograming and effector function otub also control the maturation and activation of nk cell deletion of otub profoundly enhances anticancer immunity by unleashing the activity of cd t cell and nk cell these finding suggest that otub control the activation of cd t cell and nk cell by functioning a a checkpoint of ilmediated priming
31182949,lack of response to vemurafenib in melanoma carrying braf ke mutation,vemurafenib ha been developed to target common braf mutation ve it also exerts activity towards some but not all rare braf substitution proper cataloguing of drugsensitive and insensitive rare mutation remains a challenge due to low occurrence of these event and inability of commercial pcrbased diagnostic kit to detect the full spectrum of braf gene lesion we considered the result of braf exon testing in consecutive melanoma patient braf mutation wa identified in case while drugsensitive codon substitution constituted the majority of braf gene lesion ve vk vr the fourth common braf allele wa ke accounting for melanoma case the data on braf inhibitor sensitivity of tumor with ke substitution are scarce we administered singleagent vemurafenib to a melanoma patient carrying braf ke mutation a the firstline treatment unfortunately this therapy did not result in a tumor response taken together with already published data this report indicates lack of benefit from conventional braf inhibitor in patient with braf ke mutated melanoma,Cancer,0,lack of response to vemurafenib in melanoma carrying braf ke mutation vemurafenib ha been developed to target common braf mutation ve it also exerts activity towards some but not all rare braf substitution proper cataloguing of drugsensitive and insensitive rare mutation remains a challenge due to low occurrence of these event and inability of commercial pcrbased diagnostic kit to detect the full spectrum of braf gene lesion we considered the result of braf exon testing in consecutive melanoma patient braf mutation wa identified in case while drugsensitive codon substitution constituted the majority of braf gene lesion ve vk vr the fourth common braf allele wa ke accounting for melanoma case the data on braf inhibitor sensitivity of tumor with ke substitution are scarce we administered singleagent vemurafenib to a melanoma patient carrying braf ke mutation a the firstline treatment unfortunately this therapy did not result in a tumor response taken together with already published data this report indicates lack of benefit from conventional braf inhibitor in patient with braf ke mutated melanoma
31183193,the role of p and xpo on colorectal cancer progression in yemeni patient,background the colorectal cancer crc tumorigenesis is driving by genetic alteration leading to change in protein expression such a p the p is frequently expressed in crc and it association with clinicopathological feature is still controversial moreover accumulated evidence suggests that both p and nuclear exporter protein exportin xpo are working in reciprocal manner may lead to loss of p nuclear localization and enhance cancer progression through hyperactive nuclear export accordingly the present study aimed to evaluate the expression of p in crc yemeni patient and to explore the association between the p and xpo coexpression in relation to clinicopathological feature method a series of formalin fixed paraffin embedded ffpe tissue block taken from crc patient that diagnosed a adenocarcinoma were prospectively collected and then analyzed for p and xpo expression by immunohistochemistry ihc the patient and tumor clinicopathological characteristic were retrieved from the histopathology report and the p value were considered statistically significant result the p expression wa observed in of crc tumor sample significantly the p expression wa noted in of the left side compared to of the right side colon tumor p furthermore p expression wa positively and significantly correlated with wellbut not moderate or poorlydifferentiated tumor p no significant difference wa observed between the p expression and age gender and tumor size regarding the xpo expression the p expression didnt show an association with xpo expression the coexpression of p and xpo analysis revealed that tumor with negative p and positive xpo coexpression wa noted with lymph node metastasis with significant difference p and more frequently observed in moderateor poorly differentiated tumor conclusion the loss of p accompanied with increased xpo expression wa associated with the progression of histopathological feature of crc yemeni patient further study are needed to elucidate the p genetic mutation in relation to the xpo coexpression in crc prognosis,Cancer,0,the role of p and xpo on colorectal cancer progression in yemeni patient background the colorectal cancer crc tumorigenesis is driving by genetic alteration leading to change in protein expression such a p the p is frequently expressed in crc and it association with clinicopathological feature is still controversial moreover accumulated evidence suggests that both p and nuclear exporter protein exportin xpo are working in reciprocal manner may lead to loss of p nuclear localization and enhance cancer progression through hyperactive nuclear export accordingly the present study aimed to evaluate the expression of p in crc yemeni patient and to explore the association between the p and xpo coexpression in relation to clinicopathological feature method a series of formalin fixed paraffin embedded ffpe tissue block taken from crc patient that diagnosed a adenocarcinoma were prospectively collected and then analyzed for p and xpo expression by immunohistochemistry ihc the patient and tumor clinicopathological characteristic were retrieved from the histopathology report and the p value were considered statistically significant result the p expression wa observed in of crc tumor sample significantly the p expression wa noted in of the left side compared to of the right side colon tumor p furthermore p expression wa positively and significantly correlated with wellbut not moderate or poorlydifferentiated tumor p no significant difference wa observed between the p expression and age gender and tumor size regarding the xpo expression the p expression didnt show an association with xpo expression the coexpression of p and xpo analysis revealed that tumor with negative p and positive xpo coexpression wa noted with lymph node metastasis with significant difference p and more frequently observed in moderateor poorly differentiated tumor conclusion the loss of p accompanied with increased xpo expression wa associated with the progression of histopathological feature of crc yemeni patient further study are needed to elucidate the p genetic mutation in relation to the xpo coexpression in crc prognosis
31183964,dendritic polyglycerolderived nanoarchitectures a delivery platform of gemcitabine for pancreatic cancer,dendritic polyglycerolcopolycaprolactone pgcopclderived block copolymer are synthesized and explored a nanoscale drug delivery platform for a chemotherapeutic agent gemcitabine gem which is the cornerstone of therapy for pancreatic ductal adenocarcinoma pdac current treatment strategy with gem result in suboptimal therapeutic outcome owing to microenvironmental resistance and rapid metabolic degradation of gem to address these challenge physicochemical and cellbiological property of both covalently conjugated and noncovalently stabilized variant of gemcontaining pgcopcl architecture have been evaluated selfassembly behavior drug loading and release capacity cytotoxicity and cellular uptake property of these construct in monolayer and in spheroid culture of pdac cell are investigated to realize the covalently conjugated carrier system gem in conjunction with a tertiary amine is attached to the polycarbonate block grafted from the pgcopcl core it is observed that phdependent ionization property of these amine sidechains direct the formation of selfassembly of block copolymer in the form of nanoparticles for noncovalent encapsulation a facile solventshifting technique is adopted fabrication technique are found to control colloidal and cellular property of gemloaded nanoconstructs the feasibility and potential of these newly developed architecture for designing carrier system for gem to achieve augmented prognosis for pancreatic cancer are reported,Cancer,0,dendritic polyglycerolderived nanoarchitectures a delivery platform of gemcitabine for pancreatic cancer dendritic polyglycerolcopolycaprolactone pgcopclderived block copolymer are synthesized and explored a nanoscale drug delivery platform for a chemotherapeutic agent gemcitabine gem which is the cornerstone of therapy for pancreatic ductal adenocarcinoma pdac current treatment strategy with gem result in suboptimal therapeutic outcome owing to microenvironmental resistance and rapid metabolic degradation of gem to address these challenge physicochemical and cellbiological property of both covalently conjugated and noncovalently stabilized variant of gemcontaining pgcopcl architecture have been evaluated selfassembly behavior drug loading and release capacity cytotoxicity and cellular uptake property of these construct in monolayer and in spheroid culture of pdac cell are investigated to realize the covalently conjugated carrier system gem in conjunction with a tertiary amine is attached to the polycarbonate block grafted from the pgcopcl core it is observed that phdependent ionization property of these amine sidechains direct the formation of selfassembly of block copolymer in the form of nanoparticles for noncovalent encapsulation a facile solventshifting technique is adopted fabrication technique are found to control colloidal and cellular property of gemloaded nanoconstructs the feasibility and potential of these newly developed architecture for designing carrier system for gem to achieve augmented prognosis for pancreatic cancer are reported
31185671,minimal residual disease monitoring with nextgeneration sequencing methodology in hematological malignancy,ultradeep nextgeneration sequencing ha emerged in recent year a an important diagnostic tool for the detection and followup of tumor burden in most of the known hematopoietic malignancy meticulous and highthroughput method for the lowest possible quantified disease are needed to address the deficiency of more classical technique precisionbased approach will allow u to correctly stratify each patient based on the minimal residual disease mrd after a treatment cycle in this review we consider the most prominent way to approach nextgeneration sequencing methodology to followup mrd in hematological neoplasm,Cancer,0,minimal residual disease monitoring with nextgeneration sequencing methodology in hematological malignancy ultradeep nextgeneration sequencing ha emerged in recent year a an important diagnostic tool for the detection and followup of tumor burden in most of the known hematopoietic malignancy meticulous and highthroughput method for the lowest possible quantified disease are needed to address the deficiency of more classical technique precisionbased approach will allow u to correctly stratify each patient based on the minimal residual disease mrd after a treatment cycle in this review we consider the most prominent way to approach nextgeneration sequencing methodology to followup mrd in hematological neoplasm
31186051,diverse regulatory manner of human telomerase reverse transcriptase,human telomerase reverse transcriptase htert is the core subunit of human telomerase and play important role in human cancer aberrant expression of htert is closely associated with tumorigenesis cancer cell stemness maintaining cell proliferation apoptosis inhibition senescence evasion and metastasis the molecular basis of htert regulation is highly complicated and consists of various layer a deep and fullscale comprehension of the regulatory mechanism of htert is pivotal in understanding the pathogenesis and searching for therapeutic approach in this review we summarize the recent advance regarding the diverse regulatory mechanism of htert including the transcriptional promoter mutation promoter region methylation and histone acetylation posttranscriptional mrna alternative splicing and noncoding rna and posttranslational level phosphorylation and ubiquitination which may provide novel perspective for further translational diagnosis or therapeutic strategy targeting htert,Cancer,0,diverse regulatory manner of human telomerase reverse transcriptase human telomerase reverse transcriptase htert is the core subunit of human telomerase and play important role in human cancer aberrant expression of htert is closely associated with tumorigenesis cancer cell stemness maintaining cell proliferation apoptosis inhibition senescence evasion and metastasis the molecular basis of htert regulation is highly complicated and consists of various layer a deep and fullscale comprehension of the regulatory mechanism of htert is pivotal in understanding the pathogenesis and searching for therapeutic approach in this review we summarize the recent advance regarding the diverse regulatory mechanism of htert including the transcriptional promoter mutation promoter region methylation and histone acetylation posttranscriptional mrna alternative splicing and noncoding rna and posttranslational level phosphorylation and ubiquitination which may provide novel perspective for further translational diagnosis or therapeutic strategy targeting htert
31187522,liquid biopsy in nonhodgkins lymphoma,ctdna provides an important new strategy that will aid in the treatment of nonhodgkins lymphoma immunoglobulin sequencing provides a tumor specific marker for disease activity with a sensitivity equivalent to one tumor cell per furthermore it can provide an estimate of tumor bulk and tumor response dynamic during treatment interim monitoring can identify patient at high risk of treatment failure and surveillance monitoring can identify patient month before radiographic disease progression tumor specific mutation can also be detected in ctdna and may reflect an averaging of mutation present within multiple tumor mass such analysis may aid in the molecular characterization of tumor and selection of targeted treatment for precision medicine,Cancer,0,liquid biopsy in nonhodgkins lymphoma ctdna provides an important new strategy that will aid in the treatment of nonhodgkins lymphoma immunoglobulin sequencing provides a tumor specific marker for disease activity with a sensitivity equivalent to one tumor cell per furthermore it can provide an estimate of tumor bulk and tumor response dynamic during treatment interim monitoring can identify patient at high risk of treatment failure and surveillance monitoring can identify patient month before radiographic disease progression tumor specific mutation can also be detected in ctdna and may reflect an averaging of mutation present within multiple tumor mass such analysis may aid in the molecular characterization of tumor and selection of targeted treatment for precision medicine
31188177,colonic surgery in patient with familial adenomatous polyposis,case summary a yearold woman is referred after a colonoscopy that revealed polyp throughout her colon and rectum a random selection of polyp is biopsied and reported a adenoma she is adopted and is unaware of her biological family she is found to have a deleterious germline variant in apc cdel she work a a nurse and is married with child age and year she ha had no prior abdominal operation,Cancer,0,colonic surgery in patient with familial adenomatous polyposis case summary a yearold woman is referred after a colonoscopy that revealed polyp throughout her colon and rectum a random selection of polyp is biopsied and reported a adenoma she is adopted and is unaware of her biological family she is found to have a deleterious germline variant in apc cdel she work a a nurse and is married with child age and year she ha had no prior abdominal operation
31189972,acid specific dark quencher qc phlip for multispectral optoacoustic diagnosis of breast cancer,breast cancer is the most common type of malignant growth in woman early detection of breast cancer a well a the identification of possible metastatic spread pose a significant challenge because of the structural and genetic heterogeneity that occurs during the progression of the disease currently mammography biopsy and mri scan are the standard of care technique used for breast cancer diagnosis all of which have their individual shortfall especially when it come to discriminating tumor and benign growth with this in mind we have developed a noninvasive optoacoustic imaging strategy that target the acidic environment of breast cancer a ph low insertion peptide phlip wa conjugated to the dark quencher qc yielding a nonfluorescent sonophore with high extinction coefficient in the near infrared that increase signal a a function of increasing amount of membrane insertion in an orthotopic murine breast cancer model phliptargeted optoacoustic imaging allowed u to differentiate between healthy and breast cancer tissue with high signalnoise ratio in vivo the sonophore qcphlip could detect malignancy at higher contrast than it fluorescent analog icgphlip which wa developed for fluorescenceguided surgical application phliptype optoacoustic imaging agent in clinical setting are attractive due to their ability to target breast cancer and a wide variety of other malignant growth for diagnostic purpose intuitively these agent could also be used for visualization during surgery,Cancer,0,acid specific dark quencher qc phlip for multispectral optoacoustic diagnosis of breast cancer breast cancer is the most common type of malignant growth in woman early detection of breast cancer a well a the identification of possible metastatic spread pose a significant challenge because of the structural and genetic heterogeneity that occurs during the progression of the disease currently mammography biopsy and mri scan are the standard of care technique used for breast cancer diagnosis all of which have their individual shortfall especially when it come to discriminating tumor and benign growth with this in mind we have developed a noninvasive optoacoustic imaging strategy that target the acidic environment of breast cancer a ph low insertion peptide phlip wa conjugated to the dark quencher qc yielding a nonfluorescent sonophore with high extinction coefficient in the near infrared that increase signal a a function of increasing amount of membrane insertion in an orthotopic murine breast cancer model phliptargeted optoacoustic imaging allowed u to differentiate between healthy and breast cancer tissue with high signalnoise ratio in vivo the sonophore qcphlip could detect malignancy at higher contrast than it fluorescent analog icgphlip which wa developed for fluorescenceguided surgical application phliptype optoacoustic imaging agent in clinical setting are attractive due to their ability to target breast cancer and a wide variety of other malignant growth for diagnostic purpose intuitively these agent could also be used for visualization during surgery
31191019,nse from diffuse large bcell lymphoma cell regulates macrophage polarization,backgroundaims diffuse large bcell lymphoma dlbcl is a highly common type of malignant and heterogeneous nonhodgkins lymphoma tumorassociated macrophage specially the mtype promote tumor progression and drug resistance the clinical outcome of patient with high neuronspecific enolase nse expression is worse than that with low nse expression the tumorpromoting mechanism of nse however remains unclear this study explored the role of nse in macrophage polarization associated with the immune microenvironment of dlbcl result our result showed that nse protein expression wa higher in lymphoma cell line than in the b lymphocyte functional study demonstrated that upregulation of nse in lymphoma cell could promote m polarization and migration ability of macrophage thereby consequently promoting the progression of lymphoma in vitro and in vivo further mechanism study revealed that lymphomaderived exosomes could mediate nse into macrophage nse enhanced nuclear p translocation with subsequent defective classical nuclear factorkappab activity in macrophage conclusion these result indicate that nse may be a potential target for lymphoma therapy and a prognosis marker for lymphoma,Cancer,0,nse from diffuse large bcell lymphoma cell regulates macrophage polarization backgroundaims diffuse large bcell lymphoma dlbcl is a highly common type of malignant and heterogeneous nonhodgkins lymphoma tumorassociated macrophage specially the mtype promote tumor progression and drug resistance the clinical outcome of patient with high neuronspecific enolase nse expression is worse than that with low nse expression the tumorpromoting mechanism of nse however remains unclear this study explored the role of nse in macrophage polarization associated with the immune microenvironment of dlbcl result our result showed that nse protein expression wa higher in lymphoma cell line than in the b lymphocyte functional study demonstrated that upregulation of nse in lymphoma cell could promote m polarization and migration ability of macrophage thereby consequently promoting the progression of lymphoma in vitro and in vivo further mechanism study revealed that lymphomaderived exosomes could mediate nse into macrophage nse enhanced nuclear p translocation with subsequent defective classical nuclear factorkappab activity in macrophage conclusion these result indicate that nse may be a potential target for lymphoma therapy and a prognosis marker for lymphoma
31192927,prolonged lumbosacral pain a the initial presentation in acute lymphoblastic leukemia in an adult a case report,rationale the differential diagnosis of condition manifesting a bone and joint pain is complex although many individual with acute leukemia experience bone pain lumbosacral pain a an early feature of acute lymphoblastic leukemia all is rare patient concern here we report a case of an adult who presented with a month history of persistent lumbosacral pain which had become more severe during the previous month diagnosis prior to referral his full blood count revealed no abnormality and a computerized tomography scan revealed mild bone hyperplasia of his lumbar vertebra with disc herniation of l his blood biochemistry and urinary test result had been normal after referral to our clinic test of the morphology immunology cytogenetics and molecular biology of his bone marrow led to a diagnosis of mllaf fusion positive bcell all intervention prior to his referral he had been treated with painkiller by local doctor the painkiller initially provided pain relief but their effect wore off over time after diagnosis he wa started on an adult all chemotherapy protocol outcome his symptom resolved within a week of starting chemotherapy at his most recent assessment month after diagnosis he wa on maintenance chemotherapy and in remission lesson this case illustrates that prolonged lumbosacral pain may be a symptom of a lifethreatening condition rather than only attributable to chronic inflammation or disk herniation therefore clinician need to pay attention to subtle difference in the clinical presentation of patient with lumbosacral pain,Cancer,0,prolonged lumbosacral pain a the initial presentation in acute lymphoblastic leukemia in an adult a case report rationale the differential diagnosis of condition manifesting a bone and joint pain is complex although many individual with acute leukemia experience bone pain lumbosacral pain a an early feature of acute lymphoblastic leukemia all is rare patient concern here we report a case of an adult who presented with a month history of persistent lumbosacral pain which had become more severe during the previous month diagnosis prior to referral his full blood count revealed no abnormality and a computerized tomography scan revealed mild bone hyperplasia of his lumbar vertebra with disc herniation of l his blood biochemistry and urinary test result had been normal after referral to our clinic test of the morphology immunology cytogenetics and molecular biology of his bone marrow led to a diagnosis of mllaf fusion positive bcell all intervention prior to his referral he had been treated with painkiller by local doctor the painkiller initially provided pain relief but their effect wore off over time after diagnosis he wa started on an adult all chemotherapy protocol outcome his symptom resolved within a week of starting chemotherapy at his most recent assessment month after diagnosis he wa on maintenance chemotherapy and in remission lesson this case illustrates that prolonged lumbosacral pain may be a symptom of a lifethreatening condition rather than only attributable to chronic inflammation or disk herniation therefore clinician need to pay attention to subtle difference in the clinical presentation of patient with lumbosacral pain
31193934,mira regulates chemoresistance of human osteosarcoma cell via repression of irs,chemoresistance prevents curative potential of chemotherapy in most case micrornas mirnas are key player in regulating chemoresistance in osteosarcoma which is the most common primary bone cancer bisulfite sequencing and quantitative real time pcr analysis showed that mira expression is downregulated by dna hypermethylation at it promoter region in a chemoresistant cell line sjsa compared to a chemosensitive cell line g introduction of a mira mimic in sjsa cell or an antagomir into g cell confirmed the role of mira in osteosarcoma chemoresistance bioinformatics together with biochemical assay showed that insulin receptor substrate irs is a target of mira our data concludes that mira play a role in the osteosarcoma chemoresistance and thus might serve a a useful biomarker for osteosarcoma prognosis,Cancer,0,mira regulates chemoresistance of human osteosarcoma cell via repression of irs chemoresistance prevents curative potential of chemotherapy in most case micrornas mirnas are key player in regulating chemoresistance in osteosarcoma which is the most common primary bone cancer bisulfite sequencing and quantitative real time pcr analysis showed that mira expression is downregulated by dna hypermethylation at it promoter region in a chemoresistant cell line sjsa compared to a chemosensitive cell line g introduction of a mira mimic in sjsa cell or an antagomir into g cell confirmed the role of mira in osteosarcoma chemoresistance bioinformatics together with biochemical assay showed that insulin receptor substrate irs is a target of mira our data concludes that mira play a role in the osteosarcoma chemoresistance and thus might serve a a useful biomarker for osteosarcoma prognosis
31195689,preclinical modelling of pda is organoid the new black,pancreatic ductal adenocarcinoma pda is a malignancy of the exocrine pancreas with the worst prognosis among all solid tumour and soon to become the second leading cause of cancerrelated death a more comprehensive understanding of the molecular mechanism underlying this disease is crucial to the development of diagnostic tool a well a to the identification of more effective therapy highfrequency mutation in pda occur in undruggable gene and molecular subtyping based on bulk transcriptome analysis doe not yet nominate valid therapeutic intervention strategy genomewide sequencing study have also demonstrated a considerable intra and interpatients genetic heterogeneity which further complicate this dire scenario more than in other malignancy functionalization of the pda genome and preclinical modelling at the individual patient level appear necessary to substantially improve survival rate for pancreatic cancer patient traditional human pda model including monolayer cell culture and patientderived xenograft have certainly led to valuable biological insight in the past year however those model system suffer from several limitation that have contributed to the lack of concordance between preclinical and clinical study for pda pancreatic ductal organoids have recently emerged a a reliable culture system to establish model from both normal and neoplastic pancreatic tissue pancreatic organoid culture can be efficiently generated from small tissue biopsy which open up the possibility of longitudinal study in individual patient a proofofconcept study ha demonstrated that patientderived pda organoids are able to predict response to conventional chemotherapy the use of this threedimensional culture system ha already improved our understanding of pda biology and promise to implement precision oncology by enabling the alignment of preclinical and clinical platform to guide therapeutic intervention in pda,Cancer,0,preclinical modelling of pda is organoid the new black pancreatic ductal adenocarcinoma pda is a malignancy of the exocrine pancreas with the worst prognosis among all solid tumour and soon to become the second leading cause of cancerrelated death a more comprehensive understanding of the molecular mechanism underlying this disease is crucial to the development of diagnostic tool a well a to the identification of more effective therapy highfrequency mutation in pda occur in undruggable gene and molecular subtyping based on bulk transcriptome analysis doe not yet nominate valid therapeutic intervention strategy genomewide sequencing study have also demonstrated a considerable intra and interpatients genetic heterogeneity which further complicate this dire scenario more than in other malignancy functionalization of the pda genome and preclinical modelling at the individual patient level appear necessary to substantially improve survival rate for pancreatic cancer patient traditional human pda model including monolayer cell culture and patientderived xenograft have certainly led to valuable biological insight in the past year however those model system suffer from several limitation that have contributed to the lack of concordance between preclinical and clinical study for pda pancreatic ductal organoids have recently emerged a a reliable culture system to establish model from both normal and neoplastic pancreatic tissue pancreatic organoid culture can be efficiently generated from small tissue biopsy which open up the possibility of longitudinal study in individual patient a proofofconcept study ha demonstrated that patientderived pda organoids are able to predict response to conventional chemotherapy the use of this threedimensional culture system ha already improved our understanding of pda biology and promise to implement precision oncology by enabling the alignment of preclinical and clinical platform to guide therapeutic intervention in pda
31195997,antialphaaminohydroxymethylisoxazolepropionic acid receptor glur encephalitis in a myasthenia gravis patient with complete thymectomy a case report,background autoimmune encephalitis ae is a newly recognized autoimmune disorder in which the target are protein or receptor involved in synaptic transmission and neuronal excitability alphaaminohydroxymethylisoxazolepropionic acid receptor ampar is a subtype of glutamate receptor that mediates most of the fast excitatory neurotransmission in the brain case presentation a yearold woman presented with subacute onset of memory loss and behavioral change high level of serum and csf antibody against the ampar glur were detected a wide range of abnormality in hz low to middle slow wave wa found by electroencephalograph and highintensity signal on fluidattenuated inversion recovery in both the medial temporal lobe and hippocampus were identified on brain magnetic resonance image this patient presented with myasthenia gravis and type b thymoma world health organization thymoma classification at age this case wa unique in that the patient initiated with the symptom of myasthenia gravis and thymoma two year prior to encephalitis and a complete thymectomy wa performed before ae onset without recurrence of the thymoma when encephalitis occurred conclusion thymoma wa reported to be associated with paraneoplastic neurological disease this is the first time a thymectomy ha been applied in a myasthenia gravis patient with thymoma two year prior to the onset of antiampar encephalitis this case highlight the complexity of autoimmune encephalitis associated with thymoma,Cancer,0,antialphaaminohydroxymethylisoxazolepropionic acid receptor glur encephalitis in a myasthenia gravis patient with complete thymectomy a case report background autoimmune encephalitis ae is a newly recognized autoimmune disorder in which the target are protein or receptor involved in synaptic transmission and neuronal excitability alphaaminohydroxymethylisoxazolepropionic acid receptor ampar is a subtype of glutamate receptor that mediates most of the fast excitatory neurotransmission in the brain case presentation a yearold woman presented with subacute onset of memory loss and behavioral change high level of serum and csf antibody against the ampar glur were detected a wide range of abnormality in hz low to middle slow wave wa found by electroencephalograph and highintensity signal on fluidattenuated inversion recovery in both the medial temporal lobe and hippocampus were identified on brain magnetic resonance image this patient presented with myasthenia gravis and type b thymoma world health organization thymoma classification at age this case wa unique in that the patient initiated with the symptom of myasthenia gravis and thymoma two year prior to encephalitis and a complete thymectomy wa performed before ae onset without recurrence of the thymoma when encephalitis occurred conclusion thymoma wa reported to be associated with paraneoplastic neurological disease this is the first time a thymectomy ha been applied in a myasthenia gravis patient with thymoma two year prior to the onset of antiampar encephalitis this case highlight the complexity of autoimmune encephalitis associated with thymoma
31197228,role of the dna damage response in prostate cancer formation progression and treatment,background clinical and preclinical study have revealed that alteration in dna damage response ddr pathway may play an important role in prostate cancer pca etiology and progression these alteration can influence pca response to radiotherapy and antiandrogen treatment the identification of dna repair gene aberration in pca ha driven the interest for further evaluation whether these genetic change may serve a biomarkers for patient stratification method in this review we summarize the current knowledge on ddr alteration in pca their potential impact on clinical intervention and prospect for improved management of pca we particularly focus on the influence of ddr gene mutation on pca initiation and progression and describe the underlying mechanism result and conclusion a better understanding of these mechanism will contribute to better disease management a treatment strategy can be chosen based on the specific disease property since a growing number of treatment are targeting ddr pathway alteration such a polyadpribose polymerase inhibitor furthermore the recently discovered crosstalk between the ddr and androgen receptor signaling open a new array of possible strategy to optimize treatment combination we discus how these recent and ongoing study will help to improve diagnostic prognostic and therapeutic approach for pca management,Cancer,0,role of the dna damage response in prostate cancer formation progression and treatment background clinical and preclinical study have revealed that alteration in dna damage response ddr pathway may play an important role in prostate cancer pca etiology and progression these alteration can influence pca response to radiotherapy and antiandrogen treatment the identification of dna repair gene aberration in pca ha driven the interest for further evaluation whether these genetic change may serve a biomarkers for patient stratification method in this review we summarize the current knowledge on ddr alteration in pca their potential impact on clinical intervention and prospect for improved management of pca we particularly focus on the influence of ddr gene mutation on pca initiation and progression and describe the underlying mechanism result and conclusion a better understanding of these mechanism will contribute to better disease management a treatment strategy can be chosen based on the specific disease property since a growing number of treatment are targeting ddr pathway alteration such a polyadpribose polymerase inhibitor furthermore the recently discovered crosstalk between the ddr and androgen receptor signaling open a new array of possible strategy to optimize treatment combination we discus how these recent and ongoing study will help to improve diagnostic prognostic and therapeutic approach for pca management
31199507,temporal and spatial effect and survival outcome associated with concordance between tissue and blood kras alteration in the pancancer setting,we investigated the impact of time interval primary v metastatic biopsy site variant allele fraction vaf and histology on concordance of kras alteration in tissue v circulating tumor dna ctdna and association of concordance with survival blood and tissue were evaluated by nextgeneration sequencing in patient with diverse cancer altogether patient had kras alteration ctdna tissue and both the overall blood and tissue concordance rate for kras alteration wa but wa mainly driven by the large negativenegative subset therefore specificity of one test for the other wa high while sensitivity wa not high and wa lower still in patient with v month between blood and tissue sampling v p time intervaldependent sensitivity of blood for tissue p tissue for blood positive concordance rate for kras alteration wa v colorectal v noncolorectal cancer p but site of biopsy primary v metastatic and vaf ctdna wa not impactful the presence of kras alteration in both test wa independently associated with shorter survival from diagnosis hazard ratio confidence interval and from recurrentmetastatic disease positive concordance of kras alteration between ctdna and tissue wa negatively affected by a longer time period between blood and tissue sampling and wa higher in colorectal cancer than in other malignancy the presence of kras alteration in both test wa an independent prognostic factor for poor survival,Cancer,0,temporal and spatial effect and survival outcome associated with concordance between tissue and blood kras alteration in the pancancer setting we investigated the impact of time interval primary v metastatic biopsy site variant allele fraction vaf and histology on concordance of kras alteration in tissue v circulating tumor dna ctdna and association of concordance with survival blood and tissue were evaluated by nextgeneration sequencing in patient with diverse cancer altogether patient had kras alteration ctdna tissue and both the overall blood and tissue concordance rate for kras alteration wa but wa mainly driven by the large negativenegative subset therefore specificity of one test for the other wa high while sensitivity wa not high and wa lower still in patient with v month between blood and tissue sampling v p time intervaldependent sensitivity of blood for tissue p tissue for blood positive concordance rate for kras alteration wa v colorectal v noncolorectal cancer p but site of biopsy primary v metastatic and vaf ctdna wa not impactful the presence of kras alteration in both test wa independently associated with shorter survival from diagnosis hazard ratio confidence interval and from recurrentmetastatic disease positive concordance of kras alteration between ctdna and tissue wa negatively affected by a longer time period between blood and tissue sampling and wa higher in colorectal cancer than in other malignancy the presence of kras alteration in both test wa an independent prognostic factor for poor survival
31200400,maternal tumor disease a a reason for repeated test failure in cellfree dna screening,noninvasive prenatal testing nipt is a screening test for fetal chromosome disorder recent study show an incidental detection of maternal malignancy in nipt diagnostics where the simultaneous presence of multiple aneuploidy is described a an nipt anomaly in this case the diagnosis of a maternal tumor disease wa made due to a repeat nipt failure no call,Cancer,0,maternal tumor disease a a reason for repeated test failure in cellfree dna screening noninvasive prenatal testing nipt is a screening test for fetal chromosome disorder recent study show an incidental detection of maternal malignancy in nipt diagnostics where the simultaneous presence of multiple aneuploidy is described a an nipt anomaly in this case the diagnosis of a maternal tumor disease wa made due to a repeat nipt failure no call
31201827,flt overexpression in acute leukaemia new insight into the search for molecular mechanism,flt overexpression is a recurrent event in various acute leukaemia subtypes this transcriptional deregulation is important to define the prognostic risk for many patient of note the molecular mechanism leading to this gene upregulation are unknown for a substantial number of case in this minireview we highlight the role of flt overexpression in acute leukaemia and discus emerging mechanism accounting for this upregulation the benefit of using targeted therapy are also addressed in the overexpression context posing other therapeutic possibility based on stateoftheart knowledge that could be considered for future research,Cancer,0,flt overexpression in acute leukaemia new insight into the search for molecular mechanism flt overexpression is a recurrent event in various acute leukaemia subtypes this transcriptional deregulation is important to define the prognostic risk for many patient of note the molecular mechanism leading to this gene upregulation are unknown for a substantial number of case in this minireview we highlight the role of flt overexpression in acute leukaemia and discus emerging mechanism accounting for this upregulation the benefit of using targeted therapy are also addressed in the overexpression context posing other therapeutic possibility based on stateoftheart knowledge that could be considered for future research
31203467,the role of circulating tumor dna in lung cancer mutational analysis diagnosis and surveillance now and into the future,opinion statement isolation and analysis of circulating tumor dna ctdna have emerged a an effective and promising tool for genomic profiling in nonsmall cell lung cancer analysis of ctdna can be particularly useful in situation where tissue biopsy is not safely obtainable due to poor physical condition or inaccessible tumor biopsy location in addition to identifying oncogenic driver mutation which can be treated with targetable therapy in the treatment naive advanced nonsmall cell lung cancer nsclc setting ctdna is being utilized in novel way including monitoring during an advanced nsclc patient treatment course realtime monitoring determining mechanism of resistance and lastly a a tool to identify minimal residual disease in earlystage nsclc recent research demonstrates that ctdna testing can provide a useful adjunct to tissue genotyping in nsclc utilization of ctdna into routine clinical practice for nsclc should be strongly considered,Cancer,0,the role of circulating tumor dna in lung cancer mutational analysis diagnosis and surveillance now and into the future opinion statement isolation and analysis of circulating tumor dna ctdna have emerged a an effective and promising tool for genomic profiling in nonsmall cell lung cancer analysis of ctdna can be particularly useful in situation where tissue biopsy is not safely obtainable due to poor physical condition or inaccessible tumor biopsy location in addition to identifying oncogenic driver mutation which can be treated with targetable therapy in the treatment naive advanced nonsmall cell lung cancer nsclc setting ctdna is being utilized in novel way including monitoring during an advanced nsclc patient treatment course realtime monitoring determining mechanism of resistance and lastly a a tool to identify minimal residual disease in earlystage nsclc recent research demonstrates that ctdna testing can provide a useful adjunct to tissue genotyping in nsclc utilization of ctdna into routine clinical practice for nsclc should be strongly considered
31204910,clinical feature and therapeutic efficacy in adult acute lymphoblastic leukemia with t eapbx,objective to explore the clinical feature and therapeutic efficacy in adult all patient with t eapbx method the clinic data of adult all patient with t eapbx in our hospital from nov to apr were collected the clinical featurescomplete remission cr rate overall survival o rate and relapsefree survival rf rate of patient received chemotherapy and chemotherapyhsct were analyzed result in all the patient the median age wa median wbc count wa x l median hb level wa gl median plt count wa xl pre ball were case and common ball were case patient received the induction therapy the overall cr rate wa one course cr rate wa year o rate wa and rf rate wa the o rate and rf rate of patient received transplantation were slightly higher than those of patient not received transplantation o v prfs v p conclusion most adult all patient with t eapbx is pre ball by immunophenotyping a compared with the pediatric patient the therapeutic efficacy for adult patient with t eapbx is worsen therefore stem cell transplantation is still acquired for better long term survival,Cancer,0,clinical feature and therapeutic efficacy in adult acute lymphoblastic leukemia with t eapbx objective to explore the clinical feature and therapeutic efficacy in adult all patient with t eapbx method the clinic data of adult all patient with t eapbx in our hospital from nov to apr were collected the clinical featurescomplete remission cr rate overall survival o rate and relapsefree survival rf rate of patient received chemotherapy and chemotherapyhsct were analyzed result in all the patient the median age wa median wbc count wa x l median hb level wa gl median plt count wa xl pre ball were case and common ball were case patient received the induction therapy the overall cr rate wa one course cr rate wa year o rate wa and rf rate wa the o rate and rf rate of patient received transplantation were slightly higher than those of patient not received transplantation o v prfs v p conclusion most adult all patient with t eapbx is pre ball by immunophenotyping a compared with the pediatric patient the therapeutic efficacy for adult patient with t eapbx is worsen therefore stem cell transplantation is still acquired for better long term survival
31207705,analysis of induction efficacy and prognostic factor in fltitd positive acute myeloid leukemia in the real world,objective to investigate the efficacy and prognostic factor of induction therapy in fltitd acute myeloid leukemia aml in the real world data method from january to december de novo patient with fltitdaml were enrolled in this study out of case were male and were female the median age wa year old ranged from to year old the chemotherapy regimen were used for induction therapy and all case were followed up the treatment response wa evaluated by micm and the comparison of the ratio were analyzed by chisquare test and the survival wa estimated by kaplanmeier analysis and cox proportional hazard model wa used to identify independent prognostic factor result there were fltitdaml patient with favorable prognosis gene case with npm case with runxrunxt case with cebpa double mutation and patient with other type of fltitdaml at diagnosis all patient completed at least one cycle of induction therapy and the clinical curative effect wa evaluated complete remission cr rate wa in one cycle and total cr rate wa in two cycle the cr rate of the fltitd aml patient with favorable prognosis gene wa in one cycle and in two cycle for the other type fltitdaml patient the cr rate wa in one cycle and in two cycle there wa a significant difference in cr rate between the fltitdaml patient with and without favorable prognosis gene p this indicates that the fltitdaml patient with favorable prognosis gene had relatively good therapeutic effect among other type of fltitdaml patient who did not achieve remission from one cycle of chemotherapy patient were given sorafenib plus chemotherapy and case achieved cr patient were given conventional chemotherapy and case achieved cr there wa a significant difference between sorafenib plus chemotherapy and conventional chemotherapy group chi p and this indicates that sorafenib plus chemotherapy can significantly improve the cr rate of fltitdaml patient comparing overall survival o and disease free survival dfs there wa no significant difference between sorafenib plus chemotherapy and conventional chemotherapy group p value were and respectively conclusion the overall prognosis of fltitdaml patient is poor and the stratification therapeutic efficacy of fltitdaml without favorable prognosis gene can be improved by sorafenib combined with chemotherapy,Cancer,0,analysis of induction efficacy and prognostic factor in fltitd positive acute myeloid leukemia in the real world objective to investigate the efficacy and prognostic factor of induction therapy in fltitd acute myeloid leukemia aml in the real world data method from january to december de novo patient with fltitdaml were enrolled in this study out of case were male and were female the median age wa year old ranged from to year old the chemotherapy regimen were used for induction therapy and all case were followed up the treatment response wa evaluated by micm and the comparison of the ratio were analyzed by chisquare test and the survival wa estimated by kaplanmeier analysis and cox proportional hazard model wa used to identify independent prognostic factor result there were fltitdaml patient with favorable prognosis gene case with npm case with runxrunxt case with cebpa double mutation and patient with other type of fltitdaml at diagnosis all patient completed at least one cycle of induction therapy and the clinical curative effect wa evaluated complete remission cr rate wa in one cycle and total cr rate wa in two cycle the cr rate of the fltitd aml patient with favorable prognosis gene wa in one cycle and in two cycle for the other type fltitdaml patient the cr rate wa in one cycle and in two cycle there wa a significant difference in cr rate between the fltitdaml patient with and without favorable prognosis gene p this indicates that the fltitdaml patient with favorable prognosis gene had relatively good therapeutic effect among other type of fltitdaml patient who did not achieve remission from one cycle of chemotherapy patient were given sorafenib plus chemotherapy and case achieved cr patient were given conventional chemotherapy and case achieved cr there wa a significant difference between sorafenib plus chemotherapy and conventional chemotherapy group chi p and this indicates that sorafenib plus chemotherapy can significantly improve the cr rate of fltitdaml patient comparing overall survival o and disease free survival dfs there wa no significant difference between sorafenib plus chemotherapy and conventional chemotherapy group p value were and respectively conclusion the overall prognosis of fltitdaml patient is poor and the stratification therapeutic efficacy of fltitdaml without favorable prognosis gene can be improved by sorafenib combined with chemotherapy
31208361,molecular genetic characterization reveals linear tumor evolution in a pulmonary sarcomatoid carcinoma patient with a novel phfntrk fusion a case report,background pulmonary sarcomatoid carcinoma sc consists of both carcinomatous and sarcomatous tumor with high degree of malignancy rapid progression and poor prognosis however little is known regarding how pulmonary sc develops and progress case presentation a yearold male wa initially diagnosed with stage iiia lung cancer containing both adenocarcinoma adc and sc adjuvant chemotherapy wa administrated postsurgery however recurrence with sc only soon followed mutation profiling of the patient microdissected adc and sc component of the primary lesion and recurrent tumor wa performed by targeted nextgeneration sequencing ng of cancerrelevant gene our data showed that primary scadc and the recurrent sc shared multiple gene mutation including egfr nf tp cdknb and smarca while both primary and recurrent sc had a unique tp exon splicing mutation frequently observed in sarcoma interestingly a novel phfntrk fusion wa acquired in the recurrent sc which may be a potential driver for sc recurrence conclusion the molecular genetic characteristic of tumor tissue at different stage reveals a linear tumor evolution model in this case and support that the primary sc derived from the original lung adc during the evolution of the tumor we also identified a novel phfntrk fusion which may contribute to the disease recurrence and that can be potentially targeted with ntrk inhibitor for treatment,Cancer,0,molecular genetic characterization reveals linear tumor evolution in a pulmonary sarcomatoid carcinoma patient with a novel phfntrk fusion a case report background pulmonary sarcomatoid carcinoma sc consists of both carcinomatous and sarcomatous tumor with high degree of malignancy rapid progression and poor prognosis however little is known regarding how pulmonary sc develops and progress case presentation a yearold male wa initially diagnosed with stage iiia lung cancer containing both adenocarcinoma adc and sc adjuvant chemotherapy wa administrated postsurgery however recurrence with sc only soon followed mutation profiling of the patient microdissected adc and sc component of the primary lesion and recurrent tumor wa performed by targeted nextgeneration sequencing ng of cancerrelevant gene our data showed that primary scadc and the recurrent sc shared multiple gene mutation including egfr nf tp cdknb and smarca while both primary and recurrent sc had a unique tp exon splicing mutation frequently observed in sarcoma interestingly a novel phfntrk fusion wa acquired in the recurrent sc which may be a potential driver for sc recurrence conclusion the molecular genetic characteristic of tumor tissue at different stage reveals a linear tumor evolution model in this case and support that the primary sc derived from the original lung adc during the evolution of the tumor we also identified a novel phfntrk fusion which may contribute to the disease recurrence and that can be potentially targeted with ntrk inhibitor for treatment
31208696,epigenome remodeling in cholangiocarcinoma,cholangiocarcinoma cca comprises a heterogeneous collection of malignancy arising within the biliary tract characterized by late diagnosis innate chemoresistance and abysmal prognosis sequencing data have uncovered recurrent mutation in diverse epigenetic regulator implicating epigenetic destabilization at the root of these tumor however few study have characterized biliary tumor epigenomes in this opinion article we argue that an epigenomeoriented approach to cca could establish diverse interconnection between many key aspect of research on this disease including molecular heterogeneity diverse cell of origin and prominent tumor microenvironments moreover we discus plausible cause of epigenome dysregulation in biliary tumor including genetic epigenetic metabolic microenvironmental and physiological factor lastly we assess the translational potential of epigenomics in cca to uncover robust biomarkers and therapeutic opportunity for this growing group of patient with limited treatment option,Cancer,0,epigenome remodeling in cholangiocarcinoma cholangiocarcinoma cca comprises a heterogeneous collection of malignancy arising within the biliary tract characterized by late diagnosis innate chemoresistance and abysmal prognosis sequencing data have uncovered recurrent mutation in diverse epigenetic regulator implicating epigenetic destabilization at the root of these tumor however few study have characterized biliary tumor epigenomes in this opinion article we argue that an epigenomeoriented approach to cca could establish diverse interconnection between many key aspect of research on this disease including molecular heterogeneity diverse cell of origin and prominent tumor microenvironments moreover we discus plausible cause of epigenome dysregulation in biliary tumor including genetic epigenetic metabolic microenvironmental and physiological factor lastly we assess the translational potential of epigenomics in cca to uncover robust biomarkers and therapeutic opportunity for this growing group of patient with limited treatment option
31209238,community assessment to advance computational prediction of cancer drug combination in a pharmacogenomic screen,the effectiveness of most cancer targeted therapy is shortlived tumor often develop resistance that might be overcome with drug combination however the number of possible combination is vast necessitating datadriven approach to find optimal patientspecific treatment here we report astrazenecas large drug combination dataset consisting of experiment from combination across molecularly characterized cancer cell line and result of a dream challenge to evaluate computational strategy for predicting synergistic drug pair and biomarkers team participated to provide a comprehensive methodological development and benchmarking winning method incorporate prior knowledge of drugtarget interaction synergy is predicted with an accuracy matching biological replicates for of combination however of drug combination are poorly predicted by all method genomic rationale for synergy prediction are identified including adam inhibitor antagonism when combined with pikcbd inhibition contrasting to synergy when combined with other pikpathway inhibitor in pikca mutant cell,Cancer,0,community assessment to advance computational prediction of cancer drug combination in a pharmacogenomic screen the effectiveness of most cancer targeted therapy is shortlived tumor often develop resistance that might be overcome with drug combination however the number of possible combination is vast necessitating datadriven approach to find optimal patientspecific treatment here we report astrazenecas large drug combination dataset consisting of experiment from combination across molecularly characterized cancer cell line and result of a dream challenge to evaluate computational strategy for predicting synergistic drug pair and biomarkers team participated to provide a comprehensive methodological development and benchmarking winning method incorporate prior knowledge of drugtarget interaction synergy is predicted with an accuracy matching biological replicates for of combination however of drug combination are poorly predicted by all method genomic rationale for synergy prediction are identified including adam inhibitor antagonism when combined with pikcbd inhibition contrasting to synergy when combined with other pikpathway inhibitor in pikca mutant cell
31209437,application of ushaped convolutional neural network in auto segmentation and reconstruction of d prostate model in laparoscopic prostatectomy navigation,objective to investigate the efficacy of intraoperative cognitive navigation on laparoscopic radical prostatectomy using d prostatic model created by ushaped convolutional neural network unet and reconstructed through medical image interaction tool kit mitk platform method a total of piece of prostate cancer magnetic resonance mr imaging discovery set with manual annotation were used to train a modified unet and a set of clinically demandoriented stable and efficient full convolutional neural network algorithm wa constructed the mr image were cropped and segmented automatically by using modified unet and the segmentation data were automatically reconstructed using mitk platform according to our own protocol the modeling data were output a stl format and the prostate model were simultaneously displayed on an android tablet during the operation to help achieving cognitive navigation result based on original unet architecture we established a modified unet from a case mr imaging training set the network performance wa tested and compared with human segmentation and other segmentation network by using one certain testing data set auto segmentation of multistructures such a prostate prostate tumor seminal vesicle rectus neurovascular bundle and dorsal venous complex were successfully achieved secondary automatic d reconstruction had been carried out through mitk platform during the surgery d model of prostatic area were simultaneously displayed on an android tablet and the cognitive navigation wa successfully achieved intraoperation organ visualization demonstrated the structural relationship among the key structure in great detail and the degree of tumor invasion wa visualized directly conclusion the modified unet wa able to achieve automatic segmentation of important structure of prostate area secondary d model reconstruction and demonstration could provide intraoperative visualization of vital structure of prostate area which could help achieve cognitive fusion navigation for surgeon the application of these technique could finally reduce positive surgical margin rate and may improve the efficacy and oncological outcome of laparoscopic prostatectomy,Cancer,0,application of ushaped convolutional neural network in auto segmentation and reconstruction of d prostate model in laparoscopic prostatectomy navigation objective to investigate the efficacy of intraoperative cognitive navigation on laparoscopic radical prostatectomy using d prostatic model created by ushaped convolutional neural network unet and reconstructed through medical image interaction tool kit mitk platform method a total of piece of prostate cancer magnetic resonance mr imaging discovery set with manual annotation were used to train a modified unet and a set of clinically demandoriented stable and efficient full convolutional neural network algorithm wa constructed the mr image were cropped and segmented automatically by using modified unet and the segmentation data were automatically reconstructed using mitk platform according to our own protocol the modeling data were output a stl format and the prostate model were simultaneously displayed on an android tablet during the operation to help achieving cognitive navigation result based on original unet architecture we established a modified unet from a case mr imaging training set the network performance wa tested and compared with human segmentation and other segmentation network by using one certain testing data set auto segmentation of multistructures such a prostate prostate tumor seminal vesicle rectus neurovascular bundle and dorsal venous complex were successfully achieved secondary automatic d reconstruction had been carried out through mitk platform during the surgery d model of prostatic area were simultaneously displayed on an android tablet and the cognitive navigation wa successfully achieved intraoperation organ visualization demonstrated the structural relationship among the key structure in great detail and the degree of tumor invasion wa visualized directly conclusion the modified unet wa able to achieve automatic segmentation of important structure of prostate area secondary d model reconstruction and demonstration could provide intraoperative visualization of vital structure of prostate area which could help achieve cognitive fusion navigation for surgeon the application of these technique could finally reduce positive surgical margin rate and may improve the efficacy and oncological outcome of laparoscopic prostatectomy
31209635,recent advance in invasive adenocarcinoma of the cervix,endocervical adenocarcinoma ecas are currently classified according to the world health organization who system which is predominantly based on descriptive morphologic characteristic considers factor bearing minimal etiological clinical or therapeutic relevance and lack sufficient reproducibility the international endocervical adenocarcinoma criterion and classification iecc system wa developed by a group of international collaborator to address these limitation the iecc system separate ecas into two major groupsthose that are human papillomavirusassociated hpva and those that are nonhpvassociated nhpvabased on morphology linked to etiology alone precluding the need for an expensive panel of immunohistochemical marker for most case the major type of hpva eca include the usual with villoglandular and micropapillary architectural variant and mucinous type not otherwise specified no intestinal signetring and invasive stratified mucinproducing carcinoma invasive adenocarcinoma no is morphologically uninformative yet considered part of this group when hpv positive nhpva ecas include gastric clear cell endometrioid and mesonephric type the iecc system is supported by demographic and clinical feature hpva ecas develop in younger patient are smaller and are diagnosed at an earlier stage phpv status almost all hpva ecas are p andor hpv positive prognostic parameter nhpva ecas more often have lymphovascular invasion lymph node metastasis and are silva pattern c and survival data nhpva ecas are associated with worse survival a move from the morphologybased who system to the iecc system will likely provide clinician with an improved mean to diagnose and classify ecas and ultimately to better personalize treatment for these patient,Cancer,0,recent advance in invasive adenocarcinoma of the cervix endocervical adenocarcinoma ecas are currently classified according to the world health organization who system which is predominantly based on descriptive morphologic characteristic considers factor bearing minimal etiological clinical or therapeutic relevance and lack sufficient reproducibility the international endocervical adenocarcinoma criterion and classification iecc system wa developed by a group of international collaborator to address these limitation the iecc system separate ecas into two major groupsthose that are human papillomavirusassociated hpva and those that are nonhpvassociated nhpvabased on morphology linked to etiology alone precluding the need for an expensive panel of immunohistochemical marker for most case the major type of hpva eca include the usual with villoglandular and micropapillary architectural variant and mucinous type not otherwise specified no intestinal signetring and invasive stratified mucinproducing carcinoma invasive adenocarcinoma no is morphologically uninformative yet considered part of this group when hpv positive nhpva ecas include gastric clear cell endometrioid and mesonephric type the iecc system is supported by demographic and clinical feature hpva ecas develop in younger patient are smaller and are diagnosed at an earlier stage phpv status almost all hpva ecas are p andor hpv positive prognostic parameter nhpva ecas more often have lymphovascular invasion lymph node metastasis and are silva pattern c and survival data nhpva ecas are associated with worse survival a move from the morphologybased who system to the iecc system will likely provide clinician with an improved mean to diagnose and classify ecas and ultimately to better personalize treatment for these patient
31212132,identification of a novel orally bioavailable erk inhibitor with selectivity over palpha and brd,extracellular regulated kinase erk signalling ha been implicated in driving a number of cellular phenotype including endothelial cell angiogenesis and tumour cell motility novel erk inhibitor were identified using high throughput screening with a series of pyrrolecarboxamides substituted at the position with an aroyl group being found to exhibit ic value in the micromolar range but having no selectivity against palpha map kinase truncation of the nsubstituent marginally enhanced potency fold against erk but importantly attenuated inhibition of palpha systematic variation of the substituents on the aroyl group led to the selective inhibitor bromofluorobenzoylnpyridinylhpyrrolecarboxamide ic mum for erk ic mum for palpha the crystal structure pdb oi of this compound in complex with erk ha been solved this compound wa orally bioavailable and inhibited bfgfdriven matrigel plug angiogenesis and tumour xenograft growth the selective erk inhibitor described herein provides a lead for further development into a tool compound for more extensive study seeking to examine the role of erk signalling in cancer and other disease,Cancer,0,identification of a novel orally bioavailable erk inhibitor with selectivity over palpha and brd extracellular regulated kinase erk signalling ha been implicated in driving a number of cellular phenotype including endothelial cell angiogenesis and tumour cell motility novel erk inhibitor were identified using high throughput screening with a series of pyrrolecarboxamides substituted at the position with an aroyl group being found to exhibit ic value in the micromolar range but having no selectivity against palpha map kinase truncation of the nsubstituent marginally enhanced potency fold against erk but importantly attenuated inhibition of palpha systematic variation of the substituents on the aroyl group led to the selective inhibitor bromofluorobenzoylnpyridinylhpyrrolecarboxamide ic mum for erk ic mum for palpha the crystal structure pdb oi of this compound in complex with erk ha been solved this compound wa orally bioavailable and inhibited bfgfdriven matrigel plug angiogenesis and tumour xenograft growth the selective erk inhibitor described herein provides a lead for further development into a tool compound for more extensive study seeking to examine the role of erk signalling in cancer and other disease
31212602,bioinformatics analysis for circulating cellfree dna in cancer,molecular analysis of cellfree dna cfdna that circulates in plasma and other body fluid represents a liquid biopsy approach for noninvasive cancer screening or monitoring the rapid development of sequencing technology ha made cfdna a promising source to study cancer development and progression specific genetic and epigenetic alteration have been found in plasma serum and urine cfdna and could potentially be used a diagnostic or prognostic biomarkers in various cancer type in this review we will discus the molecular characteristic of cancer cfdna and major bioinformatics approach involved in the analysis of cfdna sequencing data for detecting genetic mutation copy number alteration methylation change and nucleosome positioning variation we highlight specific challenge in sensitivity to detect genetic aberration and robustness of statistical analysis finally we provide perspective regarding the standard and continuing development of bioinformatics analysis to move this promising screening tool into clinical practice,Cancer,0,bioinformatics analysis for circulating cellfree dna in cancer molecular analysis of cellfree dna cfdna that circulates in plasma and other body fluid represents a liquid biopsy approach for noninvasive cancer screening or monitoring the rapid development of sequencing technology ha made cfdna a promising source to study cancer development and progression specific genetic and epigenetic alteration have been found in plasma serum and urine cfdna and could potentially be used a diagnostic or prognostic biomarkers in various cancer type in this review we will discus the molecular characteristic of cancer cfdna and major bioinformatics approach involved in the analysis of cfdna sequencing data for detecting genetic mutation copy number alteration methylation change and nucleosome positioning variation we highlight specific challenge in sensitivity to detect genetic aberration and robustness of statistical analysis finally we provide perspective regarding the standard and continuing development of bioinformatics analysis to move this promising screening tool into clinical practice
31212687,optimizing genetic workup in pheochromocytoma and paraganglioma by integrating diagnostic and research approach,pheochromocytoma and paragangliomas ppgl are rare neuroendocrine tumor with a strong hereditary background and a large genetic heterogeneity identification of the underlying genetic cause is crucial for the management of patient and their family a it aid differentiation between hereditary and sporadic case to improve diagnostics and clinical management we tailored an enrichment based comprehensive multigene next generation sequencing panel applicable to both analysis of tumor tissue and blood sample we applied this panel to tumor sample and compared it performance to our current routine diagnostic approach routine diagnostic sequencing of ppgl susceptibility gene wa applied to blood sample of unselected ppgl patient at a single center in dresden germany predisposing germline mutation were identified in patient analysis of ppgl tumor tissue using the dedicated ppgl panel revealed pathogenic or likely pathogenic variant in known ppgl susceptibility gene in case including mutation in idh atrx and hras these mutation suggest sporadic tumor development our result imply a diagnostic benefit from extended molecular tumor testing of ppgls and consequent improvement of patient management the approach is promising for determination of prognostic biomarkers that support therapeutic decisionmaking,Cancer,0,optimizing genetic workup in pheochromocytoma and paraganglioma by integrating diagnostic and research approach pheochromocytoma and paragangliomas ppgl are rare neuroendocrine tumor with a strong hereditary background and a large genetic heterogeneity identification of the underlying genetic cause is crucial for the management of patient and their family a it aid differentiation between hereditary and sporadic case to improve diagnostics and clinical management we tailored an enrichment based comprehensive multigene next generation sequencing panel applicable to both analysis of tumor tissue and blood sample we applied this panel to tumor sample and compared it performance to our current routine diagnostic approach routine diagnostic sequencing of ppgl susceptibility gene wa applied to blood sample of unselected ppgl patient at a single center in dresden germany predisposing germline mutation were identified in patient analysis of ppgl tumor tissue using the dedicated ppgl panel revealed pathogenic or likely pathogenic variant in known ppgl susceptibility gene in case including mutation in idh atrx and hras these mutation suggest sporadic tumor development our result imply a diagnostic benefit from extended molecular tumor testing of ppgls and consequent improvement of patient management the approach is promising for determination of prognostic biomarkers that support therapeutic decisionmaking
31212691,stabilization of intrinsically disordered dkk protein by fusion to rnabinding domain,intrinsic disorder are a common feature of hub protein in eukaryotic interactomes controlling the signaling pathway the intrinsically disordered protein idp are prone to misfolding and maintaining their functional stability remains a major challenge in validating their therapeutic potential considering that idp are highly enriched in rnabinding protein rbps here we reasoned and confirmed that idp could be stabilized by fusion to rbps dickkopf dkk wnt antagonist and a prototype idp wa fused with lysyltrna synthetase lysrs with or without the fragment crystallizable fc domain of an immunoglobulin and expressed predominantly a a soluble form from a bacterial host the functional competence wa confirmed by in vitro wnt signaling reporter and tube formation in human umbilical vein endothelial cell huvecs and in vivo matrigel plug assay the removal of lysrs by sitespecific protease cleavage prompted the insoluble aggregation confirming that the linkage to rbp chaperone the functional competence of idp while addressing to dkk a a key modulator for cancer and ischemic vascular disease our result suggest the use of rbps a stabilizer of disordered proteinaceous material for acquiring and maintaining the structural stability and functional competence which would impact the druggability of a variety of idp from human proteome,Cancer,0,stabilization of intrinsically disordered dkk protein by fusion to rnabinding domain intrinsic disorder are a common feature of hub protein in eukaryotic interactomes controlling the signaling pathway the intrinsically disordered protein idp are prone to misfolding and maintaining their functional stability remains a major challenge in validating their therapeutic potential considering that idp are highly enriched in rnabinding protein rbps here we reasoned and confirmed that idp could be stabilized by fusion to rbps dickkopf dkk wnt antagonist and a prototype idp wa fused with lysyltrna synthetase lysrs with or without the fragment crystallizable fc domain of an immunoglobulin and expressed predominantly a a soluble form from a bacterial host the functional competence wa confirmed by in vitro wnt signaling reporter and tube formation in human umbilical vein endothelial cell huvecs and in vivo matrigel plug assay the removal of lysrs by sitespecific protease cleavage prompted the insoluble aggregation confirming that the linkage to rbp chaperone the functional competence of idp while addressing to dkk a a key modulator for cancer and ischemic vascular disease our result suggest the use of rbps a stabilizer of disordered proteinaceous material for acquiring and maintaining the structural stability and functional competence which would impact the druggability of a variety of idp from human proteome
31215094,role of the hexosamine biosynthetic pathway and pentose phosphate pathway in bile acidinduced cancer development,esophageal squamous cell carcinoma esccs a well a adenocarcinoma eacs were developed in rat duodenal content reflux model reflux model the present study aimed to shed light on the mechanism by which bile acid stimulation cause cancer onset and progression metabolomics analysis were performed on sample of neoplastic and nonneoplastic tissue from reflux model and kd cultivated from a nonmetastatic primary escc and esccdr established from a metastatic thoracic lesion esccdrtcam wa prepared by treating esccdr cell with taurocholic acid tca to accelerate cancer progression the line were subjected to comprehensive genomic analysis in addition protein expression level of glucosephosphate dehydrogenase gpd nuclear factor kappa b nfkappab p and olinked nacetylglucosamine oglcnac were compared among line cancer developed in the reflux model exhibited greater hexosamine biosynthesis pathway hbp activation compared with the nonneoplastic tissue expression of oglcnac transferase ogt increased considerably in both escc and eac compared with nonneoplastic squamous epithelium conversely cell linebased experiment revealed the greater activation of the pentose phosphate pathway ppp at higher degree of malignancy gpd overexpression in response to tca exposure wa observed both nfkappab p and oglcnac were expressed more highly in esccdrtcam than in the other cell line moreover esccdrtcam cell had additional chromosomal abnormality in excess of esccdr cell overall glucose metabolism wa upregulated in both esophageal cancer tissue and cell line while bile acid are not mutagenic chronic exposure seems to trigger nfkappabp activation potentially inducing genetic mutation a well a facilitating carcinogenesis and cancer progression glucose metabolism wa upregulated in both esophageal cancer tissue and cell line and the hbp wa activated in the former the cell linebased experiment demonstrated upregulation of the pentose phosphate pathway ppp at higher degree of malignancy while bile acid are not mutagenic chronic exposure seems to trigger gpd overexpression and nfkappab p activation potentially inducing genetic mutation a well a facilitating carcinogenesis and cancer progression,Cancer,0,role of the hexosamine biosynthetic pathway and pentose phosphate pathway in bile acidinduced cancer development esophageal squamous cell carcinoma esccs a well a adenocarcinoma eacs were developed in rat duodenal content reflux model reflux model the present study aimed to shed light on the mechanism by which bile acid stimulation cause cancer onset and progression metabolomics analysis were performed on sample of neoplastic and nonneoplastic tissue from reflux model and kd cultivated from a nonmetastatic primary escc and esccdr established from a metastatic thoracic lesion esccdrtcam wa prepared by treating esccdr cell with taurocholic acid tca to accelerate cancer progression the line were subjected to comprehensive genomic analysis in addition protein expression level of glucosephosphate dehydrogenase gpd nuclear factor kappa b nfkappab p and olinked nacetylglucosamine oglcnac were compared among line cancer developed in the reflux model exhibited greater hexosamine biosynthesis pathway hbp activation compared with the nonneoplastic tissue expression of oglcnac transferase ogt increased considerably in both escc and eac compared with nonneoplastic squamous epithelium conversely cell linebased experiment revealed the greater activation of the pentose phosphate pathway ppp at higher degree of malignancy gpd overexpression in response to tca exposure wa observed both nfkappab p and oglcnac were expressed more highly in esccdrtcam than in the other cell line moreover esccdrtcam cell had additional chromosomal abnormality in excess of esccdr cell overall glucose metabolism wa upregulated in both esophageal cancer tissue and cell line while bile acid are not mutagenic chronic exposure seems to trigger nfkappabp activation potentially inducing genetic mutation a well a facilitating carcinogenesis and cancer progression glucose metabolism wa upregulated in both esophageal cancer tissue and cell line and the hbp wa activated in the former the cell linebased experiment demonstrated upregulation of the pentose phosphate pathway ppp at higher degree of malignancy while bile acid are not mutagenic chronic exposure seems to trigger gpd overexpression and nfkappab p activation potentially inducing genetic mutation a well a facilitating carcinogenesis and cancer progression
31215130,vocal cord inflammatory myofibroblastic tumor with mucoid deposit harboring timpalk fusion a potential diagnostic pitfall,a yearold japanese man who had experienced hoarseness for year presented with a vocal cord lesion a gross examination revealed a left vocal cord polyp occupying twothirds of the vocal space the endoscopically resected lesion contained scattered atypical fibroblastic stellate or ganglionlike cell with mucoid stroma vacuolated cell were also seen lymphoplasmacytic infiltrate wa largely undetectable a vocal cord polyp wa first suspected but welldifferentiated liposarcoma and inflammatory myofibroblastic tumor imt were included in the differential diagnosis the tumor cell were positive for anaplastic lymphoma kinase alk calponin and vimentin and negative for other smooth muscle marker by immunohistochemistry structure resembling myofibroblasts were not observed by electron microscopy which confirmed abundant rough endoplasmic reticulum in the tumor cell and accumulated lipid droplet in some tumor cell alk gene rearrangement wa detected by fluorescence in situ hybridization and timpalk fusion wa confirmed by rapid amplification of cdna end we diagnosed the lesion a an imt and an alkrearranged stellate cell tumor may be postulated this is the first report of a fusion partner gene of alk in a case of laryngeal imt,Cancer,0,vocal cord inflammatory myofibroblastic tumor with mucoid deposit harboring timpalk fusion a potential diagnostic pitfall a yearold japanese man who had experienced hoarseness for year presented with a vocal cord lesion a gross examination revealed a left vocal cord polyp occupying twothirds of the vocal space the endoscopically resected lesion contained scattered atypical fibroblastic stellate or ganglionlike cell with mucoid stroma vacuolated cell were also seen lymphoplasmacytic infiltrate wa largely undetectable a vocal cord polyp wa first suspected but welldifferentiated liposarcoma and inflammatory myofibroblastic tumor imt were included in the differential diagnosis the tumor cell were positive for anaplastic lymphoma kinase alk calponin and vimentin and negative for other smooth muscle marker by immunohistochemistry structure resembling myofibroblasts were not observed by electron microscopy which confirmed abundant rough endoplasmic reticulum in the tumor cell and accumulated lipid droplet in some tumor cell alk gene rearrangement wa detected by fluorescence in situ hybridization and timpalk fusion wa confirmed by rapid amplification of cdna end we diagnosed the lesion a an imt and an alkrearranged stellate cell tumor may be postulated this is the first report of a fusion partner gene of alk in a case of laryngeal imt
31216696,multidisciplinary challenge in mastocytosis and how to address with personalized medicine approach,mastocytosis is a hematopoietic neoplasm defined by abnormal expansion and focal accumulation of clonal tissue mast cell in various organsystems the disease exhibit a complex pathology and an equally complex clinical behavior the classification of the world health organization who divide mastocytosis into cutaneous form systemic variant and localized mast cell tumor in of patient with systemic mastocytosis sm a somatic point mutation in kit at codon is found whereas patient with indolent form of the disease have a normal or nearnormal life expectancy patient with advanced mast cell neoplasm including aggressive sm and mast cell leukemia have a poor prognosis with short survival time in a majority of these patient multiple somatic mutation andor an associated hematologic neoplasm such a a myeloid leukemia may be detected independent of the category of mastocytosis and the serum tryptase level patient may suffer from mediatorrelated symptom andor osteopathy depending on the presence of comorbidities the symptomatology in such patient may be mild severe or even lifethreatening most relevant comorbidities in such patient are igedependent allergy psychiatric psychological or mental problem and vitamin d deficiency the diagnosis and management of mastocytosis is an emerging challenge in clinical practice and requires vast knowledge a multidisciplinary approach and personalized medicine procedure in this article the current knowledge about mastocytosis is reviewed with special emphasis on the multidisciplinary aspect of the disease and related challenge in daily practice,Cancer,0,multidisciplinary challenge in mastocytosis and how to address with personalized medicine approach mastocytosis is a hematopoietic neoplasm defined by abnormal expansion and focal accumulation of clonal tissue mast cell in various organsystems the disease exhibit a complex pathology and an equally complex clinical behavior the classification of the world health organization who divide mastocytosis into cutaneous form systemic variant and localized mast cell tumor in of patient with systemic mastocytosis sm a somatic point mutation in kit at codon is found whereas patient with indolent form of the disease have a normal or nearnormal life expectancy patient with advanced mast cell neoplasm including aggressive sm and mast cell leukemia have a poor prognosis with short survival time in a majority of these patient multiple somatic mutation andor an associated hematologic neoplasm such a a myeloid leukemia may be detected independent of the category of mastocytosis and the serum tryptase level patient may suffer from mediatorrelated symptom andor osteopathy depending on the presence of comorbidities the symptomatology in such patient may be mild severe or even lifethreatening most relevant comorbidities in such patient are igedependent allergy psychiatric psychological or mental problem and vitamin d deficiency the diagnosis and management of mastocytosis is an emerging challenge in clinical practice and requires vast knowledge a multidisciplinary approach and personalized medicine procedure in this article the current knowledge about mastocytosis is reviewed with special emphasis on the multidisciplinary aspect of the disease and related challenge in daily practice
31216739,pten hamartoma tumor syndrome a clinical overview,the phosphatase and tensin homolog pten hamartoma tumor syndrome phts is a grouping of related genetic disorder that ha been linked to germline mutation in the pten gene these disorder include cowden syndrome c bannayanrileyruvalcaba syndrome adult lhermitteduclos disease and autism spectrum disorder associated with macrocephaly the majority of the clinical information available on phts however is related to individual diagnosed with c there is still much to be learned about this disorder since diagnostic criterion for c were only established in before the identification of the pten gene and were based primarily on feature seen in case reported in the existing literature more recently however data from several large series of patient have shown that a number of the clinical feature associated with pten mutation are either more or less common than previously reported in addition we now know that only about of patient meeting clinical diagnostic criterion for cowden syndrome actually have a detectable pten mutation thus our understanding of ptenrelated disease and their management ha evolved significantly over time the united state national comprehensive cancer network nccn ha produced and regularly update practice guideline which include clinical diagnostic criterion a well a guideline for pten testing and management of patient with mutation this review will summarize the overall literature on phts a well a recent finding which are broadening our understanding of this set of disorder,Cancer,0,pten hamartoma tumor syndrome a clinical overview the phosphatase and tensin homolog pten hamartoma tumor syndrome phts is a grouping of related genetic disorder that ha been linked to germline mutation in the pten gene these disorder include cowden syndrome c bannayanrileyruvalcaba syndrome adult lhermitteduclos disease and autism spectrum disorder associated with macrocephaly the majority of the clinical information available on phts however is related to individual diagnosed with c there is still much to be learned about this disorder since diagnostic criterion for c were only established in before the identification of the pten gene and were based primarily on feature seen in case reported in the existing literature more recently however data from several large series of patient have shown that a number of the clinical feature associated with pten mutation are either more or less common than previously reported in addition we now know that only about of patient meeting clinical diagnostic criterion for cowden syndrome actually have a detectable pten mutation thus our understanding of ptenrelated disease and their management ha evolved significantly over time the united state national comprehensive cancer network nccn ha produced and regularly update practice guideline which include clinical diagnostic criterion a well a guideline for pten testing and management of patient with mutation this review will summarize the overall literature on phts a well a recent finding which are broadening our understanding of this set of disorder
31216832,clinicopathological characteristic and differential diagnosis of interdigitating dendritic cell sarcoma,objective to analyze the clinicopathological feature and differential diagnosis of interdigitating dendritic cell sarcoma idcs method the clinical pathological feature of idcs were analyzed among them the followup result of case were available result among the idcs patient case were male and were female the age of the patient ranged from to yearsthree case were originated from lymph node and case were originated from skin stomach adrenal gland and mesentery respectively microscopically the tumor cell presented a fascicular and storiform proliferation and infiltrated by lymphocyte the tumor cell were shortspindle or ovoid with indistinct border of cytoplasm the immunohistochemistry result showed that tumor cell were s vim cd and cd positive and aeae ema cd cd desmin sma cdalpha cd cd cd hmb melana melanpan and alk negativethe braf mutation and clonal rearrangement of t and b cell were not detected among the followup period of idcs patient occurred disease progression conclusion idcs is extremely rare with unique pathological feature and it lesion is not limited to the lymph node the idcs patient with extensive lesion may have worse prognose the differential diagnosis of idcs includes other histiocytic and dendritic cell neoplasm malignant melanoma and soft tissue neoplasm,Cancer,0,clinicopathological characteristic and differential diagnosis of interdigitating dendritic cell sarcoma objective to analyze the clinicopathological feature and differential diagnosis of interdigitating dendritic cell sarcoma idcs method the clinical pathological feature of idcs were analyzed among them the followup result of case were available result among the idcs patient case were male and were female the age of the patient ranged from to yearsthree case were originated from lymph node and case were originated from skin stomach adrenal gland and mesentery respectively microscopically the tumor cell presented a fascicular and storiform proliferation and infiltrated by lymphocyte the tumor cell were shortspindle or ovoid with indistinct border of cytoplasm the immunohistochemistry result showed that tumor cell were s vim cd and cd positive and aeae ema cd cd desmin sma cdalpha cd cd cd hmb melana melanpan and alk negativethe braf mutation and clonal rearrangement of t and b cell were not detected among the followup period of idcs patient occurred disease progression conclusion idcs is extremely rare with unique pathological feature and it lesion is not limited to the lymph node the idcs patient with extensive lesion may have worse prognose the differential diagnosis of idcs includes other histiocytic and dendritic cell neoplasm malignant melanoma and soft tissue neoplasm
31217437,adenoviral vaccine targeting multiple neoantigens a strategy to eradicate large tumor combined with checkpoint blockade,neoantigens nag are promising tumor antigen for cancer vaccination with the potential of inducing robust and selective t cell response genetic vaccine based on adenovirus derived from nonhuman great ape gad elicit strong and effective t cellmediated immunity in human here we investigate for the first time the potency and efficacy of a novel gad encoding multiple neoantigens prophylactic or early therapeutic vaccination with gad efficiently control tumor growth in mouse in contrast combination of the vaccine with checkpoint inhibitor is required to eradicate large tumor gene expression profile of tumor in regression show abundance of activated tumor infiltrating t cell with a more diversified tcr repertoire in animal treated with gad and antipd compared to antipd data suggest that effectiveness of vaccination in the presence of high tumor burden correlate with the breadth of nagsspecific t cell and requires concomitant reversal of tumor suppression by checkpoint blockade,Cancer,0,adenoviral vaccine targeting multiple neoantigens a strategy to eradicate large tumor combined with checkpoint blockade neoantigens nag are promising tumor antigen for cancer vaccination with the potential of inducing robust and selective t cell response genetic vaccine based on adenovirus derived from nonhuman great ape gad elicit strong and effective t cellmediated immunity in human here we investigate for the first time the potency and efficacy of a novel gad encoding multiple neoantigens prophylactic or early therapeutic vaccination with gad efficiently control tumor growth in mouse in contrast combination of the vaccine with checkpoint inhibitor is required to eradicate large tumor gene expression profile of tumor in regression show abundance of activated tumor infiltrating t cell with a more diversified tcr repertoire in animal treated with gad and antipd compared to antipd data suggest that effectiveness of vaccination in the presence of high tumor burden correlate with the breadth of nagsspecific t cell and requires concomitant reversal of tumor suppression by checkpoint blockade
31220302,prognostic significance of chek mutation in progression of breast cancer,breast cancer bc is one of the most common cancer among woman genetic mutation reflect the development of this disease mutation in cell signaling factor can be the main cause of bc development in this study we focused on mutation in checkpoint kinase chek and their impact a a prognostic factor in the pathogenesis of bc chek is controlled in cell signaling pathway through the influence of upstream gene also several downstream gene are regulated by chek in addition mutation in chek lead to resistance of bc cell to chemotherapy and metastasis of cancer cell to other part of the body finally detection of mutation in chek can be used a a prognostic factor for patient response to treatment and for targeting downstream molecule of chek that are involved in the proliferation of breast tumor cell mutation such a cdelc and it can distinguish which patient are susceptible to metastasis,Cancer,0,prognostic significance of chek mutation in progression of breast cancer breast cancer bc is one of the most common cancer among woman genetic mutation reflect the development of this disease mutation in cell signaling factor can be the main cause of bc development in this study we focused on mutation in checkpoint kinase chek and their impact a a prognostic factor in the pathogenesis of bc chek is controlled in cell signaling pathway through the influence of upstream gene also several downstream gene are regulated by chek in addition mutation in chek lead to resistance of bc cell to chemotherapy and metastasis of cancer cell to other part of the body finally detection of mutation in chek can be used a a prognostic factor for patient response to treatment and for targeting downstream molecule of chek that are involved in the proliferation of breast tumor cell mutation such a cdelc and it can distinguish which patient are susceptible to metastasis
31220642,clinical and pathological characterization of lynchlike syndrome,background aim lynch syndrome is characterized by dna mismatch repair mmr deficiency some patient with suspected lynch syndrome have dna mmr deficiency but no detectable mutation in gene that encode mmr proteinsthis is called lynchlike syndrome lls there is no consensus on management of patient with lls we collected data from a large series of patient with lls to identify clinical and pathology feature method we collected data from a nationwideregistry of patient with colorectal cancer crc in spain we identified patient whose colorectal tumor had loss of msh msh pm or mlh based on immunohistochemistry without the mutation encoding ve in braf detected by realtime pcr andor no methylation at mlh determined by methylationspecific multiplex ligationdependent probe amplification and no pathogenic mutation in mmr gene braf or epcam determined by dna sequencing these patient were considered to have lls we collected data on demographic clinical and pathology feature and family history of neoplasm the chi test wa used to analyze the association between qualitative variable followed by the fisher exact test and the student t test or the mannwhitney test for quantitative variable result we identified patient with lls their mean age at diagnosis of crc wa year and patient were female the amsterdam i and ii criterion for lynch syndrome were fulfilled by of case and the revised bethesda guideline criterion by of case of the patient with lls were identified in universal screening there were no proportional difference in sex indication for colonoscopy immunohistochemistry pathology finding or personal history of crc or other lynch syndromerelated tumor between patient who met the amsterdam andor bethesda criterion for lynch syndrome and patient identified in universal screening for lynch syndrome without a family history of crc conclusion patient with lls have homogeneous clinical demographic and pathology characteristic regardless of family history of crc,Cancer,0,clinical and pathological characterization of lynchlike syndrome background aim lynch syndrome is characterized by dna mismatch repair mmr deficiency some patient with suspected lynch syndrome have dna mmr deficiency but no detectable mutation in gene that encode mmr proteinsthis is called lynchlike syndrome lls there is no consensus on management of patient with lls we collected data from a large series of patient with lls to identify clinical and pathology feature method we collected data from a nationwideregistry of patient with colorectal cancer crc in spain we identified patient whose colorectal tumor had loss of msh msh pm or mlh based on immunohistochemistry without the mutation encoding ve in braf detected by realtime pcr andor no methylation at mlh determined by methylationspecific multiplex ligationdependent probe amplification and no pathogenic mutation in mmr gene braf or epcam determined by dna sequencing these patient were considered to have lls we collected data on demographic clinical and pathology feature and family history of neoplasm the chi test wa used to analyze the association between qualitative variable followed by the fisher exact test and the student t test or the mannwhitney test for quantitative variable result we identified patient with lls their mean age at diagnosis of crc wa year and patient were female the amsterdam i and ii criterion for lynch syndrome were fulfilled by of case and the revised bethesda guideline criterion by of case of the patient with lls were identified in universal screening there were no proportional difference in sex indication for colonoscopy immunohistochemistry pathology finding or personal history of crc or other lynch syndromerelated tumor between patient who met the amsterdam andor bethesda criterion for lynch syndrome and patient identified in universal screening for lynch syndrome without a family history of crc conclusion patient with lls have homogeneous clinical demographic and pathology characteristic regardless of family history of crc
31221662,mutation status of ra tp and smad is superior to mutation status of ra alone for predicting prognosis after resection of colorectal liver metastasis,purpose somatic gene mutation have been increasingly recognized to impact prognosis following resection of colorectal liver metastasis clm we aimed to determine the impact of combination of somatic mutation on survival in patient undergoing clm resection experimental design we identified patient who underwent initial clm resection during and had genetic sequencing data available risk factor for overall survival o and recurrencefree survival rf were determined using cox proportional hazard model result of patient who underwent clm resection during the study period met the inclusion criterion multigene testing revealed mutation rate greater than for tp mutated in of patient apc ra pikca and smad braf wa mutated in of patient braf ra tp and smad mutation were significantly associated with o and ra tp and smad mutation were significantly associated with rf coexisting mutation in ra tp and smad were associated with significantly worse o and rf than coexisting mutation in any of these gene and mutation in or none of these gene coexisting mutation in gene conferred significantly worse o and rf than single mutation or no mutation o and rf did not differ significantly between patient with ra mutation and wildtype tp and smad and patient with wildtype ra p and respectively conclusion ra mutation status alone is not sufficient for precisely predicting prognosis after clm resection,Cancer,0,mutation status of ra tp and smad is superior to mutation status of ra alone for predicting prognosis after resection of colorectal liver metastasis purpose somatic gene mutation have been increasingly recognized to impact prognosis following resection of colorectal liver metastasis clm we aimed to determine the impact of combination of somatic mutation on survival in patient undergoing clm resection experimental design we identified patient who underwent initial clm resection during and had genetic sequencing data available risk factor for overall survival o and recurrencefree survival rf were determined using cox proportional hazard model result of patient who underwent clm resection during the study period met the inclusion criterion multigene testing revealed mutation rate greater than for tp mutated in of patient apc ra pikca and smad braf wa mutated in of patient braf ra tp and smad mutation were significantly associated with o and ra tp and smad mutation were significantly associated with rf coexisting mutation in ra tp and smad were associated with significantly worse o and rf than coexisting mutation in any of these gene and mutation in or none of these gene coexisting mutation in gene conferred significantly worse o and rf than single mutation or no mutation o and rf did not differ significantly between patient with ra mutation and wildtype tp and smad and patient with wildtype ra p and respectively conclusion ra mutation status alone is not sufficient for precisely predicting prognosis after clm resection
31230400,mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted nextgeneration sequencing,aim to characterise the mutational profile of poorly differentiated thyroid carcinoma pdtc and anaplastic thyroid carcinoma atc and to identify marker with potential diagnostic prognostic and therapeutic significance method and result targeted nextgeneration sequencing with a panel of thyroid carcinomarelated gene wa performed on tissue sample from pdtc and atc patient genetic alteration and their correlation with clinicopathological factor including survival outcome were also analysed our result showed that atc had significantly higher mutation rate of braf tp tert and pikca than pdtc p p p and p respectively nine atc case with papillary thyroid carcinoma ptc component harboured braf mutation all of which coexisted with a late mutation event tp tert or pikca nine case with oncogenic fusion six ret case one ntrk case one alk case and one pparg case were identified in pdtcs whereas only one case with oncogenic fusion ntrk wa found among atcs moreover all six case of ret fusion were found in pdtc with ptc component accounting for in pdtcatc patient concurrent tert and pikca mutation were associated with poor overall survival after adjustment for tnm stage p conclusion atc with ptc component is typically characterised by a braf mutation with a late mutation event whereas pdtc with ptc component is more closely correlated with ret fusion tert and concurrent pikca mutation predict worse overall survival in pdtcatc patient,Cancer,0,mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted nextgeneration sequencing aim to characterise the mutational profile of poorly differentiated thyroid carcinoma pdtc and anaplastic thyroid carcinoma atc and to identify marker with potential diagnostic prognostic and therapeutic significance method and result targeted nextgeneration sequencing with a panel of thyroid carcinomarelated gene wa performed on tissue sample from pdtc and atc patient genetic alteration and their correlation with clinicopathological factor including survival outcome were also analysed our result showed that atc had significantly higher mutation rate of braf tp tert and pikca than pdtc p p p and p respectively nine atc case with papillary thyroid carcinoma ptc component harboured braf mutation all of which coexisted with a late mutation event tp tert or pikca nine case with oncogenic fusion six ret case one ntrk case one alk case and one pparg case were identified in pdtcs whereas only one case with oncogenic fusion ntrk wa found among atcs moreover all six case of ret fusion were found in pdtc with ptc component accounting for in pdtcatc patient concurrent tert and pikca mutation were associated with poor overall survival after adjustment for tnm stage p conclusion atc with ptc component is typically characterised by a braf mutation with a late mutation event whereas pdtc with ptc component is more closely correlated with ret fusion tert and concurrent pikca mutation predict worse overall survival in pdtcatc patient
31231679,seterpr a robust gene predictor for sensitivity to endocrine therapy for metastatic breast cancer,there is a clinical need to predict sensitivity of metastatic hormone receptorpositive and hernegative hrher breast cancer to endocrine therapy and targeted rna sequencing rnaseq offer diagnostic potential to measure both transcriptional activity and functional mutation we developed the seterpr index to measure gene expression microarray probe set that were correlated with hormone receptor esr and pgr and robust to preanalytical and analytical influence we tested seterpr index in biopsy of metastastic hrher breast cancer against the treatment outcome in patient then we customized the seterpr assay to measure informative reference transcript and sequence the ligandbinding domain lbd of esr using dropletbased targeted rnaseq and tested that in residual rna from patient higher seterpr index in metastatic sample predicted longer pfs and o when patient received endocrine therapy a next treatment even after adjustment for clinicalpathologic risk factor pfs hr ci to p o hr ci to p mutated esr lbd wa detected in of metastasis involving of esr transcript all had high seterpr index a signature based on probe set with good preanalytical and analytical performance facilitated our customization of an accurate targeted rnaseq assay to measure both phenotype and genotype of errelated transcription elevated seterpr wa associated with prolonged sensitivity to endocrine therapy in patient with metastatic hrher breast cancer especially in the absence of mutated esr transcript,Cancer,0,seterpr a robust gene predictor for sensitivity to endocrine therapy for metastatic breast cancer there is a clinical need to predict sensitivity of metastatic hormone receptorpositive and hernegative hrher breast cancer to endocrine therapy and targeted rna sequencing rnaseq offer diagnostic potential to measure both transcriptional activity and functional mutation we developed the seterpr index to measure gene expression microarray probe set that were correlated with hormone receptor esr and pgr and robust to preanalytical and analytical influence we tested seterpr index in biopsy of metastastic hrher breast cancer against the treatment outcome in patient then we customized the seterpr assay to measure informative reference transcript and sequence the ligandbinding domain lbd of esr using dropletbased targeted rnaseq and tested that in residual rna from patient higher seterpr index in metastatic sample predicted longer pfs and o when patient received endocrine therapy a next treatment even after adjustment for clinicalpathologic risk factor pfs hr ci to p o hr ci to p mutated esr lbd wa detected in of metastasis involving of esr transcript all had high seterpr index a signature based on probe set with good preanalytical and analytical performance facilitated our customization of an accurate targeted rnaseq assay to measure both phenotype and genotype of errelated transcription elevated seterpr wa associated with prolonged sensitivity to endocrine therapy in patient with metastatic hrher breast cancer especially in the absence of mutated esr transcript
31234577,genomewide analysis of long noncoding rna profile in canine oral melanoma,mucosal melanoma mm are rare aggressive cancer in human and one of the most common form of oral cancer in dog similar biological and histological feature are shared between mm in both specie making dog a powerful model for comparative oncology study of melanoma although exome sequencing recently identified recurrent coding mutation in canine mm little is known about change in noncoding gene expression and more particularly in canine long noncoding rna lncrnas which are commonly dysregulated in human cancer here we sampled a large cohort n of canine normaltumor oral mm from three predisposed breed poodle labrador retriever and golden retriever and used deep transcriptome sequencing to identify more than differentially expressed de lncrnas we further prioritized candidate lncrnas by comparative genomic analysis to pinpoint doghuman conserved de lncrnas including soxas zebas and casc lncrnas using unsupervised coexpression network analysis with coding gene we inferred the potential function of the de lncrnas suggesting association with cancerrelated gene cell cycle and carbohydrate metabolism gene ontology go term finally we exploited our multibreed design to identify de lncrnas within breed this study provides a unique transcriptomic resource for studying oral melanoma in dog and highlight lncrnas that may potentially be diagnostic or therapeutic target for human and veterinary medicine,Cancer,0,genomewide analysis of long noncoding rna profile in canine oral melanoma mucosal melanoma mm are rare aggressive cancer in human and one of the most common form of oral cancer in dog similar biological and histological feature are shared between mm in both specie making dog a powerful model for comparative oncology study of melanoma although exome sequencing recently identified recurrent coding mutation in canine mm little is known about change in noncoding gene expression and more particularly in canine long noncoding rna lncrnas which are commonly dysregulated in human cancer here we sampled a large cohort n of canine normaltumor oral mm from three predisposed breed poodle labrador retriever and golden retriever and used deep transcriptome sequencing to identify more than differentially expressed de lncrnas we further prioritized candidate lncrnas by comparative genomic analysis to pinpoint doghuman conserved de lncrnas including soxas zebas and casc lncrnas using unsupervised coexpression network analysis with coding gene we inferred the potential function of the de lncrnas suggesting association with cancerrelated gene cell cycle and carbohydrate metabolism gene ontology go term finally we exploited our multibreed design to identify de lncrnas within breed this study provides a unique transcriptomic resource for studying oral melanoma in dog and highlight lncrnas that may potentially be diagnostic or therapeutic target for human and veterinary medicine
31239713,androgen upregulates the palmitoylation of eifl in human prostate lncap cell,background prostate cancer is the second leading cause of cancerrelated death in western country most patient diagnosed with advanced prostate cancer can be treated with the main treatment androgen deprivation therapy adt the androgen receptor ar signaling axis play a pivotal role in the progression of prostate cancer however most patient can ultimately progress to the castrationresistant prostate cancer crpc stage within year at this stage drug targeting the ar signaling axis including enzalutamide and abiraterone acetate can not prevent the progression of prostate cancer thus predicting a poor prognosis the molecular mechanism lie in the aberrant ar reactivation which exhibit an adaptive response to adt such a the presence of ar splice variant thus crpc treatment remains a challenge purpose in addition to the ar axis a mechanism leading to this progression should be determined the present study mainly compared palmitoylated protein between androgentreated lncap cell and nontreated lncap cell by palmitoylome profiling to illustrate the change at proteomic level material and method to screen the androgeninduced palmitoylated protein we conducted proteomic experiment using clickable palmitate probe alkc between three individual pair of androgentreated and nontreated lncap cell result we identified unique peptide corresponding to protein among them a number of these identified protein were palmitoylated protein particularly eifl androgen treatment significantly increased the palmitoylation level of eifl an individual subunit of eif a an initiation factor eifl play a pivotal role in the translation of mrna encoding growthpromoting protein by enhancing translation rate thus controlling cell proliferation conclusion in this study we demonstrated that the regulation of eifl palmitoylation may provide new direction for the therapy of prostate cancer moreover the increased level of androgeninduced eifl may be used a a biomarker for the diagnosis of earlystage prostate cancer,Cancer,0,androgen upregulates the palmitoylation of eifl in human prostate lncap cell background prostate cancer is the second leading cause of cancerrelated death in western country most patient diagnosed with advanced prostate cancer can be treated with the main treatment androgen deprivation therapy adt the androgen receptor ar signaling axis play a pivotal role in the progression of prostate cancer however most patient can ultimately progress to the castrationresistant prostate cancer crpc stage within year at this stage drug targeting the ar signaling axis including enzalutamide and abiraterone acetate can not prevent the progression of prostate cancer thus predicting a poor prognosis the molecular mechanism lie in the aberrant ar reactivation which exhibit an adaptive response to adt such a the presence of ar splice variant thus crpc treatment remains a challenge purpose in addition to the ar axis a mechanism leading to this progression should be determined the present study mainly compared palmitoylated protein between androgentreated lncap cell and nontreated lncap cell by palmitoylome profiling to illustrate the change at proteomic level material and method to screen the androgeninduced palmitoylated protein we conducted proteomic experiment using clickable palmitate probe alkc between three individual pair of androgentreated and nontreated lncap cell result we identified unique peptide corresponding to protein among them a number of these identified protein were palmitoylated protein particularly eifl androgen treatment significantly increased the palmitoylation level of eifl an individual subunit of eif a an initiation factor eifl play a pivotal role in the translation of mrna encoding growthpromoting protein by enhancing translation rate thus controlling cell proliferation conclusion in this study we demonstrated that the regulation of eifl palmitoylation may provide new direction for the therapy of prostate cancer moreover the increased level of androgeninduced eifl may be used a a biomarker for the diagnosis of earlystage prostate cancer
31239718,ilex hainanensis merr target itgav to suppress the proliferation and metastasis of osteosarcoma cell,background osteosarcoma o is the most common primary malignant bone tumor hence there is an urgent need to identify effective and safe therapeutic agent against o it ha been reported that ilex hainanensis merr ime possesses antitumor property integrin subunit alpha v itgav is important for the diagnosis treatment and prognosis of tumor purpose the objective of this study wa to whether ime can play a role in the treatment of osteosarcoma by regulating itgav method western blot and realtime pcr were used to detect the expression of itgav in nontumorous tissue osteosarcoma tissue and metastatic tumor the expression of itgav in mg uos and hfob a total of cell wa determined through western blotting and realtime pcr the expression of itgav in o cell treated with different concentration of ddp wa determined through western blotting agter transfecting with control or siitgav and subsequently treated with control or mumoll ddp mtt assay and transwell assay were used to detect the proliferaion and migration of cell western blot wa used to detect the expression of itgav in cell treated with different concentration of ime and mtt assay and transwell assay were used to detect the proliferaion and migration of cell mg and uos cell were treated with control mumoll ddp mumoll ime or mumoll ddp combined with mumoll ime the expression of itgav wa determined through western blotting and realtime pcr mtt assay and transwell assay were used to detect the proliferation and migration of cell inhibitory effect of ime on lung metastasis of osteosarcoma in vivo result itgav wa highly expressed in tumor with the highest expression found in metastatic tumor and higher in o cell a low concentration of ddp mumoll inhibited the expression of itgav however itgav may be related to the development of resistance to ddp silencing of itgav downregulates the proliferation and migration of o cell a the effect of lowconcentration ddp mumoll ime inhibited the proliferation and migration of mg and uos cell in a concentrationdependent manner and decreased the expression of itgav mtt and transwell assay showed that mumoll ime and mumoll ddp exhibited similar inhibitory effect on the proliferation and migration of o cell the combination of ime with ddp resulted in the amplification of these inhibitory effect both ddp and ime downregulated the expression of itgav and the inhibition of itgav wa amplified by the combination of ime with ddp invivo study have shown that ime and ddp independently or in combination may significantly inhibit the metastasis of o to the lung conclusion ime may reduce the resistance of o cell to ddp to some extent,Cancer,0,ilex hainanensis merr target itgav to suppress the proliferation and metastasis of osteosarcoma cell background osteosarcoma o is the most common primary malignant bone tumor hence there is an urgent need to identify effective and safe therapeutic agent against o it ha been reported that ilex hainanensis merr ime possesses antitumor property integrin subunit alpha v itgav is important for the diagnosis treatment and prognosis of tumor purpose the objective of this study wa to whether ime can play a role in the treatment of osteosarcoma by regulating itgav method western blot and realtime pcr were used to detect the expression of itgav in nontumorous tissue osteosarcoma tissue and metastatic tumor the expression of itgav in mg uos and hfob a total of cell wa determined through western blotting and realtime pcr the expression of itgav in o cell treated with different concentration of ddp wa determined through western blotting agter transfecting with control or siitgav and subsequently treated with control or mumoll ddp mtt assay and transwell assay were used to detect the proliferaion and migration of cell western blot wa used to detect the expression of itgav in cell treated with different concentration of ime and mtt assay and transwell assay were used to detect the proliferaion and migration of cell mg and uos cell were treated with control mumoll ddp mumoll ime or mumoll ddp combined with mumoll ime the expression of itgav wa determined through western blotting and realtime pcr mtt assay and transwell assay were used to detect the proliferation and migration of cell inhibitory effect of ime on lung metastasis of osteosarcoma in vivo result itgav wa highly expressed in tumor with the highest expression found in metastatic tumor and higher in o cell a low concentration of ddp mumoll inhibited the expression of itgav however itgav may be related to the development of resistance to ddp silencing of itgav downregulates the proliferation and migration of o cell a the effect of lowconcentration ddp mumoll ime inhibited the proliferation and migration of mg and uos cell in a concentrationdependent manner and decreased the expression of itgav mtt and transwell assay showed that mumoll ime and mumoll ddp exhibited similar inhibitory effect on the proliferation and migration of o cell the combination of ime with ddp resulted in the amplification of these inhibitory effect both ddp and ime downregulated the expression of itgav and the inhibition of itgav wa amplified by the combination of ime with ddp invivo study have shown that ime and ddp independently or in combination may significantly inhibit the metastasis of o to the lung conclusion ime may reduce the resistance of o cell to ddp to some extent
31240453,roundcell sarcoma,roundcell sarcoma represent highly malignant tumor that occur predominantly in child adolescent and young adult roundcell sarcoma are caused by recurrent translocation that involve certain transcription factor ewings sarcoma ewinglike sarcoma eg cicdux positive or bcor positive sarcoma desmoplastic small roundcell tumor dsrcts and alveolar rhabdomyosarcoma arm are typical example of this particular group of sarcoma these entity differ in their tumor genetics which is correlated with immunohistochemical expression profile and with clinical phenotype classification should be based on molecular finding immunohistochemistry may serve a a surrogate marker,Cancer,0,roundcell sarcoma roundcell sarcoma represent highly malignant tumor that occur predominantly in child adolescent and young adult roundcell sarcoma are caused by recurrent translocation that involve certain transcription factor ewings sarcoma ewinglike sarcoma eg cicdux positive or bcor positive sarcoma desmoplastic small roundcell tumor dsrcts and alveolar rhabdomyosarcoma arm are typical example of this particular group of sarcoma these entity differ in their tumor genetics which is correlated with immunohistochemical expression profile and with clinical phenotype classification should be based on molecular finding immunohistochemistry may serve a a surrogate marker
31240697,circular rna a novel biomarker for cervical cancer,besides messenger rna recent rnaseq and biochemical analysis showed another type of rna a a product of splicing which is named circular rna circrna evidence demonstrated that circrnas are abundant in the cell and are able to show celltissuespecific expression or tissue developmental stage which suggest that circrnas may have regulatory potential in recent year researcher have focused attention on circrnas because of their key function in various cellular mechanism circrnas also have the potential to be a promising biomarkers for diagnosis of various disease such a cancer growing up evidence ha shown the various role of circrnas in multiple cancer in recent year cervical cancer a one of the main cause of cancer death in woman ha been interesting for molecular research circrnas are one of the novel object which have recently been evaluated in this cancer the improvement in our knowledge of the role of circrnas in cervical cancer may lead to new transcription therapeutic approach to cervical cancer inhibition therefore the purpose of this review is to review many study which examined the role of circrnas in cervical cancer carcinogenesis and progression up till date and to summarize possible mechanism of action of circrnas in cervical neoplasm,Cancer,0,circular rna a novel biomarker for cervical cancer besides messenger rna recent rnaseq and biochemical analysis showed another type of rna a a product of splicing which is named circular rna circrna evidence demonstrated that circrnas are abundant in the cell and are able to show celltissuespecific expression or tissue developmental stage which suggest that circrnas may have regulatory potential in recent year researcher have focused attention on circrnas because of their key function in various cellular mechanism circrnas also have the potential to be a promising biomarkers for diagnosis of various disease such a cancer growing up evidence ha shown the various role of circrnas in multiple cancer in recent year cervical cancer a one of the main cause of cancer death in woman ha been interesting for molecular research circrnas are one of the novel object which have recently been evaluated in this cancer the improvement in our knowledge of the role of circrnas in cervical cancer may lead to new transcription therapeutic approach to cervical cancer inhibition therefore the purpose of this review is to review many study which examined the role of circrnas in cervical cancer carcinogenesis and progression up till date and to summarize possible mechanism of action of circrnas in cervical neoplasm
31241739,establishment of permutation for cancer risk estimation in the urothelium based on genomewide dna methylation analysis,the aim of this study wa to establish permutation for cancer risk estimation in the urothelium twentysix sample of normal control urothelium obtained from patient without urothelial carcinoma c sample of noncancerous urothelium without noticeable morphological change obtained from patient with urothelial carcinoma n and sample of the corresponding cancerous tissue t in the learning cohort and n sample in the validation cohort ie tissue sample in total were analyzed genomewide dna methylation analysis wa performed using the infinium humanmethylation k beadchip and dna methylation level were verified using pyrosequencing and massarray amplicon sequencing wa performed using the generead dnaseq targeted panel v although n sample rarely showed genetic mutation or copy number alteration they showed dna methylation alteration at cpg site compared to c sample and such alteration were inherited by or strengthened in t sample indicating that dna methylation alteration may participate in field cancerization in the urothelium receiver operating characteristic curve analysis confirmed the feasibility of cancer risk estimation to identify urothelium at the precancerous stage by dna methylation quantification cancer risk estimation permutation wa established using a combination of two marker cpg locus on the hoxc tenm and tlr gene sensitivity and specificity among them the diagnostic impact of pattern of permutation wa successfully validated in the validation cohort sensitivity and specificity these data suggest that cancer risk estimation using procedure such a urine test during health checkup might become applicable for clinical use,Cancer,0,establishment of permutation for cancer risk estimation in the urothelium based on genomewide dna methylation analysis the aim of this study wa to establish permutation for cancer risk estimation in the urothelium twentysix sample of normal control urothelium obtained from patient without urothelial carcinoma c sample of noncancerous urothelium without noticeable morphological change obtained from patient with urothelial carcinoma n and sample of the corresponding cancerous tissue t in the learning cohort and n sample in the validation cohort ie tissue sample in total were analyzed genomewide dna methylation analysis wa performed using the infinium humanmethylation k beadchip and dna methylation level were verified using pyrosequencing and massarray amplicon sequencing wa performed using the generead dnaseq targeted panel v although n sample rarely showed genetic mutation or copy number alteration they showed dna methylation alteration at cpg site compared to c sample and such alteration were inherited by or strengthened in t sample indicating that dna methylation alteration may participate in field cancerization in the urothelium receiver operating characteristic curve analysis confirmed the feasibility of cancer risk estimation to identify urothelium at the precancerous stage by dna methylation quantification cancer risk estimation permutation wa established using a combination of two marker cpg locus on the hoxc tenm and tlr gene sensitivity and specificity among them the diagnostic impact of pattern of permutation wa successfully validated in the validation cohort sensitivity and specificity these data suggest that cancer risk estimation using procedure such a urine test during health checkup might become applicable for clinical use
31242861,dock mutation diagnosed using wholeexome sequencing of the dried blood spotderived dna a case report of an iraqi girl diagnosed in japan,background dedicator of cytokinesis dock deficiency mim is a rare disease lead to a combined primary immunodeficiency pid and account for the autosomal recessivehyper immunoglobulin e syndrome arhies dock deficiency status characterizes by recurrent infection atopy and risk of cancer lymphoproliferative disease complicating pid is difficult to diagnose our aim is to present a rare case of pid and to the best of our knowledge she is the first case of dock deficiency from iraq the genetic diagnosis wa carried out in japan using dried blood spotbased dna transfer and wholeexome sequencing case presentation an yearold iraqi girl of double firstcousinparents had a history of severe eczema food allergy and repeated infection she presented with a jaw mass bilateral cervical and axillary lymphadenopathy and immunoglobulin ig assay of and fold above maximum normal level for age of ige iga and igg respectively along with a low igm eosinophilia and lymphopenia based on the jaw mass biopsy nonhodgkin lymphoma wa suggested in iraq whereas histopathological reevaluation in japan revealed the diagnosis of a polyclonal reactive proliferation spectrum of lymphoproliferative disordersplasmacytic hyperplasia complicating pid wholeexome sequencing supported the diagnosis of pid by identifying a homozygous dock mutation with previously reported pathogenicity nmcdelt ppheleufs that may be attributed to consanguinity conclusion international collaboration using an effective dna transportation technique and nextgeneration sequencing wa the key to pinpoint the diagnosis of dock deficiency our case asserted that careful pathogenetic evaluation in an advanced setting wa crucial for ruling out the neoplastic process pediatrician in area with a high prevalence of consanguinity marriage should have a high index of suspicion of dock deficiency in patient with recalcitrant eczema and frequent respiratory and skin infectious episode,Cancer,0,dock mutation diagnosed using wholeexome sequencing of the dried blood spotderived dna a case report of an iraqi girl diagnosed in japan background dedicator of cytokinesis dock deficiency mim is a rare disease lead to a combined primary immunodeficiency pid and account for the autosomal recessivehyper immunoglobulin e syndrome arhies dock deficiency status characterizes by recurrent infection atopy and risk of cancer lymphoproliferative disease complicating pid is difficult to diagnose our aim is to present a rare case of pid and to the best of our knowledge she is the first case of dock deficiency from iraq the genetic diagnosis wa carried out in japan using dried blood spotbased dna transfer and wholeexome sequencing case presentation an yearold iraqi girl of double firstcousinparents had a history of severe eczema food allergy and repeated infection she presented with a jaw mass bilateral cervical and axillary lymphadenopathy and immunoglobulin ig assay of and fold above maximum normal level for age of ige iga and igg respectively along with a low igm eosinophilia and lymphopenia based on the jaw mass biopsy nonhodgkin lymphoma wa suggested in iraq whereas histopathological reevaluation in japan revealed the diagnosis of a polyclonal reactive proliferation spectrum of lymphoproliferative disordersplasmacytic hyperplasia complicating pid wholeexome sequencing supported the diagnosis of pid by identifying a homozygous dock mutation with previously reported pathogenicity nmcdelt ppheleufs that may be attributed to consanguinity conclusion international collaboration using an effective dna transportation technique and nextgeneration sequencing wa the key to pinpoint the diagnosis of dock deficiency our case asserted that careful pathogenetic evaluation in an advanced setting wa crucial for ruling out the neoplastic process pediatrician in area with a high prevalence of consanguinity marriage should have a high index of suspicion of dock deficiency in patient with recalcitrant eczema and frequent respiratory and skin infectious episode
31243107,stk pgw a novel mutation detected in a case of msi high mixed medullarymucinous carcinoma of the transverse colon,backgroundaim to report a case of mixed medullarymucinous adenocarcinoma with unusual mutational gene profile patient and method a yearold female wa diagnosed with a colorectal carcinoma of the transverse colon the diagnostic workup of this case included thorough clinicopathological evaluation immunohistochemistry and next generation sequencing result the clinicopathological evaluation showed a tumor with morphological feature of both medullary and mucinous colorectal carcinoma immunohistochemistry revealed the loss of dna mismatch repair protein ng showed that the medullary component of this tumor had a novel stk pgw mutation which wa not present in the mucinous component both the medullary and mucinous component also had braf ve and akt pek mutation conclusion we report a novel mutation stk pgw in medullary carcinoma of the colon with an associated mucinous component,Cancer,0,stk pgw a novel mutation detected in a case of msi high mixed medullarymucinous carcinoma of the transverse colon backgroundaim to report a case of mixed medullarymucinous adenocarcinoma with unusual mutational gene profile patient and method a yearold female wa diagnosed with a colorectal carcinoma of the transverse colon the diagnostic workup of this case included thorough clinicopathological evaluation immunohistochemistry and next generation sequencing result the clinicopathological evaluation showed a tumor with morphological feature of both medullary and mucinous colorectal carcinoma immunohistochemistry revealed the loss of dna mismatch repair protein ng showed that the medullary component of this tumor had a novel stk pgw mutation which wa not present in the mucinous component both the medullary and mucinous component also had braf ve and akt pek mutation conclusion we report a novel mutation stk pgw in medullary carcinoma of the colon with an associated mucinous component
31244296,identification of flt and npm mutation in patient with acute myeloid leukaemia,objective the most frequent acquired molecular abnormality and important prognostic indicator in patientswith acute myeloid leukaemia aml are fmslike tyrosine kinase gene flt and nucleophosmin npmmutations our study aim to develop a cost effective and comprehensive inhouse conventional pcr method fordetection of fltitd fltd and npm mutation and to evaluate the frequency of these mutation in patientswith cytogenetically normal cn aml in our population method a total of sample from aml patient woman men were included in the study mutation analysis were performed using polymerase chain reactionpcr and gene sequencing result sixtyeight patient were positive for the mutation fltitd mutation weredetected in patient followed by fltd in and npm in double mutation ofnpm and fltitd were detected in case assay validation were performed using sanger sequencingand showed concordance with in house method conclusion the optimized inhouse pcr assay for thedetection of fltitd fltd and npm mutation in aml patient were robust less labour intensive and costeffective these assay can be used a diagnostic tool for mutation detection in aml patient since identification ofthese mutation are important for prognostication and optimization of patient care,Cancer,0,identification of flt and npm mutation in patient with acute myeloid leukaemia objective the most frequent acquired molecular abnormality and important prognostic indicator in patientswith acute myeloid leukaemia aml are fmslike tyrosine kinase gene flt and nucleophosmin npmmutations our study aim to develop a cost effective and comprehensive inhouse conventional pcr method fordetection of fltitd fltd and npm mutation and to evaluate the frequency of these mutation in patientswith cytogenetically normal cn aml in our population method a total of sample from aml patient woman men were included in the study mutation analysis were performed using polymerase chain reactionpcr and gene sequencing result sixtyeight patient were positive for the mutation fltitd mutation weredetected in patient followed by fltd in and npm in double mutation ofnpm and fltitd were detected in case assay validation were performed using sanger sequencingand showed concordance with in house method conclusion the optimized inhouse pcr assay for thedetection of fltitd fltd and npm mutation in aml patient were robust less labour intensive and costeffective these assay can be used a diagnostic tool for mutation detection in aml patient since identification ofthese mutation are important for prognostication and optimization of patient care
31244646,braf nonve mutated metastatic colorectal cancer in a young patient discussion from a case report,we report the case of a yearold man with a caecal adenocarcinoma with major lymph node extension and peritoneal carcinomatosis presenting a brafke mutation a triplet fu plus oxaliplatin plus irinotecan combination with bevacizumab achieved tumor control but the disease progressed immediately after cessation and the patient died month after the diagnosis a short review of braf nonve mutation show that outcome and clinical feature depend on the mutation,Cancer,0,braf nonve mutated metastatic colorectal cancer in a young patient discussion from a case report we report the case of a yearold man with a caecal adenocarcinoma with major lymph node extension and peritoneal carcinomatosis presenting a brafke mutation a triplet fu plus oxaliplatin plus irinotecan combination with bevacizumab achieved tumor control but the disease progressed immediately after cessation and the patient died month after the diagnosis a short review of braf nonve mutation show that outcome and clinical feature depend on the mutation
31247903,leveraging the role of the metastatic associated protein anterior gradient homologue in unfolded protein degradation a novel therapeutic biomarker for cancer,effective diagnostic prognostic and therapeutic biomarkers can help in tracking disease progress predict patient survival and considerably affect the drive for successful clinical management the present review aim to determine how the metastaticlinked protein anterior gradient homologue agr operates to affect cancer progression and to identify associated potential diagnostic prognostic and therapeutic biomarkers particularly in central nervous system cns tumor study that show a high expression level of agr and associate the protein expression with the resilience to chemotherapeutic treatment or with poor cancer survival are reported the primary protein structure of the seven variant of agr including their functional domain are summarized based on experiment in various biological model this review show an orchestra of multiple molecule that regulate agr expression including a feedback loop with p the agrassociated molecular function and pathway including genomic integrity proliferation apoptosis angiogenesis adhesion migration stemness and inflammation are detailed in addition the mechanism that can enable the rampant oncogenic effect of agr are clarified the different strategy used to therapeutically target agrpositive cancer cell are evaluated in light of the current evidence moreover novel associated pathway and clinically relevant deregulated gene in agr high cns tumor are identified using a metaanalysis approach,Cancer,0,leveraging the role of the metastatic associated protein anterior gradient homologue in unfolded protein degradation a novel therapeutic biomarker for cancer effective diagnostic prognostic and therapeutic biomarkers can help in tracking disease progress predict patient survival and considerably affect the drive for successful clinical management the present review aim to determine how the metastaticlinked protein anterior gradient homologue agr operates to affect cancer progression and to identify associated potential diagnostic prognostic and therapeutic biomarkers particularly in central nervous system cns tumor study that show a high expression level of agr and associate the protein expression with the resilience to chemotherapeutic treatment or with poor cancer survival are reported the primary protein structure of the seven variant of agr including their functional domain are summarized based on experiment in various biological model this review show an orchestra of multiple molecule that regulate agr expression including a feedback loop with p the agrassociated molecular function and pathway including genomic integrity proliferation apoptosis angiogenesis adhesion migration stemness and inflammation are detailed in addition the mechanism that can enable the rampant oncogenic effect of agr are clarified the different strategy used to therapeutically target agrpositive cancer cell are evaluated in light of the current evidence moreover novel associated pathway and clinically relevant deregulated gene in agr high cns tumor are identified using a metaanalysis approach
31248416,identification of novel pathogenic msh mutation and new dna repair gene variant investigation of a tunisian lynch syndrome family with discordant twin,background lynch syndrome l is a highly penetrant inherited cancer predisposition syndrome characterized by autosomal dominant inheritance and germline mutation in dna mismatch repair gene despite several genetic variation that have been identified in various population the penetrance is highly variable and the reason for this have not been fully elucidated this study investigates whether besides pathogenic mutation environment and low penetrance genetic risk factor may result in phenotype modification in a tunisian l family patient and method a tunisian family with strong colorectal cancer crc history that fulfill the amsterdam i criterion for the diagnosis of lynch syndrome wa proposed for oncogenetic counseling the index case wa a man diagnosed at the age of year with crc he ha a monozygotic twin diagnosed at the age of year with crohn disease fortyseven yearsold wa the onset age of his paternal uncle withcrc an immunohistochemical ihc labeling for the four protein mlh msh msh and pm of the mismatchrepair mmr system wa performed for the index case a targeted sequencing of msh mlh and a panel of dna repair gene wa performed for the index case and for his unaffected father result the ihc result showed a loss of msh but not mlh msh and pm protein expression genomic dna screening by targeted dna repair gene sequencing revealed an msh pathogenic mutation cct pqx confirmed by sanger sequencing this mutation wa suspected to be a causal mutation associated to the loss of msh expression and it wa found in first and second degree relative the index case ha smoking and alcohol consumption habit moreover he harbor extensive genetic variation in other dnarepair gene not shared with his unaffected father conclusion in our investigated tunisian family we confirmed the l by ihc molecular and in silico investigation we identified a novel pathogenic mutation described for the first time in tunisia these result come enriching the previously reported pathogenic mutation in l family our study brings new argument to the interpretation of mmr expression pattern and highlight new risk modifier gene eventually implicated in crc twin discordance reported in this work underscore that disease penetrance could be influenced by both genetic background and environmental factor,Cancer,0,identification of novel pathogenic msh mutation and new dna repair gene variant investigation of a tunisian lynch syndrome family with discordant twin background lynch syndrome l is a highly penetrant inherited cancer predisposition syndrome characterized by autosomal dominant inheritance and germline mutation in dna mismatch repair gene despite several genetic variation that have been identified in various population the penetrance is highly variable and the reason for this have not been fully elucidated this study investigates whether besides pathogenic mutation environment and low penetrance genetic risk factor may result in phenotype modification in a tunisian l family patient and method a tunisian family with strong colorectal cancer crc history that fulfill the amsterdam i criterion for the diagnosis of lynch syndrome wa proposed for oncogenetic counseling the index case wa a man diagnosed at the age of year with crc he ha a monozygotic twin diagnosed at the age of year with crohn disease fortyseven yearsold wa the onset age of his paternal uncle withcrc an immunohistochemical ihc labeling for the four protein mlh msh msh and pm of the mismatchrepair mmr system wa performed for the index case a targeted sequencing of msh mlh and a panel of dna repair gene wa performed for the index case and for his unaffected father result the ihc result showed a loss of msh but not mlh msh and pm protein expression genomic dna screening by targeted dna repair gene sequencing revealed an msh pathogenic mutation cct pqx confirmed by sanger sequencing this mutation wa suspected to be a causal mutation associated to the loss of msh expression and it wa found in first and second degree relative the index case ha smoking and alcohol consumption habit moreover he harbor extensive genetic variation in other dnarepair gene not shared with his unaffected father conclusion in our investigated tunisian family we confirmed the l by ihc molecular and in silico investigation we identified a novel pathogenic mutation described for the first time in tunisia these result come enriching the previously reported pathogenic mutation in l family our study brings new argument to the interpretation of mmr expression pattern and highlight new risk modifier gene eventually implicated in crc twin discordance reported in this work underscore that disease penetrance could be influenced by both genetic background and environmental factor
31248429,case report mutation analysis of primary pulmonary lymphoepitheliomalike carcinoma via wholeexome sequencing,background primary pulmonary lymphoepitheliomalike carcinoma lelc is a rare tumor subtype accounting for around of lung cancer at present research on lelc mainly focus on pathological diagnosis while the molecular mutation landscape is still unclear case presentation a yearold female presented a productive cough for three week followed by severe symptom for another week respiratory sound were weak and coarser in the right lung field ffdg petcta showed a hypermetabolic mass in the upper lobe of the right lung a well a the enlargement of right hilar and subcarinal lymph node hematoxylineosin staining and immunohistochemistry staining of the biopsy established the diagnosis of primary pulmonary lelc after thoracoscopicassisted radical resection of right lung cancer and middle lobe of right lung the patient vital sign were stable without apparent productive cough chest pain chest tightness and other subjective discomfort furtherwhole exome sequencing of the patient tumor tissue and leukocyte served a a germline mutation control revealed somatic gene mutation and of which mutation in prim kcnb cdh and atrx were most likely related to the lelc pathogenesis the recurrence of gene mutation from various cancer database and a tumor mutation burden tmb of mutationsmb were revealed a well conclusion our finding have illustrated the genomic profile of a primary pulmonary lelc case and provided a positive biomarker that immune checkpoint blockade is potentially effective for this patient in further treatment,Cancer,0,case report mutation analysis of primary pulmonary lymphoepitheliomalike carcinoma via wholeexome sequencing background primary pulmonary lymphoepitheliomalike carcinoma lelc is a rare tumor subtype accounting for around of lung cancer at present research on lelc mainly focus on pathological diagnosis while the molecular mutation landscape is still unclear case presentation a yearold female presented a productive cough for three week followed by severe symptom for another week respiratory sound were weak and coarser in the right lung field ffdg petcta showed a hypermetabolic mass in the upper lobe of the right lung a well a the enlargement of right hilar and subcarinal lymph node hematoxylineosin staining and immunohistochemistry staining of the biopsy established the diagnosis of primary pulmonary lelc after thoracoscopicassisted radical resection of right lung cancer and middle lobe of right lung the patient vital sign were stable without apparent productive cough chest pain chest tightness and other subjective discomfort furtherwhole exome sequencing of the patient tumor tissue and leukocyte served a a germline mutation control revealed somatic gene mutation and of which mutation in prim kcnb cdh and atrx were most likely related to the lelc pathogenesis the recurrence of gene mutation from various cancer database and a tumor mutation burden tmb of mutationsmb were revealed a well conclusion our finding have illustrated the genomic profile of a primary pulmonary lelc case and provided a positive biomarker that immune checkpoint blockade is potentially effective for this patient in further treatment
31248668,molecular classification of endometrial carcinoma applied to endometrial biopsy specimen towards early personalized patient management,background the current risk stratification system used to guide management of endometrial cancer are based on irreproducible post surgical pathological information hence the need for more reliable classification system using microarray and sequencing technology tcga recently identified four prognostically significant endometrial carcinoma subtypes which subsequently proved reproducible using clinically applicable surrogate test using these test we sought to determine the level of concordance between endometrial biopsy and subsequent hysterectomy specimen in assessing the molecular classification of endometrial carcinoma material and method fifty biopsy with corresponding hysterectomy specimen for endometrial carcinoma were collected additionally case of biopsy proven atypical hyperplasiaein who were found to have endometrial carcinoma on resection were included ihc for mismatch repair mmr protein mlh pm msh and msh and p wa performed microsatellite instability analysis wa performed by pcr and sanger sequencing wa performed to detect mutation in exon and of the pole gene the level of concordance for tumor grade histologic subtype immunohistochemical and molecular profile in both specimen wa determined using cohens kappa estimate result a high level of concordance wa achieved for mmrloss msihigh pwild and abnormal type in contrast grade and histologic subtype showed only moderate level of agreement pole gene mutation wa detected in two patient for both case mutation were detected only in resection specimen when comparing atypical hyperplasiaein with subsequent hysterectomy tumor the profile wa identical to that of endometrial carcinoma conclusion in our cohort of endometrial carcinoma a high level of concordance wa achieved between biopsy and hysterectomy specimen for mmrloss msihigh pwild and abnormal type superior to that of grade and histologic subtype providing earlier and more reliable prognostic information to inform management similar concordance could not be achieved for pole mutation given the low frequency of this mutation in our study,Cancer,0,molecular classification of endometrial carcinoma applied to endometrial biopsy specimen towards early personalized patient management background the current risk stratification system used to guide management of endometrial cancer are based on irreproducible post surgical pathological information hence the need for more reliable classification system using microarray and sequencing technology tcga recently identified four prognostically significant endometrial carcinoma subtypes which subsequently proved reproducible using clinically applicable surrogate test using these test we sought to determine the level of concordance between endometrial biopsy and subsequent hysterectomy specimen in assessing the molecular classification of endometrial carcinoma material and method fifty biopsy with corresponding hysterectomy specimen for endometrial carcinoma were collected additionally case of biopsy proven atypical hyperplasiaein who were found to have endometrial carcinoma on resection were included ihc for mismatch repair mmr protein mlh pm msh and msh and p wa performed microsatellite instability analysis wa performed by pcr and sanger sequencing wa performed to detect mutation in exon and of the pole gene the level of concordance for tumor grade histologic subtype immunohistochemical and molecular profile in both specimen wa determined using cohens kappa estimate result a high level of concordance wa achieved for mmrloss msihigh pwild and abnormal type in contrast grade and histologic subtype showed only moderate level of agreement pole gene mutation wa detected in two patient for both case mutation were detected only in resection specimen when comparing atypical hyperplasiaein with subsequent hysterectomy tumor the profile wa identical to that of endometrial carcinoma conclusion in our cohort of endometrial carcinoma a high level of concordance wa achieved between biopsy and hysterectomy specimen for mmrloss msihigh pwild and abnormal type superior to that of grade and histologic subtype providing earlier and more reliable prognostic information to inform management similar concordance could not be achieved for pole mutation given the low frequency of this mutation in our study
31249854,blastic variant of plasma cell myeloma mimicking squamous cell carcinoma of the uterine cervix in a supermorbidly obese female,plasmablastic plasma cell myeloma of the cervix can mimic the more common cervical squamous cell carcinoma it can be difficult to differentiate plasmablastic lymphoma of the cervix from cervical plasmablastic plasma cell myeloma the clinician must rely on clinical laboratory and radiologic finding to diagnose genital plasma cell myeloma prompt diagnosis of this rare clinical condition can potentially allow timely treatment with systemic chemotherapy,Cancer,0,blastic variant of plasma cell myeloma mimicking squamous cell carcinoma of the uterine cervix in a supermorbidly obese female plasmablastic plasma cell myeloma of the cervix can mimic the more common cervical squamous cell carcinoma it can be difficult to differentiate plasmablastic lymphoma of the cervix from cervical plasmablastic plasma cell myeloma the clinician must rely on clinical laboratory and radiologic finding to diagnose genital plasma cell myeloma prompt diagnosis of this rare clinical condition can potentially allow timely treatment with systemic chemotherapy
31254135,a longterm survivor of pediatric midline glioma with hfa km and braf ve double mutation,we report a case of yearold female with lateral ventricular glioma harboring both hfa km and braf ve mutation by the methylation analysis the tumor wa classified a a diffuse midline glioma h km mutant who grade iv however the tumor wa pathologically lowgrade and likely localized rather than diffusely infiltrating further the patient ha survived more than year after gross total resection of the tumor whereas both hfa km and braf ve have been reported a poor prognostic marker in pediatric glioma our case along with several other reported case suggests that the coexistence of these two mutation might not indicate poor prognosis the case emphasizes the importance of comprehensive assessment based on pathological genetic and clinical finding and call for further investigation of nondiffuse glioma with hfa km and glioma with hfa km and braf ve,Cancer,0,a longterm survivor of pediatric midline glioma with hfa km and braf ve double mutation we report a case of yearold female with lateral ventricular glioma harboring both hfa km and braf ve mutation by the methylation analysis the tumor wa classified a a diffuse midline glioma h km mutant who grade iv however the tumor wa pathologically lowgrade and likely localized rather than diffusely infiltrating further the patient ha survived more than year after gross total resection of the tumor whereas both hfa km and braf ve have been reported a poor prognostic marker in pediatric glioma our case along with several other reported case suggests that the coexistence of these two mutation might not indicate poor prognosis the case emphasizes the importance of comprehensive assessment based on pathological genetic and clinical finding and call for further investigation of nondiffuse glioma with hfa km and glioma with hfa km and braf ve
31260379,safe neoadjuvant trastuzumabbased treatment in her inflammatory early breast cancer in a glucose phosphate dehydrogenasedeficient postmenopausal woman a case report and review of the literature,introduction glucose phosphate dehydrogenase gpd is a basic antioxidant pathway for erythrocyte being it deficiency the most common gene mutation worldwide a breast cancer is one of the most frequent tumor many of these patient may present with gpd deficiency prior treatment without notice case report we present the case of a woman deficient for gpd with the diagnosis of stage iiib ctd cn cm herenriched early breast cancer management and outcome the patient underwent neoadjuvance with trastuzumab and anthracyclinefree chemotherapy based on docetaxel mgm mg and carboplatin auc mg she did not present hemolytic crisis and no blood transfusion were needed she achieved a good pathologic response and completed oneyear adjuvant trastuzumab without incidence discussion although the role of her and trastuzumab in oxidative stress is not yet completely understood we suggest that trastuzumab may be a suitable agent for treatment in patient with herenriched breast cancer in a nonoxidative chemotherapy scheme with acceptable response and no triggering hemolytic crisis,Cancer,0,safe neoadjuvant trastuzumabbased treatment in her inflammatory early breast cancer in a glucose phosphate dehydrogenasedeficient postmenopausal woman a case report and review of the literature introduction glucose phosphate dehydrogenase gpd is a basic antioxidant pathway for erythrocyte being it deficiency the most common gene mutation worldwide a breast cancer is one of the most frequent tumor many of these patient may present with gpd deficiency prior treatment without notice case report we present the case of a woman deficient for gpd with the diagnosis of stage iiib ctd cn cm herenriched early breast cancer management and outcome the patient underwent neoadjuvance with trastuzumab and anthracyclinefree chemotherapy based on docetaxel mgm mg and carboplatin auc mg she did not present hemolytic crisis and no blood transfusion were needed she achieved a good pathologic response and completed oneyear adjuvant trastuzumab without incidence discussion although the role of her and trastuzumab in oxidative stress is not yet completely understood we suggest that trastuzumab may be a suitable agent for treatment in patient with herenriched breast cancer in a nonoxidative chemotherapy scheme with acceptable response and no triggering hemolytic crisis
31263451,multiple endocrine neoplasia type men an update and the significance of early genetic and clinical diagnosis,multiple endocrine neoplasia type men is a rare hereditary tumor syndrome inherited in an autosomal dominant manner and characterized by a predisposition to a multitude of endocrine neoplasm primarily of parathyroid enteropancreatic and anterior pituitary origin a well a nonendocrine neoplasm other endocrine tumor in men include foregut carcinoid tumor adrenocortical tumor and rarely pheochromocytoma nonendocrine manifestation include meningioma and ependymomas lipoma angiofibromas collagenomas and leiomyoma men is caused by inactivating mutation of the tumor suppressor gene men which encodes the protein menin this syndrome can affect all age group with of patient developing menassociated tumor before year of age despite advance in the diagnosis and treatment of menassociated tumor patient with men continue to have decreased life expectancy primarily due to malignant neuroendocrine tumor the most recent clinical practice guideline for men published in highlight the need for early genetic and clinical diagnosis of men and recommend an intensive surveillance approach for both patient with this syndrome and asymptomatic carrier starting at the age of year with the goal of timely detection and management of menassociated neoplasm and ultimately decreased diseasespecific morbidity and mortality unfortunately there is no clear genotypephenotype correlation and individual mutationdependent surveillance is not possible currently,Cancer,0,multiple endocrine neoplasia type men an update and the significance of early genetic and clinical diagnosis multiple endocrine neoplasia type men is a rare hereditary tumor syndrome inherited in an autosomal dominant manner and characterized by a predisposition to a multitude of endocrine neoplasm primarily of parathyroid enteropancreatic and anterior pituitary origin a well a nonendocrine neoplasm other endocrine tumor in men include foregut carcinoid tumor adrenocortical tumor and rarely pheochromocytoma nonendocrine manifestation include meningioma and ependymomas lipoma angiofibromas collagenomas and leiomyoma men is caused by inactivating mutation of the tumor suppressor gene men which encodes the protein menin this syndrome can affect all age group with of patient developing menassociated tumor before year of age despite advance in the diagnosis and treatment of menassociated tumor patient with men continue to have decreased life expectancy primarily due to malignant neuroendocrine tumor the most recent clinical practice guideline for men published in highlight the need for early genetic and clinical diagnosis of men and recommend an intensive surveillance approach for both patient with this syndrome and asymptomatic carrier starting at the age of year with the goal of timely detection and management of menassociated neoplasm and ultimately decreased diseasespecific morbidity and mortality unfortunately there is no clear genotypephenotype correlation and individual mutationdependent surveillance is not possible currently
31263500,challenge in managing patient with hereditary cancer at gynecological service,aim to reveal current problem and challenge faced by our gynecologic service department in managing patient with hereditary cancer method we collected clinical data of patient with hereditary cancer identified via genetic testing or clinically diagnosed in case of cowden syndrome or peutzjeghers syndrome and treated in our gynecological department from to result fifteen patient had hereditary breast and ovarian cancer hboc had lynch syndrome had cowden syndrome and had peutzjeghers syndrome five patient diagnosed with hboc were younger than year at diagnosis riskreducing salpingooophorectomy rrso wa performed on patient with a brca mutation at age year seven patient overall underwent rrso and none had malignancy on pathological examination peritoneal washing cytology pwc wa suspicious for malignancy in one patient however subsequent pwc at month after rrso wa negative a patient with endometrial cancer and lynch syndrome and a patient with atypical endometrial hyperplasia aeh and cowden syndrome strongly desired fertility preservation they achieved remission after medroxyprogesterone acetate treatment and multiple dilation and curettage respectively one patient with lynch syndrome developed aeh after year of surveillance laparotomy revealed adjacent lowgrade and highgrade serous ovarian cancer with positive ascites cytology she had no recurrence during year followup after laparotomy conclusion managing patient with hereditary cancer positive or falsepositive ascites cytology discovered during rrso and desired preservation of fertility is highly challenging,Cancer,0,challenge in managing patient with hereditary cancer at gynecological service aim to reveal current problem and challenge faced by our gynecologic service department in managing patient with hereditary cancer method we collected clinical data of patient with hereditary cancer identified via genetic testing or clinically diagnosed in case of cowden syndrome or peutzjeghers syndrome and treated in our gynecological department from to result fifteen patient had hereditary breast and ovarian cancer hboc had lynch syndrome had cowden syndrome and had peutzjeghers syndrome five patient diagnosed with hboc were younger than year at diagnosis riskreducing salpingooophorectomy rrso wa performed on patient with a brca mutation at age year seven patient overall underwent rrso and none had malignancy on pathological examination peritoneal washing cytology pwc wa suspicious for malignancy in one patient however subsequent pwc at month after rrso wa negative a patient with endometrial cancer and lynch syndrome and a patient with atypical endometrial hyperplasia aeh and cowden syndrome strongly desired fertility preservation they achieved remission after medroxyprogesterone acetate treatment and multiple dilation and curettage respectively one patient with lynch syndrome developed aeh after year of surveillance laparotomy revealed adjacent lowgrade and highgrade serous ovarian cancer with positive ascites cytology she had no recurrence during year followup after laparotomy conclusion managing patient with hereditary cancer positive or falsepositive ascites cytology discovered during rrso and desired preservation of fertility is highly challenging
31264352,prognostic and predictive significance of kit protein expression and ckit gene mutation in canine cutaneous mast cell tumour a consensus of the oncologypathology working group,one of the primary objective of the oncologypathology working group opwg a joint initiative of the veterinary cancer society and the american college of veterinary pathologist is for oncologist and pathologist to collaboratively generate consensus document to standardize aspect of and provide guideline for oncologic pathology consensus is established through critical review of peerreviewed literature relevant to a subgroup particular focus subsequent acceptance and approval of the document by the opwg membership at large establishes consensus the intent of this publication is to help educate practitioner and pathologist on the value of diagnostics related to the kit receptor tyrosine kinase for canine cutaneous mast cell tumour and to provide a guide for the use of these test in veterinary medicine this document represents the opinion of the opwg and the author and doe not constitute a formal endorsement by the american college of veterinary pathologist or the veterinary cancer society,Cancer,0,prognostic and predictive significance of kit protein expression and ckit gene mutation in canine cutaneous mast cell tumour a consensus of the oncologypathology working group one of the primary objective of the oncologypathology working group opwg a joint initiative of the veterinary cancer society and the american college of veterinary pathologist is for oncologist and pathologist to collaboratively generate consensus document to standardize aspect of and provide guideline for oncologic pathology consensus is established through critical review of peerreviewed literature relevant to a subgroup particular focus subsequent acceptance and approval of the document by the opwg membership at large establishes consensus the intent of this publication is to help educate practitioner and pathologist on the value of diagnostics related to the kit receptor tyrosine kinase for canine cutaneous mast cell tumour and to provide a guide for the use of these test in veterinary medicine this document represents the opinion of the opwg and the author and doe not constitute a formal endorsement by the american college of veterinary pathologist or the veterinary cancer society
31266596,renal cell carcinoma with a mesenchymal stromal component what do we know so far,a subset of renal cell neoplasm contains a mesenchymal stromal component often resembling smooth muscle to date it remains debated whether these represent one or more distinct pathological entity the foremost of these renal cell carcinoma with angioleiomyomalike stroma also known a smooth muscle or leiomyomatous stroma ha some distinctive feature including immunohistochemical positivity for cytokeratin and often a lack of genetic change of clear cell renal cell carcinoma it is debated whether this is related to the much more common clear cell papillary renal cell carcinoma owing to the substantial similarity of their immunohistochemical phenotype the term renal angiomyoadenomatous tumour ha been used by some author in this context but this is a source of controversy with some believing it is synonymous with clear cell papillary renal cell carcinoma smooth musclerich renal cancer appear to be enriched in tuberous sclerosis complex patient but it is likely that these occur sporadically also recently renal cell carcinoma with tceb mutation and monosomy of chromosome have also been reported these have been noted to have fibromuscular stroma and cytokeratin reactivity however absence of these genetic alteration in renal cell carcinoma with smooth muscle stroma suggests that this represents only one of likely several entity other uncommon pattern of renal neoplasm such a clear cell renal cell carcinoma with degenerative fibrosis or haemangiomalike change mixed epithelial and stromal tumour with epithelial proliferation angiomyolipoma with epithelial cyst renal cell carcinoma with associated angiomyolipoma and sarcomatoid renal cell carcinoma may cause diagnostic challenge for the pathologist although knowledge of renal cell carcinoma with a stromal component ha dramatically increased recently further study is necessary to understand the molecular pathology of these tumour and if they have implication for inherited tumour syndrome,Cancer,0,renal cell carcinoma with a mesenchymal stromal component what do we know so far a subset of renal cell neoplasm contains a mesenchymal stromal component often resembling smooth muscle to date it remains debated whether these represent one or more distinct pathological entity the foremost of these renal cell carcinoma with angioleiomyomalike stroma also known a smooth muscle or leiomyomatous stroma ha some distinctive feature including immunohistochemical positivity for cytokeratin and often a lack of genetic change of clear cell renal cell carcinoma it is debated whether this is related to the much more common clear cell papillary renal cell carcinoma owing to the substantial similarity of their immunohistochemical phenotype the term renal angiomyoadenomatous tumour ha been used by some author in this context but this is a source of controversy with some believing it is synonymous with clear cell papillary renal cell carcinoma smooth musclerich renal cancer appear to be enriched in tuberous sclerosis complex patient but it is likely that these occur sporadically also recently renal cell carcinoma with tceb mutation and monosomy of chromosome have also been reported these have been noted to have fibromuscular stroma and cytokeratin reactivity however absence of these genetic alteration in renal cell carcinoma with smooth muscle stroma suggests that this represents only one of likely several entity other uncommon pattern of renal neoplasm such a clear cell renal cell carcinoma with degenerative fibrosis or haemangiomalike change mixed epithelial and stromal tumour with epithelial proliferation angiomyolipoma with epithelial cyst renal cell carcinoma with associated angiomyolipoma and sarcomatoid renal cell carcinoma may cause diagnostic challenge for the pathologist although knowledge of renal cell carcinoma with a stromal component ha dramatically increased recently further study is necessary to understand the molecular pathology of these tumour and if they have implication for inherited tumour syndrome
31268928,melanotic schwannoma of the vulva a case report and review of the literature,melanotic schwannoma is a pigmented tumor of peripheral nerve differentiation primary cutaneous presentation are extremely rare a the bulk of melanotic schwannomas tend to develop in paraspinal and axial site tumor arise sporadically and in the setting of the carney complex alteration in the gene encoding protein kinase a regulatory subunitalpha prkara underlie most patient with the carney complex and mediate melanotic schwannoma tumorigenesis melanotic schwannomas from noncutaneous site can locally recur and metastasize widely leading to a recent proposal to change the nomenclature to malignant melanotic schwannian tumor however the clinicopathologic feature of primary cutaneous melanotic schwannomas are relatively unexplored we present a case of a nodule arising on the vulva of a yearold woman microscopically a dermalbased heavily pigmented proliferation of plump spindled and epithelioid cell arrayed in nodule and fascicle wa seen lesional cell stained positively for s melana and bap but were negative for prkaralpha nextgeneration sequencing of a panel of cancerassociated gene revealed that the tumor harbored a prkara psf truncating mutation and copy neutral loss of heterozygosity of chromosome q the locus at which prkara resides importantly no other genetic abnormality or chromosomal copy number change were identified on the basis of combined histopathologic immunohistochemical and genetic feature a diagnosis of melanotic schwannoma wa rendered overall we present the first clinicopathologic description of a vulvar melanotic schwannoma review the literature concerning cutaneous presentation of melanotic schwannoma and propose that melanotic schwannian tumor native to skin may behave more indolently than their noncutaneous counterpart,Cancer,0,melanotic schwannoma of the vulva a case report and review of the literature melanotic schwannoma is a pigmented tumor of peripheral nerve differentiation primary cutaneous presentation are extremely rare a the bulk of melanotic schwannomas tend to develop in paraspinal and axial site tumor arise sporadically and in the setting of the carney complex alteration in the gene encoding protein kinase a regulatory subunitalpha prkara underlie most patient with the carney complex and mediate melanotic schwannoma tumorigenesis melanotic schwannomas from noncutaneous site can locally recur and metastasize widely leading to a recent proposal to change the nomenclature to malignant melanotic schwannian tumor however the clinicopathologic feature of primary cutaneous melanotic schwannomas are relatively unexplored we present a case of a nodule arising on the vulva of a yearold woman microscopically a dermalbased heavily pigmented proliferation of plump spindled and epithelioid cell arrayed in nodule and fascicle wa seen lesional cell stained positively for s melana and bap but were negative for prkaralpha nextgeneration sequencing of a panel of cancerassociated gene revealed that the tumor harbored a prkara psf truncating mutation and copy neutral loss of heterozygosity of chromosome q the locus at which prkara resides importantly no other genetic abnormality or chromosomal copy number change were identified on the basis of combined histopathologic immunohistochemical and genetic feature a diagnosis of melanotic schwannoma wa rendered overall we present the first clinicopathologic description of a vulvar melanotic schwannoma review the literature concerning cutaneous presentation of melanotic schwannoma and propose that melanotic schwannian tumor native to skin may behave more indolently than their noncutaneous counterpart
31273176,longterm survival of a patient with inoperable gastric cancer with distant lymph node metastasisa case report,a yearold female patient wa diagnosed with inoperable gastric cancer with distant lymph node metastasisctnm lym cstage iv for which she received s chemotherapyorally administered on day ofa day course the patient received a total of treatment course after an initial phase of stable disease due to chemotherapy she eventually showed progressive disease s chemotherapy wa discontinued because ofher social background she decided against any further chemotherapy after year she underwent metallic stent insertion through the gastric cancer which enabled her to consume food she is currently alive a of year and month from the date of first diagnosis,Cancer,0,longterm survival of a patient with inoperable gastric cancer with distant lymph node metastasisa case report a yearold female patient wa diagnosed with inoperable gastric cancer with distant lymph node metastasisctnm lym cstage iv for which she received s chemotherapyorally administered on day ofa day course the patient received a total of treatment course after an initial phase of stable disease due to chemotherapy she eventually showed progressive disease s chemotherapy wa discontinued because ofher social background she decided against any further chemotherapy after year she underwent metallic stent insertion through the gastric cancer which enabled her to consume food she is currently alive a of year and month from the date of first diagnosis
31273179,a case of sigmoid colon cancer with complete visceral inversion,complete visceral inversion occurs in individual in of case complete visceral inversion is complicated by the malformation of other organ careful attention is required when performing surgery in recent year with the development of laparoscopic surgery some case of laparoscopic surgery with complete visceral inversion have been reported herein we report a case of safely performed laparoscopic surgery for sigmoid colon cancer with complete visceral inversion along with a relevant discussion,Cancer,0,a case of sigmoid colon cancer with complete visceral inversion complete visceral inversion occurs in individual in of case complete visceral inversion is complicated by the malformation of other organ careful attention is required when performing surgery in recent year with the development of laparoscopic surgery some case of laparoscopic surgery with complete visceral inversion have been reported herein we report a case of safely performed laparoscopic surgery for sigmoid colon cancer with complete visceral inversion along with a relevant discussion
31277093,sarcomatoid carcinoma after radiotherapy for earlystage oral squamous cell carcinoma case report,rationale sarcomatoid carcinoma is a rare variant of squamous cell carcinoma scc with poor prognosis previous radiation ha been reported a one of the etiologic factor patient concern we describe a case of a yearold man presented with a painless mass in the left supraclavicular area five year before he wa diagnosed with scc in floor of mouth fom and underwent radiotherapy rt diagnosis sonographyguided biopsy on the supraclavicular lymph node revealed diffuse spindle cell proliferation with a focus of squamous differentiation local recurrence on primary site or distant metastasis wa not obvious on both computed tomography ct of the neck and ffluorodeoxyglucose positron emission tomography ct the final diagnosis wa confirmed a sarcomatoid carcinoma via surgery intervention the patient underwent surgery including explorative resection of the mouth floor excision of the submandibular gland and modified radical neck dissection following surgery the patient received adjuvant radiation therapy outcome there were no complication according to the surgery six month after adjuvant therapy distant metastasis to liver wa identified the patient is currently undergoing palliative chemotherapy lesson this may be the first reported case of sarcomatoid carcinoma arising from earlystage scc in fom that wa previously treated with rt alone when rt is performed a a single modality for oral scc even in an early stage rigorous followup should be performed,Cancer,0,sarcomatoid carcinoma after radiotherapy for earlystage oral squamous cell carcinoma case report rationale sarcomatoid carcinoma is a rare variant of squamous cell carcinoma scc with poor prognosis previous radiation ha been reported a one of the etiologic factor patient concern we describe a case of a yearold man presented with a painless mass in the left supraclavicular area five year before he wa diagnosed with scc in floor of mouth fom and underwent radiotherapy rt diagnosis sonographyguided biopsy on the supraclavicular lymph node revealed diffuse spindle cell proliferation with a focus of squamous differentiation local recurrence on primary site or distant metastasis wa not obvious on both computed tomography ct of the neck and ffluorodeoxyglucose positron emission tomography ct the final diagnosis wa confirmed a sarcomatoid carcinoma via surgery intervention the patient underwent surgery including explorative resection of the mouth floor excision of the submandibular gland and modified radical neck dissection following surgery the patient received adjuvant radiation therapy outcome there were no complication according to the surgery six month after adjuvant therapy distant metastasis to liver wa identified the patient is currently undergoing palliative chemotherapy lesson this may be the first reported case of sarcomatoid carcinoma arising from earlystage scc in fom that wa previously treated with rt alone when rt is performed a a single modality for oral scc even in an early stage rigorous followup should be performed
31278395,the cancer genome atlas of renal cell carcinoma finding and clinical implication,the cancer genome atlas tcga characterized the somatic genetic and genomic alteration in renal cell carcinoma rcc encompassing the major rcc histological subtypes including clear cell rcc ccrcc papillary rcc prcc and chromophobe rcc chrcc unique distinguishing feature were found between the rcc subtypes including in chromosomal alteration and tumour metabolism a well a within each rcc subtype of which some correlated with difference in patient survival two new rcc subtypes were defined by distinct epigenetic and metabolic pathway expression pattern the hypermethylated cpg island methylator phenotypeassociated cimp rccs and metabolically divergent chrccs and new biomarkers of poor patient outcome were identified including pbrm mutation in type prcc and cdkna loss in chrcc expression of many immune cell genespecific signature wa increased in ccrcc compared with prcc and chrcc and expression of select signature including the type t helper cell signature wa increased in cimp rcc increased expression of the type t helper cell signature correlated with poorer survival in ccrcc prcc and chrcc in addition to improving our current understanding of rcc tcga rcc study are an invaluable resource that provides the foundation for the development of improved method for diagnosis treatment and prevention of this disease,Cancer,0,the cancer genome atlas of renal cell carcinoma finding and clinical implication the cancer genome atlas tcga characterized the somatic genetic and genomic alteration in renal cell carcinoma rcc encompassing the major rcc histological subtypes including clear cell rcc ccrcc papillary rcc prcc and chromophobe rcc chrcc unique distinguishing feature were found between the rcc subtypes including in chromosomal alteration and tumour metabolism a well a within each rcc subtype of which some correlated with difference in patient survival two new rcc subtypes were defined by distinct epigenetic and metabolic pathway expression pattern the hypermethylated cpg island methylator phenotypeassociated cimp rccs and metabolically divergent chrccs and new biomarkers of poor patient outcome were identified including pbrm mutation in type prcc and cdkna loss in chrcc expression of many immune cell genespecific signature wa increased in ccrcc compared with prcc and chrcc and expression of select signature including the type t helper cell signature wa increased in cimp rcc increased expression of the type t helper cell signature correlated with poorer survival in ccrcc prcc and chrcc in addition to improving our current understanding of rcc tcga rcc study are an invaluable resource that provides the foundation for the development of improved method for diagnosis treatment and prevention of this disease
31278738,molecular genetics in the diagnosis and biology of lymphoid neoplasm,objective the workshop of the society for hematopathologyeuropean association for haematopathology reviewed the role of molecular genetics in the diagnosis and biology of lymphoid neoplasm method the workshop panel reviewed case result molecular genetic testing reveals alteration that expand the spectrum of disease such a dusp rearrangement in alknegative anaplastic large cell lymphoma large bcell lymphoma with irf rearrangement myd mutation in bcell lymphoma burkittlike lymphoma with q aberration and diagnostic criterion for highgrade bcell lymphoma therapeutic agent and natural tumor progression may be associated with transcriptional reprogramming that lead to transdifferentiation and lineage switch conclusion application of emerging technical advance ha revealed the complexity of genetic event in lymphomagenesis progression and acquired resistance to therapy they also contribute to enhanced understanding of the biology of indolent v aggressive behavior clonal evolution tumor progression and transcriptional reprogramming associated with transdifferentiation event that may occur subsequent to therapy,Cancer,0,molecular genetics in the diagnosis and biology of lymphoid neoplasm objective the workshop of the society for hematopathologyeuropean association for haematopathology reviewed the role of molecular genetics in the diagnosis and biology of lymphoid neoplasm method the workshop panel reviewed case result molecular genetic testing reveals alteration that expand the spectrum of disease such a dusp rearrangement in alknegative anaplastic large cell lymphoma large bcell lymphoma with irf rearrangement myd mutation in bcell lymphoma burkittlike lymphoma with q aberration and diagnostic criterion for highgrade bcell lymphoma therapeutic agent and natural tumor progression may be associated with transcriptional reprogramming that lead to transdifferentiation and lineage switch conclusion application of emerging technical advance ha revealed the complexity of genetic event in lymphomagenesis progression and acquired resistance to therapy they also contribute to enhanced understanding of the biology of indolent v aggressive behavior clonal evolution tumor progression and transcriptional reprogramming associated with transdifferentiation event that may occur subsequent to therapy
31280902,novel noninvasive diagnostics,molecular diagnostics have revolutionized human oncology to allow early detection targeted therapy monitoring throughout treatment and evidence of recurrence by identifying genetic signature associated with cancer liquid biopsy technique have been developed to diagnose and monitor cancer in noninvasive or minimally invasive way these technique offer new opportunity for improving cancer screening diagnosis and monitoring the impact of therapy on the patient over time liquid biopsy also drive drug development program similar diagnostics hold promise for comparable result in the veterinary field several noninvasiveminimally invasive technique have been described in veterinary medicine that could be referred to a liquid biopsy,Cancer,0,novel noninvasive diagnostics molecular diagnostics have revolutionized human oncology to allow early detection targeted therapy monitoring throughout treatment and evidence of recurrence by identifying genetic signature associated with cancer liquid biopsy technique have been developed to diagnose and monitor cancer in noninvasive or minimally invasive way these technique offer new opportunity for improving cancer screening diagnosis and monitoring the impact of therapy on the patient over time liquid biopsy also drive drug development program similar diagnostics hold promise for comparable result in the veterinary field several noninvasiveminimally invasive technique have been described in veterinary medicine that could be referred to a liquid biopsy
31281146,bcl bcl and mycpositive intravascular large bcell lymphoma presenting with bilateral adrenal gland lesion,primary adrenal lymphoma is a rare lymphoma accounting for of nonhodgkin lymphoma the leading histopathological subtype of adrenal lymphoma is diffuse large bcell lymphoma and intravascular large bcell lymphoma ivlbcl is rare here we report a case of ivlbcl occurrence a a bilateral adrenal gland tumor which wa diagnosed by ctguided biopsy tumor cell were positive for cd and mum but not for cd on immunostaining suggesting nongerminal center bcell subtype lymphoma in addition the triple expression of bcl bcl and myc wa demonstrated on tumor cell the bone marrow examination revealed the involvement of lymphoma cell but not hemophagocytosis the chromosomal analysis revealed complex karyotypic abnormality without a rearrangement of bcl or myc using fish analysis although the patient responded to rchop chemotherapy he developed central nervous system involvement by lymphoma to date the significance of the triple expression of bcl bcl and myc without gene translocation remains partially elucidated therefore an accumulation of similar case is needed to elucidate the pathogenesis and clinical significance of the triple expression of these oncoproteins,Cancer,0,bcl bcl and mycpositive intravascular large bcell lymphoma presenting with bilateral adrenal gland lesion primary adrenal lymphoma is a rare lymphoma accounting for of nonhodgkin lymphoma the leading histopathological subtype of adrenal lymphoma is diffuse large bcell lymphoma and intravascular large bcell lymphoma ivlbcl is rare here we report a case of ivlbcl occurrence a a bilateral adrenal gland tumor which wa diagnosed by ctguided biopsy tumor cell were positive for cd and mum but not for cd on immunostaining suggesting nongerminal center bcell subtype lymphoma in addition the triple expression of bcl bcl and myc wa demonstrated on tumor cell the bone marrow examination revealed the involvement of lymphoma cell but not hemophagocytosis the chromosomal analysis revealed complex karyotypic abnormality without a rearrangement of bcl or myc using fish analysis although the patient responded to rchop chemotherapy he developed central nervous system involvement by lymphoma to date the significance of the triple expression of bcl bcl and myc without gene translocation remains partially elucidated therefore an accumulation of similar case is needed to elucidate the pathogenesis and clinical significance of the triple expression of these oncoproteins
31281162,genetic analysis of japanese patient with fanconi anemia novel finding,fanconi anemia fa is an inherited bone marrow failure syndrome characterized by multiple congenital abnormality progressive bone marrow failure and a predisposition to malignancy resulting from mutation in one of the known fanc gene from fanca to fancw the protein encoded by these gene participate in a deoxyribonucleic acid interstrand crosslink repair pathway the socalled fabrca pathway the fanc gene include hereditary breast and ovarian cancer susceptibility gene such a brca or brca patient with fa display a wide range of clinical phenotype owing to the genetic heterogeneity of the disease therefore the molecular diagnosis is critical for the appropriate management of such patient recently we successfully subtyped of the japanese patient with fa and identified mutant allele through a comprehensive strategy in this review the characteristic of genetic subtyping and mutated fanc gene variant in japanese patient with fa and the genotypephenotype correlation in fa are summarized in addition the carrier frequency of pathogenic fanc gene and risk of cancer among the fanc gene mutation carrier in general japanese population are discussed,Cancer,0,genetic analysis of japanese patient with fanconi anemia novel finding fanconi anemia fa is an inherited bone marrow failure syndrome characterized by multiple congenital abnormality progressive bone marrow failure and a predisposition to malignancy resulting from mutation in one of the known fanc gene from fanca to fancw the protein encoded by these gene participate in a deoxyribonucleic acid interstrand crosslink repair pathway the socalled fabrca pathway the fanc gene include hereditary breast and ovarian cancer susceptibility gene such a brca or brca patient with fa display a wide range of clinical phenotype owing to the genetic heterogeneity of the disease therefore the molecular diagnosis is critical for the appropriate management of such patient recently we successfully subtyped of the japanese patient with fa and identified mutant allele through a comprehensive strategy in this review the characteristic of genetic subtyping and mutated fanc gene variant in japanese patient with fa and the genotypephenotype correlation in fa are summarized in addition the carrier frequency of pathogenic fanc gene and risk of cancer among the fanc gene mutation carrier in general japanese population are discussed
31283845,mesothelioma scientific clue for prevention diagnosis and therapy,mesothelioma affect mostly older individual who have been occupationally exposed to asbestos the global mesothelioma incidence and mortality rate are unknown because data are not available from developing country that continue to use large amount of asbestos the incidence rate of mesothelioma ha decreased in australia the united state and western europe where the use of asbestos wa banned or strictly regulated in the s and s demonstrating the value of these preventive measure however in these same country the overall number of death from mesothelioma ha not decreased a the size of the population and the percentage of old people have increased moreover hotspot of mesothelioma may occur when carcinogenic fiber that are present in the environment are disturbed a rural area are being developed novel immunohistochemical and molecular marker have improved the accuracy of diagnosis however about highresource country to developing country of mesothelioma diagnosis are incorrect resulting in inadequate treatment and complicating epidemiological study the discovery that germline brcaasssociated protein bap mutation cause mesothelioma and other cancer bap cancer syndrome elucidated some of the key pathogenic mechanism and treatment targeting these molecular mechanism andor modulating the immune response are being tested the role of surgery in pleural mesothelioma is controversial a it is difficult to predict who will benefit from aggressive management even when local therapy are added to existing or novel systemic treatment treatment outcome are improving however for peritoneal mesothelioma multidisciplinary international collaboration will be necessary to improve prevention early detection and treatment,Cancer,0,mesothelioma scientific clue for prevention diagnosis and therapy mesothelioma affect mostly older individual who have been occupationally exposed to asbestos the global mesothelioma incidence and mortality rate are unknown because data are not available from developing country that continue to use large amount of asbestos the incidence rate of mesothelioma ha decreased in australia the united state and western europe where the use of asbestos wa banned or strictly regulated in the s and s demonstrating the value of these preventive measure however in these same country the overall number of death from mesothelioma ha not decreased a the size of the population and the percentage of old people have increased moreover hotspot of mesothelioma may occur when carcinogenic fiber that are present in the environment are disturbed a rural area are being developed novel immunohistochemical and molecular marker have improved the accuracy of diagnosis however about highresource country to developing country of mesothelioma diagnosis are incorrect resulting in inadequate treatment and complicating epidemiological study the discovery that germline brcaasssociated protein bap mutation cause mesothelioma and other cancer bap cancer syndrome elucidated some of the key pathogenic mechanism and treatment targeting these molecular mechanism andor modulating the immune response are being tested the role of surgery in pleural mesothelioma is controversial a it is difficult to predict who will benefit from aggressive management even when local therapy are added to existing or novel systemic treatment treatment outcome are improving however for peritoneal mesothelioma multidisciplinary international collaboration will be necessary to improve prevention early detection and treatment
31292797,lynch syndrome with exclusive skin involvement time to consider a molecular definition,muirtorre syndrome mt is clinically characterized by the occurrence of skin usually sebaceous and visceral tumor in the same individual the most common underlying mechanism is a constitutional defect of the mismatch repair mmr gene that cause lynch syndrome l herewithin we report on a yearsold male patient heterozygous for a pathogenic msh missense substitution who presented with a striking cutaneous phenotype in the absence of typical l visceral tumor the patient developed skin tumor including sebaceous adenomascarcinomas and keratoacanthoma two skin tumor showed immunohistochemical loss of msh and msh expression there wa no apparent family history of neoplasia based on the variable involvement of the skin and internal organ we suggest that the definition of tumor association that are often observed a variant of inherited tumor syndrome such a mt should be guided by the underlying molecular base in addition the presence of multiple sebaceous tumor especially if showing mmr deficiency appears to be a very strong indicator of a constitutional mmr gene defect the reason underlying the high phenotypic variability of cutaneous phenotype associated with constitutional mmr defect are yet to be determined,Cancer,0,lynch syndrome with exclusive skin involvement time to consider a molecular definition muirtorre syndrome mt is clinically characterized by the occurrence of skin usually sebaceous and visceral tumor in the same individual the most common underlying mechanism is a constitutional defect of the mismatch repair mmr gene that cause lynch syndrome l herewithin we report on a yearsold male patient heterozygous for a pathogenic msh missense substitution who presented with a striking cutaneous phenotype in the absence of typical l visceral tumor the patient developed skin tumor including sebaceous adenomascarcinomas and keratoacanthoma two skin tumor showed immunohistochemical loss of msh and msh expression there wa no apparent family history of neoplasia based on the variable involvement of the skin and internal organ we suggest that the definition of tumor association that are often observed a variant of inherited tumor syndrome such a mt should be guided by the underlying molecular base in addition the presence of multiple sebaceous tumor especially if showing mmr deficiency appears to be a very strong indicator of a constitutional mmr gene defect the reason underlying the high phenotypic variability of cutaneous phenotype associated with constitutional mmr defect are yet to be determined
31292799,double heterozygous mutation in the brca and atm gene involved in development of primary metachronous tumour a case report,purpose between and of case of breast cancer bc are attributable to a genetic susceptibility the brca and brca gene described in the late s are associated with an increased risk of breast and ovarian cancer and the clinical management of carrier of pathogenic variant in these gene is defined in several clinical guideline paluchshimon et al in ann oncol suppl vv llort et al in clin transl oncol however the pathogenic variant in brca and brca represent only a third of the cause of hereditary bc easton et al in n engl j med the incorporation of ng next generation sequencing technique in the genetic diagnosis of this pathology in addition to minimising the cost and time of analysis allows the simultaneous study of other gene of high and moderate penetrance easton et al in n engl j med op cit tung et al in cancer to date there are not many case or series of patient that describe the cooccurrence of two pathogenic variant in these gene of bc case of double heterozygosis have been described with the presence of pathogenic variant in brca brca palb chek blm or nbn nomizu et al in breast cancer heidemann et al in breast cancer re treat zuradelli et al in breast cancer re treat sokolenko et al in breast cancer re treat method we report the case of a patient diagnosed with multiple tumour who presented two pathogenic variant in heterozygosis result two pathogenic variant cc a palaglu in the brca gene and cc t pargx in the atm gene were detected in heterozygosis said variant were confirmed by sangertype sequencing using specific primer conclusion the implementation of gene panel using ng in the study of hereditary cancer involves the detection of heterozygous double mutation in gene of high and moderate penetrance for cancer although with a low frequency,Cancer,0,double heterozygous mutation in the brca and atm gene involved in development of primary metachronous tumour a case report purpose between and of case of breast cancer bc are attributable to a genetic susceptibility the brca and brca gene described in the late s are associated with an increased risk of breast and ovarian cancer and the clinical management of carrier of pathogenic variant in these gene is defined in several clinical guideline paluchshimon et al in ann oncol suppl vv llort et al in clin transl oncol however the pathogenic variant in brca and brca represent only a third of the cause of hereditary bc easton et al in n engl j med the incorporation of ng next generation sequencing technique in the genetic diagnosis of this pathology in addition to minimising the cost and time of analysis allows the simultaneous study of other gene of high and moderate penetrance easton et al in n engl j med op cit tung et al in cancer to date there are not many case or series of patient that describe the cooccurrence of two pathogenic variant in these gene of bc case of double heterozygosis have been described with the presence of pathogenic variant in brca brca palb chek blm or nbn nomizu et al in breast cancer heidemann et al in breast cancer re treat zuradelli et al in breast cancer re treat sokolenko et al in breast cancer re treat method we report the case of a patient diagnosed with multiple tumour who presented two pathogenic variant in heterozygosis result two pathogenic variant cc a palaglu in the brca gene and cc t pargx in the atm gene were detected in heterozygosis said variant were confirmed by sangertype sequencing using specific primer conclusion the implementation of gene panel using ng in the study of hereditary cancer involves the detection of heterozygous double mutation in gene of high and moderate penetrance for cancer although with a low frequency
31294922,elevated nmethyltransferase expression induced by hepatic stellate cell contributes to the metastasis of hepatocellular carcinoma via regulation of the cdv isoform,the crosstalk between hepatic stellate cell hscs and hepatic carcinoma cell contributes to hepatocellular carcinoma hcc progression but the underlying mechanism is largely unknown we report here that activated hscs induce upregulation of nicotinamide nmethyltransferase nnmt which is known to regulate multiple metabolic pathway in hepatoma cell of the liver high level of nnmt in hcc tissue were positively correlated with vascular invasion increased serum hbvdna level and distant metastasis in addition functional assay showed that nnmt promoted hcc cell invasion and metastasis by altering the histone h methylation on methylation pattern and transcriptionally activating cluster of differentiation cd nnmtmediated nmethyladenosine modification of cd mrna resulted in the formation of a cdv splice variant while it product methylnicotinamide stabilized cd protein by preventing ubiquitinmediated degradation finally nnmt wa also shown to be a target of statin that inhibited metastasis of hepatoma cell taken together our study show for the first time that the nnmtcdv axis regulates hcc metastasis and present nnmt a a promising prognostic biomarker and therapeutic target for hcc,Cancer,0,elevated nmethyltransferase expression induced by hepatic stellate cell contributes to the metastasis of hepatocellular carcinoma via regulation of the cdv isoform the crosstalk between hepatic stellate cell hscs and hepatic carcinoma cell contributes to hepatocellular carcinoma hcc progression but the underlying mechanism is largely unknown we report here that activated hscs induce upregulation of nicotinamide nmethyltransferase nnmt which is known to regulate multiple metabolic pathway in hepatoma cell of the liver high level of nnmt in hcc tissue were positively correlated with vascular invasion increased serum hbvdna level and distant metastasis in addition functional assay showed that nnmt promoted hcc cell invasion and metastasis by altering the histone h methylation on methylation pattern and transcriptionally activating cluster of differentiation cd nnmtmediated nmethyladenosine modification of cd mrna resulted in the formation of a cdv splice variant while it product methylnicotinamide stabilized cd protein by preventing ubiquitinmediated degradation finally nnmt wa also shown to be a target of statin that inhibited metastasis of hepatoma cell taken together our study show for the first time that the nnmtcdv axis regulates hcc metastasis and present nnmt a a promising prognostic biomarker and therapeutic target for hcc
31296311,p major hotspot variant are associated with poorer prognostic feature in hereditary cancer patient,tp pathogenic germline variation is associated with the multicancer predisposition lifraumeni syndrome lf nextgeneration sequencing and multigene panel testing are highlighting variability in the clinical presentation of patient with tp positive result we aimed to investigate if the p variant considered a major hotspot at both germline and somatic level parghis pglyasp pglyser parggln pargtrp pargcys parghis and pargtrp were associated with poorer prognostic feature compared to other pathogenic missense variant in the dnabinding domain to do so we assessed clinical feature from carrier of germline tp pathogenic variant probands and relative from three independent datasets iarc tp database ambry single gene testing and ambry multigene panel testing we observed that compared to carrier of nonhotspot germline variant individual that carried a hotspot germline variant were more likely to present with a classic lf phenotype earlier age of first breast cancer onset and shorter time to diagnosis to any cancer further study with larger datasets addressing difference in cancer phenotype by genotype are thus needed to replicate our finding and consider variant effect and position towards future personalized clinical management of pathogenic variant carrier,Cancer,0,p major hotspot variant are associated with poorer prognostic feature in hereditary cancer patient tp pathogenic germline variation is associated with the multicancer predisposition lifraumeni syndrome lf nextgeneration sequencing and multigene panel testing are highlighting variability in the clinical presentation of patient with tp positive result we aimed to investigate if the p variant considered a major hotspot at both germline and somatic level parghis pglyasp pglyser parggln pargtrp pargcys parghis and pargtrp were associated with poorer prognostic feature compared to other pathogenic missense variant in the dnabinding domain to do so we assessed clinical feature from carrier of germline tp pathogenic variant probands and relative from three independent datasets iarc tp database ambry single gene testing and ambry multigene panel testing we observed that compared to carrier of nonhotspot germline variant individual that carried a hotspot germline variant were more likely to present with a classic lf phenotype earlier age of first breast cancer onset and shorter time to diagnosis to any cancer further study with larger datasets addressing difference in cancer phenotype by genotype are thus needed to replicate our finding and consider variant effect and position towards future personalized clinical management of pathogenic variant carrier
31296812,hereditary breast and ovarian cancer syndrome,recently olaparibbrand name lynparza tabletsa parp inhibitorhas been approved for national health insurance coverage in japan a a drug for unresectable or recurrent brcapositive hernegative breast cancer in patient with a history of cancer chemotherapy the addition of brca genetic testing a a companion diagnostic tool to the health insurance coverage is of considerable significance a a spearhead of health insurance medical care for all different type of hereditary tumor however several problem related to this companion diagnostic test have emerged including the estab lishment of a genetic counseling system and handling of brca genetic test performed at the patient own expense in addition the purpose of the companion diagnostic test is to confirm drug indication in a case however since the test result include the diagnosis of hereditary tumor there is also an urgent need to improve the medical care system and social environment for family member of patient with pathological mutation the use of genetic analysis is widespread in the clinical setting and genetic medical care is anticipated to advance in the future therefore it would be pivotal to come up with measure against hereditary tumor such a hereditary breast and ovarian cancerhbocsyndrome in this chapter we describe the current status and prospect of hboc medical care with a particular focus on companion diagnostics,Cancer,0,hereditary breast and ovarian cancer syndrome recently olaparibbrand name lynparza tabletsa parp inhibitorhas been approved for national health insurance coverage in japan a a drug for unresectable or recurrent brcapositive hernegative breast cancer in patient with a history of cancer chemotherapy the addition of brca genetic testing a a companion diagnostic tool to the health insurance coverage is of considerable significance a a spearhead of health insurance medical care for all different type of hereditary tumor however several problem related to this companion diagnostic test have emerged including the estab lishment of a genetic counseling system and handling of brca genetic test performed at the patient own expense in addition the purpose of the companion diagnostic test is to confirm drug indication in a case however since the test result include the diagnosis of hereditary tumor there is also an urgent need to improve the medical care system and social environment for family member of patient with pathological mutation the use of genetic analysis is widespread in the clinical setting and genetic medical care is anticipated to advance in the future therefore it would be pivotal to come up with measure against hereditary tumor such a hereditary breast and ovarian cancerhbocsyndrome in this chapter we describe the current status and prospect of hboc medical care with a particular focus on companion diagnostics
31297240,immune checkpoint inhibitor treatment in patient with oncogene addicted nonsmall cell lung cancer nsclc summary of a multidisciplinary roundtable discussion,the introduction of targeted treatment and more recently immune checkpoint inhibitor ici to the treatment of metastatic nonsmall cell lung cancer nsclc ha dramatically changed the prognosis of selected patient for patient with oncogeneaddicted metastatic nsclc harbouring an epidermal growth factor receptor egfr or vraf murine sarcoma viral oncogene homologue b braf mutation or an anaplastic lymphoma kinase alk or ro protooncogene receptor tyrosine kinase ro gene alteration translocation fusion amplification mutationspecific tyrosine kinase inhibitor tki are already firstline standard treatment while targeted treatment for other driver mutation affecting met ret human epidermal growth factor receptor her tropomyosin receptor kinase trk and others are currently under investigation the role of ici in these patient subgroup is currently under debate this article summarises a roundtable discussion organised by esmo open in vienna in july it review current clinical data on ici treatment in patient with metastatic oncogeneaddicted nsclc and discusses molecular diagnostic assessment potential biomarkers and radiological method for response evaluation of ici treatment the roundtable panel concluded ici should only be considered in patient with oncogeneaddicted nsclc after exhaustion of effective targeted therapy and in some case possibly after all other therapy including chemotherapy more clinical trial on combination therapy and biomarkers for ici therapy based on the specific differing characteristic of oncogeneaddicted nsclc need to be conducted,Cancer,0,immune checkpoint inhibitor treatment in patient with oncogene addicted nonsmall cell lung cancer nsclc summary of a multidisciplinary roundtable discussion the introduction of targeted treatment and more recently immune checkpoint inhibitor ici to the treatment of metastatic nonsmall cell lung cancer nsclc ha dramatically changed the prognosis of selected patient for patient with oncogeneaddicted metastatic nsclc harbouring an epidermal growth factor receptor egfr or vraf murine sarcoma viral oncogene homologue b braf mutation or an anaplastic lymphoma kinase alk or ro protooncogene receptor tyrosine kinase ro gene alteration translocation fusion amplification mutationspecific tyrosine kinase inhibitor tki are already firstline standard treatment while targeted treatment for other driver mutation affecting met ret human epidermal growth factor receptor her tropomyosin receptor kinase trk and others are currently under investigation the role of ici in these patient subgroup is currently under debate this article summarises a roundtable discussion organised by esmo open in vienna in july it review current clinical data on ici treatment in patient with metastatic oncogeneaddicted nsclc and discusses molecular diagnostic assessment potential biomarkers and radiological method for response evaluation of ici treatment the roundtable panel concluded ici should only be considered in patient with oncogeneaddicted nsclc after exhaustion of effective targeted therapy and in some case possibly after all other therapy including chemotherapy more clinical trial on combination therapy and biomarkers for ici therapy based on the specific differing characteristic of oncogeneaddicted nsclc need to be conducted
31299995,genomic landscape and it correlation with tumor mutational burden pdl expression and immune cell infiltration in chinese lung squamous cell carcinoma,introduction to depict the genomic landscape of chinese earlystage lung squamous cell carcinoma lusc and investigate it correlation with tumor mutation burden tmb pdl expression and immune infiltrates method wholeexome sequencing wa performed on surgically resected lusc tmb wa defined a the sum of nonsynonymous single nucleotide and indel variant cd tumorinfiltrating lymphocyte til density and pdl expression were evaluated by immunohistochemistry six immune infiltrates were estimated using an online database result the median tmb wa mutation per megabase positive pdl expression and cd tils density were identified in and pikca amplification wa associated with significantly higher tmb p frequent genetic alteration had no impact on pdl expression but pikca amplification and keap mutation were independently associated with significantly lower cd til density p p respectively low tmb and high cd til density were independently associated with longer diseasefree survival dfs while none of them could individually predict the overall survival o combination of tmb and pdl expression or tmb and cd til density could stratify total population into two group with distinct prognosis classifying tumorimmune microenvironment based on pdl expression and cd til density showed discrepant genomic alteration but similar tmb clinical feature and o notably patient with different smoking status had distinct prognostic factor conclusion the combination of tmb pdl expression immune infiltrates and smoking status showed the feasibility to subgroup stratification in chinese patient with earlystage lusc which might be helpful for future design of personalized immunotherapy trial in lusc,Cancer,0,genomic landscape and it correlation with tumor mutational burden pdl expression and immune cell infiltration in chinese lung squamous cell carcinoma introduction to depict the genomic landscape of chinese earlystage lung squamous cell carcinoma lusc and investigate it correlation with tumor mutation burden tmb pdl expression and immune infiltrates method wholeexome sequencing wa performed on surgically resected lusc tmb wa defined a the sum of nonsynonymous single nucleotide and indel variant cd tumorinfiltrating lymphocyte til density and pdl expression were evaluated by immunohistochemistry six immune infiltrates were estimated using an online database result the median tmb wa mutation per megabase positive pdl expression and cd tils density were identified in and pikca amplification wa associated with significantly higher tmb p frequent genetic alteration had no impact on pdl expression but pikca amplification and keap mutation were independently associated with significantly lower cd til density p p respectively low tmb and high cd til density were independently associated with longer diseasefree survival dfs while none of them could individually predict the overall survival o combination of tmb and pdl expression or tmb and cd til density could stratify total population into two group with distinct prognosis classifying tumorimmune microenvironment based on pdl expression and cd til density showed discrepant genomic alteration but similar tmb clinical feature and o notably patient with different smoking status had distinct prognostic factor conclusion the combination of tmb pdl expression immune infiltrates and smoking status showed the feasibility to subgroup stratification in chinese patient with earlystage lusc which might be helpful for future design of personalized immunotherapy trial in lusc
31300532,dataset for the reporting of renal biopsy for tumour recommendation from the international collaboration on cancer reporting iccr,the international collaboration on cancer reporting iccr ha developed a suite of detailed datasets for international implementation these datasets are based on the reporting protocol developed by the royal college of pathologist uk the royal college of pathologist of australasia and the college of american pathologist with modification undertaken by international expert group appointed according to iccr protocol the dataset for the reporting of renal biopsy for tumour is designed to provide a structured reporting template containing minimum data recording key element suitable for international use in formulating the dataset the iccr panel incorporated recommendation from the vancouver consensus conference of the international society of urological pathology isup and the edition of the who bluebook on tumour of the urinary and male genital system reporting element were divided into required core and recommended noncore component of the report required element are a follows specimen laterality histological tumour type whoisup histological tumour grade sarcomatoid morphology rhabdoid morphology necrosis lymphovascular invasion and coexisting pathology in nonneoplastic kidney recommended reporting element are a follows operative procedure tumour site histological tumour subtype and detail of ancillary study in particular it is noted that fluorescence in situ hybridisation study may assist in diagnosing translocation renal cell carcinoma rcc and in distinguishing oncocytoma and eosinophilic chromophobe rcc it is anticipated that the implementation of this dataset into routine clinical practice will facilitate uniformity of pathology reporting worldwide this in turn should have a positive impact on patient treatment and the quality of demographic information held by cancer registry,Cancer,0,dataset for the reporting of renal biopsy for tumour recommendation from the international collaboration on cancer reporting iccr the international collaboration on cancer reporting iccr ha developed a suite of detailed datasets for international implementation these datasets are based on the reporting protocol developed by the royal college of pathologist uk the royal college of pathologist of australasia and the college of american pathologist with modification undertaken by international expert group appointed according to iccr protocol the dataset for the reporting of renal biopsy for tumour is designed to provide a structured reporting template containing minimum data recording key element suitable for international use in formulating the dataset the iccr panel incorporated recommendation from the vancouver consensus conference of the international society of urological pathology isup and the edition of the who bluebook on tumour of the urinary and male genital system reporting element were divided into required core and recommended noncore component of the report required element are a follows specimen laterality histological tumour type whoisup histological tumour grade sarcomatoid morphology rhabdoid morphology necrosis lymphovascular invasion and coexisting pathology in nonneoplastic kidney recommended reporting element are a follows operative procedure tumour site histological tumour subtype and detail of ancillary study in particular it is noted that fluorescence in situ hybridisation study may assist in diagnosing translocation renal cell carcinoma rcc and in distinguishing oncocytoma and eosinophilic chromophobe rcc it is anticipated that the implementation of this dataset into routine clinical practice will facilitate uniformity of pathology reporting worldwide this in turn should have a positive impact on patient treatment and the quality of demographic information held by cancer registry
31302372,large nested urothelial carcinoma a clinicopathological study of case on transurethral resection material,large nested urothelial carcinoma lnuc is a recently recognized variant of urothelial carcinoma uc which is characterized with inverted growth pattern and bland cytology diagnosis can be extremely challenging especially in transurethral resection tur material haematoxylineosin stained slide of tur material with uc submitted to our department between and were reexamined twentytwo lnuc case were found lnuc frequency wa mean age wa were male mean tumor diameter wa cm noninvasive uc wa present in all case lowgrade in highgrade in low and highgrade in five and case were pt and pt respectively no invasion wa detected in one case in addition to mediumlarge nest small nest and conventional uc area wa present in and case respectively stromatumor interface wa irregular in case and case had invasive nest with rounded contour fibrous stromal reaction andor stromal lymphoid infiltration were present in case budding described a small nest in stromal interface of mediumlarge nest wa found in case followup wa available for case with an average of month four case had metastasis patient died of disease lnuc cause diagnostic difficulty especially in tur material large size of tumor irregularity of nest presence of stromal reaction and budding can be clue for correct diagnosis,Cancer,0,large nested urothelial carcinoma a clinicopathological study of case on transurethral resection material large nested urothelial carcinoma lnuc is a recently recognized variant of urothelial carcinoma uc which is characterized with inverted growth pattern and bland cytology diagnosis can be extremely challenging especially in transurethral resection tur material haematoxylineosin stained slide of tur material with uc submitted to our department between and were reexamined twentytwo lnuc case were found lnuc frequency wa mean age wa were male mean tumor diameter wa cm noninvasive uc wa present in all case lowgrade in highgrade in low and highgrade in five and case were pt and pt respectively no invasion wa detected in one case in addition to mediumlarge nest small nest and conventional uc area wa present in and case respectively stromatumor interface wa irregular in case and case had invasive nest with rounded contour fibrous stromal reaction andor stromal lymphoid infiltration were present in case budding described a small nest in stromal interface of mediumlarge nest wa found in case followup wa available for case with an average of month four case had metastasis patient died of disease lnuc cause diagnostic difficulty especially in tur material large size of tumor irregularity of nest presence of stromal reaction and budding can be clue for correct diagnosis
31304427,pathology of pancreatic cancer,pancreatic ductal adenocarcinoma pdac is a highly aggressive malignancy and estimated to become the second leading cause of cancerrelated death by although overall year survival rate have constantly remained below for the last decade several key point important for accurate patient stratification have emerged during recent year these key point include a highly standardized gross examination of pdac resection specimen using an axial slicing technique and inking of the circumferential resection margin crm a well a a meticulous microscopic examination taking into account the prognostic relevance of factor such a the exact resection status r v r mm v r resection histopathological tumor grading and the socalled lymph node ratio lnr with increasing use of neoadjuvant therapy in pdac tumor regression grading trg for pdac is currently rising in relevance in order to stratify and manage preoperatively treated pdac patient a all current trg system for pdac are unsatisfactory new standardized international protocol are urgently needed several morphological subtypes of pdac exist some of which share the same molecular background with classical pdac while others are characterized by a distinct molecular pathogenesis while some show a prognosis similar to classical pdac other subtypes stand out due to a better or even worse prognosis than classical pdac prognostic relevant molecular subtypes of pdac have been proposed a well however limitation of used cohort and the lacking correlation of molecular subtypes with histomorphological subtypes limit the translation of these finding into valuable clinical application lastly several macroscopic and microscopic precursor lesion of pdac have been described in genetically engineered mouse model gemm and human in recent time providing further insight into pdac carcinogenesis in addition improved diagnosis of pdac precursor represents a chance to select patient for resection before invasive pdac is present,Cancer,0,pathology of pancreatic cancer pancreatic ductal adenocarcinoma pdac is a highly aggressive malignancy and estimated to become the second leading cause of cancerrelated death by although overall year survival rate have constantly remained below for the last decade several key point important for accurate patient stratification have emerged during recent year these key point include a highly standardized gross examination of pdac resection specimen using an axial slicing technique and inking of the circumferential resection margin crm a well a a meticulous microscopic examination taking into account the prognostic relevance of factor such a the exact resection status r v r mm v r resection histopathological tumor grading and the socalled lymph node ratio lnr with increasing use of neoadjuvant therapy in pdac tumor regression grading trg for pdac is currently rising in relevance in order to stratify and manage preoperatively treated pdac patient a all current trg system for pdac are unsatisfactory new standardized international protocol are urgently needed several morphological subtypes of pdac exist some of which share the same molecular background with classical pdac while others are characterized by a distinct molecular pathogenesis while some show a prognosis similar to classical pdac other subtypes stand out due to a better or even worse prognosis than classical pdac prognostic relevant molecular subtypes of pdac have been proposed a well however limitation of used cohort and the lacking correlation of molecular subtypes with histomorphological subtypes limit the translation of these finding into valuable clinical application lastly several macroscopic and microscopic precursor lesion of pdac have been described in genetically engineered mouse model gemm and human in recent time providing further insight into pdac carcinogenesis in addition improved diagnosis of pdac precursor represents a chance to select patient for resection before invasive pdac is present
31307558,malignant phyllode tumor in lynch syndrome a case report,background lynch syndrome or hereditary nonpolyposis colorectal cancer is an autosomal dominant genetic syndrome that predisposes individual to multiple cancer type the known cancer associated with lynch syndrome include colorectal and endometrial cancer a well a cancer of the stomach ovary urinary tract hepatobiliary tract pancreas small bowel and brain there are no searchable case of malignant phyllode of the breast associated with lynch syndrome case presentation our patient wa a yearold caucasian woman who felt a lump in her left breast and wa found to have a spindle cell neoplasm definitive surgery revealed a malignant phyllode tumor on the basis of her cancer diagnosis and family history of multiple cancer a myriad myrisk hereditary cancer test panel of gene wa performed this testing revealed that she had a heterozygous msh mutation a part of the lynch syndrome panel due to positive margin the patient received adjuvant chemotherapy with doxorubicin and ifosfamide she also had a subsequent total abdominal hysterectomy and a bilateral salpingooophorectomy for risk reduction she remains in a highrisk surveillance program her family member have been tested which revealed that her two brother and daughter also carry the genetic mutation conclusion this case highlight the importance of genetic testing with rare malignancy because the full scope of phenotypic sequela for known hereditary syndrome ha not been mapped,Cancer,0,malignant phyllode tumor in lynch syndrome a case report background lynch syndrome or hereditary nonpolyposis colorectal cancer is an autosomal dominant genetic syndrome that predisposes individual to multiple cancer type the known cancer associated with lynch syndrome include colorectal and endometrial cancer a well a cancer of the stomach ovary urinary tract hepatobiliary tract pancreas small bowel and brain there are no searchable case of malignant phyllode of the breast associated with lynch syndrome case presentation our patient wa a yearold caucasian woman who felt a lump in her left breast and wa found to have a spindle cell neoplasm definitive surgery revealed a malignant phyllode tumor on the basis of her cancer diagnosis and family history of multiple cancer a myriad myrisk hereditary cancer test panel of gene wa performed this testing revealed that she had a heterozygous msh mutation a part of the lynch syndrome panel due to positive margin the patient received adjuvant chemotherapy with doxorubicin and ifosfamide she also had a subsequent total abdominal hysterectomy and a bilateral salpingooophorectomy for risk reduction she remains in a highrisk surveillance program her family member have been tested which revealed that her two brother and daughter also carry the genetic mutation conclusion this case highlight the importance of genetic testing with rare malignancy because the full scope of phenotypic sequela for known hereditary syndrome ha not been mapped
31309284,complexity of pecomas diagnostic approach molecular background clinical management,perivascular epithelioid cell neoplasm pecomas are a family of mesenchymal neoplasm with feature of both melanotic and smooth muscle differentiation pecoma morphology is highly variable and encompasses epithelioid to spindle cell often with clear cytoplasm and prominent nucleolus molecularly most pecomas are defined by a loss of function of the tsctsc complex additionally a distinct small subset of pecomas harboring rearrangement of the tfe xp gene locus ha been identified by presenting a series of three case report with distinct feature we demonstrate diagnostic pitfall a well a the importance of molecular workup of pecomas because of important therapeutic consequence,Cancer,0,complexity of pecomas diagnostic approach molecular background clinical management perivascular epithelioid cell neoplasm pecomas are a family of mesenchymal neoplasm with feature of both melanotic and smooth muscle differentiation pecoma morphology is highly variable and encompasses epithelioid to spindle cell often with clear cytoplasm and prominent nucleolus molecularly most pecomas are defined by a loss of function of the tsctsc complex additionally a distinct small subset of pecomas harboring rearrangement of the tfe xp gene locus ha been identified by presenting a series of three case report with distinct feature we demonstrate diagnostic pitfall a well a the importance of molecular workup of pecomas because of important therapeutic consequence
31312279,nonmuscle invasive bladder cancer a review of the current trend in africa,bladder cancer is the fourth most common cancer in men and the th most common cancer in woman accounting for of all cancer case approximately bladder cancer are nonmuscle invasive bladder cancer nmibc a few african study have provided considerable rate of nmibc a compared to western setting to critical step in the management of nmibc is to prevent tumor recurrence which include transurethral resection of the bladder tumor turbt for staging and histological diagnosis a second turbt for high grade tumor t tumor and intravesical adjuvant chemotherapy and immunotherapy are essential to reduce recurrence rate nevertheless variant histology multiple progressive and recurrent highgrade tumor are best treated with early radical cystectomy the african literature is scanty on the management of nmibc most of the histological type are squamous cell bladder cancer and may not conform to transurethral resection only but rather radical cystectomy most of these patient are not suitable for any form of treatment a they present with advanced disease however there is an increasing incidence of urothelial cancer in africa over the year due to urbanization it is best that major investment is made in urooncological care to address the growing challenge of these subtypes,Cancer,0,nonmuscle invasive bladder cancer a review of the current trend in africa bladder cancer is the fourth most common cancer in men and the th most common cancer in woman accounting for of all cancer case approximately bladder cancer are nonmuscle invasive bladder cancer nmibc a few african study have provided considerable rate of nmibc a compared to western setting to critical step in the management of nmibc is to prevent tumor recurrence which include transurethral resection of the bladder tumor turbt for staging and histological diagnosis a second turbt for high grade tumor t tumor and intravesical adjuvant chemotherapy and immunotherapy are essential to reduce recurrence rate nevertheless variant histology multiple progressive and recurrent highgrade tumor are best treated with early radical cystectomy the african literature is scanty on the management of nmibc most of the histological type are squamous cell bladder cancer and may not conform to transurethral resection only but rather radical cystectomy most of these patient are not suitable for any form of treatment a they present with advanced disease however there is an increasing incidence of urothelial cancer in africa over the year due to urbanization it is best that major investment is made in urooncological care to address the growing challenge of these subtypes
31316083,srebpdependent de novo fatty acid synthesis gene expression is elevated in malignant melanoma and represents a cellular survival trait,de novo fatty acid biosynthesis dnfa is a hallmark adaptation of many cancer that support survival proliferation and metastasis here we elucidate previously unexplored aspect of transcription regulation and clinical relevance of dnfa in cancer we show that elevated expression of dnfa gene is characteristic of many tumor type and correlate with poor prognosis especially in melanoma elevated dnfa gene expression depends on the srebp transcription factor in multiple melanoma cell line srebp predominantly bind to the transcription start site of dnfa gene regulating their expression by recruiting rna polymerase ii to promoter for productive transcription elongation we find that srebpregulated dnfa represents a survival trait in melanoma cell regardless of proliferative state and oncogenic mutation status indeed malignant melanoma cell exhibit elevated dnfa gene expression after the brafmek signaling pathway is blocked eg by braf inhibitor and dnfa expression remains higher in melanoma cell resistant to vemurafenib treatment than in untreated cell accordingly dnfa pathway inhibition whether by direct targeting of srebp with antisense oligonucleotides or through combinatorial effect of multiple dnfa enzyme inhibitor exerts potent cytotoxic effect on both brafisensitive and resistant melanoma cell altogether these result implicate srebp and dnfa enzyme a enticing therapeutic target in melanoma,Cancer,0,srebpdependent de novo fatty acid synthesis gene expression is elevated in malignant melanoma and represents a cellular survival trait de novo fatty acid biosynthesis dnfa is a hallmark adaptation of many cancer that support survival proliferation and metastasis here we elucidate previously unexplored aspect of transcription regulation and clinical relevance of dnfa in cancer we show that elevated expression of dnfa gene is characteristic of many tumor type and correlate with poor prognosis especially in melanoma elevated dnfa gene expression depends on the srebp transcription factor in multiple melanoma cell line srebp predominantly bind to the transcription start site of dnfa gene regulating their expression by recruiting rna polymerase ii to promoter for productive transcription elongation we find that srebpregulated dnfa represents a survival trait in melanoma cell regardless of proliferative state and oncogenic mutation status indeed malignant melanoma cell exhibit elevated dnfa gene expression after the brafmek signaling pathway is blocked eg by braf inhibitor and dnfa expression remains higher in melanoma cell resistant to vemurafenib treatment than in untreated cell accordingly dnfa pathway inhibition whether by direct targeting of srebp with antisense oligonucleotides or through combinatorial effect of multiple dnfa enzyme inhibitor exerts potent cytotoxic effect on both brafisensitive and resistant melanoma cell altogether these result implicate srebp and dnfa enzyme a enticing therapeutic target in melanoma
31317326,synchronicity of genetic variant between primary site and metastatic lymph node and prognostic impact in nodal metastatic lung adenocarcinoma,purpose nodal positive lung adenocarcinoma includes wide range of survival several method for the classification of nodalpositive lung cancer have been proposed however classification considering the impact of targetable genetic variant are lacking the possibility of genetic variant for the better stratification of nodal positive lung adenocarcinoma wa estimated method mutation of gene between primary site and metastatic lymph node lns were compared using nextgeneration sequencing subsequently mutation in egfr and braf rearrangement in alk and ro were evaluated in resected pnm adenocarcinoma case recurrencefree survival rf postrecurrence survival pr and overall survival o were evaluated with respect to targetable variant and tyrosine kinase inhibitor tki therapy after recurrence result about of variant were shared and allele frequency were similar between primary and metastatic site in pnm case egfralk were positive in primary site of case and same egfralk variant were confirmed in metastatic lns of tissueavailable case multivariate analysis indicated positive egfralk status wa associated with worse rf hr ci p and pr wa prolonged in case receiving tki therapy no postrecurrence tki therapy hr ci p o did not differ with respect to targetable variant or tki therapy conclusion case harbouring targetable genetic variant had a higher risk of recurrence but pr wa prolonged by tki therapy classification according to the targetable genetic status provides a basis for predicting recurrence and determining treatment strategy after recurrence,Cancer,0,synchronicity of genetic variant between primary site and metastatic lymph node and prognostic impact in nodal metastatic lung adenocarcinoma purpose nodal positive lung adenocarcinoma includes wide range of survival several method for the classification of nodalpositive lung cancer have been proposed however classification considering the impact of targetable genetic variant are lacking the possibility of genetic variant for the better stratification of nodal positive lung adenocarcinoma wa estimated method mutation of gene between primary site and metastatic lymph node lns were compared using nextgeneration sequencing subsequently mutation in egfr and braf rearrangement in alk and ro were evaluated in resected pnm adenocarcinoma case recurrencefree survival rf postrecurrence survival pr and overall survival o were evaluated with respect to targetable variant and tyrosine kinase inhibitor tki therapy after recurrence result about of variant were shared and allele frequency were similar between primary and metastatic site in pnm case egfralk were positive in primary site of case and same egfralk variant were confirmed in metastatic lns of tissueavailable case multivariate analysis indicated positive egfralk status wa associated with worse rf hr ci p and pr wa prolonged in case receiving tki therapy no postrecurrence tki therapy hr ci p o did not differ with respect to targetable variant or tki therapy conclusion case harbouring targetable genetic variant had a higher risk of recurrence but pr wa prolonged by tki therapy classification according to the targetable genetic status provides a basis for predicting recurrence and determining treatment strategy after recurrence
31317679,the role of brca in hereditary and familial breast and ovarian cancer,background brca pathogenic variant have become associated with familial breast and ovarian cancer and hereditary cancerpredisposition syndrome with advance in molecular biology brca profiling facilitates early diagnosis and the implementation of preventive and therapeutic strategy the gene exhibit variable prevalence among different individual and moderate interpretation complexity brca deficiency is instrumental in cancer development affect therapeutic option and is instrumental in drug resistance in addition brca profile is diverse across different group and ha been associated with the founder effect in certain population method in this review we aim to detail the spectrum of brca variant and their associated risk estimate result the relationship between brca and hereditary and familial cancer is indisputable yet brca screening method are beset with limitation and lack clinical confidence conclusion this review emphasizes the importance of screening brca genetics in addition to their clinical utility furthermore founder variant are anticipated in the saudi population,Cancer,0,the role of brca in hereditary and familial breast and ovarian cancer background brca pathogenic variant have become associated with familial breast and ovarian cancer and hereditary cancerpredisposition syndrome with advance in molecular biology brca profiling facilitates early diagnosis and the implementation of preventive and therapeutic strategy the gene exhibit variable prevalence among different individual and moderate interpretation complexity brca deficiency is instrumental in cancer development affect therapeutic option and is instrumental in drug resistance in addition brca profile is diverse across different group and ha been associated with the founder effect in certain population method in this review we aim to detail the spectrum of brca variant and their associated risk estimate result the relationship between brca and hereditary and familial cancer is indisputable yet brca screening method are beset with limitation and lack clinical confidence conclusion this review emphasizes the importance of screening brca genetics in addition to their clinical utility furthermore founder variant are anticipated in the saudi population
31319986,novel multiplex droplet digital pcr assay for scoring pdl in nonsmall cell lung cancer biopsy specimen,objective immune checkpoint inhibitor have become integrated into the clinical management of nonsmall cell lung cancer nsclc using rtqpcr we have previously identified a gene expression panel that detected presence of malignant cell mmptimp ratio and quantified pdl transcript level in small biopsy specimen however rtqpcr ha diagnostic limitation a it doe not generate absolute copy number and is not readily multiplexed to address this we have developed a multiplex droplet digital pcr ddpcr assay material and method biopsy obtained from nsclc patient n adenocarcinoma and n squamous cell carcinoma and control lung biopsy specimen n were analysed absolute mmp timp and pdl transcript copy number were determined within a single assay by multiplex ddpcr using taqman primer and the qx droplet digital pcr system result and conclusion using our optimised triplex ddpcr assay the mmptimp ratio wa significantly elevated in nsclc biopsy and using a cutoff of wa ci sensitive and specific for identifying malignant biopsy the pdltimp ratio significantly associated with pdl tumour cell immunohistochemistry staining r p pdl tumour cell staining p in summary a major advantage of our workflow is that it can accurately quantify pdl tumour level and provide sufficient nucleic acid for screening additional targetable mutation such a egfr alk and ro from a single small biopsy thereby potentially avoiding the need for rebiopsy future study will need to determine diagnostic ddpcr value that are predictive of clinical response to pdpdl immunotherapy,Cancer,0,novel multiplex droplet digital pcr assay for scoring pdl in nonsmall cell lung cancer biopsy specimen objective immune checkpoint inhibitor have become integrated into the clinical management of nonsmall cell lung cancer nsclc using rtqpcr we have previously identified a gene expression panel that detected presence of malignant cell mmptimp ratio and quantified pdl transcript level in small biopsy specimen however rtqpcr ha diagnostic limitation a it doe not generate absolute copy number and is not readily multiplexed to address this we have developed a multiplex droplet digital pcr ddpcr assay material and method biopsy obtained from nsclc patient n adenocarcinoma and n squamous cell carcinoma and control lung biopsy specimen n were analysed absolute mmp timp and pdl transcript copy number were determined within a single assay by multiplex ddpcr using taqman primer and the qx droplet digital pcr system result and conclusion using our optimised triplex ddpcr assay the mmptimp ratio wa significantly elevated in nsclc biopsy and using a cutoff of wa ci sensitive and specific for identifying malignant biopsy the pdltimp ratio significantly associated with pdl tumour cell immunohistochemistry staining r p pdl tumour cell staining p in summary a major advantage of our workflow is that it can accurately quantify pdl tumour level and provide sufficient nucleic acid for screening additional targetable mutation such a egfr alk and ro from a single small biopsy thereby potentially avoiding the need for rebiopsy future study will need to determine diagnostic ddpcr value that are predictive of clinical response to pdpdl immunotherapy
31320822,exosomes and their role in cancer progression,exosomes are a subset of extracellular vesicle and their size is approximately nm in diameter they are surrounded by a lipid bilayer membrane and secreted from almost all of cell exosomes are generated within the endocytic system a ilv intraluminal membrane vesicle and secreted during the fusion of mvb multivesicular body with the cell membrane recently it ha been reported that exosomes modulate cellcell communication contributing to the maintenance of tissue homeostasis by molecule including exosomes moreover exosomes released from cancer cell are involved in cancer progression thus data regarding the role of the exosomes in malignant cancer will lead to development of novel diagnostic and therapeutic method,Cancer,0,exosomes and their role in cancer progression exosomes are a subset of extracellular vesicle and their size is approximately nm in diameter they are surrounded by a lipid bilayer membrane and secreted from almost all of cell exosomes are generated within the endocytic system a ilv intraluminal membrane vesicle and secreted during the fusion of mvb multivesicular body with the cell membrane recently it ha been reported that exosomes modulate cellcell communication contributing to the maintenance of tissue homeostasis by molecule including exosomes moreover exosomes released from cancer cell are involved in cancer progression thus data regarding the role of the exosomes in malignant cancer will lead to development of novel diagnostic and therapeutic method
31321084,nsd mutation by hpv status in head and neck cancer difference in survival and response to dnadamaging agent,background compared to hpvnegative head and neck squamous cell carcinoma hnsccs hpvpositive hnsccs are associated with a favorable prognosis in part due to their improved treatment sensitivity inactivating mutation in nsd were shown to be a favorable prognostic biomarker in laryngeal cancer here we characterize nsd mutation from the expanded the cancer genome atlas tcga hnscc cohort n and examine their prognostic implication based on hpv status of the tumor we also begin to examine if nsd regulates response to platinumbased drug and other dnadamaging agent method tcga hnscc sample were segregated by hpv and nsd mutation using cbioportal and patient survival wa determined pathogenicity of mutation wa predicted using umdpredictor nsddepleted cell line were established by transfection with control or shrnas against nsd followed by puromycin selection and confirmed by qrtpcr cell sensitivity to dna damaging agent wa assessed using shortterm proliferation and longterm clonogenic survival assay result among hpv tumor contained alteration in the nsd gene the majority of nsd gene alteration in hpv specimen were truncating mutation within or before the enzymatic set domain the remaining alteration included homozygous gene deletion missense point mutation and inframe deletion umdpredictor categorized of missense point mutation a pathogenic for hpv hnscc n nsd mutation comprised of two truncating and missense point mutation were identified three of the missense point mutation were predicted to be pathogenic or probably pathogenic by umdpredictor kaplanmeier survival analysis determined significantly improved survival of hpv hnscc patient whose tumor harbored nsd gene alteration a compared to patient with wildtype nsd tumor interestingly the survival effect of nsd mutation observed in hpvnegative hnscc wa reversed in hpv tumor proliferation and clonogenic survival of two hpv cell line stably expressing control or nsd shrnas showed that nsddepleted cell were more sensitive to cisplatin and carboplatin but not to other dna damaging drug conclusion genetic alteration in nsd hold potential a novel prognostic biomarkers in hpv head and neck cancer nsd mutation in hpv cancer may also play a prognostic role although this effect must be examined in a larger cohort nsd downregulation result in improved sensitivity to cisplatin and carboplatin but not to other dnadamaging agent in epithelial cell increased sensitivity to platinumbased chemotherapy agent associated with nsd depletion may contribute to improved survival in hpv hnsccs further study are needed to determine mechanism through which nsd protects hpv hnscc cell from platinumbased therapy a well a confirmation of nsd effect in hpv hnscc,Cancer,0,nsd mutation by hpv status in head and neck cancer difference in survival and response to dnadamaging agent background compared to hpvnegative head and neck squamous cell carcinoma hnsccs hpvpositive hnsccs are associated with a favorable prognosis in part due to their improved treatment sensitivity inactivating mutation in nsd were shown to be a favorable prognostic biomarker in laryngeal cancer here we characterize nsd mutation from the expanded the cancer genome atlas tcga hnscc cohort n and examine their prognostic implication based on hpv status of the tumor we also begin to examine if nsd regulates response to platinumbased drug and other dnadamaging agent method tcga hnscc sample were segregated by hpv and nsd mutation using cbioportal and patient survival wa determined pathogenicity of mutation wa predicted using umdpredictor nsddepleted cell line were established by transfection with control or shrnas against nsd followed by puromycin selection and confirmed by qrtpcr cell sensitivity to dna damaging agent wa assessed using shortterm proliferation and longterm clonogenic survival assay result among hpv tumor contained alteration in the nsd gene the majority of nsd gene alteration in hpv specimen were truncating mutation within or before the enzymatic set domain the remaining alteration included homozygous gene deletion missense point mutation and inframe deletion umdpredictor categorized of missense point mutation a pathogenic for hpv hnscc n nsd mutation comprised of two truncating and missense point mutation were identified three of the missense point mutation were predicted to be pathogenic or probably pathogenic by umdpredictor kaplanmeier survival analysis determined significantly improved survival of hpv hnscc patient whose tumor harbored nsd gene alteration a compared to patient with wildtype nsd tumor interestingly the survival effect of nsd mutation observed in hpvnegative hnscc wa reversed in hpv tumor proliferation and clonogenic survival of two hpv cell line stably expressing control or nsd shrnas showed that nsddepleted cell were more sensitive to cisplatin and carboplatin but not to other dna damaging drug conclusion genetic alteration in nsd hold potential a novel prognostic biomarkers in hpv head and neck cancer nsd mutation in hpv cancer may also play a prognostic role although this effect must be examined in a larger cohort nsd downregulation result in improved sensitivity to cisplatin and carboplatin but not to other dnadamaging agent in epithelial cell increased sensitivity to platinumbased chemotherapy agent associated with nsd depletion may contribute to improved survival in hpv hnsccs further study are needed to determine mechanism through which nsd protects hpv hnscc cell from platinumbased therapy a well a confirmation of nsd effect in hpv hnscc
31321732,chronic shisha exposure alters phosphoproteome of oral keratinocytes,shisha smoking ha been epidemiologically linked to oral cancer however few study have investigated the pathobiology of shishainduced cellular transformation we studied the effect of chronic shisha exposure month in an in vitro model using immortalized nonneoplastic oral keratinocytes okftert quantitative proteomic and phosphoproteomic analysis were performed on okftert cell treated with shisha extract for a period of month pathway analysis wa carried out to identify significantly enriched biological process in shishatreated cell chronic shisha exposure resulted in increased cell scattering phenomenon in okftert cell data analysis revealed differential phosphorylation of peptide fold change p corresponding to protein protein associated with mtorc and eiff complex involved in initiating protein translation were seen to be enriched upon shisha treatment network analysis also highlighted downregulation of protein involved in type i interferon signaling in shishatreated cell quantitative phosphoproteomic approach elucidated global perturbation to the molecular milieu of oral keratinocytes upon shisha exposure further study are needed to validate putative target in oral cancer patient with shisha smoking history,Cancer,0,chronic shisha exposure alters phosphoproteome of oral keratinocytes shisha smoking ha been epidemiologically linked to oral cancer however few study have investigated the pathobiology of shishainduced cellular transformation we studied the effect of chronic shisha exposure month in an in vitro model using immortalized nonneoplastic oral keratinocytes okftert quantitative proteomic and phosphoproteomic analysis were performed on okftert cell treated with shisha extract for a period of month pathway analysis wa carried out to identify significantly enriched biological process in shishatreated cell chronic shisha exposure resulted in increased cell scattering phenomenon in okftert cell data analysis revealed differential phosphorylation of peptide fold change p corresponding to protein protein associated with mtorc and eiff complex involved in initiating protein translation were seen to be enriched upon shisha treatment network analysis also highlighted downregulation of protein involved in type i interferon signaling in shishatreated cell quantitative phosphoproteomic approach elucidated global perturbation to the molecular milieu of oral keratinocytes upon shisha exposure further study are needed to validate putative target in oral cancer patient with shisha smoking history
31322271,a germline mbd mutation wa identified in a patient with colorectal oligopolyposis and earlyonset cancer a case report,a yearold woman presented with adenomatous polyp of the left sidedcolon with early rectosigmoid cancer the patient had no previous medical history and no familial history of inherited colorectal disease no germline gene mutation associated with colorectal adenomatous polyposis including apc regulator of wnt signaling pathway muty dna glycosylase dna polymeraseepsilon catalytic subunit dna polymerase delta catalytic subunit and mismatch repair gene were detected via germline genetic testing a heterozygous germline mutation in methylcpg binding domain dna glycosylase mbd cctpgln which resulted in the generation of a stop codon wa identified by genetic analysis including wholeexome sequencing immunohistochemical staining analysis revealed that the expression of mbd protein wa absent in the cancer tissue while it wa expressed in the normal epithelium sequencing and copynumber analysis demonstrated the loss of the remaining allele of mbd in the cancer tissue furthermore somatic mutation signature analysis showed preferential transition of cytosine to thymine residue at cpg dinucleotides in cancer tissue although it ha been previously reported that germline missense mutation and somatic mutation of mbd are associated with the development of colorectal cancer this is the first report to the best of our knowledge in which a germline nonsense mutation of the mbd gene ha been identified in an earlyonset colorectal cancer patient with oligopolyposis,Cancer,0,a germline mbd mutation wa identified in a patient with colorectal oligopolyposis and earlyonset cancer a case report a yearold woman presented with adenomatous polyp of the left sidedcolon with early rectosigmoid cancer the patient had no previous medical history and no familial history of inherited colorectal disease no germline gene mutation associated with colorectal adenomatous polyposis including apc regulator of wnt signaling pathway muty dna glycosylase dna polymeraseepsilon catalytic subunit dna polymerase delta catalytic subunit and mismatch repair gene were detected via germline genetic testing a heterozygous germline mutation in methylcpg binding domain dna glycosylase mbd cctpgln which resulted in the generation of a stop codon wa identified by genetic analysis including wholeexome sequencing immunohistochemical staining analysis revealed that the expression of mbd protein wa absent in the cancer tissue while it wa expressed in the normal epithelium sequencing and copynumber analysis demonstrated the loss of the remaining allele of mbd in the cancer tissue furthermore somatic mutation signature analysis showed preferential transition of cytosine to thymine residue at cpg dinucleotides in cancer tissue although it ha been previously reported that germline missense mutation and somatic mutation of mbd are associated with the development of colorectal cancer this is the first report to the best of our knowledge in which a germline nonsense mutation of the mbd gene ha been identified in an earlyonset colorectal cancer patient with oligopolyposis
31322508,morphophenotypic characteristic of ovarian serous borderline tumor,borderline ovarian tumor bot represent particular challenge for diagnosis and clinical management a they are characterized with the feature of both benign cystadenomas and malignant carcinoma the aim of our study wa to investigate histomorphological and immunohistochemical characteristic of ovarian serouspapillary borderline tumor compared to serous cystadenomas and low and highgrade serous carcinoma altogether formalin fixed and paraffin embedded tissue specimen distributed in four group including serous cystadenoma group i serous bot group ii low group iii and high group iv grade serous carcinoma were investigated by standard immunohistochemistry using antibody against ck ck wt vimentin cdx cea er cyclin d bcl ecadherin calretinin sa ki p study result showed that ovarian serous bot are characterized with slightly increase proliferative potential compared to benign cystadenomas whilst apoptotic potential is retained with the difference from malignant serous carcinoma p mutation is not present a well a the expression of vimentin overall ovarian serous bot are characterized with highly variable immunohistochemical phenotype and the use of multiple immunohistochemical marker are recommended for the differential diagnosis from low grade serous carcinoma and benign cystadenomas,Cancer,0,morphophenotypic characteristic of ovarian serous borderline tumor borderline ovarian tumor bot represent particular challenge for diagnosis and clinical management a they are characterized with the feature of both benign cystadenomas and malignant carcinoma the aim of our study wa to investigate histomorphological and immunohistochemical characteristic of ovarian serouspapillary borderline tumor compared to serous cystadenomas and low and highgrade serous carcinoma altogether formalin fixed and paraffin embedded tissue specimen distributed in four group including serous cystadenoma group i serous bot group ii low group iii and high group iv grade serous carcinoma were investigated by standard immunohistochemistry using antibody against ck ck wt vimentin cdx cea er cyclin d bcl ecadherin calretinin sa ki p study result showed that ovarian serous bot are characterized with slightly increase proliferative potential compared to benign cystadenomas whilst apoptotic potential is retained with the difference from malignant serous carcinoma p mutation is not present a well a the expression of vimentin overall ovarian serous bot are characterized with highly variable immunohistochemical phenotype and the use of multiple immunohistochemical marker are recommended for the differential diagnosis from low grade serous carcinoma and benign cystadenomas
31327245,characteristic and diagnostic application of circulating cellfree dna in colorectal cancer,the incidence and mortality of colorectal cancer crc are considerably high in central european country it is the second most common cancer in both men and woman in hungary with newly registered patient per year these data indicate the necessity of new screening method that are more comfortable for patient hence the compliance can be increased cellfree dna cfdna level in blood is elevated in certain physiological condition such a pregnancy or high physical activity furthermore cfdna concentration alteration can also be detected in some pathological process increased cfdna amount wa observed in autoimmune and inflammatory disease a well a in various cancer including crc numerous study about origin function and mechanism of cfdna can be found in the scientific literature in this review we aimed to describe the quantitative and qualitative change of cfdna to present it function and to provide an overview of the available diagnostic application for crc cfdna can be released to the circulatory system via apoptosis necrosis or by direct secretion by living cell in cancer patient cfdna can originate from healthy and cancer cell hence genetic eg mutation in apc kras braf and epigenetic eg methylation in sept sfrp alteration of tumor cell can be examined in cfdna fraction several highthroughput sensitive and even automated method are available providing opportunity to perform standardized sample preparation and to analyse biomarker candidate quantitatively these enhancement can help to develop alternative screening method that can be easily integrated into the clinical practice and can contribute to early cancer detection orv hetil,Cancer,0,characteristic and diagnostic application of circulating cellfree dna in colorectal cancer the incidence and mortality of colorectal cancer crc are considerably high in central european country it is the second most common cancer in both men and woman in hungary with newly registered patient per year these data indicate the necessity of new screening method that are more comfortable for patient hence the compliance can be increased cellfree dna cfdna level in blood is elevated in certain physiological condition such a pregnancy or high physical activity furthermore cfdna concentration alteration can also be detected in some pathological process increased cfdna amount wa observed in autoimmune and inflammatory disease a well a in various cancer including crc numerous study about origin function and mechanism of cfdna can be found in the scientific literature in this review we aimed to describe the quantitative and qualitative change of cfdna to present it function and to provide an overview of the available diagnostic application for crc cfdna can be released to the circulatory system via apoptosis necrosis or by direct secretion by living cell in cancer patient cfdna can originate from healthy and cancer cell hence genetic eg mutation in apc kras braf and epigenetic eg methylation in sept sfrp alteration of tumor cell can be examined in cfdna fraction several highthroughput sensitive and even automated method are available providing opportunity to perform standardized sample preparation and to analyse biomarker candidate quantitatively these enhancement can help to develop alternative screening method that can be easily integrated into the clinical practice and can contribute to early cancer detection orv hetil
31330366,molecular pathogenesis of gallbladder cancer an update,gallbladder carcinoma gbc is the most aggressive gastrointestinal malignancy throughout the world with wide geographical variance it is the subtype of biliary tract malignancy that ha the poorest prognosis and lower survival among all biliary tract malignancy various factor are associated with gbc pathogenesis such a environmental microbial metabolic and molecular chronic inflammation of gallbladder due to presence of gallstone or microbial infection eg salmonella or h pylorus result in sustained production of inflammatory mediator in the tissue microenvironment which can cause genomic change linked to carcinogenesis genetic alteration are one of the major factor associated with aggressiveness and prognosis research have been done to explore suitable biomarker for early diagnosis and identify altered molecular pathway to develop appropriate biomarkers for early diagnosis therapy and predicting prognosis different agent for targeted therapy against actionable mutation of molecule like egfr vegf mtor her pdl pd met pik ncadherin vegfr mek and mek are being tried despite these advancement there is dismal improvement in the survival of gbc patient genetic aberration other than actionable mutation and epigenetic modification including aberrant expression of micrornas are also being studied both a diagnostic biomarker and therapeutic target complex pathogenesis of gbc still need to be unfolded in this review we focus on the molecular pathogenesis of gbc elucidated till date along with future direction that can be explored to achieve better management of gbc patient,Cancer,0,molecular pathogenesis of gallbladder cancer an update gallbladder carcinoma gbc is the most aggressive gastrointestinal malignancy throughout the world with wide geographical variance it is the subtype of biliary tract malignancy that ha the poorest prognosis and lower survival among all biliary tract malignancy various factor are associated with gbc pathogenesis such a environmental microbial metabolic and molecular chronic inflammation of gallbladder due to presence of gallstone or microbial infection eg salmonella or h pylorus result in sustained production of inflammatory mediator in the tissue microenvironment which can cause genomic change linked to carcinogenesis genetic alteration are one of the major factor associated with aggressiveness and prognosis research have been done to explore suitable biomarker for early diagnosis and identify altered molecular pathway to develop appropriate biomarkers for early diagnosis therapy and predicting prognosis different agent for targeted therapy against actionable mutation of molecule like egfr vegf mtor her pdl pd met pik ncadherin vegfr mek and mek are being tried despite these advancement there is dismal improvement in the survival of gbc patient genetic aberration other than actionable mutation and epigenetic modification including aberrant expression of micrornas are also being studied both a diagnostic biomarker and therapeutic target complex pathogenesis of gbc still need to be unfolded in this review we focus on the molecular pathogenesis of gbc elucidated till date along with future direction that can be explored to achieve better management of gbc patient
31330830,the molecular hallmark of the serrated pathway in colorectal cancer,colorectal cancer crc is a leading cause of cancer death worldwide it includes different subtypes that differ in their clinical and prognostic feature in the past decade in addition to the conventional adenomacarcinoma model an alternative multistep mechanism of carcinogenesis namely the serrated pathway ha been described approximately to of all crcs arise from neoplastic serrated polyp a heterogeneous group of lesion that are histologically classified into three morphologic category hyperplastic polyp sessile serrated adenomaspolyps and the traditional serrated adenomaspolyps serrated polyp are characterized by genetic braf or kras mutation and epigenetic cpg island methylator phenotype cimp alteration that cooperate to initiate and drive malignant transformation from normal colon mucosa to polyp and then to crc the high heterogeneity of the serrated lesion render their diagnostic and pathological interpretation difficult hence novel genetic and epigenetic biomarkers are required for better classification and management of crcs to date several molecular alteration have been associated with the serrated polypcrc sequence in addition the gut microbiota is emerging a a contributor tomodulator of the serrated pathway this review summarizes the state of the art of the genetic epigenetic and microbiota signature associated with serrated crcs together with their clinical implication,Cancer,0,the molecular hallmark of the serrated pathway in colorectal cancer colorectal cancer crc is a leading cause of cancer death worldwide it includes different subtypes that differ in their clinical and prognostic feature in the past decade in addition to the conventional adenomacarcinoma model an alternative multistep mechanism of carcinogenesis namely the serrated pathway ha been described approximately to of all crcs arise from neoplastic serrated polyp a heterogeneous group of lesion that are histologically classified into three morphologic category hyperplastic polyp sessile serrated adenomaspolyps and the traditional serrated adenomaspolyps serrated polyp are characterized by genetic braf or kras mutation and epigenetic cpg island methylator phenotype cimp alteration that cooperate to initiate and drive malignant transformation from normal colon mucosa to polyp and then to crc the high heterogeneity of the serrated lesion render their diagnostic and pathological interpretation difficult hence novel genetic and epigenetic biomarkers are required for better classification and management of crcs to date several molecular alteration have been associated with the serrated polypcrc sequence in addition the gut microbiota is emerging a a contributor tomodulator of the serrated pathway this review summarizes the state of the art of the genetic epigenetic and microbiota signature associated with serrated crcs together with their clinical implication
31331345,subtyping of microsatellite instabilityhigh colorectal cancer,background patient with microsatellite instabilityhigh msih colorectal cancer crc generally have a better prognosis than patient with microsatellite stable ms crc however some msih crc patient do not gain overall survival benefit from immune checkpointblockade treatment in other word heterogeneity within the subgroup of msih tumor remains poorly understood thus an indepth molecular characterization of msih tumor is urgently required method here we use nonnegative matrix factorization nmfbased consensus clustering to define crc msih subtypes in the cancer genome atlas and a french multicenter cohort gse cibersort wa used to calculate the proportion of lymphocyte in tumor tissue in msih subtypes result msih crc sample basically clustered into two subgroup msih and msih msih wa characterized by a lower braf mutational status higher frequency of chromosomal instability global hypomethylation and worse survival than msih further examination of the immune landscape showed that macrophage of the m phenotype were enriched in msih which may be associated with poor prognosis in this subgroup conclusion our result illustrate the genetic heterogeneity in msih crcs and macrophage may serve a good target for anticancer therapy in msih,Cancer,0,subtyping of microsatellite instabilityhigh colorectal cancer background patient with microsatellite instabilityhigh msih colorectal cancer crc generally have a better prognosis than patient with microsatellite stable ms crc however some msih crc patient do not gain overall survival benefit from immune checkpointblockade treatment in other word heterogeneity within the subgroup of msih tumor remains poorly understood thus an indepth molecular characterization of msih tumor is urgently required method here we use nonnegative matrix factorization nmfbased consensus clustering to define crc msih subtypes in the cancer genome atlas and a french multicenter cohort gse cibersort wa used to calculate the proportion of lymphocyte in tumor tissue in msih subtypes result msih crc sample basically clustered into two subgroup msih and msih msih wa characterized by a lower braf mutational status higher frequency of chromosomal instability global hypomethylation and worse survival than msih further examination of the immune landscape showed that macrophage of the m phenotype were enriched in msih which may be associated with poor prognosis in this subgroup conclusion our result illustrate the genetic heterogeneity in msih crcs and macrophage may serve a good target for anticancer therapy in msih
31333801,rag high expression associated with ikzf dysfunction in adult bcell acute lymphoblastic leukemia,the recombination mediated by recombination activating gene rag is not only the dominant mutational process but also the predominant driver of oncogenic genomic rearrangement in acute lymphoblastic leukemia all it is further responsible for leukemic clonal evolution in this study significant rag increase is observed in the subset of ball patient and high expression of rag is observed to be correlated with high proliferation marker ikzfencoded protein ikaros directly bind to the rag promoter and regulates rag expression in leukemic cell ck inhibitor by increasing ikaros activity significantly suppresses rag expression in all in an ikarosdependent manner patient with ikzf deletion have significantly higher expression of rag compared to that without ikzf deletion ck inhibitor treatment also result in an increase in ikzf binding to the rag promoter and suppression of rag expression in primary all cell taken together these result demonstrate that rag high expression is associated with high proliferation marker in ball our data for the first time proved that rag expression is directly suppressed by ikaros our result also reveal drive oncogenesis of ball is driven by high expression of rag with ikaros dysfunction together which have significance in an integrated prognostic model for adult all,Cancer,0,rag high expression associated with ikzf dysfunction in adult bcell acute lymphoblastic leukemia the recombination mediated by recombination activating gene rag is not only the dominant mutational process but also the predominant driver of oncogenic genomic rearrangement in acute lymphoblastic leukemia all it is further responsible for leukemic clonal evolution in this study significant rag increase is observed in the subset of ball patient and high expression of rag is observed to be correlated with high proliferation marker ikzfencoded protein ikaros directly bind to the rag promoter and regulates rag expression in leukemic cell ck inhibitor by increasing ikaros activity significantly suppresses rag expression in all in an ikarosdependent manner patient with ikzf deletion have significantly higher expression of rag compared to that without ikzf deletion ck inhibitor treatment also result in an increase in ikzf binding to the rag promoter and suppression of rag expression in primary all cell taken together these result demonstrate that rag high expression is associated with high proliferation marker in ball our data for the first time proved that rag expression is directly suppressed by ikaros our result also reveal drive oncogenesis of ball is driven by high expression of rag with ikaros dysfunction together which have significance in an integrated prognostic model for adult all
31334571,primary malignant epithelioid and rhabdoid tumor of bone harboring znfnutm fusion the expanding nut cancer family,nutm gene rearrangement is the genetic hallmark of nut carcinoma an aggressive tumor that most commonly affect the thoracic and head and neck region and often exhibit squamous differentiation the most common fusion partner gene is brd followed by brd and nsd recently nutm gene rearrangement ha been identified in rare tumor from soft tissue intracranial location and other visceral organ these tumor often show high grade malignant epithelioid to round cell histomorphology and lack evidence of squamous andor epithelial differentiation therefore their relationship with classic nut carcinoma is still uncertain here we present a primary mandible bone tumor of a yearold female exhibiting monotonous epithelioid and rhabdoid cytomorphology vesicular chromatin and prominent nucleolus the initial immunohistochemical workup wa nonspecific showing only cd positivity while being negative for cytokeratin aeae ema p etc ini expression wa retained rna sequencing wa performed and identified a rare znfnutm gene fusion which had only been reported in a single case of pulmonary nut carcinoma the fusion wa confirmed by fish for nutm gene rearrangement and supported by diffuse and strong nut immunoreactivity myc mrna upregulation and immunoreactivity a common finding in nut carcinoma wa also observed in this tumor suggesting a possible common pathogenetic mechanism and potential treatment target the patient presented with a nonmetastatic disease status and received hemimandibulectomy selective neck dissection level ib and postoperative radiation therapy she remained disease free year after the initial diagnosis,Cancer,0,primary malignant epithelioid and rhabdoid tumor of bone harboring znfnutm fusion the expanding nut cancer family nutm gene rearrangement is the genetic hallmark of nut carcinoma an aggressive tumor that most commonly affect the thoracic and head and neck region and often exhibit squamous differentiation the most common fusion partner gene is brd followed by brd and nsd recently nutm gene rearrangement ha been identified in rare tumor from soft tissue intracranial location and other visceral organ these tumor often show high grade malignant epithelioid to round cell histomorphology and lack evidence of squamous andor epithelial differentiation therefore their relationship with classic nut carcinoma is still uncertain here we present a primary mandible bone tumor of a yearold female exhibiting monotonous epithelioid and rhabdoid cytomorphology vesicular chromatin and prominent nucleolus the initial immunohistochemical workup wa nonspecific showing only cd positivity while being negative for cytokeratin aeae ema p etc ini expression wa retained rna sequencing wa performed and identified a rare znfnutm gene fusion which had only been reported in a single case of pulmonary nut carcinoma the fusion wa confirmed by fish for nutm gene rearrangement and supported by diffuse and strong nut immunoreactivity myc mrna upregulation and immunoreactivity a common finding in nut carcinoma wa also observed in this tumor suggesting a possible common pathogenetic mechanism and potential treatment target the patient presented with a nonmetastatic disease status and received hemimandibulectomy selective neck dissection level ib and postoperative radiation therapy she remained disease free year after the initial diagnosis
31335678,evaluating the tumor biology of lung adenocarcinoma a multimodal analysis,we evaluated the relationship among functional imaging modality such a petct and dwmri and lung adenocarcinoma pathologic heterogeneity extent of invasion depth and tumor cellularity a a marker of tumor microenvironmentin total lung adenocarcinoma were prospectively included all patient underwent ffluorodeoxyglucose fdg petct and mri before curative surgery pathology revealed stage i tumor stage ii tumor and stage iiia tumor comprehensive histologic subtyping wa performed for all surgically resected tumor maximum standardized uptake value suvmax and adc value were correlated with pathologic grade extent of invasion solid tumor size and tumor cellularitymean solid tumor size low mm indeterminate mm and high grade mm and suvmax low indeterminate and high grade had a significant relationship with pathologic grade based on confidence interval p and p respectively suvmax showed a strong correlation with tumor cellularity r p but wa not correlated with extent of invasion r p a significant and strong positive correlation wa observed among suvmax value and higher cellularity and pathologic grade adc did not exhibit a significant relationship with tumor cellularityintratumor heterogeneity quantification using a multimodalmultiparametric approach might be effective when tumor volume consists of a real tumor component a well a a nontumorous stromal component,Cancer,0,evaluating the tumor biology of lung adenocarcinoma a multimodal analysis we evaluated the relationship among functional imaging modality such a petct and dwmri and lung adenocarcinoma pathologic heterogeneity extent of invasion depth and tumor cellularity a a marker of tumor microenvironmentin total lung adenocarcinoma were prospectively included all patient underwent ffluorodeoxyglucose fdg petct and mri before curative surgery pathology revealed stage i tumor stage ii tumor and stage iiia tumor comprehensive histologic subtyping wa performed for all surgically resected tumor maximum standardized uptake value suvmax and adc value were correlated with pathologic grade extent of invasion solid tumor size and tumor cellularitymean solid tumor size low mm indeterminate mm and high grade mm and suvmax low indeterminate and high grade had a significant relationship with pathologic grade based on confidence interval p and p respectively suvmax showed a strong correlation with tumor cellularity r p but wa not correlated with extent of invasion r p a significant and strong positive correlation wa observed among suvmax value and higher cellularity and pathologic grade adc did not exhibit a significant relationship with tumor cellularityintratumor heterogeneity quantification using a multimodalmultiparametric approach might be effective when tumor volume consists of a real tumor component a well a a nontumorous stromal component
31335885,telomere length and it correlation with gene mutation in chronic lymphocytic leukemia in a korean population,telomere length tl is a prognostic indicator in caucasian chronic lymphocytic leukemia cll but it significance in asian cll remains unknown to investigate the prognostic significance of tl and it correlation with cytogenetic aberration and somatic mutation we analyzed tl measurement at the cellular level by interphase fluorescence in situ hybridization in patient with cll in korea the present study enrolled patient female and male diagnosed with cll according to the world health organization criterion tl of bone marrow nucleated cell at the singlecell level were measured by quantitative fluorescence in situ hybridization qfish in patient the correlation of tl with clinical characteristic cytogenetic aberration genetic mutation and overall survival were assessed the median value of mean tl in cll patient tc ratio range wa significantly shorter than that in the normal control tc ratio range p shorter tl were associated with complex karyotype p delq p presence of deletion andor mutation in atm andor tp p and shb mutation p a shorter tl wa correlated with lower hemoglobin level and adverse survival mean tl p when the proportion of cell with extremely short tl wa greater than cll patient showed poor survival p complex karyotype tp mutation and the number of mutated gene were determined to be significant adverse variable by multivariable cox analysis p p and p respectively tl wa attrited in cll and attrited telomere were correlated with adverse survival and other wellknown adverse prognostic factor we infer that tl is an independent adverse prognostic predictor in korean cll,Cancer,0,telomere length and it correlation with gene mutation in chronic lymphocytic leukemia in a korean population telomere length tl is a prognostic indicator in caucasian chronic lymphocytic leukemia cll but it significance in asian cll remains unknown to investigate the prognostic significance of tl and it correlation with cytogenetic aberration and somatic mutation we analyzed tl measurement at the cellular level by interphase fluorescence in situ hybridization in patient with cll in korea the present study enrolled patient female and male diagnosed with cll according to the world health organization criterion tl of bone marrow nucleated cell at the singlecell level were measured by quantitative fluorescence in situ hybridization qfish in patient the correlation of tl with clinical characteristic cytogenetic aberration genetic mutation and overall survival were assessed the median value of mean tl in cll patient tc ratio range wa significantly shorter than that in the normal control tc ratio range p shorter tl were associated with complex karyotype p delq p presence of deletion andor mutation in atm andor tp p and shb mutation p a shorter tl wa correlated with lower hemoglobin level and adverse survival mean tl p when the proportion of cell with extremely short tl wa greater than cll patient showed poor survival p complex karyotype tp mutation and the number of mutated gene were determined to be significant adverse variable by multivariable cox analysis p p and p respectively tl wa attrited in cll and attrited telomere were correlated with adverse survival and other wellknown adverse prognostic factor we infer that tl is an independent adverse prognostic predictor in korean cll
31337986,yap promotes multidrug resistance and inhibits autophagyrelated cell death in hepatocellular carcinoma via the racrosmtor pathway,background multidrug resistance is the major cause of chemotherapy failure in hepatocellular carcinoma hcc yap a critical effector of the hippo pathway ha been shown to contribute to the progression metastasis and invasion of cancer however the potential role of yap in mediating drug resistance remains obscure method rtqpcr and western blot were used to assess yap expression in hcc cell line cck assay flow cytometry a xenograft tumour model immunochemistry and gfpmrfplc fusion protein were utilized to evaluate the effect of yap on multidrug resistance intracellular ro production and the autophagy of hcc cell in vitro and in vivo autophagy inhibitor and rescue experiment were carried out to elucidate the mechanism by which yap promotes chemoresistance in hcc cell result we found that belfu a typical hcc cell line with chemoresistance exhibited overexpression of yap moreover the inhibition of yap by shrna or verteporfin conferred the sensitivity of belfu cell to chemotherapeutic agent through autophagyrelated cell death in vitro and in vivo mechanistically yap silencing significantly enhanced autophagic flux by increasing racdriven ro which contributed to the inactivation of mtor in hcc cell in addition the antagonist of autophagy reversed the enhanced effect of yap silencing on cell death under treatment with chemotherapeutic agent conclusion our finding suggested that yap upregulation endowed hcc cell with multidrug resistance via the racrosmtor pathway resulting in the repression of autophagyrelated cell death the blockade of yap may serve a a promising novel therapeutic strategy for overcoming chemoresistance in hcc,Cancer,0,yap promotes multidrug resistance and inhibits autophagyrelated cell death in hepatocellular carcinoma via the racrosmtor pathway background multidrug resistance is the major cause of chemotherapy failure in hepatocellular carcinoma hcc yap a critical effector of the hippo pathway ha been shown to contribute to the progression metastasis and invasion of cancer however the potential role of yap in mediating drug resistance remains obscure method rtqpcr and western blot were used to assess yap expression in hcc cell line cck assay flow cytometry a xenograft tumour model immunochemistry and gfpmrfplc fusion protein were utilized to evaluate the effect of yap on multidrug resistance intracellular ro production and the autophagy of hcc cell in vitro and in vivo autophagy inhibitor and rescue experiment were carried out to elucidate the mechanism by which yap promotes chemoresistance in hcc cell result we found that belfu a typical hcc cell line with chemoresistance exhibited overexpression of yap moreover the inhibition of yap by shrna or verteporfin conferred the sensitivity of belfu cell to chemotherapeutic agent through autophagyrelated cell death in vitro and in vivo mechanistically yap silencing significantly enhanced autophagic flux by increasing racdriven ro which contributed to the inactivation of mtor in hcc cell in addition the antagonist of autophagy reversed the enhanced effect of yap silencing on cell death under treatment with chemotherapeutic agent conclusion our finding suggested that yap upregulation endowed hcc cell with multidrug resistance via the racrosmtor pathway resulting in the repression of autophagyrelated cell death the blockade of yap may serve a a promising novel therapeutic strategy for overcoming chemoresistance in hcc
31338587,acinar cell carcinoma of the pancreas with thyroidlike follicular feature first description of a new diagnostic challenging subtype,acinar cell carcinoma acc of the pancreas are a heterogeneous group of neoplasm showing a wide spectrum of morphological feature including acinar solid glandular and trabecular architecture in addition uncommon cytological aspect have recently been described and include oncocytic spindle clear and pleomorphic cell type this wide histological spectrum represents a challenge in the diagnostic task for pathologist molecular mechanism involved in the onset and progression of acc are not completely known but in general they differ from those observed in ductal adenocarcinoma or neuroendocrine neoplasm of the pancreas and frequently include alteration in the apcbetacatenin pathway in the present paper we describe a new variant of acc showing thyroidlike follicular feature and ctnnb mutation this phenotype need to be included in the spectrum of morphological presentation of acc,Cancer,0,acinar cell carcinoma of the pancreas with thyroidlike follicular feature first description of a new diagnostic challenging subtype acinar cell carcinoma acc of the pancreas are a heterogeneous group of neoplasm showing a wide spectrum of morphological feature including acinar solid glandular and trabecular architecture in addition uncommon cytological aspect have recently been described and include oncocytic spindle clear and pleomorphic cell type this wide histological spectrum represents a challenge in the diagnostic task for pathologist molecular mechanism involved in the onset and progression of acc are not completely known but in general they differ from those observed in ductal adenocarcinoma or neuroendocrine neoplasm of the pancreas and frequently include alteration in the apcbetacatenin pathway in the present paper we describe a new variant of acc showing thyroidlike follicular feature and ctnnb mutation this phenotype need to be included in the spectrum of morphological presentation of acc
31340433,loxl function beyond amino oxidase and role in pathology including cancer,lysyl oxidase like loxl is a copperdependent amine oxidase responsible for the crosslinking of collagen and elastin in the extracellular matrix loxl belongs to a family including other member lox loxl loxl and loxl autosomal recessive mutation are rare and described in patient with stickler syndrome earlyonset myopia and nonsyndromic cleft palate along with an essential function in embryonic development multiple biological function have been attributed to loxl in various pathology related to amino oxidase activity additionally various novel role have been described for loxl such a the oxidation of fibronectin in myotendinous junction formation and of deacetylation and deacetylimination activity of stat to control of inflammatory response in tumor three distinct role were described loxl interacts with snail and contributes to proliferation and metastasis by inducing epithelialmesenchymal transition in pancreatic ductal adenocarcinoma cell loxl is localized predominantly in the nucleus associated with invasion and poor gastric cancer prognosis loxl interacts with protein involved in dna stability and mitosis completion contributing to melanoma progression and sustained proliferation here we review the structure function and activity of loxl in normal and pathological condition and discus the potential of loxl a a therapeutic target in various disease,Cancer,0,loxl function beyond amino oxidase and role in pathology including cancer lysyl oxidase like loxl is a copperdependent amine oxidase responsible for the crosslinking of collagen and elastin in the extracellular matrix loxl belongs to a family including other member lox loxl loxl and loxl autosomal recessive mutation are rare and described in patient with stickler syndrome earlyonset myopia and nonsyndromic cleft palate along with an essential function in embryonic development multiple biological function have been attributed to loxl in various pathology related to amino oxidase activity additionally various novel role have been described for loxl such a the oxidation of fibronectin in myotendinous junction formation and of deacetylation and deacetylimination activity of stat to control of inflammatory response in tumor three distinct role were described loxl interacts with snail and contributes to proliferation and metastasis by inducing epithelialmesenchymal transition in pancreatic ductal adenocarcinoma cell loxl is localized predominantly in the nucleus associated with invasion and poor gastric cancer prognosis loxl interacts with protein involved in dna stability and mitosis completion contributing to melanoma progression and sustained proliferation here we review the structure function and activity of loxl in normal and pathological condition and discus the potential of loxl a a therapeutic target in various disease
31340823,clinicopathological feature and prognosis of ciliated muconodular papillary tumor,background the pulmonary ciliated muconodular papillary tumor cmpt is a very rare tumor with only several case report in published literature and it clinicopathological feature standard treatment method and prognosis ha not been well defined method two case of cmpt diagnosed and treated in our hospital and case reported in the published literature were analyzed retrospectively result the cohort of cmpt patient comprised of male and female aged year the diameter of the primary tumor wa cm most of these lesion were subsolid nodule a observed on computed tomography and easily misdiagnosed a early lung adenocarcinoma tumor of patient were stained by immunohistochemistry method which revealed that ck cea and ttf were positive and ck wa negative in most patient the result of gene alternation demonstrated mutation in egfr kras and braf and alk rearrangement in cmpt all the patient underwent surgical treatment and did not receive postoperative adjuvant therapy the followup duration wa month and no case of tumor recurrence wa found until the final followup conclusion the incidence of cmpt wa low and rate of image misdiagnosis high immunohistochemistry is helpful for accurate diagnosis of cmpt sublobectomy may be proper and adjuvant treatment should be avoided since the disease is now prone to benign lesion furthermore since the biological behavior of this tumor is not yet fully elucidated additional case data are essential for accurate conclusion,Cancer,0,clinicopathological feature and prognosis of ciliated muconodular papillary tumor background the pulmonary ciliated muconodular papillary tumor cmpt is a very rare tumor with only several case report in published literature and it clinicopathological feature standard treatment method and prognosis ha not been well defined method two case of cmpt diagnosed and treated in our hospital and case reported in the published literature were analyzed retrospectively result the cohort of cmpt patient comprised of male and female aged year the diameter of the primary tumor wa cm most of these lesion were subsolid nodule a observed on computed tomography and easily misdiagnosed a early lung adenocarcinoma tumor of patient were stained by immunohistochemistry method which revealed that ck cea and ttf were positive and ck wa negative in most patient the result of gene alternation demonstrated mutation in egfr kras and braf and alk rearrangement in cmpt all the patient underwent surgical treatment and did not receive postoperative adjuvant therapy the followup duration wa month and no case of tumor recurrence wa found until the final followup conclusion the incidence of cmpt wa low and rate of image misdiagnosis high immunohistochemistry is helpful for accurate diagnosis of cmpt sublobectomy may be proper and adjuvant treatment should be avoided since the disease is now prone to benign lesion furthermore since the biological behavior of this tumor is not yet fully elucidated additional case data are essential for accurate conclusion
31341365,histologic feature and genomic alteration of primary colorectal adenocarcinoma predict growth pattern of liver metastasis,background different histological growth pattern hgps of colorectal carcinoma crc liver metastasis are associated with patient prognosis and response to antiangiogenic therapy however the relationship between hgps of liver metastasis and clinicopathological and genomic characteristic of primary cancer ha not been well established aim to assess whether certain clinicopathological and genomic feature of primary crc could predict the hgps of liver metastasis method a total of patient with paired resection of both primary crc and liver metastasis were divided into two group a case with desmoplastic liver metastasis and b case with replacement liver metastasis clinical information wa obtained from patient chart mismatch repair protein brafve and pdl were evaluated by immunohistochemistry five case were selected randomly from each group for whole exome sequencing wes analysis result in the primary tumor expanding growth pattern low tumor budding score tb and crohn diseaselike response cdr were associated with desmoplastic liver metastasis and better overall survival whereas infiltrating growth pattern alone of primary carcinoma could predict the replacement liver metastasis and worse overall survival p on wes analysis primary carcinoma with desmoplastic liver metastasis showed mutation in apc tp kras pikca and fat brca brca braf and dnah whereas primary carcinoma with replacement liver metastasis showed mutation in apc and tp kras fat dnh smad erbb erbb lrp and sdk conclusion the hgps tb and cdr of primary crc a well a the presence of specific genetic mutation such a those in pikca could be used to predict the hgps of liver metastasis response to therapy and patient prognosis,Cancer,0,histologic feature and genomic alteration of primary colorectal adenocarcinoma predict growth pattern of liver metastasis background different histological growth pattern hgps of colorectal carcinoma crc liver metastasis are associated with patient prognosis and response to antiangiogenic therapy however the relationship between hgps of liver metastasis and clinicopathological and genomic characteristic of primary cancer ha not been well established aim to assess whether certain clinicopathological and genomic feature of primary crc could predict the hgps of liver metastasis method a total of patient with paired resection of both primary crc and liver metastasis were divided into two group a case with desmoplastic liver metastasis and b case with replacement liver metastasis clinical information wa obtained from patient chart mismatch repair protein brafve and pdl were evaluated by immunohistochemistry five case were selected randomly from each group for whole exome sequencing wes analysis result in the primary tumor expanding growth pattern low tumor budding score tb and crohn diseaselike response cdr were associated with desmoplastic liver metastasis and better overall survival whereas infiltrating growth pattern alone of primary carcinoma could predict the replacement liver metastasis and worse overall survival p on wes analysis primary carcinoma with desmoplastic liver metastasis showed mutation in apc tp kras pikca and fat brca brca braf and dnah whereas primary carcinoma with replacement liver metastasis showed mutation in apc and tp kras fat dnh smad erbb erbb lrp and sdk conclusion the hgps tb and cdr of primary crc a well a the presence of specific genetic mutation such a those in pikca could be used to predict the hgps of liver metastasis response to therapy and patient prognosis
31341411,molecular heterogeneity in lung cancer from mechanism of origin to clinical implication,molecular heterogeneity is a frequent event in cancer responsible of several critical issue in diagnosis and treatment of oncologic patient lung tumour are characterized by high degree of molecular heterogeneity associated to different mechanism of origin including genetic epigenetic and nongenetic source in this review we provide an overview of recognized mechanism underlying molecular heterogeneity in lung cancer including epigenetic mechanism mutant allele specific imbalance genomic instability chromosomal aberration tumor mutational burden somatic mutation we focus on the role of spatial and temporal molecular heterogeneity involved in therapeutic implication in lung cancer patient,Cancer,0,molecular heterogeneity in lung cancer from mechanism of origin to clinical implication molecular heterogeneity is a frequent event in cancer responsible of several critical issue in diagnosis and treatment of oncologic patient lung tumour are characterized by high degree of molecular heterogeneity associated to different mechanism of origin including genetic epigenetic and nongenetic source in this review we provide an overview of recognized mechanism underlying molecular heterogeneity in lung cancer including epigenetic mechanism mutant allele specific imbalance genomic instability chromosomal aberration tumor mutational burden somatic mutation we focus on the role of spatial and temporal molecular heterogeneity involved in therapeutic implication in lung cancer patient
31341686,hepatic yaptfe rearranged epithelioid hemangioendothelioma,epithelioid hemangioendothelioma ehe is an uncommon lowgrade malignant vascular tumor that may arise in soft tissuebone or visceral site such a the liver and lung a this tumor exhibit epithelioid morphology it frequently cause diagnostic confusion with other epithelioid vascular neoplasm a well a carcinoma while of classic ehe are driven by a wwtrcamta fusion gene a histologically distinctive subset of ehe ha been recently shown to harbor a different fusion gene yaptfe this variant is likely underrecognized given it rarity and only recent description notably ehe frequently involves the liver but only one case of hepatic yaptfe rearranged ehe ha been reported to date we present the second case of yaptfe rearranged ehe affecting a yearold woman and presenting a multiple liver mass with characterization of the fusion gene at the transcriptomic and genomic level there are several educational point noted from this case yaptfe rearranged ehe show distinctly vasoformative focus unlike classic ehe and mimicking angiosarcoma or epithelioid hemangioma the tumor cell show a histiocytoid appearance with voluminous cytoplasm similar to other tferearranged tumor finally in the liver this tumor may in part mimic focal nodular hyperplasia of the liver which is an underrecognized diagnostic pitfall this report highlight the key diagnostic and genetic feature of this newly recognized variant of hepatic ehe to aid pathologist in appropriately classifying these tumor,Cancer,0,hepatic yaptfe rearranged epithelioid hemangioendothelioma epithelioid hemangioendothelioma ehe is an uncommon lowgrade malignant vascular tumor that may arise in soft tissuebone or visceral site such a the liver and lung a this tumor exhibit epithelioid morphology it frequently cause diagnostic confusion with other epithelioid vascular neoplasm a well a carcinoma while of classic ehe are driven by a wwtrcamta fusion gene a histologically distinctive subset of ehe ha been recently shown to harbor a different fusion gene yaptfe this variant is likely underrecognized given it rarity and only recent description notably ehe frequently involves the liver but only one case of hepatic yaptfe rearranged ehe ha been reported to date we present the second case of yaptfe rearranged ehe affecting a yearold woman and presenting a multiple liver mass with characterization of the fusion gene at the transcriptomic and genomic level there are several educational point noted from this case yaptfe rearranged ehe show distinctly vasoformative focus unlike classic ehe and mimicking angiosarcoma or epithelioid hemangioma the tumor cell show a histiocytoid appearance with voluminous cytoplasm similar to other tferearranged tumor finally in the liver this tumor may in part mimic focal nodular hyperplasia of the liver which is an underrecognized diagnostic pitfall this report highlight the key diagnostic and genetic feature of this newly recognized variant of hepatic ehe to aid pathologist in appropriately classifying these tumor
31347028,clinical evaluation of intelliplex kras g mutation kit for detection of kras mutation in codon and a novel multiplex approach,background colorectal cancer crc is among the most frequently occurring cancer worldwide and it incidence is forecasted to increase testing for kras kirsten rat sarcoma viral oncogene homolog mutation in colorectal tissue biopsy sample ha become a crucial tool to guide therapeutic decision for personalized treatment objective the objective of this study wa to determine the diagnostic sensitivity and specificity of the intelliplex kras g mutation kit using clinical specimen compared to sanger sequencing a the reference method method a total of formalinfixed paraffinembedded ffpe tissue sample with crc tumor comprising more than of the whole tissue sample were included in the study and analyzed for specific kras mutation in codon and for sample with discordant result between sanger sequencing and the intelliplex kras g mutation kit pyrosequencing wa utilized to resolve the kras mutational status result sequencing determined specimen a kras wildtype genotype while the intelliplex kras g mutation kit confirmed of the wildtype case resulting in a clinical specificity of confidence interval ci all specimen with a reported mutation in codon or of kras by sequencing were also reported a nonwildtype by the intelliplex kras g mutation kit resulting in a clinical sensitivity to detect kras mutation of ci conclusion the intelliplex kras g mutation kit demonstrates suitable specificity and sensitivity for use in clinical laboratory to determine the mutational status of kras codon and,Cancer,0,clinical evaluation of intelliplex kras g mutation kit for detection of kras mutation in codon and a novel multiplex approach background colorectal cancer crc is among the most frequently occurring cancer worldwide and it incidence is forecasted to increase testing for kras kirsten rat sarcoma viral oncogene homolog mutation in colorectal tissue biopsy sample ha become a crucial tool to guide therapeutic decision for personalized treatment objective the objective of this study wa to determine the diagnostic sensitivity and specificity of the intelliplex kras g mutation kit using clinical specimen compared to sanger sequencing a the reference method method a total of formalinfixed paraffinembedded ffpe tissue sample with crc tumor comprising more than of the whole tissue sample were included in the study and analyzed for specific kras mutation in codon and for sample with discordant result between sanger sequencing and the intelliplex kras g mutation kit pyrosequencing wa utilized to resolve the kras mutational status result sequencing determined specimen a kras wildtype genotype while the intelliplex kras g mutation kit confirmed of the wildtype case resulting in a clinical specificity of confidence interval ci all specimen with a reported mutation in codon or of kras by sequencing were also reported a nonwildtype by the intelliplex kras g mutation kit resulting in a clinical sensitivity to detect kras mutation of ci conclusion the intelliplex kras g mutation kit demonstrates suitable specificity and sensitivity for use in clinical laboratory to determine the mutational status of kras codon and
31348551,high incidence of myc rearrangement in human immunodeficiency viruspositive plasmablastic lymphoma,aim myc rearrangement are the main cytogenetic alteration in plasmablastic lymphoma pbl we aimed to investigate the relationship between myc rearrangement and the clinicopathological feature of pbl method and result myc rearrangement assessed in unpublished singlecentre pbl case and an additional case from the literature with reported myc rearrangement information individualised by patient were reviewed in asia pbl wa much less commonly diagnosed in human immunodeficiency virus hivpositive patient versus p with older age median age at diagnosis year versus year p and a lower ebv infection rate versus p than in nonasian region overall myc rearrangement were identified in of pbl case and igh wa the partner in almost all available case a confirmed with a mycigh fusion probe the myc rearrangement rate in hivpositive case wa significantly higher than that in hivnegative case p patient with myc rearrangement showed a trend towards an inferior median survival time month versus month p and year overall survival versus p conclusion myc rearrangement wa frequently identified in pbl patient and igh wa the partner gene in an overwhelming majority of myc rearrangement in addition the myc rearrangement rate wa significantly higher in hivpositive pbl patient than that in hivnegative patient myc rearrangement may play an important role in the pathogenesis of hivpositive pbl but further study are required to understand the underlying mechanism,Cancer,0,high incidence of myc rearrangement in human immunodeficiency viruspositive plasmablastic lymphoma aim myc rearrangement are the main cytogenetic alteration in plasmablastic lymphoma pbl we aimed to investigate the relationship between myc rearrangement and the clinicopathological feature of pbl method and result myc rearrangement assessed in unpublished singlecentre pbl case and an additional case from the literature with reported myc rearrangement information individualised by patient were reviewed in asia pbl wa much less commonly diagnosed in human immunodeficiency virus hivpositive patient versus p with older age median age at diagnosis year versus year p and a lower ebv infection rate versus p than in nonasian region overall myc rearrangement were identified in of pbl case and igh wa the partner in almost all available case a confirmed with a mycigh fusion probe the myc rearrangement rate in hivpositive case wa significantly higher than that in hivnegative case p patient with myc rearrangement showed a trend towards an inferior median survival time month versus month p and year overall survival versus p conclusion myc rearrangement wa frequently identified in pbl patient and igh wa the partner gene in an overwhelming majority of myc rearrangement in addition the myc rearrangement rate wa significantly higher in hivpositive pbl patient than that in hivnegative patient myc rearrangement may play an important role in the pathogenesis of hivpositive pbl but further study are required to understand the underlying mechanism
31350202,next generation sequencing reveals novel mutation in mismatch repair gene and other cancer predisposition gene in asian patient with suspected lynch syndrome,background although at least gene are implicated in lynch syndrome l up to of suspected case are owing to undefined gene we utilized next generation sequencing ng to characterize the mutation profile of patient with cancer ca suspected to have l patient and method we enrolled asian patient with ca from our ca genetics clinic from to suspected to have l and obtained germline dna for ng using trusight cancer frameshift nonsense and known deleterious mutation were considered pathogenic polymorphism t nonsense mutation n or ercccca nonsense mutation n without l gene mutation which is of clinical interest conclusion in this asian study ng proved to be feasible in screening for causative mutation in patient with ca suspected to have l,Cancer,0,next generation sequencing reveals novel mutation in mismatch repair gene and other cancer predisposition gene in asian patient with suspected lynch syndrome background although at least gene are implicated in lynch syndrome l up to of suspected case are owing to undefined gene we utilized next generation sequencing ng to characterize the mutation profile of patient with cancer ca suspected to have l patient and method we enrolled asian patient with ca from our ca genetics clinic from to suspected to have l and obtained germline dna for ng using trusight cancer frameshift nonsense and known deleterious mutation were considered pathogenic polymorphism t nonsense mutation n or ercccca nonsense mutation n without l gene mutation which is of clinical interest conclusion in this asian study ng proved to be feasible in screening for causative mutation in patient with ca suspected to have l
31350313,parallel analysis of somatic mutation in plasma circulating tumor dna ctdna and matched tumor tissue in earlystage breast cancer,purpose early detection and intervention can decrease the mortality of breast cancer significantly assessment of geneticgenomic variant in circulating tumor dna ctdna have generated great enthusiasm for their potential application a clinically actionable biomarkers in the management of earlystage breast cancerexperimental design in this study serial plasma and matched tissue specimen from patient with earlystage breast cancer who need chemotherapy and individual with benign breast tumor were deeply sequenced via nextgeneration sequencing ng technique using large gene panel result cancer tissue in this cohort of patient showed profound intratumor heterogeneity ithgs that were properly reflected by ctdna testing integrating the ctdna detection rate of in this cohort with the corresponding predictive result based on breast imaging reporting and data system classification birads could increase the positive predictive value up to and potentially dramatically reduce surgical overtreatment patient with positive ctdna after surgery showed a higher percentage of lymph node metastasis indicating potential recurrence and remote metastasis the ctdnapositive rate were significantly decreased after chemotherapy in basallike and her tumor subtypes but were persistent despite chemotherapy in luminal type the tumor mutation burden in blood btmb assessed on the basis of ctdna testing wa positively correlated with the tmb in tumor tissue ttmb providing a candidate biomarker warranting further study of it potential used for precise immunotherapy in cancer conclusion these data showed that ctdna evaluation is a feasible sensitive and specific biomarker for diagnosis and differential diagnosis of patient with earlystage breast cancer who need chemotherapy,Cancer,0,parallel analysis of somatic mutation in plasma circulating tumor dna ctdna and matched tumor tissue in earlystage breast cancer purpose early detection and intervention can decrease the mortality of breast cancer significantly assessment of geneticgenomic variant in circulating tumor dna ctdna have generated great enthusiasm for their potential application a clinically actionable biomarkers in the management of earlystage breast cancerexperimental design in this study serial plasma and matched tissue specimen from patient with earlystage breast cancer who need chemotherapy and individual with benign breast tumor were deeply sequenced via nextgeneration sequencing ng technique using large gene panel result cancer tissue in this cohort of patient showed profound intratumor heterogeneity ithgs that were properly reflected by ctdna testing integrating the ctdna detection rate of in this cohort with the corresponding predictive result based on breast imaging reporting and data system classification birads could increase the positive predictive value up to and potentially dramatically reduce surgical overtreatment patient with positive ctdna after surgery showed a higher percentage of lymph node metastasis indicating potential recurrence and remote metastasis the ctdnapositive rate were significantly decreased after chemotherapy in basallike and her tumor subtypes but were persistent despite chemotherapy in luminal type the tumor mutation burden in blood btmb assessed on the basis of ctdna testing wa positively correlated with the tmb in tumor tissue ttmb providing a candidate biomarker warranting further study of it potential used for precise immunotherapy in cancer conclusion these data showed that ctdna evaluation is a feasible sensitive and specific biomarker for diagnosis and differential diagnosis of patient with earlystage breast cancer who need chemotherapy
31351510,giant lumbar polypoid tumor with bulla on it surface,dear editor acrochordons are common benign neoplasm found in everyday practice we present a rare case of a giant and single acrochordon on the lumbar region with sign of ischemia the correlation of clinical dermatoscopic and histopathological analysis may help the clinician differentiate this entity from other benign and malignant dermatosis a yearold man presented to the outpatient clinic complaining of a lumbar mass that had been growing for two year the lesion wa asymptomatic except for recent discomfort when lying in the supine decubitus position on examination there wa a single erythematous nontender pedunculated lesion cm x cm x cm in size with flaccid bulla on it surface and firm consistency figure ab dermoscopy showed regularly arranged dotted vessel in a violaceous background and bulla filled with serous fluid figure cd his personal and family medical history were unremarkable shave excision wa performed and the sample wa sent for histopathologic analysis histopathology revealed a normal epidermis surrounding a core of loose collagen fiber papillary dermis showed a mixed inflammatory cell infiltrate congested capillary and extravasated erythrocyte scattered cluster of adipocytes were found in the deep dermis figure the diagnosis of a giant ischemic acrochordon wa established acrochordons also commonly known a skin tag are benign pedunculated neoplasm frequently found on the neck axilla or groin they represent fibroepithelial polyp that originate from ectoderm and mesoderm tissue they can be pigmented or skin colored and usually range between to mm in size skin tag can affect nearly of the general population giant and solitary acrochordons are an uncommon clinical variant differential diagnosis of this pathology may be challenging in the particular clinical context of this patient benign neoplasm such a dermatofibroma neurofibroma and epidermal inclusion cyst can be clinically similar to giant skin tag histopathological analysis of acrochordons usually show papillomatosis irregular acanthosis loose collagen fiber and dilated capillary a fibrolipomatous variant of acrochordon may reveal adipose tissue lobule between septum of collagen on pathological examination local ischemia due to twisting of the stalk may induce the formation of intradermal or subepidermal blister in these tumor histopathologic characteristic found in ischemic acrochordons are neutrophil infiltration congested capillary and extravasated erythrocyte fibroepithelioma of pinkus fep is a rare variant of basal cell carcinoma that may clinically mimic benign polypoid tumor and ha a certain predilection for the lumbosacral area dermoscopic characteristic of fibroepithelioma of pinkus that may aid the clinician in this diagnosis are fine arborizing vessel either alone or associated with dotted vessel and white streak cosmetically adequate treatment of a giant acrochordon can be performed by shave excision and electrodesiccation of it pedicle choudhary et al reported good result with this technique on a giant acrochordon on the thigh,Cancer,0,giant lumbar polypoid tumor with bulla on it surface dear editor acrochordons are common benign neoplasm found in everyday practice we present a rare case of a giant and single acrochordon on the lumbar region with sign of ischemia the correlation of clinical dermatoscopic and histopathological analysis may help the clinician differentiate this entity from other benign and malignant dermatosis a yearold man presented to the outpatient clinic complaining of a lumbar mass that had been growing for two year the lesion wa asymptomatic except for recent discomfort when lying in the supine decubitus position on examination there wa a single erythematous nontender pedunculated lesion cm x cm x cm in size with flaccid bulla on it surface and firm consistency figure ab dermoscopy showed regularly arranged dotted vessel in a violaceous background and bulla filled with serous fluid figure cd his personal and family medical history were unremarkable shave excision wa performed and the sample wa sent for histopathologic analysis histopathology revealed a normal epidermis surrounding a core of loose collagen fiber papillary dermis showed a mixed inflammatory cell infiltrate congested capillary and extravasated erythrocyte scattered cluster of adipocytes were found in the deep dermis figure the diagnosis of a giant ischemic acrochordon wa established acrochordons also commonly known a skin tag are benign pedunculated neoplasm frequently found on the neck axilla or groin they represent fibroepithelial polyp that originate from ectoderm and mesoderm tissue they can be pigmented or skin colored and usually range between to mm in size skin tag can affect nearly of the general population giant and solitary acrochordons are an uncommon clinical variant differential diagnosis of this pathology may be challenging in the particular clinical context of this patient benign neoplasm such a dermatofibroma neurofibroma and epidermal inclusion cyst can be clinically similar to giant skin tag histopathological analysis of acrochordons usually show papillomatosis irregular acanthosis loose collagen fiber and dilated capillary a fibrolipomatous variant of acrochordon may reveal adipose tissue lobule between septum of collagen on pathological examination local ischemia due to twisting of the stalk may induce the formation of intradermal or subepidermal blister in these tumor histopathologic characteristic found in ischemic acrochordons are neutrophil infiltration congested capillary and extravasated erythrocyte fibroepithelioma of pinkus fep is a rare variant of basal cell carcinoma that may clinically mimic benign polypoid tumor and ha a certain predilection for the lumbosacral area dermoscopic characteristic of fibroepithelioma of pinkus that may aid the clinician in this diagnosis are fine arborizing vessel either alone or associated with dotted vessel and white streak cosmetically adequate treatment of a giant acrochordon can be performed by shave excision and electrodesiccation of it pedicle choudhary et al reported good result with this technique on a giant acrochordon on the thigh
31354263,photothermal effect of nayfyberpefeo superparamagnetic nanoprobes in the treatment of melanoma,objective the study aimed to synthesize superparamagnetic nayfyberpefeo upconversion nanoprobes and to study their photothermal effect for the treatment of malignant melanoma method morphological characteristic of the synthesized nanoprobes were examined by scanning electron microscopy their biocompatibility and biodistribution profile were assessed through blood routinebiochemistry test and the inductively coupled plasmaoptical emission spectrometrybased analysis of tissue metal element their photothermal conversion efficiency and their potential a contrast agent for upconversion luminescence uclmagnetic resonance imaging mri dualmodal imaging were tested efficacy in photothermal therapy which wa achieved by combining nanoprobes with nearinfrared nir irradiation wa evaluated in both a cell line and balbc mouse model the underlying mechanism were interrogated by molecular approach including the mtt assay flow cytometry semiquantitative pcr western blot and immunohistochemistry result our synthesized nayfyberpefeo nanoprobes exhibited a uniform cubic morphology with a diameter of nm subcutaneous administration led to no severe longlasting adverse effect in mouse possibly due to complete removal of these nanomaterials within one month our nanoprobes possessed superior photothermal conversion efficiency and strong contrasting effect during uclmri dualmodal imaging corroborating their application in imagingguided photothermal therapy combinatorial treatment of these nanoprobes with nir irradiation induced profound apoptosisnecrosis in a cell similarly the same treatment modality led to strong therapeutic effect in balbc mouse implanted with a tumor xenograft mechanistic study suggested an involvement of heat shock protein in mediating the observed antitumor effect of our nanoprobes conclusion our study describes a convenient method to synthesize a new type of superparamagnetic upconversion nanoprobes which possess high biocompatibility and can be used in imagingguided photothermal therapy for the treatment of malignant melanoma importantly our finding will promote clinical application of nayfyberpefeo a novel theranostic agent in treating melanoma and many other tumor,Cancer,0,photothermal effect of nayfyberpefeo superparamagnetic nanoprobes in the treatment of melanoma objective the study aimed to synthesize superparamagnetic nayfyberpefeo upconversion nanoprobes and to study their photothermal effect for the treatment of malignant melanoma method morphological characteristic of the synthesized nanoprobes were examined by scanning electron microscopy their biocompatibility and biodistribution profile were assessed through blood routinebiochemistry test and the inductively coupled plasmaoptical emission spectrometrybased analysis of tissue metal element their photothermal conversion efficiency and their potential a contrast agent for upconversion luminescence uclmagnetic resonance imaging mri dualmodal imaging were tested efficacy in photothermal therapy which wa achieved by combining nanoprobes with nearinfrared nir irradiation wa evaluated in both a cell line and balbc mouse model the underlying mechanism were interrogated by molecular approach including the mtt assay flow cytometry semiquantitative pcr western blot and immunohistochemistry result our synthesized nayfyberpefeo nanoprobes exhibited a uniform cubic morphology with a diameter of nm subcutaneous administration led to no severe longlasting adverse effect in mouse possibly due to complete removal of these nanomaterials within one month our nanoprobes possessed superior photothermal conversion efficiency and strong contrasting effect during uclmri dualmodal imaging corroborating their application in imagingguided photothermal therapy combinatorial treatment of these nanoprobes with nir irradiation induced profound apoptosisnecrosis in a cell similarly the same treatment modality led to strong therapeutic effect in balbc mouse implanted with a tumor xenograft mechanistic study suggested an involvement of heat shock protein in mediating the observed antitumor effect of our nanoprobes conclusion our study describes a convenient method to synthesize a new type of superparamagnetic upconversion nanoprobes which possess high biocompatibility and can be used in imagingguided photothermal therapy for the treatment of malignant melanoma importantly our finding will promote clinical application of nayfyberpefeo a novel theranostic agent in treating melanoma and many other tumor
31355228,prognostic significance of the pank family expression in acute myeloid leukemia,background acute myeloid leukemia aml is a highly heterogenous hematological malignancy and it prognostication depends on the genetic mutation and expression profile of each patient pantothenate kinase pank is a regulatory enzyme that control coenzyme a coa biosynthesis it ha four isoforms encoded by pank respectively whether the expression of the pank family ha prognostic significance in aml remains unclear method we screened the cancer genome atlas database for aml patient with complete pank expression data eightyfour aml patient met the criterion and were included in this study clinical characteristic at diagnosis including peripheral blood pb white blood cell count wbc blast percentage in pb and bone marrow bm frenchamericanbritish fab subtypes and the frequency of common genetic mutation were described survival wa estimated using the kaplanmeier method and the logrank test multivariate cox proportional hazard model were constructed for eventfree survival efs and overall survival o using a limited backward elimination procedure result patient with high pank expression had significantly longer eventfree survival efs and overall survival o than patient with low pank expression p p respectively whereas patient with high pank expression had shorter efs and o than patient with low pank expression p p respectively multivariate analysis confirmed that high pank expression wa an independent risk factor for efs and o both p conclusion our study suggested that high pank expression might have favorable effect on aml while high pank expression wa indicative of poor prognosis,Cancer,0,prognostic significance of the pank family expression in acute myeloid leukemia background acute myeloid leukemia aml is a highly heterogenous hematological malignancy and it prognostication depends on the genetic mutation and expression profile of each patient pantothenate kinase pank is a regulatory enzyme that control coenzyme a coa biosynthesis it ha four isoforms encoded by pank respectively whether the expression of the pank family ha prognostic significance in aml remains unclear method we screened the cancer genome atlas database for aml patient with complete pank expression data eightyfour aml patient met the criterion and were included in this study clinical characteristic at diagnosis including peripheral blood pb white blood cell count wbc blast percentage in pb and bone marrow bm frenchamericanbritish fab subtypes and the frequency of common genetic mutation were described survival wa estimated using the kaplanmeier method and the logrank test multivariate cox proportional hazard model were constructed for eventfree survival efs and overall survival o using a limited backward elimination procedure result patient with high pank expression had significantly longer eventfree survival efs and overall survival o than patient with low pank expression p p respectively whereas patient with high pank expression had shorter efs and o than patient with low pank expression p p respectively multivariate analysis confirmed that high pank expression wa an independent risk factor for efs and o both p conclusion our study suggested that high pank expression might have favorable effect on aml while high pank expression wa indicative of poor prognosis
31366136,early colorectal cancer provide new evidence for a lynch syndrometocmmrd phenotypic continuum,lynch syndrome l is the most common hereditary colorectal cancer crc syndrome caused by heterozygous mutation in the mismatch repair mmr gene biallelic mutation in these gene lead however to constitutive mismatch repair deficiency cmmrd in this study we follow the diagnostic journey of a year old patient with crc with a clinical phenotype overlapping cmmrd we perform molecular and functional assay to discard a cmmrd diagnosis then identify by exome sequencing and validation in a cohort of l patient a candidate variant in the mlh utr region in homozygosis we propose that this variant together with other candidate could be responsible for ageofonset modulation our data support the idea that lowrisk modifier allele may influence early development of cancer in l leading to a lstocmmrd phenotypic continuum therefore it is essential that larger effort are directed to the identification and study of these genetic modifier in order to provide optimal cancer prevention strategy to these patient,Cancer,0,early colorectal cancer provide new evidence for a lynch syndrometocmmrd phenotypic continuum lynch syndrome l is the most common hereditary colorectal cancer crc syndrome caused by heterozygous mutation in the mismatch repair mmr gene biallelic mutation in these gene lead however to constitutive mismatch repair deficiency cmmrd in this study we follow the diagnostic journey of a year old patient with crc with a clinical phenotype overlapping cmmrd we perform molecular and functional assay to discard a cmmrd diagnosis then identify by exome sequencing and validation in a cohort of l patient a candidate variant in the mlh utr region in homozygosis we propose that this variant together with other candidate could be responsible for ageofonset modulation our data support the idea that lowrisk modifier allele may influence early development of cancer in l leading to a lstocmmrd phenotypic continuum therefore it is essential that larger effort are directed to the identification and study of these genetic modifier in order to provide optimal cancer prevention strategy to these patient
31367542,molecular testing strategy in nonsmall cell lung cancer optimizing the diagnostic journey,molecular testing identifies patient with advanced nonsmall cell lung cancer nsclc who may benefit from targeted therapy or immunotherapy ie immune checkpoint inhibitor treatment for patient with high tumor mutational burden tmb microsatellite instabilityhigh or mismatch repairdeficient tumor current guideline state that molecular testing should be conducted at the time of initial diagnosis and tumor progression on targeted therapy in realworld clinical practice in the united state u molecular testing is often not conducted or happens late in the diagnostic journey resulting in delayed or inappropriate treatment herein we review the rationale for molecular testing in advanced nsclc along with bestpractice guideline based on published recommendation and our own clinical experience including a case study we propose three strategy to optimize molecular testing in newly diagnosed patient with advanced nsclc i pulmonologists interventional radiologist or thoracic surgeon order molecular test a soon a advanced nsclc with an adenocarcinoma component is suspected ii liquid biopsy conducted early in the diagnostic pathway and iii pathologistdirected reflex testing a conducted in other area of oncology to help facilitate these strategy we outline our recommendation for optimal sample collection technique and stewardship in summary we believe that implementation of these individual strategy will allow clinician to effectively leverage available treatment option for advanced nsclc reducing the time to optimal treatment and improving patient outcome,Cancer,0,molecular testing strategy in nonsmall cell lung cancer optimizing the diagnostic journey molecular testing identifies patient with advanced nonsmall cell lung cancer nsclc who may benefit from targeted therapy or immunotherapy ie immune checkpoint inhibitor treatment for patient with high tumor mutational burden tmb microsatellite instabilityhigh or mismatch repairdeficient tumor current guideline state that molecular testing should be conducted at the time of initial diagnosis and tumor progression on targeted therapy in realworld clinical practice in the united state u molecular testing is often not conducted or happens late in the diagnostic journey resulting in delayed or inappropriate treatment herein we review the rationale for molecular testing in advanced nsclc along with bestpractice guideline based on published recommendation and our own clinical experience including a case study we propose three strategy to optimize molecular testing in newly diagnosed patient with advanced nsclc i pulmonologists interventional radiologist or thoracic surgeon order molecular test a soon a advanced nsclc with an adenocarcinoma component is suspected ii liquid biopsy conducted early in the diagnostic pathway and iii pathologistdirected reflex testing a conducted in other area of oncology to help facilitate these strategy we outline our recommendation for optimal sample collection technique and stewardship in summary we believe that implementation of these individual strategy will allow clinician to effectively leverage available treatment option for advanced nsclc reducing the time to optimal treatment and improving patient outcome
31367627,multimodalityimaging manifestation of primary renalallograft synovial sarcoma first case report and literature review,background primary renal synovial sarcoma prss is an extremely rare tumor with a poor prognosis it imaging and immunohistochemical characteristic may overlap with other renal tumor which render it early diagnosis in a dilemma the diagnosis of primary renal synovial sarcoma requires histopathology and the confirmation of sytssx gene fusion using molecular technique case of primary renal synovial sarcoma have been previously reported in the literature however to our knowledge primary renal allograft synovial sarcoma wa never described case summary a yearold male patient who underwent kidney transplantation month ago came to our hospital for regular followup traditional ultrasonography revealed multiple hypoecho neoplasm in the renal allograft contrastenhanced computed tomography cect showed slightly hyperdensity mass with slow homogeneous enhancement ultrasoundguided biopsy wa conducted for accurate pathological diagnosis the neoplasm were diagnosed a synovial sarcoma by pathological immunohistochemical and genetic analysis positron emission tomographyct showed no evidence of metastasis at approximately one week post biopsy contrastenhanced ultrasound wa conducted to eliminate active hemorrhage one month later cect showed that the biggest neoplasm grew from cm to cm in diameter parametric imaging wa conducted with sonoliver cap to conduct further quantitative analysis which showed that the enhancement pattern wa heterogeneous hypervascular enhancement radical surgical resection of the whole renal allograft and ureter wa conducted without additional adjuvant chemotherapy or external radiotherapy anlotinib wa chosen for targeted therapy with a good response conclusion we propose multimodality imaging for accurate diagnosis of renal allograft synovial sarcoma especially when it is formed by spindleshaped cell,Cancer,0,multimodalityimaging manifestation of primary renalallograft synovial sarcoma first case report and literature review background primary renal synovial sarcoma prss is an extremely rare tumor with a poor prognosis it imaging and immunohistochemical characteristic may overlap with other renal tumor which render it early diagnosis in a dilemma the diagnosis of primary renal synovial sarcoma requires histopathology and the confirmation of sytssx gene fusion using molecular technique case of primary renal synovial sarcoma have been previously reported in the literature however to our knowledge primary renal allograft synovial sarcoma wa never described case summary a yearold male patient who underwent kidney transplantation month ago came to our hospital for regular followup traditional ultrasonography revealed multiple hypoecho neoplasm in the renal allograft contrastenhanced computed tomography cect showed slightly hyperdensity mass with slow homogeneous enhancement ultrasoundguided biopsy wa conducted for accurate pathological diagnosis the neoplasm were diagnosed a synovial sarcoma by pathological immunohistochemical and genetic analysis positron emission tomographyct showed no evidence of metastasis at approximately one week post biopsy contrastenhanced ultrasound wa conducted to eliminate active hemorrhage one month later cect showed that the biggest neoplasm grew from cm to cm in diameter parametric imaging wa conducted with sonoliver cap to conduct further quantitative analysis which showed that the enhancement pattern wa heterogeneous hypervascular enhancement radical surgical resection of the whole renal allograft and ureter wa conducted without additional adjuvant chemotherapy or external radiotherapy anlotinib wa chosen for targeted therapy with a good response conclusion we propose multimodality imaging for accurate diagnosis of renal allograft synovial sarcoma especially when it is formed by spindleshaped cell
31368038,clinical application of epigenetics in gastroenteropancreatic neuroendocrine neoplasm moving towards liquid biopsy,highthroughput analysis including nextgeneration sequencing and microarrays have strongly improved our understanding of cancer biology however genomic data on rare cancer type such a neuroendocrine neoplasm ha been lagging behind neuroendocrine neoplasm nens develop from endocrine cell spread throughout the body and are highly heterogeneous in biological behavior in this challenging disease there is an urgent need for new therapy and new diagnostic prognostic followup and predictive biomarkers to aid patient management the last decade molecular data on neuroendocrine neoplasm of the gastrointestinal tract and pancreas termed gastroenteropancreatic nens gepnens ha strongly expanded the aim of this review is to give an overview of the recent advance on epigenetic level and highlight their clinical application to address the current need in gepnens we illustrate how molecular alteration can be and are being used a therapeutic target how mutation in daxxatrx and copy number variation could be used a prognostic biomarkers how far we are in identifying predictive biomarkers and how genetics can contribute to gepnen classification finally we discus recent study on liquid biopsy in the field of gepnens and illustrate how liquid biopsy can play a role in patient management in conclusion molecular study have suggested multiple potential biomarkers but further validation is ongoing,Cancer,0,clinical application of epigenetics in gastroenteropancreatic neuroendocrine neoplasm moving towards liquid biopsy highthroughput analysis including nextgeneration sequencing and microarrays have strongly improved our understanding of cancer biology however genomic data on rare cancer type such a neuroendocrine neoplasm ha been lagging behind neuroendocrine neoplasm nens develop from endocrine cell spread throughout the body and are highly heterogeneous in biological behavior in this challenging disease there is an urgent need for new therapy and new diagnostic prognostic followup and predictive biomarkers to aid patient management the last decade molecular data on neuroendocrine neoplasm of the gastrointestinal tract and pancreas termed gastroenteropancreatic nens gepnens ha strongly expanded the aim of this review is to give an overview of the recent advance on epigenetic level and highlight their clinical application to address the current need in gepnens we illustrate how molecular alteration can be and are being used a therapeutic target how mutation in daxxatrx and copy number variation could be used a prognostic biomarkers how far we are in identifying predictive biomarkers and how genetics can contribute to gepnen classification finally we discus recent study on liquid biopsy in the field of gepnens and illustrate how liquid biopsy can play a role in patient management in conclusion molecular study have suggested multiple potential biomarkers but further validation is ongoing
31371806,myeloid neoplasm in the setting of sickle cell disease an intrinsic association with the underlying condition rather than a coincidence report of case and review of the literature,myeloid neoplasm occasionally occur in patient with sickle cell disease and the underlying connection between the two disease is unclear herein we retrospectively analyzed four case of sickle cell disease patient who developed myeloid neoplasm age at time of diagnosis ranged from to year with a median of year two patient were treated with hydroxyurea and the other two with supportive care alone with one out of the four patient receiving additional treatment with hematopoietic stem cell transplant three patient presented with leukocytosis and the remaining patient presented with pancytopenia two patient were diagnosed with myelodysplastic syndromemyeloproliferative neoplasm one with myelodysplastic syndrome and the other with acute myeloid leukemia all four case demonstrated certain degree of myelodysplasia and complex cytogenetic abnormality with q andor q or with q kmta rearrangement this cytogenetic profile resembles that seen in therapyrelated myeloid neoplasm suggesting that myeloid neoplasm in the setting of sickle cell disease may represent a subcategory of the disease distinct from de novo myeloid neoplasm in general extensive literature review further demonstrates this similarity in cytogenetic profile a well a in other associated pathologic feature potential etiology includes therapy for sickle cell disease diseaserelated immunomodulation or diseaserelated chronic inflammation we hypothesize that constant hematopoietic hyperplasia stimulated by a hemolysisinduced cytokine storm may increase the chance of somatic mutationscytogenetic aberration resulting in transformation of myeloid precursor this group of myeloid neoplasm seems to herald a dismal clinical outcome with median survival year although the exact pathogenesis and biology of the disease remain to be investigated by large cohort in future study,Cancer,0,myeloid neoplasm in the setting of sickle cell disease an intrinsic association with the underlying condition rather than a coincidence report of case and review of the literature myeloid neoplasm occasionally occur in patient with sickle cell disease and the underlying connection between the two disease is unclear herein we retrospectively analyzed four case of sickle cell disease patient who developed myeloid neoplasm age at time of diagnosis ranged from to year with a median of year two patient were treated with hydroxyurea and the other two with supportive care alone with one out of the four patient receiving additional treatment with hematopoietic stem cell transplant three patient presented with leukocytosis and the remaining patient presented with pancytopenia two patient were diagnosed with myelodysplastic syndromemyeloproliferative neoplasm one with myelodysplastic syndrome and the other with acute myeloid leukemia all four case demonstrated certain degree of myelodysplasia and complex cytogenetic abnormality with q andor q or with q kmta rearrangement this cytogenetic profile resembles that seen in therapyrelated myeloid neoplasm suggesting that myeloid neoplasm in the setting of sickle cell disease may represent a subcategory of the disease distinct from de novo myeloid neoplasm in general extensive literature review further demonstrates this similarity in cytogenetic profile a well a in other associated pathologic feature potential etiology includes therapy for sickle cell disease diseaserelated immunomodulation or diseaserelated chronic inflammation we hypothesize that constant hematopoietic hyperplasia stimulated by a hemolysisinduced cytokine storm may increase the chance of somatic mutationscytogenetic aberration resulting in transformation of myeloid precursor this group of myeloid neoplasm seems to herald a dismal clinical outcome with median survival year although the exact pathogenesis and biology of the disease remain to be investigated by large cohort in future study
31372496,clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p immunohistochemical expression,tp mutation are common in breast cancer and are typically associated with more aggressive tumor characteristic but little is known about the clinicopathological and epidemiological relevance of p protein expression a tp mutation surrogate in breast cancer subtypes in this study of chinese woman with invasive breast cancer we defined breast cancer subtypes using immunohistochemical ihc measure of hormone receptor and her in conjunction with histologic grade p expression status wa then used to further stratify subtypes into ppositive and pnegative odds ratio or and confidence interval ci in caseonly logistic regression analysis were used to examine heterogeneity across different subtypes the frequency of p protein expression varied by breast cancer subtype being lowest in the luminal alike and highest in the triplenegative and herenriched subtypes pvalue in luminal alike and blikehernegative subtypes p positivity wa associated with earlyonset tumor high grade high proliferative index and basal marker ck and egfr expression further compared with luminal alikepnegative patient alikeppositive patient were more likely to be parous adjusted or parous v nulliparous pvalue and to have breastfed adjusted or ever v never pvalue p positivity wa not associated with examined clinical and risk factor in other tumor subtypes overall these finding suggest that p expression which is readily available in many setting can be used to identify phenotype of luminal alike breast cancer with distinct clinical and epidemiological implication,Cancer,0,clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p immunohistochemical expression tp mutation are common in breast cancer and are typically associated with more aggressive tumor characteristic but little is known about the clinicopathological and epidemiological relevance of p protein expression a tp mutation surrogate in breast cancer subtypes in this study of chinese woman with invasive breast cancer we defined breast cancer subtypes using immunohistochemical ihc measure of hormone receptor and her in conjunction with histologic grade p expression status wa then used to further stratify subtypes into ppositive and pnegative odds ratio or and confidence interval ci in caseonly logistic regression analysis were used to examine heterogeneity across different subtypes the frequency of p protein expression varied by breast cancer subtype being lowest in the luminal alike and highest in the triplenegative and herenriched subtypes pvalue in luminal alike and blikehernegative subtypes p positivity wa associated with earlyonset tumor high grade high proliferative index and basal marker ck and egfr expression further compared with luminal alikepnegative patient alikeppositive patient were more likely to be parous adjusted or parous v nulliparous pvalue and to have breastfed adjusted or ever v never pvalue p positivity wa not associated with examined clinical and risk factor in other tumor subtypes overall these finding suggest that p expression which is readily available in many setting can be used to identify phenotype of luminal alike breast cancer with distinct clinical and epidemiological implication
31372733,hereditary colon cancer in lynch syndromehnpcc syndrome in germany,background hereditary nonpolyposis colorectal cancer lynchhnpcc syndrome is based on a germline mutation inducing increased occurrence of colorectal cancer and extracolonic carcinoma in young age the german hnpcc consortium aim to increase awareness for detection of hereditary colon cancer among patient and physician objective reliable detection of hnpcc patient is based on a thorough documentation of patient medical history and on further diagnostics delivered by human genetics and surgical pathology this manuscript present a standardized diagnostic concept method relevant literature is reviewed and discussed and diagnostic parameter are outlined in addition operating figure of the german hnpcc consortium are presented result the german hnpcc consortium is based on an efficient cooperation between clinical physician human geneticist and surgical pathologist after a funding period from the deutsche krebshilfe hnpcc diagnostics and preventive medical examination were transferred into standard care in germany in total family patient were included in hnpcc diagnostics to date in family mutation of the mlh msh msh pm or epcamgene have been detected furthermore pathogenic variant and variant of unknown significance were found conclusion reliable detection of hnpcc patient is based on a standardized diagnostic concept which ha been established within the german hnpcc consortium,Cancer,0,hereditary colon cancer in lynch syndromehnpcc syndrome in germany background hereditary nonpolyposis colorectal cancer lynchhnpcc syndrome is based on a germline mutation inducing increased occurrence of colorectal cancer and extracolonic carcinoma in young age the german hnpcc consortium aim to increase awareness for detection of hereditary colon cancer among patient and physician objective reliable detection of hnpcc patient is based on a thorough documentation of patient medical history and on further diagnostics delivered by human genetics and surgical pathology this manuscript present a standardized diagnostic concept method relevant literature is reviewed and discussed and diagnostic parameter are outlined in addition operating figure of the german hnpcc consortium are presented result the german hnpcc consortium is based on an efficient cooperation between clinical physician human geneticist and surgical pathologist after a funding period from the deutsche krebshilfe hnpcc diagnostics and preventive medical examination were transferred into standard care in germany in total family patient were included in hnpcc diagnostics to date in family mutation of the mlh msh msh pm or epcamgene have been detected furthermore pathogenic variant and variant of unknown significance were found conclusion reliable detection of hnpcc patient is based on a standardized diagnostic concept which ha been established within the german hnpcc consortium
31372940,clinical implication of chromosomal instability cin and kinetochore abnormality in breast cancer,genetic instability is a defining property of cancer cell and is the basis of various lesion including point mutation copy number alteration and translocation chromosomal instability cin is part of the genetic instability of cancer and consists of copy number alteration in whole or part of cancer cell chromosome cin is observed in differing degree in most cancer in breast cancer cin is commonly part of the genomic landscape of the disease and ha a higher incidence in aggressive subtypes tumor suppressor that are commonly mutated or disabled in cancer such a p and prb play role in protection against cin and a a result their dysfunction contributes to the establishment or tolerance of cin several structural and regulatory protein of the centromere and kinetochore the complex structure that is responsible for the correct distribution of genetic material in the daughter cell during mitosis are direct or mostly indirect transcription target of p and prb thus despite the absence of structural defect in gene encoding for centromere and kinetochore component dysfunction of these tumor suppressor may have profound implication for the correct function of the mitotic apparatus contributing to cin cin and it prognostic and therapeutic implication in breast cancer are discussed in this article,Cancer,0,clinical implication of chromosomal instability cin and kinetochore abnormality in breast cancer genetic instability is a defining property of cancer cell and is the basis of various lesion including point mutation copy number alteration and translocation chromosomal instability cin is part of the genetic instability of cancer and consists of copy number alteration in whole or part of cancer cell chromosome cin is observed in differing degree in most cancer in breast cancer cin is commonly part of the genomic landscape of the disease and ha a higher incidence in aggressive subtypes tumor suppressor that are commonly mutated or disabled in cancer such a p and prb play role in protection against cin and a a result their dysfunction contributes to the establishment or tolerance of cin several structural and regulatory protein of the centromere and kinetochore the complex structure that is responsible for the correct distribution of genetic material in the daughter cell during mitosis are direct or mostly indirect transcription target of p and prb thus despite the absence of structural defect in gene encoding for centromere and kinetochore component dysfunction of these tumor suppressor may have profound implication for the correct function of the mitotic apparatus contributing to cin cin and it prognostic and therapeutic implication in breast cancer are discussed in this article
31373163,cytokine r r r r r r r and r snp in relation with prognostic factor in acute myeloid leukemia,background cytokine were correlated with survival and disease progression in acute myeloid leukemia aml we aimed to evaluate the multivariate effect of tnfalpha r r r il r r il r tgfbeta r ifngamma r single nucleotide polymorphism snp on aml risk the multivariate effect of snp on overall survival o in aml and the association between the investigated snp and prognostic factor in aml method all snp were genotyped in adult aml case and healthy individual aml patient were investigated for flt itd d dnmta r and npm type a mutation result univariate analysis revealed that age above year had a negative influence on survival p lactate dehydrogenase ldh level platelet plt count iul and cytogenetic highrisk were independent significant predictor for death in aml p corrected hr p corrected hr p corrected hr respectively conclusion age above year plt count tnfalpha r variant genotype blast percentage ldh level and cytogenetic highrisk may be used a independent risk factor to assess aml mortality,Cancer,0,cytokine r r r r r r r and r snp in relation with prognostic factor in acute myeloid leukemia background cytokine were correlated with survival and disease progression in acute myeloid leukemia aml we aimed to evaluate the multivariate effect of tnfalpha r r r il r r il r tgfbeta r ifngamma r single nucleotide polymorphism snp on aml risk the multivariate effect of snp on overall survival o in aml and the association between the investigated snp and prognostic factor in aml method all snp were genotyped in adult aml case and healthy individual aml patient were investigated for flt itd d dnmta r and npm type a mutation result univariate analysis revealed that age above year had a negative influence on survival p lactate dehydrogenase ldh level platelet plt count iul and cytogenetic highrisk were independent significant predictor for death in aml p corrected hr p corrected hr p corrected hr respectively conclusion age above year plt count tnfalpha r variant genotype blast percentage ldh level and cytogenetic highrisk may be used a independent risk factor to assess aml mortality
31378236,nonsmall cell lung cancer epidemiology screening diagnosis and treatment,lung cancer remains the leading cause of cancer death in the united state in the past decade significant advance have been made in the science of nonsmall cell lung cancer nsclc screening ha been introduced with the goal of early detection the national lung screening trial found a lung cancer mortality benefit of and a decrease in allcause mortality with the use of lowdose chest computed tomography in highrisk individual the treatment of lung cancer ha also evolved with the introduction of several line of tyrosine kinase inhibitor in patient with egfr alk ro and ntrk mutation similarly immune checkpoint inhibitor icis have dramatically changed the landscape of nsclc treatment furthermore the result of new trial continue to help u understand the role of these novel agent and which patient are more likely to benefit icis are now part of the firstline nsclc treatment armamentarium a monotherapy combined with chemotherapy or after definite chemoradiotherapy in patient with stage iii unresectable nsclc expression of programmed cell death proteinligand in malignant cell ha been studied a a potential biomarker for response to icis however important drawback exist that limit it discriminatory potential identification of accurate predictive biomarkers beyond programmed cell death proteinligand expression remains essential to select the most appropriate candidate for ici therapy many question remain unanswered regarding the proper sequence and combination of these new agent however the field is moving rapidly and the overall direction is optimistic,Cancer,0,nonsmall cell lung cancer epidemiology screening diagnosis and treatment lung cancer remains the leading cause of cancer death in the united state in the past decade significant advance have been made in the science of nonsmall cell lung cancer nsclc screening ha been introduced with the goal of early detection the national lung screening trial found a lung cancer mortality benefit of and a decrease in allcause mortality with the use of lowdose chest computed tomography in highrisk individual the treatment of lung cancer ha also evolved with the introduction of several line of tyrosine kinase inhibitor in patient with egfr alk ro and ntrk mutation similarly immune checkpoint inhibitor icis have dramatically changed the landscape of nsclc treatment furthermore the result of new trial continue to help u understand the role of these novel agent and which patient are more likely to benefit icis are now part of the firstline nsclc treatment armamentarium a monotherapy combined with chemotherapy or after definite chemoradiotherapy in patient with stage iii unresectable nsclc expression of programmed cell death proteinligand in malignant cell ha been studied a a potential biomarker for response to icis however important drawback exist that limit it discriminatory potential identification of accurate predictive biomarkers beyond programmed cell death proteinligand expression remains essential to select the most appropriate candidate for ici therapy many question remain unanswered regarding the proper sequence and combination of these new agent however the field is moving rapidly and the overall direction is optimistic
31383941,apc transcription study and molecular diagnosis of familial adenomatous polyposis,familial adenomatous polyposis fap is characterised by the development of hundred to thousand of colorectal adenoma and result from inherited or somatic mosaic variant in the apc gene index patient with suspected fap are usually investigated by apc coding region sequence and dosage analysis in a clinical diagnostic setting the identification of an apc variant which is predicted to alter protein function enables predictive genetic testing to guide the management of family member this report describes a generation family with a phenotype consistent with fap but in which an apc variant had not been identified despite testing to explore this further quantitative pcr qpcr wa employed to assess apc transcription demonstrating reduced level of apc rna next generation sequencing ng identified the apc utr exon variant c ga that had been reported previously in an another fap family with apc allelic imbalance quantitative rna study and dna sequencing of the apc promoter exon may be useful diagnostically for patient with suspected fap when coding region variant can not be identified,Cancer,0,apc transcription study and molecular diagnosis of familial adenomatous polyposis familial adenomatous polyposis fap is characterised by the development of hundred to thousand of colorectal adenoma and result from inherited or somatic mosaic variant in the apc gene index patient with suspected fap are usually investigated by apc coding region sequence and dosage analysis in a clinical diagnostic setting the identification of an apc variant which is predicted to alter protein function enables predictive genetic testing to guide the management of family member this report describes a generation family with a phenotype consistent with fap but in which an apc variant had not been identified despite testing to explore this further quantitative pcr qpcr wa employed to assess apc transcription demonstrating reduced level of apc rna next generation sequencing ng identified the apc utr exon variant c ga that had been reported previously in an another fap family with apc allelic imbalance quantitative rna study and dna sequencing of the apc promoter exon may be useful diagnostically for patient with suspected fap when coding region variant can not be identified
31384200,cribriformmorular variant of papillary thyroid carcinoma and it association with familial adenomatous polyposis,the cribriformmorular variant of papillary thyroid carcinoma cmvptc is an uncommon variant of papillary thyroid carcinoma cmvptc can be associated with familial adenomatous polyposis fap an autosomaldominant polyposis syndrome caused by a mutation in the apc gene that lead to a disruption of the wntbetacatenin pathway understanding the relation between cmvptc and fap is a diagnostic tool for both pathologist and clinician because fap ha several implication for patient and their family,Cancer,0,cribriformmorular variant of papillary thyroid carcinoma and it association with familial adenomatous polyposis the cribriformmorular variant of papillary thyroid carcinoma cmvptc is an uncommon variant of papillary thyroid carcinoma cmvptc can be associated with familial adenomatous polyposis fap an autosomaldominant polyposis syndrome caused by a mutation in the apc gene that lead to a disruption of the wntbetacatenin pathway understanding the relation between cmvptc and fap is a diagnostic tool for both pathologist and clinician because fap ha several implication for patient and their family
31384696,the link between colon cancer and congenital hypertrophy of the retinal pigment epithelium chrpe,purpose clarify the difference between familial adenomatous polyposis fapassociated congenital hypertrophy of the retinal epithelium chrpe and benign variant with regard to lesion characteristic and associated risk observation an eighteenyearold man with no past medical history wa found to have multiple lesion in both eye that were consistent with fapassociated chrpe although family history wa negative for colon cancer a colonoscopy wa performed and hundred of polyp were found extending from the rectum to the distal colon with pathological finding of tubular adenoma genetic testing wa consistent with a possible de novo adenomatous polyposis coli apc mutation conclusion fap is an autosomal dominant syndrome that cause colorectal cancer by age thirtyfive in ninetyfive percent of case there ha been no established relationship between the benign variant of chrpe and fap and patient with benign variant have no increased risk of colon cancer while the lack of distinction in nomenclature and similar lesion appearance often lead to misdiagnosis and overtreatment there are distinct ocular exam feature that can provide the correct diagnosis the exam finding that distinguish fapassociated chrpe lesion are bilateralism occurrence in multiple quadrant pisiform shape and irregular border knowing these feature can be of great aid especially in the setting of suspected de novo familial adenomatous polyposis,Cancer,0,the link between colon cancer and congenital hypertrophy of the retinal pigment epithelium chrpe purpose clarify the difference between familial adenomatous polyposis fapassociated congenital hypertrophy of the retinal epithelium chrpe and benign variant with regard to lesion characteristic and associated risk observation an eighteenyearold man with no past medical history wa found to have multiple lesion in both eye that were consistent with fapassociated chrpe although family history wa negative for colon cancer a colonoscopy wa performed and hundred of polyp were found extending from the rectum to the distal colon with pathological finding of tubular adenoma genetic testing wa consistent with a possible de novo adenomatous polyposis coli apc mutation conclusion fap is an autosomal dominant syndrome that cause colorectal cancer by age thirtyfive in ninetyfive percent of case there ha been no established relationship between the benign variant of chrpe and fap and patient with benign variant have no increased risk of colon cancer while the lack of distinction in nomenclature and similar lesion appearance often lead to misdiagnosis and overtreatment there are distinct ocular exam feature that can provide the correct diagnosis the exam finding that distinguish fapassociated chrpe lesion are bilateralism occurrence in multiple quadrant pisiform shape and irregular border knowing these feature can be of great aid especially in the setting of suspected de novo familial adenomatous polyposis
31385070,sarcoma with mganutm fusion in the lung an emerging entity,we here document a sarcoma with a recently reported mganutm fusion a yearold man presented with a nodule in the right lung which grew to a giant mass in year the tumor showed uniform oval to spindle cell proliferation in a hypervascular stroma associated with focal myxoid change and peculiar collagen deposition resembling an osteoid the tumor showed an undifferentiated phenotype including negativity for cytokeratin although it wa immunoreactive to bcor and muc and wa initially suspected a bcorassociated sarcoma after complete resection the tumor recurred in the mediastinal lymph node and the patient died of the disease rna sequencing detected mga exon nutm exon which wa confirmed by reverse transcriptasepolymerase chain reaction sanger sequencing fluorescence in situ hybridization and nut immunohistochemistry clinicopathological feature of the present case were similar to some of the reported case of mganutm sarcoma suggesting the emergence of a distinct tumor subtype,Cancer,0,sarcoma with mganutm fusion in the lung an emerging entity we here document a sarcoma with a recently reported mganutm fusion a yearold man presented with a nodule in the right lung which grew to a giant mass in year the tumor showed uniform oval to spindle cell proliferation in a hypervascular stroma associated with focal myxoid change and peculiar collagen deposition resembling an osteoid the tumor showed an undifferentiated phenotype including negativity for cytokeratin although it wa immunoreactive to bcor and muc and wa initially suspected a bcorassociated sarcoma after complete resection the tumor recurred in the mediastinal lymph node and the patient died of the disease rna sequencing detected mga exon nutm exon which wa confirmed by reverse transcriptasepolymerase chain reaction sanger sequencing fluorescence in situ hybridization and nut immunohistochemistry clinicopathological feature of the present case were similar to some of the reported case of mganutm sarcoma suggesting the emergence of a distinct tumor subtype
31400126,the value of detecting mll gene rearrangement in child with acute monocytic leukemia,objective to assess the value of detecting the rearrangement of mixed lineage leukemia mll gene in child with acute mononuclear leukemia aml method dualcolor fluorescence in situ hybridization fish probe wa used to detect mll gene rearrangement in child with aml by interphase fish the result were compared with that of conventional g banding chromosomal analysis result among the child were detected by fish with positive hybridization signal with a detection rate for mll gene rearrangement being twelve reciprocal translocation and interruption of q were detected by g banding analysis the difference in the detection rate between the two method wa statistically significant p conclusion the sensitivity of fish assay for mll gene rearrangement wa significantly higher than that of g banding chromosomal karyotyping combined use of both method for child with aml can improve the detection rate of mll gene rearrangement and provide crucial clue for clinical diagnosis treatment and prognosis,Cancer,0,the value of detecting mll gene rearrangement in child with acute monocytic leukemia objective to assess the value of detecting the rearrangement of mixed lineage leukemia mll gene in child with acute mononuclear leukemia aml method dualcolor fluorescence in situ hybridization fish probe wa used to detect mll gene rearrangement in child with aml by interphase fish the result were compared with that of conventional g banding chromosomal analysis result among the child were detected by fish with positive hybridization signal with a detection rate for mll gene rearrangement being twelve reciprocal translocation and interruption of q were detected by g banding analysis the difference in the detection rate between the two method wa statistically significant p conclusion the sensitivity of fish assay for mll gene rearrangement wa significantly higher than that of g banding chromosomal karyotyping combined use of both method for child with aml can improve the detection rate of mll gene rearrangement and provide crucial clue for clinical diagnosis treatment and prognosis
31404155,helical and kinase domain mutation of pikca and their association with hormone receptor expression in breast cancer,breast cancer is one of the major cause of female morbidity and mortality accounting for of the total cancer case in woman phosphatidylinositolbisphosphate kinase catalytic alpha subunit pikca mutation serve a major role in downstream signaling of receptor tyrosine kinase the present study aimed to elucidate the frequency of exon and mutation of pikca and their role in disease progression a total of tumor sample from confirmed breast cancer patient were collected from the histopathology laboratory at king fahd hospital of the university alkhobar saudi arabia sanger sequencing wa performed on extracted dna to identify the mutation on exon and of pikca the result were further validated by competitive allelespecific taqman polymerase chain reaction three mutation namely ek and ek within exon and hr within exon were observed in patient among these patient carried the hr mutation of the kinase domain while the remaining patient carried mutation in the helical domain pikca mutation were associated with the estrogen receptorpositiveprogesterone receptorpositive erpr group of tumor in contrast to the erpr group p furthermore it wa observed that the pikca mutation wa associated with a poor disease prognosis taken together the current study emphasized the potential of pikca mutation a an important biomarker for breast cancer classification and the possible use of pikca inhibitor a targeted therapy for breast cancer,Cancer,0,helical and kinase domain mutation of pikca and their association with hormone receptor expression in breast cancer breast cancer is one of the major cause of female morbidity and mortality accounting for of the total cancer case in woman phosphatidylinositolbisphosphate kinase catalytic alpha subunit pikca mutation serve a major role in downstream signaling of receptor tyrosine kinase the present study aimed to elucidate the frequency of exon and mutation of pikca and their role in disease progression a total of tumor sample from confirmed breast cancer patient were collected from the histopathology laboratory at king fahd hospital of the university alkhobar saudi arabia sanger sequencing wa performed on extracted dna to identify the mutation on exon and of pikca the result were further validated by competitive allelespecific taqman polymerase chain reaction three mutation namely ek and ek within exon and hr within exon were observed in patient among these patient carried the hr mutation of the kinase domain while the remaining patient carried mutation in the helical domain pikca mutation were associated with the estrogen receptorpositiveprogesterone receptorpositive erpr group of tumor in contrast to the erpr group p furthermore it wa observed that the pikca mutation wa associated with a poor disease prognosis taken together the current study emphasized the potential of pikca mutation a an important biomarker for breast cancer classification and the possible use of pikca inhibitor a targeted therapy for breast cancer
31406244,fdaapproved drug screen identifies proteasome a a synthetic lethal target in mycdriven neuroblastoma,mycn amplification in neuroblastoma predicts poor prognosis and resistance to therapy yet pharmacological strategy of direct myc inhibition remain unsuccessful due to it undruggable protein structure we herein developed a synthetic lethal screen against mycnamplified neuroblastoma using clinically approved therapeutic reagent we performed a highthroughput screen from a library of fdaapproved drug for candidate that elicit synthetic lethal effect in mycdriven neuroblastoma cell the proteasome inhibitor which are fda approved for the firstline treatment of multiple myeloma emerge a top hit to elicit mycmediated synthetic lethality proteasome inhibition activates the perkeifalphaatf axis in myctransformed cell and induces baxmediated apoptosis through atfdependent noxa and trib induction a combination screen reveals the proteasome inhibitor bortezomib btz and the histone deacetylase hdac inhibitor vorinostat saha concertedly induce dramatic cell death in part through synergistic activation of bax this combination cause marked tumor suppression in vivo supporting dual proteasomehdac inhibition a a potential therapeutic approach for mycdriven cancer this fdaapproved drug screen with in vivo validation thus provides a rationale for clinical evaluation of bortezomib alone or in combination with vorinostat in mycdriven neuroblastoma patient,Cancer,0,fdaapproved drug screen identifies proteasome a a synthetic lethal target in mycdriven neuroblastoma mycn amplification in neuroblastoma predicts poor prognosis and resistance to therapy yet pharmacological strategy of direct myc inhibition remain unsuccessful due to it undruggable protein structure we herein developed a synthetic lethal screen against mycnamplified neuroblastoma using clinically approved therapeutic reagent we performed a highthroughput screen from a library of fdaapproved drug for candidate that elicit synthetic lethal effect in mycdriven neuroblastoma cell the proteasome inhibitor which are fda approved for the firstline treatment of multiple myeloma emerge a top hit to elicit mycmediated synthetic lethality proteasome inhibition activates the perkeifalphaatf axis in myctransformed cell and induces baxmediated apoptosis through atfdependent noxa and trib induction a combination screen reveals the proteasome inhibitor bortezomib btz and the histone deacetylase hdac inhibitor vorinostat saha concertedly induce dramatic cell death in part through synergistic activation of bax this combination cause marked tumor suppression in vivo supporting dual proteasomehdac inhibition a a potential therapeutic approach for mycdriven cancer this fdaapproved drug screen with in vivo validation thus provides a rationale for clinical evaluation of bortezomib alone or in combination with vorinostat in mycdriven neuroblastoma patient
31407494,risk stratification for lung adenocarcinoma on egfr and tp mutation status chemotherapy and pdl immunotherapy,the overall survival rate for lung cancer remain unsatisfactorily low even for patient with biomarkers for which target therapy or immunotherapy are recommended better identification of atrisk patient is needed to achieve more effective personalized treatment here we derived a riskstratifying gene signature consisting of five gene that had the greatest differential expression by stage from lung adenocarcinoma luad transcriptomes the new gene signature enabled survival prognosis for multiple luad datasets from different platform of transcriptomics and risk stratification for patient with and without a mutation in tp or egfr with high and low level of pdl and with and without adjuvant chemotherapy treatment using these evaluation it wa also shown to be more robust compared to several other gene signature functional analysis of the five gene and their proteinprotein interaction partner indicated that they are functionally enriched in cell cycle endocytosis and egfr regulation which are biological process associated with lung cancer and drug resistance extensive discussion on related experimental study suggest that the five gene are novel and sensible target for developing new drug andor tackling drug resistance problem for luad,Cancer,0,risk stratification for lung adenocarcinoma on egfr and tp mutation status chemotherapy and pdl immunotherapy the overall survival rate for lung cancer remain unsatisfactorily low even for patient with biomarkers for which target therapy or immunotherapy are recommended better identification of atrisk patient is needed to achieve more effective personalized treatment here we derived a riskstratifying gene signature consisting of five gene that had the greatest differential expression by stage from lung adenocarcinoma luad transcriptomes the new gene signature enabled survival prognosis for multiple luad datasets from different platform of transcriptomics and risk stratification for patient with and without a mutation in tp or egfr with high and low level of pdl and with and without adjuvant chemotherapy treatment using these evaluation it wa also shown to be more robust compared to several other gene signature functional analysis of the five gene and their proteinprotein interaction partner indicated that they are functionally enriched in cell cycle endocytosis and egfr regulation which are biological process associated with lung cancer and drug resistance extensive discussion on related experimental study suggest that the five gene are novel and sensible target for developing new drug andor tackling drug resistance problem for luad
31409085,an update on inherited colon cancer and gastrointestinal polyposis,background it is estimated that of colorectal cancer arise due to a known genetic syndrome individual with these cancer syndrome are also at risk of extracolonic cancer polyposis and nonpolyposis hereditary syndrome are generally recognized inclusion of nextgeneration sequencing technology especially multiplegene panel testing in routine laboratory practice ha made identifying the cause of these disease significantly easier purpose to summarize current knowledge of the cause clinical manifestation diagnostic criterion and recommendation for presymptomatic screening of individual at risk of hereditary gastrointestinal polyposis and colorectal cancer syndrome we dicuss currently defined syndrome detected by multiplegene panel nextgeneration sequencing these include constitutional mismatch repair deficiency biallelic mlh msh msh pm gene mutation gastric adenocarcinoma and proximal polyposis of the stomach apc gene nthlassociated polyposis polymerase proofreadingassociated polyposis pold pole gene juvenile polyposis smad bmpra gene and serrated polyposis syndrome another aim is to summarize recent knowledge about wellknown syndrome including hereditary nonpolyposis colon cancer lynch syndrome familial adenomatous polyposis mutyhassociated polyposis and peutzjeghers and cowdenpten hamartoma tumor syndrome conclusion awareness of hereditary polyposiscolon cancer syndrome enables early diagnosis and prevention of cancer in affected individual and their relative genetic counseling presymptomatic testing of atrisk individual and efficient screening may be beneficial for affected family thank to lenka foretova md phd masaryk memorial cancer institute brno for a critical review of the manuscript and valuable advice the author declares she ha no potential conflict of interest concerning drug product or service used in the study the editorial board declares that the manuscript met the icmje recommendation for biomedical paper submitted accepted,Cancer,0,an update on inherited colon cancer and gastrointestinal polyposis background it is estimated that of colorectal cancer arise due to a known genetic syndrome individual with these cancer syndrome are also at risk of extracolonic cancer polyposis and nonpolyposis hereditary syndrome are generally recognized inclusion of nextgeneration sequencing technology especially multiplegene panel testing in routine laboratory practice ha made identifying the cause of these disease significantly easier purpose to summarize current knowledge of the cause clinical manifestation diagnostic criterion and recommendation for presymptomatic screening of individual at risk of hereditary gastrointestinal polyposis and colorectal cancer syndrome we dicuss currently defined syndrome detected by multiplegene panel nextgeneration sequencing these include constitutional mismatch repair deficiency biallelic mlh msh msh pm gene mutation gastric adenocarcinoma and proximal polyposis of the stomach apc gene nthlassociated polyposis polymerase proofreadingassociated polyposis pold pole gene juvenile polyposis smad bmpra gene and serrated polyposis syndrome another aim is to summarize recent knowledge about wellknown syndrome including hereditary nonpolyposis colon cancer lynch syndrome familial adenomatous polyposis mutyhassociated polyposis and peutzjeghers and cowdenpten hamartoma tumor syndrome conclusion awareness of hereditary polyposiscolon cancer syndrome enables early diagnosis and prevention of cancer in affected individual and their relative genetic counseling presymptomatic testing of atrisk individual and efficient screening may be beneficial for affected family thank to lenka foretova md phd masaryk memorial cancer institute brno for a critical review of the manuscript and valuable advice the author declares she ha no potential conflict of interest concerning drug product or service used in the study the editorial board declares that the manuscript met the icmje recommendation for biomedical paper submitted accepted
31412428,molecular biomarkers predicting early development of endometrial carcinoma a pilot study,objective endometrial carcinoma represents the most common gynaecological cancer and the sixth most frequent cancer among woman worldwide the year survival of patient with stage i endometrial carcinoma is versus for stage iii or for stage iv disease therefore early detection could improve survival rate specifically in the most prevalent type endometrial cancer develops from hyperplastic endometrium the aim of the study wa to evaluate the utility of cancer gene mutation from endometrial biopsy towards predicting synchronous or metachronous development of malignant lesion the aim of the study wa to evaluate whether endometrial biopsy could already carry mutation in cancer gene useful for predicting or anticipating subsequent cancer development method patient with a previous endometrial biopsy negative for cancer followed by a subsequent biopsy positive for cancer were included in the study a fifty cancer gene targeted nextgeneration sequencing panel were used to investigate mutation in matched noncancerous and malignant sample result all biopsy from cancer tissue harboured mutation in one or more of the following gene apc ctnnb fbxw hnfa kras mtor nra pikca pten rb and tp additionally of the biopsy from matched noncancerous tissue exhibited mutation in pten kras or pikca gene conclusion these result suggest that detecting pathogenic mutation in oncogene or tumour suppressor gene in an otherwise benign condition is associated with a risk of developing a malignant disease given the identification of mutation several month or year before the appearance of a malignancy our finding suggests that a closer monitoring of patient who present such molecular alteration in noncancerous uterine mass is warranted,Cancer,0,molecular biomarkers predicting early development of endometrial carcinoma a pilot study objective endometrial carcinoma represents the most common gynaecological cancer and the sixth most frequent cancer among woman worldwide the year survival of patient with stage i endometrial carcinoma is versus for stage iii or for stage iv disease therefore early detection could improve survival rate specifically in the most prevalent type endometrial cancer develops from hyperplastic endometrium the aim of the study wa to evaluate the utility of cancer gene mutation from endometrial biopsy towards predicting synchronous or metachronous development of malignant lesion the aim of the study wa to evaluate whether endometrial biopsy could already carry mutation in cancer gene useful for predicting or anticipating subsequent cancer development method patient with a previous endometrial biopsy negative for cancer followed by a subsequent biopsy positive for cancer were included in the study a fifty cancer gene targeted nextgeneration sequencing panel were used to investigate mutation in matched noncancerous and malignant sample result all biopsy from cancer tissue harboured mutation in one or more of the following gene apc ctnnb fbxw hnfa kras mtor nra pikca pten rb and tp additionally of the biopsy from matched noncancerous tissue exhibited mutation in pten kras or pikca gene conclusion these result suggest that detecting pathogenic mutation in oncogene or tumour suppressor gene in an otherwise benign condition is associated with a risk of developing a malignant disease given the identification of mutation several month or year before the appearance of a malignancy our finding suggests that a closer monitoring of patient who present such molecular alteration in noncancerous uterine mass is warranted
31412611,fluorescence in situ hybridization fish for detecting anaplastic lymphoma kinase alk rearrangement in lung cancer clinically relevant technical aspect,in the vysis break apart alk fluorescence in situ hybridization fish assay wa approved by the united state food and drug administration a a companion diagnostic for detecting alk rearrangement in lung cancer patient who may benefit from treatment of tyrosine kinase inhibitor therapy this assay is the current gold standard according to updated alk testing guideline from the college of american pathologist the international association for the study of lung cancer and the association for molecular pathology published in alk immunohistochemistry is formally an alternative to alk fish and simultaneous detection of multiple hot spot including at least alk ro ret met erbb braf and kras gene is also recommended while performing next generation sequencing ngsbased testing therefore alk status in a specimen can be tested by different method and platform even in the same institution or laboratory in this review we discus several clinically relevant technical aspect of alk fish including pro and con of the unique twostep to cell analysis approach employed in the vysis break apart alk fish assay including the preset cutoff value of for a positive result technical aspect and biology of discordant result obtained by different method and incidental finding such a alk copy number gain or amplification and coexistent driver mutation these issue have practical implication for alk testing in the clinical laboratory following the updated guideline,Cancer,0,fluorescence in situ hybridization fish for detecting anaplastic lymphoma kinase alk rearrangement in lung cancer clinically relevant technical aspect in the vysis break apart alk fluorescence in situ hybridization fish assay wa approved by the united state food and drug administration a a companion diagnostic for detecting alk rearrangement in lung cancer patient who may benefit from treatment of tyrosine kinase inhibitor therapy this assay is the current gold standard according to updated alk testing guideline from the college of american pathologist the international association for the study of lung cancer and the association for molecular pathology published in alk immunohistochemistry is formally an alternative to alk fish and simultaneous detection of multiple hot spot including at least alk ro ret met erbb braf and kras gene is also recommended while performing next generation sequencing ngsbased testing therefore alk status in a specimen can be tested by different method and platform even in the same institution or laboratory in this review we discus several clinically relevant technical aspect of alk fish including pro and con of the unique twostep to cell analysis approach employed in the vysis break apart alk fish assay including the preset cutoff value of for a positive result technical aspect and biology of discordant result obtained by different method and incidental finding such a alk copy number gain or amplification and coexistent driver mutation these issue have practical implication for alk testing in the clinical laboratory following the updated guideline
31413087,ilrstatadar p interplay promotes oncogenicity in multiple myeloma with q amplification,q amplification is an important prognostic marker in multiple myeloma in this study we identified that ilr the interleukin membrane receptor and adar an rna editing enzyme are critical gene located within the minimally amplified q region loss of individual gene caused suppression to the oncogenic phenotype the magnitude of which wa enhanced when both gene were concomitantly lost mechanistically ilr and adar collaborated to induce a hyperactivation of the oncogenic stat pathway high ilr confers hypersensitivity to interleukin binding whereas adar form a constitutive feedforward loop with stat in a pisoformpredominant manner in this respect adarp act a a direct transcriptional target for stat and this statinducedp in turn directly interacts with and stabilizes the former protein leading to a larger pool of protein acting a oncogenic transcription factor for prosurvival gene the importance of both ilr and adarp in stat signaling wa further validated when concomitant knockdown of both gene impeded ilinducedstat pathway activation clinical evaluation of various datasets of myeloma patient showed that low expression of either one or both gene wa closely associated with a compromised stat signature confirming the involvement of ilr and adar in the stat pathway and underscoring their essential role in disease pathogenesis in summary our finding highlight the complexity of the stat pathway in myeloma in association with q amplification this study therefore reveals a novel perspective on q abnormality in myeloma and a potential therapeutic target for this cohort of highrisk patient,Cancer,0,ilrstatadar p interplay promotes oncogenicity in multiple myeloma with q amplification q amplification is an important prognostic marker in multiple myeloma in this study we identified that ilr the interleukin membrane receptor and adar an rna editing enzyme are critical gene located within the minimally amplified q region loss of individual gene caused suppression to the oncogenic phenotype the magnitude of which wa enhanced when both gene were concomitantly lost mechanistically ilr and adar collaborated to induce a hyperactivation of the oncogenic stat pathway high ilr confers hypersensitivity to interleukin binding whereas adar form a constitutive feedforward loop with stat in a pisoformpredominant manner in this respect adarp act a a direct transcriptional target for stat and this statinducedp in turn directly interacts with and stabilizes the former protein leading to a larger pool of protein acting a oncogenic transcription factor for prosurvival gene the importance of both ilr and adarp in stat signaling wa further validated when concomitant knockdown of both gene impeded ilinducedstat pathway activation clinical evaluation of various datasets of myeloma patient showed that low expression of either one or both gene wa closely associated with a compromised stat signature confirming the involvement of ilr and adar in the stat pathway and underscoring their essential role in disease pathogenesis in summary our finding highlight the complexity of the stat pathway in myeloma in association with q amplification this study therefore reveals a novel perspective on q abnormality in myeloma and a potential therapeutic target for this cohort of highrisk patient
31414211,mycn amplification drive an aggressive form of spinal ependymoma,spinal ependymal tumor form a histologically and molecularly heterogeneous group of tumor with generally good prognosis however their treatment can be challenging if infiltration of the spinal cord or dissemination throughout the central nervous system cns occurs and in these case clinical outcome remains poor here we describe a new and relatively rare subgroup of spinal ependymal tumor identified using dna methylation profiling that is distinct from other molecular subgroup of ependymoma copy number variation plot derived from dna methylation array showed mycn amplification a a characteristic genetic alteration in all case of our cohort n which wa subsequently validated using fluorescence in situ hybridization the histological diagnosis wa anaplastic ependymoma who grade iii in ten case and classic ependymoma who grade ii in three case histological reevaluation in five primary tumor and seven relapse showed characteristic histological feature of ependymoma namely pseudorosettes gfap and ema positivity electron microscopy revealed cilium complex intercellular junction and intermediate filament in a representative sample taking these finding into account we suggest to designate this molecular subgroup spinal ependymoma with mycn amplification spepnmycn spepnmycn tumor showed distinct growth pattern with intradural extramedullary localization mostly within the thoracic and cervical spine diffuse leptomeningeal spread throughout the whole cns and infiltrative invasion of the spinal cord dissemination wa observed in of case despite highintensity treatment spepnmycn showed significantly worse median progression free survival pfs month and median overall survival o month than all other previously described molecular spinal ependymoma subgroup o and pfs were similar to supratentorial ependymoma with relafusion stepnrela and posterior fossa ependymoma a pfepna further highlighting the aggressiveness of this distinct new subgroup we therefore propose to establish spepnmycn a a new molecular subgroup in ependymoma and advocate for testing newly diagnosed spinal ependymal tumor for mycn amplification,Cancer,0,mycn amplification drive an aggressive form of spinal ependymoma spinal ependymal tumor form a histologically and molecularly heterogeneous group of tumor with generally good prognosis however their treatment can be challenging if infiltration of the spinal cord or dissemination throughout the central nervous system cns occurs and in these case clinical outcome remains poor here we describe a new and relatively rare subgroup of spinal ependymal tumor identified using dna methylation profiling that is distinct from other molecular subgroup of ependymoma copy number variation plot derived from dna methylation array showed mycn amplification a a characteristic genetic alteration in all case of our cohort n which wa subsequently validated using fluorescence in situ hybridization the histological diagnosis wa anaplastic ependymoma who grade iii in ten case and classic ependymoma who grade ii in three case histological reevaluation in five primary tumor and seven relapse showed characteristic histological feature of ependymoma namely pseudorosettes gfap and ema positivity electron microscopy revealed cilium complex intercellular junction and intermediate filament in a representative sample taking these finding into account we suggest to designate this molecular subgroup spinal ependymoma with mycn amplification spepnmycn spepnmycn tumor showed distinct growth pattern with intradural extramedullary localization mostly within the thoracic and cervical spine diffuse leptomeningeal spread throughout the whole cns and infiltrative invasion of the spinal cord dissemination wa observed in of case despite highintensity treatment spepnmycn showed significantly worse median progression free survival pfs month and median overall survival o month than all other previously described molecular spinal ependymoma subgroup o and pfs were similar to supratentorial ependymoma with relafusion stepnrela and posterior fossa ependymoma a pfepna further highlighting the aggressiveness of this distinct new subgroup we therefore propose to establish spepnmycn a a new molecular subgroup in ependymoma and advocate for testing newly diagnosed spinal ependymal tumor for mycn amplification
31416192,understanding the mechanism of resistance in egfrpositive nsclc from tissue to liquid biopsy to guide treatment strategy,liquid biopsy ha emerged a an alternative source of nucleic acid for the management of epidermal growth factor receptor egfrmutant nonsmall cell lung cancer nsclc the use of circulating cellfree dna cfdna ha been recently introduced in clinical practice resulting in the improvement of the identification of druggable egfr mutation for the diagnosis and monitoring of response to targeted therapy egfrdependent tm and c mutation and independent mesenchymal epithelial transition met gene amplification kirsten rat sarcoma kras phosphatidylinositol bisphosphate kinase catalytic subunit alpha isoform pikca and raf murine sarcoma viral oncogene homolog b braf gene mutation mechanism of resistance to egfr tyrosine kinase inhibitor tkis have been evaluated in plasma sample from nsclc patient using highly sensitive method ie digital droplet pcr next generation sequencing allowing for the switch to other therapy therefore liquid biopsy is a noninvasive method able to detect the molecular dynamic change that occur under the pressure of treatment and to capture tumor heterogeneity more efficiently than is allowed by tissue biopsy this review address how liquid biopsy may be used to guide the choice of treatment strategy in egfrmutant nsclc,Cancer,0,understanding the mechanism of resistance in egfrpositive nsclc from tissue to liquid biopsy to guide treatment strategy liquid biopsy ha emerged a an alternative source of nucleic acid for the management of epidermal growth factor receptor egfrmutant nonsmall cell lung cancer nsclc the use of circulating cellfree dna cfdna ha been recently introduced in clinical practice resulting in the improvement of the identification of druggable egfr mutation for the diagnosis and monitoring of response to targeted therapy egfrdependent tm and c mutation and independent mesenchymal epithelial transition met gene amplification kirsten rat sarcoma kras phosphatidylinositol bisphosphate kinase catalytic subunit alpha isoform pikca and raf murine sarcoma viral oncogene homolog b braf gene mutation mechanism of resistance to egfr tyrosine kinase inhibitor tkis have been evaluated in plasma sample from nsclc patient using highly sensitive method ie digital droplet pcr next generation sequencing allowing for the switch to other therapy therefore liquid biopsy is a noninvasive method able to detect the molecular dynamic change that occur under the pressure of treatment and to capture tumor heterogeneity more efficiently than is allowed by tissue biopsy this review address how liquid biopsy may be used to guide the choice of treatment strategy in egfrmutant nsclc
31421692,current state of biomarkers for the diagnosis and assessment of treatment efficacy of prostate cancer,in recent year with the westernization of lifestyle reduced physical activity and increased prostatespecific antigen psa testing the incidence of prostate cancer pca ha risen significantly in developing country currently psa is the only pca biomarker applied clinically but it doe not perform well in the early diagnosis and distinguishing between benign prostatic hyperplasia and prostate cancer with the advance in deep sequencing technology a series of new pca biomarkers have been recently proposed to improve the diagnostic value of psa such a prostate cancer antigen pca tmprssets fusion gene microrna and other regulatory noncoding rna in addition the prostate health index phi ha been approved by the u food and drug administration fda for clinical use in the detection of pca the prostatespecific membrane antigen psma ha been confirmed to be specifically expressed on the surface of pca cell in this review we provide an updated summary of the value and feature of these novel biomarkers in the diagnosis and treatment of pca,Cancer,0,current state of biomarkers for the diagnosis and assessment of treatment efficacy of prostate cancer in recent year with the westernization of lifestyle reduced physical activity and increased prostatespecific antigen psa testing the incidence of prostate cancer pca ha risen significantly in developing country currently psa is the only pca biomarker applied clinically but it doe not perform well in the early diagnosis and distinguishing between benign prostatic hyperplasia and prostate cancer with the advance in deep sequencing technology a series of new pca biomarkers have been recently proposed to improve the diagnostic value of psa such a prostate cancer antigen pca tmprssets fusion gene microrna and other regulatory noncoding rna in addition the prostate health index phi ha been approved by the u food and drug administration fda for clinical use in the detection of pca the prostatespecific membrane antigen psma ha been confirmed to be specifically expressed on the surface of pca cell in this review we provide an updated summary of the value and feature of these novel biomarkers in the diagnosis and treatment of pca
31426797,unusual synchronous double primary treatmentnaive lung adenocarcinoma harboring tm and lr mutation in earlystage lung cancer,background concurrent mutation of synchronous multiple primary nonsmall cell lung cancer smpnsclc is rare and only a few case have been reported herein we present a case of earlystage smpnsclc with tm and lr mutation case presentation a yearold male patient presented to the thoracic surgery department due to a tumor in the right lower lung the tumor wa detected more than year previously during a health examination however the patient ignored the problem because the clinician at that time stated that the lesion wa highly likely to be benign chest computed topography ct wa ordered and the image showed a welldefined tumor in the right lower lung and a faint nodular lesion over the left lower lung field a ctguided biopsy result showed the presence of atypical cell and positive staining of ttf and ck surgical intervention wa performed the right and leftsided tumor disclosed micropapillary predominant adenocarcinoma and acinarpredominant adenocarcinoma respectively both tumor were positive for ttf but negative for alk and p realtime pcr analysis showed that the rightsided tumor had an epidermal growth factor receptor egfr mutation presenting a point mutation tm in exon while the leftsided tumor had a point mutation lr in exon of egfr conclusion our patient case suggests that tumor resembling a benign pattern with central calcification may be misdiagnosed thus early screening for lung cancer is important and intensive effort to make a diagnosis through surgical resection or biopsy to allow for tailored optimal treatment may be preferential for the best patient outcome,Cancer,0,unusual synchronous double primary treatmentnaive lung adenocarcinoma harboring tm and lr mutation in earlystage lung cancer background concurrent mutation of synchronous multiple primary nonsmall cell lung cancer smpnsclc is rare and only a few case have been reported herein we present a case of earlystage smpnsclc with tm and lr mutation case presentation a yearold male patient presented to the thoracic surgery department due to a tumor in the right lower lung the tumor wa detected more than year previously during a health examination however the patient ignored the problem because the clinician at that time stated that the lesion wa highly likely to be benign chest computed topography ct wa ordered and the image showed a welldefined tumor in the right lower lung and a faint nodular lesion over the left lower lung field a ctguided biopsy result showed the presence of atypical cell and positive staining of ttf and ck surgical intervention wa performed the right and leftsided tumor disclosed micropapillary predominant adenocarcinoma and acinarpredominant adenocarcinoma respectively both tumor were positive for ttf but negative for alk and p realtime pcr analysis showed that the rightsided tumor had an epidermal growth factor receptor egfr mutation presenting a point mutation tm in exon while the leftsided tumor had a point mutation lr in exon of egfr conclusion our patient case suggests that tumor resembling a benign pattern with central calcification may be misdiagnosed thus early screening for lung cancer is important and intensive effort to make a diagnosis through surgical resection or biopsy to allow for tailored optimal treatment may be preferential for the best patient outcome
31426864,ffdgpetbased radiomics signature predicts mgmt promoter methylation status in primary diffuse glioma,background the methylation status of the omethylguaninedna methyltransferase mgmt promoter ha emerged a a favorable independent prognostic and predictive biomarker in glioma this study aimed to build a radiomics signature based on ffluorodeoxyglucose fdg positron emission tomography pet for noninvasive measurement of the mgmt promoter methylation status in glioma method one hundred and seven pathologyconfirmed primary diffuse glioma patient were retrospectively included and randomly assigned to the primary n or validation cohort n the mgmt promoter methylation status wa measured by pyrosequencing a total of radiomics feature were extracted from the threedimensional region of interest roi on the standard uptake value suv map that were generated from the original ffdg pet data a radiomics signature a clinical signature and a fusion signature that combined the clinical and radiomics feature together were generated the performance of the three signature wa evaluated by receiver operating characteristic roc curve analysis and the patient prognosis wa stratified based on the mgmt promoter methylation status and the signature with the best performance result five radiomics feature were selected to construct the radiomics signature and displayed the best performance with area under the receiver operating characteristic roc curve auc reaching and in the primary and validation cohort respectively which outweigh the performance of clinical signature and fusion signature with a median followup time of month the radiomics signature stratified the glioma patient into two risk group with significantly different prognosis p conclusion ffdgpetbased radiomics is a promising approach for preoperatively evaluating the mgmt promoter methylation status in glioma and predicting the prognosis of glioma patient noninvasively,Cancer,0,ffdgpetbased radiomics signature predicts mgmt promoter methylation status in primary diffuse glioma background the methylation status of the omethylguaninedna methyltransferase mgmt promoter ha emerged a a favorable independent prognostic and predictive biomarker in glioma this study aimed to build a radiomics signature based on ffluorodeoxyglucose fdg positron emission tomography pet for noninvasive measurement of the mgmt promoter methylation status in glioma method one hundred and seven pathologyconfirmed primary diffuse glioma patient were retrospectively included and randomly assigned to the primary n or validation cohort n the mgmt promoter methylation status wa measured by pyrosequencing a total of radiomics feature were extracted from the threedimensional region of interest roi on the standard uptake value suv map that were generated from the original ffdg pet data a radiomics signature a clinical signature and a fusion signature that combined the clinical and radiomics feature together were generated the performance of the three signature wa evaluated by receiver operating characteristic roc curve analysis and the patient prognosis wa stratified based on the mgmt promoter methylation status and the signature with the best performance result five radiomics feature were selected to construct the radiomics signature and displayed the best performance with area under the receiver operating characteristic roc curve auc reaching and in the primary and validation cohort respectively which outweigh the performance of clinical signature and fusion signature with a median followup time of month the radiomics signature stratified the glioma patient into two risk group with significantly different prognosis p conclusion ffdgpetbased radiomics is a promising approach for preoperatively evaluating the mgmt promoter methylation status in glioma and predicting the prognosis of glioma patient noninvasively
31427547,androgen receptor expression in triple negative breast carcinoma and it association with the clinicopathological parameter,introduction androgen receptor ar is the most frequently expressed biomarker in all subtypes of breast carcinoma triple negative breast carcinoma tnbc is breast carcinoma that lack oestrogen and progesterone receptor immunoexpression a well a absence of herneu gene amplification this make targeted therapy not feasible in this cancer and hence ha poorer prognosis detecting ar expression could be another milestone in the management of tnbc a ar is a prognostic predictive marker and potential index for targeted treatment this study aimed to assess expression of ar in tnbc by immunohistochemistry and it association with clinicopathological parameter method we analysed the expression of ar in tnbc case from penang general hospital for a period of year to androgen receptor immunoreactivity wa considered positive if of tumour cell nucleus were stained irrespective of staining intensity result the prevalence of ar expression in tnbc wa with the proportion of arpositive tumour cell ranged from to these include invasive carcinoma no special type nst and other invasive carcinoma subtypes papillary lobular clear cell and medullary carcinoma sixtyseven case that showed ar immunonegativity were invasive carcinoma nst n clear cell carcinoma n and metaplastic carcinoma n androgen receptor immunoexpression wa inversely correlated with tumour grade p but not the tumour stage tumour size and nodal status conclusion ar is expressed in about onethird of tnbc and loss of ar immunoexpression doe not predict adverse clinical outcome larger cohort for better characterisation of the role of ar immunoexpression in tnbc are warranted,Cancer,0,androgen receptor expression in triple negative breast carcinoma and it association with the clinicopathological parameter introduction androgen receptor ar is the most frequently expressed biomarker in all subtypes of breast carcinoma triple negative breast carcinoma tnbc is breast carcinoma that lack oestrogen and progesterone receptor immunoexpression a well a absence of herneu gene amplification this make targeted therapy not feasible in this cancer and hence ha poorer prognosis detecting ar expression could be another milestone in the management of tnbc a ar is a prognostic predictive marker and potential index for targeted treatment this study aimed to assess expression of ar in tnbc by immunohistochemistry and it association with clinicopathological parameter method we analysed the expression of ar in tnbc case from penang general hospital for a period of year to androgen receptor immunoreactivity wa considered positive if of tumour cell nucleus were stained irrespective of staining intensity result the prevalence of ar expression in tnbc wa with the proportion of arpositive tumour cell ranged from to these include invasive carcinoma no special type nst and other invasive carcinoma subtypes papillary lobular clear cell and medullary carcinoma sixtyseven case that showed ar immunonegativity were invasive carcinoma nst n clear cell carcinoma n and metaplastic carcinoma n androgen receptor immunoexpression wa inversely correlated with tumour grade p but not the tumour stage tumour size and nodal status conclusion ar is expressed in about onethird of tnbc and loss of ar immunoexpression doe not predict adverse clinical outcome larger cohort for better characterisation of the role of ar immunoexpression in tnbc are warranted
31428516,highthroughput assessment of the antibody profile in ovarian cancer ascitic fluid,the identification of effective biomarkers for early diagnosis prognosis and response to treatment remains a challenge in ovarian cancer oc research here we present an unbiased highthroughput approach to profile ascitic fluid autoantibody in order to obtain a tumorspecific antigen signature in oc we first reported the reactivity of immunoglobulin ig purified from oc patient ascites towards two different oc cell line using a discovery set of ig we selected tumorspecific antigen from a phage display cdna library after biopanning protein were expressed a fusion protein and used in protein array to enable largescale immunoscreening with independent set of cancer and noncancerous control finally the selected antigen were validated by elisa the initial screening identified eight antigenic clone creb mrpl exosc bcor hmgn hipr olfm and kiaa these antigen were all validated by elisa in a study involving ascitic ig from patient with oc with other cancer and without cancer with creb showing the highest sensitivity and specificity notably we were able to identify an association between the tumorassociated ta antibody response and the response to a firstline tumor treatment platinumbased chemotherapy a stronger association wa found by combining three antigen bcor creb and mrlp a a single antibody signature measurement of an ascitic fluid antibody response to multiple ta antigen may aid in the identification of new prognostic signature in oc patient and shift attention to new potentially relevant target,Cancer,0,highthroughput assessment of the antibody profile in ovarian cancer ascitic fluid the identification of effective biomarkers for early diagnosis prognosis and response to treatment remains a challenge in ovarian cancer oc research here we present an unbiased highthroughput approach to profile ascitic fluid autoantibody in order to obtain a tumorspecific antigen signature in oc we first reported the reactivity of immunoglobulin ig purified from oc patient ascites towards two different oc cell line using a discovery set of ig we selected tumorspecific antigen from a phage display cdna library after biopanning protein were expressed a fusion protein and used in protein array to enable largescale immunoscreening with independent set of cancer and noncancerous control finally the selected antigen were validated by elisa the initial screening identified eight antigenic clone creb mrpl exosc bcor hmgn hipr olfm and kiaa these antigen were all validated by elisa in a study involving ascitic ig from patient with oc with other cancer and without cancer with creb showing the highest sensitivity and specificity notably we were able to identify an association between the tumorassociated ta antibody response and the response to a firstline tumor treatment platinumbased chemotherapy a stronger association wa found by combining three antigen bcor creb and mrlp a a single antibody signature measurement of an ascitic fluid antibody response to multiple ta antigen may aid in the identification of new prognostic signature in oc patient and shift attention to new potentially relevant target
31428572,mutation spectrum of cancerassociated gene in patient with early onset of colorectal cancer,background colorectal cancer crc incidence is rising worldwide a well a in the republic of kazakhstan while it occurrence is also increasing in the younger population hereditary form associated with the development of colon and rectal cancer and earlyonset crc have never been studied in the population of kazakhstan the aim of this research wa to investigate the spectrum of crcrelated gene mutation to determine which mutation cause early onset of crc in the kazakhstan population method the study included unrelated patient from kazakhstan range year in age with early onset crc genomic dna wa obtained from peripheral blood of the patient nextgeneration sequencing wa performed using the trusightcancer kit on the miseq platform the studio variant wa used to annotate and interpret genetic variant result bioinformatics analysis of nextgeneration sequencing data revealed variant from gene of them missense synonymous variant utr variant frameshift variant five stopgain variant four inframe deletion two splice donor one splice acceptor variant and intron or noncoding variant apc brca alk brip egfr fanca fancd fanci hnfa men nsd pm recql ret slx wrn and xpc gene mutated most often according to the acmg guideline and lovdclinvar database variant were pathogenic frameshifts five missenses five stopgain one inframe deletion and three splicesite mutation and were vus with population frequency of them were attributed a deleterious in the study of all pathogenic mutation found in kazakhstani patient with early crc onset were identified in the subgroup with a family history of crc and primary multiple tumor in apc pathogenic mutation were most often conclusion pathogenic and likely pathogenic mutation were found in out of patient eight novel pathogenic mutation detected in fanci apc bmpr atm and dicer gene have not been reported in previous literature given the high frequency and wide spectrum of mutation ng analysis must be carried out in family with a history of crccrcrelated cancer with the purpose to identify causeeffective mutation clarify the clinical diagnosis and prevent the development of the disease in other family member,Cancer,0,mutation spectrum of cancerassociated gene in patient with early onset of colorectal cancer background colorectal cancer crc incidence is rising worldwide a well a in the republic of kazakhstan while it occurrence is also increasing in the younger population hereditary form associated with the development of colon and rectal cancer and earlyonset crc have never been studied in the population of kazakhstan the aim of this research wa to investigate the spectrum of crcrelated gene mutation to determine which mutation cause early onset of crc in the kazakhstan population method the study included unrelated patient from kazakhstan range year in age with early onset crc genomic dna wa obtained from peripheral blood of the patient nextgeneration sequencing wa performed using the trusightcancer kit on the miseq platform the studio variant wa used to annotate and interpret genetic variant result bioinformatics analysis of nextgeneration sequencing data revealed variant from gene of them missense synonymous variant utr variant frameshift variant five stopgain variant four inframe deletion two splice donor one splice acceptor variant and intron or noncoding variant apc brca alk brip egfr fanca fancd fanci hnfa men nsd pm recql ret slx wrn and xpc gene mutated most often according to the acmg guideline and lovdclinvar database variant were pathogenic frameshifts five missenses five stopgain one inframe deletion and three splicesite mutation and were vus with population frequency of them were attributed a deleterious in the study of all pathogenic mutation found in kazakhstani patient with early crc onset were identified in the subgroup with a family history of crc and primary multiple tumor in apc pathogenic mutation were most often conclusion pathogenic and likely pathogenic mutation were found in out of patient eight novel pathogenic mutation detected in fanci apc bmpr atm and dicer gene have not been reported in previous literature given the high frequency and wide spectrum of mutation ng analysis must be carried out in family with a history of crccrcrelated cancer with the purpose to identify causeeffective mutation clarify the clinical diagnosis and prevent the development of the disease in other family member
31433233,molecular cytogenetic analysis of patient with plasma cell myeloma in tolna and baranya county in hungary,introduction plasma cell myeloma is a hematological malignancy with heterogeneous genomic landscape and diverse clinical course recurrent chromosomal and subchromosomal aberration commonly occur in this entity and are associated with the pathogenesis and progression of the disease the identification of these alteration aid genetic characterization classification and prognostication of patient aim molecular cytogenetic investigation of plasma cell myeloma patient treated at the university of pecs clinical center and janos balassa county hospital of tolna county szekszard between and were evaluated in our study method patient were screened for genetic aberration using fluorescence in situ hybridization translocation involving the immunoglobulin heavy chain gene loss of p and p chromosome arm gain of q chromosome arm and unbalanced aberration of chromosome were investigated loss and gain of p q q p q q and p chromosome arm were analyzed using multiplex ligationdependent probe amplification in patient during the investigated period bone marrow karyotyping wa also performed result in total genetic aberration were identified using our targeted approach the frequency of specific aberration correlated with data of the recent literature concordance of result gained by fluorescence in situ hybridization and multiplex ligationdependent probe amplification wa by analyzing the same chromosome arm the latter technique revealed additional genetic aberration in patient sample a compared to fluorescence in situ hybridization conclusion our result suggest that the combined application of the two molecular cytogenetic method may facilitate a more detailed characterization of genetic aberration of plasma cell myeloma patient in hungary orv hetil,Cancer,0,molecular cytogenetic analysis of patient with plasma cell myeloma in tolna and baranya county in hungary introduction plasma cell myeloma is a hematological malignancy with heterogeneous genomic landscape and diverse clinical course recurrent chromosomal and subchromosomal aberration commonly occur in this entity and are associated with the pathogenesis and progression of the disease the identification of these alteration aid genetic characterization classification and prognostication of patient aim molecular cytogenetic investigation of plasma cell myeloma patient treated at the university of pecs clinical center and janos balassa county hospital of tolna county szekszard between and were evaluated in our study method patient were screened for genetic aberration using fluorescence in situ hybridization translocation involving the immunoglobulin heavy chain gene loss of p and p chromosome arm gain of q chromosome arm and unbalanced aberration of chromosome were investigated loss and gain of p q q p q q and p chromosome arm were analyzed using multiplex ligationdependent probe amplification in patient during the investigated period bone marrow karyotyping wa also performed result in total genetic aberration were identified using our targeted approach the frequency of specific aberration correlated with data of the recent literature concordance of result gained by fluorescence in situ hybridization and multiplex ligationdependent probe amplification wa by analyzing the same chromosome arm the latter technique revealed additional genetic aberration in patient sample a compared to fluorescence in situ hybridization conclusion our result suggest that the combined application of the two molecular cytogenetic method may facilitate a more detailed characterization of genetic aberration of plasma cell myeloma patient in hungary orv hetil
31433323,melanocytic skin neoplasm what lesson from genomic aberration,study on the genomic aberration in melanocytic neoplasm have shown a complex genomic landscape in nevus and melanoma a mapkinase pathway activation wa generally found produced by different chromosomal aberration including braf nra hras gnaq gna bap ctnnb mapk prkara and nf mutation and alk ro ntrk ret met braf ntrk and prkca fusion melanoma also showed a variable number of additional mutation ablating tumorsuppression mechanism and activating other oncogenic pathway including cdkna loss pten loss a well a tp and tertpromoter mutation moreover borderline melanocytic tumor displayed the same chromosomal aberration but more mutation than nevus and fewer than melanoma in this context the notion that melanocytic neoplasm can be classified a benignmalignant is hardly supportable because all neoplasm harbor a certain number of mutation and the progression risk that is the malignant potential is related and proportional to the burden of pathogenic mutation moreover from the genomic analysis in parallel to the current diagnostic category of nevus melanoma and melanocytomas some aggregation or class of tumor based on the characteristic type of driver mutationsfusions emerge a possible and more rationale including spitzoid neoplasm blue neoplasm bapinactivated melanocytic neoplasm deep penetrating melanocytic neoplasm pigmentsynthesizing melanocytic neoplasm and common melanocytic neoplasm each of these class showing the same driver mutationsfusions demonstrates to have the same pathogenesis and may be genetically considered a a single tumor although with a variable amount of progression risk histologic feature being an expression of the mutational state could be used to obtain an approximate risk assessment in each single tumor,Cancer,0,melanocytic skin neoplasm what lesson from genomic aberration study on the genomic aberration in melanocytic neoplasm have shown a complex genomic landscape in nevus and melanoma a mapkinase pathway activation wa generally found produced by different chromosomal aberration including braf nra hras gnaq gna bap ctnnb mapk prkara and nf mutation and alk ro ntrk ret met braf ntrk and prkca fusion melanoma also showed a variable number of additional mutation ablating tumorsuppression mechanism and activating other oncogenic pathway including cdkna loss pten loss a well a tp and tertpromoter mutation moreover borderline melanocytic tumor displayed the same chromosomal aberration but more mutation than nevus and fewer than melanoma in this context the notion that melanocytic neoplasm can be classified a benignmalignant is hardly supportable because all neoplasm harbor a certain number of mutation and the progression risk that is the malignant potential is related and proportional to the burden of pathogenic mutation moreover from the genomic analysis in parallel to the current diagnostic category of nevus melanoma and melanocytomas some aggregation or class of tumor based on the characteristic type of driver mutationsfusions emerge a possible and more rationale including spitzoid neoplasm blue neoplasm bapinactivated melanocytic neoplasm deep penetrating melanocytic neoplasm pigmentsynthesizing melanocytic neoplasm and common melanocytic neoplasm each of these class showing the same driver mutationsfusions demonstrates to have the same pathogenesis and may be genetically considered a a single tumor although with a variable amount of progression risk histologic feature being an expression of the mutational state could be used to obtain an approximate risk assessment in each single tumor
31440211,gonadal failure is common in longterm survivor of childhood highrisk neuroblastoma treated with highdose chemotherapy and autologous stem cell rescue,background neuroblastoma is the most common extracranial solid tumor in child intensive therapy including autologous stemcell transplantation hsct ha improved the poor prognosis of highrisk neuroblastoma hrnbl but may impair gonadal function objective to investigate the gonadal function and fertility in longterm survivor of childhood hrnbl design a cohort including all finnish n female longterm year survivor of hrnbl and an age and sexmatched control group n wa examined at a median age of year oncologic treatment pubertal timing hormonal therapy and the number of offspring were recorded and pituitary and gonadal hormone were measured result altogether of the longterm survivor of hrnbl entered puberty spontaneously puberty wa hormonally induced in four survivor three female among the female survivor with spontaneous puberty seven had spontaneous menarche but developed ovarian failure soon after puberty nine female currently needed estrogen substitution amh a marker of ovarian reserve wa lower in the female survivor than control median v mugl p a a group male survivor had smaller testicular size v ml p and lower inhibin b v ngl p compared with control male with altogether survivor male fulfilling the criterion of gonadal failure absent puberty small testicle size or increased fsh with need of testosterone substitution gonadal failure wa more common in female and male survivor treated with totalbody irradiation three survivor one male had offspring all treated without totalbody irradiation and moderate dose of alkylating chemotherapy growth velocity wa compromised in all survivor after hrnbl diagnosis with absent pubertal growth spurt in survivor with complete growth data conclusion gonadal failure is common in longterm survivor of hrnbl treated with hsct fertility may be preserved in some survivor treated without totalbody irradiation,Cancer,0,gonadal failure is common in longterm survivor of childhood highrisk neuroblastoma treated with highdose chemotherapy and autologous stem cell rescue background neuroblastoma is the most common extracranial solid tumor in child intensive therapy including autologous stemcell transplantation hsct ha improved the poor prognosis of highrisk neuroblastoma hrnbl but may impair gonadal function objective to investigate the gonadal function and fertility in longterm survivor of childhood hrnbl design a cohort including all finnish n female longterm year survivor of hrnbl and an age and sexmatched control group n wa examined at a median age of year oncologic treatment pubertal timing hormonal therapy and the number of offspring were recorded and pituitary and gonadal hormone were measured result altogether of the longterm survivor of hrnbl entered puberty spontaneously puberty wa hormonally induced in four survivor three female among the female survivor with spontaneous puberty seven had spontaneous menarche but developed ovarian failure soon after puberty nine female currently needed estrogen substitution amh a marker of ovarian reserve wa lower in the female survivor than control median v mugl p a a group male survivor had smaller testicular size v ml p and lower inhibin b v ngl p compared with control male with altogether survivor male fulfilling the criterion of gonadal failure absent puberty small testicle size or increased fsh with need of testosterone substitution gonadal failure wa more common in female and male survivor treated with totalbody irradiation three survivor one male had offspring all treated without totalbody irradiation and moderate dose of alkylating chemotherapy growth velocity wa compromised in all survivor after hrnbl diagnosis with absent pubertal growth spurt in survivor with complete growth data conclusion gonadal failure is common in longterm survivor of hrnbl treated with hsct fertility may be preserved in some survivor treated without totalbody irradiation
31441848,management of tumor rupture and abdominal compartment syndrome in an infant with bilateral high risk stage neuroblastoma a case report,rationale tumor rupture and bleeding at initial presentation of infant with neuroblastoma nbl is a rare but life threatening condition and challenge in pediatric oncology here we report successful multidisciplinary management of an abdominal compartment syndrome a a result of tumor rupture and bleeding in an infant with bilateral high risk stage nbl patient concern the patient wa admitted to a cooperating hospital with vomiting failure to thrive and a large mass in the abdomen and wa then referred to our center diagnosis stage nbl with mycn amplification and p deletion wa diagnosed in an month old girl due to rapid and massive tumor growth she developed abdominal compression with renal failure severe bleeding and tumor lysis syndrome tl intervention surgical decompression by enterostomy local and systemic bleeding control with platelet and coagulation factor antiinfective and tl therapy were effective in stabilizing the patient condition this allowed initiation of the multimodal antineoplastic treatment according to protocol nb outcome mechanical ventilation wa stopped after day the abdominal wall wa closed month after the start of therapy and treatment according to the protocol be started and successfully completed lesson only the immediate coordinated multidisciplinary intervention managed to overcome the lifethreatening abdominal compartment syndrome and it associated problem eventually enabling successful curative treatment,Cancer,0,management of tumor rupture and abdominal compartment syndrome in an infant with bilateral high risk stage neuroblastoma a case report rationale tumor rupture and bleeding at initial presentation of infant with neuroblastoma nbl is a rare but life threatening condition and challenge in pediatric oncology here we report successful multidisciplinary management of an abdominal compartment syndrome a a result of tumor rupture and bleeding in an infant with bilateral high risk stage nbl patient concern the patient wa admitted to a cooperating hospital with vomiting failure to thrive and a large mass in the abdomen and wa then referred to our center diagnosis stage nbl with mycn amplification and p deletion wa diagnosed in an month old girl due to rapid and massive tumor growth she developed abdominal compression with renal failure severe bleeding and tumor lysis syndrome tl intervention surgical decompression by enterostomy local and systemic bleeding control with platelet and coagulation factor antiinfective and tl therapy were effective in stabilizing the patient condition this allowed initiation of the multimodal antineoplastic treatment according to protocol nb outcome mechanical ventilation wa stopped after day the abdominal wall wa closed month after the start of therapy and treatment according to the protocol be started and successfully completed lesson only the immediate coordinated multidisciplinary intervention managed to overcome the lifethreatening abdominal compartment syndrome and it associated problem eventually enabling successful curative treatment
31443309,malignant pleural effusion and it current management a review,malignant pleural effusion mpe is an exudative effusion with malignant cell mpe is a common symptom and accompanying manifestation of metastatic disease it affect up to of all patient with cancer and is the most common in lung breast cancer lymphoma gynecological malignancy and malignant mesothelioma in the last year many study were performed focusing on the pathophysiological mechanism of mpe with the advancement in molecular technique the importance of tumorhost cell interaction is becoming more apparent additionally the process of pathogenesis is greatly affected by activating mutation of egfr kras pikca braf met emlalk and ret which correlate with an increased incidence of mpe considering all these change the author aim to present a literature review of the newest finding review of the guideline and pathophysiological novelty in this field review of the just recently after seven year published practice guideline a well a analysis of more than article from the pubmed medline database that were almost exclusively published in indexed journal in the last few year have relevance and contribute to the better understanding of the presented topic mpe still present a severe medical condition in patient with advanced malignancy recent finding in the field of pathophysiological mechanism of mpe emphasize the role of molecular factor and mutation in the dynamic of the disease and it prognosis treatment guideline offer a patientcentric approach with the use of new scoring system an out of hospital approach and ultrasound the current guideline address multiple area of interest bring novelty in the form of validated prediction tool and can based on evidence improve patient outcome however the role of biomarkers in a clinical setting possible new treatment modality and certain specific situation still present a challenge for new research,Cancer,0,malignant pleural effusion and it current management a review malignant pleural effusion mpe is an exudative effusion with malignant cell mpe is a common symptom and accompanying manifestation of metastatic disease it affect up to of all patient with cancer and is the most common in lung breast cancer lymphoma gynecological malignancy and malignant mesothelioma in the last year many study were performed focusing on the pathophysiological mechanism of mpe with the advancement in molecular technique the importance of tumorhost cell interaction is becoming more apparent additionally the process of pathogenesis is greatly affected by activating mutation of egfr kras pikca braf met emlalk and ret which correlate with an increased incidence of mpe considering all these change the author aim to present a literature review of the newest finding review of the guideline and pathophysiological novelty in this field review of the just recently after seven year published practice guideline a well a analysis of more than article from the pubmed medline database that were almost exclusively published in indexed journal in the last few year have relevance and contribute to the better understanding of the presented topic mpe still present a severe medical condition in patient with advanced malignancy recent finding in the field of pathophysiological mechanism of mpe emphasize the role of molecular factor and mutation in the dynamic of the disease and it prognosis treatment guideline offer a patientcentric approach with the use of new scoring system an out of hospital approach and ultrasound the current guideline address multiple area of interest bring novelty in the form of validated prediction tool and can based on evidence improve patient outcome however the role of biomarkers in a clinical setting possible new treatment modality and certain specific situation still present a challenge for new research
31448040,multiple hemorragic brain lesion revealing metastatic melanoma,nearly of patient with metastatic melanoma develop brain metastasis we here report the case of an yearold woman hospitalized for secondarily generalized clonic seizure of the left leg with partial convulsive seizure in the resuscitation department melanoma resection of the left ankle had been performed month before her admission neurological examination showed left ataxic crural monoparesis electroencephalogram showed central and right frontal focus with leftsided dissemination gadoliniumenhanced magnetic resonance imaging mri of the brain showed multiple supratentorial and subtentorial encephalic lesion with varying size and shape with t hypersignal a and a haemorrhage on tweighted sequence b and b gadoliniumenhancing t with perilesional edema on flair sequence positron emission tomography pet showed multiple lymph node and bone metastasis lymph node biopsy wa negative for ve antibody with no brafve mutation by immunohistochemistry an increase in the number of metastatic lesion wa observed during control brain ct scan despite brain radiotherapy session motivating palliative care epileptic seizure were controlled with levetiracetam in patient with multiple hemorrhagic and spontaneous brain lesion it is essential to obtain information on patient history of melanoma and to perform a thorough dermatologic examination in order to investigate it cause and to establish adequate therapeutic treatment,Cancer,0,multiple hemorragic brain lesion revealing metastatic melanoma nearly of patient with metastatic melanoma develop brain metastasis we here report the case of an yearold woman hospitalized for secondarily generalized clonic seizure of the left leg with partial convulsive seizure in the resuscitation department melanoma resection of the left ankle had been performed month before her admission neurological examination showed left ataxic crural monoparesis electroencephalogram showed central and right frontal focus with leftsided dissemination gadoliniumenhanced magnetic resonance imaging mri of the brain showed multiple supratentorial and subtentorial encephalic lesion with varying size and shape with t hypersignal a and a haemorrhage on tweighted sequence b and b gadoliniumenhancing t with perilesional edema on flair sequence positron emission tomography pet showed multiple lymph node and bone metastasis lymph node biopsy wa negative for ve antibody with no brafve mutation by immunohistochemistry an increase in the number of metastatic lesion wa observed during control brain ct scan despite brain radiotherapy session motivating palliative care epileptic seizure were controlled with levetiracetam in patient with multiple hemorrhagic and spontaneous brain lesion it is essential to obtain information on patient history of melanoma and to perform a thorough dermatologic examination in order to investigate it cause and to establish adequate therapeutic treatment
31452453,how many papilla in conventional papillary carcinoma a clinical evidencebased pathology study of unifocal encapsulated papillary thyroid carcinoma with emphasis on the diagnosis of noninvasive follicular thyroid neoplasm with papillarylike nuclear feature,background the percentage of papilla is a crucial criterion in differentiating noninvasive follicular thyroid neoplasm with papillarylike nuclear feature niftp from papillary thyroid carcinoma ptcs and in subclassifying ptc into classic and follicular variant since the description of niftp three study have shown that the presence of any papilla may be associated with nodal metastasis which led to modification of the niftp criterion from papilla compared with in the nnx group nodal metastasis were only present in tumor with papilla in noninvasive ueptc n n disease wa seen only in tumor with papilla a higher percentage of papilla within the tumor also correlated with an increased frequency of brafve and decreased rate of nrasqr none of the nraspositive case had nodal disease including the invasive tumor among patient with followup median year patient had distant metastasis all detected at the initial presentation all three tumor displayed follicular growth and capsular or vascular invasion there wa no locoregional recurrence in the entire cohort conclusion in ueptc there is a strong correlation between high percentage of papillary growth presence of nodal metastasis and brafras genotype regardless of invasive status nodal metastasis were not seen in tumor with papilla irrespective of invasive status these finding indicate that the initial criterion of papilla is still valid for the diagnosis of niftp reinstituting this criterion will spare a carcinoma diagnosis and unnecessary therapy with it side effect on patient who have negligible clinical risk,Cancer,0,how many papilla in conventional papillary carcinoma a clinical evidencebased pathology study of unifocal encapsulated papillary thyroid carcinoma with emphasis on the diagnosis of noninvasive follicular thyroid neoplasm with papillarylike nuclear feature background the percentage of papilla is a crucial criterion in differentiating noninvasive follicular thyroid neoplasm with papillarylike nuclear feature niftp from papillary thyroid carcinoma ptcs and in subclassifying ptc into classic and follicular variant since the description of niftp three study have shown that the presence of any papilla may be associated with nodal metastasis which led to modification of the niftp criterion from papilla compared with in the nnx group nodal metastasis were only present in tumor with papilla in noninvasive ueptc n n disease wa seen only in tumor with papilla a higher percentage of papilla within the tumor also correlated with an increased frequency of brafve and decreased rate of nrasqr none of the nraspositive case had nodal disease including the invasive tumor among patient with followup median year patient had distant metastasis all detected at the initial presentation all three tumor displayed follicular growth and capsular or vascular invasion there wa no locoregional recurrence in the entire cohort conclusion in ueptc there is a strong correlation between high percentage of papillary growth presence of nodal metastasis and brafras genotype regardless of invasive status nodal metastasis were not seen in tumor with papilla irrespective of invasive status these finding indicate that the initial criterion of papilla is still valid for the diagnosis of niftp reinstituting this criterion will spare a carcinoma diagnosis and unnecessary therapy with it side effect on patient who have negligible clinical risk
31452761,mirap regulates proliferation and apoptosis of colon cancer cell by potentially targeting btg,microrna mirmirnaap ha been reported to be abnormally expressed in various type of cancer including colorectal cancer crc bcell translocation gene btg ha also been implicated with crc however the association between mirap and btg in crc to the best of our knowledge ha not been investigated in order to assess whether mirap is associated with crc reverse transcriptionquantitative pcr wa performed on paired crc and paracancerous tissue for mirna analysis for the screening and validation of mirap expression in colon cancer several colon cancer cell line hct hct sw ht lovo and caco and the normal colorectal epithelial cell line ncm were examined the highest expression level of mirap were detected in the hct which wa selected for further experimentation the hct cell were divided into control mirap mimic and inhibitor group and cell proliferation wa tested using an mtt assay additionally mirap inhibitormimic or btg plasmid were transfected into the hct cell and flow cytometry wa performed to analyze cell cycle distribution tunel analysis wa performed to detect apoptosis protein level of factor in the downstream signaling pathway mediated by mirap erkmitogenactivated extracellular signalregulated kinase mek were detected mirap wa revealed to be overexpressed in human crc tissue and colon cancer cell line knockdown of mirap suppressed proliferation of hct cell and apoptosis wa increased it further markedly upregulated expression level of btg and inhibited activation of protein of the erkmek signaling pathway in addition overexpression of btg in hct cell triggered g phase cell cycle arrest and increased apoptosis via the erkmek signaling pathway in conclusion the present study demonstrated that the effect of mirap on colon cancer cell proliferation and apoptosis were similar to those of the tumor suppressor gene btg the mirapbtg axis may have potential implication for diagnostic and therapeutic approach in crc,Cancer,0,mirap regulates proliferation and apoptosis of colon cancer cell by potentially targeting btg microrna mirmirnaap ha been reported to be abnormally expressed in various type of cancer including colorectal cancer crc bcell translocation gene btg ha also been implicated with crc however the association between mirap and btg in crc to the best of our knowledge ha not been investigated in order to assess whether mirap is associated with crc reverse transcriptionquantitative pcr wa performed on paired crc and paracancerous tissue for mirna analysis for the screening and validation of mirap expression in colon cancer several colon cancer cell line hct hct sw ht lovo and caco and the normal colorectal epithelial cell line ncm were examined the highest expression level of mirap were detected in the hct which wa selected for further experimentation the hct cell were divided into control mirap mimic and inhibitor group and cell proliferation wa tested using an mtt assay additionally mirap inhibitormimic or btg plasmid were transfected into the hct cell and flow cytometry wa performed to analyze cell cycle distribution tunel analysis wa performed to detect apoptosis protein level of factor in the downstream signaling pathway mediated by mirap erkmitogenactivated extracellular signalregulated kinase mek were detected mirap wa revealed to be overexpressed in human crc tissue and colon cancer cell line knockdown of mirap suppressed proliferation of hct cell and apoptosis wa increased it further markedly upregulated expression level of btg and inhibited activation of protein of the erkmek signaling pathway in addition overexpression of btg in hct cell triggered g phase cell cycle arrest and increased apoptosis via the erkmek signaling pathway in conclusion the present study demonstrated that the effect of mirap on colon cancer cell proliferation and apoptosis were similar to those of the tumor suppressor gene btg the mirapbtg axis may have potential implication for diagnostic and therapeutic approach in crc
31455365,alk rearrangement a highfrequency alteration in ovarian metastasis from lung adenocarcinoma,background ovarian metastatic tumor from lung adenocarcinoma are rare and a serial study of these tumor is lacking to date additionally a better understanding of the clinicopathological and molecular characteristic of metastatic tumor is needed method seven case of ovarian metastasis from lung adenocarcinoma from to at our institute were investigated the result were combined with those found in literature review a total of case were analyzed in the present study we examined clinicopathological and immunohistochemical characteristic further detected alk rearrangement by fish fluorescence in situ hybridization and assessed egfr and kras mutation using sanger sequencing or the amplification refractory mutation system arm result the mean age of the patient wa year range year eleven of sixteen patient developed ovarian tumor within a mean time of month range month from the initial diagnosis of lung adenocarcinoma patient had lung tumor and ovarian mass simultaneously five tumor occurred in the bilateral ovary and the others were unilateral ovarian tumor all seven case from our institute were positive for ttf and napsin a but negative for pax in four case alk df wa diffusely and strongly expressed with alk rearrangement overall alk rearrangement wa found by fish or immunohistochemistry in case in two case egfr mutation in exon and respectively were found one patient did not detected egfr or alk mutation in the metastatic tumor but the primary lung adenocarcinoma did harbor an egfr mutation two case had no alteration in three gene above although the mean survival time of the patient with alk rearrangement wa longer than those without mean survival time m v m no statistical significance of the difference wa found conclusion a the largest case series of ovarian metastasis from lung adenocarcinoma our finding indicate that alk rearrangement is the most common molecular alteration although patient with alk rearrangement appear to have a better prognosis than do those without alk rearrangement more case with longer followup and multivariant analysis are needed to clarify this point,Cancer,0,alk rearrangement a highfrequency alteration in ovarian metastasis from lung adenocarcinoma background ovarian metastatic tumor from lung adenocarcinoma are rare and a serial study of these tumor is lacking to date additionally a better understanding of the clinicopathological and molecular characteristic of metastatic tumor is needed method seven case of ovarian metastasis from lung adenocarcinoma from to at our institute were investigated the result were combined with those found in literature review a total of case were analyzed in the present study we examined clinicopathological and immunohistochemical characteristic further detected alk rearrangement by fish fluorescence in situ hybridization and assessed egfr and kras mutation using sanger sequencing or the amplification refractory mutation system arm result the mean age of the patient wa year range year eleven of sixteen patient developed ovarian tumor within a mean time of month range month from the initial diagnosis of lung adenocarcinoma patient had lung tumor and ovarian mass simultaneously five tumor occurred in the bilateral ovary and the others were unilateral ovarian tumor all seven case from our institute were positive for ttf and napsin a but negative for pax in four case alk df wa diffusely and strongly expressed with alk rearrangement overall alk rearrangement wa found by fish or immunohistochemistry in case in two case egfr mutation in exon and respectively were found one patient did not detected egfr or alk mutation in the metastatic tumor but the primary lung adenocarcinoma did harbor an egfr mutation two case had no alteration in three gene above although the mean survival time of the patient with alk rearrangement wa longer than those without mean survival time m v m no statistical significance of the difference wa found conclusion a the largest case series of ovarian metastasis from lung adenocarcinoma our finding indicate that alk rearrangement is the most common molecular alteration although patient with alk rearrangement appear to have a better prognosis than do those without alk rearrangement more case with longer followup and multivariant analysis are needed to clarify this point
31461190,adenomatous polyposis coli a a major regulator of human embryonic stem cell selfrenewal,human embryonic stem cell hescs provide an essential tool to investigate early human development study disease pathogenesis and examine therapeutic intervention adenomatous polyposis coli apc is a negative regulator of wntbetacatenin signaling implicated in the majority of sporadic colorectal cancer and in the autosomal dominant inherited syndrome familial adenomatous polyposis fap study into the role of wntbetacatenin signaling in hescs arrived at conflicting result due at least in part to variation in culture condition and the use of external inhibitor and agonist here we directly targeted apc in hescs carrying a germline apc mutation derived from affected blastocyst following preimplantation genetic diagnosis pgd for fap in order to answer open question regarding the role of apc in regulating pluripotency and differentiation potential of hescs using clustered regularly interspaced short palindromic repeat crisprcrispr associated protein ca we generated second hit apc mutation in faphescs despite high crisprcas targeting efficiency and the successful isolation of many clone none of the isolated clone carried a loss of function mutation in the wildtype wt apc allele using a fluorescent betacatenin reporter and analysis of mutatedallele frequency in the apc locus we show that apc double mutant hescs robustly activate wntbetacatenin signaling that result in rapid differentiation to endodermal and mesodermal lineage here we provide direct evidence for a strict requirement for constant betacatenin degradation through the apc destruction complex in order to maintain pluripotency highlighting a fundamental role for apc in selfrenewal of hescs stem cell,Cancer,0,adenomatous polyposis coli a a major regulator of human embryonic stem cell selfrenewal human embryonic stem cell hescs provide an essential tool to investigate early human development study disease pathogenesis and examine therapeutic intervention adenomatous polyposis coli apc is a negative regulator of wntbetacatenin signaling implicated in the majority of sporadic colorectal cancer and in the autosomal dominant inherited syndrome familial adenomatous polyposis fap study into the role of wntbetacatenin signaling in hescs arrived at conflicting result due at least in part to variation in culture condition and the use of external inhibitor and agonist here we directly targeted apc in hescs carrying a germline apc mutation derived from affected blastocyst following preimplantation genetic diagnosis pgd for fap in order to answer open question regarding the role of apc in regulating pluripotency and differentiation potential of hescs using clustered regularly interspaced short palindromic repeat crisprcrispr associated protein ca we generated second hit apc mutation in faphescs despite high crisprcas targeting efficiency and the successful isolation of many clone none of the isolated clone carried a loss of function mutation in the wildtype wt apc allele using a fluorescent betacatenin reporter and analysis of mutatedallele frequency in the apc locus we show that apc double mutant hescs robustly activate wntbetacatenin signaling that result in rapid differentiation to endodermal and mesodermal lineage here we provide direct evidence for a strict requirement for constant betacatenin degradation through the apc destruction complex in order to maintain pluripotency highlighting a fundamental role for apc in selfrenewal of hescs stem cell
31462891,haploinsufficiency of nrc drive glucocorticoid resistance in adult acute lymphoblastic leukemia cell by downregulating the mitochondrial apoptosis axis and is sensitive to bcl blockage,background relapse represents the leading cause of death in both child and adult patient with acute lymphoblastic leukemia all development of chemoresistance is ultimately responsible for treatment failure and relapse therefore understanding the molecular basis underlying resistance is imperative for developing innovative treatment strategy glucocorticoid gc such dexamethasone and prednisolone are the backbone of combination chemotherapy regimen for treating all lymphoid tumor however the biological mechanism of primary gc resistance in all is not completely understood we previously performed a longitudinal wholeexome sequencing analysis on diagnosisrelapse pair from adult patient with all our data revealed that relapsespecific truncation mutation in the nrc gene encoding the gc receptor are frequently detected method in the current study we used discoverybased strategy including rna sequencing rnaseq and crisprcas followed by confirmatory testing in human all cell line bone marrow blast sample from all patient and xenograft model to elucidate the mechanism responsible for resistance result our result revealed a positive correlation between endogenous expression of nrc in all cell and sensitivity to gc and clinical outcome we further confirmed that ectopic expression of nrc in all cell could reverse gc resistance while deletion of nrc confers resistance to gc in all cell line and xenograft model rnaseq analysis revealed a remarkable abundance of gene signature involved in pathway in cancer dna replication mismatch repair p signalling cell cycle and apoptosis regulated by nrc significantly increased expression of proapoptotic gene including bcllbim bmf bad bax and bok and decreased transcription of antiapoptotic gene including bcl bcll and bag were observed in gcresistant all cell following ectopic expression of nrc finally we explored that gc resistance in all cell with haploinsufficiency of nrc can be treated with bcl blockage conclusion our finding suggest that the status of nrc gene mutation and basal expression level of nrc in all cell are associated with sensitivity to gc and clinical treatment outcome early intervention strategy by rational combination of bcl blockage may constitute a promising new treatment option to gcresistant all and significantly improving the chance of treating poor prednisone responder,Cancer,0,haploinsufficiency of nrc drive glucocorticoid resistance in adult acute lymphoblastic leukemia cell by downregulating the mitochondrial apoptosis axis and is sensitive to bcl blockage background relapse represents the leading cause of death in both child and adult patient with acute lymphoblastic leukemia all development of chemoresistance is ultimately responsible for treatment failure and relapse therefore understanding the molecular basis underlying resistance is imperative for developing innovative treatment strategy glucocorticoid gc such dexamethasone and prednisolone are the backbone of combination chemotherapy regimen for treating all lymphoid tumor however the biological mechanism of primary gc resistance in all is not completely understood we previously performed a longitudinal wholeexome sequencing analysis on diagnosisrelapse pair from adult patient with all our data revealed that relapsespecific truncation mutation in the nrc gene encoding the gc receptor are frequently detected method in the current study we used discoverybased strategy including rna sequencing rnaseq and crisprcas followed by confirmatory testing in human all cell line bone marrow blast sample from all patient and xenograft model to elucidate the mechanism responsible for resistance result our result revealed a positive correlation between endogenous expression of nrc in all cell and sensitivity to gc and clinical outcome we further confirmed that ectopic expression of nrc in all cell could reverse gc resistance while deletion of nrc confers resistance to gc in all cell line and xenograft model rnaseq analysis revealed a remarkable abundance of gene signature involved in pathway in cancer dna replication mismatch repair p signalling cell cycle and apoptosis regulated by nrc significantly increased expression of proapoptotic gene including bcllbim bmf bad bax and bok and decreased transcription of antiapoptotic gene including bcl bcll and bag were observed in gcresistant all cell following ectopic expression of nrc finally we explored that gc resistance in all cell with haploinsufficiency of nrc can be treated with bcl blockage conclusion our finding suggest that the status of nrc gene mutation and basal expression level of nrc in all cell are associated with sensitivity to gc and clinical treatment outcome early intervention strategy by rational combination of bcl blockage may constitute a promising new treatment option to gcresistant all and significantly improving the chance of treating poor prednisone responder
31467295,association of caspase polymorphism n insdel and asphis with progressionfree survival and tumor infiltrating lymphocyte in early breast cancer,the caspase variant casp n insdel and asphis have previously been identified to promote survival of tlymphocytes and to indicate reduced breast cancer susceptibility besides some preliminary finding prognostic relevance of these polymorphism in patient with existing breast cancer ha not been investigated considering an immunomodulatory role of these polymorphism we genotyped early breast cancer patient and correlated caspase variant with diseasefree survival dfs and the presence of tumor infiltrating lymphocyte tils early breast cancer specimen were collected a part of the multicenter prospective pia study genotyping wa performed by pyrosequencing tils status wa assessed using hematoxylin eosin staining the casp del variant wa significantly associated with improved dfs in an alleledose dependent manner p homozygosity for the del variant wa an independent predictor for improved dfs hr ci p in patient with the hishis genotype there wa no event of recurrence during observation time combined analysis of diplotypes revealed an influence of both polymorphism on dfs p interestingly patient with the hishis variant among the unstratified patient cohort and among the luminallike subtype by trend had tumor with lower lymphocyte infiltration p we propose a prognostically favorable role of the del and the his variant in primary breast cancer and suggest for the first time an association between polymorphism in apoptosisrelated gene and the immunophenotype in breast cancer our finding encourage further investigation of caspase polymorphism a biomarkers for prognostic and immunotherapeutic consideration,Cancer,0,association of caspase polymorphism n insdel and asphis with progressionfree survival and tumor infiltrating lymphocyte in early breast cancer the caspase variant casp n insdel and asphis have previously been identified to promote survival of tlymphocytes and to indicate reduced breast cancer susceptibility besides some preliminary finding prognostic relevance of these polymorphism in patient with existing breast cancer ha not been investigated considering an immunomodulatory role of these polymorphism we genotyped early breast cancer patient and correlated caspase variant with diseasefree survival dfs and the presence of tumor infiltrating lymphocyte tils early breast cancer specimen were collected a part of the multicenter prospective pia study genotyping wa performed by pyrosequencing tils status wa assessed using hematoxylin eosin staining the casp del variant wa significantly associated with improved dfs in an alleledose dependent manner p homozygosity for the del variant wa an independent predictor for improved dfs hr ci p in patient with the hishis genotype there wa no event of recurrence during observation time combined analysis of diplotypes revealed an influence of both polymorphism on dfs p interestingly patient with the hishis variant among the unstratified patient cohort and among the luminallike subtype by trend had tumor with lower lymphocyte infiltration p we propose a prognostically favorable role of the del and the his variant in primary breast cancer and suggest for the first time an association between polymorphism in apoptosisrelated gene and the immunophenotype in breast cancer our finding encourage further investigation of caspase polymorphism a biomarkers for prognostic and immunotherapeutic consideration
31479144,medication use to reduce risk of breast cancer u preventive service task force recommendation statement,importance breast cancer is the most common nonskin cancer among woman in the united state and the second leading cause of cancer death the median age at diagnosis is year and an estimated in woman will develop breast cancer at some point in their lifetime african american woman are more likely to die of breast cancer compared with woman of other race objective to update the u preventive service task force uspstf recommendation on medication for risk reduction of primary breast cancer evidence review the uspstf reviewed evidence on the accuracy of risk assessment method to identify woman who could benefit from riskreducing medication for breast cancer a well a evidence on the effectiveness adverse effect and subgroup variation of these medication the uspstf reviewed evidence from randomized trial observational study and diagnostic accuracy study of risk stratification model in woman without preexisting breast cancer or ductal carcinoma in situ finding the uspstf found convincing evidence that risk assessment tool can predict the number of case of breast cancer expected to develop in a population however these risk assessment tool perform modestly at best in discriminating between individual woman who will or will not develop breast cancer the uspstf found convincing evidence that riskreducing medication tamoxifen raloxifene or aromatase inhibitor provide at least a moderate benefit in reducing risk for invasive estrogen receptorpositive breast cancer in postmenopausal woman at increased risk for breast cancer the uspstf found that the benefit of taking tamoxifen raloxifene and aromatase inhibitor to reduce risk for breast cancer are no greater than small in woman not at increased risk for the disease the uspstf found convincing evidence that tamoxifen and raloxifene and adequate evidence that aromatase inhibitor are associated with small to moderate harm overall the uspstf determined that the net benefit of taking medication to reduce risk of breast cancer is larger in woman who have a greater risk for developing breast cancer conclusion and recommendation the uspstf recommends that clinician offer to prescribe riskreducing medication such a tamoxifen raloxifene or aromatase inhibitor to woman who are at increased risk for breast cancer and at low risk for adverse medication effect b recommendation the uspstf recommends against the routine use of riskreducing medication such a tamoxifen raloxifene or aromatase inhibitor in woman who are not at increased risk for breast cancer d recommendation this recommendation applies to asymptomatic woman year and older including woman with previous benign breast lesion on biopsy such a atypical ductal or lobular hyperplasia and lobular carcinoma in situ this recommendation doe not apply to woman who have a current or previous diagnosis of breast cancer or ductal carcinoma in situ,Cancer,0,medication use to reduce risk of breast cancer u preventive service task force recommendation statement importance breast cancer is the most common nonskin cancer among woman in the united state and the second leading cause of cancer death the median age at diagnosis is year and an estimated in woman will develop breast cancer at some point in their lifetime african american woman are more likely to die of breast cancer compared with woman of other race objective to update the u preventive service task force uspstf recommendation on medication for risk reduction of primary breast cancer evidence review the uspstf reviewed evidence on the accuracy of risk assessment method to identify woman who could benefit from riskreducing medication for breast cancer a well a evidence on the effectiveness adverse effect and subgroup variation of these medication the uspstf reviewed evidence from randomized trial observational study and diagnostic accuracy study of risk stratification model in woman without preexisting breast cancer or ductal carcinoma in situ finding the uspstf found convincing evidence that risk assessment tool can predict the number of case of breast cancer expected to develop in a population however these risk assessment tool perform modestly at best in discriminating between individual woman who will or will not develop breast cancer the uspstf found convincing evidence that riskreducing medication tamoxifen raloxifene or aromatase inhibitor provide at least a moderate benefit in reducing risk for invasive estrogen receptorpositive breast cancer in postmenopausal woman at increased risk for breast cancer the uspstf found that the benefit of taking tamoxifen raloxifene and aromatase inhibitor to reduce risk for breast cancer are no greater than small in woman not at increased risk for the disease the uspstf found convincing evidence that tamoxifen and raloxifene and adequate evidence that aromatase inhibitor are associated with small to moderate harm overall the uspstf determined that the net benefit of taking medication to reduce risk of breast cancer is larger in woman who have a greater risk for developing breast cancer conclusion and recommendation the uspstf recommends that clinician offer to prescribe riskreducing medication such a tamoxifen raloxifene or aromatase inhibitor to woman who are at increased risk for breast cancer and at low risk for adverse medication effect b recommendation the uspstf recommends against the routine use of riskreducing medication such a tamoxifen raloxifene or aromatase inhibitor in woman who are not at increased risk for breast cancer d recommendation this recommendation applies to asymptomatic woman year and older including woman with previous benign breast lesion on biopsy such a atypical ductal or lobular hyperplasia and lobular carcinoma in situ this recommendation doe not apply to woman who have a current or previous diagnosis of breast cancer or ductal carcinoma in situ
31479615,the origin and pathogenesis of endometriosis,recent molecular genetic finding on endometriosis and normal endometrium suggest a modified model in which circulating epithelial progenitor or stem cell intended to regenerate uterine endometrium after menstruation may become overreactive and trapped outside the uterus these trapped epitheliumcommitted progenitor cell form nascent gland through clonal expansion and recruit polyclonal stromal cell leading to the establishment of deep infiltrating endometriosis once formed the ectopic tissue becomes subject to immune surveillance resulting in chronic inflammation the inflammatory response orchestrated by nuclear factorkappab signaling is exacerbated by aberration in the estrogen receptorbeta and progesterone receptor pathway which are also affected by local inflammation forming a dysregulated inflammationhormonal loop glandular epithelium within endometriotic tissue harbor cancerassociated mutation that are frequently detected in endometriosisrelated ovarian cancer in this review we summarize recent advance that have illuminated the origin and pathogenesis of endometriosis and have provided new avenue for research that promise to improve the early diagnosis and management of endometriosis,Cancer,0,the origin and pathogenesis of endometriosis recent molecular genetic finding on endometriosis and normal endometrium suggest a modified model in which circulating epithelial progenitor or stem cell intended to regenerate uterine endometrium after menstruation may become overreactive and trapped outside the uterus these trapped epitheliumcommitted progenitor cell form nascent gland through clonal expansion and recruit polyclonal stromal cell leading to the establishment of deep infiltrating endometriosis once formed the ectopic tissue becomes subject to immune surveillance resulting in chronic inflammation the inflammatory response orchestrated by nuclear factorkappab signaling is exacerbated by aberration in the estrogen receptorbeta and progesterone receptor pathway which are also affected by local inflammation forming a dysregulated inflammationhormonal loop glandular epithelium within endometriotic tissue harbor cancerassociated mutation that are frequently detected in endometriosisrelated ovarian cancer in this review we summarize recent advance that have illuminated the origin and pathogenesis of endometriosis and have provided new avenue for research that promise to improve the early diagnosis and management of endometriosis
31481959,a novel btk gene mutation in a child with atypical xlinked agammaglobulinemia and recurrent hemophagocytosis a case report,xlinked agammaglobulinemia xla caused by a mutation in the brutons tyrosine kinase btk gene is rarely reported in patient with recurrent hemophagocytic lymphohistiocytosis hlh this mutation lead to significantly reduced number of circulatory b cell and serum immunoglobulin in patient therefore they exhibit repetitive bacterial infection since infancy and immunoglobulin ig replacement therapy is the primary treatment hlh is a lifethreatening condition with manifestation of nonremitting fever hepatosplenomegaly cytopenia coagulopathy lipid disorder and multiple organ failure it is caused by the immune dysregulation between cytotoxic t cell nk cell and histiocyte the treatment is based on hlh protocol including immunotherapy chemotherapy supportive therapy and stem cell transplantation however a we know more about the classification and pathophysiology of hlh the treatment is modified tcelldirected immunotherapy is effective in patient with primary hlh and strong immunosuppression is contraindicated in patient with severe ongoing infection or some primary immunodeficiency disease pid here we report the case of a yearold boy who presented with ecthyma gangrenosum and several episode of pyogenic infection during childhood at the age of year he exhibited cyclic hlh every month the remission of hlh episode finally achieved after he received monthly ig replacement therapy mgkg at the th hlh however transient elevation of igm wa incidentally discovered after cycle of monthly ig replacement therapy igmsecreting multiple myeloma waldenstroms macroglobulinemia and lymphoma were excluded the igm level then declined and returned to the normal range within a year the patient and his parent received wholegenome sequencing analysis it revealed a novel hemizygous cga mutation in the btk gene and xla wa diagnosed xla exhibit a spectrum of clinical and immunological presentation in patient the identification of the mutation in the btk gene contribute to an accurate diagnosis ig replacement therapy is the primary treatment for hlh in patient with xla,Cancer,0,a novel btk gene mutation in a child with atypical xlinked agammaglobulinemia and recurrent hemophagocytosis a case report xlinked agammaglobulinemia xla caused by a mutation in the brutons tyrosine kinase btk gene is rarely reported in patient with recurrent hemophagocytic lymphohistiocytosis hlh this mutation lead to significantly reduced number of circulatory b cell and serum immunoglobulin in patient therefore they exhibit repetitive bacterial infection since infancy and immunoglobulin ig replacement therapy is the primary treatment hlh is a lifethreatening condition with manifestation of nonremitting fever hepatosplenomegaly cytopenia coagulopathy lipid disorder and multiple organ failure it is caused by the immune dysregulation between cytotoxic t cell nk cell and histiocyte the treatment is based on hlh protocol including immunotherapy chemotherapy supportive therapy and stem cell transplantation however a we know more about the classification and pathophysiology of hlh the treatment is modified tcelldirected immunotherapy is effective in patient with primary hlh and strong immunosuppression is contraindicated in patient with severe ongoing infection or some primary immunodeficiency disease pid here we report the case of a yearold boy who presented with ecthyma gangrenosum and several episode of pyogenic infection during childhood at the age of year he exhibited cyclic hlh every month the remission of hlh episode finally achieved after he received monthly ig replacement therapy mgkg at the th hlh however transient elevation of igm wa incidentally discovered after cycle of monthly ig replacement therapy igmsecreting multiple myeloma waldenstroms macroglobulinemia and lymphoma were excluded the igm level then declined and returned to the normal range within a year the patient and his parent received wholegenome sequencing analysis it revealed a novel hemizygous cga mutation in the btk gene and xla wa diagnosed xla exhibit a spectrum of clinical and immunological presentation in patient the identification of the mutation in the btk gene contribute to an accurate diagnosis ig replacement therapy is the primary treatment for hlh in patient with xla
31483231,overview of current immunotherapy targeting mutated kras cancer,the occurrence of somatic substitution mutation of the kras protooncogene is highly prevalent in certain cancer type which often lead to constant activation of proliferative pathway and subsequent neoplastic transformation it is often seen a a gateway mutation in carcinogenesis and ha been commonly deemed a a predictive biomarker for poor prognosis and relapse when conventional chemotherapeutics are employed additionally it mutational status also render egfr targeted therapy ineffective owing to it downstream location effort to discover new approach targeting this menacing culprit have been ongoing for year without much success and with incidence of kras positive cancer patient being on the rise researcher are now turning towards immunotherapy a the way forward in this scoping review recent immunotherapeutic development and advance in both preclinical and clinical study targeting kras directly or indirectly via it downstream signal transduction machinery will be discussed additionally some of the challenge and limitation of various kras targeting immunotherapeutic approach such a vaccine adoptive t cell therapy and checkpoint inhibitor against kras positive cancer will be deliberated,Cancer,0,overview of current immunotherapy targeting mutated kras cancer the occurrence of somatic substitution mutation of the kras protooncogene is highly prevalent in certain cancer type which often lead to constant activation of proliferative pathway and subsequent neoplastic transformation it is often seen a a gateway mutation in carcinogenesis and ha been commonly deemed a a predictive biomarker for poor prognosis and relapse when conventional chemotherapeutics are employed additionally it mutational status also render egfr targeted therapy ineffective owing to it downstream location effort to discover new approach targeting this menacing culprit have been ongoing for year without much success and with incidence of kras positive cancer patient being on the rise researcher are now turning towards immunotherapy a the way forward in this scoping review recent immunotherapeutic development and advance in both preclinical and clinical study targeting kras directly or indirectly via it downstream signal transduction machinery will be discussed additionally some of the challenge and limitation of various kras targeting immunotherapeutic approach such a vaccine adoptive t cell therapy and checkpoint inhibitor against kras positive cancer will be deliberated
31491579,recurrent undifferentiated carcinoma of the sella in a patient with lynch syndrome,background lynch syndrome l is a cancerpredisposing condition resulting from germline mutation in deoxyribonucleic acid mismatch repair gene patient are at high risk for a multitude of tumor but no report of undifferentiated sellar carcinoma have previously been described case description a yearold female with l due to msh and msh mutation presented with panhypopituitarism and a sellar mass she wa initially diagnosed with pituitary apoplexy and treated nonoperatively the mass selfresolved the mass recurred year later and she underwent endoscopic endonasal biopsy demonstrating an undifferentiated carcinoma of the sella with msh and msh loss the tumor wa negative for pituitary marker and weakly positive for p the patient further developed lung and bone metastasis and wa treated with radiation and chemotherapy conclusion this is the first report of an undifferentiated carcinoma of the sella our patient harbored a diagnosis of l and demonstrated local tumor recurrence and aggressive systemic progression patient with l should undergo close followup and active surveillance to detect and treat these aggressive lesion in a timely manner,Cancer,0,recurrent undifferentiated carcinoma of the sella in a patient with lynch syndrome background lynch syndrome l is a cancerpredisposing condition resulting from germline mutation in deoxyribonucleic acid mismatch repair gene patient are at high risk for a multitude of tumor but no report of undifferentiated sellar carcinoma have previously been described case description a yearold female with l due to msh and msh mutation presented with panhypopituitarism and a sellar mass she wa initially diagnosed with pituitary apoplexy and treated nonoperatively the mass selfresolved the mass recurred year later and she underwent endoscopic endonasal biopsy demonstrating an undifferentiated carcinoma of the sella with msh and msh loss the tumor wa negative for pituitary marker and weakly positive for p the patient further developed lung and bone metastasis and wa treated with radiation and chemotherapy conclusion this is the first report of an undifferentiated carcinoma of the sella our patient harbored a diagnosis of l and demonstrated local tumor recurrence and aggressive systemic progression patient with l should undergo close followup and active surveillance to detect and treat these aggressive lesion in a timely manner
31492087,genetic testing of thyroid nodule using a gene panel developed on a new generation sequencing platform,introduction twentyfive percent of fineneedle aspiration biopsy sample of thyroid nodule produce indeterminate cytological result genetic testing of nodule can contribute to accurate diagnosis aim developing the first gene panel in europe utilizing the most relevant thyroid oncogene with mutation method examination of the isolated dna from biopsy sample by ion torrent new generation sequencing result the validation of our method wa performed on tumor tissue sample in which genetic variation were identified yet unknown in thyroid tumor axin wa the most polymorphic gene while braf cta ve wa the most frequently identified mutation we detected clinically relevant variant of which have not been described in the literature six of our cytologically malignant and of our indeterminate a well a of our cytologically benign sample were identified a containing pathologic variant in a driver gene braf cta nra cca conclusion we have developed a validated reliable new generation sequencingbased method with high positive predictive value and sensitivity suitable for the early detection of malignant lesion in the thyroid orv hetil,Cancer,0,genetic testing of thyroid nodule using a gene panel developed on a new generation sequencing platform introduction twentyfive percent of fineneedle aspiration biopsy sample of thyroid nodule produce indeterminate cytological result genetic testing of nodule can contribute to accurate diagnosis aim developing the first gene panel in europe utilizing the most relevant thyroid oncogene with mutation method examination of the isolated dna from biopsy sample by ion torrent new generation sequencing result the validation of our method wa performed on tumor tissue sample in which genetic variation were identified yet unknown in thyroid tumor axin wa the most polymorphic gene while braf cta ve wa the most frequently identified mutation we detected clinically relevant variant of which have not been described in the literature six of our cytologically malignant and of our indeterminate a well a of our cytologically benign sample were identified a containing pathologic variant in a driver gene braf cta nra cca conclusion we have developed a validated reliable new generation sequencingbased method with high positive predictive value and sensitivity suitable for the early detection of malignant lesion in the thyroid orv hetil
31492174,the first report of molecular characterized brdnut carcinoma in brazil a case report,background nut midline carcinoma is a rare and aggressive subset of squamous cell carcinoma which is characterized by the translocation of nuclear protein in testis gene that is mostly fused with bromodomain and extraterminal family protein we describe here the first brazilian case of nut midline carcinoma with brdnut fusion detected in a nextgeneration sequencing panel and we present the clinical evolution of this patient case presentation a yearold caucasian man wa diagnosed with poorly differentiated squamous cell carcinoma of the left maxillary sinus with negative in situ hybridization for epsteinbarr encoding region and human papillomavirus genotyping he received induction therapy chemoradiotherapy with weekly systemic chemotherapy and concurrently weekly intraarterial chemotherapy new imaging evaluation month after the end of the last treatment revealed a good partial response in the primary lesion however positron emission tomographycomputed tomography showed multiple suspicious lesion in his bone and lung which were histologically confirmed he died exactly month after metastatic disease wa diagnosed conclusion nut midline carcinoma is usually very aggressive currently there is no standard of care for treatment of nut midline carcinoma the definitive diagnosis must be by demonstration of nutm rearrangement immunohistochemical staining of greater than of tumor nucleus on formalinfixed paraffinembedded tissue using the monoclonal rabbit antibody to nut clone cb ha a specificity of and sensitivity of for the diagnosis of nut midline carcinoma our case is the first brazilian case of nut midline carcinoma with brdnut fusion,Cancer,0,the first report of molecular characterized brdnut carcinoma in brazil a case report background nut midline carcinoma is a rare and aggressive subset of squamous cell carcinoma which is characterized by the translocation of nuclear protein in testis gene that is mostly fused with bromodomain and extraterminal family protein we describe here the first brazilian case of nut midline carcinoma with brdnut fusion detected in a nextgeneration sequencing panel and we present the clinical evolution of this patient case presentation a yearold caucasian man wa diagnosed with poorly differentiated squamous cell carcinoma of the left maxillary sinus with negative in situ hybridization for epsteinbarr encoding region and human papillomavirus genotyping he received induction therapy chemoradiotherapy with weekly systemic chemotherapy and concurrently weekly intraarterial chemotherapy new imaging evaluation month after the end of the last treatment revealed a good partial response in the primary lesion however positron emission tomographycomputed tomography showed multiple suspicious lesion in his bone and lung which were histologically confirmed he died exactly month after metastatic disease wa diagnosed conclusion nut midline carcinoma is usually very aggressive currently there is no standard of care for treatment of nut midline carcinoma the definitive diagnosis must be by demonstration of nutm rearrangement immunohistochemical staining of greater than of tumor nucleus on formalinfixed paraffinembedded tissue using the monoclonal rabbit antibody to nut clone cb ha a specificity of and sensitivity of for the diagnosis of nut midline carcinoma our case is the first brazilian case of nut midline carcinoma with brdnut fusion
31498304,in vivo inhibition of microrna to decrease tumor growth in mouse,micrornas mirnas are important regulator of gene expression through their ability to destabilize mrna and inhibit translation of target mrna an everincreasing number of study have identified mirnas a potential biomarkers for cancer diagnosis and prognosis and also a therapeutic target adding an extra dimension to cancer evaluation and treatment in the context of thyroid cancer tumorigenesis result not only from mutation in important gene but also from the overexpression of many mirnas accordingly the role of mirnas in the control of thyroid gene expression is evolving a an important mechanism in cancer herein we present a protocol to examine the effect of mirnainhibitor delivery a a therapeutic modality in thyroid cancer using human tumor xenograft and orthotopic mouse model after engineering stable thyroid tumoral cell expressing gfp and luciferase cell are injected into nude mouse to develop tumor which can be followed by bioluminescence the in vivo inhibition of a mirna can reduce tumor growth and upregulate mirna gene target this method can be used to assess the importance of a determined mirna in vivo in addition to identifying new therapeutic target,Cancer,0,in vivo inhibition of microrna to decrease tumor growth in mouse micrornas mirnas are important regulator of gene expression through their ability to destabilize mrna and inhibit translation of target mrna an everincreasing number of study have identified mirnas a potential biomarkers for cancer diagnosis and prognosis and also a therapeutic target adding an extra dimension to cancer evaluation and treatment in the context of thyroid cancer tumorigenesis result not only from mutation in important gene but also from the overexpression of many mirnas accordingly the role of mirnas in the control of thyroid gene expression is evolving a an important mechanism in cancer herein we present a protocol to examine the effect of mirnainhibitor delivery a a therapeutic modality in thyroid cancer using human tumor xenograft and orthotopic mouse model after engineering stable thyroid tumoral cell expressing gfp and luciferase cell are injected into nude mouse to develop tumor which can be followed by bioluminescence the in vivo inhibition of a mirna can reduce tumor growth and upregulate mirna gene target this method can be used to assess the importance of a determined mirna in vivo in addition to identifying new therapeutic target
31505033,histopathological evaluation of minor salivary gland papillarycystic tumour focus on genetic alteration in sialadenoma papilliferum and intraductal papillary mucinous neoplasm,aim minor salivary gland tumour showing a predominant papillarycystic structure are rare and constitute a mixture of various type of neoplasm thus the histopathological assessment of these tumour pose a significant diagnostic challenge we aimed to delineate the histological characteristic of these tumour and further mutational aspect with a particular focus on sialadenoma papilliferum sp and intraductal papillary mucinous neoplasm ipmn method and result we retrieved papillarycystic tumour of the minor salivary gland and performed histological reevaluation and mutation analysis of several key oncogene the histological classification were a follows sp n splike intraductal papillary tumour spipt n ipmn n intraductal papilloma cystadenoma and cystadenocarcinoma two three and two respectively whereas sp typically consisted of a combination of exophytic squamous epithelium and endophytic intraductal papillary infolding spipt lacked the exophytic component sp and spipt frequently harboured braf ve mutation which were identified in both squamous and ductal component ipmn wa characterised by a welldemarcated cystic lesion filled exclusively with a papillary proliferation of mucinous cell and a high rate of akt ek mutation intraductal papilloma were unilocular cystic lesion with intraluminal papillary growth of bland columnar cell in contrast both cystadenomas and cystadenocarcinomas showed a multicystic appearance with a papillary configuration cystadenocarcinomas invaded the surrounding tissue and were composed of markedly atypical tumour cell conclusion the appropriate interpretation of histological finding and specific genetic alteration eg braf ve and akt ek in sp and ipmn would be useful for the correct diagnosis of minor salivary gland papillarycystic tumour,Cancer,0,histopathological evaluation of minor salivary gland papillarycystic tumour focus on genetic alteration in sialadenoma papilliferum and intraductal papillary mucinous neoplasm aim minor salivary gland tumour showing a predominant papillarycystic structure are rare and constitute a mixture of various type of neoplasm thus the histopathological assessment of these tumour pose a significant diagnostic challenge we aimed to delineate the histological characteristic of these tumour and further mutational aspect with a particular focus on sialadenoma papilliferum sp and intraductal papillary mucinous neoplasm ipmn method and result we retrieved papillarycystic tumour of the minor salivary gland and performed histological reevaluation and mutation analysis of several key oncogene the histological classification were a follows sp n splike intraductal papillary tumour spipt n ipmn n intraductal papilloma cystadenoma and cystadenocarcinoma two three and two respectively whereas sp typically consisted of a combination of exophytic squamous epithelium and endophytic intraductal papillary infolding spipt lacked the exophytic component sp and spipt frequently harboured braf ve mutation which were identified in both squamous and ductal component ipmn wa characterised by a welldemarcated cystic lesion filled exclusively with a papillary proliferation of mucinous cell and a high rate of akt ek mutation intraductal papilloma were unilocular cystic lesion with intraluminal papillary growth of bland columnar cell in contrast both cystadenomas and cystadenocarcinomas showed a multicystic appearance with a papillary configuration cystadenocarcinomas invaded the surrounding tissue and were composed of markedly atypical tumour cell conclusion the appropriate interpretation of histological finding and specific genetic alteration eg braf ve and akt ek in sp and ipmn would be useful for the correct diagnosis of minor salivary gland papillarycystic tumour
31507098,efficacy of egfrtkis with or without upfront brain radiotherapy for egfrmutant nsclc patient with central nervous system metastasis,background although the clinical efficacy of epidermal growth factor receptor tyrosine kinase inhibitor egfrtkis in egfrmutant nonsmall cell lung cancer nsclc patient ha been demonstrated their efficacy in egfrmutant nsclcs with central nervous system cns metastasis and the role of radiotherapy remain unclear this study aimed to determine if it is preferable to add upfront cranial radiotherapy to egfrtkis in patient with egfrmutant nsclc with newly diagnosed brain metastasis method we retrospectively analyzed the data of egfrmutant nsclc patient with cns metastasis who received egfrtkis a a firstline therapy result a total of patient were enrolled and patient received upfront brain radiotherapy while patient received first and second generation egfrtkis first the median time to treatment failure ttf wa month confidence interval ci the median survival time mst wa month ci the overall response rate of the cns wa the median cns progressionfree survival pfs wa month ci brain radiotherapy prior to egfrtki prolonged ttf v month p and tended to prolong cnspfs v month p but wa not significantly associated with overall survival mst v month p univariate and multivariate analysis indicated that poor performance status and the presence of extracranial metastasis were poor prognostic factor related to overall survival conclusion egfrtki showed a favorable effect for egfrmutant nsclc patient with cns metastasis prolonged ttf and cnspfs were observed with upfront brain radiotherapy,Cancer,0,efficacy of egfrtkis with or without upfront brain radiotherapy for egfrmutant nsclc patient with central nervous system metastasis background although the clinical efficacy of epidermal growth factor receptor tyrosine kinase inhibitor egfrtkis in egfrmutant nonsmall cell lung cancer nsclc patient ha been demonstrated their efficacy in egfrmutant nsclcs with central nervous system cns metastasis and the role of radiotherapy remain unclear this study aimed to determine if it is preferable to add upfront cranial radiotherapy to egfrtkis in patient with egfrmutant nsclc with newly diagnosed brain metastasis method we retrospectively analyzed the data of egfrmutant nsclc patient with cns metastasis who received egfrtkis a a firstline therapy result a total of patient were enrolled and patient received upfront brain radiotherapy while patient received first and second generation egfrtkis first the median time to treatment failure ttf wa month confidence interval ci the median survival time mst wa month ci the overall response rate of the cns wa the median cns progressionfree survival pfs wa month ci brain radiotherapy prior to egfrtki prolonged ttf v month p and tended to prolong cnspfs v month p but wa not significantly associated with overall survival mst v month p univariate and multivariate analysis indicated that poor performance status and the presence of extracranial metastasis were poor prognostic factor related to overall survival conclusion egfrtki showed a favorable effect for egfrmutant nsclc patient with cns metastasis prolonged ttf and cnspfs were observed with upfront brain radiotherapy
31511296,mutated ra targeting the untargetable with t cell,the ra family of protein is at the apex of several pathway implicated in a multitude of epithelial cancer but ha remained stubbornly resistant to the wave of targeted small molecule and antibody that have revolutionized clinical oncology kras the most commonly mutated of the isoforms represents an attractive target for treatment given it ubiquity central role a a driver mutation and association with poor prognosis this review is a comprehensive summary of the existing approach to targeting kras spanning smallmolecule inhibitor cancer vaccine and with a focus on trial in adoptive cell therapy here we explain how the limitation of existing drug and nonspecific immunebased therapy are circumvented with technique in modern immunotherapy the success outlined represent the most promising path to finally targeting the prototypical undruggable ra oncogene family,Cancer,0,mutated ra targeting the untargetable with t cell the ra family of protein is at the apex of several pathway implicated in a multitude of epithelial cancer but ha remained stubbornly resistant to the wave of targeted small molecule and antibody that have revolutionized clinical oncology kras the most commonly mutated of the isoforms represents an attractive target for treatment given it ubiquity central role a a driver mutation and association with poor prognosis this review is a comprehensive summary of the existing approach to targeting kras spanning smallmolecule inhibitor cancer vaccine and with a focus on trial in adoptive cell therapy here we explain how the limitation of existing drug and nonspecific immunebased therapy are circumvented with technique in modern immunotherapy the success outlined represent the most promising path to finally targeting the prototypical undruggable ra oncogene family
31512231,exosome dna critical regulator of tumor immunity and a diagnostic biomarker,nanosized cellular vesicle exosome contains a variety of biological cargo including dna fragment from celloforigin despite it biological stability and clinical utility in tumor diagnosis exosome dna exodna is very little studied a compare with exosome rna cytoplasmic accumulation of damaged dna from nucleus and mitochondrion often lead to it packaging in exosomes by yet unknown pathway exodna modulates tumor immunity via paracrine interaction and activation of cytosolic dna sensor pathway for example sting cgas and so forth in specific immune cell subset in addition to priming tumor immunity exodna is also emerging a a critical regulator of checkpoint immunotherapy a a useful diagnostic biomaterial exodna contains a variety of clinically relevant tumorspecific mutation representing multiple gene eg egfr braf ra idh and her thus making it a promising liquid biopsy material for therapy recommendation hence exodna in addition to tumor immunity modulation is also emerging a a suitable diagnostic material for personalized therapy in cancer here we review the current status of exodna research and it potential us in tumor biology,Cancer,0,exosome dna critical regulator of tumor immunity and a diagnostic biomarker nanosized cellular vesicle exosome contains a variety of biological cargo including dna fragment from celloforigin despite it biological stability and clinical utility in tumor diagnosis exosome dna exodna is very little studied a compare with exosome rna cytoplasmic accumulation of damaged dna from nucleus and mitochondrion often lead to it packaging in exosomes by yet unknown pathway exodna modulates tumor immunity via paracrine interaction and activation of cytosolic dna sensor pathway for example sting cgas and so forth in specific immune cell subset in addition to priming tumor immunity exodna is also emerging a a critical regulator of checkpoint immunotherapy a a useful diagnostic biomaterial exodna contains a variety of clinically relevant tumorspecific mutation representing multiple gene eg egfr braf ra idh and her thus making it a promising liquid biopsy material for therapy recommendation hence exodna in addition to tumor immunity modulation is also emerging a a suitable diagnostic material for personalized therapy in cancer here we review the current status of exodna research and it potential us in tumor biology
31515871,cryptic recurrent acinnutm fusion in nonkmtarearranged infant acute lymphoblastic leukemia,infant acute lymphoblastic leukemia all are rare hematological malignancy occurring in child younger than year of age most frequently associated with kmta rearrangement kmtar the smaller subset without kmtar which represents of infant all case is poorly characterized here we report two case of chemotherapysensitive nonkmtar infant all transcriptome analysis revealed identical acinnutm gene fusion in both case derived from cryptic chromosomal rearrangement undetected by standard cytogenetic approach two isoforms of the gene fusion joining exon or of acin to exon of nutm were identified both fusion transcript contained the functional dnabinding sap safab acinus and pia domain of acin and most of nutm the detection of the acinnutm fusion by rtpcr allowed the molecular monitoring of minimal residual disease in a clinical setting based on publicly available genomic datasets and literature review we predict that nutm gene fusion are recurrent event in infant all a such we propose two clinically relevant assay to screen for nutm rearrangement in bone marrow cell independent of the fusion partner numt immunohistochemistry and nutm rna expression in sum our study identifies acinnutm a a recurrent and possibly cryptic fusion in nonkmtar infant all provides clinical tool to screen for nutmrearranged leukemia and contributes to the refinement of this new subgroup,Cancer,0,cryptic recurrent acinnutm fusion in nonkmtarearranged infant acute lymphoblastic leukemia infant acute lymphoblastic leukemia all are rare hematological malignancy occurring in child younger than year of age most frequently associated with kmta rearrangement kmtar the smaller subset without kmtar which represents of infant all case is poorly characterized here we report two case of chemotherapysensitive nonkmtar infant all transcriptome analysis revealed identical acinnutm gene fusion in both case derived from cryptic chromosomal rearrangement undetected by standard cytogenetic approach two isoforms of the gene fusion joining exon or of acin to exon of nutm were identified both fusion transcript contained the functional dnabinding sap safab acinus and pia domain of acin and most of nutm the detection of the acinnutm fusion by rtpcr allowed the molecular monitoring of minimal residual disease in a clinical setting based on publicly available genomic datasets and literature review we predict that nutm gene fusion are recurrent event in infant all a such we propose two clinically relevant assay to screen for nutm rearrangement in bone marrow cell independent of the fusion partner numt immunohistochemistry and nutm rna expression in sum our study identifies acinnutm a a recurrent and possibly cryptic fusion in nonkmtar infant all provides clinical tool to screen for nutmrearranged leukemia and contributes to the refinement of this new subgroup
31516752,loss of psp expression is associated with early psa recurrence and deteriorates outcome of pten deleted prostate cancer,objective prostate secretory protein of amino acid psp is a target gene of the ezh transcriptional repressor and is often downregulated in prostate cancer however it prognostic value is disputed method immunohistochemical analysis of a tissue microarray of prostate cancer specimen wa performed to evaluate psp expression correlation of psp expression with tumor phenotype patient prognosis tmprsserg fusion status ezh expression and pten deletion wa studied result psp expression wa increased in benign prostatic hyperplasia however it wa downregulated in and negative in of the interpretable prostate cancer specimen the loss of psp expression wa inversely correlated to ezh expression p p loss of psp wa linked to early prostatespecific antigen recurrence but with little absolute effect p however it provided additional prognostic impact in cancer specimen with pten deletion loss of psp deteriorated prognosis of cancer patient with pten deletion by more than p the combination of pten deletion and psp loss provided independent prognostic information that wa observed in several subgroup defined by classical and quantitative gleason grade conclusion the result of our study suggest that combined psppten analysis can be potentially used in the clinical prognosis of prostate cancer,Cancer,0,loss of psp expression is associated with early psa recurrence and deteriorates outcome of pten deleted prostate cancer objective prostate secretory protein of amino acid psp is a target gene of the ezh transcriptional repressor and is often downregulated in prostate cancer however it prognostic value is disputed method immunohistochemical analysis of a tissue microarray of prostate cancer specimen wa performed to evaluate psp expression correlation of psp expression with tumor phenotype patient prognosis tmprsserg fusion status ezh expression and pten deletion wa studied result psp expression wa increased in benign prostatic hyperplasia however it wa downregulated in and negative in of the interpretable prostate cancer specimen the loss of psp expression wa inversely correlated to ezh expression p p loss of psp wa linked to early prostatespecific antigen recurrence but with little absolute effect p however it provided additional prognostic impact in cancer specimen with pten deletion loss of psp deteriorated prognosis of cancer patient with pten deletion by more than p the combination of pten deletion and psp loss provided independent prognostic information that wa observed in several subgroup defined by classical and quantitative gleason grade conclusion the result of our study suggest that combined psppten analysis can be potentially used in the clinical prognosis of prostate cancer
31521947,rectal cancer subclones respond differentially to neoadjuvant therapy,treatment of locally advanced rectal cancer includes chemotherapy radiation and surgery but patient response to neoadjuvant treatment are variable we have shown that rectal tumor are comprised of multiple genetically distinct subclones unique subclones within tumor may harbor mutation which contribute to interpatient variation in response to neoadjuvant chemoradiotherapy ncrt analysis of the influence of ncrt on the extent and nature of intratumoral genetic heterogeneity in rectal cancer may provide insight into mechanism of resistance locally advanced rectal cancer patient underwent pretreatment biopsy at the time of surgery tissue from the treated tumor wa obtained and analyzed pre and posttreatment specimen were subjected to whole exome and confirmatory deep sequencing for somatic mutation copy number variation wa assessed using oncoscan snp array genomic data were analyzed using pyclone to identify subclonal tumor population following ncrt alteration that persisted or were enriched in the posttreatment tumor specimen following ncrt were defined for each patient thirtytwo sample were obtained from ten patient pyclone identified to genetic subclones per tumor substantial change in the proportion of individual subclones in pre versus posttreatment tumor material were found in all patient resistant subclones recurrently contained mutation in tp apc abca muc and thsd recurrent copy number variation wa observed across multiple chromosome region after ncrt pathway analysis including variant allele and copy number change associated with resistant subclones revealed significantly altered pathway especially those linked to the apc and tp gene which were the two most frequently mutated gene intratumoral heterogeneity is evident in pretreatment rectal cancer following treatment subclonal population are selectively modified and enrichment of a subset of pretreatment subclones is seen further study are needed to define recurrent alteration at diagnosis that may contribute to resistance to ncrt,Cancer,0,rectal cancer subclones respond differentially to neoadjuvant therapy treatment of locally advanced rectal cancer includes chemotherapy radiation and surgery but patient response to neoadjuvant treatment are variable we have shown that rectal tumor are comprised of multiple genetically distinct subclones unique subclones within tumor may harbor mutation which contribute to interpatient variation in response to neoadjuvant chemoradiotherapy ncrt analysis of the influence of ncrt on the extent and nature of intratumoral genetic heterogeneity in rectal cancer may provide insight into mechanism of resistance locally advanced rectal cancer patient underwent pretreatment biopsy at the time of surgery tissue from the treated tumor wa obtained and analyzed pre and posttreatment specimen were subjected to whole exome and confirmatory deep sequencing for somatic mutation copy number variation wa assessed using oncoscan snp array genomic data were analyzed using pyclone to identify subclonal tumor population following ncrt alteration that persisted or were enriched in the posttreatment tumor specimen following ncrt were defined for each patient thirtytwo sample were obtained from ten patient pyclone identified to genetic subclones per tumor substantial change in the proportion of individual subclones in pre versus posttreatment tumor material were found in all patient resistant subclones recurrently contained mutation in tp apc abca muc and thsd recurrent copy number variation wa observed across multiple chromosome region after ncrt pathway analysis including variant allele and copy number change associated with resistant subclones revealed significantly altered pathway especially those linked to the apc and tp gene which were the two most frequently mutated gene intratumoral heterogeneity is evident in pretreatment rectal cancer following treatment subclonal population are selectively modified and enrichment of a subset of pretreatment subclones is seen further study are needed to define recurrent alteration at diagnosis that may contribute to resistance to ncrt
31527860,declining detection rate for apc and biallelic mutyh variant in polyposis patient implication for dna testing policy,this study aimed to determine the prevalence of apcassociated familial adenomatous polyposis fap and mutyhassociated polyposis map in a large cohort taking into account factor a adenoma count and year of diagnosis all application form used to send patient in for apc and mutyh variant analysis between and were collected n using the data provided on the application form the apc and biallelic mutyh prevalence wa determined and possible predictive factor were examined using multivariate multinomial logistic regression analysis in spss the prevalence of disease causing variant in the apc gene significantly increase with adenoma count while map show a peak prevalence in individual with adenoma logistic regression analysis show significant odds ratio for adenoma count age at diagnosis and interestingly a decline in the chance of finding a variant in either gene over time moreover in of patient with faprelated extracolonic manifestation a variant wa identified the overall detection rate are above for patient with adenoma aged adenoma aged t variant in the tumor or a firstdegree relative with adenoma therefore apc and mutyh testing in patient with adenoma aged adenoma aged is advised almost all fap and map patient not meeting these criterion showed other characteristic that can be used a an indication to prompt genetic testing,Cancer,0,declining detection rate for apc and biallelic mutyh variant in polyposis patient implication for dna testing policy this study aimed to determine the prevalence of apcassociated familial adenomatous polyposis fap and mutyhassociated polyposis map in a large cohort taking into account factor a adenoma count and year of diagnosis all application form used to send patient in for apc and mutyh variant analysis between and were collected n using the data provided on the application form the apc and biallelic mutyh prevalence wa determined and possible predictive factor were examined using multivariate multinomial logistic regression analysis in spss the prevalence of disease causing variant in the apc gene significantly increase with adenoma count while map show a peak prevalence in individual with adenoma logistic regression analysis show significant odds ratio for adenoma count age at diagnosis and interestingly a decline in the chance of finding a variant in either gene over time moreover in of patient with faprelated extracolonic manifestation a variant wa identified the overall detection rate are above for patient with adenoma aged adenoma aged t variant in the tumor or a firstdegree relative with adenoma therefore apc and mutyh testing in patient with adenoma aged adenoma aged is advised almost all fap and map patient not meeting these criterion showed other characteristic that can be used a an indication to prompt genetic testing
31530409,hepatic epithelioid angiomyolipomapecoma and focal nodular hyperplasia in a patient with a previous history of cutaneous melanoma,hepatic perivascular epithelioid cell tumor pecomas are uncommon mesenchymal neoplasm pecomas concurrent with other hepatic lesion is a very rare occurrence with only two previously reported case we report a primary hepatic pecoma associated with focal nodular hyperplasia in a patient with a previous history of cutaneous melanoma diagnostic imaging study suggested a hepatic adenoma and the patient underwent a segmentectomy the tumor wa mainly composed of epithelioid cell adipose tissue and smooth muscle fiber intermixed with blood vessel the neoplastic cell were diffusely immunoreactive for hmb melana and smooth muscle actin but not for hepatocyte s mitf or braf molecular study were negative for brafv mutation the final diagnosis wa hepatic epithelioid angiomyolipomapecoma the differential diagnosis of hepatic pecoma is discussed,Cancer,0,hepatic epithelioid angiomyolipomapecoma and focal nodular hyperplasia in a patient with a previous history of cutaneous melanoma hepatic perivascular epithelioid cell tumor pecomas are uncommon mesenchymal neoplasm pecomas concurrent with other hepatic lesion is a very rare occurrence with only two previously reported case we report a primary hepatic pecoma associated with focal nodular hyperplasia in a patient with a previous history of cutaneous melanoma diagnostic imaging study suggested a hepatic adenoma and the patient underwent a segmentectomy the tumor wa mainly composed of epithelioid cell adipose tissue and smooth muscle fiber intermixed with blood vessel the neoplastic cell were diffusely immunoreactive for hmb melana and smooth muscle actin but not for hepatocyte s mitf or braf molecular study were negative for brafv mutation the final diagnosis wa hepatic epithelioid angiomyolipomapecoma the differential diagnosis of hepatic pecoma is discussed
31533138,predictive marker of immunotherapy of colorectal cancer,colorectal carcinoma are heterogeneous in their morphologic immunologic and molecular aspect the smooth and sharply demarcated medullary carcinoma present with an expansive border and high tumor stroma ratio the high load of cancer neoantigens a a consequence of microsatellite instability result in numerous reactive regional lymph node in contrast the low grade ms type carcinoma are spiculated desmoplastic and hard frequently with smaller and sometimes also desmoplastic lymph node metastasis this macroscopic and histological heterogeneity is mirrored on the immunohistochemical and molecular level and is decisive from prognostic and predictive point of view a immunotherapy opened a new front in the therapy of colorectal cancer the pathology report ha to quantify and qualify the characteristic of the tumor microenvironment the peritumoral and intratumoral lymphoid infiltration and tumor stroma ratio in order to improve patient selection,Cancer,0,predictive marker of immunotherapy of colorectal cancer colorectal carcinoma are heterogeneous in their morphologic immunologic and molecular aspect the smooth and sharply demarcated medullary carcinoma present with an expansive border and high tumor stroma ratio the high load of cancer neoantigens a a consequence of microsatellite instability result in numerous reactive regional lymph node in contrast the low grade ms type carcinoma are spiculated desmoplastic and hard frequently with smaller and sometimes also desmoplastic lymph node metastasis this macroscopic and histological heterogeneity is mirrored on the immunohistochemical and molecular level and is decisive from prognostic and predictive point of view a immunotherapy opened a new front in the therapy of colorectal cancer the pathology report ha to quantify and qualify the characteristic of the tumor microenvironment the peritumoral and intratumoral lymphoid infiltration and tumor stroma ratio in order to improve patient selection
31534167,nonhematopoietic stat induces epithelial tight junction dysfunction and promotes intestinal inflammation and tumorigenesis,enhanced gut permeability due to dysregulated epithelial tight junction is often associated with inflammatory bowel disease ibd which have a greater risk for developing colorectal cancer stat activation wa detected in inflamed colonic epithelium of active ibd patient suggesting a role of epithelial stat in colitis development here we demonstrated that nonhematopoietic stat but not hematopoietic stat triggered dssinduced colitis and subsequent tumorigenesis this could be due to the enhancingeffect of stat on gut permeability and microbiota translocation via interruption of epithelial tight junction integrity mechanistically longmyosin lightchain kinase mlck wa identified a a target of stat leading to epithelial tight junction dysfunction and microbiotadriven colitis furthermore neutralization of il which wa primarily derived from type innate lymphoid cell ilc in a microbiotadependent way inhibited epithelial stat activation and improved gut permeability and dssinduced colitis importantly pharmacological inhibition of stat reduces murine intestinal tumor formation and tumoral pstat level positively correlated to the clinical stage and poor prognosis of human colorectal cancer thus our study reveals a direct role of stat in the disruption of epithelial tight junction integrity and colitis development and suggests stat a a potential therapeutic and prophylactic target for ibd and colitisassociated cancer,Cancer,0,nonhematopoietic stat induces epithelial tight junction dysfunction and promotes intestinal inflammation and tumorigenesis enhanced gut permeability due to dysregulated epithelial tight junction is often associated with inflammatory bowel disease ibd which have a greater risk for developing colorectal cancer stat activation wa detected in inflamed colonic epithelium of active ibd patient suggesting a role of epithelial stat in colitis development here we demonstrated that nonhematopoietic stat but not hematopoietic stat triggered dssinduced colitis and subsequent tumorigenesis this could be due to the enhancingeffect of stat on gut permeability and microbiota translocation via interruption of epithelial tight junction integrity mechanistically longmyosin lightchain kinase mlck wa identified a a target of stat leading to epithelial tight junction dysfunction and microbiotadriven colitis furthermore neutralization of il which wa primarily derived from type innate lymphoid cell ilc in a microbiotadependent way inhibited epithelial stat activation and improved gut permeability and dssinduced colitis importantly pharmacological inhibition of stat reduces murine intestinal tumor formation and tumoral pstat level positively correlated to the clinical stage and poor prognosis of human colorectal cancer thus our study reveals a direct role of stat in the disruption of epithelial tight junction integrity and colitis development and suggests stat a a potential therapeutic and prophylactic target for ibd and colitisassociated cancer
31538107,malignant struma ovarii presenting with follicular carcinoma a case report with molecular analysis,malignant struma ovarii presenting with follicular carcinoma is extremely rare and it mechanism of tumorigenesis remains unknown here we present a case of malignant struma ovarii with peritoneal dissemination of follicular carcinoma for which a molecular analysis for major oncogenic gene alteration in follicular thyroid carcinoma wa performed a yearold nulliparous woman wa referred with a diagnosis of highly differentiated follicular carcinoma of ovarian origin primary thyroid cancer wa not diagnosed and she had a normal thyroid function i scintigraphy revealed multiple peritoneal dissemination that wa surgically resected histologically the tumor consisted of numerous follicle without nuclear feature of papillary thyroid carcinoma tumor sample were investigated for cancerrelated gene including ra braf and p and ppargpax gene fusion by targeted dna sequencing and fluorescence in situ hybridization respectively no major oncogenic gene alteration were detected these negative finding suggest a different mechanism of tumorigenesis from that of adulttype follicular thyroid carcinoma,Cancer,0,malignant struma ovarii presenting with follicular carcinoma a case report with molecular analysis malignant struma ovarii presenting with follicular carcinoma is extremely rare and it mechanism of tumorigenesis remains unknown here we present a case of malignant struma ovarii with peritoneal dissemination of follicular carcinoma for which a molecular analysis for major oncogenic gene alteration in follicular thyroid carcinoma wa performed a yearold nulliparous woman wa referred with a diagnosis of highly differentiated follicular carcinoma of ovarian origin primary thyroid cancer wa not diagnosed and she had a normal thyroid function i scintigraphy revealed multiple peritoneal dissemination that wa surgically resected histologically the tumor consisted of numerous follicle without nuclear feature of papillary thyroid carcinoma tumor sample were investigated for cancerrelated gene including ra braf and p and ppargpax gene fusion by targeted dna sequencing and fluorescence in situ hybridization respectively no major oncogenic gene alteration were detected these negative finding suggest a different mechanism of tumorigenesis from that of adulttype follicular thyroid carcinoma
31539535,estrogen signaling and estrogen receptor a prognostic indicator in laryngeal cancer,laryngeal squamous cell carcinoma lscc ha been shown to respond to betaestradiol however the presence and characterization of estrogen receptor er and other sex hormone receptor in lscc are still being determined sex hormone receptor and the way sex hormone impact lscc tumor are important for understanding which patient would benefit from hormone therapy such a antiestrogen therapy this information also ha prognostic value a there may be a correlation between er profile and lscc aggression recent work by our team and others ha shown that the canonical er estrogen receptor alpha eralpha and it splice variant eralpha are important modulators of estrogen signaling in lscc this review describes some common betaestradiol signaling pathway and explains how these signaling pathway might control lscc tumor growth we also show that loss of eralpha but not eralpha imbues lscc with enhanced aggression a pattern which ha previously only been observed in breast cancer we make a case for using eralpha a a tumorigenic modulator and pathogenic marker in lscc on par with the use of eralpha a a prognostic marker in breast cancer,Cancer,0,estrogen signaling and estrogen receptor a prognostic indicator in laryngeal cancer laryngeal squamous cell carcinoma lscc ha been shown to respond to betaestradiol however the presence and characterization of estrogen receptor er and other sex hormone receptor in lscc are still being determined sex hormone receptor and the way sex hormone impact lscc tumor are important for understanding which patient would benefit from hormone therapy such a antiestrogen therapy this information also ha prognostic value a there may be a correlation between er profile and lscc aggression recent work by our team and others ha shown that the canonical er estrogen receptor alpha eralpha and it splice variant eralpha are important modulators of estrogen signaling in lscc this review describes some common betaestradiol signaling pathway and explains how these signaling pathway might control lscc tumor growth we also show that loss of eralpha but not eralpha imbues lscc with enhanced aggression a pattern which ha previously only been observed in breast cancer we make a case for using eralpha a a tumorigenic modulator and pathogenic marker in lscc on par with the use of eralpha a a prognostic marker in breast cancer
31540291,nextgeneration sequencing improves diagnosis prognosis and clinical management of myeloid neoplasm,molecular diagnosis of myeloid neoplasm mn is based on the detection of multiple genetic alteration using various technique nextgeneration sequencing ng ha been proved a a useful method for analyzing many gene simultaneously in this context we analyzed diagnostic sample from patient affected by mn and ten relapse sample from a subset of acute myeloid leukemia patient using two enrichmentcapture ng gene panel pathogenicity classification of variant wa enhanced by the development and application of a custom oncohematology score a total of pathogenic variant were detected in of patient for structural alteration of those identified by cytogenetics were detected by ng of copy number variant and three out of three translocation the detection of variant using ng changed the diagnosis of seven patient and the prognosis of patient and enabled u to identify suitable candidate for clinical trial regarding aml six of the ten relapsed patient lost or gained variant comparing with diagnostic sample in conclusion the use of ng panel in mn improves genetic characterization of the disease compared with conventional method thus demonstrating it potential clinical utility in routine clinical testing this approach lead to betteradjusted treatment for each patient,Cancer,0,nextgeneration sequencing improves diagnosis prognosis and clinical management of myeloid neoplasm molecular diagnosis of myeloid neoplasm mn is based on the detection of multiple genetic alteration using various technique nextgeneration sequencing ng ha been proved a a useful method for analyzing many gene simultaneously in this context we analyzed diagnostic sample from patient affected by mn and ten relapse sample from a subset of acute myeloid leukemia patient using two enrichmentcapture ng gene panel pathogenicity classification of variant wa enhanced by the development and application of a custom oncohematology score a total of pathogenic variant were detected in of patient for structural alteration of those identified by cytogenetics were detected by ng of copy number variant and three out of three translocation the detection of variant using ng changed the diagnosis of seven patient and the prognosis of patient and enabled u to identify suitable candidate for clinical trial regarding aml six of the ten relapsed patient lost or gained variant comparing with diagnostic sample in conclusion the use of ng panel in mn improves genetic characterization of the disease compared with conventional method thus demonstrating it potential clinical utility in routine clinical testing this approach lead to betteradjusted treatment for each patient
31546041,euracaniaslc proposal for updating the histologic classification of pleural mesothelioma towards a more multidisciplinary approach,introduction molecular and immunologic breakthrough are transforming the management of thoracic cancer although advance have not been a marked for malignant pleural mesothelioma where pathologic diagnosis ha been essentially limited to three histologic subtypes method a multidisciplinary group pathologist molecular biologist surgeon radiologist and oncologist sponsored by european network for rare adult solid cancersinternational association for the study of lung cancer met in to critically review the current classification result recommendation include classification should be updated to include architectural pattern and stromal and cytologic feature that refine prognostication subject to data accrual malignant mesothelioma in situ could be an additional category grading of epithelioid malignant pleural mesothelioma should be routinely undertaken favorableunfavorable histologic characteristic should be routinely reported clinically relevant molecular data programmed death ligand brca associated protein bap and cyclin dependent kinase inhibitor a should be incorporated into report if undertaken other molecular data should be accrued a part of future trial resection specimen ie extended pleurectomydecortication and extrapleural pneumonectomy should be pathologically staged with smaller specimen being clinically staged ideally at least three separate area should be sampled from the pleural cavity including area of interest identified on presurgical imaging imageacquisition protocolsimaging terminology should be standardized to aid researchrefine clinical staging multidisciplinary tumor board should include pathologist to ensure appropriate treatment option are considered all histologic subtypes should be considered potential candidate for chemotherapy patient with sarcomatoid or biphasic mesothelioma should not be excluded from firstline clinical trial unless there is a compelling reason tumor subtyping should be further assessed in relation to duration of response to immunotherapy and systematic screening of all patient for germline mutation is not recommended in the absence of a family history suspicious for bap syndrome conclusion these multidisciplinary recommendation for pathology classification and application will allow more informative pathologic reporting and potential risk stratification to support clinical practice research investigation and clinical trial,Cancer,0,euracaniaslc proposal for updating the histologic classification of pleural mesothelioma towards a more multidisciplinary approach introduction molecular and immunologic breakthrough are transforming the management of thoracic cancer although advance have not been a marked for malignant pleural mesothelioma where pathologic diagnosis ha been essentially limited to three histologic subtypes method a multidisciplinary group pathologist molecular biologist surgeon radiologist and oncologist sponsored by european network for rare adult solid cancersinternational association for the study of lung cancer met in to critically review the current classification result recommendation include classification should be updated to include architectural pattern and stromal and cytologic feature that refine prognostication subject to data accrual malignant mesothelioma in situ could be an additional category grading of epithelioid malignant pleural mesothelioma should be routinely undertaken favorableunfavorable histologic characteristic should be routinely reported clinically relevant molecular data programmed death ligand brca associated protein bap and cyclin dependent kinase inhibitor a should be incorporated into report if undertaken other molecular data should be accrued a part of future trial resection specimen ie extended pleurectomydecortication and extrapleural pneumonectomy should be pathologically staged with smaller specimen being clinically staged ideally at least three separate area should be sampled from the pleural cavity including area of interest identified on presurgical imaging imageacquisition protocolsimaging terminology should be standardized to aid researchrefine clinical staging multidisciplinary tumor board should include pathologist to ensure appropriate treatment option are considered all histologic subtypes should be considered potential candidate for chemotherapy patient with sarcomatoid or biphasic mesothelioma should not be excluded from firstline clinical trial unless there is a compelling reason tumor subtyping should be further assessed in relation to duration of response to immunotherapy and systematic screening of all patient for germline mutation is not recommended in the absence of a family history suspicious for bap syndrome conclusion these multidisciplinary recommendation for pathology classification and application will allow more informative pathologic reporting and potential risk stratification to support clinical practice research investigation and clinical trial
31547595,cytogenetics and cytogenomics evaluation in cancer,the availability of cytogenetics and cytogenomics technology improved the detection and identification of tumor molecular signature a well a the understanding of cancer initiation and progression the use of largescale and highthroughput cytogenomics technology ha led to a fast identification of several cancer candidate biomarkers associated with diagnosis prognosis and therapeutic the advent of array comparative genomic hybridization and nextgeneration sequencing technology ha significantly improved the knowledge about cancer biology underlining driver gene to guide targeted therapy development drugresistance prediction and pharmacogenetics however few of these candidate biomarkers have made the transition to the clinic with a clear benefit for the patient technological progress helped to demonstrate that cellular heterogeneity play a significant role in tumor progression and resistancesensitivity to cancer therapy representing the major challenge of precision cancer therapy a paradigm shift ha been introduced in cancer genomics with the recent advent of singlecell sequencing since it present a lot of application with a clear benefit to oncological patient namely detection of intratumoral heterogeneity mapping clonal evolution monitoring the development of therapy resistance and detection of rare tumor cell population it seems now evident that no single biomarker could provide the whole information necessary to early detect and predict the behavior and prognosis of tumor the promise of precision medicine is based on the molecular profiling of tumor being vital the continuous progress of highthroughput technology and the multidisciplinary effort to catalogue chromosomal rearrangement and genomic alteration of human cancer and to do a good interpretation of the relation genotypephenotype,Cancer,0,cytogenetics and cytogenomics evaluation in cancer the availability of cytogenetics and cytogenomics technology improved the detection and identification of tumor molecular signature a well a the understanding of cancer initiation and progression the use of largescale and highthroughput cytogenomics technology ha led to a fast identification of several cancer candidate biomarkers associated with diagnosis prognosis and therapeutic the advent of array comparative genomic hybridization and nextgeneration sequencing technology ha significantly improved the knowledge about cancer biology underlining driver gene to guide targeted therapy development drugresistance prediction and pharmacogenetics however few of these candidate biomarkers have made the transition to the clinic with a clear benefit for the patient technological progress helped to demonstrate that cellular heterogeneity play a significant role in tumor progression and resistancesensitivity to cancer therapy representing the major challenge of precision cancer therapy a paradigm shift ha been introduced in cancer genomics with the recent advent of singlecell sequencing since it present a lot of application with a clear benefit to oncological patient namely detection of intratumoral heterogeneity mapping clonal evolution monitoring the development of therapy resistance and detection of rare tumor cell population it seems now evident that no single biomarker could provide the whole information necessary to early detect and predict the behavior and prognosis of tumor the promise of precision medicine is based on the molecular profiling of tumor being vital the continuous progress of highthroughput technology and the multidisciplinary effort to catalogue chromosomal rearrangement and genomic alteration of human cancer and to do a good interpretation of the relation genotypephenotype
31555790,sensing of circulating cancer biomarkers with metal nanoparticles,the analysis of circulating cancer biomarkers including cellfree and circulating tumor dna circulating tumor cell microrna and exosomes hold promise in revolutionizing cancer diagnosis and prognosis using body fluid analysis also known a liquid biopsy to enable clinical application of these biomarkers new analytical tool capable of detecting them in very low concentration in complex sample matrix are needed metal nanoparticles have emerged a extraordinary analytical scaffold because of their unique optoelectronic property and ease of functionalization hence multiple analytical technique have been developed based on these nanoparticles and their plasmonic property the aim of this review is to summarize and discus the present development on the use of metal nanoparticles for the analysis of circulating cancer biomarkers we examine how metal nanoparticles can be used a analytical transducer in various sensing principle such a aggregation induced colorimetric assay plasmon resonance energy transfer surface enhanced raman spectroscopy and refractive index sensing and signal amplification element in surface plasmon resonance spectroscopy and electrochemical detection we critically discus the clinical relevance of each category of circulating biomarkers followed by a thorough analysis of how these nanoparticlebased design have overcome some of the main challenge that gold standard analytical technique currently face and what new direction the field may take in the future,Cancer,0,sensing of circulating cancer biomarkers with metal nanoparticles the analysis of circulating cancer biomarkers including cellfree and circulating tumor dna circulating tumor cell microrna and exosomes hold promise in revolutionizing cancer diagnosis and prognosis using body fluid analysis also known a liquid biopsy to enable clinical application of these biomarkers new analytical tool capable of detecting them in very low concentration in complex sample matrix are needed metal nanoparticles have emerged a extraordinary analytical scaffold because of their unique optoelectronic property and ease of functionalization hence multiple analytical technique have been developed based on these nanoparticles and their plasmonic property the aim of this review is to summarize and discus the present development on the use of metal nanoparticles for the analysis of circulating cancer biomarkers we examine how metal nanoparticles can be used a analytical transducer in various sensing principle such a aggregation induced colorimetric assay plasmon resonance energy transfer surface enhanced raman spectroscopy and refractive index sensing and signal amplification element in surface plasmon resonance spectroscopy and electrochemical detection we critically discus the clinical relevance of each category of circulating biomarkers followed by a thorough analysis of how these nanoparticlebased design have overcome some of the main challenge that gold standard analytical technique currently face and what new direction the field may take in the future
31558473,analysis of biomarkers and association with clinical outcome in patient with differentiated thyroid cancer subanalysis of the sorafenib phase iii decision trial,purpose the phase iii decision trial nct eudract established sorafenib efficacy in locally recurrent or metastatic progressive differentiated thyroid cancer dtc refractory to radioactive iodine we conducted a retrospective exploratory biomarker analysis of patient from decision experimental design candidate biomarkers baseline plasma protein baseline and duringtreatment serum thyroglobulin and relevant tumor mutation braf nra hras and kras were analyzed for correlation with clinical outcome result plasma biomarker and thyroglobulin data were available for of and of patient respectively elevated baseline vegfa wa independently associated with poor prognosis for progressionfree survival pfs hr confidence interval ci p overall survival hr ci p and diseasecontrol rate dcr or p elevated baseline thyroglobulin wa independently associated with poor pfs hr ci p from baseline wa achieved by and of patient receiving sorafenib and placebo respectively p thyroglobulin reduction had longer pfs than those without reduction hr ci sorafenib p placebo p braf mutation were associated with better pfs ra mutation were associated with worse pfs although neither wa independently prognostic in multivariate model no examined biomarker predicted sorafenib benefit conclusion we identified biomarkers associated with poor prognosis in dtc including elevated baseline vegfa and thyroglobulin and the presence of ra mutation serum thyroglobulin may be a biomarker of tumor response and progression,Cancer,0,analysis of biomarkers and association with clinical outcome in patient with differentiated thyroid cancer subanalysis of the sorafenib phase iii decision trial purpose the phase iii decision trial nct eudract established sorafenib efficacy in locally recurrent or metastatic progressive differentiated thyroid cancer dtc refractory to radioactive iodine we conducted a retrospective exploratory biomarker analysis of patient from decision experimental design candidate biomarkers baseline plasma protein baseline and duringtreatment serum thyroglobulin and relevant tumor mutation braf nra hras and kras were analyzed for correlation with clinical outcome result plasma biomarker and thyroglobulin data were available for of and of patient respectively elevated baseline vegfa wa independently associated with poor prognosis for progressionfree survival pfs hr confidence interval ci p overall survival hr ci p and diseasecontrol rate dcr or p elevated baseline thyroglobulin wa independently associated with poor pfs hr ci p from baseline wa achieved by and of patient receiving sorafenib and placebo respectively p thyroglobulin reduction had longer pfs than those without reduction hr ci sorafenib p placebo p braf mutation were associated with better pfs ra mutation were associated with worse pfs although neither wa independently prognostic in multivariate model no examined biomarker predicted sorafenib benefit conclusion we identified biomarkers associated with poor prognosis in dtc including elevated baseline vegfa and thyroglobulin and the presence of ra mutation serum thyroglobulin may be a biomarker of tumor response and progression
31561847,identification and management of patient with lynch syndrome,about of colorectal cancer crc case occurred in the context of an underlying hereditary predisposition syndrome lynch syndrome is the main cause of hereditary crc but is also associated with a higher risk of other cancer such a endometrial cancer and ovarian cancer it is the consequence of constitutional mutation in a mismatch repair mmr gene involved in dna repair mlh msh msh or pm or of the epcam gene msh promotor if a mutation predisposing to lynch syndrome is identified in an individual special monitoring should be initiated adapted to estimated cancer risk clinical criterion amsterdam ii and bethesda have been validated to identify the patient who should be referred for genetic counseling in order to initiate constitutional dna testing furthermore the french national cancer institute inca systematically recommend tumoral testing looking for mmr system failure in case of crc diagnosed under endometrial cancer diagnosed under or whatever the age in patient diagnosed with crc or endometrial cancer harbouring personal or familal history of lunch syndrome cancer in this review we will discus how to detect lynch syndrome identification of the index case and family screening and how to monitor it in,Cancer,0,identification and management of patient with lynch syndrome about of colorectal cancer crc case occurred in the context of an underlying hereditary predisposition syndrome lynch syndrome is the main cause of hereditary crc but is also associated with a higher risk of other cancer such a endometrial cancer and ovarian cancer it is the consequence of constitutional mutation in a mismatch repair mmr gene involved in dna repair mlh msh msh or pm or of the epcam gene msh promotor if a mutation predisposing to lynch syndrome is identified in an individual special monitoring should be initiated adapted to estimated cancer risk clinical criterion amsterdam ii and bethesda have been validated to identify the patient who should be referred for genetic counseling in order to initiate constitutional dna testing furthermore the french national cancer institute inca systematically recommend tumoral testing looking for mmr system failure in case of crc diagnosed under endometrial cancer diagnosed under or whatever the age in patient diagnosed with crc or endometrial cancer harbouring personal or familal history of lunch syndrome cancer in this review we will discus how to detect lynch syndrome identification of the index case and family screening and how to monitor it in
31569934,modern view on epidermal dysplasia carcinogenesis,squamous cell carcinoma of the skin develops from the spectrum of facultative precancerous condition which in the course of malignant transformation through cancer stage in situ without early treatment fully transform into invasive squamous cell carcinoma according to classical model of carcinogenesis the transformation of actinic keratosis into squamous cell carcinoma of the skin occurs due to a mutation in one gene more often a tumor suppressor and undergoes a stage of development with lack of control of cell cycle the aim of the research is to supplement current knowledge of genetic determination of pathogenetic mechanism of epidermal dysplasia of the skin by studying the genetic determinant in the skin lesion of varying degree of malignancy material and method we analyzed skin bioptates of patient with epidermal dysplasia of the skin gr patient with actinic keratosis gr patient with noninvasive squamous cell carcinoma of the skin gr patient with invasive squamous cell carcinoma of the skin by molecular genetic testing of gene polymorphism tp ga lmyc tg tnfalpha ga in tumor tissue the histological examination revealed the level of dysplasia of the epidermis result in case of the same disease duration in patient of grgr lmyc tt is a genetic component of malignant transformation of epithelial skin cell p and the development of invasive squamous cell carcinoma other variant of tg and gg gene do not have such prognostic value for the risk of skin cancer compared to tt significant difference were found in the distribution of ga when comparing gr with gr p and gr with gr p a significant increase in the distribution of ga genotype wa revealed in patient with invasive form of keratinocyte intraepidermal neoplasia a allele wa more likely to be detected in patient of gr compared to gr p that prof the association of this allele with the development of invasive malignancy of the skin the association of gg genotype and tnfalpha g allele with the development of malignant skin lesion wa found comparing the distribution of g allele in patient of gr and gr we found it significant increase in patient of gr comparative analysis of gene polymorphism with tumor invasion level showed a significant difference only in gg genotype between patient with grade iii of kin keratinocyte intraepidermal neoplasia in gr and patient with kin iii of gr p and ga between patient with kin iii of gr and kin iii of gr p conclusion our work ha supplemented modern vision of genetic component in pathogenetic mechanism of the development of epidermal dysplasia of the skin thus the association of lmyc tt with the development of malignant skin lesion of different invasiveness and the modifying effect of tnfalpha ga and tp ga gene variant on pathological transformation in the focus of ed depending on the level of epithelial dysplasia wa revealed,Cancer,0,modern view on epidermal dysplasia carcinogenesis squamous cell carcinoma of the skin develops from the spectrum of facultative precancerous condition which in the course of malignant transformation through cancer stage in situ without early treatment fully transform into invasive squamous cell carcinoma according to classical model of carcinogenesis the transformation of actinic keratosis into squamous cell carcinoma of the skin occurs due to a mutation in one gene more often a tumor suppressor and undergoes a stage of development with lack of control of cell cycle the aim of the research is to supplement current knowledge of genetic determination of pathogenetic mechanism of epidermal dysplasia of the skin by studying the genetic determinant in the skin lesion of varying degree of malignancy material and method we analyzed skin bioptates of patient with epidermal dysplasia of the skin gr patient with actinic keratosis gr patient with noninvasive squamous cell carcinoma of the skin gr patient with invasive squamous cell carcinoma of the skin by molecular genetic testing of gene polymorphism tp ga lmyc tg tnfalpha ga in tumor tissue the histological examination revealed the level of dysplasia of the epidermis result in case of the same disease duration in patient of grgr lmyc tt is a genetic component of malignant transformation of epithelial skin cell p and the development of invasive squamous cell carcinoma other variant of tg and gg gene do not have such prognostic value for the risk of skin cancer compared to tt significant difference were found in the distribution of ga when comparing gr with gr p and gr with gr p a significant increase in the distribution of ga genotype wa revealed in patient with invasive form of keratinocyte intraepidermal neoplasia a allele wa more likely to be detected in patient of gr compared to gr p that prof the association of this allele with the development of invasive malignancy of the skin the association of gg genotype and tnfalpha g allele with the development of malignant skin lesion wa found comparing the distribution of g allele in patient of gr and gr we found it significant increase in patient of gr comparative analysis of gene polymorphism with tumor invasion level showed a significant difference only in gg genotype between patient with grade iii of kin keratinocyte intraepidermal neoplasia in gr and patient with kin iii of gr p and ga between patient with kin iii of gr and kin iii of gr p conclusion our work ha supplemented modern vision of genetic component in pathogenetic mechanism of the development of epidermal dysplasia of the skin thus the association of lmyc tt with the development of malignant skin lesion of different invasiveness and the modifying effect of tnfalpha ga and tp ga gene variant on pathological transformation in the focus of ed depending on the level of epithelial dysplasia wa revealed
31570430,promoter methylation downregulates bcell translocation gene expression in breast carcinoma,backgroundaim the mechanism responsible for bcell translocation gene btg downregulation in breast carcinoma remains unknown we examined the btg expression status in breast carcinoma cell and investigated the mechanism underlying the observed alteration material and method four breast carcinoma cell line skbr mdamb td and mcf and one normal mammary epithelial cell line mcfa were analyzed btg expression wa examined using quantitative reverse transcription polymerase chain reaction pcr and western blot methylation status of the btg promoter wa analyzed using methylationspecific pcr msp to investigate the effect of methylation on btg the cell were treated with a demethylating agent result the carcinoma cell expressed significantly lower level of btg mrna and protein than normal cell the btg promoter wa highly methylated in the carcinoma cell azadeoxycytidine significantly restored btg expression conclusion downregulation of btg expression through epigenetic repression is involved in mammary carcinogenesis btg is a potential diagnostic marker and therapeutic target for breast carcinoma,Cancer,0,promoter methylation downregulates bcell translocation gene expression in breast carcinoma backgroundaim the mechanism responsible for bcell translocation gene btg downregulation in breast carcinoma remains unknown we examined the btg expression status in breast carcinoma cell and investigated the mechanism underlying the observed alteration material and method four breast carcinoma cell line skbr mdamb td and mcf and one normal mammary epithelial cell line mcfa were analyzed btg expression wa examined using quantitative reverse transcription polymerase chain reaction pcr and western blot methylation status of the btg promoter wa analyzed using methylationspecific pcr msp to investigate the effect of methylation on btg the cell were treated with a demethylating agent result the carcinoma cell expressed significantly lower level of btg mrna and protein than normal cell the btg promoter wa highly methylated in the carcinoma cell azadeoxycytidine significantly restored btg expression conclusion downregulation of btg expression through epigenetic repression is involved in mammary carcinogenesis btg is a potential diagnostic marker and therapeutic target for breast carcinoma
31571071,optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibody confirms it expression in normal and malignant breast tissue,purpose significant controversy exists regarding the expression pattern of estrogen receptor beta erbeta in normal and diseased breast tissue to address this issue we have validated two erbeta antibody optimized the ihc protocol for both antibody and now report the expression pattern of erbeta in normal and malignant breast tissue method erbeta antibody specificity wa determined using western blot and ihc analysis erbeta protein expression pattern were assessed via ihc in normal breast tissue and invasive breast carcinoma further we report the detailed protocol of the erbeta ihc assay developed in our capclia certified laboratory to provide a standardized method for future study result we have confirmed the specificity of two independent erbeta monoclonal antibody one that detects total ie full length plus splice variant which do not include the ligand binding domain erbeta protein ppz and one that detects only the fulllength form which includes the ligand binding domain of erbeta ppg using these two antibody we demonstrate that erbeta is highly expressed in normal human breast tissue a well a in of invasive breast cancer further these two antibody exhibited similar staining pattern across multiple different tissue and were highly concordant with regard to determining erbeta positivity in breast cancer conclusion erbeta protein wa shown to be abundant in the majority of normal breast epithelial cell and is present in of breast cancer use of these two antibody along with their standardized ihc protocol provide a reference for future study aimed at determining the utility of erbeta a a prognostic andor predictive biomarker in various tissue of benign or malignant state,Cancer,0,optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibody confirms it expression in normal and malignant breast tissue purpose significant controversy exists regarding the expression pattern of estrogen receptor beta erbeta in normal and diseased breast tissue to address this issue we have validated two erbeta antibody optimized the ihc protocol for both antibody and now report the expression pattern of erbeta in normal and malignant breast tissue method erbeta antibody specificity wa determined using western blot and ihc analysis erbeta protein expression pattern were assessed via ihc in normal breast tissue and invasive breast carcinoma further we report the detailed protocol of the erbeta ihc assay developed in our capclia certified laboratory to provide a standardized method for future study result we have confirmed the specificity of two independent erbeta monoclonal antibody one that detects total ie full length plus splice variant which do not include the ligand binding domain erbeta protein ppz and one that detects only the fulllength form which includes the ligand binding domain of erbeta ppg using these two antibody we demonstrate that erbeta is highly expressed in normal human breast tissue a well a in of invasive breast cancer further these two antibody exhibited similar staining pattern across multiple different tissue and were highly concordant with regard to determining erbeta positivity in breast cancer conclusion erbeta protein wa shown to be abundant in the majority of normal breast epithelial cell and is present in of breast cancer use of these two antibody along with their standardized ihc protocol provide a reference for future study aimed at determining the utility of erbeta a a prognostic andor predictive biomarker in various tissue of benign or malignant state
31577852,longitudinal analysis of a secondary brca mutation using digital droplet pcr,development of resistance to platinum and polyadpribose polymerase inhibitor via secondary brca gene mutation that restore functional homologous recombination ha been observed in a number of cancer type here we report a case of somatic brca mutation in a patient with high grade serous ovarian carcinoma a secondary mutation predicted to restore the brca open reading frame wa detected at low frequency in whole exome sequencing of a peritoneal biopsy at disease progression after treatment that included carboplatin and olaparib we used digital droplet pcr ddpcr to verify the presence and frequency of this mutation in the biopsy sample at progression and also used this approach to assess the presence of the secondary mutation in preceding biopsy at diagnosis and first relapse we found no evidence for the secondary mutation being present prior to the final progression biopsy suggesting that this mutation wa acquired late in the course of treatment ddpcr provides a sensitive and specific technique to investigate the presence of low frequency mutation in a time series of biopsy,Cancer,0,longitudinal analysis of a secondary brca mutation using digital droplet pcr development of resistance to platinum and polyadpribose polymerase inhibitor via secondary brca gene mutation that restore functional homologous recombination ha been observed in a number of cancer type here we report a case of somatic brca mutation in a patient with high grade serous ovarian carcinoma a secondary mutation predicted to restore the brca open reading frame wa detected at low frequency in whole exome sequencing of a peritoneal biopsy at disease progression after treatment that included carboplatin and olaparib we used digital droplet pcr ddpcr to verify the presence and frequency of this mutation in the biopsy sample at progression and also used this approach to assess the presence of the secondary mutation in preceding biopsy at diagnosis and first relapse we found no evidence for the secondary mutation being present prior to the final progression biopsy suggesting that this mutation wa acquired late in the course of treatment ddpcr provides a sensitive and specific technique to investigate the presence of low frequency mutation in a time series of biopsy
31583141,acute myeloid leukemia in an infant with tpq translocation case report and a review of the literature,acute myeloid leukemia aml patient with tpp constitute a small subgroup with a distinct genetic and clinical profile we present a unique case of a female infant with monocytic aml associated with tpq a rarely reported variation of tpp the patient presented with leukemia cutis and demonstrated erythrophagocytosis in the diagnostic bone marrow she responded well to standard aml chemotherapy and is currently in remission here we highlight her case a the youngest aml patient with t described in the literature discus the significance and prognostic implication of this genetic variant and review p fusion protein in aml,Cancer,0,acute myeloid leukemia in an infant with tpq translocation case report and a review of the literature acute myeloid leukemia aml patient with tpp constitute a small subgroup with a distinct genetic and clinical profile we present a unique case of a female infant with monocytic aml associated with tpq a rarely reported variation of tpp the patient presented with leukemia cutis and demonstrated erythrophagocytosis in the diagnostic bone marrow she responded well to standard aml chemotherapy and is currently in remission here we highlight her case a the youngest aml patient with t described in the literature discus the significance and prognostic implication of this genetic variant and review p fusion protein in aml
31587141,kabuki syndrome review of the clinical feature diagnosis and epigenetic mechanism,background kabuki syndrome k is a infrequent inherited malformation syndrome caused by mutation in a h lysine methylase kmtd or an xlinked histone h lysine demethylase utxkdma the characteristic in patient with k have not yet been well recognized data source we used database including pubmed and google scholar to search for publication about the clinical feature and the etiology of kabuki syndrome the most relevant article to the scope of this review were chosen for analysis result clinical diagnosis of k is challenging in initial period because many clinical characteristic become apparent only in subsequent year recently the genetic and functional interaction between ksassociated gene and their product have been elucidated new clinical finding were reported including nervous system and intellectual performance endocrinerelated disorder and immune deficiency and autoimmune disease cancer risk of kabuki syndrome wa reviewed meanwhile we discussed the kabukilike syndrome digital clinical genetic service such a dysmorphology database can improve availability and provide highquality diagnostic service given the significant clinical relevance of ksassociated gene and epigenetic modification crosstalk effort in the research for new mechanism are thus of maximum interest conclusion kabuki syndrome ha a strong clinical and biological heterogeneity the main pathogenesis of kabuki syndrome is the imbalance between switchon and off of the chromatin the direction of drug research may be to regulate the normal opening of chromatin small molecule inhibitor of histone deacetylases maybe helpful in treatment of mental retardation and reduce cancer risk in k,Cancer,0,kabuki syndrome review of the clinical feature diagnosis and epigenetic mechanism background kabuki syndrome k is a infrequent inherited malformation syndrome caused by mutation in a h lysine methylase kmtd or an xlinked histone h lysine demethylase utxkdma the characteristic in patient with k have not yet been well recognized data source we used database including pubmed and google scholar to search for publication about the clinical feature and the etiology of kabuki syndrome the most relevant article to the scope of this review were chosen for analysis result clinical diagnosis of k is challenging in initial period because many clinical characteristic become apparent only in subsequent year recently the genetic and functional interaction between ksassociated gene and their product have been elucidated new clinical finding were reported including nervous system and intellectual performance endocrinerelated disorder and immune deficiency and autoimmune disease cancer risk of kabuki syndrome wa reviewed meanwhile we discussed the kabukilike syndrome digital clinical genetic service such a dysmorphology database can improve availability and provide highquality diagnostic service given the significant clinical relevance of ksassociated gene and epigenetic modification crosstalk effort in the research for new mechanism are thus of maximum interest conclusion kabuki syndrome ha a strong clinical and biological heterogeneity the main pathogenesis of kabuki syndrome is the imbalance between switchon and off of the chromatin the direction of drug research may be to regulate the normal opening of chromatin small molecule inhibitor of histone deacetylases maybe helpful in treatment of mental retardation and reduce cancer risk in k
31592503,integrative molecular analysis of patient with advanced and metastatic cancer,purpose we developed a precision medicine program for patient with advanced cancer using integrative wholeexome sequencing and transcriptome analysis patient and method five hundred fifteen patient with locally advancedmetastatic solid tumor were prospectively enrolled and paired tumornormal sequencing wa performed seven hundred fiftynine tumor from patient were evaluated result most frequent tumor type were prostate brain bladder and kidney cancer most frequently altered gene were tp cdkna apc ktmd pten and brca pathogenic germline alteration were present in of patient most frequently chek brca brca and msh novel gene fusion were identified including a rbmcdk fusion in a metastatic prostate cancer sample the rate of clinically relevant alteration wa by wholeexome sequencing which wa improved by by adding rna sequencing in patient with more than one sequenced tumor sample n of actionable mutation were concordant conclusion integrative analysis may uncover informative alteration for an advanced pancancer patient population these alteration are consistent in spatially and temporally heterogeneous sample,Cancer,0,integrative molecular analysis of patient with advanced and metastatic cancer purpose we developed a precision medicine program for patient with advanced cancer using integrative wholeexome sequencing and transcriptome analysis patient and method five hundred fifteen patient with locally advancedmetastatic solid tumor were prospectively enrolled and paired tumornormal sequencing wa performed seven hundred fiftynine tumor from patient were evaluated result most frequent tumor type were prostate brain bladder and kidney cancer most frequently altered gene were tp cdkna apc ktmd pten and brca pathogenic germline alteration were present in of patient most frequently chek brca brca and msh novel gene fusion were identified including a rbmcdk fusion in a metastatic prostate cancer sample the rate of clinically relevant alteration wa by wholeexome sequencing which wa improved by by adding rna sequencing in patient with more than one sequenced tumor sample n of actionable mutation were concordant conclusion integrative analysis may uncover informative alteration for an advanced pancancer patient population these alteration are consistent in spatially and temporally heterogeneous sample
31596728,a molecular subcluster of colon cancer cell with low vdr expression is sensitive to chemotherapy braf inhibitor and pikmtor inhibitor treatment,gene expression based consensus molecular subtypes cm and nonnegative matrix factorization nmf subclusters are robust colon cancer classification system although the molecular feature are clear colon cancer subgroup based intervention are limited to address this problem we analyze the cm and nmf subgroup guided drug sensitivity in colon cancer cell line cm subtype cell are sensitive to fluorouracil while cm subtype cell are sensitive to cisplatin treatment in nmf classification a subcluster is specifically sensitive to chemotherapy braf inhibitor pikmtor inhibitor and notch inhibitor treatment this subcluster ha low frequency of tp pole pikca and braf mutation transcriptional analysis demonstrates low notch signaling activity low cdx and vdr expression in this subcluster cdx and vdr are significantly associated with the sensitivity of chemotherapy braf inhibitor and pikmtor inhibitor moreover a positive correlation between vdr and cdx is identified vdr and cdx mediated regulatory network are constructed at last three or four subclusters classification is validated in colon cancer patient overall our result suggest a molecular subcluster of colon cancer cell with low cdx and vdr expression is sensitive to chemotherapy braf inhibitor and pikmtor inhibitor treatment and provide an example of translation of cancer classification to subgroup guided therapy,Cancer,0,a molecular subcluster of colon cancer cell with low vdr expression is sensitive to chemotherapy braf inhibitor and pikmtor inhibitor treatment gene expression based consensus molecular subtypes cm and nonnegative matrix factorization nmf subclusters are robust colon cancer classification system although the molecular feature are clear colon cancer subgroup based intervention are limited to address this problem we analyze the cm and nmf subgroup guided drug sensitivity in colon cancer cell line cm subtype cell are sensitive to fluorouracil while cm subtype cell are sensitive to cisplatin treatment in nmf classification a subcluster is specifically sensitive to chemotherapy braf inhibitor pikmtor inhibitor and notch inhibitor treatment this subcluster ha low frequency of tp pole pikca and braf mutation transcriptional analysis demonstrates low notch signaling activity low cdx and vdr expression in this subcluster cdx and vdr are significantly associated with the sensitivity of chemotherapy braf inhibitor and pikmtor inhibitor moreover a positive correlation between vdr and cdx is identified vdr and cdx mediated regulatory network are constructed at last three or four subclusters classification is validated in colon cancer patient overall our result suggest a molecular subcluster of colon cancer cell with low cdx and vdr expression is sensitive to chemotherapy braf inhibitor and pikmtor inhibitor treatment and provide an example of translation of cancer classification to subgroup guided therapy
31597339,clinical practice use of liquid biopsy to identify rasbraf mutation in patient with metastatic colorectal cancer mcrc a single institution experience,tumor heterogeneity represents a possible cause of error in detecting predictive genetic alteration on tumor tissue and can be overcome by testing alteration in circulating tumor dna ctdna using liquid biopsy we assessed consecutive patient with a diagnosis of metastatic colorectal cancer mcrc using idylla biocartis a fully automated platform that evaluates the most frequent mutation of kras nra and braf gene we correlated the result of liquid biopsy and standard tissuebased next generation sequencing ng analysis to patient clinical feature the overall agreement wa concordance wa and in treatmentnaive patient and in the patient subgroup with liver metastasis respectively in liver metastasis positive treatmentnaive patient sensitivity specificity and positive predictive value ppv were and respectively circulating mutational fraction cmf wa significantly higher in patient with liver metastasis and high carcinoembryonic antigen cea level in a subgroup of patient pretreated with antiepidermal growth factor receptor egfr agent emerging kras mutation were evidenced in of case testing rasbraf mutation on plasma using the idylla biocartis platform is feasible and reliable in mcrc patient in clinical practice,Cancer,0,clinical practice use of liquid biopsy to identify rasbraf mutation in patient with metastatic colorectal cancer mcrc a single institution experience tumor heterogeneity represents a possible cause of error in detecting predictive genetic alteration on tumor tissue and can be overcome by testing alteration in circulating tumor dna ctdna using liquid biopsy we assessed consecutive patient with a diagnosis of metastatic colorectal cancer mcrc using idylla biocartis a fully automated platform that evaluates the most frequent mutation of kras nra and braf gene we correlated the result of liquid biopsy and standard tissuebased next generation sequencing ng analysis to patient clinical feature the overall agreement wa concordance wa and in treatmentnaive patient and in the patient subgroup with liver metastasis respectively in liver metastasis positive treatmentnaive patient sensitivity specificity and positive predictive value ppv were and respectively circulating mutational fraction cmf wa significantly higher in patient with liver metastasis and high carcinoembryonic antigen cea level in a subgroup of patient pretreated with antiepidermal growth factor receptor egfr agent emerging kras mutation were evidenced in of case testing rasbraf mutation on plasma using the idylla biocartis platform is feasible and reliable in mcrc patient in clinical practice
31597840,the differential diagnosis of classical myeloproliferative neoplasm mpn the updated who criterion,the classical myeloproliferative neoplasm mpn polycythemia vera pv essential thrombocythemia et and primary myelofibrosis pmf are characterized by clonal myeloproliferation without feature of myelodysplasia the diagnostic approach proposed by the world health organization who us clinical feature peripheral blood count and smear analysis bone marrow bm morphology karyotype and molecular genetic test to classify mpn subtypes the detection of characteristic driver mutation like jakvf jak exon mpl and calrecticulin calr is a major diagnostic feature jak mutation are detected in more than of patient with pv and are therefore used a highly sensitive clonal marker in this subtype however jak mutation may also occur in et and pmf while calr is virtually not seen in pv therefore bm remains the central diagnostic platform and is essential for distinguishing et from prefibrotic pmf and diagnosing case which do not express jak mpl or calr wildtype or triplenegative mpn the standardization of relevant bm feature is mandatory to recognize characteristic and easy to assess pattern that enable an accurate discrimination between the mpn subtypes key parameter include cellularity erythropoiesis and neutrophil granulopoiesis in context with specific feature of megakaryocyte a well a the bm fiber content especially in early stage mpn that present with thrombocytosis and clinically mimic essential thrombocythemia,Cancer,0,the differential diagnosis of classical myeloproliferative neoplasm mpn the updated who criterion the classical myeloproliferative neoplasm mpn polycythemia vera pv essential thrombocythemia et and primary myelofibrosis pmf are characterized by clonal myeloproliferation without feature of myelodysplasia the diagnostic approach proposed by the world health organization who us clinical feature peripheral blood count and smear analysis bone marrow bm morphology karyotype and molecular genetic test to classify mpn subtypes the detection of characteristic driver mutation like jakvf jak exon mpl and calrecticulin calr is a major diagnostic feature jak mutation are detected in more than of patient with pv and are therefore used a highly sensitive clonal marker in this subtype however jak mutation may also occur in et and pmf while calr is virtually not seen in pv therefore bm remains the central diagnostic platform and is essential for distinguishing et from prefibrotic pmf and diagnosing case which do not express jak mpl or calr wildtype or triplenegative mpn the standardization of relevant bm feature is mandatory to recognize characteristic and easy to assess pattern that enable an accurate discrimination between the mpn subtypes key parameter include cellularity erythropoiesis and neutrophil granulopoiesis in context with specific feature of megakaryocyte a well a the bm fiber content especially in early stage mpn that present with thrombocytosis and clinically mimic essential thrombocythemia
31602010,drug resistance in papillary rcc from putative mechanism to clinical practicality,papillary renal cell carcinoma prcc is the second most common renal cell carcinoma rcc subtype and account for of all rccs despite clinical need few pharmacogenomics study in prcc have been performed moreover current research fails to adequately include prcc laboratory model such a the achn or caki prcc cell line the molecular mechanism involved in prcc development and drug resistance are more diverse than in clearcell rcc in which inactivation of vhl occurs in the majority of tumour drug resistance to multiple therapy in prcc occurs via genetic alteration such a mutation resulting in abnormal receptor tyrosine kinase activation or ralbp inhibition dysregulation of signalling pathway such a gskbetaeifebp pikakt and the mapk or interleukin signalling pathway deregulation of cellular process such a resistance to apoptosis or epithelialtomesenchymal transition and interaction between the cell and it environment for example through activation of matrix metalloproteinases improved understanding of resistance mechanism will facilitate drug discovery and provide new effective therapy further study on novel resistance biomarkers are needed to improve patient prognosis and stratification a well a drug development,Cancer,0,drug resistance in papillary rcc from putative mechanism to clinical practicality papillary renal cell carcinoma prcc is the second most common renal cell carcinoma rcc subtype and account for of all rccs despite clinical need few pharmacogenomics study in prcc have been performed moreover current research fails to adequately include prcc laboratory model such a the achn or caki prcc cell line the molecular mechanism involved in prcc development and drug resistance are more diverse than in clearcell rcc in which inactivation of vhl occurs in the majority of tumour drug resistance to multiple therapy in prcc occurs via genetic alteration such a mutation resulting in abnormal receptor tyrosine kinase activation or ralbp inhibition dysregulation of signalling pathway such a gskbetaeifebp pikakt and the mapk or interleukin signalling pathway deregulation of cellular process such a resistance to apoptosis or epithelialtomesenchymal transition and interaction between the cell and it environment for example through activation of matrix metalloproteinases improved understanding of resistance mechanism will facilitate drug discovery and provide new effective therapy further study on novel resistance biomarkers are needed to improve patient prognosis and stratification a well a drug development
31602213,detection of ctdna in the plasma of patient with papillary thyroid carcinoma,a total of of thyroid nodule that are evaluated by fineneedle aspiration are not clearly determined to be benign or malignant gene mutation analysis is recommended for the evaluation of thyroid nodule using clinical guideline the detection of circulating tumor dna ctdna ha the potential to aid in the screening diagnosis and prediction of thyroid cancer prognosis and can be used when tissue are difficult to obtain in the present study wholeexome sequencing wes wa performed on tumor and matched normal tissue from patient with papillary thyroid carcinoma ptc in quanzhou china hotspot mutation in tumor dna and cellfree dna were identified in the validation cohort which included patient with ptc braf ve occurred in five sample and wa the most frequent mutation observed variation allele frequency vaf of braf ve detected by wes wa positively correlated with vaf determined using digital pcr r p a number of novel mutated gene were identified including zinc finger protein pleckstrin homology like domain family a member rbmx like lysine methyltransferase a and trichohyalin along with the reported gene braf nra and mucin cell surface associated somatic mutated gene were enriched in the focal adhesion pathway a determined by kyoto encyclopedia of gene and genome or gene ontology analysis in the validation cohort of tumor were braf vepositive and the sensitivity and specificity of braf ve ctdna were and respectively braf ve wa associated with aggressive tumor factor including lymph node metastasis p and advanced disease stage p the present study investigated the accuracy of ctdna detection in patient with ptc and provided evidence that ctdna can be used a an evaluation of tumor dna in thyroid nodule,Cancer,0,detection of ctdna in the plasma of patient with papillary thyroid carcinoma a total of of thyroid nodule that are evaluated by fineneedle aspiration are not clearly determined to be benign or malignant gene mutation analysis is recommended for the evaluation of thyroid nodule using clinical guideline the detection of circulating tumor dna ctdna ha the potential to aid in the screening diagnosis and prediction of thyroid cancer prognosis and can be used when tissue are difficult to obtain in the present study wholeexome sequencing wes wa performed on tumor and matched normal tissue from patient with papillary thyroid carcinoma ptc in quanzhou china hotspot mutation in tumor dna and cellfree dna were identified in the validation cohort which included patient with ptc braf ve occurred in five sample and wa the most frequent mutation observed variation allele frequency vaf of braf ve detected by wes wa positively correlated with vaf determined using digital pcr r p a number of novel mutated gene were identified including zinc finger protein pleckstrin homology like domain family a member rbmx like lysine methyltransferase a and trichohyalin along with the reported gene braf nra and mucin cell surface associated somatic mutated gene were enriched in the focal adhesion pathway a determined by kyoto encyclopedia of gene and genome or gene ontology analysis in the validation cohort of tumor were braf vepositive and the sensitivity and specificity of braf ve ctdna were and respectively braf ve wa associated with aggressive tumor factor including lymph node metastasis p and advanced disease stage p the present study investigated the accuracy of ctdna detection in patient with ptc and provided evidence that ctdna can be used a an evaluation of tumor dna in thyroid nodule
31602373,detection of novel fusion transcript vtiacfap in hepatocellular carcinoma,background hepatocellular carcinoma hcc is now the secondhighest cause of cancer death worldwide recent study have discovered a wide range of somatic mutation in hcc these mutation involve various vital signaling pathway such a wntbetacatenin p telomerase reverse transcriptase tert chromatin remodeling rasmapk signaling and oxidative stress however fusion transcript have not been broadly explored in hcc method to identify novel fusion transcript in hcc in the first phase of our study we performed targeted rna sequencing in hcc and paired nonhcc tissue on patient with a diagnosis of hcc undergoing liver transplantation result a a result of these study we discovered the novel fusion transcript vtiacfap in the second phase of our study we measured the expression of wildtype vtia in hcc specimen which showed that of exhibited upregulation of wildtype vtia in their tumor vtia vesicle transport via interaction with tsnare homolog a is a member of the soluble nethylmaleimidesensitive factor nsf attachment protein receptor snare gene family which is essential for membrane trafficking and function in endocytosis autophagy and golgi transport notably it is known that autophagy is involved in hcc conclusion the link between novel fusion transcript vtiacfap and autophagy a a potential therapeutic target in hcc patient deserves further investigation moreover this study show that fusion transcript are worthy of additional exploration in hcc,Cancer,0,detection of novel fusion transcript vtiacfap in hepatocellular carcinoma background hepatocellular carcinoma hcc is now the secondhighest cause of cancer death worldwide recent study have discovered a wide range of somatic mutation in hcc these mutation involve various vital signaling pathway such a wntbetacatenin p telomerase reverse transcriptase tert chromatin remodeling rasmapk signaling and oxidative stress however fusion transcript have not been broadly explored in hcc method to identify novel fusion transcript in hcc in the first phase of our study we performed targeted rna sequencing in hcc and paired nonhcc tissue on patient with a diagnosis of hcc undergoing liver transplantation result a a result of these study we discovered the novel fusion transcript vtiacfap in the second phase of our study we measured the expression of wildtype vtia in hcc specimen which showed that of exhibited upregulation of wildtype vtia in their tumor vtia vesicle transport via interaction with tsnare homolog a is a member of the soluble nethylmaleimidesensitive factor nsf attachment protein receptor snare gene family which is essential for membrane trafficking and function in endocytosis autophagy and golgi transport notably it is known that autophagy is involved in hcc conclusion the link between novel fusion transcript vtiacfap and autophagy a a potential therapeutic target in hcc patient deserves further investigation moreover this study show that fusion transcript are worthy of additional exploration in hcc
31602389,molecular approach to metastatic colorectal cancer better diagnosis better treatment,molecular diagnostics of metastatic colorectal cancer mcrc are coming of age whereas for many year ra mutation were the only relevant molecular alteration examined in mcrc nowadays the braf her and microsatellite instability status of a given tumor is gaining importance since it ha not only prognostic relevance but open new avenue for therapeutic approach this review summarizes the recent advance in molecular approach to mcrc and their therapeutic consequence and discusses novel approach for molecular diagnostics in mcrc,Cancer,0,molecular approach to metastatic colorectal cancer better diagnosis better treatment molecular diagnostics of metastatic colorectal cancer mcrc are coming of age whereas for many year ra mutation were the only relevant molecular alteration examined in mcrc nowadays the braf her and microsatellite instability status of a given tumor is gaining importance since it ha not only prognostic relevance but open new avenue for therapeutic approach this review summarizes the recent advance in molecular approach to mcrc and their therapeutic consequence and discusses novel approach for molecular diagnostics in mcrc
31606421,ctnnb and apc mutation in odontogenic carcinoma with dentinoid,the purpose of the present study is to report case of odontogenic carcinoma with dentinoid a rare lowgrade odontogenic carcinoma associated with facial deformity and bone loss and to investigate the presence of pathogenic mutation in these sample by using a nextgeneration sequencing approach we sequenced a panel of oncogene and tumor suppressor gene commonly mutated in human cancer microscopic feature of both case revealed solid area of malignant odontogenic tumor with a large amount of dentinoid material we identified pathogenic mutation in the gene ctnnb and apc both of which are part of the wntsignaling pathway consistent with wntsignaling activation both tumor showed strong betacatenin accumulation in the cytoplasm and in the nucleus the molecular profile of odontogenic carcinoma with dentinoid may help in it diagnosis a well a in the identification of potential molecular target for therapy in the future,Cancer,0,ctnnb and apc mutation in odontogenic carcinoma with dentinoid the purpose of the present study is to report case of odontogenic carcinoma with dentinoid a rare lowgrade odontogenic carcinoma associated with facial deformity and bone loss and to investigate the presence of pathogenic mutation in these sample by using a nextgeneration sequencing approach we sequenced a panel of oncogene and tumor suppressor gene commonly mutated in human cancer microscopic feature of both case revealed solid area of malignant odontogenic tumor with a large amount of dentinoid material we identified pathogenic mutation in the gene ctnnb and apc both of which are part of the wntsignaling pathway consistent with wntsignaling activation both tumor showed strong betacatenin accumulation in the cytoplasm and in the nucleus the molecular profile of odontogenic carcinoma with dentinoid may help in it diagnosis a well a in the identification of potential molecular target for therapy in the future
31608732,liquid biopsy tracking of lung tumor evolution over time,introduction the rise of the personalized era in lung cancer prompted the evaluation of novel diagnostic tool to overcome some of the limit of traditional tumor genotyping liquid biopsy refers to a multitude of minimally invasive technique that can allow a realtime biomolecular characterization of the tumor through the analysis of human body fluidsareas covered herein we provide a comprehensive overview of the role of liquid biopsy in lung cancer mainly focusing on the most studied member of the liquid biopsy family cellfree dna cfdna and circulating tumor cell ctcsexpert opinion among the different component of the large liquid biopsy family cfdna is the most studied and widely adopted source for tumor genotyping in lung cancer already entered clinical practice for detection of both sensitizing and resistance egfr mutation however the impressive technological advance made in the last few year are expanding it potential application allowing a more comprehensive plasma genotyping through nextgeneration sequencing and moving from advancedmetastatic disease to novel frontier such a early detection and minimal residual disease evaluation,Cancer,0,liquid biopsy tracking of lung tumor evolution over time introduction the rise of the personalized era in lung cancer prompted the evaluation of novel diagnostic tool to overcome some of the limit of traditional tumor genotyping liquid biopsy refers to a multitude of minimally invasive technique that can allow a realtime biomolecular characterization of the tumor through the analysis of human body fluidsareas covered herein we provide a comprehensive overview of the role of liquid biopsy in lung cancer mainly focusing on the most studied member of the liquid biopsy family cellfree dna cfdna and circulating tumor cell ctcsexpert opinion among the different component of the large liquid biopsy family cfdna is the most studied and widely adopted source for tumor genotyping in lung cancer already entered clinical practice for detection of both sensitizing and resistance egfr mutation however the impressive technological advance made in the last few year are expanding it potential application allowing a more comprehensive plasma genotyping through nextgeneration sequencing and moving from advancedmetastatic disease to novel frontier such a early detection and minimal residual disease evaluation
31612916,dramatic response of folfirinox regimen in a collision pancreatic adenocarcinoma patient with a germline brca mutation a case report,germline brca and brca mutation are the most common gene mutation in familial pancreatic adenocarcinoma several report have demonstrated the utility of platinumbased chemotherapy for treating cancer patient who harbour a brca mutation here we discus a yearold japanese female with no relevant past history who presented with epigastralgia and fever in september a computed tomography scan revealed a lowdensity lowenhanced tumour mm in diameter in the head of the pancreas the pathological diagnosis wa a ductal pancreatic carcinoma a mm lowenhanced metastatic tumour wa also detected in segment of the liver because she had early onset of the disease and a family historyher mother died of pancreatic adenocarcinoma at age we considered a diagnosis of familial pancreatic adenocarcinoma she received modified folfirinox two month after starting chemotherapy she wa diagnosed with an invasive ductal carcinoma in the right breast folfirinox wa continued for cycle month the primary pancreatic adenocarcinoma shrank and the liver metastatic focus disappeared but the size of the breast tumour increased total right breast excision and sentinel lymph node dissection were performed folfirinox wa continued and after cycle month both her pancreatic adenocarcinoma and liver metastasis were no longer visible using imaging pancreatoduodenectomy wa performed and the primary tumour had shrunk to mm genetic testing revealed a germline brca mutation the folfirinox regimen showed dramatic effect on the collision pancreatic but not on the breast cancer,Cancer,0,dramatic response of folfirinox regimen in a collision pancreatic adenocarcinoma patient with a germline brca mutation a case report germline brca and brca mutation are the most common gene mutation in familial pancreatic adenocarcinoma several report have demonstrated the utility of platinumbased chemotherapy for treating cancer patient who harbour a brca mutation here we discus a yearold japanese female with no relevant past history who presented with epigastralgia and fever in september a computed tomography scan revealed a lowdensity lowenhanced tumour mm in diameter in the head of the pancreas the pathological diagnosis wa a ductal pancreatic carcinoma a mm lowenhanced metastatic tumour wa also detected in segment of the liver because she had early onset of the disease and a family historyher mother died of pancreatic adenocarcinoma at age we considered a diagnosis of familial pancreatic adenocarcinoma she received modified folfirinox two month after starting chemotherapy she wa diagnosed with an invasive ductal carcinoma in the right breast folfirinox wa continued for cycle month the primary pancreatic adenocarcinoma shrank and the liver metastatic focus disappeared but the size of the breast tumour increased total right breast excision and sentinel lymph node dissection were performed folfirinox wa continued and after cycle month both her pancreatic adenocarcinoma and liver metastasis were no longer visible using imaging pancreatoduodenectomy wa performed and the primary tumour had shrunk to mm genetic testing revealed a germline brca mutation the folfirinox regimen showed dramatic effect on the collision pancreatic but not on the breast cancer
31622660,genomics of gynaecological carcinosarcoma and future treatment option,gynaecological carcinosarcoma are the most lethal gynaecological malignancy that are often highly resistant to standard chemotherapy they are composed of both carcinomatous and sarcomatous component and are associated with high rate of metastatic disease due to their rarity molecular study have been carried out on relatively few tumour revealing a broad spectrum of heterogeneity in this review we have collated the gene mutation gene expression epigenetic regulation and protein expression reported by a number of study on gynaecological carcinosarcoma based on these result we describe potential therapeutic that may demonstrate efficacy and present any preclinical study that have been carried out we also describe the preclinical model currently available for future research to assess the potential of molecularly matched therapy interestingly overexpression of many biomarkers in carcinosarcoma tumour often doesnt correlate with a worse prognosis therefore we propose that profiling the mutational landscape gene expression and gene amplificationdeletion may better indicate potential treatment strategy and predict response thus improving outcome for woman with this rare aggressive disease,Cancer,0,genomics of gynaecological carcinosarcoma and future treatment option gynaecological carcinosarcoma are the most lethal gynaecological malignancy that are often highly resistant to standard chemotherapy they are composed of both carcinomatous and sarcomatous component and are associated with high rate of metastatic disease due to their rarity molecular study have been carried out on relatively few tumour revealing a broad spectrum of heterogeneity in this review we have collated the gene mutation gene expression epigenetic regulation and protein expression reported by a number of study on gynaecological carcinosarcoma based on these result we describe potential therapeutic that may demonstrate efficacy and present any preclinical study that have been carried out we also describe the preclinical model currently available for future research to assess the potential of molecularly matched therapy interestingly overexpression of many biomarkers in carcinosarcoma tumour often doesnt correlate with a worse prognosis therefore we propose that profiling the mutational landscape gene expression and gene amplificationdeletion may better indicate potential treatment strategy and predict response thus improving outcome for woman with this rare aggressive disease
31623866,the role of exosomes and myc in therapy resistance of acute myeloid leukemia challenge and opportunity,acute myeloid leukemia aml is caused by abnormal production of white blood cell red blood cell or platelet the leukemia cell communicate with their microenvironment through nanovesicle exosomes that are nm in diameter these nanovesicles are released from body fluid upon fusion of an endocytic compartment with the cell membrane exosomes function a cargo to deliver signaling molecule to distant cell this allows crosstalk between hematopoietic cell and other distant target cell environment exosomes support leukemia growth by acting a messenger between tumor cell and the microenvironment a well a inducing oncogenic factor such a cmyc exosomes have also been used a biomarkers in the clinical diagnosis of leukemia glycogen synthase kinase gsk and protein phosphatase a ppa are two crucial signaling molecule involved in the aml pathogenesis and myc stability gsk is a serinethreonine protein kinase that coordinate with over different protein during physiologicalpathological condition in blood cell the dysregulation in gsk ha been reported during hematological malignancy gsk act a a tumor suppressor by targeting cmyc mcl and betacatenin conversely gsk can also act a tumor promoter in some instance the pharmacological modulators of gsk such a abt bromoindirubinoxime bio g and ly have shown promise in the treatment of hematological malignancy ppa is a heterotrimeric serinethreonine phosphatase involved in the regulation of hematological malignancy ppaactivating drug pad can effectively antagonize leukemogenesis the discovery of exosomes kinase inhibitor and phosphatase activator have provided new hope to the leukemia patient this review discusses the role of exosomes gsk and ppa in the pathogenesis of leukemia we provide evidence from both preclinical and clinical study,Cancer,0,the role of exosomes and myc in therapy resistance of acute myeloid leukemia challenge and opportunity acute myeloid leukemia aml is caused by abnormal production of white blood cell red blood cell or platelet the leukemia cell communicate with their microenvironment through nanovesicle exosomes that are nm in diameter these nanovesicles are released from body fluid upon fusion of an endocytic compartment with the cell membrane exosomes function a cargo to deliver signaling molecule to distant cell this allows crosstalk between hematopoietic cell and other distant target cell environment exosomes support leukemia growth by acting a messenger between tumor cell and the microenvironment a well a inducing oncogenic factor such a cmyc exosomes have also been used a biomarkers in the clinical diagnosis of leukemia glycogen synthase kinase gsk and protein phosphatase a ppa are two crucial signaling molecule involved in the aml pathogenesis and myc stability gsk is a serinethreonine protein kinase that coordinate with over different protein during physiologicalpathological condition in blood cell the dysregulation in gsk ha been reported during hematological malignancy gsk act a a tumor suppressor by targeting cmyc mcl and betacatenin conversely gsk can also act a tumor promoter in some instance the pharmacological modulators of gsk such a abt bromoindirubinoxime bio g and ly have shown promise in the treatment of hematological malignancy ppa is a heterotrimeric serinethreonine phosphatase involved in the regulation of hematological malignancy ppaactivating drug pad can effectively antagonize leukemogenesis the discovery of exosomes kinase inhibitor and phosphatase activator have provided new hope to the leukemia patient this review discusses the role of exosomes gsk and ppa in the pathogenesis of leukemia we provide evidence from both preclinical and clinical study
31631483,a first japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline brca mutation,germline mutation and copy number change in dna damage repair ddr gene such a brca are associated with aggressive form of prostate cancer pca although the prevalence of brca variant in pca is increasing in japan the genomic and biological implication in japanese patient are unclear an yearold male presented with prostatic adenocarcinoma with neuroendocrine differentiation accompanied by metastatic lung nodule and brain metastasis platinumbased doublet chemotherapy combined with etoposide resulted in partial and complete remission of brain and lung metastasis respectively nextgeneration sequencing of biopsy and peripheral blood sample demonstrated a somatic brca mutation at cac and a germline mutation at pe the patient son had been diagnosed with breast cancer year ago and wa found to have the same germline brca mutation brca mutation increase the risk of aggressive pca and other cancer type in japanese male these form may be highly responsive to platinumbased chemotherapy,Cancer,0,a first japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline brca mutation germline mutation and copy number change in dna damage repair ddr gene such a brca are associated with aggressive form of prostate cancer pca although the prevalence of brca variant in pca is increasing in japan the genomic and biological implication in japanese patient are unclear an yearold male presented with prostatic adenocarcinoma with neuroendocrine differentiation accompanied by metastatic lung nodule and brain metastasis platinumbased doublet chemotherapy combined with etoposide resulted in partial and complete remission of brain and lung metastasis respectively nextgeneration sequencing of biopsy and peripheral blood sample demonstrated a somatic brca mutation at cac and a germline mutation at pe the patient son had been diagnosed with breast cancer year ago and wa found to have the same germline brca mutation brca mutation increase the risk of aggressive pca and other cancer type in japanese male these form may be highly responsive to platinumbased chemotherapy
31641593,malignant fibrous histiocytoma arising from the renal capsule and gene mutation screening a case report,malignant fibrous histiocytoma mfh is an aggressive soft tissue sarcoma renal mfh is rare and information about it molecular characterization is limited we present here the case of a yearold man who wa incidentally found to have a huge right renal mass on computed tomography radical nephrectomy wa performed pathological diagnosis wa mfh arising from the renal capsule we used ion ampliseq cancer hotspot panel version primer to perform gene mutation screening we detected mutation in hotspot oncogene csfr fgfr kdr apc pdgfra tp flt erbb kit stk ret but these were not matched to driver mutation,Cancer,0,malignant fibrous histiocytoma arising from the renal capsule and gene mutation screening a case report malignant fibrous histiocytoma mfh is an aggressive soft tissue sarcoma renal mfh is rare and information about it molecular characterization is limited we present here the case of a yearold man who wa incidentally found to have a huge right renal mass on computed tomography radical nephrectomy wa performed pathological diagnosis wa mfh arising from the renal capsule we used ion ampliseq cancer hotspot panel version primer to perform gene mutation screening we detected mutation in hotspot oncogene csfr fgfr kdr apc pdgfra tp flt erbb kit stk ret but these were not matched to driver mutation
31641659,intraoral ebvpositive sporadic burkitt lymphoma in an elderly patient with bilateral presentation,sporadic burkitt lymphoma sbl is a variant of burkitt lymphoma that occurs worldwide affecting mainly child and young adult association with epsteinbarr virus ebv can be identified in approximately of case herein we described a case of a yearold male presenting intraoral bilateral mandibular swelling subjacent to fixed dental prosthesis with one month of duration incisional biopsy were performed and after two day the patient wa hospitalized due to malaise and breathing difficulty and died after a week when an abdominal tumor wa detected the mandibular biopsy revealed a diffuse proliferation of mediumsized monomorphic atypical lymphoid cell exhibiting numerous mitoses and area of starrysky pattern the tumor showed immunohistochemical positivity for cd cd bcl and ki it wa negative for cd bcl vsc and mum positivity for ebv wa found by in situ hybridization the final diagnosis wa intraoral sbl positive for ebv clinical morphological and molecular criterion are necessary for the correct diagnosis of aggressive bcell neoplasm positive for ebv in elderly patient,Cancer,0,intraoral ebvpositive sporadic burkitt lymphoma in an elderly patient with bilateral presentation sporadic burkitt lymphoma sbl is a variant of burkitt lymphoma that occurs worldwide affecting mainly child and young adult association with epsteinbarr virus ebv can be identified in approximately of case herein we described a case of a yearold male presenting intraoral bilateral mandibular swelling subjacent to fixed dental prosthesis with one month of duration incisional biopsy were performed and after two day the patient wa hospitalized due to malaise and breathing difficulty and died after a week when an abdominal tumor wa detected the mandibular biopsy revealed a diffuse proliferation of mediumsized monomorphic atypical lymphoid cell exhibiting numerous mitoses and area of starrysky pattern the tumor showed immunohistochemical positivity for cd cd bcl and ki it wa negative for cd bcl vsc and mum positivity for ebv wa found by in situ hybridization the final diagnosis wa intraoral sbl positive for ebv clinical morphological and molecular criterion are necessary for the correct diagnosis of aggressive bcell neoplasm positive for ebv in elderly patient
31647020,a rare simultaneous coexistence of epithelioid gastrointestinal stromal tumor and schwannoma in the stomach a case report,background gastrointestinal stromal tumor gist a type of mesenchymal tumor in the gastrointestinal tract are believed to be closely associated with pdgfra and ckit mutation schwannoma in the stomach which is an unusual location is a rare disorder the simultaneous occurrence of the two disease is rarer than metachronous occurrence and it pathological characteristic have not been reported to date we present a case report on a patient with simultaneous coexistence of gastric schwannoma and gist case presentation a yearold female visited our hospital complaining of intermittent abdominal pain for the previous month ct revealed a cm slight homogeneous enhancement in the lesser curvature of the stomach the mass wa nodular soft tissue which wa removed by radical surgery two solid tumor with different volume were located in the stomach histologically and immunohistochemically different the larger tumor consisted of spindle cell surrounded by a peripheral lymphoid cuff and wa positive for s the larger tumor wa therefore classified a a gastric schwannoma the smaller tumor wa composed of mediumsized round oval cell with amphiphilic granular cytoplasm vacuolization wa also observed the tumor cell were positive for dog and sporadically positive for cd and cd hence the smaller tumor wa diagnosed a epithelioid gist sanger sequencing revealed that the gist tumor cell contained a deletion mutation c deldel which wa located in exon of pdgfra conclusion gist combined with gastric schwannoma are a considerably rare subgroup of gastric tumor related clinical research is comparatively weak and the mechanism remains unknown we reviewed related article to provide knowledge to improve the correct identification diagnosis and management of patient with gastric cancer all pathologist involved in the diagnosis and clinician involved in the treatment should be aware of this new kind of disease pattern to improve their understanding of the disease,Cancer,0,a rare simultaneous coexistence of epithelioid gastrointestinal stromal tumor and schwannoma in the stomach a case report background gastrointestinal stromal tumor gist a type of mesenchymal tumor in the gastrointestinal tract are believed to be closely associated with pdgfra and ckit mutation schwannoma in the stomach which is an unusual location is a rare disorder the simultaneous occurrence of the two disease is rarer than metachronous occurrence and it pathological characteristic have not been reported to date we present a case report on a patient with simultaneous coexistence of gastric schwannoma and gist case presentation a yearold female visited our hospital complaining of intermittent abdominal pain for the previous month ct revealed a cm slight homogeneous enhancement in the lesser curvature of the stomach the mass wa nodular soft tissue which wa removed by radical surgery two solid tumor with different volume were located in the stomach histologically and immunohistochemically different the larger tumor consisted of spindle cell surrounded by a peripheral lymphoid cuff and wa positive for s the larger tumor wa therefore classified a a gastric schwannoma the smaller tumor wa composed of mediumsized round oval cell with amphiphilic granular cytoplasm vacuolization wa also observed the tumor cell were positive for dog and sporadically positive for cd and cd hence the smaller tumor wa diagnosed a epithelioid gist sanger sequencing revealed that the gist tumor cell contained a deletion mutation c deldel which wa located in exon of pdgfra conclusion gist combined with gastric schwannoma are a considerably rare subgroup of gastric tumor related clinical research is comparatively weak and the mechanism remains unknown we reviewed related article to provide knowledge to improve the correct identification diagnosis and management of patient with gastric cancer all pathologist involved in the diagnosis and clinician involved in the treatment should be aware of this new kind of disease pattern to improve their understanding of the disease
31650704,comparative aspect of mast cell neoplasia in animal and the role of kit in prognosis and treatment,mast cell neoplasia clinical presentation and biological behaviour vary considerably across mammalian specie ranging from a solitary benign mass to an aggressive systemic malignancy mutation in the kit protooncogene receptor tyrosine kinase kit gene are common molecular abnormality involved in mast cell tumorigenesis kit mutation often occur in dog cat and human neoplastic mast cell and result in altered kit protein structure and function in dog certain kit mutation are associated with more malignant and lethal disease in contrast kit mutation in feline and human mast cell neoplasm are not correlated with prognosis but are of value in diagnosis and treatment planning in human kit genetic abnormality have not been well investigated in other specie although aberrant cytoplasmic kit protein staining detected in neoplasm of the ferret horse and cow resembles aberrant kit staining pattern detected in neoplastic mast cell of dog cat and human mutation within kit are classified a either regulatorytype or enzymatic pockettype mutation according to their location within the kit protooncogene mutation within the enzymatic pocket domain confer tumour resistance to tyrosine kinase inhibitor tkis hence knowledge of tumour kit mutation status add valuable information for optimizing patient treatment strategy the use of tkis in combination with conventional chemotherapeutics ha opened a new treatment avenue for patient unresponsive to existing drug this review highlight the similarity and difference of mast cell neoplasia in mammal with a special focus on the involvement of kit in the canine and feline form in comparison to human mast cell neoplasia,Cancer,0,comparative aspect of mast cell neoplasia in animal and the role of kit in prognosis and treatment mast cell neoplasia clinical presentation and biological behaviour vary considerably across mammalian specie ranging from a solitary benign mass to an aggressive systemic malignancy mutation in the kit protooncogene receptor tyrosine kinase kit gene are common molecular abnormality involved in mast cell tumorigenesis kit mutation often occur in dog cat and human neoplastic mast cell and result in altered kit protein structure and function in dog certain kit mutation are associated with more malignant and lethal disease in contrast kit mutation in feline and human mast cell neoplasm are not correlated with prognosis but are of value in diagnosis and treatment planning in human kit genetic abnormality have not been well investigated in other specie although aberrant cytoplasmic kit protein staining detected in neoplasm of the ferret horse and cow resembles aberrant kit staining pattern detected in neoplastic mast cell of dog cat and human mutation within kit are classified a either regulatorytype or enzymatic pockettype mutation according to their location within the kit protooncogene mutation within the enzymatic pocket domain confer tumour resistance to tyrosine kinase inhibitor tkis hence knowledge of tumour kit mutation status add valuable information for optimizing patient treatment strategy the use of tkis in combination with conventional chemotherapeutics ha opened a new treatment avenue for patient unresponsive to existing drug this review highlight the similarity and difference of mast cell neoplasia in mammal with a special focus on the involvement of kit in the canine and feline form in comparison to human mast cell neoplasia
31653094,tumor brca test for patient with epithelial ovarian cancer the role of molecular pathology in the era of parp inhibitor therapy,the parp inhibitor olaparib ha been approved in the maintenance setting of platinumsensitive epithelial ovarian cancer patient with germline or somatic brca mutation therefore the availability of a tumor brca test ha become a clinical need we report the result of the clinical implementation of a tumor brca test within the frame of an institutional workflow for the management of patient with nonmucinous and nonborderline epithelial ovarian cancer in total patient with epithelial ovarian cancer were prospectively analyzed brca status wa evaluated on formalinfixed paraffinembedded tumor specimen using nextgeneration sequencing technology the tumor brca test had a success rate of of successfully analyzed case and a median turnaround time of calendar day among the case brca or brca pathogeniclikely pathogenic mutation were found in case and variant of uncertain significance in case the concordance rate between tumor brca test result and germline brca status wa with five case harboring pathogeniclikely pathogenic somaticonly mutation the nextgeneration sequencingbased tumor brca test showed a high success rate and a turnaround time compatible with clinical purpose the tumor brca test could be implemented in a molecular diagnostic setting and it may guide the clinical management of patient with epithelial ovarian cancer,Cancer,0,tumor brca test for patient with epithelial ovarian cancer the role of molecular pathology in the era of parp inhibitor therapy the parp inhibitor olaparib ha been approved in the maintenance setting of platinumsensitive epithelial ovarian cancer patient with germline or somatic brca mutation therefore the availability of a tumor brca test ha become a clinical need we report the result of the clinical implementation of a tumor brca test within the frame of an institutional workflow for the management of patient with nonmucinous and nonborderline epithelial ovarian cancer in total patient with epithelial ovarian cancer were prospectively analyzed brca status wa evaluated on formalinfixed paraffinembedded tumor specimen using nextgeneration sequencing technology the tumor brca test had a success rate of of successfully analyzed case and a median turnaround time of calendar day among the case brca or brca pathogeniclikely pathogenic mutation were found in case and variant of uncertain significance in case the concordance rate between tumor brca test result and germline brca status wa with five case harboring pathogeniclikely pathogenic somaticonly mutation the nextgeneration sequencingbased tumor brca test showed a high success rate and a turnaround time compatible with clinical purpose the tumor brca test could be implemented in a molecular diagnostic setting and it may guide the clinical management of patient with epithelial ovarian cancer
31655381,d magnetic mosfeo hybrid nanostructures for ultrasensitive exosome detection in gmr sensor,exosome released from cell play an important role in intercellular communication and show great clinical potential in early cancer screening and prognosis herein an ultrasensitive giant magnetoresistance gmr biosensor wa developed for exosome detection which wa based on d mosfeo nanostructures mofe a magnetic responsive probe for signal amplification the mofe can be readily synthesized with simple phase transfer method compared to pure feo magnetic nanoparticles mnps the layered mo function a a template for recruiting high loading density of mnps a magnetic probe after modified by aptamer we discover that the d magnetic mofe hybrid nanostructures enable both multidentate targeting and multimagnetic particlebased signal amplification increasing the magnetic sensor performance especially in sensitivity and output signal moreover the d magnetic nanocomposites afford high selectivity and excellent reproducibility with detection limit of exosomes in gmr sensor result demonstrate that the magnetic strategy based on d structure introduced here provide a new dimension for exosome detection which show great potential of engineering d magnetic nanobioprobes for gmr based liquid biopsy application,Cancer,0,d magnetic mosfeo hybrid nanostructures for ultrasensitive exosome detection in gmr sensor exosome released from cell play an important role in intercellular communication and show great clinical potential in early cancer screening and prognosis herein an ultrasensitive giant magnetoresistance gmr biosensor wa developed for exosome detection which wa based on d mosfeo nanostructures mofe a magnetic responsive probe for signal amplification the mofe can be readily synthesized with simple phase transfer method compared to pure feo magnetic nanoparticles mnps the layered mo function a a template for recruiting high loading density of mnps a magnetic probe after modified by aptamer we discover that the d magnetic mofe hybrid nanostructures enable both multidentate targeting and multimagnetic particlebased signal amplification increasing the magnetic sensor performance especially in sensitivity and output signal moreover the d magnetic nanocomposites afford high selectivity and excellent reproducibility with detection limit of exosomes in gmr sensor result demonstrate that the magnetic strategy based on d structure introduced here provide a new dimension for exosome detection which show great potential of engineering d magnetic nanobioprobes for gmr based liquid biopsy application
31679010,fineneedle aspiration feature of bcorccnb sarcoma,objective bcorccnb sarcoma bcs is an undifferentiated tumor that ha some clinical and morphologic similarity to classic ewing sarcoma but it is characterized by a distinct bcorccnb gene fusion there are no report describing it cytomorphologic finding method we describe cytologic finding of five molecularly proven bcs case four male and one female aged year result smear showed mainly round cell but some spindle cell and rhabdoidlike cell were also observed dispersed cell dominated in smear but also distinct pseudopapillary structure with vascular core were noted in four case scant connective tissue fragment were found in four case there wa no rosette formation in any case conclusion bcs should be differentiated from other round cell tumor some cytologic feature especially rhabdoidlike cell connective tissue fragment and pseudopapillary formation combined with immunohistochemical and molecular study may be helpful in making the appropriate diagnosis,Cancer,0,fineneedle aspiration feature of bcorccnb sarcoma objective bcorccnb sarcoma bcs is an undifferentiated tumor that ha some clinical and morphologic similarity to classic ewing sarcoma but it is characterized by a distinct bcorccnb gene fusion there are no report describing it cytomorphologic finding method we describe cytologic finding of five molecularly proven bcs case four male and one female aged year result smear showed mainly round cell but some spindle cell and rhabdoidlike cell were also observed dispersed cell dominated in smear but also distinct pseudopapillary structure with vascular core were noted in four case scant connective tissue fragment were found in four case there wa no rosette formation in any case conclusion bcs should be differentiated from other round cell tumor some cytologic feature especially rhabdoidlike cell connective tissue fragment and pseudopapillary formation combined with immunohistochemical and molecular study may be helpful in making the appropriate diagnosis
31681586,long noncoding rna in myeloid malignancy,acute myeloid leukemia aml represents of adult leukemia and of childhood leukemia aml are characterized by the presence of blast or more in the bone marrow or defining cytogenetic abnormality laboratory diagnosis of myelodysplastic syndrome md depend on morphological change based on dysplasia in peripheral blood and bone marrow including peripheral blood smear bone marrow aspirate smear and bone marrow biopsy a leukemic cell are not functional the patient develops anemia neutropenia and thrombocytopenia leading to fatigue recurrent infection and hemorrhage the genetic background and associated mutation in aml blast determine the clinical course of the disease over the last decade noncoding rna transcript that do not codify for protein but play a role in regulation of function have been shown to have multiple application in the diagnosis prognosis and therapeutic approach of various type of cancer including myeloid malignancy after a comprehensive review of current literature we found report of multiple long noncoding rna lncrnas that can differentiate between aml type and how their exogenous modulation can dramatically change the behavior of aml cell these lncrnas include h linc rpc crinde rpp znfas ac sfmbt linc meg ac pvt hottip snhg and ccat in addition by performing an analysis on available aml data in the cancer genome atlas tcga we found lncrnas with significantly differential expression between patient in favorable intermediatenormal or poor cytogenetic risk category these are dancr prdmdt snhg oipas snhg jpx ftx kcnqot tpas and gas the identification of a molecular signature based on lncrnas ha the potential for have deep clinical significance a it could potentially help better define the evolution from lowgrade md to highgrade md to aml changing the course of therapy this would allow clinician to provide a more personalized patienttailored therapeutic approach moving from transfusionbased therapy a is the case for lowgrade md to the introduction of azacytidinebased chemotherapy or allogeneic stem cell transplantation which is the current treatment for highgrade md,Cancer,0,long noncoding rna in myeloid malignancy acute myeloid leukemia aml represents of adult leukemia and of childhood leukemia aml are characterized by the presence of blast or more in the bone marrow or defining cytogenetic abnormality laboratory diagnosis of myelodysplastic syndrome md depend on morphological change based on dysplasia in peripheral blood and bone marrow including peripheral blood smear bone marrow aspirate smear and bone marrow biopsy a leukemic cell are not functional the patient develops anemia neutropenia and thrombocytopenia leading to fatigue recurrent infection and hemorrhage the genetic background and associated mutation in aml blast determine the clinical course of the disease over the last decade noncoding rna transcript that do not codify for protein but play a role in regulation of function have been shown to have multiple application in the diagnosis prognosis and therapeutic approach of various type of cancer including myeloid malignancy after a comprehensive review of current literature we found report of multiple long noncoding rna lncrnas that can differentiate between aml type and how their exogenous modulation can dramatically change the behavior of aml cell these lncrnas include h linc rpc crinde rpp znfas ac sfmbt linc meg ac pvt hottip snhg and ccat in addition by performing an analysis on available aml data in the cancer genome atlas tcga we found lncrnas with significantly differential expression between patient in favorable intermediatenormal or poor cytogenetic risk category these are dancr prdmdt snhg oipas snhg jpx ftx kcnqot tpas and gas the identification of a molecular signature based on lncrnas ha the potential for have deep clinical significance a it could potentially help better define the evolution from lowgrade md to highgrade md to aml changing the course of therapy this would allow clinician to provide a more personalized patienttailored therapeutic approach moving from transfusionbased therapy a is the case for lowgrade md to the introduction of azacytidinebased chemotherapy or allogeneic stem cell transplantation which is the current treatment for highgrade md
31681608,epigenetic target in synovial sarcoma a minireview,synovial sarcoma s are a type of soft tissue sarcoma sts and represent of all sts case although s can arise at any age it typically affect younger individual aged and is therefore part of both pediatric and adult clinical practice s occurs primarily in the limb often near joint but can present anywhere it is characterized by the recurrent pathognomonic chromosomal translocation txpq that most frequently fuse ssx or ssx gene with s this lead to the expression of the ssssx fusion protein which cause disturbance in several interacting multiprotein complex such a the switchsucrose nonfermentable swisnf complex also known a the baf complex and the polycomb repressive complex and prc and prc furthermore this promotes widespread epigenetic rewiring leading to aberrant gene expression that drive the pathogenesis of s good prognosis are characterized predominantly by small tumor size and young patient age whereas high tumor grade and an increased genomic complexity of the tumor constitute poor prognostic factor the current therapeutic strategy relies on chemotherapy and radiotherapy the latter of which can lead to chronic side effect for pediatric patient we will focus on the known role of swisnf prc and prc a the main effector of the ssssxmediated genome modification and we present existing biological rationale for potential therapeutic target and treatment strategy,Cancer,0,epigenetic target in synovial sarcoma a minireview synovial sarcoma s are a type of soft tissue sarcoma sts and represent of all sts case although s can arise at any age it typically affect younger individual aged and is therefore part of both pediatric and adult clinical practice s occurs primarily in the limb often near joint but can present anywhere it is characterized by the recurrent pathognomonic chromosomal translocation txpq that most frequently fuse ssx or ssx gene with s this lead to the expression of the ssssx fusion protein which cause disturbance in several interacting multiprotein complex such a the switchsucrose nonfermentable swisnf complex also known a the baf complex and the polycomb repressive complex and prc and prc furthermore this promotes widespread epigenetic rewiring leading to aberrant gene expression that drive the pathogenesis of s good prognosis are characterized predominantly by small tumor size and young patient age whereas high tumor grade and an increased genomic complexity of the tumor constitute poor prognostic factor the current therapeutic strategy relies on chemotherapy and radiotherapy the latter of which can lead to chronic side effect for pediatric patient we will focus on the known role of swisnf prc and prc a the main effector of the ssssxmediated genome modification and we present existing biological rationale for potential therapeutic target and treatment strategy
33372216,stereotactic radiosurgery for choroid plexus tumor a report of the international radiosurgery research foundation,choroid plexus tumor cpt are rare epithelial tumor of the choroid plexus gross total resection gtr may be curative but it is not always possible,Cancer,0,stereotactic radiosurgery for choroid plexus tumor a report of the international radiosurgery research foundation choroid plexus tumor cpt are rare epithelial tumor of the choroid plexus gross total resection gtr may be curative but it is not always possible
33649522,genetic metaanalysis of cancer diagnosis following statin use identifies new association and implicates human leukocyte antigen hla in woman,we sought to perform a genomic evaluation of the risk of incident cancer in statin user free of cancer at study entry patient who previously participated in two phase iv trial tnt and ideal with genetic data were used npooled a gwas metaanalysis using cox modeling for the prediction of incident cancer wa conducted in the pooled cohort and sexstratified r near hladoa gene wa associated with higher risk of incident cancer amongst woman with prevalent coronary artery disease cad taking statin hazard ratio hr confidence interval ci p  using the uk biobank and focusing exclusively on woman statin user with cad nfemale r remained significantly associated with incident cancer hr ci p  the association wa not observed in nonstatin user in this genetic metaanalysis we have identified a variant in woman statin user with prevalent cad that wa associated with incident cancer possibly implicating the human leukocyte antigen pathway,Cancer,0,genetic metaanalysis of cancer diagnosis following statin use identifies new association and implicates human leukocyte antigen hla in woman we sought to perform a genomic evaluation of the risk of incident cancer in statin user free of cancer at study entry patient who previously participated in two phase iv trial tnt and ideal with genetic data were used npooled a gwas metaanalysis using cox modeling for the prediction of incident cancer wa conducted in the pooled cohort and sexstratified r near hladoa gene wa associated with higher risk of incident cancer amongst woman with prevalent coronary artery disease cad taking statin hazard ratio hr confidence interval ci p  using the uk biobank and focusing exclusively on woman statin user with cad nfemale r remained significantly associated with incident cancer hr ci p  the association wa not observed in nonstatin user in this genetic metaanalysis we have identified a variant in woman statin user with prevalent cad that wa associated with incident cancer possibly implicating the human leukocyte antigen pathway
35285277,single agent v or v plus defactinib in krasmutant nonsmallcell lung cancer the ramp phase ii trial,kras mutation occur in approximately of lung adenocarcinoma mainly in codon of case pgc being the prevalent one followed by pgv and pgd and respectively treatment option for advanced kras mutant nonsmallcell lung cancer krasmt nsclc are limited to chemotherapy and immune checkpoint inhibitor cpi however clinical trial exploring specific targeted agent are expected to change the treatment landscape of this disease here we describe the design and scientific rationale of the randomized phase ii open label ramp study which will evaluate the efficacy and safety of v versus v in combination with defactinib in advanced krasmt nsclc patient after failure of prior platinumbased chemotherapy and cpi,Cancer,0,single agent v or v plus defactinib in krasmutant nonsmallcell lung cancer the ramp phase ii trial kras mutation occur in approximately of lung adenocarcinoma mainly in codon of case pgc being the prevalent one followed by pgv and pgd and respectively treatment option for advanced kras mutant nonsmallcell lung cancer krasmt nsclc are limited to chemotherapy and immune checkpoint inhibitor cpi however clinical trial exploring specific targeted agent are expected to change the treatment landscape of this disease here we describe the design and scientific rationale of the randomized phase ii open label ramp study which will evaluate the efficacy and safety of v versus v in combination with defactinib in advanced krasmt nsclc patient after failure of prior platinumbased chemotherapy and cpi
35608106,targeting fgfr alteration with adjuvant infigratinib in invasive urothelial carcinoma the phase iii proof trial,proof is an ongoing randomized doubleblind placebocontrolled adjuvant phase iii trial nct in approximately patient from center worldwide eligibility criterion include postsurgical highrisk muscleinvasive upper tract urothelial cancer of patient or urothelial bladder cancer susceptible fgfr alteration activating mutation gene fusion or rearrangement  day following radical surgery and ineligible foror refusing cisplatinbased neoadjuvant chemotherapy patient receive either oral infigratinib mg or placebo daily on day of a day cycle for up to week or until recurrence unacceptable toxicity or death primary end point centrally determined diseasefree survival dfs secondary end point investigatorassessed dfs metastasisfree survival overall survival and safetytolerability exploratory end point correlative biomarker analysis qualityoflife and infigratinib pharmacokinetics,Cancer,0,targeting fgfr alteration with adjuvant infigratinib in invasive urothelial carcinoma the phase iii proof trial proof is an ongoing randomized doubleblind placebocontrolled adjuvant phase iii trial nct in approximately patient from center worldwide eligibility criterion include postsurgical highrisk muscleinvasive upper tract urothelial cancer of patient or urothelial bladder cancer susceptible fgfr alteration activating mutation gene fusion or rearrangement  day following radical surgery and ineligible foror refusing cisplatinbased neoadjuvant chemotherapy patient receive either oral infigratinib mg or placebo daily on day of a day cycle for up to week or until recurrence unacceptable toxicity or death primary end point centrally determined diseasefree survival dfs secondary end point investigatorassessed dfs metastasisfree survival overall survival and safetytolerability exploratory end point correlative biomarker analysis qualityoflife and infigratinib pharmacokinetics
35927017,clinicopathological characteristic genetics and prognosis of patient with myeloid sarcoma a singlecenter study,myeloid sarcoma m is a rare tumour comprising myeloid blast occurring at an anatomical site other than the bone marrow we sought to investigate both paediatric and adult patient with m diagnosed at our institution and determine possible correlation among their clinicopathological phenotypic molecular and prognostic feature,Cancer,0,clinicopathological characteristic genetics and prognosis of patient with myeloid sarcoma a singlecenter study myeloid sarcoma m is a rare tumour comprising myeloid blast occurring at an anatomical site other than the bone marrow we sought to investigate both paediatric and adult patient with m diagnosed at our institution and determine possible correlation among their clinicopathological phenotypic molecular and prognostic feature
35950566,libretto a phase iii study of adjuvant selpercatinib or placebo in stage ibiiia ret fusionpositive nonsmallcell lung cancer,selpercatinib a firstinclass highly selective and potent central nervous systemactive ret kinase inhibitor demonstrated clinically meaningful activity with manageable toxicity in pretreated and treatmentnaive advancedmetastatic ret fusionpositive nonsmallcell lung cancer nsclc libretto is a global randomized doubleblind phase iii trial evaluating selpercatinib versus placebo in stage ibiiia ret fusionpositive nsclc previously treated with definitive surgery or radiation participant must have undergone available anticancer therapy including chemotherapy or durvalumab or not be suitable for it per investigator discretion the primary end point is investigatorassessed eventfree survival efs in the primary analysis population stage iiiiia ret fusionpositive nsclc key secondary end point include efs in the overall population overall survival and time to distant disease recurrence in the central nervous system,Cancer,0,libretto a phase iii study of adjuvant selpercatinib or placebo in stage ibiiia ret fusionpositive nonsmallcell lung cancer selpercatinib a firstinclass highly selective and potent central nervous systemactive ret kinase inhibitor demonstrated clinically meaningful activity with manageable toxicity in pretreated and treatmentnaive advancedmetastatic ret fusionpositive nonsmallcell lung cancer nsclc libretto is a global randomized doubleblind phase iii trial evaluating selpercatinib versus placebo in stage ibiiia ret fusionpositive nsclc previously treated with definitive surgery or radiation participant must have undergone available anticancer therapy including chemotherapy or durvalumab or not be suitable for it per investigator discretion the primary end point is investigatorassessed eventfree survival efs in the primary analysis population stage iiiiia ret fusionpositive nsclc key secondary end point include efs in the overall population overall survival and time to distant disease recurrence in the central nervous system
35969032,libretto a phase iii study of selpercatinib in multikinase inhibitornave retmutant medullary thyroid cancer,selpercatinib is a firstinclass highly selective and potent central nervous systemactive ret kinase inhibitor in the phase iii trial selpercatinib demonstrated clinically meaningful antitumor activity with manageable toxicity in heavily pretreated and treatmentnaive patient with retmutant medullary thyroid cancer mtc libretto nct is a multicenter openlabel randomized controlled phase iii trial comparing selpercatinib to cabozantinib or vandetanib in patient with advancedmetastatic retmutant mtc the primary objective is to compare progressionfree survival per recist by blinded independent central review of patient with progressive advanced multikinase inhibitornaive retmutant mtc treated with selpercatinib versus cabozantinib or vandetanib key secondary objective are to compare other efficacy outcome per recist and tolerability of selpercatinib versus cabozantinib or vandetanib,Cancer,0,libretto a phase iii study of selpercatinib in multikinase inhibitornave retmutant medullary thyroid cancer selpercatinib is a firstinclass highly selective and potent central nervous systemactive ret kinase inhibitor in the phase iii trial selpercatinib demonstrated clinically meaningful antitumor activity with manageable toxicity in heavily pretreated and treatmentnaive patient with retmutant medullary thyroid cancer mtc libretto nct is a multicenter openlabel randomized controlled phase iii trial comparing selpercatinib to cabozantinib or vandetanib in patient with advancedmetastatic retmutant mtc the primary objective is to compare progressionfree survival per recist by blinded independent central review of patient with progressive advanced multikinase inhibitornaive retmutant mtc treated with selpercatinib versus cabozantinib or vandetanib key secondary objective are to compare other efficacy outcome per recist and tolerability of selpercatinib versus cabozantinib or vandetanib
36066851,epikoengotov alpelisib plus olaparib v cytotoxic chemotherapy in highgrade serous ovarian cancer phase iii study,patient with platinumresistant or refractory highgrade serous ovarian cancer hgsoc have a poor prognosis and their management represents a substantial unmet medical need preclinical data and result from a phase ib trial demonstrated the efficacy and tolerability of the combination of the specific phosphatidylinositolkinase pik inhibitor alpelisib plus the polyadenosine diphosphateribose polymerase parp inhibitor olaparib in platinumresistant nonbrcamutated ovarian cancer here we describe the study design and rationale for the phase iii multicenter openlabel randomized activecontrolled epikoengotov trial investigating alpelisib in combination with olaparib compared with standardofcare chemotherapy in patient with platinumresistant or refractory hgsoc with no germline brca mutation progressionfree survival blinded independent review committee is the primary end point overall survival is a key secondary end point clinical trial registration nct clinicaltrialsgov,Cancer,0,epikoengotov alpelisib plus olaparib v cytotoxic chemotherapy in highgrade serous ovarian cancer phase iii study patient with platinumresistant or refractory highgrade serous ovarian cancer hgsoc have a poor prognosis and their management represents a substantial unmet medical need preclinical data and result from a phase ib trial demonstrated the efficacy and tolerability of the combination of the specific phosphatidylinositolkinase pik inhibitor alpelisib plus the polyadenosine diphosphateribose polymerase parp inhibitor olaparib in platinumresistant nonbrcamutated ovarian cancer here we describe the study design and rationale for the phase iii multicenter openlabel randomized activecontrolled epikoengotov trial investigating alpelisib in combination with olaparib compared with standardofcare chemotherapy in patient with platinumresistant or refractory hgsoc with no germline brca mutation progressionfree survival blinded independent review committee is the primary end point overall survival is a key secondary end point clinical trial registration nct clinicaltrialsgov
36169546,hepatocellular adenoma subtypes based on classification system exploratory study of gadoxetate disodiumenhanced mri feature with proposal of a diagnostic algorithm,background the classification of hepatocellular adenoma hcas wa updated in on the basis of genetic and molecular analysis objective the purpose of this article wa to evaluate feature on gadoxetate disodiumenhanced mri of hca subtypes on the basis of the classification and to propose a diagnostic algorithm for determining subtype using these feature method this retrospective study included patient woman seven men mean age  sd year with histologically confirmed hca evaluated by gadoxetate disodiumenhanced mri from january to january subtypes were reclassified using criterion hepatocyte nuclear factor mutated hca hhca inflammatory hca ihca catenin exon activated hca hca mixed inflammatory and hca ihca sonic hedgehog hca shhca and unclassified hca uhca qualitative mri feature were assessed livertolesion contrast enhancement ratio llcers were measured subtypes were compared and a diagnostic algorithm wa proposed result the analysis included hcas hhcas ihcas six hca four ihca five shhca and three uhcas hhcas showed homogeneous diffuse intralesional steatosis in whereas all other hcas showed this finding in p p p p p the hcas and ihcas showed fluid component in whereas all other hcas showed this finding in p p conclusion finding on gadoxetate disodiumenhanced mri including hepatobiliary phase characteristic were associated with hca subtypes using the classification clinical impact the algorithm identified common hca subtypes with high accuracy including those with catenin exon mutation,Cancer,0,hepatocellular adenoma subtypes based on classification system exploratory study of gadoxetate disodiumenhanced mri feature with proposal of a diagnostic algorithm background the classification of hepatocellular adenoma hcas wa updated in on the basis of genetic and molecular analysis objective the purpose of this article wa to evaluate feature on gadoxetate disodiumenhanced mri of hca subtypes on the basis of the classification and to propose a diagnostic algorithm for determining subtype using these feature method this retrospective study included patient woman seven men mean age  sd year with histologically confirmed hca evaluated by gadoxetate disodiumenhanced mri from january to january subtypes were reclassified using criterion hepatocyte nuclear factor mutated hca hhca inflammatory hca ihca catenin exon activated hca hca mixed inflammatory and hca ihca sonic hedgehog hca shhca and unclassified hca uhca qualitative mri feature were assessed livertolesion contrast enhancement ratio llcers were measured subtypes were compared and a diagnostic algorithm wa proposed result the analysis included hcas hhcas ihcas six hca four ihca five shhca and three uhcas hhcas showed homogeneous diffuse intralesional steatosis in whereas all other hcas showed this finding in p p p p p the hcas and ihcas showed fluid component in whereas all other hcas showed this finding in p p conclusion finding on gadoxetate disodiumenhanced mri including hepatobiliary phase characteristic were associated with hca subtypes using the classification clinical impact the algorithm identified common hca subtypes with high accuracy including those with catenin exon mutation
36200726,the utility of ctdna in colorectal cancer with peritoneal metastasis,the development of peritoneal metastasis pm in patient with colorectal cancer crc connotates a poor prognosis circulating tumour ctdna is a promising tumour biomarker in the management crc this systematic review aimed to summarize the role of ctdna in patient with crc and pm,Cancer,0,the utility of ctdna in colorectal cancer with peritoneal metastasis the development of peritoneal metastasis pm in patient with colorectal cancer crc connotates a poor prognosis circulating tumour ctdna is a promising tumour biomarker in the management crc this systematic review aimed to summarize the role of ctdna in patient with crc and pm
36210487,black patient with metastatic castrateresistant prostate cancer have a shorter time interval between psa and clinical progression on novel hormonal therapy plus avelumab,black men are at higher risk for prostate cancer death previous study showed a benefit of different therapy including immunebased therapy for black men with metastatic prostate cancer we sought to explore the efficacy of the pdl inhibitor avelumab in black men with metastatic castrateresistant prostate cancer mcrpc progressing after abiraterone or enzalutamide,Cancer,0,black patient with metastatic castrateresistant prostate cancer have a shorter time interval between psa and clinical progression on novel hormonal therapy plus avelumab black men are at higher risk for prostate cancer death previous study showed a benefit of different therapy including immunebased therapy for black men with metastatic prostate cancer we sought to explore the efficacy of the pdl inhibitor avelumab in black men with metastatic castrateresistant prostate cancer mcrpc progressing after abiraterone or enzalutamide
36210645,clinical result of active surveillance for extraabdominal desmoidtype fibromatosis,the treatment of choice for desmoidtype fibromatosis df ha been changed to active surveillance a however few study have reported clinical outcome of a modality in asian country this study aimed to clarify the significance of a a a df treatment modality,Cancer,0,clinical result of active surveillance for extraabdominal desmoidtype fibromatosis the treatment of choice for desmoidtype fibromatosis df ha been changed to active surveillance a however few study have reported clinical outcome of a modality in asian country this study aimed to clarify the significance of a a a df treatment modality
36343306,in multiple myeloma highrisk secondary genetic event observed at relapse are present from diagnosis in tiny undetectable subclonal population,multiple myeloma mm is characterized by copy number abnormality cnas some of which influence patient outcome and are sometimes observed only at relapse suggesting their acquisition during tumor evolution however the presence of microsubclones may be missed in bulk analysis here we use singlecell genomics to determine how often these highrisk event are missed at diagnosis and selected at relapse,Cancer,0,in multiple myeloma highrisk secondary genetic event observed at relapse are present from diagnosis in tiny undetectable subclonal population multiple myeloma mm is characterized by copy number abnormality cnas some of which influence patient outcome and are sometimes observed only at relapse suggesting their acquisition during tumor evolution however the presence of microsubclones may be missed in bulk analysis here we use singlecell genomics to determine how often these highrisk event are missed at diagnosis and selected at relapse
36346441,a threecomponent multibvalue diffusionweighted imaging might be a useful biomarker for detecting microstructural feature in glioma with difference in malignancy and idh mutation status,the purpose of the study wa to explore the performance of a threecomponent diffusion model in evaluating the degree of malignancy and isocitrate dehydrogenase idh gene type of glioma,Cancer,0,a threecomponent multibvalue diffusionweighted imaging might be a useful biomarker for detecting microstructural feature in glioma with difference in malignancy and idh mutation status the purpose of the study wa to explore the performance of a threecomponent diffusion model in evaluating the degree of malignancy and isocitrate dehydrogenase idh gene type of glioma
36356599,nonviral precision t cell receptor replacement for personalized cell therapy,t cell receptor tcrs enable t cell to specifically recognize mutation in cancer cell here we developed a clinicalgrade approach based on crisprcas nonviral precision genomeediting to simultaneously knockout the two endogenous tcr gene trac which encodes tcr and trbc which encodes tcr we also inserted into the trac locus two chain of a neoantigenspecific tcr neotcr isolated from circulating t cell of patient the neotcrs were isolated using a personalized library of soluble predicted neoantigenhla capture reagent sixteen patient with different refractory solid cancer received up to three distinct neotcr transgenic cell product each product expressed a patientspecific neotcr and wa administered in a celldoseescalation firstinhuman phase i clinical trial nct one patient had grade cytokine release syndrome and one patient had grade encephalitis all participant had the expected side effect from the lymphodepleting chemotherapy five patient had stable disease and the other eleven had disease progression a the best response on the therapy neotcr transgenic t cell were detected in tumour biopsy sample after infusion at frequency higher than the native tcrs before infusion this study demonstrates the feasibility of isolating and cloning multiple tcrs that recognize mutational neoantigens moreover simultaneous knockout of the endogenous tcr and knockin of neotcrs using singlestep nonviral precision genomeediting are achieved the manufacture of neotcr engineered t cell at clinical grade the safety of infusing up to three geneedited neotcr t cell product and the ability of the transgenic t cell to traffic to the tumour of patient are also demonstrated,Cancer,0,nonviral precision t cell receptor replacement for personalized cell therapy t cell receptor tcrs enable t cell to specifically recognize mutation in cancer cell here we developed a clinicalgrade approach based on crisprcas nonviral precision genomeediting to simultaneously knockout the two endogenous tcr gene trac which encodes tcr and trbc which encodes tcr we also inserted into the trac locus two chain of a neoantigenspecific tcr neotcr isolated from circulating t cell of patient the neotcrs were isolated using a personalized library of soluble predicted neoantigenhla capture reagent sixteen patient with different refractory solid cancer received up to three distinct neotcr transgenic cell product each product expressed a patientspecific neotcr and wa administered in a celldoseescalation firstinhuman phase i clinical trial nct one patient had grade cytokine release syndrome and one patient had grade encephalitis all participant had the expected side effect from the lymphodepleting chemotherapy five patient had stable disease and the other eleven had disease progression a the best response on the therapy neotcr transgenic t cell were detected in tumour biopsy sample after infusion at frequency higher than the native tcrs before infusion this study demonstrates the feasibility of isolating and cloning multiple tcrs that recognize mutational neoantigens moreover simultaneous knockout of the endogenous tcr and knockin of neotcrs using singlestep nonviral precision genomeediting are achieved the manufacture of neotcr engineered t cell at clinical grade the safety of infusing up to three geneedited neotcr t cell product and the ability of the transgenic t cell to traffic to the tumour of patient are also demonstrated
36380563,the effect of egfrtkis on survival in advanced nonsmallcell lung cancer with egfr mutation a realworld study,few largescale study have been published using realworld data related to overall survival o improvement in advanced epidermal growth factor receptor egfrmutant lung cancer patient therefore little is known regarding the characteristic of patient who could benefit most from egfrtyrosine kinase inhibitor tkis our study aimed to assess whether egfrtki treatment confers survival benefit among advanced nonsmallcell lung cancer nsclc patient harboring egfr mutation in the chinese population,Cancer,0,the effect of egfrtkis on survival in advanced nonsmallcell lung cancer with egfr mutation a realworld study few largescale study have been published using realworld data related to overall survival o improvement in advanced epidermal growth factor receptor egfrmutant lung cancer patient therefore little is known regarding the characteristic of patient who could benefit most from egfrtyrosine kinase inhibitor tkis our study aimed to assess whether egfrtki treatment confers survival benefit among advanced nonsmallcell lung cancer nsclc patient harboring egfr mutation in the chinese population
36422647,prediction of outcome in patient with local recurrent nasopharyngeal carcinoma development and validation of a fourfactor prognostic model integrating baseline characteristic and ffdg petct parameter,to investigate the prognostic value of ffdg petct parameter in local recurrent nasopharyngeal carcinoma lrnpc and establish a prognostic tool for lrnpc patient based on these ffdg petct parameter,Cancer,0,prediction of outcome in patient with local recurrent nasopharyngeal carcinoma development and validation of a fourfactor prognostic model integrating baseline characteristic and ffdg petct parameter to investigate the prognostic value of ffdg petct parameter in local recurrent nasopharyngeal carcinoma lrnpc and establish a prognostic tool for lrnpc patient based on these ffdg petct parameter
36453446,pretreatment neutrophiltolymphocyte ratio significantly affect progression free survival in positive egfr mutation advanced lung adenocarcinoma with egfrtki treatment in bali indonesia,introduction today recommendation about initial response evaluation criterion in solid tumor recist and it frequency still vary while early diagnosis of progression affect patient prognosis and subsequent treatment option method this study aim to examine progression free survival pfs of positive egfr mutation advanced lung adenocarcinoma receiving tyrosine kinase inhibitor tki and factor that influence it this wa an observational study with retrospective cohort design conducted at prof igng ngoerah hospital from january to december sample wa data from epidermal growth factor receptor egfr positive mutation advanced lung adenocarcinoma patient who were treated with egfrtki at prof igng ngoerah hospital denpasar bali from january to february total sample wa result median pfs wa month ci and minimum pfs wa month in univariate analysis hazard ration hr of older age smoker distant metastasis brain metastasis increased neutrophiltolymphocyte ration nlr and exon mutation to shorter pfs wa ci ci ci ci ci and ci multivariate analysis showed only increased nlr affected pfs significantly with hr ci conclusion median pfs of egfr positive mutation advanced lung adenocarcinoma patient who received tki wa month and minimum value wa month increased age smoking distant metastasis brain metastasis and exon mutation were not associated with pfs nlr significantly affected pfs,Cancer,0,pretreatment neutrophiltolymphocyte ratio significantly affect progression free survival in positive egfr mutation advanced lung adenocarcinoma with egfrtki treatment in bali indonesia introduction today recommendation about initial response evaluation criterion in solid tumor recist and it frequency still vary while early diagnosis of progression affect patient prognosis and subsequent treatment option method this study aim to examine progression free survival pfs of positive egfr mutation advanced lung adenocarcinoma receiving tyrosine kinase inhibitor tki and factor that influence it this wa an observational study with retrospective cohort design conducted at prof igng ngoerah hospital from january to december sample wa data from epidermal growth factor receptor egfr positive mutation advanced lung adenocarcinoma patient who were treated with egfrtki at prof igng ngoerah hospital denpasar bali from january to february total sample wa result median pfs wa month ci and minimum pfs wa month in univariate analysis hazard ration hr of older age smoker distant metastasis brain metastasis increased neutrophiltolymphocyte ration nlr and exon mutation to shorter pfs wa ci ci ci ci ci and ci multivariate analysis showed only increased nlr affected pfs significantly with hr ci conclusion median pfs of egfr positive mutation advanced lung adenocarcinoma patient who received tki wa month and minimum value wa month increased age smoking distant metastasis brain metastasis and exon mutation were not associated with pfs nlr significantly affected pfs
36475784,tresbien ogsg encorafenib binimetinib and cetuximab for early recurrent stage iiiii braf vemutated colorectal cancer,the braf ve mutation account for approximately of colorectal cancer crc case and is an extremely poor prognostic factor however there are no clear recommendation regarding firstline therapy for patient with early recurrent braf vemutated crc during or after adjuvant chemotherapy recently a novel combination of encorafenib binimetinib and cetuximab showed a higher response rate than standard chemotherapy in patient with braf vemutated crc here we describe our plan for the tresbien study ogsg which is an openlabel multicenter singlearm phase ii study designed to evaluate whether encorafenib binimetinib and cetuximab are effective for patient with early recurrent braf vemutated colorectal cancer during or after adjuvant chemotherapy the planned number of subject is,Cancer,0,tresbien ogsg encorafenib binimetinib and cetuximab for early recurrent stage iiiii braf vemutated colorectal cancer the braf ve mutation account for approximately of colorectal cancer crc case and is an extremely poor prognostic factor however there are no clear recommendation regarding firstline therapy for patient with early recurrent braf vemutated crc during or after adjuvant chemotherapy recently a novel combination of encorafenib binimetinib and cetuximab showed a higher response rate than standard chemotherapy in patient with braf vemutated crc here we describe our plan for the tresbien study ogsg which is an openlabel multicenter singlearm phase ii study designed to evaluate whether encorafenib binimetinib and cetuximab are effective for patient with early recurrent braf vemutated colorectal cancer during or after adjuvant chemotherapy the planned number of subject is
36517606,temporary inferior vena cava filter factor associated with nonremoval,inferior vena cava filter ivcf placement is indicated when there is a deep vein thrombosis andor a pulmonary embolism and a contraindication of anticoagulation due to the increased risk of recurrent deep venous thrombosis when left in place ivcf removal is indicated once anticoagulant treatment can be reintroduced however many temporary ivcf are not removed we aimed to analyze the removal rate and predictor of filter nonremoval in a university hospital setting,Cancer,0,temporary inferior vena cava filter factor associated with nonremoval inferior vena cava filter ivcf placement is indicated when there is a deep vein thrombosis andor a pulmonary embolism and a contraindication of anticoagulation due to the increased risk of recurrent deep venous thrombosis when left in place ivcf removal is indicated once anticoagulant treatment can be reintroduced however many temporary ivcf are not removed we aimed to analyze the removal rate and predictor of filter nonremoval in a university hospital setting
36542815,circulating tumor dna profiling for detection risk stratification and classification of brain lymphoma,clinical outcome of patient with cns lymphoma cnsls are remarkably heterogeneous yet identification of patient at high risk for treatment failure is challenging furthermore cnsl diagnosis often remains unconfirmed because of contraindication for invasive stereotactic biopsy therefore improved biomarkers are needed to better stratify patient into risk group predict treatment response and noninvasively identify cnsl,Cancer,0,circulating tumor dna profiling for detection risk stratification and classification of brain lymphoma clinical outcome of patient with cns lymphoma cnsls are remarkably heterogeneous yet identification of patient at high risk for treatment failure is challenging furthermore cnsl diagnosis often remains unconfirmed because of contraindication for invasive stereotactic biopsy therefore improved biomarkers are needed to better stratify patient into risk group predict treatment response and noninvasively identify cnsl
36572322,reconstruction of primary and secondary aortic infection with an antimicrobial graft,in situ reconstruction isr with autologous vein is the preferred method in infectious native aortic aneurysm inaas or vascular endograft infection vgei however access to biological substitute can prove difficult and lack versatility this study evaluates survival and freedom from reinfection after isr of inaavgei using the antimicrobial intergard synergy graft combining silver and triclosan,Cancer,0,reconstruction of primary and secondary aortic infection with an antimicrobial graft in situ reconstruction isr with autologous vein is the preferred method in infectious native aortic aneurysm inaas or vascular endograft infection vgei however access to biological substitute can prove difficult and lack versatility this study evaluates survival and freedom from reinfection after isr of inaavgei using the antimicrobial intergard synergy graft combining silver and triclosan
36586323,is there a role for tumor volume in prediction of prognosis for oral cancer,new prognostic factor in oral squamous cell carcinoma oscc tumor host and environmentrelated have been introduced recently to complete those traditionally considered among them tumor volume tv could be the most interesting and applicable in clinical practice considering the routine use of computed tomography in tumor staging in this retrospective study we aimed to investigate whether a correlation exists among these new prognostic factor and survival outcome,Cancer,0,is there a role for tumor volume in prediction of prognosis for oral cancer new prognostic factor in oral squamous cell carcinoma oscc tumor host and environmentrelated have been introduced recently to complete those traditionally considered among them tumor volume tv could be the most interesting and applicable in clinical practice considering the routine use of computed tomography in tumor staging in this retrospective study we aimed to investigate whether a correlation exists among these new prognostic factor and survival outcome
36606708,sequence analysis of relapsed or refractory diffuse large bcell lymphoma unravel three genetic subgroup of patient and the gna mutant a poor prognostic biomarker result of lnhep study,advance in molecular profiling of newly diagnosed diffuse large bcell lymphoma dlbcl have recently refine genetic subgroup genetic subgroup remain undetermined at the time of relapse or refractory rr disease this study aim to decipher genetic subgroup and search for prognostic molecular biomarkers in patient with rrdlbcl from to targeted nextgeneration sequencing analysis of germlinematched tumor sample and fresh tissue from rrdlbcl patient were performed unsupervised clustering of somatic mutation wa performed and correlation with patient outcome were sought a number of patient with rrdlbcl were included in lnhep study and a molecular tumor landscape wa successfully analyzed in of patient tumor sample the median age wa year range median number of previous treatment wa range the most frequently mutated gene were tp n mutation of sample crebbp n bcl n kmtd n and pim n unsupervised clustering separated three genetic subgroup entitled bst enriched in bcl socs and tnfrsf mutation tks enriched in tp kmtd and stat mutation and pcm enriched in pim cdb and myd mutation median overall survival o wa confidence interval ci month o wa not significantly different between the three genetic subgroup gna mutant wa significantly associated with an increased risk of death hazard ratio ci p and shorter o p at the time of relapse or refractory disease three genetic subgroup of dlbcl patient were delineated which could help advance precision molecular medicine program,Cancer,0,sequence analysis of relapsed or refractory diffuse large bcell lymphoma unravel three genetic subgroup of patient and the gna mutant a poor prognostic biomarker result of lnhep study advance in molecular profiling of newly diagnosed diffuse large bcell lymphoma dlbcl have recently refine genetic subgroup genetic subgroup remain undetermined at the time of relapse or refractory rr disease this study aim to decipher genetic subgroup and search for prognostic molecular biomarkers in patient with rrdlbcl from to targeted nextgeneration sequencing analysis of germlinematched tumor sample and fresh tissue from rrdlbcl patient were performed unsupervised clustering of somatic mutation wa performed and correlation with patient outcome were sought a number of patient with rrdlbcl were included in lnhep study and a molecular tumor landscape wa successfully analyzed in of patient tumor sample the median age wa year range median number of previous treatment wa range the most frequently mutated gene were tp n mutation of sample crebbp n bcl n kmtd n and pim n unsupervised clustering separated three genetic subgroup entitled bst enriched in bcl socs and tnfrsf mutation tks enriched in tp kmtd and stat mutation and pcm enriched in pim cdb and myd mutation median overall survival o wa confidence interval ci month o wa not significantly different between the three genetic subgroup gna mutant wa significantly associated with an increased risk of death hazard ratio ci p and shorter o p at the time of relapse or refractory disease three genetic subgroup of dlbcl patient were delineated which could help advance precision molecular medicine program
36607719,application of intraoperative rapid molecular diagnosis in precision surgery for glioma mimic the world health organization cns integrated diagnosis,with the advent of the molecular era the diagnosis and treatment system of glioma have also changed a single histological type can not be used for prognosis grade only by combining molecular diagnosis can precision medicine be realized,Cancer,0,application of intraoperative rapid molecular diagnosis in precision surgery for glioma mimic the world health organization cns integrated diagnosis with the advent of the molecular era the diagnosis and treatment system of glioma have also changed a single histological type can not be used for prognosis grade only by combining molecular diagnosis can precision medicine be realized
36610490,phase i study safety and efficacy of an ex vivoexpanded allogeneic natural killer cell mg with rituximab for relapsedrefractory b cell nonhodgkin lymphoma,the prognosis of nonhodgkin lymphoma nhl remains poor with an unmet need for novel therapy mg an ex vivoexpanded allogeneic natural killer nk cell can enhance rituximab antibodydependent cytotoxicity in relapsedrefractory rr b cell nonhodgkin lymphoma this study assessed the safety and efficacy of mg plus rituximab for patient with rr nhl patient received escalating dos of iv mg plus rituximab every week il wa administered sc after mg treatment fludarabine plus cyclophosphamide wa administered iv before rituximab treatment in cycle and a design wa used to determine the maximum tolerated dose mtd and maximum feasible dose assessment were performed over a cycle period with an extended maintenance period of up to cycle nine patient received different dos of mg and rituximab mtd could not be determined because of the absence of doselimiting toxicity treatmentrelated adverse event mostly grade or occurred in of patient only patient experienced grade cytokine release syndrome mg persisted for at least day in patient four patient achieved a partial response and patient attained a complete response for an overall response rate of two patient showed prolonged response and low exhaustion marker level in t cell for allogeneic nk cell therapy strategy including the use of the highaffinity hfcriiiav variant of the kir bx haplotype with lymphodepleting chemotherapy may be promising option for improving clinical efficacy in the antibody combination therapeutic setting a an offtheshelf product mg plus rituximab presented a favorable safety profile and overall response rate in patient with rr nhl,Cancer,0,phase i study safety and efficacy of an ex vivoexpanded allogeneic natural killer cell mg with rituximab for relapsedrefractory b cell nonhodgkin lymphoma the prognosis of nonhodgkin lymphoma nhl remains poor with an unmet need for novel therapy mg an ex vivoexpanded allogeneic natural killer nk cell can enhance rituximab antibodydependent cytotoxicity in relapsedrefractory rr b cell nonhodgkin lymphoma this study assessed the safety and efficacy of mg plus rituximab for patient with rr nhl patient received escalating dos of iv mg plus rituximab every week il wa administered sc after mg treatment fludarabine plus cyclophosphamide wa administered iv before rituximab treatment in cycle and a design wa used to determine the maximum tolerated dose mtd and maximum feasible dose assessment were performed over a cycle period with an extended maintenance period of up to cycle nine patient received different dos of mg and rituximab mtd could not be determined because of the absence of doselimiting toxicity treatmentrelated adverse event mostly grade or occurred in of patient only patient experienced grade cytokine release syndrome mg persisted for at least day in patient four patient achieved a partial response and patient attained a complete response for an overall response rate of two patient showed prolonged response and low exhaustion marker level in t cell for allogeneic nk cell therapy strategy including the use of the highaffinity hfcriiiav variant of the kir bx haplotype with lymphodepleting chemotherapy may be promising option for improving clinical efficacy in the antibody combination therapeutic setting a an offtheshelf product mg plus rituximab presented a favorable safety profile and overall response rate in patient with rr nhl
36621911,diagnosis and management of parathyroid carcinoma a stateoftheart review,parathyroid carcinoma is one of the least common endocrine malignancy and account for approximately of all patient with primary hyperparathyroidism a systematic review of peerreviewed literature published between january and march via medline embase cochrane central register of controlled trial eudract clinicaltrialsgov cinahl and scopus wa conducted manuscript were eligible if they included data on adult nonpregnant population with parathyroid carcinoma no restriction regarding intervention comparators or duration of followup were imposed single case report review or metaanalyses were excluded outcome of interest were molecular pathogenesis clinical presentation differential diagnosis treatment followup and overall survival study quality wa evaluated using the newcastleottawa scale for observational study this review included study from country reporting on more than patient with parathyroid carcinoma cdc mutation ha been recognised a playing a pivotal role in molecular pathogenesis parathyroid carcinoma typically present with markedly increased calcium and parathyroid hormone level the most frequently described symptom were bone and muscle pain or weakness en bloc resection remains the gold standard for the surgical approach the year overall survival ranged from to with resistant hypercalcaemia a significant cause of mortality emerging evidence indicating that targeted therapy based on molecular biomarkers present a novel treatment option the rarity of pc and need for personalised treatment warrant multidisciplinary management in a centre of excellence with a track record in pc management,Cancer,0,diagnosis and management of parathyroid carcinoma a stateoftheart review parathyroid carcinoma is one of the least common endocrine malignancy and account for approximately of all patient with primary hyperparathyroidism a systematic review of peerreviewed literature published between january and march via medline embase cochrane central register of controlled trial eudract clinicaltrialsgov cinahl and scopus wa conducted manuscript were eligible if they included data on adult nonpregnant population with parathyroid carcinoma no restriction regarding intervention comparators or duration of followup were imposed single case report review or metaanalyses were excluded outcome of interest were molecular pathogenesis clinical presentation differential diagnosis treatment followup and overall survival study quality wa evaluated using the newcastleottawa scale for observational study this review included study from country reporting on more than patient with parathyroid carcinoma cdc mutation ha been recognised a playing a pivotal role in molecular pathogenesis parathyroid carcinoma typically present with markedly increased calcium and parathyroid hormone level the most frequently described symptom were bone and muscle pain or weakness en bloc resection remains the gold standard for the surgical approach the year overall survival ranged from to with resistant hypercalcaemia a significant cause of mortality emerging evidence indicating that targeted therapy based on molecular biomarkers present a novel treatment option the rarity of pc and need for personalised treatment warrant multidisciplinary management in a centre of excellence with a track record in pc management
36621979,loss of cbx cause genomic instability and wnt activation in high grade serous ovarian carcinoma cell,high grade serous ovarian carcinoma hgsoc is lethal with insidious onset rapid progression poor prognosis and limited treatment option polycomb repressor complex prc and are intimately involved in progression of many type of cancer including hgsoc unlike the consistent constitution of prc prc consists of diverse component whose clinical significance in hgsoc are not entirely clear here prognosisassociated prc component were identified through datamining cbx promoted proliferation and reduced apoptosis of hgsoc cell line ovcar ovcar and caov complete loss of cbx by crisprcas editing cbxko destabilized genome stability with increased spontaneous chromosomal break and tendency to polyploidy accompanied by disrupted cell cycle especially stalled gm transition and caused severe cell death wntcateninleftcfl wa activated in surviving ovcarcbxko clone to bypass the crisis caused by loss of cbx the relieve of tcfl corepromoter region occupied by cbx might be one of the possible explanation to tcfl increase in ovcarcbxko clone subcutaneous tumor model further validated that depletion of cbx repressed hgsoc cell line derived tumor growth high immunohistochemistry score of cbx in primary ovarian cancer tissue associated with advanced clinical stage p poor overall survival hr ci and progression free survival hr ci in hgsoc overall our result suggested that cbx wa a promising prognostic factor and therapeutic target in hgsoc,Cancer,0,loss of cbx cause genomic instability and wnt activation in high grade serous ovarian carcinoma cell high grade serous ovarian carcinoma hgsoc is lethal with insidious onset rapid progression poor prognosis and limited treatment option polycomb repressor complex prc and are intimately involved in progression of many type of cancer including hgsoc unlike the consistent constitution of prc prc consists of diverse component whose clinical significance in hgsoc are not entirely clear here prognosisassociated prc component were identified through datamining cbx promoted proliferation and reduced apoptosis of hgsoc cell line ovcar ovcar and caov complete loss of cbx by crisprcas editing cbxko destabilized genome stability with increased spontaneous chromosomal break and tendency to polyploidy accompanied by disrupted cell cycle especially stalled gm transition and caused severe cell death wntcateninleftcfl wa activated in surviving ovcarcbxko clone to bypass the crisis caused by loss of cbx the relieve of tcfl corepromoter region occupied by cbx might be one of the possible explanation to tcfl increase in ovcarcbxko clone subcutaneous tumor model further validated that depletion of cbx repressed hgsoc cell line derived tumor growth high immunohistochemistry score of cbx in primary ovarian cancer tissue associated with advanced clinical stage p poor overall survival hr ci and progression free survival hr ci in hgsoc overall our result suggested that cbx wa a promising prognostic factor and therapeutic target in hgsoc
36628811,fertility preference and practice among young woman with breast cancer germline genetic carrier versus noncarriers,young woman with breast cancer who carry germline genetic pathogenic variant may face distinct fertility concern yet limited data exist comparing fertility preference and practice between carrier and noncarriers,Cancer,0,fertility preference and practice among young woman with breast cancer germline genetic carrier versus noncarriers young woman with breast cancer who carry germline genetic pathogenic variant may face distinct fertility concern yet limited data exist comparing fertility preference and practice between carrier and noncarriers
36634747,genomic landscape of chinese patient with hepatocellular carcinoma using nextgeneration sequencing and it association with the prognosis,the occurrence of hepatocellular carcinoma hcc is not entirely clear at present this study comprehensively described the landscape of genetic aberration in chinese hcc patient using nextgeneration sequencing ng and investigated the association of genetic aberration with clinicopathological characteristic and prognosis,Cancer,0,genomic landscape of chinese patient with hepatocellular carcinoma using nextgeneration sequencing and it association with the prognosis the occurrence of hepatocellular carcinoma hcc is not entirely clear at present this study comprehensively described the landscape of genetic aberration in chinese hcc patient using nextgeneration sequencing ng and investigated the association of genetic aberration with clinicopathological characteristic and prognosis
36637703,population pharmacokinetics pharmacogenomics and adverse event of osimertinib and it two active metabolite az and az in japanese patient with advanced nonsmall cell lung cancer a prospective observational study,potential novel strategy for adverse event ae management of osimertinib therapy including therapeutic drug monitoring and the use of biomarkers have not yet been fully investigated this study aimed to evaluate the relationship between exposure to osimertinib especially it active metabolite az and az and aes and the relationship between germline polymorphism and aes,Cancer,0,population pharmacokinetics pharmacogenomics and adverse event of osimertinib and it two active metabolite az and az in japanese patient with advanced nonsmall cell lung cancer a prospective observational study potential novel strategy for adverse event ae management of osimertinib therapy including therapeutic drug monitoring and the use of biomarkers have not yet been fully investigated this study aimed to evaluate the relationship between exposure to osimertinib especially it active metabolite az and az and aes and the relationship between germline polymorphism and aes
36690721,prognostic refinement of nsmp highrisk endometrial cancer using oestrogen receptor immunohistochemistry,riskassessment of endometrial cancer ec is based on clinicopathological factor and molecular subgroup it is unclear whether adding hormone receptor expression lcam expression or ctnnb status yield prognostic refinement,Cancer,0,prognostic refinement of nsmp highrisk endometrial cancer using oestrogen receptor immunohistochemistry riskassessment of endometrial cancer ec is based on clinicopathological factor and molecular subgroup it is unclear whether adding hormone receptor expression lcam expression or ctnnb status yield prognostic refinement
36708875,p interacted with nmyc and regulated it protein stability via altering it posttranslational modification in neuroblastoma,mycn amplification is an independent risk factor for poor prognosis in neuroblastoma nb but it protein product can not be directly targeted because of protein structure thus this study aimed to explore novel way to indirectly target nmyc by regulating it posttranslational modification ptms and therefore protein stability nmyc coimmunoprecipitation combined with hplcmsms identified ptm residue and potential nmycinteracting protein notably both acetylation and ubiquitination were identified on lysine of nmyc we then discovered that p which can interact with nmyc modulated the protein stability of nmyc in mycnamplified nb cell line and simultaneously regulated the acetylation level and ubiquitination level on lysine of nmyc protein in vitro furthermore p correlated with poor prognosis in nb patient taken together p can be considered a a potential therapeutic target to treat mycnamplified nb patient and other identified ptms and interacting protein also provide potential target for further study,Cancer,0,p interacted with nmyc and regulated it protein stability via altering it posttranslational modification in neuroblastoma mycn amplification is an independent risk factor for poor prognosis in neuroblastoma nb but it protein product can not be directly targeted because of protein structure thus this study aimed to explore novel way to indirectly target nmyc by regulating it posttranslational modification ptms and therefore protein stability nmyc coimmunoprecipitation combined with hplcmsms identified ptm residue and potential nmycinteracting protein notably both acetylation and ubiquitination were identified on lysine of nmyc we then discovered that p which can interact with nmyc modulated the protein stability of nmyc in mycnamplified nb cell line and simultaneously regulated the acetylation level and ubiquitination level on lysine of nmyc protein in vitro furthermore p correlated with poor prognosis in nb patient taken together p can be considered a a potential therapeutic target to treat mycnamplified nb patient and other identified ptms and interacting protein also provide potential target for further study
36719787,intratumor injection of thermosensitive polypeptide with resveratrol inhibits glioblastoma growth,local tumor treatment is a feasible measure for patient with glioblastoma gbm who are unsuitable for surgical resection interferonelastinlike polypeptide ifnelpv is a slowrelease biodegradable thermosensitive fusion protein with antitumor immunity and resveratrol re is a polyphenolic compound with an antitumor effect in this study we found that intratumor injection of ifnelpv combined with intraperitoneal injection of re is more effective in delaying gbm growth in mouse specifically in an orthotopic gbm model we found a significant improvement in the median survival with this strategy our result suggested that the combined use of ifnelpv and re ha a dramatic synergistic effect on gbm thus providing a novel and effective therapeutic strategy for tumor impact statement we report a novel and effective strategy in which the combined use of interferonelastinlike polypeptide ifnelpv and re effectively inhibits glioblastoma growth ifnelpv can create a reservoir in the tumor and continuously release ifn to produce a powerful in situ antitumor immune response furthermore the combination of ifnelpv and re is more effective in inhibiting tumor growth,Cancer,0,intratumor injection of thermosensitive polypeptide with resveratrol inhibits glioblastoma growth local tumor treatment is a feasible measure for patient with glioblastoma gbm who are unsuitable for surgical resection interferonelastinlike polypeptide ifnelpv is a slowrelease biodegradable thermosensitive fusion protein with antitumor immunity and resveratrol re is a polyphenolic compound with an antitumor effect in this study we found that intratumor injection of ifnelpv combined with intraperitoneal injection of re is more effective in delaying gbm growth in mouse specifically in an orthotopic gbm model we found a significant improvement in the median survival with this strategy our result suggested that the combined use of ifnelpv and re ha a dramatic synergistic effect on gbm thus providing a novel and effective therapeutic strategy for tumor impact statement we report a novel and effective strategy in which the combined use of interferonelastinlike polypeptide ifnelpv and re effectively inhibits glioblastoma growth ifnelpv can create a reservoir in the tumor and continuously release ifn to produce a powerful in situ antitumor immune response furthermore the combination of ifnelpv and re is more effective in inhibiting tumor growth
36730386,atypical molecular feature of pediatric tectal glioma a single institutional series,we present child diagnosed between and y female and male with molecularly distinct tectal glioma kras mutant egfr mutant srgapraf fusion that contributes to the growing literature of this uncommonly biopsied tumor the patient with egfr rc mutation had a more severe course earlier diagnosis subsequent leptomeningeal metastatic disease required more aggressive therapy and died year after diagnosis patient with kras mutation and srgapraf fusion had a more indolent course our series expands the molecular phenotype of tectal glioma with the potential for leptomeningeal dissemination future study on establishing genotypicphenotypic correlation from those who undergo biopsy are needed,Cancer,0,atypical molecular feature of pediatric tectal glioma a single institutional series we present child diagnosed between and y female and male with molecularly distinct tectal glioma kras mutant egfr mutant srgapraf fusion that contributes to the growing literature of this uncommonly biopsied tumor the patient with egfr rc mutation had a more severe course earlier diagnosis subsequent leptomeningeal metastatic disease required more aggressive therapy and died year after diagnosis patient with kras mutation and srgapraf fusion had a more indolent course our series expands the molecular phenotype of tectal glioma with the potential for leptomeningeal dissemination future study on establishing genotypicphenotypic correlation from those who undergo biopsy are needed
36736685,ampliconbased ng test for assessing mlh promoter methylation and it correlation with braf mutation in colorectal cancer patient,detecting mlh promoter methylation is highly relevant to differentiate between possible lynch syndrome patient or patient with sporadic cause of mlhpms deficiency in colorectal crc and endometrial cancer here we aimed to develop a test for assessing mlh promoter methylation based in next generation sequencing ng and to evaluate the concordance of mlh methylation and brafv mutation status in crc for that we performed a series of experiment with dna from tumor saliva and commercial control sample and our in house developed ampliconbased ng test in patient sample mlh methylation above wa only observed in tumor with mlhpms loss we confirmed the reproducibility and accuracy of mlh promoter analysis performing a serial dilution experiment with completely methylated and unmethylated control dna and a comparison between two ng platform ion proton and illumina in mlhpms deficient tumor the mlh methylation status wa concordant with the braf mutation status in of the case our ampliconbased ng test showed a great sensitivity and specificity for detecting mlh methylation in crc sample with a high agreement with the evaluation of braf mutation this simple and affordable test could be used a a reflex test to identify patient with sporadic cause of mlhpms deficiency in crc aiding to genetic test referral and identification of lynch syndrome patient,Cancer,0,ampliconbased ng test for assessing mlh promoter methylation and it correlation with braf mutation in colorectal cancer patient detecting mlh promoter methylation is highly relevant to differentiate between possible lynch syndrome patient or patient with sporadic cause of mlhpms deficiency in colorectal crc and endometrial cancer here we aimed to develop a test for assessing mlh promoter methylation based in next generation sequencing ng and to evaluate the concordance of mlh methylation and brafv mutation status in crc for that we performed a series of experiment with dna from tumor saliva and commercial control sample and our in house developed ampliconbased ng test in patient sample mlh methylation above wa only observed in tumor with mlhpms loss we confirmed the reproducibility and accuracy of mlh promoter analysis performing a serial dilution experiment with completely methylated and unmethylated control dna and a comparison between two ng platform ion proton and illumina in mlhpms deficient tumor the mlh methylation status wa concordant with the braf mutation status in of the case our ampliconbased ng test showed a great sensitivity and specificity for detecting mlh methylation in crc sample with a high agreement with the evaluation of braf mutation this simple and affordable test could be used a a reflex test to identify patient with sporadic cause of mlhpms deficiency in crc aiding to genetic test referral and identification of lynch syndrome patient
36738086,genomic and proteomic characterization of philadelphialike blineage acute lymphoblastic leukemia a report of indian patient,the gold standard for the identification of philadelphia phlike acute lymphoblastic leukemia all patient is gene expression profiling because of it diverse nature it identification is extremely difficult and expensive on the genomic and proteomic landscape of phlike all patient there is a paucity of published literature from developing country,Cancer,0,genomic and proteomic characterization of philadelphialike blineage acute lymphoblastic leukemia a report of indian patient the gold standard for the identification of philadelphia phlike acute lymphoblastic leukemia all patient is gene expression profiling because of it diverse nature it identification is extremely difficult and expensive on the genomic and proteomic landscape of phlike all patient there is a paucity of published literature from developing country
36738229,molecular disparity of hladpb is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation,an increased incidence of subsequent solid cancer sscs ha been reported in longterm survivor of allogeneic hematopoietic stem cell transplantation allohsct and ssc is associated with inferior mortality and morbidity previous study showed that the incidence of ssc is significantly higher in those who underwent allohsct from hlamismatched donor suggesting that persistent alloimmunity may predispose patient to sscs it wa recently reported that in a cohort of patient who received allohsct from an unrelated donor matched at hlaa b c drb and dqb locus hladpb alloimmunity determined by high mismatched eplets me and predicted indirectly recognizable hla epitope pirche score p wa associated with relapse protection and increased risk of acute graftversushost disease gvhd,Cancer,0,molecular disparity of hladpb is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation an increased incidence of subsequent solid cancer sscs ha been reported in longterm survivor of allogeneic hematopoietic stem cell transplantation allohsct and ssc is associated with inferior mortality and morbidity previous study showed that the incidence of ssc is significantly higher in those who underwent allohsct from hlamismatched donor suggesting that persistent alloimmunity may predispose patient to sscs it wa recently reported that in a cohort of patient who received allohsct from an unrelated donor matched at hlaa b c drb and dqb locus hladpb alloimmunity determined by high mismatched eplets me and predicted indirectly recognizable hla epitope pirche score p wa associated with relapse protection and increased risk of acute graftversushost disease gvhd
36751054,genomic profiling and prognostic factor of h kmmutant spinal cord diffuse glioma,h kaltered diffuse midline glioma is a highly lethal pediatrictype tumor without efficacious treatment recent finding have highlighted the heterogeneity among diffuse midline glioma with different location and age compared to tumor located in the brain stem and thalamus the molecular and clinicopathological feature of h kaltered spinal cord glioma are still largely elusive thus hindering the accurate management of patient here we aimed to characterize the clinicopathological and molecular feature of h kmmutant spinal cord glioma in consecutive case we found that the h kmmutant spinal cord glioma with a median age of year old had a significantly better prognosis than h kmmutant brain tumor we noticed a molecular heterogeneity of h kmmutant spinal cord astrocytoma via targeted sequencing with case tp mutation which occurred in of case is mutually exclusive with ppmd and nf mutation the tpmutant case had a significantly higher number of copy number variant cnv and a marginally higher proportion of pediatric patient age at diagnosis are associated with a worse prognosis interestingly the histological type an independent prognostic factor in multivariate cox regression can also stratify molecular feature of h kmmutant spinal cord glioma including the rb pathway kraspik pathway and chromosome arm cnv in conclusion although all h kmmutant spinal cord diffuse glioma were diagnosed a who grade the histological type molecular feature representing chromatin instability and molecular alteration associated with accelerated cell proliferative activity should not be ignored in clinical management,Cancer,0,genomic profiling and prognostic factor of h kmmutant spinal cord diffuse glioma h kaltered diffuse midline glioma is a highly lethal pediatrictype tumor without efficacious treatment recent finding have highlighted the heterogeneity among diffuse midline glioma with different location and age compared to tumor located in the brain stem and thalamus the molecular and clinicopathological feature of h kaltered spinal cord glioma are still largely elusive thus hindering the accurate management of patient here we aimed to characterize the clinicopathological and molecular feature of h kmmutant spinal cord glioma in consecutive case we found that the h kmmutant spinal cord glioma with a median age of year old had a significantly better prognosis than h kmmutant brain tumor we noticed a molecular heterogeneity of h kmmutant spinal cord astrocytoma via targeted sequencing with case tp mutation which occurred in of case is mutually exclusive with ppmd and nf mutation the tpmutant case had a significantly higher number of copy number variant cnv and a marginally higher proportion of pediatric patient age at diagnosis are associated with a worse prognosis interestingly the histological type an independent prognostic factor in multivariate cox regression can also stratify molecular feature of h kmmutant spinal cord glioma including the rb pathway kraspik pathway and chromosome arm cnv in conclusion although all h kmmutant spinal cord diffuse glioma were diagnosed a who grade the histological type molecular feature representing chromatin instability and molecular alteration associated with accelerated cell proliferative activity should not be ignored in clinical management
36764880,clinical utility of axillary nodal marker in breast cancer,deescalation of axillary surgery for lymph node ln positive breast cancer is facilitated by marking involved node which when removed with sentinel node constitute riskadapted targeted axillary dissection tad whether after chemotherapy or for primary surgery selected patient with biopsyproven involvement of node may be eligible for axillary conservation likewise impalpable recurrence or stage patient with localised axillary disease may benefit in these context several device are used to mark biopsied node to facilitate their accurate surgical removal we report our experience using the paramagnetic magseed endomag cambridge uk,Cancer,0,clinical utility of axillary nodal marker in breast cancer deescalation of axillary surgery for lymph node ln positive breast cancer is facilitated by marking involved node which when removed with sentinel node constitute riskadapted targeted axillary dissection tad whether after chemotherapy or for primary surgery selected patient with biopsyproven involvement of node may be eligible for axillary conservation likewise impalpable recurrence or stage patient with localised axillary disease may benefit in these context several device are used to mark biopsied node to facilitate their accurate surgical removal we report our experience using the paramagnetic magseed endomag cambridge uk
36779536,braf ve and rnf comutations predict patient outcome with targeted therapy in realworld case of colorectal cancer,antibrafegfr therapy is approved for metastatic colorectal cancer mcrc with brafve mutation although not all patient respond novel recent finding indicate the potential of rnf mutation to predict outcome in patient with brafmutated microsatellite stable ms mcrc treated with antibrafegfr therapy this study aimed to independently and rapidly validate brafvernf comutations a predictive biomarkers of benefit to antiegfrbraf therapy clinical data were derived from electronic health record data from u cancer clinic between january and march from the flatiron healthfoundation medicine realworld clinicogenomic mcrc database realworld case of brafvemutated mcrc with patient receiving antibrafegfr therapy n were included patient who were ms with rnf mutation had favorable progressionfree survival hazard ratio hr ci ci and overall survival hr ci compared with wild type no difference in outcome wa observed between patient group with rnfmutant versus wildtype receiving standardofcare chemotherapy brafvernf comutations predict mcrc antibrafegfr outcome in diverse clinical setting,Cancer,0,braf ve and rnf comutations predict patient outcome with targeted therapy in realworld case of colorectal cancer antibrafegfr therapy is approved for metastatic colorectal cancer mcrc with brafve mutation although not all patient respond novel recent finding indicate the potential of rnf mutation to predict outcome in patient with brafmutated microsatellite stable ms mcrc treated with antibrafegfr therapy this study aimed to independently and rapidly validate brafvernf comutations a predictive biomarkers of benefit to antiegfrbraf therapy clinical data were derived from electronic health record data from u cancer clinic between january and march from the flatiron healthfoundation medicine realworld clinicogenomic mcrc database realworld case of brafvemutated mcrc with patient receiving antibrafegfr therapy n were included patient who were ms with rnf mutation had favorable progressionfree survival hazard ratio hr ci ci and overall survival hr ci compared with wild type no difference in outcome wa observed between patient group with rnfmutant versus wildtype receiving standardofcare chemotherapy brafvernf comutations predict mcrc antibrafegfr outcome in diverse clinical setting
36785917,costeffectiveness of pancreas surveillance the cdknapleiden cohort,cdknapleiden mutation carrier have a high lifetime risk of developing pancreatic ductal adenocarcinoma pdac with very poor survival surveillance may improve prognosis,Cancer,0,costeffectiveness of pancreas surveillance the cdknapleiden cohort cdknapleiden mutation carrier have a high lifetime risk of developing pancreatic ductal adenocarcinoma pdac with very poor survival surveillance may improve prognosis
36787023,comparison of the radiomicsbased predictive model using machine learning and nomogram for epidermal growth factor receptor mutation status and subtypes in lung adenocarcinoma,the purpose of this study is to develop the predictive model for epidermal growth factor receptor egfr mutation status and subtypes exon point mutation lr and exon deletion mutation del and evaluate their clinical usefulness total patient with lung adenocarcinoma were retrospectively analyzed the analysis of variance and the least absolute shrinkage were used for feature selection from plain computed tomography image then radiomic score radscore wa calculated for the training and test cohort two machine learning ml model with fold were applied to construct the predictive model with radscore clinical feature and the combination of radscore and clinical feature the nomogram wa developed using radscore and clinical feature the prediction performance wa evaluated by the area under the receiver operating characteristic curve auc finally decision curve analysis dca wa performed using the best ml and nomogram model in the test cohort the auc of the best ml and the nomogram model were confidence interval and in the egfr mutation group and in the lr mutation group a well a and in the del group the dca showed that the nomogram model have comparable result with ml model we constructed two predictive model for egfr mutation status and subtypes the nomogram model had comparable result to the ml model because the superiority of the performance of ml and nomogram model varied depending on the prediction group appropriate model selection is necessary,Cancer,0,comparison of the radiomicsbased predictive model using machine learning and nomogram for epidermal growth factor receptor mutation status and subtypes in lung adenocarcinoma the purpose of this study is to develop the predictive model for epidermal growth factor receptor egfr mutation status and subtypes exon point mutation lr and exon deletion mutation del and evaluate their clinical usefulness total patient with lung adenocarcinoma were retrospectively analyzed the analysis of variance and the least absolute shrinkage were used for feature selection from plain computed tomography image then radiomic score radscore wa calculated for the training and test cohort two machine learning ml model with fold were applied to construct the predictive model with radscore clinical feature and the combination of radscore and clinical feature the nomogram wa developed using radscore and clinical feature the prediction performance wa evaluated by the area under the receiver operating characteristic curve auc finally decision curve analysis dca wa performed using the best ml and nomogram model in the test cohort the auc of the best ml and the nomogram model were confidence interval and in the egfr mutation group and in the lr mutation group a well a and in the del group the dca showed that the nomogram model have comparable result with ml model we constructed two predictive model for egfr mutation status and subtypes the nomogram model had comparable result to the ml model because the superiority of the performance of ml and nomogram model varied depending on the prediction group appropriate model selection is necessary
36788105,pdgfrb and notch mutation are detectable in a wider range of pericytic tumor including myopericytomas angioleiomyomas glomus tumor and their combined tumor,pericytic tumor are subclassified a myopericytomas myofibromas angioleiomyomas and glomus tumor according to the current world health organization classification these pericytic tumor form a continuous morphologic spectrum including those with combined morphology however to our knowledge no widely accepted criterion for classifying tumor with combined morphology are available recent study have identified plateletderived growth factor receptorbeta pdgfrb gene mutation in a subset of myofibromas myopericytomas and myopericytomatoses but not in angioleiomyomas notch receptor notch mutation have been reported in a subset of infantile myofibromatosis to assess their potential role in classifying pericytic tumor we investigated pdgfrb and notch mutation in pericytic tumor of variable morphology including some combined form our result show these mutation to be present in a variety of pericytic tumor such a myopericytomas pdgfrb notch myopericytomatoses myofibromas angioleiomyomas and glomus tumor point mutation were identified in tumor in pdgfrb exon yc sf and g tumor in pdgfrb exon mi hl and nk and tumor in notch exon ast dn g ta ek g and va all pdgfrb mutation and notch g ta and g mutation were classified a deleteriousdamaging by  of pathogenicity prediction tool in silico fivemutationpositive tumor including myopericytomaangioleiomyoma myopericytomatosesmyofibroma myofibromamyopericytoma and angioleiomyomamyopericytoma were of combined morphology therefore we found pdgfrb and notch mutation to be detectable in a much wider variety of pericytic tumor than previously reported and confirmed myopericytomas myofibromas angioleiomyomas and glomus tumor a member harboring pdgfrb or notch mutation our result thus suggest that pdgfrb or notch mutation are not useful for subclassifying member of the pericytic tumor family,Cancer,0,pdgfrb and notch mutation are detectable in a wider range of pericytic tumor including myopericytomas angioleiomyomas glomus tumor and their combined tumor pericytic tumor are subclassified a myopericytomas myofibromas angioleiomyomas and glomus tumor according to the current world health organization classification these pericytic tumor form a continuous morphologic spectrum including those with combined morphology however to our knowledge no widely accepted criterion for classifying tumor with combined morphology are available recent study have identified plateletderived growth factor receptorbeta pdgfrb gene mutation in a subset of myofibromas myopericytomas and myopericytomatoses but not in angioleiomyomas notch receptor notch mutation have been reported in a subset of infantile myofibromatosis to assess their potential role in classifying pericytic tumor we investigated pdgfrb and notch mutation in pericytic tumor of variable morphology including some combined form our result show these mutation to be present in a variety of pericytic tumor such a myopericytomas pdgfrb notch myopericytomatoses myofibromas angioleiomyomas and glomus tumor point mutation were identified in tumor in pdgfrb exon yc sf and g tumor in pdgfrb exon mi hl and nk and tumor in notch exon ast dn g ta ek g and va all pdgfrb mutation and notch g ta and g mutation were classified a deleteriousdamaging by  of pathogenicity prediction tool in silico fivemutationpositive tumor including myopericytomaangioleiomyoma myopericytomatosesmyofibroma myofibromamyopericytoma and angioleiomyomamyopericytoma were of combined morphology therefore we found pdgfrb and notch mutation to be detectable in a much wider variety of pericytic tumor than previously reported and confirmed myopericytomas myofibromas angioleiomyomas and glomus tumor a member harboring pdgfrb or notch mutation our result thus suggest that pdgfrb or notch mutation are not useful for subclassifying member of the pericytic tumor family
36789545,pathologic cytogenetic and molecular feature of acute myeloid leukemia with megakaryocytic differentiation a report from the childrens oncology group,acute myeloid leukemia aml with megakaryocytic differentiation amkl is a rare subtype of aml more common in child recent literature ha identified multiple fusion associated with this type of leukemia,Cancer,0,pathologic cytogenetic and molecular feature of acute myeloid leukemia with megakaryocytic differentiation a report from the childrens oncology group acute myeloid leukemia aml with megakaryocytic differentiation amkl is a rare subtype of aml more common in child recent literature ha identified multiple fusion associated with this type of leukemia
36789775,prevalence and therapeutic implication of clonal hematopoiesis of indeterminate potential in young patient with stroke,undetermined stroke etiology hamper optimal secondary prevention in a large proportion of young patient we explored whether genetic screening for clonal hematopoiesis of indetermined potential chip a novel risk factor for stroke could identify patient with myeloid precursor lesion or covert myeloid neoplasm requiring specific treatment,Cancer,0,prevalence and therapeutic implication of clonal hematopoiesis of indeterminate potential in young patient with stroke undetermined stroke etiology hamper optimal secondary prevention in a large proportion of young patient we explored whether genetic screening for clonal hematopoiesis of indetermined potential chip a novel risk factor for stroke could identify patient with myeloid precursor lesion or covert myeloid neoplasm requiring specific treatment
36790533,the perrs snp induces pigmentation phenotype of dyschromatosis universalis hereditaria,dyschromatosis universalis hereditaria duh is a pigmentary genodermatosis characterized by a mixture of hyperpigmented and hypopigmented macule distributed randomly over the body although sterile alpha motif and sh domaincontaining protein sash and atpbinding cassette subfamily b member abcb have been identified a causative gene for this disorder some case involve unknown pathogenic gene in this study wholeexome sequencing data analysis and sanger sequencing were utilized for a fourgeneration extended chinese family with duh a singlenucleotide polymorphism snp c c t pps r variant in exon of period circadian regulator per nm wa detected in each affected individual of the duh family the c c t snp of per perrs snp and a novel mutation in exon of sash c c g ptr were both found in the proband the affected individual carrying perrs snp in this family demonstrated mildpigmented phenotype compared to those of the proband carrying perrs snp and sash tr mutation increased melanin synthesis wa induced by perrs snp in the melanocyte of affected epithelial tissue mutated sash or perrs snp alone or cooperation of mutation of sash and perrs snp synergistically led to increased melanin synthesis and enhanced proliferation of melanoma cell in vitro we also phenotypically characterized a commercially available zebrafish mutant line harboring the perrs snp to induce melanocyte proliferation in vivo our result are the first to reveal that this per snp may be pathogenic for a novel duh subtype with mild hyperpigmented andor hypopigmented phenotype and that mutation of sash and per cooperatively promotes hyperpigmentation phenotype key message per r snp is identified to be associated with hyperpigmentation andor hypopigmentation phenotype and the novel pathogenic variant of per r snp probably contributed the pathogenesis of duh sashtr mutation is confirmed to associate with duh a novel autosomal dominant inheritance duh subtype with mild pigmentated phenotype is caused by the perrs snp,Cancer,0,the perrs snp induces pigmentation phenotype of dyschromatosis universalis hereditaria dyschromatosis universalis hereditaria duh is a pigmentary genodermatosis characterized by a mixture of hyperpigmented and hypopigmented macule distributed randomly over the body although sterile alpha motif and sh domaincontaining protein sash and atpbinding cassette subfamily b member abcb have been identified a causative gene for this disorder some case involve unknown pathogenic gene in this study wholeexome sequencing data analysis and sanger sequencing were utilized for a fourgeneration extended chinese family with duh a singlenucleotide polymorphism snp c c t pps r variant in exon of period circadian regulator per nm wa detected in each affected individual of the duh family the c c t snp of per perrs snp and a novel mutation in exon of sash c c g ptr were both found in the proband the affected individual carrying perrs snp in this family demonstrated mildpigmented phenotype compared to those of the proband carrying perrs snp and sash tr mutation increased melanin synthesis wa induced by perrs snp in the melanocyte of affected epithelial tissue mutated sash or perrs snp alone or cooperation of mutation of sash and perrs snp synergistically led to increased melanin synthesis and enhanced proliferation of melanoma cell in vitro we also phenotypically characterized a commercially available zebrafish mutant line harboring the perrs snp to induce melanocyte proliferation in vivo our result are the first to reveal that this per snp may be pathogenic for a novel duh subtype with mild hyperpigmented andor hypopigmented phenotype and that mutation of sash and per cooperatively promotes hyperpigmentation phenotype key message per r snp is identified to be associated with hyperpigmentation andor hypopigmentation phenotype and the novel pathogenic variant of per r snp probably contributed the pathogenesis of duh sashtr mutation is confirmed to associate with duh a novel autosomal dominant inheritance duh subtype with mild pigmentated phenotype is caused by the perrs snp
36791667,a global collaborative study of cicrearranged bcorccnbrearranged and other ultrarare unclassified undifferentiated small round cell sarcoma graceful,undifferentiated small round cell sarcoma urcss represent a diagnostic challenge and their optimal treatment is unknown we aimed to define the clinical characteristic treatment and outcome of urcs patient,Cancer,0,a global collaborative study of cicrearranged bcorccnbrearranged and other ultrarare unclassified undifferentiated small round cell sarcoma graceful undifferentiated small round cell sarcoma urcss represent a diagnostic challenge and their optimal treatment is unknown we aimed to define the clinical characteristic treatment and outcome of urcs patient
36801606,the role of tumour biological factor in technical anatomical resectability assessment of colorectal liver metastasis following induction systemic treatment an analysis of the dutch cairo trial,large intersurgeon variability exists in technical anatomical resectability assessment of colorectal cancer liveronly metastasis crlm following induction systemic therapy we evaluated the role of tumour biological factor in predicting resectability and early recurrence after surgery for initially unresectable crlm,Cancer,0,the role of tumour biological factor in technical anatomical resectability assessment of colorectal liver metastasis following induction systemic treatment an analysis of the dutch cairo trial large intersurgeon variability exists in technical anatomical resectability assessment of colorectal cancer liveronly metastasis crlm following induction systemic therapy we evaluated the role of tumour biological factor in predicting resectability and early recurrence after surgery for initially unresectable crlm
36804622,ro a a possible prognostic biomarker of cervical adenocarcinoma an exploratory analysis with nextgeneration sequencing,given the difference in clinical and biological characteristic between cervical adenocarcinoma and squamous cell carcinoma this study aimed to conduct an exploratory analysis to examine the molecular characteristic of cervical adenocarcinoma in a japanese population,Cancer,0,ro a a possible prognostic biomarker of cervical adenocarcinoma an exploratory analysis with nextgeneration sequencing given the difference in clinical and biological characteristic between cervical adenocarcinoma and squamous cell carcinoma this study aimed to conduct an exploratory analysis to examine the molecular characteristic of cervical adenocarcinoma in a japanese population
36823302,vorasidenib and ivosidenib in idhmutant lowgrade glioma a randomized perioperative phase trial,vorasidenib and ivosidenib inhibit mutant form of isocitrate dehydrogenase midh and have shown preliminary clinical activity against midh glioma we evaluated both agent in a perioperative phase trial to explore the mechanism of action in recurrent lowgrade glioma igg and select a molecule for phase testing primary endpoint wa concentration of dhydroxyglutarate hg the metabolic product of midh enzyme measured in tumor tissue from patient with midhrh nonenhancing glioma following randomized treatment with vorasidenib mg or mg once daily qd ivosidenib mg qd or mg twice daily or no treatment before surgery tumor hg concentration were reduced by credible interval cri and cri in patient treated with vorasidenib mg qd and ivosidenib mg qd respectively both agent were well tolerated and followup is ongoing in exploratory analysis hg reduction wa associated with increased dna hydroxymethylcytosine reversal of proneural and stemness gene expression signature decreased tumor cell proliferation and immune cell activation vorasidenib which showed brain penetrance and more consistent hg suppression than ivosidenib wa advanced to phase testing in patient with midh lggs funded by agio pharmaceutical inc and servier pharmaceutical llc clinicaltrialsgov number nct,Cancer,0,vorasidenib and ivosidenib in idhmutant lowgrade glioma a randomized perioperative phase trial vorasidenib and ivosidenib inhibit mutant form of isocitrate dehydrogenase midh and have shown preliminary clinical activity against midh glioma we evaluated both agent in a perioperative phase trial to explore the mechanism of action in recurrent lowgrade glioma igg and select a molecule for phase testing primary endpoint wa concentration of dhydroxyglutarate hg the metabolic product of midh enzyme measured in tumor tissue from patient with midhrh nonenhancing glioma following randomized treatment with vorasidenib mg or mg once daily qd ivosidenib mg qd or mg twice daily or no treatment before surgery tumor hg concentration were reduced by credible interval cri and cri in patient treated with vorasidenib mg qd and ivosidenib mg qd respectively both agent were well tolerated and followup is ongoing in exploratory analysis hg reduction wa associated with increased dna hydroxymethylcytosine reversal of proneural and stemness gene expression signature decreased tumor cell proliferation and immune cell activation vorasidenib which showed brain penetrance and more consistent hg suppression than ivosidenib wa advanced to phase testing in patient with midh lggs funded by agio pharmaceutical inc and servier pharmaceutical llc clinicaltrialsgov number nct
36835468,the antitumorigenic role of cannabinoid receptor in colon cancer a study in mouse and human,the endocannabinoid system particularly cannabinoid receptor cb in mouse and cnr in human ha controversial pathophysiological implication in colon cancer here we investigate the role of cb in potentiating the immune response in colon cancer in mouse and determine the influence of cnr variant in human comparing wildtype wt mouse to cb knockout cb mouse we performed a spontaneous cancer study in aging mouse and subsequently used the aomdss model of colitisassociated colorectal cancer and a model for hereditary colon cancer apcmin additionally we analyzed genomic data in a large human population to determine the relationship between cnr variant and colon cancer incidence aging cb mouse exhibited a higher incidence of spontaneous precancerous lesion in the colon compared to wt control the aomdsstreated cb and apcmincb mouse experienced aggravated tumorigenesis and enhanced splenic population of immunosuppressive myeloidderived suppressor cell along with abated antitumor cd t cell importantly corroborative genomic data reveal a significant association between nonsynonymous variant of cnr and the incidence of colon cancer in human taken together the result suggest that endogenous cb activation suppresses colon tumorigenesis by shifting the balance towards antitumor immune cell in mouse and thus portray the prognostic value of cnr variant for colon cancer patient,Cancer,0,the antitumorigenic role of cannabinoid receptor in colon cancer a study in mouse and human the endocannabinoid system particularly cannabinoid receptor cb in mouse and cnr in human ha controversial pathophysiological implication in colon cancer here we investigate the role of cb in potentiating the immune response in colon cancer in mouse and determine the influence of cnr variant in human comparing wildtype wt mouse to cb knockout cb mouse we performed a spontaneous cancer study in aging mouse and subsequently used the aomdss model of colitisassociated colorectal cancer and a model for hereditary colon cancer apcmin additionally we analyzed genomic data in a large human population to determine the relationship between cnr variant and colon cancer incidence aging cb mouse exhibited a higher incidence of spontaneous precancerous lesion in the colon compared to wt control the aomdsstreated cb and apcmincb mouse experienced aggravated tumorigenesis and enhanced splenic population of immunosuppressive myeloidderived suppressor cell along with abated antitumor cd t cell importantly corroborative genomic data reveal a significant association between nonsynonymous variant of cnr and the incidence of colon cancer in human taken together the result suggest that endogenous cb activation suppresses colon tumorigenesis by shifting the balance towards antitumor immune cell in mouse and thus portray the prognostic value of cnr variant for colon cancer patient
36841040,the potential of rasrafmekerk mapk signaling pathway inhibitor in ovarian cancer a systematic review and metaanalysis,the rasrafmekerk mapk pathway play a role in ovarian carcinogenesis lowgrade serous ovarian carcinoma lgsoc frequently harbor activating mapk mutation mapk inhibitor have been used in small subset of ovarian carcinoma oc patient to control tumor growth therefore we performed a metaanalysis to evaluate the effectiveness of mapk inhibitor in oc patient we aimed to determine the clinical benefit rate cbr the subgroup of mapk inhibitor with the best cbr and overall response rate orr and the most common adverse event,Cancer,0,the potential of rasrafmekerk mapk signaling pathway inhibitor in ovarian cancer a systematic review and metaanalysis the rasrafmekerk mapk pathway play a role in ovarian carcinogenesis lowgrade serous ovarian carcinoma lgsoc frequently harbor activating mapk mutation mapk inhibitor have been used in small subset of ovarian carcinoma oc patient to control tumor growth therefore we performed a metaanalysis to evaluate the effectiveness of mapk inhibitor in oc patient we aimed to determine the clinical benefit rate cbr the subgroup of mapk inhibitor with the best cbr and overall response rate orr and the most common adverse event
36841906,revisiting prognostic factor in glioma with leptomeningeal metastasis a comprehensive analysis of clinical and molecular factor and treatment modality,to comprehensively investigate prognostic factor including clinical and molecular factor and treatment modality in adult glioma patient with leptomeningeal metastasis lm,Cancer,0,revisiting prognostic factor in glioma with leptomeningeal metastasis a comprehensive analysis of clinical and molecular factor and treatment modality to comprehensively investigate prognostic factor including clinical and molecular factor and treatment modality in adult glioma patient with leptomeningeal metastasis lm
36857646,rational design of nonlinear hybridization immunosensor chain reaction for simultaneous ultrasensitive detection of two tumor marker protein,sensitive biomarker detection technique are beneficial for both disease diagnosis and postoperative examination the nonlinear hybridization chain reaction nhcr is widely used a an output signal amplification technique for biosensor platform a novel hairpinfree nhcr wa developed in this study a a flow cytometric immunoassay to detect alphafetoprotein afp and prostate specific antigen psa first the target afp is captured on magnetic bead mb that are modified with capture antibody then the prepared biotinstreptavidinbiotin bsb system which link biotinylated detection antibody and biotinylated trigger dna together through the high affinity between biotinstreptavidin interaction is added to label the target afp forming a sandwich complex with three trigger dna chain each trigger dna chain grows a dendritic dna nanostructure following a nonlinear hybridization chain reaction a the substrate flue chain are labeled with fluorophores the selfassembly process of dendritic dna is accompanied by the continuous release of fluorophores dendrite with strong fluorescence then form on the surface of mb finally the target afp is quantified by analyzing the fluorescent mb using flow cytometry the proposed immunoassay ha a high selectivity along with isothermal enzymefree and exponential amplification efficiency it show a limit of detection lod of pg ml the proposed biosensor wa also successfully used to quantitatively detect afp in serum sample it may be utilized to detect multiple tumor marker simultaneously by changing the size of mb and antibodyantigen pair most tumor marker are only related to tumor diagnosis but without specificity so the combined detection of multiple tumor marker can improve the accuracy of early tumor diagnosis,Cancer,0,rational design of nonlinear hybridization immunosensor chain reaction for simultaneous ultrasensitive detection of two tumor marker protein sensitive biomarker detection technique are beneficial for both disease diagnosis and postoperative examination the nonlinear hybridization chain reaction nhcr is widely used a an output signal amplification technique for biosensor platform a novel hairpinfree nhcr wa developed in this study a a flow cytometric immunoassay to detect alphafetoprotein afp and prostate specific antigen psa first the target afp is captured on magnetic bead mb that are modified with capture antibody then the prepared biotinstreptavidinbiotin bsb system which link biotinylated detection antibody and biotinylated trigger dna together through the high affinity between biotinstreptavidin interaction is added to label the target afp forming a sandwich complex with three trigger dna chain each trigger dna chain grows a dendritic dna nanostructure following a nonlinear hybridization chain reaction a the substrate flue chain are labeled with fluorophores the selfassembly process of dendritic dna is accompanied by the continuous release of fluorophores dendrite with strong fluorescence then form on the surface of mb finally the target afp is quantified by analyzing the fluorescent mb using flow cytometry the proposed immunoassay ha a high selectivity along with isothermal enzymefree and exponential amplification efficiency it show a limit of detection lod of pg ml the proposed biosensor wa also successfully used to quantitatively detect afp in serum sample it may be utilized to detect multiple tumor marker simultaneously by changing the size of mb and antibodyantigen pair most tumor marker are only related to tumor diagnosis but without specificity so the combined detection of multiple tumor marker can improve the accuracy of early tumor diagnosis
36859545,bleb promote cell survival by assembling oncogenic signalling hub,most human cell require anchorage for survival cellsubstrate adhesion activates diverse signalling pathway without which cell undergo anoikisa form of programmed cell death acquisition of anoikis resistance is a pivotal step in cancer disease progression a metastasizing cell often lose firm attachment to surrounding tissue in these poorly attached state cell adopt rounded morphology and form small hemispherical plasma membrane protrusion called bleb bleb function ha been thoroughly investigated in the context of amoeboid migration but it ha been examined far less in other scenario here we show by threedimensional imaging and manipulation of cell morphological state that blebbing trigger the formation of plasma membraneproximal signalling hub that confer anoikis resistance specifically in melanoma cell blebbing generates plasma membrane contour that recruit curvaturesensing septin protein a scaffold for constitutively active mutant nra and effector these signalling hub activate erk and pikwellestablished promoter of prosurvival pathway inhibition of bleb or septins ha little effect on the survival of welladhered cell but in detached cell it cause nra mislocalization reduced mapk and pik activity and ultimately death this unveils a morphological requirement for mutant nra to operate a an effective oncoprotein furthermore whereas some brafmutated melanoma cell do not rely on this survival pathway in a basal state inhibition of braf and mek strongly sensitizes them to both bleb and septin inhibition moreover fibroblast engineered to sustain blebbing acquire the same anoikis resistance a cancer cell even without harbouring oncogenic mutation thus bleb are potent signalling organelle capable of integrating myriad cellular information flow into concerted cellular response in this case granting robust anoikis resistance,Cancer,0,bleb promote cell survival by assembling oncogenic signalling hub most human cell require anchorage for survival cellsubstrate adhesion activates diverse signalling pathway without which cell undergo anoikisa form of programmed cell death acquisition of anoikis resistance is a pivotal step in cancer disease progression a metastasizing cell often lose firm attachment to surrounding tissue in these poorly attached state cell adopt rounded morphology and form small hemispherical plasma membrane protrusion called bleb bleb function ha been thoroughly investigated in the context of amoeboid migration but it ha been examined far less in other scenario here we show by threedimensional imaging and manipulation of cell morphological state that blebbing trigger the formation of plasma membraneproximal signalling hub that confer anoikis resistance specifically in melanoma cell blebbing generates plasma membrane contour that recruit curvaturesensing septin protein a scaffold for constitutively active mutant nra and effector these signalling hub activate erk and pikwellestablished promoter of prosurvival pathway inhibition of bleb or septins ha little effect on the survival of welladhered cell but in detached cell it cause nra mislocalization reduced mapk and pik activity and ultimately death this unveils a morphological requirement for mutant nra to operate a an effective oncoprotein furthermore whereas some brafmutated melanoma cell do not rely on this survival pathway in a basal state inhibition of braf and mek strongly sensitizes them to both bleb and septin inhibition moreover fibroblast engineered to sustain blebbing acquire the same anoikis resistance a cancer cell even without harbouring oncogenic mutation thus bleb are potent signalling organelle capable of integrating myriad cellular information flow into concerted cellular response in this case granting robust anoikis resistance
36877099,trustii a global phase ii study of taletrectinib in rospositive nonsmallcell lung cancer and other solid tumor,crizotinib and entrectinib have been approved to treat ro fusionpositive ro nonsmallcell lung cancer however unmet need remain including treatment of patient with resistance mutation efficacy in brain metastasis and avoidance of neurological side effect taletrectinib wa designed to improve efficacy overcome resistance to firstgeneration ro inhibitor and address brain metastasis while conferring fewer neurological adverse event all of these feature are demonstrated and supported by the interim data from the regional phase ii trusti clinical study here we describe the rationale and design of trustii a global phase ii study of taletrectinib in patient with locally advancedmetastatic ro nonsmallcell lung cancer and other ro solid tumor the primary end point is confirmed objective response rate secondary end point include duration of response progressionfree survival overall survival and safety this trial is enrolling patient in north america europe and asia,Cancer,0,trustii a global phase ii study of taletrectinib in rospositive nonsmallcell lung cancer and other solid tumor crizotinib and entrectinib have been approved to treat ro fusionpositive ro nonsmallcell lung cancer however unmet need remain including treatment of patient with resistance mutation efficacy in brain metastasis and avoidance of neurological side effect taletrectinib wa designed to improve efficacy overcome resistance to firstgeneration ro inhibitor and address brain metastasis while conferring fewer neurological adverse event all of these feature are demonstrated and supported by the interim data from the regional phase ii trusti clinical study here we describe the rationale and design of trustii a global phase ii study of taletrectinib in patient with locally advancedmetastatic ro nonsmallcell lung cancer and other ro solid tumor the primary end point is confirmed objective response rate secondary end point include duration of response progressionfree survival overall survival and safety this trial is enrolling patient in north america europe and asia
36889321,pd blockade plus chemoradiotherapy a preoperative therapy for patient with brpclapc a biomolecular exploratory phase ii trial,this is a phase ii study of pd blockade plus chemoradiotherapy a preoperative therapy for patient with locally advanced or borderline resectable pancreatic cancer lapc or brpc respectively twentynine patient are enrolled in the study the objective response rate orr is and the r resection rate is the month progressionfree survival pfs rate and month overall survival o rate are and respectively grade or higher adverse event are anemia thrombocytopenia and jaundice circulating tumor dna analysis reveals that patient with a decline in maximal somatic variant allelic frequency maxvaf between the first clinical evaluation and baseline have a longer survival outcome and a higher response rate and surgical rate than those who are not pd blockade plus chemoradiotherapy a preoperative therapy display promising antitumor activity and multiomics potential predictive biomarkers are identified and warrant further verification,Cancer,0,pd blockade plus chemoradiotherapy a preoperative therapy for patient with brpclapc a biomolecular exploratory phase ii trial this is a phase ii study of pd blockade plus chemoradiotherapy a preoperative therapy for patient with locally advanced or borderline resectable pancreatic cancer lapc or brpc respectively twentynine patient are enrolled in the study the objective response rate orr is and the r resection rate is the month progressionfree survival pfs rate and month overall survival o rate are and respectively grade or higher adverse event are anemia thrombocytopenia and jaundice circulating tumor dna analysis reveals that patient with a decline in maximal somatic variant allelic frequency maxvaf between the first clinical evaluation and baseline have a longer survival outcome and a higher response rate and surgical rate than those who are not pd blockade plus chemoradiotherapy a preoperative therapy display promising antitumor activity and multiomics potential predictive biomarkers are identified and warrant further verification
36892071,investigation of phenylimidazoaquinolines a potential antiproliferative agent,background it ha been demonstrated that the lead compound phenylimidazoaquinoline a selectively inhibits cyp enzyme additionally cyp inhibition ha been linked to inducing antiproliferative effect in various breast cancer cell line a well a relieving drug resistance caused by cyp upregulation material method herein novel analog of phenylimidazoaquinoline a have been synthesized with varied substitution on the phenyl and imidazole ring antiproliferative testing wa conducted using h thymidine uptake assay result phenylimidazoaquinoline a and phenylsubstituted analog c ome n napthalene displayed excellent antiproliferative activity demonstrating their potency against cancer cell line for the first time molecular modeling suggested that c and n bind similarly to a in the cyp binding site,Cancer,0,investigation of phenylimidazoaquinolines a potential antiproliferative agent background it ha been demonstrated that the lead compound phenylimidazoaquinoline a selectively inhibits cyp enzyme additionally cyp inhibition ha been linked to inducing antiproliferative effect in various breast cancer cell line a well a relieving drug resistance caused by cyp upregulation material method herein novel analog of phenylimidazoaquinoline a have been synthesized with varied substitution on the phenyl and imidazole ring antiproliferative testing wa conducted using h thymidine uptake assay result phenylimidazoaquinoline a and phenylsubstituted analog c ome n napthalene displayed excellent antiproliferative activity demonstrating their potency against cancer cell line for the first time molecular modeling suggested that c and n bind similarly to a in the cyp binding site
36921335,efficacy and safety of trastuzumab a a single agent in firstline treatment of heroverexpressing metastatic breast cancer,to evaluate the efficacy and safety of firstline singleagent trastuzumab in woman with heroverexpressing metastatic breast cancer,Cancer,0,efficacy and safety of trastuzumab a a single agent in firstline treatment of heroverexpressing metastatic breast cancer to evaluate the efficacy and safety of firstline singleagent trastuzumab in woman with heroverexpressing metastatic breast cancer
36925640,construction of anoikisrelated lncrnas risk model predicts prognosis and immunotherapy response for gastric adenocarcinoma patient,background anoikis act a a programmed cell death that is activated during carcinogenesis to remove undetected cell isolated from ecm further anoikis based risk stratification is expected to provide a deeper understanding of stomach adenocarcinoma stad carcinogenesis method the information of stad patient were acquired from tcga dataset anoikisrelated gene were obtained from the molecular signature database and pearson correlation analysis wa performed to identify the anoikisrelated lncrnas arls we performed machine learning algorithm including univariate cox regression and least absolute shrinkage and selection operator lasso analysis on the arls to build the osscore and ossignature clinical subgroup analysis tumor mutation burden tmb detection drug susceptibility analysis immune infiltration and pathway enrichment analysis were further performed to comprehensive explore the clinical significance result we established a stad prognostic model based on five arls and it prognostic value wa verified survival analysis showed that the overall survival of highrisk score patient wa significantly shorter than that of lowrisk score patient the column diagram show satisfactory discrimination and calibration the calibration curve verifies the good agreement between the prediction of the line graph and the actual observation tide analysis and drug sensitivity analysis showed significant difference between different risk group conclusion the novel prognostic model based on anoikisrelated lncrnas we identified could be used for prognosis prediction and precise therapy in gastric adenocarcinoma,Cancer,0,construction of anoikisrelated lncrnas risk model predicts prognosis and immunotherapy response for gastric adenocarcinoma patient background anoikis act a a programmed cell death that is activated during carcinogenesis to remove undetected cell isolated from ecm further anoikis based risk stratification is expected to provide a deeper understanding of stomach adenocarcinoma stad carcinogenesis method the information of stad patient were acquired from tcga dataset anoikisrelated gene were obtained from the molecular signature database and pearson correlation analysis wa performed to identify the anoikisrelated lncrnas arls we performed machine learning algorithm including univariate cox regression and least absolute shrinkage and selection operator lasso analysis on the arls to build the osscore and ossignature clinical subgroup analysis tumor mutation burden tmb detection drug susceptibility analysis immune infiltration and pathway enrichment analysis were further performed to comprehensive explore the clinical significance result we established a stad prognostic model based on five arls and it prognostic value wa verified survival analysis showed that the overall survival of highrisk score patient wa significantly shorter than that of lowrisk score patient the column diagram show satisfactory discrimination and calibration the calibration curve verifies the good agreement between the prediction of the line graph and the actual observation tide analysis and drug sensitivity analysis showed significant difference between different risk group conclusion the novel prognostic model based on anoikisrelated lncrnas we identified could be used for prognosis prediction and precise therapy in gastric adenocarcinoma
36926316,disruption of estrogen receptor beta dna binding domain impairs it tumor suppressive effect in triple negative breast cancer,triple negative breast cancer tnbc is an aggressive subtype of the disease which account for a disproportionately high percentage of breast cancer morbidity and mortality for these reason a better understanding of tnbc biology is required and the development of novel therapeutic approach are critically needed estrogen receptor beta er is a reported tumor suppressor that is expressed in approximately of primary tnbc tumor where it is associated with favorable prognostic feature and patient outcome previous study have shown that er mediates the assembly of corepressor complex on dna to inhibit the expression of multiple growth promoting gene and to suppress the ability of oncogenic transcription factor to drive cancer progression to further elucidate the molecular mechanism by which er elicits it anticancer effect we developed mdamb cell that inducibly express a mutant form of er incapable of directly binding dna we demonstrate that disruption of ers direct interaction with dna abolishes it ability to regulate the expression of well characterized immediate response gene and render it unable to suppress tnbc cell proliferation loss of dna binding also diminishes the ability of er to suppress oncogenic nfb signaling even though it still physically associate with nfb and other critical cofactor these finding enhance our understanding of how er function in this disease and provide a model system that can be utilized to further investigate the mechanistic process by which er elicits it anticancer effect,Cancer,0,disruption of estrogen receptor beta dna binding domain impairs it tumor suppressive effect in triple negative breast cancer triple negative breast cancer tnbc is an aggressive subtype of the disease which account for a disproportionately high percentage of breast cancer morbidity and mortality for these reason a better understanding of tnbc biology is required and the development of novel therapeutic approach are critically needed estrogen receptor beta er is a reported tumor suppressor that is expressed in approximately of primary tnbc tumor where it is associated with favorable prognostic feature and patient outcome previous study have shown that er mediates the assembly of corepressor complex on dna to inhibit the expression of multiple growth promoting gene and to suppress the ability of oncogenic transcription factor to drive cancer progression to further elucidate the molecular mechanism by which er elicits it anticancer effect we developed mdamb cell that inducibly express a mutant form of er incapable of directly binding dna we demonstrate that disruption of ers direct interaction with dna abolishes it ability to regulate the expression of well characterized immediate response gene and render it unable to suppress tnbc cell proliferation loss of dna binding also diminishes the ability of er to suppress oncogenic nfb signaling even though it still physically associate with nfb and other critical cofactor these finding enhance our understanding of how er function in this disease and provide a model system that can be utilized to further investigate the mechanistic process by which er elicits it anticancer effect
36926333,unique profile on the progress free survival and overall survival in patient with advanced nonsmall cell lung cancer in the qujing area southwest china,china southwestern region qujing harbor a high incidence of nonsmall cell lung cancer nsclc and related mortality this study wa designed to reveal the impact of an immunerelated prognostic signature irps on advanced nsclc in the qujing,Cancer,0,unique profile on the progress free survival and overall survival in patient with advanced nonsmall cell lung cancer in the qujing area southwest china china southwestern region qujing harbor a high incidence of nonsmall cell lung cancer nsclc and related mortality this study wa designed to reveal the impact of an immunerelated prognostic signature irps on advanced nsclc in the qujing
36926986,realworld experience with neurotrophic tyrosine receptor kinase fusionpositive tumor and tropomyosin receptor kinase inhibitor in veteran,neurotrophic tyrosine receptor kinase ntrk gene fusion are found in a broad range of tumor type clinical trial demonstrated high response rate to tropomyosin receptor kinase trk inhibitor in ntrk fusionpositive cancer but few report have described realworld experience with these targeted agent we evaluated the prevalence of ntrk fusion and the outcome with trk inhibitor therapy in a realworld population of patient in the veteran health administration,Cancer,0,realworld experience with neurotrophic tyrosine receptor kinase fusionpositive tumor and tropomyosin receptor kinase inhibitor in veteran neurotrophic tyrosine receptor kinase ntrk gene fusion are found in a broad range of tumor type clinical trial demonstrated high response rate to tropomyosin receptor kinase trk inhibitor in ntrk fusionpositive cancer but few report have described realworld experience with these targeted agent we evaluated the prevalence of ntrk fusion and the outcome with trk inhibitor therapy in a realworld population of patient in the veteran health administration
36927431,pancancer analysis confirms the prognostic and immunological effect of prostate tumor overexpressed in human cancer,prostate tumor overexpressed ptov is a conserved oncogenic adaptor protein associated with cancer progression and may be an independent prognostic marker for several malignancy consequently using pancancer research to explore the significance of ptov is valuable and may reveal novel target for cancer treatment,Cancer,0,pancancer analysis confirms the prognostic and immunological effect of prostate tumor overexpressed in human cancer prostate tumor overexpressed ptov is a conserved oncogenic adaptor protein associated with cancer progression and may be an independent prognostic marker for several malignancy consequently using pancancer research to explore the significance of ptov is valuable and may reveal novel target for cancer treatment
36927529,macrophage sting signaling promotes nk cell to suppress colorectal cancer liver metastasis via bblbb costimulation,macrophage innate immune response play an important role in tumorigenesis however the role and mechanism of macrophage sting signaling in modulating tumor microenvironment to suppress tumor growth at secondary site remains largely unclear,Cancer,0,macrophage sting signaling promotes nk cell to suppress colorectal cancer liver metastasis via bblbb costimulation macrophage innate immune response play an important role in tumorigenesis however the role and mechanism of macrophage sting signaling in modulating tumor microenvironment to suppress tumor growth at secondary site remains largely unclear
36927893,orthopaedic management of bone metastasis,thanks to advancement in cancer therapy an increasing number of cancer patient are expected to live longer with cancer in japan activity of daily livingadland quality of lifeqolof cancer patient ha become much more important than ever because a decline in mobility negatively affect adl and qol the management of locomotive organ of cancer patient is crucial in the japanese orthopaedic association decided their annual activity theme aslocomotive syndrome in cancer patient with the concept of preventing and improving locomotive syndrome for longer and healthier life of cancer patient bone metastasis a a major cause of locomotive syndrome in cancer patient need to be evaluated and managed properly for better adl and qol of cancer patient pathological fracture spinal instability and spinal injury cause not only severe pain and massive functional impairment of patient but increased nursing care burden to resolve these problem surgery play a major role possible surgical procedure include internal fixation curettage cementation and arthroplasty for the long bone whereas percutaneous vertebroplasty decompression posterioranterior spinal fusion and total en bloc spondylectomy for the spine less invasive surgical procedure tends to be chosen for a patient with poorer prognosis the main purpose of bone metastasis surgery is to maintain adl and qol of cancer patient hopefully during the remaining survival time therefore estimated survival should be considered when determining the surgical strategy in addition caseby case careful perioperative management is required because cancer therapy can vary widely in patient age cancer type and tumor stage to accommodate the variety of orthopaedic surgery to the diversity of cancer therapy the corporation between oncologist and orthopaedic surgeon is indispensable,Cancer,0,orthopaedic management of bone metastasis thanks to advancement in cancer therapy an increasing number of cancer patient are expected to live longer with cancer in japan activity of daily livingadland quality of lifeqolof cancer patient ha become much more important than ever because a decline in mobility negatively affect adl and qol the management of locomotive organ of cancer patient is crucial in the japanese orthopaedic association decided their annual activity theme aslocomotive syndrome in cancer patient with the concept of preventing and improving locomotive syndrome for longer and healthier life of cancer patient bone metastasis a a major cause of locomotive syndrome in cancer patient need to be evaluated and managed properly for better adl and qol of cancer patient pathological fracture spinal instability and spinal injury cause not only severe pain and massive functional impairment of patient but increased nursing care burden to resolve these problem surgery play a major role possible surgical procedure include internal fixation curettage cementation and arthroplasty for the long bone whereas percutaneous vertebroplasty decompression posterioranterior spinal fusion and total en bloc spondylectomy for the spine less invasive surgical procedure tends to be chosen for a patient with poorer prognosis the main purpose of bone metastasis surgery is to maintain adl and qol of cancer patient hopefully during the remaining survival time therefore estimated survival should be considered when determining the surgical strategy in addition caseby case careful perioperative management is required because cancer therapy can vary widely in patient age cancer type and tumor stage to accommodate the variety of orthopaedic surgery to the diversity of cancer therapy the corporation between oncologist and orthopaedic surgeon is indispensable
36928082,cdx expression correlate with clinical outcome in msih metastatic colorectal cancer patient receiving immune checkpoint inhibitor,immune checkpoint inhibitor icis showed efficacy in metastatic colorectal cancer mcrc with mismatchrepair deficiency or high microsatellite instability dmmrmsih unfortunately a patient subgroup did not benefit from immunotherapy caudalrelated homeobox transcription factor cdx would seem to influence immunotherapy sensitivity promoting the chemokine cxc motif ligand cxcl expression therefore we investigated cdx role a a prognosticpredictive marker in patient with mcrc msih we retrospectively collected data from msih mcrc patient treated with icis between and the primary endpoint wa the month progressionfreesurvival pfs rate the secondary endpoint were overall survival o pfs objective response rate orr and disease control rate dcr the pfs rate at month wa in cdx positive patient v in cdx negative patient p the median pfs wa not reached nr in the cdx positive group versus month ci in cdx negative patient p median o wa nr in cdxpositive patient versus month confidence interval ci in cdxnegative patient p all cdxpositive patient achieved a disease response one of them a complete response among cdxnegative patient one achieved stable disease while the other progressed rapidly orr v p dcr v p twelve patient received stline pembrolizumab cdx positive and cdx negative not reaching median pfs while two patient cdx positive and cdx negative received rdline pembrolizumab reaching a median pfs of month ci p although our study report result on a small population the prognostic role of cdx in crc seems confirmed and could drive a promising predictive role in defining the population more sensitive to immunotherapy treatment modulating the cdxcxcl axis in cdxnegative patient could help overcome primary resistance to immunotherapy,Cancer,0,cdx expression correlate with clinical outcome in msih metastatic colorectal cancer patient receiving immune checkpoint inhibitor immune checkpoint inhibitor icis showed efficacy in metastatic colorectal cancer mcrc with mismatchrepair deficiency or high microsatellite instability dmmrmsih unfortunately a patient subgroup did not benefit from immunotherapy caudalrelated homeobox transcription factor cdx would seem to influence immunotherapy sensitivity promoting the chemokine cxc motif ligand cxcl expression therefore we investigated cdx role a a prognosticpredictive marker in patient with mcrc msih we retrospectively collected data from msih mcrc patient treated with icis between and the primary endpoint wa the month progressionfreesurvival pfs rate the secondary endpoint were overall survival o pfs objective response rate orr and disease control rate dcr the pfs rate at month wa in cdx positive patient v in cdx negative patient p the median pfs wa not reached nr in the cdx positive group versus month ci in cdx negative patient p median o wa nr in cdxpositive patient versus month confidence interval ci in cdxnegative patient p all cdxpositive patient achieved a disease response one of them a complete response among cdxnegative patient one achieved stable disease while the other progressed rapidly orr v p dcr v p twelve patient received stline pembrolizumab cdx positive and cdx negative not reaching median pfs while two patient cdx positive and cdx negative received rdline pembrolizumab reaching a median pfs of month ci p although our study report result on a small population the prognostic role of cdx in crc seems confirmed and could drive a promising predictive role in defining the population more sensitive to immunotherapy treatment modulating the cdxcxcl axis in cdxnegative patient could help overcome primary resistance to immunotherapy
36928336,establishing an rna fusion panel in soft tissue sarcoma with clinical validation,the diagnosis and classification of soft tissue sarcoma sts remain challenging because of the rarity and overlapping morphologic manifestation of diverse sts subtypes characteristic gene fusion are commonly detected in sts and represent useful diagnostic marker this study established and validated a customdesigned rna sequencing panel that identified gene fusion in sts the analytical performance validation yielded excellent accuracy with ci sensitivity and ci specificity clinical performance were further confirmed with clinical formalinfixed and paraffinembedded ffpe sample from sts patient fusion were detected in of sample the common fusion ssssx family ewsrrelated fusion colapdgfb foxoassociated fusion and fusassociated fusion were identified in corresponding sts subtypes the rna panel detected specific fusion in several case where no conclusive diagnosis can be made based on the morphology and immunohistochemistry result data collected in this study demonstrate that the rna fusion panel can better classify sts subtypes and serve a a good supplement for histopathology exhibiting a great potential for the sts precise diagnosis,Cancer,0,establishing an rna fusion panel in soft tissue sarcoma with clinical validation the diagnosis and classification of soft tissue sarcoma sts remain challenging because of the rarity and overlapping morphologic manifestation of diverse sts subtypes characteristic gene fusion are commonly detected in sts and represent useful diagnostic marker this study established and validated a customdesigned rna sequencing panel that identified gene fusion in sts the analytical performance validation yielded excellent accuracy with ci sensitivity and ci specificity clinical performance were further confirmed with clinical formalinfixed and paraffinembedded ffpe sample from sts patient fusion were detected in of sample the common fusion ssssx family ewsrrelated fusion colapdgfb foxoassociated fusion and fusassociated fusion were identified in corresponding sts subtypes the rna panel detected specific fusion in several case where no conclusive diagnosis can be made based on the morphology and immunohistochemistry result data collected in this study demonstrate that the rna fusion panel can better classify sts subtypes and serve a a good supplement for histopathology exhibiting a great potential for the sts precise diagnosis
36928393,genetic testing in epithelial ovarian cancer implementation of the tumorfirst workflow,the new tumorfirst workflow for genetic testing in epithelial ovarian cancer detects woman with a genetic predisposition effectively and efficiently tumorfirst indicates that the tumor dna of all patient diagnosed with epithelial ovarian cancer is examined for the presence of pathogenic variant in amongst others brca and brca gene woman with an aberrant tumor dna test result are eligible for genetic testing using a sample of blood to detect heredity simultaneously the tumor dna test provides information on the effectiveness of additional treatment with parp inhibitor thereby the tumorfirst workflow save time and healthcare cost this workflow is currently implemented on a national level the focus of implementation is transferring knowledge to healthcare professional on requesting interpreting and reporting the tumor dna test and providing adequate support this nationwide implementation of tumorfirst can improve the recognition of heredity in epithelial ovarian cancer,Cancer,0,genetic testing in epithelial ovarian cancer implementation of the tumorfirst workflow the new tumorfirst workflow for genetic testing in epithelial ovarian cancer detects woman with a genetic predisposition effectively and efficiently tumorfirst indicates that the tumor dna of all patient diagnosed with epithelial ovarian cancer is examined for the presence of pathogenic variant in amongst others brca and brca gene woman with an aberrant tumor dna test result are eligible for genetic testing using a sample of blood to detect heredity simultaneously the tumor dna test provides information on the effectiveness of additional treatment with parp inhibitor thereby the tumorfirst workflow save time and healthcare cost this workflow is currently implemented on a national level the focus of implementation is transferring knowledge to healthcare professional on requesting interpreting and reporting the tumor dna test and providing adequate support this nationwide implementation of tumorfirst can improve the recognition of heredity in epithelial ovarian cancer
36928584,toripalimab combined with lenvatinib and gemox is a promising regimen a firstline treatment for advanced intrahepatic cholangiocarcinoma a singlecenter singlearm phase study,advanced intrahepatic cholangiocarcinoma icc ha a dismal prognosis here we report the efficacy and safety of combining toripalimab lenvatinib and gemcitabine plus oxaliplatin gemox a firstline therapy for advanced icc thirty patient with pathologically confirmed advanced icc received intravenous gemcitabine gm on day and and oxaliplatin mgm qw for six cycle along with intravenous toripalimab mg qw and oral lenvatinib mg once daily for one year the expression of programmed deathligand pdl and genetic status wa investigated in paraffinembedded tissue using immunohistochemistry and wholeexome sequencing wes analysis the primary endpoint wa the objective response rate orr secondary outcome included safety overall survival o progressionfree survival pfs disease control rate dcr and duration of response dor a of july the median followup time wa month and the orr wa twentythree patient achieved partial response and one achieved complete response patient with dna damage response ddrrelated gene mutation showed a higher orr while patient with tumor area positivity  pdl staining showed a trend of high orr but without significant difference the median o pfs and dor were and month respectively the dcr wa further of patient experienced manageable grade  adverse event aes commonly neutropenia and leukocytopenia in conclusion toripalimab plus lenvatinib and gemox are promising firstline regimen for the treatment of advanced icc a phaseiii multicenter doubleblinded randomized study to validate our finding wa approved by the national medical product administration nmpa no lptrial registration clinical trial nct,Cancer,0,toripalimab combined with lenvatinib and gemox is a promising regimen a firstline treatment for advanced intrahepatic cholangiocarcinoma a singlecenter singlearm phase study advanced intrahepatic cholangiocarcinoma icc ha a dismal prognosis here we report the efficacy and safety of combining toripalimab lenvatinib and gemcitabine plus oxaliplatin gemox a firstline therapy for advanced icc thirty patient with pathologically confirmed advanced icc received intravenous gemcitabine gm on day and and oxaliplatin mgm qw for six cycle along with intravenous toripalimab mg qw and oral lenvatinib mg once daily for one year the expression of programmed deathligand pdl and genetic status wa investigated in paraffinembedded tissue using immunohistochemistry and wholeexome sequencing wes analysis the primary endpoint wa the objective response rate orr secondary outcome included safety overall survival o progressionfree survival pfs disease control rate dcr and duration of response dor a of july the median followup time wa month and the orr wa twentythree patient achieved partial response and one achieved complete response patient with dna damage response ddrrelated gene mutation showed a higher orr while patient with tumor area positivity  pdl staining showed a trend of high orr but without significant difference the median o pfs and dor were and month respectively the dcr wa further of patient experienced manageable grade  adverse event aes commonly neutropenia and leukocytopenia in conclusion toripalimab plus lenvatinib and gemox are promising firstline regimen for the treatment of advanced icc a phaseiii multicenter doubleblinded randomized study to validate our finding wa approved by the national medical product administration nmpa no lptrial registration clinical trial nct
36928600,characterization of pancreatic cancer with ultralow tumor mutational burden,in pancreatic cancer pc tumor mutation burden tmb ha been reported to be lower than in other cancer with it clinical significance remaining unclear we analyzed the dataset of wholeexome sequencing and gene expression profiling of resected pc case the median tmb wa the tmb wa classified a high  low  or ultralow nineteen sample were classified a tmblow and were classified a tmbultralow no sample were tmbhigh tmbultralow pc had significantly fewer borderline resectable lesion p and fewer adenosquamous carcinoma p than tbmlow pc furthermore the tmbultralow pc showed significantly lower detection rate of driver mutation and copy number variation microsatellite instability wa not significantly correlated with the tmb status the tmbultralow pc had a significantly better prognosis than tbmlow pc p a multivariate analysis identified tmbultralow pc a an independent favorable prognostic factor hazard ratio p a gene expression analysis showed that tmbultralow pc wa associated with reduced tp inactivation p and reduced chromosomal instability p compared to tbmlow pc tmbultralow pc had specific gene expression signature and a better prognosis than tmblow pc,Cancer,0,characterization of pancreatic cancer with ultralow tumor mutational burden in pancreatic cancer pc tumor mutation burden tmb ha been reported to be lower than in other cancer with it clinical significance remaining unclear we analyzed the dataset of wholeexome sequencing and gene expression profiling of resected pc case the median tmb wa the tmb wa classified a high  low  or ultralow nineteen sample were classified a tmblow and were classified a tmbultralow no sample were tmbhigh tmbultralow pc had significantly fewer borderline resectable lesion p and fewer adenosquamous carcinoma p than tbmlow pc furthermore the tmbultralow pc showed significantly lower detection rate of driver mutation and copy number variation microsatellite instability wa not significantly correlated with the tmb status the tmbultralow pc had a significantly better prognosis than tbmlow pc p a multivariate analysis identified tmbultralow pc a an independent favorable prognostic factor hazard ratio p a gene expression analysis showed that tmbultralow pc wa associated with reduced tp inactivation p and reduced chromosomal instability p compared to tbmlow pc tmbultralow pc had specific gene expression signature and a better prognosis than tmblow pc
36929074,statistical method for integrative clustering of multiomics data,cancer are heterogeneous disease caused by accumulated mutation or abnormal alteration at multilevels of biological process including genomics epigenomics transcriptomics and proteomics there is a great clinical interest in identifying cancer molecular subtypes for disease prognosis and personalized medicine integrative clustering is a powerful unsupervised learning method that ha been increasingly used to identify cancer molecular subtypes using multiomics data including somatic mutation dna copy number dna methylation and gene expression integrative clustering method are generally classified into modelbased or nonparametric approach in this chapter we will give an overview of the frequently used modelbased method including icluster iclusterplus and iclusterbayes and the nonparametric method integrative nonnegative matrix factorization intnmf we will use the integrative analysis of uveal melanoma and lowergrade glioma to illustrate these representative method finally we will discus the strength and limitation of these representative method and give suggestion for performing integrative analysis of cancer multiomics data in practice,Cancer,0,statistical method for integrative clustering of multiomics data cancer are heterogeneous disease caused by accumulated mutation or abnormal alteration at multilevels of biological process including genomics epigenomics transcriptomics and proteomics there is a great clinical interest in identifying cancer molecular subtypes for disease prognosis and personalized medicine integrative clustering is a powerful unsupervised learning method that ha been increasingly used to identify cancer molecular subtypes using multiomics data including somatic mutation dna copy number dna methylation and gene expression integrative clustering method are generally classified into modelbased or nonparametric approach in this chapter we will give an overview of the frequently used modelbased method including icluster iclusterplus and iclusterbayes and the nonparametric method integrative nonnegative matrix factorization intnmf we will use the integrative analysis of uveal melanoma and lowergrade glioma to illustrate these representative method finally we will discus the strength and limitation of these representative method and give suggestion for performing integrative analysis of cancer multiomics data in practice
36929286,prognostic significance of the genetic variant of lymphotoxin alpha pthrasn in egyptian patient with advanced hepatocellular carcinoma,hepatocellular carcinoma hcc is one of the most common malignancy worldwide in term of mortality and susceptibility is attributed to genetic lifestyle and environmental factor lymphotoxin alpha lta ha a crucial role in communicating the lymphocyte with stromal cell and provoking cytotoxic effect on the cancer cell there are no report on the contribution of the lta c ca pthrasn r gene polymorphism to hcc susceptibility the main aim of this study is to investigate the association of lta c ca pthrasn r variant with the hcc risk in the egyptian population,Cancer,0,prognostic significance of the genetic variant of lymphotoxin alpha pthrasn in egyptian patient with advanced hepatocellular carcinoma hepatocellular carcinoma hcc is one of the most common malignancy worldwide in term of mortality and susceptibility is attributed to genetic lifestyle and environmental factor lymphotoxin alpha lta ha a crucial role in communicating the lymphocyte with stromal cell and provoking cytotoxic effect on the cancer cell there are no report on the contribution of the lta c ca pthrasn r gene polymorphism to hcc susceptibility the main aim of this study is to investigate the association of lta c ca pthrasn r variant with the hcc risk in the egyptian population
36929402,trend in survival rate of nonsmall cell lung cancer with use of molecular testing and targeted therapy in korea,over the past year treatment of nonsmall cell lung cancer nsclc ha been continually revolutionized however standard clinical trial may not reflect current multiple line of treatment and corresponding outcome in a timely manner,Cancer,0,trend in survival rate of nonsmall cell lung cancer with use of molecular testing and targeted therapy in korea over the past year treatment of nonsmall cell lung cancer nsclc ha been continually revolutionized however standard clinical trial may not reflect current multiple line of treatment and corresponding outcome in a timely manner
36929451,integration of clinical and spatial data to explore lipid metabolismrelated gene for predicting prognosis and immune microenvironment in glioma,lipid metabolism is crucial to tumor growth and immune microenvironment a well a drug sensitivity in glioma identifying prognostic indicator of glioma and elucidating the mechanism of glioma progression are critical for improving the prognosis of glioma patient in this study we investigated the role and prognostic value of metabolismrelated gene in glioma by integrative analysis of datasets from geo cgga and tcga based on clinical data and transcriptome data we found that the expression pattern of three major pathway related to lipid metabolism is fatty acidhighphospholipidhightriglyceridelow which is associated with better prognosis and immune infiltration the gene involved in these three pathway were used to generate a prognostic model which showed high stability and efficiency in the test set and validation set the spatial transcriptome of glioma patient revealed that the microenvironment of the region with high expression of risk gene cav and scd is in a state of hypoxia emt and cell cycle arrest and thus can be used a marker of metabolic reprogramming in the tumor microenvironment in the highrisk group m macrophage and m macrophage were significantly enriched and the risk score wa significantly correlated with gene mutation and methylation of risk gene we further performed drug sensitivity screening corresponding to different risk gene this study provided novel insight into the differential immune microenvironment with different expression pattern of metablismrelated gene and highlighted the spatial and temporal synergy of tumor progression and metabolic reprogramming,Cancer,0,integration of clinical and spatial data to explore lipid metabolismrelated gene for predicting prognosis and immune microenvironment in glioma lipid metabolism is crucial to tumor growth and immune microenvironment a well a drug sensitivity in glioma identifying prognostic indicator of glioma and elucidating the mechanism of glioma progression are critical for improving the prognosis of glioma patient in this study we investigated the role and prognostic value of metabolismrelated gene in glioma by integrative analysis of datasets from geo cgga and tcga based on clinical data and transcriptome data we found that the expression pattern of three major pathway related to lipid metabolism is fatty acidhighphospholipidhightriglyceridelow which is associated with better prognosis and immune infiltration the gene involved in these three pathway were used to generate a prognostic model which showed high stability and efficiency in the test set and validation set the spatial transcriptome of glioma patient revealed that the microenvironment of the region with high expression of risk gene cav and scd is in a state of hypoxia emt and cell cycle arrest and thus can be used a marker of metabolic reprogramming in the tumor microenvironment in the highrisk group m macrophage and m macrophage were significantly enriched and the risk score wa significantly correlated with gene mutation and methylation of risk gene we further performed drug sensitivity screening corresponding to different risk gene this study provided novel insight into the differential immune microenvironment with different expression pattern of metablismrelated gene and highlighted the spatial and temporal synergy of tumor progression and metabolic reprogramming
36929579,pten mutation predicts unfavorable fertility preserving treatment outcome in the young patient with endometrioid endometrial cancer and atypical hyperplasia,this study aimed to investigate the impact of molecular classification and pten kras and pikca gene mutation on the outcome of fertilitypreserving treatment in the patient with endometrioid endometrial cancer eec and endometrial atypical hyperplasia eah,Cancer,0,pten mutation predicts unfavorable fertility preserving treatment outcome in the young patient with endometrioid endometrial cancer and atypical hyperplasia this study aimed to investigate the impact of molecular classification and pten kras and pikca gene mutation on the outcome of fertilitypreserving treatment in the patient with endometrioid endometrial cancer eec and endometrial atypical hyperplasia eah
36929593,large cell calcifying sertoli cell tumour molecular and immunohistochemical assessment of a series comprising nonmetastasising and metastasising neoplasm,large cell calcifying sertoli cell tumour lccsct is a type of testicular sex cordstromal tumour that may occur sporadically or in the context of carney complex and other genetic syndrome a subset is clinically malignant and the molecular mechanism that drive such aggressive behaviour remain unknown method and result we analysed sample from patient with lccsct nonmetastasising and eight metastasising using prkara immunohistochemistry ihc and nextgeneration sequencing all tumour except two case and both metastasising demonstrated loss of prkara expression among case with interpretable sequencing result all harboured pathogenic single nucleotide variant of prkara evidence of loss of heterozygosity loh of prkara wa present in all tumour with interpretable zygosity data but the mechanism of loh were different for nonmetastasising and metastasising tumour nonmetastasising tumour demonstrated only copyneutral loh while metastasising tumour demonstrated a spectrum of mechanism of loh including copyloss loh two concurrent mutation or copyneutral loh relevant molecular finding in nonmetastasising lccsct were limited to prkara variant in contrast all metastasising lccscts with interpretable data harboured additional pathogenic variant including but not restricted to brca mutation with evidence of loh and biallelic cdknab deletion three patient harboured prkara variant of inferred germline origin including one with carney complex and two without known syndromic feature conclusion this study further confirms that prkara ihc is a useful diagnostic tool for both nonmetastasising and metastasising tumour and suggests that molecular analysis can be helpful to identify nonmetastasising tumour with malignant potential in selected patient importantly these result highlight that germline assessment could be beneficial for all patient presenting with lccsct,Cancer,0,large cell calcifying sertoli cell tumour molecular and immunohistochemical assessment of a series comprising nonmetastasising and metastasising neoplasm large cell calcifying sertoli cell tumour lccsct is a type of testicular sex cordstromal tumour that may occur sporadically or in the context of carney complex and other genetic syndrome a subset is clinically malignant and the molecular mechanism that drive such aggressive behaviour remain unknown method and result we analysed sample from patient with lccsct nonmetastasising and eight metastasising using prkara immunohistochemistry ihc and nextgeneration sequencing all tumour except two case and both metastasising demonstrated loss of prkara expression among case with interpretable sequencing result all harboured pathogenic single nucleotide variant of prkara evidence of loss of heterozygosity loh of prkara wa present in all tumour with interpretable zygosity data but the mechanism of loh were different for nonmetastasising and metastasising tumour nonmetastasising tumour demonstrated only copyneutral loh while metastasising tumour demonstrated a spectrum of mechanism of loh including copyloss loh two concurrent mutation or copyneutral loh relevant molecular finding in nonmetastasising lccsct were limited to prkara variant in contrast all metastasising lccscts with interpretable data harboured additional pathogenic variant including but not restricted to brca mutation with evidence of loh and biallelic cdknab deletion three patient harboured prkara variant of inferred germline origin including one with carney complex and two without known syndromic feature conclusion this study further confirms that prkara ihc is a useful diagnostic tool for both nonmetastasising and metastasising tumour and suggests that molecular analysis can be helpful to identify nonmetastasising tumour with malignant potential in selected patient importantly these result highlight that germline assessment could be beneficial for all patient presenting with lccsct
36930079,ikzf is a novel prognostic biomarker for head and neck squamous cell carcinoma a study based on bioinformatics analysis,in the past few year immunotherapy of tumor ha become an extensive research hotspot and the value of ikzf family gene in the tumor microenvironment ha also been increasingly recognized however the expression of the ikaros family zinc finger ikzf gene in human head and neck squamous cell carcinoma hnscc and it prognostic value were not reported for the main subset until now in the present study we analyzed the relationship between ikzf gene expression and the survival of hnscc patient to evaluate the potential of ikzf a a prognostic biomarker for hnscc comprehensively multiple online analysis tool including ualcan cbioportal gepia webgestalt string genomic data common and timer database were utilized in our study we observed that the hnscc patient with higher ikzf expression tended to exhibit longer overall survival univariate and multivariate cox regression analysis indicated that age and grade were independent prognostic indicator in hnscc moreover gene ontology and kegg function enrichment analysis showed that several pathway in hnscc might be pivotal pathway regulated by ikzf which revealed that ikzf wa probably participating in the occurrence and development of hnscc furthermore the hypomethylation of the ikzf gene wa closely associated with gene that observed mutation in hnscc ikzf wa significantly correlated with several immune cell in hnscc eg cd t cell cd cell and dendritic cell we explored the potential prognostic value and role of the ikzf in hnscc revealing that ikzf wa probably a novel and reliable prognostic biomarker for patient with hnscc,Cancer,0,ikzf is a novel prognostic biomarker for head and neck squamous cell carcinoma a study based on bioinformatics analysis in the past few year immunotherapy of tumor ha become an extensive research hotspot and the value of ikzf family gene in the tumor microenvironment ha also been increasingly recognized however the expression of the ikaros family zinc finger ikzf gene in human head and neck squamous cell carcinoma hnscc and it prognostic value were not reported for the main subset until now in the present study we analyzed the relationship between ikzf gene expression and the survival of hnscc patient to evaluate the potential of ikzf a a prognostic biomarker for hnscc comprehensively multiple online analysis tool including ualcan cbioportal gepia webgestalt string genomic data common and timer database were utilized in our study we observed that the hnscc patient with higher ikzf expression tended to exhibit longer overall survival univariate and multivariate cox regression analysis indicated that age and grade were independent prognostic indicator in hnscc moreover gene ontology and kegg function enrichment analysis showed that several pathway in hnscc might be pivotal pathway regulated by ikzf which revealed that ikzf wa probably participating in the occurrence and development of hnscc furthermore the hypomethylation of the ikzf gene wa closely associated with gene that observed mutation in hnscc ikzf wa significantly correlated with several immune cell in hnscc eg cd t cell cd cell and dendritic cell we explored the potential prognostic value and role of the ikzf in hnscc revealing that ikzf wa probably a novel and reliable prognostic biomarker for patient with hnscc
36930084,an integrative pancancer analysis illustrating the key role of lrp in cervical cancer,low density lipoprotein receptorrelated protein lrp wa involved in the progression of several tumor however it role in cervical cancer still remains uncertain,Cancer,0,an integrative pancancer analysis illustrating the key role of lrp in cervical cancer low density lipoprotein receptorrelated protein lrp wa involved in the progression of several tumor however it role in cervical cancer still remains uncertain
36930112,comprehensive analysis of pancancer reveals the potential of slca a a prognostic and immunological biomarker,slca play an important role in the development of multiple cancer type pancancer analysis may have significant impact on the exploration of the relationship between slca gene expression prognosis and the molecular mechanism of tumorigenesis in this study through the analysis of tcga and geo datasets we explored the expression level and survival prognosis of slca in pancancer and further explored the difference in slca gene mutation methylation and phosphorylation between tumor and normal tissue in addition we focused on the biological function of this gene and the relationship between the prognosis and immune infiltration by immune infiltration analysis and enrichment analysis in order to evaluate the diagnostic and prognostic significance of slca in carcinoma the study found that slca wa highly expressed in kind of tumor and there were statistically significant difference in the prognosis of tumor the phosphorylation level of s increased in ov rcc and ucec there wa a statistically negative correlation between the cd tcell infiltration level and the slca expression in hnsc lusc sarc tgct and kirc the cancerrelated fibroblast were positively correlated with slca expression in blca brca kirc kirp paad pcpg and thca the enrichment analysis indicated that the tumorigenesis mechanism of this gene wa mainly related to glycolysis and glucose metabolism synthesis slca wa a promising prognostic and immunological biomarker in pancancer,Cancer,0,comprehensive analysis of pancancer reveals the potential of slca a a prognostic and immunological biomarker slca play an important role in the development of multiple cancer type pancancer analysis may have significant impact on the exploration of the relationship between slca gene expression prognosis and the molecular mechanism of tumorigenesis in this study through the analysis of tcga and geo datasets we explored the expression level and survival prognosis of slca in pancancer and further explored the difference in slca gene mutation methylation and phosphorylation between tumor and normal tissue in addition we focused on the biological function of this gene and the relationship between the prognosis and immune infiltration by immune infiltration analysis and enrichment analysis in order to evaluate the diagnostic and prognostic significance of slca in carcinoma the study found that slca wa highly expressed in kind of tumor and there were statistically significant difference in the prognosis of tumor the phosphorylation level of s increased in ov rcc and ucec there wa a statistically negative correlation between the cd tcell infiltration level and the slca expression in hnsc lusc sarc tgct and kirc the cancerrelated fibroblast were positively correlated with slca expression in blca brca kirc kirp paad pcpg and thca the enrichment analysis indicated that the tumorigenesis mechanism of this gene wa mainly related to glycolysis and glucose metabolism synthesis slca wa a promising prognostic and immunological biomarker in pancancer
36930129,rectum adenocarcinoma metabolic subtypes analysis and a risk prognostic model construction based on fatty acid metabolism gene,fatty acid metabolism is an essential part of cancer research due to it role in cancer initiation and progression however it characteristic and prognostic value in rectum adenocarcinoma have not been systematically evaluated we collected fatty acid metabolism gene expression profile and clinical information from the cancer genome atlas and gene expression omnibus database after excluding individual lacking clinical information and the presence of genetic mutation we performed consistent clustering of the remaining patient and selected stable clustering result to group patient differentially expressed gene and gene set enrichment analysis were compared between subgroup while metabolic signature identification and decoding the tumor microenvironment were performed in addition we explored the survival status of patient among different subgroup and identified signature gene affecting survival by least absolute shrinkage and selection operator regression finally we selected signature gene to construct a risk prognostic model by multivariate cox regression and evaluated model efficacy by univariate cox regression and the receiver operating characteristic curve by consensus clustering patient were distinguished into stable subpopulation gene set enrichment analysis and metabolic signature identification effectively defined completely different subtypes of fatty acid metabolism fatty acid catabolic subtype and fatty acid anabolic subtype among them patient with the fatty acid catabolic subtype had a poorer prognosis with a significantly lower proportion of myeloid dendritic cell infiltration within the tumor microenvironment aquaporin hazard ratio hr p x inactive specific transcript hr p and interleukin induced hr p were selected by multivariate cox regression which constructed a risk prognostic model the independent hazard ratio of the model wa and the area under curve wa higher than age gender and tumor stage showing better predictive efficacy our study revealed the heterogeneity of fatty acid metabolism in rectum adenocarcinoma defined completely distinct subtypes of fatty acid metabolism and finally established a novel fatty acid metabolismrelated risk prognostic model the study contributes to the early risk assessment and monitoring of individual prognosis and provides data to support individualized patient treatment,Cancer,0,rectum adenocarcinoma metabolic subtypes analysis and a risk prognostic model construction based on fatty acid metabolism gene fatty acid metabolism is an essential part of cancer research due to it role in cancer initiation and progression however it characteristic and prognostic value in rectum adenocarcinoma have not been systematically evaluated we collected fatty acid metabolism gene expression profile and clinical information from the cancer genome atlas and gene expression omnibus database after excluding individual lacking clinical information and the presence of genetic mutation we performed consistent clustering of the remaining patient and selected stable clustering result to group patient differentially expressed gene and gene set enrichment analysis were compared between subgroup while metabolic signature identification and decoding the tumor microenvironment were performed in addition we explored the survival status of patient among different subgroup and identified signature gene affecting survival by least absolute shrinkage and selection operator regression finally we selected signature gene to construct a risk prognostic model by multivariate cox regression and evaluated model efficacy by univariate cox regression and the receiver operating characteristic curve by consensus clustering patient were distinguished into stable subpopulation gene set enrichment analysis and metabolic signature identification effectively defined completely different subtypes of fatty acid metabolism fatty acid catabolic subtype and fatty acid anabolic subtype among them patient with the fatty acid catabolic subtype had a poorer prognosis with a significantly lower proportion of myeloid dendritic cell infiltration within the tumor microenvironment aquaporin hazard ratio hr p x inactive specific transcript hr p and interleukin induced hr p were selected by multivariate cox regression which constructed a risk prognostic model the independent hazard ratio of the model wa and the area under curve wa higher than age gender and tumor stage showing better predictive efficacy our study revealed the heterogeneity of fatty acid metabolism in rectum adenocarcinoma defined completely distinct subtypes of fatty acid metabolism and finally established a novel fatty acid metabolismrelated risk prognostic model the study contributes to the early risk assessment and monitoring of individual prognosis and provides data to support individualized patient treatment
36930419,copy number alteration is an independent prognostic biomarker in triplenegative breast cancer patient,nextgeneration sequencing ng ha enabled comprehensive genomic profiling to identify gene alteration that play important role in cancer biology however the clinical significance of these genomic alteration in triplenegative breast cancer tnbc patient ha not yet been fully elucidated the aim of this study wa to clarify the clinical significance of genomic profiling data including copy number alteration cna and tumor mutation burden tmb in tnbc patient,Cancer,0,copy number alteration is an independent prognostic biomarker in triplenegative breast cancer patient nextgeneration sequencing ng ha enabled comprehensive genomic profiling to identify gene alteration that play important role in cancer biology however the clinical significance of these genomic alteration in triplenegative breast cancer tnbc patient ha not yet been fully elucidated the aim of this study wa to clarify the clinical significance of genomic profiling data including copy number alteration cna and tumor mutation burden tmb in tnbc patient
36930678,pcb a pseudotemporal causalitybased bayesian approach to identify emtassociated regulatory relationship of a event and rbps during breast cancer progression,during breast cancer metastasis the developmental process epithelialmesenchymal em transition is abnormally activated transcriptional regulatory network controlling em transition are wellstudied however alternative rna splicing also play a critical regulatory role during this process alternative splicing wa proved to control the em transition process and rnabinding protein were determined to regulate alternative splicing a comprehensive understanding of alternative splicing and the rnabinding protein that regulate it during em transition and their dynamic impact on breast cancer remains largely unknown to accurately study the dynamic regulatory relationship timeseries data of the em transition process are essential however only crosssectional data of epithelial and mesenchymal specimen are available therefore we developed a pseudotemporal causalitybased bayesian pcb approach to infer the dynamic regulatory relationship between alternative splicing event and rnabinding protein our study shed light on facilitating the regulatory networkbased approach to identify key rnabinding protein or target alternative splicing event for the diagnosis or treatment of cancer the data and code for pcb are available at httphkumathhkuhkwkcpcbdatacodezip,Cancer,0,pcb a pseudotemporal causalitybased bayesian approach to identify emtassociated regulatory relationship of a event and rbps during breast cancer progression during breast cancer metastasis the developmental process epithelialmesenchymal em transition is abnormally activated transcriptional regulatory network controlling em transition are wellstudied however alternative rna splicing also play a critical regulatory role during this process alternative splicing wa proved to control the em transition process and rnabinding protein were determined to regulate alternative splicing a comprehensive understanding of alternative splicing and the rnabinding protein that regulate it during em transition and their dynamic impact on breast cancer remains largely unknown to accurately study the dynamic regulatory relationship timeseries data of the em transition process are essential however only crosssectional data of epithelial and mesenchymal specimen are available therefore we developed a pseudotemporal causalitybased bayesian pcb approach to infer the dynamic regulatory relationship between alternative splicing event and rnabinding protein our study shed light on facilitating the regulatory networkbased approach to identify key rnabinding protein or target alternative splicing event for the diagnosis or treatment of cancer the data and code for pcb are available at httphkumathhkuhkwkcpcbdatacodezip
36930754,nanoengineered gallium ion incorporated formulation for safe and efficient reversal of parp inhibition and platinum resistance in ovarian cancer,platinumbased chemotherapy remains the main systemic treatment of ovarian cancer oc however the inevitable development of platinum and poly adenosine diphosphateribose polymerase inhibitor parpi resistance is associated with poor outcome which becomes a major obstacle in the management of this disease the present study developed allinone nanoparticles that contained the parpi olaparib and gallium ga iii olaparibga to effectively reverse parpi resistance in platinumresistant acis and skovcis oc cell and in skovcis tumor model notably the olaparibga suppressed skovcis tumor growth with negligible toxicity moreover the suppression effect wa more evident when combining olaparibga with cisplatin or carboplatin a evaluated in acis and skovcis cell mechanistically the combined treatment induced dna damage which elicited the activation of ataxia telangiectasia mutated atmamt and radrelated atr checkpoint kinase chkchk signal transduction pathway this led to the arrest of cell cycle progression at s and gm phase which eventually resulted in apoptosis and cell death due to unrepairable dna damage in addition effective therapeutic response to olaparibga and cisplatin combination or olaparibga and carboplatin combination were observed in skovcis tumorbearing animal model altogether the present finding demonstrate that olaparibga ha therapeutic implication in platinumresistant oc cell and the combination of olaparibga with cisplatin or carboplatin may be promising for treating patient with oc who exhibit resistance to both parpi and platinum,Cancer,0,nanoengineered gallium ion incorporated formulation for safe and efficient reversal of parp inhibition and platinum resistance in ovarian cancer platinumbased chemotherapy remains the main systemic treatment of ovarian cancer oc however the inevitable development of platinum and poly adenosine diphosphateribose polymerase inhibitor parpi resistance is associated with poor outcome which becomes a major obstacle in the management of this disease the present study developed allinone nanoparticles that contained the parpi olaparib and gallium ga iii olaparibga to effectively reverse parpi resistance in platinumresistant acis and skovcis oc cell and in skovcis tumor model notably the olaparibga suppressed skovcis tumor growth with negligible toxicity moreover the suppression effect wa more evident when combining olaparibga with cisplatin or carboplatin a evaluated in acis and skovcis cell mechanistically the combined treatment induced dna damage which elicited the activation of ataxia telangiectasia mutated atmamt and radrelated atr checkpoint kinase chkchk signal transduction pathway this led to the arrest of cell cycle progression at s and gm phase which eventually resulted in apoptosis and cell death due to unrepairable dna damage in addition effective therapeutic response to olaparibga and cisplatin combination or olaparibga and carboplatin combination were observed in skovcis tumorbearing animal model altogether the present finding demonstrate that olaparibga ha therapeutic implication in platinumresistant oc cell and the combination of olaparibga with cisplatin or carboplatin may be promising for treating patient with oc who exhibit resistance to both parpi and platinum
36930789,kras nra braf and pikca mutation rate clinicopathological association and their prognostic value in iranian colorectal cancer patient,mutation in kras nra braf and pikca gene are critical factor in clinical evaluation of colorectal cancer crc development and progression in iran however the data regarding genetic profile of crc patient is limited except for kras exon and braf vf mutation this study aimed to investigate the mutational spectrum and prognostic effect of these gene and explore the relationship between these mutation and clinicopathological feature of crc,Cancer,0,kras nra braf and pikca mutation rate clinicopathological association and their prognostic value in iranian colorectal cancer patient mutation in kras nra braf and pikca gene are critical factor in clinical evaluation of colorectal cancer crc development and progression in iran however the data regarding genetic profile of crc patient is limited except for kras exon and braf vf mutation this study aimed to investigate the mutational spectrum and prognostic effect of these gene and explore the relationship between these mutation and clinicopathological feature of crc
36931075,adjuvant durvalumab after concurrent chemoradiotherapy for patient with unresectable stage iii nsclc harbouring uncommon genomic alteration,adjuvant durvalumab is the standard of care for patient with stage iii unresectable nonsmall cell lung cancer nsclc without progression after concurrent chemoradiation ccrt patient with stage iii nsclc harbouring epidermal growth factor receptor egfr mutation and anaplastic lymphoma kinase rearrangement do not seem to benefit from durvalumab data are lacking about patient harbouring other driver genomic alteration dga we performed a multicentre n netherlands and italy retrospective study including consecutive patient with unresectable stage iii nsclc and treated with ccrtwith or without adjuvant durvalumabbetween and we enrolled patient of which received adjuvant durvalumab sixtysix patient had dga kras mutation egfr common mutation and uncommon dga in the entire population the median pfs wa month ci and month ci with and without durvalumab p in the dga group excluding common egfr mpfs wa month ci with and ci without durvalumab p for patient with kras mutation mpfs wa month ci with and month ci without durvalumab p among patient with uncommon dga mpfs wa month ci with and month ci without durvalumab p we have shown a meaningful survival benefit of adjuvant durvalumab in patient harbouring kras mutation and uncommon dga this is the largest stage iii nsclc cohort showing the efficacy of durvalumab in patient with uncommon dga further prospective study are needed to confirm our result,Cancer,0,adjuvant durvalumab after concurrent chemoradiotherapy for patient with unresectable stage iii nsclc harbouring uncommon genomic alteration adjuvant durvalumab is the standard of care for patient with stage iii unresectable nonsmall cell lung cancer nsclc without progression after concurrent chemoradiation ccrt patient with stage iii nsclc harbouring epidermal growth factor receptor egfr mutation and anaplastic lymphoma kinase rearrangement do not seem to benefit from durvalumab data are lacking about patient harbouring other driver genomic alteration dga we performed a multicentre n netherlands and italy retrospective study including consecutive patient with unresectable stage iii nsclc and treated with ccrtwith or without adjuvant durvalumabbetween and we enrolled patient of which received adjuvant durvalumab sixtysix patient had dga kras mutation egfr common mutation and uncommon dga in the entire population the median pfs wa month ci and month ci with and without durvalumab p in the dga group excluding common egfr mpfs wa month ci with and ci without durvalumab p for patient with kras mutation mpfs wa month ci with and month ci without durvalumab p among patient with uncommon dga mpfs wa month ci with and month ci without durvalumab p we have shown a meaningful survival benefit of adjuvant durvalumab in patient harbouring kras mutation and uncommon dga this is the largest stage iii nsclc cohort showing the efficacy of durvalumab in patient with uncommon dga further prospective study are needed to confirm our result
23318425,dmap is an essential regulator of atm activity and function,the hereditary autosomal recessive disease ataxia telangiectasia at is caused by mutation in the dna damage kinase atm atm main function is to orchestrate dna repair thereby maintaining genomic stability atm activity is increased in response to several stimulus including ionising radiation ir and hypotonic stress dnmtassociated protein dmap is a member of the tipp histone acetyl transferase hat complex which acetylates histone h at lysine hk to affect chromatin relaxation and modulate atm activation here we demonstrate that dmap is required for both mode of atm activation knockdown of dmap impaired irinduced atm activation and consequently resulted in radiosensitivity and impaired the gm checkpoint moreover dmap wa also required for efficient atm signalling in response to hypotonic stress overexpression of dmap increased irinduced atm substrate phosphorylation suggesting that dmap function is rate limiting for atm signalling dmap associated with tipdependent hat activity and depletion of dmap reduced hk acetylation in response to dna damage treatment with histone deacetylase inhibitor rescued irinduced atm signalling in dmapdepleted cell these result suggest that dmap is a critical regulator of atm activity and function,Non-Cancer,1,dmap is an essential regulator of atm activity and function the hereditary autosomal recessive disease ataxia telangiectasia at is caused by mutation in the dna damage kinase atm atm main function is to orchestrate dna repair thereby maintaining genomic stability atm activity is increased in response to several stimulus including ionising radiation ir and hypotonic stress dnmtassociated protein dmap is a member of the tipp histone acetyl transferase hat complex which acetylates histone h at lysine hk to affect chromatin relaxation and modulate atm activation here we demonstrate that dmap is required for both mode of atm activation knockdown of dmap impaired irinduced atm activation and consequently resulted in radiosensitivity and impaired the gm checkpoint moreover dmap wa also required for efficient atm signalling in response to hypotonic stress overexpression of dmap increased irinduced atm substrate phosphorylation suggesting that dmap function is rate limiting for atm signalling dmap associated with tipdependent hat activity and depletion of dmap reduced hk acetylation in response to dna damage treatment with histone deacetylase inhibitor rescued irinduced atm signalling in dmapdepleted cell these result suggest that dmap is a critical regulator of atm activity and function
23656349,a clinical and genetic overview of year neurofibromatosis type molecular diagnostics in the netherlands,nf mutation are the underlying cause of neurofibromatosis type nf a neurocardiofaciocutaneous syndrome ncfc because of the clinical overlap between ncfcs genetic analysis of nf is necessary to confirm a clinical diagnosis nf this report describes the clinical and genetic finding of year of nf molecular diagnostics in the netherlands a pathogenic mutation wa found in of the index patient mostly de novo the majority of the index patient fulfilled the national institute of health nf criterion a pathogenic mutation wa found in of these patient seventyfour percent of the index patient with an nf pathogenic mutation and not fulfilling the nf criterion is year in agreement with the fact that some nf symptom appear after puberty genotypephenotype correlation were studied for index patient nf patient with a type microdeletion have a sixfold higher risk of special education v nf patient with an intragenic mutation no evidently milder nf phenotype for patient with a missense mutation wa observed fortysix prenatal analysis were performed in family of which showed heterozygosity for the familial pathogenic mutation this indicates that there is a need for prenatal nf testing,Non-Cancer,1,a clinical and genetic overview of year neurofibromatosis type molecular diagnostics in the netherlands nf mutation are the underlying cause of neurofibromatosis type nf a neurocardiofaciocutaneous syndrome ncfc because of the clinical overlap between ncfcs genetic analysis of nf is necessary to confirm a clinical diagnosis nf this report describes the clinical and genetic finding of year of nf molecular diagnostics in the netherlands a pathogenic mutation wa found in of the index patient mostly de novo the majority of the index patient fulfilled the national institute of health nf criterion a pathogenic mutation wa found in of these patient seventyfour percent of the index patient with an nf pathogenic mutation and not fulfilling the nf criterion is year in agreement with the fact that some nf symptom appear after puberty genotypephenotype correlation were studied for index patient nf patient with a type microdeletion have a sixfold higher risk of special education v nf patient with an intragenic mutation no evidently milder nf phenotype for patient with a missense mutation wa observed fortysix prenatal analysis were performed in family of which showed heterozygosity for the familial pathogenic mutation this indicates that there is a need for prenatal nf testing
23807778,adultonset mastocytosis in the skin is highly suggestive of systemic mastocytosis,adultonset urticaria pigmentosamastocytosis in the skin almost always persists throughout life the prevalence of systemic mastocytosis in such patient is not precisely known bone marrow biopsy from patient with mastocytosis in the skin and all available skin biopsy n were subjected to a meticulous cytological histological immunohistochemical and molecular analysis for the presence of whodefined diagnostic criterion for systemic mastocytosis compact mast cell infiltrates major criterion atypical mast cell morphology kit dv abnormal expression of cd by mast cell and serum tryptase level ngml minor criterion systemic mastocytosis is diagnosed when the major diagnostic criterion plus one minor criterion or at least three minor criterion are fulfilled systemic mastocytosis wa confirmed in patient by the diagnosis of compact mast cell infiltrates plus at least one minor diagnostic criterion n or at least three minor diagnostic criterion n in two patient only two minor diagnostic criterion were detectable insufficient for the diagnosis of systemic mastocytosis by the use of highly sensitive molecular method including the analysis of microdissected mast cell kit dv wa found in all bone marrow biopsy investigated for it but only in of the skin biopsy it is important to state that even in case with insufficient diagnostic criterion for systemic mastocytosis kit dvpositive mast cell were detected in the bone marrow this study demonstrates for the first time that almost all patient with adultonset mastocytosis in the skin in fact have systemic mastocytosis with cutaneous involvement,Non-Cancer,1,adultonset mastocytosis in the skin is highly suggestive of systemic mastocytosis adultonset urticaria pigmentosamastocytosis in the skin almost always persists throughout life the prevalence of systemic mastocytosis in such patient is not precisely known bone marrow biopsy from patient with mastocytosis in the skin and all available skin biopsy n were subjected to a meticulous cytological histological immunohistochemical and molecular analysis for the presence of whodefined diagnostic criterion for systemic mastocytosis compact mast cell infiltrates major criterion atypical mast cell morphology kit dv abnormal expression of cd by mast cell and serum tryptase level ngml minor criterion systemic mastocytosis is diagnosed when the major diagnostic criterion plus one minor criterion or at least three minor criterion are fulfilled systemic mastocytosis wa confirmed in patient by the diagnosis of compact mast cell infiltrates plus at least one minor diagnostic criterion n or at least three minor diagnostic criterion n in two patient only two minor diagnostic criterion were detectable insufficient for the diagnosis of systemic mastocytosis by the use of highly sensitive molecular method including the analysis of microdissected mast cell kit dv wa found in all bone marrow biopsy investigated for it but only in of the skin biopsy it is important to state that even in case with insufficient diagnostic criterion for systemic mastocytosis kit dvpositive mast cell were detected in the bone marrow this study demonstrates for the first time that almost all patient with adultonset mastocytosis in the skin in fact have systemic mastocytosis with cutaneous involvement
23921094,nonaggressive systemic mastocytosis sm without skin lesion associated with insectinduced anaphylaxis show unique feature versus other indolent sm,background indolent systemic mastocytosis ism without skin lesion ism show a higher prevalence in male lower serum baseline tryptase level and kit mutation more frequently restricted to bone marrow bm mast cell mc than ism with skin lesion ism interestingly in almost onehalf of ism patient mcmediator release episode are triggered exclusively by insect objective we aimed to determine the clinical and laboratory feature of ism associated with insectinduced anaphylaxis insectisms versus other patient with ism method a total of patient presenting with mc activation syndrome including insectisms ism triggered by other factor otherisms ism and nonclonal mc activation syndrome were studied result compared with otherisms and ism patient insectisms case showed marked male predominance v and p a distinct pattern of mcrelated symptom and significantly lower median serum baseline tryptase level v and mugl p moreover insectisms less frequently presented bm mc aggregate v and p and they systematically showed mcrestricted kit mutation conclusion ism patient with anaphylaxis triggered exclusively by insect display clinical and laboratory feature that are significantly different from other ism case including other ism and ism patient suggesting that they represent a unique subgroup of ism with a particularly low bm mc burden in the absence of adverse prognostic factor,Non-Cancer,1,nonaggressive systemic mastocytosis sm without skin lesion associated with insectinduced anaphylaxis show unique feature versus other indolent sm background indolent systemic mastocytosis ism without skin lesion ism show a higher prevalence in male lower serum baseline tryptase level and kit mutation more frequently restricted to bone marrow bm mast cell mc than ism with skin lesion ism interestingly in almost onehalf of ism patient mcmediator release episode are triggered exclusively by insect objective we aimed to determine the clinical and laboratory feature of ism associated with insectinduced anaphylaxis insectisms versus other patient with ism method a total of patient presenting with mc activation syndrome including insectisms ism triggered by other factor otherisms ism and nonclonal mc activation syndrome were studied result compared with otherisms and ism patient insectisms case showed marked male predominance v and p a distinct pattern of mcrelated symptom and significantly lower median serum baseline tryptase level v and mugl p moreover insectisms less frequently presented bm mc aggregate v and p and they systematically showed mcrestricted kit mutation conclusion ism patient with anaphylaxis triggered exclusively by insect display clinical and laboratory feature that are significantly different from other ism case including other ism and ism patient suggesting that they represent a unique subgroup of ism with a particularly low bm mc burden in the absence of adverse prognostic factor
24005976,common variant of znf rptor and trafip gene and psoriasis risk,psoriasis vulgaris is a genetically heterogenous disease with unclear molecular background we assessed the association of psoriasis and it main clinical phenotype with common variant of three potential psoriasis susceptibility gene znf rptor and trafp we genotyped common variant in a cohort of casecontrol individual using taqman genotyping assay and sequencing minor allele of all four trafip variant were more frequent among case the strongest significant association wa observed for r or p minor allele of this snp wa always present in two haplotype found to be associated with increased psoriasis risk rsg rsg rst rsa or p and rsa rsa rst rsg or p analysis of clinically relevant phenotype revealed association of r with pustular psoriasis or p we observed significant connection of severity of cutaneous disease with variation at r and suggestive with three remaining trafip snp another positive association were found between age of onset and familial aggregation of disease smoking and younger age of onset smoking and occurrence of pustular psoriasis nail involvement and arthropatic psoriasis nail involvement and more severe course of psoriasis we found no statistically significant difference in the prevalence of the examined variant of rptor and znf gene among our case and control we have replicated the association of trafiprs variant with the susceptibility to psoriasis we have found new association with clinically relevant subphenotypes such a pustular psoriasis or moderatetosevere case we ascertain no connection of rptor and znf variant with psoriasis or it subphenotypes,Non-Cancer,1,common variant of znf rptor and trafip gene and psoriasis risk psoriasis vulgaris is a genetically heterogenous disease with unclear molecular background we assessed the association of psoriasis and it main clinical phenotype with common variant of three potential psoriasis susceptibility gene znf rptor and trafp we genotyped common variant in a cohort of casecontrol individual using taqman genotyping assay and sequencing minor allele of all four trafip variant were more frequent among case the strongest significant association wa observed for r or p minor allele of this snp wa always present in two haplotype found to be associated with increased psoriasis risk rsg rsg rst rsa or p and rsa rsa rst rsg or p analysis of clinically relevant phenotype revealed association of r with pustular psoriasis or p we observed significant connection of severity of cutaneous disease with variation at r and suggestive with three remaining trafip snp another positive association were found between age of onset and familial aggregation of disease smoking and younger age of onset smoking and occurrence of pustular psoriasis nail involvement and arthropatic psoriasis nail involvement and more severe course of psoriasis we found no statistically significant difference in the prevalence of the examined variant of rptor and znf gene among our case and control we have replicated the association of trafiprs variant with the susceptibility to psoriasis we have found new association with clinically relevant subphenotypes such a pustular psoriasis or moderatetosevere case we ascertain no connection of rptor and znf variant with psoriasis or it subphenotypes
24075869,disruption of helixcapping residue and reveals a role in hiv entry for a specialized hinge segment of the membrane proximal external region of gp,hiv human immunodeficiency virus type us it trimeric gp envelope env protein consisting of noncovalently associated gp and gp subunit to mediate entry into human t lymphocyte a facile virus fusion mechanism compensates for the sparse env copy number observed on viral particle and includes a aminoacid lentivirusspecific adaptation at the gp base amino acid residue termed the membrane proximal external region mper we show by nmr and epr that the mper consists of a structurally conserved pair of viral lipidimmersed helix separated by a hinge with tandem joint that can be locked by capping residue between helix this design foster efficient hiv fusion via interconverting structure while at the same time affording immune escape disruption of both joint by double alanine mutation at env position and aa result in attenuation of envmediated cellcell fusion and hemifusion a well a viral infectivity mediated by both cddependent and cdindependent virus the potential mechanism of disruption wa revealed by structural analysis of mper conformational change induced by aa mutation a deeper acyl chainburied mper middle section and the elimination of crosshinge rigidbody motion almost certainly impede requisite structural rearrangement during the fusion process explaining the absence of mper aa variant among all known naturally occurring hiv viral sequence furthermore those broadly neutralization antibody directed against the hiv mper exploit the tandem joint architecture involving helix capping thereby disrupting hinge function,Non-Cancer,1,disruption of helixcapping residue and reveals a role in hiv entry for a specialized hinge segment of the membrane proximal external region of gp hiv human immunodeficiency virus type us it trimeric gp envelope env protein consisting of noncovalently associated gp and gp subunit to mediate entry into human t lymphocyte a facile virus fusion mechanism compensates for the sparse env copy number observed on viral particle and includes a aminoacid lentivirusspecific adaptation at the gp base amino acid residue termed the membrane proximal external region mper we show by nmr and epr that the mper consists of a structurally conserved pair of viral lipidimmersed helix separated by a hinge with tandem joint that can be locked by capping residue between helix this design foster efficient hiv fusion via interconverting structure while at the same time affording immune escape disruption of both joint by double alanine mutation at env position and aa result in attenuation of envmediated cellcell fusion and hemifusion a well a viral infectivity mediated by both cddependent and cdindependent virus the potential mechanism of disruption wa revealed by structural analysis of mper conformational change induced by aa mutation a deeper acyl chainburied mper middle section and the elimination of crosshinge rigidbody motion almost certainly impede requisite structural rearrangement during the fusion process explaining the absence of mper aa variant among all known naturally occurring hiv viral sequence furthermore those broadly neutralization antibody directed against the hiv mper exploit the tandem joint architecture involving helix capping thereby disrupting hinge function
24088119,lower lip pit van der woude or kabuki syndrome,kabuki syndrome k is a multiple congenital anomalymental retardation syndrome with characteristic facial feature despite more than documented case and recent correlation of mll mutation a a genetic cause it full clinical spectrum is still being defined this report describes two patient who were initially diagnosed with van der woude syndrome vws based on the presence of lower lip pit however this finding can occur with k albeit infrequently for patient with lower lip pit a thorough evaluation should be made to distinguish between vws and k a there are difference in longterm prognosis,Non-Cancer,1,lower lip pit van der woude or kabuki syndrome kabuki syndrome k is a multiple congenital anomalymental retardation syndrome with characteristic facial feature despite more than documented case and recent correlation of mll mutation a a genetic cause it full clinical spectrum is still being defined this report describes two patient who were initially diagnosed with van der woude syndrome vws based on the presence of lower lip pit however this finding can occur with k albeit infrequently for patient with lower lip pit a thorough evaluation should be made to distinguish between vws and k a there are difference in longterm prognosis
24106199,striking hematological abnormality in patient with microcephalic osteodysplastic primordial dwarfism type ii mopd ii a potential role of pericentrin in hematopoiesis,background microcephalic osteodysplastic primordial dwarfism type ii mopd ii is a rare primordial dwarfism that is similar to seckel syndrome seckel syndrome is known to be associated with various hematological abnormality however hematological finding in mopd ii patient have not been previously reported the present study aimed to describe the hematological finding in a series of eight patient with mopd ii from a single center material and method the study included eight patient with mopd ii that were analyzed via molecular testing and physical and laboratory examination result molecular testing showed that seven of the eight patient had pericentrin pcnt gene mutation hematological evaluation showed that patient had thrombocytosis had leukocytosis had both leukocytosis and thrombocytosis and had anemia conclusion we report leukocytosis and thrombocytosis a a common hematologic abnormality in patient with mopd ii the present finding may improve our understanding of the potential function of the pcnt gene in hematopoietic cell proliferation and differentiation,Non-Cancer,1,striking hematological abnormality in patient with microcephalic osteodysplastic primordial dwarfism type ii mopd ii a potential role of pericentrin in hematopoiesis background microcephalic osteodysplastic primordial dwarfism type ii mopd ii is a rare primordial dwarfism that is similar to seckel syndrome seckel syndrome is known to be associated with various hematological abnormality however hematological finding in mopd ii patient have not been previously reported the present study aimed to describe the hematological finding in a series of eight patient with mopd ii from a single center material and method the study included eight patient with mopd ii that were analyzed via molecular testing and physical and laboratory examination result molecular testing showed that seven of the eight patient had pericentrin pcnt gene mutation hematological evaluation showed that patient had thrombocytosis had leukocytosis had both leukocytosis and thrombocytosis and had anemia conclusion we report leukocytosis and thrombocytosis a a common hematologic abnormality in patient with mopd ii the present finding may improve our understanding of the potential function of the pcnt gene in hematopoietic cell proliferation and differentiation
24144875,hlae restricted cd t cell subset are phenotypically altered in multiple sclerosis patient,background the importance of qa restricted cd t cell in regulating autoreactive t cell response ha been demonstrated in animal model for autoimmune disorder including multiple sclerosis m objective we hypothesize that their human variant hlae restricted cd t cell fulfills a similar regulatory role in man and that these cell are of importance in m method a large cohort of m patient and healthy control wa genotyped for the two known hlae polymorphism flow cytometry wa used to determine hlae expression kinetics and to phenotype hlae restricted cd t cell immunohistochemistry wa performed to investigate hlae expression in the central nervous system cns of m patient result hlae is upregulated on immune cell upon in vitro activation and this upregulation is polymorphismdependent for t and b cell t and b cell in lesion of m patient show enhanced hlae expression furthermore nkgccd t cell of m patient have a significantly lower foxp expression while nkgacd t cell of m patient produce higher level of proinflammatory cytokine compared to those of healthy individual conclusion our study indicates that the hlae system is altered in m and could play a regulatory role in disease,Non-Cancer,1,hlae restricted cd t cell subset are phenotypically altered in multiple sclerosis patient background the importance of qa restricted cd t cell in regulating autoreactive t cell response ha been demonstrated in animal model for autoimmune disorder including multiple sclerosis m objective we hypothesize that their human variant hlae restricted cd t cell fulfills a similar regulatory role in man and that these cell are of importance in m method a large cohort of m patient and healthy control wa genotyped for the two known hlae polymorphism flow cytometry wa used to determine hlae expression kinetics and to phenotype hlae restricted cd t cell immunohistochemistry wa performed to investigate hlae expression in the central nervous system cns of m patient result hlae is upregulated on immune cell upon in vitro activation and this upregulation is polymorphismdependent for t and b cell t and b cell in lesion of m patient show enhanced hlae expression furthermore nkgccd t cell of m patient have a significantly lower foxp expression while nkgacd t cell of m patient produce higher level of proinflammatory cytokine compared to those of healthy individual conclusion our study indicates that the hlae system is altered in m and could play a regulatory role in disease
24200965,dynamic of histone h deposition in proliferating and senescent cell reveals a daxxdependent targeting to pmlnbs important for pericentromeric heterochromatin organization,oncogeneinduced senescence is a permanent cell cycle arrest characterized by extensive chromatin reorganization here we investigated the specific targeting and dynamic of histone h variant in human primary senescent cell we show that newly synthesized epitopetagged h is incorporated in senescent cell but doe not accumulate in senescenceassociated heterochromatin focus sahf instead we observe that new h colocalizes with it specific histone chaperone within the promyelocytic leukemia nuclear body pmlnbs and is targeted to pmlnbs in a daxxdependent manner both in proliferating and senescent cell we further show that overexpression of daxx enhances targeting of h in large pmlnbs devoid of transcriptional activity and promotes the accumulation of hp independently of hkme loss of h from pericentromeric heterochromatin upon daxx or pml depletion suggests that the targeting of h to pmlnbs is implicated in pericentromeric heterochromatin organization together our result underline the importance of the replicationindependent chromatin assembly pathway for histone replacement in nondividing senescent cell and establish pmlnbs a important regulatory site for the incorporation of new h into chromatin,Non-Cancer,1,dynamic of histone h deposition in proliferating and senescent cell reveals a daxxdependent targeting to pmlnbs important for pericentromeric heterochromatin organization oncogeneinduced senescence is a permanent cell cycle arrest characterized by extensive chromatin reorganization here we investigated the specific targeting and dynamic of histone h variant in human primary senescent cell we show that newly synthesized epitopetagged h is incorporated in senescent cell but doe not accumulate in senescenceassociated heterochromatin focus sahf instead we observe that new h colocalizes with it specific histone chaperone within the promyelocytic leukemia nuclear body pmlnbs and is targeted to pmlnbs in a daxxdependent manner both in proliferating and senescent cell we further show that overexpression of daxx enhances targeting of h in large pmlnbs devoid of transcriptional activity and promotes the accumulation of hp independently of hkme loss of h from pericentromeric heterochromatin upon daxx or pml depletion suggests that the targeting of h to pmlnbs is implicated in pericentromeric heterochromatin organization together our result underline the importance of the replicationindependent chromatin assembly pathway for histone replacement in nondividing senescent cell and establish pmlnbs a important regulatory site for the incorporation of new h into chromatin
24201121,monoclonality and cytogenetic abnormality in hyaline vascular castleman disease,hyaline vascular castleman disease is traditionally regarded a a reactive hyperplastic process occasional case however have been reported with cytogenetic anomaly bringing this concept into question in this study we used conventional and methylationspecific polymerase chain reaction method to assess the human androgen receptor alpha humara gene in female patient with hyaline vascular castleman disease and compared the result with three case of plasma cell castleman disease and case of agematched lymphoid hyperplasia we also assessed for immunoglobulin gene and tcell receptor gene rearrangement and conventional cytogenetic analysis wa performed in three case of hyaline vascular castleman disease in case with informative result conventional and methylationspecific human androgen receptor alpha gene analysis yielded a monoclonal pattern in of and of case of hyaline vascular castleman disease respectively a monoclonal pattern wa also detected in three case of plasma cell castleman disease but not in case of lymphoid hyperplasia the frequency of monoclonality wa higher for lesion cm in size and for the stromalrich variant cytogenetic abnormality in stromal cell were revealed in two case of hyaline vascular castleman disease and no case showed monoclonal immunoglobulin or tcell receptor gene rearrangement followup data showed persistent disease in of patient we conclude that hyaline vascular castleman disease is often a monoclonal proliferation most likely of lymph node stromal cell,Non-Cancer,1,monoclonality and cytogenetic abnormality in hyaline vascular castleman disease hyaline vascular castleman disease is traditionally regarded a a reactive hyperplastic process occasional case however have been reported with cytogenetic anomaly bringing this concept into question in this study we used conventional and methylationspecific polymerase chain reaction method to assess the human androgen receptor alpha humara gene in female patient with hyaline vascular castleman disease and compared the result with three case of plasma cell castleman disease and case of agematched lymphoid hyperplasia we also assessed for immunoglobulin gene and tcell receptor gene rearrangement and conventional cytogenetic analysis wa performed in three case of hyaline vascular castleman disease in case with informative result conventional and methylationspecific human androgen receptor alpha gene analysis yielded a monoclonal pattern in of and of case of hyaline vascular castleman disease respectively a monoclonal pattern wa also detected in three case of plasma cell castleman disease but not in case of lymphoid hyperplasia the frequency of monoclonality wa higher for lesion cm in size and for the stromalrich variant cytogenetic abnormality in stromal cell were revealed in two case of hyaline vascular castleman disease and no case showed monoclonal immunoglobulin or tcell receptor gene rearrangement followup data showed persistent disease in of patient we conclude that hyaline vascular castleman disease is often a monoclonal proliferation most likely of lymph node stromal cell
24262698,mastocytosis,mastocytosis is a disorder of abnormal mast cell proliferation with clinical feature that include flushing pruritus abdominal pain diarrhea hypotension syncope and musculoskeletal pain these feature are the result of mast cell mediator release and infiltration into target organ patient of all age may be affected although in child manifestation primarily involve the skin most patient with systemic disease have a somatically acquired activating mutation in the kit oncogene this article discusses the cause and pathogenesis of mastocytosis with an overview of the clinical feature and the approach to diagnosis evaluation and therapy in adult and pediatric patient,Non-Cancer,1,mastocytosis mastocytosis is a disorder of abnormal mast cell proliferation with clinical feature that include flushing pruritus abdominal pain diarrhea hypotension syncope and musculoskeletal pain these feature are the result of mast cell mediator release and infiltration into target organ patient of all age may be affected although in child manifestation primarily involve the skin most patient with systemic disease have a somatically acquired activating mutation in the kit oncogene this article discusses the cause and pathogenesis of mastocytosis with an overview of the clinical feature and the approach to diagnosis evaluation and therapy in adult and pediatric patient
24289326,a new germline mutation in kit associated with diffuse cutaneous mastocytosis in a chinese family,diffuse cutaneous mastocytosis dcm is an extremely rare disease characterized by massive proliferation of mast cell infiltrating the entire skin we report a chinese family with indolent dcm and detection of a new germline kit mutation located in the fifth immunoglobulinlike loop of the kit protein which probably result in a gainoffunction effect and consequent overactivation of mast cell our report expands the knowledge of correlation between the genotype of kit mutation and the phenotype of dcm,Non-Cancer,1,a new germline mutation in kit associated with diffuse cutaneous mastocytosis in a chinese family diffuse cutaneous mastocytosis dcm is an extremely rare disease characterized by massive proliferation of mast cell infiltrating the entire skin we report a chinese family with indolent dcm and detection of a new germline kit mutation located in the fifth immunoglobulinlike loop of the kit protein which probably result in a gainoffunction effect and consequent overactivation of mast cell our report expands the knowledge of correlation between the genotype of kit mutation and the phenotype of dcm
24291262,dynamic recruitment of active proteasomes into polyglutamine initiated inclusion body,neurodegenerative disorder such a huntington disease are hallmarked by neuronal intracellular inclusion body formation whether proteasomes are irreversibly recruited into inclusion body in these protein misfolding disorder is a controversial subject in addition it ha been proposed that the proteasomes may become clogged by the aggregated protein fragment leading to impairment of the ubiquitinproteasome system here we show by fluorescence pulsechase experiment in living cell that proteasomes are dynamically and reversibly recruited into inclusion body a these recruited proteasomes remain catalytically active and accessible to substrate our result challenge the concept of proteasome sequestration and impairment in huntington disease and support the reported absence of proteasome impairment in mouse model of huntington disease,Non-Cancer,1,dynamic recruitment of active proteasomes into polyglutamine initiated inclusion body neurodegenerative disorder such a huntington disease are hallmarked by neuronal intracellular inclusion body formation whether proteasomes are irreversibly recruited into inclusion body in these protein misfolding disorder is a controversial subject in addition it ha been proposed that the proteasomes may become clogged by the aggregated protein fragment leading to impairment of the ubiquitinproteasome system here we show by fluorescence pulsechase experiment in living cell that proteasomes are dynamically and reversibly recruited into inclusion body a these recruited proteasomes remain catalytically active and accessible to substrate our result challenge the concept of proteasome sequestration and impairment in huntington disease and support the reported absence of proteasome impairment in mouse model of huntington disease
24374145,phase i evaluation of xl an oral potent and selective jak inhibitor,this phase i study evaluated selective jak inhibitor xl in patient with myelofibrosis the initial dose cohort were and mg orally on day of a day cycle central andor peripheral neurotoxicity developed in all patient subsequently patient were treated on lower dos neurotoxicity wa again observed leading to study termination peripheral neuropathy resolved in and central neurotoxicity in all patient within month after therapy cessation myelosuppression wa minimal the terminal halflife of xl wa approximately h with steady state reached by day international working group defined response were seen in three patient,Non-Cancer,1,phase i evaluation of xl an oral potent and selective jak inhibitor this phase i study evaluated selective jak inhibitor xl in patient with myelofibrosis the initial dose cohort were and mg orally on day of a day cycle central andor peripheral neurotoxicity developed in all patient subsequently patient were treated on lower dos neurotoxicity wa again observed leading to study termination peripheral neuropathy resolved in and central neurotoxicity in all patient within month after therapy cessation myelosuppression wa minimal the terminal halflife of xl wa approximately h with steady state reached by day international working group defined response were seen in three patient
24389310,srsfp hotspot mutation is highly associated with advanced form of mastocytosis and mutation in epigenetic regulator gene,mastocytosis is a rare and chronic disease with phenotype ranging from indolent to severe prognosis for this disease is variable and very few biomarkers to predict disease evolution or outcome are currently known we have performed comprehensive screening in our large cohort of mastocytosis patient for mutation previously found in other myeloid disease and that could serve a prognostic indicator kit srsfp and tet mutation were by far the most frequent detected in and of patient respectively where tet and srsfp mutation both correlated with advanced disease phenotype srsfp hotspot mutation wa found almost exclusively in patient diagnosed with associated clonal hematologic nonmast cell disease statistically tet and srsfp mutation were highly associated suggesting a mechanistic link between these two factor finally analysis of both clonal and sorted cell population from patient confirms the presence of these mutation in the mast cell component of the disease suggests an ontological mutation hierarchy and provides evidence for the expansion of multiple clone this highlight the prognostic potential of such approach if applied systematically for delineating the role of specific mutation in predisposing andor driving distinct disease phenotype,Non-Cancer,1,srsfp hotspot mutation is highly associated with advanced form of mastocytosis and mutation in epigenetic regulator gene mastocytosis is a rare and chronic disease with phenotype ranging from indolent to severe prognosis for this disease is variable and very few biomarkers to predict disease evolution or outcome are currently known we have performed comprehensive screening in our large cohort of mastocytosis patient for mutation previously found in other myeloid disease and that could serve a prognostic indicator kit srsfp and tet mutation were by far the most frequent detected in and of patient respectively where tet and srsfp mutation both correlated with advanced disease phenotype srsfp hotspot mutation wa found almost exclusively in patient diagnosed with associated clonal hematologic nonmast cell disease statistically tet and srsfp mutation were highly associated suggesting a mechanistic link between these two factor finally analysis of both clonal and sorted cell population from patient confirms the presence of these mutation in the mast cell component of the disease suggests an ontological mutation hierarchy and provides evidence for the expansion of multiple clone this highlight the prognostic potential of such approach if applied systematically for delineating the role of specific mutation in predisposing andor driving distinct disease phenotype
24402730,benign mast cell hyperplasia and atypical mast cell infiltrates in penile lichen planus in adult men,introduction lichen planus lp is a chronic cytokinemediated disease of possible autoimmune etiology of men have anogenital manifestation erosive penile lp cause a scarring phimosis of the foreskin in uncircumcised men mast cell a potent immune modulators have been implicated in a number of autoimmune and chronic inflammatory disease but have not been investigated in lp material and method formalinfixed tissue of circumcision specimen of adult men affected by lp were evaluated for the extent of mast cell and lymphocyte infiltrates characterized immunohistochemically with antibody to cd c and human mast cell tryptase specimen with dense mast cell infiltrates were analyzed for point mutation of the ckit gene dv result unaffected skin and modified mucosa of foreskin contained mast cellsmm the inflammatory infiltrate of lplesions displayed mast cellsmm in foreskin mast cellsmm in and mast cellsmm average range in foreskin lesional mast cell of foreskin showed aberrant cdexpression andor spindled morphology with men having erosive lp a lymphocytic vasculitis and a systemic mastocytosis neither cdexpression nor ckit mutation were identified atypical mast cell infiltrates in lp correlated with high disease activity erosive lp and presence of lymphocytic vasculitis conclusion increased mast cell in penile lp mostly representing a benign hyperplasiaactivation syndrome suggests them a target for innovative therapy option for symptomatic lppatients not responding to corticosteroid therapy presently the biological implication of atypical mast cell infiltrates in penile lp are unknown,Non-Cancer,1,benign mast cell hyperplasia and atypical mast cell infiltrates in penile lichen planus in adult men introduction lichen planus lp is a chronic cytokinemediated disease of possible autoimmune etiology of men have anogenital manifestation erosive penile lp cause a scarring phimosis of the foreskin in uncircumcised men mast cell a potent immune modulators have been implicated in a number of autoimmune and chronic inflammatory disease but have not been investigated in lp material and method formalinfixed tissue of circumcision specimen of adult men affected by lp were evaluated for the extent of mast cell and lymphocyte infiltrates characterized immunohistochemically with antibody to cd c and human mast cell tryptase specimen with dense mast cell infiltrates were analyzed for point mutation of the ckit gene dv result unaffected skin and modified mucosa of foreskin contained mast cellsmm the inflammatory infiltrate of lplesions displayed mast cellsmm in foreskin mast cellsmm in and mast cellsmm average range in foreskin lesional mast cell of foreskin showed aberrant cdexpression andor spindled morphology with men having erosive lp a lymphocytic vasculitis and a systemic mastocytosis neither cdexpression nor ckit mutation were identified atypical mast cell infiltrates in lp correlated with high disease activity erosive lp and presence of lymphocytic vasculitis conclusion increased mast cell in penile lp mostly representing a benign hyperplasiaactivation syndrome suggests them a target for innovative therapy option for symptomatic lppatients not responding to corticosteroid therapy presently the biological implication of atypical mast cell infiltrates in penile lp are unknown
24418349,blood expression profile of fragile x premutation carrier identify candidate gene involved in neurodegenerative and infertility phenotype,male premutation carrier presenting between and cgg repeat in the fragilexassociated fmr gene are at risk of developing fragile x tremorataxia syndrome fxtas and female undergo premature ovarian failure pof here we have evaluated gene expression profile from blood in male fmr premutation carrier and detected a strong deregulation of gene enriched in fxtas relevant biological pathway including inflammation neuronal homeostasis and viability gene expression profiling distinguished between control individual carrier with fxtas and carrier without fxtas with level of expanded fmr mrna being increased in fxtas patient in vitro study in a neuronal cell model indicate that expression level of expanded fmr utr are relevant in modulating the transcriptome thus perturbation of the transcriptome may be an interplay between the cgg expansion size and fmr expression level several deregulated gene dffa bcll bcll app sod rnf hdac kcnc atxn atxn and eap were validated in brain sample of a fxtas mouse model downregulation of eap a gene involved in the female reproductive system physiology wa confirmed in female carrier decreased level were detected in female carrier with pof compared to those without pof suggesting that eap level contribute to ovarian insufficiency in summary gene expression profiling in blood ha uncovered mechanism that may underlie different pathological aspect of the premutation a better understanding of the transcriptome dynamic in relation with expanded fmr mrna expression level and cgg expansion size may provide mechanistic insight into the disease process and a more accurate fxtas diagnosis to the myriad of phenotype associated with the premutation,Non-Cancer,1,blood expression profile of fragile x premutation carrier identify candidate gene involved in neurodegenerative and infertility phenotype male premutation carrier presenting between and cgg repeat in the fragilexassociated fmr gene are at risk of developing fragile x tremorataxia syndrome fxtas and female undergo premature ovarian failure pof here we have evaluated gene expression profile from blood in male fmr premutation carrier and detected a strong deregulation of gene enriched in fxtas relevant biological pathway including inflammation neuronal homeostasis and viability gene expression profiling distinguished between control individual carrier with fxtas and carrier without fxtas with level of expanded fmr mrna being increased in fxtas patient in vitro study in a neuronal cell model indicate that expression level of expanded fmr utr are relevant in modulating the transcriptome thus perturbation of the transcriptome may be an interplay between the cgg expansion size and fmr expression level several deregulated gene dffa bcll bcll app sod rnf hdac kcnc atxn atxn and eap were validated in brain sample of a fxtas mouse model downregulation of eap a gene involved in the female reproductive system physiology wa confirmed in female carrier decreased level were detected in female carrier with pof compared to those without pof suggesting that eap level contribute to ovarian insufficiency in summary gene expression profiling in blood ha uncovered mechanism that may underlie different pathological aspect of the premutation a better understanding of the transcriptome dynamic in relation with expanded fmr mrna expression level and cgg expansion size may provide mechanistic insight into the disease process and a more accurate fxtas diagnosis to the myriad of phenotype associated with the premutation
24443360,sensitive kit dv mutation analysis of blood a a diagnostic test in mastocytosis,the recent progress in sensitive kit dv mutation analysis suggests that mutation analysis of peripheral blood pb represents a promising diagnostic test in mastocytosis however there is a need for systematic assessment of the analytical sensitivity and specificity of the approach in order to establish it value in clinical use we therefore evaluated sensitive kit dv mutation analysis of pb a a diagnostic test in an entire caseseries of adult with mastocytosis we demonstrate for the first time that by using a sufficiently sensitive kit dv mutation analysis it is possible to detect the mutation in pb in nearly all adult mastocytosis patient the mutation wa detected in pb in of systemic mastocytosis and of cutaneous mastocytosis patient the test wa specific a determined by analysis of clinically relevant control patient who all tested negative mutation analysis of pb wa significantly more sensitive than serum tryptase ngml of patient with low tryptase tested mutation positive the test is furthermore readily available and we consider the result to serve a a foundation of experimental evidence to support the inclusion of the test in diagnostic algorithm and clinical practice in mastocytosis,Non-Cancer,1,sensitive kit dv mutation analysis of blood a a diagnostic test in mastocytosis the recent progress in sensitive kit dv mutation analysis suggests that mutation analysis of peripheral blood pb represents a promising diagnostic test in mastocytosis however there is a need for systematic assessment of the analytical sensitivity and specificity of the approach in order to establish it value in clinical use we therefore evaluated sensitive kit dv mutation analysis of pb a a diagnostic test in an entire caseseries of adult with mastocytosis we demonstrate for the first time that by using a sufficiently sensitive kit dv mutation analysis it is possible to detect the mutation in pb in nearly all adult mastocytosis patient the mutation wa detected in pb in of systemic mastocytosis and of cutaneous mastocytosis patient the test wa specific a determined by analysis of clinically relevant control patient who all tested negative mutation analysis of pb wa significantly more sensitive than serum tryptase ngml of patient with low tryptase tested mutation positive the test is furthermore readily available and we consider the result to serve a a foundation of experimental evidence to support the inclusion of the test in diagnostic algorithm and clinical practice in mastocytosis
24452316,variable clinical expressivity of stat mutation in hyperimmunoglobulin e syndrome genetic and clinical study of six patient,background and purpose autosomal dominant hyper ige syndrome adhies is a rare and complex primary immunodeficiency that affect multiple system mutation in signal transducer and activator of transcription stat gene cause adhies these mutation have a dominantnegative effect and the presence of such mutation is associated with a clinical phenotype we aim to describe genetic and clinical characteristic of patient with adhies in our clinic and to highlight the variability of clinical pattern in the same family method we describe six patient four individual of the same family and two unrelated patient all patient were given a clinical score based on disease phenotype according to the national institute of health nih score mutation analysis of stat wa done by pcr amplification of all coding exon followed by bidirectional sequencing using the bigdye kit v and an abi genetic analyzer applied biosystems result all six patient had dna binding region point mutation a proband and his three child with ppheleu mutation a patient with pargtrp substitution and a patient with parggln mutation all of these mutation were previously reported patient differed in infectious immunologic and somatic feature we observed an extreme variability in disease phenotype within the reported family with one genetically affected patient displaying an unaffected phenotype conclusion although the genetic cause of adhies is known more study are required to better understand the possible additional factor that may affect disease expressivity within family and the clinical diversity of the disease,Non-Cancer,1,variable clinical expressivity of stat mutation in hyperimmunoglobulin e syndrome genetic and clinical study of six patient background and purpose autosomal dominant hyper ige syndrome adhies is a rare and complex primary immunodeficiency that affect multiple system mutation in signal transducer and activator of transcription stat gene cause adhies these mutation have a dominantnegative effect and the presence of such mutation is associated with a clinical phenotype we aim to describe genetic and clinical characteristic of patient with adhies in our clinic and to highlight the variability of clinical pattern in the same family method we describe six patient four individual of the same family and two unrelated patient all patient were given a clinical score based on disease phenotype according to the national institute of health nih score mutation analysis of stat wa done by pcr amplification of all coding exon followed by bidirectional sequencing using the bigdye kit v and an abi genetic analyzer applied biosystems result all six patient had dna binding region point mutation a proband and his three child with ppheleu mutation a patient with pargtrp substitution and a patient with parggln mutation all of these mutation were previously reported patient differed in infectious immunologic and somatic feature we observed an extreme variability in disease phenotype within the reported family with one genetically affected patient displaying an unaffected phenotype conclusion although the genetic cause of adhies is known more study are required to better understand the possible additional factor that may affect disease expressivity within family and the clinical diversity of the disease
24475179,plakophilin catenin associate with the etver transcription factor to positively modulate gene activity,member of the plakophilincatenin subfamily pkp and facilitate the linkage of desmosome junctional component to each other eg desmosomal cadherins to desmoplakin and the intermediatefilament cytoskeleton pkps also contribute to desmosomal stabilization and the trafficking of it component the function of pkps outside of the desmosome are less well studied despite evidence suggesting their role in mrna regulation smallgtpase modulation eg midbody scission during cell division and cell survival following dna damage pkpcatenins are further believed to have role in the nucleus given their nuclear localization in some context and the known nuclear role of structurally related catenins such a betacatenin and pcatenin further pkpcatenin activity in the nuclear compartment have become of increased interest with the identification of interaction between pkpcatenin and rna pol iii and pkp with singlestranded dna consistent with earlier report suggesting possible nuclear role in development we previously demonstrated prominent nuclear localization of pkp in xenopus naive ectoderm animal cap cell and recently resolved a similar localization in mouse embryonic stem cell here we report the association and positive functional interaction of pkp with a transcription factor ets variant gene etv which ha critical role in neural development and prominent role in human genetic disease our result are the first to report the interaction of a sequencespecific transcription factor with any pkp using xenopus laevis embryo and mammalian cell we provide evidence for the pkpetv complex on both biochemical and functional level,Non-Cancer,1,plakophilin catenin associate with the etver transcription factor to positively modulate gene activity member of the plakophilincatenin subfamily pkp and facilitate the linkage of desmosome junctional component to each other eg desmosomal cadherins to desmoplakin and the intermediatefilament cytoskeleton pkps also contribute to desmosomal stabilization and the trafficking of it component the function of pkps outside of the desmosome are less well studied despite evidence suggesting their role in mrna regulation smallgtpase modulation eg midbody scission during cell division and cell survival following dna damage pkpcatenins are further believed to have role in the nucleus given their nuclear localization in some context and the known nuclear role of structurally related catenins such a betacatenin and pcatenin further pkpcatenin activity in the nuclear compartment have become of increased interest with the identification of interaction between pkpcatenin and rna pol iii and pkp with singlestranded dna consistent with earlier report suggesting possible nuclear role in development we previously demonstrated prominent nuclear localization of pkp in xenopus naive ectoderm animal cap cell and recently resolved a similar localization in mouse embryonic stem cell here we report the association and positive functional interaction of pkp with a transcription factor ets variant gene etv which ha critical role in neural development and prominent role in human genetic disease our result are the first to report the interaction of a sequencespecific transcription factor with any pkp using xenopus laevis embryo and mammalian cell we provide evidence for the pkpetv complex on both biochemical and functional level
24498434,structural and functional characterization of cargobinding site on the musubunit of adaptor protein complex,adaptor protein ap complex facilitate protein trafficking by playing key role in the selection of cargo molecule to be sorted in postgolgi compartment four ap complex ap to ap contain a mediumsized subunit mumu that recognizes yxxosequences o is a bulky hydrophobic residue which are sorting signal in transmembrane protein a conserved canonical region in mu subunit mediates recognition of yxxosignals by mean of a critical aspartic acid recently we found that a noncanonical yxxosignal on the cytosolic tail of the alzheimers disease amyloid precursor protein app bind to a distinct region of the mu subunit of the ap complex in this study we aimed to determine the functionality of both binding site of mu on the recognition of the noncanonical yxxosignal of app we found that substitution in either binding site abrogated the interaction with the apptail in yeasttwo hybrid experiment further characterization by isothermal titration calorimetry showed instead loss of binding to the app signal with only the substitution rd at the noncanonical site in contrast to a decrease in binding affinity with the substitution da at the canonical site we solved the crystal structure of the cterminal domain of the da mutant bound to this noncanonical yxxosignal this structure showed no significant difference compared to that of wildtype mu both differential scanning fluorimetry and limited proteolysis analysis demonstrated that the da substitution rendered mu less stable suggesting an explanation for it lower binding affinity to the app signal finally in contrast to overexpression of the da mutant and acting in a dominantnegative manner overexpression of mu with either a fa or a rd substitution at the noncanonical site halted app transport at the golgi apparatus together our analysis support that the functional recognition of the noncanonical yxxosignal of app is limited to the noncanonical site of mu,Non-Cancer,1,structural and functional characterization of cargobinding site on the musubunit of adaptor protein complex adaptor protein ap complex facilitate protein trafficking by playing key role in the selection of cargo molecule to be sorted in postgolgi compartment four ap complex ap to ap contain a mediumsized subunit mumu that recognizes yxxosequences o is a bulky hydrophobic residue which are sorting signal in transmembrane protein a conserved canonical region in mu subunit mediates recognition of yxxosignals by mean of a critical aspartic acid recently we found that a noncanonical yxxosignal on the cytosolic tail of the alzheimers disease amyloid precursor protein app bind to a distinct region of the mu subunit of the ap complex in this study we aimed to determine the functionality of both binding site of mu on the recognition of the noncanonical yxxosignal of app we found that substitution in either binding site abrogated the interaction with the apptail in yeasttwo hybrid experiment further characterization by isothermal titration calorimetry showed instead loss of binding to the app signal with only the substitution rd at the noncanonical site in contrast to a decrease in binding affinity with the substitution da at the canonical site we solved the crystal structure of the cterminal domain of the da mutant bound to this noncanonical yxxosignal this structure showed no significant difference compared to that of wildtype mu both differential scanning fluorimetry and limited proteolysis analysis demonstrated that the da substitution rendered mu less stable suggesting an explanation for it lower binding affinity to the app signal finally in contrast to overexpression of the da mutant and acting in a dominantnegative manner overexpression of mu with either a fa or a rd substitution at the noncanonical site halted app transport at the golgi apparatus together our analysis support that the functional recognition of the noncanonical yxxosignal of app is limited to the noncanonical site of mu
24501290,highrisk woman should have brca testing,the u preventive service task force released new guideline recommending brca mutation testing be limited to highrisk woman who have received genetic counseling,Non-Cancer,1,highrisk woman should have brca testing the u preventive service task force released new guideline recommending brca mutation testing be limited to highrisk woman who have received genetic counseling
24522987,the impact of molecular testing on the surgical management of patient with thyroid nodule,background the use of molecular test a an adjunct to fna diagnosis of thyroid nodule ha been increasing however the true impact of these test on surgical practice ha not been demonstrated this study examines the usefulness of molecular testing on surgical management decision in patient referred for thyroid surgery at a tertiary care center method clinical information wa collected from patient who presented to john hopkins hospital for surgical consultation regarding a thyroid nodule and who underwent molecular testing between august and march test included an rnabased gene expression classifier a dnabased somatic mutation panel braf nra andor retptc translocation a surgical management algorithm wa created by consensus of four thyroid surgeon postsurgical pathology analysis in each case wa then used to judge the appropriateness of the surgical decisionmaking and the usefulness of preoperative molecular testing in guiding surgical planning result of patient assessed by preoperative molecular testing underwent surgery surgical management wa altered in nine patient on the basis of molecular testing of these surgical management change wa appropriate relative to the postoperative pathology analysis for three patient and inappropriate for six patient conclusion in this study molecular testing of thyroid nodule did not alter the surgical management of the majority of patient with thyroid nodule these result indicate that molecular testing may be overused in patient for whom the result would not change surgical management furthermore our data question the usefulness of the molecular test examined in guiding preoperative surgical decisionmaking,Non-Cancer,1,the impact of molecular testing on the surgical management of patient with thyroid nodule background the use of molecular test a an adjunct to fna diagnosis of thyroid nodule ha been increasing however the true impact of these test on surgical practice ha not been demonstrated this study examines the usefulness of molecular testing on surgical management decision in patient referred for thyroid surgery at a tertiary care center method clinical information wa collected from patient who presented to john hopkins hospital for surgical consultation regarding a thyroid nodule and who underwent molecular testing between august and march test included an rnabased gene expression classifier a dnabased somatic mutation panel braf nra andor retptc translocation a surgical management algorithm wa created by consensus of four thyroid surgeon postsurgical pathology analysis in each case wa then used to judge the appropriateness of the surgical decisionmaking and the usefulness of preoperative molecular testing in guiding surgical planning result of patient assessed by preoperative molecular testing underwent surgery surgical management wa altered in nine patient on the basis of molecular testing of these surgical management change wa appropriate relative to the postoperative pathology analysis for three patient and inappropriate for six patient conclusion in this study molecular testing of thyroid nodule did not alter the surgical management of the majority of patient with thyroid nodule these result indicate that molecular testing may be overused in patient for whom the result would not change surgical management furthermore our data question the usefulness of the molecular test examined in guiding preoperative surgical decisionmaking
24531980,erdheimchester disease with an ffluorodeoxyglucoseavid breast mass and braf ve mutation,erdheimchester disease ecd is a nonlangerhans cell histiocytosis herein we report a case of a yearold woman who developed bilateral knee pain imaging procedure revealed multiple long bone lesion and a welldefined ffluorodeoxyglucoseavid mass in the left breast the breast mass wa resected and an open biopsy wa performed on the right femoral lesion both specimen revealed involvement by histiocytic infiltrates with feature suggestive of ecd the braf ve mutation wa detected by dna sequencing and immunohistochemistry,Non-Cancer,1,erdheimchester disease with an ffluorodeoxyglucoseavid breast mass and braf ve mutation erdheimchester disease ecd is a nonlangerhans cell histiocytosis herein we report a case of a yearold woman who developed bilateral knee pain imaging procedure revealed multiple long bone lesion and a welldefined ffluorodeoxyglucoseavid mass in the left breast the breast mass wa resected and an open biopsy wa performed on the right femoral lesion both specimen revealed involvement by histiocytic infiltrates with feature suggestive of ecd the braf ve mutation wa detected by dna sequencing and immunohistochemistry
24558502,fibrous papule of the face similar to tuberous sclerosis complexassociated angiofibroma show activation of the mammalian target of rapamycin pathway evidence for a novel therapeutic strategy,fibrous papule of the face are hamartoma characterized by stellateshaped stromal cell multinucleated giant cell and proliferative blood vessel in the dermis the pathogenesis of fibrous papule remains unclear there is a striking microscopic resemblance between fibrous papule and tuberous sclerosis complex tscassociated angiofibromas a germline mutation of the tsc or tsc gene leading to activation of the mammalian target of rapamycin mtor pathway account for the pathogenesis of tscassociated angiofibromas activated mtor subsequently activates p ribosomal protein s kinase psk and ribosomal protein s s by phosphorylation rapamycin a mtor inhibitor is effective in treating tscassociated angiofibromas the aim of this study wa to understand whether the mtor pathway is activated in fibrous papule we studied immunoexpressions of phosphorylated p mtor effector in fibrous papule tscassociated angiofibromas and normal skin control pmtor ppsk and p were highly expressed in dermal stromal cell and epidermal keratinocytes in fibrous papule and tscassociated angiofibromas but not in fibroblast and epidermal keratinocytes of normal skin control p the result suggest topical rapamycin may be a novel treatment option for fibrous papule,Non-Cancer,1,fibrous papule of the face similar to tuberous sclerosis complexassociated angiofibroma show activation of the mammalian target of rapamycin pathway evidence for a novel therapeutic strategy fibrous papule of the face are hamartoma characterized by stellateshaped stromal cell multinucleated giant cell and proliferative blood vessel in the dermis the pathogenesis of fibrous papule remains unclear there is a striking microscopic resemblance between fibrous papule and tuberous sclerosis complex tscassociated angiofibromas a germline mutation of the tsc or tsc gene leading to activation of the mammalian target of rapamycin mtor pathway account for the pathogenesis of tscassociated angiofibromas activated mtor subsequently activates p ribosomal protein s kinase psk and ribosomal protein s s by phosphorylation rapamycin a mtor inhibitor is effective in treating tscassociated angiofibromas the aim of this study wa to understand whether the mtor pathway is activated in fibrous papule we studied immunoexpressions of phosphorylated p mtor effector in fibrous papule tscassociated angiofibromas and normal skin control pmtor ppsk and p were highly expressed in dermal stromal cell and epidermal keratinocytes in fibrous papule and tscassociated angiofibromas but not in fibroblast and epidermal keratinocytes of normal skin control p the result suggest topical rapamycin may be a novel treatment option for fibrous papule
24601692,macronodular adrenal hyperplasia due to mutation in an armadillo repeat containing armc gene a clinical and genetic investigation,context inactivating germline mutation of the probable tumor suppressor gene armadillo repeat containing armc have recently been identified a a genetic cause of macronodular adrenal hyperplasia mah objective we searched for armc mutation in a large cohort of patient with mah the clinical phenotype of patient with and without armc mutation wa compared method blood dna from mah patient wa genotyped using sanger sequencing diurnal serum cortisol measurement plasma acth level urinary steroid day liddles test adrenal computed tomography and weight of adrenal gland at adrenalectomy were assessed result germline armc mutation were found in of patient in silico analysis of the mutation indicated that seven predicted major implication for gene function latenight cortisol level were higher in patient with armcdamaging mutation compared with those without andor with nonpathogenic mutation v p all patient carrying a pathogenic armc mutation had clinical cushing syndrome seven of seven compared with of of those without or with mutation that were predicted to be benign p repeatedmeasures analysis showed overall higher urinary hydroxycorticosteroids and free cortisol value in the patient with armcdamaging mutation during the day liddles test p conclusion armc mutation are implicated in clinically severe cushing syndrome associated with mah knowledge of a patient armc status ha important clinical implication for the diagnosis of cushing syndrome and genetic counseling of patient and their family,Non-Cancer,1,macronodular adrenal hyperplasia due to mutation in an armadillo repeat containing armc gene a clinical and genetic investigation context inactivating germline mutation of the probable tumor suppressor gene armadillo repeat containing armc have recently been identified a a genetic cause of macronodular adrenal hyperplasia mah objective we searched for armc mutation in a large cohort of patient with mah the clinical phenotype of patient with and without armc mutation wa compared method blood dna from mah patient wa genotyped using sanger sequencing diurnal serum cortisol measurement plasma acth level urinary steroid day liddles test adrenal computed tomography and weight of adrenal gland at adrenalectomy were assessed result germline armc mutation were found in of patient in silico analysis of the mutation indicated that seven predicted major implication for gene function latenight cortisol level were higher in patient with armcdamaging mutation compared with those without andor with nonpathogenic mutation v p all patient carrying a pathogenic armc mutation had clinical cushing syndrome seven of seven compared with of of those without or with mutation that were predicted to be benign p repeatedmeasures analysis showed overall higher urinary hydroxycorticosteroids and free cortisol value in the patient with armcdamaging mutation during the day liddles test p conclusion armc mutation are implicated in clinically severe cushing syndrome associated with mah knowledge of a patient armc status ha important clinical implication for the diagnosis of cushing syndrome and genetic counseling of patient and their family
24608375,mri without magnet removal in neurofibromatosis type patient with cochlear and auditory brainstem implant,objective to assess the impact on image quality of mri without magnet removal in cochlear implant ci and auditory brainstem implant abi user with neurofibromatosis type nf study design prospective cohort setting tertiary center for cochlear and auditory brainstem implantation patient thirteen patient abi ci with nf underwent a total of mri scan intervention mri without magnet removal main outcome measure ability to visualize the ipsilateral and contralateral cerebellopontine angle cpa and internal auditory meati iam with head mri result of the scan were of the head of the spine and of other region scanning wa performed with a tight head bandage and plastic card there were no case of altered implant function or demagnetization of the device magneta grading system wa used to assess the view of the ipsilateral iamcpa in of head scan the view wa unimpaired grade in there wa distortion grade in case the view wa entirely obscured by artifact grade view of the contralateral cpa and iam were unimpaired in all case the best sequence for the depiction of the ipsilateral iamcpa percent graded a were a follows axial d inversion recovery prepared fast spoiled gradient echo mm coronal tw of the iamcpa and mm axial tw of the iamcpa conclusion mri scanning without magnet removal is safe and well tolerated in nf patient with auditory implant with appropriate mri sequence the image quality is not significantly impaired,Non-Cancer,1,mri without magnet removal in neurofibromatosis type patient with cochlear and auditory brainstem implant objective to assess the impact on image quality of mri without magnet removal in cochlear implant ci and auditory brainstem implant abi user with neurofibromatosis type nf study design prospective cohort setting tertiary center for cochlear and auditory brainstem implantation patient thirteen patient abi ci with nf underwent a total of mri scan intervention mri without magnet removal main outcome measure ability to visualize the ipsilateral and contralateral cerebellopontine angle cpa and internal auditory meati iam with head mri result of the scan were of the head of the spine and of other region scanning wa performed with a tight head bandage and plastic card there were no case of altered implant function or demagnetization of the device magneta grading system wa used to assess the view of the ipsilateral iamcpa in of head scan the view wa unimpaired grade in there wa distortion grade in case the view wa entirely obscured by artifact grade view of the contralateral cpa and iam were unimpaired in all case the best sequence for the depiction of the ipsilateral iamcpa percent graded a were a follows axial d inversion recovery prepared fast spoiled gradient echo mm coronal tw of the iamcpa and mm axial tw of the iamcpa conclusion mri scanning without magnet removal is safe and well tolerated in nf patient with auditory implant with appropriate mri sequence the image quality is not significantly impaired
24616478,metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically baffexposed b cell,b cell activation lead to proliferation and ab production that can protect from pathogen or promote autoimmunity regulation of cell metabolism is essential to support the demand of lymphocyte growth and effector function and may regulate tolerance in this study we tested the regulation and role of glucose uptake and metabolism in the proliferation and ab production of control anergic and autoimmuneprone b cell control b cell had a balanced increase in lactate production and oxygen consumption following activation with proportionally increased glucose transporter glut expression and mitochondrial mass upon either lp or bcr stimulation this contrasted with metabolic reprogramming of t cell which had lower glycolytic flux when resting but disproportionately increased this pathway upon activation importantly tolerance greatly affected b cell metabolic reprogramming anergic b cell remained metabolically quiescent with only a modest increase in glycolysis and oxygen consumption with lp stimulation b cell chronically stimulated with elevated baff however rapidly increased glycolysis and ab production upon stimulation induction of glycolysis wa critical for ab production a glycolytic inhibition with the pyruvate dehydrogenase kinase inhibitor dichloroacetate sharply suppressed b cell proliferation and ab secretion in vitro and in vivo furthermore b cellspecific deletion of glut led to reduced b cell number and impaired ab production in vivo together these data show that activated b cell require glutdependent metabolic reprogramming to support proliferation and ab production that is distinct from t cell and that this glycolytic reprogramming is regulated in tolerance,Non-Cancer,1,metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically baffexposed b cell b cell activation lead to proliferation and ab production that can protect from pathogen or promote autoimmunity regulation of cell metabolism is essential to support the demand of lymphocyte growth and effector function and may regulate tolerance in this study we tested the regulation and role of glucose uptake and metabolism in the proliferation and ab production of control anergic and autoimmuneprone b cell control b cell had a balanced increase in lactate production and oxygen consumption following activation with proportionally increased glucose transporter glut expression and mitochondrial mass upon either lp or bcr stimulation this contrasted with metabolic reprogramming of t cell which had lower glycolytic flux when resting but disproportionately increased this pathway upon activation importantly tolerance greatly affected b cell metabolic reprogramming anergic b cell remained metabolically quiescent with only a modest increase in glycolysis and oxygen consumption with lp stimulation b cell chronically stimulated with elevated baff however rapidly increased glycolysis and ab production upon stimulation induction of glycolysis wa critical for ab production a glycolytic inhibition with the pyruvate dehydrogenase kinase inhibitor dichloroacetate sharply suppressed b cell proliferation and ab secretion in vitro and in vivo furthermore b cellspecific deletion of glut led to reduced b cell number and impaired ab production in vivo together these data show that activated b cell require glutdependent metabolic reprogramming to support proliferation and ab production that is distinct from t cell and that this glycolytic reprogramming is regulated in tolerance
24626649,adult mastocytosis a review of the santo antonio hospital s experience and an evaluation of world health organization criterion for the diagnosis of systemic disease,background mastocytosis is a clonal disorder characterized by the accumulation of abnormal mast cell in the skin andor in extracutaneous organ objective to present all case of mastocytosis seen in the porto hospital center and evaluate the performance of world health organization diagnostic criterion for systemic disease method the case of twentyfour adult patient with mastocytosis were reviewed their clinical and laboratorial characteristic were assessed and the property of the criterion used to diagnose systemic mastocytosis were evaluated result the age of disease onset ranged from to year twentythree patient had cutaneous involvement and were referred by dermatologist urticaria pigmentosa wa the most common manifestation of the disease one patient with severe systemic mast cell mediatorrelated symptom showed the activating vg kit mutation the bone marrow wa examined in of patient and mast cell immunophenotyping wa performed in of the participant systemic disease wa detected in of case and of the sample had elevated serum tryptase level all the diagnostic criterion for systemic mastocytosis had high specificity and positive predictive value bone marrow biopsy had the lowest sensitivity negative predictive value and efficiency while the highest such value were observed for mast cell immunophenotyping patient were treated with regimen including antihistamine sodium cromoglycate alphainterferon hydroxyurea and phototherapy conclusion cutaneous involvement is often seen in adult mastocytosis patient with most individual presenting with indolent systemic disease although serum tryptase level are a good indicator of mast cell burden bone marrow biopsy should also be performed in patient with normal serum tryptase with flow cytometry being the most adequate method to diagnose systemic disease,Non-Cancer,1,adult mastocytosis a review of the santo antonio hospital s experience and an evaluation of world health organization criterion for the diagnosis of systemic disease background mastocytosis is a clonal disorder characterized by the accumulation of abnormal mast cell in the skin andor in extracutaneous organ objective to present all case of mastocytosis seen in the porto hospital center and evaluate the performance of world health organization diagnostic criterion for systemic disease method the case of twentyfour adult patient with mastocytosis were reviewed their clinical and laboratorial characteristic were assessed and the property of the criterion used to diagnose systemic mastocytosis were evaluated result the age of disease onset ranged from to year twentythree patient had cutaneous involvement and were referred by dermatologist urticaria pigmentosa wa the most common manifestation of the disease one patient with severe systemic mast cell mediatorrelated symptom showed the activating vg kit mutation the bone marrow wa examined in of patient and mast cell immunophenotyping wa performed in of the participant systemic disease wa detected in of case and of the sample had elevated serum tryptase level all the diagnostic criterion for systemic mastocytosis had high specificity and positive predictive value bone marrow biopsy had the lowest sensitivity negative predictive value and efficiency while the highest such value were observed for mast cell immunophenotyping patient were treated with regimen including antihistamine sodium cromoglycate alphainterferon hydroxyurea and phototherapy conclusion cutaneous involvement is often seen in adult mastocytosis patient with most individual presenting with indolent systemic disease although serum tryptase level are a good indicator of mast cell burden bone marrow biopsy should also be performed in patient with normal serum tryptase with flow cytometry being the most adequate method to diagnose systemic disease
24647736,multiple nonglycemic genomic locus are newly associated with blood level of glycated hemoglobin in east asian,glycated hemoglobin ac hbac is used a a measure of glycemic control and also a a diagnostic criterion for diabetes to discover novel locus harboring common variant associated with hbac in east asian we conducted a metaanalysis of genomewide association study gwas n we replicated our finding in three additional study comprising individual of east asian ancestry ten variant showed association that reached genomewide significance in the discovery data set of which nine four novel variant at tmem p value x hbslmyb x myob x and cyba x a well a five variant at locus that had been previously identified cdkal gpcabcb gck ank and fnki showed consistent evidence of association in replication data set these variant explained of the variance in hbac several of these variant tmem hbslmyb cyba myob ank and fnk showed no association with either blood glucose or type diabetes among individual with nondiabetic level of fasting glucose had hbac after adjustment for these six variant our east asian gwas metaanalysis ha identified novel variant associated with hbac a well a demonstrated that the effect of known variant are largely transferable across ethnic group variant affecting erythrocyte parameter rather than glucose metabolism may be relevant to the use of hbac for diagnosing diabetes in these population,Non-Cancer,1,multiple nonglycemic genomic locus are newly associated with blood level of glycated hemoglobin in east asian glycated hemoglobin ac hbac is used a a measure of glycemic control and also a a diagnostic criterion for diabetes to discover novel locus harboring common variant associated with hbac in east asian we conducted a metaanalysis of genomewide association study gwas n we replicated our finding in three additional study comprising individual of east asian ancestry ten variant showed association that reached genomewide significance in the discovery data set of which nine four novel variant at tmem p value x hbslmyb x myob x and cyba x a well a five variant at locus that had been previously identified cdkal gpcabcb gck ank and fnki showed consistent evidence of association in replication data set these variant explained of the variance in hbac several of these variant tmem hbslmyb cyba myob ank and fnk showed no association with either blood glucose or type diabetes among individual with nondiabetic level of fasting glucose had hbac after adjustment for these six variant our east asian gwas metaanalysis ha identified novel variant associated with hbac a well a demonstrated that the effect of known variant are largely transferable across ethnic group variant affecting erythrocyte parameter rather than glucose metabolism may be relevant to the use of hbac for diagnosing diabetes in these population
24676424,neurofibromatosis type gene mutation analysis using sequence capture and highthroughput sequencing,neurofibromatosis type syndrome nf is caused by mutation in the nf gene availability of new sequencing technology prompted u to search for an alternative method for nf mutation analysis genomic dna wa isolated from saliva avoiding invasive sampling the nf exon with an additional bp of flanking intronic sequence were captured and enriched using the seqcap ez choice library protocol the captured dna wa sequenced with the roche g junior system the mean coverage of the targeted region were x and x in separate set of sample an nf mutation wa discovered in out of separate patient sample our study provides proof of principle that the sequence capture methodology combined with highthroughput sequencing is applicable to nf mutation analysis deep intronic mutation may however remain undetectable and change at the dna level may not predict the outcome at the mrna or protein level,Non-Cancer,1,neurofibromatosis type gene mutation analysis using sequence capture and highthroughput sequencing neurofibromatosis type syndrome nf is caused by mutation in the nf gene availability of new sequencing technology prompted u to search for an alternative method for nf mutation analysis genomic dna wa isolated from saliva avoiding invasive sampling the nf exon with an additional bp of flanking intronic sequence were captured and enriched using the seqcap ez choice library protocol the captured dna wa sequenced with the roche g junior system the mean coverage of the targeted region were x and x in separate set of sample an nf mutation wa discovered in out of separate patient sample our study provides proof of principle that the sequence capture methodology combined with highthroughput sequencing is applicable to nf mutation analysis deep intronic mutation may however remain undetectable and change at the dna level may not predict the outcome at the mrna or protein level
24676943,fast and robust nextgeneration sequencing technique using ion torrent personal genome machine for the screening of neurofibromatosis type nf gene,neurofibromatosis type nf gene exhibit one of the highest spontaneous mutation rate in the human genome identification of the nf mutation is challenging because the nf gene is very large and complex lacking mutational hot spot there is no clustering of mutation there are several pseudogenes and a wide spectrum of different type of mutation ha been recognized to date nf mutation or deleted region have been detected with a number of technique with the appearance of nextgeneration sequencing ng machine molecular biology is in a new revolutionary phase our aim wa to work out a method to use the highthroughput ng machine ion torrent pgm in diagnostic setting for neurofibromatosis type in our examination we could reveal distinct variation in nf gene in seven patient this is an absolutely new method for exploring the genetic background of neurofibromatosis type exhibiting the extremely high throughput of ng in a diagnostic setting,Non-Cancer,1,fast and robust nextgeneration sequencing technique using ion torrent personal genome machine for the screening of neurofibromatosis type nf gene neurofibromatosis type nf gene exhibit one of the highest spontaneous mutation rate in the human genome identification of the nf mutation is challenging because the nf gene is very large and complex lacking mutational hot spot there is no clustering of mutation there are several pseudogenes and a wide spectrum of different type of mutation ha been recognized to date nf mutation or deleted region have been detected with a number of technique with the appearance of nextgeneration sequencing ng machine molecular biology is in a new revolutionary phase our aim wa to work out a method to use the highthroughput ng machine ion torrent pgm in diagnostic setting for neurofibromatosis type in our examination we could reveal distinct variation in nf gene in seven patient this is an absolutely new method for exploring the genetic background of neurofibromatosis type exhibiting the extremely high throughput of ng in a diagnostic setting
24688314,comparison of method for the extraction of dna from formalinfixed paraffinembedded archival tissue,aim discussing a protocol involving xyleneethanol deparaffinization on slide followed by a kitbased extraction that allows for the extraction of high quality dna from ffpe tissue method dna wa extracted from the ffpe tissue of randomly selected block method involving deparaffinization on slide or tube enzyme digestion overnight or for hour and isolation using phenol chloroform method or a silicabased commercial kit were compared in term of yield concentration and the amplifiability result the highest yield of dna wa produced from the sample that were deparaffinized on slide digested for hour and isolated with a commercial kit sample isolated with the phenolchloroform method produced dna of lower purity than the sample that were purified with kit the sample isolated with the commercial kit resulted in better pcr amplification conclusion silicabased commercial kit and deparaffinized on slide should be considered for dna extraction from ffpe,Non-Cancer,1,comparison of method for the extraction of dna from formalinfixed paraffinembedded archival tissue aim discussing a protocol involving xyleneethanol deparaffinization on slide followed by a kitbased extraction that allows for the extraction of high quality dna from ffpe tissue method dna wa extracted from the ffpe tissue of randomly selected block method involving deparaffinization on slide or tube enzyme digestion overnight or for hour and isolation using phenol chloroform method or a silicabased commercial kit were compared in term of yield concentration and the amplifiability result the highest yield of dna wa produced from the sample that were deparaffinized on slide digested for hour and isolated with a commercial kit sample isolated with the phenolchloroform method produced dna of lower purity than the sample that were purified with kit the sample isolated with the commercial kit resulted in better pcr amplification conclusion silicabased commercial kit and deparaffinized on slide should be considered for dna extraction from ffpe
24690944,massively parallel sequencing of patient with intellectual disability congenital anomaly andor autism spectrum disorder with a targeted gene panel,developmental delay andor intellectual disability ddid affect of all child at least half of these are thought to have a genetic etiology recent study have shown that massively parallel sequencing mp using a targeted gene panel is particularly suited for diagnostic testing for genetically heterogeneous condition we report on our experience with using massively parallel sequencing of a targeted gene panel of gene for investigating the genetic etiology of eight patient with a wide range of phenotype including ddid congenital anomaly andor autism spectrum disorder targeted sequence enrichment wa performed using the agilent sureselect target enrichment kit and sequenced on the illumina hiseq using pairedend read for all eight patient of the targeted region achieved read depth of at least x with average read depth overlapping target ranging from x to x causative variant were successfully identified in two of the eight patient a nonsense mutation in the atrx gene and a canonical splice site mutation in the lcam gene in a third patient a canonical splice site variant in the uspx gene could likely explain all or some of her clinical phenotype these result confirm the value of targeted mp for investigating ddid in child for diagnostic purpose however targeted gene mp wa less likely to provide a genetic diagnosis for child whose phenotype includes autism,Non-Cancer,1,massively parallel sequencing of patient with intellectual disability congenital anomaly andor autism spectrum disorder with a targeted gene panel developmental delay andor intellectual disability ddid affect of all child at least half of these are thought to have a genetic etiology recent study have shown that massively parallel sequencing mp using a targeted gene panel is particularly suited for diagnostic testing for genetically heterogeneous condition we report on our experience with using massively parallel sequencing of a targeted gene panel of gene for investigating the genetic etiology of eight patient with a wide range of phenotype including ddid congenital anomaly andor autism spectrum disorder targeted sequence enrichment wa performed using the agilent sureselect target enrichment kit and sequenced on the illumina hiseq using pairedend read for all eight patient of the targeted region achieved read depth of at least x with average read depth overlapping target ranging from x to x causative variant were successfully identified in two of the eight patient a nonsense mutation in the atrx gene and a canonical splice site mutation in the lcam gene in a third patient a canonical splice site variant in the uspx gene could likely explain all or some of her clinical phenotype these result confirm the value of targeted mp for investigating ddid in child for diagnostic purpose however targeted gene mp wa less likely to provide a genetic diagnosis for child whose phenotype includes autism
24694135,computing global minimizers to a constrained bspline image registration problem from optimal l perturbation to block match data,purpose block matching is a wellknown strategy for estimating corresponding voxel location between a pair of image according to an image similarity metric though robust to issue such a image noise and large magnitude voxel displacement the estimated point match are not guaranteed to be spatially accurate however the underlying optimization problem solved by the block matching procedure is similar in structure to the class of optimization problem associated with bspline based registration method by exploiting this relationship the author derive a numerical method for computing a global minimizer to a constrained bspline registration problem that incorporates the robustness of block matching with the global smoothness property inherent to bspline parameterization method the method reformulates the traditional bspline registration problem a a basis pursuit problem describing the minimallperturbation to block match pair required to produce a bspline fitting error within a given tolerance the sparsity pattern of the optimal perturbation then defines a voxel point cloud subset on which the bspline fit is a global minimizer to a constrained variant of the bspline registration problem a opposed to traditional bspline algorithm the optimization step involving the actual image data is addressed by block matching result the performance of the method is measured in term of spatial accuracy using ten inhaleexhale thoracic ct image pair available for download atwwwdirlabcom obtained from the copdgene dataset and corresponding set of expertdetermined landmark point pair the result of the validation procedure demonstrate that the method can achieve a high spatial accuracy on a significantly complex image set conclusion the proposed methodology is demonstrated to achieve a high spatial accuracy and is generalizable in that in can employ any displacement field parameterization described a a least square fit to block match generated estimate thus the framework allows for a wide range of image similarity block match metric and physical modeling combination,Non-Cancer,1,computing global minimizers to a constrained bspline image registration problem from optimal l perturbation to block match data purpose block matching is a wellknown strategy for estimating corresponding voxel location between a pair of image according to an image similarity metric though robust to issue such a image noise and large magnitude voxel displacement the estimated point match are not guaranteed to be spatially accurate however the underlying optimization problem solved by the block matching procedure is similar in structure to the class of optimization problem associated with bspline based registration method by exploiting this relationship the author derive a numerical method for computing a global minimizer to a constrained bspline registration problem that incorporates the robustness of block matching with the global smoothness property inherent to bspline parameterization method the method reformulates the traditional bspline registration problem a a basis pursuit problem describing the minimallperturbation to block match pair required to produce a bspline fitting error within a given tolerance the sparsity pattern of the optimal perturbation then defines a voxel point cloud subset on which the bspline fit is a global minimizer to a constrained variant of the bspline registration problem a opposed to traditional bspline algorithm the optimization step involving the actual image data is addressed by block matching result the performance of the method is measured in term of spatial accuracy using ten inhaleexhale thoracic ct image pair available for download atwwwdirlabcom obtained from the copdgene dataset and corresponding set of expertdetermined landmark point pair the result of the validation procedure demonstrate that the method can achieve a high spatial accuracy on a significantly complex image set conclusion the proposed methodology is demonstrated to achieve a high spatial accuracy and is generalizable in that in can employ any displacement field parameterization described a a least square fit to block match generated estimate thus the framework allows for a wide range of image similarity block match metric and physical modeling combination
24704721,card deficiency and spontaneous central nervous system candidiasis complete clinical remission with gmcsf therapy,we demonstrate autosomalrecessive caspase recruitment domaincontaining protein card deficiency in a patient with relapsing c albicans meningoencephalitis we identified a novel hypomorphic mutation with intact th response but impaired gmcsf response we report complete clinical remission with adjunctive gmcsf therapy suggesting that a cardgmcsf axis contributes to susceptibility to candidiasis,Non-Cancer,1,card deficiency and spontaneous central nervous system candidiasis complete clinical remission with gmcsf therapy we demonstrate autosomalrecessive caspase recruitment domaincontaining protein card deficiency in a patient with relapsing c albicans meningoencephalitis we identified a novel hypomorphic mutation with intact th response but impaired gmcsf response we report complete clinical remission with adjunctive gmcsf therapy suggesting that a cardgmcsf axis contributes to susceptibility to candidiasis
24718618,rapid and efficient conversion of integrationfree human induced pluripotent stem cell to gmpgrade culture condition,data suggest that clinical application of human induced pluripotent stem cell hipscs will be realized nonetheless clinical application will require hipscs that are free of exogenous dna and that can be manufactured through good manufacturing practice gmp optimally derivation of hipscs should be rapid and efficient in order to minimize manipulation reduce potential for accumulation of mutation and minimize financial cost previous study reported the use of modified synthetic mrna to reprogram fibroblast to a pluripotent state here we provide an optimized fully chemically defined and feederfree protocol for the derivation of hipscs using synthetic mrna the protocol result in derivation of fully reprogrammed hipsc line from adult dermal fibroblast in less than two week the hipsc line were successfully tested for their identity purity stability and safety at a gmp facility and cryopreserved to our knowledge a a proof of principle these are the first integrationfree ipscs line that were reproducibly generated through synthetic mrna reprogramming that could be putatively used for clinical purpose,Non-Cancer,1,rapid and efficient conversion of integrationfree human induced pluripotent stem cell to gmpgrade culture condition data suggest that clinical application of human induced pluripotent stem cell hipscs will be realized nonetheless clinical application will require hipscs that are free of exogenous dna and that can be manufactured through good manufacturing practice gmp optimally derivation of hipscs should be rapid and efficient in order to minimize manipulation reduce potential for accumulation of mutation and minimize financial cost previous study reported the use of modified synthetic mrna to reprogram fibroblast to a pluripotent state here we provide an optimized fully chemically defined and feederfree protocol for the derivation of hipscs using synthetic mrna the protocol result in derivation of fully reprogrammed hipsc line from adult dermal fibroblast in less than two week the hipsc line were successfully tested for their identity purity stability and safety at a gmp facility and cryopreserved to our knowledge a a proof of principle these are the first integrationfree ipscs line that were reproducibly generated through synthetic mrna reprogramming that could be putatively used for clinical purpose
24744588,hla variant related to primary sclerosing cholangitis influence rejection after liver transplantation,aim to investigate influence of human leukocyte antigen hla and killer immunoglobulinelike receptor kir genotype on risk of acute rejection ar after liver transplantation ltx method in this retrospective study we included adult donorrecipient pair with a minimum of mo followup after ltx for whom dna wa available from both donor and recipient clinical data all early complication including episode and severity of ar and graftpatient survival were registered the diagnosis of ar wa based on clinical biochemical and histological criterion all suspected episode of ar were biopsy confirmed key classical hla locus hlaa hlab hlac and hladrb were genotyped using sanger sequencing kir gene were genotyped using a novel real time pcr approach which allows for determination of the diploid copy number of each kir gene immunohistochemical staining for t cd b cd and natural killer nk cell cd and cd were performed on liver biopsy from different patient group primary sclerosing cholangitis psc primary biliary cirrhosis and nonautoimmune liver disease in each group with similar grade of ar result fourtyfour patient were transplanted on the basis of psc of them had ar v in the nonpsc group p no significant impact of donorrecipient matching for hla and kir genotype wa detected in the overall recipient population an increased risk of ar wa detected for hlab p or ci hlac p or ci and hladrb p or ci and a decreased risk for hladrb p or ci for hlab hlac and drb the association remained evident in a subgroup analysis of nonpsc recipient p p and p respectively in psc recipient corresponding p value were and for hlab hlac and drb respectively a dosage effect of ar prevalence according to the psc associated hla allele wa also notable in the total recipient population for hlab the frequency of ar wa in hlab homozygous recipient in heterozygous recipient and in recipient lacking hlab p the same wa observed for the hlac allele with ar in and in recipient being homozygous heterozygous and lacking hlac respectively p immunohistochemical analysis showed similar infiltration of t b and nk cell in biopsy with ar in all three group conclusion we found significant association between the pscassociated hlab hlac hladrb and hladrb allele and risk of ar in liver transplant recipient,Non-Cancer,1,hla variant related to primary sclerosing cholangitis influence rejection after liver transplantation aim to investigate influence of human leukocyte antigen hla and killer immunoglobulinelike receptor kir genotype on risk of acute rejection ar after liver transplantation ltx method in this retrospective study we included adult donorrecipient pair with a minimum of mo followup after ltx for whom dna wa available from both donor and recipient clinical data all early complication including episode and severity of ar and graftpatient survival were registered the diagnosis of ar wa based on clinical biochemical and histological criterion all suspected episode of ar were biopsy confirmed key classical hla locus hlaa hlab hlac and hladrb were genotyped using sanger sequencing kir gene were genotyped using a novel real time pcr approach which allows for determination of the diploid copy number of each kir gene immunohistochemical staining for t cd b cd and natural killer nk cell cd and cd were performed on liver biopsy from different patient group primary sclerosing cholangitis psc primary biliary cirrhosis and nonautoimmune liver disease in each group with similar grade of ar result fourtyfour patient were transplanted on the basis of psc of them had ar v in the nonpsc group p no significant impact of donorrecipient matching for hla and kir genotype wa detected in the overall recipient population an increased risk of ar wa detected for hlab p or ci hlac p or ci and hladrb p or ci and a decreased risk for hladrb p or ci for hlab hlac and drb the association remained evident in a subgroup analysis of nonpsc recipient p p and p respectively in psc recipient corresponding p value were and for hlab hlac and drb respectively a dosage effect of ar prevalence according to the psc associated hla allele wa also notable in the total recipient population for hlab the frequency of ar wa in hlab homozygous recipient in heterozygous recipient and in recipient lacking hlab p the same wa observed for the hlac allele with ar in and in recipient being homozygous heterozygous and lacking hlac respectively p immunohistochemical analysis showed similar infiltration of t b and nk cell in biopsy with ar in all three group conclusion we found significant association between the pscassociated hlab hlac hladrb and hladrb allele and risk of ar in liver transplant recipient
24745670,diagnostic criterion and classification of mastocytosis in,mastocytosis is characterized by accumulation of pathologic mast cell in tissue most patient with mastocytosis experience mast cell activation symptom in response to various trigger the diagnosis of mastocytosis should be made from objective pathologic finding modern diagnostic criterion and classification of mastocytosis were proposed in by an international consensus group and formed the basis of the current world health organization who guideline which have been validated to correlate with prognosis and help selection of therapy in this article the who criterion for diagnosis and classification are summarized and practical aspect to avoid common pitfall in diagnostic workup are discussed,Non-Cancer,1,diagnostic criterion and classification of mastocytosis in mastocytosis is characterized by accumulation of pathologic mast cell in tissue most patient with mastocytosis experience mast cell activation symptom in response to various trigger the diagnosis of mastocytosis should be made from objective pathologic finding modern diagnostic criterion and classification of mastocytosis were proposed in by an international consensus group and formed the basis of the current world health organization who guideline which have been validated to correlate with prognosis and help selection of therapy in this article the who criterion for diagnosis and classification are summarized and practical aspect to avoid common pitfall in diagnostic workup are discussed
24745675,flow cytometry in mastocytosis utility a a diagnostic and prognostic tool,this article present information for the identification and characterization of mast cell from bone marrow and other tissue using multiparametric flow cytometry in addition it provides guideline for the application of this technique in the subclassification of systemic mastocytosis and assessment of the longterm prognosis of patient individually,Non-Cancer,1,flow cytometry in mastocytosis utility a a diagnostic and prognostic tool this article present information for the identification and characterization of mast cell from bone marrow and other tissue using multiparametric flow cytometry in addition it provides guideline for the application of this technique in the subclassification of systemic mastocytosis and assessment of the longterm prognosis of patient individually
24745676,mastocytosis immunophenotypical feature of the transformed mast cell are unique among hematopoietic cell,mastocytosis is a disease of bone marrow origin histologically characterized by compact tissue infiltrates of atypical mast cell never seen in reactive state most patient with mastocytosis have transformed mast cell carrying an activating point mutation at codon of kit and also show an elevated serum tryptase level in this article immunophenotypical feature of mast cell are described based on these feature mast cell are not closely related to other myeloid cell using the knowledge on aberrantly expressed antigen by mast cell the hematopathologist should be able to recognize the disease even in the presence of unusual morphologic finding or an associated hematologic nonmast cell lineage disease,Non-Cancer,1,mastocytosis immunophenotypical feature of the transformed mast cell are unique among hematopoietic cell mastocytosis is a disease of bone marrow origin histologically characterized by compact tissue infiltrates of atypical mast cell never seen in reactive state most patient with mastocytosis have transformed mast cell carrying an activating point mutation at codon of kit and also show an elevated serum tryptase level in this article immunophenotypical feature of mast cell are described based on these feature mast cell are not closely related to other myeloid cell using the knowledge on aberrantly expressed antigen by mast cell the hematopathologist should be able to recognize the disease even in the presence of unusual morphologic finding or an associated hematologic nonmast cell lineage disease
24745677,pathology of extramedullary mastocytosis,mastocytosis encompasses a group of clinically and pathologically heterogeneous disorder most commonly involving the skin which typically take the form of urticaria pigmentosa mastocytosis may also involve other organ most often bone marrow followed by gastrointestinal tract liver spleen and lymph node the presence of extracutaneous involvement by mastocytosis is a major diagnostic criterion for systemic disease however mast cell infiltrates are often subtle in skin and extracutaneous organ and the histologic feature of mastocytosis at different anatomic site may be variable this article review the pathologic feature and clinical correlate of mastocytosis involving skin and other extramedullary site,Non-Cancer,1,pathology of extramedullary mastocytosis mastocytosis encompasses a group of clinically and pathologically heterogeneous disorder most commonly involving the skin which typically take the form of urticaria pigmentosa mastocytosis may also involve other organ most often bone marrow followed by gastrointestinal tract liver spleen and lymph node the presence of extracutaneous involvement by mastocytosis is a major diagnostic criterion for systemic disease however mast cell infiltrates are often subtle in skin and extracutaneous organ and the histologic feature of mastocytosis at different anatomic site may be variable this article review the pathologic feature and clinical correlate of mastocytosis involving skin and other extramedullary site
24750133,the kit dv allele burden predicts survival in patient with mastocytosis and correlate with the who type of the disease,kit dv is present in a majority of patient with systemic mastocytosis sm we determined the kit dv allele burden by quantitative realtime pcr in bone marrow and peripheral blood of patient with mastocytosis kit dv wa detected in patient significant difference in the median allele burden were observed between disease subgroup cutaneous mastocytosis indolent sm smoldering sm aggressive sm and sm with associated hematologic nonmast cell lineage disease p the kit dv burden also correlated with serum tryptase r p but not with mast cell infiltration in bone marrow or mediator symptom moreover the allele burden wa of prognostic significance regarding survival p patient responding to cytoreductive therapy showed a significant decrease in kit dv p to conclude the kit dv burden correlate with the variant of mastocytosis predicts survival and is a valuable followup parameter in sm,Non-Cancer,1,the kit dv allele burden predicts survival in patient with mastocytosis and correlate with the who type of the disease kit dv is present in a majority of patient with systemic mastocytosis sm we determined the kit dv allele burden by quantitative realtime pcr in bone marrow and peripheral blood of patient with mastocytosis kit dv wa detected in patient significant difference in the median allele burden were observed between disease subgroup cutaneous mastocytosis indolent sm smoldering sm aggressive sm and sm with associated hematologic nonmast cell lineage disease p the kit dv burden also correlated with serum tryptase r p but not with mast cell infiltration in bone marrow or mediator symptom moreover the allele burden wa of prognostic significance regarding survival p patient responding to cytoreductive therapy showed a significant decrease in kit dv p to conclude the kit dv burden correlate with the variant of mastocytosis predicts survival and is a valuable followup parameter in sm
24765772,the case of hnfbeta mutation with medullary cyst,we describe one case of longterm postnatal followup of hyperechoic fetal kidney related to hnfbeta mutation with cystic change over a year period in a female patient this diagnosis wa suspected on the basis of the renal u finding and wa confirmed by complementary genetic examination after birth cortical cyst were detected and at the age of medullary cyst were found that disappeared with time currently our patient display hyperechoic kidney with only cortical cyst this case report highlight the variability of u appearance in relation with hnfbeta genetic mutation,Non-Cancer,1,the case of hnfbeta mutation with medullary cyst we describe one case of longterm postnatal followup of hyperechoic fetal kidney related to hnfbeta mutation with cystic change over a year period in a female patient this diagnosis wa suspected on the basis of the renal u finding and wa confirmed by complementary genetic examination after birth cortical cyst were detected and at the age of medullary cyst were found that disappeared with time currently our patient display hyperechoic kidney with only cortical cyst this case report highlight the variability of u appearance in relation with hnfbeta genetic mutation
24767283,leopard syndrome clinical dilemma in differential diagnosis of rasopathies,background diagnosis within rasopathies still represents a challenge nevertheless many effort have been made by clinician to identify specific clinical feature which might help in differentiating one disorder from another here we describe a child initially diagnosed with neurofibromatosisnoonan syndrome the followup of the proband the clinical evaluation of his father together with a genebygene testing approach led u to the proper diagnosis case presentation we report a yearold male with multiple cafeaulait macule several lentigo and dysmorphic feature that suggest noonan syndrome initially diagnosed with neurofibromatosisnoonan syndrome however after a few year of clinical and ophthalmological followup the absence of typical feature of neurofibromatosis type and the lack of nf mutation led u to reconsider the original diagnosis a new examination of the patient and his similarly affected father who wa initially referred a healthy led u to suspect leopard syndrome the diagnosis wa then confirmed by the occurrence in both patient of a heterozygous mutation c c t pthrmet of ptpn subsequently the proband wa also found to have type arnoldchiari malformation in association with syringomyelia conclusion our experience suggests that differential clinical diagnosis among rasopathies remains ambiguous and raise doubt on the current diagnostic clinical criterion in some case genetic test represent the only conclusive proof for a correct diagnosis and consequently for establishing individual prognosis and providing adequate followup thus molecular testing represents an essential tool in differential diagnosis of rasophaties this view is further strengthened by the increasing accessibility of new sequencing techniquesfinally to our knowledge the described case represents the third report of the occurrence of arnold chiari malformation and the second description of syringomyelia with leopard syndrome,Non-Cancer,1,leopard syndrome clinical dilemma in differential diagnosis of rasopathies background diagnosis within rasopathies still represents a challenge nevertheless many effort have been made by clinician to identify specific clinical feature which might help in differentiating one disorder from another here we describe a child initially diagnosed with neurofibromatosisnoonan syndrome the followup of the proband the clinical evaluation of his father together with a genebygene testing approach led u to the proper diagnosis case presentation we report a yearold male with multiple cafeaulait macule several lentigo and dysmorphic feature that suggest noonan syndrome initially diagnosed with neurofibromatosisnoonan syndrome however after a few year of clinical and ophthalmological followup the absence of typical feature of neurofibromatosis type and the lack of nf mutation led u to reconsider the original diagnosis a new examination of the patient and his similarly affected father who wa initially referred a healthy led u to suspect leopard syndrome the diagnosis wa then confirmed by the occurrence in both patient of a heterozygous mutation c c t pthrmet of ptpn subsequently the proband wa also found to have type arnoldchiari malformation in association with syringomyelia conclusion our experience suggests that differential clinical diagnosis among rasopathies remains ambiguous and raise doubt on the current diagnostic clinical criterion in some case genetic test represent the only conclusive proof for a correct diagnosis and consequently for establishing individual prognosis and providing adequate followup thus molecular testing represents an essential tool in differential diagnosis of rasophaties this view is further strengthened by the increasing accessibility of new sequencing techniquesfinally to our knowledge the described case represents the third report of the occurrence of arnold chiari malformation and the second description of syringomyelia with leopard syndrome
24777453,rare and lowfrequency coding variant in cxcr and other gene are associated with hematological trait,hematological trait are important clinical parameter to test the effect of rare and lowfrequency coding variant on hematological trait we analyzed hemoglobin concentration hematocrit level white blood cell wbc count and platelet count in individual genotyped on an exome array we identified several missense variant in cxcr associated with reduced wbc count genebased p x in a separate familybased resequencing study we identified a cxcr frameshift mutation in a pedigree with congenital neutropenia that abolished ligandinduced cxcr signal transduction and chemotaxis we also identified missense or splicesite variant in key hematopoiesis regulator epo tfr hbb tubb and shb associated with blood cell trait finally we were able to detect association between a rare somatic jak mutation encoding pvalphe and platelet count p x a well a hemoglobin concentration p hematocrit level p x and wbc count p x in conclusion exome array complement genomewide association study in identifying new variant that contribute to complex human trait,Non-Cancer,1,rare and lowfrequency coding variant in cxcr and other gene are associated with hematological trait hematological trait are important clinical parameter to test the effect of rare and lowfrequency coding variant on hematological trait we analyzed hemoglobin concentration hematocrit level white blood cell wbc count and platelet count in individual genotyped on an exome array we identified several missense variant in cxcr associated with reduced wbc count genebased p x in a separate familybased resequencing study we identified a cxcr frameshift mutation in a pedigree with congenital neutropenia that abolished ligandinduced cxcr signal transduction and chemotaxis we also identified missense or splicesite variant in key hematopoiesis regulator epo tfr hbb tubb and shb associated with blood cell trait finally we were able to detect association between a rare somatic jak mutation encoding pvalphe and platelet count p x a well a hemoglobin concentration p hematocrit level p x and wbc count p x in conclusion exome array complement genomewide association study in identifying new variant that contribute to complex human trait
24780089,new molecular diagnostic kit to assess ychromosome deletion in the japanese population,objective deletion in the azoospermia factor region are the most common known molecular genetic cause of human male infertility involving spermatogenetic failure testing for these deletion in japanese dna sample using conventional sequencetagged site probe occasionally lead to considerable nonspecific or faint product in the japanese population the aim of the present study wa to evaluate the sensitivity and specificity of a newly developed kit for the detection of azoospermia factor microdeletions in the japanese population method sequencetagged site probe were reselected and the luminex suspension array assay wa carried out validation wa retrospectively carried out with dna sequence with known microdeletions which were divided into four category result category deletion that corresponded to the conventional classification of azoospermia factor deletion were present in men which can result in intrachromosomal homologous recombination kit data confirmed the presence of deletion of this type in dna sequence known to harbor the azoospermia factor deletion category deletion involved cytogenetic abnormality in men whereas category deletion in men were atypical classification including the grgr deletion a these deletion are thought to be a result of palindromic unit and nonhomologous recombination these microdeletions might impact in the interpretation of some clinical finding the rest of the case were assigned to category a normal variant polymorphismno deletion conclusion the present finding show that this new kit offer good sensitivity and specificity with the advantage of saving in term of cost and time,Non-Cancer,1,new molecular diagnostic kit to assess ychromosome deletion in the japanese population objective deletion in the azoospermia factor region are the most common known molecular genetic cause of human male infertility involving spermatogenetic failure testing for these deletion in japanese dna sample using conventional sequencetagged site probe occasionally lead to considerable nonspecific or faint product in the japanese population the aim of the present study wa to evaluate the sensitivity and specificity of a newly developed kit for the detection of azoospermia factor microdeletions in the japanese population method sequencetagged site probe were reselected and the luminex suspension array assay wa carried out validation wa retrospectively carried out with dna sequence with known microdeletions which were divided into four category result category deletion that corresponded to the conventional classification of azoospermia factor deletion were present in men which can result in intrachromosomal homologous recombination kit data confirmed the presence of deletion of this type in dna sequence known to harbor the azoospermia factor deletion category deletion involved cytogenetic abnormality in men whereas category deletion in men were atypical classification including the grgr deletion a these deletion are thought to be a result of palindromic unit and nonhomologous recombination these microdeletions might impact in the interpretation of some clinical finding the rest of the case were assigned to category a normal variant polymorphismno deletion conclusion the present finding show that this new kit offer good sensitivity and specificity with the advantage of saving in term of cost and time
24789688,fiftyfour novel mutation in the nf gene and integrated analysis of the mutation that modulate splicing,neurofibromatosis type nf is a common autosomal dominant genetic disorder caused by mutation in the nf gene one of the hallmark of nf is the high mutation rate in this gene in this study we present different nf mutation and novel mutation detected at both the genomic dna and mrna level using a retrospective case series review we found that of these different mutation induced aberrant splicing of note of these splicing error were caused by exonic variant in addition one mutation produced mosaicism in the posttranscriptional profile however study investigating these splicing aberration are limited in order to better understand the pathogenicity of nf and to provide a more accurate interpretation in molecular diagnostic testing combined computational analysis were employed to elucidate the underlying mechanism of the variant modulating nf gene splicing,Non-Cancer,1,fiftyfour novel mutation in the nf gene and integrated analysis of the mutation that modulate splicing neurofibromatosis type nf is a common autosomal dominant genetic disorder caused by mutation in the nf gene one of the hallmark of nf is the high mutation rate in this gene in this study we present different nf mutation and novel mutation detected at both the genomic dna and mrna level using a retrospective case series review we found that of these different mutation induced aberrant splicing of note of these splicing error were caused by exonic variant in addition one mutation produced mosaicism in the posttranscriptional profile however study investigating these splicing aberration are limited in order to better understand the pathogenicity of nf and to provide a more accurate interpretation in molecular diagnostic testing combined computational analysis were employed to elucidate the underlying mechanism of the variant modulating nf gene splicing
24795088,highquality dna from fingernail for genetic analysis,the availability of highquality germline dna is an important prerequisite for a variety of genetic analysis we have shown previously that fingernail clipping provide an optimal source of autologous constitutional dna for pcrbased application however most existing protocol for nucleic acid purification from nail do not provide sufficiently high yield of pure and intact dna for more demanding downstream analysis such a next generation sequencing ng we have extensively tested and systematically modified a number of different protocol for dna purification from nail material to optimize the yield and quality the integrity of dna wa determined by pcr amplification of short bp and longrange kb sequence using different target gene among the method tested the prepfiler forensic dna extraction kit wa identified a the most appropriate approach to isolation of highquality dna from nail clipping a standardized input of mg nail material to piece of fingernail clipping yielded a mean of mug dna range to mug subsequent pcranalysis revealed efficient amplifiability of short and midrange target in and and longrange fragment in of the sample tested the adequacy for next generation sequencing application wa demonstrated by successful highresolution hlatyping in ten transplant recipient hence the protocol presented facilitates the exploitation of fingernail material even for demanding genomic analysis both in research and diagnostics,Non-Cancer,1,highquality dna from fingernail for genetic analysis the availability of highquality germline dna is an important prerequisite for a variety of genetic analysis we have shown previously that fingernail clipping provide an optimal source of autologous constitutional dna for pcrbased application however most existing protocol for nucleic acid purification from nail do not provide sufficiently high yield of pure and intact dna for more demanding downstream analysis such a next generation sequencing ng we have extensively tested and systematically modified a number of different protocol for dna purification from nail material to optimize the yield and quality the integrity of dna wa determined by pcr amplification of short bp and longrange kb sequence using different target gene among the method tested the prepfiler forensic dna extraction kit wa identified a the most appropriate approach to isolation of highquality dna from nail clipping a standardized input of mg nail material to piece of fingernail clipping yielded a mean of mug dna range to mug subsequent pcranalysis revealed efficient amplifiability of short and midrange target in and and longrange fragment in of the sample tested the adequacy for next generation sequencing application wa demonstrated by successful highresolution hlatyping in ten transplant recipient hence the protocol presented facilitates the exploitation of fingernail material even for demanding genomic analysis both in research and diagnostics
24806963,peptideindependent stabilization of mhc class i molecule breach cellular quality control,the intracellular trafficking of major histocompatibility complex class i mhci protein is directed by three quality control mechanism that test for their structural integrity which is correlated to the binding of highaffinity antigenic peptide ligand to investigate which molecular feature of mhci these quality control mechanism detect we have followed the hypothesis that suboptimally loaded mhci molecule are characterized by their conformational mobility in the fpocket region of the peptidebinding site we have created a novel variant of an mhci protein kbyc in which two alphahelices in this region are linked by a disulfide bond that mimic the conformational and dynamic effect of bound highaffinity peptide kbyc show a remarkable increase in the binding affinity to it light chain beta microglobulin betam and bypass all three cellular quality control step our data demonstrate that coupling between peptide and betam binding to the mhci heavy chain is mediated by conformational dynamic that the folded conformation of mhci supported by betam play a decisive role in passing the ertocellsurface transport quality control and that betam association is also tested by the cell surface quality control that lead to mhci endocytosis,Non-Cancer,1,peptideindependent stabilization of mhc class i molecule breach cellular quality control the intracellular trafficking of major histocompatibility complex class i mhci protein is directed by three quality control mechanism that test for their structural integrity which is correlated to the binding of highaffinity antigenic peptide ligand to investigate which molecular feature of mhci these quality control mechanism detect we have followed the hypothesis that suboptimally loaded mhci molecule are characterized by their conformational mobility in the fpocket region of the peptidebinding site we have created a novel variant of an mhci protein kbyc in which two alphahelices in this region are linked by a disulfide bond that mimic the conformational and dynamic effect of bound highaffinity peptide kbyc show a remarkable increase in the binding affinity to it light chain beta microglobulin betam and bypass all three cellular quality control step our data demonstrate that coupling between peptide and betam binding to the mhci heavy chain is mediated by conformational dynamic that the folded conformation of mhci supported by betam play a decisive role in passing the ertocellsurface transport quality control and that betam association is also tested by the cell surface quality control that lead to mhci endocytosis
24807696,novel mechanism of transcriptional repression of the human atp binding cassette transporter a gene in hepatic cell by the winged helixforkhead box transcription factor a,atp binding cassette transporter a abca play a key role in the biogenesis of hdl by promoting the efflux of cellular cholesterol and phospholipid to lipid free apoai mutation in the abca gene cause tangier disease which is characterized by near or complete absence of circulating plasma hdl in the present study we show that the winged helixforkhead box containing transcription factor a foxa shown previously to play a role in glucose and bile acid homeostasis in the liver and in energy utilization in adipose tissue is a negative modulator of abca gene expression in hepatic cell we show that the abca promoter contains three foxa binding element in the proximal region two of the site are localized in a region of the abca promoter enriched in binding element for transcriptional repressor protein whereas the third site is the core of the tata element of the abca promoter inhibition of foxa binding to the abca promoter by sitedirected mutagenesis or foxa gene expression by sirna wa associated with increased abca promoter activity and protein level overexpression of foxa inhibited both the constitutive abca gene expression a well a abca gene induction by oxysterols and retinoids via nuclear receptor lxralpharxralpha in summary the present study identifies transcription factor foxa a a negative modulator of abca gene expression in hepatic cell and reveals a novel mechanism of transcriptional repression by foxa which involves the tata element of the abca gene,Non-Cancer,1,novel mechanism of transcriptional repression of the human atp binding cassette transporter a gene in hepatic cell by the winged helixforkhead box transcription factor a atp binding cassette transporter a abca play a key role in the biogenesis of hdl by promoting the efflux of cellular cholesterol and phospholipid to lipid free apoai mutation in the abca gene cause tangier disease which is characterized by near or complete absence of circulating plasma hdl in the present study we show that the winged helixforkhead box containing transcription factor a foxa shown previously to play a role in glucose and bile acid homeostasis in the liver and in energy utilization in adipose tissue is a negative modulator of abca gene expression in hepatic cell we show that the abca promoter contains three foxa binding element in the proximal region two of the site are localized in a region of the abca promoter enriched in binding element for transcriptional repressor protein whereas the third site is the core of the tata element of the abca promoter inhibition of foxa binding to the abca promoter by sitedirected mutagenesis or foxa gene expression by sirna wa associated with increased abca promoter activity and protein level overexpression of foxa inhibited both the constitutive abca gene expression a well a abca gene induction by oxysterols and retinoids via nuclear receptor lxralpharxralpha in summary the present study identifies transcription factor foxa a a negative modulator of abca gene expression in hepatic cell and reveals a novel mechanism of transcriptional repression by foxa which involves the tata element of the abca gene
24815379,application of coldpcr for improved detection of nf mosaic mutation,somatic mosaicism represents the coexistence of two or more cell population with different genotype in one person and it is involved in monogenic disorder somatic mosaicism characterizes approximately to of patient with de novo neurofibromatosis type nf the identification of mosaicism is crucial to patient and their family because the clinical course of the disease and it transmission risk is influenced by the degree and distribution of mutated cell moreover in nf the capability of discriminating patient with mosaicism is especially important to make differential diagnosis with schwannomatosis however the identification of mosaic variant is considerably difficult and the development of specific molecular technique to detect low level of unknown molecular alteration is required coamplification at lower denaturation temperature coldpcr ha been described a a powerful method to selectively amplify minority allele from mixture of wildtype and mutationcontaining sequence here we applied coldpcr to molecular analysis of patient with nf mosaicism with the use of coldpcr followed by direct sequencing we were able to detect nf mutation in blood dna of three patient with nf mosaicism our study ha shown the capability of coldpcr in enriching lowrepresented mutated allele in blood dna sample making it usable for molecular diagnosis of patient with mosaicism,Non-Cancer,1,application of coldpcr for improved detection of nf mosaic mutation somatic mosaicism represents the coexistence of two or more cell population with different genotype in one person and it is involved in monogenic disorder somatic mosaicism characterizes approximately to of patient with de novo neurofibromatosis type nf the identification of mosaicism is crucial to patient and their family because the clinical course of the disease and it transmission risk is influenced by the degree and distribution of mutated cell moreover in nf the capability of discriminating patient with mosaicism is especially important to make differential diagnosis with schwannomatosis however the identification of mosaic variant is considerably difficult and the development of specific molecular technique to detect low level of unknown molecular alteration is required coamplification at lower denaturation temperature coldpcr ha been described a a powerful method to selectively amplify minority allele from mixture of wildtype and mutationcontaining sequence here we applied coldpcr to molecular analysis of patient with nf mosaicism with the use of coldpcr followed by direct sequencing we were able to detect nf mutation in blood dna of three patient with nf mosaicism our study ha shown the capability of coldpcr in enriching lowrepresented mutated allele in blood dna sample making it usable for molecular diagnosis of patient with mosaicism
24819622,surgical treatment of lumbosacral pseudarthrosis and spondyloptosis in a patient with neurofibromatosis type and a large lumbar anterior meningocele case report and review of the literature,background lumbar anterior meningocele mc is rare in patient with neurofibromatosis type nf although spinal fusion with maximum possible resection of the cele might be indicated in these special case report describing operative procedure are lacking clinical presentation we present a young woman with nf and lower back pain due to lumbar anterior mc extensive osteolysis and deformation of the lumbar spine after harrington spondylodesis from t to s in she developed lumbosacral pseudarthrosis and transcutaneous migration of the spondylodesis thus the left pole of the spondylodesis wa shortened below the level of l in year later the patient presented with lower back pain and wound infection imaging revealed the mc and avulsion of the right s screw with lumbosacral pseudarthrosis and spondyloptosis and transcutaneous migration of the right spondylodesis pole threestage surgery wa indicated with explantation of the harrington system in the first step and posterior fusion from t to s in the second step finally vertebral resection gathering of the cele and implantation of a customized titanium cage wa achieved through an anterior transabdominal approach postoperatively the patient reported sufficient reduction of lower back pain conclusion lumbar anterior mc is rare in patient with nf and may cause spinal instability when surgery is indicated longrange spinal fusion and reduction of the cele should be considered surgery may be challenging requiring a staged operative procedure and an interdisciplinary collaboration,Non-Cancer,1,surgical treatment of lumbosacral pseudarthrosis and spondyloptosis in a patient with neurofibromatosis type and a large lumbar anterior meningocele case report and review of the literature background lumbar anterior meningocele mc is rare in patient with neurofibromatosis type nf although spinal fusion with maximum possible resection of the cele might be indicated in these special case report describing operative procedure are lacking clinical presentation we present a young woman with nf and lower back pain due to lumbar anterior mc extensive osteolysis and deformation of the lumbar spine after harrington spondylodesis from t to s in she developed lumbosacral pseudarthrosis and transcutaneous migration of the spondylodesis thus the left pole of the spondylodesis wa shortened below the level of l in year later the patient presented with lower back pain and wound infection imaging revealed the mc and avulsion of the right s screw with lumbosacral pseudarthrosis and spondyloptosis and transcutaneous migration of the right spondylodesis pole threestage surgery wa indicated with explantation of the harrington system in the first step and posterior fusion from t to s in the second step finally vertebral resection gathering of the cele and implantation of a customized titanium cage wa achieved through an anterior transabdominal approach postoperatively the patient reported sufficient reduction of lower back pain conclusion lumbar anterior mc is rare in patient with nf and may cause spinal instability when surgery is indicated longrange spinal fusion and reduction of the cele should be considered surgery may be challenging requiring a staged operative procedure and an interdisciplinary collaboration
24829188,reducing falsepositive incidental finding with ensemble genotyping and logistic regression based variant filtering method,a whole genome sequencing wgs uncovers variant associated with rare and common disease an immediate challenge is to minimize falsepositive finding due to sequencing and variant calling error false positive can be reduced by combining result from orthogonal sequencing method but costly here we present variant filtering approach using logistic regression lr and ensemble genotyping to minimize false positive without sacrificing sensitivity we evaluated the method using paired wgs datasets of an extended family prepared using two sequencing platform and a validated set of variant in na using lr or ensemble genotyping based filtering falsenegative rate were significantly reduced by to fold at the same level of false discovery rate for heterozygous and for homozygous single nucleotide variant snvs for heterozygous and for homozygous insertion for heterozygous and for homozygous deletion compared to the filtering based on genotype quality score moreover ensemble genotyping excluded of of false positive while retaining of of true positive in de novo mutation dnm discovery in na and performed better than a consensus method using two sequencing platform our proposed method were effective in prioritizing phenotypeassociated variant and an ensemble genotyping would be essential to minimize falsepositive dnm candidate,Non-Cancer,1,reducing falsepositive incidental finding with ensemble genotyping and logistic regression based variant filtering method a whole genome sequencing wgs uncovers variant associated with rare and common disease an immediate challenge is to minimize falsepositive finding due to sequencing and variant calling error false positive can be reduced by combining result from orthogonal sequencing method but costly here we present variant filtering approach using logistic regression lr and ensemble genotyping to minimize false positive without sacrificing sensitivity we evaluated the method using paired wgs datasets of an extended family prepared using two sequencing platform and a validated set of variant in na using lr or ensemble genotyping based filtering falsenegative rate were significantly reduced by to fold at the same level of false discovery rate for heterozygous and for homozygous single nucleotide variant snvs for heterozygous and for homozygous insertion for heterozygous and for homozygous deletion compared to the filtering based on genotype quality score moreover ensemble genotyping excluded of of false positive while retaining of of true positive in de novo mutation dnm discovery in na and performed better than a consensus method using two sequencing platform our proposed method were effective in prioritizing phenotypeassociated variant and an ensemble genotyping would be essential to minimize falsepositive dnm candidate
24835570,chromatin and transcription transition of mammalian adult germline stem cell and spermatogenesis,adult germline stem cell agscs selfrenew thy enriched or commit to gametogenesis kit enriched to better understand how chromatin regulates agsc biology and gametogenesis we derived stagespecific highresolution profile of dna methylation hmc histone modificationsvariants and rnaseq in agscs and during spermatogenesis first we define striking signaling and transcriptional difference between agsc type involving key selfrenewal and proliferation pathway second key pluripotency factor eg nanog are silent in agscs and bear particular chromatindname attribute that may poise them for reactivation after fertilization third agscs display chromatin poisingbivalency of enhancer and promoter for embryonic transcription factor remarkably gametogenesis occurs without significant change in dname and instead involves transcription of dnamethylated promoter bearing high rnapol hkac hkme low cg content and often hmc furthermore key finding were confirmed in human sperm here we reveal agsc signaling asymmetry and chromatindname strategy in agscs to poise key transcription factor and to activate dnamethylated promoter during gametogenesis,Non-Cancer,1,chromatin and transcription transition of mammalian adult germline stem cell and spermatogenesis adult germline stem cell agscs selfrenew thy enriched or commit to gametogenesis kit enriched to better understand how chromatin regulates agsc biology and gametogenesis we derived stagespecific highresolution profile of dna methylation hmc histone modificationsvariants and rnaseq in agscs and during spermatogenesis first we define striking signaling and transcriptional difference between agsc type involving key selfrenewal and proliferation pathway second key pluripotency factor eg nanog are silent in agscs and bear particular chromatindname attribute that may poise them for reactivation after fertilization third agscs display chromatin poisingbivalency of enhancer and promoter for embryonic transcription factor remarkably gametogenesis occurs without significant change in dname and instead involves transcription of dnamethylated promoter bearing high rnapol hkac hkme low cg content and often hmc furthermore key finding were confirmed in human sperm here we reveal agsc signaling asymmetry and chromatindname strategy in agscs to poise key transcription factor and to activate dnamethylated promoter during gametogenesis
24850616,a limited form of proteus syndrome with bilateral plantar cerebriform collagenomas and varicose vein secondary to a mosaic akt mutation,importance proteus syndrome is an extremely rare disorder of mosaic postnatal overgrowth affecting multiple tissue including bone soft tissue and skin it typically manifest in early childhood with asymmetric and progressive skeletal overgrowth that lead to severe distortion of the skeleton and disability the genetic basis ha recently been identified a a somatic activating mutation in the akt gene which encodes an enzyme mediating cell proliferation and apoptosis observation we present a yearold man who developed plantar cerebriform collagenomas on the sol of both foot and varicose vein in early childhood in the absence of any skeletal or other connective tissue abnormality although the patient did not meet the diagnostic criterion for proteus syndrome he wa found to have the cga pglulys akt mutation in lesional skin but not in his blood conclusion and relevance to our knowledge this is the mildest molecularly confirmed case of proteus syndrome occurring in the absence of the characteristic skeletal overgrowth these finding extend the spectrum of proteus syndrome pathological characteristic and suggest that somatic mutation late in development and restricted in distribution cause subtle clinical presentation that do not meet the published clinical criterion,Non-Cancer,1,a limited form of proteus syndrome with bilateral plantar cerebriform collagenomas and varicose vein secondary to a mosaic akt mutation importance proteus syndrome is an extremely rare disorder of mosaic postnatal overgrowth affecting multiple tissue including bone soft tissue and skin it typically manifest in early childhood with asymmetric and progressive skeletal overgrowth that lead to severe distortion of the skeleton and disability the genetic basis ha recently been identified a a somatic activating mutation in the akt gene which encodes an enzyme mediating cell proliferation and apoptosis observation we present a yearold man who developed plantar cerebriform collagenomas on the sol of both foot and varicose vein in early childhood in the absence of any skeletal or other connective tissue abnormality although the patient did not meet the diagnostic criterion for proteus syndrome he wa found to have the cga pglulys akt mutation in lesional skin but not in his blood conclusion and relevance to our knowledge this is the mildest molecularly confirmed case of proteus syndrome occurring in the absence of the characteristic skeletal overgrowth these finding extend the spectrum of proteus syndrome pathological characteristic and suggest that somatic mutation late in development and restricted in distribution cause subtle clinical presentation that do not meet the published clinical criterion
24906339,tracking histone variant nucleosomes across the human cell cycle using biophysical biochemical and cytological analysis,histone variant such a h macroha haz and cenpa are important epigenetic modifier of the chromatin state in eukaryotic genome the centromeric histone h variant cenpacenh epigenetically mark centromere and is required for assembly of the kinetochore complex a region of the chromosome that is responsible for proper genome segregation during mitosis several diverse technique using biochemical cell biology and biophysical approach have been utilized to study the nature of the cenpa nucleosome across the cell cycle in this chapter we describe method for cenpa nucleosome purification and separation of cenpa from other core histone using traditional sdspage and more resolving technique such a triton acid urea tau and twodimensional gel we also discus method for observation of cenpa on chromatin fiber using immunofluorescence finally we provide a detailed description of analysis of chromatin structure using atomic force microscopy,Non-Cancer,1,tracking histone variant nucleosomes across the human cell cycle using biophysical biochemical and cytological analysis histone variant such a h macroha haz and cenpa are important epigenetic modifier of the chromatin state in eukaryotic genome the centromeric histone h variant cenpacenh epigenetically mark centromere and is required for assembly of the kinetochore complex a region of the chromosome that is responsible for proper genome segregation during mitosis several diverse technique using biochemical cell biology and biophysical approach have been utilized to study the nature of the cenpa nucleosome across the cell cycle in this chapter we describe method for cenpa nucleosome purification and separation of cenpa from other core histone using traditional sdspage and more resolving technique such a triton acid urea tau and twodimensional gel we also discus method for observation of cenpa on chromatin fiber using immunofluorescence finally we provide a detailed description of analysis of chromatin structure using atomic force microscopy
24908902,a case of lateonset segmental neurofibromatosis,segmental neurofibromatosis nf is a rare variant of neurofibromatosis to our knowledge there have been few report of case presenting later in life the recognition of nf is important a there have been report of paraneoplastic manifestation and transmission to offspring here we present the case of a patient who presented with nf first appearing in her mids this case illustrates the subtle nature of nf which often lead to misdiagnosis,Non-Cancer,1,a case of lateonset segmental neurofibromatosis segmental neurofibromatosis nf is a rare variant of neurofibromatosis to our knowledge there have been few report of case presenting later in life the recognition of nf is important a there have been report of paraneoplastic manifestation and transmission to offspring here we present the case of a patient who presented with nf first appearing in her mids this case illustrates the subtle nature of nf which often lead to misdiagnosis
24947681,anaphylaxis a a clinical manifestation of clonal mast cell disorder,clonal mast cell disorder comprise a heterogeneous group of disorder characterized by the presence of gain of function kit mutation and a constitutively altered activationassociated mast cell immunophenotype frequently associated with clinical manifestation related to the release of mast cell mediator these disorder do not always fulfil the world health organization whoproposed criterion for mastocytosis particularly when lowsensitive diagnostic approach are performed anaphylaxis is a frequent presentation of clonal mast cell disorder particularly in mastocytosis patient without typical skin lesion the presence of cardiovascular symptom eg hypotension occurring after a hymenoptera sting or spontaneously in the absence of cutaneous manifestation such a urticaria is characteristic and differs from the presentation of anaphylaxis in the general population without mastocytosis,Non-Cancer,1,anaphylaxis a a clinical manifestation of clonal mast cell disorder clonal mast cell disorder comprise a heterogeneous group of disorder characterized by the presence of gain of function kit mutation and a constitutively altered activationassociated mast cell immunophenotype frequently associated with clinical manifestation related to the release of mast cell mediator these disorder do not always fulfil the world health organization whoproposed criterion for mastocytosis particularly when lowsensitive diagnostic approach are performed anaphylaxis is a frequent presentation of clonal mast cell disorder particularly in mastocytosis patient without typical skin lesion the presence of cardiovascular symptom eg hypotension occurring after a hymenoptera sting or spontaneously in the absence of cutaneous manifestation such a urticaria is characteristic and differs from the presentation of anaphylaxis in the general population without mastocytosis
24954252,accuracy of pedicle screw placement in the thoracic and lumbosacral spine using a conventional intraoperative fluoroscopyguided technique a national neurosurgical education and training center analysis of consecutive screw,objective pedicle screw placement is a very common procedure used to stabilize all three column of the thoracic and lumbar spine the purpose of this study is to evaluate the incidence of screw misplacement and related complication in patient who underwent fluoroscopyguided transpedicular screw fixation at a neurosurgical teaching institution method we retrospectively reviewed consecutive patient who underwent fluoroscopyguided transpedicular screw fixation from january to may in the department of neurosurgery kantonsspital aarau a certified swiss national neurosurgical education and training center the accuracy of the pedicle screw trajectory wa assessed using reconstructed postoperative axial sagittal and coronal computed tomography image the displacement wa classified a minor mm result a total of pedicle screw were placed in consecutive patient in the thoracic and lumbosacral spine all surgery were performed under the supervision of boardcertified neurosurgeon and faculty member a total of surgeon including trainee participated in all procedure a total of screw breaching the pedicle were identified with minor violation moderate violation and severe violation sixteen patient developed postoperative radiculopathy all of these patient belonged to the subgroup of severe screw displacement conclusion the data presented confirm that for a training and education center transpedicular fluoroscopyguided screw fixation remains a technically demanding procedure a defined in this study neurological symptom are likely associated only with severe screw misplacement,Non-Cancer,1,accuracy of pedicle screw placement in the thoracic and lumbosacral spine using a conventional intraoperative fluoroscopyguided technique a national neurosurgical education and training center analysis of consecutive screw objective pedicle screw placement is a very common procedure used to stabilize all three column of the thoracic and lumbar spine the purpose of this study is to evaluate the incidence of screw misplacement and related complication in patient who underwent fluoroscopyguided transpedicular screw fixation at a neurosurgical teaching institution method we retrospectively reviewed consecutive patient who underwent fluoroscopyguided transpedicular screw fixation from january to may in the department of neurosurgery kantonsspital aarau a certified swiss national neurosurgical education and training center the accuracy of the pedicle screw trajectory wa assessed using reconstructed postoperative axial sagittal and coronal computed tomography image the displacement wa classified a minor mm result a total of pedicle screw were placed in consecutive patient in the thoracic and lumbosacral spine all surgery were performed under the supervision of boardcertified neurosurgeon and faculty member a total of surgeon including trainee participated in all procedure a total of screw breaching the pedicle were identified with minor violation moderate violation and severe violation sixteen patient developed postoperative radiculopathy all of these patient belonged to the subgroup of severe screw displacement conclusion the data presented confirm that for a training and education center transpedicular fluoroscopyguided screw fixation remains a technically demanding procedure a defined in this study neurological symptom are likely associated only with severe screw misplacement
24962530,evaluation and optimisation of indel detection workflow for ion torrent sequencing of the brca and brca gene,background the ion torrent pgm is a popular benchtop sequencer that show promise in replacing conventional sanger sequencing a the gold standard for mutation detection despite the pgms reported high accuracy in calling single nucleotide variation it tends to generate many false positive call in detecting insertion and deletion indels which may hinder it utility for clinical genetic testing result recently the proprietary analytical workflow for the ion torrent sequencer torrent suite t underwent a series of upgrade we evaluated three major upgrade of t by calling indels in the brca and brca gene our analysis revealed that false negative indels could be generated by t under both default calling parameter and parameter adjusted for maximum sensitivity however indel calling with the same data using the open source variant caller gatk and samtools showed that false negative could be minimised with the use of appropriate bioinformatics analysis furthermore we identified two variant calling measure qualitybydepth qd and variation of the width of gap and insert varw which substantially reduced false positive indels including nonhomopolymer associated error without compromising sensitivity in our best case scenario that involved the tmap aligner and samtools we achieved sensitivity specificity and false discovery rate fdr in indel calling from all sample which is a good performance for mutation screening using pgm conclusion new version of t bwa and gatk have shown improvement in indel calling sensitivity and specificity over their older counterpart however the variant caller of t exhibit a lower sensitivity than gatk and samtools our finding demonstrate that although indel calling from pgm sequence may appear to be noisy at first glance proper computational indel calling analysis is able to maximize both the sensitivity and specificity at the single base level paving the way for the usage of this technology for future clinical genetic testing,Non-Cancer,1,evaluation and optimisation of indel detection workflow for ion torrent sequencing of the brca and brca gene background the ion torrent pgm is a popular benchtop sequencer that show promise in replacing conventional sanger sequencing a the gold standard for mutation detection despite the pgms reported high accuracy in calling single nucleotide variation it tends to generate many false positive call in detecting insertion and deletion indels which may hinder it utility for clinical genetic testing result recently the proprietary analytical workflow for the ion torrent sequencer torrent suite t underwent a series of upgrade we evaluated three major upgrade of t by calling indels in the brca and brca gene our analysis revealed that false negative indels could be generated by t under both default calling parameter and parameter adjusted for maximum sensitivity however indel calling with the same data using the open source variant caller gatk and samtools showed that false negative could be minimised with the use of appropriate bioinformatics analysis furthermore we identified two variant calling measure qualitybydepth qd and variation of the width of gap and insert varw which substantially reduced false positive indels including nonhomopolymer associated error without compromising sensitivity in our best case scenario that involved the tmap aligner and samtools we achieved sensitivity specificity and false discovery rate fdr in indel calling from all sample which is a good performance for mutation screening using pgm conclusion new version of t bwa and gatk have shown improvement in indel calling sensitivity and specificity over their older counterpart however the variant caller of t exhibit a lower sensitivity than gatk and samtools our finding demonstrate that although indel calling from pgm sequence may appear to be noisy at first glance proper computational indel calling analysis is able to maximize both the sensitivity and specificity at the single base level paving the way for the usage of this technology for future clinical genetic testing
24963042,mpdrc prospective study of reducedintensity allogeneic hematopoietic stem cell transplantation in patient with myelofibrosis,from to patient with primary myelofibrosis or myelofibrosis mf preceded by essential thrombocythemia or polycythemia vera were enrolled into a prospective phase clinical trial of reducedintensity allogeneic hematopoietic stem cell transplantation ahsct myeloproliferative disorder research consortium trial the study included patient with sibling donor n receiving fludarabinemelphalan flumel a a preparative regimen and patient with unrelated donor n receiving conditioning with flumel plus antithymocyte globulin atg patient characteristic in the cohort were similar engraftment occurred in of sibling and of unrelated transplant whereas secondary graft failure occurred in and respectively with a median followup of month for patient alive the overall survival o wa in the sibling group median not reached and in the unrelated group median o month confidence interval ci hazard ratio ci p nonrelapse mortality wa in sibling and in unrelated ahsct survival correlated with type of donor but not with the degree of histocompatibility match age or jakvf status in patient with mf with sibling donor ahsct is an effective therapy whereas ahsct from unrelated donor with flumelatg conditioning led to a high rate of graft failure and limited survival this trial wa registered at wwwclinicaltrialsgov a nct,Non-Cancer,1,mpdrc prospective study of reducedintensity allogeneic hematopoietic stem cell transplantation in patient with myelofibrosis from to patient with primary myelofibrosis or myelofibrosis mf preceded by essential thrombocythemia or polycythemia vera were enrolled into a prospective phase clinical trial of reducedintensity allogeneic hematopoietic stem cell transplantation ahsct myeloproliferative disorder research consortium trial the study included patient with sibling donor n receiving fludarabinemelphalan flumel a a preparative regimen and patient with unrelated donor n receiving conditioning with flumel plus antithymocyte globulin atg patient characteristic in the cohort were similar engraftment occurred in of sibling and of unrelated transplant whereas secondary graft failure occurred in and respectively with a median followup of month for patient alive the overall survival o wa in the sibling group median not reached and in the unrelated group median o month confidence interval ci hazard ratio ci p nonrelapse mortality wa in sibling and in unrelated ahsct survival correlated with type of donor but not with the degree of histocompatibility match age or jakvf status in patient with mf with sibling donor ahsct is an effective therapy whereas ahsct from unrelated donor with flumelatg conditioning led to a high rate of graft failure and limited survival this trial wa registered at wwwclinicaltrialsgov a nct
24967879,gene expression profile in longterm non progressor hiv infected patient in search of potential resistance factor,longterm nonprogressors ltnp represent a minority of hivinfected individual characterized by documented infection for more than year a stable cd t cell count over mm and low viremia in the absence of antiretroviral treatment protective factor described so far such a the ccrdelta deletion protective hla allele or defective virus fail to fully explain the partial protection phenotype the existence of additional host resistance mechanism in ltnp patient wa investigated here using a whole human genome microarray study comparing gene expression profile of unstimulated peripheral blood mononuclear cell from ltnp patient hiv infected patient under antiretroviral therapy with cd t cell level above mm st a well a healthy individual gene that were up or downregulated exclusively in ltnp st or in both group in comparison to control were identified and classified in functional category using ingenuity pathway analysis st and ltnp patient group revealed distinct genetic profile regarding gene number in each category and up or downregulation of specific gene which could have a bearing on the outcome of each group we selected some relevant gene to validate the differential expression using quantitative realtime qrtpcr among others we found several gene related to the canonical wntbetacatenin signaling pathway our result identify new possible host gene and molecule that could be involved in the mechanism leading to the slower progression to aid and sustained cd t cell count that is peculiar to ltnp patient,Non-Cancer,1,gene expression profile in longterm non progressor hiv infected patient in search of potential resistance factor longterm nonprogressors ltnp represent a minority of hivinfected individual characterized by documented infection for more than year a stable cd t cell count over mm and low viremia in the absence of antiretroviral treatment protective factor described so far such a the ccrdelta deletion protective hla allele or defective virus fail to fully explain the partial protection phenotype the existence of additional host resistance mechanism in ltnp patient wa investigated here using a whole human genome microarray study comparing gene expression profile of unstimulated peripheral blood mononuclear cell from ltnp patient hiv infected patient under antiretroviral therapy with cd t cell level above mm st a well a healthy individual gene that were up or downregulated exclusively in ltnp st or in both group in comparison to control were identified and classified in functional category using ingenuity pathway analysis st and ltnp patient group revealed distinct genetic profile regarding gene number in each category and up or downregulation of specific gene which could have a bearing on the outcome of each group we selected some relevant gene to validate the differential expression using quantitative realtime qrtpcr among others we found several gene related to the canonical wntbetacatenin signaling pathway our result identify new possible host gene and molecule that could be involved in the mechanism leading to the slower progression to aid and sustained cd t cell count that is peculiar to ltnp patient
24970375,ataxia telangiectasia derived ip cell show preserved xray sensitivity and decreased chromosomal instability,ataxia telangiectasia is a neurodegenerative inherited disease with chromosomal instability and hypersensitivity to ionizing radiation ip cell lacking atm atips cell exhibited hypersensitivity to xray irradiation one of the characteristic of the disease while parental ataxia telangiectasia cell exhibited significant chromosomal abnormality atips cell did not show any chromosomal instability in vitro for at least passage day whole exome analysis also showed a comparable nucleotide substitution rate in atips cell taken together these data show that atm is involved in protection from irradiationinduced cell death,Non-Cancer,1,ataxia telangiectasia derived ip cell show preserved xray sensitivity and decreased chromosomal instability ataxia telangiectasia is a neurodegenerative inherited disease with chromosomal instability and hypersensitivity to ionizing radiation ip cell lacking atm atips cell exhibited hypersensitivity to xray irradiation one of the characteristic of the disease while parental ataxia telangiectasia cell exhibited significant chromosomal abnormality atips cell did not show any chromosomal instability in vitro for at least passage day whole exome analysis also showed a comparable nucleotide substitution rate in atips cell taken together these data show that atm is involved in protection from irradiationinduced cell death
25012610,a novel mutation in the csfr gene cause a variable leukoencephalopathy with spheroid,hereditary diffuse leukoencephalopathy with neuroaxonal spheroid is a neurodegenerative disease associated with mutation in the colonystimulating factor receptor gene csfr a yearold woman with a year history of depression presented with neurological sign and a recent cognitive decline the diagnosis of hereditary diffuse leukoencephalopathy with neuroaxonal spheroid wa suspected based on the finding of a predominant frontal leukoencephalopathy and neuroaxonal spheroid on brain biopsy she share with her mother a novel csfr exon missense mutation cg a pvm the mother ha a longstanding bipolar disorder and mild multifocal white matter abnormality in her s this is the first report of hereditary diffuse leukoencephalopathy with neuroaxonal spheroid due to this novel csfr missense mutation our report suggests that either marked intrafamilial variability or incomplete penetrance can be associated with csfr mutation the observation of a small bone cyst in our patient support the hypothesis that hereditary diffuse leukoencephalopathy with neuroaxonal spheroid and polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy may belong to a spectrum of overlapping phenotype,Non-Cancer,1,a novel mutation in the csfr gene cause a variable leukoencephalopathy with spheroid hereditary diffuse leukoencephalopathy with neuroaxonal spheroid is a neurodegenerative disease associated with mutation in the colonystimulating factor receptor gene csfr a yearold woman with a year history of depression presented with neurological sign and a recent cognitive decline the diagnosis of hereditary diffuse leukoencephalopathy with neuroaxonal spheroid wa suspected based on the finding of a predominant frontal leukoencephalopathy and neuroaxonal spheroid on brain biopsy she share with her mother a novel csfr exon missense mutation cg a pvm the mother ha a longstanding bipolar disorder and mild multifocal white matter abnormality in her s this is the first report of hereditary diffuse leukoencephalopathy with neuroaxonal spheroid due to this novel csfr missense mutation our report suggests that either marked intrafamilial variability or incomplete penetrance can be associated with csfr mutation the observation of a small bone cyst in our patient support the hypothesis that hereditary diffuse leukoencephalopathy with neuroaxonal spheroid and polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy may belong to a spectrum of overlapping phenotype
25029267,dermatologic and dental aspect of the international tuberous sclerosis complex consensus statement,importance the international tuberous sclerosis complex clinical consensus conference wa convened to update the last consensus statement in skin and dental lesion are common in tuberous sclerosis complex tsc and are a frequent concern for patient recognition of these lesion is imperative for early diagnosis given the treatment advance that may improve patient outcome objective to detail recommendation for the diagnosis surveillance and management of skin and dental lesion in tsc evidence review the tsc dermatology and dentistry subcommittee of subcommittee reviewed the relevant literature from to finding a consensus on skin and dental issue wa achieved within the dermatology and dentistry subcommittee before recommendation were presented discussed and agreed on in a group meeting of all subcommittee from june to conclusion and relevance skin and dental finding comprise of major feature and of minor feature in the diagnostic criterion a definite diagnosis of tsc is defined a the presence of at least major feature or major and or more minor feature in addition a pathological mutation in tsc or tsc is diagnostic skin and oral examination should be performed annually and every to month respectively intervention may be indicated for tsc skin or oral lesion that are bleeding symptomatic disfiguring or negatively affecting function option presented include surgical excision laser or use of a mammalian target of rapamycin inhibitor,Non-Cancer,1,dermatologic and dental aspect of the international tuberous sclerosis complex consensus statement importance the international tuberous sclerosis complex clinical consensus conference wa convened to update the last consensus statement in skin and dental lesion are common in tuberous sclerosis complex tsc and are a frequent concern for patient recognition of these lesion is imperative for early diagnosis given the treatment advance that may improve patient outcome objective to detail recommendation for the diagnosis surveillance and management of skin and dental lesion in tsc evidence review the tsc dermatology and dentistry subcommittee of subcommittee reviewed the relevant literature from to finding a consensus on skin and dental issue wa achieved within the dermatology and dentistry subcommittee before recommendation were presented discussed and agreed on in a group meeting of all subcommittee from june to conclusion and relevance skin and dental finding comprise of major feature and of minor feature in the diagnostic criterion a definite diagnosis of tsc is defined a the presence of at least major feature or major and or more minor feature in addition a pathological mutation in tsc or tsc is diagnostic skin and oral examination should be performed annually and every to month respectively intervention may be indicated for tsc skin or oral lesion that are bleeding symptomatic disfiguring or negatively affecting function option presented include surgical excision laser or use of a mammalian target of rapamycin inhibitor
25039926,the presence of mast cell clonality in patient with unexplained anaphylaxis,background the mechanism by which mast cell in patient with unexplained anaphylaxis uea are triggered remain elusive onset of episode is unpredictable and often recurrent the substantial overlap between the clinical manifestation of uea and clonal mast cell disorder cmd suggests an association between these rare disorder the two form of cmd characterized to date are systemic mastocytosis sm and monoclonal mast cell activation syndrome mmas objective to examine the hypothesis that the pathogenesis of uea reflects the presence of aberrant subpopulation of mast cell method thirty men woman patient year suffering from uea and with no sign of cutaneous mastocytosis were recruited patient underwent an initial complete allergy workup to confirm the diagnosis of uea level of baseline serum tryptase sbt and total ige were determined in addition a bone marrow examination wa performed on all patient to investigate possible underlying cmd result fourteen of our case nine men five woman were diagnosed with cmd with sm and four with mmas four of the patient with sm had mast cell aggregate in their bone marrow all patient with sm exhibited a sbt level ngml whereas this level wa elevated in only two of those with mmas and four with uae but not diagnosed with cmd total ige level were lower in the group of patient with cmd p ngml and cardiovascular symptom such a syncope,Non-Cancer,1,the presence of mast cell clonality in patient with unexplained anaphylaxis background the mechanism by which mast cell in patient with unexplained anaphylaxis uea are triggered remain elusive onset of episode is unpredictable and often recurrent the substantial overlap between the clinical manifestation of uea and clonal mast cell disorder cmd suggests an association between these rare disorder the two form of cmd characterized to date are systemic mastocytosis sm and monoclonal mast cell activation syndrome mmas objective to examine the hypothesis that the pathogenesis of uea reflects the presence of aberrant subpopulation of mast cell method thirty men woman patient year suffering from uea and with no sign of cutaneous mastocytosis were recruited patient underwent an initial complete allergy workup to confirm the diagnosis of uea level of baseline serum tryptase sbt and total ige were determined in addition a bone marrow examination wa performed on all patient to investigate possible underlying cmd result fourteen of our case nine men five woman were diagnosed with cmd with sm and four with mmas four of the patient with sm had mast cell aggregate in their bone marrow all patient with sm exhibited a sbt level ngml whereas this level wa elevated in only two of those with mmas and four with uae but not diagnosed with cmd total ige level were lower in the group of patient with cmd p ngml and cardiovascular symptom such a syncope
25040297,the role of serum erythropoietin level and jak vf allele burden in the diagnosis of polycythaemia vera,low serum erythropoietin epo is a minor criterion of polycythaemia vera pv but it diagnostic usefulness relies on study performed before the discovery of jak vf mutation the objective of the present study wa to evaluate the diagnostic accuracy of serum epo and jak vf allele burden a marker of pv a well a the combination of different diagnostic criterion in patient with pv with essential thrombocythaemia and with nonclonal erythrocytosis low epo showed good diagnostic accuracy a a marker for pv with the area under the curve auc of the chemiluminescentenhanced enzyme immunoassay ceia being better than that of radioimmunoassay ria and for ceia and ria respectively jak vf quantification displayed an excellent diagnostic accuracy with an auc of a haematocrit male or female plus the presence of the jak vf mutation had a sensitivity and specificity of and respectively adding low epo or the jak vf allele burden did not improve the diagnostic accuracy for pv whereas the inclusion of both improved the sensitivity up to and maintaining specificity haematocrit and qualitative jak vf mutation allow a reliable diagnosis of pv incorporation of epo andor jak vf mutant load doe not improve the diagnostic accuracy,Non-Cancer,1,the role of serum erythropoietin level and jak vf allele burden in the diagnosis of polycythaemia vera low serum erythropoietin epo is a minor criterion of polycythaemia vera pv but it diagnostic usefulness relies on study performed before the discovery of jak vf mutation the objective of the present study wa to evaluate the diagnostic accuracy of serum epo and jak vf allele burden a marker of pv a well a the combination of different diagnostic criterion in patient with pv with essential thrombocythaemia and with nonclonal erythrocytosis low epo showed good diagnostic accuracy a a marker for pv with the area under the curve auc of the chemiluminescentenhanced enzyme immunoassay ceia being better than that of radioimmunoassay ria and for ceia and ria respectively jak vf quantification displayed an excellent diagnostic accuracy with an auc of a haematocrit male or female plus the presence of the jak vf mutation had a sensitivity and specificity of and respectively adding low epo or the jak vf allele burden did not improve the diagnostic accuracy for pv whereas the inclusion of both improved the sensitivity up to and maintaining specificity haematocrit and qualitative jak vf mutation allow a reliable diagnosis of pv incorporation of epo andor jak vf mutant load doe not improve the diagnostic accuracy
25040471,ataxia telangiectasia more variation at clinical and cellular level,ataxia telangiectasia at is a rare recessively inherited disorder resulting in a progressive neurological decline it is caused by biallelic mutation of the atm gene that encodes a kda serinethreonine protein kinase responsible for phosphorylating many target protein atm is activated by autotransphosphorylation in response to dna double strand break and lead to the activation of cell cycle checkpoint and either dna repair or apoptosis a part of the cellular response to dna damage the allelic heterogeneity in at is striking while the majority of mutation are truncating leading to instability and loss of the atm protein from the allele a significant proportion of patient carry one of a small number of mutation that are either missense or leaky splice site mutation resulting in retention of some atm with activity the allelic heterogeneity in atm therefore result in an equally striking clinical heterogeneity there is also locus heterogeneity because mutation of the mre gene can cause an obvious at like disorder both clinically and also at the cellular level and mutation of the rnf gene result in a much milder clinical phenotype neurologically with the major clinical feature being an immunological defect,Non-Cancer,1,ataxia telangiectasia more variation at clinical and cellular level ataxia telangiectasia at is a rare recessively inherited disorder resulting in a progressive neurological decline it is caused by biallelic mutation of the atm gene that encodes a kda serinethreonine protein kinase responsible for phosphorylating many target protein atm is activated by autotransphosphorylation in response to dna double strand break and lead to the activation of cell cycle checkpoint and either dna repair or apoptosis a part of the cellular response to dna damage the allelic heterogeneity in at is striking while the majority of mutation are truncating leading to instability and loss of the atm protein from the allele a significant proportion of patient carry one of a small number of mutation that are either missense or leaky splice site mutation resulting in retention of some atm with activity the allelic heterogeneity in atm therefore result in an equally striking clinical heterogeneity there is also locus heterogeneity because mutation of the mre gene can cause an obvious at like disorder both clinically and also at the cellular level and mutation of the rnf gene result in a much milder clinical phenotype neurologically with the major clinical feature being an immunological defect
25044986,prenatal diagnosis of clove syndrome confirmed by detection of a mosaic pikca mutation in cultured amniocytes,congenital lipomatous asymmetric overgrowth of the trunk lymphatic capillary venous and combinedtype vascular malformation epidermal nevus skeletal and spinal anomaly clove syndrome a segmental overgrowth syndrome is caused by post zygotic somatic mutation in pikca a gene involved in the receptor tyrosine kinase phosphatidylinositol kinase piakt growthsignaling pathway prenatal ultrasound finding of lymphovascular malformation segmental overgrowth and skeletal defect can raise suspicion for clove syndrome but molecular confirmation of pikca mutation on prenatally obtained sample is challenging because of somatic mosaicism we detected a mosaic diseasecausing mutation in pikca by sequencing of dna extracted from cultured amniotic cell but not from dna directly prepared from an amniotic fluid sample in a fetus with prenatally suspected clove syndrome the infant wa born prematurely and displayed severe lymphovascular malformation and segmental overgrowth consistent with a clinical diagnosis of clove syndrome he passed away at day of life we discus the complexity and limitation of genetic testing for somatic mosaic mutation in the prenatal period and highlight the potential need for multiple approach to arrive at a molecular diagnosis wiley periodical inc,Non-Cancer,1,prenatal diagnosis of clove syndrome confirmed by detection of a mosaic pikca mutation in cultured amniocytes congenital lipomatous asymmetric overgrowth of the trunk lymphatic capillary venous and combinedtype vascular malformation epidermal nevus skeletal and spinal anomaly clove syndrome a segmental overgrowth syndrome is caused by post zygotic somatic mutation in pikca a gene involved in the receptor tyrosine kinase phosphatidylinositol kinase piakt growthsignaling pathway prenatal ultrasound finding of lymphovascular malformation segmental overgrowth and skeletal defect can raise suspicion for clove syndrome but molecular confirmation of pikca mutation on prenatally obtained sample is challenging because of somatic mosaicism we detected a mosaic diseasecausing mutation in pikca by sequencing of dna extracted from cultured amniotic cell but not from dna directly prepared from an amniotic fluid sample in a fetus with prenatally suspected clove syndrome the infant wa born prematurely and displayed severe lymphovascular malformation and segmental overgrowth consistent with a clinical diagnosis of clove syndrome he passed away at day of life we discus the complexity and limitation of genetic testing for somatic mosaic mutation in the prenatal period and highlight the potential need for multiple approach to arrive at a molecular diagnosis wiley periodical inc
25081057,selective suppression of excessive glunc expression rescue early epilepsy in a tuberous sclerosis murine model,tuberous sclerosis complex tsc caused by dominant mutation in either tsc or tsc tumour suppressor gene is characterized by the presence of brain malformation the cortical tuber that are thought to contribute to the generation of pharmacoresistant epilepsy here we report that tuberless heterozygote tsc mouse show functional upregulation of cortical glunccontaining nmethyldaspartate receptor nmdars in an mtordependent manner and exhibit recurrent unprovoked seizure during early postnatal life p seizure are generated intracortically in the granular layer of the neocortex slow kinetics of aberrant gluncmediated current in spiny stellate cell promotes excessive temporal integration of persistent nmdarmediated recurrent excitation and seizure generation accordingly specific gluncd antagonist block seizure in tsc mouse in vivo and in vitro likewise glunc expression is upregulated in tsc human surgical resection and a gluncd antagonist reduces paroxysmal hyperexcitability thus glunc receptor constitutes a promising molecular target to treat epilepsy in tsc patient,Non-Cancer,1,selective suppression of excessive glunc expression rescue early epilepsy in a tuberous sclerosis murine model tuberous sclerosis complex tsc caused by dominant mutation in either tsc or tsc tumour suppressor gene is characterized by the presence of brain malformation the cortical tuber that are thought to contribute to the generation of pharmacoresistant epilepsy here we report that tuberless heterozygote tsc mouse show functional upregulation of cortical glunccontaining nmethyldaspartate receptor nmdars in an mtordependent manner and exhibit recurrent unprovoked seizure during early postnatal life p seizure are generated intracortically in the granular layer of the neocortex slow kinetics of aberrant gluncmediated current in spiny stellate cell promotes excessive temporal integration of persistent nmdarmediated recurrent excitation and seizure generation accordingly specific gluncd antagonist block seizure in tsc mouse in vivo and in vitro likewise glunc expression is upregulated in tsc human surgical resection and a gluncd antagonist reduces paroxysmal hyperexcitability thus glunc receptor constitutes a promising molecular target to treat epilepsy in tsc patient
25088585,participation of the eligase trim in nfkappab p activation and nfatdependent activation of crel upon tcell receptor engagement,the nuclear factor kappab nfkappab family member p and crel chiefly orchestrate lymphocyte activation following tcell receptor tcr engagement in contrast to p which is rapidly mobilized crel activation occurs subsequently a it involves a nuclear factor of activated tcells nfatdependent upregulation step however how tcr ligation drive p and crel activation is not fully understood because several ubiquitylated component of nfkappab signaling cascade accumulate in close proximity to membrane we screened a sirna library against eligases that contain transmembrane domain on tcrmediated nfkappab activation here we report the identification of the endoplasmic reticulum resident trim protein a an enhancer of nfkappab promoter activity we found that knocking down trim by rna interference reduced the activation of p while the translocation of crel into the nucleus wa blunted we further observed that crel induction wa diminished without trim a nfat activation wa compromised these result unveil that trim is a selective regulator of p and of crel activation,Non-Cancer,1,participation of the eligase trim in nfkappab p activation and nfatdependent activation of crel upon tcell receptor engagement the nuclear factor kappab nfkappab family member p and crel chiefly orchestrate lymphocyte activation following tcell receptor tcr engagement in contrast to p which is rapidly mobilized crel activation occurs subsequently a it involves a nuclear factor of activated tcells nfatdependent upregulation step however how tcr ligation drive p and crel activation is not fully understood because several ubiquitylated component of nfkappab signaling cascade accumulate in close proximity to membrane we screened a sirna library against eligases that contain transmembrane domain on tcrmediated nfkappab activation here we report the identification of the endoplasmic reticulum resident trim protein a an enhancer of nfkappab promoter activity we found that knocking down trim by rna interference reduced the activation of p while the translocation of crel into the nucleus wa blunted we further observed that crel induction wa diminished without trim a nfat activation wa compromised these result unveil that trim is a selective regulator of p and of crel activation
25116393,overexpression of gremlin in patient with loeysdietz syndrome implication on pathophysiology and early disease detection,background the loeysdietz syndrome lds is an inherited connective tissue disorder caused by mutation in the transforming growth factor beta tgfbeta receptor tgfbr or tgfbr most patient with lds develop severe aortic aneurysm resulting in early need of surgical intervention in order to gain further insight into the pathophysiology of the disorder we investigated circulating outgrowth endothelial cell oec from the peripheral blood of lds patient from a cohort of patient including patient with novel tgfbeta receptor mutation method and result we performed gene expression profiling of oecs using microarray analysis followed by quantitative pcr for verification of gene expression compared to oecs of age and sexmatched healthy control oecs isolated from three lds patient displayed altered expression of several gene belonging to the tgfbeta pathway especially those affecting bone morphogenic protein bmp signalling including bmp bmp and bmpra gene expression of bmp antagonist gremlin grem showed the most prominent upregulation this increase wa confirmed at the protein level by immunoblotting of ldsoecs in immunohistochemistry abundant gremlin protein expression could be verified in endothelial cell a well a smooth muscle cell within the arterial medium furthermore gremlin plasma level of lds patient were significantly elevated compared to healthy control subject conclusion these finding open new avenue in the understanding of the pathogenesis of loeysdietz syndrome and the development of new diagnostic serological method for early disease detection,Non-Cancer,1,overexpression of gremlin in patient with loeysdietz syndrome implication on pathophysiology and early disease detection background the loeysdietz syndrome lds is an inherited connective tissue disorder caused by mutation in the transforming growth factor beta tgfbeta receptor tgfbr or tgfbr most patient with lds develop severe aortic aneurysm resulting in early need of surgical intervention in order to gain further insight into the pathophysiology of the disorder we investigated circulating outgrowth endothelial cell oec from the peripheral blood of lds patient from a cohort of patient including patient with novel tgfbeta receptor mutation method and result we performed gene expression profiling of oecs using microarray analysis followed by quantitative pcr for verification of gene expression compared to oecs of age and sexmatched healthy control oecs isolated from three lds patient displayed altered expression of several gene belonging to the tgfbeta pathway especially those affecting bone morphogenic protein bmp signalling including bmp bmp and bmpra gene expression of bmp antagonist gremlin grem showed the most prominent upregulation this increase wa confirmed at the protein level by immunoblotting of ldsoecs in immunohistochemistry abundant gremlin protein expression could be verified in endothelial cell a well a smooth muscle cell within the arterial medium furthermore gremlin plasma level of lds patient were significantly elevated compared to healthy control subject conclusion these finding open new avenue in the understanding of the pathogenesis of loeysdietz syndrome and the development of new diagnostic serological method for early disease detection
25122853,poor performance of the determine hiv agab combo fourthgeneration rapid test for detection of acute infection in a national household survey in swaziland,fourthgeneration hiv rapid test rts claim to detect both p antigen ag and hiv antibody ab for early identification of acute infection important for targeting prevention and reducing hiv transmission in a nationally representative household survey in swaziland adult age to year received homebased hiv rapid testing in and of the individual were ab positive ab by the determine hiv abab combo test and of those were confirmed to be reactive in the unigold test determine combo identified individual a having acute infection agab negative ab however none had detectable hiv rna and of remained hiv negative at their week followup visit were lost to followup all rtnonreactive sample were pooled and tested by nucleic acid amplification testing naat to identify acute infection naat identified of the hiv antibodynegative specimen a hiv rna positive with rna level ranging from to copiesml however none of them were ag by determine combo followup testing of of the naatpositive individual at month demonstrated seroconversions individual wa lost to followup therefore the determine combo test had a sensitivity of confidence interval to and positive predictive value of for the detection of acute infection the ability of the thgeneration determine combo to detect antigen wa very poor in swaziland thus the determine combo test doe not add any value to the current testing algorithm rather it add additional cost and complexity to hiv diagnosis the detection of acute hiv infection may need to rely on other testing strategy,Non-Cancer,1,poor performance of the determine hiv agab combo fourthgeneration rapid test for detection of acute infection in a national household survey in swaziland fourthgeneration hiv rapid test rts claim to detect both p antigen ag and hiv antibody ab for early identification of acute infection important for targeting prevention and reducing hiv transmission in a nationally representative household survey in swaziland adult age to year received homebased hiv rapid testing in and of the individual were ab positive ab by the determine hiv abab combo test and of those were confirmed to be reactive in the unigold test determine combo identified individual a having acute infection agab negative ab however none had detectable hiv rna and of remained hiv negative at their week followup visit were lost to followup all rtnonreactive sample were pooled and tested by nucleic acid amplification testing naat to identify acute infection naat identified of the hiv antibodynegative specimen a hiv rna positive with rna level ranging from to copiesml however none of them were ag by determine combo followup testing of of the naatpositive individual at month demonstrated seroconversions individual wa lost to followup therefore the determine combo test had a sensitivity of confidence interval to and positive predictive value of for the detection of acute infection the ability of the thgeneration determine combo to detect antigen wa very poor in swaziland thus the determine combo test doe not add any value to the current testing algorithm rather it add additional cost and complexity to hiv diagnosis the detection of acute hiv infection may need to rely on other testing strategy
25123125,metabolism and insulin signaling in common metabolic disorder and inherited insulin resistance,type diabetes obesity and polycystic ovary syndrome pcos are common metabolic disorder which are observed with increasing prevalence and which are caused by a complex interplay between genetic and environmental factor including increased calorie intake and physical inactivity these metabolic disorder are all characterized by reduced plasma adiponectin and insulin resistance in peripheral tissue quantitatively skeletal muscle is the major site of insulin resistance both low plasma adiponectin and insulin resistance contribute to an increased risk of type diabetes and cardiovascular disease in several study we have investigated insulin action on glucose and lipid metabolism and at the molecular level insulin signaling to glucose transport and glycogen synthesis in skeletal muscle from healthy individual and in obesity pcos and type diabetes moreover we have described a novel syndrome characterized by postprandial hyperinsulinemic hypoglycemia and insulin resistance this syndrome is caused by a mutation in the tyrosine kinase domain of the insulin receptor gene insr we have studied individual with this mutation a a model of inherited insulin resistance type diabetes obesity and pcos are characterized by pronounced defect in the insulinstimulated glucose uptake in particular glycogen synthesis and to a lesser extent glucose oxidation and the ability of insulin to suppress lipid oxidation in inherited insulin resistance however only insulin action on glucose uptake and glycogen synthesis is impaired this suggests that the defect in glucose and lipid oxidation in the common metabolic disorder are secondary to other factor in young woman with pcos the degree of insulin resistance wa similar to that seen in middleaged patient with type diabetes this support the hypothesis of an unique pathogenesis of insulin resistance in pcos insulin in physiological concentration stimulates glucose uptake in human skeletal muscle in vivo by activation of the insulin signaling cascade to glucose transport through the enzyme irs pik akt astbcd and rac and to glycogen synthesis through akt inhibition of gsk and activation of glycogen synthase g via dephosphorylation of serine residue in both the nhterminal site a and the coohterminal end site ab in type diabetes obesity and pcos there is although with some variation from study to study defect in insulin signaling through irs pik akt and astbcd which can explain reduced insulin action on glucose transport in type diabetes an altered intracellular distribution of snap and impaired activation of rac also seem to play a role for reduced insulin action on glucose transport in all common metabolic disorder we observed an impaired insulin activation of g which seems to be caused by attenuated dephosphorylation of g at site a whereas a the inhibition of gsk and the dephosphorylation of g at it target site site aa appeared to be completely normal in individual with inherited insulin resistance we observed largely the same defect in insulin action on irs pik akt and g a well a a normal inhibition of gsk and dephosphorylation of g at site ab in these individual however a markedly reduced insulin clearance seems to partially rescue insulin signaling to glucose transport and g adiponectin is thought to improve insulin sensitivity primarily by increasing lipid oxidation through activation of the enzyme ampk and possibly via crosstalking of adiponectin with insulin signaling and hence glucose transport and glycogen synthesis we demonstrated a strong correlation between plasma adiponectin and insulin action on glucose disposal and glycogen synthesis in obesity type diabetes and pcos in individual with inherited insulin resistance plasma adiponectin wa normal but the correlation of adiponectin with insulinstimulated glucose uptake and glycogen synthesis wa at least equally strong moreover we found a correlation between plasma adiponectin and insulin activation of g this result is supported by a number of recent study of animal model and muscle cell line which have shown that adiponectin augments insulin action on enzyme in the insulin signaling cascade in contrast we observed no difference in the abundance or activity of ampk in obesity type diabetes pcos or inherited insulin resistance this indicates that reduced insulin sensitivity in these condition is not mediated via abnormal ampk activity the result from these study demonstrate that the wellestablished abnormality in insulin action on glucose uptake and glycogen synthesis are reflected by defect in insulin signaling to these cellular process in type diabetes obesity and pcos and a expected also in inherited insulin resistance caused by a mutation in insr in common metabolic disorder low plasma adiponectin may contribute to insulin resistance and defect in insulin signaling whereas in inherited insulin resistance a normal plasma adiponectin and reduced insulin clearance could contribute to maintain a sufficient activation of the insulin signaling cascade the insight gained from these study have improved our understanding of the molecular mechanism underlying insulin resistance in skeletal muscle of human and can form the basis for further study which can lead to the development of treatment that more directly target insulin resistance and hence reduce the risk of type diabetes and cardiovascular disease,Non-Cancer,1,metabolism and insulin signaling in common metabolic disorder and inherited insulin resistance type diabetes obesity and polycystic ovary syndrome pcos are common metabolic disorder which are observed with increasing prevalence and which are caused by a complex interplay between genetic and environmental factor including increased calorie intake and physical inactivity these metabolic disorder are all characterized by reduced plasma adiponectin and insulin resistance in peripheral tissue quantitatively skeletal muscle is the major site of insulin resistance both low plasma adiponectin and insulin resistance contribute to an increased risk of type diabetes and cardiovascular disease in several study we have investigated insulin action on glucose and lipid metabolism and at the molecular level insulin signaling to glucose transport and glycogen synthesis in skeletal muscle from healthy individual and in obesity pcos and type diabetes moreover we have described a novel syndrome characterized by postprandial hyperinsulinemic hypoglycemia and insulin resistance this syndrome is caused by a mutation in the tyrosine kinase domain of the insulin receptor gene insr we have studied individual with this mutation a a model of inherited insulin resistance type diabetes obesity and pcos are characterized by pronounced defect in the insulinstimulated glucose uptake in particular glycogen synthesis and to a lesser extent glucose oxidation and the ability of insulin to suppress lipid oxidation in inherited insulin resistance however only insulin action on glucose uptake and glycogen synthesis is impaired this suggests that the defect in glucose and lipid oxidation in the common metabolic disorder are secondary to other factor in young woman with pcos the degree of insulin resistance wa similar to that seen in middleaged patient with type diabetes this support the hypothesis of an unique pathogenesis of insulin resistance in pcos insulin in physiological concentration stimulates glucose uptake in human skeletal muscle in vivo by activation of the insulin signaling cascade to glucose transport through the enzyme irs pik akt astbcd and rac and to glycogen synthesis through akt inhibition of gsk and activation of glycogen synthase g via dephosphorylation of serine residue in both the nhterminal site a and the coohterminal end site ab in type diabetes obesity and pcos there is although with some variation from study to study defect in insulin signaling through irs pik akt and astbcd which can explain reduced insulin action on glucose transport in type diabetes an altered intracellular distribution of snap and impaired activation of rac also seem to play a role for reduced insulin action on glucose transport in all common metabolic disorder we observed an impaired insulin activation of g which seems to be caused by attenuated dephosphorylation of g at site a whereas a the inhibition of gsk and the dephosphorylation of g at it target site site aa appeared to be completely normal in individual with inherited insulin resistance we observed largely the same defect in insulin action on irs pik akt and g a well a a normal inhibition of gsk and dephosphorylation of g at site ab in these individual however a markedly reduced insulin clearance seems to partially rescue insulin signaling to glucose transport and g adiponectin is thought to improve insulin sensitivity primarily by increasing lipid oxidation through activation of the enzyme ampk and possibly via crosstalking of adiponectin with insulin signaling and hence glucose transport and glycogen synthesis we demonstrated a strong correlation between plasma adiponectin and insulin action on glucose disposal and glycogen synthesis in obesity type diabetes and pcos in individual with inherited insulin resistance plasma adiponectin wa normal but the correlation of adiponectin with insulinstimulated glucose uptake and glycogen synthesis wa at least equally strong moreover we found a correlation between plasma adiponectin and insulin activation of g this result is supported by a number of recent study of animal model and muscle cell line which have shown that adiponectin augments insulin action on enzyme in the insulin signaling cascade in contrast we observed no difference in the abundance or activity of ampk in obesity type diabetes pcos or inherited insulin resistance this indicates that reduced insulin sensitivity in these condition is not mediated via abnormal ampk activity the result from these study demonstrate that the wellestablished abnormality in insulin action on glucose uptake and glycogen synthesis are reflected by defect in insulin signaling to these cellular process in type diabetes obesity and pcos and a expected also in inherited insulin resistance caused by a mutation in insr in common metabolic disorder low plasma adiponectin may contribute to insulin resistance and defect in insulin signaling whereas in inherited insulin resistance a normal plasma adiponectin and reduced insulin clearance could contribute to maintain a sufficient activation of the insulin signaling cascade the insight gained from these study have improved our understanding of the molecular mechanism underlying insulin resistance in skeletal muscle of human and can form the basis for further study which can lead to the development of treatment that more directly target insulin resistance and hence reduce the risk of type diabetes and cardiovascular disease
25160545,early neurodevelopmental screening in tuberous sclerosis complex a potential window of opportunity,background infant born with tuberous sclerosis complex a genetic condition resulting from a mutation in tsc or tsc are at increased risk for intellectual disability andor autism feature of epilepsy neuropathology genetics a well a timing and type of mechanismbased medication have been proposed a risk factor neurodevelopmental outcome have been reported among these study however few include data about the individual early neurodevelopmental profile a factor that may contribute significantly to these outcome further there is no clinical standard for the neurodevelopmental assessment of these infant the paucity of data regarding the natural history of neurodevelopment in infant with tuberous sclerosis complex and the lack of a gold standard for neurodevelopmental evaluation present a significant challenge for clinician and researcher method during the first year of life we tracked the onset of infantile spasm the type and timing of antiepileptic treatment and the associated response of two agematched infant with tuberous sclerosis complex we also employed capute scale a a part of a structured neurodevelopmental evaluation to characterize and compare their neurodevelopmental profile result infant developed infantile spasm with confirmed hypsarrhythmia at month of age treatment with vigabatrin wa initiated within hour with near immediate cessation of seizure and no further seizure to date expressive language delay wa detected at month and treated with speech andor language therapy infant developed complex partial seizure at month treatment included levetiracetam oxcarbazepine and the ketogenic diet vigabatrin wa initiated on detection of hypsarrhythmia after month intractable epilepsy persists to date global developmental delay wa evident by month and treated with physical occupational and speech andor language therapy conclusion many risk factor have been associated with intellectual disability andor autism in individual with tuberous sclerosis complex however few data are available regarding practical clinical tool for early identification in our case series inclusion of the capute scale a a part of routine medical care led to the identification of developmental delay in the first month of life and selection of targeted neurodevelopmental intervention development of a riskbased assessment using this approach will be the focus of future study a it may provide a potential window of opportunity for both research and clinical purpose in research it may serve a an objective outcome measure clinically this type of assessment ha potential for informing clinical treatment decision and serving a a prognostic indicator of longterm cognitive and psychiatric outcome,Non-Cancer,1,early neurodevelopmental screening in tuberous sclerosis complex a potential window of opportunity background infant born with tuberous sclerosis complex a genetic condition resulting from a mutation in tsc or tsc are at increased risk for intellectual disability andor autism feature of epilepsy neuropathology genetics a well a timing and type of mechanismbased medication have been proposed a risk factor neurodevelopmental outcome have been reported among these study however few include data about the individual early neurodevelopmental profile a factor that may contribute significantly to these outcome further there is no clinical standard for the neurodevelopmental assessment of these infant the paucity of data regarding the natural history of neurodevelopment in infant with tuberous sclerosis complex and the lack of a gold standard for neurodevelopmental evaluation present a significant challenge for clinician and researcher method during the first year of life we tracked the onset of infantile spasm the type and timing of antiepileptic treatment and the associated response of two agematched infant with tuberous sclerosis complex we also employed capute scale a a part of a structured neurodevelopmental evaluation to characterize and compare their neurodevelopmental profile result infant developed infantile spasm with confirmed hypsarrhythmia at month of age treatment with vigabatrin wa initiated within hour with near immediate cessation of seizure and no further seizure to date expressive language delay wa detected at month and treated with speech andor language therapy infant developed complex partial seizure at month treatment included levetiracetam oxcarbazepine and the ketogenic diet vigabatrin wa initiated on detection of hypsarrhythmia after month intractable epilepsy persists to date global developmental delay wa evident by month and treated with physical occupational and speech andor language therapy conclusion many risk factor have been associated with intellectual disability andor autism in individual with tuberous sclerosis complex however few data are available regarding practical clinical tool for early identification in our case series inclusion of the capute scale a a part of routine medical care led to the identification of developmental delay in the first month of life and selection of targeted neurodevelopmental intervention development of a riskbased assessment using this approach will be the focus of future study a it may provide a potential window of opportunity for both research and clinical purpose in research it may serve a an objective outcome measure clinically this type of assessment ha potential for informing clinical treatment decision and serving a a prognostic indicator of longterm cognitive and psychiatric outcome
25171276,prognostic value of postoperative urinary retention after male sling insertion,introduction while urinary retention is a known complication of advance male sling am placement for postprostatectomy incontinence ppi there is minimal data regarding ultimate continence outcome for patient who experience this complication the purpose of this study wa to determine the rate of continence after am placement in patient who had postoperative urinary retention a compared with those patient who did not material and method a retrospective review wa conducted of patient who underwent am placement for ppi between and with postoperative void trial tov preoperative factor such a urodynamic finding daily pad number ppd and weight were recorded follow up data included pad use need for catheterization and complication statistical analysis compared patient with and without postoperative urinary retention result thirtyfive patient were included with a mean follow up of month complete continence wa while of patient were improved ppd improved from pad to pad after am placement sixteen patient had postoperative urinary retention requiring clean intermittent catheterization cic of the patient in postoperative retention were completely continent ppd compared to of patient who passed first tov p all patient who required cic were able to void within day conclusion postoperative urinary retention after am placement for ppi occurs in about of patient and is shortlived patient who experienced postoperative urinary retention had good continence outcome,Non-Cancer,1,prognostic value of postoperative urinary retention after male sling insertion introduction while urinary retention is a known complication of advance male sling am placement for postprostatectomy incontinence ppi there is minimal data regarding ultimate continence outcome for patient who experience this complication the purpose of this study wa to determine the rate of continence after am placement in patient who had postoperative urinary retention a compared with those patient who did not material and method a retrospective review wa conducted of patient who underwent am placement for ppi between and with postoperative void trial tov preoperative factor such a urodynamic finding daily pad number ppd and weight were recorded follow up data included pad use need for catheterization and complication statistical analysis compared patient with and without postoperative urinary retention result thirtyfive patient were included with a mean follow up of month complete continence wa while of patient were improved ppd improved from pad to pad after am placement sixteen patient had postoperative urinary retention requiring clean intermittent catheterization cic of the patient in postoperative retention were completely continent ppd compared to of patient who passed first tov p all patient who required cic were able to void within day conclusion postoperative urinary retention after am placement for ppi occurs in about of patient and is shortlived patient who experienced postoperative urinary retention had good continence outcome
25174872,iljanus kinasesignal transducer and activator of transcription signaling dysregulates bim expression in autoimmune lymphoproliferative syndrome,background autoimmune lymphoproliferative syndrome alp is a human disorder of t cell homeostasis caused by mutation that impair fasmediated apoptosis a defining characteristic of alp is the expansion of double negative t cell dntc relatively little is known about how defective fasdriven cell death and the bcl apoptotic pathway intersect in alp patient objective we studied change in bcl family member expression in alp to determine whether the bcl pathway might provide a therapeutic target method we used flow cytometry to analyze the expression of pro and antiapoptotic bcl family member in t cell from alp patient and determined the in vitro sensitivity of alp dntc to the proapoptotic bh mimetic abt result the proapoptotic molecule bim wa significantly elevated in dntc although no general pattern of individual antiapoptotic bcl family member emerged increased expression of bim wa always accompanied by increased expression of at least antiapoptotic bcl family member strikingly bim level in dntc correlated significantly with serum il in alp patient and il wa sufficient to mildly induce bim in normal and alp t cell via a janus kinasesignal transducer and activator of transcription dependent mechanism finally abt preferentially killed alp dntc in vitro conclusion combined these data show that an iljanus kinasesignal transducer and activator of transcription pathway drive bim expression in alp dntc which render them sensitive to bh mimetics uncovering a potentially novel therapeutic approach to alp,Non-Cancer,1,iljanus kinasesignal transducer and activator of transcription signaling dysregulates bim expression in autoimmune lymphoproliferative syndrome background autoimmune lymphoproliferative syndrome alp is a human disorder of t cell homeostasis caused by mutation that impair fasmediated apoptosis a defining characteristic of alp is the expansion of double negative t cell dntc relatively little is known about how defective fasdriven cell death and the bcl apoptotic pathway intersect in alp patient objective we studied change in bcl family member expression in alp to determine whether the bcl pathway might provide a therapeutic target method we used flow cytometry to analyze the expression of pro and antiapoptotic bcl family member in t cell from alp patient and determined the in vitro sensitivity of alp dntc to the proapoptotic bh mimetic abt result the proapoptotic molecule bim wa significantly elevated in dntc although no general pattern of individual antiapoptotic bcl family member emerged increased expression of bim wa always accompanied by increased expression of at least antiapoptotic bcl family member strikingly bim level in dntc correlated significantly with serum il in alp patient and il wa sufficient to mildly induce bim in normal and alp t cell via a janus kinasesignal transducer and activator of transcription dependent mechanism finally abt preferentially killed alp dntc in vitro conclusion combined these data show that an iljanus kinasesignal transducer and activator of transcription pathway drive bim expression in alp dntc which render them sensitive to bh mimetics uncovering a potentially novel therapeutic approach to alp
25246557,bimodal activation of bubr by bub sustains mitotic checkpoint signaling,the mitotic checkpoint also known a the spindle assembly checkpoint prevents premature anaphase onset through generation of an inhibitor of the e ubiquitin ligase apcc whose ubiquitination of cyclin b and securin target them for degradation combining in vitro reconstitution and cellbased assay we now identify dual mechanism through which bub promotes mitotic checkpoint signaling bub enhances signaling at unattached kinetochore not only by facilitating binding of bubr but also by enhancing cdc recruitment to kinetochore mediated by bubrs internal cdc binding site downstream of kinetochoreproduced complex bub promotes binding of bubrs conserved amino terminal cdc binding domain to a site in cdc that becomes exposed by initial mad binding this latter bubstimulated event generates the final mitotic checkpoint complex of bubbubrcdc that selectively inhibits ubiquitination of securin and cyclin b by apcccdc thus bub promotes two distinct bubrcdc interaction involving each of the two cdc binding site of bubr and acting at unattached kinetochore or cytoplasmically respectively to facilitate production of the mitotic checkpoint inhibitor,Non-Cancer,1,bimodal activation of bubr by bub sustains mitotic checkpoint signaling the mitotic checkpoint also known a the spindle assembly checkpoint prevents premature anaphase onset through generation of an inhibitor of the e ubiquitin ligase apcc whose ubiquitination of cyclin b and securin target them for degradation combining in vitro reconstitution and cellbased assay we now identify dual mechanism through which bub promotes mitotic checkpoint signaling bub enhances signaling at unattached kinetochore not only by facilitating binding of bubr but also by enhancing cdc recruitment to kinetochore mediated by bubrs internal cdc binding site downstream of kinetochoreproduced complex bub promotes binding of bubrs conserved amino terminal cdc binding domain to a site in cdc that becomes exposed by initial mad binding this latter bubstimulated event generates the final mitotic checkpoint complex of bubbubrcdc that selectively inhibits ubiquitination of securin and cyclin b by apcccdc thus bub promotes two distinct bubrcdc interaction involving each of the two cdc binding site of bubr and acting at unattached kinetochore or cytoplasmically respectively to facilitate production of the mitotic checkpoint inhibitor
25246615,mastl is required for timely activation of apcc in meiosis i and cdk reactivation in meiosis ii,in mitosis the greatwall kinase called microtubuleassociated serinethreonine kinase like mastl in mammal is essential for prometaphase entry or progression by suppressing protein phosphatase a ppa activity ppa suppression in turn lead to high level of cdk substrate phosphorylation we have used a mouse model with an oocytespecific deletion of mastl to show that mastlnull oocyte resume meiosis i and reach metaphase i normally but that the onset and completion of anaphase i are delayed moreover after the completion of meiosis i mastlnull oocyte failed to enter meiosis ii mii because they reassembled a nuclear structure containing decondensed chromatin our result show that mastl is required for the timely activation of anaphasepromoting complexcyclosome to allow meiosis i exit and for the rapid rise of cdk activity that is needed for the entry into mii in mouse oocyte,Non-Cancer,1,mastl is required for timely activation of apcc in meiosis i and cdk reactivation in meiosis ii in mitosis the greatwall kinase called microtubuleassociated serinethreonine kinase like mastl in mammal is essential for prometaphase entry or progression by suppressing protein phosphatase a ppa activity ppa suppression in turn lead to high level of cdk substrate phosphorylation we have used a mouse model with an oocytespecific deletion of mastl to show that mastlnull oocyte resume meiosis i and reach metaphase i normally but that the onset and completion of anaphase i are delayed moreover after the completion of meiosis i mastlnull oocyte failed to enter meiosis ii mii because they reassembled a nuclear structure containing decondensed chromatin our result show that mastl is required for the timely activation of anaphasepromoting complexcyclosome to allow meiosis i exit and for the rapid rise of cdk activity that is needed for the entry into mii in mouse oocyte
25282103,defining the role of common variation in the genomic and biological architecture of adult human height,using genomewide data from individual we identified variant at genomewide significance that together explained onefifth of the heritability for adult height by testing different number of variant in independent study we show that the most strongly associated and snp explained and of phenotypic variance furthermore all common variant together captured of heritability the variant clustered in locus were enriched for gene pathway and tissue type known to be involved in growth and together implicated gene and pathway not highlighted in earlier effort such a signaling by fibroblast growth factor wntbetacatenin and chondroitin sulfaterelated gene we identified several gene and pathway not previously connected with human skeletal growth including mtor osteoglycin and binding of hyaluronic acid our result indicate a genetic architecture for human height that is characterized by a very large but finite number thousand of causal variant,Non-Cancer,1,defining the role of common variation in the genomic and biological architecture of adult human height using genomewide data from individual we identified variant at genomewide significance that together explained onefifth of the heritability for adult height by testing different number of variant in independent study we show that the most strongly associated and snp explained and of phenotypic variance furthermore all common variant together captured of heritability the variant clustered in locus were enriched for gene pathway and tissue type known to be involved in growth and together implicated gene and pathway not highlighted in earlier effort such a signaling by fibroblast growth factor wntbetacatenin and chondroitin sulfaterelated gene we identified several gene and pathway not previously connected with human skeletal growth including mtor osteoglycin and binding of hyaluronic acid our result indicate a genetic architecture for human height that is characterized by a very large but finite number thousand of causal variant
25310214,langerhans cell histiocytosis,background langerhans cell histiocytosis lch is a rare histiocytic disorder of unknown etiopathogenesis it clinical presentation is variable and range from isolated skin or bone disease to a lifethreatening multisystem condition lch can occur at any age but is more frequent in the pediatric population a neoplastic origin of this disease ha been suggested due to the discovery of the mutually exclusive activating somatic braf ve and mapk gene mutation that occur in about of patient method a survey of recent literature focused on the diagnosis management and prognosis of langerhans cell histiocytosis data were collected analyzed and discussed with an emphasis on contemporary clinical practice result lch is common in the pediatric population compared with adult child usually have a more aggressive clinical course that requires systemic chemotherapy patient with lowrisk lch have an excellent prognosis and a longterm survival rate that may be a high a by contrast patient with highrisk lch have a survival rate close to typically adult patient present with limited skin or bone involvement that can be treated with surgical resection or focal radiation therapy resulting in an overall survival rate of smoking cessation can result in the improvement of respiratory symptom and the spontaneous resolution of pulmonary lch targeted therapy with braf inhibitor ha been used in select patient with lch and the result have been encouraging conclusion our understanding of lch ha improved in the last year available treatment regimen can control the disease in the majority of patient the discovery of novel driver mutation and the development of targeted therapy promise better outcome with fewer longterm therapyrelated adverse event particularly for pediatric and adolescent patient,Non-Cancer,1,langerhans cell histiocytosis background langerhans cell histiocytosis lch is a rare histiocytic disorder of unknown etiopathogenesis it clinical presentation is variable and range from isolated skin or bone disease to a lifethreatening multisystem condition lch can occur at any age but is more frequent in the pediatric population a neoplastic origin of this disease ha been suggested due to the discovery of the mutually exclusive activating somatic braf ve and mapk gene mutation that occur in about of patient method a survey of recent literature focused on the diagnosis management and prognosis of langerhans cell histiocytosis data were collected analyzed and discussed with an emphasis on contemporary clinical practice result lch is common in the pediatric population compared with adult child usually have a more aggressive clinical course that requires systemic chemotherapy patient with lowrisk lch have an excellent prognosis and a longterm survival rate that may be a high a by contrast patient with highrisk lch have a survival rate close to typically adult patient present with limited skin or bone involvement that can be treated with surgical resection or focal radiation therapy resulting in an overall survival rate of smoking cessation can result in the improvement of respiratory symptom and the spontaneous resolution of pulmonary lch targeted therapy with braf inhibitor ha been used in select patient with lch and the result have been encouraging conclusion our understanding of lch ha improved in the last year available treatment regimen can control the disease in the majority of patient the discovery of novel driver mutation and the development of targeted therapy promise better outcome with fewer longterm therapyrelated adverse event particularly for pediatric and adolescent patient
25313664,gene therapy for inherited muscle disease where genetics meet rehabilitation medicine,the development of clinical vector to correct genetic mutation that cause inherited myopathy and related disorder of skeletal muscle is advancing at an impressive rate adenoassociated virus vector are attractive for clinical use because adenoassociated virus do not cause human disease and these vector are able to persist for year new vector are now becoming available a gene therapy delivery tool and recent preclinical experiment have demonstrated the feasibility safety and efficacy of gene therapy with adenoassociated virus for longterm correction of muscle pathology and weakness in myotubularindeficient canine and murine disease model in this review recent advance in the application of gene therapy to treat inherited muscle disorder are presented including duchenne muscular dystrophy and xlinked myotubular myopathy potential area for therapeutic synergy between rehabilitation medicine and genetics are also discussed,Non-Cancer,1,gene therapy for inherited muscle disease where genetics meet rehabilitation medicine the development of clinical vector to correct genetic mutation that cause inherited myopathy and related disorder of skeletal muscle is advancing at an impressive rate adenoassociated virus vector are attractive for clinical use because adenoassociated virus do not cause human disease and these vector are able to persist for year new vector are now becoming available a gene therapy delivery tool and recent preclinical experiment have demonstrated the feasibility safety and efficacy of gene therapy with adenoassociated virus for longterm correction of muscle pathology and weakness in myotubularindeficient canine and murine disease model in this review recent advance in the application of gene therapy to treat inherited muscle disorder are presented including duchenne muscular dystrophy and xlinked myotubular myopathy potential area for therapeutic synergy between rehabilitation medicine and genetics are also discussed
25324352,prospective blinded study of brafve mutation detection in cellfree dna of patient with systemic histiocytic disorder,unlabelled patient with langerhans cell histiocytosis lch and erdheimchester disease ecd have a high frequency of brafve mutation and respond to raf inhibitor however detection of mutation in tissue biopsy is particularly challenging in histiocytoses due to low tumor content and stromal contamination we applied a dropletdigital pcr assay for quantitative detection of the brafve mutation in plasma and urine cellfree cf dna and performed a prospective blinded study in patient with ecdlch there wa concordance between tissue and urinary cfdna genotype in treatmentnaive sample cfdna analysis facilitated identification of previously undescribed krasgsmutant ecd and dynamically tracked disease burden in patient treated with a variety of therapy these result indicate that cfdna brafve mutational analysis in plasma and urine provides a convenient and reliable method of detecting mutational status and can serve a a noninvasive biomarker to monitor response to therapy in lch and ecd significance patient with brafvemutant histiocytic disorder have remarkable response to raf inhibition but mutation detection in tissue in these disorder is challenging here we identify that analysis of plasma and urinary cfdna provides a reliable method to detect the brafve mutation and monitor response to therapy in these disorder,Non-Cancer,1,prospective blinded study of brafve mutation detection in cellfree dna of patient with systemic histiocytic disorder unlabelled patient with langerhans cell histiocytosis lch and erdheimchester disease ecd have a high frequency of brafve mutation and respond to raf inhibitor however detection of mutation in tissue biopsy is particularly challenging in histiocytoses due to low tumor content and stromal contamination we applied a dropletdigital pcr assay for quantitative detection of the brafve mutation in plasma and urine cellfree cf dna and performed a prospective blinded study in patient with ecdlch there wa concordance between tissue and urinary cfdna genotype in treatmentnaive sample cfdna analysis facilitated identification of previously undescribed krasgsmutant ecd and dynamically tracked disease burden in patient treated with a variety of therapy these result indicate that cfdna brafve mutational analysis in plasma and urine provides a convenient and reliable method of detecting mutational status and can serve a a noninvasive biomarker to monitor response to therapy in lch and ecd significance patient with brafvemutant histiocytic disorder have remarkable response to raf inhibition but mutation detection in tissue in these disorder is challenging here we identify that analysis of plasma and urinary cfdna provides a reliable method to detect the brafve mutation and monitor response to therapy in these disorder
25324521,microscopic validation of macroscopic in vivo image enabled by sameslide optical and nuclear fusion,unlabelled it is currently difficult to determine the molecular and cellular basis for radioscintigraphic signal obtained during macroscopic in vivo imaging the field is in need of technology that help bridge the macroscopic and microscopic regime to solve this problem we developed a fiducial marker fm simultaneously compatible with color nearinfrared nir fluorescence and nm autoradiography and conventional hematoxylineosin he histology method the fm wa constructed from an optimized concentration of commercially available human serum albumin and nm nir fluorophores mtcpertechnetate dimethyl sulfoxide and glutaraldehyde lymphangioleiomyomatosis cell coexpressing the sodium iodide symporter and green fluorescent protein were labeled with nm fluorophore and mtcpertechnatate and then administered intratracheally into cd mouse after in vivo spect imaging and ex vivo spect and nir fluorescence imaging of the lung mum frozen section were prepared and processed for nm nir fluorophore costaining autoradiography and he staining on the same slide using the fm to coregister all datasets result optimized fm composed of mum unlabeled human serum albumin mum nir fluorescent human serum albumin dimethyl sulfoxide and glutaraldehyde in phosphatebuffered saline ph were prepared within min displayed homogeneity and stability and were visible by all imaging modality including he staining using these fm tissue displaying high signal by spect could be dissected and analyzed on the same slide and at the microscopic level for nm nir fluorescence nm nir fluorescence autoradiography and he histopathologic staining conclusion when multimodal fm are combined with a new technique for simultaneous sameslide nir fluorescence imaging autoradiography and he staining macroscopic in vivo image can now be studied unambiguously at the microscopic level,Non-Cancer,1,microscopic validation of macroscopic in vivo image enabled by sameslide optical and nuclear fusion unlabelled it is currently difficult to determine the molecular and cellular basis for radioscintigraphic signal obtained during macroscopic in vivo imaging the field is in need of technology that help bridge the macroscopic and microscopic regime to solve this problem we developed a fiducial marker fm simultaneously compatible with color nearinfrared nir fluorescence and nm autoradiography and conventional hematoxylineosin he histology method the fm wa constructed from an optimized concentration of commercially available human serum albumin and nm nir fluorophores mtcpertechnetate dimethyl sulfoxide and glutaraldehyde lymphangioleiomyomatosis cell coexpressing the sodium iodide symporter and green fluorescent protein were labeled with nm fluorophore and mtcpertechnatate and then administered intratracheally into cd mouse after in vivo spect imaging and ex vivo spect and nir fluorescence imaging of the lung mum frozen section were prepared and processed for nm nir fluorophore costaining autoradiography and he staining on the same slide using the fm to coregister all datasets result optimized fm composed of mum unlabeled human serum albumin mum nir fluorescent human serum albumin dimethyl sulfoxide and glutaraldehyde in phosphatebuffered saline ph were prepared within min displayed homogeneity and stability and were visible by all imaging modality including he staining using these fm tissue displaying high signal by spect could be dissected and analyzed on the same slide and at the microscopic level for nm nir fluorescence nm nir fluorescence autoradiography and he histopathologic staining conclusion when multimodal fm are combined with a new technique for simultaneous sameslide nir fluorescence imaging autoradiography and he staining macroscopic in vivo image can now be studied unambiguously at the microscopic level
25347658,minimally invasive option in dupuytrens contracture aponeurotomy enzyme stretching and fat grafting,learning objective after studying this article the participant should be able to perform needle aponeurotomy fat grafting digit widget insertion and collagenase injection for dupuytrens cord describe how cord can be stretched without surgery explain to patient the risk and benefit of these new alternative of treatment summary surgery for dupuytrens contracture used to be the only alternative of treatment the past year have seen the widespread adoption of minimally invasive treatment in the form of needle aponeurotomy and collagenase injection to disrupt the cord and restore range of motion even newer and perhaps a effective treatment such a fat grafting and mechanical stretching with the digit widget may also end up being important tool of treatment the reader will be introduced to all of these modality with text illustration and video,Non-Cancer,1,minimally invasive option in dupuytrens contracture aponeurotomy enzyme stretching and fat grafting learning objective after studying this article the participant should be able to perform needle aponeurotomy fat grafting digit widget insertion and collagenase injection for dupuytrens cord describe how cord can be stretched without surgery explain to patient the risk and benefit of these new alternative of treatment summary surgery for dupuytrens contracture used to be the only alternative of treatment the past year have seen the widespread adoption of minimally invasive treatment in the form of needle aponeurotomy and collagenase injection to disrupt the cord and restore range of motion even newer and perhaps a effective treatment such a fat grafting and mechanical stretching with the digit widget may also end up being important tool of treatment the reader will be introduced to all of these modality with text illustration and video
25367873,earlyonset crohn disease and autoimmunity associated with a variant in ctla,objective ibd is a group of complex systemic disorder associated with intestinal inflammation and extraintestinal manifestation recent study revealed mendelian form of ibd which contributed significantly to our understanding of disease pathogenesis and the heritability of ibd design we performed exome sequencing in a family with crohn disease cd and severe autoimmunity analysed immune cell phenotype and function in affected and nonaffected individual and performed in silico and in vitro analysis of cytotoxic t lymphocyteassociated protein ctla structure and function result a novel missense variant wa identified in ctla encoding ctla a coinhibitory protein expressed by t cell and required for regulation of t cell activation the residue affected by the mutation ctla tyr is evolutionarily highly conserved and the identified yc variant is predicted to affect protein folding and structural stability and demonstrated to cause impaired ctla dimerisation and cd binding intestinal inflammation and autoimmunity in carrier of ctla yc exhibit incomplete penetrance with a spectrum of clinical presentation ranging from asymptomatic carrier status to fatal autoimmunity and intestinal inflammation in a clinically affected ctla yc carrier t cell proliferation wa increased in vitro and associated with an increased ratio of memory to naive t cell in vivo consistent with impaired regulation of t cell activation conclusion our result support the concept that variant in ctla provide the basis for a novel mendelian form of earlyonset cd associated with systemic autoimmunity incomplete penetrance of autoimmunity further indicates the presence of other genetic andor environmental modifier,Non-Cancer,1,earlyonset crohn disease and autoimmunity associated with a variant in ctla objective ibd is a group of complex systemic disorder associated with intestinal inflammation and extraintestinal manifestation recent study revealed mendelian form of ibd which contributed significantly to our understanding of disease pathogenesis and the heritability of ibd design we performed exome sequencing in a family with crohn disease cd and severe autoimmunity analysed immune cell phenotype and function in affected and nonaffected individual and performed in silico and in vitro analysis of cytotoxic t lymphocyteassociated protein ctla structure and function result a novel missense variant wa identified in ctla encoding ctla a coinhibitory protein expressed by t cell and required for regulation of t cell activation the residue affected by the mutation ctla tyr is evolutionarily highly conserved and the identified yc variant is predicted to affect protein folding and structural stability and demonstrated to cause impaired ctla dimerisation and cd binding intestinal inflammation and autoimmunity in carrier of ctla yc exhibit incomplete penetrance with a spectrum of clinical presentation ranging from asymptomatic carrier status to fatal autoimmunity and intestinal inflammation in a clinically affected ctla yc carrier t cell proliferation wa increased in vitro and associated with an increased ratio of memory to naive t cell in vivo consistent with impaired regulation of t cell activation conclusion our result support the concept that variant in ctla provide the basis for a novel mendelian form of earlyonset cd associated with systemic autoimmunity incomplete penetrance of autoimmunity further indicates the presence of other genetic andor environmental modifier
25381388,the immunophenotype of mast cell and it utility in the diagnostic workup of systemic mastocytosis,sm comprises a heterogeneous group of disorder characterized by an abnormal accumulation of clonal mc in or more tissue frequently involving the skin and bm despite the fact that most adult patient carry the same genetic lesion dv kit mutation the disease present with multiple variant with very distinct clinical and biologic feature a diverse prognosis and different therapeutic requirement recent advance in the standardization of the study of bm mc by mfc allowed reproducible identification and characterization of normalreactive mc and their precursor a well a the establishment of the normal mc maturational profile analysis of large group of patient versus normalreactive sample ha highlighted the existence of aberrant mc phenotype in sm which are essential for the diagnosis of the disease in turn clearly distinct and altered maturationassociated immunophenotypic profile have been reported recently in sm which provide criterion for the distinction between ism patient with mcrestricted and multilineage kit mutation thus immunphenotyping also contributes to prognostic stratification of ism particularly when analysis of the kit mutation on highly purified bm cell is not routinely available in the diagnostic workup of the disease,Non-Cancer,1,the immunophenotype of mast cell and it utility in the diagnostic workup of systemic mastocytosis sm comprises a heterogeneous group of disorder characterized by an abnormal accumulation of clonal mc in or more tissue frequently involving the skin and bm despite the fact that most adult patient carry the same genetic lesion dv kit mutation the disease present with multiple variant with very distinct clinical and biologic feature a diverse prognosis and different therapeutic requirement recent advance in the standardization of the study of bm mc by mfc allowed reproducible identification and characterization of normalreactive mc and their precursor a well a the establishment of the normal mc maturational profile analysis of large group of patient versus normalreactive sample ha highlighted the existence of aberrant mc phenotype in sm which are essential for the diagnosis of the disease in turn clearly distinct and altered maturationassociated immunophenotypic profile have been reported recently in sm which provide criterion for the distinction between ism patient with mcrestricted and multilineage kit mutation thus immunphenotyping also contributes to prognostic stratification of ism particularly when analysis of the kit mutation on highly purified bm cell is not routinely available in the diagnostic workup of the disease
25399868,trf and lamin ac interact to facilitate the functional organization of chromosome end,telomere protect the end of linear genome and the gradual loss of telomere is associated with cellular ageing telomere protection involves the insertion of the overhang facilitated by telomere repeatbinding factor trf into telomeric dna forming tloops we present evidence suggesting that tloops can also form at interstitial telomeric sequence in a trfdependent manner forming an interstitial tloop itl we demonstrate that trf association with interstitial telomeric sequence is stabilized by colocalization with atype lamins lamin ac we also find that lamin ac interacts with trf and that reduction in level of lamin ac or mutation in lmna that cause an autosomal dominant premature ageing disorderhutchinson gilford progeria syndrome hgpslead to reduced itl formation and telomere loss we propose that cellular and organismal ageing are intertwined through the effect of the interaction between trf and lamin ac on chromosome structure,Non-Cancer,1,trf and lamin ac interact to facilitate the functional organization of chromosome end telomere protect the end of linear genome and the gradual loss of telomere is associated with cellular ageing telomere protection involves the insertion of the overhang facilitated by telomere repeatbinding factor trf into telomeric dna forming tloops we present evidence suggesting that tloops can also form at interstitial telomeric sequence in a trfdependent manner forming an interstitial tloop itl we demonstrate that trf association with interstitial telomeric sequence is stabilized by colocalization with atype lamins lamin ac we also find that lamin ac interacts with trf and that reduction in level of lamin ac or mutation in lmna that cause an autosomal dominant premature ageing disorderhutchinson gilford progeria syndrome hgpslead to reduced itl formation and telomere loss we propose that cellular and organismal ageing are intertwined through the effect of the interaction between trf and lamin ac on chromosome structure
25401994,jak mutationpositive polycythemia vera presenting a central retinal artery occlusion,purpose to report the case of a yearold man who presented with profound visual loss in his right eye because of a central retinal artery occlusion accompanied by a stroke in the ipsilateral middle cerebral artery with left upper extremity sequela method the patient underwent a comprehensive ophthalmologic examination fluorescein angiography thorough neuroophthalmology evaluation including magnetic resonance imaging and magnetic resonance angiography lead electrocardiogram transesophageal echocardiogram bilateral carotid artery doppler holter monitoring comprehensive laboratory testing bone marrow biopsy and genetic testing result despite an initially normal hematocrit the etiology of the central retinal artery occlusion and that of the nearly concomitant stroke in the right medial cerebral artery territory wa confirmed by bone marrow biopsy to be polycythemia vera positive jak mutation patient received treatment with aspirin serial phlebotomy and hydroxyurea demonstrating a slight improvement in vision and substantial normalization of neurologic and hematological status at the time of this report year later patient remains stable conclusion central retinal artery occlusion a disease with a frequently devastating visual outcome is often not an isolated ocular occurrence in the absence of an obvious local trigger a thorough workup is always warranted especially in younger patient a the ocular pathology oftentimes may herald severe cerebrocardiovascular event,Non-Cancer,1,jak mutationpositive polycythemia vera presenting a central retinal artery occlusion purpose to report the case of a yearold man who presented with profound visual loss in his right eye because of a central retinal artery occlusion accompanied by a stroke in the ipsilateral middle cerebral artery with left upper extremity sequela method the patient underwent a comprehensive ophthalmologic examination fluorescein angiography thorough neuroophthalmology evaluation including magnetic resonance imaging and magnetic resonance angiography lead electrocardiogram transesophageal echocardiogram bilateral carotid artery doppler holter monitoring comprehensive laboratory testing bone marrow biopsy and genetic testing result despite an initially normal hematocrit the etiology of the central retinal artery occlusion and that of the nearly concomitant stroke in the right medial cerebral artery territory wa confirmed by bone marrow biopsy to be polycythemia vera positive jak mutation patient received treatment with aspirin serial phlebotomy and hydroxyurea demonstrating a slight improvement in vision and substantial normalization of neurologic and hematological status at the time of this report year later patient remains stable conclusion central retinal artery occlusion a disease with a frequently devastating visual outcome is often not an isolated ocular occurrence in the absence of an obvious local trigger a thorough workup is always warranted especially in younger patient a the ocular pathology oftentimes may herald severe cerebrocardiovascular event
25441388,differentiating skinlimited and multisystem langerhans cell histiocytosis,objective to identify feature associated with multisystem involvement and therapeutic failure in patient with skin langerhans cell histiocytosis lch study design we reviewed medical record of consecutive patient with lch with skin involvement evaluated at texas childrens hospital and analyzed clinical feature laboratory result and the presence of circulating cell with the brafve mutation with respect to initial staging and clinical outcome result skin disease in patient older than month of age at diagnosis wa associated with the presence of multisystem disease or ci forty percent of patient referred for presumed skinlimited lch had underlying multisystem involvement onehalf of these with riskorgan involvement patient with skinlimited lch had a year progressionfree survival of after initial therapy and none developed multisystem disease patient with skinmultisystem involvement had a year progressionfree survival of with vinblastineprednisone therapy and riskorgan involvement did not correlate with failure to achieve nonactive disease circulating cell with brafve were detected at higher frequency in patient with multisystem involvement of skinmultisystem v of skinlimited p conclusion skinlimited lch necessitates infrequent therapeutic intervention and ha a lower risk of progression relative to skin plus multisystem lch the lessaggressive clinical course and lack of circulating cell with the brafve mutation in skinlimited lch suggest a different mechanism of disease origin compared with multisystem or riskorgan disease,Non-Cancer,1,differentiating skinlimited and multisystem langerhans cell histiocytosis objective to identify feature associated with multisystem involvement and therapeutic failure in patient with skin langerhans cell histiocytosis lch study design we reviewed medical record of consecutive patient with lch with skin involvement evaluated at texas childrens hospital and analyzed clinical feature laboratory result and the presence of circulating cell with the brafve mutation with respect to initial staging and clinical outcome result skin disease in patient older than month of age at diagnosis wa associated with the presence of multisystem disease or ci forty percent of patient referred for presumed skinlimited lch had underlying multisystem involvement onehalf of these with riskorgan involvement patient with skinlimited lch had a year progressionfree survival of after initial therapy and none developed multisystem disease patient with skinmultisystem involvement had a year progressionfree survival of with vinblastineprednisone therapy and riskorgan involvement did not correlate with failure to achieve nonactive disease circulating cell with brafve were detected at higher frequency in patient with multisystem involvement of skinmultisystem v of skinlimited p conclusion skinlimited lch necessitates infrequent therapeutic intervention and ha a lower risk of progression relative to skin plus multisystem lch the lessaggressive clinical course and lack of circulating cell with the brafve mutation in skinlimited lch suggest a different mechanism of disease origin compared with multisystem or riskorgan disease
25468659,loss of function in heparan sulfate elongation gene ext and ext result in improved nitric oxide bioavailability and endothelial function,background heparanase is the major enzyme involved in degradation of endothelial heparan sulfate which is associated with impaired endothelial nitric oxide synthesis however the effect of heparan sulfate chain length in relation to endothelial function and nitric oxide availability ha never been investigated we studied the effect of heterozygous mutation in heparan sulfate elongation gene ext and ext on endothelial function in vitro a well a in vivo method and result flowmediated dilation a marker of nitric oxide bioavailability wa studied in ext and ext mouse versus control n per group a well a in human subject with heterozygous loss of function mutation in ext and ext n hereditary multiple exostosis and n control endothelial function wa measured in microvascular endothelial cell under laminar flow with or without sirna targeting ext or ext endothelial glycocalyx and maximal arteriolar dilatation were significantly altered in ext and ext mouse compared to wildtype littermates glycocalyx wildtype mum ext mum and ext mum p maximal arteriolar dilation during reperfusion wildtype ext and ext p in human brachial artery flowmediated dilation wa significantly increased in hereditary multiple exostosis patient hereditary multiple exostosis versus control p in line silencing of microvascular endothelial cell ext and ext under flow led to significant upregulation of endothelial nitric oxide synthesis and phosphoendothelial nitric oxide synthesis protein expression conclusion our data implicate that heparan sulfate elongation gene ext and ext are involved in maintaining endothelial homeostasis presumably via increased nitric oxide bioavailability,Non-Cancer,1,loss of function in heparan sulfate elongation gene ext and ext result in improved nitric oxide bioavailability and endothelial function background heparanase is the major enzyme involved in degradation of endothelial heparan sulfate which is associated with impaired endothelial nitric oxide synthesis however the effect of heparan sulfate chain length in relation to endothelial function and nitric oxide availability ha never been investigated we studied the effect of heterozygous mutation in heparan sulfate elongation gene ext and ext on endothelial function in vitro a well a in vivo method and result flowmediated dilation a marker of nitric oxide bioavailability wa studied in ext and ext mouse versus control n per group a well a in human subject with heterozygous loss of function mutation in ext and ext n hereditary multiple exostosis and n control endothelial function wa measured in microvascular endothelial cell under laminar flow with or without sirna targeting ext or ext endothelial glycocalyx and maximal arteriolar dilatation were significantly altered in ext and ext mouse compared to wildtype littermates glycocalyx wildtype mum ext mum and ext mum p maximal arteriolar dilation during reperfusion wildtype ext and ext p in human brachial artery flowmediated dilation wa significantly increased in hereditary multiple exostosis patient hereditary multiple exostosis versus control p in line silencing of microvascular endothelial cell ext and ext under flow led to significant upregulation of endothelial nitric oxide synthesis and phosphoendothelial nitric oxide synthesis protein expression conclusion our data implicate that heparan sulfate elongation gene ext and ext are involved in maintaining endothelial homeostasis presumably via increased nitric oxide bioavailability
25476696,intestinal epithelial myd is a sensor switching host metabolism towards obesity according to nutritional status,obesity is associated with a cluster of metabolic disorder lowgrade inflammation and altered gut microbiota whether host metabolism is controlled by intestinal innate immune system and the gut microbiota is unknown here we report that inducible intestinal epithelial cellspecific deletion of myd partially protects against dietinduced obesity diabetes and inflammation this is associated with increased energy expenditure an improved glucose homeostasis reduced hepatic steatosis fat mass and inflammation protection is transferred following gut microbiota transplantation to germfree recipient we also demonstrate that intestinal epithelial myd deletion increase antiinflammatory endocannabinoids restores antimicrobial peptide production and increase intestinal regulatory t cell during dietinduced obesity targeting myd after the onset of obesity reduces fat mass and inflammation our work thus identifies intestinal epithelial myd a a sensor changing host metabolism according to the nutritional status and we show that targeting intestinal epithelial myd constitutes a putative therapeutic target for obesity and related disorder,Non-Cancer,1,intestinal epithelial myd is a sensor switching host metabolism towards obesity according to nutritional status obesity is associated with a cluster of metabolic disorder lowgrade inflammation and altered gut microbiota whether host metabolism is controlled by intestinal innate immune system and the gut microbiota is unknown here we report that inducible intestinal epithelial cellspecific deletion of myd partially protects against dietinduced obesity diabetes and inflammation this is associated with increased energy expenditure an improved glucose homeostasis reduced hepatic steatosis fat mass and inflammation protection is transferred following gut microbiota transplantation to germfree recipient we also demonstrate that intestinal epithelial myd deletion increase antiinflammatory endocannabinoids restores antimicrobial peptide production and increase intestinal regulatory t cell during dietinduced obesity targeting myd after the onset of obesity reduces fat mass and inflammation our work thus identifies intestinal epithelial myd a a sensor changing host metabolism according to the nutritional status and we show that targeting intestinal epithelial myd constitutes a putative therapeutic target for obesity and related disorder
25486933,strategy for identifying repurposed drug for the treatment of cerebral cavernous malformation,background cerebral cavernous malformation ccm is a hemorrhagic stroke disease affecting up to of north american that ha no approved nonsurgical treatment a subset of patient have a hereditary form of the disease due primarily to lossoffunction mutation in krit ccm or pdcd we sought to identify known drug that could be repurposed to treat ccm method and result we developed an unbiased screening platform based on both cellular and animal model of loss of function of ccm our discovery strategy consisted of step an automated immunofluorescence and machinelearningbased primary screen of structural phenotype in human endothelial cell deficient in ccm a secondary screen of functional change in endothelial stability in these same cell a rapid in vivo tertiary screen of dermal microvascular leak in mouse lacking endothelial ccm and finally a quaternary screen of ccm lesion burden in these same mouse we screened known drug and bioactive compound and identified candidate cholecalciferol vitamin d and tempol a scavenger of superoxide for further study each drug decreased lesion burden in a mouse model of ccm vascular disease by conclusion by identifying known drug a potential therapeutic for ccm we have decreased the time cost and risk of bringing treatment to patient each drug also prompt additional exploration of biomarkers of ccm disease we further suggest that the structurefunction screening platform presented here may be adapted and scaled to facilitate drug discovery for diverse lossoffunction genetic vascular disease,Non-Cancer,1,strategy for identifying repurposed drug for the treatment of cerebral cavernous malformation background cerebral cavernous malformation ccm is a hemorrhagic stroke disease affecting up to of north american that ha no approved nonsurgical treatment a subset of patient have a hereditary form of the disease due primarily to lossoffunction mutation in krit ccm or pdcd we sought to identify known drug that could be repurposed to treat ccm method and result we developed an unbiased screening platform based on both cellular and animal model of loss of function of ccm our discovery strategy consisted of step an automated immunofluorescence and machinelearningbased primary screen of structural phenotype in human endothelial cell deficient in ccm a secondary screen of functional change in endothelial stability in these same cell a rapid in vivo tertiary screen of dermal microvascular leak in mouse lacking endothelial ccm and finally a quaternary screen of ccm lesion burden in these same mouse we screened known drug and bioactive compound and identified candidate cholecalciferol vitamin d and tempol a scavenger of superoxide for further study each drug decreased lesion burden in a mouse model of ccm vascular disease by conclusion by identifying known drug a potential therapeutic for ccm we have decreased the time cost and risk of bringing treatment to patient each drug also prompt additional exploration of biomarkers of ccm disease we further suggest that the structurefunction screening platform presented here may be adapted and scaled to facilitate drug discovery for diverse lossoffunction genetic vascular disease
25488918,brca diffuses a oligomeric cluster with rad and change mobility after dna damage in live cell,genome maintenance by homologous recombination depends on coordinating many protein in time and space to assemble at dna break site to understand this process we followed the mobility of brca a critical recombination mediator in live cell at the singlemolecule level using both singleparticle tracking and fluorescence correlation spectroscopy brcagfp and yfp were compared to distinguish diffusion from fluorophore behavior diffusive behavior of fluorescent rad and rad wa determined for comparison all fluorescent protein were expressed from endogenous locus we found that nuclear brca existed in oligomeric cluster and exhibited heterogeneous mobility dna damage increased brca transient binding presumably including binding to damaged site despite it very different size rad displayed mobility similar to brca which indicates physical interaction between these protein both before and after induction of dna damage we propose that brcamediated sequestration of nuclear rad serf to prevent inappropriate dna interaction and that all rad is delivered to dna damage site in association with brca,Non-Cancer,1,brca diffuses a oligomeric cluster with rad and change mobility after dna damage in live cell genome maintenance by homologous recombination depends on coordinating many protein in time and space to assemble at dna break site to understand this process we followed the mobility of brca a critical recombination mediator in live cell at the singlemolecule level using both singleparticle tracking and fluorescence correlation spectroscopy brcagfp and yfp were compared to distinguish diffusion from fluorophore behavior diffusive behavior of fluorescent rad and rad wa determined for comparison all fluorescent protein were expressed from endogenous locus we found that nuclear brca existed in oligomeric cluster and exhibited heterogeneous mobility dna damage increased brca transient binding presumably including binding to damaged site despite it very different size rad displayed mobility similar to brca which indicates physical interaction between these protein both before and after induction of dna damage we propose that brcamediated sequestration of nuclear rad serf to prevent inappropriate dna interaction and that all rad is delivered to dna damage site in association with brca
25522665,regulation of t cell by mtor the known knowns and the known unknown,mammalianmechanistic target of rapamycin mtor is emerging a an important integrator of environmental cue critical for the regulation of t cell activation differentiation and function recent study leveraging pharmacologic inhibition or t cell specific genetic deletion of signaling component in the mtor pathway have provided important insight into the mechanism involved and have been informative in defining target downstream of mtor that promote immune regulation however these study have also presented confusing and at time contradictory finding highlighting the complexity involved in examining the mtor pathway in distinct context here we review current understanding of the role of mtor in t cell biology highlighting emerging concept and area of investigation where the precise role of mtor ha yet to be fully discerned,Non-Cancer,1,regulation of t cell by mtor the known knowns and the known unknown mammalianmechanistic target of rapamycin mtor is emerging a an important integrator of environmental cue critical for the regulation of t cell activation differentiation and function recent study leveraging pharmacologic inhibition or t cell specific genetic deletion of signaling component in the mtor pathway have provided important insight into the mechanism involved and have been informative in defining target downstream of mtor that promote immune regulation however these study have also presented confusing and at time contradictory finding highlighting the complexity involved in examining the mtor pathway in distinct context here we review current understanding of the role of mtor in t cell biology highlighting emerging concept and area of investigation where the precise role of mtor ha yet to be fully discerned
25537430,d coregistration of xray and mrmammograms initial clinical result and potential incremental diagnostic value,purpose d coregistration of xray and mrmammograms xm and mm is a new method of image fusion the present study aim to evaluate it clinical feasibility radiological accuracy and potential clinical value method xm and mm of patient were coregistered result were evaluated by a blinded reader result precision of the d coregistration wa very good meanscore m and lesion were easier to delineate m in relevant additional diagnostic information wa present accounting for a more confident diagnosis in m conclusion d coregistration is feasible accurate and of potential clinical value,Non-Cancer,1,d coregistration of xray and mrmammograms initial clinical result and potential incremental diagnostic value purpose d coregistration of xray and mrmammograms xm and mm is a new method of image fusion the present study aim to evaluate it clinical feasibility radiological accuracy and potential clinical value method xm and mm of patient were coregistered result were evaluated by a blinded reader result precision of the d coregistration wa very good meanscore m and lesion were easier to delineate m in relevant additional diagnostic information wa present accounting for a more confident diagnosis in m conclusion d coregistration is feasible accurate and of potential clinical value
25557241,outcome of preimplantation genetic diagnosis in neurofibromatosis type,objective to examine the effect of patient and facility level factor on the success of preimplantation genetic diagnosis pgd in patient with neurofibromatosis nf design retrospective review setting large pgd reference laboratory patient all patient with nf referred from june to may intervention none main outcome measure embryo nf mutation status and live birth rate result seventyseven couple underwent pgd cycle during the study period the average maternal age at the time of embryo biopsy wa year the majority of embryo had a day single blastomere biopsy without aneuploidy screening a diagnosis wa obtained for of biopsied embryo of biopsy were nondiagnostic due to technical failure diagnosis wa more often obtained for embryo of parent with familial disease and for embryo biopsied at center that referred multiple nf case among diagnosed embryo were unaffected by the parental nf mutation twentytwo of the cycle had a confirmed live birth if the observed success rate is applied to cycle with unknown outcome cycle are expected to have resulted in live birth in multivariate logistic regression having a live birth wa significantly associated with having more unaffected embryo available for transfer odds ratio per additional embryo confidence interval conclusion advance in biopsy and diagnostic technique which increase the number of unaffected embryo identified may improve live birth rate for patient with nf clinician should counsel patient about their fertility and reproductive option early with the use of diseasespecific data to set appropriate expectation for the pgd process,Non-Cancer,1,outcome of preimplantation genetic diagnosis in neurofibromatosis type objective to examine the effect of patient and facility level factor on the success of preimplantation genetic diagnosis pgd in patient with neurofibromatosis nf design retrospective review setting large pgd reference laboratory patient all patient with nf referred from june to may intervention none main outcome measure embryo nf mutation status and live birth rate result seventyseven couple underwent pgd cycle during the study period the average maternal age at the time of embryo biopsy wa year the majority of embryo had a day single blastomere biopsy without aneuploidy screening a diagnosis wa obtained for of biopsied embryo of biopsy were nondiagnostic due to technical failure diagnosis wa more often obtained for embryo of parent with familial disease and for embryo biopsied at center that referred multiple nf case among diagnosed embryo were unaffected by the parental nf mutation twentytwo of the cycle had a confirmed live birth if the observed success rate is applied to cycle with unknown outcome cycle are expected to have resulted in live birth in multivariate logistic regression having a live birth wa significantly associated with having more unaffected embryo available for transfer odds ratio per additional embryo confidence interval conclusion advance in biopsy and diagnostic technique which increase the number of unaffected embryo identified may improve live birth rate for patient with nf clinician should counsel patient about their fertility and reproductive option early with the use of diseasespecific data to set appropriate expectation for the pgd process
25578100,risk factor for anaphylaxis in patient with mastocytosis,introduction symptom resulting from the activation and release of mediator from the mast cell are observed in about of the patient with mastocytosis objective the aim of the study wa to assess the prevalence of anaphylactic reaction and to identify the risk factor for anaphylaxis in patient with mastocytosis depending on the type of the disease furthermore we analyzed a response to treatment of mediatorrelated symptom in this patient group patient and method the study group included adult patient with mastocytosis the diagnostic workup included a histopathological examination flow cytometry kit mutation analysis and measurement of tryptase level the diagnosis of allergy wa confirmed by the skin prick test and serum immunoglobulin e level result the prevalence of anaphylactic reaction in the study group wa and wa higher in patient with systemic mastocytosis p specifically in it indolent variant p than in patient with cutaneous mastocytosis the most frequent trigger of anaphylaxis were food insect sting and drug tryptase level were higher in patient with a history of anaphylaxis p a well a in those with symptom provoked by physical factor p such symptom were reported in patient and were more common in patient with systemic mastocytosis compared with those with cutaneous mastocytosis p the treatment wa ineffective in patient and resulted only in partial remission in patient conclusion the study showed a significant incidence of symptom related to physical factor in patient with mastocytosis and anaphylaxis in history risk factor for anaphylaxis included increased serum tryptase level and indolent variant of systemic mastocytosis standard pharmacological treatment wa ineffective in of the patient who may require biological treatment,Non-Cancer,1,risk factor for anaphylaxis in patient with mastocytosis introduction symptom resulting from the activation and release of mediator from the mast cell are observed in about of the patient with mastocytosis objective the aim of the study wa to assess the prevalence of anaphylactic reaction and to identify the risk factor for anaphylaxis in patient with mastocytosis depending on the type of the disease furthermore we analyzed a response to treatment of mediatorrelated symptom in this patient group patient and method the study group included adult patient with mastocytosis the diagnostic workup included a histopathological examination flow cytometry kit mutation analysis and measurement of tryptase level the diagnosis of allergy wa confirmed by the skin prick test and serum immunoglobulin e level result the prevalence of anaphylactic reaction in the study group wa and wa higher in patient with systemic mastocytosis p specifically in it indolent variant p than in patient with cutaneous mastocytosis the most frequent trigger of anaphylaxis were food insect sting and drug tryptase level were higher in patient with a history of anaphylaxis p a well a in those with symptom provoked by physical factor p such symptom were reported in patient and were more common in patient with systemic mastocytosis compared with those with cutaneous mastocytosis p the treatment wa ineffective in patient and resulted only in partial remission in patient conclusion the study showed a significant incidence of symptom related to physical factor in patient with mastocytosis and anaphylaxis in history risk factor for anaphylaxis included increased serum tryptase level and indolent variant of systemic mastocytosis standard pharmacological treatment wa ineffective in of the patient who may require biological treatment
25582384,the impact of sensitive kit dv detection on recognition of indolent systemic mastocytosis,patient with systemic mastocytosis sm need a highly sensitive diagnostic test for dv detection of the kit receptor gene along with histologycytology and flow cytometry evaluation bone marrow bm from consecutive adult patient referred with a suspicion of sm to multidisciplinary outpatient clinic for mastocytosis in verona were tested both by amplification refractory mutation system reverse transcriptase quantitative real time polymerase chain reaction armsrtqpcr and rtpcrrestriction fragment length polymorphism rflp followed by denaturinghigh performance liquid chromatography dhplc and sanger sequencing armsrtqpcr identified dv mutation in patient corresponding to of case showing cd mast cell mc whereas rtpcrrflpdhplcsequencing revealed dv mutation in patient according to the who criterion sm cutaneous mastocytosis cm monoclonal mc activation syndrome mmas and sm associated with haematologic nonmast cell disorder smahnmd were diagnosed seventeen out sm patient would have not satisfied sufficient who criterion on the basis of the sole rtpcrrflp these patient had significantly lower serum tryptase level and amount of cd mc therefore armsrtqpcr might result particularly useful in patient that do not fulfil major bm histological criterion for the recognition of indolent sm with a very low mc burden,Non-Cancer,1,the impact of sensitive kit dv detection on recognition of indolent systemic mastocytosis patient with systemic mastocytosis sm need a highly sensitive diagnostic test for dv detection of the kit receptor gene along with histologycytology and flow cytometry evaluation bone marrow bm from consecutive adult patient referred with a suspicion of sm to multidisciplinary outpatient clinic for mastocytosis in verona were tested both by amplification refractory mutation system reverse transcriptase quantitative real time polymerase chain reaction armsrtqpcr and rtpcrrestriction fragment length polymorphism rflp followed by denaturinghigh performance liquid chromatography dhplc and sanger sequencing armsrtqpcr identified dv mutation in patient corresponding to of case showing cd mast cell mc whereas rtpcrrflpdhplcsequencing revealed dv mutation in patient according to the who criterion sm cutaneous mastocytosis cm monoclonal mc activation syndrome mmas and sm associated with haematologic nonmast cell disorder smahnmd were diagnosed seventeen out sm patient would have not satisfied sufficient who criterion on the basis of the sole rtpcrrflp these patient had significantly lower serum tryptase level and amount of cd mc therefore armsrtqpcr might result particularly useful in patient that do not fulfil major bm histological criterion for the recognition of indolent sm with a very low mc burden
25586219,bp promotes microhomologymediated endjoining in gphase cell,alternative nonhomologous end joining altnhej wa originally identified a a backup repair mechanism in the absence of classical nhej cnhej factor but recent study have demonstrated that altnhej is active even when cnhej a well a homologous recombination is available the function of bp in nhej process are not well understood here we report that bp promotes dna doublestrand break dsb repair and genomic stability not only in cnhejproficient but also deficient human gphase cell using an array of repair substrate we show that these effect of bp are correlated with a promotion of microhomologymediated endjoining mmej a subtype of altnhej in gphase consistent with a specific role in mmej we confirm that bp status doe not affect cnhej bp support sequence deletion during mmej consistent with a putative role in facilitating endresection interestingly promotion of mmej by bp in gphase cell is only observed in the presence of functional brca depletion of both bp and brca increase repair needing microhomology usage and augments loss of dna sequence suggesting that mmej is a highly regulated dsb repair process together these finding significantly expand our understanding of the cellcycledependent role of bp in dsb repair,Non-Cancer,1,bp promotes microhomologymediated endjoining in gphase cell alternative nonhomologous end joining altnhej wa originally identified a a backup repair mechanism in the absence of classical nhej cnhej factor but recent study have demonstrated that altnhej is active even when cnhej a well a homologous recombination is available the function of bp in nhej process are not well understood here we report that bp promotes dna doublestrand break dsb repair and genomic stability not only in cnhejproficient but also deficient human gphase cell using an array of repair substrate we show that these effect of bp are correlated with a promotion of microhomologymediated endjoining mmej a subtype of altnhej in gphase consistent with a specific role in mmej we confirm that bp status doe not affect cnhej bp support sequence deletion during mmej consistent with a putative role in facilitating endresection interestingly promotion of mmej by bp in gphase cell is only observed in the presence of functional brca depletion of both bp and brca increase repair needing microhomology usage and augments loss of dna sequence suggesting that mmej is a highly regulated dsb repair process together these finding significantly expand our understanding of the cellcycledependent role of bp in dsb repair
25600436,identification of chimeric antigen receptor that mediate constitutive or inducible proliferation of t cell,this study compared secondgeneration chimeric antigen receptor car encoding signaling domain composed of cd icos and bb tnfrsf here we report that certain car endow t cell with the ability to undergo longterm autonomous proliferation transduction of primary human t cell with lentiviral vector encoding some of the car resulted in sustained proliferation for up to month following a single stimulation through the tcell receptor tcr sustained numeric expansion wa independent of cognate antigen and did not require the addition of exogenous cytokine or feeder cell after a single stimulation of the tcr and cd result from gene array and functional assay linked sustained cytokine secretion and expression of tbet tbx eomes and gata to the effect sustained expression of the endogenous il locus ha not been reported in primary t cell sustained proliferation wa dependent on car structure and high expression the latter of which wa necessary but not sufficient the mechanism involves constitutive signaling through nfkappab akt erk and nfat the propagated car t cell retained a diverse tcr repertoire and cellular transformation wa not observed the car with a constitutive growth phenotype displayed inferior antitumor effect and engraftment in vivo therefore the design of car that have a nonconstitutive growth phenotype may be a strategy to improve efficacy and engraftment of car t cell the identification of car that confer constitutive or nonconstitutive growth pattern may explain observation that car t cell have differential survival pattern in clinical trial,Non-Cancer,1,identification of chimeric antigen receptor that mediate constitutive or inducible proliferation of t cell this study compared secondgeneration chimeric antigen receptor car encoding signaling domain composed of cd icos and bb tnfrsf here we report that certain car endow t cell with the ability to undergo longterm autonomous proliferation transduction of primary human t cell with lentiviral vector encoding some of the car resulted in sustained proliferation for up to month following a single stimulation through the tcell receptor tcr sustained numeric expansion wa independent of cognate antigen and did not require the addition of exogenous cytokine or feeder cell after a single stimulation of the tcr and cd result from gene array and functional assay linked sustained cytokine secretion and expression of tbet tbx eomes and gata to the effect sustained expression of the endogenous il locus ha not been reported in primary t cell sustained proliferation wa dependent on car structure and high expression the latter of which wa necessary but not sufficient the mechanism involves constitutive signaling through nfkappab akt erk and nfat the propagated car t cell retained a diverse tcr repertoire and cellular transformation wa not observed the car with a constitutive growth phenotype displayed inferior antitumor effect and engraftment in vivo therefore the design of car that have a nonconstitutive growth phenotype may be a strategy to improve efficacy and engraftment of car t cell the identification of car that confer constitutive or nonconstitutive growth pattern may explain observation that car t cell have differential survival pattern in clinical trial
25612910,evaluation of somatic mutation in tibial pseudarthrosis sample in neurofibromatosis type,background tibial pseudarthrosis is associated with neurofibromatosis type nf and there is wide clinical variability of the tibial dysplasia in nf suggesting the possibility of genetic modifier double inactivation of nf is postulated to be necessary for the development of tibial pseudarthrosis but tissue or cell of origin of the second hit mutation remains unclear method exome sequencing of different section of surgically resected nf tibial pseudarthrosis tissue wa performed and compared to germline peripheral blood result a germline nf splice site mutation cat pl mdel wa identified from dna extracted from peripheral blood exome sequencing of dna extracted from tissue removed during surgery of the tibial pseudarthrosis showed a somatic mutation of nf cgt pe in the normal germline allele further analysis of different region of the tibial pseudarthrosis sample showed enrichment of the somatic mutation in the soft tissue within the pseudarthrosis site and absence of the somatic mutation in cortical bone in addition a germline variant in ptpn cct ptm a gene involved in the ra signal transduction pathway wa identified although the clinical significance is unknown conclusion given that the nf somatic mutation wa primarily detected in the proliferative soft tissue at the pseudarthrosis site it is likely that the second hit occurred in mesenchymal progenitor from the periosteum these result are consistent with a defect of differentiation which may explain why the mutation is found in proliferative cell and not within cortical bone tissue a the latter by definition contains mostly mature differentiated osteoblast and osteocyte,Non-Cancer,1,evaluation of somatic mutation in tibial pseudarthrosis sample in neurofibromatosis type background tibial pseudarthrosis is associated with neurofibromatosis type nf and there is wide clinical variability of the tibial dysplasia in nf suggesting the possibility of genetic modifier double inactivation of nf is postulated to be necessary for the development of tibial pseudarthrosis but tissue or cell of origin of the second hit mutation remains unclear method exome sequencing of different section of surgically resected nf tibial pseudarthrosis tissue wa performed and compared to germline peripheral blood result a germline nf splice site mutation cat pl mdel wa identified from dna extracted from peripheral blood exome sequencing of dna extracted from tissue removed during surgery of the tibial pseudarthrosis showed a somatic mutation of nf cgt pe in the normal germline allele further analysis of different region of the tibial pseudarthrosis sample showed enrichment of the somatic mutation in the soft tissue within the pseudarthrosis site and absence of the somatic mutation in cortical bone in addition a germline variant in ptpn cct ptm a gene involved in the ra signal transduction pathway wa identified although the clinical significance is unknown conclusion given that the nf somatic mutation wa primarily detected in the proliferative soft tissue at the pseudarthrosis site it is likely that the second hit occurred in mesenchymal progenitor from the periosteum these result are consistent with a defect of differentiation which may explain why the mutation is found in proliferative cell and not within cortical bone tissue a the latter by definition contains mostly mature differentiated osteoblast and osteocyte
25623620,hypogammaglobulinemia in child after allogeneic hematopoietic stem cell transplantation a cytokine mediated immunoglobulin isotype class switch arrest,background hypogammaglobulinemia hypoigg is common early posthsct in child occasionally necessitating longterm immunoglobulin ig g replacement therapy igg replacement may not reduce mortality although infectious complication are decreased procedure clinical data and sample from child were analyzed retrospectively with the aim to identify risk factor for developing longterm hypoigg ie requiring month igg replacement posthsct and studying the underlying biology laboratory study covered serum cytokine ighg genotyping and routine laboratory investigation result were analyzed statistically result fortyeight percent of the child developed longterm hypoigg these child were younger year and had higher acute gvhd incidence but had better overall survival v p significantly lower ig level posthsct but equal immune cell recovery were seen in patient with longterm hypoigg compared with those of transient or no hypoigg prehsct il and and posthsct baff and april level were significantly higher in the longterm hypoigg group conclusion finding suggests an unfavorable cytokine milieu for graftderived immune recovery possibly inducing ig isotype class switch arrest younger age acute gvhd and higher prehsct il level were identified a significant risk factor for longterm hypoigg longterm hypoigg posthsct doe not need to be unfavorable and could be an effect of deteriorated cytokine signaling,Non-Cancer,1,hypogammaglobulinemia in child after allogeneic hematopoietic stem cell transplantation a cytokine mediated immunoglobulin isotype class switch arrest background hypogammaglobulinemia hypoigg is common early posthsct in child occasionally necessitating longterm immunoglobulin ig g replacement therapy igg replacement may not reduce mortality although infectious complication are decreased procedure clinical data and sample from child were analyzed retrospectively with the aim to identify risk factor for developing longterm hypoigg ie requiring month igg replacement posthsct and studying the underlying biology laboratory study covered serum cytokine ighg genotyping and routine laboratory investigation result were analyzed statistically result fortyeight percent of the child developed longterm hypoigg these child were younger year and had higher acute gvhd incidence but had better overall survival v p significantly lower ig level posthsct but equal immune cell recovery were seen in patient with longterm hypoigg compared with those of transient or no hypoigg prehsct il and and posthsct baff and april level were significantly higher in the longterm hypoigg group conclusion finding suggests an unfavorable cytokine milieu for graftderived immune recovery possibly inducing ig isotype class switch arrest younger age acute gvhd and higher prehsct il level were identified a significant risk factor for longterm hypoigg longterm hypoigg posthsct doe not need to be unfavorable and could be an effect of deteriorated cytokine signaling
25637637,protein of the mitotic checkpoint and spindle are related to chromosomal instability and unfavourable prognosis in patient with myelodysplastic syndrome,aim to study the immunoexpression of protein related to the mitotic checkpoint cell division cycle cdc mitotic arrest deficient mad and the mitotic spindle aurorab in patient with myelodysplastic syndrome md method protein expression wa analysed in bone marrow tissue sample from patient with md using immunohistochemistry prognostic marker transfusion dependency depth of cytopenia chromosomal abnormality and survival were also studied result higher mad expression wa observed among patient with platelet xl v respectively higher cdc expression wa identified among patient with three dysplasia compared with patient who presented with one or two dysplasia v v respectively among patient who exhibited a complex versus noncomplex karyotype v respectively and among patient with platelet xl v respectively higher aurorab expression wa found in patient with an abnormal versus normal karyotype v respectively high expression of mad and cdc wa associated with severe thrombocytopenia we also found statistically significant difference in the overall survival rate when comparing different degree of cdc mad and aurorab protein expression conclusion to the best of our knowledge this is the first report to demonstrate that these protein are associated with chromosomal abnormality and poor prognosis in patient with md,Non-Cancer,1,protein of the mitotic checkpoint and spindle are related to chromosomal instability and unfavourable prognosis in patient with myelodysplastic syndrome aim to study the immunoexpression of protein related to the mitotic checkpoint cell division cycle cdc mitotic arrest deficient mad and the mitotic spindle aurorab in patient with myelodysplastic syndrome md method protein expression wa analysed in bone marrow tissue sample from patient with md using immunohistochemistry prognostic marker transfusion dependency depth of cytopenia chromosomal abnormality and survival were also studied result higher mad expression wa observed among patient with platelet xl v respectively higher cdc expression wa identified among patient with three dysplasia compared with patient who presented with one or two dysplasia v v respectively among patient who exhibited a complex versus noncomplex karyotype v respectively and among patient with platelet xl v respectively higher aurorab expression wa found in patient with an abnormal versus normal karyotype v respectively high expression of mad and cdc wa associated with severe thrombocytopenia we also found statistically significant difference in the overall survival rate when comparing different degree of cdc mad and aurorab protein expression conclusion to the best of our knowledge this is the first report to demonstrate that these protein are associated with chromosomal abnormality and poor prognosis in patient with md
25659728,mutational profiling in patient with md ready for everyday use in the clinic,multiple recurrent somatic mutation were identified in the majority of patient with myelodysplastic syndrome md but investigating the broad spectrum of molecular marker in md exceeds many laboratory capacity when traditional molecular technique are used highthroughput second generation sequencing nextgeneration sequencing ng ha proven to be applicable for comprehensive biomarker mutation analysis allowing to increase diagnostic sensitivity and accuracy and to improve risk stratification and prognostication in addition to cytomorphology and cytogenetic analysis in patient with md amplicon deepsequencing enables comprehensive biomarker analysis in a multitude of patient per investigation in an acceptable turnaround time and at affordable cost comprehensive myeloid marker panel were successfully introduced into diagnostic practice therefore molecular mutation analysis is ready for use in all patient with suspected md may contribute to risk stratification in possible candidate for allogeneic stem cell transplantation and should become an integral part of clinical research study in md patient,Non-Cancer,1,mutational profiling in patient with md ready for everyday use in the clinic multiple recurrent somatic mutation were identified in the majority of patient with myelodysplastic syndrome md but investigating the broad spectrum of molecular marker in md exceeds many laboratory capacity when traditional molecular technique are used highthroughput second generation sequencing nextgeneration sequencing ng ha proven to be applicable for comprehensive biomarker mutation analysis allowing to increase diagnostic sensitivity and accuracy and to improve risk stratification and prognostication in addition to cytomorphology and cytogenetic analysis in patient with md amplicon deepsequencing enables comprehensive biomarker analysis in a multitude of patient per investigation in an acceptable turnaround time and at affordable cost comprehensive myeloid marker panel were successfully introduced into diagnostic practice therefore molecular mutation analysis is ready for use in all patient with suspected md may contribute to risk stratification in possible candidate for allogeneic stem cell transplantation and should become an integral part of clinical research study in md patient
25662299,paediatric mastocytosis a systematic review of case,paediatric mastocytosis wa previously considered to be a benign and spontaneously regressing disease however this evolution is impossible to predict to clarify the characteristic and course of paediatric mastocytosis we performed a literature review of case published between and april lesion occurred before the age of year in of case and presented a urticaria pigmentosa of case mastocytoma or diffuse cutaneous mastocytosis the maletofemale ratio wa kit dv mutation wa detected in of tested patient clinical regression complete or partial occurred in of case and stabilization in however the outcome wa fatal in of patient,Non-Cancer,1,paediatric mastocytosis a systematic review of case paediatric mastocytosis wa previously considered to be a benign and spontaneously regressing disease however this evolution is impossible to predict to clarify the characteristic and course of paediatric mastocytosis we performed a literature review of case published between and april lesion occurred before the age of year in of case and presented a urticaria pigmentosa of case mastocytoma or diffuse cutaneous mastocytosis the maletofemale ratio wa kit dv mutation wa detected in of tested patient clinical regression complete or partial occurred in of case and stabilization in however the outcome wa fatal in of patient
25663681,cd t cell stat phosphorylation precedes acute gvhd and subsequent th tissue invasion correlate with gvhd severity and therapeutic response,th cell contribute to severe gvhd in murine bone marrow transplantation targeted deletion of the rorgammat transcription factor or blockade of the jakstat axis suppresses il production and alloreactivity by th cell here we show that pstat y is increased significantly in cd t cell among human recipient of allogeneic hct before the onset of grade iiiv acute gvhd examination of targetorgan tissue at the time of gvhd diagnosis indicates that the amount of rorgammat th cell is significantly higher in severe gvhd greater accumulation of tissueresident th cell also correlate with the use of mtx compared with rapabased gvhd prophylaxis a well a a poor therapeutic response to glucocorticoid rorgammat is optimally suppressed by concurrent neutralization of torc with rapa and inhibition of stat activation with si supporting that mtor and statdependent pathway converge upon rorgammat gene expression raparesistant t cell proliferation can be totally inhibited by stat blockade during initial allosensitization we conclude that stat signaling and resultant th tissue accumulation are closely associated with acute gvhd onset severity and treatment outcome future study are needed to validate the association of stat activity in acute gvhd novel gvhd prevention strategy that incorporate dual stat and mtor inhibition merit investigation,Non-Cancer,1,cd t cell stat phosphorylation precedes acute gvhd and subsequent th tissue invasion correlate with gvhd severity and therapeutic response th cell contribute to severe gvhd in murine bone marrow transplantation targeted deletion of the rorgammat transcription factor or blockade of the jakstat axis suppresses il production and alloreactivity by th cell here we show that pstat y is increased significantly in cd t cell among human recipient of allogeneic hct before the onset of grade iiiv acute gvhd examination of targetorgan tissue at the time of gvhd diagnosis indicates that the amount of rorgammat th cell is significantly higher in severe gvhd greater accumulation of tissueresident th cell also correlate with the use of mtx compared with rapabased gvhd prophylaxis a well a a poor therapeutic response to glucocorticoid rorgammat is optimally suppressed by concurrent neutralization of torc with rapa and inhibition of stat activation with si supporting that mtor and statdependent pathway converge upon rorgammat gene expression raparesistant t cell proliferation can be totally inhibited by stat blockade during initial allosensitization we conclude that stat signaling and resultant th tissue accumulation are closely associated with acute gvhd onset severity and treatment outcome future study are needed to validate the association of stat activity in acute gvhd novel gvhd prevention strategy that incorporate dual stat and mtor inhibition merit investigation
25667416,immunodeficiency and autoimmune enterocolopathy linked to nfat haploinsufficiency,the link between autoimmune disease and primary immunodeficiency syndrome ha been increasingly appreciated immunologic evaluation of a young man with autoimmune enterocolopathy and unexplained infection revealed evidence of immunodeficiency including igg subclass deficiency impaired aginduced lymphocyte proliferation reduced cytokine production by cd t lymphocyte and decreased number of nk cell genetic evaluation identified haploinsufficiency of nfat a transcription factor regulating immune cell function and cellular adaptation to hyperosmotic stress a a possible cause of this syndrome inhibition or deletion of nfat in normal human and murine cell recapitulated several of the immune deficit identified in the patient these result provide evidence of a primary immunodeficiency disorder associated with organspecific autoimmunity linked to nfat deficiency,Non-Cancer,1,immunodeficiency and autoimmune enterocolopathy linked to nfat haploinsufficiency the link between autoimmune disease and primary immunodeficiency syndrome ha been increasingly appreciated immunologic evaluation of a young man with autoimmune enterocolopathy and unexplained infection revealed evidence of immunodeficiency including igg subclass deficiency impaired aginduced lymphocyte proliferation reduced cytokine production by cd t lymphocyte and decreased number of nk cell genetic evaluation identified haploinsufficiency of nfat a transcription factor regulating immune cell function and cellular adaptation to hyperosmotic stress a a possible cause of this syndrome inhibition or deletion of nfat in normal human and murine cell recapitulated several of the immune deficit identified in the patient these result provide evidence of a primary immunodeficiency disorder associated with organspecific autoimmunity linked to nfat deficiency
25727006,cenpa k ubiquitylation is required for cenpa deposition at the centromere,cenpa is a centromerespecific histone h variant that epigenetically determines centromere identity to ensure kinetochore assembly and proper chromosome segregation but the precise mechanism of it specific localization within centromeric heterochromatin remains obscure we have discovered that cularbxcops e ligase activity is required for cenpa ubiquitylation on lysine k and cenpa centromere localization a mutation of cenpa kr reduces interaction with hjurp a cenpaspecific histone chaperone and abrogates localization of cenpa to the centromere addition of monoubiquitin is sufficient to restore cenpa kr to centromere and the interaction with hjurp indicating that signaling ubiquitylation is required for cenpa loading at centromere the cularbx complex is required for loading newly synthesized cenpa and maintaining preassembled cenpa at centromere thus cenpa kr ubiquitylation mediated by the cularbxcops complex is essential for cenpa deposition at the centromere,Non-Cancer,1,cenpa k ubiquitylation is required for cenpa deposition at the centromere cenpa is a centromerespecific histone h variant that epigenetically determines centromere identity to ensure kinetochore assembly and proper chromosome segregation but the precise mechanism of it specific localization within centromeric heterochromatin remains obscure we have discovered that cularbxcops e ligase activity is required for cenpa ubiquitylation on lysine k and cenpa centromere localization a mutation of cenpa kr reduces interaction with hjurp a cenpaspecific histone chaperone and abrogates localization of cenpa to the centromere addition of monoubiquitin is sufficient to restore cenpa kr to centromere and the interaction with hjurp indicating that signaling ubiquitylation is required for cenpa loading at centromere the cularbx complex is required for loading newly synthesized cenpa and maintaining preassembled cenpa at centromere thus cenpa kr ubiquitylation mediated by the cularbxcops complex is essential for cenpa deposition at the centromere
25741140,screening analysis of candidate gene mutation in a kindred with polycystic liver disease,aim to find potential mutable site by detecting mutation of the candidate gene in a kindred with polycystic liver disease pcld method first we chose a kindred with pcld and obtained five venous blood sample of this kindred after the family member signed the informed consent form in the kindred two case were diagnosed with pcld and the left three case were normal individual all the blood sample were preserved at c second we extracted the genomic dna from the venous blood sample of the kindred using a qiaamp dna mini kit and then performed longrange polymerase chain reaction pcr with different primer the exon of pkd were all sequenced with the forward and reverse primer to ensure the accuracy of the result next we purified the pcr product and directly sequenced them using big dye terminator chemistry version the sequencing reaction wa conducted with biomekfx beckman finally we analyzed the result result a total of normal exon were identified in detecting mutation of the pkd gene a synonymous mutation occurred in exon the mutation wa a homozygous t in the proband and wa c in the reference sequence this mutation wa located in the third codon and did not change the amino acid encoded by the codon missense mutation occurred in exon and these mutation were located in the second codon they changed the amino acid sequence and existed in the dbsnp library a nonsense mutation occurred in exon the mutation wa a heterozygous ct in the proband and wa c in the reference sequence this mutation wa located in the first codon and resulted in a termination codon this mutation had an obvious influence on the encoded protein and changed the length of the protein from to amino acid this wa a new mutation that wa not present in the dbsnp library conclusion the nonsense mutation of exon existed in the proband and in the third individual additionally the proband wa heterozygous for this mutation so the mutable site wa a pathogenic mutation,Non-Cancer,1,screening analysis of candidate gene mutation in a kindred with polycystic liver disease aim to find potential mutable site by detecting mutation of the candidate gene in a kindred with polycystic liver disease pcld method first we chose a kindred with pcld and obtained five venous blood sample of this kindred after the family member signed the informed consent form in the kindred two case were diagnosed with pcld and the left three case were normal individual all the blood sample were preserved at c second we extracted the genomic dna from the venous blood sample of the kindred using a qiaamp dna mini kit and then performed longrange polymerase chain reaction pcr with different primer the exon of pkd were all sequenced with the forward and reverse primer to ensure the accuracy of the result next we purified the pcr product and directly sequenced them using big dye terminator chemistry version the sequencing reaction wa conducted with biomekfx beckman finally we analyzed the result result a total of normal exon were identified in detecting mutation of the pkd gene a synonymous mutation occurred in exon the mutation wa a homozygous t in the proband and wa c in the reference sequence this mutation wa located in the third codon and did not change the amino acid encoded by the codon missense mutation occurred in exon and these mutation were located in the second codon they changed the amino acid sequence and existed in the dbsnp library a nonsense mutation occurred in exon the mutation wa a heterozygous ct in the proband and wa c in the reference sequence this mutation wa located in the first codon and resulted in a termination codon this mutation had an obvious influence on the encoded protein and changed the length of the protein from to amino acid this wa a new mutation that wa not present in the dbsnp library conclusion the nonsense mutation of exon existed in the proband and in the third individual additionally the proband wa heterozygous for this mutation so the mutable site wa a pathogenic mutation
25759145,atm gene single nucleotide polymorphism predict regimenrelated gastrointestinal toxicity in patient allografted after reduced conditioning,polymorphism of gene involved in innate and adaptive immunity have become an object of major interest in regard to hematopoietic stem cell transplantation hsct complication regimenrelated gastrointestinal toxicity rrgit is the dominant complication during the preengraftment period and ha been linked to increased risk of graftversushost disease gvhd development according to our hypothesis functional variant of gene participating in dna damage response ddr may have an impact on the extent of tissue damage caused by the conditioning regimen in our singlecenter study we analyzed patient who underwent hsct from hlaidentical donor after reduced conditioning the patient were genotyped for single nucleotide polymorphism snp r tg r ag r tg r ct and r tc of the atm genethe essential member of the ddr pathway using allelespecific matrixassisted laser desorptionionization timeofflight malditof mass spectrometry assay because of almost absolute linkage disequilibrium observed among all snp association of major atm haplotype atmatm with rrgit and acute gvhd agvhd wa analyzed importantly the univariate and multivariate analysis showed that patient homozygous for atm haplotype rst rsa rst rsc and rst are more likely to suffer from highgrade rrgit than atm homozygous patient the association with agvhd wa not significant to our knowledge this is the first report showing the atm gene variability in relation to rrgit in the allogeneic hsct setting,Non-Cancer,1,atm gene single nucleotide polymorphism predict regimenrelated gastrointestinal toxicity in patient allografted after reduced conditioning polymorphism of gene involved in innate and adaptive immunity have become an object of major interest in regard to hematopoietic stem cell transplantation hsct complication regimenrelated gastrointestinal toxicity rrgit is the dominant complication during the preengraftment period and ha been linked to increased risk of graftversushost disease gvhd development according to our hypothesis functional variant of gene participating in dna damage response ddr may have an impact on the extent of tissue damage caused by the conditioning regimen in our singlecenter study we analyzed patient who underwent hsct from hlaidentical donor after reduced conditioning the patient were genotyped for single nucleotide polymorphism snp r tg r ag r tg r ct and r tc of the atm genethe essential member of the ddr pathway using allelespecific matrixassisted laser desorptionionization timeofflight malditof mass spectrometry assay because of almost absolute linkage disequilibrium observed among all snp association of major atm haplotype atmatm with rrgit and acute gvhd agvhd wa analyzed importantly the univariate and multivariate analysis showed that patient homozygous for atm haplotype rst rsa rst rsc and rst are more likely to suffer from highgrade rrgit than atm homozygous patient the association with agvhd wa not significant to our knowledge this is the first report showing the atm gene variability in relation to rrgit in the allogeneic hsct setting
25780857,evaluation of von willebrand factor phenotype and genotype in hemophilia a patient with and without identified f mutation,background hemophilia a ha is an xlinked bleeding disorder caused by a deficiency in factor viii fviii von willebrand disease vwd is characterized by a quantitative or qualitative defect in von willebrand factor vwf patient with vwd with severely low vwf or vwd type n vwdn a vwd subtype distinguished by defective vwf binding to fviii may have reduced fviii level secondary to their vwd these patient superficially resemble patient with ha and pose a potential for misdiagnosis objective to investigate the unexplained cause of bleeding in ha patient without known fviii mutation by assessing plasma vwf antigen vwfag fviii binding capacity and vwf genotype patientsmethods thirtyseven of patient with ha studied a part of the hemophilia inhibitor research study lacked identifiable f mutation these patient case and patient with identified f mutation control were evaluated for vwfag a patient vwf capacity to bind fviii vwffviiib and vwf sequence result four case had vwfag iu dl and vwf mutation consistent with type vwd six case and one control were heterozygous for mutation previously reported to cause type vwd vwd n five case and one control or predicted to be deleterious by polyphen and sift prediction tool n case one control had vwfag iu dl and seven patient four case and three control including two case who were heterozygous for a known vwdn mutation had reduced vwffviiib conclusion these data emphasize that some patient diagnosed with ha require vwf assessment in order to achieve a comprehensive diagnosis and an optimal treatment strategy,Non-Cancer,1,evaluation of von willebrand factor phenotype and genotype in hemophilia a patient with and without identified f mutation background hemophilia a ha is an xlinked bleeding disorder caused by a deficiency in factor viii fviii von willebrand disease vwd is characterized by a quantitative or qualitative defect in von willebrand factor vwf patient with vwd with severely low vwf or vwd type n vwdn a vwd subtype distinguished by defective vwf binding to fviii may have reduced fviii level secondary to their vwd these patient superficially resemble patient with ha and pose a potential for misdiagnosis objective to investigate the unexplained cause of bleeding in ha patient without known fviii mutation by assessing plasma vwf antigen vwfag fviii binding capacity and vwf genotype patientsmethods thirtyseven of patient with ha studied a part of the hemophilia inhibitor research study lacked identifiable f mutation these patient case and patient with identified f mutation control were evaluated for vwfag a patient vwf capacity to bind fviii vwffviiib and vwf sequence result four case had vwfag iu dl and vwf mutation consistent with type vwd six case and one control were heterozygous for mutation previously reported to cause type vwd vwd n five case and one control or predicted to be deleterious by polyphen and sift prediction tool n case one control had vwfag iu dl and seven patient four case and three control including two case who were heterozygous for a known vwdn mutation had reduced vwffviiib conclusion these data emphasize that some patient diagnosed with ha require vwf assessment in order to achieve a comprehensive diagnosis and an optimal treatment strategy
25824806,clinical and laboratory characterization of case of castleman disease patient from a single centre paraneoplastic pemphigus is an unfavourable prognostic factor,this study retrospectively collected the clinical and laboratory data of patient with castleman disease cd from a single medical centre clinical classification identified patient with unicentric castleman disease and with multicentric castleman disease pathological classification revealed case of hyaline vascular variant mixed cellular variant mix and plasmacytic variant clinical complication occurred in cd patient including case of paraneoplastic pemphigus pnp and case with renal complication haematological involvement pleural effusion andor ascites and poem syndrome polyneuropathy organomegaly endocrinopathy monoclonal gammopathy and skin change were also found univariate analysis showed that presence of clinical complication and pnp were both risk factor relating to cd patient survival prognostic factor showing p in univariate analysis and those with clinical significance were subjected to multivariate analysis using a cox regression model pnp presence and age over year both significantly adversely affected survival thus only presence of pnp wa identified a an independent unfavourable survival risk factor in both univariate and multivariate analysis overall the present data provide a panoramic description of cd case and emphasize that the presence of pnp is an adverse prognostic factor,Non-Cancer,1,clinical and laboratory characterization of case of castleman disease patient from a single centre paraneoplastic pemphigus is an unfavourable prognostic factor this study retrospectively collected the clinical and laboratory data of patient with castleman disease cd from a single medical centre clinical classification identified patient with unicentric castleman disease and with multicentric castleman disease pathological classification revealed case of hyaline vascular variant mixed cellular variant mix and plasmacytic variant clinical complication occurred in cd patient including case of paraneoplastic pemphigus pnp and case with renal complication haematological involvement pleural effusion andor ascites and poem syndrome polyneuropathy organomegaly endocrinopathy monoclonal gammopathy and skin change were also found univariate analysis showed that presence of clinical complication and pnp were both risk factor relating to cd patient survival prognostic factor showing p in univariate analysis and those with clinical significance were subjected to multivariate analysis using a cox regression model pnp presence and age over year both significantly adversely affected survival thus only presence of pnp wa identified a an independent unfavourable survival risk factor in both univariate and multivariate analysis overall the present data provide a panoramic description of cd case and emphasize that the presence of pnp is an adverse prognostic factor
25833810,activation of kit modulates the function of tumor necrosis factorrelated apoptosisinducing ligand receptor trailr in mast cell,background mastocytosis is characterized by the accumulation of mast cell mc associated with activating mutation of kit tumor necrosis factorrelated apoptosisinducing ligand receptor trailrs are preferentially expressed on neoplastic cell and induce the extrinsic apoptotic pathway recent study reported on the expression of trailrs and trailinduced apoptosis in cultured human mc which depend on stem cell factor scfinduced or constitutive kit activation material and method we sought to further define the impact of trailrs on mc in vivo and in vitro using creloxp recombination we generated mouse with mcspecific and ubiquitous knockout of trailr in these mouse anaphylaxis and number of mc were investigated we also explored the expression and function of trailrs in cultured murine and human mc upon activation of kit by conducting immunofluorescence staining we analyzed the expression of trailrs in mc infiltrating the bone marrow of patient with mastocytosis result mcspecific deletion of trailr wa associated with a slight but significant increase in anaphylaxis number of mc in mcspecific knockout of trailr were comparable to control whereas cultured ildependent murine mc from wildtype mouse were resistant to trailinduced apoptosis scfstimulated mc underwent apoptosis in response to trail interestingly activating kit mutation also promoted sensitivity to trailmediated apoptosis in human mc in line with these finding mc infiltrating the bone marrow of patient with mastocytosis expressed trailr conclusion activation of kit regulates the function of trailrs in mc trailr may represent an attractive diagnostic and therapeutic target in disease associated with kit mutation such a mastocytosis,Non-Cancer,1,activation of kit modulates the function of tumor necrosis factorrelated apoptosisinducing ligand receptor trailr in mast cell background mastocytosis is characterized by the accumulation of mast cell mc associated with activating mutation of kit tumor necrosis factorrelated apoptosisinducing ligand receptor trailrs are preferentially expressed on neoplastic cell and induce the extrinsic apoptotic pathway recent study reported on the expression of trailrs and trailinduced apoptosis in cultured human mc which depend on stem cell factor scfinduced or constitutive kit activation material and method we sought to further define the impact of trailrs on mc in vivo and in vitro using creloxp recombination we generated mouse with mcspecific and ubiquitous knockout of trailr in these mouse anaphylaxis and number of mc were investigated we also explored the expression and function of trailrs in cultured murine and human mc upon activation of kit by conducting immunofluorescence staining we analyzed the expression of trailrs in mc infiltrating the bone marrow of patient with mastocytosis result mcspecific deletion of trailr wa associated with a slight but significant increase in anaphylaxis number of mc in mcspecific knockout of trailr were comparable to control whereas cultured ildependent murine mc from wildtype mouse were resistant to trailinduced apoptosis scfstimulated mc underwent apoptosis in response to trail interestingly activating kit mutation also promoted sensitivity to trailmediated apoptosis in human mc in line with these finding mc infiltrating the bone marrow of patient with mastocytosis expressed trailr conclusion activation of kit regulates the function of trailrs in mc trailr may represent an attractive diagnostic and therapeutic target in disease associated with kit mutation such a mastocytosis
25837692,the clinical and laboratory evaluation of the patient with erythrocytosis,erythrocytosis is frequently encountered a an incidental abnormality on laboratory testing that reveals persistent elevation of the hematocrit level in men and in woman in many case erythrocytosis is the manifestation of an underlying cardiopulmonary process druginduced due to androgen or secondary to smoking rather than a primary bone marrow disorder such a polycythemia vera a systematic approach to the clinical and laboratory evaluation of each patient is indicated to consider diverse differential diagnosis possibility and to identify the underlying etiology of erythrocytosis in order to formulate appropriate subspecialist referral and management plan a thorough medical history and meticulous physical examination supplemented by a focused initial laboratory evaluation will enable the general practitioner to ascertain the etiology of erythrocytosis in the majority of case patient with clinical and laboratory feature suggestive of polycythemia vera and those patient without an apparent underlying condition known to cause erythrocytosis benefit from early referral to a hematologist for further specialized diagnostic evaluation and therapy consideration,Non-Cancer,1,the clinical and laboratory evaluation of the patient with erythrocytosis erythrocytosis is frequently encountered a an incidental abnormality on laboratory testing that reveals persistent elevation of the hematocrit level in men and in woman in many case erythrocytosis is the manifestation of an underlying cardiopulmonary process druginduced due to androgen or secondary to smoking rather than a primary bone marrow disorder such a polycythemia vera a systematic approach to the clinical and laboratory evaluation of each patient is indicated to consider diverse differential diagnosis possibility and to identify the underlying etiology of erythrocytosis in order to formulate appropriate subspecialist referral and management plan a thorough medical history and meticulous physical examination supplemented by a focused initial laboratory evaluation will enable the general practitioner to ascertain the etiology of erythrocytosis in the majority of case patient with clinical and laboratory feature suggestive of polycythemia vera and those patient without an apparent underlying condition known to cause erythrocytosis benefit from early referral to a hematologist for further specialized diagnostic evaluation and therapy consideration
25853332,apol toxin innate immunity and kidney injury,the discovery that two common apol allele were strongly associated with nondiabetic kidney disease in african descent population led to hope for improved diagnosis and treatment unfortunately we still do not have a clear understanding of the biological function played by apol in podocytes or other kidney cell nor how the renal risk allele initiate the development of nephropathy important clue for apol function may be gleaned from the natural defense mechanism of apol against trypanosome infection and from similar protein eg diphtheria toxin mammalian bcl family member this review provides an update on the biological function for circulating trypanosome resistance and intracellular emerging role for autophagy apol further we introduce a multimer model for apol in kidney cell that reconciles the gainoffunction variant with the recessive inheritance pattern of apol renal risk allele,Non-Cancer,1,apol toxin innate immunity and kidney injury the discovery that two common apol allele were strongly associated with nondiabetic kidney disease in african descent population led to hope for improved diagnosis and treatment unfortunately we still do not have a clear understanding of the biological function played by apol in podocytes or other kidney cell nor how the renal risk allele initiate the development of nephropathy important clue for apol function may be gleaned from the natural defense mechanism of apol against trypanosome infection and from similar protein eg diphtheria toxin mammalian bcl family member this review provides an update on the biological function for circulating trypanosome resistance and intracellular emerging role for autophagy apol further we introduce a multimer model for apol in kidney cell that reconciles the gainoffunction variant with the recessive inheritance pattern of apol renal risk allele
25858055,anaphylaxis after hymenoptera sting is it venom allergy a clonal disorder or both,a yearold man presented with loss of consciousness minute after being stung by a yellow jacket in his backyard epinephrine and fluid were required for resuscitation allergy evaluation revealed specific ige to yellow jacket and honeybee and the patient wa started on venom immunotherapy he had systemic reaction during buildup and a severe anaphylactic episode requiring dos of intramuscular epinephrine at maintenance dos immunotherapy wa discontinued serum tryptase level after such episode wa ngml with a baseline level of ngml week later the physical examination wa unremarkable including no skin lesion of cutaneous mastocytosis because of elevated baseline tryptase level a bone marrow biopsy wa performed which revealed multifocal dense infiltrates of mast cell a diagnosis of systemic mastocytosis wa made the patient wa treated with omalizumab and wa able to tolerate immunotherapy and is currently maintained on lifelong immunotherapy he wa restung in the field and ha not had anaphylaxis,Non-Cancer,1,anaphylaxis after hymenoptera sting is it venom allergy a clonal disorder or both a yearold man presented with loss of consciousness minute after being stung by a yellow jacket in his backyard epinephrine and fluid were required for resuscitation allergy evaluation revealed specific ige to yellow jacket and honeybee and the patient wa started on venom immunotherapy he had systemic reaction during buildup and a severe anaphylactic episode requiring dos of intramuscular epinephrine at maintenance dos immunotherapy wa discontinued serum tryptase level after such episode wa ngml with a baseline level of ngml week later the physical examination wa unremarkable including no skin lesion of cutaneous mastocytosis because of elevated baseline tryptase level a bone marrow biopsy wa performed which revealed multifocal dense infiltrates of mast cell a diagnosis of systemic mastocytosis wa made the patient wa treated with omalizumab and wa able to tolerate immunotherapy and is currently maintained on lifelong immunotherapy he wa restung in the field and ha not had anaphylaxis
25862606,simultaneous assessment of nfkappabp phosphorylation and nuclear localization using imaging flow cytometry,aberrant activity of nuclear factorkappab nfkappab is associated with many disease and is therapeutically targeted posttranslational modification particularly phosphorylation of the relap subunit are essential for cytoplasmic to nuclear localization of nfkappabp and initiation of transcription of downstream target gene immunoblot and phosphoflow cytometry have been used to study the relationship between phosphorylation motif and nfkappab activation and microscopic analysis of nuclear localization of p is also used a a parameter for activation the labor intensive nature of these approach commonly limit the number of sampling point or replicates recent insight into the relationship between p phosphorylation motif and their nuclear localization indicate that these parameter have different significance and should not be used interchangeably in this study we demonstrate feasibility and reproducibility of studying the relationship between p phosphorylation and nuclear translocation using imaging flow cytometry ifc tnfalpha or pmaionomycininduced phosphorylation of p at serine in cell line model and healthy donor lymphocyte served a the experimental model ifc analysis demonstrated that expression of phosphorylated serine pps increased rapidly following stimulation and that nuclear localization of pps followed the nuclear localization pattern of total p however in the presence of tacrolimus pps expression wa inhibited without affecting nuclear localization of total p the data demonstrate the application of ifc to simultaneously assess phosphorylation of p and it cellular localization and the result obtained by this analysis corroborate current insight regarding the specific effect of tacrolimus on serine phosphorylation,Non-Cancer,1,simultaneous assessment of nfkappabp phosphorylation and nuclear localization using imaging flow cytometry aberrant activity of nuclear factorkappab nfkappab is associated with many disease and is therapeutically targeted posttranslational modification particularly phosphorylation of the relap subunit are essential for cytoplasmic to nuclear localization of nfkappabp and initiation of transcription of downstream target gene immunoblot and phosphoflow cytometry have been used to study the relationship between phosphorylation motif and nfkappab activation and microscopic analysis of nuclear localization of p is also used a a parameter for activation the labor intensive nature of these approach commonly limit the number of sampling point or replicates recent insight into the relationship between p phosphorylation motif and their nuclear localization indicate that these parameter have different significance and should not be used interchangeably in this study we demonstrate feasibility and reproducibility of studying the relationship between p phosphorylation and nuclear translocation using imaging flow cytometry ifc tnfalpha or pmaionomycininduced phosphorylation of p at serine in cell line model and healthy donor lymphocyte served a the experimental model ifc analysis demonstrated that expression of phosphorylated serine pps increased rapidly following stimulation and that nuclear localization of pps followed the nuclear localization pattern of total p however in the presence of tacrolimus pps expression wa inhibited without affecting nuclear localization of total p the data demonstrate the application of ifc to simultaneously assess phosphorylation of p and it cellular localization and the result obtained by this analysis corroborate current insight regarding the specific effect of tacrolimus on serine phosphorylation
25899109,anaphylaxis with clonal mast cell in normal looking skin a new entity,background patient with elevated basal tryptase sbt mugl and anaphylaxis may have an underlying mastocytosis a monoclonal mast cell activation syndrome with aberrant mast cell mc at extracutaneous site ha been described in patient with severe hypotension or anaphylaxis method a mc in patient with elevated sbt might be altered in the skin a well we studied mc in normal neck skin in anaphylaxis and urticaria patient with elevated sbt result a mean of sd mcmm wa counted in normal neck skin in patient with anaphylaxis sd in seven patient with urticaria sd in two patient with eczema sd in five patient with systemic mastocytosis sm in comparison with autopsy skin mcmm sd in five of of the anaphylaxis and three of five sm patient more than of mc were spindle shaped and expressed cd antigen conclusion we could show for the first time that the normal skin can harbour clonal mc in anaphylaxis patient analogous to the criterion for mastocytosis we suggest a skin score criterion including an elevated number of mc spindle shape cd expression ckit mutation and sbt value mugl in patient with anaphylaxis and elevated sbt skin should be biopsied and a with the approach for mastocytosis diagnosis in the bone marrow mc should be analysed for their number clonality and ckit mutation this approach should be confirmed in further study patient with aberrant skin mc should be handled a mastocytosis patient,Non-Cancer,1,anaphylaxis with clonal mast cell in normal looking skin a new entity background patient with elevated basal tryptase sbt mugl and anaphylaxis may have an underlying mastocytosis a monoclonal mast cell activation syndrome with aberrant mast cell mc at extracutaneous site ha been described in patient with severe hypotension or anaphylaxis method a mc in patient with elevated sbt might be altered in the skin a well we studied mc in normal neck skin in anaphylaxis and urticaria patient with elevated sbt result a mean of sd mcmm wa counted in normal neck skin in patient with anaphylaxis sd in seven patient with urticaria sd in two patient with eczema sd in five patient with systemic mastocytosis sm in comparison with autopsy skin mcmm sd in five of of the anaphylaxis and three of five sm patient more than of mc were spindle shaped and expressed cd antigen conclusion we could show for the first time that the normal skin can harbour clonal mc in anaphylaxis patient analogous to the criterion for mastocytosis we suggest a skin score criterion including an elevated number of mc spindle shape cd expression ckit mutation and sbt value mugl in patient with anaphylaxis and elevated sbt skin should be biopsied and a with the approach for mastocytosis diagnosis in the bone marrow mc should be analysed for their number clonality and ckit mutation this approach should be confirmed in further study patient with aberrant skin mc should be handled a mastocytosis patient
25911850,analysis of oxidative stress status through mn test and serum mda level in pcos woman,polycystic ovary syndrome pcos is a multifactorial reproductive healthcare problem affecting of woman and a leading cause of female infertility worldwide the potential genetic contributor of pcos are unclear however over the past decade emerging evidence ha shown that increased oxidative stress o and decreased antioxidant status were often linked with pcos the present casecontrol study wa aimed to assess the reactive oxygen specie induced o in woman from south india a total of individual comprising of patient and control were enrolled in the present study for all the subject the frequency of micronucleated cell mnc in epithelial sample and serum malondialdehyde mda level were estimated to assess genomic instability and cytotoxicity respectively a statistically significant difference between the group were identified with respect to body mass index waist to hip ratio luteinizing hormone and prolactin level however the mean follicle stimulating hormone wa not different between the group p the frequency of mn cell v and mean serum mda v level were considerably higher in patient than control p furthermore a positive correlation wa observed between mnc and mda level in patient r p and not in control r p suggest high o in pcos woman therefore mn assay and serum mda level may serve together or individually a biomarkers of o in pcos woman,Non-Cancer,1,analysis of oxidative stress status through mn test and serum mda level in pcos woman polycystic ovary syndrome pcos is a multifactorial reproductive healthcare problem affecting of woman and a leading cause of female infertility worldwide the potential genetic contributor of pcos are unclear however over the past decade emerging evidence ha shown that increased oxidative stress o and decreased antioxidant status were often linked with pcos the present casecontrol study wa aimed to assess the reactive oxygen specie induced o in woman from south india a total of individual comprising of patient and control were enrolled in the present study for all the subject the frequency of micronucleated cell mnc in epithelial sample and serum malondialdehyde mda level were estimated to assess genomic instability and cytotoxicity respectively a statistically significant difference between the group were identified with respect to body mass index waist to hip ratio luteinizing hormone and prolactin level however the mean follicle stimulating hormone wa not different between the group p the frequency of mn cell v and mean serum mda v level were considerably higher in patient than control p furthermore a positive correlation wa observed between mnc and mda level in patient r p and not in control r p suggest high o in pcos woman therefore mn assay and serum mda level may serve together or individually a biomarkers of o in pcos woman
25923088,porphobilinogen deaminase gene mutation in polish patient with nonerythroid acute intermittent porphyria,background acute intermittent porphyria aip is an metabolic disorder characterized by a partial deficiency of the porphobilinogen deaminase the enzyme of heme biosynthesis the metabolic defect in aip involves an approximately halfnormal activity of porphobilinogen deaminase pbgd ec the enzyme catalyzing condensation of four porphobilinogen molecule to hydroxymethylbilane due to tissuespecific alternative transcript splicing the pbgd gene mutation within the range of exon may lead to classical aip involving erythrocyte and all the other tissue mutation within intron and exon may result in the socalled nonerythroid aip in which the pbgd activity is normal in erythrocyte and diminished in other tissue objective the aim of the present study wa to characterise molecular error in the pbgd gene in polish patient with nonerythroid aip and to evaluate the efficacy of the dna sequencing method in the early diagnosis of this disorder material and method twenty five member of nine nonerythroid aip family were assessed in each of them dna sequencing wa performed using the big dye terminator cycle sequencing kit v on the hitachi analyzer applied biosystem usa result four mutation were detected in intron of the pbgd gene including one unreported novel mutation del agtgctgag of an unknown biological mechanism and three previously described mutation ie g a t c g c responsible for abnormal transcript splicing in the area of exon of asymptomatic member of proband family in subject were diagnosed with aip and in the aip wa excluded based on the dna sequencing method conclusion dna sequencing based analysis is the only reliable method for correct diagnosis of asymptomatic nonerythroid aip patient with normal urinary excretion of heme precursor the mutation found in polish patient with nonerythroid aip represented those of splice defect and resulted in abnormal exon splicing,Non-Cancer,1,porphobilinogen deaminase gene mutation in polish patient with nonerythroid acute intermittent porphyria background acute intermittent porphyria aip is an metabolic disorder characterized by a partial deficiency of the porphobilinogen deaminase the enzyme of heme biosynthesis the metabolic defect in aip involves an approximately halfnormal activity of porphobilinogen deaminase pbgd ec the enzyme catalyzing condensation of four porphobilinogen molecule to hydroxymethylbilane due to tissuespecific alternative transcript splicing the pbgd gene mutation within the range of exon may lead to classical aip involving erythrocyte and all the other tissue mutation within intron and exon may result in the socalled nonerythroid aip in which the pbgd activity is normal in erythrocyte and diminished in other tissue objective the aim of the present study wa to characterise molecular error in the pbgd gene in polish patient with nonerythroid aip and to evaluate the efficacy of the dna sequencing method in the early diagnosis of this disorder material and method twenty five member of nine nonerythroid aip family were assessed in each of them dna sequencing wa performed using the big dye terminator cycle sequencing kit v on the hitachi analyzer applied biosystem usa result four mutation were detected in intron of the pbgd gene including one unreported novel mutation del agtgctgag of an unknown biological mechanism and three previously described mutation ie g a t c g c responsible for abnormal transcript splicing in the area of exon of asymptomatic member of proband family in subject were diagnosed with aip and in the aip wa excluded based on the dna sequencing method conclusion dna sequencing based analysis is the only reliable method for correct diagnosis of asymptomatic nonerythroid aip patient with normal urinary excretion of heme precursor the mutation found in polish patient with nonerythroid aip represented those of splice defect and resulted in abnormal exon splicing
25924711,high genetic risk individual benefit less from resistance exercise intervention,objective genetic factor have an important role in body mass index bmi variation and also likely have a role in the weight loss and body composition response to physical activityexercise with the recent identification of bmiassociated genetic variant it is possible to investigate the interaction of these genetic factor with exercise on body composition outcome method in a blockrandomized clinical trial of resistance exercise among woman n we examined whether the putative effect of exercise on weight and dualenergy xray absorptiometryderived body composition measurement differs according to genetic risk for obesity approximately onehalf of the sample wa randomized to an intervention consisting of a supervised intensive resistance exercise program lasting year genetic risk for obesity wa defined a a genetic risk score grs comprised of singlenucleotide polymorphism snp known to be associated with bmi variation we examined the interaction of exercise intervention and the grs on anthropometric and body composition measurement after year of the exercise intervention result we found statistically significant interaction for body weight p body fat p body fat p and abdominal fat p whereby the putative effect of exercise is greater among those with a lower level of genetic risk for obesity no single snp appears to be a major driver of these interaction conclusion the weightloss response to resistance exercise including change in body composition differs according to an individual genetic risk for obesity,Non-Cancer,1,high genetic risk individual benefit less from resistance exercise intervention objective genetic factor have an important role in body mass index bmi variation and also likely have a role in the weight loss and body composition response to physical activityexercise with the recent identification of bmiassociated genetic variant it is possible to investigate the interaction of these genetic factor with exercise on body composition outcome method in a blockrandomized clinical trial of resistance exercise among woman n we examined whether the putative effect of exercise on weight and dualenergy xray absorptiometryderived body composition measurement differs according to genetic risk for obesity approximately onehalf of the sample wa randomized to an intervention consisting of a supervised intensive resistance exercise program lasting year genetic risk for obesity wa defined a a genetic risk score grs comprised of singlenucleotide polymorphism snp known to be associated with bmi variation we examined the interaction of exercise intervention and the grs on anthropometric and body composition measurement after year of the exercise intervention result we found statistically significant interaction for body weight p body fat p body fat p and abdominal fat p whereby the putative effect of exercise is greater among those with a lower level of genetic risk for obesity no single snp appears to be a major driver of these interaction conclusion the weightloss response to resistance exercise including change in body composition differs according to an individual genetic risk for obesity
25934766,analysis of phenotype and outcome in essential thrombocythemia with calr or jak mutation,the jak vf mutation the thrombopoietin receptor mpl wkl mutation and calreticulin calr mutation are mutually exclusive in essential thrombocythemia and support a novel molecular categorization of essential thrombocythemia calr mutation account for approximately of case of essential thrombocythemia in a retrospective study we examined the frequency of mpl and calr mutation in jak vfnegative case of essential thrombocythemia n in addition we compared the clinical phenotype and outcome of calr mutant case of essential thrombocythemia with a cohort of jak vfpositive essential thrombocythemia n calrpositive case represented of doublenegative case of essential thrombocythemia and most carried calr type or type indels however we also identified one patient who wa positive for both the jak vf and the calr mutation this study revealed that calr mutant essential thrombocythemia is associated with younger age higher platelet count lower erythrocyte count leukocyte count hemoglobin and hematocrit and increased risk of progression to myelofibrosis in comparison with jak vfpositive essential thrombocythemia analysis of the calr mutant group according to indel type showed that calr type deletion is strongly associated with male gender calr mutant patient had a better overall survival than jak vfpositive patient in particular patient of age year or younger in conclusion this study in a belgian cohort of patient support and extends the growing body of evidence that calr mutant case of essential thrombocythemia are phenotypically distinct from jak vfpositive case with regard to clinical and hematologic presentation a well a overall survival,Non-Cancer,1,analysis of phenotype and outcome in essential thrombocythemia with calr or jak mutation the jak vf mutation the thrombopoietin receptor mpl wkl mutation and calreticulin calr mutation are mutually exclusive in essential thrombocythemia and support a novel molecular categorization of essential thrombocythemia calr mutation account for approximately of case of essential thrombocythemia in a retrospective study we examined the frequency of mpl and calr mutation in jak vfnegative case of essential thrombocythemia n in addition we compared the clinical phenotype and outcome of calr mutant case of essential thrombocythemia with a cohort of jak vfpositive essential thrombocythemia n calrpositive case represented of doublenegative case of essential thrombocythemia and most carried calr type or type indels however we also identified one patient who wa positive for both the jak vf and the calr mutation this study revealed that calr mutant essential thrombocythemia is associated with younger age higher platelet count lower erythrocyte count leukocyte count hemoglobin and hematocrit and increased risk of progression to myelofibrosis in comparison with jak vfpositive essential thrombocythemia analysis of the calr mutant group according to indel type showed that calr type deletion is strongly associated with male gender calr mutant patient had a better overall survival than jak vfpositive patient in particular patient of age year or younger in conclusion this study in a belgian cohort of patient support and extends the growing body of evidence that calr mutant case of essential thrombocythemia are phenotypically distinct from jak vfpositive case with regard to clinical and hematologic presentation a well a overall survival
25936905,evaluation of posterior hippocampal epileptogenicity during epilepsy surgery for temporal lobe cavernoma by the occipital approach,background cavernomas frequently are associated with intractable epilepsy when cavernomas located in the temporal lobe are associated with intractable epilepsy the hippocampus also may have an epileptic focus the objective in the present study wa to clarify the importance of evaluation of the posterior hippocampal epileptogenicity during epilepsy surgery for posteromedial temporal lobe cavernoma case description in this study we describe rare case of medically intractable epilepsy in patient with posteromedial temporal lobe cavernomas who underwent surgery via the occipital approach using longitudinal insertion of depth electrode into the hippocampus we evaluated epileptogenicity in both patient from the cavernoma cavity and it surrounding hemosiderin a well a from the posterior hippocampus near the cavernoma we show that the transoccipital approach to the posteromedial temporal lobe is compatible with depth electrode insertion and subdural electrode placement on the temporal lobe enabling an accurate evaluation of potential epileptogenic zone in the posterior part of the hippocampus both patient did not experience any seizure and had no postoperative neurologic deficit and their cognitive function were intact conclusion the transoccipital approach enables the optimization of the extent of posterior hippocampectomy while avoiding unnecessary resection for seizure control we suggest resecting the posterior part of the hippocampus in addition to the cavernoma and surrounding area in patient with medically refractory epilepsy due to a posteromedial temporal cavernoma tailored systematic resection guided by intraoperative electrocorticography and electroencephalography with a depth electrode wa important and necessary in the present case,Non-Cancer,1,evaluation of posterior hippocampal epileptogenicity during epilepsy surgery for temporal lobe cavernoma by the occipital approach background cavernomas frequently are associated with intractable epilepsy when cavernomas located in the temporal lobe are associated with intractable epilepsy the hippocampus also may have an epileptic focus the objective in the present study wa to clarify the importance of evaluation of the posterior hippocampal epileptogenicity during epilepsy surgery for posteromedial temporal lobe cavernoma case description in this study we describe rare case of medically intractable epilepsy in patient with posteromedial temporal lobe cavernomas who underwent surgery via the occipital approach using longitudinal insertion of depth electrode into the hippocampus we evaluated epileptogenicity in both patient from the cavernoma cavity and it surrounding hemosiderin a well a from the posterior hippocampus near the cavernoma we show that the transoccipital approach to the posteromedial temporal lobe is compatible with depth electrode insertion and subdural electrode placement on the temporal lobe enabling an accurate evaluation of potential epileptogenic zone in the posterior part of the hippocampus both patient did not experience any seizure and had no postoperative neurologic deficit and their cognitive function were intact conclusion the transoccipital approach enables the optimization of the extent of posterior hippocampectomy while avoiding unnecessary resection for seizure control we suggest resecting the posterior part of the hippocampus in addition to the cavernoma and surrounding area in patient with medically refractory epilepsy due to a posteromedial temporal cavernoma tailored systematic resection guided by intraoperative electrocorticography and electroencephalography with a depth electrode wa important and necessary in the present case
25963654,spindle checkpoint factor bub and bub promote dna doublestrand break repair by nonhomologous end joining,the nonhomologous endjoining nhej pathway is essential for the preservation of genome integrity a it efficiently repair dna doublestrand break dsbs previous biochemical and genetic investigation have indicated that despite the importance of this pathway the entire complement of gene regulating nhej remains unknown to address this we employed a plasmidbased nhej dna repair screen in budding yeast saccharomyces cerevisiae using putative nonessential dna repairrelated component a query among the newly identified gene associated with nhej deficiency upon disruption are two spindle assembly checkpoint kinase bub and bub both observation of resulting phenotype and chromatin immunoprecipitation demonstrated that bub and either alone or in combination with cell cycle regulator are recruited near the dsb where phosphorylated rad or ha accumulates largescale proteomic analysis of bub kinase phosphorylated in response to dna damage identified previously unknown kinase substrate on tel stq site moreover bub nhej function appears to be conserved in mammalian cell bp which influence dsb repair by nhej colocalizes with human bub and is recruited to the break site thus while bub is not a core component of nhej machinery our data support it dual role in mitotic exit and promotion of nhej repair in yeast and mammal,Non-Cancer,1,spindle checkpoint factor bub and bub promote dna doublestrand break repair by nonhomologous end joining the nonhomologous endjoining nhej pathway is essential for the preservation of genome integrity a it efficiently repair dna doublestrand break dsbs previous biochemical and genetic investigation have indicated that despite the importance of this pathway the entire complement of gene regulating nhej remains unknown to address this we employed a plasmidbased nhej dna repair screen in budding yeast saccharomyces cerevisiae using putative nonessential dna repairrelated component a query among the newly identified gene associated with nhej deficiency upon disruption are two spindle assembly checkpoint kinase bub and bub both observation of resulting phenotype and chromatin immunoprecipitation demonstrated that bub and either alone or in combination with cell cycle regulator are recruited near the dsb where phosphorylated rad or ha accumulates largescale proteomic analysis of bub kinase phosphorylated in response to dna damage identified previously unknown kinase substrate on tel stq site moreover bub nhej function appears to be conserved in mammalian cell bp which influence dsb repair by nhej colocalizes with human bub and is recruited to the break site thus while bub is not a core component of nhej machinery our data support it dual role in mitotic exit and promotion of nhej repair in yeast and mammal
26001169,impaired function of bone marrow stromal cell in systemic mastocytosis,patient with systemic mastocytosis sm have a wide variety of problem including skeletal abnormality the disease result from a mutation of the stem cell receptor ckit in mast cell and we wondered if the function of bone marrow stromal cell bmscs also known a msc or mesenchymal stem cell might be affected by the invasion of bone marrow by mutant mast cell a expected bmscs from sm patient do not have a mutation in ckit but they proliferate poorly in addition while osteogenic differentiation of the bmscs seems to be deficient their adipogenic potential appears to be increased since the hematopoietic supportive ability of bmscs are also important we also studied the engraftment in nsg mouse of human cd hematopoietic progenitor after being cocultured with bmscs of healthy volunteer v bmscs derived from patient with sm bmscs derived from the bone marrow of patient with sm could not support hematopoiesis to the extent that healthy bmscs do finally we performed an expression analysis and found significant difference between healthy and sm derived bmscs in the expression of gene with a variety of function including the wnt signaling ossification and bone remodeling we suggest that some of the symptom associated with sm might be driven by epigenetic change in bmscs caused by dysfunctional mast cell in the bone marrow of the patient,Non-Cancer,1,impaired function of bone marrow stromal cell in systemic mastocytosis patient with systemic mastocytosis sm have a wide variety of problem including skeletal abnormality the disease result from a mutation of the stem cell receptor ckit in mast cell and we wondered if the function of bone marrow stromal cell bmscs also known a msc or mesenchymal stem cell might be affected by the invasion of bone marrow by mutant mast cell a expected bmscs from sm patient do not have a mutation in ckit but they proliferate poorly in addition while osteogenic differentiation of the bmscs seems to be deficient their adipogenic potential appears to be increased since the hematopoietic supportive ability of bmscs are also important we also studied the engraftment in nsg mouse of human cd hematopoietic progenitor after being cocultured with bmscs of healthy volunteer v bmscs derived from patient with sm bmscs derived from the bone marrow of patient with sm could not support hematopoiesis to the extent that healthy bmscs do finally we performed an expression analysis and found significant difference between healthy and sm derived bmscs in the expression of gene with a variety of function including the wnt signaling ossification and bone remodeling we suggest that some of the symptom associated with sm might be driven by epigenetic change in bmscs caused by dysfunctional mast cell in the bone marrow of the patient
26008683,costotransverse screw fixation in a severe cervicothoracic deformity because of a type neurofibromatosis case report,background context spinal implant placement may be challenging in case of severe cervicothoracic spinal deformity and anatomical anomaly a in type neurofibromatosis intralaminar screwing of the thoracic spine ha been described in few case in which pedicle were hypoplasic the costovertebral joint have never been used before a an anchorage point for screw purpose the purpose of the study wa to describe a new thoracic fixation technique to be used in severe deformity whenever the posterior arch lamina and pedicle is not available because of anatomic abnormality study design this is a case report method an yearold woman with progressive tetraparesis caused by increasing deformity of cervicothoracic spine underwent evaluation and surgical treatment procedure and technique were described the clinical feature the radiological finding and the outcome were assessed complication and local recurrence were also recorded result costotransverse joint screwing wa successfully used in one case of severe cervicothoracic spine deformity with major hypoplasia of the pedicle the posterior arch of one thoracic vertebra became mobile soon after periosteal stripping probably because of iatrogenic fracture of the only existent pedicle the fourcortical trajectory of the screw resulted in a good bone purchase allowing the surgeon to complete the procedure no local or general complication were recorded during year of followup conclusion the procedure wa used a a salvage technique during a difficult surgery where a local complication forced a change of strategy although the implant remained stable long enough to achieve fusion it still consists of placing a screw through a joint that remains slightly mobile this could possibly result in a screw loosening in the long period if fusion is not achieved we suggest the use of this technique when all the other option have been explored and excluded for anatomical reason,Non-Cancer,1,costotransverse screw fixation in a severe cervicothoracic deformity because of a type neurofibromatosis case report background context spinal implant placement may be challenging in case of severe cervicothoracic spinal deformity and anatomical anomaly a in type neurofibromatosis intralaminar screwing of the thoracic spine ha been described in few case in which pedicle were hypoplasic the costovertebral joint have never been used before a an anchorage point for screw purpose the purpose of the study wa to describe a new thoracic fixation technique to be used in severe deformity whenever the posterior arch lamina and pedicle is not available because of anatomic abnormality study design this is a case report method an yearold woman with progressive tetraparesis caused by increasing deformity of cervicothoracic spine underwent evaluation and surgical treatment procedure and technique were described the clinical feature the radiological finding and the outcome were assessed complication and local recurrence were also recorded result costotransverse joint screwing wa successfully used in one case of severe cervicothoracic spine deformity with major hypoplasia of the pedicle the posterior arch of one thoracic vertebra became mobile soon after periosteal stripping probably because of iatrogenic fracture of the only existent pedicle the fourcortical trajectory of the screw resulted in a good bone purchase allowing the surgeon to complete the procedure no local or general complication were recorded during year of followup conclusion the procedure wa used a a salvage technique during a difficult surgery where a local complication forced a change of strategy although the implant remained stable long enough to achieve fusion it still consists of placing a screw through a joint that remains slightly mobile this could possibly result in a screw loosening in the long period if fusion is not achieved we suggest the use of this technique when all the other option have been explored and excluded for anatomical reason
26011312,expression analysis of microrna in patient with polycythemia vera and essential thrombocythemia and correlation with jak allele burden and laboratory finding,introduction the jakvf mutation ha emerged in recent year a a diagnostic a well a a treatment target in patient with polycythemia vera pv and essential thrombocythemia et the disease phenotype is also influenced by other factor such a microrna mirna deregulation the aim of this study wa to investigate mir expression level in these patient with those obtained from healthy control subject and it correlation with jak allele burden and laboratory finding method in total forty patient with a clinical diagnosis of pv and et were examined at the time of diagnosis ten healthy subject were checked a control we performed jak vf allele burden measurement and expression analysis of mirbp mirbp mirap and mirap in leukocyte isolated from peripheral blood by quantitative realtime polymerase chain reaction result mirbp and mirap were upregulated in both patient with pv p and p respectively and et p and p respectively in pv group a significant correlation wa observed between mirap and platelet count p r the correlation between mirna and jak allele burden wa not significant conclusion in conclusion our data indicate that other factor such a aberrant mir expression may influence on the disease phenotype in patient with pv and et,Non-Cancer,1,expression analysis of microrna in patient with polycythemia vera and essential thrombocythemia and correlation with jak allele burden and laboratory finding introduction the jakvf mutation ha emerged in recent year a a diagnostic a well a a treatment target in patient with polycythemia vera pv and essential thrombocythemia et the disease phenotype is also influenced by other factor such a microrna mirna deregulation the aim of this study wa to investigate mir expression level in these patient with those obtained from healthy control subject and it correlation with jak allele burden and laboratory finding method in total forty patient with a clinical diagnosis of pv and et were examined at the time of diagnosis ten healthy subject were checked a control we performed jak vf allele burden measurement and expression analysis of mirbp mirbp mirap and mirap in leukocyte isolated from peripheral blood by quantitative realtime polymerase chain reaction result mirbp and mirap were upregulated in both patient with pv p and p respectively and et p and p respectively in pv group a significant correlation wa observed between mirap and platelet count p r the correlation between mirna and jak allele burden wa not significant conclusion in conclusion our data indicate that other factor such a aberrant mir expression may influence on the disease phenotype in patient with pv and et
26020630,pseudomonas aeruginosa exot induces atypical anoikis apoptosis in target host cell by transforming crk adaptor protein into a cytotoxin,previously we demonstrated that pseudomonas aeruginosa exot induces potent apoptosis in host epithelial cell in a manner that primarily depends on it adpribosyltransferase domain adprt activity however the mechanism underlying exotadprtinduced apoptosis remains undetermined we now report that exotadprt disrupts focal adhesion site activates pbeta and jnk and interferes with integrinmediated survival signaling causing atypical anoikis we show that exotadprtinduced anoikis is mediated by the crk adaptor protein we found that crk knockout cell are significantly more resistant to exotinduced apoptosis while crk cell complemented with crk are rendered sensitive to exotinduced apoptosis moreover a dominant negative dn mutant form of crk phenocopies exotinduced apoptosis both kinetically and mechanistically crk is generally believed to be a component of focal adhesion fa and it role in cellular survival remains controversial in that it ha been found to be either prosurvival or proapoptosis our data demonstrate that although crk is recruited to fa site it function is likely not required for fa assembly or for survival per se however when modified by exot or by mutagenesis it can be transformed into a cytotoxin that induces anoikis by disrupting fa site and interfering with integrin survival signaling to our knowledge this is the first example whereby a bacterial toxin exerts it cytotoxicity by subverting the function of an innocuous host cellular protein and turning it against the host cell,Non-Cancer,1,pseudomonas aeruginosa exot induces atypical anoikis apoptosis in target host cell by transforming crk adaptor protein into a cytotoxin previously we demonstrated that pseudomonas aeruginosa exot induces potent apoptosis in host epithelial cell in a manner that primarily depends on it adpribosyltransferase domain adprt activity however the mechanism underlying exotadprtinduced apoptosis remains undetermined we now report that exotadprt disrupts focal adhesion site activates pbeta and jnk and interferes with integrinmediated survival signaling causing atypical anoikis we show that exotadprtinduced anoikis is mediated by the crk adaptor protein we found that crk knockout cell are significantly more resistant to exotinduced apoptosis while crk cell complemented with crk are rendered sensitive to exotinduced apoptosis moreover a dominant negative dn mutant form of crk phenocopies exotinduced apoptosis both kinetically and mechanistically crk is generally believed to be a component of focal adhesion fa and it role in cellular survival remains controversial in that it ha been found to be either prosurvival or proapoptosis our data demonstrate that although crk is recruited to fa site it function is likely not required for fa assembly or for survival per se however when modified by exot or by mutagenesis it can be transformed into a cytotoxin that induces anoikis by disrupting fa site and interfering with integrin survival signaling to our knowledge this is the first example whereby a bacterial toxin exerts it cytotoxicity by subverting the function of an innocuous host cellular protein and turning it against the host cell
26022167,tuberous sclerosis complex,tuberous sclerosis complex is an autosomaldominant neurocutaneous multisystem disorder characterized by cellular hyperplasia and tissue dysplasia the genetic cause is mutation in the tsc gene found on chromosome q and tsc gene found on chromosome p the clinical phenotype resulting from mutation in either of the gene are variable in each individual herein advance in the understanding of molecular mechanism in tuberous sclerosis complex are reviewed and current guideline for diagnosis treatment followup and management are summarized,Non-Cancer,1,tuberous sclerosis complex tuberous sclerosis complex is an autosomaldominant neurocutaneous multisystem disorder characterized by cellular hyperplasia and tissue dysplasia the genetic cause is mutation in the tsc gene found on chromosome q and tsc gene found on chromosome p the clinical phenotype resulting from mutation in either of the gene are variable in each individual herein advance in the understanding of molecular mechanism in tuberous sclerosis complex are reviewed and current guideline for diagnosis treatment followup and management are summarized
26059211,anetoderma in a patient with terminal osseous dysplasia with pigmentary defect,terminal osseous dysplasia with pigmentary defect todpd is a rare xlinked syndrome classically characterized by distal limb anomaly pigmented skin defect of the face and recurrent digital fibroma xinactivation play a major role in determining the range of phenotypic expression thus patient can demonstrate a wide spectrum of disease severity making accurate diagnosis more challenging recent study have identified a flna cga mutation a the cause of todpd allowing for diagnostic genetic testing we present a case of molecularly confirmed todpd in a girl with the xxx chromosomal complement and deformity of the hand and foot craniofacial abnormality and discolored linear facial lesion skin biopsy of the patient facial lesion revealed absent papillary dermal elastic fiber consistent with anetoderma which contrast with the dermal hypoplasia described in the only other such facial biopsy reported in the literature the finding of absent elastic fiber in the skin lesion suggests that mutated filamin a in part exerts it effect through dysregulated elastin biology which may explain the nature of many connective tissue pleotropic effect in flnarelated disorder,Non-Cancer,1,anetoderma in a patient with terminal osseous dysplasia with pigmentary defect terminal osseous dysplasia with pigmentary defect todpd is a rare xlinked syndrome classically characterized by distal limb anomaly pigmented skin defect of the face and recurrent digital fibroma xinactivation play a major role in determining the range of phenotypic expression thus patient can demonstrate a wide spectrum of disease severity making accurate diagnosis more challenging recent study have identified a flna cga mutation a the cause of todpd allowing for diagnostic genetic testing we present a case of molecularly confirmed todpd in a girl with the xxx chromosomal complement and deformity of the hand and foot craniofacial abnormality and discolored linear facial lesion skin biopsy of the patient facial lesion revealed absent papillary dermal elastic fiber consistent with anetoderma which contrast with the dermal hypoplasia described in the only other such facial biopsy reported in the literature the finding of absent elastic fiber in the skin lesion suggests that mutated filamin a in part exerts it effect through dysregulated elastin biology which may explain the nature of many connective tissue pleotropic effect in flnarelated disorder
26067933,detection of the kit dv mutation in peripheral blood of systemic mastocytosis diagnostic implication,recent study have found the kit dv mutation in peripheral blood of virtually all adult systemic mastocytosis patient once highly sensitive pcr technique were used thus detection of the kit dv mutation in peripheral blood ha been proposed to be included in the diagnostic workup of systemic mastocytosis algorithm however the precise frequency of the mutation the biological significance of peripheral bloodmutated cell and their potential association with involvement of bone marrow hematopoietic cell other than mast cell still remain to be investigated here we determined the frequency of peripheral blood involvement by the kit dv mutation a assessed by two highly sensitive pcr method and investigated it relationship with multilineage involvement of bone marrow hematopoiesis overall our result confirmed the presence of the kit dv mutation in peripheral blood of most systemic mastocytosis case with an increasing frequency from indolent systemic mastocytosis without skin lesion to indolent systemic mastocytosis with skin involvement and more aggressive disease subtypes a assessed by the allelespecific oligonucleotideqpcr method which wa more sensitive p than the peptide nucleic acidmediated pcr approach although the presence of the kit mutation in peripheral blood a assessed by the allelespecific oligonucleotideqpcr technique did not accurately predict for multilineage bone marrow involvement of hematopoiesis the allelespecific oligonucleotideqpcr allele burden and the peptide nucleic acidmediatedpcr approach did these result suggest that both method provide clinically useful and complementary information through the identification andor quantification of the kit dv mutation in peripheral blood of patient suspected of systemic mastocytosis,Non-Cancer,1,detection of the kit dv mutation in peripheral blood of systemic mastocytosis diagnostic implication recent study have found the kit dv mutation in peripheral blood of virtually all adult systemic mastocytosis patient once highly sensitive pcr technique were used thus detection of the kit dv mutation in peripheral blood ha been proposed to be included in the diagnostic workup of systemic mastocytosis algorithm however the precise frequency of the mutation the biological significance of peripheral bloodmutated cell and their potential association with involvement of bone marrow hematopoietic cell other than mast cell still remain to be investigated here we determined the frequency of peripheral blood involvement by the kit dv mutation a assessed by two highly sensitive pcr method and investigated it relationship with multilineage involvement of bone marrow hematopoiesis overall our result confirmed the presence of the kit dv mutation in peripheral blood of most systemic mastocytosis case with an increasing frequency from indolent systemic mastocytosis without skin lesion to indolent systemic mastocytosis with skin involvement and more aggressive disease subtypes a assessed by the allelespecific oligonucleotideqpcr method which wa more sensitive p than the peptide nucleic acidmediated pcr approach although the presence of the kit mutation in peripheral blood a assessed by the allelespecific oligonucleotideqpcr technique did not accurately predict for multilineage bone marrow involvement of hematopoiesis the allelespecific oligonucleotideqpcr allele burden and the peptide nucleic acidmediatedpcr approach did these result suggest that both method provide clinically useful and complementary information through the identification andor quantification of the kit dv mutation in peripheral blood of patient suspected of systemic mastocytosis
26095439,urinary betapgfalpha and nmethyl histamine correlate with bone marrow biopsy finding in mast cell disorder,background the utility of measuring histamine and prostaglandin metabolite in the urine of patient with mastocytosis ha not been critically examined in a large series of patient this study examined the relationship between the extent of increase in urinary excretion of betaprostaglandinfalpha and nmethyl histamine with serum tryptase whole blood serotonin and bone marrow finding including morphology percentage involvement and abnormal mast cell phenotype method this wa a retrospective analysis of patient who were continuously enrolled in the study for a period of year we recorded serum tryptase whole blood serotonin level of urinary mast cell metabolite betaprostaglandinfalpha and nmethyl histamine nmh and bone marrow finding result urinary mast cell metabolite betaprostaglandinfalpha and nmethyl histamine correlated with level of serum tryptase mast cell burden in the bone marrow the presence of mast cell aggregate and atypical mast cell on bone marrow biopsy whole blood serotonin did not have a significant correlation with the serum tryptase or mast cell burden in the bone marrow urinary nmh wa significantly different between ckit dvpositive and ckit dvnegative patient while betaprostaglandinfalpha wa not urinary betaprostaglandinfalpha h excretion ng and nmh level muggm cr corresponded with the high degree of bone marrow biopsy positive for atypical mast cell the presence of aggregate and ckit mutation conclusion easily obtained and quantified urinary metabolite of histamine greater than twice the upper limit of normal and prostaglandin d time the upper limit of normal correlate well with bone marrow finding of mastocytosis,Non-Cancer,1,urinary betapgfalpha and nmethyl histamine correlate with bone marrow biopsy finding in mast cell disorder background the utility of measuring histamine and prostaglandin metabolite in the urine of patient with mastocytosis ha not been critically examined in a large series of patient this study examined the relationship between the extent of increase in urinary excretion of betaprostaglandinfalpha and nmethyl histamine with serum tryptase whole blood serotonin and bone marrow finding including morphology percentage involvement and abnormal mast cell phenotype method this wa a retrospective analysis of patient who were continuously enrolled in the study for a period of year we recorded serum tryptase whole blood serotonin level of urinary mast cell metabolite betaprostaglandinfalpha and nmethyl histamine nmh and bone marrow finding result urinary mast cell metabolite betaprostaglandinfalpha and nmethyl histamine correlated with level of serum tryptase mast cell burden in the bone marrow the presence of mast cell aggregate and atypical mast cell on bone marrow biopsy whole blood serotonin did not have a significant correlation with the serum tryptase or mast cell burden in the bone marrow urinary nmh wa significantly different between ckit dvpositive and ckit dvnegative patient while betaprostaglandinfalpha wa not urinary betaprostaglandinfalpha h excretion ng and nmh level muggm cr corresponded with the high degree of bone marrow biopsy positive for atypical mast cell the presence of aggregate and ckit mutation conclusion easily obtained and quantified urinary metabolite of histamine greater than twice the upper limit of normal and prostaglandin d time the upper limit of normal correlate well with bone marrow finding of mastocytosis
26099230,vertical extraventricular functional hemispherotomy a new variant for hemispheric disconnection technical note and result in three patient,purpose hemispherectomy and disconnective hemispherotomy are the most effective epilepsy surgical procedure for the treatment of epilepsy due to hemispheric pathology such a sturgeweber syndrome diffuse hemispheric cortical dysplasia and posttraumatic and postischemic focal lesion disconnective hemispherotomy is nowadays preferred to reduce surgical morbidity in term of early and late complication ie cerebral superficial hemosiderosis despite the number of existing technical variant conceived to further reduce the amount of brain tissue to be removed postoperative hydrocephalus still persists and may account for an average incidence of according to different series and review a new variant of disconnective vertical hemispherotomy we termed vertical extraventricular parasagittal hemispherotomy is described aiming to further reduce the amount of removed brain tissue and so the risk of postoperative hydrocephalus in favor of a pure hemispheric disconnection method three patient affected by drugresistant epilepsy due to different hemispheric pathology posttraumatic epilepsy sturgeweber syndrome diffuse hemispheric cortical dysplasia were considered to be candidate for vertical extraventricular parasagittal hemispherotomy disconnective based on presurgical evaluation protocol the oldest patient wa year old the two youngest were both year old result none of the patient experienced early and late surgical complication after a mean followup of month range month two patient were seizure free one relapsed seizure month later postoperative hydrocephalus never occurred conclusion vertical extraventricular parasagittal hemispherotomy may be an efficacious and less invasive technique a it consists in a pure disconnection of the hemisphere with less amount of brain tissue removed and a theoretical reduced risk of postoperative hydrocephalus,Non-Cancer,1,vertical extraventricular functional hemispherotomy a new variant for hemispheric disconnection technical note and result in three patient purpose hemispherectomy and disconnective hemispherotomy are the most effective epilepsy surgical procedure for the treatment of epilepsy due to hemispheric pathology such a sturgeweber syndrome diffuse hemispheric cortical dysplasia and posttraumatic and postischemic focal lesion disconnective hemispherotomy is nowadays preferred to reduce surgical morbidity in term of early and late complication ie cerebral superficial hemosiderosis despite the number of existing technical variant conceived to further reduce the amount of brain tissue to be removed postoperative hydrocephalus still persists and may account for an average incidence of according to different series and review a new variant of disconnective vertical hemispherotomy we termed vertical extraventricular parasagittal hemispherotomy is described aiming to further reduce the amount of removed brain tissue and so the risk of postoperative hydrocephalus in favor of a pure hemispheric disconnection method three patient affected by drugresistant epilepsy due to different hemispheric pathology posttraumatic epilepsy sturgeweber syndrome diffuse hemispheric cortical dysplasia were considered to be candidate for vertical extraventricular parasagittal hemispherotomy disconnective based on presurgical evaluation protocol the oldest patient wa year old the two youngest were both year old result none of the patient experienced early and late surgical complication after a mean followup of month range month two patient were seizure free one relapsed seizure month later postoperative hydrocephalus never occurred conclusion vertical extraventricular parasagittal hemispherotomy may be an efficacious and less invasive technique a it consists in a pure disconnection of the hemisphere with less amount of brain tissue removed and a theoretical reduced risk of postoperative hydrocephalus
26134128,herpesvirus genome recognition induced acetylation of nuclear ifi is essential for it cytoplasmic translocation inflammasome and ifnbeta response,the ilbeta and type i interferonbeta ifnbeta molecule are important inflammatory cytokine elicited by the eukaryotic host a innate immune response against invading pathogen and danger signal recently a predominantly nuclear gammainterferoninducible protein ifi involved in transcriptional regulation ha emerged a an innate dna sensor which induced ilbeta and ifnbeta production through inflammasome and sting activation respectively herpesvirus kshv ebv and hsv episomal dsdna genome recognition by ifi lead to ifiascprocaspase inflammasome association cytoplasmic translocation and ilbeta production independent of asc hsv genome recognition result in ifi interaction with sting in the cytoplasm to induce interferonbeta production however the mechanism of ifiinflammasome formation cytoplasmic redistribution and sting activation are not known our study here demonstrate that recognition of herpesvirus genome in the nucleus by ifi lead into it interaction with histone acetyltransferase p and ifi acetylation resulting in ifiasc interaction inflammasome assembly increased interaction with rangtpase cytoplasmic redistribution caspase activation ilbeta production and interaction with sting which result in irf phosphorylation nuclear pirf localization and interferonbeta production asc and sting knockdown did not affect ifi acetylation indicating that this modification is upstream of inflammasomeassembly and stingactivation vaccinia virus replicating in the cytoplasm did not induce nuclear ifi acetylation and cytoplasmic translocation ifi physically associate with kshv and hsv genome a revealed by proximity ligation microscopy and chromatinimmunoprecipitation study which is not hampered by the inhibition of acetylation thus suggesting that acetylation of ifi is not required for it innate sensing of nuclear viral genome collectively these study identify the increased nuclear acetylation of ifi a a dynamic essential postgenome recognition event in the nucleus that is common to the ifimediated innate response of inflammasome induction and ifnbeta production during herpesvirus kshv ebv hsv infection,Non-Cancer,1,herpesvirus genome recognition induced acetylation of nuclear ifi is essential for it cytoplasmic translocation inflammasome and ifnbeta response the ilbeta and type i interferonbeta ifnbeta molecule are important inflammatory cytokine elicited by the eukaryotic host a innate immune response against invading pathogen and danger signal recently a predominantly nuclear gammainterferoninducible protein ifi involved in transcriptional regulation ha emerged a an innate dna sensor which induced ilbeta and ifnbeta production through inflammasome and sting activation respectively herpesvirus kshv ebv and hsv episomal dsdna genome recognition by ifi lead to ifiascprocaspase inflammasome association cytoplasmic translocation and ilbeta production independent of asc hsv genome recognition result in ifi interaction with sting in the cytoplasm to induce interferonbeta production however the mechanism of ifiinflammasome formation cytoplasmic redistribution and sting activation are not known our study here demonstrate that recognition of herpesvirus genome in the nucleus by ifi lead into it interaction with histone acetyltransferase p and ifi acetylation resulting in ifiasc interaction inflammasome assembly increased interaction with rangtpase cytoplasmic redistribution caspase activation ilbeta production and interaction with sting which result in irf phosphorylation nuclear pirf localization and interferonbeta production asc and sting knockdown did not affect ifi acetylation indicating that this modification is upstream of inflammasomeassembly and stingactivation vaccinia virus replicating in the cytoplasm did not induce nuclear ifi acetylation and cytoplasmic translocation ifi physically associate with kshv and hsv genome a revealed by proximity ligation microscopy and chromatinimmunoprecipitation study which is not hampered by the inhibition of acetylation thus suggesting that acetylation of ifi is not required for it innate sensing of nuclear viral genome collectively these study identify the increased nuclear acetylation of ifi a a dynamic essential postgenome recognition event in the nucleus that is common to the ifimediated innate response of inflammasome induction and ifnbeta production during herpesvirus kshv ebv hsv infection
26149588,hymenoptera anaphylaxis and ckit mutation an unexpected association,clinical manifestation of mastocytosis in adult comprise sign and symptom linked to mast cell mc activation including anaphylaxis depending on mc burden adult can be diagnosed with systemic mastocytosis when the who criterion are fulfilled or with other clonal mc disorder characterized by mc mediator symptom and demonstration of activating kit mutation andor expression of cd on mc there is a specific link between mastocytosis and hymenoptera venom allergy hva the reported frequency of hva in mastocytosis is and raise to in patient affected by indolent systemic mastocytosis without skin lesion the presentation of hva characterized by severe hypotension in the absence of urticarial or angioedema is typical in patient with an underlying mc disorder even in the presence of normal baseline serum tryptase level,Non-Cancer,1,hymenoptera anaphylaxis and ckit mutation an unexpected association clinical manifestation of mastocytosis in adult comprise sign and symptom linked to mast cell mc activation including anaphylaxis depending on mc burden adult can be diagnosed with systemic mastocytosis when the who criterion are fulfilled or with other clonal mc disorder characterized by mc mediator symptom and demonstration of activating kit mutation andor expression of cd on mc there is a specific link between mastocytosis and hymenoptera venom allergy hva the reported frequency of hva in mastocytosis is and raise to in patient affected by indolent systemic mastocytosis without skin lesion the presentation of hva characterized by severe hypotension in the absence of urticarial or angioedema is typical in patient with an underlying mc disorder even in the presence of normal baseline serum tryptase level
26152315,large maculopapular cutaneous lesion are associated with favorable outcome in childhoodonset mastocytosis,background mastocytosis characterized by pathologic accumulation of mast cell can manifest itself in adulthood or childhood pediatric patient usually have cutaneous mastocytosis cm with mast cell infiltrates limited to the skin and spontaneous improvement of skin lesion after several year however there are some patient with persistent disease resembling adulthoodonset mastocytosis objective the current classification of cm differentiates between subforms in clinical practice we noticed that different variant of these subforms might exist particularly in patient with childhoodonset mastocytosis therefore in the present study we aimed to investigate whether specific cutaneous lesion in patient with childhoodonset mastocytosis are associated with other disease parameter method we analyzed patient with a disease onset of less than age year using a systematic dermatologic approach result one hundred twentytwo patient presented with maculopapular cutaneous mastocytosis mpcm patient presented with diffuse cm and patient presented with solitary mastocytoma of the skin patient with mpcm showed particularly heterogeneous cutaneous lesion and were therefore grouped into variant presenting either with small lesion mpcmsmall skin lesion cm in diameter n or atypical lesion mpcmother n patient with mpcmlarge lesion compared with those with mpcmsmall lesion were characterized by significantly lower tryptase level shorter disease duration and earlier disease onset in addition more patient with mpcmlarge lesion exhibited spontaneous regression of cutaneous lesion conclusion our data show that patient with mpcmlarge lesion compared with those with mpcmsmall lesion have a more favorable disease course and suggest exploring the size of cutaneous lesion a a prognostic parameter in childhoodonset mpcm,Non-Cancer,1,large maculopapular cutaneous lesion are associated with favorable outcome in childhoodonset mastocytosis background mastocytosis characterized by pathologic accumulation of mast cell can manifest itself in adulthood or childhood pediatric patient usually have cutaneous mastocytosis cm with mast cell infiltrates limited to the skin and spontaneous improvement of skin lesion after several year however there are some patient with persistent disease resembling adulthoodonset mastocytosis objective the current classification of cm differentiates between subforms in clinical practice we noticed that different variant of these subforms might exist particularly in patient with childhoodonset mastocytosis therefore in the present study we aimed to investigate whether specific cutaneous lesion in patient with childhoodonset mastocytosis are associated with other disease parameter method we analyzed patient with a disease onset of less than age year using a systematic dermatologic approach result one hundred twentytwo patient presented with maculopapular cutaneous mastocytosis mpcm patient presented with diffuse cm and patient presented with solitary mastocytoma of the skin patient with mpcm showed particularly heterogeneous cutaneous lesion and were therefore grouped into variant presenting either with small lesion mpcmsmall skin lesion cm in diameter n or atypical lesion mpcmother n patient with mpcmlarge lesion compared with those with mpcmsmall lesion were characterized by significantly lower tryptase level shorter disease duration and earlier disease onset in addition more patient with mpcmlarge lesion exhibited spontaneous regression of cutaneous lesion conclusion our data show that patient with mpcmlarge lesion compared with those with mpcmsmall lesion have a more favorable disease course and suggest exploring the size of cutaneous lesion a a prognostic parameter in childhoodonset mpcm
26153655,increased il plasma level in indolent systemic mastocytosis patient are associated with high risk of disease progression,systemic mastocytosis sm is a heterogeneous disease with altered interleukin il and il plasma level however no study ha simultaneously investigated the plasma level of ilbeta il il ccl and clusterin in sm at diagnosis and correlated them with disease outcome here we investigated ilbeta il il ccl and clusterin plasma level in sm patient indolent sm ism and aggressive smand analyzed their prognostic impact among ism case grouped according to the extent of hematopoietic involvement of the bone marrow cell by the kit dv mutation although increased ilbeta il and ccl level were detected in sm patient versus healthy control only il and ccl level gradually increased with disease severity moreover increased il plasma level were associated with ism progression to more aggressive disease in particular among ism patient with multilineal kit mutation ismml these patient also showing a higher frequency of organomegalies versus other ismml patient of note all ism patient who progressed had increased il plasma level already at diagnosis our result indicate that sm patient display an altered plasma cytokine profile already at diagnosis increased il plasma level emerging a an early marker for disease progression among ism case in particular among highrisk ism patient who carry multilineage kit mutation,Non-Cancer,1,increased il plasma level in indolent systemic mastocytosis patient are associated with high risk of disease progression systemic mastocytosis sm is a heterogeneous disease with altered interleukin il and il plasma level however no study ha simultaneously investigated the plasma level of ilbeta il il ccl and clusterin in sm at diagnosis and correlated them with disease outcome here we investigated ilbeta il il ccl and clusterin plasma level in sm patient indolent sm ism and aggressive smand analyzed their prognostic impact among ism case grouped according to the extent of hematopoietic involvement of the bone marrow cell by the kit dv mutation although increased ilbeta il and ccl level were detected in sm patient versus healthy control only il and ccl level gradually increased with disease severity moreover increased il plasma level were associated with ism progression to more aggressive disease in particular among ism patient with multilineal kit mutation ismml these patient also showing a higher frequency of organomegalies versus other ismml patient of note all ism patient who progressed had increased il plasma level already at diagnosis our result indicate that sm patient display an altered plasma cytokine profile already at diagnosis increased il plasma level emerging a an early marker for disease progression among ism case in particular among highrisk ism patient who carry multilineage kit mutation
26159157,massive gastric polyposis associated with a germline smad gene mutation,juvenile polyposis syndrome jps is a rare autosomal dominant disorder characterized by the development of multiple hamartomatous polyp in the gastrointestinal tract polyp are most common in the colorectum of patient and the stomach causative mutation for jps have been identified in two gene to date smad and bmpra smad mutation are associated with a higher incidence of gastric polyposis in this case report we describe two patient with massive gastric polyposis associated with a smad mutation both presented with anaemia and both had colonic polyp initial endoscopic finding revealed giant rugal fold suggestive of menetrier disease however a other possible gastropathies could not be differentiated on the basis of histology a definitive diagnosis of jps required additional mutation analysis in patient with polyposis predominant in or limited to the stomach establishing a diagnosis based solely on the pathological feature of polyp can be challenging due to difficulty in differentiating jps from other hypertrophic gastropathies mutation analysis should be considered early in the diagnostic process in case of suspected juvenile polyposis thus facilitating rapid diagnosis and adequate followup,Non-Cancer,1,massive gastric polyposis associated with a germline smad gene mutation juvenile polyposis syndrome jps is a rare autosomal dominant disorder characterized by the development of multiple hamartomatous polyp in the gastrointestinal tract polyp are most common in the colorectum of patient and the stomach causative mutation for jps have been identified in two gene to date smad and bmpra smad mutation are associated with a higher incidence of gastric polyposis in this case report we describe two patient with massive gastric polyposis associated with a smad mutation both presented with anaemia and both had colonic polyp initial endoscopic finding revealed giant rugal fold suggestive of menetrier disease however a other possible gastropathies could not be differentiated on the basis of histology a definitive diagnosis of jps required additional mutation analysis in patient with polyposis predominant in or limited to the stomach establishing a diagnosis based solely on the pathological feature of polyp can be challenging due to difficulty in differentiating jps from other hypertrophic gastropathies mutation analysis should be considered early in the diagnostic process in case of suspected juvenile polyposis thus facilitating rapid diagnosis and adequate followup
26221972,a polymorphism in a phosphotyrosine signalling motif of cd ly slamf alters sh domain binding and tcell activation,signalling lymphocyte activation molecule slam family member regulate activation and inhibition in the innate and adaptive immune system genomewide association study identified their genetic locus q a highly polymorphic and associated with susceptibility to systemic lupus erythematosus sle here we show that the val variant of the nonsynonymous single nucleotide polymorphism snp r in the slam family member cd ly slamf ha a twofold lower affinity compared with the sleassociated met variant for the small adaptor protein sap comparison of the two variant in tcell line revealed the val variant to be significantly more highly expressed than cd met activation wa diminished in cell expressing cd val compared with cd met a measured by upregulation of cd there wa no correlation between homozygosity at r and activation in peripheral blood mononuclear cell from healthy donor these finding identify potential mechanism by which a single snp can perturb finetuning in the immune system with significant functional consequence,Non-Cancer,1,a polymorphism in a phosphotyrosine signalling motif of cd ly slamf alters sh domain binding and tcell activation signalling lymphocyte activation molecule slam family member regulate activation and inhibition in the innate and adaptive immune system genomewide association study identified their genetic locus q a highly polymorphic and associated with susceptibility to systemic lupus erythematosus sle here we show that the val variant of the nonsynonymous single nucleotide polymorphism snp r in the slam family member cd ly slamf ha a twofold lower affinity compared with the sleassociated met variant for the small adaptor protein sap comparison of the two variant in tcell line revealed the val variant to be significantly more highly expressed than cd met activation wa diminished in cell expressing cd val compared with cd met a measured by upregulation of cd there wa no correlation between homozygosity at r and activation in peripheral blood mononuclear cell from healthy donor these finding identify potential mechanism by which a single snp can perturb finetuning in the immune system with significant functional consequence
26230867,pathologic finding in nemo deficiency a surgical and autopsy survey,hypomorphic mutation in nuclear factor kappab nfkappab essential modulator nemo encoded by ikbkg lead to a variable combined immunodeficiency which put patient at risk of early death from infectious complication the spectrum of clinical manifestation includes inflammatory disorder especially colitis because of the multiple complication of nemo deficiency a variety of biopsy excisional and autopsy material from these patient may be subject to pathologic examination therefore using sample from a cohort of patient with this disorder we aimed to survey the pathologic spectrum of nemo deficiency and search for correlation between specific genotype and phenotype clinical and laboratory data mutation analysis and pathology from patient were examined including autopsy no specific genotypepathology correlation wa identified however we confirmed an association between ectodermal dysplasia and inflammatory condition we found no characteristic pathology to identify patient with nemo deficiency therefore history physical examination and specific infection must remain the clue to suggest the diagnosis variability among patient and by infection make the pathologic recognition of nemo deficiency challenging,Non-Cancer,1,pathologic finding in nemo deficiency a surgical and autopsy survey hypomorphic mutation in nuclear factor kappab nfkappab essential modulator nemo encoded by ikbkg lead to a variable combined immunodeficiency which put patient at risk of early death from infectious complication the spectrum of clinical manifestation includes inflammatory disorder especially colitis because of the multiple complication of nemo deficiency a variety of biopsy excisional and autopsy material from these patient may be subject to pathologic examination therefore using sample from a cohort of patient with this disorder we aimed to survey the pathologic spectrum of nemo deficiency and search for correlation between specific genotype and phenotype clinical and laboratory data mutation analysis and pathology from patient were examined including autopsy no specific genotypepathology correlation wa identified however we confirmed an association between ectodermal dysplasia and inflammatory condition we found no characteristic pathology to identify patient with nemo deficiency therefore history physical examination and specific infection must remain the clue to suggest the diagnosis variability among patient and by infection make the pathologic recognition of nemo deficiency challenging
26276780,morphologically occult systemic mastocytosis in bone marrow clinicopathologic feature and an algorithmic approach to diagnosis,objective bone marrow bm biopsy specimen involved by systemic mastocytosis sm typically show multifocal compact dense aggregate of spindled mast cell mc however some case lack aggregate formation and fulfill the world health organization criterion for sm based on minor criterion method we identified bm case of kit dvmutated morphologically occult sm in the bm result all patient had some combination of allergicmc activating symptom peripheral blood count were generally normal bm aspirate showed or less mc which were only occasionally spindled bm biopsy specimen showed no morphologic classic mc lesion tryptase immunohistochemistry ihc demonstrated interstitial individually distributed mc up to with prominent spindling lacking aggregate formation mc coexpressed cd by ihc andor flow cytometry spindled mc constituted more than of total mc in all case and more than in of case conclusion morphologically occult involvement of normalappearing bm by sm will be missed without appropriate clinical suspicion and pathologic evaluation by tryptase and cd ihc and kit dv mutation analysis on the basis of these finding we propose a costeffective datadriven evidencebased algorithmic approach to the workup of these case,Non-Cancer,1,morphologically occult systemic mastocytosis in bone marrow clinicopathologic feature and an algorithmic approach to diagnosis objective bone marrow bm biopsy specimen involved by systemic mastocytosis sm typically show multifocal compact dense aggregate of spindled mast cell mc however some case lack aggregate formation and fulfill the world health organization criterion for sm based on minor criterion method we identified bm case of kit dvmutated morphologically occult sm in the bm result all patient had some combination of allergicmc activating symptom peripheral blood count were generally normal bm aspirate showed or less mc which were only occasionally spindled bm biopsy specimen showed no morphologic classic mc lesion tryptase immunohistochemistry ihc demonstrated interstitial individually distributed mc up to with prominent spindling lacking aggregate formation mc coexpressed cd by ihc andor flow cytometry spindled mc constituted more than of total mc in all case and more than in of case conclusion morphologically occult involvement of normalappearing bm by sm will be missed without appropriate clinical suspicion and pathologic evaluation by tryptase and cd ihc and kit dv mutation analysis on the basis of these finding we propose a costeffective datadriven evidencebased algorithmic approach to the workup of these case
26291959,hematopoietic stem cell transplantation for cd ligand deficiency single institution experience,background xlinked hyperigm syndrome xhigm due to mutation in the gene encoding cd ligand result in failure of ig class switching and an increased propensity for recurrent sinopulmonary and other infection and thus decreased life expectancy allogeneic hematopoietic stem cell transplantation hsct is curative but longterm followup data are limited procedure we conducted a retrospective analysis of seven patient who have undergone allogeneic hsct for higm syndrome at duke university medical center result median age at transplant wa year range none of the patient had active hepatic or pulmonary disease immediately prior to transplant but all had a history of serious infection five patient received myeloablative conditioning and two patient received reduced intensity conditioning graft source included bone marrow peripheral blood and unrelated umbilical cord blood posttransplantation complication included venoocclusive disease hemorrhagic cystitis adenoviremia and cryptosporidium recurrence in one patient each two patient developed acute gvhd grade iiiv that resolved promptly with treatment and none developed extensive chronic gvhd all patient are intravenous iggindependent and have normal antibody titer immunoglobulin ig a level normalized in all but one patient and t and b cell number and function are otherwise normal in all all patient are alive at a median followup of range year posttransplantation with predominantly donor chimerism and no recurrent infection conclusion allogeneic hsct result in excellent survival and sustained immune reconstitution in patient with cd ligand deficiency using both myeloablative and reduced intensity conditioning approach and various graft source including bone marrow peripheral blood and umbilical cord blood,Non-Cancer,1,hematopoietic stem cell transplantation for cd ligand deficiency single institution experience background xlinked hyperigm syndrome xhigm due to mutation in the gene encoding cd ligand result in failure of ig class switching and an increased propensity for recurrent sinopulmonary and other infection and thus decreased life expectancy allogeneic hematopoietic stem cell transplantation hsct is curative but longterm followup data are limited procedure we conducted a retrospective analysis of seven patient who have undergone allogeneic hsct for higm syndrome at duke university medical center result median age at transplant wa year range none of the patient had active hepatic or pulmonary disease immediately prior to transplant but all had a history of serious infection five patient received myeloablative conditioning and two patient received reduced intensity conditioning graft source included bone marrow peripheral blood and unrelated umbilical cord blood posttransplantation complication included venoocclusive disease hemorrhagic cystitis adenoviremia and cryptosporidium recurrence in one patient each two patient developed acute gvhd grade iiiv that resolved promptly with treatment and none developed extensive chronic gvhd all patient are intravenous iggindependent and have normal antibody titer immunoglobulin ig a level normalized in all but one patient and t and b cell number and function are otherwise normal in all all patient are alive at a median followup of range year posttransplantation with predominantly donor chimerism and no recurrent infection conclusion allogeneic hsct result in excellent survival and sustained immune reconstitution in patient with cd ligand deficiency using both myeloablative and reduced intensity conditioning approach and various graft source including bone marrow peripheral blood and umbilical cord blood
26369259,an adverse implication of radiation therapy for implantretained maxillofacial prosthesis,we report the year postoperative course of a patient whose maxillary defect wa reconstructed with maxillofacial implantretained facial prosthesis the patient received gy of radiation therapy adjunctive hyperbaric oxygen therapy wa administered and four mm long maxillofacial implant were inserted four year and month after insertion surgery two of the four implant were lost and the others showed bone regression in the surrounding bone all implant were replaced with epitec system maxillofacial implant placed in nonirradiated bone eleven year and month after replacement the epitec system ha been maintaining good and firm osseointegration appropriate selection of implant site and no history of radiation therapy are key to successful implant reconstruction however adjunctive hyperbaric oxygen therapy is believed to be effective osseointegrated implant should be inserted at a point appropriately distant from an irradiated lesion,Non-Cancer,1,an adverse implication of radiation therapy for implantretained maxillofacial prosthesis we report the year postoperative course of a patient whose maxillary defect wa reconstructed with maxillofacial implantretained facial prosthesis the patient received gy of radiation therapy adjunctive hyperbaric oxygen therapy wa administered and four mm long maxillofacial implant were inserted four year and month after insertion surgery two of the four implant were lost and the others showed bone regression in the surrounding bone all implant were replaced with epitec system maxillofacial implant placed in nonirradiated bone eleven year and month after replacement the epitec system ha been maintaining good and firm osseointegration appropriate selection of implant site and no history of radiation therapy are key to successful implant reconstruction however adjunctive hyperbaric oxygen therapy is believed to be effective osseointegrated implant should be inserted at a point appropriately distant from an irradiated lesion
26400824,effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patient with immune thrombocytopenia,background thrombopoietin receptor agonist are new treatment for patient with chronic immune thrombocytopenia itp how one of these agent romiplostim ha impacted practice pattern especially the use of intravenous immune globulin ivig ha not been evaluated outside of clinical trial study design and method this wa a retrospective cohort study of adult itp patient treated with romiplostim in four canadian center patient had primary or secondary itp and were followed for year before starting weekly romiplostim treatment we compared ivig use clinical outcome and cost before and after romiplostim result twentynine patient with itp received romiplostim median age wa year interquartile range iqr year and patient had a median of two prior itp treatment iqr including splenectomy n median platelet plt count wa x before and x after romiplostim median duration of romiplostim treatment wa month patient used a median of two ivig infusion per year before and per year after starting romiplostim p for patient who received weekly romiplostim for at least month n ivig infusion were three iqr per year before and iqr per year after romiplostim result were squewed by two high ivig user nineteen patient discontinued romiplostim treatment during followup because of lack of response n sustained response n toxicity n or response to splenectomy n overall health care cost were similar before and after romiplostim when concomitant treatment nursing resource and hospitalization were considered conclusion romiplostim wa associated with improved plt count and fewer ivig infusion for most itp patient in practice romiplostim wa generally not continued long term and wa cost neutral for overall itp management,Non-Cancer,1,effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patient with immune thrombocytopenia background thrombopoietin receptor agonist are new treatment for patient with chronic immune thrombocytopenia itp how one of these agent romiplostim ha impacted practice pattern especially the use of intravenous immune globulin ivig ha not been evaluated outside of clinical trial study design and method this wa a retrospective cohort study of adult itp patient treated with romiplostim in four canadian center patient had primary or secondary itp and were followed for year before starting weekly romiplostim treatment we compared ivig use clinical outcome and cost before and after romiplostim result twentynine patient with itp received romiplostim median age wa year interquartile range iqr year and patient had a median of two prior itp treatment iqr including splenectomy n median platelet plt count wa x before and x after romiplostim median duration of romiplostim treatment wa month patient used a median of two ivig infusion per year before and per year after starting romiplostim p for patient who received weekly romiplostim for at least month n ivig infusion were three iqr per year before and iqr per year after romiplostim result were squewed by two high ivig user nineteen patient discontinued romiplostim treatment during followup because of lack of response n sustained response n toxicity n or response to splenectomy n overall health care cost were similar before and after romiplostim when concomitant treatment nursing resource and hospitalization were considered conclusion romiplostim wa associated with improved plt count and fewer ivig infusion for most itp patient in practice romiplostim wa generally not continued long term and wa cost neutral for overall itp management
26430803,modeling linkage disequilibrium increase accuracy of polygenic risk score,polygenic risk score have shown great promise in predicting complex disease risk and will become more accurate a training sample size increase the standard approach for calculating risk score involves linkage disequilibrium ldbased marker pruning and applying a p value threshold to association statistic but this discard information and can reduce predictive accuracy we introduce ldpred a method that infers the posterior mean effect size of each marker by using a prior on effect size and ld information from an external reference panel theory and simulation show that ldpred outperforms the approach of pruning followed by thresholding particularly at large sample size accordingly predicted r increased from to in a large schizophrenia dataset and from to in a large multiple sclerosis dataset a similar relative improvement in accuracy wa observed for three additional large disease datasets and for noneuropean schizophrenia sample the advantage of ldpred over existing method will grow a sample size increase,Non-Cancer,1,modeling linkage disequilibrium increase accuracy of polygenic risk score polygenic risk score have shown great promise in predicting complex disease risk and will become more accurate a training sample size increase the standard approach for calculating risk score involves linkage disequilibrium ldbased marker pruning and applying a p value threshold to association statistic but this discard information and can reduce predictive accuracy we introduce ldpred a method that infers the posterior mean effect size of each marker by using a prior on effect size and ld information from an external reference panel theory and simulation show that ldpred outperforms the approach of pruning followed by thresholding particularly at large sample size accordingly predicted r increased from to in a large schizophrenia dataset and from to in a large multiple sclerosis dataset a similar relative improvement in accuracy wa observed for three additional large disease datasets and for noneuropean schizophrenia sample the advantage of ldpred over existing method will grow a sample size increase
26432562,a case of recurrent ischemic stroke involving subacute progressive intracranial cerebral arterial sclerosis prior to diagnosis with jakmutated polycythemia vera,case report a yearold man presenting with no vascular risk factor visited our hospital with right hemiparesis and total aphasia diffusionweighted magnetic resonance imaging of the brain showed multiple hyperintensities in watershed distribution in the left hemisphere magnetic resonance angiography mra revealed stenosis of the middle cerebral artery despite normal mra finding month prior one year after the first stroke the patient experienced a recurrent ischemic stroke involving the left anterior choroidal artery pulmonary embolism and deep venous thrombosis after the recurrent stroke event hemoglobin level increased gradually two year after the first stroke a jakvf mutation wa detected conclusion our report suggests that progressive intracranial arterial sclerosis and venous thrombosis of undetermined etiology could be several initial symptom of polycythemia vera,Non-Cancer,1,a case of recurrent ischemic stroke involving subacute progressive intracranial cerebral arterial sclerosis prior to diagnosis with jakmutated polycythemia vera case report a yearold man presenting with no vascular risk factor visited our hospital with right hemiparesis and total aphasia diffusionweighted magnetic resonance imaging of the brain showed multiple hyperintensities in watershed distribution in the left hemisphere magnetic resonance angiography mra revealed stenosis of the middle cerebral artery despite normal mra finding month prior one year after the first stroke the patient experienced a recurrent ischemic stroke involving the left anterior choroidal artery pulmonary embolism and deep venous thrombosis after the recurrent stroke event hemoglobin level increased gradually two year after the first stroke a jakvf mutation wa detected conclusion our report suggests that progressive intracranial arterial sclerosis and venous thrombosis of undetermined etiology could be several initial symptom of polycythemia vera
26456532,diagnosis and classification of mastocytosis in nonspecialized versus reference centre a spanish network on mastocytosis rema study on patient,the diagnosis of rare disease such a mastocytosis remains a challenge despite this the precise benefit of referral of mastocytosis patient to highly specialized reference centre are poorly defined and whether patient should be managed at nonspecialized versus reference centre remains a matter of debate to evaluate the quality and efficiency of diagnostic procedure performed at the reference centre for mastocytosis in spain rema versus other nonreference centre we retrospectively analysed a series of patient for the overall degree of agreement obtained for the world health organization who diagnostic and classification criterion betwen the referring and rema centre our result showed that not all who diagnostic criterion were frequently investigated at the referring centre among the five who diagnostic criterion the highest degree of agreement wa obtained for serum tryptase level median confidence interval in turn the overall agreement wa significantly lower for the major histopathological criterion and the other three minor criterion cytomorphology immunophenotyping of bm mast cell and detection of the kit mutation referral of patient with diagnostic suspicion of mastocytosis to a multidisciplinary reference centre improves diagnostic efficiency and quality,Non-Cancer,1,diagnosis and classification of mastocytosis in nonspecialized versus reference centre a spanish network on mastocytosis rema study on patient the diagnosis of rare disease such a mastocytosis remains a challenge despite this the precise benefit of referral of mastocytosis patient to highly specialized reference centre are poorly defined and whether patient should be managed at nonspecialized versus reference centre remains a matter of debate to evaluate the quality and efficiency of diagnostic procedure performed at the reference centre for mastocytosis in spain rema versus other nonreference centre we retrospectively analysed a series of patient for the overall degree of agreement obtained for the world health organization who diagnostic and classification criterion betwen the referring and rema centre our result showed that not all who diagnostic criterion were frequently investigated at the referring centre among the five who diagnostic criterion the highest degree of agreement wa obtained for serum tryptase level median confidence interval in turn the overall agreement wa significantly lower for the major histopathological criterion and the other three minor criterion cytomorphology immunophenotyping of bm mast cell and detection of the kit mutation referral of patient with diagnostic suspicion of mastocytosis to a multidisciplinary reference centre improves diagnostic efficiency and quality
26456649,generation and periodontal differentiation of human gingival fibroblastsderived integrationfree induced pluripotent stem cell,induced pluripotent stem cell ipscs have been recognized a a promising cell source for periodontal tissue regeneration however the conventional virusbased reprogramming approach is associated with a high risk of genetic mutation and limit their therapeutic utility here we successfully generated ipscs from readily accessible human gingival fibroblast hgfs through an integrationfree and feederfree approach via delivery of reprogramming factor of oct sox klf lmyc lin and tp shrna with episomal plasmid vector the ipscs presented similar morphology and proliferation characteristic a embryonic stem cell escs and expressed pluripotent marker including oct tra nanog and ssea additionally these cell maintained a normal karyotype and showed decreased cpg methylation ratio in the promoter region of oct and nanog in vivo teratoma formation assay revealed the development of tissue representative of three germ layer confirming the acquisition of pluripotency furthermore treatment of the ipscs in vitro with enamel matrix derivative emd or growthdifferentiation factor gdf significantly upregulated the expression of periodontal tissue marker associated with bone periodontal ligament and cementum respectively taken together our data demonstrate that hgfs are a valuable cell source for generating integrationfree ipscs which could be sequentially induced toward periodontal cell under the treatment of emd and gdf,Non-Cancer,1,generation and periodontal differentiation of human gingival fibroblastsderived integrationfree induced pluripotent stem cell induced pluripotent stem cell ipscs have been recognized a a promising cell source for periodontal tissue regeneration however the conventional virusbased reprogramming approach is associated with a high risk of genetic mutation and limit their therapeutic utility here we successfully generated ipscs from readily accessible human gingival fibroblast hgfs through an integrationfree and feederfree approach via delivery of reprogramming factor of oct sox klf lmyc lin and tp shrna with episomal plasmid vector the ipscs presented similar morphology and proliferation characteristic a embryonic stem cell escs and expressed pluripotent marker including oct tra nanog and ssea additionally these cell maintained a normal karyotype and showed decreased cpg methylation ratio in the promoter region of oct and nanog in vivo teratoma formation assay revealed the development of tissue representative of three germ layer confirming the acquisition of pluripotency furthermore treatment of the ipscs in vitro with enamel matrix derivative emd or growthdifferentiation factor gdf significantly upregulated the expression of periodontal tissue marker associated with bone periodontal ligament and cementum respectively taken together our data demonstrate that hgfs are a valuable cell source for generating integrationfree ipscs which could be sequentially induced toward periodontal cell under the treatment of emd and gdf
26460258,an unusual longterm outcome of a child with primary myelofibrosis harboring a jak mutation,we report an extremely rare case of a female child who presented the onset of primary myelofibrosis pmf harboring jak janus kinase gene mutation jakvf when she wa month old she wa monitored over year a period in which she wa treated with spleen radiotherapy and recombinant interferon alpha she also underwent splenectomy when she wa year old due to massive splenomegaly anemia and various infection disease episode the longstanding evolution of the patient enabled u to verify that there were no complication related to postsplenectomy event andor blast transformation to the best of our knowledge this is the first reported case of severe pmf with jak mutation in a child we provide evidence that a better quality of life and long survival in pediatric pmf may be provided by splenectomy,Non-Cancer,1,an unusual longterm outcome of a child with primary myelofibrosis harboring a jak mutation we report an extremely rare case of a female child who presented the onset of primary myelofibrosis pmf harboring jak janus kinase gene mutation jakvf when she wa month old she wa monitored over year a period in which she wa treated with spleen radiotherapy and recombinant interferon alpha she also underwent splenectomy when she wa year old due to massive splenomegaly anemia and various infection disease episode the longstanding evolution of the patient enabled u to verify that there were no complication related to postsplenectomy event andor blast transformation to the best of our knowledge this is the first reported case of severe pmf with jak mutation in a child we provide evidence that a better quality of life and long survival in pediatric pmf may be provided by splenectomy
26468051,the common gammachain cytokine receptor tricksandtreats for t cell,originally identified a the third subunit of the highaffinity il receptor complex the common gammachain gammac also act a a nonredundant receptor subunit for a series of other cytokine collectively known a gammac family cytokine gammac play essential role in t cell development and differentiation so that understanding the molecular basis of it signaling and regulation is a critical issue in t cell immunology unlike most other cytokine receptor gammac is thought to be constitutively expressed and limited in it function to the assembly of highaffinity cytokine receptor surprisingly recent study reported a series of finding that unseat gammac a a simple housekeeping gene and unveiled gammac a a new regulatory molecule in t cell activation and differentiation cytokineindependent binding of gammac to other cytokine receptor subunit suggested a preassociation model of gammac with proprietary cytokine receptor also identification of a gammac splice isoform revealed expression of soluble gammac protein sgammac sgammac directly interacted with surface ilrbeta to suppress il signaling and to promote proinflammatory th cell differentiation a a result endogenously produced sgammac exacerbated autoimmune inflammatory disease while the removal of endogenous sgammac significantly ameliorated disease outcome these data provide new insight into the role of both membrane and soluble gammac in cytokine signaling and open new venue to interfere and modulate gammac signaling during immune activation these unexpected discovery further underscore the perspective that gammac biology remains largely uncharted territory that invite further exploration,Non-Cancer,1,the common gammachain cytokine receptor tricksandtreats for t cell originally identified a the third subunit of the highaffinity il receptor complex the common gammachain gammac also act a a nonredundant receptor subunit for a series of other cytokine collectively known a gammac family cytokine gammac play essential role in t cell development and differentiation so that understanding the molecular basis of it signaling and regulation is a critical issue in t cell immunology unlike most other cytokine receptor gammac is thought to be constitutively expressed and limited in it function to the assembly of highaffinity cytokine receptor surprisingly recent study reported a series of finding that unseat gammac a a simple housekeeping gene and unveiled gammac a a new regulatory molecule in t cell activation and differentiation cytokineindependent binding of gammac to other cytokine receptor subunit suggested a preassociation model of gammac with proprietary cytokine receptor also identification of a gammac splice isoform revealed expression of soluble gammac protein sgammac sgammac directly interacted with surface ilrbeta to suppress il signaling and to promote proinflammatory th cell differentiation a a result endogenously produced sgammac exacerbated autoimmune inflammatory disease while the removal of endogenous sgammac significantly ameliorated disease outcome these data provide new insight into the role of both membrane and soluble gammac in cytokine signaling and open new venue to interfere and modulate gammac signaling during immune activation these unexpected discovery further underscore the perspective that gammac biology remains largely uncharted territory that invite further exploration
26471738,evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patient,secondary failure of platelet recovery sfpr is a serious complication observed in approximately of allogeneic hematopoietic stem cell transplant hsct recipient although the standard therapeutic approach ha been frequent platelet transfusion romiplostim a thrombopoietin receptor agonist may have utility in treating sfpr the primary objective of this singlecenter retrospective analysis wa to assess effectiveness of romiplostim for sfpr and to evaluate patient factor which may influence clinical outcome the primary outcome measure of response wa defined a achievement of platelet count x l without transfusion for consecutive day during the study period patient underwent hsct and received romiplostim for sfpr seven patient responded to romiplostim requiring a median of three dos range to achieve independence from platelet transfusion disease relapse occurred in of all patient two responder and three nonresponders median survival posthsct wa day among responder and day among nonresponders p no serious adverse event were reported and rate of graftversushost disease did not increase following administration of romiplostim thrombopoietin receptor agonist including romiplostim offer a treatment option for persistent thrombocytopenia following hsct positive clinical response to romiplostim posthsct is associated with improved outcome,Non-Cancer,1,evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patient secondary failure of platelet recovery sfpr is a serious complication observed in approximately of allogeneic hematopoietic stem cell transplant hsct recipient although the standard therapeutic approach ha been frequent platelet transfusion romiplostim a thrombopoietin receptor agonist may have utility in treating sfpr the primary objective of this singlecenter retrospective analysis wa to assess effectiveness of romiplostim for sfpr and to evaluate patient factor which may influence clinical outcome the primary outcome measure of response wa defined a achievement of platelet count x l without transfusion for consecutive day during the study period patient underwent hsct and received romiplostim for sfpr seven patient responded to romiplostim requiring a median of three dos range to achieve independence from platelet transfusion disease relapse occurred in of all patient two responder and three nonresponders median survival posthsct wa day among responder and day among nonresponders p no serious adverse event were reported and rate of graftversushost disease did not increase following administration of romiplostim thrombopoietin receptor agonist including romiplostim offer a treatment option for persistent thrombocytopenia following hsct positive clinical response to romiplostim posthsct is associated with improved outcome
26485416,cerebellar enterogenous cyst with atypical appearance and pathological finding,background intracranial enterogenous cyst are rare and occur mainly in the posterior fossa these cyst are usually extraaxial midline anterior to the brainstem or at the cerebellopontine angle intracranial intraaxial enterogenous cyst are extremely rare we report a case of an intraaxial cerebellar enterogenous cyst in which diagnosis wa difficult because the lesion resembled an arachnoid cyst in appearance and showed atypical pathologic finding case description a yearold woman had a year history of progressive headache giddiness and unsteadiness of gait magnetic resonance imaging showed a cystic lesion with isointensity to cerebrospinal fluid in the left cerebellar hemisphere reaching into the fourth ventricle the patient underwent fenestration of the cyst and creation of a communication between the fourth ventricle and cyst because the tight attachment of the cyst wall to the cerebellum prevented total removal of the cyst although pathologic examination did not show finding typical of enterogenous cyst the diagnosis wa finally made based on the presence of basement membrane and immunohistochemical result conclusion the diagnosis of enterogenous cyst is based mainly on histologic finding because characteristic finding on neuroimaging have not been defined although total resection of enterogenous cyst is recommended in general partial resection while ensuring the cyst communicates adequately with the surrounding cerebrospinal fluid space with or without a shunt procedure may be useful if the cyst is adherent to surrounding neurovascular structure,Non-Cancer,1,cerebellar enterogenous cyst with atypical appearance and pathological finding background intracranial enterogenous cyst are rare and occur mainly in the posterior fossa these cyst are usually extraaxial midline anterior to the brainstem or at the cerebellopontine angle intracranial intraaxial enterogenous cyst are extremely rare we report a case of an intraaxial cerebellar enterogenous cyst in which diagnosis wa difficult because the lesion resembled an arachnoid cyst in appearance and showed atypical pathologic finding case description a yearold woman had a year history of progressive headache giddiness and unsteadiness of gait magnetic resonance imaging showed a cystic lesion with isointensity to cerebrospinal fluid in the left cerebellar hemisphere reaching into the fourth ventricle the patient underwent fenestration of the cyst and creation of a communication between the fourth ventricle and cyst because the tight attachment of the cyst wall to the cerebellum prevented total removal of the cyst although pathologic examination did not show finding typical of enterogenous cyst the diagnosis wa finally made based on the presence of basement membrane and immunohistochemical result conclusion the diagnosis of enterogenous cyst is based mainly on histologic finding because characteristic finding on neuroimaging have not been defined although total resection of enterogenous cyst is recommended in general partial resection while ensuring the cyst communicates adequately with the surrounding cerebrospinal fluid space with or without a shunt procedure may be useful if the cyst is adherent to surrounding neurovascular structure
26511139,correlation between mutation and mrna expression of apc and mutyh gene new insight into hereditary colorectal polyposis predisposition,background transcript dosage imbalance may influence the transcriptome to gain insight into the role of altered gene expression in hereditary colorectal polyposis predisposition in the present study we analyzed absolute and allelespecific expression ase of adenomatous polyposis coli apc and muty homolog mutyh gene method we analyzed dna and rna extracted from peripheral blood mononuclear cell pbmc of familial polyposis patient and healthy blood donor selected according similar gender and age patient were studied for germline alteration in both gene using dhplc mlpa and automated sequencing apc and mutyh mrna expression level were investigated by quantitative realtime pcr qrtpcr analysis using taqman assay and by ase assay using dhplcbased primer extension result twenty out of patient showed germline mutation in apc gene and six in mutyh gene twentynine patient did not show mutation in both gene result from qrtpcr indicated that gene expression of both apc and mutyh wa reduced in patient analyzed in particular a significant reduction in apc expression wa observed in patient without apc germline mutation v control group p while apc expression in the mutation carrier patient although lower compared to control individual did not show statistical significance on the other hand a significant reduced mutyh expression wa detected in patient with mutyh mutation v control group p altered ase of apc wa detected in four out of eight apc mutation carrier in particular one case showed a complete loss of one allele among apc mutation negative case out of showed a moderate ase ase of mutyh did not show any altered expression in the case analyzed spearmans rho test analysis showed a positive and significant correlation between apc and mutyh gene both in case and in control p and p conclusion apc and mutyh showed a reduced germline expression not always corresponding to gene mutation expression of apc is decreased in mutation negative case and this appears to be a promising indicator of fap predisposition while for mutyh gene mutation is associated to reduced mrna expression this study could improve the predictive genetic diagnosis of atrisk individual belonging to family with reduced mrna expression regardless of presence of mutation,Non-Cancer,1,correlation between mutation and mrna expression of apc and mutyh gene new insight into hereditary colorectal polyposis predisposition background transcript dosage imbalance may influence the transcriptome to gain insight into the role of altered gene expression in hereditary colorectal polyposis predisposition in the present study we analyzed absolute and allelespecific expression ase of adenomatous polyposis coli apc and muty homolog mutyh gene method we analyzed dna and rna extracted from peripheral blood mononuclear cell pbmc of familial polyposis patient and healthy blood donor selected according similar gender and age patient were studied for germline alteration in both gene using dhplc mlpa and automated sequencing apc and mutyh mrna expression level were investigated by quantitative realtime pcr qrtpcr analysis using taqman assay and by ase assay using dhplcbased primer extension result twenty out of patient showed germline mutation in apc gene and six in mutyh gene twentynine patient did not show mutation in both gene result from qrtpcr indicated that gene expression of both apc and mutyh wa reduced in patient analyzed in particular a significant reduction in apc expression wa observed in patient without apc germline mutation v control group p while apc expression in the mutation carrier patient although lower compared to control individual did not show statistical significance on the other hand a significant reduced mutyh expression wa detected in patient with mutyh mutation v control group p altered ase of apc wa detected in four out of eight apc mutation carrier in particular one case showed a complete loss of one allele among apc mutation negative case out of showed a moderate ase ase of mutyh did not show any altered expression in the case analyzed spearmans rho test analysis showed a positive and significant correlation between apc and mutyh gene both in case and in control p and p conclusion apc and mutyh showed a reduced germline expression not always corresponding to gene mutation expression of apc is decreased in mutation negative case and this appears to be a promising indicator of fap predisposition while for mutyh gene mutation is associated to reduced mrna expression this study could improve the predictive genetic diagnosis of atrisk individual belonging to family with reduced mrna expression regardless of presence of mutation
26513044,nevus anemicus associated with neurofibromatosis type in a neonate a case report,neurofibromatosis type nf is a multisystemic autosomal dominant disease affecting approximately individual in the diagnostic criterion developed by nih in allow unequivocal diagnosis in all case but the youngest child due to the variable phenotypic expression the diagnosis of nf in the youngest may be challenging particularly when the distinctive cutaneous lesion are missing we describe the case of a neonate who presented at birth solely with a nevus anemicus although this is not considered a diagnostic feature given the presence of a few cafe au lait lesion in the patient father the genetic test wa performed and the diagnosis of nf confirmed to our knowledge the association between nevus anemicus and nf is only anedoctal the peculiarity clinical manifestation of this case highlight the high variable expressivity of the nf gene mutation and reinforces the importance of genetic counseling in affected individual,Non-Cancer,1,nevus anemicus associated with neurofibromatosis type in a neonate a case report neurofibromatosis type nf is a multisystemic autosomal dominant disease affecting approximately individual in the diagnostic criterion developed by nih in allow unequivocal diagnosis in all case but the youngest child due to the variable phenotypic expression the diagnosis of nf in the youngest may be challenging particularly when the distinctive cutaneous lesion are missing we describe the case of a neonate who presented at birth solely with a nevus anemicus although this is not considered a diagnostic feature given the presence of a few cafe au lait lesion in the patient father the genetic test wa performed and the diagnosis of nf confirmed to our knowledge the association between nevus anemicus and nf is only anedoctal the peculiarity clinical manifestation of this case highlight the high variable expressivity of the nf gene mutation and reinforces the importance of genetic counseling in affected individual
26524254,altered cerebellum development and impaired motor coordination in mouse lacking the btg gene involvement of cyclin d,cerebellar granule neuron develop postnatally from cerebellar granule precursor gcps which are located in the external granule layer egl where they massively proliferate thereafter gcps become postmitotic migrate inward to form the internal granule layer igl further differentiate and form synapsis with purkinje cell dendrite we previously showed that the btg family gene tisbtg is required for normal gcp migration here we investigated the role in cerebellar development of the related gene btg which regulates stem cell quiescence in adult neurogenic niche and is expressed in the cerebellum knockout of btg in mouse caused a major increase of the proliferation of the gcps in the egl whose thickness increased remaining hyperplastic even after postnatal day when the egl is normally reduced to a few gcp layer this wa accompanied by a slight decrease of differentiation and migration of the gcps and increase of apoptosis the gcps of double btgtisnull mouse presented combined major defect of proliferation and migration outside the egl indicating that each gene play unique and crucial role in cerebellar development remarkably these developmental defect lead to a permanent increase of the adult cerebellar volume in btgnull and double mutant mouse and to impairment in all mutant including tisnull of the cerebellumdependent motor coordination gain and lossoffunction strategy in a gcp cell line revealed that btg regulates the proliferation of gcps selectively through cyclin d thus btg play a critical role for cerebellar maturation and function,Non-Cancer,1,altered cerebellum development and impaired motor coordination in mouse lacking the btg gene involvement of cyclin d cerebellar granule neuron develop postnatally from cerebellar granule precursor gcps which are located in the external granule layer egl where they massively proliferate thereafter gcps become postmitotic migrate inward to form the internal granule layer igl further differentiate and form synapsis with purkinje cell dendrite we previously showed that the btg family gene tisbtg is required for normal gcp migration here we investigated the role in cerebellar development of the related gene btg which regulates stem cell quiescence in adult neurogenic niche and is expressed in the cerebellum knockout of btg in mouse caused a major increase of the proliferation of the gcps in the egl whose thickness increased remaining hyperplastic even after postnatal day when the egl is normally reduced to a few gcp layer this wa accompanied by a slight decrease of differentiation and migration of the gcps and increase of apoptosis the gcps of double btgtisnull mouse presented combined major defect of proliferation and migration outside the egl indicating that each gene play unique and crucial role in cerebellar development remarkably these developmental defect lead to a permanent increase of the adult cerebellar volume in btgnull and double mutant mouse and to impairment in all mutant including tisnull of the cerebellumdependent motor coordination gain and lossoffunction strategy in a gcp cell line revealed that btg regulates the proliferation of gcps selectively through cyclin d thus btg play a critical role for cerebellar maturation and function
26531733,neurofibromatosis associated panhypopituitarism presenting a hypoglycaemic seizure and strokelike symptom,a yearold man with a known history of neurofibromatosis nf presented within day of diarrhoeal illness followed by encephalopathy facial twitching hypoglycaemia hypotension tachycardia and lowgrade fever examination showed multiple cafeaulait spot and neurofibroma over the trunk arm and leg and receptive aphasia with right homonymous hemianopia which resolved workup for cardiac inflammatory and infectious aetiology wa unrevealing a brain mri showed gyral swelling with increased t fluidattenuated inversion recovery signal and diffusion restriction in the left cerebral cortex neuroendocrine finding suggested panhypopituitarism with centrally derived adrenal insufficiency supportive treatment hormone supplementation antibiotic antiviral and levetiracetam yielded clinical improvement a followup brain mri showed focal left parietooccipital atrophy with finding of cortical laminar necrosis in conclusion we describe a case of nfassociated panhypopituitarism presenting a hypoglycaemic seizure and strokelike finding hitherto unreported manifestation of nf prompt recognition and treatment of these associated condition can prevent devastating complication,Non-Cancer,1,neurofibromatosis associated panhypopituitarism presenting a hypoglycaemic seizure and strokelike symptom a yearold man with a known history of neurofibromatosis nf presented within day of diarrhoeal illness followed by encephalopathy facial twitching hypoglycaemia hypotension tachycardia and lowgrade fever examination showed multiple cafeaulait spot and neurofibroma over the trunk arm and leg and receptive aphasia with right homonymous hemianopia which resolved workup for cardiac inflammatory and infectious aetiology wa unrevealing a brain mri showed gyral swelling with increased t fluidattenuated inversion recovery signal and diffusion restriction in the left cerebral cortex neuroendocrine finding suggested panhypopituitarism with centrally derived adrenal insufficiency supportive treatment hormone supplementation antibiotic antiviral and levetiracetam yielded clinical improvement a followup brain mri showed focal left parietooccipital atrophy with finding of cortical laminar necrosis in conclusion we describe a case of nfassociated panhypopituitarism presenting a hypoglycaemic seizure and strokelike finding hitherto unreported manifestation of nf prompt recognition and treatment of these associated condition can prevent devastating complication
26537623,remission and platelet response with romiplostim in primary immune thrombocytopenia final result from a phase study,in anecdotal report some patient with immune thrombocytopenia itp maintained platelet count after discontinuing romiplostim here we examined rate of platelet response x l remission splenectomy and adverse event in patient with primary itp duration x l at the end of month entered a dose taper in which the romiplostim dose wa decreased a long a platelet count were maintained remission platelet count x l for consecutive week with no itp treatment wa evaluated in patient once romiplostim wa discontinued over the month a high response rate wa observed platelet response occurred quickly median week and wa observed for a cumulative median of month remission wa observed in patient there were no significantly predictor of remission most patient had remission start before the forced taper no new safety signal were identified thus in patient with earlystage itp romiplostim wa well tolerated and induced rapid response with remission occurring in approximately onethird of patient nct amgen,Non-Cancer,1,remission and platelet response with romiplostim in primary immune thrombocytopenia final result from a phase study in anecdotal report some patient with immune thrombocytopenia itp maintained platelet count after discontinuing romiplostim here we examined rate of platelet response x l remission splenectomy and adverse event in patient with primary itp duration x l at the end of month entered a dose taper in which the romiplostim dose wa decreased a long a platelet count were maintained remission platelet count x l for consecutive week with no itp treatment wa evaluated in patient once romiplostim wa discontinued over the month a high response rate wa observed platelet response occurred quickly median week and wa observed for a cumulative median of month remission wa observed in patient there were no significantly predictor of remission most patient had remission start before the forced taper no new safety signal were identified thus in patient with earlystage itp romiplostim wa well tolerated and induced rapid response with remission occurring in approximately onethird of patient nct amgen
26545049,microdeletion delq excluding the mn gene in a patient with craniofacial anomaly,several study have recently reported that q deletion encompassing the mn gene are associated with craniofacial anomaly these observation are consistent with the hypothesis that mn haploinsufficiency may be solely responsible for craniofacial anomaly andor cleft palate we report here the case of a yearold boy presenting with global developmental delay and craniofacial anomaly including severe maxillary protrusion and retromicrognathia arraycgh detected a mb de novo deletion of chromosome q which did not encompass the mn gene thought to be the main pathological candidate in q deletion this observation combined with data from other patient from the database of chromosomal imbalance and phenotype in human using ensemble resource decipher suggests that other gene in the q region are likely involved in craniofacial anomaly andor may contribute to the phenotypic variability observed in patient with mn deletion,Non-Cancer,1,microdeletion delq excluding the mn gene in a patient with craniofacial anomaly several study have recently reported that q deletion encompassing the mn gene are associated with craniofacial anomaly these observation are consistent with the hypothesis that mn haploinsufficiency may be solely responsible for craniofacial anomaly andor cleft palate we report here the case of a yearold boy presenting with global developmental delay and craniofacial anomaly including severe maxillary protrusion and retromicrognathia arraycgh detected a mb de novo deletion of chromosome q which did not encompass the mn gene thought to be the main pathological candidate in q deletion this observation combined with data from other patient from the database of chromosomal imbalance and phenotype in human using ensemble resource decipher suggests that other gene in the q region are likely involved in craniofacial anomaly andor may contribute to the phenotypic variability observed in patient with mn deletion
26546030,update on mastocytosis part pathophysiology clinical feature and diagnosis,mastocytosis is a term used to describe a heterogeneous group of disorder characterized by clonal proliferation of mast cell in various organ the organ most often affected is the skin mastocytosis is a relatively rare disorder that affect both sex equally it can occur at any age although it tends to appear in the first decade of life or later between the second and fifth decade our understanding of the pathophysiology of mastocytosis ha improved greatly in recent year with the discovery that somatic ckit mutation and aberrant immunophenotypic feature have an important role the clinical manifestation of mastocytosis are diverse and skin lesion are the key to diagnosis in most patient,Non-Cancer,1,update on mastocytosis part pathophysiology clinical feature and diagnosis mastocytosis is a term used to describe a heterogeneous group of disorder characterized by clonal proliferation of mast cell in various organ the organ most often affected is the skin mastocytosis is a relatively rare disorder that affect both sex equally it can occur at any age although it tends to appear in the first decade of life or later between the second and fifth decade our understanding of the pathophysiology of mastocytosis ha improved greatly in recent year with the discovery that somatic ckit mutation and aberrant immunophenotypic feature have an important role the clinical manifestation of mastocytosis are diverse and skin lesion are the key to diagnosis in most patient
26556733,effect of zoledronic acid on bone fusion in osteoporotic patient after lumbar fusion,unlabelled treatment with zoledronic acid in osteoporotic patient with spinal fusion shortens the duration of time to fusion improves the fusion rate prevents the subsequent adjacent vertebral compression fracture improves the clinical outcome and prevents immobilizationinduced bone loss in the hip introduction the objective of the study wa to explore the effect of zoledronic acid on the healing process in osteoporotic patient following spinal fusion in a randomized placebocontrolled and tripleblinded study method seventynine osteoporotic patient with singlelevel degenerative spondylolisthesis were randomly assigned to receive either zoledronic acid infusion zoledronic acid group or saline infusion control after spinal fusion functional radiography and ct scan were used to evaluate fusion status bone formation wa graded into three category grade a bridging bone bonding with adjacent vertebral body grade b bridging bone bonding with either superior or inferior vertebral body or grade c incomplete bony bridging a solid fusion wa defined a less than of angular motion with grade a or b bone formation adjacent vertebral compression fracture vcf were assessed on mri at month after surgery serum level of carboxy terminal crosslinked telopeptide of type i collagen betactx and aminoterminal propeptide of type i procollagen pinp wa measured bone mineral density bmd wa measured by dxa oswestry disability index odi wa used to assess the clinical outcome result grade a or b bridging bone wa more frequently observed in zoledronic acid group at and month postoperation compared to the control group p at month postoperation bridging bone and solid fusion were not significantly different between group no patient in zoledronic acid group showed avcf whereas six patient in the control group did p both betactx and pinp were suppressed in zoledronic acid group bmd at the femoral neck decreased rapidly and did not return to the preoperative level in the control at and month after surgery zoledronic acid prevented this immobilizationinduced bone loss and increased bmd odi showed the improved clinical outcome compared with control at and month postsurgery conclusion treatment with zoledronic acid in osteoporotic patient with spinal fusion shortens the time to fusion improves the fusion rate prevents subsequent avcfs and improves clinical outcome,Non-Cancer,1,effect of zoledronic acid on bone fusion in osteoporotic patient after lumbar fusion unlabelled treatment with zoledronic acid in osteoporotic patient with spinal fusion shortens the duration of time to fusion improves the fusion rate prevents the subsequent adjacent vertebral compression fracture improves the clinical outcome and prevents immobilizationinduced bone loss in the hip introduction the objective of the study wa to explore the effect of zoledronic acid on the healing process in osteoporotic patient following spinal fusion in a randomized placebocontrolled and tripleblinded study method seventynine osteoporotic patient with singlelevel degenerative spondylolisthesis were randomly assigned to receive either zoledronic acid infusion zoledronic acid group or saline infusion control after spinal fusion functional radiography and ct scan were used to evaluate fusion status bone formation wa graded into three category grade a bridging bone bonding with adjacent vertebral body grade b bridging bone bonding with either superior or inferior vertebral body or grade c incomplete bony bridging a solid fusion wa defined a less than of angular motion with grade a or b bone formation adjacent vertebral compression fracture vcf were assessed on mri at month after surgery serum level of carboxy terminal crosslinked telopeptide of type i collagen betactx and aminoterminal propeptide of type i procollagen pinp wa measured bone mineral density bmd wa measured by dxa oswestry disability index odi wa used to assess the clinical outcome result grade a or b bridging bone wa more frequently observed in zoledronic acid group at and month postoperation compared to the control group p at month postoperation bridging bone and solid fusion were not significantly different between group no patient in zoledronic acid group showed avcf whereas six patient in the control group did p both betactx and pinp were suppressed in zoledronic acid group bmd at the femoral neck decreased rapidly and did not return to the preoperative level in the control at and month after surgery zoledronic acid prevented this immobilizationinduced bone loss and increased bmd odi showed the improved clinical outcome compared with control at and month postsurgery conclusion treatment with zoledronic acid in osteoporotic patient with spinal fusion shortens the time to fusion improves the fusion rate prevents subsequent avcfs and improves clinical outcome
26584349,mesenchymal stem cell engineered to express selectin ligand and il exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis,systemic administration of mesenchymal stem cell msc affords the potential to ameliorate the symptom of multiple sclerosis m in both preclinical and clinical study however the efficacy of mscbased therapy for m likely depends on the number of cell that home to inflamed tissue and on the controlled production of paracrine and immunomodulatory factor previously we reported that engineered msc expressing pselectin glycoprotein ligand psgl and sialyllewisx slex via mrna transfection facilitated the targeted delivery of antiinflammatory cytokine interleukin il to inflamed ear here we evaluated whether targeted delivery of msc with triple psglslexil engineering improves therapeutic outcome in mouse experimental autoimmune encephalomyelitis eae a murine model for human m we found psglslex mrna transfection significantly enhanced msc homing to the inflamed spinal cord this is consistent with result from in vitro flow chamber assay in which psglslex mrna transfection significantly increased the percentage of rolling and adherent cell on activated brain microvascular endothelial cell which mimic the inflamed endothelium of blood brainspinal cord barrier in eae in addition iltransfected msc show significant inhibitory activity on the proliferation of cd t lymphocyte from eae mouse in vivo treatment with msc engineered with psglslexil in eae mouse exhibited a superior therapeutic function over native unmodified msc evidenced by significantly improved myelination and decreased lymphocyte infiltration into the white matter of the spinal cord our strategy of targeted delivery of performanceenhanced msc could potentially be utilized to increase the effectiveness of mscbased therapy for m and other central nervous system cns disorder,Non-Cancer,1,mesenchymal stem cell engineered to express selectin ligand and il exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis systemic administration of mesenchymal stem cell msc affords the potential to ameliorate the symptom of multiple sclerosis m in both preclinical and clinical study however the efficacy of mscbased therapy for m likely depends on the number of cell that home to inflamed tissue and on the controlled production of paracrine and immunomodulatory factor previously we reported that engineered msc expressing pselectin glycoprotein ligand psgl and sialyllewisx slex via mrna transfection facilitated the targeted delivery of antiinflammatory cytokine interleukin il to inflamed ear here we evaluated whether targeted delivery of msc with triple psglslexil engineering improves therapeutic outcome in mouse experimental autoimmune encephalomyelitis eae a murine model for human m we found psglslex mrna transfection significantly enhanced msc homing to the inflamed spinal cord this is consistent with result from in vitro flow chamber assay in which psglslex mrna transfection significantly increased the percentage of rolling and adherent cell on activated brain microvascular endothelial cell which mimic the inflamed endothelium of blood brainspinal cord barrier in eae in addition iltransfected msc show significant inhibitory activity on the proliferation of cd t lymphocyte from eae mouse in vivo treatment with msc engineered with psglslexil in eae mouse exhibited a superior therapeutic function over native unmodified msc evidenced by significantly improved myelination and decreased lymphocyte infiltration into the white matter of the spinal cord our strategy of targeted delivery of performanceenhanced msc could potentially be utilized to increase the effectiveness of mscbased therapy for m and other central nervous system cns disorder
26584588,the human decapping scavenger enzyme dcps modulates microrna turnover,the decapping scavenger enzyme dcps is known for it role in hydrolyzing the cap structure following mrna degradation recently we discovered a new function in mirna degradation activation for the ortholog of dcps in c elegans here we show that human dcps conserve it role in mirna turnover in human cell dcps is a nucleocytoplasmic shuttling protein that activates mirna degradation independently of it scavenger decapping activity in the cytoplasmic compartment we also demonstrate that this new function for dcps requires the contribution of the exonuclease xrn our finding support a conserved role of dcps a a modulator of mirna turnover in animal,Non-Cancer,1,the human decapping scavenger enzyme dcps modulates microrna turnover the decapping scavenger enzyme dcps is known for it role in hydrolyzing the cap structure following mrna degradation recently we discovered a new function in mirna degradation activation for the ortholog of dcps in c elegans here we show that human dcps conserve it role in mirna turnover in human cell dcps is a nucleocytoplasmic shuttling protein that activates mirna degradation independently of it scavenger decapping activity in the cytoplasmic compartment we also demonstrate that this new function for dcps requires the contribution of the exonuclease xrn our finding support a conserved role of dcps a a modulator of mirna turnover in animal
26586230,diverse cutaneous presentation of langerhans cell histiocytosis in child a retrospective cohort study,background langerhans cell histiocytosis lch is a rare disease frequently affecting young child procedure we performed a retrospective study in patient younger than year old manifesting with skin symptom and documented their different cutaneous lesion and systemic symptom we compared subgroup of child with singlesystem skinonly and multisystem disease and sought sign predictive for multisystem disease in a small sample of patient braf mutation were analyzed in archived biopsy result a wide spectrum of cutaneous presentation varying from crusted nodule and papule blister vascular tumorlike lesion scaling orange to red macule frequently in seborrheic region to purpuric macule and papule wa documented in our cohort of child otitis externa wa a common manifestation and mucosal lesion were seen in three patient a novel manifestation wa a redblue nodule that appeared in a patient after a vaccination none of the cutaneous lesion wa predictive for the classification or final outcome a a singlesystem or multisystem disease however later onset and a more protracted course of skin lesion were more frequent finding in multisystem lch mucosal lesion and otitis externa were almost exclusively seen in patient with multisystem disease a finding that warrant further investigation both wildtype wt and mutated braf were found not only in multisystem lch but also in skinonly lch two case with rapidly resolving congenital lesion had wt braf conclusion late onset and a protracted course of skin lesion are associated with mslch whereas wt braf is found in rapidly resolving skin lesion,Non-Cancer,1,diverse cutaneous presentation of langerhans cell histiocytosis in child a retrospective cohort study background langerhans cell histiocytosis lch is a rare disease frequently affecting young child procedure we performed a retrospective study in patient younger than year old manifesting with skin symptom and documented their different cutaneous lesion and systemic symptom we compared subgroup of child with singlesystem skinonly and multisystem disease and sought sign predictive for multisystem disease in a small sample of patient braf mutation were analyzed in archived biopsy result a wide spectrum of cutaneous presentation varying from crusted nodule and papule blister vascular tumorlike lesion scaling orange to red macule frequently in seborrheic region to purpuric macule and papule wa documented in our cohort of child otitis externa wa a common manifestation and mucosal lesion were seen in three patient a novel manifestation wa a redblue nodule that appeared in a patient after a vaccination none of the cutaneous lesion wa predictive for the classification or final outcome a a singlesystem or multisystem disease however later onset and a more protracted course of skin lesion were more frequent finding in multisystem lch mucosal lesion and otitis externa were almost exclusively seen in patient with multisystem disease a finding that warrant further investigation both wildtype wt and mutated braf were found not only in multisystem lch but also in skinonly lch two case with rapidly resolving congenital lesion had wt braf conclusion late onset and a protracted course of skin lesion are associated with mslch whereas wt braf is found in rapidly resolving skin lesion
26622064,kit dvmutated bone marrow mesenchymal stem cell in indolent systemic mastocytosis are associated with disease progression,multilineage involvement of bone marrow bm hematopoiesis by the somatic kit dv mutation is present in a subset of adult indolent systemic mastocytosis ism patient in association with a poorer prognosis here we investigated the potential involvement of bm mesenchymal stem cell msc from ism patient by the kit dv mutation and it potential impact on disease progression and outcome this mutation wa investigated in highly purified bm msc and other bm cell population from ism patient followed for a median of month kit dvmutated msc were detected in of case all mscmutated patient had multilineage kit mutation v p and they more frequently showed involvement of lymphoid plus myeloid bm cell v p and a polyclonal pattern of inactivation of the xchromosome of kitmutated bm mast cell v p v other multilineage ism case moreover presence of kitmutated msc wa associated with more advanced disease feature a greater rate of disease progression v p and a shorter progressionfree survival p overall these result support the notion that ism patient with mutated msc may have acquired the kit mutation in a common pluripotent progenitor cell prior to differentiation into msc and hematopoietic precursor cell before the xchromosome inactivation process occurs from a clinical point of view acquisition of the kit mutation in an earlier bm precursor cell confers a significantly greater risk for disease progression and a poorer outcome,Non-Cancer,1,kit dvmutated bone marrow mesenchymal stem cell in indolent systemic mastocytosis are associated with disease progression multilineage involvement of bone marrow bm hematopoiesis by the somatic kit dv mutation is present in a subset of adult indolent systemic mastocytosis ism patient in association with a poorer prognosis here we investigated the potential involvement of bm mesenchymal stem cell msc from ism patient by the kit dv mutation and it potential impact on disease progression and outcome this mutation wa investigated in highly purified bm msc and other bm cell population from ism patient followed for a median of month kit dvmutated msc were detected in of case all mscmutated patient had multilineage kit mutation v p and they more frequently showed involvement of lymphoid plus myeloid bm cell v p and a polyclonal pattern of inactivation of the xchromosome of kitmutated bm mast cell v p v other multilineage ism case moreover presence of kitmutated msc wa associated with more advanced disease feature a greater rate of disease progression v p and a shorter progressionfree survival p overall these result support the notion that ism patient with mutated msc may have acquired the kit mutation in a common pluripotent progenitor cell prior to differentiation into msc and hematopoietic precursor cell before the xchromosome inactivation process occurs from a clinical point of view acquisition of the kit mutation in an earlier bm precursor cell confers a significantly greater risk for disease progression and a poorer outcome
26626649,direct intrahepatic portocaval shunt for treatment of portal thrombosis and buddchiari syndrome,buddchiari syndrome bcs refers to hepatic venous outflow obstruction that in severe case can lead to acute liver failure prompting consideration of revascularization or transplantation here a year old female with angiographically proven bcs secondary to jakvf positive polycythemia vera on therapeutic warfarin presented with acute liver failure alf imaging revealed a new near complete thrombotic occlusion of the main portal vein with extension into the superior mesenteric vein an emergent direct intrahepatic portocaval shunt dip wa created and liver function promptly normalized she ha been maintained on rivaroxaban since that time serial assessment over year demonstrated continued shunt patency and improved flow in the mesenteric vasculature on ultrasound a well a normal liver function dip is a viable alternative in the treatment of alf from bcs when standard recanalization is not feasible improved blood flow may also improve portalmesenteric clot burden while further investigation is needed new targeted anticoagulant may be viable a a long term anticoagulation strategy,Non-Cancer,1,direct intrahepatic portocaval shunt for treatment of portal thrombosis and buddchiari syndrome buddchiari syndrome bcs refers to hepatic venous outflow obstruction that in severe case can lead to acute liver failure prompting consideration of revascularization or transplantation here a year old female with angiographically proven bcs secondary to jakvf positive polycythemia vera on therapeutic warfarin presented with acute liver failure alf imaging revealed a new near complete thrombotic occlusion of the main portal vein with extension into the superior mesenteric vein an emergent direct intrahepatic portocaval shunt dip wa created and liver function promptly normalized she ha been maintained on rivaroxaban since that time serial assessment over year demonstrated continued shunt patency and improved flow in the mesenteric vasculature on ultrasound a well a normal liver function dip is a viable alternative in the treatment of alf from bcs when standard recanalization is not feasible improved blood flow may also improve portalmesenteric clot burden while further investigation is needed new targeted anticoagulant may be viable a a long term anticoagulation strategy
26706013,genotypephenotype correlation in tuberous sclerosis complex,tuberous sclerosis complex tsc is an autosomal dominant disorder characterized by the development of widespread hamartomatous lesion in various organ including brain skin kidney heart and eye central nervous system is almost invariably involved with up to of patient presenting with epilepsy and at least half of patient having intellectual disability or other neuropsychiatric disorder including autism spectrum disorder tsc is caused by the mutation in one of the gene tsc at q and tsc at p they respectively encode for hamartin and tuberin which form an intracellular complex inhibiting the mammalian target of rapamycin mammalian target of rapamycin overactivation following the genetic defect determines the cell growth and proliferation responsible for tscrelated lesion a well a the alteration in neuronal excitability and synaptogenesis leading to epilepsy and neuropsychiatric disorder a causative mutation for the disorder is identified in about of patient with a clinical diagnosis of tsc mosaicism and technology limit likely explain most of the no mutation identified case this review confirms that patient with tsc mutation considered a a group usually present a more severe phenotype characterized by higher number of tuber earlier age at seizure onset and higher prevalence of intellectual disability however the clinical phenotype of the disease present a high variability thus making the prediction of the phenotype on an individual basis still challenging the increasing application of new molecular technique to subject with tsc ha the potential to significantly reduce the rate of patient with no mutation demonstrated and to identify an increasing higher number of mutation this would hopefully allow a better characterization of higher risk mutation which might help clinician to plan individualized surveillance plan furthermore the increasing availability of disease registry to collect clinical and genetics data of patient help to define more valid and clinically oriented genotype or phenotype correlation,Non-Cancer,1,genotypephenotype correlation in tuberous sclerosis complex tuberous sclerosis complex tsc is an autosomal dominant disorder characterized by the development of widespread hamartomatous lesion in various organ including brain skin kidney heart and eye central nervous system is almost invariably involved with up to of patient presenting with epilepsy and at least half of patient having intellectual disability or other neuropsychiatric disorder including autism spectrum disorder tsc is caused by the mutation in one of the gene tsc at q and tsc at p they respectively encode for hamartin and tuberin which form an intracellular complex inhibiting the mammalian target of rapamycin mammalian target of rapamycin overactivation following the genetic defect determines the cell growth and proliferation responsible for tscrelated lesion a well a the alteration in neuronal excitability and synaptogenesis leading to epilepsy and neuropsychiatric disorder a causative mutation for the disorder is identified in about of patient with a clinical diagnosis of tsc mosaicism and technology limit likely explain most of the no mutation identified case this review confirms that patient with tsc mutation considered a a group usually present a more severe phenotype characterized by higher number of tuber earlier age at seizure onset and higher prevalence of intellectual disability however the clinical phenotype of the disease present a high variability thus making the prediction of the phenotype on an individual basis still challenging the increasing application of new molecular technique to subject with tsc ha the potential to significantly reduce the rate of patient with no mutation demonstrated and to identify an increasing higher number of mutation this would hopefully allow a better characterization of higher risk mutation which might help clinician to plan individualized surveillance plan furthermore the increasing availability of disease registry to collect clinical and genetics data of patient help to define more valid and clinically oriented genotype or phenotype correlation
26748894,spleen enlargement is a risk factor for thrombosis in essential thrombocythemia evaluation on patient,spleen enlargement present in of essential thrombocythemia et patient at diagnosis is a feature clinically easy to assess confirmable by echography with a very low chance of misinterpretation nonetheless the clinical and prognostic role of splenomegaly ha been seldom evaluated from to et patient retrospectively collected in the database of the lazio cooperative group and bologna university hospital were evaluable for spleen enlargement at diagnosis and included in the analysis on the whole spleen wa enlarged in patient in most case splenomegaly wa mild cm patient with splenomegaly were younger predominantly male presented higher platelet count and jakvf allele burden and had a lower incidence of concomitant cardiovascular risk factor at least one thrombotic event during followup occurred in patient without spleen enlargement compared to patient with spleen enlargement p despite comparable use of cytoreductiveantiplatelet therapy in the two group the cumulative risk of thrombosis at year wa significantly higher in patient with baseline splenomegaly versus in patient without splenomegaly p in multivariate analysis exploring risk factor for thrombosis splenomegaly retained it negative prognostic role together with previous thrombosis leucocyte count and male gender baseline splenomegaly seems to be an independent additional risk factor for thrombosis in nonstrictly whodefined et patient this data could be useful in the reallife clinical management of these patient,Non-Cancer,1,spleen enlargement is a risk factor for thrombosis in essential thrombocythemia evaluation on patient spleen enlargement present in of essential thrombocythemia et patient at diagnosis is a feature clinically easy to assess confirmable by echography with a very low chance of misinterpretation nonetheless the clinical and prognostic role of splenomegaly ha been seldom evaluated from to et patient retrospectively collected in the database of the lazio cooperative group and bologna university hospital were evaluable for spleen enlargement at diagnosis and included in the analysis on the whole spleen wa enlarged in patient in most case splenomegaly wa mild cm patient with splenomegaly were younger predominantly male presented higher platelet count and jakvf allele burden and had a lower incidence of concomitant cardiovascular risk factor at least one thrombotic event during followup occurred in patient without spleen enlargement compared to patient with spleen enlargement p despite comparable use of cytoreductiveantiplatelet therapy in the two group the cumulative risk of thrombosis at year wa significantly higher in patient with baseline splenomegaly versus in patient without splenomegaly p in multivariate analysis exploring risk factor for thrombosis splenomegaly retained it negative prognostic role together with previous thrombosis leucocyte count and male gender baseline splenomegaly seems to be an independent additional risk factor for thrombosis in nonstrictly whodefined et patient this data could be useful in the reallife clinical management of these patient
26760961,hepatitis b virus x protein binding to hepsin promotes c production by inducing il secretion from hepatocytes,hepatitis b virus hbv x protein hbx is an important effector for hbvassociated pathogenesis in this study we identified hepsin a an hbxinteracting protein and investigated the effect of hepsin on hbxmediated complement component c secretion in hepatocytes in vivo and in vitro binding between hbx and hepsin wa confirmed by coimmunoprecipitation and glutathione stransferase pulldown assay hbx synergized with hepsin to promote c production by potentiating interleukin il secretion knockdown of endogenous hepsin attenuated c and il secretion induced by hbx in hepatic cell in addition level of hepsin protein correlated positively with c expression in human nontumor liver tissue further exploration revealed that hbx and hepsin increased c promoter activity by upregulating the expression and phosphorylation of the transcription factor caatenhancer binding protein beta cebpbeta which bind to the ilil response element in the c promoter hbx and hepsin synergistically enhanced il mrna level and promoter activity by increasing the nuclear translocation of nuclear factor kappab nfkappab our finding show for the first time that binding between hbx and hepsin promotes c production by inducing il secretion in hepatocytes,Non-Cancer,1,hepatitis b virus x protein binding to hepsin promotes c production by inducing il secretion from hepatocytes hepatitis b virus hbv x protein hbx is an important effector for hbvassociated pathogenesis in this study we identified hepsin a an hbxinteracting protein and investigated the effect of hepsin on hbxmediated complement component c secretion in hepatocytes in vivo and in vitro binding between hbx and hepsin wa confirmed by coimmunoprecipitation and glutathione stransferase pulldown assay hbx synergized with hepsin to promote c production by potentiating interleukin il secretion knockdown of endogenous hepsin attenuated c and il secretion induced by hbx in hepatic cell in addition level of hepsin protein correlated positively with c expression in human nontumor liver tissue further exploration revealed that hbx and hepsin increased c promoter activity by upregulating the expression and phosphorylation of the transcription factor caatenhancer binding protein beta cebpbeta which bind to the ilil response element in the c promoter hbx and hepsin synergistically enhanced il mrna level and promoter activity by increasing the nuclear translocation of nuclear factor kappab nfkappab our finding show for the first time that binding between hbx and hepsin promotes c production by inducing il secretion in hepatocytes
26775773,the spectrum of nephrocutaneous disease and association genetic cause of nephrocutaneous disease,there are a significant number of disease and treatment consideration of considerable importance relating to the skin and renal system this emphasizes the need for dermatologist in practice or in clinical training to be aware of these association part i of this part continuing medical education article review the genetic syndrome with both renal and cutaneous involvement that are most important for the dermatologist to be able to identify manage and appropriately refer to nephrology colleague part ii review the inflammatory syndrome with relevant renal manifestation and therapeutic agent commonly used by dermatologist that have druginduced effect on or require close consideration of renal function in addition we will likewise review therapeutic agent commonly used by nephrologists that have druginduced effect on the skin that dermatologist are likely to encounter in clinical practice in both part of this continuing medical education article we discus diagnosis management and appropriate referral to our nephrology colleague in the context of each nephrocutaneous association there are a significant number of dermatosis associated with renal abnormality and disease emphasizing the need for dermatologist to be keenly aware of their presence in order to avoid overlooking important skin condition with potentially devastating renal complication this review discusses important nephrocutaneous disease association with recommendation for the appropriate urgency of referral to nephrology colleague for diagnosis surveillance and early management of potential renal sequela,Non-Cancer,1,the spectrum of nephrocutaneous disease and association genetic cause of nephrocutaneous disease there are a significant number of disease and treatment consideration of considerable importance relating to the skin and renal system this emphasizes the need for dermatologist in practice or in clinical training to be aware of these association part i of this part continuing medical education article review the genetic syndrome with both renal and cutaneous involvement that are most important for the dermatologist to be able to identify manage and appropriately refer to nephrology colleague part ii review the inflammatory syndrome with relevant renal manifestation and therapeutic agent commonly used by dermatologist that have druginduced effect on or require close consideration of renal function in addition we will likewise review therapeutic agent commonly used by nephrologists that have druginduced effect on the skin that dermatologist are likely to encounter in clinical practice in both part of this continuing medical education article we discus diagnosis management and appropriate referral to our nephrology colleague in the context of each nephrocutaneous association there are a significant number of dermatosis associated with renal abnormality and disease emphasizing the need for dermatologist to be keenly aware of their presence in order to avoid overlooking important skin condition with potentially devastating renal complication this review discusses important nephrocutaneous disease association with recommendation for the appropriate urgency of referral to nephrology colleague for diagnosis surveillance and early management of potential renal sequela
26873836,natural history of renal angiomyolipoma aml most patient with large amls cm can be offered active surveillance a an initial management strategy,background the natural history of renal angiomyolipoma aml is unknown treatment recommendation are based on smaller case series with selection bias towards symptomatic patient objective to define the natural history of renal aml including growth rate size and clinical presentation design setting and participant we used a unique radiology datamining system montage montage healthcare system philadelphia pa usa to retrospectively review the radiology database in an academic health centre between and to identify all renal amls of patient identified with amls had three or more imaging study suitable for analysis intervention angioembolisation surgery radiofrequency ablation and mammalian target of rapamycin inhibitor outcome measurement and statistical analysis the primary end point wa the growth rate of untreated amls we used a linear mixedeffects model to determine change in growth rate over time we evaluated the association among growth rate size and patient factor a well a intervention result and limitation the majority of untreated amls had not grown at a median followup of mo with no difference in growth rate between amls cm most amls occurred in female participant and were asymptomatic tuberous sclerosis complex tsc wa confirmed in n and presented at an earlier age median size wa cm but wa significantly larger for tsc cm pcm do not require early intervention based on size alone the vast majority are sporadic asymptomatic and initially harmless with a negligible growth rate our finding support a policy of initial active surveillance for all asymptomatic amls patient summary we evaluated the natural history and growth rate of renal amls we found no difference in growth rate between amls and cm initial a appears to be a safe management option,Non-Cancer,1,natural history of renal angiomyolipoma aml most patient with large amls cm can be offered active surveillance a an initial management strategy background the natural history of renal angiomyolipoma aml is unknown treatment recommendation are based on smaller case series with selection bias towards symptomatic patient objective to define the natural history of renal aml including growth rate size and clinical presentation design setting and participant we used a unique radiology datamining system montage montage healthcare system philadelphia pa usa to retrospectively review the radiology database in an academic health centre between and to identify all renal amls of patient identified with amls had three or more imaging study suitable for analysis intervention angioembolisation surgery radiofrequency ablation and mammalian target of rapamycin inhibitor outcome measurement and statistical analysis the primary end point wa the growth rate of untreated amls we used a linear mixedeffects model to determine change in growth rate over time we evaluated the association among growth rate size and patient factor a well a intervention result and limitation the majority of untreated amls had not grown at a median followup of mo with no difference in growth rate between amls cm most amls occurred in female participant and were asymptomatic tuberous sclerosis complex tsc wa confirmed in n and presented at an earlier age median size wa cm but wa significantly larger for tsc cm pcm do not require early intervention based on size alone the vast majority are sporadic asymptomatic and initially harmless with a negligible growth rate our finding support a policy of initial active surveillance for all asymptomatic amls patient summary we evaluated the natural history and growth rate of renal amls we found no difference in growth rate between amls and cm initial a appears to be a safe management option
26911863,a novel folliclestimulating hormone receptor mutation causing primary ovarian failure a fertility application of whole exome sequencing,study question can whole exome sequencing wes and in vitro validation study be used to find the causative genetic etiology in a patient with primary ovarian failure and infertility summary answer a novel folliclestimulating hormone receptor fshr mutation wa found by wes and shown via in vitro flow cytometry study to affect membrane trafficking what is known already wes may diagnose up to of patient with suspected disorder of sex development dsd fshr mutation are an extremely rare cause of xx gonadal dysgenesis with primary amenorrhea due to hypergonadotropic ovarian failure study design size duration a wes study wa followed by flow cytometry study of mutant protein function participantsmaterials setting method the study subject were two turkish sister with hypergonadotropic primary amenorrhea their parent and two unaffected sister the affected sibling and both parent were sequenced triowes transient transfection of hek t cell wa performed with a vector containing wildtype fshr a well a the novel fshr variant that wa discovered by wes cellular localization of fshr protein a well a fshstimulated cyclic amp camp production wa evaluated using flow cytometry main result and the role of chance both affected sister were homozygous for a previously unreported missense mutation cgt pasptyr in the second transmembrane domain of fshr modeling predicted disrupted secondary structure flow cytometry demonstrated an average of reduction in cellsurface signal detection p the mean fluorescent signal for camp second messenger of fshr stimulated by fsh wa reduced by in the mutanttransfected cell p limitation reason for caution this is an in vitro validation all novel purported genetic variant can be clinically reported only a variant of uncertain significance until more patient with a similar phenotype are discovered with the same variant wider implication of the finding we report the first wesdiscovered fshr mutation validated by quantitative flow cytometry wes is a valuable tool for diagnosis of rare genetic disease and flow cytometry allows for quantitative characterization of purported variant wesassisted diagnosis allows for treatment aimed at the underlying molecular etiology of disease future study should focus on pharmacological and assisted reproductive treatment aimed at the disrupted fshr so that patient with fsh resistance can be treated by personalized medicine study fundingcompeting interest ev is partially funded by the dsd translational research network nichd rhd msb is funded by the neuroendocrinology sex difference and reproduction training grant nichd thd the author have no competing interest to disclose,Non-Cancer,1,a novel folliclestimulating hormone receptor mutation causing primary ovarian failure a fertility application of whole exome sequencing study question can whole exome sequencing wes and in vitro validation study be used to find the causative genetic etiology in a patient with primary ovarian failure and infertility summary answer a novel folliclestimulating hormone receptor fshr mutation wa found by wes and shown via in vitro flow cytometry study to affect membrane trafficking what is known already wes may diagnose up to of patient with suspected disorder of sex development dsd fshr mutation are an extremely rare cause of xx gonadal dysgenesis with primary amenorrhea due to hypergonadotropic ovarian failure study design size duration a wes study wa followed by flow cytometry study of mutant protein function participantsmaterials setting method the study subject were two turkish sister with hypergonadotropic primary amenorrhea their parent and two unaffected sister the affected sibling and both parent were sequenced triowes transient transfection of hek t cell wa performed with a vector containing wildtype fshr a well a the novel fshr variant that wa discovered by wes cellular localization of fshr protein a well a fshstimulated cyclic amp camp production wa evaluated using flow cytometry main result and the role of chance both affected sister were homozygous for a previously unreported missense mutation cgt pasptyr in the second transmembrane domain of fshr modeling predicted disrupted secondary structure flow cytometry demonstrated an average of reduction in cellsurface signal detection p the mean fluorescent signal for camp second messenger of fshr stimulated by fsh wa reduced by in the mutanttransfected cell p limitation reason for caution this is an in vitro validation all novel purported genetic variant can be clinically reported only a variant of uncertain significance until more patient with a similar phenotype are discovered with the same variant wider implication of the finding we report the first wesdiscovered fshr mutation validated by quantitative flow cytometry wes is a valuable tool for diagnosis of rare genetic disease and flow cytometry allows for quantitative characterization of purported variant wesassisted diagnosis allows for treatment aimed at the underlying molecular etiology of disease future study should focus on pharmacological and assisted reproductive treatment aimed at the disrupted fshr so that patient with fsh resistance can be treated by personalized medicine study fundingcompeting interest ev is partially funded by the dsd translational research network nichd rhd msb is funded by the neuroendocrinology sex difference and reproduction training grant nichd thd the author have no competing interest to disclose
26942200,mechanical and histological effect of resorbable blasting medium surface treatment on the initial stability of orthodontic miniimplants,introduction this study aimed to evaluate the effect of resorbable blasting medium rbm treatment on early stability of orthodontic miniimplants by mechanical histomorphometric and histological analysis method ninetysix for mechanical study and for histological study and histomorphometric analysis titanium orthodontic miniimplants omis with machined machined group or rbmtreated cap surface rbm group were implanted in the tibia of rabbit maximum initial torque mit wa measured during insertion and maximum removal torque mrt and removal angular momentum ram were measured at and week after implantation bonetoimplant contact bic and bone area ba were analyzed at week after implantation result rbm group exhibited significantly lower mit and significantly higher mrt and ram at week than machined group no significant difference in mrt ram and bic between the two group wa noted at week although ba wa significantly higher in rbm group than in machined group rbm group showed little bone resorption whereas machined group showed new bone formation after bone resorption conclusion rbm surface treatment can provide early stability of omis around week after insertion whereas stability of machined surface omis may decrease in early stage because of bone resorption although it can subsequently recover by new bone apposition,Non-Cancer,1,mechanical and histological effect of resorbable blasting medium surface treatment on the initial stability of orthodontic miniimplants introduction this study aimed to evaluate the effect of resorbable blasting medium rbm treatment on early stability of orthodontic miniimplants by mechanical histomorphometric and histological analysis method ninetysix for mechanical study and for histological study and histomorphometric analysis titanium orthodontic miniimplants omis with machined machined group or rbmtreated cap surface rbm group were implanted in the tibia of rabbit maximum initial torque mit wa measured during insertion and maximum removal torque mrt and removal angular momentum ram were measured at and week after implantation bonetoimplant contact bic and bone area ba were analyzed at week after implantation result rbm group exhibited significantly lower mit and significantly higher mrt and ram at week than machined group no significant difference in mrt ram and bic between the two group wa noted at week although ba wa significantly higher in rbm group than in machined group rbm group showed little bone resorption whereas machined group showed new bone formation after bone resorption conclusion rbm surface treatment can provide early stability of omis around week after insertion whereas stability of machined surface omis may decrease in early stage because of bone resorption although it can subsequently recover by new bone apposition
26967226,metformin facilitates amyloidbeta generation by beta and gammasecretases via autophagy activation,the evidence of strong pathological association between type diabetes and alzheimers disease ad ha increased in recent year contrary to suggestion that antidiabetes drug may have potential for treating ad we demonstrate here that the insulin sensitizing antidiabetes drug metformin glucophage increased the generation of amyloidbeta abeta one of the major pathological hallmark of ad by promoting beta and gammasecretasemediated cleavage of amyloidbeta protein precursor abetapp in shsyy cell in addition we show that metformin caused autophagosome accumulation in tg ad model mouse extremely high gammasecretase activity wa also detected in autophagic vacuole apparently a novel site of abeta peptide generation together these data suggest that metformininduced accumulation of autophagosomes resulted in increased gammasecretase activity and abeta generation additional experiment indicated that metformin increased phosphorylation of ampactivated protein kinase which activates autophagy by suppressing mammalian target of rapamycin mtor the suppression of mtor then induces the abnormal accumulation of autophagosomes we conclude that metformin an antidiabetes drug may exacerbate ad pathogenesis by promoting amyloidogenic abetapp processing in autophagosomes,Non-Cancer,1,metformin facilitates amyloidbeta generation by beta and gammasecretases via autophagy activation the evidence of strong pathological association between type diabetes and alzheimers disease ad ha increased in recent year contrary to suggestion that antidiabetes drug may have potential for treating ad we demonstrate here that the insulin sensitizing antidiabetes drug metformin glucophage increased the generation of amyloidbeta abeta one of the major pathological hallmark of ad by promoting beta and gammasecretasemediated cleavage of amyloidbeta protein precursor abetapp in shsyy cell in addition we show that metformin caused autophagosome accumulation in tg ad model mouse extremely high gammasecretase activity wa also detected in autophagic vacuole apparently a novel site of abeta peptide generation together these data suggest that metformininduced accumulation of autophagosomes resulted in increased gammasecretase activity and abeta generation additional experiment indicated that metformin increased phosphorylation of ampactivated protein kinase which activates autophagy by suppressing mammalian target of rapamycin mtor the suppression of mtor then induces the abnormal accumulation of autophagosomes we conclude that metformin an antidiabetes drug may exacerbate ad pathogenesis by promoting amyloidogenic abetapp processing in autophagosomes
26970326,extending the spectrum of radiological finding in patient with severe osteopetrosis and different genetic background,purpose to evaluate radiological finding in a cohort of patient with infantile malignant osteopetrosis in order to establish the correlation between radiological finding and different genetic background material and method clinical file genetic analysis result and radiological examination of child treated for osteopetrosis with bone marrow transplantation in a referral center in the last year were retrospectively evaluated the study received institutional review board irb approval result twentytwo patient were included in the study male four female age month year month and the median age wa month mean month there were patient with different mutation in the tcirg gene five with mutation in the snx gene four child harbored rank mutation and one patient had a clcn mutation we noted more severe radiological finding in patient with tcirg and rank mutation including fracture osteopetrorickets hydrocephalus and hepatomegaly varus deformity of the femoral neck wa seen exclusively in patient with a tcirg mutation conclusion the variable genetic spectrum of osteopetrosis is associated with a variable radiological presentation these correlation may be helpful for priority in genetic analysis,Non-Cancer,1,extending the spectrum of radiological finding in patient with severe osteopetrosis and different genetic background purpose to evaluate radiological finding in a cohort of patient with infantile malignant osteopetrosis in order to establish the correlation between radiological finding and different genetic background material and method clinical file genetic analysis result and radiological examination of child treated for osteopetrosis with bone marrow transplantation in a referral center in the last year were retrospectively evaluated the study received institutional review board irb approval result twentytwo patient were included in the study male four female age month year month and the median age wa month mean month there were patient with different mutation in the tcirg gene five with mutation in the snx gene four child harbored rank mutation and one patient had a clcn mutation we noted more severe radiological finding in patient with tcirg and rank mutation including fracture osteopetrorickets hydrocephalus and hepatomegaly varus deformity of the femoral neck wa seen exclusively in patient with a tcirg mutation conclusion the variable genetic spectrum of osteopetrosis is associated with a variable radiological presentation these correlation may be helpful for priority in genetic analysis
26986033,eightyear followup finding of surgical treatment for severe dystrophic change in the cervical spine associated with neurofibromatosis type i a case report,longterm followup finding for dystrophic change in the cervical spine caused by neurofibromatosis type have been rarely reported a yearold boy with severe dural ectasia in the cervical spine underwent cervical posterior fusion from c to c for prevention of cervical spine fracture and spinal injury we followed him up for year after surgery we measured the progression of the destruction on yearly mri the dural ectasia gradually progressed until year postoperatively subsequently no further enlargement of the dural sac occurred at the year followup examination the patient had no limitation in the activity of daily life,Non-Cancer,1,eightyear followup finding of surgical treatment for severe dystrophic change in the cervical spine associated with neurofibromatosis type i a case report longterm followup finding for dystrophic change in the cervical spine caused by neurofibromatosis type have been rarely reported a yearold boy with severe dural ectasia in the cervical spine underwent cervical posterior fusion from c to c for prevention of cervical spine fracture and spinal injury we followed him up for year after surgery we measured the progression of the destruction on yearly mri the dural ectasia gradually progressed until year postoperatively subsequently no further enlargement of the dural sac occurred at the year followup examination the patient had no limitation in the activity of daily life
27011217,the oculocerebrorenal syndrome of lowe an update,the oculocerebrorenal syndrome of lowe is a rare xlinked multisystemic disorder characterized by the triad of congenital cataract intellectual disability and proximal renal tubular dysfunction whereas the ocular manifestation and severe muscular hypotonia are the typical first diagnostic clue apparent at birth the manifestation of incomplete renal fanconi syndrome are often recognized only later in life other characteristic feature are progressive severe growth retardation and behavioral problem with tantrum many patient develop a debilitating arthropathy treatment is symptomatic and the life span rarely exceeds year the causative oculocerebrorenal syndrome of lowe gene ocrl encodes the inositol polyphosphate phosphatase ocrl ocrl variant have not only been found in classic lowe syndrome but also in patient with a predominantly renal phenotype classified a dent disease type dent recent data indicate that there is a phenotypic continuum between dent disease and lowe syndrome suggesting that there are individual difference in the ability to compensate for the loss of enzyme function extensive research ha demonstrated that ocrl is involved in multiple intracellular process involving endocytic trafficking and actin skeleton dynamic this explains the multiorgan manifestation of the disease still the mechanism underlying the wide phenotypic spectrum are poorly understood and we are far from a causative therapy in this review we provide an update on clinical and molecular genetic finding in lowe syndrome and the cellular and physiological function of ocrl,Non-Cancer,1,the oculocerebrorenal syndrome of lowe an update the oculocerebrorenal syndrome of lowe is a rare xlinked multisystemic disorder characterized by the triad of congenital cataract intellectual disability and proximal renal tubular dysfunction whereas the ocular manifestation and severe muscular hypotonia are the typical first diagnostic clue apparent at birth the manifestation of incomplete renal fanconi syndrome are often recognized only later in life other characteristic feature are progressive severe growth retardation and behavioral problem with tantrum many patient develop a debilitating arthropathy treatment is symptomatic and the life span rarely exceeds year the causative oculocerebrorenal syndrome of lowe gene ocrl encodes the inositol polyphosphate phosphatase ocrl ocrl variant have not only been found in classic lowe syndrome but also in patient with a predominantly renal phenotype classified a dent disease type dent recent data indicate that there is a phenotypic continuum between dent disease and lowe syndrome suggesting that there are individual difference in the ability to compensate for the loss of enzyme function extensive research ha demonstrated that ocrl is involved in multiple intracellular process involving endocytic trafficking and actin skeleton dynamic this explains the multiorgan manifestation of the disease still the mechanism underlying the wide phenotypic spectrum are poorly understood and we are far from a causative therapy in this review we provide an update on clinical and molecular genetic finding in lowe syndrome and the cellular and physiological function of ocrl
27012200,rspondin facilitates differentiation of proliferating chondrocytes into hypertrophic chondrocytes by enhancing wntbetacatenin signaling in endochondral ossification,endochondral ossification is a crucial process for longitudinal growth of bone differentiating chondrocytes in growth cartilage form four sequential zone of proliferation alignment into column hypertrophy and substitution of chondrocytes with osteoblast wntbetacatenin signaling is essential for differentiation of proliferating chondrocytes into hypertrophic chondrocytes in growth cartilage rspondin rspo a member of rspondin family is an agonist for wnt signaling but it role in chondrocyte differentiation remains unknown here we report that growth cartilage of rspoknockout mouse show a decreased amount of betacatenin and increased amount collagen type ii cii and sox in the abnormally extended proliferating zone in contrast expression of collagen type x cx in the hypertrophic zone remains unchanged differentiating chondrogenic atdc cell mimicking proliferating chondrocytes upregulate rspo and it putative receptor lgr in parallel addition of recombinant human rspo to differentiating atdc cell decrease expression of cola sox and acan a well a production of proteoglycans in contrast lentivirusmediated knockdown of rspo ha the opposite effect the effect of rspo on chondrogenic differentiation is mediated by wntbetacatenin signaling and not by wntpcp or wntca signaling we propose that rspo activates wntbetacatenin signaling to reduce cola and sox and to facilitate differentiation of proliferating chondrocytes into hypertrophic chondrocytes in growth cartilage,Non-Cancer,1,rspondin facilitates differentiation of proliferating chondrocytes into hypertrophic chondrocytes by enhancing wntbetacatenin signaling in endochondral ossification endochondral ossification is a crucial process for longitudinal growth of bone differentiating chondrocytes in growth cartilage form four sequential zone of proliferation alignment into column hypertrophy and substitution of chondrocytes with osteoblast wntbetacatenin signaling is essential for differentiation of proliferating chondrocytes into hypertrophic chondrocytes in growth cartilage rspondin rspo a member of rspondin family is an agonist for wnt signaling but it role in chondrocyte differentiation remains unknown here we report that growth cartilage of rspoknockout mouse show a decreased amount of betacatenin and increased amount collagen type ii cii and sox in the abnormally extended proliferating zone in contrast expression of collagen type x cx in the hypertrophic zone remains unchanged differentiating chondrogenic atdc cell mimicking proliferating chondrocytes upregulate rspo and it putative receptor lgr in parallel addition of recombinant human rspo to differentiating atdc cell decrease expression of cola sox and acan a well a production of proteoglycans in contrast lentivirusmediated knockdown of rspo ha the opposite effect the effect of rspo on chondrogenic differentiation is mediated by wntbetacatenin signaling and not by wntpcp or wntca signaling we propose that rspo activates wntbetacatenin signaling to reduce cola and sox and to facilitate differentiation of proliferating chondrocytes into hypertrophic chondrocytes in growth cartilage
27013236,a pot mutation implicates defective telomere end fillin and telomere truncation in coat plus,coat plus cp can be caused by mutation in the ctc component of cst which promotes polymerase alpha polalphaprimasedependent fillin throughout the genome and at telomere the cellular pathology relating to cp ha not been established we identified a homozygous pot sl substitution potcp in two sibling with cp potcpinduced a proliferative arrest that could be bypassed by telomerase potcpwas expressed at normal level bound tpp and telomere and blocked atr signaling potcpwas defective in regulating telomerase leading to telomere elongation rather than the telomere shortening observed in other telomeropathies potcpwas also defective in the maintenance of the telomeric c strand causing extended overhang and stochastic telomere truncation that could be healed by telomerase consistent with shortening of the telomeric c strand metaphase chromosome showed loss of telomere synthesized by leading strand dna synthesis we propose that cp is caused by a defect in potcstdependent telomere fillin we further propose that deficiency in the fillin step generates truncated telomere that halt proliferation in cell lacking telomerase whereas in tissue expressing telomerase eg bone marrow the truncation are healed the proposed etiology can explain why cp present with feature distinct from those associated with telomerase defect eg dyskeratosis congenita,Non-Cancer,1,a pot mutation implicates defective telomere end fillin and telomere truncation in coat plus coat plus cp can be caused by mutation in the ctc component of cst which promotes polymerase alpha polalphaprimasedependent fillin throughout the genome and at telomere the cellular pathology relating to cp ha not been established we identified a homozygous pot sl substitution potcp in two sibling with cp potcpinduced a proliferative arrest that could be bypassed by telomerase potcpwas expressed at normal level bound tpp and telomere and blocked atr signaling potcpwas defective in regulating telomerase leading to telomere elongation rather than the telomere shortening observed in other telomeropathies potcpwas also defective in the maintenance of the telomeric c strand causing extended overhang and stochastic telomere truncation that could be healed by telomerase consistent with shortening of the telomeric c strand metaphase chromosome showed loss of telomere synthesized by leading strand dna synthesis we propose that cp is caused by a defect in potcstdependent telomere fillin we further propose that deficiency in the fillin step generates truncated telomere that halt proliferation in cell lacking telomerase whereas in tissue expressing telomerase eg bone marrow the truncation are healed the proposed etiology can explain why cp present with feature distinct from those associated with telomerase defect eg dyskeratosis congenita
27070304,mastocytosis a comprehensive insight,mastocytosis refers to a heterogeneous group of clinical disorder characterized by an abnormal accumulation of mast cell mc in various tissue the skin is the organ most frequently involved but all organ may be affected the clinical sign and symptom are produced by the functional effect of mast cellderived mediator and the anatomical distribution of the mast cell the whoclassification defines category of mastocytosis skin disease with or without systemic involvement is by far the most common form of childhood mastocytosis measurement of serum tryptase is important in the diagnostic algorithm of pediatric mastocytosis in child with tryptase ngml the diagnosis of cutaneous mastocytosis cm may be decided upon without bone marrow examination bme unless other sign of sm are present if the baseline tryptase level exceeds ngml a bme should be considered regardless of age if the serum tryptase is ngml in child without other sign of sm the provisional diagnosis mastocytosis in the skin mi can be established and monitored until puberty if mi remains present after puberty a bme should be performed in adultonset mastocytosis a complete staging and application of the systemic mastocytosis criterion should always be performed treatment is mainly directed at alleviation of symptom a ckit mutation prove to be very important in the pathogenesis of mastocytosis targeted therapy using kit inhibitor may evolve a important future therapeutic option,Non-Cancer,1,mastocytosis a comprehensive insight mastocytosis refers to a heterogeneous group of clinical disorder characterized by an abnormal accumulation of mast cell mc in various tissue the skin is the organ most frequently involved but all organ may be affected the clinical sign and symptom are produced by the functional effect of mast cellderived mediator and the anatomical distribution of the mast cell the whoclassification defines category of mastocytosis skin disease with or without systemic involvement is by far the most common form of childhood mastocytosis measurement of serum tryptase is important in the diagnostic algorithm of pediatric mastocytosis in child with tryptase ngml the diagnosis of cutaneous mastocytosis cm may be decided upon without bone marrow examination bme unless other sign of sm are present if the baseline tryptase level exceeds ngml a bme should be considered regardless of age if the serum tryptase is ngml in child without other sign of sm the provisional diagnosis mastocytosis in the skin mi can be established and monitored until puberty if mi remains present after puberty a bme should be performed in adultonset mastocytosis a complete staging and application of the systemic mastocytosis criterion should always be performed treatment is mainly directed at alleviation of symptom a ckit mutation prove to be very important in the pathogenesis of mastocytosis targeted therapy using kit inhibitor may evolve a important future therapeutic option
27072151,recurrence after robotic myomectomy is it associated with use of gnrh agonist,gonadotropinreleasing hormone gnrh agonist therapy is used before myomectomy to decrease the size of the fibroid but it association with fibroid recurrence postoperatively remains unsettled we undertook a retrospective study of roboticassisted myomectomy rm patient at our academic medical center to determine symptomatic recurrence and reoperation rate in those who did versus did not receive preoperative gnrh therapy only patient who had their index myomectomy at least year prior to the chart review were included in this study of rm patient identified between january and december patient had symptomatic recurrence a early a month to a late a month postoperatively the symptomatic recurrence group had significantly higher preoperative gnrh use v nonrecurrence p a total of of all patient underwent reoperation gnrh agonist use wa significantly higher in the reoperation group v no reoperation p cavity entry during the initial surgery wa also more frequent in the reoperation group v p whereas the presence of multiple fibroid size of the largest leiomyoma and uterine volume were not statistically different between group our study is among the earliest to report rm reoperation rate in patient receiving preoperative gnrh therapy showing that the role of gnrh agonist therapy to shrink myoma may not be beneficial when measured against risk of disease recurrence,Non-Cancer,1,recurrence after robotic myomectomy is it associated with use of gnrh agonist gonadotropinreleasing hormone gnrh agonist therapy is used before myomectomy to decrease the size of the fibroid but it association with fibroid recurrence postoperatively remains unsettled we undertook a retrospective study of roboticassisted myomectomy rm patient at our academic medical center to determine symptomatic recurrence and reoperation rate in those who did versus did not receive preoperative gnrh therapy only patient who had their index myomectomy at least year prior to the chart review were included in this study of rm patient identified between january and december patient had symptomatic recurrence a early a month to a late a month postoperatively the symptomatic recurrence group had significantly higher preoperative gnrh use v nonrecurrence p a total of of all patient underwent reoperation gnrh agonist use wa significantly higher in the reoperation group v no reoperation p cavity entry during the initial surgery wa also more frequent in the reoperation group v p whereas the presence of multiple fibroid size of the largest leiomyoma and uterine volume were not statistically different between group our study is among the earliest to report rm reoperation rate in patient receiving preoperative gnrh therapy showing that the role of gnrh agonist therapy to shrink myoma may not be beneficial when measured against risk of disease recurrence
27103127,romiplostim in child with immune thrombocytopenia a phase randomised doubleblind placebocontrolled study,background the thrombopoietin receptor agonist romiplostim could be an effective treatment in symptomatic child with persistent or chronic immune thrombocytopenia we aimed to assess whether romiplostim is safe and effective in child with immune thrombocytopenia of more than month duration method in this phase doubleblind study eligible participant were child with immune thrombocytopenia aged year to year and mean platelet count x l or less mean of two measurement during the screening period with no single count greater than x l and were recruited from site in the usa canada and australia participant were randomly assigned through the interactive voice response system to receive weekly romiplostim or placebo for week stratified by age year to x l without rescue drug use in the preceding week in or more of the final week week this study is registered with clinicaltrialsgov nct finding between jan and sept patient were randomly assigned to romiplostim and to placebo durable platelet response wa seen in patient in the romiplostim group and two in the placebo group p odds ratio ci durable platelet response rate with romiplostim by age were for year to younger than year for year to younger than year and for year to younger than year one of patient in the placebo group had serious adverse event compared with of patient in the romiplostim group of these serious adverse event headache and thrombocytosis in one of patient in the romiplostim group were considered treatment related no patient withdrew due to adverse event interpretation in child with chronic immune thrombocytopenia romiplostim induced a high rate of platelet response with no new safety signal ongoing romiplostim study will provide further information a to longterm efficacy safety and remission in child with immune thrombocytopenia funding amgen inc,Non-Cancer,1,romiplostim in child with immune thrombocytopenia a phase randomised doubleblind placebocontrolled study background the thrombopoietin receptor agonist romiplostim could be an effective treatment in symptomatic child with persistent or chronic immune thrombocytopenia we aimed to assess whether romiplostim is safe and effective in child with immune thrombocytopenia of more than month duration method in this phase doubleblind study eligible participant were child with immune thrombocytopenia aged year to year and mean platelet count x l or less mean of two measurement during the screening period with no single count greater than x l and were recruited from site in the usa canada and australia participant were randomly assigned through the interactive voice response system to receive weekly romiplostim or placebo for week stratified by age year to x l without rescue drug use in the preceding week in or more of the final week week this study is registered with clinicaltrialsgov nct finding between jan and sept patient were randomly assigned to romiplostim and to placebo durable platelet response wa seen in patient in the romiplostim group and two in the placebo group p odds ratio ci durable platelet response rate with romiplostim by age were for year to younger than year for year to younger than year and for year to younger than year one of patient in the placebo group had serious adverse event compared with of patient in the romiplostim group of these serious adverse event headache and thrombocytosis in one of patient in the romiplostim group were considered treatment related no patient withdrew due to adverse event interpretation in child with chronic immune thrombocytopenia romiplostim induced a high rate of platelet response with no new safety signal ongoing romiplostim study will provide further information a to longterm efficacy safety and remission in child with immune thrombocytopenia funding amgen inc
27135461,thrombopoietin receptor agonist use in child data from the pediatric itp consortium of north america icon study,background data on secondline treatment option for pediatric patient with immune thrombocytopenia itp are limited thrombopoietin receptor agonist tpora provide a nonimmunosuppressive option for child who require an increased platelet count procedure we performed a multicenter retrospective study of pediatric itp patient followed at itp consortium of north america icon site to characterize tpora use result seventynine child had a total of treatment eltrombopag romiplostim and eight trialed on both the majority had primary itp and most had chronic itp however had persistent itp and had newly diagnosed itp during the first month of treatment achieved a platelet count x l romiplostim eltrombopag p at least once in the absence of rescue therapy the average time to a response wa week for romiplostim and week for eltrombopag p only of patient demonstrated a stable response with consistent dosing over time an intermittent response with constant dose titration wa seen in and an initial response that waned to no response wa seen in significant adverse event were minimal with the exception of two patient with thrombotic event and one who developed a neutralizing antibody conclusion our result demonstrate that tpora agent are being used in child with itp of varying duration and severity the response wa similar to clinical trial but the sustainability of response varied future study need to focus on the ideal timing and rationale for these medication in pediatric patient,Non-Cancer,1,thrombopoietin receptor agonist use in child data from the pediatric itp consortium of north america icon study background data on secondline treatment option for pediatric patient with immune thrombocytopenia itp are limited thrombopoietin receptor agonist tpora provide a nonimmunosuppressive option for child who require an increased platelet count procedure we performed a multicenter retrospective study of pediatric itp patient followed at itp consortium of north america icon site to characterize tpora use result seventynine child had a total of treatment eltrombopag romiplostim and eight trialed on both the majority had primary itp and most had chronic itp however had persistent itp and had newly diagnosed itp during the first month of treatment achieved a platelet count x l romiplostim eltrombopag p at least once in the absence of rescue therapy the average time to a response wa week for romiplostim and week for eltrombopag p only of patient demonstrated a stable response with consistent dosing over time an intermittent response with constant dose titration wa seen in and an initial response that waned to no response wa seen in significant adverse event were minimal with the exception of two patient with thrombotic event and one who developed a neutralizing antibody conclusion our result demonstrate that tpora agent are being used in child with itp of varying duration and severity the response wa similar to clinical trial but the sustainability of response varied future study need to focus on the ideal timing and rationale for these medication in pediatric patient
27215853,telomereassociated aging disorder,telomere are dynamic nucleoproteindna structure that cap and protect linear chromosome end several monogenic inherited disease that display feature of human premature aging correlate with shortened telomere and are referred to collectively a telomeropathies these disorder have overlapping symptom and a common underlying mechanism of telomere dysfunction but also exhibit variable symptom and age of onset suggesting they fall along a spectrum of disorder primary telomeropathies are caused by defect in the telomere maintenance machinery whereas secondary telomeropathies have some overlapping symptom with primary telomeropathies but are generally caused by mutation in dna repair protein that contribute to telomere preservation here we review both the primary and secondary telomeropathies discus potential mechanism for tissue specificity and age of onset and highlight outstanding question in the field and future direction toward elucidating disease etiology and developing therapeutic strategy,Non-Cancer,1,telomereassociated aging disorder telomere are dynamic nucleoproteindna structure that cap and protect linear chromosome end several monogenic inherited disease that display feature of human premature aging correlate with shortened telomere and are referred to collectively a telomeropathies these disorder have overlapping symptom and a common underlying mechanism of telomere dysfunction but also exhibit variable symptom and age of onset suggesting they fall along a spectrum of disorder primary telomeropathies are caused by defect in the telomere maintenance machinery whereas secondary telomeropathies have some overlapping symptom with primary telomeropathies but are generally caused by mutation in dna repair protein that contribute to telomere preservation here we review both the primary and secondary telomeropathies discus potential mechanism for tissue specificity and age of onset and highlight outstanding question in the field and future direction toward elucidating disease etiology and developing therapeutic strategy
27216612,everolimus improves neuropsychiatric symptom in a patient with tuberous sclerosis carrying a novel tsc mutation,tuberous sclerosis complex tsc is a neurocutaneous disorder characterized by multiple symptom including neuropsychological deficit such a seizure intellectual disability and autism tsc is inherited in an autosomal dominant pattern and is caused by mutation in either the tsc or tsc gene which enhance activation of the mammalian target of rapamycin mtor signaling pathway recent study have suggested that mtor inhibitor such a rapamycin can reverse tscassociated deficit in rodent model of tsc in addition clinical trial are ongoing to test the efficacy of mtor inhibitor toward the psychiatric symptom associated with tsc here we report a case study of a korean patient with tsc who exhibited multiple symptom including frequent seizure intellectual disability language delay and social problem we performed whole exome sequencing and identified a novel small deletion mutation in tsc expressing the novel deletion mutant in hekt cell significantly increased mtor pathway activation furthermore everolimus treatment showed not only reduction in sega size but dramatically improved behavioral deficit including autism related behavior in the patient in summary we identified a novel small deletion mutation in tsc associated with severe tsc in a korean family that enhances the activation of mtor signaling in vitro everolimus treatment improved behavioral deficit in the patient,Non-Cancer,1,everolimus improves neuropsychiatric symptom in a patient with tuberous sclerosis carrying a novel tsc mutation tuberous sclerosis complex tsc is a neurocutaneous disorder characterized by multiple symptom including neuropsychological deficit such a seizure intellectual disability and autism tsc is inherited in an autosomal dominant pattern and is caused by mutation in either the tsc or tsc gene which enhance activation of the mammalian target of rapamycin mtor signaling pathway recent study have suggested that mtor inhibitor such a rapamycin can reverse tscassociated deficit in rodent model of tsc in addition clinical trial are ongoing to test the efficacy of mtor inhibitor toward the psychiatric symptom associated with tsc here we report a case study of a korean patient with tsc who exhibited multiple symptom including frequent seizure intellectual disability language delay and social problem we performed whole exome sequencing and identified a novel small deletion mutation in tsc expressing the novel deletion mutant in hekt cell significantly increased mtor pathway activation furthermore everolimus treatment showed not only reduction in sega size but dramatically improved behavioral deficit including autism related behavior in the patient in summary we identified a novel small deletion mutation in tsc associated with severe tsc in a korean family that enhances the activation of mtor signaling in vitro everolimus treatment improved behavioral deficit in the patient
27241812,angiopoietin mediates thrombininduced monocyte adhesion and endothelial permeability,unlabelled essential mechanism of thrombininduced inflammation is not fully understood thrombin induced monocyte adhesion and barrier loss require angiopoietin ang ang mediates vessel leakage and monocyte adhesion through shppmapk pathway calcium dependent shppmapk activation regulates ang expression through a feedback loop summary background thrombin imparts an inflammatory phenotype to the endothelium by promoting increased monocyte adhesion and vascular permeability however the molecular player that govern these event are incompletely understood objective the aim of this study wa to determine whether angiopoietin ang ha a role if any in regulating inflammatory signal initiated by thrombin method assessment of vascular leakage by mile assay wa performed by intradermal injection on the foot paw surface level of intercellular adhesion molecule icam were determined by flow cytometry overexpression knockdown and phosphorylation of protein were determined by western blotting result in timecourse experiment thrombinstimulated ang upregulation peaked prior to the expression of adhesion molecule icam in human umbilical veinderived endothelial cell huvecs knockdown of ang blocked both thrombininduced monocyte adhesion and icam expression in addition ang mouse displayed defective vascular leakage when treated with thrombin introducing ang protein in ang mouse failed to recover a wildtype phenotype mechanistically ang appears to regulate the thrombinactivated calcium spike that is required for tyrosine phosphatase shp and p mapk activation further downregulation of shp attenuated both thrombininduced ang expression and monocyte adhesion downregulation of the adaptor protein gab a coactivator of shp a well a overexpression of the gab mutant incapable of interacting with shp yfgab inhibited thrombinmediated effect including downstream activation of p mapk which in turn wa required for ang expression conclusion the data establish an essential role of the gabshppmapk signaling pathway and ang in regulating thrombininduced monocyte adhesion and vascular leakage,Non-Cancer,1,angiopoietin mediates thrombininduced monocyte adhesion and endothelial permeability unlabelled essential mechanism of thrombininduced inflammation is not fully understood thrombin induced monocyte adhesion and barrier loss require angiopoietin ang ang mediates vessel leakage and monocyte adhesion through shppmapk pathway calcium dependent shppmapk activation regulates ang expression through a feedback loop summary background thrombin imparts an inflammatory phenotype to the endothelium by promoting increased monocyte adhesion and vascular permeability however the molecular player that govern these event are incompletely understood objective the aim of this study wa to determine whether angiopoietin ang ha a role if any in regulating inflammatory signal initiated by thrombin method assessment of vascular leakage by mile assay wa performed by intradermal injection on the foot paw surface level of intercellular adhesion molecule icam were determined by flow cytometry overexpression knockdown and phosphorylation of protein were determined by western blotting result in timecourse experiment thrombinstimulated ang upregulation peaked prior to the expression of adhesion molecule icam in human umbilical veinderived endothelial cell huvecs knockdown of ang blocked both thrombininduced monocyte adhesion and icam expression in addition ang mouse displayed defective vascular leakage when treated with thrombin introducing ang protein in ang mouse failed to recover a wildtype phenotype mechanistically ang appears to regulate the thrombinactivated calcium spike that is required for tyrosine phosphatase shp and p mapk activation further downregulation of shp attenuated both thrombininduced ang expression and monocyte adhesion downregulation of the adaptor protein gab a coactivator of shp a well a overexpression of the gab mutant incapable of interacting with shp yfgab inhibited thrombinmediated effect including downstream activation of p mapk which in turn wa required for ang expression conclusion the data establish an essential role of the gabshppmapk signaling pathway and ang in regulating thrombininduced monocyte adhesion and vascular leakage
27255792,mutsbeta promotes trinucleotide repeat expansion by recruiting dna polymerase beta to nascent cagn or ctgn hairpin for errorprone dna synthesis,expansion of cag ctg repeat cause a number of familial neurodegenerative disorder although the underlying mechanism remains largely unknown component involved in dna mismatch repair particularly mismatch recognition protein mutsbeta a mshmsh heterodimer are implicated in cag ctg repeat expansion in addition to recognizing small insertiondeletion loopouts mutsbeta also specifically bind dna hairpin imperfect heteroduplexes formed within cagn ctgn sequence however whether or not and how mutsbeta binding trigger expansion of cag ctg repeat remain unknown we show here that purified recombinant mutsbeta physically interacts with dna polymerase beta polbeta and stimulates polbetacatalyzed cagn or ctgn hairpin retention consistent with these in vitro observation mutsbeta and polbeta interact with each other in vivo and colocalize at cag ctg repeat during dna replication our data support a model for errorprone processing of cagn or ctgn hairpin by mutsbeta and polbeta during dna replication andor repair mutsbeta recognizes cagn or ctgn hairpin formed in the nascent dna strand and recruit polbeta to the complex which then utilizes the hairpin a a primer for extension leading to cag ctg repeat expansion this study provides a novel mechanism for trinucleotide repeat expansion in both dividing and nondividing cell,Non-Cancer,1,mutsbeta promotes trinucleotide repeat expansion by recruiting dna polymerase beta to nascent cagn or ctgn hairpin for errorprone dna synthesis expansion of cag ctg repeat cause a number of familial neurodegenerative disorder although the underlying mechanism remains largely unknown component involved in dna mismatch repair particularly mismatch recognition protein mutsbeta a mshmsh heterodimer are implicated in cag ctg repeat expansion in addition to recognizing small insertiondeletion loopouts mutsbeta also specifically bind dna hairpin imperfect heteroduplexes formed within cagn ctgn sequence however whether or not and how mutsbeta binding trigger expansion of cag ctg repeat remain unknown we show here that purified recombinant mutsbeta physically interacts with dna polymerase beta polbeta and stimulates polbetacatalyzed cagn or ctgn hairpin retention consistent with these in vitro observation mutsbeta and polbeta interact with each other in vivo and colocalize at cag ctg repeat during dna replication our data support a model for errorprone processing of cagn or ctgn hairpin by mutsbeta and polbeta during dna replication andor repair mutsbeta recognizes cagn or ctgn hairpin formed in the nascent dna strand and recruit polbeta to the complex which then utilizes the hairpin a a primer for extension leading to cag ctg repeat expansion this study provides a novel mechanism for trinucleotide repeat expansion in both dividing and nondividing cell
27259010,ctnnb mutation and estrogen receptor expression in neuromuscular choristoma and it associated fibromatosis,neuromuscular choristoma nmc is a very rare developmental malformation characterized by the endoneurial intercalation of mature muscle fiber among peripheral nerve fiber nmc typically arises in the major proximal peripheral nerve most commonly the sciatic nerve and may involve the lumbosacral and brachial plexus patient present clinically with progressive neuropathy or plexopathy nmc is strongly associated with development of a fibromatosis histologically identical to conventional desmoidtype fibromatosis nmcfibromatosis the development of nmcfibromatosis is often precipitated by iatrogenic trauma ie biopsy desmoidtype fibromatosis is characterized by ctnnb exon mutation which result in aberrant nuclear betacatenin localization and dysregulated canonical wnt signaling in contrast the pathogenesis of nmc and nmcfibromatosis is unknown desmoidtype fibromatosis express estrogen receptor er specifically the erbeta isoform erbeta and endocrine therapy may be used in surgically unresectable case in contrast the er expression profile of nmcfibromatosis is unknown we evaluated a series of nmc and nmcfibromatosis for ctnnb mutation betacatenin expression and er isoform expression five nmcs occurred in female and male patient median age y range t psf and c ag pta four patient subsequently developed nmcfibromatosis and all case contained ctnnb mutation including pta and psf mutation in patient the nmc and nmcfibromatosis had identical ctnnb mutation only nmc had no detectable ctnnb mutation however the patient subsequent nmcfibromatosis had a ctnnb pta mutation all nmc and nmcfibromatosis showed aberrant nuclear localization of betacatenin nuclear erbeta expression and no eralpha expression the presence of ctnnb mutation both in nmc and nmcfibromatosis may be a shared molecular genetic abnormality underlying their pathogenesis,Non-Cancer,1,ctnnb mutation and estrogen receptor expression in neuromuscular choristoma and it associated fibromatosis neuromuscular choristoma nmc is a very rare developmental malformation characterized by the endoneurial intercalation of mature muscle fiber among peripheral nerve fiber nmc typically arises in the major proximal peripheral nerve most commonly the sciatic nerve and may involve the lumbosacral and brachial plexus patient present clinically with progressive neuropathy or plexopathy nmc is strongly associated with development of a fibromatosis histologically identical to conventional desmoidtype fibromatosis nmcfibromatosis the development of nmcfibromatosis is often precipitated by iatrogenic trauma ie biopsy desmoidtype fibromatosis is characterized by ctnnb exon mutation which result in aberrant nuclear betacatenin localization and dysregulated canonical wnt signaling in contrast the pathogenesis of nmc and nmcfibromatosis is unknown desmoidtype fibromatosis express estrogen receptor er specifically the erbeta isoform erbeta and endocrine therapy may be used in surgically unresectable case in contrast the er expression profile of nmcfibromatosis is unknown we evaluated a series of nmc and nmcfibromatosis for ctnnb mutation betacatenin expression and er isoform expression five nmcs occurred in female and male patient median age y range t psf and c ag pta four patient subsequently developed nmcfibromatosis and all case contained ctnnb mutation including pta and psf mutation in patient the nmc and nmcfibromatosis had identical ctnnb mutation only nmc had no detectable ctnnb mutation however the patient subsequent nmcfibromatosis had a ctnnb pta mutation all nmc and nmcfibromatosis showed aberrant nuclear localization of betacatenin nuclear erbeta expression and no eralpha expression the presence of ctnnb mutation both in nmc and nmcfibromatosis may be a shared molecular genetic abnormality underlying their pathogenesis
27311832,crebbp mutation in individual without rubinsteintaybi syndrome phenotype,mutation in crebbp cause rubinsteintaybi syndrome by using exome sequencing and by using sanger in one patient crebbp mutation were detected in patient who did not or only in a very limited manner resemble rubinsteintaybi syndrome the combined facial sign typical for rubinsteintaybi syndrome were absent none had broad thumb and three had only somewhat broad hallux all had apparent developmental delay being the reason for molecular analysis five had short stature and seven had microcephaly the facial characteristic were variable main characteristic were short palpebral fissure telecanthi depressed nasal ridge short nose anteverted naris short columella and long philtrum six patient had autistic behavior and two had selfinjurious behavior other symptom were recurrent upper airway infection n feeding problem n and impaired hearing n major malformation occurred infrequently all patient had a de novo missense mutation in the last part of exon or beginning of exon of crebbp between base pair and codon and no missense or truncating mutation in this region have been described to be associated with the classical rubinsteintaybi syndrome phenotype no functional study have yet been performed but we hypothesize that the mutation disturb proteinprotein interaction by altering zinc finger function we conclude that patient with missense mutation in this specific crebbp region show a phenotype that differs substantially from that in patient with rubinsteintaybi syndrome and may prove to constitute one or more separate entity wiley periodical inc,Non-Cancer,1,crebbp mutation in individual without rubinsteintaybi syndrome phenotype mutation in crebbp cause rubinsteintaybi syndrome by using exome sequencing and by using sanger in one patient crebbp mutation were detected in patient who did not or only in a very limited manner resemble rubinsteintaybi syndrome the combined facial sign typical for rubinsteintaybi syndrome were absent none had broad thumb and three had only somewhat broad hallux all had apparent developmental delay being the reason for molecular analysis five had short stature and seven had microcephaly the facial characteristic were variable main characteristic were short palpebral fissure telecanthi depressed nasal ridge short nose anteverted naris short columella and long philtrum six patient had autistic behavior and two had selfinjurious behavior other symptom were recurrent upper airway infection n feeding problem n and impaired hearing n major malformation occurred infrequently all patient had a de novo missense mutation in the last part of exon or beginning of exon of crebbp between base pair and codon and no missense or truncating mutation in this region have been described to be associated with the classical rubinsteintaybi syndrome phenotype no functional study have yet been performed but we hypothesize that the mutation disturb proteinprotein interaction by altering zinc finger function we conclude that patient with missense mutation in this specific crebbp region show a phenotype that differs substantially from that in patient with rubinsteintaybi syndrome and may prove to constitute one or more separate entity wiley periodical inc
27323230,the cilium a cellular antenna with an influence on obesity risk,primary cilium are organelle that are present on many different cell type either transiently or permanently they play a crucial role in receiving signal from the environment and passing these signal to other part of the cell in that way they are involved in diverse process such a adipocyte differentiation and olfactory sensation mutation in gene coding for ciliary protein often have pleiotropic effect and lead to clinical condition ciliopathies with multiple symptom in this study we reviewed observation from ciliopathies with obesity a one of the symptom it show that variation in ciliarelated gene is itself not a major cause of obesity in the population but may be a part of the multifactorial aetiology of this complex condition both common polymorphism and rare deleterious variant may contribute to the obesity risk genotypephenotype relationship have been noticed among the ciliary gene obesity differs with regard to severity and age of onset which may relate to the influence of each gene on the balance between pro and antiadipogenic process analysis of the function and location of the protein encoded by these ciliary gene suggests that obesity is more linked to activity at the basal area of the cilium including initiation of the intraflagellar transport but less to the intraflagellar transport itself regarding the role of cilium three possible mechanistic process underlying obesity are described adipogenesis neuronal food intake regulation and food odour perception,Non-Cancer,1,the cilium a cellular antenna with an influence on obesity risk primary cilium are organelle that are present on many different cell type either transiently or permanently they play a crucial role in receiving signal from the environment and passing these signal to other part of the cell in that way they are involved in diverse process such a adipocyte differentiation and olfactory sensation mutation in gene coding for ciliary protein often have pleiotropic effect and lead to clinical condition ciliopathies with multiple symptom in this study we reviewed observation from ciliopathies with obesity a one of the symptom it show that variation in ciliarelated gene is itself not a major cause of obesity in the population but may be a part of the multifactorial aetiology of this complex condition both common polymorphism and rare deleterious variant may contribute to the obesity risk genotypephenotype relationship have been noticed among the ciliary gene obesity differs with regard to severity and age of onset which may relate to the influence of each gene on the balance between pro and antiadipogenic process analysis of the function and location of the protein encoded by these ciliary gene suggests that obesity is more linked to activity at the basal area of the cilium including initiation of the intraflagellar transport but less to the intraflagellar transport itself regarding the role of cilium three possible mechanistic process underlying obesity are described adipogenesis neuronal food intake regulation and food odour perception
27346689,largescale exomewide association analysis identifies locus for white blood cell trait and pleiotropy with immunemediated disease,white blood cell play diverse role in innate and adaptive immunity genetic association analysis of phenotypic variation in circulating white blood cell wbc count from large sample of otherwise healthy individual can provide insight into gene and biologic pathway involved in production differentiation or clearance of particular wbc lineage myeloid lymphoid and also potentially inform the genetic basis of autoimmune allergic and blood disease we performed an exome arraybased metaanalysis of total wbc and subtype count neutrophil monocyte lymphocyte basophil and eosinophil in a multiancestry discovery and replication sample of individual from study we identified common variant of which were coding variant associated with one or more wbc trait the majority of which are pleiotropically associated with autoimmune disease based on functional annotation these locus included gene encoding surface marker of myeloid lymphoid or hematopoietic stem cell differentiation cd cd cd transcription factor regulating lineage specification during hematopoiesis asxl irf ikzf jmjdc etspsmg and molecule involved in neutrophil clearanceapoptosis corf lta adhesion tnxb or centrosome and microtubule structurefunction kif tubd together with recent report of somatic asxl mutation among individual with idiopathic cytopenia or clonal hematopoiesis of undetermined significance the identification of a common regulatory utr variant of asxl suggests that both germline and somatic asxl mutation contribute to lower blood count in otherwise asymptomatic individual these association result shed light on genetic mechanism that regulate circulating wbc count and suggest a prominent shared genetic architecture with inflammatory and autoimmune disease,Non-Cancer,1,largescale exomewide association analysis identifies locus for white blood cell trait and pleiotropy with immunemediated disease white blood cell play diverse role in innate and adaptive immunity genetic association analysis of phenotypic variation in circulating white blood cell wbc count from large sample of otherwise healthy individual can provide insight into gene and biologic pathway involved in production differentiation or clearance of particular wbc lineage myeloid lymphoid and also potentially inform the genetic basis of autoimmune allergic and blood disease we performed an exome arraybased metaanalysis of total wbc and subtype count neutrophil monocyte lymphocyte basophil and eosinophil in a multiancestry discovery and replication sample of individual from study we identified common variant of which were coding variant associated with one or more wbc trait the majority of which are pleiotropically associated with autoimmune disease based on functional annotation these locus included gene encoding surface marker of myeloid lymphoid or hematopoietic stem cell differentiation cd cd cd transcription factor regulating lineage specification during hematopoiesis asxl irf ikzf jmjdc etspsmg and molecule involved in neutrophil clearanceapoptosis corf lta adhesion tnxb or centrosome and microtubule structurefunction kif tubd together with recent report of somatic asxl mutation among individual with idiopathic cytopenia or clonal hematopoiesis of undetermined significance the identification of a common regulatory utr variant of asxl suggests that both germline and somatic asxl mutation contribute to lower blood count in otherwise asymptomatic individual these association result shed light on genetic mechanism that regulate circulating wbc count and suggest a prominent shared genetic architecture with inflammatory and autoimmune disease
27353973,usefulness of fetal autopsy in the diagnosis of blomstrand chondrodysplasia a report of three case,blomstrand osteochondrodysplasia bocd is a rare autosomal recessive sclerosing skeletal dysplasia characterized by accelerated chondrocyte differentiation in this article we discus three case where lethal skeletal dysplasia wa suspected and blomstrand dysplasia wa diagnosed by autopsy antenatal ultrasound finding include increased nuchal translucency tetramicromelia and polyhydramnios radiological hallmark is advanced skeletal maturation and bone sclerosis histology of long bone revealed narrow cartilagenous cap and change in the physeal growth zone which showed severe hypoplasia and disorganization of proliferative phase and hypertrophic phase homozygous and compound heterozygous mutation in pthr gene have been implicated in the pathogenesis of this chondrodysplasia,Non-Cancer,1,usefulness of fetal autopsy in the diagnosis of blomstrand chondrodysplasia a report of three case blomstrand osteochondrodysplasia bocd is a rare autosomal recessive sclerosing skeletal dysplasia characterized by accelerated chondrocyte differentiation in this article we discus three case where lethal skeletal dysplasia wa suspected and blomstrand dysplasia wa diagnosed by autopsy antenatal ultrasound finding include increased nuchal translucency tetramicromelia and polyhydramnios radiological hallmark is advanced skeletal maturation and bone sclerosis histology of long bone revealed narrow cartilagenous cap and change in the physeal growth zone which showed severe hypoplasia and disorganization of proliferative phase and hypertrophic phase homozygous and compound heterozygous mutation in pthr gene have been implicated in the pathogenesis of this chondrodysplasia
27417417,the er membraneanchored ubiquitin ligase hrd is a positive regulator of tcell immunity,identification of positive regulator of tcell immunity induced during autoimmune disease is critical for developing novel therapy the endoplasmic reticulum resident ubiquitin ligase hrd ha recently emerged a a critical regulator of dendritic cell antigen presentation but it role in tcell immunity is unknown here we show that genetic deletion of hrd in mouse inhibits tcell proliferation production of il and differentiation of th and th cell and consequently protects mouse from experimental autoimmune encephalomyelitis hrd facilitates tcell proliferation by the destruction of cyclindependent kinase inhibitor pkip and deletion of pkip in hrdnull tcells rescue proliferative capacity but not the production of cytokine including il ifngamma and il tcell expression of hrd is higher in patient with multiple sclerosis than in healthy individual and knockdown of hrd in human cd t cell inhibits activation and differentiation to th and th cell our study identifies hrd a a previously unappreciated positive regulator of t cell and implies that hrd is a potential therapeutic target for autoimmune disease,Non-Cancer,1,the er membraneanchored ubiquitin ligase hrd is a positive regulator of tcell immunity identification of positive regulator of tcell immunity induced during autoimmune disease is critical for developing novel therapy the endoplasmic reticulum resident ubiquitin ligase hrd ha recently emerged a a critical regulator of dendritic cell antigen presentation but it role in tcell immunity is unknown here we show that genetic deletion of hrd in mouse inhibits tcell proliferation production of il and differentiation of th and th cell and consequently protects mouse from experimental autoimmune encephalomyelitis hrd facilitates tcell proliferation by the destruction of cyclindependent kinase inhibitor pkip and deletion of pkip in hrdnull tcells rescue proliferative capacity but not the production of cytokine including il ifngamma and il tcell expression of hrd is higher in patient with multiple sclerosis than in healthy individual and knockdown of hrd in human cd t cell inhibits activation and differentiation to th and th cell our study identifies hrd a a previously unappreciated positive regulator of t cell and implies that hrd is a potential therapeutic target for autoimmune disease
27441947,the impact of mosaicism in preimplantation genetic diagnosis pgd approach to pgd for dominant disorder in couple without family history,objective mosaicism in certain dominant disorder may result in a nonmendelian transmission for the causative mutation preimplantation genetic diagnosis pgd is available for patient with inherited disorder to achieve an unaffected pregnancy we present our experience for two female patient with different dominantly inherited autosomal disorder neurofibromatosis type nf and tuberous sclerosis complex type tsc method pgd protocol development wa carried out using single cell from the patient pgd wa carried out on polar body and different embryonic cell result protocol development for nf using lymphocyte from the patient suggested mosaicism for the mutation this wa supported further by quantitative fluorescentpcr performed on genomic dna during pgd polar body and blastomere lacked the mutation that probably wa absent or present at very low level in the patient germline single lymphocyte analysis during protocol development for tsc did not indicate mosaicism however analysis of single buccal cell and multiple embryo biopsy across two consecutive ivfpgd cycle confirmed gonosomal mosaicism conclusion the trend in pgd is for blastocyst biopsy followed by whole genome amplification eliminating single cell analysis in the case of certain dominantly inherited disorder prepgd single cell analysis is beneficial to identify potential mosaicism that ensures robust protocol john wiley son ltd,Non-Cancer,1,the impact of mosaicism in preimplantation genetic diagnosis pgd approach to pgd for dominant disorder in couple without family history objective mosaicism in certain dominant disorder may result in a nonmendelian transmission for the causative mutation preimplantation genetic diagnosis pgd is available for patient with inherited disorder to achieve an unaffected pregnancy we present our experience for two female patient with different dominantly inherited autosomal disorder neurofibromatosis type nf and tuberous sclerosis complex type tsc method pgd protocol development wa carried out using single cell from the patient pgd wa carried out on polar body and different embryonic cell result protocol development for nf using lymphocyte from the patient suggested mosaicism for the mutation this wa supported further by quantitative fluorescentpcr performed on genomic dna during pgd polar body and blastomere lacked the mutation that probably wa absent or present at very low level in the patient germline single lymphocyte analysis during protocol development for tsc did not indicate mosaicism however analysis of single buccal cell and multiple embryo biopsy across two consecutive ivfpgd cycle confirmed gonosomal mosaicism conclusion the trend in pgd is for blastocyst biopsy followed by whole genome amplification eliminating single cell analysis in the case of certain dominantly inherited disorder prepgd single cell analysis is beneficial to identify potential mosaicism that ensures robust protocol john wiley son ltd
27445228,erdheimchester disease with novel gene mutation discovered a an incidental finding in explanted liver of a patient with hepatitis c cirrhosis a case report and literature review,erdheimchester disease ecd is a rare form of nonlangerhans cell histiocytosis characterized by xanthogranulomatous infiltration of foamy histiocyte frequently involving bone and other organ system we herein report a unique case of ecd discovered incidentally in an explanted liver in a yearold male with endstage liver disease secondary to hepatitis c cirrhosis histological examination and immunohistochemical study in the explanted liver revealed prominent foamy histiocyte that were cd positive but cda and s negative mutational hotspot analysis of the explanted liver using a panel of most common cancerrelated gene performed by next generation sequencing ng revealed likely somatic mutation in the pdgfra pten and hnfa gene but no braf codon mutation were detected the bone marrow showed similar finding a in the liver whole body pet and bone scan demonstrated increased heterogeneous uptake in bilateral humeral and femoral diaphysis most compatible with ecd to our knowledge this is the first case report of ecd that involves mainly bone marrow and liver with novel genomic alteration our case highlight the diversity and complexity of this disease entity and the importance of multimodality approach integrating clinical and radiologic feature with histopathologic and moleculargenomic finding,Non-Cancer,1,erdheimchester disease with novel gene mutation discovered a an incidental finding in explanted liver of a patient with hepatitis c cirrhosis a case report and literature review erdheimchester disease ecd is a rare form of nonlangerhans cell histiocytosis characterized by xanthogranulomatous infiltration of foamy histiocyte frequently involving bone and other organ system we herein report a unique case of ecd discovered incidentally in an explanted liver in a yearold male with endstage liver disease secondary to hepatitis c cirrhosis histological examination and immunohistochemical study in the explanted liver revealed prominent foamy histiocyte that were cd positive but cda and s negative mutational hotspot analysis of the explanted liver using a panel of most common cancerrelated gene performed by next generation sequencing ng revealed likely somatic mutation in the pdgfra pten and hnfa gene but no braf codon mutation were detected the bone marrow showed similar finding a in the liver whole body pet and bone scan demonstrated increased heterogeneous uptake in bilateral humeral and femoral diaphysis most compatible with ecd to our knowledge this is the first case report of ecd that involves mainly bone marrow and liver with novel genomic alteration our case highlight the diversity and complexity of this disease entity and the importance of multimodality approach integrating clinical and radiologic feature with histopathologic and moleculargenomic finding
27470532,tuberous sclerosis complex associated with vascular anomaly or overgrowth,background dysregulation of the mammalian target of rapamycin pathway is the underlying pathogenic mechanism in tuberous sclerosis complex tsc other syndrome caused by genetic alteration in this pathway frequently manifest a vascular anomaly or asymmetric overgrowth rarely these feature have been documented in tsc objective to collate case of tsc with vascular anomaly or overgrowth that have been published and to assemble additional recent case a this finding ha been underreported method tsc case from three pediatric dermatology referral center on two continent were reviewed to identify individual noted to have hemihypertrophy or vascular anomaly result we report five additional case of tsc associated with vascular anomaly or overgrowth that contribute to our understanding of some of the pathway and treatment involved in vascular anomaly conclusion hemihypertrophy and vascular anomaly may be more frequent in the setting of tsc than previously appreciated a common pathogenetic mechanism may tie these manifestation together,Non-Cancer,1,tuberous sclerosis complex associated with vascular anomaly or overgrowth background dysregulation of the mammalian target of rapamycin pathway is the underlying pathogenic mechanism in tuberous sclerosis complex tsc other syndrome caused by genetic alteration in this pathway frequently manifest a vascular anomaly or asymmetric overgrowth rarely these feature have been documented in tsc objective to collate case of tsc with vascular anomaly or overgrowth that have been published and to assemble additional recent case a this finding ha been underreported method tsc case from three pediatric dermatology referral center on two continent were reviewed to identify individual noted to have hemihypertrophy or vascular anomaly result we report five additional case of tsc associated with vascular anomaly or overgrowth that contribute to our understanding of some of the pathway and treatment involved in vascular anomaly conclusion hemihypertrophy and vascular anomaly may be more frequent in the setting of tsc than previously appreciated a common pathogenetic mechanism may tie these manifestation together
27488869,erdheimchester disease with emperipolesis a unique case involving the heart,histiocytosis is an uncommon disease characterized by excessive accumulation of histiocyte here we report a rare case of nonlangerhanscell histiocytosis in a yearold woman who presented with severe symptom of pericardial effusion radiologic investigation also detected multiple bone lower limb vertebra rib and ilium lesion resected pericardium showed abundant mono or multinucleated nonfoamy histiocyte cdcdscdalphalangerin in a fibroinflammatory background the histiocyte demonstrated emperipolesis of lymphocyte a hallmark feature of rosaidorfman disease rdd however molecular analysis revealed a braf ve mutation of the proliferating histiocyte highlighting the neoplastic feature frequently observed in another nonlangerhanscell histiocytosis known a erdheimchester disease ecd we consider this case to be a unique presentation of ecd harboring some rddlike cell with emperipolesis but not a case of rdd with a braf mutation concerning it clinical manifestation involvement of the heart and bone and neoplastic feature,Non-Cancer,1,erdheimchester disease with emperipolesis a unique case involving the heart histiocytosis is an uncommon disease characterized by excessive accumulation of histiocyte here we report a rare case of nonlangerhanscell histiocytosis in a yearold woman who presented with severe symptom of pericardial effusion radiologic investigation also detected multiple bone lower limb vertebra rib and ilium lesion resected pericardium showed abundant mono or multinucleated nonfoamy histiocyte cdcdscdalphalangerin in a fibroinflammatory background the histiocyte demonstrated emperipolesis of lymphocyte a hallmark feature of rosaidorfman disease rdd however molecular analysis revealed a braf ve mutation of the proliferating histiocyte highlighting the neoplastic feature frequently observed in another nonlangerhanscell histiocytosis known a erdheimchester disease ecd we consider this case to be a unique presentation of ecd harboring some rddlike cell with emperipolesis but not a case of rdd with a braf mutation concerning it clinical manifestation involvement of the heart and bone and neoplastic feature
27498064,defining a new aggressiveness classification and using nfatc localization a a prognostic factor in cherubism,cherubism is a rare genetic disease characterized by bilateral giant cell reparative granuloma of the jaw consisting of a fibrotic stroma with giant multinucleated cell gmcs and osteoclastic feature cherubism severity is highly variable and recurrence after surgery is the most important risk currently there are no prognostic indicator the aim of this study were to evaluate the osteoclastogenesis phenotype by histologic examination of nuclear factor of activated t cell nfatc localization and tartrateresistant acid phosphatase trap activity and to correlate the result to disease aggressiveness to define prognostic indicator based on cherubism evolution year after surgery class of cherubism aggressiveness were identified mild group a moderate group b and severe group c histologically in grade a and b cherubism lesion gmcs were negative for both trap activity and nfatc nuclear localization in contrast in grade c cherubism lesion gmcs were all positive for trap activity and nfatc nuclear localization and displayed osteoclastlike feature other histopathologic finding were not different among the group our result establish that trap activity and nftac nuclear localization are associated with aggressive cherubism and therefore could be added to routine pathologic examination to aid in prognosis and management of the disease the finding of nfatc nuclear localization in aggressive tumor support the addition of anticalcineurin treatment to the therapeutic arsenal for cherubism,Non-Cancer,1,defining a new aggressiveness classification and using nfatc localization a a prognostic factor in cherubism cherubism is a rare genetic disease characterized by bilateral giant cell reparative granuloma of the jaw consisting of a fibrotic stroma with giant multinucleated cell gmcs and osteoclastic feature cherubism severity is highly variable and recurrence after surgery is the most important risk currently there are no prognostic indicator the aim of this study were to evaluate the osteoclastogenesis phenotype by histologic examination of nuclear factor of activated t cell nfatc localization and tartrateresistant acid phosphatase trap activity and to correlate the result to disease aggressiveness to define prognostic indicator based on cherubism evolution year after surgery class of cherubism aggressiveness were identified mild group a moderate group b and severe group c histologically in grade a and b cherubism lesion gmcs were negative for both trap activity and nfatc nuclear localization in contrast in grade c cherubism lesion gmcs were all positive for trap activity and nfatc nuclear localization and displayed osteoclastlike feature other histopathologic finding were not different among the group our result establish that trap activity and nftac nuclear localization are associated with aggressive cherubism and therefore could be added to routine pathologic examination to aid in prognosis and management of the disease the finding of nfatc nuclear localization in aggressive tumor support the addition of anticalcineurin treatment to the therapeutic arsenal for cherubism
27545739,mastocytosis,mastocytosis is a rare disease caused by excessive production of mast cell clinical presentation is variable often based on the type of mastocytosis but in all type of mastocytosis there seems to be an increase in the risk of anaphylaxis systemic mastocytosis is diagnosed based on bone marrow biopsy treatment is variable based on the type of mastocytosis but trigger avoidance and anaphylaxis treatment are mainstay there are no therapy that change the natural course of mastocytosis for cutaneous mastocytosis treatment is conservative and aimed at symptom relief,Non-Cancer,1,mastocytosis mastocytosis is a rare disease caused by excessive production of mast cell clinical presentation is variable often based on the type of mastocytosis but in all type of mastocytosis there seems to be an increase in the risk of anaphylaxis systemic mastocytosis is diagnosed based on bone marrow biopsy treatment is variable based on the type of mastocytosis but trigger avoidance and anaphylaxis treatment are mainstay there are no therapy that change the natural course of mastocytosis for cutaneous mastocytosis treatment is conservative and aimed at symptom relief
27558955,molecular hydrogen suppresses activated wntbetacatenin signaling,molecular hydrogen h is effective for many disease however molecular base of h have not been fully elucidated cumulative evidence indicates that h act a a gaseous signal modulator we found that h suppresses activated wntbetacatenin signaling by promoting phosphorylation and degradation omicronf betacatenin either complete inhibition of gsk or mutation at ck and gskphosphorylation site of betacatenin abolished the suppressive effect of h h did not increase gskmediated phosphorylation of glycogen synthase indicating that h ha no direct effect on gsk itself knockdown of adenomatous polyposis coli apc or axin which form the betacatenin degradation complex minimized the suppressive effect of h on betacatenin accumulation accordingly the effect of h requires ckgskphosphorylation site of betacatenin a well a the betacatenin degradation complex comprised of ck gsk apc and axin we additionally found that h reduces the activation of wntbetacatenin signaling in human osteoarthritis chondrocytes oral intake of h water tended to ameliorate cartilage degradation in a surgeryinduced rat osteoarthritis model through attenuating betacatenin accumulation we first demonstrate that h suppresses abnormally activated wntbetacatenin signaling which account for the protective role of h in a fraction of disease,Non-Cancer,1,molecular hydrogen suppresses activated wntbetacatenin signaling molecular hydrogen h is effective for many disease however molecular base of h have not been fully elucidated cumulative evidence indicates that h act a a gaseous signal modulator we found that h suppresses activated wntbetacatenin signaling by promoting phosphorylation and degradation omicronf betacatenin either complete inhibition of gsk or mutation at ck and gskphosphorylation site of betacatenin abolished the suppressive effect of h h did not increase gskmediated phosphorylation of glycogen synthase indicating that h ha no direct effect on gsk itself knockdown of adenomatous polyposis coli apc or axin which form the betacatenin degradation complex minimized the suppressive effect of h on betacatenin accumulation accordingly the effect of h requires ckgskphosphorylation site of betacatenin a well a the betacatenin degradation complex comprised of ck gsk apc and axin we additionally found that h reduces the activation of wntbetacatenin signaling in human osteoarthritis chondrocytes oral intake of h water tended to ameliorate cartilage degradation in a surgeryinduced rat osteoarthritis model through attenuating betacatenin accumulation we first demonstrate that h suppresses abnormally activated wntbetacatenin signaling which account for the protective role of h in a fraction of disease
27651169,gene panel sequencing improves the diagnostic workup of patient with idiopathic erythrocytosis and identifies new mutation,erythrocytosis is a rare disorder characterized by increased red cell mass and elevated hemoglobin concentration and hematocrit several genetic variant have been identified a cause for erythrocytosis in gene belonging to different pathway including oxygen sensing erythropoiesis and oxygen transport however despite clinical investigation and screening for these mutation the cause of disease can not be found in a considerable number of patient who are classified a having idiopathic erythrocytosis in this study we developed a targeted nextgeneration sequencing panel encompassing the exonic region of gene from relevant pathway kb and sequenced patient with idiopathic erythrocytosis the panel effectively screened of coding region of these gene with an average coverage of x it identified different rare variant all leading to alteration of protein sequence with out of case having at least one of these variant ten of these were known erythrocytosiscausing variant which had been missed following existing diagnostic algorithm twentytwo were novel variant in erythrocytosisassociated gene egln epa vhl bpgm jak shb and in novel gene included in the panel eg epo egln hifa o some with a high likelihood of functionality for which future segregation functional and replication study will be useful to provide further evidence for causality the rest were classified a polymorphism overall these result demonstrate the benefit of using a gene panel rather than existing method in which focused genetic screening is performed depending on biochemical measurement the gene panel improves diagnostic accuracy and provides the opportunity for discovery of novel variant,Non-Cancer,1,gene panel sequencing improves the diagnostic workup of patient with idiopathic erythrocytosis and identifies new mutation erythrocytosis is a rare disorder characterized by increased red cell mass and elevated hemoglobin concentration and hematocrit several genetic variant have been identified a cause for erythrocytosis in gene belonging to different pathway including oxygen sensing erythropoiesis and oxygen transport however despite clinical investigation and screening for these mutation the cause of disease can not be found in a considerable number of patient who are classified a having idiopathic erythrocytosis in this study we developed a targeted nextgeneration sequencing panel encompassing the exonic region of gene from relevant pathway kb and sequenced patient with idiopathic erythrocytosis the panel effectively screened of coding region of these gene with an average coverage of x it identified different rare variant all leading to alteration of protein sequence with out of case having at least one of these variant ten of these were known erythrocytosiscausing variant which had been missed following existing diagnostic algorithm twentytwo were novel variant in erythrocytosisassociated gene egln epa vhl bpgm jak shb and in novel gene included in the panel eg epo egln hifa o some with a high likelihood of functionality for which future segregation functional and replication study will be useful to provide further evidence for causality the rest were classified a polymorphism overall these result demonstrate the benefit of using a gene panel rather than existing method in which focused genetic screening is performed depending on biochemical measurement the gene panel improves diagnostic accuracy and provides the opportunity for discovery of novel variant
27666661,molecular screening strategy for nflike syndrome with cafeaulait macule review,multiple cafeaulait macule calm are usually associated with neurofibromatosis type nf one of the most common hereditary disorder however a group of genetic disorder presenting with calm have mutation that are involved in human skin pigmentation regulation signaling pathway including kit ligandkit protooncogene receptor tyrosine kinase and rasmitogenactivated protein kinase these disorder which include legius syndrome noonan syndrome with multiple lentigo or leopard syndrome and familial progressive hyperpigmentation are difficult to distinguish from nf at early stage using skin appearance alone furthermore certain syndrome are clinically overlapping and molecular testing is a vital diagnostic method the present review aim to provide an overview of these nflike inherited disease and recommend a costeffective strategy for making a clear diagnosis among these disease with an ambiguous borderline,Non-Cancer,1,molecular screening strategy for nflike syndrome with cafeaulait macule review multiple cafeaulait macule calm are usually associated with neurofibromatosis type nf one of the most common hereditary disorder however a group of genetic disorder presenting with calm have mutation that are involved in human skin pigmentation regulation signaling pathway including kit ligandkit protooncogene receptor tyrosine kinase and rasmitogenactivated protein kinase these disorder which include legius syndrome noonan syndrome with multiple lentigo or leopard syndrome and familial progressive hyperpigmentation are difficult to distinguish from nf at early stage using skin appearance alone furthermore certain syndrome are clinically overlapping and molecular testing is a vital diagnostic method the present review aim to provide an overview of these nflike inherited disease and recommend a costeffective strategy for making a clear diagnosis among these disease with an ambiguous borderline
27698644,proximal interphalangeal joint fibromatosis after pyrocarbon implant insertion a case report,background pyrocarbon implant represent an increasingly popular method to treat proximal interphalangeal joint dysfunction to this point no association ha been shown between pyrocarbon biomaterials and fibromatosis we present a potentially serious and destructive complication associated with pyrocarbon arthroplasty method we demonstrate a clinical case involving pyrocarbon arthroplasty and subsequent fibromatosis development in an otherwise healthy yearold female to present this association we illustrate the diagnostic workup involved in a rapidly expanding soft tissue mass of the hand and explain the appropriate treatment result pyrocarbon arthroplasty wa associated with development of locally destructive fibromatosis confirmed by histopathological examination treatment involved wide resection with preservation of local structure conclusion we describe the first association between fibromatosis and pyrocarbon biomaterial due to fibromatosis destructive effect clinician should be aware of potential complication associated with these material and know how to accurately diagnose and treat these lesion,Non-Cancer,1,proximal interphalangeal joint fibromatosis after pyrocarbon implant insertion a case report background pyrocarbon implant represent an increasingly popular method to treat proximal interphalangeal joint dysfunction to this point no association ha been shown between pyrocarbon biomaterials and fibromatosis we present a potentially serious and destructive complication associated with pyrocarbon arthroplasty method we demonstrate a clinical case involving pyrocarbon arthroplasty and subsequent fibromatosis development in an otherwise healthy yearold female to present this association we illustrate the diagnostic workup involved in a rapidly expanding soft tissue mass of the hand and explain the appropriate treatment result pyrocarbon arthroplasty wa associated with development of locally destructive fibromatosis confirmed by histopathological examination treatment involved wide resection with preservation of local structure conclusion we describe the first association between fibromatosis and pyrocarbon biomaterial due to fibromatosis destructive effect clinician should be aware of potential complication associated with these material and know how to accurately diagnose and treat these lesion
27711228,dnamva vaccination of hiv infected participant with viral suppression on antiretroviral therapy followed by treatment interruption elicitation of immune response without control of reemergent virus,gvth a phase openlabel trial of a dna primemodified vaccinia ankara mva boost vaccine govxb wa undertaken in hiv infected participant on antiretroviral treatment art to evaluate safety and vaccineelicited t cell response and explore the ability of elicited cd t cell to control viral rebound during analytical treatment interruption ti nine men who began antiretroviral therapy art within month of seroconversion and had sustained plasma hiv rna copiesml for at least month were enrolled median age wa year median preart hiv rna wa copiesml and mean baseline cd count wa mul two dna followed by mva inoculation were given week apart eight subject completed all vaccination and ti clinical and laboratory adverse event were generally mild with no serious or grade event only reactogenicity event were considered related to study drug no treatment emergent viral resistance wa seen the vaccination did not reduce viral reservoir and virus reemerged in all participant during ti with a median time to reemergence of week eight of participant had cd t cell that could be stimulated by vaccinematched gag peptide prior to vaccination vaccination boosted these response a well a eliciting previously undetected cd response elicited t cell did not display sign of exhaustion during ti temporal pattern of viral reemergence and gagspecific cd t cell expansion suggested that vaccinespecific cd t cell had been stimulated by reemergent virus in only of participant in these transient decrease in viremia were associated with gag selection in known cd t cell epitope we hypothesize that escape mutation already archived in the viral reservoir plus a poor ability of cd t cell to traffic to and control virus at site of reemergence limited the therapeutic efficacy of the dnamva vaccine trial registration clinicaltrialsgov nct,Non-Cancer,1,dnamva vaccination of hiv infected participant with viral suppression on antiretroviral therapy followed by treatment interruption elicitation of immune response without control of reemergent virus gvth a phase openlabel trial of a dna primemodified vaccinia ankara mva boost vaccine govxb wa undertaken in hiv infected participant on antiretroviral treatment art to evaluate safety and vaccineelicited t cell response and explore the ability of elicited cd t cell to control viral rebound during analytical treatment interruption ti nine men who began antiretroviral therapy art within month of seroconversion and had sustained plasma hiv rna copiesml for at least month were enrolled median age wa year median preart hiv rna wa copiesml and mean baseline cd count wa mul two dna followed by mva inoculation were given week apart eight subject completed all vaccination and ti clinical and laboratory adverse event were generally mild with no serious or grade event only reactogenicity event were considered related to study drug no treatment emergent viral resistance wa seen the vaccination did not reduce viral reservoir and virus reemerged in all participant during ti with a median time to reemergence of week eight of participant had cd t cell that could be stimulated by vaccinematched gag peptide prior to vaccination vaccination boosted these response a well a eliciting previously undetected cd response elicited t cell did not display sign of exhaustion during ti temporal pattern of viral reemergence and gagspecific cd t cell expansion suggested that vaccinespecific cd t cell had been stimulated by reemergent virus in only of participant in these transient decrease in viremia were associated with gag selection in known cd t cell epitope we hypothesize that escape mutation already archived in the viral reservoir plus a poor ability of cd t cell to traffic to and control virus at site of reemergence limited the therapeutic efficacy of the dnamva vaccine trial registration clinicaltrialsgov nct
27737891,the nlrp inflammasome function a a driver of the myelodysplastic syndrome phenotype,despite genetic heterogeneity myelodysplastic syndrome mdss share feature of cytological dysplasia and ineffective hematopoiesis we report that a hallmark of mdss is activation of the nlrp inflammasome which drive clonal expansion and pyroptotic cell death independent of genotype md hematopoietic stem and progenitor cell hspcs overexpress inflammasome protein and manifest activated nlrp complex that direct activation of caspase generation of interleukinbeta ilbeta and il and pyroptotic cell death mechanistically pyroptosis is triggered by the alarmin sa that is found in excess in md hspcs and bone marrow plasma further like somatic gene mutation sainduced signaling activates nadph oxidase nox increasing level of reactive oxygen specie ro that initiate cation influx cell swelling and betacatenin activation notably knockdown of nlrp or caspase neutralization of sa and pharmacologic inhibition of nlrp or nox suppress pyroptosis ro generation and nuclear betacatenin in mdss and are sufficient to restore effective hematopoiesis thus alarmins and founder gene mutation in mdss license a common redoxsensitive inflammasome circuit which suggests new avenue for therapeutic intervention,Non-Cancer,1,the nlrp inflammasome function a a driver of the myelodysplastic syndrome phenotype despite genetic heterogeneity myelodysplastic syndrome mdss share feature of cytological dysplasia and ineffective hematopoiesis we report that a hallmark of mdss is activation of the nlrp inflammasome which drive clonal expansion and pyroptotic cell death independent of genotype md hematopoietic stem and progenitor cell hspcs overexpress inflammasome protein and manifest activated nlrp complex that direct activation of caspase generation of interleukinbeta ilbeta and il and pyroptotic cell death mechanistically pyroptosis is triggered by the alarmin sa that is found in excess in md hspcs and bone marrow plasma further like somatic gene mutation sainduced signaling activates nadph oxidase nox increasing level of reactive oxygen specie ro that initiate cation influx cell swelling and betacatenin activation notably knockdown of nlrp or caspase neutralization of sa and pharmacologic inhibition of nlrp or nox suppress pyroptosis ro generation and nuclear betacatenin in mdss and are sufficient to restore effective hematopoiesis thus alarmins and founder gene mutation in mdss license a common redoxsensitive inflammasome circuit which suggests new avenue for therapeutic intervention
27777166,rathke cleft cyst with evidence of rupture into subarachnoid space,background a rathke cleft cyst rcc with nonhemorrhagic rupture mimicking pituitary apoplexy ha been reported rarely case description a yearold woman previously diagnosed with asymptomatic rcc came to u with a severe headache along with visual dysfunction and symptom of pituitary insufficiency fluidattenuated inversion recovery magnetic resonance imaging demonstrated diffuse hyperintensity in the cerebral cistern whereas watery clear cerebrospinal fluid wa obtained by lumbar puncture surgery performed month after onset revealed a nonhemorrhagic lesion with a final diagnosis of nonhemorrhagic rcc rupture conclusion we conclude that nonhemorrhagic rcc rupture and subsequent leakage of the content into subarachnoid space were the underlying pathogenesis in the present case of rcc resembling apoplexy,Non-Cancer,1,rathke cleft cyst with evidence of rupture into subarachnoid space background a rathke cleft cyst rcc with nonhemorrhagic rupture mimicking pituitary apoplexy ha been reported rarely case description a yearold woman previously diagnosed with asymptomatic rcc came to u with a severe headache along with visual dysfunction and symptom of pituitary insufficiency fluidattenuated inversion recovery magnetic resonance imaging demonstrated diffuse hyperintensity in the cerebral cistern whereas watery clear cerebrospinal fluid wa obtained by lumbar puncture surgery performed month after onset revealed a nonhemorrhagic lesion with a final diagnosis of nonhemorrhagic rcc rupture conclusion we conclude that nonhemorrhagic rcc rupture and subsequent leakage of the content into subarachnoid space were the underlying pathogenesis in the present case of rcc resembling apoplexy
27810866,cutaneous and visceral chronic granulomatous disease triggered by a rubella virus vaccine strain in child with primary immunodeficiency,persistence of rubella live vaccine ha been associated with chronic skin granuloma in child with primary immunodeficiency we describe additional child with these finding including with visceral extension to the spleen,Non-Cancer,1,cutaneous and visceral chronic granulomatous disease triggered by a rubella virus vaccine strain in child with primary immunodeficiency persistence of rubella live vaccine ha been associated with chronic skin granuloma in child with primary immunodeficiency we describe additional child with these finding including with visceral extension to the spleen
27815897,synchronization and desynchronization of cell by intervention on the spindle assembly checkpoint,cell cycle checkpoint are surveillance mechanism that sequentially and continuously monitor cell cycle progression thereby contributing to the preservation of genetic stability among them the spindle assembly checkpoint sac prevents the occurrence of abnormal division by halting the metaphase to anaphase transition following the detection of erroneous microtubuleskinetochore attachment most synchronization strategy are based on the activation of cell cycle checkpoint to enrich the population of cell in a specific phase of the cell cycle here we develop a twostep protocol of sequential cell synchronization and desynchronization employing antimitotic sacinducing agent ie nocodazole or paclitaxel in combination with the depletion of the sac kinase mp we describe cytofluorometric and timelapse videomicroscopy method to detect cell cycle progression including the assessment of cell cycle distribution quantification of mitotic cell fraction and analysis of single cell fate profile of living cell we applied these method to validate the synchronizationdesynchronization protocol and to qualitatively and quantitatively determine the impact of sac inactivation on the activity of antimitotic agent,Non-Cancer,1,synchronization and desynchronization of cell by intervention on the spindle assembly checkpoint cell cycle checkpoint are surveillance mechanism that sequentially and continuously monitor cell cycle progression thereby contributing to the preservation of genetic stability among them the spindle assembly checkpoint sac prevents the occurrence of abnormal division by halting the metaphase to anaphase transition following the detection of erroneous microtubuleskinetochore attachment most synchronization strategy are based on the activation of cell cycle checkpoint to enrich the population of cell in a specific phase of the cell cycle here we develop a twostep protocol of sequential cell synchronization and desynchronization employing antimitotic sacinducing agent ie nocodazole or paclitaxel in combination with the depletion of the sac kinase mp we describe cytofluorometric and timelapse videomicroscopy method to detect cell cycle progression including the assessment of cell cycle distribution quantification of mitotic cell fraction and analysis of single cell fate profile of living cell we applied these method to validate the synchronizationdesynchronization protocol and to qualitatively and quantitatively determine the impact of sac inactivation on the activity of antimitotic agent
27821113,case report of whole genome sequencing in the xy female identification of a novel sry mutation and revision of a misdiagnosis of androgen insensitivity syndrome,background the xy female is characterised by a male karyotype and female phenotype arising due to any interruption in the sexual development pathway in utero the cause is usually genetic and various gene are implicated case presentation herein we describe a xy woman who wa first diagnosed with androgen insensitivity syndrome testicular feminisation at year however this wa later questioned due to the presence of intact mullerian structure the clinical phenotype suggested several susceptibility gene including sry dhh nra nrb ar amh and amhr to study candidate gene simultaneously we performed whole genome sequencing this revealed a novel and likely pathogenic missense variant pargpro cgc in sry one of the major gene implicated in complete gonadal dysgenesis hence securing this condition over androgen insensitivity syndrome a the cause of the patient disorder of sexual development conclusion this case highlight the emerging clinical utility of whole genome sequencing a a tool in differentiating disorder of sexual development,Non-Cancer,1,case report of whole genome sequencing in the xy female identification of a novel sry mutation and revision of a misdiagnosis of androgen insensitivity syndrome background the xy female is characterised by a male karyotype and female phenotype arising due to any interruption in the sexual development pathway in utero the cause is usually genetic and various gene are implicated case presentation herein we describe a xy woman who wa first diagnosed with androgen insensitivity syndrome testicular feminisation at year however this wa later questioned due to the presence of intact mullerian structure the clinical phenotype suggested several susceptibility gene including sry dhh nra nrb ar amh and amhr to study candidate gene simultaneously we performed whole genome sequencing this revealed a novel and likely pathogenic missense variant pargpro cgc in sry one of the major gene implicated in complete gonadal dysgenesis hence securing this condition over androgen insensitivity syndrome a the cause of the patient disorder of sexual development conclusion this case highlight the emerging clinical utility of whole genome sequencing a a tool in differentiating disorder of sexual development
27826699,a unique case of multiple nonossifying fibroma with polyostotic monomelic distribution and aggressive clinical course,multiple nonossifying fibroma mnofs occur either isolated or in association with other anomaly are usually localized in the long bone of the lower limb may be radiographically confused with other skeletal lesion and tend to heal spontaneously with the completion of the skeletal growth segmental distribution either monomelic or polymelic and ipsilateral is rare and commonly observed in the context of developmental disease known a rasopathies which are caused by mutation in gene that encode component or regulator within the rasmitogenactivated protein kinase signaling pathway we describe here the radiographic and pathologic feature of an yearold caucasian boy whose clinical history started at the age of when the diagnosis of aneurysmal bone cyst wa made on a lytic lesion of his left clavicle over the following year the patient developed polyostotic and monomelic lesion within the left humerus radius and ulna no other skeletal and extraskeletal anomaly were clinically detected the lesion were interpreted a consistent with polyostotic fibrous dysplasia and mnofs and showed an unusually aggressive clinical course with progressive increase in size and coalescence the definitive diagnosis of mnofs wa made after the exclusion of fibrous dysplasia by molecular analysis the polyostotic and monomelic distribution of the lesion and the unusually aggressive clinical course contribute to make this case of mnofs unique,Non-Cancer,1,a unique case of multiple nonossifying fibroma with polyostotic monomelic distribution and aggressive clinical course multiple nonossifying fibroma mnofs occur either isolated or in association with other anomaly are usually localized in the long bone of the lower limb may be radiographically confused with other skeletal lesion and tend to heal spontaneously with the completion of the skeletal growth segmental distribution either monomelic or polymelic and ipsilateral is rare and commonly observed in the context of developmental disease known a rasopathies which are caused by mutation in gene that encode component or regulator within the rasmitogenactivated protein kinase signaling pathway we describe here the radiographic and pathologic feature of an yearold caucasian boy whose clinical history started at the age of when the diagnosis of aneurysmal bone cyst wa made on a lytic lesion of his left clavicle over the following year the patient developed polyostotic and monomelic lesion within the left humerus radius and ulna no other skeletal and extraskeletal anomaly were clinically detected the lesion were interpreted a consistent with polyostotic fibrous dysplasia and mnofs and showed an unusually aggressive clinical course with progressive increase in size and coalescence the definitive diagnosis of mnofs wa made after the exclusion of fibrous dysplasia by molecular analysis the polyostotic and monomelic distribution of the lesion and the unusually aggressive clinical course contribute to make this case of mnofs unique
27830539,primary autoimmune myelofibrosis a case report and review of the literature,autoimmune myelofibrosis is a rare distinct clinicopathological entity that can occur in isolation primary or in association with systemic autoimmune disorder secondary such a systemic lupus erythematosus and sjogrens syndrome this disease is characterized by isolated or combined chronic cytopenia associated with autoimmune phenomenon and bonemarrow fibrosis due to the rarity of this disease patient are frequently misdiagnosed a having primary myelofibrosis the most common form of bonemarrow fibrosis distinguishing between both disease entity is essential given the drastic therapeutic and prognostic difference between both disorder we report a case of primary autoimmune myelofibrosis presenting with severe isolated anemia refractory to multiple line of therapy this patient wa initially misdiagnosed a primary myelofibrosis the absence of the characteristic feature of primary myelofibrosis and the lack of a clonal abnormality on cytogenetic and molecular study particularly jak calr and mpl mutation analysis confirmed the absence of an aberrant neoplastic process furthermore the presence of monoclonal tcell receptor gamma gene rearrangement delineated the presence of an autoimmune disorder supporting our diagnosis of primary autoimmune myelofibrosis,Non-Cancer,1,primary autoimmune myelofibrosis a case report and review of the literature autoimmune myelofibrosis is a rare distinct clinicopathological entity that can occur in isolation primary or in association with systemic autoimmune disorder secondary such a systemic lupus erythematosus and sjogrens syndrome this disease is characterized by isolated or combined chronic cytopenia associated with autoimmune phenomenon and bonemarrow fibrosis due to the rarity of this disease patient are frequently misdiagnosed a having primary myelofibrosis the most common form of bonemarrow fibrosis distinguishing between both disease entity is essential given the drastic therapeutic and prognostic difference between both disorder we report a case of primary autoimmune myelofibrosis presenting with severe isolated anemia refractory to multiple line of therapy this patient wa initially misdiagnosed a primary myelofibrosis the absence of the characteristic feature of primary myelofibrosis and the lack of a clonal abnormality on cytogenetic and molecular study particularly jak calr and mpl mutation analysis confirmed the absence of an aberrant neoplastic process furthermore the presence of monoclonal tcell receptor gamma gene rearrangement delineated the presence of an autoimmune disorder supporting our diagnosis of primary autoimmune myelofibrosis
27831994,pseudarthrosis repair using autologous cultured osteoblast in complex type neurofibromatosis spinal deformity a case report and review of the literature,study design a case report and literature review objective to report a late dislocation of the vertebra caused by progressive dural ectasia combined with type neurofibromatosis nf and the clinical result of pseudarthrosis repair using autologous cultured osteoblast summary of background data nf is a wellknown genetic disorder that is commonly characterized by spinal deformity including kyphoscoliosis late dislocation of the vertebra resulting from progressive dural ectasia after surgical correction of nf scoliosis is a very rare occurrence and pseudarthrosis frequently develops after surgical intervention for this complex spinal deformity method a yearold female patient with nf scoliosis underwent surgical correction with posterior instrumented fusion seventeen year later dislocation of the lumbar spine with implant failure resulting from massive progressive dural ectasia wa observed she underwent anterior interbody fusion three time and posterior instrumented fusion four time for pseudarthrosis followed by surgical deformity correction for the last operation autologous cultured osteoblast were used a a therapeutic approach to repair the pseudarthrosis and a threedimensional printing technique wa used to understand the surgical anatomy of the dislocated lumbar spine in detail result after the final operation bone union wa achieved and confirmed by clinical and radiological examination conclusion spine surgeon should be knowledgeable about the possibility of late destabilization of the spine due to pulsatile dural ectasia and a high rate of pseudarthrosis in neurofibromatosis autologous cultured osteoblast may prove to be a modality that can be applied pseudarthrosis repair to treat complex spinal deformity level of evidence,Non-Cancer,1,pseudarthrosis repair using autologous cultured osteoblast in complex type neurofibromatosis spinal deformity a case report and review of the literature study design a case report and literature review objective to report a late dislocation of the vertebra caused by progressive dural ectasia combined with type neurofibromatosis nf and the clinical result of pseudarthrosis repair using autologous cultured osteoblast summary of background data nf is a wellknown genetic disorder that is commonly characterized by spinal deformity including kyphoscoliosis late dislocation of the vertebra resulting from progressive dural ectasia after surgical correction of nf scoliosis is a very rare occurrence and pseudarthrosis frequently develops after surgical intervention for this complex spinal deformity method a yearold female patient with nf scoliosis underwent surgical correction with posterior instrumented fusion seventeen year later dislocation of the lumbar spine with implant failure resulting from massive progressive dural ectasia wa observed she underwent anterior interbody fusion three time and posterior instrumented fusion four time for pseudarthrosis followed by surgical deformity correction for the last operation autologous cultured osteoblast were used a a therapeutic approach to repair the pseudarthrosis and a threedimensional printing technique wa used to understand the surgical anatomy of the dislocated lumbar spine in detail result after the final operation bone union wa achieved and confirmed by clinical and radiological examination conclusion spine surgeon should be knowledgeable about the possibility of late destabilization of the spine due to pulsatile dural ectasia and a high rate of pseudarthrosis in neurofibromatosis autologous cultured osteoblast may prove to be a modality that can be applied pseudarthrosis repair to treat complex spinal deformity level of evidence
27855285,computational drug treatment simulation on projection of dysregulated protein network derived from the myelodysplastic mutanome match clinical response in patient,although the majority of md patient fail to achieve clinical improvement to approved therapy some patient benefit from treatment predicting patient response prior to therapy would improve treatment effectiveness avoid treatmentrelated adverse event and reduce healthcare cost three separate cohort of md patient were used to simulate drug response to lenalidomide alone hypomethylating agent hma alone or hma plus lenalidomide utilizing a computational biology program genomic abnormality in each patient were used to create an intracellular pathway map that wa then used to screen for drug response in the lenalidomide treated cohort computer modeling correctly matched clinical response in patient in the second cohort hma patient were modeled and correctly matched to response in in the third cohort computer modeling correctly matched response in patient this computational biology network approach identified ggh overexpression a a potential resistance factor to hma treatment and paradoxical activation of betacatenin through csnka inhibition a a resistance factor to lenalidomide treatment we demonstrate that a computational technology is able to map the complexity of the md mutanome to simulate and predict drug response this tool can improve understanding of md biology and mechanism of drug sensitivity and resistance,Non-Cancer,1,computational drug treatment simulation on projection of dysregulated protein network derived from the myelodysplastic mutanome match clinical response in patient although the majority of md patient fail to achieve clinical improvement to approved therapy some patient benefit from treatment predicting patient response prior to therapy would improve treatment effectiveness avoid treatmentrelated adverse event and reduce healthcare cost three separate cohort of md patient were used to simulate drug response to lenalidomide alone hypomethylating agent hma alone or hma plus lenalidomide utilizing a computational biology program genomic abnormality in each patient were used to create an intracellular pathway map that wa then used to screen for drug response in the lenalidomide treated cohort computer modeling correctly matched clinical response in patient in the second cohort hma patient were modeled and correctly matched to response in in the third cohort computer modeling correctly matched response in patient this computational biology network approach identified ggh overexpression a a potential resistance factor to hma treatment and paradoxical activation of betacatenin through csnka inhibition a a resistance factor to lenalidomide treatment we demonstrate that a computational technology is able to map the complexity of the md mutanome to simulate and predict drug response this tool can improve understanding of md biology and mechanism of drug sensitivity and resistance
27859271,genetics meet pathology an increasingly important relationship,the analytical power of modern method for dna analysis ha outstripped our capability to interpret and understand the data generated to make good use of this genomic data in a biomedical setting whether for research or diagnosis it is vital that we understand the mechanism through which mutation affect biochemical pathway and physiological system this lie at the centre of what genetics is all about and it is the reason why genetics and genomics should go hand in hand whenever possible in this annual review issue of the journal of pathology we have assembled a collection of expert review covering a wide range of topic through these we illustrate the power of genetic analysis to improve our understanding of normal physiology and disease pathology and thereby to think in rational way about clinical management copyright pathological society of great britain and ireland published by john wiley son ltd,Non-Cancer,1,genetics meet pathology an increasingly important relationship the analytical power of modern method for dna analysis ha outstripped our capability to interpret and understand the data generated to make good use of this genomic data in a biomedical setting whether for research or diagnosis it is vital that we understand the mechanism through which mutation affect biochemical pathway and physiological system this lie at the centre of what genetics is all about and it is the reason why genetics and genomics should go hand in hand whenever possible in this annual review issue of the journal of pathology we have assembled a collection of expert review covering a wide range of topic through these we illustrate the power of genetic analysis to improve our understanding of normal physiology and disease pathology and thereby to think in rational way about clinical management copyright pathological society of great britain and ireland published by john wiley son ltd
27885891,wiskottaldrich syndrome in a child presenting with macrothrombocytopenia,wiskottaldrich syndrome wa is a rare xlinked recessive disease resulting from variant in the wa gene characterized by a triad of immunodeficiency eczema and thrombocytopenia despite the fact that wa is traditionally differentiated from immune thrombocytopenia itp by small size of wa platelet in practice microthrombocytopenia may occasionally not be present and in certain case wa patient exhibit some parallelism to itp patient we characterized one patient presenting with the classic form of the disease but increased mean platelet volume molecular study revealed a novel hemizygous bp deletion in wa gene cdelc leading to a frameshift and stop codon at amino acid pargglyfs nextgeneration sequencing of a total of additional gene known to harbor variant implicated in inherited platelet disorder did not identify additional defect the pathogenesis of macrothrombocytopenia in this case is not known but probably the coexistence of a still unidentified additional genetic variant might be involved,Non-Cancer,1,wiskottaldrich syndrome in a child presenting with macrothrombocytopenia wiskottaldrich syndrome wa is a rare xlinked recessive disease resulting from variant in the wa gene characterized by a triad of immunodeficiency eczema and thrombocytopenia despite the fact that wa is traditionally differentiated from immune thrombocytopenia itp by small size of wa platelet in practice microthrombocytopenia may occasionally not be present and in certain case wa patient exhibit some parallelism to itp patient we characterized one patient presenting with the classic form of the disease but increased mean platelet volume molecular study revealed a novel hemizygous bp deletion in wa gene cdelc leading to a frameshift and stop codon at amino acid pargglyfs nextgeneration sequencing of a total of additional gene known to harbor variant implicated in inherited platelet disorder did not identify additional defect the pathogenesis of macrothrombocytopenia in this case is not known but probably the coexistence of a still unidentified additional genetic variant might be involved
27935710,quantification of atpb protein in dried blood spot by peptide immunosrm a a potential screen for wilson disease,wilson disease wd a copper transport disorder caused by a genetic defect in the atpb gene ha been a long time strong candidate for newborn screening nb since early intervention can give better result by preventing irreversible neurological disability or liver cirrhosis several previous pilot study measuring ceruloplasmin cp in infant or child showed that this marker alone wa insufficient to meet the universal screening for wd wd result from mutation that cause absent or markedly diminished level of atpb therefore atpb could serve a a marker for the screening of wd if the protein can be detected from dried blood spot db this study demonstrates that the immunosrm platform can quantify atpb in db in the picomolar range and that the assay readily distinguishes affected case from normal control p the assay precision wa cv and the protein wa stable for a week in db at room temperature these promising proofofconcept data open up the possibility of screening wd in newborn and the potential for a multiplexed assay for screening a variety of congenital disorder using protein a biomarkers in db,Non-Cancer,1,quantification of atpb protein in dried blood spot by peptide immunosrm a a potential screen for wilson disease wilson disease wd a copper transport disorder caused by a genetic defect in the atpb gene ha been a long time strong candidate for newborn screening nb since early intervention can give better result by preventing irreversible neurological disability or liver cirrhosis several previous pilot study measuring ceruloplasmin cp in infant or child showed that this marker alone wa insufficient to meet the universal screening for wd wd result from mutation that cause absent or markedly diminished level of atpb therefore atpb could serve a a marker for the screening of wd if the protein can be detected from dried blood spot db this study demonstrates that the immunosrm platform can quantify atpb in db in the picomolar range and that the assay readily distinguishes affected case from normal control p the assay precision wa cv and the protein wa stable for a week in db at room temperature these promising proofofconcept data open up the possibility of screening wd in newborn and the potential for a multiplexed assay for screening a variety of congenital disorder using protein a biomarkers in db
27939943,the mitotic checkpoint complex requires an evolutionary conserved cassette to bind and inhibit active apcc,the spindle assembly checkpoint sac ensures genomic stability by preventing sister chromatid separation until all chromosome are attached to the spindle it catalyzes the production of the mitotic checkpoint complex mcc which inhibits cdc to inactivate the anaphase promoting complexcyclosome apcc here we show that two cdcbinding motif in bubr of the recently identified abba motif class are crucial for the mcc to recognize active apcccdc mutating these motif eliminates mcc binding to the apcc thereby abolishing the sac and preventing cell from arresting in response to microtubule poison these abba motif flank a ken box to form a cassette that is highly conserved through evolution both in the arrangement and spacing of the abbakenabba motif and association with the aminoterminal ken box required to form the mcc we propose that the abbakenabba cassette hold the mcc onto the apcc by binding the two cdc molecule in the mccapcc complex,Non-Cancer,1,the mitotic checkpoint complex requires an evolutionary conserved cassette to bind and inhibit active apcc the spindle assembly checkpoint sac ensures genomic stability by preventing sister chromatid separation until all chromosome are attached to the spindle it catalyzes the production of the mitotic checkpoint complex mcc which inhibits cdc to inactivate the anaphase promoting complexcyclosome apcc here we show that two cdcbinding motif in bubr of the recently identified abba motif class are crucial for the mcc to recognize active apcccdc mutating these motif eliminates mcc binding to the apcc thereby abolishing the sac and preventing cell from arresting in response to microtubule poison these abba motif flank a ken box to form a cassette that is highly conserved through evolution both in the arrangement and spacing of the abbakenabba motif and association with the aminoterminal ken box required to form the mcc we propose that the abbakenabba cassette hold the mcc onto the apcc by binding the two cdc molecule in the mccapcc complex
28019712,inferior vena cava filter,use of inferior vena cava ivc filter ha increased dramatically in recent decade despite a lack of evidence that their use ha impacted venous thromboembolism vterelated mortality this increased use appears to be primarily driven by the insertion of retrievable filter for prophylactic indication a growing body of evidence however suggests that ivc filter are frequently associated with clinically important adverse event prompting a closer look at their role we sought to narratively review the current evidence on the efficacy and safety of ivc filter placement inferior vena cava filter remain the only treatment option for patient with an acute within week proximal deep vein thrombosis dvt or pulmonary embolism and an absolute contraindication to anticoagulation in such patient anticoagulation should be resumed and ivc filter removed a soon a the contraindication ha passed for all other indication there is insufficient evidence to support the use of ivc filter and highquality trial are required in patient where an ivc filter remains regular followup to reassess removal and screen for filterrelated complication should occur,Non-Cancer,1,inferior vena cava filter use of inferior vena cava ivc filter ha increased dramatically in recent decade despite a lack of evidence that their use ha impacted venous thromboembolism vterelated mortality this increased use appears to be primarily driven by the insertion of retrievable filter for prophylactic indication a growing body of evidence however suggests that ivc filter are frequently associated with clinically important adverse event prompting a closer look at their role we sought to narratively review the current evidence on the efficacy and safety of ivc filter placement inferior vena cava filter remain the only treatment option for patient with an acute within week proximal deep vein thrombosis dvt or pulmonary embolism and an absolute contraindication to anticoagulation in such patient anticoagulation should be resumed and ivc filter removed a soon a the contraindication ha passed for all other indication there is insufficient evidence to support the use of ivc filter and highquality trial are required in patient where an ivc filter remains regular followup to reassess removal and screen for filterrelated complication should occur
28120103,mutation in chromatin regulator functionally link cornelia de lange syndrome and clinically overlapping phenotype,the coordinated tissuespecific regulation of gene expression is essential for the proper development of all organism mutation in multiple transcriptional regulator cause a group of neurodevelopmental disorder termed transcriptomopathies that share core phenotypical feature including growth retardation developmental delay intellectual disability and facial dysmorphism cornelia de lange syndrome cdls belongs to this class of disorder and is caused by mutation in different subunit or regulator of the cohesin complex herein we report on the clinical and molecular characterization of seven patient with feature overlapping with cdls who were found to carry mutation in chromatin regulator previously associated to other neurodevelopmental disorder that are frequently considered in the differential diagnosis of cdls the identified mutation affect the methyltransferaseencoding gene kmta and setd and different subunit of the swisnf chromatinremodeling complex complementary to this a patient with coffinsiris syndrome wa found to carry a missense substitution in nipbl our finding indicate that mutation in a variety of chromatinassociated factor result in overlapping clinical phenotype underscoring the genetic heterogeneity that should be considered when assessing the clinical and molecular diagnosis of neurodevelopmental syndrome it is clear that emerging molecular mechanism of chromatin dysregulation are central to understanding the pathogenesis of these clinically overlapping genetic disorder,Non-Cancer,1,mutation in chromatin regulator functionally link cornelia de lange syndrome and clinically overlapping phenotype the coordinated tissuespecific regulation of gene expression is essential for the proper development of all organism mutation in multiple transcriptional regulator cause a group of neurodevelopmental disorder termed transcriptomopathies that share core phenotypical feature including growth retardation developmental delay intellectual disability and facial dysmorphism cornelia de lange syndrome cdls belongs to this class of disorder and is caused by mutation in different subunit or regulator of the cohesin complex herein we report on the clinical and molecular characterization of seven patient with feature overlapping with cdls who were found to carry mutation in chromatin regulator previously associated to other neurodevelopmental disorder that are frequently considered in the differential diagnosis of cdls the identified mutation affect the methyltransferaseencoding gene kmta and setd and different subunit of the swisnf chromatinremodeling complex complementary to this a patient with coffinsiris syndrome wa found to carry a missense substitution in nipbl our finding indicate that mutation in a variety of chromatinassociated factor result in overlapping clinical phenotype underscoring the genetic heterogeneity that should be considered when assessing the clinical and molecular diagnosis of neurodevelopmental syndrome it is clear that emerging molecular mechanism of chromatin dysregulation are central to understanding the pathogenesis of these clinically overlapping genetic disorder
28146470,rare and lowfrequency coding variant alter human adult height,height is a highly heritable classic polygenic trait with approximately common associated variant identified through genomewide association study so far here we report heightassociated coding variant with lower minorallele frequency in the range of and effect of up to centimetre per allele such a those in ihh stc ar and crispld greater than ten time the average effect of common variant in functional followup study rare heightincreasing allele of stc giving an increase of centimetre per allele compromised proteolytic inhibition of pappa and increased cleavage of igfbp in vitro resulting in higher bioavailability of insulinlike growth factor these heightassociated variant overlap gene that are mutated in monogenic growth disorder and highlight new biological candidate such a adamts ilra and nox and pathway such a proteoglycan and glycosaminoglycan synthesis involved in growth our result demonstrate that sufficiently large sample size can uncover rare and lowfrequency variant of moderatetolarge effect associated with polygenic human phenotype and that these variant implicate relevant gene and pathway,Non-Cancer,1,rare and lowfrequency coding variant alter human adult height height is a highly heritable classic polygenic trait with approximately common associated variant identified through genomewide association study so far here we report heightassociated coding variant with lower minorallele frequency in the range of and effect of up to centimetre per allele such a those in ihh stc ar and crispld greater than ten time the average effect of common variant in functional followup study rare heightincreasing allele of stc giving an increase of centimetre per allele compromised proteolytic inhibition of pappa and increased cleavage of igfbp in vitro resulting in higher bioavailability of insulinlike growth factor these heightassociated variant overlap gene that are mutated in monogenic growth disorder and highlight new biological candidate such a adamts ilra and nox and pathway such a proteoglycan and glycosaminoglycan synthesis involved in growth our result demonstrate that sufficiently large sample size can uncover rare and lowfrequency variant of moderatetolarge effect associated with polygenic human phenotype and that these variant implicate relevant gene and pathway
28163183,a femoral common vein aneurysm in a patient with neurofibromatosis syndrome type,neurofibromatosis type i nfi also called von recklinghausen disease is an autosomal dominant disease secondary to a genetic mutation on the long arm of chromosome this disorder affect neural crest cell cutaneous clinical form are the most frequent with multiple benign skin neurofibroma associated with cafe au lait skin spot and iris hamartoma vascular abnormality in nf are rare but have also been well described the most frequent abnormality are characterized by arterial aneurysm degeneration stenosis and malformation venous location are rare but some case of venous aneurysm were described with rupture a complication we present a rare case of thrombosed venous femoral aneurysm associated with a pulmonary embolism in a patient affected by nf,Non-Cancer,1,a femoral common vein aneurysm in a patient with neurofibromatosis syndrome type neurofibromatosis type i nfi also called von recklinghausen disease is an autosomal dominant disease secondary to a genetic mutation on the long arm of chromosome this disorder affect neural crest cell cutaneous clinical form are the most frequent with multiple benign skin neurofibroma associated with cafe au lait skin spot and iris hamartoma vascular abnormality in nf are rare but have also been well described the most frequent abnormality are characterized by arterial aneurysm degeneration stenosis and malformation venous location are rare but some case of venous aneurysm were described with rupture a complication we present a rare case of thrombosed venous femoral aneurysm associated with a pulmonary embolism in a patient affected by nf
28165011,mtorcindependent tfeb activation via akt inhibition promotes cellular clearance in neurodegenerative storage disease,neurodegenerative disease characterized by aberrant accumulation of undigested cellular component represent unmet medical condition for which the identification of actionable target is urgently needed here we identify a pharmacologically actionable pathway that control cellular clearance via akt modulation of transcription factor eb tfeb a master regulator of lysosomal pathway we show that akt phosphorylates tfeb at ser and represses tfeb nuclear translocation independently of mechanistic target of rapamycin complex mtorc a known tfeb inhibitor the autophagy enhancer trehalose activates tfeb by diminishing akt activity administration of trehalose to a mouse model of batten disease a prototypical neurodegenerative disease presenting with intralysosomal storage enhances clearance of proteolipid aggregate reduces neuropathology and prolongs survival of diseased mouse pharmacological inhibition of akt promotes cellular clearance in cell from patient with a variety of lysosomal disease thus suggesting broad applicability of this approach these finding open new perspective for the clinical translation of tfebmediated enhancement of cellular clearance in neurodegenerative storage disease,Non-Cancer,1,mtorcindependent tfeb activation via akt inhibition promotes cellular clearance in neurodegenerative storage disease neurodegenerative disease characterized by aberrant accumulation of undigested cellular component represent unmet medical condition for which the identification of actionable target is urgently needed here we identify a pharmacologically actionable pathway that control cellular clearance via akt modulation of transcription factor eb tfeb a master regulator of lysosomal pathway we show that akt phosphorylates tfeb at ser and represses tfeb nuclear translocation independently of mechanistic target of rapamycin complex mtorc a known tfeb inhibitor the autophagy enhancer trehalose activates tfeb by diminishing akt activity administration of trehalose to a mouse model of batten disease a prototypical neurodegenerative disease presenting with intralysosomal storage enhances clearance of proteolipid aggregate reduces neuropathology and prolongs survival of diseased mouse pharmacological inhibition of akt promotes cellular clearance in cell from patient with a variety of lysosomal disease thus suggesting broad applicability of this approach these finding open new perspective for the clinical translation of tfebmediated enhancement of cellular clearance in neurodegenerative storage disease
28291640,pegylated interferon alfaa in patient with essential thrombocythaemia or polycythaemia vera a posthoc median month followup of an openlabel phase trial,background pegylated interferon alfaa is an immunomodulatory agent used to treat polycythemia vera the durability of response and longterm safety of this drug in patient with polycythaemia vera and essential thrombocythaemia have not been reported here we present longterm efficacy and safety data from a singlecentre openlabel phase trial after a median of month follow up method patient older than year who were diagnosed with essential thrombocythaemia or polycythaemia vera according to who criterion were eligible to enrol in our study the initial starting dose of pegylated interferon alfaa wa mug subcutaneously once per week but wa decreased in a stepwise manner due to toxic effect to a final starting dose of mg per week three patient were started at a dose of mg per week three at mg per week at mg per week at mg per week and at mg per week treatment wa continued for a long a the patient derived clinical benefit with reduction in dose and frequency of administration allowed at the discretion of the treating physician haematological response were assessed every month on the basis of blood count a defined by the european leukemianet critieria the primary endpoint of the initial study wa the proportion of patient with a haematological response complete haematological response wa defined a normalisation of blood count for patient with essential thrombocythaemia platelet x per l for patient with polycythaemia vera haemoglobin gl without phlebotomy with complete resolution of palpable splenomegaly or symptom in the absence of a thrombotic event data were analysed with descriptive statistic and in the intentiontotreat population this study is registered with clinicaltrialsgov number nct and is ongoing but not enrolling new patient finding between may and dec patient were followed up for a median of month iqr month pegylated interferon alfaa induced haematological of patient and molecular response of patient in patient with essential thrombocythaemia and patient with polycythaemia vera with median duration of month iqr and month respectively of haematological responder and of molecular responder with the jak valphe mutation have maintained some response during followup maintained their best molecular response nine of ten patient who had a complete response five of who had a partial response and three of five who had a minor response the incidence of major venousthrombotic event during the study wa per personyears overall of patient discontinued therapy due to treatmentrelated toxicity although toxicity rate decreased over time five patient had treatmentlimiting grade or toxicity after month on therapy patient are still enrolled on the study interpretation pegylated interferon alfaa can induce durable haematological and molecular response in patient with essential thrombocythaemia and polycythaemia vera this drug alone and in combination with other drug could be explored further in clinical trial funding u national cancer institute,Non-Cancer,1,pegylated interferon alfaa in patient with essential thrombocythaemia or polycythaemia vera a posthoc median month followup of an openlabel phase trial background pegylated interferon alfaa is an immunomodulatory agent used to treat polycythemia vera the durability of response and longterm safety of this drug in patient with polycythaemia vera and essential thrombocythaemia have not been reported here we present longterm efficacy and safety data from a singlecentre openlabel phase trial after a median of month follow up method patient older than year who were diagnosed with essential thrombocythaemia or polycythaemia vera according to who criterion were eligible to enrol in our study the initial starting dose of pegylated interferon alfaa wa mug subcutaneously once per week but wa decreased in a stepwise manner due to toxic effect to a final starting dose of mg per week three patient were started at a dose of mg per week three at mg per week at mg per week at mg per week and at mg per week treatment wa continued for a long a the patient derived clinical benefit with reduction in dose and frequency of administration allowed at the discretion of the treating physician haematological response were assessed every month on the basis of blood count a defined by the european leukemianet critieria the primary endpoint of the initial study wa the proportion of patient with a haematological response complete haematological response wa defined a normalisation of blood count for patient with essential thrombocythaemia platelet x per l for patient with polycythaemia vera haemoglobin gl without phlebotomy with complete resolution of palpable splenomegaly or symptom in the absence of a thrombotic event data were analysed with descriptive statistic and in the intentiontotreat population this study is registered with clinicaltrialsgov number nct and is ongoing but not enrolling new patient finding between may and dec patient were followed up for a median of month iqr month pegylated interferon alfaa induced haematological of patient and molecular response of patient in patient with essential thrombocythaemia and patient with polycythaemia vera with median duration of month iqr and month respectively of haematological responder and of molecular responder with the jak valphe mutation have maintained some response during followup maintained their best molecular response nine of ten patient who had a complete response five of who had a partial response and three of five who had a minor response the incidence of major venousthrombotic event during the study wa per personyears overall of patient discontinued therapy due to treatmentrelated toxicity although toxicity rate decreased over time five patient had treatmentlimiting grade or toxicity after month on therapy patient are still enrolled on the study interpretation pegylated interferon alfaa can induce durable haematological and molecular response in patient with essential thrombocythaemia and polycythaemia vera this drug alone and in combination with other drug could be explored further in clinical trial funding u national cancer institute
28295149,enlarged posterior fossa on prenatal imaging differential diagnosis associated anomaly and postnatal outcome,introduction the primary aim of this study wa to ascertain the prevalence of the individual condition and of associated anomaly in fetus with the prenatal diagnosis of enlarged posterior fossa pf and to explore the diagnostic accuracy of ultrasound in these anomaly the secondary aim wa to evaluate the postnatal outcome of child affected by pf anomaly material and method all fetus with enlarged pf detected by prenatal sonography at a referral center from to were analyzed retrospectively some were also studied by fetal magnetic resonance imaging mri or volume ultrasound examination fetal sonographic and mri were compared using following classification dandywalker malformation dwm megacisterna magna mcm blake pouch cyst isolated vermian hypoplasia vermian agenesis pf arachnoid cyst ac and cerebellar hypoplasia ch result the ultrasound diagnosis of the fetus were a follows mcm n of these isolated n dwm n isolated n vermian hypoplasia n isolated n blake pouch cyst n isolated n ch n none isolated and ac in the pf n isolated thirteen of the karyotyped fetus were aneuploid including seven with dwm associated malformation were found in case there were live birth including with confirmed dwm six of whom show a normal development twelve infant with isolated mcm show normal development there were eight falsepositive prenatal diagnosis or resolution until birth of enlarged pf three with blake pouch cyst two with mcm and one with vermian hypoplasia conclusion an enlarged pf requires specific diagnosis for the best possible counseling the term dandywalker variant should not be used anymore isolated mcm and blake pouch cyst can either resolve or be normal variant but may also indicate the presence of a more severe anomaly or associated malformation,Non-Cancer,1,enlarged posterior fossa on prenatal imaging differential diagnosis associated anomaly and postnatal outcome introduction the primary aim of this study wa to ascertain the prevalence of the individual condition and of associated anomaly in fetus with the prenatal diagnosis of enlarged posterior fossa pf and to explore the diagnostic accuracy of ultrasound in these anomaly the secondary aim wa to evaluate the postnatal outcome of child affected by pf anomaly material and method all fetus with enlarged pf detected by prenatal sonography at a referral center from to were analyzed retrospectively some were also studied by fetal magnetic resonance imaging mri or volume ultrasound examination fetal sonographic and mri were compared using following classification dandywalker malformation dwm megacisterna magna mcm blake pouch cyst isolated vermian hypoplasia vermian agenesis pf arachnoid cyst ac and cerebellar hypoplasia ch result the ultrasound diagnosis of the fetus were a follows mcm n of these isolated n dwm n isolated n vermian hypoplasia n isolated n blake pouch cyst n isolated n ch n none isolated and ac in the pf n isolated thirteen of the karyotyped fetus were aneuploid including seven with dwm associated malformation were found in case there were live birth including with confirmed dwm six of whom show a normal development twelve infant with isolated mcm show normal development there were eight falsepositive prenatal diagnosis or resolution until birth of enlarged pf three with blake pouch cyst two with mcm and one with vermian hypoplasia conclusion an enlarged pf requires specific diagnosis for the best possible counseling the term dandywalker variant should not be used anymore isolated mcm and blake pouch cyst can either resolve or be normal variant but may also indicate the presence of a more severe anomaly or associated malformation
28298420,staged induction of hiv glycandependent broadly neutralizing antibody,a preventive hiv vaccine should induce hivspecific broadly neutralizing antibody bnabs however bnabs generally require high level of somatic hypermutation shm to acquire breadth and current vaccine strategy have not been successful in inducing bnabs because bnabs directed against a glycosylated site adjacent to the third variable loop v of the hiv envelope protein require limited shm the vglycan epitope is an attractive vaccine target by studying the cooperation among multiple vglycan b cell lineage and their coevolution with autologous virus throughout year of infection we identify key event in the ontogeny of a vglycan bnab two autologous neutralizing antibody lineage selected for virus escape mutation and consequently allowed initiation and affinity maturation of a vglycan bnab lineage the nucleotide substitution required to initiate the bnab lineage occurred at a lowprobability site for activationinduced cytidine deaminase activity cooperation of b cell lineage and an improbable mutation critical for bnab activity defined the necessary event leading to breadth in this vglycan bnab lineage these finding may in part explain why initiation of vglycan bnabs is rare and suggest an immunization strategy for inducing similar vglycan bnabs,Non-Cancer,1,staged induction of hiv glycandependent broadly neutralizing antibody a preventive hiv vaccine should induce hivspecific broadly neutralizing antibody bnabs however bnabs generally require high level of somatic hypermutation shm to acquire breadth and current vaccine strategy have not been successful in inducing bnabs because bnabs directed against a glycosylated site adjacent to the third variable loop v of the hiv envelope protein require limited shm the vglycan epitope is an attractive vaccine target by studying the cooperation among multiple vglycan b cell lineage and their coevolution with autologous virus throughout year of infection we identify key event in the ontogeny of a vglycan bnab two autologous neutralizing antibody lineage selected for virus escape mutation and consequently allowed initiation and affinity maturation of a vglycan bnab lineage the nucleotide substitution required to initiate the bnab lineage occurred at a lowprobability site for activationinduced cytidine deaminase activity cooperation of b cell lineage and an improbable mutation critical for bnab activity defined the necessary event leading to breadth in this vglycan bnab lineage these finding may in part explain why initiation of vglycan bnabs is rare and suggest an immunization strategy for inducing similar vglycan bnabs
28347285,wholeexome sequencing and digital pcr identified a novel compound heterozygous mutation in the nphp gene in a case of joubert syndrome and related disorder,background joubert syndrome and related disorder jsrd is a clinically and genetically heterogeneous condition with autosomal recessive or xlinked inheritance which share a distinctive neuroradiological hallmark the socalled molar tooth sign jsrd is classified into six clinical subtypes based on associated variable multiorgan involvement to date causative gene have been identified in jsrd which make genetic diagnosis difficult case presentation we report here a case of a yearold japanese woman diagnosed with j with oculorenal defect with a novel compound heterozygous mutation pserdeletion in the nphp gene wholeexome sequencing wes of the patient identified the novel nonsense mutation in an apparently homozygous state however it wa absent in her mother and heterozygous in her father a read depthbased copy number variation cnv detection algorithm using wes data of the family predicted a large heterozygous deletion mutation in the patient and her mother which wa validated by digital polymerase chain reaction indicating that the patient wa compound heterozygous for the paternal nonsense mutation and the maternal deletion mutation spanning the site of the single nucleotide change conclusion it should be noted that analytical pipeline that focus purely on sequence information can not distinguish homozygosity from hemizygosity because of it inability to detect large deletion the ability to detect cnvs in addition to single nucleotide variant and small insertiondeletions make wes an attractive diagnostic tool for genetically heterogeneous disorder,Non-Cancer,1,wholeexome sequencing and digital pcr identified a novel compound heterozygous mutation in the nphp gene in a case of joubert syndrome and related disorder background joubert syndrome and related disorder jsrd is a clinically and genetically heterogeneous condition with autosomal recessive or xlinked inheritance which share a distinctive neuroradiological hallmark the socalled molar tooth sign jsrd is classified into six clinical subtypes based on associated variable multiorgan involvement to date causative gene have been identified in jsrd which make genetic diagnosis difficult case presentation we report here a case of a yearold japanese woman diagnosed with j with oculorenal defect with a novel compound heterozygous mutation pserdeletion in the nphp gene wholeexome sequencing wes of the patient identified the novel nonsense mutation in an apparently homozygous state however it wa absent in her mother and heterozygous in her father a read depthbased copy number variation cnv detection algorithm using wes data of the family predicted a large heterozygous deletion mutation in the patient and her mother which wa validated by digital polymerase chain reaction indicating that the patient wa compound heterozygous for the paternal nonsense mutation and the maternal deletion mutation spanning the site of the single nucleotide change conclusion it should be noted that analytical pipeline that focus purely on sequence information can not distinguish homozygosity from hemizygosity because of it inability to detect large deletion the ability to detect cnvs in addition to single nucleotide variant and small insertiondeletions make wes an attractive diagnostic tool for genetically heterogeneous disorder
28378438,legius syndrome a case report,legius syndrome is a rare genetic disorder caused by heterozygous germ line lossoffunction spred mutation in japan a family with legius syndrome wa first described in by sakai et al we described a first solitary case of legius syndrome identified by nextgeneration sequencing in japan a yearold woman presented with multiple cafeaulait macule and freckle but ha no other feature of neurofibromatosis type nf sequencing result showed the presence of a mutation in exon of spred cct resulting in the protein at position pargx when a dermatological clinician see an adult patient showing only pigmented lesion and no other specifically diagnostic feature of nf it is important to suspect the possibility of legius syndrome,Non-Cancer,1,legius syndrome a case report legius syndrome is a rare genetic disorder caused by heterozygous germ line lossoffunction spred mutation in japan a family with legius syndrome wa first described in by sakai et al we described a first solitary case of legius syndrome identified by nextgeneration sequencing in japan a yearold woman presented with multiple cafeaulait macule and freckle but ha no other feature of neurofibromatosis type nf sequencing result showed the presence of a mutation in exon of spred cct resulting in the protein at position pargx when a dermatological clinician see an adult patient showing only pigmented lesion and no other specifically diagnostic feature of nf it is important to suspect the possibility of legius syndrome
28423318,oligodendrocyte nf control aberrant notch activation and regulates myelin structure and behavior,the rasopathy neurofibromatosis type nf is one of the most common autosomal dominant genetic disorder in nf patient neurological issue may result from damaged myelin and mouse with a neurofibromin gene nf mutation show white matter wm defect including myelin decompaction using mouse genetics we find that altered nf genedose in mature oligodendrocyte result in progressive myelin defect and behavioral abnormality mediated by aberrant notch activation blocking notch upstream mitogenactivated protein kinase mapk or nitric oxide signaling rescue myelin defect in hemizygous nf mutant and pharmacological gamma secretase inhibition rescue aberrant behavior with no effect in wildtype wt mouse concomitant pathway inhibition rescue myelin abnormality in homozygous mutant notch activation is also observed in nf mouse brain and cell containing active notch are increased in nf patient wm we thus identify notch a an nf effector regulating myelin structure and behavior in a rasopathy and suggest that inhibition of notch signaling may be a therapeutic strategy for nf,Non-Cancer,1,oligodendrocyte nf control aberrant notch activation and regulates myelin structure and behavior the rasopathy neurofibromatosis type nf is one of the most common autosomal dominant genetic disorder in nf patient neurological issue may result from damaged myelin and mouse with a neurofibromin gene nf mutation show white matter wm defect including myelin decompaction using mouse genetics we find that altered nf genedose in mature oligodendrocyte result in progressive myelin defect and behavioral abnormality mediated by aberrant notch activation blocking notch upstream mitogenactivated protein kinase mapk or nitric oxide signaling rescue myelin defect in hemizygous nf mutant and pharmacological gamma secretase inhibition rescue aberrant behavior with no effect in wildtype wt mouse concomitant pathway inhibition rescue myelin abnormality in homozygous mutant notch activation is also observed in nf mouse brain and cell containing active notch are increased in nf patient wm we thus identify notch a an nf effector regulating myelin structure and behavior in a rasopathy and suggest that inhibition of notch signaling may be a therapeutic strategy for nf
28427233,assessment of the interlaboratory variability and robustness of jakvf mutation assay a study involving a consortium of italian laboratory,to date a plenty of technique for the detection of jakvf is used over different laboratory with substantial difference in specificity and sensitivity therefore to provide reliable and comparable result the standardization of molecular technique is mandatorya network of center wa established to evaluate the inter and intralaboratory variability in jakvf quantification identify the most robust assay for the standardization of the molecular test and allow consistent interpretation of individual patient analysis result the study wa conceived in different round in which all center had to blindly test dna sample with different jakvf allele burden ab using both quantitative and qualitative assaysthe positivity of sample with an ab wa not detected by qualitative assay conversely laboratory performing the quantitative approach were able to determine the expected jakvf ab quantitative result were reliable across all mutation load with moderate variability at low ab and cv and respectively remarkably all laboratory clearly distinguished between the and mutated samplesin conclusion a qualitative approach is not sensitive enough to detect the jakvf mutation especially at low ab on the contrary the ipsogen jak mutaquant ceivd kit resulted in a high efficient and sensitive quantification detection of all mutation load this study set the basis for the standardization of molecular technique for jakvf determination which will require the employment of approved operating procedure and the use of certificated standard such a the recent who st international reference panel for genomic jakvf,Non-Cancer,1,assessment of the interlaboratory variability and robustness of jakvf mutation assay a study involving a consortium of italian laboratory to date a plenty of technique for the detection of jakvf is used over different laboratory with substantial difference in specificity and sensitivity therefore to provide reliable and comparable result the standardization of molecular technique is mandatorya network of center wa established to evaluate the inter and intralaboratory variability in jakvf quantification identify the most robust assay for the standardization of the molecular test and allow consistent interpretation of individual patient analysis result the study wa conceived in different round in which all center had to blindly test dna sample with different jakvf allele burden ab using both quantitative and qualitative assaysthe positivity of sample with an ab wa not detected by qualitative assay conversely laboratory performing the quantitative approach were able to determine the expected jakvf ab quantitative result were reliable across all mutation load with moderate variability at low ab and cv and respectively remarkably all laboratory clearly distinguished between the and mutated samplesin conclusion a qualitative approach is not sensitive enough to detect the jakvf mutation especially at low ab on the contrary the ipsogen jak mutaquant ceivd kit resulted in a high efficient and sensitive quantification detection of all mutation load this study set the basis for the standardization of molecular technique for jakvf determination which will require the employment of approved operating procedure and the use of certificated standard such a the recent who st international reference panel for genomic jakvf
28429859,aneurysm in neurofibromatosis type evidence for vasculopathy,there have been anecdotal report of vasculopathy associated with neurofibromatosis type nf given the increasing use of bevacizumab a vascular endothelial growth factor inhibitor which result in an increased risk of bleeding it is important to ascertain if there is a predisposition to vascular abnormality in nf in our unit nf patient undergo annual mri brain and internal auditory meatus imaging we noted incidental intracranial aneurysm in some patient and sought to determine the prevalence of intracranial aneurysm in our cohort of nf patient we conducted a retrospective audit of the mri image of nf patient from to axial t brain mri image were assessed for vascular abnormality by two neuroradiologists blinded to patient clinical detail intracranial aneurysm were detected in four patient and an aneurysm clip related to previous surgery wa noted in one additional patient using standard mri imaging sequence alone we provide evidence of intracranial aneurysm in of our cohort this compare with an estimated overall prevalence of in the general population we discus these finding a well a other evidence for a vasculopathy associated with nf,Non-Cancer,1,aneurysm in neurofibromatosis type evidence for vasculopathy there have been anecdotal report of vasculopathy associated with neurofibromatosis type nf given the increasing use of bevacizumab a vascular endothelial growth factor inhibitor which result in an increased risk of bleeding it is important to ascertain if there is a predisposition to vascular abnormality in nf in our unit nf patient undergo annual mri brain and internal auditory meatus imaging we noted incidental intracranial aneurysm in some patient and sought to determine the prevalence of intracranial aneurysm in our cohort of nf patient we conducted a retrospective audit of the mri image of nf patient from to axial t brain mri image were assessed for vascular abnormality by two neuroradiologists blinded to patient clinical detail intracranial aneurysm were detected in four patient and an aneurysm clip related to previous surgery wa noted in one additional patient using standard mri imaging sequence alone we provide evidence of intracranial aneurysm in of our cohort this compare with an estimated overall prevalence of in the general population we discus these finding a well a other evidence for a vasculopathy associated with nf
28432683,prospective evaluation of the diagnostic value of sensitive kit dv mutation analysis of blood in adult with suspected systemic mastocytosis,background sensitive kit dv mutation analysis of blood ha been proposed to guide bone marrow bm investigation in suspected systemic mastocytosis sm the aim of this prospective study wa for the first time to compare the dv status of the screening blood sample used to guide bm biopsy in suspected sm to the outcome of the subsequent bm investigation method fiftyeight adult patient with suspected sm were included the outcome of sensitive kit dv analysis of blood wa compared to the result of the bm investigation result screening blood sample from of patient tested dvpositive in of these sm wa subsequently diagnosed in the bm investigation one patient with a dvpositive screening sample wa diagnosed with monoclonal mc activation syndrome screening blood sample from patient tested dvnegative sm wa subsequently diagnosed in five of these whereas nine patient did not fulfill any diagnostic sm criterion excluding tryptase criterion of the sm patient tested dvpositive thirteen sm patient presented with hymenoptera venominduced anaphylaxis no skin lesion and baseline serum tryptase ngml of these tested dvpositive in the screening blood sample conclusion this prospective study demonstrates that a dvpositive result in a screening blood sample identifies sm among patient with hymenoptera venominduced anaphylaxis in whom the diagnosis would most probably have been missed with potential severe implication the observed falsenegative screening result also underline that bm investigation is mandatory in all adult patient with clear sign of or highly suspected sm regardless of the kit mutation status,Non-Cancer,1,prospective evaluation of the diagnostic value of sensitive kit dv mutation analysis of blood in adult with suspected systemic mastocytosis background sensitive kit dv mutation analysis of blood ha been proposed to guide bone marrow bm investigation in suspected systemic mastocytosis sm the aim of this prospective study wa for the first time to compare the dv status of the screening blood sample used to guide bm biopsy in suspected sm to the outcome of the subsequent bm investigation method fiftyeight adult patient with suspected sm were included the outcome of sensitive kit dv analysis of blood wa compared to the result of the bm investigation result screening blood sample from of patient tested dvpositive in of these sm wa subsequently diagnosed in the bm investigation one patient with a dvpositive screening sample wa diagnosed with monoclonal mc activation syndrome screening blood sample from patient tested dvnegative sm wa subsequently diagnosed in five of these whereas nine patient did not fulfill any diagnostic sm criterion excluding tryptase criterion of the sm patient tested dvpositive thirteen sm patient presented with hymenoptera venominduced anaphylaxis no skin lesion and baseline serum tryptase ngml of these tested dvpositive in the screening blood sample conclusion this prospective study demonstrates that a dvpositive result in a screening blood sample identifies sm among patient with hymenoptera venominduced anaphylaxis in whom the diagnosis would most probably have been missed with potential severe implication the observed falsenegative screening result also underline that bm investigation is mandatory in all adult patient with clear sign of or highly suspected sm regardless of the kit mutation status
28475226,molecular cytogenetic characterization of five f complex rearrangement utility for haemophilia a genetic counselling,background genomic inversion are usually balanced but unusual pattern have been described in haemophilia a ha patient for intron inv and intron inv inversion leading to the hypothesis of more complex rearrangement involving deletion or duplication aim to characterize five abnormal pattern either in southern blot and longrange pcr for inv or in pcr for inv material and method all patient were studied using cytogenetic microarray analysis cma result in all case cma analysis found that each inversion wa associated with complex xq rearrangement in three patient cma analysis showed large duplication ranging from to kb and encompassing a various number of contiguous gene among which rabb rabb duplication is a strong candidate gene for xlinked intellectual disability xlid surprisingly none of the severe ha patient with rabb duplication reported in this study or in the literature exhibited xlid we hypothesise that f complex rearrangement down regulated rabb expression in the two remaining patient cma analysis found xq large deletion from to kb moyamoya syndrome wa strongly suspected in one of them who carried brcc deletion conclusion because several f neighbouring gene are associated with other pathology such a xlid and cardiovascular disease all ha patient where complex xq rearrangement wa suspected should be referred to a geneticist for possible utility of a pangenomic study such investigation should be carefully considered in genetic counselling in female carrier to assess the risk of transmitting severe ha with a contiguous gene syndrome,Non-Cancer,1,molecular cytogenetic characterization of five f complex rearrangement utility for haemophilia a genetic counselling background genomic inversion are usually balanced but unusual pattern have been described in haemophilia a ha patient for intron inv and intron inv inversion leading to the hypothesis of more complex rearrangement involving deletion or duplication aim to characterize five abnormal pattern either in southern blot and longrange pcr for inv or in pcr for inv material and method all patient were studied using cytogenetic microarray analysis cma result in all case cma analysis found that each inversion wa associated with complex xq rearrangement in three patient cma analysis showed large duplication ranging from to kb and encompassing a various number of contiguous gene among which rabb rabb duplication is a strong candidate gene for xlinked intellectual disability xlid surprisingly none of the severe ha patient with rabb duplication reported in this study or in the literature exhibited xlid we hypothesise that f complex rearrangement down regulated rabb expression in the two remaining patient cma analysis found xq large deletion from to kb moyamoya syndrome wa strongly suspected in one of them who carried brcc deletion conclusion because several f neighbouring gene are associated with other pathology such a xlid and cardiovascular disease all ha patient where complex xq rearrangement wa suspected should be referred to a geneticist for possible utility of a pangenomic study such investigation should be carefully considered in genetic counselling in female carrier to assess the risk of transmitting severe ha with a contiguous gene syndrome
28500564,calcium signaling from normal b cell development to tolerance breakdown and autoimmunity,maintenance of selftolerance of autoreactive lymphocyte is a fundamental mechanism to prevent the onset of autoimmune disease deciphering the mechanism involved in the deregulation leading to tolerance disruption and autoimmunity is still a major area of interest to identify new therapeutic target and option ca signaling play a major role in b cell normal development and is therefore finely tuned by b cell receptor bcrdependent and independent pathway developmental change in the characteristic of bcrdependent ca signal a well a the modulation of basal intracellular concentration cai contribute strongly to selftolerance maintaining mechanism responsible for the physical or functional elimination of autoreactive b cell such a clonal deletion receptor editing and anergy implication of ca signal in b tolerance mechanism mainly occurs through the specific activation of transcriptional program depending on the amplitude shape and duration of ca signal a large number of study reported ca signaling defect in autoimmune pathology such a systemic lupus erythematosus sle rheumatoid arthritis ra and primary sjogrens syndrome ps however the precise nature of the molecular event responsible for these deregulation is not fully understood moreover the demonstration of a direct correlation between ca signaling defect and tolerance disruption is still lacking the recent identification of protein involved in b cell ca signal such a orai stromal interaction molecule and transient receptor potential is opening new horizon for understanding ca signaling defect observed in autoimmune disease and for proposing potentially new therapeutic solution this review aim to present an overview of the developmental evolution of bcr dependent ca signaling and to place this signaling pathway in the context of mechanism involved in tolerance maintenance and breakdown,Non-Cancer,1,calcium signaling from normal b cell development to tolerance breakdown and autoimmunity maintenance of selftolerance of autoreactive lymphocyte is a fundamental mechanism to prevent the onset of autoimmune disease deciphering the mechanism involved in the deregulation leading to tolerance disruption and autoimmunity is still a major area of interest to identify new therapeutic target and option ca signaling play a major role in b cell normal development and is therefore finely tuned by b cell receptor bcrdependent and independent pathway developmental change in the characteristic of bcrdependent ca signal a well a the modulation of basal intracellular concentration cai contribute strongly to selftolerance maintaining mechanism responsible for the physical or functional elimination of autoreactive b cell such a clonal deletion receptor editing and anergy implication of ca signal in b tolerance mechanism mainly occurs through the specific activation of transcriptional program depending on the amplitude shape and duration of ca signal a large number of study reported ca signaling defect in autoimmune pathology such a systemic lupus erythematosus sle rheumatoid arthritis ra and primary sjogrens syndrome ps however the precise nature of the molecular event responsible for these deregulation is not fully understood moreover the demonstration of a direct correlation between ca signaling defect and tolerance disruption is still lacking the recent identification of protein involved in b cell ca signal such a orai stromal interaction molecule and transient receptor potential is opening new horizon for understanding ca signaling defect observed in autoimmune disease and for proposing potentially new therapeutic solution this review aim to present an overview of the developmental evolution of bcr dependent ca signaling and to place this signaling pathway in the context of mechanism involved in tolerance maintenance and breakdown
28504684,fully automated plex fluorescent immunohistochemistry with tyramide signal amplification and same specie antibody,the ability to simultaneously visualize the presence abundance location and functional state of many target in cell and tissue ha been described a a true nextgeneration approach in immunohistochemistry ihc a typical requirement for multiplex ihc mihc is the use of different animal specie for each primary ab and secondary ab antibody pair although ab from different specie have been used with differently labeled speciesspecific ab quite often the appropriate combination of antibody is not available more recently sequential detection of multiple antigen using ab from the same specie used a microwaving treatment between successive antigen detection cycle to elute previously bound ab ab complex and therefore to prevent the crossreactivity of antispecies ab used in subsequent detection cycle we present here a fully automated ab ab complex heat deactivation hd method on ventanas benchmark ultra slide stainer this method is applied to detection using fluorophoreconjugated tyramide deposited on the tissue and take advantage of the strong covalent bonding of the detection substrate to the tissue preventing it elution in the hd process the hd process wa characterized for effectiveness in preventing ab crossreactivity impact on the epitope and impact on the fluorophores an automated plex fluorescent ihc assay wa further developed using the hd method and rabbit ab for cd cd cd cd and foxp immune biomarkers in human tissue specimen the fluorophores were carefully chosen and the narrowband filter were designed to allow visualization of the staining under fluorescent microscope with minimal bleed through the automated plex fluorescent ihc assay achieved staining result comparable to the respective singleplex chromogenic ihc assay this technology enables automated mihc using unmodified ab from same specie and the corresponding antispecies ab on a clinically established automated platform to ensure staining quality reliability and reproducibility,Non-Cancer,1,fully automated plex fluorescent immunohistochemistry with tyramide signal amplification and same specie antibody the ability to simultaneously visualize the presence abundance location and functional state of many target in cell and tissue ha been described a a true nextgeneration approach in immunohistochemistry ihc a typical requirement for multiplex ihc mihc is the use of different animal specie for each primary ab and secondary ab antibody pair although ab from different specie have been used with differently labeled speciesspecific ab quite often the appropriate combination of antibody is not available more recently sequential detection of multiple antigen using ab from the same specie used a microwaving treatment between successive antigen detection cycle to elute previously bound ab ab complex and therefore to prevent the crossreactivity of antispecies ab used in subsequent detection cycle we present here a fully automated ab ab complex heat deactivation hd method on ventanas benchmark ultra slide stainer this method is applied to detection using fluorophoreconjugated tyramide deposited on the tissue and take advantage of the strong covalent bonding of the detection substrate to the tissue preventing it elution in the hd process the hd process wa characterized for effectiveness in preventing ab crossreactivity impact on the epitope and impact on the fluorophores an automated plex fluorescent ihc assay wa further developed using the hd method and rabbit ab for cd cd cd cd and foxp immune biomarkers in human tissue specimen the fluorophores were carefully chosen and the narrowband filter were designed to allow visualization of the staining under fluorescent microscope with minimal bleed through the automated plex fluorescent ihc assay achieved staining result comparable to the respective singleplex chromogenic ihc assay this technology enables automated mihc using unmodified ab from same specie and the corresponding antispecies ab on a clinically established automated platform to ensure staining quality reliability and reproducibility
28512266,activating mapk erk mutation in an aggressive case of disseminated juvenile xanthogranuloma,juvenile xanthogranuloma jxg is a rare histiocytic disorder that is usually benign and selflimiting we present a case of atypical aggressive jxg harboring a novel mitogenactivated protein kinase mapk pathway mutation in the mapk gene which encodes mitogenactivated protein kinase or extracellular signalregulated erk our analysis revealed that the mutation result in constitutive erk activation that is resistant to braf or mek inhibitor but susceptible to an erk inhibitor these data highlight the importance of identifying specific mapk pathway alteration a part of the diagnostic workup for patient with histiocytic disorder rather than initiating empiric treatment with mek inhibitor,Non-Cancer,1,activating mapk erk mutation in an aggressive case of disseminated juvenile xanthogranuloma juvenile xanthogranuloma jxg is a rare histiocytic disorder that is usually benign and selflimiting we present a case of atypical aggressive jxg harboring a novel mitogenactivated protein kinase mapk pathway mutation in the mapk gene which encodes mitogenactivated protein kinase or extracellular signalregulated erk our analysis revealed that the mutation result in constitutive erk activation that is resistant to braf or mek inhibitor but susceptible to an erk inhibitor these data highlight the importance of identifying specific mapk pathway alteration a part of the diagnostic workup for patient with histiocytic disorder rather than initiating empiric treatment with mek inhibitor
28604711,the anaphase promoting complex impact repair choice by protecting ubiquitin signalling at dna damage site,doublestrand break dsbs are repaired through two major pathway homologydirected recombination hdr and nonhomologous end joining nhej while hdr can only occur in sg nhej can happen in all cell cycle phase except mitosis how then is the repair choice made in sg cell here we provide evidence demonstrating that apccdh play a critical role in choosing the repair pathway in sg cell our result suggest that the default for all dsbs is to recruit bp and rif brca is blocked from being recruited to broken end because it recruitment signal klinked polyubiquitin chain on histone is actively destroyed by the deubiquitinating enzyme usp we show that the removal of usp depends on apccdh and requires chk activation known to be catalysed by ssdnarpaatr signalling at the end designated for hdr linking the status of end processing to rif or brca recruitment,Non-Cancer,1,the anaphase promoting complex impact repair choice by protecting ubiquitin signalling at dna damage site doublestrand break dsbs are repaired through two major pathway homologydirected recombination hdr and nonhomologous end joining nhej while hdr can only occur in sg nhej can happen in all cell cycle phase except mitosis how then is the repair choice made in sg cell here we provide evidence demonstrating that apccdh play a critical role in choosing the repair pathway in sg cell our result suggest that the default for all dsbs is to recruit bp and rif brca is blocked from being recruited to broken end because it recruitment signal klinked polyubiquitin chain on histone is actively destroyed by the deubiquitinating enzyme usp we show that the removal of usp depends on apccdh and requires chk activation known to be catalysed by ssdnarpaatr signalling at the end designated for hdr linking the status of end processing to rif or brca recruitment
28605748,characterization of the phenotype associated with microduplication reciprocal to nf microdeletion syndrome,q microduplication syndrome is a recently described relatively rare condition associated with a nonspecific phenotype intellectual disability developmental delay and dysmorphisms are the only clinical feature common to a majority of case seventeen patient have been reported so far here we present another patient with q duplication and no sign of neurofibromatosis type identified by arraycgh we compared clinical feature and genetic data with those of previously reported patient with q microduplications we also analyzed the gene content of the duplicated region in order to investigate the possible role of specific gene in the clinical phenotype of our patient,Non-Cancer,1,characterization of the phenotype associated with microduplication reciprocal to nf microdeletion syndrome q microduplication syndrome is a recently described relatively rare condition associated with a nonspecific phenotype intellectual disability developmental delay and dysmorphisms are the only clinical feature common to a majority of case seventeen patient have been reported so far here we present another patient with q duplication and no sign of neurofibromatosis type identified by arraycgh we compared clinical feature and genetic data with those of previously reported patient with q microduplications we also analyzed the gene content of the duplicated region in order to investigate the possible role of specific gene in the clinical phenotype of our patient
28612357,multidimensional assessment of patient condition and mutational analysis in peripheral blood a tool to improve outcome prediction in myelodysplastic syndrome a prospective study of the spanish md group,the international prognostic scoring system and it revised form ipssr are the most widely used index for prognostic assessment of patient with myelodysplastic syndrome md but can only partially account for the observed variation in patient outcome this study aimed to evaluate the relative contribution of patient condition and mutational status in peripheral blood when added to the ipssr for estimating overall survival and the risk of leukemic transformation in patient with md a prospective cohort of consecutive patient with md were included in the study series and categorized according to the ipssr patient were further stratified according to patient condition assessed using the multidimensional lee index for older adult and genetic mutation peripheral blood sample screened using nextgeneration sequencing the change in likelihoodratio wa tested in cox model after adding individual covariates the addition of the lee index to the ipssr significantly improved prediction of overall survival hazard ratio hr confidence interval ci p and mutational analysis significantly improved prediction of leukemic evolution hr p nonleukemic death wa strongly linked to patient condition hr p but not to ipssr score p or mutational status p adjustment for exposure to diseasemodifying therapy evaluated a a timedependent covariate had no effect on the proposed model predictive ability in conclusion patient condition assessed by the multidimensional lee index and patient mutational status can improve the prediction of clinical outcome of patient with md already stratified by ipssr,Non-Cancer,1,multidimensional assessment of patient condition and mutational analysis in peripheral blood a tool to improve outcome prediction in myelodysplastic syndrome a prospective study of the spanish md group the international prognostic scoring system and it revised form ipssr are the most widely used index for prognostic assessment of patient with myelodysplastic syndrome md but can only partially account for the observed variation in patient outcome this study aimed to evaluate the relative contribution of patient condition and mutational status in peripheral blood when added to the ipssr for estimating overall survival and the risk of leukemic transformation in patient with md a prospective cohort of consecutive patient with md were included in the study series and categorized according to the ipssr patient were further stratified according to patient condition assessed using the multidimensional lee index for older adult and genetic mutation peripheral blood sample screened using nextgeneration sequencing the change in likelihoodratio wa tested in cox model after adding individual covariates the addition of the lee index to the ipssr significantly improved prediction of overall survival hazard ratio hr confidence interval ci p and mutational analysis significantly improved prediction of leukemic evolution hr p nonleukemic death wa strongly linked to patient condition hr p but not to ipssr score p or mutational status p adjustment for exposure to diseasemodifying therapy evaluated a a timedependent covariate had no effect on the proposed model predictive ability in conclusion patient condition assessed by the multidimensional lee index and patient mutational status can improve the prediction of clinical outcome of patient with md already stratified by ipssr
28630220,beyond cervical lipoma myoclonus gait disorder and multisystem involvement leading to mitochondrial disease,madelungs disease benign symmetric lipomatosis is a rare syndrome in which there are multiple lipoma around the neck upper limb and trunk in the context of chronic alcoholism we report on a female patient with lipoma and slightly progressive myoclonus neuropathy myopathy ataxia and respiratory systemic involvement labelled in the past a madelungs disease multisystem involvement and family history of lipoma led to the development of mitochondrial genetic test which can assess two concurrent mitochondrial mutation the mag mutation in mttk gene related merrf myoclonic epilepsy with raggedred fibre phenotype and mtc mutation in the mtnd gene responsible for leber hereditary optic neuropathy phenotype,Non-Cancer,1,beyond cervical lipoma myoclonus gait disorder and multisystem involvement leading to mitochondrial disease madelungs disease benign symmetric lipomatosis is a rare syndrome in which there are multiple lipoma around the neck upper limb and trunk in the context of chronic alcoholism we report on a female patient with lipoma and slightly progressive myoclonus neuropathy myopathy ataxia and respiratory systemic involvement labelled in the past a madelungs disease multisystem involvement and family history of lipoma led to the development of mitochondrial genetic test which can assess two concurrent mitochondrial mutation the mag mutation in mttk gene related merrf myoclonic epilepsy with raggedred fibre phenotype and mtc mutation in the mtnd gene responsible for leber hereditary optic neuropathy phenotype
28654064,detection and visualization of dna damageinduced protein complex in suspension cell culture using the proximity ligation assay,the dna damage response orchestrates the repair of dna lesion that occur spontaneously are caused by genotoxic stress or appear in the context of programmed dna break in lymphocyte the ataxiatelangiectasia mutated kinase atm atm and radrelated kinase atr and the catalytic subunit of dnadependent protein kinase dnapkcs are among the first that are activated upon induction of dna damage and are central regulator of a network that control dna repair apoptosis and cell survival a part of a tumorsuppressive pathway atm and atr activate p through phosphorylation thereby regulating the transcriptional activity of p dna damage also result in the formation of socalled ionizing radiationinduced focus irif that represent complex of dna damage sensor and repair protein that accumulate at the site of dna damage which are visualized by fluorescence microscopy colocalization of protein in irifs however doe not necessarily imply direct proteinprotein interaction a the resolution of fluorescence microscopy is limited in situ proximity ligation assay pla is a novel technique that allows the direct visualization of proteinprotein interaction in cell and tissue with unprecedented specificity and sensitivity this technique is based on the spatial proximity of specific antibody binding to the protein of interest when the interrogated protein are within nm an amplification reaction is triggered by oligonucleotides that are conjugated to the antibody and the amplification product is visualized by fluorescent labeling yielding a signal that corresponds to the subcellular location of the interacting protein using the established functional interaction between atm and p a an example it is demonstrated here how pla can be used in suspension cell culture to study the direct interaction between protein that are integral part of the dna damage response,Non-Cancer,1,detection and visualization of dna damageinduced protein complex in suspension cell culture using the proximity ligation assay the dna damage response orchestrates the repair of dna lesion that occur spontaneously are caused by genotoxic stress or appear in the context of programmed dna break in lymphocyte the ataxiatelangiectasia mutated kinase atm atm and radrelated kinase atr and the catalytic subunit of dnadependent protein kinase dnapkcs are among the first that are activated upon induction of dna damage and are central regulator of a network that control dna repair apoptosis and cell survival a part of a tumorsuppressive pathway atm and atr activate p through phosphorylation thereby regulating the transcriptional activity of p dna damage also result in the formation of socalled ionizing radiationinduced focus irif that represent complex of dna damage sensor and repair protein that accumulate at the site of dna damage which are visualized by fluorescence microscopy colocalization of protein in irifs however doe not necessarily imply direct proteinprotein interaction a the resolution of fluorescence microscopy is limited in situ proximity ligation assay pla is a novel technique that allows the direct visualization of proteinprotein interaction in cell and tissue with unprecedented specificity and sensitivity this technique is based on the spatial proximity of specific antibody binding to the protein of interest when the interrogated protein are within nm an amplification reaction is triggered by oligonucleotides that are conjugated to the antibody and the amplification product is visualized by fluorescent labeling yielding a signal that corresponds to the subcellular location of the interacting protein using the established functional interaction between atm and p a an example it is demonstrated here how pla can be used in suspension cell culture to study the direct interaction between protein that are integral part of the dna damage response
28671121,selenomethionine attenuates the amyloidbeta level by both inhibiting amyloidbeta production and modulating autophagy in neuronaabetappswe cell,alzheimers disease ad is a complex and progressive neurological disorder and amyloidbeta abeta ha been recognized a the major cause of ad inhibiting abeta production andor enhancing the clearance of abeta to reduce it level are still the effective therapeutic strategy pursued in antiad research in previous study we have reported that selenomethionine semet a major form of selenium in animal and human with significant antioxidant capacity can reduce both amyloidbeta abeta deposition and tau hyperphosphorylation in a triple transgenic mouse model of ad in this study a semet treatment significantly decreased the abeta level in neuronaabetappswe nasw cell and the antiamyloid effect of semet wa attributed to it ability to inhibit abeta generation by suppressing the activity of bace furthermore both the lciilci ratio and the number of lcpositive puncta were significantly decreased in semettreated cell suggesting that semet also promoted abeta clearance by modulating the autophagy pathway subsequently semet inhibited the initiation of autophagy through the aktmtorpsk signaling pathway and enhanced autophagic turnover by promoting autophagosomelysosome fusion and autophagic clearance our result further highlight the potential therapeutic effect of semet on ad,Non-Cancer,1,selenomethionine attenuates the amyloidbeta level by both inhibiting amyloidbeta production and modulating autophagy in neuronaabetappswe cell alzheimers disease ad is a complex and progressive neurological disorder and amyloidbeta abeta ha been recognized a the major cause of ad inhibiting abeta production andor enhancing the clearance of abeta to reduce it level are still the effective therapeutic strategy pursued in antiad research in previous study we have reported that selenomethionine semet a major form of selenium in animal and human with significant antioxidant capacity can reduce both amyloidbeta abeta deposition and tau hyperphosphorylation in a triple transgenic mouse model of ad in this study a semet treatment significantly decreased the abeta level in neuronaabetappswe nasw cell and the antiamyloid effect of semet wa attributed to it ability to inhibit abeta generation by suppressing the activity of bace furthermore both the lciilci ratio and the number of lcpositive puncta were significantly decreased in semettreated cell suggesting that semet also promoted abeta clearance by modulating the autophagy pathway subsequently semet inhibited the initiation of autophagy through the aktmtorpsk signaling pathway and enhanced autophagic turnover by promoting autophagosomelysosome fusion and autophagic clearance our result further highlight the potential therapeutic effect of semet on ad
28679735,hematopoietic stem cell transplantation in patient hemizygous for hypomorphic ikbkgnemo mutation,xlinked recessive ectodermal dysplasia with immunodeficiency is a rare primary immunodeficiency caused by hypomorphic mutation of the ikbkg gene encoding the nuclear factor kappab essential modulator nemo protein this condition display enormous allelic immunological and clinical heterogeneity and therapeutic decision are difficult because nemo operates in both hematopoietic and nonhematopoietic cell hematopoietic stem cell transplantation hsct is potentially lifesaving but the small number of case report available suggests it ha been reserved for only the most severe case here we report the health status before hsct transplantation outcome and clinical followup for a series of patient from unrelated kindred from country between them these patient carry different hypomorphic ikbkg mutation hsct wa performed from hlaidentical related donor n hlamatched unrelated donor n hlamismatched unrelated donor n and hlahaploidentical related donor n engraftment wa documented in patient and graftversushost disease in patient up to patient died to month after hsct the global survival rate after hsct among nemodeficient child wa at a median followup after hsct of month range month preexisting mycobacterial infection and colitis were associated with poor hsct outcome the underlying mutation doe not appear to have any influence a patient with the same mutation had different outcome transplantation did not appear to cure colitis possibly a a result of cellintrinsic disorder of the epithelial barrier overall hsct can cure most clinical feature of patient with a variety of ikbkg mutation,Non-Cancer,1,hematopoietic stem cell transplantation in patient hemizygous for hypomorphic ikbkgnemo mutation xlinked recessive ectodermal dysplasia with immunodeficiency is a rare primary immunodeficiency caused by hypomorphic mutation of the ikbkg gene encoding the nuclear factor kappab essential modulator nemo protein this condition display enormous allelic immunological and clinical heterogeneity and therapeutic decision are difficult because nemo operates in both hematopoietic and nonhematopoietic cell hematopoietic stem cell transplantation hsct is potentially lifesaving but the small number of case report available suggests it ha been reserved for only the most severe case here we report the health status before hsct transplantation outcome and clinical followup for a series of patient from unrelated kindred from country between them these patient carry different hypomorphic ikbkg mutation hsct wa performed from hlaidentical related donor n hlamatched unrelated donor n hlamismatched unrelated donor n and hlahaploidentical related donor n engraftment wa documented in patient and graftversushost disease in patient up to patient died to month after hsct the global survival rate after hsct among nemodeficient child wa at a median followup after hsct of month range month preexisting mycobacterial infection and colitis were associated with poor hsct outcome the underlying mutation doe not appear to have any influence a patient with the same mutation had different outcome transplantation did not appear to cure colitis possibly a a result of cellintrinsic disorder of the epithelial barrier overall hsct can cure most clinical feature of patient with a variety of ikbkg mutation
28694401,type neurofibromatosis complicated by pulmonary arterial hypertension a case report,neurofibromatosis type i nf is a rare genetic disease caused by mutation in the nf gene which encodes the tumor suppressor neurofibromin precapillary pulmonary hypertension is a severe complication of nf initially described in patient with advanced parenchymal lung disease which may complicate the course of nf presently described is a case of neurofibromatosis complicated by pulmonary hypertension,Non-Cancer,1,type neurofibromatosis complicated by pulmonary arterial hypertension a case report neurofibromatosis type i nf is a rare genetic disease caused by mutation in the nf gene which encodes the tumor suppressor neurofibromin precapillary pulmonary hypertension is a severe complication of nf initially described in patient with advanced parenchymal lung disease which may complicate the course of nf presently described is a case of neurofibromatosis complicated by pulmonary hypertension
28699658,telomere length and somatic mutation in correlation with response to immunosuppressive treatment in aplastic anaemia,we investigated the frequency of cytogenetic aberration and somatic mutation of prognostic relevance in patient with aplastic anaemia aa clonality wa determined by gbandingfluorescence in situ hybridization fish n and targeted capture sequencing wa performed for haematopoiesisrelated gene n the telomere length tl of bone marrow nucleated cell wa measured at the single cell level by fish n eighteen patient showed disease progression and monosomy wa the most predominant cytogenetic evolution at disease transformation one third of patient presented at least mutation the most frequently mutated gene were notch nf scrib bcor and dnmta the patient group with clonal change showed an adverse response to immunosuppressive treatment ist compared to the nonclonal group but this finding did not show statistical significance the tl of aa patient wa significantly shorter than normal control and patient with clonal change showed significantly shorter tl patient with tl showed a higher response rate to ist p in conclusion the patient with clonal change or tl attrition showed a poor response to ist shorter tl can be used not only a a biomarker but also a a predictive marker for treatment response to ist,Non-Cancer,1,telomere length and somatic mutation in correlation with response to immunosuppressive treatment in aplastic anaemia we investigated the frequency of cytogenetic aberration and somatic mutation of prognostic relevance in patient with aplastic anaemia aa clonality wa determined by gbandingfluorescence in situ hybridization fish n and targeted capture sequencing wa performed for haematopoiesisrelated gene n the telomere length tl of bone marrow nucleated cell wa measured at the single cell level by fish n eighteen patient showed disease progression and monosomy wa the most predominant cytogenetic evolution at disease transformation one third of patient presented at least mutation the most frequently mutated gene were notch nf scrib bcor and dnmta the patient group with clonal change showed an adverse response to immunosuppressive treatment ist compared to the nonclonal group but this finding did not show statistical significance the tl of aa patient wa significantly shorter than normal control and patient with clonal change showed significantly shorter tl patient with tl showed a higher response rate to ist p in conclusion the patient with clonal change or tl attrition showed a poor response to ist shorter tl can be used not only a a biomarker but also a a predictive marker for treatment response to ist
28700486,progression of primary myelofibrosis to polycythemia vera a case report,rationale this case report describes the progression of primary myelofibrosis pmf to polycythemia vera pv and discus it potential mechanism patient concern the patient wa admitted because of abdominal discomfort and enlarged spleen for month diagnosis a case of pmf progressed to pv wa retrospectively analyzed there were month between the diagnosis of pmf and pv the jak vf mutation wa positive before and after the diagnosis of pv however new chromosomal abnormality were detected during the progression intervention for treatment of pmf the danazol calcitriol and thalidomide were given then the use of thalidomide and calcitriol wa stopped and hydroxyurea wa started for treatment of pv interferon treatment wa given whereas hydroxyurea wa continued outcome after month of the progression at the recent followup this patient had no obvious symptom or thrombosis lesson pmf rarely progress to pv however the progression will significantly improve the quality of life and prognosis,Non-Cancer,1,progression of primary myelofibrosis to polycythemia vera a case report rationale this case report describes the progression of primary myelofibrosis pmf to polycythemia vera pv and discus it potential mechanism patient concern the patient wa admitted because of abdominal discomfort and enlarged spleen for month diagnosis a case of pmf progressed to pv wa retrospectively analyzed there were month between the diagnosis of pmf and pv the jak vf mutation wa positive before and after the diagnosis of pv however new chromosomal abnormality were detected during the progression intervention for treatment of pmf the danazol calcitriol and thalidomide were given then the use of thalidomide and calcitriol wa stopped and hydroxyurea wa started for treatment of pv interferon treatment wa given whereas hydroxyurea wa continued outcome after month of the progression at the recent followup this patient had no obvious symptom or thrombosis lesson pmf rarely progress to pv however the progression will significantly improve the quality of life and prognosis
28736931,genetic variant in hsdb smad and ipo impact circulating lipid in response to fenofibrate in individual with type diabetes,individual with type diabetes td and dyslipidemia are at an increased risk of cardiovascular disease fibrates are a class of drug prescribed to treat dyslipidemia but variation in response ha been observed to evaluate common and rare genetic variant that impact lipid response to fenofibrate in statintreated patient with td we examined lipid change in response to fenofibrate therapy using a genomewide association study gwas association were followedup using gene expression study in mouse common variant in smad and ipo were marginally associated with lipid change in black subject p x rare variant and gene expression change were assessed using a false discovery rate approach akra and hsdb were associated with lipid change in white subject q mouse fed fenofibrate displayed reduction in hsdb gene expression q association of variant in smad ipo and hsdb with gene expression change in mouse indicate that transforming growth factorbeta tgfbeta and nrf signaling pathway may influence fenofibrate effect on dyslipidemia in patient with td,Non-Cancer,1,genetic variant in hsdb smad and ipo impact circulating lipid in response to fenofibrate in individual with type diabetes individual with type diabetes td and dyslipidemia are at an increased risk of cardiovascular disease fibrates are a class of drug prescribed to treat dyslipidemia but variation in response ha been observed to evaluate common and rare genetic variant that impact lipid response to fenofibrate in statintreated patient with td we examined lipid change in response to fenofibrate therapy using a genomewide association study gwas association were followedup using gene expression study in mouse common variant in smad and ipo were marginally associated with lipid change in black subject p x rare variant and gene expression change were assessed using a false discovery rate approach akra and hsdb were associated with lipid change in white subject q mouse fed fenofibrate displayed reduction in hsdb gene expression q association of variant in smad ipo and hsdb with gene expression change in mouse indicate that transforming growth factorbeta tgfbeta and nrf signaling pathway may influence fenofibrate effect on dyslipidemia in patient with td
28784848,cutting edge ilinduced expression of the amino acid transporter slca and cd is a prerequisite for nkgdmediated activation of human nk cell,priming of human nk cell with il is necessary to render them functionally competent upon nkgd engagement we examined the underlying mechanism that control nkgd responsiveness in nk cell and found that il upregulates expression of the amino acid transporter slca and cd using specific inhibitor to block slca and cd function we found that production of ifngamma and degranulation by cdbright and cddim nk cell following nkgd stimulation were dependent on both transporter il priming increased the activity of mtorc and inhibition of mtorc abrogated the ability of the ilprimed nk cell to produce ifngamma in response to nkgdmediated stimulation this study identifies a series of ilinduced cellular change that regulates the nkgd responsiveness in human nk cell,Non-Cancer,1,cutting edge ilinduced expression of the amino acid transporter slca and cd is a prerequisite for nkgdmediated activation of human nk cell priming of human nk cell with il is necessary to render them functionally competent upon nkgd engagement we examined the underlying mechanism that control nkgd responsiveness in nk cell and found that il upregulates expression of the amino acid transporter slca and cd using specific inhibitor to block slca and cd function we found that production of ifngamma and degranulation by cdbright and cddim nk cell following nkgd stimulation were dependent on both transporter il priming increased the activity of mtorc and inhibition of mtorc abrogated the ability of the ilprimed nk cell to produce ifngamma in response to nkgdmediated stimulation this study identifies a series of ilinduced cellular change that regulates the nkgd responsiveness in human nk cell
28801073,newborn screening for carnitine palmitoyltransferase ii deficiency using ccc evaluation of additional index for adequate sensitivity and lower falsepositivity,background carnitine palmitoyltransferase cpt ii deficiency is one of the most common form of mitochondrial fatty acid oxidation disorder faod however newborn screening nb for this potentially fatal disease ha not been established partly because reliable index are not available method we diagnosed cpt ii deficiency in a monthold boy presenting with hypoglycemic encephalopathy which apparently had been missed in the nb using c and c concentration a index by referring to his acylcarnitine profile from the nb we adopted the ccc ratio cutoff and c concentration cutoff nmolml a alternative index for cpt ii deficiency such that an analysis of a dried blood specimen collected at postnatal day five retroactively yielded the correct diagnosis thereafter positive case were assessed by measuring the fatty acid oxidation ability of intact lymphocyte andor cpt ii activity in the lysates of lymphocyte the diagnosis were then further confirmed by genetic analysis result the disease wa diagnosed in seven of newborn suspected of having cpt ii deficiency based on nb we also analyzed the falsenegative patient and five symptomatic patient for comparison value for the nb index of the falsenegative symptomatic patient were lower than those of the seven affected newborn although it wa difficult to differentiate the falsenegative patient from heterozygous carrier and falsepositive subject the fatty acid oxidation ability of the lymphocyte and cpt ii activity clearly confirmed the diagnosis among several other index proposed previously cc completely differentiated the seven nbspositive patient and the falsenegative patient from the heterozygous carrier and the falsepositive subject genetic analysis revealed kind of variant allele the most prevalent detected in ten allele in nine patient from eight family wa cta pfy a finding in line with those of several previous report on japanese patient conclusion these finding suggested that cpt ii deficiency can be screened by using ccc and c a index an appropriate cutoff level is required to achieve adequate sensitivity albeit at the cost of a considerable increase in the falsepositive rate which might be reduced by using additional index such a cc,Non-Cancer,1,newborn screening for carnitine palmitoyltransferase ii deficiency using ccc evaluation of additional index for adequate sensitivity and lower falsepositivity background carnitine palmitoyltransferase cpt ii deficiency is one of the most common form of mitochondrial fatty acid oxidation disorder faod however newborn screening nb for this potentially fatal disease ha not been established partly because reliable index are not available method we diagnosed cpt ii deficiency in a monthold boy presenting with hypoglycemic encephalopathy which apparently had been missed in the nb using c and c concentration a index by referring to his acylcarnitine profile from the nb we adopted the ccc ratio cutoff and c concentration cutoff nmolml a alternative index for cpt ii deficiency such that an analysis of a dried blood specimen collected at postnatal day five retroactively yielded the correct diagnosis thereafter positive case were assessed by measuring the fatty acid oxidation ability of intact lymphocyte andor cpt ii activity in the lysates of lymphocyte the diagnosis were then further confirmed by genetic analysis result the disease wa diagnosed in seven of newborn suspected of having cpt ii deficiency based on nb we also analyzed the falsenegative patient and five symptomatic patient for comparison value for the nb index of the falsenegative symptomatic patient were lower than those of the seven affected newborn although it wa difficult to differentiate the falsenegative patient from heterozygous carrier and falsepositive subject the fatty acid oxidation ability of the lymphocyte and cpt ii activity clearly confirmed the diagnosis among several other index proposed previously cc completely differentiated the seven nbspositive patient and the falsenegative patient from the heterozygous carrier and the falsepositive subject genetic analysis revealed kind of variant allele the most prevalent detected in ten allele in nine patient from eight family wa cta pfy a finding in line with those of several previous report on japanese patient conclusion these finding suggested that cpt ii deficiency can be screened by using ccc and c a index an appropriate cutoff level is required to achieve adequate sensitivity albeit at the cost of a considerable increase in the falsepositive rate which might be reduced by using additional index such a cc
28813671,oct and sox work a transcriptional activator in reprogramming human fibroblast,sox and oct in conjunction with klf and cmyc are sufficient to reprogram human fibroblast to induced pluripotent stem cell ipscs but it is unclear if they function a transcriptional activator or a repressor we now show that like oct sox function a a transcriptional activator we substituted soxvp a strong activator for wildtype wt sox and we saw an increase in the efficiency and rate of reprogramming whereas the soxhp fusion a strong repressor eliminated reprogramming we report that at an early stage of reprogramming virtually all dnabound oct sox and soxvp were embedded in putative enhancer about half of which were created de novo those associated with soxvp were on average stronger than those bearing wt sox many newly created putative enhancer were transient and many transcription factor location on dna changed a reprogramming progressed these result are consistent with the idea that during reprogramming there is an intermediate state that is distinct from both parental cell and ipscs,Non-Cancer,1,oct and sox work a transcriptional activator in reprogramming human fibroblast sox and oct in conjunction with klf and cmyc are sufficient to reprogram human fibroblast to induced pluripotent stem cell ipscs but it is unclear if they function a transcriptional activator or a repressor we now show that like oct sox function a a transcriptional activator we substituted soxvp a strong activator for wildtype wt sox and we saw an increase in the efficiency and rate of reprogramming whereas the soxhp fusion a strong repressor eliminated reprogramming we report that at an early stage of reprogramming virtually all dnabound oct sox and soxvp were embedded in putative enhancer about half of which were created de novo those associated with soxvp were on average stronger than those bearing wt sox many newly created putative enhancer were transient and many transcription factor location on dna changed a reprogramming progressed these result are consistent with the idea that during reprogramming there is an intermediate state that is distinct from both parental cell and ipscs
28845713,thrombopoietinreceptor agonist for child with immune thrombocytopenia a systematic review,objective we conducted a systematic review to assess the efficacy and safety of thrombopoietinreceptor agonist tporas for pediatric immune thrombocytopenia itp method we searched pubmed embase and cochrane library from their earliest record to january randomized controlled trial rcts were included primary outcome were durable response and clinically significant bleeding secondary outcome were overall response overall bleeding event the use of rescue medication and adverse event aes result five randomized rcts participant were included compared with placebo group the proportion of patient achieving durable platelet response wa significantly higher in eltrombopag p or romiplostim p group so wa the overall response in eltrombopag rr ci or romiplostim rr ci group both clinically significant bleeding p and total bleeding p in eltrombopag group were significantly less frequent than those in placebo group while no significant difference between romiplostim and placebo group the proportion of patient receiving rescue medication the incidence of overall aes and serious aes between tporeceptor agonist and placebo group were not significantly different conclusion tporas might improve both durable and overall platelet response in pediatric itp compared with placebo,Non-Cancer,1,thrombopoietinreceptor agonist for child with immune thrombocytopenia a systematic review objective we conducted a systematic review to assess the efficacy and safety of thrombopoietinreceptor agonist tporas for pediatric immune thrombocytopenia itp method we searched pubmed embase and cochrane library from their earliest record to january randomized controlled trial rcts were included primary outcome were durable response and clinically significant bleeding secondary outcome were overall response overall bleeding event the use of rescue medication and adverse event aes result five randomized rcts participant were included compared with placebo group the proportion of patient achieving durable platelet response wa significantly higher in eltrombopag p or romiplostim p group so wa the overall response in eltrombopag rr ci or romiplostim rr ci group both clinically significant bleeding p and total bleeding p in eltrombopag group were significantly less frequent than those in placebo group while no significant difference between romiplostim and placebo group the proportion of patient receiving rescue medication the incidence of overall aes and serious aes between tporeceptor agonist and placebo group were not significantly different conclusion tporas might improve both durable and overall platelet response in pediatric itp compared with placebo
28880435,thrombocytopenia and cd expression is decoupled from alphagranule deficiency with mutation of the first growth factorindependent b zinc finger,essential the phenotype of different growth factorindependent b gfib variant are not established gfib variant produce heterogeneous clinical phenotype dependent on the site of mutation mutation of the first nondnabinding zincfinger cause a mild platelet and clinical phenotype gfib regulates the cd promoter platelet cd expression is an indicator of gfib mutation summary background mutation of the growth factorindependent b gfib fifth dnabinding zincfinger domain cause macrothrombocytopenia and alphagranule deficiency leading to clinical bleeding the phenotype associated with gfib variant disrupting nondnabinding zincfingers remain uncharacterized objective to determine the functional and phenotypic consequence of gfib variant disrupting nondnabinding zincfinger domain method the gfib cf variant and a novel gfib c delgtgggcac splice variant were identified in four unrelated family phenotypic feature dnabinding property and transcriptional effect were determined and compared with those in individual with a gfib h f mutation of the fifth dnabinding zincfinger patientspecific induced pluripotent stem cell ipscderived megakaryocyte were generated to facilitate disease modeling result the dnabinding gfib variant cf which is predicted to disrupt the first nondnabinding zincfinger domain is associated with macrothrombocytopenia without alphagranule deficiency or bleeding symptom a gfib splice variant c delgtgggcac which generates a short gfib isoform that lack nondnabinding zincfingers and is associated with increased platelet cd expression only without quantitative or morphologic platelet abnormality gfib represses the cd promoter and this repression is attenuated by different gfib zincfinger mutation suggesting that deregulation of cd expression occurs at a direct transcriptional level patientspecific ipscderived megakaryocyte phenocopy these observation conclusion disruption of gfib nondnabinding zincfinger is associated with mild to moderate thrombocytopenia without alphagranule deficiency or bleeding symptomatology indicating that the site of gfib mutation ha important phenotypic implication platelet cd expression appears to be a common feature of perturbed gfib function and may have diagnostic utility,Non-Cancer,1,thrombocytopenia and cd expression is decoupled from alphagranule deficiency with mutation of the first growth factorindependent b zinc finger essential the phenotype of different growth factorindependent b gfib variant are not established gfib variant produce heterogeneous clinical phenotype dependent on the site of mutation mutation of the first nondnabinding zincfinger cause a mild platelet and clinical phenotype gfib regulates the cd promoter platelet cd expression is an indicator of gfib mutation summary background mutation of the growth factorindependent b gfib fifth dnabinding zincfinger domain cause macrothrombocytopenia and alphagranule deficiency leading to clinical bleeding the phenotype associated with gfib variant disrupting nondnabinding zincfingers remain uncharacterized objective to determine the functional and phenotypic consequence of gfib variant disrupting nondnabinding zincfinger domain method the gfib cf variant and a novel gfib c delgtgggcac splice variant were identified in four unrelated family phenotypic feature dnabinding property and transcriptional effect were determined and compared with those in individual with a gfib h f mutation of the fifth dnabinding zincfinger patientspecific induced pluripotent stem cell ipscderived megakaryocyte were generated to facilitate disease modeling result the dnabinding gfib variant cf which is predicted to disrupt the first nondnabinding zincfinger domain is associated with macrothrombocytopenia without alphagranule deficiency or bleeding symptom a gfib splice variant c delgtgggcac which generates a short gfib isoform that lack nondnabinding zincfingers and is associated with increased platelet cd expression only without quantitative or morphologic platelet abnormality gfib represses the cd promoter and this repression is attenuated by different gfib zincfinger mutation suggesting that deregulation of cd expression occurs at a direct transcriptional level patientspecific ipscderived megakaryocyte phenocopy these observation conclusion disruption of gfib nondnabinding zincfinger is associated with mild to moderate thrombocytopenia without alphagranule deficiency or bleeding symptomatology indicating that the site of gfib mutation ha important phenotypic implication platelet cd expression appears to be a common feature of perturbed gfib function and may have diagnostic utility
28919366,prevalence and risk factor for fragility fracture in systemic mastocytosis,objective systemic mastocytosis sm is characterized by the accumulation of mast cell in tissue other than the skin bone involvement although frequent ha not been thoroughly evaluated primary objective wa to determine risk factor associated with fragility fracture ff in sm secondary objective were to evaluate the ability of bone marrow tryptase bmt level to identify patient with ff and to describe bone involvement in sm method we analyzed retrospectively all consecutive patient seen in our expert center with a diagnosis of sm according to the who criterion and with complete bone assessment we collected data about lifetime fracture type of cutaneous manifestation degranulation symptom blood and bmt level bone mineral density assessed by densitometry and kit mutation we performed a univariate analysis investigating the factor associated with ff and then a logistic multivariable regression analysis we assessed the ability of bone marrow tryptase to identify patient with ff result eightynine patient with sm were included thirtysix patient suffered from osteoporosis and twentyfive experienced lifetime ff univariate analysis identified age at diagnosis and disease onset presence of telangiectasia macularis eruptiva perstans digestive symptom mast cell activation symptom elevated bmt low femoral and lumbar bmd a associated with ff multivariate analysis identified elevated bmt low femoral t score and older age at diagnosis a independently associated with ff conclusion low femoral tscore bmt level and older age at diagnosis are marker associated with ff in sm bmt may represent an important biomarker to predict ff in sm patient,Non-Cancer,1,prevalence and risk factor for fragility fracture in systemic mastocytosis objective systemic mastocytosis sm is characterized by the accumulation of mast cell in tissue other than the skin bone involvement although frequent ha not been thoroughly evaluated primary objective wa to determine risk factor associated with fragility fracture ff in sm secondary objective were to evaluate the ability of bone marrow tryptase bmt level to identify patient with ff and to describe bone involvement in sm method we analyzed retrospectively all consecutive patient seen in our expert center with a diagnosis of sm according to the who criterion and with complete bone assessment we collected data about lifetime fracture type of cutaneous manifestation degranulation symptom blood and bmt level bone mineral density assessed by densitometry and kit mutation we performed a univariate analysis investigating the factor associated with ff and then a logistic multivariable regression analysis we assessed the ability of bone marrow tryptase to identify patient with ff result eightynine patient with sm were included thirtysix patient suffered from osteoporosis and twentyfive experienced lifetime ff univariate analysis identified age at diagnosis and disease onset presence of telangiectasia macularis eruptiva perstans digestive symptom mast cell activation symptom elevated bmt low femoral and lumbar bmd a associated with ff multivariate analysis identified elevated bmt low femoral t score and older age at diagnosis a independently associated with ff conclusion low femoral tscore bmt level and older age at diagnosis are marker associated with ff in sm bmt may represent an important biomarker to predict ff in sm patient
28942514,intrauterine hyperglycemiainduced inflammatory signalling via the receptor for advanced glycation end product in the cardiac muscle of the infant of diabetic mother rat,purpose gestational diabetes is associated with increased risk to the health of the mother and her offspring in particular the infant of diabetic mother idms exhibit elevated level of preterm birth macrosomia hypoglycemia hypocalcemia and cardiomyopathy we have previously reported that idms showed abnormality in cardiac aktrelated insulin signalling and that these deficiency in aktrelated signalling were attenuated by supplementing the maternal diet with fishoil herein we investigated whether the eicosapentaenoic acid epa found in fish oil can be used to attenuate diabetes associated impairment in cardiomyocyte signalling method pregnant diabetic rat were administered streptozotocin before receiving epa or water and their infant were designated idmepa idmw we assessed the potential molecular pathway for this effect in the primary cardiac cell from newborn rat heart result insulin resistance a determined by diminished glut translocation following insulin stimulation the level of advanced glycation end product age and reactive oxygen specie were elevated in the neonatal heart of idmw compared with that seen in the offspring born from nondiabetic control animal similarly the receptor of age rage mrna level reactive oxygen specie and the amount of nuclear factorkappab nfkappab tumor necrosis factoralpha tnfalpha and interleukin il mrna were higher in the heart from the idmw when compared to that observed in the heart of offspring born to nondiabetic animal these deleterious effect of gestational diabetes were significantly decreased in the offspring of diabetic mother receiving epa supplementation conclusion taken together our data suggest that the epa in fish oil may improve the impaired signalling and the excessive protein glycation in the cardiac muscle of infant exposed to intrauterine hyperglycemia,Non-Cancer,1,intrauterine hyperglycemiainduced inflammatory signalling via the receptor for advanced glycation end product in the cardiac muscle of the infant of diabetic mother rat purpose gestational diabetes is associated with increased risk to the health of the mother and her offspring in particular the infant of diabetic mother idms exhibit elevated level of preterm birth macrosomia hypoglycemia hypocalcemia and cardiomyopathy we have previously reported that idms showed abnormality in cardiac aktrelated insulin signalling and that these deficiency in aktrelated signalling were attenuated by supplementing the maternal diet with fishoil herein we investigated whether the eicosapentaenoic acid epa found in fish oil can be used to attenuate diabetes associated impairment in cardiomyocyte signalling method pregnant diabetic rat were administered streptozotocin before receiving epa or water and their infant were designated idmepa idmw we assessed the potential molecular pathway for this effect in the primary cardiac cell from newborn rat heart result insulin resistance a determined by diminished glut translocation following insulin stimulation the level of advanced glycation end product age and reactive oxygen specie were elevated in the neonatal heart of idmw compared with that seen in the offspring born from nondiabetic control animal similarly the receptor of age rage mrna level reactive oxygen specie and the amount of nuclear factorkappab nfkappab tumor necrosis factoralpha tnfalpha and interleukin il mrna were higher in the heart from the idmw when compared to that observed in the heart of offspring born to nondiabetic animal these deleterious effect of gestational diabetes were significantly decreased in the offspring of diabetic mother receiving epa supplementation conclusion taken together our data suggest that the epa in fish oil may improve the impaired signalling and the excessive protein glycation in the cardiac muscle of infant exposed to intrauterine hyperglycemia
28951259,chimerism in pediatric hematopoietic stem cell transplantation and it correlation with the clinical outcome,hematopoietic stem cell transplantation hsct is the only hope to cure many inherited and acquired hematological disorder in child monitoring of chimerism help to predict the posttransplantation event with the intention to enhance the longterm disease free survival dfs the study aimed to investigate the importance of early chimerism detection to predict the clinical outcome following hsct the study included nine recipient six betathalassemia and three severe aplastic anemia patient and their hla identical sibling donor chimerism detection wa performed by analysis of short tandem repeat str polymerase chain reaction pcr for detection and quantification of the relative amount of donor and recipient cell present on day peripheral blood pb wa the main stem cell source for hsc transplantation disease free survival dfs wa while overall survival wa for pbsc transplant at the median follow up period of year the early detection of chimerism by pcrstr analysis for child with betathalassemia and aplastic anemia correlated with the outcome of hsct in patient complete chimerism wa associated with diseasefree survival while mixed chimerism and autologous pattern were associated with poor prognosis in conclusion early chimerism testing is clinically important in prediction of outcome after allogeneic hsc transplantation,Non-Cancer,1,chimerism in pediatric hematopoietic stem cell transplantation and it correlation with the clinical outcome hematopoietic stem cell transplantation hsct is the only hope to cure many inherited and acquired hematological disorder in child monitoring of chimerism help to predict the posttransplantation event with the intention to enhance the longterm disease free survival dfs the study aimed to investigate the importance of early chimerism detection to predict the clinical outcome following hsct the study included nine recipient six betathalassemia and three severe aplastic anemia patient and their hla identical sibling donor chimerism detection wa performed by analysis of short tandem repeat str polymerase chain reaction pcr for detection and quantification of the relative amount of donor and recipient cell present on day peripheral blood pb wa the main stem cell source for hsc transplantation disease free survival dfs wa while overall survival wa for pbsc transplant at the median follow up period of year the early detection of chimerism by pcrstr analysis for child with betathalassemia and aplastic anemia correlated with the outcome of hsct in patient complete chimerism wa associated with diseasefree survival while mixed chimerism and autologous pattern were associated with poor prognosis in conclusion early chimerism testing is clinically important in prediction of outcome after allogeneic hsc transplantation
28951535,dimerization of the adaptor gad facilitates antigen receptor signaling by promoting the cooperative binding of gad to the adaptor lat,the accurate assembly of signalosomes centered on the adaptor protein lat linker of activated t cell is required for antigen receptor signaling in t cell and mast cell during signalosome assembly member of the growth factor receptorbound protein grb family of cytosolic adaptor protein bind cooperatively to lat through interaction with it phosphorylated tyrosine ptyr residue we demonstrated the src homology sh domainmediated dimerization of the grb family member grbrelated adaptor downstream of shc gad gad dimerization wa mediated by an sh domain interface which is distinct from the ptyr binding pocket and which promoted cooperative preferential binding of paired gad to lat this sh domainintrinsic mechanism of cooperativity which we quantified by mathematical modeling enabled gad to discriminate between dually and singly phosphorylated lat molecule mutational inactivation of the dimerization interface reduced cooperativity and abrogated gad signaling in t cell and mast cell the dimerizationdependent cooperative binding of gad to lat may increase antigen receptor sensitivity by reducing signalosome formation at incompletely phosphorylated lat molecule thereby prioritizing the formation of complete signalosomes,Non-Cancer,1,dimerization of the adaptor gad facilitates antigen receptor signaling by promoting the cooperative binding of gad to the adaptor lat the accurate assembly of signalosomes centered on the adaptor protein lat linker of activated t cell is required for antigen receptor signaling in t cell and mast cell during signalosome assembly member of the growth factor receptorbound protein grb family of cytosolic adaptor protein bind cooperatively to lat through interaction with it phosphorylated tyrosine ptyr residue we demonstrated the src homology sh domainmediated dimerization of the grb family member grbrelated adaptor downstream of shc gad gad dimerization wa mediated by an sh domain interface which is distinct from the ptyr binding pocket and which promoted cooperative preferential binding of paired gad to lat this sh domainintrinsic mechanism of cooperativity which we quantified by mathematical modeling enabled gad to discriminate between dually and singly phosphorylated lat molecule mutational inactivation of the dimerization interface reduced cooperativity and abrogated gad signaling in t cell and mast cell the dimerizationdependent cooperative binding of gad to lat may increase antigen receptor sensitivity by reducing signalosome formation at incompletely phosphorylated lat molecule thereby prioritizing the formation of complete signalosomes
28960434,utility and limitation of exome sequencing in the molecular diagnosis of pediatric inherited platelet disorder,inherited platelet disorder ipd are a heterogeneous group of rare disorder that affect platelet number and function and often predispose to other significant medical complication in spite of the identification of over ipd diseaseassociated gene a molecular diagnosis is only identified in a minority of affected patient without a clinically suspected etiology we studied a cohort of pediatric patient with suspected ipds by exome sequencing e to examine the performance of the exome test for ipd gene determine if this exomewide diagnostic test provided a higher diagnostic yield than ha been previously reported to evaluate the frequency of variant of uncertain significance identified and to identify candidate variant for functional evaluation in patient with an uncertain or negative diagnosis we established a high priority gene list of gene evaluated exome capture kit performance and determined the coverage for these gene and diseaserelated variant we identified likely disease causing variant in of the probands and variant of uncertain significance in of patient studied in conclusion e ha the potential to molecularly diagnose cause of ipd and to identify candidate gene for functional evaluation robust exome sequencing also requires that coverage of gene known to be associated with clinical finding of interest need to be carefully examined and supplemented if necessary clinician who undertake e should understand the limitation of the test and the full significance of result that may be returned,Non-Cancer,1,utility and limitation of exome sequencing in the molecular diagnosis of pediatric inherited platelet disorder inherited platelet disorder ipd are a heterogeneous group of rare disorder that affect platelet number and function and often predispose to other significant medical complication in spite of the identification of over ipd diseaseassociated gene a molecular diagnosis is only identified in a minority of affected patient without a clinically suspected etiology we studied a cohort of pediatric patient with suspected ipds by exome sequencing e to examine the performance of the exome test for ipd gene determine if this exomewide diagnostic test provided a higher diagnostic yield than ha been previously reported to evaluate the frequency of variant of uncertain significance identified and to identify candidate variant for functional evaluation in patient with an uncertain or negative diagnosis we established a high priority gene list of gene evaluated exome capture kit performance and determined the coverage for these gene and diseaserelated variant we identified likely disease causing variant in of the probands and variant of uncertain significance in of patient studied in conclusion e ha the potential to molecularly diagnose cause of ipd and to identify candidate gene for functional evaluation robust exome sequencing also requires that coverage of gene known to be associated with clinical finding of interest need to be carefully examined and supplemented if necessary clinician who undertake e should understand the limitation of the test and the full significance of result that may be returned
28967629,mutation in aifm cause an xlinked childhood cerebellar ataxia partially responsive to riboflavin,background aifm encodes a mitochondrial flavoprotein with a dual role nadh oxidoreductase and regulator of apoptosis which us riboflavin a a cofactor mutation in the xlinked aifm were reported in relation to two main phenotype a severe infantile mitochondrial encephalomyopathy and an earlyonset axonal sensorimotor neuropathy with hearing loss in this paper we report two unrelated male harboring aifm mutation one of which is novel who display distinct phenotype including progressive ataxia which partially improved with riboflavin treatment method for both patient trio whole exome sequencing wa performed validation and segregation were performed with sanger sequencing following the diagnosis patient were treated with up to mg riboflavinday for month ataxia wa assessed by the icars scale at baseline and and month following treatment result patient presented at the age of year with auditory neuropathy followed by progressive ataxia vermian atrophy and axonal neuropathy patient presented at the age of year with severe limb and palatal myoclonus followed by ataxia cerebellar atrophy ophthalmoplegia sensorineural hearing loss hyporeflexia and cardiomyopathy two deleterious missense mutation were found in the aifm gene p metthr mutation located in the fad dependent oxidoreductase domain and the novel p thrile mutation located in a highly conserved dna binding motif ataxia score decreased by in patient and in patient following month of treatment conclusion aifm mutation cause childhood cerebellar ataxia which may be partially treatable in some patient with high dose riboflavin,Non-Cancer,1,mutation in aifm cause an xlinked childhood cerebellar ataxia partially responsive to riboflavin background aifm encodes a mitochondrial flavoprotein with a dual role nadh oxidoreductase and regulator of apoptosis which us riboflavin a a cofactor mutation in the xlinked aifm were reported in relation to two main phenotype a severe infantile mitochondrial encephalomyopathy and an earlyonset axonal sensorimotor neuropathy with hearing loss in this paper we report two unrelated male harboring aifm mutation one of which is novel who display distinct phenotype including progressive ataxia which partially improved with riboflavin treatment method for both patient trio whole exome sequencing wa performed validation and segregation were performed with sanger sequencing following the diagnosis patient were treated with up to mg riboflavinday for month ataxia wa assessed by the icars scale at baseline and and month following treatment result patient presented at the age of year with auditory neuropathy followed by progressive ataxia vermian atrophy and axonal neuropathy patient presented at the age of year with severe limb and palatal myoclonus followed by ataxia cerebellar atrophy ophthalmoplegia sensorineural hearing loss hyporeflexia and cardiomyopathy two deleterious missense mutation were found in the aifm gene p metthr mutation located in the fad dependent oxidoreductase domain and the novel p thrile mutation located in a highly conserved dna binding motif ataxia score decreased by in patient and in patient following month of treatment conclusion aifm mutation cause childhood cerebellar ataxia which may be partially treatable in some patient with high dose riboflavin
29021147,atypical haematological presentation in a case of polycythaemia vera with a new variant mutation detected in exon cgt pmetile,one of the major genetic insight into the pathogenesis of polycythaemia vera included the identification of the somatic point gainoffunction mutation in janus kinase genefirst jakvf on exon present in of the case and later on exon in the literature we can find some reported study where different exon mutation are identified unlike patient with jakvf mutation in exon the mutation at exon is not usually associated with an increase in the three haematopoietic series erythrocytosis leucocytosis and thrombocytosis it appears to be associated with a distinct syndrome mostly characterised by isolated and more marked erythrocytosis independently of the mutational variant we report here the case of a patient who is jakexon positive presenting a novel mutationcgt pmetileassociated with cct phistyr mutation previously described evidencing an atypical clinical phenotype,Non-Cancer,1,atypical haematological presentation in a case of polycythaemia vera with a new variant mutation detected in exon cgt pmetile one of the major genetic insight into the pathogenesis of polycythaemia vera included the identification of the somatic point gainoffunction mutation in janus kinase genefirst jakvf on exon present in of the case and later on exon in the literature we can find some reported study where different exon mutation are identified unlike patient with jakvf mutation in exon the mutation at exon is not usually associated with an increase in the three haematopoietic series erythrocytosis leucocytosis and thrombocytosis it appears to be associated with a distinct syndrome mostly characterised by isolated and more marked erythrocytosis independently of the mutational variant we report here the case of a patient who is jakexon positive presenting a novel mutationcgt pmetileassociated with cct phistyr mutation previously described evidencing an atypical clinical phenotype
29059455,angiocrine wnt signaling control liver growth and metabolic maturation in mouse,postnatal liver development is characterized by hepatocyte growth proliferation and functional maturation notably canonical wnt signaling in hepatocytes ha been identified a an important regulator of final adult liver size and metabolic liver zonation the cellular origin of wnt ligand responsible for homeostatic liverbody weight ratio lwbw remained unclear which wa also attributable to a lack of suitable endothelial cre driver mouse to comprehensively analyze the effect of hepatic angiocrine wnt signaling on liver development and metabolic function we used endothelial subtypespecific stabcre driver mouse to delete wls from hepatic endothelial cell hecs the resultant stabcretgwt wlsflfl wlshecko mouse were viable but showed a significantly reduced lwbw specifically ablation of angiocrine wnt signaling impaired metabolic zonation in the liver a shown by loss of pericentral betacatenindependent target gene such a glutamine synthase glul rhbg axin and cytochrome p e a well a by extended expression of periportal gene such a arginase furthermore endothelial subtypespecific expression of a cterminally yfptagged wls fusion protein in wlshecko mouse stabcretgwt wlsflfl rosawlsyfpflwt wlsrescue restored metabolic liver zonation interestingly lipid metabolism wa altered in wlshecko mouse exhibiting significantly reduced plasma cholesterol level while maintaining normal plasma triglyceride and blood glucose concentration on the contrary zonal expression of endomucin lyve and other marker of hec heterogeneity were not altered in wlshecko liver conclusion angiocrine wnt signaling control liver growth a well a development of metabolic liver zonation in mouse whereas intrahepatic hec zonation is not affected hepatology,Non-Cancer,1,angiocrine wnt signaling control liver growth and metabolic maturation in mouse postnatal liver development is characterized by hepatocyte growth proliferation and functional maturation notably canonical wnt signaling in hepatocytes ha been identified a an important regulator of final adult liver size and metabolic liver zonation the cellular origin of wnt ligand responsible for homeostatic liverbody weight ratio lwbw remained unclear which wa also attributable to a lack of suitable endothelial cre driver mouse to comprehensively analyze the effect of hepatic angiocrine wnt signaling on liver development and metabolic function we used endothelial subtypespecific stabcre driver mouse to delete wls from hepatic endothelial cell hecs the resultant stabcretgwt wlsflfl wlshecko mouse were viable but showed a significantly reduced lwbw specifically ablation of angiocrine wnt signaling impaired metabolic zonation in the liver a shown by loss of pericentral betacatenindependent target gene such a glutamine synthase glul rhbg axin and cytochrome p e a well a by extended expression of periportal gene such a arginase furthermore endothelial subtypespecific expression of a cterminally yfptagged wls fusion protein in wlshecko mouse stabcretgwt wlsflfl rosawlsyfpflwt wlsrescue restored metabolic liver zonation interestingly lipid metabolism wa altered in wlshecko mouse exhibiting significantly reduced plasma cholesterol level while maintaining normal plasma triglyceride and blood glucose concentration on the contrary zonal expression of endomucin lyve and other marker of hec heterogeneity were not altered in wlshecko liver conclusion angiocrine wnt signaling control liver growth a well a development of metabolic liver zonation in mouse whereas intrahepatic hec zonation is not affected hepatology
29070606,treatment of hemorrhagic head and neck lesion by direct puncture and nbca embolization,lifethreatening bleeding in the head and neck region requires urgent management these hemorrhagic lesion for example a ruptured pseudoaneurysm are often treated by transarterial embolization tae but prior intervention or surgery inflammation anatomic variant and vessel tortuosity may render an endovascular approach challenging timeconsuming and sometimes impossible we report two case of severe head and neck hemorrhage successfully embolized with nbutyl cyanoacrylate via direct puncture and propose this approach a a fast safe and effective alternative to tae,Non-Cancer,1,treatment of hemorrhagic head and neck lesion by direct puncture and nbca embolization lifethreatening bleeding in the head and neck region requires urgent management these hemorrhagic lesion for example a ruptured pseudoaneurysm are often treated by transarterial embolization tae but prior intervention or surgery inflammation anatomic variant and vessel tortuosity may render an endovascular approach challenging timeconsuming and sometimes impossible we report two case of severe head and neck hemorrhage successfully embolized with nbutyl cyanoacrylate via direct puncture and propose this approach a a fast safe and effective alternative to tae
29101828,jakvf detection and allele burden measurement in saliva v peripheral blood in patient with myelofibrosis,we previously demonstrated that peripheral blood pb is a reliable source for testing jakvf mutation in patient with myelofibrosis mf saliva ha also been tested to detect such mutation however it diagnostic accuracy a compared to pb ha not been validated in this study we prospectively tested patient with mf for jakvf mutation using both saliva and pb collected at the same time from each patient the concordance between the source wa with a sensitivity of and a specificity of the only factor associated with false positivity on saliva wa ongoing transfusion dependency jakvf testing using saliva is a simple noninvasive and potentially a more reliable method than pb for measuring jak status and assessing vf allelic burden in patient with transfusion dependency,Non-Cancer,1,jakvf detection and allele burden measurement in saliva v peripheral blood in patient with myelofibrosis we previously demonstrated that peripheral blood pb is a reliable source for testing jakvf mutation in patient with myelofibrosis mf saliva ha also been tested to detect such mutation however it diagnostic accuracy a compared to pb ha not been validated in this study we prospectively tested patient with mf for jakvf mutation using both saliva and pb collected at the same time from each patient the concordance between the source wa with a sensitivity of and a specificity of the only factor associated with false positivity on saliva wa ongoing transfusion dependency jakvf testing using saliva is a simple noninvasive and potentially a more reliable method than pb for measuring jak status and assessing vf allelic burden in patient with transfusion dependency
29127134,radiation retinopathy treated successfully with aflibercept,aflibercept aflibercept is a novel antivascular endothelial growth factor drug indicated for wet agerelated macular degeneration and macular oedema secondary to retinal vein occlusion and diabetic macular oedema while only newly introduced on the market it is growing in popularity and over million dos have been prescribed worldwide due to it versatile mechanism it is indicated for numerous eye pathology and in particular ha been adapted to treat various type of retinopathy to our knowledge this is the first case report of solely using aflibercept to treat cystoid macular oedema in radiation retinopathy,Non-Cancer,1,radiation retinopathy treated successfully with aflibercept aflibercept aflibercept is a novel antivascular endothelial growth factor drug indicated for wet agerelated macular degeneration and macular oedema secondary to retinal vein occlusion and diabetic macular oedema while only newly introduced on the market it is growing in popularity and over million dos have been prescribed worldwide due to it versatile mechanism it is indicated for numerous eye pathology and in particular ha been adapted to treat various type of retinopathy to our knowledge this is the first case report of solely using aflibercept to treat cystoid macular oedema in radiation retinopathy
29133782,mtor intersects antibodyinducing signal from taci in marginal zone b cell,mechanistic target of rapamycin mtor enhances immunity in addition to orchestrating metabolism here we show that mtor coordinate immunometabolic reconfiguration of marginal zone mz b cell a preactivated lymphocyte subset that mount antibody response to tcellindependent antigen through a tolllike receptor tlramplified pathway involving transmembrane activator and caml interactor taci this receptor interacts with mtor via the tlr adapter myd the resulting mtor activation instigates mz bcell proliferation immunoglobulin g igg class switching and plasmablast differentiation through a rapamycinsensitive pathway that integrates metabolic and antibodyinducing transcription program including nfkappab disruption of tacimtor interaction by rapamycin truncation of the mydbinding domain of taci or bcellconditional mtor deficiency interrupt taci signaling via nfkappab and cooperation with tlrs thereby hampering igg production to tcellindependent antigen but not bcell survival thus mtor drive innatelike antibody response by linking proximal taci signaling event with distal immunometabolic transcription program,Non-Cancer,1,mtor intersects antibodyinducing signal from taci in marginal zone b cell mechanistic target of rapamycin mtor enhances immunity in addition to orchestrating metabolism here we show that mtor coordinate immunometabolic reconfiguration of marginal zone mz b cell a preactivated lymphocyte subset that mount antibody response to tcellindependent antigen through a tolllike receptor tlramplified pathway involving transmembrane activator and caml interactor taci this receptor interacts with mtor via the tlr adapter myd the resulting mtor activation instigates mz bcell proliferation immunoglobulin g igg class switching and plasmablast differentiation through a rapamycinsensitive pathway that integrates metabolic and antibodyinducing transcription program including nfkappab disruption of tacimtor interaction by rapamycin truncation of the mydbinding domain of taci or bcellconditional mtor deficiency interrupt taci signaling via nfkappab and cooperation with tlrs thereby hampering igg production to tcellindependent antigen but not bcell survival thus mtor drive innatelike antibody response by linking proximal taci signaling event with distal immunometabolic transcription program
29146131,dysregulation of autophagy in melanocyte contributes to hypopigmented macule in tuberous sclerosis complex,background tuberous sclerosis complex tsc gene mutation lead to constitutive activation of the mammalian target of rapamycin mtor pathway resulting in a broad range of symptom hypopigmented macule are the earliest sign although we have already confirmed that topical rapamycin treatment an mtor inhibitor protects patient with tsc against macular hypopigmentation the pathogenesis of such lesion remains poorly understood objective recently emerging evidence support a role for autophagy in skin pigmentation herein we investigated the impact of autophagic dysregulation on tscassociated hypopigmentation method skin sample from patient with tsc each bearing characteristic hypopigmented macule and healthy donor were subjected to immunohistochemical and electron microscopic analysis in addition tscknockdown kd wa investigated in human epidermal melanocyte by melanin content examination realtime pcr western blotting analysis and intracellular immunofluorescence staining result activation of the mtor signaling pathway decreased melanocytic pigmentation in hypopigmented macule of patient with tsc and in tsckd melanocyte in addition lc expression a marker of autophagy and autophagosome count increased whereas intracellular accumulation of autophagic degradative substrate p and ubiquitinated protein wa evident in tsckd melanocyte furthermore depigmentation in tsckd melanocyte wa accelerated by inhibiting autophagy atgkd or bafilomycin apretreatment and wa completely reversed by induction of autophagy via mtordependent rapamycin or mtorindependent smer exposure finally dysregulation of autophagy marked by increased lc expression and accumulation of ubiquitinated protein wa also observed in melanocyte of tscrelated hypopigmented macule conclusion our data demonstrate that melanocyte of patient with tsc display autophagic dysregulation which thereby reduced pigmentation serving a the basis for the hypomelanotic macule characteristic of tsc,Non-Cancer,1,dysregulation of autophagy in melanocyte contributes to hypopigmented macule in tuberous sclerosis complex background tuberous sclerosis complex tsc gene mutation lead to constitutive activation of the mammalian target of rapamycin mtor pathway resulting in a broad range of symptom hypopigmented macule are the earliest sign although we have already confirmed that topical rapamycin treatment an mtor inhibitor protects patient with tsc against macular hypopigmentation the pathogenesis of such lesion remains poorly understood objective recently emerging evidence support a role for autophagy in skin pigmentation herein we investigated the impact of autophagic dysregulation on tscassociated hypopigmentation method skin sample from patient with tsc each bearing characteristic hypopigmented macule and healthy donor were subjected to immunohistochemical and electron microscopic analysis in addition tscknockdown kd wa investigated in human epidermal melanocyte by melanin content examination realtime pcr western blotting analysis and intracellular immunofluorescence staining result activation of the mtor signaling pathway decreased melanocytic pigmentation in hypopigmented macule of patient with tsc and in tsckd melanocyte in addition lc expression a marker of autophagy and autophagosome count increased whereas intracellular accumulation of autophagic degradative substrate p and ubiquitinated protein wa evident in tsckd melanocyte furthermore depigmentation in tsckd melanocyte wa accelerated by inhibiting autophagy atgkd or bafilomycin apretreatment and wa completely reversed by induction of autophagy via mtordependent rapamycin or mtorindependent smer exposure finally dysregulation of autophagy marked by increased lc expression and accumulation of ubiquitinated protein wa also observed in melanocyte of tscrelated hypopigmented macule conclusion our data demonstrate that melanocyte of patient with tsc display autophagic dysregulation which thereby reduced pigmentation serving a the basis for the hypomelanotic macule characteristic of tsc
29150943,muscle regeneration potential and satellite cell activation profile during recovery following hindlimb immobilization in mouse,reduced muscle activity lead to muscle atrophy and function loss in patient and animal model satellite cell sc are postnatal muscle stem cell that play a pivotal role in skeletal muscle regeneration following injury the regenerative potential satellite cell number and marker during recovery following immobilization of the hindlimb for day were explored in mouse exposed to day of hindlimb immobilization in those exposed to recovery day splint removal and in contralateral control muscle muscle precursor cell were isolated from all hindlimb muscle fluorescenceactivated cell sorting facs and sc and muscle regeneration were identified using immunofluorescence gastrocnemius and soleus and electron microscopy em gastrocnemius expression of ki pax myod and myogenin wa quantified rtpcr from sc facs yield body and grip strength were determined following day hindlimb immobilization a decline in sc facs immunofluorescence wa observed together with an upregulation of sc activation marker and sign of muscle regeneration including fusion to existing myofibers em recovery following hindlimb immobilization wa characterized by a program of muscle regeneration event hindlimb immobilization induced a decline in sc together with an upregulation of marker of sc activation suggesting that fusion to existing myofibers take place during unloading muscle recovery induced a significant rise in muscle precursor cell and regeneration event along with reduced sc activation expression marker and a concomitant rise in terminal muscle differentiation expression these are novel finding of potential applicability for the treatment of disuse muscle atrophy which is commonly associated with severe chronic and acute condition,Non-Cancer,1,muscle regeneration potential and satellite cell activation profile during recovery following hindlimb immobilization in mouse reduced muscle activity lead to muscle atrophy and function loss in patient and animal model satellite cell sc are postnatal muscle stem cell that play a pivotal role in skeletal muscle regeneration following injury the regenerative potential satellite cell number and marker during recovery following immobilization of the hindlimb for day were explored in mouse exposed to day of hindlimb immobilization in those exposed to recovery day splint removal and in contralateral control muscle muscle precursor cell were isolated from all hindlimb muscle fluorescenceactivated cell sorting facs and sc and muscle regeneration were identified using immunofluorescence gastrocnemius and soleus and electron microscopy em gastrocnemius expression of ki pax myod and myogenin wa quantified rtpcr from sc facs yield body and grip strength were determined following day hindlimb immobilization a decline in sc facs immunofluorescence wa observed together with an upregulation of sc activation marker and sign of muscle regeneration including fusion to existing myofibers em recovery following hindlimb immobilization wa characterized by a program of muscle regeneration event hindlimb immobilization induced a decline in sc together with an upregulation of marker of sc activation suggesting that fusion to existing myofibers take place during unloading muscle recovery induced a significant rise in muscle precursor cell and regeneration event along with reduced sc activation expression marker and a concomitant rise in terminal muscle differentiation expression these are novel finding of potential applicability for the treatment of disuse muscle atrophy which is commonly associated with severe chronic and acute condition
29157620,unicentric castleman disease,unicentric castleman disease ucd is a rare lymphoproliferative disorder that manifest typically a proliferation of a single lymph node or region of lymph node histologically hyaline vascular variant is found in a majority of ucds ucd commonly present in younger patient population patient with ucd may be asymptomatic or present with symptom related to mass effect on surrounding structure it is difficult to achieve a definitive diagnosis by imaging alone histologic examination of the lesion remains the gold standard for diagnosis complete surgical resection is the best primary treatment modality for ucd resulting in excellent longterm survival and low recurrence rate,Non-Cancer,1,unicentric castleman disease unicentric castleman disease ucd is a rare lymphoproliferative disorder that manifest typically a proliferation of a single lymph node or region of lymph node histologically hyaline vascular variant is found in a majority of ucds ucd commonly present in younger patient population patient with ucd may be asymptomatic or present with symptom related to mass effect on surrounding structure it is difficult to achieve a definitive diagnosis by imaging alone histologic examination of the lesion remains the gold standard for diagnosis complete surgical resection is the best primary treatment modality for ucd resulting in excellent longterm survival and low recurrence rate
29171770,emerging biomarkers of lymphangioleiomyomatosis,introduction lymphangioleiomyomatosis lam is a destructive lung disease affecting primarily woman lam is caused by inactivating mutation in the tuberous sclerosis complex tsc gene resulting in hyperactivation of mechanisticmammalian target of rapamycin complex mtorc over the past five year there have been remarkable advance in the diagnosis and therapy of lam including the identification of vascular endothelial growth factor d vegfd a a diagnostic biomarker and the u food and drug administration approval of sirolimus a therapy for lam in appropriate clinical situation vegfd testing can make lung biopsy unnecessary to diagnose lam however there remains an urgent unmet need for additional biomarkers of disease activity andor response to therapy area covered this work review vegfd an established lam biomarker and discusses emerging biomarkers including circulating lam cell imaging lipid and metabolite biomarkers focusing on those with the highest potential impact for lam patient expert commentary ongoing research priority include the development of validated biomarkers to noninvasively diagnose lam in woman whose vegfd level are not diagnostic accurately predict the likelihood of disease progression and quantitatively measure disease activity and lam cell burden these biomarkers would enable personalized precision clinical care and fasttrack clinical trial implementation with high clinical impact,Non-Cancer,1,emerging biomarkers of lymphangioleiomyomatosis introduction lymphangioleiomyomatosis lam is a destructive lung disease affecting primarily woman lam is caused by inactivating mutation in the tuberous sclerosis complex tsc gene resulting in hyperactivation of mechanisticmammalian target of rapamycin complex mtorc over the past five year there have been remarkable advance in the diagnosis and therapy of lam including the identification of vascular endothelial growth factor d vegfd a a diagnostic biomarker and the u food and drug administration approval of sirolimus a therapy for lam in appropriate clinical situation vegfd testing can make lung biopsy unnecessary to diagnose lam however there remains an urgent unmet need for additional biomarkers of disease activity andor response to therapy area covered this work review vegfd an established lam biomarker and discusses emerging biomarkers including circulating lam cell imaging lipid and metabolite biomarkers focusing on those with the highest potential impact for lam patient expert commentary ongoing research priority include the development of validated biomarkers to noninvasively diagnose lam in woman whose vegfd level are not diagnostic accurately predict the likelihood of disease progression and quantitatively measure disease activity and lam cell burden these biomarkers would enable personalized precision clinical care and fasttrack clinical trial implementation with high clinical impact
29177536,novel biotechnological platform based on baculovirus occlusion body carrying babesia bovis small antigenic peptide for the design of a diagnostic enzymelinked immunosorbent assay elisa,baculoviruses are large dna virus of insect principally employed in recombinant protein expression it ability to form occlusion body ob which are composed mainly of polyhedrin protein polh make them biotechnologically attractive a these crystal polyhedron can incorporate foreign peptide and can be easily isolated on the other hand peptide microarrays allow rapid and inexpensive highthroughput serological screening of new candidate to be incorporated to ob to integrate these biotechnological approach we worked on babesia bovis one of the causative agent of bovine babesiosis current molecular diagnosis of infection with b bovis includes enzymelinked immunosorbent assay elisa technique which use merozoite lysate obtained from infected bovine erythrocyte however it is important to produce recombinant antigen that replace the use of crude antigen here we describe a new biotechnological platform for the design of indirect elisa based on antigenic peptide of amino acid residue of b bovis apbb selected from a peptide microarray and expressed a a fusion to polh an sfpolheg packaging cell line infected with recombinant baculoviruses carrying polhapbb fusion yielded higher level of chimeric polyhedron highlighting the advantage of a transcontribution of a mutant copy of polyhedrin finally the use of dissolved recombinant polyhedron a antigen wa successful in an elisa assay a b bovispositive serum recognized the fusion polhapbb thus the use of this platform resulted in a promising alternative for molecular diagnosis of relevant infectious disease,Non-Cancer,1,novel biotechnological platform based on baculovirus occlusion body carrying babesia bovis small antigenic peptide for the design of a diagnostic enzymelinked immunosorbent assay elisa baculoviruses are large dna virus of insect principally employed in recombinant protein expression it ability to form occlusion body ob which are composed mainly of polyhedrin protein polh make them biotechnologically attractive a these crystal polyhedron can incorporate foreign peptide and can be easily isolated on the other hand peptide microarrays allow rapid and inexpensive highthroughput serological screening of new candidate to be incorporated to ob to integrate these biotechnological approach we worked on babesia bovis one of the causative agent of bovine babesiosis current molecular diagnosis of infection with b bovis includes enzymelinked immunosorbent assay elisa technique which use merozoite lysate obtained from infected bovine erythrocyte however it is important to produce recombinant antigen that replace the use of crude antigen here we describe a new biotechnological platform for the design of indirect elisa based on antigenic peptide of amino acid residue of b bovis apbb selected from a peptide microarray and expressed a a fusion to polh an sfpolheg packaging cell line infected with recombinant baculoviruses carrying polhapbb fusion yielded higher level of chimeric polyhedron highlighting the advantage of a transcontribution of a mutant copy of polyhedrin finally the use of dissolved recombinant polyhedron a antigen wa successful in an elisa assay a b bovispositive serum recognized the fusion polhapbb thus the use of this platform resulted in a promising alternative for molecular diagnosis of relevant infectious disease
29196283,ringed telangiectasias an unusual presentation of telangiectasia macularis eruptiva perstans,telangiectasia macularis eruptiva perstans tmep is a rare form of cutaneous mastocytosis while most cutaneous mastocytoses occur in child and are asymptomatic tmep occurs predominantly in adult and is associated with systemic manifestation requiring medical management tmep is typically characterised by scattered redbrown macule on the trunk and extremity but must be differentiated from other telangiectatic condition such a scleroderma hereditary haemorrhagic telangiectasia and telangiectasias secondary to cirrhosis practitioner must be aware that variant to the classic presentation of tmep exist such a the ringed telangiectasias we describe diagnostic workup including tissue biopsy must be considered in such patient after a thorough history and physical have been performed and other telangiectatic process have been ruled out the treatment of cutaneous mastocytosis aim at controlling symptom and preventing mast cell degranulation cosmetic treatment includes the use ofpsoralen and ultraviolet a puva therapy total skin electron beam radiation and flashlamp pulseddye laser treatment,Non-Cancer,1,ringed telangiectasias an unusual presentation of telangiectasia macularis eruptiva perstans telangiectasia macularis eruptiva perstans tmep is a rare form of cutaneous mastocytosis while most cutaneous mastocytoses occur in child and are asymptomatic tmep occurs predominantly in adult and is associated with systemic manifestation requiring medical management tmep is typically characterised by scattered redbrown macule on the trunk and extremity but must be differentiated from other telangiectatic condition such a scleroderma hereditary haemorrhagic telangiectasia and telangiectasias secondary to cirrhosis practitioner must be aware that variant to the classic presentation of tmep exist such a the ringed telangiectasias we describe diagnostic workup including tissue biopsy must be considered in such patient after a thorough history and physical have been performed and other telangiectatic process have been ruled out the treatment of cutaneous mastocytosis aim at controlling symptom and preventing mast cell degranulation cosmetic treatment includes the use ofpsoralen and ultraviolet a puva therapy total skin electron beam radiation and flashlamp pulseddye laser treatment
29237664,giant retrocardiac foregut duplication cyst presenting with left atrial compression and palpitation,a yearold man presented with a month history of palpitation and shortness of breath an ecg showed premature atrial contraction and episode of supraventricular tachycardia a subsequent echocardiogram showed a retrocardiac cystic mass that wa compressing the left atrium a ct scan confirmed these finding by showing a large leftsided posterior mediastinal cyst compressing the left atrium and pulmonary vein the cyst wa successfully excised from the retrocardiac position via left thoracotomy after which there wa complete resolution of the palpitation histopathology showed it to be a mediastinal cyst most likely a foregut duplication of the enterogenic variant this is an extremely unusual case of foregut duplication cyst presenting with compression of the left atrium and pulmonary vein leading to atrial arrhythmia,Non-Cancer,1,giant retrocardiac foregut duplication cyst presenting with left atrial compression and palpitation a yearold man presented with a month history of palpitation and shortness of breath an ecg showed premature atrial contraction and episode of supraventricular tachycardia a subsequent echocardiogram showed a retrocardiac cystic mass that wa compressing the left atrium a ct scan confirmed these finding by showing a large leftsided posterior mediastinal cyst compressing the left atrium and pulmonary vein the cyst wa successfully excised from the retrocardiac position via left thoracotomy after which there wa complete resolution of the palpitation histopathology showed it to be a mediastinal cyst most likely a foregut duplication of the enterogenic variant this is an extremely unusual case of foregut duplication cyst presenting with compression of the left atrium and pulmonary vein leading to atrial arrhythmia
29240865,mast cell burden in a patient with cutaneous disease,mastocytosis is a disease characterized by the abnormal clonal proliferation of mast cell in skin andor extracutaneous organ often relating to activating mutation of ckit histopathology special stain such a giemsa leder and toluidine blue are key for the diagnosis of cutaneous mastocytosis cm in adult skin lesion can be associated with systemic disease tryptase is a diagnostic marker in mastocytosis and thought to reflect the burden of mast cell disease in this report we present a case of cutaneous mast cell disease with associated finding of elevated serum tryptase and mast cell infiltration of the bone marrow consistent with indolent systemic mastocytosis,Non-Cancer,1,mast cell burden in a patient with cutaneous disease mastocytosis is a disease characterized by the abnormal clonal proliferation of mast cell in skin andor extracutaneous organ often relating to activating mutation of ckit histopathology special stain such a giemsa leder and toluidine blue are key for the diagnosis of cutaneous mastocytosis cm in adult skin lesion can be associated with systemic disease tryptase is a diagnostic marker in mastocytosis and thought to reflect the burden of mast cell disease in this report we present a case of cutaneous mast cell disease with associated finding of elevated serum tryptase and mast cell infiltration of the bone marrow consistent with indolent systemic mastocytosis
29249553,liver angiomyolipomas in tuberous sclerosis complextheir incidence and course,background the purpose of this study wa to evaluate the epidemiology and clinical significance of hepatic angiomyolipomas in patient with tuberous sclerosis complex method we performed a retrospective analysis of clinical and imaging data from patient with tuberous sclerosis complex the prevalence progression and potential relationship between liver lesion and other clinical finding including genetic association were assessed result twentyeight of patient had hepatic lesion there wa a predominance of female over male patient in individual with liver lesion versus with statistical significance in patient under five year of age p all individual having hepatic lesion who also had available genetic testing data n were diagnosed with a tsc gene mutation all patient with liver lesion had coexisting renal angiomyolipomas amls p the age of onset of renal lesion wa lower and their prevalence wa significantly higher in patient with liver involvement p in most instance hepatic lesion measured several millimeter in diameter and were clinically asymptomatic progressive lesion growth wa documented in six individual but with no clinical consequence to date conclusion this study confirms the association of hepatic lesion with tsc mutation a common origin of liver and renal amls a well a the predominance of female patient in this group hepatic amls are relatively common but mostly benign lesion,Non-Cancer,1,liver angiomyolipomas in tuberous sclerosis complextheir incidence and course background the purpose of this study wa to evaluate the epidemiology and clinical significance of hepatic angiomyolipomas in patient with tuberous sclerosis complex method we performed a retrospective analysis of clinical and imaging data from patient with tuberous sclerosis complex the prevalence progression and potential relationship between liver lesion and other clinical finding including genetic association were assessed result twentyeight of patient had hepatic lesion there wa a predominance of female over male patient in individual with liver lesion versus with statistical significance in patient under five year of age p all individual having hepatic lesion who also had available genetic testing data n were diagnosed with a tsc gene mutation all patient with liver lesion had coexisting renal angiomyolipomas amls p the age of onset of renal lesion wa lower and their prevalence wa significantly higher in patient with liver involvement p in most instance hepatic lesion measured several millimeter in diameter and were clinically asymptomatic progressive lesion growth wa documented in six individual but with no clinical consequence to date conclusion this study confirms the association of hepatic lesion with tsc mutation a common origin of liver and renal amls a well a the predominance of female patient in this group hepatic amls are relatively common but mostly benign lesion
29271416,cryoem structure of human atratrip complex,atr ataxia telangiectasiamutated and radrelated protein kinase and atrip atrinteracting protein form a complex and play a critical role in response to replication stress and dna damage here we determined the cryoelectron microscopy em structure of the human atratrip complex at a resolution and built an atomic model of the cterminal catalytic core of atr residue at a resolution the complex adopts a hollow heart shape consisting of two atr monomer in distinct conformation the em map for atrip reveals heat repeat in an extended s shape the conformational flexibility of atr allows atrip to properly lock the ntermini of the two atr monomer to favor atratrip complex formation and functional diversity the isolated headhead and tailtail each adopts a pseudo fold symmetry the catalytic pocket face outward and substrate access is not restricted by inhibitory element our study provide a structural basis for understanding the assembly of the atratrip complex and a framework for characterizing atrmediated dna repair pathway,Non-Cancer,1,cryoem structure of human atratrip complex atr ataxia telangiectasiamutated and radrelated protein kinase and atrip atrinteracting protein form a complex and play a critical role in response to replication stress and dna damage here we determined the cryoelectron microscopy em structure of the human atratrip complex at a resolution and built an atomic model of the cterminal catalytic core of atr residue at a resolution the complex adopts a hollow heart shape consisting of two atr monomer in distinct conformation the em map for atrip reveals heat repeat in an extended s shape the conformational flexibility of atr allows atrip to properly lock the ntermini of the two atr monomer to favor atratrip complex formation and functional diversity the isolated headhead and tailtail each adopts a pseudo fold symmetry the catalytic pocket face outward and substrate access is not restricted by inhibitory element our study provide a structural basis for understanding the assembly of the atratrip complex and a framework for characterizing atrmediated dna repair pathway
29276006,wnt signaling perturbation underlie the genetic heterogeneity of robinow syndrome,locus heterogeneity characterizes a variety of skeletal dysplasia often due to interacting or overlapping signaling pathway robinow syndrome is a skeletal disorder historically refractory to molecular diagnosis potentially stemming from substantial genetic heterogeneity all current known pathogenic variant reside in gene within the noncanonical wnt signaling pathway including ror wnta and more recently dvl and dvl however of autosomaldominant robinow syndrome case remain molecularly unsolved to investigate this missing heritability we recruited family with at least one family member clinically diagnosed with robinow or robinowlike phenotype and performed genetic and genomic study in total four family with variant in fzd were identified a well a three individual from two family with biallelic variant in nxn that cosegregate with the phenotype importantly both fzd and nxn are relevant protein partner in the wnta interactome supporting their role in skeletal development in addition to confirming that clustered frameshifting variant in dvl and dvl are the main contributor to dominant robinow syndrome we also found likely pathogenic variant in candidate gene gpc and rac both linked to the wnt signaling pathway these data support an initial hypothesis that robinow syndrome result from perturbation of the wntpcp pathway suggest specific relevant domain of the protein involved and reveal key contributor in this signaling cascade during human embryonic development contrary to the view that nonallelic genetic heterogeneity hamper gene discovery this study demonstrates the utility of rare disease genomic study to parse gene function in human developmental pathway,Non-Cancer,1,wnt signaling perturbation underlie the genetic heterogeneity of robinow syndrome locus heterogeneity characterizes a variety of skeletal dysplasia often due to interacting or overlapping signaling pathway robinow syndrome is a skeletal disorder historically refractory to molecular diagnosis potentially stemming from substantial genetic heterogeneity all current known pathogenic variant reside in gene within the noncanonical wnt signaling pathway including ror wnta and more recently dvl and dvl however of autosomaldominant robinow syndrome case remain molecularly unsolved to investigate this missing heritability we recruited family with at least one family member clinically diagnosed with robinow or robinowlike phenotype and performed genetic and genomic study in total four family with variant in fzd were identified a well a three individual from two family with biallelic variant in nxn that cosegregate with the phenotype importantly both fzd and nxn are relevant protein partner in the wnta interactome supporting their role in skeletal development in addition to confirming that clustered frameshifting variant in dvl and dvl are the main contributor to dominant robinow syndrome we also found likely pathogenic variant in candidate gene gpc and rac both linked to the wnt signaling pathway these data support an initial hypothesis that robinow syndrome result from perturbation of the wntpcp pathway suggest specific relevant domain of the protein involved and reveal key contributor in this signaling cascade during human embryonic development contrary to the view that nonallelic genetic heterogeneity hamper gene discovery this study demonstrates the utility of rare disease genomic study to parse gene function in human developmental pathway
29288088,telangiectasias in ataxia telangiectasia clinical significance role of atm deficiency and potential pathophysiological mechanism,ataxia telangiectasia at is named after the two key clinical feature that characterize it classical phenotype namely a progressive cerebellar gait disorder ataxia and vascular anomaly telangiectasias visible in the conjunctiva and skin at is an autosomal recessively inherited disorder caused by mutation in the atm gene that encodes the atm protein while the ataxia is subject of many publication the telangiectasias are under emphasised we here describe the observation that the absence or presence of atm protein and the level of residual atm kinase activity are related to the occurrence of telangiectasias and describe the clinical consequence of these vascular malformation finally we hypothesize that atm dysfunction dysregulates angiogenesis,Non-Cancer,1,telangiectasias in ataxia telangiectasia clinical significance role of atm deficiency and potential pathophysiological mechanism ataxia telangiectasia at is named after the two key clinical feature that characterize it classical phenotype namely a progressive cerebellar gait disorder ataxia and vascular anomaly telangiectasias visible in the conjunctiva and skin at is an autosomal recessively inherited disorder caused by mutation in the atm gene that encodes the atm protein while the ataxia is subject of many publication the telangiectasias are under emphasised we here describe the observation that the absence or presence of atm protein and the level of residual atm kinase activity are related to the occurrence of telangiectasias and describe the clinical consequence of these vascular malformation finally we hypothesize that atm dysfunction dysregulates angiogenesis
29298625,initial romiplostim dosing and time to platelet response in patient with treatment refractory immune thrombocytopenia,backgroundrationale romiplostim is a thrombopoietin receptor agonist recommended a a secondline therapy for immune thrombocytopenia an initial dose of mcgkgweek subcutaneously with weekly mcgkg dose escalation is recommended per package labeling optimizing romiplostim dosing for hospitalized corticosteroid and intravenous immunoglobulinrefractory patient with severe thrombocytopenia secondary to immune thrombocytopenia may be critical for improving platelet response reducing the risk of bleeding and decreasing hospital length of stay limited data are available evaluating the efficacy and safety of higher initial dos objective the primary objective of this study wa to compare the time to platelet x l between patient who received an initial romiplostim dose of mcgkgweek compared to the standard initial dose of mcgkgweek secondary objective included time to platelet response x l and x l percentage of patient achieving platelet response hospital length of stay and incidence of adverse event and bleeding complication method this wa a retrospective singlecenter cohort study including hospitalized adult with corticosteroid and intravenous immunoglobulinrefractory immune thrombocytopenia a baseline platelet mcgkgweek a review of electronic medical record and descriptive statistic generated finding result a total of patient were included in cohort and in cohort patient in cohort had a median initial dose of mcgkgweek patient in cohort achieved a platelet x l in a median of day versus day for cohort more patient in cohort achieved a platelet x l v and platelet x l v the median hospital length of stay wa shorter in cohort v day clinically relevant nonmajor bleeding wa noted less frequently in cohort v while major bleeding wa more frequent in cohort v no thrombotic event occurred conclusion our study suggests that higher initial romiplostim dos may be safe for hospitalized patient with treatmentrefractory immune thrombocytopenia compared to food and drug administrationapproved dosing higher initial dos may shorten time to platelet response and hospital length of stay further largescale study are needed to confirm these finding,Non-Cancer,1,initial romiplostim dosing and time to platelet response in patient with treatment refractory immune thrombocytopenia backgroundrationale romiplostim is a thrombopoietin receptor agonist recommended a a secondline therapy for immune thrombocytopenia an initial dose of mcgkgweek subcutaneously with weekly mcgkg dose escalation is recommended per package labeling optimizing romiplostim dosing for hospitalized corticosteroid and intravenous immunoglobulinrefractory patient with severe thrombocytopenia secondary to immune thrombocytopenia may be critical for improving platelet response reducing the risk of bleeding and decreasing hospital length of stay limited data are available evaluating the efficacy and safety of higher initial dos objective the primary objective of this study wa to compare the time to platelet x l between patient who received an initial romiplostim dose of mcgkgweek compared to the standard initial dose of mcgkgweek secondary objective included time to platelet response x l and x l percentage of patient achieving platelet response hospital length of stay and incidence of adverse event and bleeding complication method this wa a retrospective singlecenter cohort study including hospitalized adult with corticosteroid and intravenous immunoglobulinrefractory immune thrombocytopenia a baseline platelet mcgkgweek a review of electronic medical record and descriptive statistic generated finding result a total of patient were included in cohort and in cohort patient in cohort had a median initial dose of mcgkgweek patient in cohort achieved a platelet x l in a median of day versus day for cohort more patient in cohort achieved a platelet x l v and platelet x l v the median hospital length of stay wa shorter in cohort v day clinically relevant nonmajor bleeding wa noted less frequently in cohort v while major bleeding wa more frequent in cohort v no thrombotic event occurred conclusion our study suggests that higher initial romiplostim dos may be safe for hospitalized patient with treatmentrefractory immune thrombocytopenia compared to food and drug administrationapproved dosing higher initial dos may shorten time to platelet response and hospital length of stay further largescale study are needed to confirm these finding
29305257,the expression of mctla in skin lesion inversely correlate with the severity of psoriasis,background psoriasis is a chronic inflammatory disease characterized by epidermal hyperplasia and increased t cell infiltration cytotoxic t lymphocyte antigen ctla is a key factor that affect t cell function and immune response however whether the expression of ctla affect the severity of psoriasis is still unknown objective the aim of the project wa to investigate the correlation between the expression of ctla and the severity of psoriasis method the plasma soluble ctla level and membrane ctla expression were measured by enzymelinked immunosorbent assay and immunohistochemistry analysis in mild moderate and severe psoriasis patient respectively imiquimodinduced mouse model of psoriasis wa treated with ctla immunoglobulin fusion protein ctla ig or antictla antibody epidermal thickness and infiltrating cd t cell count were evaluated result the plasma soluble ctla level had no significant difference among mild moderate and severe patient p however the membrane ctla expression in skin wa significantly higher in mild psoriasis patient compared to moderate and severe psoriasis patient v v p furthermore in imiquimodinduced mouse model of psoriasis the result showed that mimicking ctla function improved the skin phenotype and reduced epidermal thickness v mum n p a well a infiltrating cd t cell count v p compared to control group however blocking ctla function aggregated the skin phenotype including enhanced epidermal thickness and infiltrating cd t cell count compared to control group conclusion these result indicated that the expression of mctla in skin lesion inversely correlated with the severity of psoriasis and ctla might play a critical role in the disease severity of psoriasis,Non-Cancer,1,the expression of mctla in skin lesion inversely correlate with the severity of psoriasis background psoriasis is a chronic inflammatory disease characterized by epidermal hyperplasia and increased t cell infiltration cytotoxic t lymphocyte antigen ctla is a key factor that affect t cell function and immune response however whether the expression of ctla affect the severity of psoriasis is still unknown objective the aim of the project wa to investigate the correlation between the expression of ctla and the severity of psoriasis method the plasma soluble ctla level and membrane ctla expression were measured by enzymelinked immunosorbent assay and immunohistochemistry analysis in mild moderate and severe psoriasis patient respectively imiquimodinduced mouse model of psoriasis wa treated with ctla immunoglobulin fusion protein ctla ig or antictla antibody epidermal thickness and infiltrating cd t cell count were evaluated result the plasma soluble ctla level had no significant difference among mild moderate and severe patient p however the membrane ctla expression in skin wa significantly higher in mild psoriasis patient compared to moderate and severe psoriasis patient v v p furthermore in imiquimodinduced mouse model of psoriasis the result showed that mimicking ctla function improved the skin phenotype and reduced epidermal thickness v mum n p a well a infiltrating cd t cell count v p compared to control group however blocking ctla function aggregated the skin phenotype including enhanced epidermal thickness and infiltrating cd t cell count compared to control group conclusion these result indicated that the expression of mctla in skin lesion inversely correlated with the severity of psoriasis and ctla might play a critical role in the disease severity of psoriasis
29330464,eltrombopag versus romiplostim in treatment of child with persistent or chronic immune thrombocytopenia a systematic review incorporating an indirectcomparison metaanalysis,in absence of direct comparison we conducted an indirectcomparison metaanalysis to evaluate the efficacy and safety of thrombopoietinreceptor agoniststporas in treatment of pediatric persistent or chronic immune thrombocytopeniaitp pubmed embase cochrane library clinical trialsgov china national knowledge infrastructure and chinese biomedical literature database were searched from their earliest record to may randomized controlled trial comparing the tporas with placebo in pediatric itp were included outcome included overall response rateprimary durable response overall or clinically significant bleeding the proportion of patient receiving rescue medication and safety five randomized placebocontrolled studiesn were analyzed the overall responserisk ratiorr confidence intervalci the incidence of adverse event rr ci durable responserr ci and the proportion of patient receiving rescue treatmentrr ci were similar between eltrombopag and romiplostim group nevertheless eltrombopag might have lower risk of overall bleedingrr ci and clinically significant bleedingrr ci than romiplostim this metaanalysis suggests that eltrombopag might be similar to romiplostim in efficacy and safety but seems to reduce the risk of bleeding compared to romiplostim furthermore cost of the treatment comorbidity of patient and drug compliance should also be considered in clinical decision making,Non-Cancer,1,eltrombopag versus romiplostim in treatment of child with persistent or chronic immune thrombocytopenia a systematic review incorporating an indirectcomparison metaanalysis in absence of direct comparison we conducted an indirectcomparison metaanalysis to evaluate the efficacy and safety of thrombopoietinreceptor agoniststporas in treatment of pediatric persistent or chronic immune thrombocytopeniaitp pubmed embase cochrane library clinical trialsgov china national knowledge infrastructure and chinese biomedical literature database were searched from their earliest record to may randomized controlled trial comparing the tporas with placebo in pediatric itp were included outcome included overall response rateprimary durable response overall or clinically significant bleeding the proportion of patient receiving rescue medication and safety five randomized placebocontrolled studiesn were analyzed the overall responserisk ratiorr confidence intervalci the incidence of adverse event rr ci durable responserr ci and the proportion of patient receiving rescue treatmentrr ci were similar between eltrombopag and romiplostim group nevertheless eltrombopag might have lower risk of overall bleedingrr ci and clinically significant bleedingrr ci than romiplostim this metaanalysis suggests that eltrombopag might be similar to romiplostim in efficacy and safety but seems to reduce the risk of bleeding compared to romiplostim furthermore cost of the treatment comorbidity of patient and drug compliance should also be considered in clinical decision making
29331029,characterization of cd hematopoietic cell in systemic mastocytosis potential role in disease dissemination,background recent study show that most systemic mastocytosis sm patient including indolent sm ism with ism and without skin lesion ism carry the kit dv mutation in pb leukocyte we investigated the potential association between the degree of involvement of bm hematopoiesis by the kit dv mutation and the distribution of different maturationassociated compartment of bone marrow bm and peripheral blood pb cd hematopoietic precursor hpc in ism and identified the specific pb cell compartment that carry this mutation method the distribution of different maturationassociated subset of bm and pb cd hpc from newly diagnosed kitmutated ism patient and healthy control wa analyzed by flow cytometry in patient distinct facspurified pb cell compartment were also investigated for the kit mutation result ism patient showed higher percentage of both bm and pb mccommitted cd hpc v control particularly among ism case with mcrestricted kit mutation ismmc this wa associated with progressive blockade of maturation of cd hpc to the neutrophil lineage from ismmc to multilineage kitmutated case ismml regarding the frequency of kitmutated case and cell population in pb variable pattern were observed the percentage of kitmutated pb cd hpc eosinophil neutrophil monocyte and t cell increasing from ismsmc and ismsmc to ismml patient conclusion the presence of the kit dv mutation in pb of ism patient is associated with early involvement of circulating cd hpc and multiple myeloid cell subpopulation kitmutated pb cd hpc potentially contributing to early dissemination of the disease,Non-Cancer,1,characterization of cd hematopoietic cell in systemic mastocytosis potential role in disease dissemination background recent study show that most systemic mastocytosis sm patient including indolent sm ism with ism and without skin lesion ism carry the kit dv mutation in pb leukocyte we investigated the potential association between the degree of involvement of bm hematopoiesis by the kit dv mutation and the distribution of different maturationassociated compartment of bone marrow bm and peripheral blood pb cd hematopoietic precursor hpc in ism and identified the specific pb cell compartment that carry this mutation method the distribution of different maturationassociated subset of bm and pb cd hpc from newly diagnosed kitmutated ism patient and healthy control wa analyzed by flow cytometry in patient distinct facspurified pb cell compartment were also investigated for the kit mutation result ism patient showed higher percentage of both bm and pb mccommitted cd hpc v control particularly among ism case with mcrestricted kit mutation ismmc this wa associated with progressive blockade of maturation of cd hpc to the neutrophil lineage from ismmc to multilineage kitmutated case ismml regarding the frequency of kitmutated case and cell population in pb variable pattern were observed the percentage of kitmutated pb cd hpc eosinophil neutrophil monocyte and t cell increasing from ismsmc and ismsmc to ismml patient conclusion the presence of the kit dv mutation in pb of ism patient is associated with early involvement of circulating cd hpc and multiple myeloid cell subpopulation kitmutated pb cd hpc potentially contributing to early dissemination of the disease
29339522,effect of betaagonists on lam progression and treatment,lymphangioleiomyomatosis lam a rare disease of woman is associated with cystic lung destruction resulting from the proliferation of abnormal smooth musclelike lam cell with mutation in the tuberous sclerosis complex tsc gene tsc andor tsc the mutant gene and encoded protein are responsible for activation of the mechanistic target of rapamycin mtor which is inhibited by sirolimus rapamycin a drug used to treat lam patient who have lam may also be treated with bronchodilator for asthmalike symptom due to lam we observed stabilization of forced expiratory volume in s over time in patient receiving sirolimus and longacting betaagonists with shortacting rescue inhaler compared with patient receiving only sirolimus because betaagonists increase camp and pka activity we investigated effect of pka activation on the mtor pathway human skin tsc fibroblast or lam lung cell incubated shortterm with isoproterenol betaagonist showed a sirolimusindependent increase in phosphorylation of s a downstream effector of the mtor pathway and increased cell growth cell incubated longterm with isoproterenol which may lead to betaadrenergic receptor desensitization did not show increased s phosphorylation inhibition of pka blocked the isoproterenol effect on s phosphorylation thus activation of pka by betaagonists increased phosphos independent of mtor an effect abrogated by betaagonistdriven receptor desensitization in agreement retrospective clinical data from patient with lam suggested that a combination of bronchodilator in conjunction with sirolimus may be preferable to sirolimus alone for stabilization of pulmonary function,Non-Cancer,1,effect of betaagonists on lam progression and treatment lymphangioleiomyomatosis lam a rare disease of woman is associated with cystic lung destruction resulting from the proliferation of abnormal smooth musclelike lam cell with mutation in the tuberous sclerosis complex tsc gene tsc andor tsc the mutant gene and encoded protein are responsible for activation of the mechanistic target of rapamycin mtor which is inhibited by sirolimus rapamycin a drug used to treat lam patient who have lam may also be treated with bronchodilator for asthmalike symptom due to lam we observed stabilization of forced expiratory volume in s over time in patient receiving sirolimus and longacting betaagonists with shortacting rescue inhaler compared with patient receiving only sirolimus because betaagonists increase camp and pka activity we investigated effect of pka activation on the mtor pathway human skin tsc fibroblast or lam lung cell incubated shortterm with isoproterenol betaagonist showed a sirolimusindependent increase in phosphorylation of s a downstream effector of the mtor pathway and increased cell growth cell incubated longterm with isoproterenol which may lead to betaadrenergic receptor desensitization did not show increased s phosphorylation inhibition of pka blocked the isoproterenol effect on s phosphorylation thus activation of pka by betaagonists increased phosphos independent of mtor an effect abrogated by betaagonistdriven receptor desensitization in agreement retrospective clinical data from patient with lam suggested that a combination of bronchodilator in conjunction with sirolimus may be preferable to sirolimus alone for stabilization of pulmonary function
29357781,dynamic dosing of romiplostim in patient with immune thrombocytopenia purpura two case report,romiplostim is a thrombopoietin receptor agonist approved for the treatment of immune thrombocytopenia purpura when following fdaapproved romiplostim prescribing recommendation to withhold treatment for platelet count above kmicrol some patient exhibit a precipitous decline in their platelet count potentially causing patient harm we present two case where stable platelet count were achieved only through persistent weekly dosing of romiplostim despite platelet count above kmicrol on the day of administration therefore continuous weekly dosing of romiplostim despite platelet count being above kmicrol combined with twice weekly vigilant monitoring is an alternative method of romiplostim dosing that mitigates severe fluctuation in platelet we also discus important detail postulated mechanism and evidencebased mitigation strategy,Non-Cancer,1,dynamic dosing of romiplostim in patient with immune thrombocytopenia purpura two case report romiplostim is a thrombopoietin receptor agonist approved for the treatment of immune thrombocytopenia purpura when following fdaapproved romiplostim prescribing recommendation to withhold treatment for platelet count above kmicrol some patient exhibit a precipitous decline in their platelet count potentially causing patient harm we present two case where stable platelet count were achieved only through persistent weekly dosing of romiplostim despite platelet count above kmicrol on the day of administration therefore continuous weekly dosing of romiplostim despite platelet count being above kmicrol combined with twice weekly vigilant monitoring is an alternative method of romiplostim dosing that mitigates severe fluctuation in platelet we also discus important detail postulated mechanism and evidencebased mitigation strategy
29370381,ablation of grb specifically in muscle impact muscle size and glucose metabolism in mouse,grb is an adaptortype signaling protein most highly expressed in tissue involved in insulin action and glucose metabolism such a muscle pancreas and adipose germline deletion of grb in mouse creates a phenotype with larger muscle and improved glucose homeostasis however it ha not been determined whether grb ablation specifically in muscle is sufficient to induce hypermuscularity or affect whole body glucose metabolism in this study we generated musclespecific grbdeficient mouse grbmko by crossing grbfloxflox mouse with mouse expressing cre recombinase under control of the human alphaskeletal actin promoter oneyearold grbmko mouse had enlarged muscle with greater crosssectional area of fiber compared with wildtype wt mouse this degree of hypermuscularity did not affect whole body glucose homeostasis under basal condition however hyperinsulinemiceuglycemic clamp study revealed that grbmko mouse had greater glucose uptake into muscle compared with wt mouse insulin signaling wa increased at the level of phosphoakt in muscle of grbmko mouse compared with wt mouse consistent with a role of grb a a modulator of proximal insulin receptor signaling we conclude that ablation of grb in muscle is sufficient to affect muscle size and metabolism supporting an important role for this protein in growth and metabolic pathway,Non-Cancer,1,ablation of grb specifically in muscle impact muscle size and glucose metabolism in mouse grb is an adaptortype signaling protein most highly expressed in tissue involved in insulin action and glucose metabolism such a muscle pancreas and adipose germline deletion of grb in mouse creates a phenotype with larger muscle and improved glucose homeostasis however it ha not been determined whether grb ablation specifically in muscle is sufficient to induce hypermuscularity or affect whole body glucose metabolism in this study we generated musclespecific grbdeficient mouse grbmko by crossing grbfloxflox mouse with mouse expressing cre recombinase under control of the human alphaskeletal actin promoter oneyearold grbmko mouse had enlarged muscle with greater crosssectional area of fiber compared with wildtype wt mouse this degree of hypermuscularity did not affect whole body glucose homeostasis under basal condition however hyperinsulinemiceuglycemic clamp study revealed that grbmko mouse had greater glucose uptake into muscle compared with wt mouse insulin signaling wa increased at the level of phosphoakt in muscle of grbmko mouse compared with wt mouse consistent with a role of grb a a modulator of proximal insulin receptor signaling we conclude that ablation of grb in muscle is sufficient to affect muscle size and metabolism supporting an important role for this protein in growth and metabolic pathway
29385279,chronic lymphoproliferative disorder of nkcells a singleinstitution review with emphasis on relative utility of multimodality diagnostic tool,background chronic lymphoproliferative disorder of nkcells clpdnk manifest a a persistent increase x l for month of mature nkcells in peripheral blood with an indolent clinical course the disease is rare and only limited case series have been published method we retrospectively studied patient with clpdnk diagnosed at our institution between and result patient included men and woman with a median age of year range year ten patient had cytopenia bone marrow involvement by clpdnk ranged from the most commonly detected antigenic aberrancy by low cytometry immunophenotyping were a follows cddecreaseddim cduniform cdpartial cdbright and kir restriction jakstat pathway mutation were detected in of patient and involved stat n and jak n the presence of mutation tended to correlate with the occurrence of other cytopenia anemiathrombocytopenia and requirement for treatment seven patient received singleagent therapy with amelioration of symptom patient were observed there were no diseaseassociated death or progression to more aggressive disease during the followup interval median month conclusion patient with clpdnk have an indolent clinical course and frequent hematologic manifestation that are responsive to singleagent therapy mutation in stat are common and portend more pronounced clinical manifestation,Non-Cancer,1,chronic lymphoproliferative disorder of nkcells a singleinstitution review with emphasis on relative utility of multimodality diagnostic tool background chronic lymphoproliferative disorder of nkcells clpdnk manifest a a persistent increase x l for month of mature nkcells in peripheral blood with an indolent clinical course the disease is rare and only limited case series have been published method we retrospectively studied patient with clpdnk diagnosed at our institution between and result patient included men and woman with a median age of year range year ten patient had cytopenia bone marrow involvement by clpdnk ranged from the most commonly detected antigenic aberrancy by low cytometry immunophenotyping were a follows cddecreaseddim cduniform cdpartial cdbright and kir restriction jakstat pathway mutation were detected in of patient and involved stat n and jak n the presence of mutation tended to correlate with the occurrence of other cytopenia anemiathrombocytopenia and requirement for treatment seven patient received singleagent therapy with amelioration of symptom patient were observed there were no diseaseassociated death or progression to more aggressive disease during the followup interval median month conclusion patient with clpdnk have an indolent clinical course and frequent hematologic manifestation that are responsive to singleagent therapy mutation in stat are common and portend more pronounced clinical manifestation
29411231,analysis of chronic granulomatous disease in the kavkazi population in israel reveals phenotypic heterogeneity in patient with the same ncf mutation cga,purpose chronic granulomatous disease cgd is an innate immune deficiency disorder of phagocyte resulting from mutation in the component of the nadph oxidase complex that impair the synthesis of oxygen radical thus rendering patient susceptible to recurrent infection and excessive hyperinflammatory response the most common autosomal recessive form of cgd is pphox deficiency which is often clinically milder than the more common xlinked recessive form here we report data on genetics clinical and biochemical finding in cgd patient of kavkazi origin with the nonsense mutation cga in the ncf gene leading to pphox deficiency method diagnosis wa based on detailed clinical evaluation respiratory burst activity by cytochrome c reduction and dihydrorhodamine dhr assay by flow cytometry expression of pphox by immunoblotting and molecular confirmation by dna sequence analysis result twelve male and five female patient with median age at onset of year range day to year were included in the study the present cohort display an encouraging overall longterm survival with median followup of year clinical manifestation varied from mild to severe expression of the disease correlation between genotype and phenotype is unpredictable although the kavkazi patient were more severely affected than other patient with pphox deficiency conclusion kavkazi cgd patient harbor a common genetic mutation that is associated with a heterogeneous clinical phenotype early diagnosis and proper clinical management in an experienced phagocytic leukocyte center is imperative to ensure favorable patient outcome new treatment strategy are ongoing but result are not yet conclusive,Non-Cancer,1,analysis of chronic granulomatous disease in the kavkazi population in israel reveals phenotypic heterogeneity in patient with the same ncf mutation cga purpose chronic granulomatous disease cgd is an innate immune deficiency disorder of phagocyte resulting from mutation in the component of the nadph oxidase complex that impair the synthesis of oxygen radical thus rendering patient susceptible to recurrent infection and excessive hyperinflammatory response the most common autosomal recessive form of cgd is pphox deficiency which is often clinically milder than the more common xlinked recessive form here we report data on genetics clinical and biochemical finding in cgd patient of kavkazi origin with the nonsense mutation cga in the ncf gene leading to pphox deficiency method diagnosis wa based on detailed clinical evaluation respiratory burst activity by cytochrome c reduction and dihydrorhodamine dhr assay by flow cytometry expression of pphox by immunoblotting and molecular confirmation by dna sequence analysis result twelve male and five female patient with median age at onset of year range day to year were included in the study the present cohort display an encouraging overall longterm survival with median followup of year clinical manifestation varied from mild to severe expression of the disease correlation between genotype and phenotype is unpredictable although the kavkazi patient were more severely affected than other patient with pphox deficiency conclusion kavkazi cgd patient harbor a common genetic mutation that is associated with a heterogeneous clinical phenotype early diagnosis and proper clinical management in an experienced phagocytic leukocyte center is imperative to ensure favorable patient outcome new treatment strategy are ongoing but result are not yet conclusive
29428355,dissecting wnt signaling for melanocyte regulation during wound healing,abnormal pigmentation is commonly seen in the wound scar despite advancement in the research of wound healing little is known about the repopulation of melanocyte in the healed skin previous study have shown the capacity of melanocyte stem cell in the hair follicle to contribute skin epidermal melanocyte after injury in mouse and human here we focused on the wnt pathway known to be a vital regulator of melanocyte stem cell in effort to better understand the regulation of folliclederived epidermal melanocyte during wound healing we showed that transgenic expression of wnt inhibitor dkk in melanocyte reduced epidermal melanocyte in the wound scar conversely forced activation of wnt signaling by genetically stabilizing betacatenin in melanocyte increase epidermal melanocyte furthermore we show that deletion of wntless wls a gene required for wnt ligand secretion within epithelial cell result in failure in activating wnt signaling in adjacent epidermal melanocyte these result show the essential function of extrinsic wnt ligand in initiating wnt signaling in folliclederived epidermal melanocyte during wound healing collectively our result suggest the potential for wnt signal regulation to promote melanocyte regeneration and provide a potential molecular window to promote proper melanocyte regeneration after wounding and in condition such a vitiligo,Non-Cancer,1,dissecting wnt signaling for melanocyte regulation during wound healing abnormal pigmentation is commonly seen in the wound scar despite advancement in the research of wound healing little is known about the repopulation of melanocyte in the healed skin previous study have shown the capacity of melanocyte stem cell in the hair follicle to contribute skin epidermal melanocyte after injury in mouse and human here we focused on the wnt pathway known to be a vital regulator of melanocyte stem cell in effort to better understand the regulation of folliclederived epidermal melanocyte during wound healing we showed that transgenic expression of wnt inhibitor dkk in melanocyte reduced epidermal melanocyte in the wound scar conversely forced activation of wnt signaling by genetically stabilizing betacatenin in melanocyte increase epidermal melanocyte furthermore we show that deletion of wntless wls a gene required for wnt ligand secretion within epithelial cell result in failure in activating wnt signaling in adjacent epidermal melanocyte these result show the essential function of extrinsic wnt ligand in initiating wnt signaling in folliclederived epidermal melanocyte during wound healing collectively our result suggest the potential for wnt signal regulation to promote melanocyte regeneration and provide a potential molecular window to promote proper melanocyte regeneration after wounding and in condition such a vitiligo
29437806,rhabdomyolysis in stuvewiedemann syndrome,a monthold male infant with stuvewiedemann syndrome sw presented with an acute respiratory arrest secondary to a rhinovirus respiratory infection from which he wa rapidly resuscitated he developed an acute kidney injury requiring supportive treatment and on day of his illness wa noted to have developed severe rhabdomyolysis creatine kinase level ul normal ul he wa born from consanguineous parent with homozygous mutation in the leukaemia inhibitory factor receptor he had skeletal dysplasia with metabolic bone disease and episode of hyperthermia with lactic acidosis he also had paroxysmal ventricular tachycardia treated with prophylactic propranolol this is a case report of a child with sw who had a febrile illness and epileptic seizure which led to severe rhabdomyolysis outside the context of anaesthesia and we would like to draw the attention of clinician to this potential complication,Non-Cancer,1,rhabdomyolysis in stuvewiedemann syndrome a monthold male infant with stuvewiedemann syndrome sw presented with an acute respiratory arrest secondary to a rhinovirus respiratory infection from which he wa rapidly resuscitated he developed an acute kidney injury requiring supportive treatment and on day of his illness wa noted to have developed severe rhabdomyolysis creatine kinase level ul normal ul he wa born from consanguineous parent with homozygous mutation in the leukaemia inhibitory factor receptor he had skeletal dysplasia with metabolic bone disease and episode of hyperthermia with lactic acidosis he also had paroxysmal ventricular tachycardia treated with prophylactic propranolol this is a case report of a child with sw who had a febrile illness and epileptic seizure which led to severe rhabdomyolysis outside the context of anaesthesia and we would like to draw the attention of clinician to this potential complication
29458761,method to study dna end resection i recombinant protein purification,accurate repair of dna doublestrand break dsbs is carried out by homologous recombination in order to repair dna break by the recombination pathway the terminated dna strand at dsb site must be first nucleolytically processed to produce overhang the process is termed dna end resection and involves the interplay of several nuclease complex dna end resection commits dsb repair to the recombination pathway including a process termed singlestrand annealing a resected dna end are generally nonligatable by the competing nonhomologous endjoining machinery biochemical reconstitution experiment provided invaluable mechanistic insight into the dna end resection pathway in this chapter we describe preparation procedure of key protein involved in dna end resection in human cell including the mreradnbs complex phosphorylated variant of ctip the dna nucleasehelicase with it helicase partner bloom blm or werner wrn a well a the singlestranded dnabinding protein replication protein a the availability of recombinant dna end resection factor will help to further elucidate resection mechanism and regulatory process that may involve novel protein partner and posttranslational modification,Non-Cancer,1,method to study dna end resection i recombinant protein purification accurate repair of dna doublestrand break dsbs is carried out by homologous recombination in order to repair dna break by the recombination pathway the terminated dna strand at dsb site must be first nucleolytically processed to produce overhang the process is termed dna end resection and involves the interplay of several nuclease complex dna end resection commits dsb repair to the recombination pathway including a process termed singlestrand annealing a resected dna end are generally nonligatable by the competing nonhomologous endjoining machinery biochemical reconstitution experiment provided invaluable mechanistic insight into the dna end resection pathway in this chapter we describe preparation procedure of key protein involved in dna end resection in human cell including the mreradnbs complex phosphorylated variant of ctip the dna nucleasehelicase with it helicase partner bloom blm or werner wrn a well a the singlestranded dnabinding protein replication protein a the availability of recombinant dna end resection factor will help to further elucidate resection mechanism and regulatory process that may involve novel protein partner and posttranslational modification
29463272,colonic perineurioma benign fibroblastic polyp case report and review of the literature,background colorectal perineuriomas are uncommon benign mucosalbased proliferation of mesenchymal cell that express perineurial marker often associated with colonic crypt displaying a serratedhyperplastic architecture the vast majority of case arise distal to the splenic flexure and have been described a sessile polyp using molecular analysis braf mutation have been demonstrated in the serrated crypt epithelium we report a new case of perineurioma presenting a a pedunculated polyp in the transverse colon with prominent hemosiderin deposit in the uninvolved lamina propria that separated the perineurial proliferation from the surface epithelium a previously unreported histological finding by using immunohistochemistry we demonstrated the presence of braf ve mutated protein in the serrated crypt epithelium in addition a review of the literature on colorectal perineurioma is provided case presentation a mm pedunculated polyp wa removed from the transverse colon of a year old man who presented with epigastric pain weight loss and rectal bleeding a proliferation of uniform plump spindled cell expanded the lamina propria and separated serrated colonic crypt the epithelial component closely resembled microvesicular hyperplastic polyp immunohistochemical stain for epithelial membrane antigen ema glucose transporter glut and collagen iv were positive in the stromal proliferation a mutationspecific monoclonal antibody directed against braf ve showed positive cytoplasmic staining in the serrated crypt epithelium but not in the perineurial proliferation conspicuous hemosiderin deposition wa seen in the inflamed lamina propria between the perineurial proliferation and the surface epithelium conclusion although the majority of colorectal perineuriomas occur in the sigmoid colon and rectum and are described a sessile polyp colorectal perineurioma can present a a pedunculated polyp proximal to the splenic flexure a described in this case conspicuous hemosiderin deposition can be seen in the superficial lamina propria braf mutation are limited to the serrated crypt epithelium,Non-Cancer,1,colonic perineurioma benign fibroblastic polyp case report and review of the literature background colorectal perineuriomas are uncommon benign mucosalbased proliferation of mesenchymal cell that express perineurial marker often associated with colonic crypt displaying a serratedhyperplastic architecture the vast majority of case arise distal to the splenic flexure and have been described a sessile polyp using molecular analysis braf mutation have been demonstrated in the serrated crypt epithelium we report a new case of perineurioma presenting a a pedunculated polyp in the transverse colon with prominent hemosiderin deposit in the uninvolved lamina propria that separated the perineurial proliferation from the surface epithelium a previously unreported histological finding by using immunohistochemistry we demonstrated the presence of braf ve mutated protein in the serrated crypt epithelium in addition a review of the literature on colorectal perineurioma is provided case presentation a mm pedunculated polyp wa removed from the transverse colon of a year old man who presented with epigastric pain weight loss and rectal bleeding a proliferation of uniform plump spindled cell expanded the lamina propria and separated serrated colonic crypt the epithelial component closely resembled microvesicular hyperplastic polyp immunohistochemical stain for epithelial membrane antigen ema glucose transporter glut and collagen iv were positive in the stromal proliferation a mutationspecific monoclonal antibody directed against braf ve showed positive cytoplasmic staining in the serrated crypt epithelium but not in the perineurial proliferation conspicuous hemosiderin deposition wa seen in the inflamed lamina propria between the perineurial proliferation and the surface epithelium conclusion although the majority of colorectal perineuriomas occur in the sigmoid colon and rectum and are described a sessile polyp colorectal perineurioma can present a a pedunculated polyp proximal to the splenic flexure a described in this case conspicuous hemosiderin deposition can be seen in the superficial lamina propria braf mutation are limited to the serrated crypt epithelium
29478616,tuberous sclerosis complex,tuberous sclerosis complex tsc is an autosomaldominant or sporadic multisystem disorder that result from mutation in either tsc or tsc the primary organ affected include the brain skin lung kidney and heart all with variable frequency penetrance and severity there are over known allelic variant for tsc including nonsense and misssense mutation and all pathogenic mutation are inactivating leading to lossoffunction effect on the encoded protein tsc and tsc these protein form a complex to constitutively inhibit the mammalian target of rapamycin mtor signaling cascade and a a consequence mtor signaling is constitutively active within all tscassociated lesion the mtor inhibitor rapamycin sirolimus and everolimus have been shown to reduce renal and brain lesion size and improve pulmonary function in tsc and these compound may also decrease seizure frequency the clinical application of mtor inhibitor in tsc ha provided one of the first example of precision medicine in a neurodevelopmental disorder,Non-Cancer,1,tuberous sclerosis complex tuberous sclerosis complex tsc is an autosomaldominant or sporadic multisystem disorder that result from mutation in either tsc or tsc the primary organ affected include the brain skin lung kidney and heart all with variable frequency penetrance and severity there are over known allelic variant for tsc including nonsense and misssense mutation and all pathogenic mutation are inactivating leading to lossoffunction effect on the encoded protein tsc and tsc these protein form a complex to constitutively inhibit the mammalian target of rapamycin mtor signaling cascade and a a consequence mtor signaling is constitutively active within all tscassociated lesion the mtor inhibitor rapamycin sirolimus and everolimus have been shown to reduce renal and brain lesion size and improve pulmonary function in tsc and these compound may also decrease seizure frequency the clinical application of mtor inhibitor in tsc ha provided one of the first example of precision medicine in a neurodevelopmental disorder
29493003,phosphatidylinositolbisphosphate kinase catalytic subunit alpha pikcarelated overgrowth spectrum a brief report,a patient with extensive multisystem overgrowth caused by a somatic gain of function pikcamutation is described this case is an example of the clinical diversity of the pikcarelated overgrowth spectrum pro a the patient had overlapping feature of congenital lipomatous overgrowth vascular malformation epidermal nevus and skeletal abnormality clove syndrome and megalencephalycapillary malformation polymicrogyria mcap syndrome and underline the utility of this umbrella term,Non-Cancer,1,phosphatidylinositolbisphosphate kinase catalytic subunit alpha pikcarelated overgrowth spectrum a brief report a patient with extensive multisystem overgrowth caused by a somatic gain of function pikcamutation is described this case is an example of the clinical diversity of the pikcarelated overgrowth spectrum pro a the patient had overlapping feature of congenital lipomatous overgrowth vascular malformation epidermal nevus and skeletal abnormality clove syndrome and megalencephalycapillary malformation polymicrogyria mcap syndrome and underline the utility of this umbrella term
29519755,osteopontindeficient progenitor cell display enhanced differentiation to adipocytes,objective osteopontin opn spp is a protein upregulated in white adipose tissue wat of obese subject deletion of opn protects mouse from highfat dietinduced wat inflammation and insulin resistance however the alteration mediated by loss of opn in wat before the obesogenic challenge have not yet been investigated therefore we hypothesised that the lack of opn might enhance the proadipogenic micro environment before obesity driven inflammation method opn deficiency wa tested in visceral v and subcutaneous sc wat from wt and spp female mouse gene expression for hypoxia inflammation and adipogenesis wa checked in wt v spp mouse n adipocytes progenitor cell apc were isolated by fluorescence cell sorting and role of opn deficiency in adipogenesis wa investigated by cell image and rtpcr result we show that spp maintained normal body and fatpad weight although hypoxia and inflammation marker were significantly reduced in contrast expression of gene involved in adipogenesis wa increased in wat from spp mouse strikingly apc from spp were diminished but differentiated more efficiently to adipocytes than those from control mouse conclusion apc from scwat of lean opndeficient mouse display an enhanced capacity for differentiating to adipocytes these alteration may explain the healthy expansion of wat in the opndeficient model which is associated with reduced inflammation and insulin resistance,Non-Cancer,1,osteopontindeficient progenitor cell display enhanced differentiation to adipocytes objective osteopontin opn spp is a protein upregulated in white adipose tissue wat of obese subject deletion of opn protects mouse from highfat dietinduced wat inflammation and insulin resistance however the alteration mediated by loss of opn in wat before the obesogenic challenge have not yet been investigated therefore we hypothesised that the lack of opn might enhance the proadipogenic micro environment before obesity driven inflammation method opn deficiency wa tested in visceral v and subcutaneous sc wat from wt and spp female mouse gene expression for hypoxia inflammation and adipogenesis wa checked in wt v spp mouse n adipocytes progenitor cell apc were isolated by fluorescence cell sorting and role of opn deficiency in adipogenesis wa investigated by cell image and rtpcr result we show that spp maintained normal body and fatpad weight although hypoxia and inflammation marker were significantly reduced in contrast expression of gene involved in adipogenesis wa increased in wat from spp mouse strikingly apc from spp were diminished but differentiated more efficiently to adipocytes than those from control mouse conclusion apc from scwat of lean opndeficient mouse display an enhanced capacity for differentiating to adipocytes these alteration may explain the healthy expansion of wat in the opndeficient model which is associated with reduced inflammation and insulin resistance
29525761,rare case of thoracic endometriosis presenting with lung nodule and pneumothorax,we present the case of a yearold nigerian woman who wa referred to the respiratory team with a month history of breathlessness she wa concurrently being investigated for an abdominal mass and rectal and vaginal bleeding consequently she underwent crosssectional imaging of her chest abdomen and pelvis revealing a small rightsided pneumothorax and right lower lobe pleuralbased lesion shortly thereafter she wa admitted to the hospital with chest pain and required chest drain insertion this partially treated her pneumothorax but she required referral to a cardiothoracic centre for definitive diagnosis and to manage her nonresolving pneumothorax biopsy from the videoassisted thoracoscopic surgery confirmed the very rare diagnosis of thoracic endometriosis,Non-Cancer,1,rare case of thoracic endometriosis presenting with lung nodule and pneumothorax we present the case of a yearold nigerian woman who wa referred to the respiratory team with a month history of breathlessness she wa concurrently being investigated for an abdominal mass and rectal and vaginal bleeding consequently she underwent crosssectional imaging of her chest abdomen and pelvis revealing a small rightsided pneumothorax and right lower lobe pleuralbased lesion shortly thereafter she wa admitted to the hospital with chest pain and required chest drain insertion this partially treated her pneumothorax but she required referral to a cardiothoracic centre for definitive diagnosis and to manage her nonresolving pneumothorax biopsy from the videoassisted thoracoscopic surgery confirmed the very rare diagnosis of thoracic endometriosis
29535107,diagnosis of sporadic neurofibromatosis type in the paediatric population,objective onset of symptom in severe sporadic neurofibromatosis type nf is typically within childhood however there is poor awareness of presenting feature in young child potentially resulting in delayed diagnosis and poorer outcome we have reviewed presentation of sporadic paediatric nf to raise awareness of early feature highlighting those requiring further investigation design patient diagnosed with nf at age atypical feature including cerebellar hypoplasia in three case and focal cortical dysplasia in five out of seven seizurerelated presentation five case presented with a sometimes transient or intermittent cranial nerve mononeuropathy the mean delay to diagnosis wa year in eight case this exceeded year most significant delay occurred in mononeuropathy ophthalmological andor seizure presentation with a mean delay of and year respectively eightyfour per cent of case needed intervention in childhood conclusion all nonvestibular schwannoma nf presentation in childhood had significant diagnostic delay we emphasise the importance of detailed assessment of skin and eye in unusual presentation and propose an aide to prompt timely referral to specialist service,Non-Cancer,1,diagnosis of sporadic neurofibromatosis type in the paediatric population objective onset of symptom in severe sporadic neurofibromatosis type nf is typically within childhood however there is poor awareness of presenting feature in young child potentially resulting in delayed diagnosis and poorer outcome we have reviewed presentation of sporadic paediatric nf to raise awareness of early feature highlighting those requiring further investigation design patient diagnosed with nf at age atypical feature including cerebellar hypoplasia in three case and focal cortical dysplasia in five out of seven seizurerelated presentation five case presented with a sometimes transient or intermittent cranial nerve mononeuropathy the mean delay to diagnosis wa year in eight case this exceeded year most significant delay occurred in mononeuropathy ophthalmological andor seizure presentation with a mean delay of and year respectively eightyfour per cent of case needed intervention in childhood conclusion all nonvestibular schwannoma nf presentation in childhood had significant diagnostic delay we emphasise the importance of detailed assessment of skin and eye in unusual presentation and propose an aide to prompt timely referral to specialist service
29540686,a nonconserved amino acid variant regulates differential signalling between human and mouse cd,cd superagonistic antibody cdsab can preferentially activate and expand immunosuppressive regulatory t cell treg in mouse however preclinical trial assessing cdsabs for the therapy of autoimmune disease reveal severe systemic inflammatory response syndrome in human thereby implying the existence of distinct signalling ability between human and mouse cd here we show that a single amino acid variant within the cterminal prolinerich motif of human and mouse cd p in human v a in mouse regulates cdinduced nfkappab activation and proinflammatory cytokine gene expression moreover this yapp sequence in human is crucial for the association of cd with the nck adaptor protein for actin cytoskeleton reorganisation event necessary for cd autonomous signalling this study thus unveils different outcome between human and mouse cd signalling to underscore the importance of specie difference when transferring result from preclinical model to the bedside,Non-Cancer,1,a nonconserved amino acid variant regulates differential signalling between human and mouse cd cd superagonistic antibody cdsab can preferentially activate and expand immunosuppressive regulatory t cell treg in mouse however preclinical trial assessing cdsabs for the therapy of autoimmune disease reveal severe systemic inflammatory response syndrome in human thereby implying the existence of distinct signalling ability between human and mouse cd here we show that a single amino acid variant within the cterminal prolinerich motif of human and mouse cd p in human v a in mouse regulates cdinduced nfkappab activation and proinflammatory cytokine gene expression moreover this yapp sequence in human is crucial for the association of cd with the nck adaptor protein for actin cytoskeleton reorganisation event necessary for cd autonomous signalling this study thus unveils different outcome between human and mouse cd signalling to underscore the importance of specie difference when transferring result from preclinical model to the bedside
29545013,clinic pathogenic mechanism and drug testing of two inherited thrombocytopenia ankrdrelated thrombocytopenia and myhrelated disease,inherited thrombocytopenia it are a heterogeneous group of disorder characterized by low platelet count resulting in impaired hemostasis patient can have spontaneous hemorrhage andor excessive bleeding provoked by hemostatic challenge a trauma or surgery to date it encompass different rare monogenic disorder caused by mutation of gene this review will focus on the major discovery that have been made in the last year on the diagnosis treatment and molecular mechanism of ankrdrelated thrombocytopenia and myhrelated disease furthermore we will discus the use a thrombopoietin mimetic a a novel approach to treat the thrombocytopenia in these patient we will propose the use of a new d bone marrow model to study the mechanism of action of these drug and to test their efficacy and safety in patient the overall purpose of this review is to point out that important progress have been made in understanding the pathogenesis of ankrdrelated thrombocytopenia and myhrelated disease and new therapeutic approach have been proposed and tested future advancement in this research will rely in the development of more physiological model to study the regulation of human platelet biogenesis disease mechanism and specific pharmacologic target,Non-Cancer,1,clinic pathogenic mechanism and drug testing of two inherited thrombocytopenia ankrdrelated thrombocytopenia and myhrelated disease inherited thrombocytopenia it are a heterogeneous group of disorder characterized by low platelet count resulting in impaired hemostasis patient can have spontaneous hemorrhage andor excessive bleeding provoked by hemostatic challenge a trauma or surgery to date it encompass different rare monogenic disorder caused by mutation of gene this review will focus on the major discovery that have been made in the last year on the diagnosis treatment and molecular mechanism of ankrdrelated thrombocytopenia and myhrelated disease furthermore we will discus the use a thrombopoietin mimetic a a novel approach to treat the thrombocytopenia in these patient we will propose the use of a new d bone marrow model to study the mechanism of action of these drug and to test their efficacy and safety in patient the overall purpose of this review is to point out that important progress have been made in understanding the pathogenesis of ankrdrelated thrombocytopenia and myhrelated disease and new therapeutic approach have been proposed and tested future advancement in this research will rely in the development of more physiological model to study the regulation of human platelet biogenesis disease mechanism and specific pharmacologic target
29549173,clinical spectrum of pyruvate kinase deficiency data from the pyruvate kinase deficiency natural history study,an international multicenter registry wa established to collect retrospective and prospective clinical data on patient with pyruvate kinase pk deficiency the most common glycolytic defect causing congenital nonspherocytic hemolytic anemia medical history and laboratory and radiologic data were retrospectively collected at enrollment for patient with molecularly confirmed pk deficiency perinatal complication were common including anemia that required transfusion hyperbilirubinemia hydrops and prematurity nearly all newborn were treated with phototherapy and many were treated with exchange transfusion child age year and younger were often transfused until splenectomy splenectomy of patient wa associated with a median increase in hemoglobin of gdl and a decreased transfusion burden in of patient predictor of a response to splenectomy included higher presplenectomy hemoglobin p lower indirect bilirubin p and missense pklr mutation p postsplenectomy thrombosis wa reported in of patient the most frequent complication included iron overload and gallstone but other complication such a aplastic crisis osteopeniabone fragility extramedullary hematopoiesis postsplenectomy sepsis pulmonary hypertension and leg ulcer were not uncommon overall of patient had both a splenectomy and cholecystectomy in those who had a splenectomy without simultaneous cholecystectomy later required a cholecystectomy although the risk of complication increase with severity of anemia and a genotypephenotype relationship wa observed complication were common in all patient with pk deficiency diagnostic testing for pk deficiency should be considered in patient with apparent congenital hemolytic anemia and close monitoring for iron overload gallstone and other complication is needed regardless of baseline hemoglobin this trial wa registered at wwwclinicaltrialsgov a nct,Non-Cancer,1,clinical spectrum of pyruvate kinase deficiency data from the pyruvate kinase deficiency natural history study an international multicenter registry wa established to collect retrospective and prospective clinical data on patient with pyruvate kinase pk deficiency the most common glycolytic defect causing congenital nonspherocytic hemolytic anemia medical history and laboratory and radiologic data were retrospectively collected at enrollment for patient with molecularly confirmed pk deficiency perinatal complication were common including anemia that required transfusion hyperbilirubinemia hydrops and prematurity nearly all newborn were treated with phototherapy and many were treated with exchange transfusion child age year and younger were often transfused until splenectomy splenectomy of patient wa associated with a median increase in hemoglobin of gdl and a decreased transfusion burden in of patient predictor of a response to splenectomy included higher presplenectomy hemoglobin p lower indirect bilirubin p and missense pklr mutation p postsplenectomy thrombosis wa reported in of patient the most frequent complication included iron overload and gallstone but other complication such a aplastic crisis osteopeniabone fragility extramedullary hematopoiesis postsplenectomy sepsis pulmonary hypertension and leg ulcer were not uncommon overall of patient had both a splenectomy and cholecystectomy in those who had a splenectomy without simultaneous cholecystectomy later required a cholecystectomy although the risk of complication increase with severity of anemia and a genotypephenotype relationship wa observed complication were common in all patient with pk deficiency diagnostic testing for pk deficiency should be considered in patient with apparent congenital hemolytic anemia and close monitoring for iron overload gallstone and other complication is needed regardless of baseline hemoglobin this trial wa registered at wwwclinicaltrialsgov a nct
29550597,buckling collapse of midcervical spine secondary to neurofibromatosis,buckling collapse is the term typically used to describe severe kyphosis degree characteristically seen in thoracolumbar tuberculosis neurofibromatosis is rarely associated with severe cervical kyphosis dystrophic change in vertebra make surgical correction and fusion challenging singlestage cervical osteotomy eg pedicle subtraction osteotomy vertebral column resection are commonly done in cervicothoracic junction however it is technically challenging and associated with high risk of vertebral artery injury neural injury etc when performed in higher cervical spine hence in our case we did a staged procedure performing circumferential osteotomy for buckling kyphosis in the midcervical spine because it involved midcervical spine and there wa no chintochest deformity we preferred the anteriorposterioranterior sequence,Non-Cancer,1,buckling collapse of midcervical spine secondary to neurofibromatosis buckling collapse is the term typically used to describe severe kyphosis degree characteristically seen in thoracolumbar tuberculosis neurofibromatosis is rarely associated with severe cervical kyphosis dystrophic change in vertebra make surgical correction and fusion challenging singlestage cervical osteotomy eg pedicle subtraction osteotomy vertebral column resection are commonly done in cervicothoracic junction however it is technically challenging and associated with high risk of vertebral artery injury neural injury etc when performed in higher cervical spine hence in our case we did a staged procedure performing circumferential osteotomy for buckling kyphosis in the midcervical spine because it involved midcervical spine and there wa no chintochest deformity we preferred the anteriorposterioranterior sequence
29557343,chemotherapyrelated cardiac dysfunction a systematic review of genetic variant modulating individual risk,chemotherapyrelated cardiac dysfunction is a significant side effect of anticancer treatment risk stratification is based on clinical and treatmentrelated risk factor that do not adequately explain individual susceptibility the addition of genetic variant may improve risk assessment we conducted a systematic literature search in pubmed and embase to identify study investigating genetic risk factor for chemotherapyrelated cardiac dysfunction included were article describing genetic variant in human altering susceptibility to chemotherapyrelated cardiac dysfunction the validity of identified study wa assessed by criterion including assessment of population stratification statistical methodology and replication of finding we identified study exploring genetic risk factor for anthracyclineinduced cardiotoxicity n and study related to trastuzumabassociated cardiotoxicity n the majority of study had a candidate gene approach whereas genomewide association study have been performed we identified genetic variant in gene and intergenic variant reported significant at least once the overall validity of study wa limited with small cohort failure to assess population ancestry and lack of replication snp with the most robust evidence up to this point are celf r sarcomere structure and function rarg r topoisomerasebeta expression slca r drug transport ugta r drug metabolism and intergenic variant r existing evidence support the hypothesis that genetic variation contributes to chemotherapyrelated cardiac dysfunction although many variant identified by this systematic review show potential to improve risk stratification future study are necessary for validation and assessment of their value in a diagnostic and prognostic setting,Non-Cancer,1,chemotherapyrelated cardiac dysfunction a systematic review of genetic variant modulating individual risk chemotherapyrelated cardiac dysfunction is a significant side effect of anticancer treatment risk stratification is based on clinical and treatmentrelated risk factor that do not adequately explain individual susceptibility the addition of genetic variant may improve risk assessment we conducted a systematic literature search in pubmed and embase to identify study investigating genetic risk factor for chemotherapyrelated cardiac dysfunction included were article describing genetic variant in human altering susceptibility to chemotherapyrelated cardiac dysfunction the validity of identified study wa assessed by criterion including assessment of population stratification statistical methodology and replication of finding we identified study exploring genetic risk factor for anthracyclineinduced cardiotoxicity n and study related to trastuzumabassociated cardiotoxicity n the majority of study had a candidate gene approach whereas genomewide association study have been performed we identified genetic variant in gene and intergenic variant reported significant at least once the overall validity of study wa limited with small cohort failure to assess population ancestry and lack of replication snp with the most robust evidence up to this point are celf r sarcomere structure and function rarg r topoisomerasebeta expression slca r drug transport ugta r drug metabolism and intergenic variant r existing evidence support the hypothesis that genetic variation contributes to chemotherapyrelated cardiac dysfunction although many variant identified by this systematic review show potential to improve risk stratification future study are necessary for validation and assessment of their value in a diagnostic and prognostic setting
29610969,bendamustine and rituximab br versus dexamethasone rituximab and cyclophosphamide drc in patient with waldenstrom macroglobulinemia,the treatment approach for waldenstrom macroglobulinemia wm are largely based upon information from singlearm phase ii trial without comparative data we compared the efficacy of two commonly used regimen in routine practice bendamustinerituximab br and dexamethasone rituximab plus cyclophosphamide drc and evaluated their activity with respect to the patient mydlp mutation status of consecutive patient received br with relapsedrefractory wm and received drc had relapsedrefractory wm in the treatmentnaive setting overall response rate orr wa with br versus with drc p twoyear progressionfree survival pfs with br and drc wa and respectively p in salvage setting orr wa with br versus with drc p median pfs with br wa versus month with drc year pfs wa versus p median diseasespecific survival wa not reached with br versus month with drc p the timetoevent endpoint and depth of response were independent of the myd mutation status grade adverse event of both regimen were comparable a trend for longer pfs wa observed with br although the regimen have comparable toxicity the activity of br and drc appears to be unaffected by patient myd mutation status,Non-Cancer,1,bendamustine and rituximab br versus dexamethasone rituximab and cyclophosphamide drc in patient with waldenstrom macroglobulinemia the treatment approach for waldenstrom macroglobulinemia wm are largely based upon information from singlearm phase ii trial without comparative data we compared the efficacy of two commonly used regimen in routine practice bendamustinerituximab br and dexamethasone rituximab plus cyclophosphamide drc and evaluated their activity with respect to the patient mydlp mutation status of consecutive patient received br with relapsedrefractory wm and received drc had relapsedrefractory wm in the treatmentnaive setting overall response rate orr wa with br versus with drc p twoyear progressionfree survival pfs with br and drc wa and respectively p in salvage setting orr wa with br versus with drc p median pfs with br wa versus month with drc year pfs wa versus p median diseasespecific survival wa not reached with br versus month with drc p the timetoevent endpoint and depth of response were independent of the myd mutation status grade adverse event of both regimen were comparable a trend for longer pfs wa observed with br although the regimen have comparable toxicity the activity of br and drc appears to be unaffected by patient myd mutation status
29627788,treatment of hemorrhagic head and neck lesion by direct puncture and nbca embolization,lifethreatening bleeding in the head and neck region requires urgent management these hemorrhagic lesion for example a ruptured pseudoaneurysm are often treated by transarterial embolization tae but prior intervention or surgery inflammation anatomic variant and vessel tortuosity may render an endovascular approach challenging timeconsuming and sometimes impossible we report two case of severe head and neck hemorrhage successfully embolized with nbutyl cyanoacrylate via direct puncture and propose this approach a a fast safe and effective alternative to tae,Non-Cancer,1,treatment of hemorrhagic head and neck lesion by direct puncture and nbca embolization lifethreatening bleeding in the head and neck region requires urgent management these hemorrhagic lesion for example a ruptured pseudoaneurysm are often treated by transarterial embolization tae but prior intervention or surgery inflammation anatomic variant and vessel tortuosity may render an endovascular approach challenging timeconsuming and sometimes impossible we report two case of severe head and neck hemorrhage successfully embolized with nbutyl cyanoacrylate via direct puncture and propose this approach a a fast safe and effective alternative to tae
29653965,patient with cdg mutation reveal a role for human cdgamma in treg diversity and suppressive function,integrity of the tcell receptorcd complex is crucial for positive and negative selection of t cell in the thymus and for effector and regulatory function of peripheral t lymphocyte in human cdd cde and cdz gene defect are a cause of severe immune deficiency and present early in life with increased susceptibility to infection by contrast cdg mutation lead to milder phenotype mainly characterized by autoimmunity however the role of cdgamma in establishing and maintaining immune tolerance ha not been elucidated in this manuscript we aimed to investigate abnormality of tcell repertoire and function in patient with genetic defect in cdg associated with autoimmunity high throughput sequencing wa used to study composition and diversity of the tcell receptor beta trb repertoire in regulatory t cell tregs conventional cd tconv and cd t cell from patient with cdg mutation and healthy control treg function wa assessed by studying it ability to suppress proliferation of tconv cell treg cell of patient with cdg defect had reduced diversity increased clonality and reduced suppressive function the trb repertoire of tconv cell from patient with cdg deficiency wa enriched for hydrophobic amino acid at position and of the cdr a biomarker of selfreactivity these data demonstrate that the tcell repertoire of patient with cdg mutation is characterized by a molecular signature that may contribute to the increased rate of autoimmunity associated with this condition,Non-Cancer,1,patient with cdg mutation reveal a role for human cdgamma in treg diversity and suppressive function integrity of the tcell receptorcd complex is crucial for positive and negative selection of t cell in the thymus and for effector and regulatory function of peripheral t lymphocyte in human cdd cde and cdz gene defect are a cause of severe immune deficiency and present early in life with increased susceptibility to infection by contrast cdg mutation lead to milder phenotype mainly characterized by autoimmunity however the role of cdgamma in establishing and maintaining immune tolerance ha not been elucidated in this manuscript we aimed to investigate abnormality of tcell repertoire and function in patient with genetic defect in cdg associated with autoimmunity high throughput sequencing wa used to study composition and diversity of the tcell receptor beta trb repertoire in regulatory t cell tregs conventional cd tconv and cd t cell from patient with cdg mutation and healthy control treg function wa assessed by studying it ability to suppress proliferation of tconv cell treg cell of patient with cdg defect had reduced diversity increased clonality and reduced suppressive function the trb repertoire of tconv cell from patient with cdg deficiency wa enriched for hydrophobic amino acid at position and of the cdr a biomarker of selfreactivity these data demonstrate that the tcell repertoire of patient with cdg mutation is characterized by a molecular signature that may contribute to the increased rate of autoimmunity associated with this condition
29676361,a yearold male with extensive cerebral venous thrombosis clinicopathological correlation of a rare case,we present the autopsy finding and differential diagnosis of a yearold immunocompetent male patient who presented primarily with extensive cerebral vein thrombosis and wa found to have a rare association with jakvf mutation positivity,Non-Cancer,1,a yearold male with extensive cerebral venous thrombosis clinicopathological correlation of a rare case we present the autopsy finding and differential diagnosis of a yearold immunocompetent male patient who presented primarily with extensive cerebral vein thrombosis and wa found to have a rare association with jakvf mutation positivity
29712894,increased proteasomal activity support photoreceptor survival in inherited retinal degeneration,inherited retinal degeneration affecting more than million people worldwide are caused by mutation in over gene this suggests that the most efficient therapeutic strategy would be mutation independent ie targeting common pathological condition arising from many diseasecausing mutation previous study revealed that one such condition is an insufficiency of the ubiquitinproteasome system to process misfolded or mistargeted protein in affected photoreceptor cell we now report that retinal degeneration in mouse can be significantly delayed by increasing photoreceptor proteasomal activity the largest effect is observed upon overexpression of the s proteasome cap subunit paalpha which enhanced ubiquitinindependent protein degradation in photoreceptors applying this strategy to mouse bearing one copy of the ph rhodopsin mutant a mutation frequently encountered in human patient quadruple the number of surviving photoreceptors in the inferior retina of monthold mouse this striking therapeutic effect demonstrates that proteasomes are an attractive target for fighting inherited blindness,Non-Cancer,1,increased proteasomal activity support photoreceptor survival in inherited retinal degeneration inherited retinal degeneration affecting more than million people worldwide are caused by mutation in over gene this suggests that the most efficient therapeutic strategy would be mutation independent ie targeting common pathological condition arising from many diseasecausing mutation previous study revealed that one such condition is an insufficiency of the ubiquitinproteasome system to process misfolded or mistargeted protein in affected photoreceptor cell we now report that retinal degeneration in mouse can be significantly delayed by increasing photoreceptor proteasomal activity the largest effect is observed upon overexpression of the s proteasome cap subunit paalpha which enhanced ubiquitinindependent protein degradation in photoreceptors applying this strategy to mouse bearing one copy of the ph rhodopsin mutant a mutation frequently encountered in human patient quadruple the number of surviving photoreceptors in the inferior retina of monthold mouse this striking therapeutic effect demonstrates that proteasomes are an attractive target for fighting inherited blindness
29728376,reconciling newborn screening and a novel splice variant in btd associated with partial biotinidase deficiency a babyseq project case report,here we report a newborn female infant from the wellbaby cohort of the babyseq project who wa identified with compound heterozygous btd gene variant the two identified variant included a wellestablished pathogenic variant cct pargcys that cause profound biotinidase deficiency btd in homozygosity in addition a novel splice variant cga p wa identified in the invariant splice donor region of intron potentially predictive of loss of function the novel variant wa predicted to impact splicing of exon however given the absence of any reported pathogenic variant in exon and the presence of alternative splicing with exon absent in most tissue in the gtex database we assigned an initial classification of uncertain significance followup medical record review of statemandated newborn screen nb result revealed an initial outofrange biotinidase activity level level from a repeat nb sample barely passed cutoff into the normal range to determine whether the infant wa biotinidasedeficient subsequent diagnostic enzyme activity testing wa performed confirming partial btd and resulted in a change of management for this patient this led to reclassification of the novel splice variant based on these result in conclusion combining the genetic and nb result together prompted clinical followup that confirmed partial btd and informed this novel splice site reclassification emphasizing the importance of combining iterative genetic and phenotypic evaluation,Non-Cancer,1,reconciling newborn screening and a novel splice variant in btd associated with partial biotinidase deficiency a babyseq project case report here we report a newborn female infant from the wellbaby cohort of the babyseq project who wa identified with compound heterozygous btd gene variant the two identified variant included a wellestablished pathogenic variant cct pargcys that cause profound biotinidase deficiency btd in homozygosity in addition a novel splice variant cga p wa identified in the invariant splice donor region of intron potentially predictive of loss of function the novel variant wa predicted to impact splicing of exon however given the absence of any reported pathogenic variant in exon and the presence of alternative splicing with exon absent in most tissue in the gtex database we assigned an initial classification of uncertain significance followup medical record review of statemandated newborn screen nb result revealed an initial outofrange biotinidase activity level level from a repeat nb sample barely passed cutoff into the normal range to determine whether the infant wa biotinidasedeficient subsequent diagnostic enzyme activity testing wa performed confirming partial btd and resulted in a change of management for this patient this led to reclassification of the novel splice variant based on these result in conclusion combining the genetic and nb result together prompted clinical followup that confirmed partial btd and informed this novel splice site reclassification emphasizing the importance of combining iterative genetic and phenotypic evaluation
29728436,splenic cyst and it management in a monthold boy a rare complication of invasive meningococcal disease,splenic complication of invasive meningococcal disease imd are well recognised though cyst formation is rare particularly in paediatric population the best approach to their management is not yet established this case outline the management of a splenic cyst in a monthold boy following severe imd the case took place in the context of an acute emergence of serogroup w prompting significant medium attention and subsequent change in vaccination practice at a jurisdictional level in australia the patient wa critically unwell early in the illness then later a collection in the left upper quadrant wa detected shown on ultrasound to be a x cm splenic cyst in this case the cyst wa managed by ultrasoundguided drainage tube insertion the residual collection wa small and stable on subsequent imaging,Non-Cancer,1,splenic cyst and it management in a monthold boy a rare complication of invasive meningococcal disease splenic complication of invasive meningococcal disease imd are well recognised though cyst formation is rare particularly in paediatric population the best approach to their management is not yet established this case outline the management of a splenic cyst in a monthold boy following severe imd the case took place in the context of an acute emergence of serogroup w prompting significant medium attention and subsequent change in vaccination practice at a jurisdictional level in australia the patient wa critically unwell early in the illness then later a collection in the left upper quadrant wa detected shown on ultrasound to be a x cm splenic cyst in this case the cyst wa managed by ultrasoundguided drainage tube insertion the residual collection wa small and stable on subsequent imaging
29760532,apoptotic cellinduced ahr activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mouse and human,the transcription factor ahr modulates immunity at multiple level here we report that phagocyte exposed to apoptotic cell exhibited rapid activation of ahr which drove production of the cytokine il activation of ahr wa dependent on interaction between apoptoticcell dna and the patternrecognition receptor tlr that wa required for the prevention of immune response to dna and histone in vivo moreover disease progression in mouse systemic lupus erythematosus sle correlated with strength of the ahr signal and the disease course could be altered by modulation of ahr activity deletion of ahr in the myeloid lineage caused systemic autoimmunity in mouse and an enhanced ahr transcriptional signature correlated with disease in patient with sle thus ahr activity induced by apoptotic cell phagocyte maintains peripheral tolerance,Non-Cancer,1,apoptotic cellinduced ahr activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mouse and human the transcription factor ahr modulates immunity at multiple level here we report that phagocyte exposed to apoptotic cell exhibited rapid activation of ahr which drove production of the cytokine il activation of ahr wa dependent on interaction between apoptoticcell dna and the patternrecognition receptor tlr that wa required for the prevention of immune response to dna and histone in vivo moreover disease progression in mouse systemic lupus erythematosus sle correlated with strength of the ahr signal and the disease course could be altered by modulation of ahr activity deletion of ahr in the myeloid lineage caused systemic autoimmunity in mouse and an enhanced ahr transcriptional signature correlated with disease in patient with sle thus ahr activity induced by apoptotic cell phagocyte maintains peripheral tolerance
29775646,the rna binding protein ar support hematopoiesis at multiple level,recent biochemical characterization of arsenic resistance protein ar ha established it a central in determining the fate of nascent ribonucleic acid rna polymerase ii rnapii transcript through interaction with the nuclear methylguanosine capbinding complex ar promotes cotranscriptional processing coupled with nuclear export or degradation of several class of rnapii transcript allowing for gene expression program that facilitate rapid and sustained proliferation of immortalized cell in culture however rapidly dividing cell in culture do not represent the physiological condition of the vast majority of cell in an adult mammal to examine function of ar in a physiological setting we generated inducible ar knockout mouse and found that deletion of ar from adult mouse resulted in defective hematopoiesis in bone marrow and thymus importantly only some of this defect could be explained by the requirement of ar for rapid proliferation which we found to be celltype specific in vivo rather ar wa required for survival of developing thymocytes and for limiting differentiation of bone marrow resident longterm hematopoietic stem cell a a result ar knockout led to rapid thymic involution and loss of the ability of mouse to regenerate peripheral blood after myeloablation these in vivo data demonstrate that ar expression is important at several step of hematopoiesis likely because ar act on gene expression program underlying essential cell fate decision such a the decision to dieproliferate or differentiate,Non-Cancer,1,the rna binding protein ar support hematopoiesis at multiple level recent biochemical characterization of arsenic resistance protein ar ha established it a central in determining the fate of nascent ribonucleic acid rna polymerase ii rnapii transcript through interaction with the nuclear methylguanosine capbinding complex ar promotes cotranscriptional processing coupled with nuclear export or degradation of several class of rnapii transcript allowing for gene expression program that facilitate rapid and sustained proliferation of immortalized cell in culture however rapidly dividing cell in culture do not represent the physiological condition of the vast majority of cell in an adult mammal to examine function of ar in a physiological setting we generated inducible ar knockout mouse and found that deletion of ar from adult mouse resulted in defective hematopoiesis in bone marrow and thymus importantly only some of this defect could be explained by the requirement of ar for rapid proliferation which we found to be celltype specific in vivo rather ar wa required for survival of developing thymocytes and for limiting differentiation of bone marrow resident longterm hematopoietic stem cell a a result ar knockout led to rapid thymic involution and loss of the ability of mouse to regenerate peripheral blood after myeloablation these in vivo data demonstrate that ar expression is important at several step of hematopoiesis likely because ar act on gene expression program underlying essential cell fate decision such a the decision to dieproliferate or differentiate
29781571,new approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoff and ratio,background the main goal of newborn screening nb for sickle cell disease scd is to detect affected neonate so that specific preventive care can be implemented highperformance liquid chromatography hplc used for nb ha high sensitivity and specificity but we lack guideline for quantitative hemoglobin hb fraction interpretation the purpose of this study wa to determine cutoff value to standardize quantitative interpretation in scd nb for different clinical situation such a red blood cell transfusion or betathalassemia which can be real screening pitfall method retrospective study of sample from the neonatal screening program analyzed in our laboratory precise hba and hb percentage at birth were recorded and median value established for each gestational age allowing percentage result to be expressed in normal gestationspecific multiple of the median mom three threshold value of clinical interest were determined result high level of hba mom allowed identification of newborn who received transfusion low level of hb mom allowed detection of the association between hb and other mutation of the betaglobin gene ie hbhope betathalassemia etc an hbahbs ratio to distinguish healthy carrier from scd with sbetathalassemia the screening accuracy for each threshold wa established the screening accuracy of lowlevel hba which is determinant in identifying the subgroup of patient at risk of betathalassemia will be determined prospectively conclusion this new approach introduces tool for a quantitative interpretation in scd nb by hplc method and could allow standardization of interpretation between center,Non-Cancer,1,new approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoff and ratio background the main goal of newborn screening nb for sickle cell disease scd is to detect affected neonate so that specific preventive care can be implemented highperformance liquid chromatography hplc used for nb ha high sensitivity and specificity but we lack guideline for quantitative hemoglobin hb fraction interpretation the purpose of this study wa to determine cutoff value to standardize quantitative interpretation in scd nb for different clinical situation such a red blood cell transfusion or betathalassemia which can be real screening pitfall method retrospective study of sample from the neonatal screening program analyzed in our laboratory precise hba and hb percentage at birth were recorded and median value established for each gestational age allowing percentage result to be expressed in normal gestationspecific multiple of the median mom three threshold value of clinical interest were determined result high level of hba mom allowed identification of newborn who received transfusion low level of hb mom allowed detection of the association between hb and other mutation of the betaglobin gene ie hbhope betathalassemia etc an hbahbs ratio to distinguish healthy carrier from scd with sbetathalassemia the screening accuracy for each threshold wa established the screening accuracy of lowlevel hba which is determinant in identifying the subgroup of patient at risk of betathalassemia will be determined prospectively conclusion this new approach introduces tool for a quantitative interpretation in scd nb by hplc method and could allow standardization of interpretation between center
29789409,characterization of an activating rh insulinlike growth factor receptor variant in a male with extreme tall height,objective the insulinlike growth factor receptor igfr is important in growth and development and inactivating igfr mutation cause short stature and relatively high level of serum igfi we identified an unclassified igfrrh variant in a male with extreme tall height very low level of serum igfi and delayed and prolonged growth spurt the index case mother and three son all carried the variant but so far only the eldest son age year presented with tall height we hypothesized that the variant could constitute an activating mutation design the igfrrh variant wa investigated in igfr mouse embryonic fibroblast rcells by cell cycle colony formation and transcriptome analysis result the igfrrh r exhibited significantly increased cell proliferation g progression and colony formation in soft agar rna sequencing identified differentially expressed gene between rwt and r adjusted p e most gene were upregulated in r including the gene encoding the androgen receptor ar gene expression profiling showed the most significant enrichment in extracellular matrix organization p e collagen biosynthesis p e and cell adhesion p e retrospective biochemical analysis of the index case revealed decreased testosterone and sex hormonebinding globulin level whereas lh and fsh were within normal range this profile suggests an increased sensitivity to androgen which is compatible with the enhanced expression of ar in r cell conclusion our finding suggest that rh constitutes an activating igfr variant the possible deregulation of collagen turnover and increased androgen sensitivity implicates an association to tall phenotype in male carrier,Non-Cancer,1,characterization of an activating rh insulinlike growth factor receptor variant in a male with extreme tall height objective the insulinlike growth factor receptor igfr is important in growth and development and inactivating igfr mutation cause short stature and relatively high level of serum igfi we identified an unclassified igfrrh variant in a male with extreme tall height very low level of serum igfi and delayed and prolonged growth spurt the index case mother and three son all carried the variant but so far only the eldest son age year presented with tall height we hypothesized that the variant could constitute an activating mutation design the igfrrh variant wa investigated in igfr mouse embryonic fibroblast rcells by cell cycle colony formation and transcriptome analysis result the igfrrh r exhibited significantly increased cell proliferation g progression and colony formation in soft agar rna sequencing identified differentially expressed gene between rwt and r adjusted p e most gene were upregulated in r including the gene encoding the androgen receptor ar gene expression profiling showed the most significant enrichment in extracellular matrix organization p e collagen biosynthesis p e and cell adhesion p e retrospective biochemical analysis of the index case revealed decreased testosterone and sex hormonebinding globulin level whereas lh and fsh were within normal range this profile suggests an increased sensitivity to androgen which is compatible with the enhanced expression of ar in r cell conclusion our finding suggest that rh constitutes an activating igfr variant the possible deregulation of collagen turnover and increased androgen sensitivity implicates an association to tall phenotype in male carrier
29794022,yap control endothelial activation and vascular inflammation through traf,rationale microvascular inflammation and endothelial dysfunction secondary to unchecked activation of endothelium play a critical role in the pathophysiology of sepsis and organ failure the intrinsic signaling mechanism responsible for dampening excessive activation of endothelial cell are not completely understood objective to determine the central role of yap yesassociated protein the major transcriptional coactivator of the hippo pathway in modulating the strength and magnitude of endothelial activation and vascular inflammation method and result endothelialspecific yap knockout mouse showed increased basal expression of eselectin and icam intercellular adhesion molecule in endothelial cell a greater number of adherent neutrophil in postcapillary venule and increased neutrophil count in bronchoalveolar lavage fluid lipopolysaccharide challenge of these mouse augmented nfkappab nuclear factorkappab activation expression of endothelial adhesion protein neutrophil and monocyte adhesion to cremaster muscle venule transendothelial neutrophil migration and lung inflammatory injury deletion of yap in endothelial cell also markedly augmented the inflammatory response and cardiovascular dysfunction in a polymicrobial sepsis model induced by cecal ligation and puncture yap functioned by interacting with the e ubiquitinprotein ligase tlr tolllike receptor signaling adaptor traf tumor necrosis factor receptorassociated factor to ubiquitinate traf and thus promoted traf degradation and modification resulting in inhibition of nfkappab activation traf depletion in endothelial cell rescued the augmented inflammatory phenotype in mouse with endothelial cellspecific deletion of yap conclusion yap modulates the activation of endothelial cell and suppresses vascular inflammation through preventing trafmediated nfkappab activation and is hence essential for limiting the severity of sepsisinduced inflammation and organ failure,Non-Cancer,1,yap control endothelial activation and vascular inflammation through traf rationale microvascular inflammation and endothelial dysfunction secondary to unchecked activation of endothelium play a critical role in the pathophysiology of sepsis and organ failure the intrinsic signaling mechanism responsible for dampening excessive activation of endothelial cell are not completely understood objective to determine the central role of yap yesassociated protein the major transcriptional coactivator of the hippo pathway in modulating the strength and magnitude of endothelial activation and vascular inflammation method and result endothelialspecific yap knockout mouse showed increased basal expression of eselectin and icam intercellular adhesion molecule in endothelial cell a greater number of adherent neutrophil in postcapillary venule and increased neutrophil count in bronchoalveolar lavage fluid lipopolysaccharide challenge of these mouse augmented nfkappab nuclear factorkappab activation expression of endothelial adhesion protein neutrophil and monocyte adhesion to cremaster muscle venule transendothelial neutrophil migration and lung inflammatory injury deletion of yap in endothelial cell also markedly augmented the inflammatory response and cardiovascular dysfunction in a polymicrobial sepsis model induced by cecal ligation and puncture yap functioned by interacting with the e ubiquitinprotein ligase tlr tolllike receptor signaling adaptor traf tumor necrosis factor receptorassociated factor to ubiquitinate traf and thus promoted traf degradation and modification resulting in inhibition of nfkappab activation traf depletion in endothelial cell rescued the augmented inflammatory phenotype in mouse with endothelial cellspecific deletion of yap conclusion yap modulates the activation of endothelial cell and suppresses vascular inflammation through preventing trafmediated nfkappab activation and is hence essential for limiting the severity of sepsisinduced inflammation and organ failure
29804876,distant insulin signaling regulates vertebrate pigmentation through the sheddase bace,patterning of vertebrate melanophores is essential for mate selection and protection from uvinduced damage patterning can be influenced by circulating longrange factor such a hormone but it is unclear how their activity is controlled in recipient cell to prevent excess in cell number and migration the zebrafish wanderlust mutant harbor a mutation in the sheddase bace and exhibit hyperdendritic and hyperproliferative melanophores that localize to aberrant site we performed a chemical screen to identify suppressor of the wanderlust phenotype and found that inhibition of insulinpikgammamtor signaling rescue the defect in normal physiology bace cleaves the insulin receptor whereas it loss result in hyperactive insulinpikmtor signaling insulin b an isoform enriched in the head drive the melanophore defect these result suggest that insulin signaling is negatively regulated by melanophorespecific expression of a sheddase highlighting how longdistance factor can be regulated in a celltypespecific manner,Non-Cancer,1,distant insulin signaling regulates vertebrate pigmentation through the sheddase bace patterning of vertebrate melanophores is essential for mate selection and protection from uvinduced damage patterning can be influenced by circulating longrange factor such a hormone but it is unclear how their activity is controlled in recipient cell to prevent excess in cell number and migration the zebrafish wanderlust mutant harbor a mutation in the sheddase bace and exhibit hyperdendritic and hyperproliferative melanophores that localize to aberrant site we performed a chemical screen to identify suppressor of the wanderlust phenotype and found that inhibition of insulinpikgammamtor signaling rescue the defect in normal physiology bace cleaves the insulin receptor whereas it loss result in hyperactive insulinpikmtor signaling insulin b an isoform enriched in the head drive the melanophore defect these result suggest that insulin signaling is negatively regulated by melanophorespecific expression of a sheddase highlighting how longdistance factor can be regulated in a celltypespecific manner
29855039,hypohidrotic ectodermal dysplasia clinical and molecular review,hypohidrotic ectodermal dysplasia hed is a genetic human disorder which affect structure of ectodermal origin although there are autosomal recessive and dominant form xlinked xl is the most frequent form of the disease this xlhed phenotype is associated with mutation in the gene encoding the transmembrane protein ectodysplasin eda a member of the tnfalpharelated signaling pathway the protein from this pathway are involved in signal transduction from ectoderm to mesenchyme leading to the development of ectodermderived structure in the fetus such a hair teeth skin nail and eccrine sweat gland the aim of this review wa to update the main clinical characteristic of hed regarding to recent molecular advance in the comprehension of all the possible gene involved in this group of disorder since it is known that edaaedar signaling ha multiple role in ectodermal organ development regulating their initiation morphogenesis and differentiation step the knowledge of the biological mechanism that generate hed is needed for both a better detection of possible case and for the design of efficient prevention and treatment approach,Non-Cancer,1,hypohidrotic ectodermal dysplasia clinical and molecular review hypohidrotic ectodermal dysplasia hed is a genetic human disorder which affect structure of ectodermal origin although there are autosomal recessive and dominant form xlinked xl is the most frequent form of the disease this xlhed phenotype is associated with mutation in the gene encoding the transmembrane protein ectodysplasin eda a member of the tnfalpharelated signaling pathway the protein from this pathway are involved in signal transduction from ectoderm to mesenchyme leading to the development of ectodermderived structure in the fetus such a hair teeth skin nail and eccrine sweat gland the aim of this review wa to update the main clinical characteristic of hed regarding to recent molecular advance in the comprehension of all the possible gene involved in this group of disorder since it is known that edaaedar signaling ha multiple role in ectodermal organ development regulating their initiation morphogenesis and differentiation step the knowledge of the biological mechanism that generate hed is needed for both a better detection of possible case and for the design of efficient prevention and treatment approach
29856837,eltrombopag versus romiplostim in treatment of adult patient with immune thrombocytopenia a systematic review incorporating an indirectcomparison metaanalysis,purpose in absence of direct comparison randomized controlled trial rcts indirect comparison wa conducted to evaluate the efficacy and safety of thrombopoietinreceptor agonist tporas in treatment of adult immune thrombocytopenia itp method we searched pubmed embase and cochrane library clinical trialsgov china national knowledge infrastructure and chinese biomedical literature database from their earliest record to may rcts comparing the tporas with placebo in adult itp were included primary outcome were the overall response rate secondary outcome included safety durable response overall or clinically significant bleeding and the proportion of patient receiving rescue medication result nine randomized placebocontrolled trial participant were included in this systematic review overall response risk ratiorr confidence intervalci the incidence of adverse event rr ci durable response rr ci the incidence of overall bleeding rr ci and clinically significant bleeding rr ci and the proportion of patient receiving rescue treatment rr ci were similar between eltrombopag and romiplostim conclusion eltrombopag and romiplostim might be equivalent in efficacy and safety for adult itp however physician should still take into account drug cost and comorbidities of the specific patient while making decision on the treatment of itp with tporas registration prospero international prospective register of systematic review prospero crd,Non-Cancer,1,eltrombopag versus romiplostim in treatment of adult patient with immune thrombocytopenia a systematic review incorporating an indirectcomparison metaanalysis purpose in absence of direct comparison randomized controlled trial rcts indirect comparison wa conducted to evaluate the efficacy and safety of thrombopoietinreceptor agonist tporas in treatment of adult immune thrombocytopenia itp method we searched pubmed embase and cochrane library clinical trialsgov china national knowledge infrastructure and chinese biomedical literature database from their earliest record to may rcts comparing the tporas with placebo in adult itp were included primary outcome were the overall response rate secondary outcome included safety durable response overall or clinically significant bleeding and the proportion of patient receiving rescue medication result nine randomized placebocontrolled trial participant were included in this systematic review overall response risk ratiorr confidence intervalci the incidence of adverse event rr ci durable response rr ci the incidence of overall bleeding rr ci and clinically significant bleeding rr ci and the proportion of patient receiving rescue treatment rr ci were similar between eltrombopag and romiplostim conclusion eltrombopag and romiplostim might be equivalent in efficacy and safety for adult itp however physician should still take into account drug cost and comorbidities of the specific patient while making decision on the treatment of itp with tporas registration prospero international prospective register of systematic review prospero crd
29884702,mtor complex signaling regulates the generation and function of central and effector foxp regulatory t cell,the mechanisticmammalian target of rapamycin mtor ha emerged a a critical integrator of signal from the immune microenvironment capable of regulating t cell activation differentiation and function the precise role of mtor in the control of regulatory t cell treg differentiation and function is complex pharmacologic inhibition and genetic deletion of mtor promotes the generation of tregs even under condition that would normally promote generation of effector t cell alternatively mtor activity ha been observed to be increased in tregs and the genetic deletion of the mtor complex mtorcscaffold protein raptor inhibits treg function in this study by employing both pharmacologic inhibitor and genetically altered t cell we seek to clarify the role of mtor in tregs our study demonstrate that inhibition of mtor during t cell activation promotes the generation of longlived central tregs with a memorylike phenotype in mouse metabolically these central memory tregs possess enhanced spare respiratory capacity similar to cd memory cell alternatively the generation of effector tregs etregs requires mtor function indeed genetic deletion of rptor lead to the decreased expression of icos and pd on the etregs overall our study define a subset of mtorchi etregs and mtorclo central tregs,Non-Cancer,1,mtor complex signaling regulates the generation and function of central and effector foxp regulatory t cell the mechanisticmammalian target of rapamycin mtor ha emerged a a critical integrator of signal from the immune microenvironment capable of regulating t cell activation differentiation and function the precise role of mtor in the control of regulatory t cell treg differentiation and function is complex pharmacologic inhibition and genetic deletion of mtor promotes the generation of tregs even under condition that would normally promote generation of effector t cell alternatively mtor activity ha been observed to be increased in tregs and the genetic deletion of the mtor complex mtorcscaffold protein raptor inhibits treg function in this study by employing both pharmacologic inhibitor and genetically altered t cell we seek to clarify the role of mtor in tregs our study demonstrate that inhibition of mtor during t cell activation promotes the generation of longlived central tregs with a memorylike phenotype in mouse metabolically these central memory tregs possess enhanced spare respiratory capacity similar to cd memory cell alternatively the generation of effector tregs etregs requires mtor function indeed genetic deletion of rptor lead to the decreased expression of icos and pd on the etregs overall our study define a subset of mtorchi etregs and mtorclo central tregs
29885404,in situ analysis of mtorc and cellular metabolismrelated protein in human lymphangioleiomyomatosis,lymphangioleiomyomatosis lam is a rare progressive cystic lung disease with feature of a lowgrade neoplasm it is primarily caused by mutation in tsc or tsc gene sirolimus an inhibitor of mtor complex mtorc slows down disease progression in some but not all patient hitherto other potential therapeutic target such a mtor complex mtorc and various metabolic pathway have not been investigated in human lam tissue the aim of this study wa to assess activity of mtorc mtorc and various metabolic pathway in human lam tissue through analysis of protein expression immunohistochemical analysis of p mtorc downstream protein rictor mtorc scaffold protein a well a glut gapdh atpb gls mct acss and cpta metabolic pathway marker were performed on lung tissue from patient with sporadic lam immunoreactivity wa assessed in lam cell with bronchial smooth muscle cell a control expression of p rictor gapdh gls mct acss and cpta wa significantly higher in lam cell than in bronchial smooth muscle cell p no significant difference were found between lam cell and normal bronchial smooth muscle cell in glut and atpb expression the result are uniquely derived from human tissue and indicate that in addition to mtorc mtorc may also play an important role in the pathobiology of lam furthermore glutaminolysis acetate utilization and fatty acid betaoxidation appear to be the preferred bioenergetic pathway in lam cell mtorc and these preferred bioenergetic pathway appear worthy of further study a they may represent possible therapeutic target in the treatment of lam,Non-Cancer,1,in situ analysis of mtorc and cellular metabolismrelated protein in human lymphangioleiomyomatosis lymphangioleiomyomatosis lam is a rare progressive cystic lung disease with feature of a lowgrade neoplasm it is primarily caused by mutation in tsc or tsc gene sirolimus an inhibitor of mtor complex mtorc slows down disease progression in some but not all patient hitherto other potential therapeutic target such a mtor complex mtorc and various metabolic pathway have not been investigated in human lam tissue the aim of this study wa to assess activity of mtorc mtorc and various metabolic pathway in human lam tissue through analysis of protein expression immunohistochemical analysis of p mtorc downstream protein rictor mtorc scaffold protein a well a glut gapdh atpb gls mct acss and cpta metabolic pathway marker were performed on lung tissue from patient with sporadic lam immunoreactivity wa assessed in lam cell with bronchial smooth muscle cell a control expression of p rictor gapdh gls mct acss and cpta wa significantly higher in lam cell than in bronchial smooth muscle cell p no significant difference were found between lam cell and normal bronchial smooth muscle cell in glut and atpb expression the result are uniquely derived from human tissue and indicate that in addition to mtorc mtorc may also play an important role in the pathobiology of lam furthermore glutaminolysis acetate utilization and fatty acid betaoxidation appear to be the preferred bioenergetic pathway in lam cell mtorc and these preferred bioenergetic pathway appear worthy of further study a they may represent possible therapeutic target in the treatment of lam
29915580,cdhladr regulatory t cell change with aging they increase in number but lose checkpoint inhibitory molecule and suppressive function,cd regulatory t cell have been intensively studied during aging but little is still known about agerelated change of other regulatory t cell subset it wa therefore the goal of the present study to analyze cdhuman leukocyte antigenantigen d related hladr t cell in old age a cell population reported to have suppressive activity and to be connected to specific genetic variant we demonstrate a strong increase in the number of cdhladr t cell with age in a cohort of female sardinian a well a in elderly male and female person from austria we also show that cdhladr t cell lack classical activation molecule such a cd and cd but contain increased number of checkpoint inhibitory molecule such a cytotoxic t lymphocyteassociated antigen t cell immunoglobulin and mucin protein lag and pd when compared with their hladr counterpart they also have the capacity to inhibit the proliferation of autologous peripheral blood mononuclear cell this suppressive activity is however decreased when cdhladr t cell from elderly person are analyzed in accordance with this finding cdhladr t cell from person of old age contain lower percentage of checkpoint inhibitory molecule than young control we conclude that in spite of high abundance of a cd regulatory t cell subset in old age it expression of checkpoint inhibitory molecule and it suppressive function on a per cell basis are reduced reduction of suppressive capacity may support uncontrolled subclinical inflammatory process referred to a inflammaging,Non-Cancer,1,cdhladr regulatory t cell change with aging they increase in number but lose checkpoint inhibitory molecule and suppressive function cd regulatory t cell have been intensively studied during aging but little is still known about agerelated change of other regulatory t cell subset it wa therefore the goal of the present study to analyze cdhuman leukocyte antigenantigen d related hladr t cell in old age a cell population reported to have suppressive activity and to be connected to specific genetic variant we demonstrate a strong increase in the number of cdhladr t cell with age in a cohort of female sardinian a well a in elderly male and female person from austria we also show that cdhladr t cell lack classical activation molecule such a cd and cd but contain increased number of checkpoint inhibitory molecule such a cytotoxic t lymphocyteassociated antigen t cell immunoglobulin and mucin protein lag and pd when compared with their hladr counterpart they also have the capacity to inhibit the proliferation of autologous peripheral blood mononuclear cell this suppressive activity is however decreased when cdhladr t cell from elderly person are analyzed in accordance with this finding cdhladr t cell from person of old age contain lower percentage of checkpoint inhibitory molecule than young control we conclude that in spite of high abundance of a cd regulatory t cell subset in old age it expression of checkpoint inhibitory molecule and it suppressive function on a per cell basis are reduced reduction of suppressive capacity may support uncontrolled subclinical inflammatory process referred to a inflammaging
29929111,calcification in cerebral parenchyma affect pharmacoresistant epilepsy in tuberous sclerosis,purpose tuberous sclerosis tsc is an autosomal dominant inherited disease caused by mutation in the tsc or tsc gene and result in the overactivation of the mammalian target of the rapamycin mtor signaling pathway rapamycin an mtor inhibitor is clinically used to treat hamartomatous lesionsas in tsc and it effect on controlling epilepsy is also reported in many study this study aim to evaluate the risk factor of pharmacoresistant epilepsy in patient with tsc receiving longterm rapamycin treatment method a total of patient with tsc taking rapamycin for over year were enrolled in this study factor that might influence seizure control were statistically analyzed by multiple factor analysis a subgroup analysis wa also conducted to access the relationship between calcified epileptic focus and pharmacoresistant epilepsy clinical trial registration number chictroob result seizure wa controlled in patient but wa not managed in patient considered to be drug resistant logistic regression analysis showed that calcification in the cerebral parenchyma wa a risk factor of pharmacoresistant epilepsy p odds ratio or fifteen of patient with calcified epileptic focus suffered from pharmacoresistant epilepsy seizure in patient with calcified epileptic focus were probably pharmacoresistant p conclusion calcification in epileptic focus strongly indicates pharmacoresistant epilepsy in patient with tsc even when treated with appropriate antiepilepsy drug aeds and rapamycin calcification can be used to evaluate pharmacoresistant epilepsy in patient with tsc,Non-Cancer,1,calcification in cerebral parenchyma affect pharmacoresistant epilepsy in tuberous sclerosis purpose tuberous sclerosis tsc is an autosomal dominant inherited disease caused by mutation in the tsc or tsc gene and result in the overactivation of the mammalian target of the rapamycin mtor signaling pathway rapamycin an mtor inhibitor is clinically used to treat hamartomatous lesionsas in tsc and it effect on controlling epilepsy is also reported in many study this study aim to evaluate the risk factor of pharmacoresistant epilepsy in patient with tsc receiving longterm rapamycin treatment method a total of patient with tsc taking rapamycin for over year were enrolled in this study factor that might influence seizure control were statistically analyzed by multiple factor analysis a subgroup analysis wa also conducted to access the relationship between calcified epileptic focus and pharmacoresistant epilepsy clinical trial registration number chictroob result seizure wa controlled in patient but wa not managed in patient considered to be drug resistant logistic regression analysis showed that calcification in the cerebral parenchyma wa a risk factor of pharmacoresistant epilepsy p odds ratio or fifteen of patient with calcified epileptic focus suffered from pharmacoresistant epilepsy seizure in patient with calcified epileptic focus were probably pharmacoresistant p conclusion calcification in epileptic focus strongly indicates pharmacoresistant epilepsy in patient with tsc even when treated with appropriate antiepilepsy drug aeds and rapamycin calcification can be used to evaluate pharmacoresistant epilepsy in patient with tsc
29930110,analysis of shared heritability in common disorder of the brain,disorder of the brain can exhibit considerable epidemiological comorbidity and often share symptom provoking debate about their etiologic overlap we quantified the genetic sharing of brain disorder from genomewide association study of patient and control participant and assessed their relationship to phenotype from individual psychiatric disorder share common variant risk whereas neurological disorder appear more distinct from one another and from the psychiatric disorder we also identified significant sharing between disorder and a number of brain phenotype including cognitive measure further we conducted simulation to explore how statistical power diagnostic misclassification and phenotypic heterogeneity affect genetic correlation these result highlight the importance of common genetic variation a a risk factor for brain disorder and the value of heritabilitybased method in understanding their etiology,Non-Cancer,1,analysis of shared heritability in common disorder of the brain disorder of the brain can exhibit considerable epidemiological comorbidity and often share symptom provoking debate about their etiologic overlap we quantified the genetic sharing of brain disorder from genomewide association study of patient and control participant and assessed their relationship to phenotype from individual psychiatric disorder share common variant risk whereas neurological disorder appear more distinct from one another and from the psychiatric disorder we also identified significant sharing between disorder and a number of brain phenotype including cognitive measure further we conducted simulation to explore how statistical power diagnostic misclassification and phenotypic heterogeneity affect genetic correlation these result highlight the importance of common genetic variation a a risk factor for brain disorder and the value of heritabilitybased method in understanding their etiology
29945600,membranebound and soluble form of an nmda receptor extracellular domain retain epitope targeted in autoimmune encephalitis,background antinmda receptor encephalitis anre is a potentially lethal disease attributed to autoantibody against the nmethyldaspartate receptor nmdar full recovery is possible if therapy is initiated early in the disease course detection of anre antibody in the cerebrospinal fluid csf is essential for diagnosis the assay for anreassociated igg often rely on cell transiently transfected with nmdar gene a cell line that stably express pathogenic nmdar epitope could improve standardization of the assay and provide antigen that could be used in commercial solid state assay system result we expressed the amino terminal domain atd of the glun nmdar subunit nr a a fusion protein on the outer plasma membrane of t cell creating a stable cell population tatd that is recognized by anre patient monoclonal antibody in flow cytometry and immunofluorescence assay the atd fusion protein also contains a myc tag and a xhis tag which provide functionality for immunoassay and antigen purification and a tev protease site which allows the atd domain to be specifically released from the cell in essentially pure form atd mobilized from the t atd cell line maintained the pathogenic anre epitope in elisa binding assay csf and serum from anre patient also bound the tatd cell line whereas normal csf and serum did not conclusion the tatd cell line is potentially adaptable to a variety of format to identify antibody associated with anre including cellbased and soluble antigen format and demonstrates a useful method to produce complex protein for research drug discovery and clinical diagnosis,Non-Cancer,1,membranebound and soluble form of an nmda receptor extracellular domain retain epitope targeted in autoimmune encephalitis background antinmda receptor encephalitis anre is a potentially lethal disease attributed to autoantibody against the nmethyldaspartate receptor nmdar full recovery is possible if therapy is initiated early in the disease course detection of anre antibody in the cerebrospinal fluid csf is essential for diagnosis the assay for anreassociated igg often rely on cell transiently transfected with nmdar gene a cell line that stably express pathogenic nmdar epitope could improve standardization of the assay and provide antigen that could be used in commercial solid state assay system result we expressed the amino terminal domain atd of the glun nmdar subunit nr a a fusion protein on the outer plasma membrane of t cell creating a stable cell population tatd that is recognized by anre patient monoclonal antibody in flow cytometry and immunofluorescence assay the atd fusion protein also contains a myc tag and a xhis tag which provide functionality for immunoassay and antigen purification and a tev protease site which allows the atd domain to be specifically released from the cell in essentially pure form atd mobilized from the t atd cell line maintained the pathogenic anre epitope in elisa binding assay csf and serum from anre patient also bound the tatd cell line whereas normal csf and serum did not conclusion the tatd cell line is potentially adaptable to a variety of format to identify antibody associated with anre including cellbased and soluble antigen format and demonstrates a useful method to produce complex protein for research drug discovery and clinical diagnosis
29948574,t nk il receptor gamma chain mutation a challenging diagnosis of atypical severe combined immunodeficiency,purpose all reported patient with hypomorphic xlinked severe combined immunodeficiency xscid due to cct prc mutation in the gene ilrg encoding the common gamma chain gammac have presented with opportunistic infection within the first year of life despite the presence of nearly normal nk and t cell number reporting five child of one extended family with hemizygous mutation in ilrg we explore potential diagnostic clue and extend our comprehension of the functional impact of this mutation method whole exome sequencing wes detailed immune phenotyping cytokineinduced stat phosphorylation b t and nk cell activation and quantification of sjtrecs in five arab child with cct prc ilrg mutation result the mean age at clinical presentation with respiratory tract infection or diarrhea wa range month none of the child presented with opportunistic infection diagnostic clue were early onset in the first year of life and a suggestive family history associated with reduced naive cd t cell and absent switched memory b cell number and phenotype of nk cell and innatelike lymphocyte were normal the diagnosis wa made by wes and corroborated by absent stat phosphorylation and reduced functional response after il and il stimulation four patient underwent successful hematopoietic stem cell transplantation conclusion a early diagnosis and treatment are important a high index of suspicion in the diagnosis of cct prc xscid is needed this requires prompt genetic testing by next generation sequencing in order to avoid unnecessary delay in the definite diagnosis since immunological work up may not be discriminating assay directly testing cytokine signaling or cytokinedependent function are helpful in confirming the functional impact of the identified hypomorphic variant,Non-Cancer,1,t nk il receptor gamma chain mutation a challenging diagnosis of atypical severe combined immunodeficiency purpose all reported patient with hypomorphic xlinked severe combined immunodeficiency xscid due to cct prc mutation in the gene ilrg encoding the common gamma chain gammac have presented with opportunistic infection within the first year of life despite the presence of nearly normal nk and t cell number reporting five child of one extended family with hemizygous mutation in ilrg we explore potential diagnostic clue and extend our comprehension of the functional impact of this mutation method whole exome sequencing wes detailed immune phenotyping cytokineinduced stat phosphorylation b t and nk cell activation and quantification of sjtrecs in five arab child with cct prc ilrg mutation result the mean age at clinical presentation with respiratory tract infection or diarrhea wa range month none of the child presented with opportunistic infection diagnostic clue were early onset in the first year of life and a suggestive family history associated with reduced naive cd t cell and absent switched memory b cell number and phenotype of nk cell and innatelike lymphocyte were normal the diagnosis wa made by wes and corroborated by absent stat phosphorylation and reduced functional response after il and il stimulation four patient underwent successful hematopoietic stem cell transplantation conclusion a early diagnosis and treatment are important a high index of suspicion in the diagnosis of cct prc xscid is needed this requires prompt genetic testing by next generation sequencing in order to avoid unnecessary delay in the definite diagnosis since immunological work up may not be discriminating assay directly testing cytokine signaling or cytokinedependent function are helpful in confirming the functional impact of the identified hypomorphic variant
29968256,genotypephenotype correlation in type neurofibromatosis pmetdel mutation and milder disease,a few genotypephenotype correlation have been described in type neurofibromatosis one deletion pmetdel seems to be responsible for a mild form of the condition in which there is absence of externally visible neurofibroma we report a mother and a son with this mutation,Non-Cancer,1,genotypephenotype correlation in type neurofibromatosis pmetdel mutation and milder disease a few genotypephenotype correlation have been described in type neurofibromatosis one deletion pmetdel seems to be responsible for a mild form of the condition in which there is absence of externally visible neurofibroma we report a mother and a son with this mutation
29969437,inherited pphox deficiency differs from classic chronic granulomatous disease,biallelic lossoffunction lof mutation of the ncf gene encoding the pphox subunit of the phagocyte nadph oxidase have been described in only patient we report on pphoxdeficient patient from additional family in country these patient display different inframe or outofframe mutation of ncf that are homozygous in of the family and compound heterozygous in another when overexpressed in nb neutrophillike cell and ebvtransformed b cell in vitro the mutant allele were found to be lof with the exception of the prc and cdel allele which were hypomorphic particleinduced nadph oxidase activity wa severely impaired in the patient neutrophil whereas pmainduced dihydrorhodamine dhr oxidation which is widely used a a diagnostic test for chronic granulomatous disease cgd wa normal or mildly impaired in the patient moreover the nadph oxidase activity of ebvtransformed b cell wa also severely impaired whereas that of mononuclear phagocyte wa normal finally the killing of candida albicans and aspergillus fumigatus hypha by neutrophil wa conserved in these patient unlike in patient with cgd the patient suffer from hyperinflammation and peripheral infection but they do not have any of the invasive bacterial or fungal infection seen in cgd inherited pphox deficiency underlies a distinctive condition resembling a mild atypical form of cgd,Non-Cancer,1,inherited pphox deficiency differs from classic chronic granulomatous disease biallelic lossoffunction lof mutation of the ncf gene encoding the pphox subunit of the phagocyte nadph oxidase have been described in only patient we report on pphoxdeficient patient from additional family in country these patient display different inframe or outofframe mutation of ncf that are homozygous in of the family and compound heterozygous in another when overexpressed in nb neutrophillike cell and ebvtransformed b cell in vitro the mutant allele were found to be lof with the exception of the prc and cdel allele which were hypomorphic particleinduced nadph oxidase activity wa severely impaired in the patient neutrophil whereas pmainduced dihydrorhodamine dhr oxidation which is widely used a a diagnostic test for chronic granulomatous disease cgd wa normal or mildly impaired in the patient moreover the nadph oxidase activity of ebvtransformed b cell wa also severely impaired whereas that of mononuclear phagocyte wa normal finally the killing of candida albicans and aspergillus fumigatus hypha by neutrophil wa conserved in these patient unlike in patient with cgd the patient suffer from hyperinflammation and peripheral infection but they do not have any of the invasive bacterial or fungal infection seen in cgd inherited pphox deficiency underlies a distinctive condition resembling a mild atypical form of cgd
29973720,mechanism for remodelling of the cell cycle checkpoint protein mad by the atpase trip,the maintenance of genome stability during mitosis is coordinated by the spindle assembly checkpoint sac through it effector the mitotic checkpoint complex mcc an inhibitor of the anaphasepromoting complex apcc also known a the cyclosome unattached kinetochore control mcc assembly by catalysing a change in the topology of the betasheet of mad an mcc subunit thereby generating the active closed mad cmad conformer disassembly of free mcc which is required for sac inactivation and chromosome segregation is an atpdependent process driven by the aaa atpase trip in combination with pcomet an sac antagonist trip remodels cmad into inactive open mad omad here we present a mechanism that explains how trippcomet disassembles the mcc cryoelectron microscopy structure of the trippcometcmadcdc complex reveal that pcomet recruit cmad to a defined site on the trip hexameric ring positioning the n terminus of cmad madnt to insert into the axial pore of trip and distorting the trip ring to initiate remodelling molecular modelling suggests that by gripping madnt within it axial pore trip couple sequential atpdriven translocation of it hexameric ring along madnt to push upwards on and simultaneously rotate the globular domain of the pcometcmad complex this unwinds a region of the alphaa helix of cmad that is required to stabilize the cmad betasheet thus destabilizing cmad in favour of omad and dissociating mad from pcomet our study provides insight into how specific substrate are recruited to aaa atpases through adaptor protein and suggests a model of how translocation through the axial pore of aaa atpases is coupled to protein remodelling,Non-Cancer,1,mechanism for remodelling of the cell cycle checkpoint protein mad by the atpase trip the maintenance of genome stability during mitosis is coordinated by the spindle assembly checkpoint sac through it effector the mitotic checkpoint complex mcc an inhibitor of the anaphasepromoting complex apcc also known a the cyclosome unattached kinetochore control mcc assembly by catalysing a change in the topology of the betasheet of mad an mcc subunit thereby generating the active closed mad cmad conformer disassembly of free mcc which is required for sac inactivation and chromosome segregation is an atpdependent process driven by the aaa atpase trip in combination with pcomet an sac antagonist trip remodels cmad into inactive open mad omad here we present a mechanism that explains how trippcomet disassembles the mcc cryoelectron microscopy structure of the trippcometcmadcdc complex reveal that pcomet recruit cmad to a defined site on the trip hexameric ring positioning the n terminus of cmad madnt to insert into the axial pore of trip and distorting the trip ring to initiate remodelling molecular modelling suggests that by gripping madnt within it axial pore trip couple sequential atpdriven translocation of it hexameric ring along madnt to push upwards on and simultaneously rotate the globular domain of the pcometcmad complex this unwinds a region of the alphaa helix of cmad that is required to stabilize the cmad betasheet thus destabilizing cmad in favour of omad and dissociating mad from pcomet our study provides insight into how specific substrate are recruited to aaa atpases through adaptor protein and suggests a model of how translocation through the axial pore of aaa atpases is coupled to protein remodelling
29984440,type von willebrand disease in indiaclinical spectrum and molecular profile,introduction type von willebrand disease vwd is the rare and most severe form of vwd which result from a nearcomplete deficiency of the von willebrand factor vwf this study evaluates in detail the molecular pathology of type vwd in india one hundred and two patient from family were evaluated patient and method phenotypic data including bleeding score b were documented using structured questionnaire diagnosis of type vwd wa based on undetectable vwf antigen level in the plasma genomic dna from these patient wa screened for mutation in vwf gene structural modeling and expression study were carried out for missense mutation result out of patient mutation could be identified in n fiftyfive different gene variant were identified thirtyfour were novel mutation could be identified in both the allele in patient while no causative mutation could be identified in patient twentyfour patient had mutation clustered in the propeptide region of vwf interestingly five mutation accounted for the defect in patient structural analysis and in vitro study on missense mutation imply impaired process associated with secretion of vwf conclusion this study is one of the largest series to define the molecular basis of type vwd,Non-Cancer,1,type von willebrand disease in indiaclinical spectrum and molecular profile introduction type von willebrand disease vwd is the rare and most severe form of vwd which result from a nearcomplete deficiency of the von willebrand factor vwf this study evaluates in detail the molecular pathology of type vwd in india one hundred and two patient from family were evaluated patient and method phenotypic data including bleeding score b were documented using structured questionnaire diagnosis of type vwd wa based on undetectable vwf antigen level in the plasma genomic dna from these patient wa screened for mutation in vwf gene structural modeling and expression study were carried out for missense mutation result out of patient mutation could be identified in n fiftyfive different gene variant were identified thirtyfour were novel mutation could be identified in both the allele in patient while no causative mutation could be identified in patient twentyfour patient had mutation clustered in the propeptide region of vwf interestingly five mutation accounted for the defect in patient structural analysis and in vitro study on missense mutation imply impaired process associated with secretion of vwf conclusion this study is one of the largest series to define the molecular basis of type vwd
30007456,cutaneous mastocytosis in adult and child new classification and prognostic factor,the skin is one of the most frequent tissue affected in patient with mastocytosis but cutaneous lesion are highly heterogeneous in shape size color number localization and distribution the world health organization recognizes subtypes of cutaneous mastocytosis cm maculopapular cm mpcm diffuse cm and mastocytoma of skin an international task force of expert in mastocytosis ha recently proposed subdividing mpcm into monomorphic and polymorphic which could predict the duration of the disease in child more research is warranted to develop an improved classification of cm that ideally should incorporate robust factor with prognostic impact on disease behavior,Non-Cancer,1,cutaneous mastocytosis in adult and child new classification and prognostic factor the skin is one of the most frequent tissue affected in patient with mastocytosis but cutaneous lesion are highly heterogeneous in shape size color number localization and distribution the world health organization recognizes subtypes of cutaneous mastocytosis cm maculopapular cm mpcm diffuse cm and mastocytoma of skin an international task force of expert in mastocytosis ha recently proposed subdividing mpcm into monomorphic and polymorphic which could predict the duration of the disease in child more research is warranted to develop an improved classification of cm that ideally should incorporate robust factor with prognostic impact on disease behavior
30007458,bone marrow expression of mast cell disorder,mast cell disorder comprise a heterogeneous group of rare disease the diagnosis of which still remains a challenge bone marrow analysis constitutes the most appropriate site for screening systemic involvement in mastocytosis morphologic immunohistochemical flow cytometric immunophenotyping and molecular study should be routinely performed for diagnosticprognostic purpose in experienced reference center during the diagnostic workup in suspected systemic mastocytosis the author review the most relevant characteristic of bone marrow expression of mast cell disorder a well a the different methodological approach to be applied to perform an objective and reproducible diagnosis and classification of mastocytosis and other mast cell disorder,Non-Cancer,1,bone marrow expression of mast cell disorder mast cell disorder comprise a heterogeneous group of rare disease the diagnosis of which still remains a challenge bone marrow analysis constitutes the most appropriate site for screening systemic involvement in mastocytosis morphologic immunohistochemical flow cytometric immunophenotyping and molecular study should be routinely performed for diagnosticprognostic purpose in experienced reference center during the diagnostic workup in suspected systemic mastocytosis the author review the most relevant characteristic of bone marrow expression of mast cell disorder a well a the different methodological approach to be applied to perform an objective and reproducible diagnosis and classification of mastocytosis and other mast cell disorder
30009677,generation of cd fluorescent reporter human induced pluripotent stem cell for monitoring hematopoietic differentiation,hematopoietic stem and progenitor cell hspcs derived from human induced pluripotent stem cell hipscs hold great promise for disease modeling drug screen and eventually cell therapy approach during in vitro differentiation of hipscs into hematoendothelial progenitor the emergence of cdpositive cell indicates a critical step of lineage specification to facilitate the monitoring of hematopoietic differentiation of hipscs we established fluorescent reporter cell for the stem and progenitor cell marker cd an iresgfp internal ribosome entry site green fluorescent protein construct wa introduced by crisprcas into the untranslated region of one endogenous cd allele singlecell clone were generated after excision of the floxed puromycin resistance cassette by cre recombination and correct insertion wa confirmed by genotyping polymerase chain reaction and southern blot to validate their functionality the reporter hipscs were in vitro differentiated toward cd cell using the stemdiff hematopoietic kit combined with shortterm inhibition of gsk glycogen synthase kinase all cell expressing nuclear gfp were positive for cell surface cd thus allowing the direct monitoring of the differentiation of hipscs into cd cell either by flow cytometry or confocal microscopy after fluorescenceactivated cell sorting cell displaying high gfp expression exhibited increased colonyforming potential in the methocult colonyforming unit assay a compared with cd cell obtained by magneticactivated cell sorting in summary we have generated functional cd gfp reporter hipscs which not only permit labelfree separation of hspcs but also tracing of the emergence and fate of cd progenitor at the singlecell level,Non-Cancer,1,generation of cd fluorescent reporter human induced pluripotent stem cell for monitoring hematopoietic differentiation hematopoietic stem and progenitor cell hspcs derived from human induced pluripotent stem cell hipscs hold great promise for disease modeling drug screen and eventually cell therapy approach during in vitro differentiation of hipscs into hematoendothelial progenitor the emergence of cdpositive cell indicates a critical step of lineage specification to facilitate the monitoring of hematopoietic differentiation of hipscs we established fluorescent reporter cell for the stem and progenitor cell marker cd an iresgfp internal ribosome entry site green fluorescent protein construct wa introduced by crisprcas into the untranslated region of one endogenous cd allele singlecell clone were generated after excision of the floxed puromycin resistance cassette by cre recombination and correct insertion wa confirmed by genotyping polymerase chain reaction and southern blot to validate their functionality the reporter hipscs were in vitro differentiated toward cd cell using the stemdiff hematopoietic kit combined with shortterm inhibition of gsk glycogen synthase kinase all cell expressing nuclear gfp were positive for cell surface cd thus allowing the direct monitoring of the differentiation of hipscs into cd cell either by flow cytometry or confocal microscopy after fluorescenceactivated cell sorting cell displaying high gfp expression exhibited increased colonyforming potential in the methocult colonyforming unit assay a compared with cd cell obtained by magneticactivated cell sorting in summary we have generated functional cd gfp reporter hipscs which not only permit labelfree separation of hspcs but also tracing of the emergence and fate of cd progenitor at the singlecell level
30051161,toxoplasma gondii chromosomal passenger complex is essential for the organization of a functional mitotic spindle a prerequisite for productive endodyogeny,the phylum apicomplexa encompasses deadly pathogen such a malaria and cryptosporidium apicomplexa cell division is mechanistically divergent from that of their mammalian host potentially representing an attractive source of drug target depending on the specie apicomplexan parasite can modulate the output of cell division producing two to thousand of daughter cell at once the inherent flexibility of their cell division mechanism allows these parasite to adapt to different niche facilitating their dissemination toxoplasma gondii tachyzoites divide using a unique form of cell division called endodyogeny this process involves a single round of dna replication closed nuclear mitosis and assembly of two daughter cell within a mother in higher eukaryote the foursubunit chromosomal passenger complex cpc aurora kinase b arkbincenpborealinsurvivin promotes chromosome biorientation by detaching incorrect kinetochoremicrotubule attachment playing an essential role in controlling cell division fidelity herein we report the characterization of the toxoplasma cpc aurora kinase arkincenpincenp we show that the cpc exhibit dynamic localization in a cell cycledependent manner tgark interacts with both tgincenps with tgincenp being essential for it translocation to the nucleus while tgincenp appears to be dispensable interfering with tgark or tgincenp result in pronounced division and growth defect significant anticancer drug development effort have focused on targeting human arkb parasite treatment with low dos of hesperadin a known inhibitor of human arkb at higher concentration phenocopies the tgark and tgincenp mutant overall our study provides new insight into the mechanism underpinning cell cycle control in apicomplexa and highlight tgark a potential drug target,Non-Cancer,1,toxoplasma gondii chromosomal passenger complex is essential for the organization of a functional mitotic spindle a prerequisite for productive endodyogeny the phylum apicomplexa encompasses deadly pathogen such a malaria and cryptosporidium apicomplexa cell division is mechanistically divergent from that of their mammalian host potentially representing an attractive source of drug target depending on the specie apicomplexan parasite can modulate the output of cell division producing two to thousand of daughter cell at once the inherent flexibility of their cell division mechanism allows these parasite to adapt to different niche facilitating their dissemination toxoplasma gondii tachyzoites divide using a unique form of cell division called endodyogeny this process involves a single round of dna replication closed nuclear mitosis and assembly of two daughter cell within a mother in higher eukaryote the foursubunit chromosomal passenger complex cpc aurora kinase b arkbincenpborealinsurvivin promotes chromosome biorientation by detaching incorrect kinetochoremicrotubule attachment playing an essential role in controlling cell division fidelity herein we report the characterization of the toxoplasma cpc aurora kinase arkincenpincenp we show that the cpc exhibit dynamic localization in a cell cycledependent manner tgark interacts with both tgincenps with tgincenp being essential for it translocation to the nucleus while tgincenp appears to be dispensable interfering with tgark or tgincenp result in pronounced division and growth defect significant anticancer drug development effort have focused on targeting human arkb parasite treatment with low dos of hesperadin a known inhibitor of human arkb at higher concentration phenocopies the tgark and tgincenp mutant overall our study provides new insight into the mechanism underpinning cell cycle control in apicomplexa and highlight tgark a potential drug target
30065290,myelofibrosis treatment algorithm,two novel prognostic system for primary myelofibrosis pmf were recently unveiled gipss genetically inspired prognostic scoring system and mips mutationenhanced international prognostic scoring system for transplantage patient gipss is based exclusively on genetic marker mutation and karyotype mips includes mutation and clinical risk factor in it most recent adaptation the prognostic value of mips ha been bolstered by the inclusion of a threetiered cytogenetic risk stratification and use of hemoglobin threshold that are adjusted for sex and severity mips version gipss feature four mips three and mips version five risk category mips is most useful in the absence of cytogenetic information mips version is more comprehensive than mips and is the preferred model in the presence of cytogenetic information both mips and mips version require an online score calculator httpwwwmipssscoreit gipps offer a lower complexity prognostic tool that reliably identifies candidate for allogeneic stem cell transplant gipss highrisk disease or longterm observation with little or no therapeutic intervention gipss lowrisk disease ultimately we favor a stepwise prognostication approach that start with gipss but also considers mips version for confirming the most appropriate treatment approach for the individual patient,Non-Cancer,1,myelofibrosis treatment algorithm two novel prognostic system for primary myelofibrosis pmf were recently unveiled gipss genetically inspired prognostic scoring system and mips mutationenhanced international prognostic scoring system for transplantage patient gipss is based exclusively on genetic marker mutation and karyotype mips includes mutation and clinical risk factor in it most recent adaptation the prognostic value of mips ha been bolstered by the inclusion of a threetiered cytogenetic risk stratification and use of hemoglobin threshold that are adjusted for sex and severity mips version gipss feature four mips three and mips version five risk category mips is most useful in the absence of cytogenetic information mips version is more comprehensive than mips and is the preferred model in the presence of cytogenetic information both mips and mips version require an online score calculator httpwwwmipssscoreit gipps offer a lower complexity prognostic tool that reliably identifies candidate for allogeneic stem cell transplant gipss highrisk disease or longterm observation with little or no therapeutic intervention gipss lowrisk disease ultimately we favor a stepwise prognostication approach that start with gipss but also considers mips version for confirming the most appropriate treatment approach for the individual patient
30085095,bioengineered pbgd variant improves the therapeutic index of gene therapy vector for acute intermittent porphyria,a firstinhuman gene therapy trial using a recombinant adenoassociated viral raav vector for acute intermittent porphyria aip reveals that higher dos would be required to reach therapeutic level of the porphobilinogen deaminase pbgd transgene we developed a hyperfunctional pbgd protein to improve the therapeutic index without increasing vector dose a consensus protein sequence from mammal specie wa compared to the human pbgd sequence and eight amino acid were selected im and n variant showed the highest increase in enzymatic activity when expressed in prokaryotic and eukaryotic system in silico analysis indicates that isoleucine to methionine and asparagine to serine variant did not affect the active site of the enzyme in vitro analysis indicated a synergistic interaction between these two substitution that improve kinetic stability finally full protection against a phenobarbitalinduced attack wa achieved in aip mouse after the administration of x gckg of raavpbgdimns vector three time lower than the dose required to achieve full protection with the control raavhpbgd vector in conclusion we have developed and characterized a hyperfunctional pbgd protein the inclusion of this variant sequence in a raav vector allows the effective dose to be lowered in aip mouse,Non-Cancer,1,bioengineered pbgd variant improves the therapeutic index of gene therapy vector for acute intermittent porphyria a firstinhuman gene therapy trial using a recombinant adenoassociated viral raav vector for acute intermittent porphyria aip reveals that higher dos would be required to reach therapeutic level of the porphobilinogen deaminase pbgd transgene we developed a hyperfunctional pbgd protein to improve the therapeutic index without increasing vector dose a consensus protein sequence from mammal specie wa compared to the human pbgd sequence and eight amino acid were selected im and n variant showed the highest increase in enzymatic activity when expressed in prokaryotic and eukaryotic system in silico analysis indicates that isoleucine to methionine and asparagine to serine variant did not affect the active site of the enzyme in vitro analysis indicated a synergistic interaction between these two substitution that improve kinetic stability finally full protection against a phenobarbitalinduced attack wa achieved in aip mouse after the administration of x gckg of raavpbgdimns vector three time lower than the dose required to achieve full protection with the control raavhpbgd vector in conclusion we have developed and characterized a hyperfunctional pbgd protein the inclusion of this variant sequence in a raav vector allows the effective dose to be lowered in aip mouse
30092282,rna binding protein hur regulates extracellular matrix gene expression and ph homeostasis independent of controlling hifalpha signaling in nucleus pulposus cell,nucleus pulposus np cell reside in the hypoxic niche of the intervertebral disc study have demonstrated that rnabinding protein hur modulates hypoxic signaling in several cancer however it function in the disc is unknown hur did not show cytoplasmic translocation in hypoxia and it silencing did not alter level of hifalpha or hiftargets in np cell rnasequencing data revealed that important extracellular matrixrelated gene including several collagen mmps aggrecan tgfbeta and sdc were regulated by hur further analysis of hursilenced np cell confirmed that hur maintained expression of these matrix gene we confirmed decreased level of secreted collagen i and sdc and increased prommp in hurknockdown cell in addition messenger ribonucleoprotein immunoprecipitation demonstrated hur binding to tgfbeta and sdc mrna interestingly while hur bound to hifalpha and vegf mrna it wa clear that compensatory mechanism sustained their expression when hur wa silenced noteworthy despite the presence of multiple hurbinding site and reported interaction in other cell type hur showed no binding to pgk eno pdk and pfkfb in np cell metabolic study showed a significant decrease in the extracellular acidification rate ecar and mitochondrial oxygen consumption rate ocr and acidic ph in hursilenced np cell without appreciable change in total ocr these change were likely due to decreased ca expression in hur silenced cell taken together our study demonstrates for the first time that hur regulates extracellular matrix ecm and ph homeostasis of np cell and ha important implication in the maintenance of intervertebral disc health,Non-Cancer,1,rna binding protein hur regulates extracellular matrix gene expression and ph homeostasis independent of controlling hifalpha signaling in nucleus pulposus cell nucleus pulposus np cell reside in the hypoxic niche of the intervertebral disc study have demonstrated that rnabinding protein hur modulates hypoxic signaling in several cancer however it function in the disc is unknown hur did not show cytoplasmic translocation in hypoxia and it silencing did not alter level of hifalpha or hiftargets in np cell rnasequencing data revealed that important extracellular matrixrelated gene including several collagen mmps aggrecan tgfbeta and sdc were regulated by hur further analysis of hursilenced np cell confirmed that hur maintained expression of these matrix gene we confirmed decreased level of secreted collagen i and sdc and increased prommp in hurknockdown cell in addition messenger ribonucleoprotein immunoprecipitation demonstrated hur binding to tgfbeta and sdc mrna interestingly while hur bound to hifalpha and vegf mrna it wa clear that compensatory mechanism sustained their expression when hur wa silenced noteworthy despite the presence of multiple hurbinding site and reported interaction in other cell type hur showed no binding to pgk eno pdk and pfkfb in np cell metabolic study showed a significant decrease in the extracellular acidification rate ecar and mitochondrial oxygen consumption rate ocr and acidic ph in hursilenced np cell without appreciable change in total ocr these change were likely due to decreased ca expression in hur silenced cell taken together our study demonstrates for the first time that hur regulates extracellular matrix ecm and ph homeostasis of np cell and ha important implication in the maintenance of intervertebral disc health
30098008,everolimus in infant with tuberous sclerosis complexrelated west syndrome first result from a singlecenter prospective observational study,tuberous sclerosis complex tsc is the most common cause of west syndrome w currently available treatment option are ineffective in the majority of affected infant andor associated with potential serious side effect based on the assumption that mtor overactivation result in increased neuroexcitability in tsc mtor inhibitor have been studied a antiseizure therapy a a result everolimus recently received approval for the adjunctive treatment of patient aged year with refractory tscassociated focal and secondary generalized seizure however efficacy and safety data for infant with tscassociated w are still lacking therefore a prospective openlabel observational study wa initiated at our center to evaluate everolimus addon treatment in infant with tscassociated w previously refractory to standard treatment for this preliminary report data from four male infant with tsc and a median observation period of range month after treatment initiation were analyzed two infant showed electroclinical remission until day after everolimus treatment initiation in one additional infant hypsarrhythmia resolved no relapse after initial response wa documented developmental progress improved in three infant tolerability wa similar to that described in older child according to our preliminary result everolimus appears to have the potential to treat successfully both spasm and hypsarrhythmia in infant with tscassociated w contributing to better developmental progress,Non-Cancer,1,everolimus in infant with tuberous sclerosis complexrelated west syndrome first result from a singlecenter prospective observational study tuberous sclerosis complex tsc is the most common cause of west syndrome w currently available treatment option are ineffective in the majority of affected infant andor associated with potential serious side effect based on the assumption that mtor overactivation result in increased neuroexcitability in tsc mtor inhibitor have been studied a antiseizure therapy a a result everolimus recently received approval for the adjunctive treatment of patient aged year with refractory tscassociated focal and secondary generalized seizure however efficacy and safety data for infant with tscassociated w are still lacking therefore a prospective openlabel observational study wa initiated at our center to evaluate everolimus addon treatment in infant with tscassociated w previously refractory to standard treatment for this preliminary report data from four male infant with tsc and a median observation period of range month after treatment initiation were analyzed two infant showed electroclinical remission until day after everolimus treatment initiation in one additional infant hypsarrhythmia resolved no relapse after initial response wa documented developmental progress improved in three infant tolerability wa similar to that described in older child according to our preliminary result everolimus appears to have the potential to treat successfully both spasm and hypsarrhythmia in infant with tscassociated w contributing to better developmental progress
30115720,tension haemothorax from a bleeding branch of the renal artery following isolated penetrating thoracic trauma a rare presentation,a yearold man presented to a major trauma centre with two posterolateral thoracic stab injury over the right scapula and thoracoabdominal junction he wa tachycardic and hypotensive with a chest xray revealing a large rightsided tension haemothorax requiring insertion of two intercostal chest drain a subsequent ct scan demonstrated a grade right kidney laceration with active back bleeding from a renal artery branch through a right diaphragmatic defect into the pleural cavity embolisation of the feeding renal vessel controlled the bleeding and avoided the need for a nephrectomy the patient required subsequent videoassisted thoracoscopic evacuation of the haemothorax and diaphragmatic repair confirming that there wa no associated lung or major vessel injury a ureteric stent wa ultimately inserted to manage a persistent urinary leak this case highlight a rare cause for a common traumatic presentation and the need for a multidisciplinary approach in effective management of complex multiorgan trauma,Non-Cancer,1,tension haemothorax from a bleeding branch of the renal artery following isolated penetrating thoracic trauma a rare presentation a yearold man presented to a major trauma centre with two posterolateral thoracic stab injury over the right scapula and thoracoabdominal junction he wa tachycardic and hypotensive with a chest xray revealing a large rightsided tension haemothorax requiring insertion of two intercostal chest drain a subsequent ct scan demonstrated a grade right kidney laceration with active back bleeding from a renal artery branch through a right diaphragmatic defect into the pleural cavity embolisation of the feeding renal vessel controlled the bleeding and avoided the need for a nephrectomy the patient required subsequent videoassisted thoracoscopic evacuation of the haemothorax and diaphragmatic repair confirming that there wa no associated lung or major vessel injury a ureteric stent wa ultimately inserted to manage a persistent urinary leak this case highlight a rare cause for a common traumatic presentation and the need for a multidisciplinary approach in effective management of complex multiorgan trauma
30124220,a case of growth hormone deficiency combined with neurofibromatosis type and it gene analysis,neurofibromatosis type nf is an autosomal dominant genetic disorder caused by nf gene mutation cafe au lait spot neurofibromatosis lisch nodule axillary freckling dermal neurofibroma and skeletal dysplasia are the most common manifestation for this disease a yearold boy visited third xiangya hospital central south university due to growthretardation he wa eventually diagnosed a nf with growth hormone deficiency a novel heterozygous splicing mutation c tc iv tc of nf gene wa identified in the patient and his mother considering nf may present with short stature due to growth hormone deficiency all child with short stature combined with cafe au lait spot should be screened for nf which may assist the clinical diagnosis and the genetic counseling,Non-Cancer,1,a case of growth hormone deficiency combined with neurofibromatosis type and it gene analysis neurofibromatosis type nf is an autosomal dominant genetic disorder caused by nf gene mutation cafe au lait spot neurofibromatosis lisch nodule axillary freckling dermal neurofibroma and skeletal dysplasia are the most common manifestation for this disease a yearold boy visited third xiangya hospital central south university due to growthretardation he wa eventually diagnosed a nf with growth hormone deficiency a novel heterozygous splicing mutation c tc iv tc of nf gene wa identified in the patient and his mother considering nf may present with short stature due to growth hormone deficiency all child with short stature combined with cafe au lait spot should be screened for nf which may assist the clinical diagnosis and the genetic counseling
30150778,distinct systemic microbiome and microbial translocation are associated with plasma level of anticd autoantibody in hiv infection,microbial signal have been linked to autoantibody induction recently we found that purified anticd autoantibody from the plasma of chronic hivinfected patient under viralsuppressed antiretroviral therapy art play a pathologic role in poor cd t cell recovery the purpose of the study wa to investigate the association of systemic microbiome and anticd autoantibody production in hiv plasma microbiome from healthy control and hivinfected subject under viralsuppressed art were analyzed by miseq sequencing plasma level of autoantibody and microbial translocation lp total bacterial s rdna soluble cd and lp binding protein were analyzed by elisa limulus amebocyte assay and qpcr we found that plasma level of anticd igg but not anticd igg wa increased in hiv subject compared to healthy control hiv subject with plasma anticd igg ngml high had reduced microbial diversity compared to hiv subject with anticd igg ngml low moreover plasma anticd igg level wa associated with elevated microbial translocation and reduced microbial diversity in hiv subject the alphaproteobacteria class wa significantly enriched in hiv subject with low anticd igg compared to patient with high anticd igg even after controlling for false discovery rate fdr the microbial component were different from the phylum to genus level in hiv subject with high anticd igg compared to the other two group but these difference were not significant after controlling for fdr these result suggest that systemic microbial translocation and microbiome may associate with anticd autoantibody production in arttreated hiv disease,Non-Cancer,1,distinct systemic microbiome and microbial translocation are associated with plasma level of anticd autoantibody in hiv infection microbial signal have been linked to autoantibody induction recently we found that purified anticd autoantibody from the plasma of chronic hivinfected patient under viralsuppressed antiretroviral therapy art play a pathologic role in poor cd t cell recovery the purpose of the study wa to investigate the association of systemic microbiome and anticd autoantibody production in hiv plasma microbiome from healthy control and hivinfected subject under viralsuppressed art were analyzed by miseq sequencing plasma level of autoantibody and microbial translocation lp total bacterial s rdna soluble cd and lp binding protein were analyzed by elisa limulus amebocyte assay and qpcr we found that plasma level of anticd igg but not anticd igg wa increased in hiv subject compared to healthy control hiv subject with plasma anticd igg ngml high had reduced microbial diversity compared to hiv subject with anticd igg ngml low moreover plasma anticd igg level wa associated with elevated microbial translocation and reduced microbial diversity in hiv subject the alphaproteobacteria class wa significantly enriched in hiv subject with low anticd igg compared to patient with high anticd igg even after controlling for false discovery rate fdr the microbial component were different from the phylum to genus level in hiv subject with high anticd igg compared to the other two group but these difference were not significant after controlling for fdr these result suggest that systemic microbial translocation and microbiome may associate with anticd autoantibody production in arttreated hiv disease
30154114,scid genotype and month posttransplant cd count predict survival and immune recovery,the primary immune deficiency treatment consortium pidtc performed a retrospective analysis of patient with severe combined immunodeficiency scid who received a hematopoietic cell transplantation hct a firstline treatment between and in north american institution overall survival wa higher after hct from matchedsibling donor msds among recipient of nonmsd hct multivariate analysis showed that the scid genotype strongly influenced survival and immune reconstitution overall survival wa similar for patient with rag ilrg or jak defect and wa significantly better compared with patient with ada or dclrec mutation patient with rag or dclrec mutation had poorer immune reconstitution than other genotype although survival did not correlate with the type of conditioning regimen recipient of reducedintensity or myeloablative conditioning had a lower incidence of treatment failure and better t and bcell reconstitution but a higher risk for graftversushost disease compared with those receiving no conditioning or immunosuppression only infectionfree status and younger age at hct were associated with improved survival typical scid leaky scid and omenn syndrome had similar outcome landmark analysis identified cd and cdcdra cell count at and month posthct a biomarkers predictive of overall survival and longterm tcell reconstitution our data emphasize the need for patienttailored treatment strategy depending upon the underlying scid genotype the prognostic significance of cd cell count a early a month after hct emphasizes the importance of close followup of immune reconstitution to identify patient who may need additional intervention to prevent poor longterm outcome,Non-Cancer,1,scid genotype and month posttransplant cd count predict survival and immune recovery the primary immune deficiency treatment consortium pidtc performed a retrospective analysis of patient with severe combined immunodeficiency scid who received a hematopoietic cell transplantation hct a firstline treatment between and in north american institution overall survival wa higher after hct from matchedsibling donor msds among recipient of nonmsd hct multivariate analysis showed that the scid genotype strongly influenced survival and immune reconstitution overall survival wa similar for patient with rag ilrg or jak defect and wa significantly better compared with patient with ada or dclrec mutation patient with rag or dclrec mutation had poorer immune reconstitution than other genotype although survival did not correlate with the type of conditioning regimen recipient of reducedintensity or myeloablative conditioning had a lower incidence of treatment failure and better t and bcell reconstitution but a higher risk for graftversushost disease compared with those receiving no conditioning or immunosuppression only infectionfree status and younger age at hct were associated with improved survival typical scid leaky scid and omenn syndrome had similar outcome landmark analysis identified cd and cdcdra cell count at and month posthct a biomarkers predictive of overall survival and longterm tcell reconstitution our data emphasize the need for patienttailored treatment strategy depending upon the underlying scid genotype the prognostic significance of cd cell count a early a month after hct emphasizes the importance of close followup of immune reconstitution to identify patient who may need additional intervention to prevent poor longterm outcome
30177503,inheritance of oct predetermines fate choice in human embryonic stem cell,it is well known that clonal cell can make different fate decision but it is unclear whether these decision are determined during or before a cell own lifetime here we engineered an endogenous fluorescent reporter for the pluripotency factor oct to study the timing of differentiation decision in human embryonic stem cell by tracking singlecell oct level over multiple cell cycle generation we found that the decision to differentiate is largely determined before the differentiation stimulus is presented and can be predicted by a cell preexisting oct signaling pattern we further quantified how maternal oct level were transmitted to and distributed between daughter cell a mother cell underwent division newly established oct level in daughter cell rapidly became more predictive of final oct expression status these result imply that the choice between developmental cell fate can be largely predetermined at the time of cell birth through inheritance of a pluripotency factor,Non-Cancer,1,inheritance of oct predetermines fate choice in human embryonic stem cell it is well known that clonal cell can make different fate decision but it is unclear whether these decision are determined during or before a cell own lifetime here we engineered an endogenous fluorescent reporter for the pluripotency factor oct to study the timing of differentiation decision in human embryonic stem cell by tracking singlecell oct level over multiple cell cycle generation we found that the decision to differentiate is largely determined before the differentiation stimulus is presented and can be predicted by a cell preexisting oct signaling pattern we further quantified how maternal oct level were transmitted to and distributed between daughter cell a mother cell underwent division newly established oct level in daughter cell rapidly became more predictive of final oct expression status these result imply that the choice between developmental cell fate can be largely predetermined at the time of cell birth through inheritance of a pluripotency factor
30179860,loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mouse,preeclampsia remains a clinical challenge due to it poorly understood pathogenesis a prevailing notion is that increased placental production of soluble fmslike tyrosine kinase sflt cause the maternal syndrome by inhibiting proangiogenic placental growth factor plgf and vegf however the significance of plgf suppression in preeclampsia is uncertain to test whether preeclampsia result from the imbalance of angiogenic factor reflected by an abnormal sfltplgf ratio we studied plgf ko pgf mouse and noted that the mouse did not develop sign or sequela of preeclampsia despite a marked elevation in circulating sflt notably plgf ko mouse had morphologically distinct placenta showing an accumulation of junctional zone glycogen we next considered the role of placental plgf in an established model of preeclampsia pregnant catecholomethyltransferasedeficient comtdeficient mouse by generating mouse with deletion in both the pgf and comt gene deletion of placental plgf in the context of comt loss resulted in a reduction in maternal blood pressure and increased placental glycogen indicating that loss of plgf might be protective against the development of preeclampsia these result identify a role for plgf in placental development and support a complex model for the pathogenesis of preeclampsia beyond an angiogenic factor imbalance,Non-Cancer,1,loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mouse preeclampsia remains a clinical challenge due to it poorly understood pathogenesis a prevailing notion is that increased placental production of soluble fmslike tyrosine kinase sflt cause the maternal syndrome by inhibiting proangiogenic placental growth factor plgf and vegf however the significance of plgf suppression in preeclampsia is uncertain to test whether preeclampsia result from the imbalance of angiogenic factor reflected by an abnormal sfltplgf ratio we studied plgf ko pgf mouse and noted that the mouse did not develop sign or sequela of preeclampsia despite a marked elevation in circulating sflt notably plgf ko mouse had morphologically distinct placenta showing an accumulation of junctional zone glycogen we next considered the role of placental plgf in an established model of preeclampsia pregnant catecholomethyltransferasedeficient comtdeficient mouse by generating mouse with deletion in both the pgf and comt gene deletion of placental plgf in the context of comt loss resulted in a reduction in maternal blood pressure and increased placental glycogen indicating that loss of plgf might be protective against the development of preeclampsia these result identify a role for plgf in placental development and support a complex model for the pathogenesis of preeclampsia beyond an angiogenic factor imbalance
30184455,baloxavir marboxil for uncomplicated influenza in adult and adolescent,background baloxavir marboxil is a selective inhibitor of influenza capdependent endonuclease it ha shown therapeutic activity in preclinical model of influenza a and b virus infection including strain resistant to current antiviral agent method we conducted two randomized doubleblind controlled trial involving otherwise healthy outpatient with acute uncomplicated influenza after a doseranging to mg placebocontrolled trial we undertook a placebo and oseltamivircontrolled trial of single weightbased dos of baloxavir or mg in patient to year of age during the season the dose of oseltamivir wa mg twice daily for day the primary efficacy end point wa the time to alleviation of influenza symptom in the intentiontotreat infected population result in the phase trial the median time to alleviation of influenza symptom wa to hour shorter in the baloxavir group than in the placebo group p in the phase trial the intentiontotreat infected population included patient to of patient in each group had influenza ahn infection the median time to alleviation of symptom wa hour confidence interval ci to with baloxavir a compared with hour ci to with placebo p the time to alleviation of symptom wa similar with baloxavir and oseltamivir baloxavir wa associated with greater reduction in viral load day after initiation of the regimen than placebo or oseltamivir adverse event were reported in of baloxavir recipient of placebo recipient and of oseltamivir recipient the emergence of polymerase acidic protein variant with itmf substitution conferring reduced susceptibility to baloxavir occurred in and of baloxavir recipient in the phase trial and phase trial respectively conclusion singledose baloxavir wa without evident safety concern wa superior to placebo in alleviating influenza symptom and wa superior to both oseltamivir and placebo in reducing the viral load day after initiation of the trial regimen in patient with uncomplicated influenza evidence for the development of decreased susceptibility to baloxavir after treatment wa also observed funded by shionogi japiccti number and capstone clinicaltrialsgov number nct,Non-Cancer,1,baloxavir marboxil for uncomplicated influenza in adult and adolescent background baloxavir marboxil is a selective inhibitor of influenza capdependent endonuclease it ha shown therapeutic activity in preclinical model of influenza a and b virus infection including strain resistant to current antiviral agent method we conducted two randomized doubleblind controlled trial involving otherwise healthy outpatient with acute uncomplicated influenza after a doseranging to mg placebocontrolled trial we undertook a placebo and oseltamivircontrolled trial of single weightbased dos of baloxavir or mg in patient to year of age during the season the dose of oseltamivir wa mg twice daily for day the primary efficacy end point wa the time to alleviation of influenza symptom in the intentiontotreat infected population result in the phase trial the median time to alleviation of influenza symptom wa to hour shorter in the baloxavir group than in the placebo group p in the phase trial the intentiontotreat infected population included patient to of patient in each group had influenza ahn infection the median time to alleviation of symptom wa hour confidence interval ci to with baloxavir a compared with hour ci to with placebo p the time to alleviation of symptom wa similar with baloxavir and oseltamivir baloxavir wa associated with greater reduction in viral load day after initiation of the regimen than placebo or oseltamivir adverse event were reported in of baloxavir recipient of placebo recipient and of oseltamivir recipient the emergence of polymerase acidic protein variant with itmf substitution conferring reduced susceptibility to baloxavir occurred in and of baloxavir recipient in the phase trial and phase trial respectively conclusion singledose baloxavir wa without evident safety concern wa superior to placebo in alleviating influenza symptom and wa superior to both oseltamivir and placebo in reducing the viral load day after initiation of the trial regimen in patient with uncomplicated influenza evidence for the development of decreased susceptibility to baloxavir after treatment wa also observed funded by shionogi japiccti number and capstone clinicaltrialsgov number nct
30188763,suppression of wntbetacatenin signaling by egf receptor is required for hair follicle development,mouse that lack the epidermal growth factor receptor egfr fail to develop a hair coat but the mechanism responsible for this deficit is not completely understood here we show that egfr play a critical role to attenuate winglesstype mmtv integration site family member wntbetacatenin signaling during postnatal hair follicle development genetic ablation of egfr in mouse resulted in increased mitotic activity in matrix cell apoptosis in hair follicle and impaired differentiation of epithelial lineage that form hair egfr is activated in wildtype hair follicle stem cell marked with sox or nfatc and is essential to restrain proliferation and support stem cell number and their quiescence we observed elevated level of wnt b a b and transcript and hyperactivation of the betacatenin pathway in egfr knockout follicle using primary keratinocytes we linked ligandinduced egfr activation to suppression of nascent mrna synthesis of wnt gene overexpression of the wnt antagonist sfrp in mouse lacking egfr demonstrated that elevated wnts are a major cause for the hair follicle defect colocalization of transforming growth factor alpha and wnts regulated by egfr in stem cell and progeny indicates that egfr autocrine loop control wnts our finding define a novel mechanism that integrates egfr and wntbetacatenin pathway to coordinate the delicate balance between proliferation and differentiation during development,Non-Cancer,1,suppression of wntbetacatenin signaling by egf receptor is required for hair follicle development mouse that lack the epidermal growth factor receptor egfr fail to develop a hair coat but the mechanism responsible for this deficit is not completely understood here we show that egfr play a critical role to attenuate winglesstype mmtv integration site family member wntbetacatenin signaling during postnatal hair follicle development genetic ablation of egfr in mouse resulted in increased mitotic activity in matrix cell apoptosis in hair follicle and impaired differentiation of epithelial lineage that form hair egfr is activated in wildtype hair follicle stem cell marked with sox or nfatc and is essential to restrain proliferation and support stem cell number and their quiescence we observed elevated level of wnt b a b and transcript and hyperactivation of the betacatenin pathway in egfr knockout follicle using primary keratinocytes we linked ligandinduced egfr activation to suppression of nascent mrna synthesis of wnt gene overexpression of the wnt antagonist sfrp in mouse lacking egfr demonstrated that elevated wnts are a major cause for the hair follicle defect colocalization of transforming growth factor alpha and wnts regulated by egfr in stem cell and progeny indicates that egfr autocrine loop control wnts our finding define a novel mechanism that integrates egfr and wntbetacatenin pathway to coordinate the delicate balance between proliferation and differentiation during development
30201950,hepatic agomediated rna silencing control energy metabolism linked to ampk activation and obesityassociated pathophysiology,rna silencing inhibits mrna translation while mrna translation account for the majority of cellular energy expenditure it is unclear if rna silencing regulates energy homeostasis here we report that hepatic argonaute agomediated rna silencing regulates both intrinsic energy production and consumption and disturbs energy metabolism in the pathogenesis of obesity ago regulates expression of specific mirnas including mir mir and mira causing metabolic disruption while simultaneously suppressing the expression of gene regulating glucose and lipid metabolism including hnfbeta cav and ampka liverspecific agodeletion enhances mitochondrial oxidation and atp consumption associated with mrna translation which result in ampk activation and improves obesityassociated pathophysiology notably hepatic agodeficiency improves glucose metabolism in condition of insulin receptor antagonist treatment highfat diet challenge and hepatic ampkalphadeletion the regulation of energy metabolism by ago provides a novel paradigm in which rna silencing play an integral role in determining basal metabolic activity in obesityassociated sequela,Non-Cancer,1,hepatic agomediated rna silencing control energy metabolism linked to ampk activation and obesityassociated pathophysiology rna silencing inhibits mrna translation while mrna translation account for the majority of cellular energy expenditure it is unclear if rna silencing regulates energy homeostasis here we report that hepatic argonaute agomediated rna silencing regulates both intrinsic energy production and consumption and disturbs energy metabolism in the pathogenesis of obesity ago regulates expression of specific mirnas including mir mir and mira causing metabolic disruption while simultaneously suppressing the expression of gene regulating glucose and lipid metabolism including hnfbeta cav and ampka liverspecific agodeletion enhances mitochondrial oxidation and atp consumption associated with mrna translation which result in ampk activation and improves obesityassociated pathophysiology notably hepatic agodeficiency improves glucose metabolism in condition of insulin receptor antagonist treatment highfat diet challenge and hepatic ampkalphadeletion the regulation of energy metabolism by ago provides a novel paradigm in which rna silencing play an integral role in determining basal metabolic activity in obesityassociated sequela
30207489,the italian mastocytosis registry year experience from a hospitalbased registry,aim we collected reallife data on the management of patient with mastocytosis in the italian mastocytosis registry method six hundred patient diagnosed with mastocytosis between and were included from center result among adult n patient were diagnosed with systemic mastocytosis in adult no bone marrow study were performed resulting in a provisional diagnosis of mastocytosis of the skin this diagnosis wa most frequently established in nonhematologic center in total pediatric patient had cutaneous mastocytosis we confirmed that in the most patient with systemic mastocytosis serum tryptase level were ngml and kit dv wa detectable conclusion the italian mastocytosis registry revealed some centerspecific approach for diagnosis and therapy epidemiological evidence on this condition is provided,Non-Cancer,1,the italian mastocytosis registry year experience from a hospitalbased registry aim we collected reallife data on the management of patient with mastocytosis in the italian mastocytosis registry method six hundred patient diagnosed with mastocytosis between and were included from center result among adult n patient were diagnosed with systemic mastocytosis in adult no bone marrow study were performed resulting in a provisional diagnosis of mastocytosis of the skin this diagnosis wa most frequently established in nonhematologic center in total pediatric patient had cutaneous mastocytosis we confirmed that in the most patient with systemic mastocytosis serum tryptase level were ngml and kit dv wa detectable conclusion the italian mastocytosis registry revealed some centerspecific approach for diagnosis and therapy epidemiological evidence on this condition is provided
30216543,functional monoamine oxidase b gene intron polymorphism predicts putaminal dopamine turnover in de novo parkinson disease,objective the objective of this study wa to evaluate the effect of common functional polymorphism in gene involved in dopamine metabolism on striatal dopamine turnover in de novo parkinson disease pd method this wa an observerblinded cohort study investigating effect of common functional polymorphism in dopa decarboxylase ddc r monoamine oxidase b maob r catecholomethyltransferase comt r and dopamine transportersolute carrier family member datslca variable number tandem repeat gene on ffluorodopa uptake and an effective distribution volume ratio inverse of dopamine turnover measured by ffluorodopa pet in untreated pd patient result patient carrying the maobcccct genotype lowintermediate enzyme activity had a lower dopamine turnover in the putamen higher mean effective distribution volume ratio when compared with patient with maobttt genotype high enzyme activity striatal pet measure were not different between variant in the remaining gene conclusion the maob r polymorphism predicts putaminal dopamine turnover in early pd with the maobtt allele linked to high enzyme activity leading to higher intrinsic dopamine turnover which ha been demonstrated to constitute a risk factor for motor complication the author movement disorder published by wiley periodical inc on behalf of international parkinson and movement disorder society,Non-Cancer,1,functional monoamine oxidase b gene intron polymorphism predicts putaminal dopamine turnover in de novo parkinson disease objective the objective of this study wa to evaluate the effect of common functional polymorphism in gene involved in dopamine metabolism on striatal dopamine turnover in de novo parkinson disease pd method this wa an observerblinded cohort study investigating effect of common functional polymorphism in dopa decarboxylase ddc r monoamine oxidase b maob r catecholomethyltransferase comt r and dopamine transportersolute carrier family member datslca variable number tandem repeat gene on ffluorodopa uptake and an effective distribution volume ratio inverse of dopamine turnover measured by ffluorodopa pet in untreated pd patient result patient carrying the maobcccct genotype lowintermediate enzyme activity had a lower dopamine turnover in the putamen higher mean effective distribution volume ratio when compared with patient with maobttt genotype high enzyme activity striatal pet measure were not different between variant in the remaining gene conclusion the maob r polymorphism predicts putaminal dopamine turnover in early pd with the maobtt allele linked to high enzyme activity leading to higher intrinsic dopamine turnover which ha been demonstrated to constitute a risk factor for motor complication the author movement disorder published by wiley periodical inc on behalf of international parkinson and movement disorder society
30224494,influenza hemagglutinin membrane anchor,virus with membrane fuse them with cellular membrane to transfer their genome into cell at the beginning of infection for influenza virus the membrane glycoprotein involved in fusion is the hemagglutinin ha the d structure of which is known from xray crystallographic study the soluble ectodomain fragment used in these study lacked the membrane anchor portion of the molecule since this region ha a role in membrane fusion we have determined it structure by analyzing the intact fulllength molecule in a detergent micelle using cryoem we have also compared the structure of fulllength hadetergent micelle with fulllength hafab complex detergent micelle to describe an infectivityneutralizing monoclonal fab that bind near the ectodomain membrane anchor junction we determine a highresolution ha structure which compare favorably in detail with the structure of the ectodomain seen by xray crystallography we detect clearly all five carbohydrate side chain of ha and we find that the ectodomain is joined to the membrane anchor by flexible eightresiduelong linkers the linkers extend into the detergent micelle to join a central triplehelical structure that is a major component of the membrane anchor,Non-Cancer,1,influenza hemagglutinin membrane anchor virus with membrane fuse them with cellular membrane to transfer their genome into cell at the beginning of infection for influenza virus the membrane glycoprotein involved in fusion is the hemagglutinin ha the d structure of which is known from xray crystallographic study the soluble ectodomain fragment used in these study lacked the membrane anchor portion of the molecule since this region ha a role in membrane fusion we have determined it structure by analyzing the intact fulllength molecule in a detergent micelle using cryoem we have also compared the structure of fulllength hadetergent micelle with fulllength hafab complex detergent micelle to describe an infectivityneutralizing monoclonal fab that bind near the ectodomain membrane anchor junction we determine a highresolution ha structure which compare favorably in detail with the structure of the ectodomain seen by xray crystallography we detect clearly all five carbohydrate side chain of ha and we find that the ectodomain is joined to the membrane anchor by flexible eightresiduelong linkers the linkers extend into the detergent micelle to join a central triplehelical structure that is a major component of the membrane anchor
30255984,genetics genomics and genotypephenotype correlation of tsc insight for clinical practice,tuberous sclerosis complex tsc is a multisystem autosomal dominant condition caused by inactivating pathogenic variant in either the tsc or the tsc gene leading to hyperactivation of the mtor pathway here we present an update on the genetic and genomic aspect of tsc with a focus on clinical and laboratory practice we briefly summarize the structure of tsc and tsc a well a their protein product and discus current diagnostic testing addressing mosaicism we consider genotypephenotype correlation a an example of precision medicine and discus genetic counseling in tsc with the aim of providing geneticist and health care practitioner involved in the care of tsc individual with useful tool for their practice,Non-Cancer,1,genetics genomics and genotypephenotype correlation of tsc insight for clinical practice tuberous sclerosis complex tsc is a multisystem autosomal dominant condition caused by inactivating pathogenic variant in either the tsc or the tsc gene leading to hyperactivation of the mtor pathway here we present an update on the genetic and genomic aspect of tsc with a focus on clinical and laboratory practice we briefly summarize the structure of tsc and tsc a well a their protein product and discus current diagnostic testing addressing mosaicism we consider genotypephenotype correlation a an example of precision medicine and discus genetic counseling in tsc with the aim of providing geneticist and health care practitioner involved in the care of tsc individual with useful tool for their practice
30269836,identification of a novel titin variant underlying myocardial involvement in neurofibromatosis type,because of the rare cooccurrence it remains a question whether cardiomyopathy is a true association of neurofibromatosis type a boy with cafeaulait spot manifested restrictive cardiomyopathy whole exome sequencing confirmed the genetic diagnosis of neurofibromatosis and further identified a novel titin ttn missense variant the significance of the variant is supported by it de novo origin in silico prediction and evolutionary conservation modern genetics raise an intriguing explanation for the unexpected phenotype and add to the evolving role of ttn variant in cardiomyopathy,Non-Cancer,1,identification of a novel titin variant underlying myocardial involvement in neurofibromatosis type because of the rare cooccurrence it remains a question whether cardiomyopathy is a true association of neurofibromatosis type a boy with cafeaulait spot manifested restrictive cardiomyopathy whole exome sequencing confirmed the genetic diagnosis of neurofibromatosis and further identified a novel titin ttn missense variant the significance of the variant is supported by it de novo origin in silico prediction and evolutionary conservation modern genetics raise an intriguing explanation for the unexpected phenotype and add to the evolving role of ttn variant in cardiomyopathy
30317357,xeroderma pigmentosum cockayne syndrome complex xpcs another case,we present the case of a year old girl with clinical manifestation typical of xpcs an extremely rare combination of xeroderma pigmentosum and cockayne syndrome she had a swelling above the upper lip and multiple brown spot on her face neck arm and back she wa globally delayed deaf dumb and photophobic mri brain showed mild cerebral atrophy and bilateral demyelination de sanctis cacchione variant dscs and rothmund thomson syndrome rts which were among the differential diagnosis were ruled out upon careful evaluation supportive treatment wa given and regular checkup were recommended to monitor the progression of the disease but our patient did not show up for the follow up this report show that the diagnosis of xpcs can be based on clinical feature and mri finding when the genetic testing is not available,Non-Cancer,1,xeroderma pigmentosum cockayne syndrome complex xpcs another case we present the case of a year old girl with clinical manifestation typical of xpcs an extremely rare combination of xeroderma pigmentosum and cockayne syndrome she had a swelling above the upper lip and multiple brown spot on her face neck arm and back she wa globally delayed deaf dumb and photophobic mri brain showed mild cerebral atrophy and bilateral demyelination de sanctis cacchione variant dscs and rothmund thomson syndrome rts which were among the differential diagnosis were ruled out upon careful evaluation supportive treatment wa given and regular checkup were recommended to monitor the progression of the disease but our patient did not show up for the follow up this report show that the diagnosis of xpcs can be based on clinical feature and mri finding when the genetic testing is not available
30343341,ataxia telangiectasia alters the apob and reelin pathway,autosomal recessive ataxia telangiectasia at is characterized by radiosensitivity immunodeficiency and cerebellar neurodegeneration at is caused by inactivating mutation in the ataxia telangiectasiamutated atm gene a serinethreonine protein kinase involved in dna damage response and excitatory neurotransmission the selective vulnerability of cerebellar purkinje neuron pn to at is not well understood employing global proteomic profiling of cerebrospinal fluid from patient at age around year we detected reduced calbindin reelin cerebellin cerebellin protocadherin fat sempahorin a and increased apolipoprotein b and j peptide bioinformatic enrichment wa observed for pathway of lipoprotein endocytosis extracellular matrix receptor interaction peptidase activity adhesion calcium binding and complement immunity this seemed important since secretion of reelin from glutamatergic afferent axon is crucial for pn lipoprotein receptor endocytosis and lipid signaling reelin expression is downregulated by irradiation and reelinapob mutation are known cause of ataxia validation effort in monthold atm mouse before onset of motor deficit confirmed cerebellar transcript reduction for reelin receptor apoervldlr with increase for their ligand apoeapoh and cholesterol hydroxylase cypa concomitant dysregulations were found for vglutsemaa a climbing fiber marker glutamate receptor like grinb and calcium homeostasis factor atpb calb itpr while factor involved in dna damage oxidative stress neuroinflammation and cell adhesion were normal at this stage quantitative immunoblots confirmed apob and apoj increase and vldlr reduction in cerebellar tissue at the age of month these finding show that apob excess and reelin signaling deficit reflect the neurodegeneration in at in a sensitive and specific way a extracellular factor apolipoproteins and their cargo such a vitamin e may be useful for neuroprotective intervention,Non-Cancer,1,ataxia telangiectasia alters the apob and reelin pathway autosomal recessive ataxia telangiectasia at is characterized by radiosensitivity immunodeficiency and cerebellar neurodegeneration at is caused by inactivating mutation in the ataxia telangiectasiamutated atm gene a serinethreonine protein kinase involved in dna damage response and excitatory neurotransmission the selective vulnerability of cerebellar purkinje neuron pn to at is not well understood employing global proteomic profiling of cerebrospinal fluid from patient at age around year we detected reduced calbindin reelin cerebellin cerebellin protocadherin fat sempahorin a and increased apolipoprotein b and j peptide bioinformatic enrichment wa observed for pathway of lipoprotein endocytosis extracellular matrix receptor interaction peptidase activity adhesion calcium binding and complement immunity this seemed important since secretion of reelin from glutamatergic afferent axon is crucial for pn lipoprotein receptor endocytosis and lipid signaling reelin expression is downregulated by irradiation and reelinapob mutation are known cause of ataxia validation effort in monthold atm mouse before onset of motor deficit confirmed cerebellar transcript reduction for reelin receptor apoervldlr with increase for their ligand apoeapoh and cholesterol hydroxylase cypa concomitant dysregulations were found for vglutsemaa a climbing fiber marker glutamate receptor like grinb and calcium homeostasis factor atpb calb itpr while factor involved in dna damage oxidative stress neuroinflammation and cell adhesion were normal at this stage quantitative immunoblots confirmed apob and apoj increase and vldlr reduction in cerebellar tissue at the age of month these finding show that apob excess and reelin signaling deficit reflect the neurodegeneration in at in a sensitive and specific way a extracellular factor apolipoproteins and their cargo such a vitamin e may be useful for neuroprotective intervention
30389854,wntbetacatenin signaling play a crucial role in myoblast fusion through regulation of nephrin expression during development,skeletal muscle development is controlled by a series of multiple orchestrated regulatory pathway wntbetacatenin is one of the most important pathway for myogenesis however it remains unclear how this signaling pathway regulates myogenesis in a temporal and spatialspecific manner here we show that wntbetacatenin signaling is crucial for myoblast fusion through regulation of the nephrin nphs gene in the myogcreexpressing myoblast population mouse deficient for the betacatenin gene in myogcreexpressing myoblasts ctnnbffmyogcre mouse displayed myoblast fusion defect but not migration or cell proliferation defect the promoter region of nphs contains the conserved betacateninbinding element and nphs expression wa induced by the activation of wntbetacatenin signaling the induction of nphs in cultured myoblasts from ctnnbffmyogcre mouse restored the myoblast fusion defect indicating that nephrin is functionally relevant in wntbetacatenindependent myoblast fusion taken together our result indicate that wntbetacatenin signaling is crucial for myoblast fusion through the regulation of the nphs gene,Non-Cancer,1,wntbetacatenin signaling play a crucial role in myoblast fusion through regulation of nephrin expression during development skeletal muscle development is controlled by a series of multiple orchestrated regulatory pathway wntbetacatenin is one of the most important pathway for myogenesis however it remains unclear how this signaling pathway regulates myogenesis in a temporal and spatialspecific manner here we show that wntbetacatenin signaling is crucial for myoblast fusion through regulation of the nephrin nphs gene in the myogcreexpressing myoblast population mouse deficient for the betacatenin gene in myogcreexpressing myoblasts ctnnbffmyogcre mouse displayed myoblast fusion defect but not migration or cell proliferation defect the promoter region of nphs contains the conserved betacateninbinding element and nphs expression wa induced by the activation of wntbetacatenin signaling the induction of nphs in cultured myoblasts from ctnnbffmyogcre mouse restored the myoblast fusion defect indicating that nephrin is functionally relevant in wntbetacatenindependent myoblast fusion taken together our result indicate that wntbetacatenin signaling is crucial for myoblast fusion through the regulation of the nphs gene
30405212,tenofovir disoproxil fumarate discontinuation for renal outcome any room for treatment personalization,tenofovir disoproxil fumarate tdf is a very effective antiviral drug that ha been associated with tubular dysfunction the aim of this study wa to analyze the demographic pharmacokinetic and pharmacogenetic variable associated with tdf discontinuation for renal outcome in stable hivpositive patient using multivariable analysis three hundred and four patient were included male with median age and ecrcl of year and mlmin respectively after a median followup of month patient discontinued tdf for renal adverse event persistent urinary abnormality n or ecrcl mlmin n providing an incidence of event per patientyear the probability of tdf discontinuation wa higher with several feature male gender older age not caucasian ancestry absence of intravenous drug abuse protease inhibitor previous indinavir hcvpositivity lower cd cell count detectable hivrna lower ecrcl spoturine proteinuria and higher tenofovir concentration but not genetic variant tenofovir plasma concentration were prognostic of tdf discontinuation for renal adverse event suggesting that doseadjustment may be warranted for longterm safety,Non-Cancer,1,tenofovir disoproxil fumarate discontinuation for renal outcome any room for treatment personalization tenofovir disoproxil fumarate tdf is a very effective antiviral drug that ha been associated with tubular dysfunction the aim of this study wa to analyze the demographic pharmacokinetic and pharmacogenetic variable associated with tdf discontinuation for renal outcome in stable hivpositive patient using multivariable analysis three hundred and four patient were included male with median age and ecrcl of year and mlmin respectively after a median followup of month patient discontinued tdf for renal adverse event persistent urinary abnormality n or ecrcl mlmin n providing an incidence of event per patientyear the probability of tdf discontinuation wa higher with several feature male gender older age not caucasian ancestry absence of intravenous drug abuse protease inhibitor previous indinavir hcvpositivity lower cd cell count detectable hivrna lower ecrcl spoturine proteinuria and higher tenofovir concentration but not genetic variant tenofovir plasma concentration were prognostic of tdf discontinuation for renal adverse event suggesting that doseadjustment may be warranted for longterm safety
30414531,identification of a somatic mutation in the rheb gene through high depth and ultrahigh depth next generation sequencing in a patient with hemimegalencephaly and drug resistant epilepsy,malformation of cortical development are a frequent cause of drugresistant epilepsy and developmental delay hemimegalencephaly is a malformation of cortical development characterized by enlargement of all or a part of one cerebral hemisphere germline and somatic mutation in gene belonging to the mammalian target of rapamycin mtor pathway ha been identified in patient suffering from epilepsy secondary to hemimegalencephaly and focal cortical dysplasia we present here a patient suffering from severe neonatal epilepsy since h of life secondary to hemimegalencephaly requiring an anatomic hemispherectomy surgical procedure for seizure control where by mean of nextgeneration sequencing at an ultrahigh depth coverage we were able to identify a novel somatic mutation in the rheb gene nm ca t p gluval the histopathological diagnosis wa cortical dysplasia type iib determined by the presence of dysmorphic neuron of variable size with nuclear alteration and balloon cell in the context of hemimegalencephaly which are similar to that have been demonstrated in hyperactivating rheb model this is the first report of a somatic mutation in rheb gene in a patient suffering from epilepsy secondary to hemimegalencephaly it highlight different current topic in the field of genetics of malformation of cortical development asomatic mosaicism is not uncommon in these neurodevelopmental disorder bthe molecular diagnostic approach should involve the use of stateoftheart method and the sampling of different tissue cnew finding might facilitate therapeutic discovery while providing an improved understanding of normal brain development,Non-Cancer,1,identification of a somatic mutation in the rheb gene through high depth and ultrahigh depth next generation sequencing in a patient with hemimegalencephaly and drug resistant epilepsy malformation of cortical development are a frequent cause of drugresistant epilepsy and developmental delay hemimegalencephaly is a malformation of cortical development characterized by enlargement of all or a part of one cerebral hemisphere germline and somatic mutation in gene belonging to the mammalian target of rapamycin mtor pathway ha been identified in patient suffering from epilepsy secondary to hemimegalencephaly and focal cortical dysplasia we present here a patient suffering from severe neonatal epilepsy since h of life secondary to hemimegalencephaly requiring an anatomic hemispherectomy surgical procedure for seizure control where by mean of nextgeneration sequencing at an ultrahigh depth coverage we were able to identify a novel somatic mutation in the rheb gene nm ca t p gluval the histopathological diagnosis wa cortical dysplasia type iib determined by the presence of dysmorphic neuron of variable size with nuclear alteration and balloon cell in the context of hemimegalencephaly which are similar to that have been demonstrated in hyperactivating rheb model this is the first report of a somatic mutation in rheb gene in a patient suffering from epilepsy secondary to hemimegalencephaly it highlight different current topic in the field of genetics of malformation of cortical development asomatic mosaicism is not uncommon in these neurodevelopmental disorder bthe molecular diagnostic approach should involve the use of stateoftheart method and the sampling of different tissue cnew finding might facilitate therapeutic discovery while providing an improved understanding of normal brain development
30475086,cystic hygroma a preliminary genetic study and a short review from the literature,background the objective of this study is to examine the hypothesis that cystic hygroma ch with normal karyotype can manifest a a mendelian inherited trait and that a genetic similitude with hereditary lymphedema exists to reach this goal we investigated the prevalence of genetic variant in angiogenesis and lymphangiogenesis gene in a cohort of euploid fetus with ch that almost resolved before delivery a short review of case from literature is also reported method and result five fetus were screened using a nextgeneration sequencing approach by targeting gene known to be associated with vascular and lymphatic malformation the genetic evaluation revealed two novel variant in kdr and krit gene conclusion a review of the literature to date revealed that an association exists between ch and hereditary lymphedema and similar to lymphedema ch can be inherited in autosomal recessive and autosomal dominant manner with the latter most likely associated with a better prognosis about kdr and krit gene no other similar association are reported in the literature and caution is needed in their interpretation in conclusion we thought that a genetic test for the outcome of familial ch could be of enormous prognostic value,Non-Cancer,1,cystic hygroma a preliminary genetic study and a short review from the literature background the objective of this study is to examine the hypothesis that cystic hygroma ch with normal karyotype can manifest a a mendelian inherited trait and that a genetic similitude with hereditary lymphedema exists to reach this goal we investigated the prevalence of genetic variant in angiogenesis and lymphangiogenesis gene in a cohort of euploid fetus with ch that almost resolved before delivery a short review of case from literature is also reported method and result five fetus were screened using a nextgeneration sequencing approach by targeting gene known to be associated with vascular and lymphatic malformation the genetic evaluation revealed two novel variant in kdr and krit gene conclusion a review of the literature to date revealed that an association exists between ch and hereditary lymphedema and similar to lymphedema ch can be inherited in autosomal recessive and autosomal dominant manner with the latter most likely associated with a better prognosis about kdr and krit gene no other similar association are reported in the literature and caution is needed in their interpretation in conclusion we thought that a genetic test for the outcome of familial ch could be of enormous prognostic value
30488427,detection of kit dv in peripheral blood of child with manifestation of cutaneous mastocytosis suggests systemic disease,the use of allelespecific quantitative polymerase chain reaction to identify kit dv in the peripheral blood of adult with mastocytosis ha been reported to have value in the diagnosis assessment of disease burden and management of this disease to examine the value of this assay in child with cutaneous manifestation of mastocytosis we assessed data on patient with all variant of paediatriconset mastocytosis including those known to have systemic disease to correlate kit mutation status with clinical finding serum tryptase level and bone marrow histopathology we found that kit dv wa not identified in the peripheral blood of child known to have only cutaneous disease specificity but wa found in those known to have both cutaneous and systemicprobable systemic disease sensitivity of these finding were the basis of the development of an algorithm to assist in the decision for when to perform a bone marrow biopsy in child presenting with cutaneous manifestation of mastocytosis,Non-Cancer,1,detection of kit dv in peripheral blood of child with manifestation of cutaneous mastocytosis suggests systemic disease the use of allelespecific quantitative polymerase chain reaction to identify kit dv in the peripheral blood of adult with mastocytosis ha been reported to have value in the diagnosis assessment of disease burden and management of this disease to examine the value of this assay in child with cutaneous manifestation of mastocytosis we assessed data on patient with all variant of paediatriconset mastocytosis including those known to have systemic disease to correlate kit mutation status with clinical finding serum tryptase level and bone marrow histopathology we found that kit dv wa not identified in the peripheral blood of child known to have only cutaneous disease specificity but wa found in those known to have both cutaneous and systemicprobable systemic disease sensitivity of these finding were the basis of the development of an algorithm to assist in the decision for when to perform a bone marrow biopsy in child presenting with cutaneous manifestation of mastocytosis
30513309,circular rna involvement in aging an emerging player with great potential,circular rna circrna is a class of newly discovered noncoding rna ncrna presenting a a special covalent loop without a cap or tail multiple biological property of circrna have been revealed during the past decade such a widespread expression high conservation cellspecificity tissuespecificity and developmental stagespecific expression pattern a well a resistance to rnase r digestion circrna also exhibit diverse biological function including regulation of host gene alternative splicing mirna sponge protein trap and even protein synthesis recently a global accumulation of circrnas during aging ha been identified across different specie indicating a potential role a a causal factor in aging and agerelated disease the high stability could be one of the mechanism contributing to this phenomenon circrna could play a role in aging such a neural aging muscle aging reproductive aging skin aging immunosenescence visual aging and agerelated disease like alzheimers disease via interaction with mirnas rna binding protein modulation of parental gene transcription mainly at the transcriptional and posttranscriptional level the present study will focus on the advancement of circrna regarding aging and agerelated disease we will also discus the biogenesis property biological function and the perspective of circrna,Non-Cancer,1,circular rna involvement in aging an emerging player with great potential circular rna circrna is a class of newly discovered noncoding rna ncrna presenting a a special covalent loop without a cap or tail multiple biological property of circrna have been revealed during the past decade such a widespread expression high conservation cellspecificity tissuespecificity and developmental stagespecific expression pattern a well a resistance to rnase r digestion circrna also exhibit diverse biological function including regulation of host gene alternative splicing mirna sponge protein trap and even protein synthesis recently a global accumulation of circrnas during aging ha been identified across different specie indicating a potential role a a causal factor in aging and agerelated disease the high stability could be one of the mechanism contributing to this phenomenon circrna could play a role in aging such a neural aging muscle aging reproductive aging skin aging immunosenescence visual aging and agerelated disease like alzheimers disease via interaction with mirnas rna binding protein modulation of parental gene transcription mainly at the transcriptional and posttranscriptional level the present study will focus on the advancement of circrna regarding aging and agerelated disease we will also discus the biogenesis property biological function and the perspective of circrna
30514913,carnitine palmitoyltransferase ii deficiency with a focus on newborn screening,carnitine palmitoyltransferase cpt ii deficiency is one of the most common form of mitochondrial fatty acid oxidation disorder it clinical phenotype are classified into the muscle severe infantile and lethal neonatal form among caucasian the muscle form predominates and the cc t psl variant is detected in most case whereas among the japanese ct a pfy is the variant allele occurring with the highest frequency and can apparently cause symptom of the severe infantile form newborn screening nb for this potentially fatal disease ha not been established we encountered an infantile case of cpt ii deficiency not detected in nb using c and c concentration a index and therefore we adopted the c cc ratio a an alternative primary index a a result the disease wa diagnosed in nine of nbspositive subject the value for c cc in the affected newborn partly overlapped with those in unaffected one among several other index proposed previously cc ha emerged a a more promising index based on these finding nationwide nb for cpt ii deficiency using both c cc and cc a index wa officially approved and started in april we diagnosed the disease in four young child presenting with symptom of the muscle form whose value for the new index were not elevated although it is still difficult to detect all case of the muscle form of cpt ii deficiency in nb our system is expected to save many affected child in japan with the severe infantile form predominating,Non-Cancer,1,carnitine palmitoyltransferase ii deficiency with a focus on newborn screening carnitine palmitoyltransferase cpt ii deficiency is one of the most common form of mitochondrial fatty acid oxidation disorder it clinical phenotype are classified into the muscle severe infantile and lethal neonatal form among caucasian the muscle form predominates and the cc t psl variant is detected in most case whereas among the japanese ct a pfy is the variant allele occurring with the highest frequency and can apparently cause symptom of the severe infantile form newborn screening nb for this potentially fatal disease ha not been established we encountered an infantile case of cpt ii deficiency not detected in nb using c and c concentration a index and therefore we adopted the c cc ratio a an alternative primary index a a result the disease wa diagnosed in nine of nbspositive subject the value for c cc in the affected newborn partly overlapped with those in unaffected one among several other index proposed previously cc ha emerged a a more promising index based on these finding nationwide nb for cpt ii deficiency using both c cc and cc a index wa officially approved and started in april we diagnosed the disease in four young child presenting with symptom of the muscle form whose value for the new index were not elevated although it is still difficult to detect all case of the muscle form of cpt ii deficiency in nb our system is expected to save many affected child in japan with the severe infantile form predominating
30517645,juno the receptor of sperm izumo is expressed by the human oocyte and is essential for human fertilisation,study question is juno protein present at the surface membrane of human oocyte and involved in the fertilisation process summary answer juno protein is expressed on the plasma membrane of human oocyte and it inhibition by a monoclonal antibody completely block gamete fusion what is known already fusion of gamete membrane is the culminating event of the fertilisation process but it molecular mechanism are poorly understood until now three molecule have been shown to be essential cd tetraspanin in the oocyte izumo protein on the sperm and juno it corresponding receptor on the oocyte oocyte cd and sperm izumo have been identified in human gamete and their interaction is also wellconserved among several mammalian specie the presence of juno on human oocyte however ha not yet been reported nor ha it role in fertilisation been investigated study design size duration we selected an antihuman juno antibody in order to investigate the presence of juno on the oocyte membrane surface and studied it potential involvement in gamete membrane interaction during fertilisation participantsmaterials setting method monoclonal antibody against human juno antihjuno mab were produced by immunisation of mouse with hek cell transfected with the putative human juno sequence hekhjuno these antibody were used for immunostaining experiment and in vitro fertilisation assay with human gamete germetheque biobank main result and the role of chance three hybridoma supernatant verified by immunostaining revealed specifically hekhjuno cell the three purified monoclonal antibody fje igg fje igg and fjf igga recognised the soluble recombinant human juno protein and in a western blot of hekhjuno extract a protein with an expected mw of kda in addition soluble recombinant human izumo protein inhibited the binding of antihjuno mabs to cell expressing hjuno using these antihjuno mabs in immunostaining we identified the presence of juno protein at the plasma membrane of human oocyte furthermore we revealed a progressive expression of juno according to oocyte maturity finally we showed that human zonafree oocyte inseminated in the presence of antihjuno mab were not fertilised by human sperm these result suggest that a seen in the mouse juno is indeed involved in human gamete membrane fusion during fertilisation largescale data na limitation reason for caution in accordance with french bioethics law functional test were performed using zonafree oocyte which of course doe not fully encompass all normal in vivo physiological condition however these in vitro test do provide direct information regarding spermoocyte membrane interaction wider implication of the finding mechanism of gamete fusion appear to be homologous between mouse and human however some difference do exist and analysing the human mechanism is essential in fact this is the first report describing the presence of juno on human oocyte and it involvement in human fertilisation this discovery allows further examination of the understanding of molecular mechanism that drive gamete fusion a crucial challenge at a time when infertility affect of reproductively active couple study fundingcompeting interest this work wa supported by the agence nationale pour la recherche grant no anrbvs and by association institut du cancer et dimmunogenetique icig there are no competing interest,Non-Cancer,1,juno the receptor of sperm izumo is expressed by the human oocyte and is essential for human fertilisation study question is juno protein present at the surface membrane of human oocyte and involved in the fertilisation process summary answer juno protein is expressed on the plasma membrane of human oocyte and it inhibition by a monoclonal antibody completely block gamete fusion what is known already fusion of gamete membrane is the culminating event of the fertilisation process but it molecular mechanism are poorly understood until now three molecule have been shown to be essential cd tetraspanin in the oocyte izumo protein on the sperm and juno it corresponding receptor on the oocyte oocyte cd and sperm izumo have been identified in human gamete and their interaction is also wellconserved among several mammalian specie the presence of juno on human oocyte however ha not yet been reported nor ha it role in fertilisation been investigated study design size duration we selected an antihuman juno antibody in order to investigate the presence of juno on the oocyte membrane surface and studied it potential involvement in gamete membrane interaction during fertilisation participantsmaterials setting method monoclonal antibody against human juno antihjuno mab were produced by immunisation of mouse with hek cell transfected with the putative human juno sequence hekhjuno these antibody were used for immunostaining experiment and in vitro fertilisation assay with human gamete germetheque biobank main result and the role of chance three hybridoma supernatant verified by immunostaining revealed specifically hekhjuno cell the three purified monoclonal antibody fje igg fje igg and fjf igga recognised the soluble recombinant human juno protein and in a western blot of hekhjuno extract a protein with an expected mw of kda in addition soluble recombinant human izumo protein inhibited the binding of antihjuno mabs to cell expressing hjuno using these antihjuno mabs in immunostaining we identified the presence of juno protein at the plasma membrane of human oocyte furthermore we revealed a progressive expression of juno according to oocyte maturity finally we showed that human zonafree oocyte inseminated in the presence of antihjuno mab were not fertilised by human sperm these result suggest that a seen in the mouse juno is indeed involved in human gamete membrane fusion during fertilisation largescale data na limitation reason for caution in accordance with french bioethics law functional test were performed using zonafree oocyte which of course doe not fully encompass all normal in vivo physiological condition however these in vitro test do provide direct information regarding spermoocyte membrane interaction wider implication of the finding mechanism of gamete fusion appear to be homologous between mouse and human however some difference do exist and analysing the human mechanism is essential in fact this is the first report describing the presence of juno on human oocyte and it involvement in human fertilisation this discovery allows further examination of the understanding of molecular mechanism that drive gamete fusion a crucial challenge at a time when infertility affect of reproductively active couple study fundingcompeting interest this work wa supported by the agence nationale pour la recherche grant no anrbvs and by association institut du cancer et dimmunogenetique icig there are no competing interest
30545997,systemic mastocytosis version nccn clinical practice guideline in oncology,mastocytosis is a group of heterogeneous disorder resulting from the clonal proliferation of abnormal mast cell and their accumulation in the skin andor in various extracutaneous organ systemic mastocytosis is the most common form of mastocytosis diagnosed in adult characterized by mast cell infiltration of one or more extracutaneous organ with or without skin involvement the identification of kit dv mutation and the emergence of novel targeted therapy have significantly improved the diagnosis and treatment of systemic mastocytosis however certain aspect of clinical care particularly the diagnosis assessment and management of mediatorrelated symptom continue to present challenge this manuscript discusses the recommendation outlined in the nccn guideline for the diagnosis and management of patient with systemic mastocytosis,Non-Cancer,1,systemic mastocytosis version nccn clinical practice guideline in oncology mastocytosis is a group of heterogeneous disorder resulting from the clonal proliferation of abnormal mast cell and their accumulation in the skin andor in various extracutaneous organ systemic mastocytosis is the most common form of mastocytosis diagnosed in adult characterized by mast cell infiltration of one or more extracutaneous organ with or without skin involvement the identification of kit dv mutation and the emergence of novel targeted therapy have significantly improved the diagnosis and treatment of systemic mastocytosis however certain aspect of clinical care particularly the diagnosis assessment and management of mediatorrelated symptom continue to present challenge this manuscript discusses the recommendation outlined in the nccn guideline for the diagnosis and management of patient with systemic mastocytosis
30558068,familial intracranial arachnoid cyst with a missense mutation cc t in rere a case report,rationale arachnoid cyst are relatively common intracranial spaceoccupying lesion nevertheless familial intracranial arachnoid cyst are extremely rare with only a few case having been reported patient concern the proband wa a yearold girl who had experienced generalized tonicclonic seizure time in the day prior to admission nine month later her yearold younger female cousin presented to u with a day history of headache diagnosis brain magnetic resonance imaging mri confirmed the diagnosis of arachnoid cyst for both of the girl intervention a cystperitoneal shunting and cyst fenestration were performed for the yearold girl and her cousin separately sanger sequencing revealed a heterozygous missense mutation cc t in the arginineglutamic acid dipeptide repeat gene rere outcome the outcome wa favorable and the followup wa uneventful lesson we hypothesize that the mutation in rere may be associated with the pathogenesis of familial intracranial arachnoid cyst,Non-Cancer,1,familial intracranial arachnoid cyst with a missense mutation cc t in rere a case report rationale arachnoid cyst are relatively common intracranial spaceoccupying lesion nevertheless familial intracranial arachnoid cyst are extremely rare with only a few case having been reported patient concern the proband wa a yearold girl who had experienced generalized tonicclonic seizure time in the day prior to admission nine month later her yearold younger female cousin presented to u with a day history of headache diagnosis brain magnetic resonance imaging mri confirmed the diagnosis of arachnoid cyst for both of the girl intervention a cystperitoneal shunting and cyst fenestration were performed for the yearold girl and her cousin separately sanger sequencing revealed a heterozygous missense mutation cc t in the arginineglutamic acid dipeptide repeat gene rere outcome the outcome wa favorable and the followup wa uneventful lesson we hypothesize that the mutation in rere may be associated with the pathogenesis of familial intracranial arachnoid cyst
30580065,arteriovenous fistula inside cervical spinal canal associated with neurofibromatosis type,background neurofibromatosis type nf is an autosomal dominant disease caused by mutation on chromosome which affect the skin vascular system nervous system and skeleton system arteriovenous fistula avf is one of the recognized complication of nf case description we report a case of a yearold woman with nf with cervical spine avf inside the cervical spinal canal who presented with progressive spinal cord compression which wa abnormal after sufficient preparation the patient underwent vascular embolization and then symptom of spinal cord compression significantly improved conclusion this report reminds reader of the possibility of avf if there is a spaceoccupying lesion inside the cervical spinal canal and to do computed tomography angiography examination when necessary,Non-Cancer,1,arteriovenous fistula inside cervical spinal canal associated with neurofibromatosis type background neurofibromatosis type nf is an autosomal dominant disease caused by mutation on chromosome which affect the skin vascular system nervous system and skeleton system arteriovenous fistula avf is one of the recognized complication of nf case description we report a case of a yearold woman with nf with cervical spine avf inside the cervical spinal canal who presented with progressive spinal cord compression which wa abnormal after sufficient preparation the patient underwent vascular embolization and then symptom of spinal cord compression significantly improved conclusion this report reminds reader of the possibility of avf if there is a spaceoccupying lesion inside the cervical spinal canal and to do computed tomography angiography examination when necessary
30588981,mammalian target of rapamycin inhibitor in a patient with polycystic kidney diseasetuberous sclerosis contiguous gene syndrome,the mutation associated with polycystic kidney disease are closely aligned with that of tuberous sclerosis tsc in chromosome occasionally the presence of these mutation in an individual can lead to a presence of a disease phenotype with a combination of polycystic kidney disease and tsc contiguous gene syndrome we present a case report of a young girl who presented with skin lesion central nervous system tuber and cystic disease of the kidney she wa treated with mammalian target of rapamycin inhibitor with a favorable outcome,Non-Cancer,1,mammalian target of rapamycin inhibitor in a patient with polycystic kidney diseasetuberous sclerosis contiguous gene syndrome the mutation associated with polycystic kidney disease are closely aligned with that of tuberous sclerosis tsc in chromosome occasionally the presence of these mutation in an individual can lead to a presence of a disease phenotype with a combination of polycystic kidney disease and tsc contiguous gene syndrome we present a case report of a young girl who presented with skin lesion central nervous system tuber and cystic disease of the kidney she wa treated with mammalian target of rapamycin inhibitor with a favorable outcome
30609671,development of iieoetpz and iieoetpzmo novel tirapazamine tpzbased radioiodinated pharmaceutical for application in theranostic management of hypoxia,introduction benzotriazinedioxides btdos such a tirapazamine tpz and it derivative act a radiosensitizers of hypoxic tissue the benzotriazinemonoxide btmo metabolite sr tpzmo of tpz also ha radiosensitizing property and via unknown mechanism is a potent enhancer of the radiosensitizing effect of tpz unlike their nitroimidazole radiosensitizer counterpart radiolabeled benzotriazine oxide have not been used a radiopharmaceutical for diagnostic imaging or molecular radiotherapy mrt of hypoxia the radioiodination chemistry for preparing model radioiodinated btdos and btmos is now reported hypothesis radioiodinated iodoethoxyethylaminobenzotriazinedioxide ieoetpz a novel bioisosteric analogue of tpz and iodoethoxyethylaminobenzotriazineoxide ieoetpzmo it monoxide analogue are candidate for in vivo and in vitro investigation of biochemical mechanism in pathology that develop hypoxic microenvironments in theory both radiotracers can be prepared from the same precursor method radioiodination procedure were based on classical nucleophilic iiodide substitution on toseoetpz p and by iiodide exchange on ieoetpz p reaction parameter including temperature reaction time solvent and the influence of pivalic acid on product formation and the corresponding radiochemical yield rcy were investigated result the iiodide labeling reaction invariably led to the synthesis of both product but with careful manipulation of condition the preferred product could be recovered a the major product radioiodide exchange on p in acn at c for min afforded the highest rcy of iieoetpz which upon solid phase purification on an alumina cartridge gave yield of the product with over of radiochemical purity similarly radioiodide exchange on p in acn at c for min with pivalic acid afforded the highest yield of iieoetpzmo exclusively with no trace of iieoetpz in both case extended reaction time andor elevated temperature resulted in the formation of at least two additional radioactive reaction product conclusion radioiodination of p and p with iiodide lead to the facile formation of iieoetpzmo at c and short reaction time the facile reduction of the noxide moiety wa minimized to afford acceptable radiochemical yield of iieoetpz from either precursor regeneration of iieoetpz from iieoetpzmo is impractical after reaction workup,Non-Cancer,1,development of iieoetpz and iieoetpzmo novel tirapazamine tpzbased radioiodinated pharmaceutical for application in theranostic management of hypoxia introduction benzotriazinedioxides btdos such a tirapazamine tpz and it derivative act a radiosensitizers of hypoxic tissue the benzotriazinemonoxide btmo metabolite sr tpzmo of tpz also ha radiosensitizing property and via unknown mechanism is a potent enhancer of the radiosensitizing effect of tpz unlike their nitroimidazole radiosensitizer counterpart radiolabeled benzotriazine oxide have not been used a radiopharmaceutical for diagnostic imaging or molecular radiotherapy mrt of hypoxia the radioiodination chemistry for preparing model radioiodinated btdos and btmos is now reported hypothesis radioiodinated iodoethoxyethylaminobenzotriazinedioxide ieoetpz a novel bioisosteric analogue of tpz and iodoethoxyethylaminobenzotriazineoxide ieoetpzmo it monoxide analogue are candidate for in vivo and in vitro investigation of biochemical mechanism in pathology that develop hypoxic microenvironments in theory both radiotracers can be prepared from the same precursor method radioiodination procedure were based on classical nucleophilic iiodide substitution on toseoetpz p and by iiodide exchange on ieoetpz p reaction parameter including temperature reaction time solvent and the influence of pivalic acid on product formation and the corresponding radiochemical yield rcy were investigated result the iiodide labeling reaction invariably led to the synthesis of both product but with careful manipulation of condition the preferred product could be recovered a the major product radioiodide exchange on p in acn at c for min afforded the highest rcy of iieoetpz which upon solid phase purification on an alumina cartridge gave yield of the product with over of radiochemical purity similarly radioiodide exchange on p in acn at c for min with pivalic acid afforded the highest yield of iieoetpzmo exclusively with no trace of iieoetpz in both case extended reaction time andor elevated temperature resulted in the formation of at least two additional radioactive reaction product conclusion radioiodination of p and p with iiodide lead to the facile formation of iieoetpzmo at c and short reaction time the facile reduction of the noxide moiety wa minimized to afford acceptable radiochemical yield of iieoetpz from either precursor regeneration of iieoetpz from iieoetpzmo is impractical after reaction workup
30639322,zmiz variant cause a syndromic neurodevelopmental disorder,zmiz is a coactivator of several transcription factor including p the androgen receptor and notch here we report subject with intellectual disability and developmental delay carrying variant in zmiz the associated feature include growth failure feeding difficulty microcephaly facial dysmorphism and various other congenital malformation of these unrelated subject carried de novo heterozygous singlenucleotide variant snvs or singlebase insertionsdeletions sibling harbored a heterozygous singlebase insertion and subject had a balanced translocation disrupting zmiz or involving a regulatory region of zmiz in total we identified point mutation that affect key protein region including a sumo acceptor site a central disordered alaninerich motif a prolinerich domain and a transactivation domain all identified variant were absent from all available exome and genome database in vitro zmiz showed impaired coactivation of the androgen receptor in vivo overexpression of zmiz mutant allele in developing mouse brain using in utero electroporation resulted in abnormal pyramidal neuron morphology polarization and positioning underscoring the importance of zmiz in neural development and supporting mutation in zmiz a the cause of a rare neurodevelopmental syndrome,Non-Cancer,1,zmiz variant cause a syndromic neurodevelopmental disorder zmiz is a coactivator of several transcription factor including p the androgen receptor and notch here we report subject with intellectual disability and developmental delay carrying variant in zmiz the associated feature include growth failure feeding difficulty microcephaly facial dysmorphism and various other congenital malformation of these unrelated subject carried de novo heterozygous singlenucleotide variant snvs or singlebase insertionsdeletions sibling harbored a heterozygous singlebase insertion and subject had a balanced translocation disrupting zmiz or involving a regulatory region of zmiz in total we identified point mutation that affect key protein region including a sumo acceptor site a central disordered alaninerich motif a prolinerich domain and a transactivation domain all identified variant were absent from all available exome and genome database in vitro zmiz showed impaired coactivation of the androgen receptor in vivo overexpression of zmiz mutant allele in developing mouse brain using in utero electroporation resulted in abnormal pyramidal neuron morphology polarization and positioning underscoring the importance of zmiz in neural development and supporting mutation in zmiz a the cause of a rare neurodevelopmental syndrome
30651914,aneurysmal bone cyst of the frontal bone a radiologicpathologic correlation,we present a case of yearold female who presented for a progressive frontal swelling with ipsilateral headache subsequent ct scan revealed an extradural and expansile multiloculated mass with thin and strongly enhanced septation and mri evaluation showed internal hyperintensity on t with no restriction of diffusion and confirmed the multiple cystic space with enhancing septation and rare hemorrhagic fluidfluid level surgery wa performed and diagnosis of aneurysmal bone cyst wa made on frozen section identification of usp fusion gene by in situ hybridization technique permitted to confirm the diagnosis of primary abc although aneurysmal bone cyst abc of the skull is a very rare entity and account for of all abc we should think about it in front of osteolytic and cystic skull change even with very few fluidfluid level following description of our case and differential diagnosis we conduct a literature review of skull abc imaging characteristic and discus the interest of usp rearrangement identification,Non-Cancer,1,aneurysmal bone cyst of the frontal bone a radiologicpathologic correlation we present a case of yearold female who presented for a progressive frontal swelling with ipsilateral headache subsequent ct scan revealed an extradural and expansile multiloculated mass with thin and strongly enhanced septation and mri evaluation showed internal hyperintensity on t with no restriction of diffusion and confirmed the multiple cystic space with enhancing septation and rare hemorrhagic fluidfluid level surgery wa performed and diagnosis of aneurysmal bone cyst wa made on frozen section identification of usp fusion gene by in situ hybridization technique permitted to confirm the diagnosis of primary abc although aneurysmal bone cyst abc of the skull is a very rare entity and account for of all abc we should think about it in front of osteolytic and cystic skull change even with very few fluidfluid level following description of our case and differential diagnosis we conduct a literature review of skull abc imaging characteristic and discus the interest of usp rearrangement identification
30704988,editing aberrant splice site efficiently restores betaglobin expression in betathalassemia,the thalassemia are compelling target for therapeutic genome editing in part because monoallelic correction of a subset of hematopoietic stem cell hscs would be sufficient for enduring disease amelioration a primary challenge is the development of efficient repair strategy that are effective in hscs here we demonstrate that allelic disruption of aberrant splice site one of the major class of thalassemia mutation is a robust approach to restore gene function we target the ivsga mutation using ca ribonucleoprotein rnp and the ivsct mutation by casacpf rnp in primary cd hematopoietic stem and progenitor cell hspcs from betathalassemia patient each of these nuclease complex achieves high efficiency and penetrance of therapeutic edits erythroid progeny of edited patient hspcs show reversal of aberrant splicing and restoration of betaglobin expression this strategy could enable correction of a substantial fraction of transfusiondependent betathalassemia genotype with currently available geneediting technology,Non-Cancer,1,editing aberrant splice site efficiently restores betaglobin expression in betathalassemia the thalassemia are compelling target for therapeutic genome editing in part because monoallelic correction of a subset of hematopoietic stem cell hscs would be sufficient for enduring disease amelioration a primary challenge is the development of efficient repair strategy that are effective in hscs here we demonstrate that allelic disruption of aberrant splice site one of the major class of thalassemia mutation is a robust approach to restore gene function we target the ivsga mutation using ca ribonucleoprotein rnp and the ivsct mutation by casacpf rnp in primary cd hematopoietic stem and progenitor cell hspcs from betathalassemia patient each of these nuclease complex achieves high efficiency and penetrance of therapeutic edits erythroid progeny of edited patient hspcs show reversal of aberrant splicing and restoration of betaglobin expression this strategy could enable correction of a substantial fraction of transfusiondependent betathalassemia genotype with currently available geneediting technology
30778901,disruption of spermatogenesis and infertility in ataxia with oculomotor apraxia type aoa,ataxia with oculomotor apraxia type aoa is a rare autosomal recessive cerebellar ataxia characterized by onset between and year of age and a range of neurological feature that include progressive cerebellar atrophy axonal sensorimotor neuropathy oculomotor apraxia in a majority of patient and elevated serum alphafetoprotein afp aoa is caused by mutation of the setx gene which encodes senataxin a dnarna helicase involved in transcription regulation rna processing and dna maintenance disruption of senataxin in rodent led to defective spermatogenesis and sterility in male uncovering a key role for senataxin in male germ cell survival here we report the first clinical and cellular evidence of impaired spermatogenesis in aoa patient we assessed sperm production in three aoa patient and testicular pathology in one patient and compared the finding to those of setxknockout mouse sperm production wa impaired in all patient assessed analysis of testicular biopsy from an aoa patient recapitulate feature of the histology seen in setxknockout mouse strongly suggesting an underlying mechanism centering on dnadamagemediated germ cell apoptosis these finding support a role for senataxin in human reproductive function and highlight a novel clinical feature of aoa that extends the extraneurological role of senataxin this raise an important reproductive counseling issue for clinician and fertility specialist should be aware of setx mutation a a possible diagnosis in young male patient presenting with oligospermia or azoospermia since infertility may presage the later onset of neurological manifestation in some individual,Non-Cancer,1,disruption of spermatogenesis and infertility in ataxia with oculomotor apraxia type aoa ataxia with oculomotor apraxia type aoa is a rare autosomal recessive cerebellar ataxia characterized by onset between and year of age and a range of neurological feature that include progressive cerebellar atrophy axonal sensorimotor neuropathy oculomotor apraxia in a majority of patient and elevated serum alphafetoprotein afp aoa is caused by mutation of the setx gene which encodes senataxin a dnarna helicase involved in transcription regulation rna processing and dna maintenance disruption of senataxin in rodent led to defective spermatogenesis and sterility in male uncovering a key role for senataxin in male germ cell survival here we report the first clinical and cellular evidence of impaired spermatogenesis in aoa patient we assessed sperm production in three aoa patient and testicular pathology in one patient and compared the finding to those of setxknockout mouse sperm production wa impaired in all patient assessed analysis of testicular biopsy from an aoa patient recapitulate feature of the histology seen in setxknockout mouse strongly suggesting an underlying mechanism centering on dnadamagemediated germ cell apoptosis these finding support a role for senataxin in human reproductive function and highlight a novel clinical feature of aoa that extends the extraneurological role of senataxin this raise an important reproductive counseling issue for clinician and fertility specialist should be aware of setx mutation a a possible diagnosis in young male patient presenting with oligospermia or azoospermia since infertility may presage the later onset of neurological manifestation in some individual
30818012,mucus penetrating property of soft distensible lipid nanocapsules,designing nanomaterials to release their drug payload upon exposure to an exogenous trigger can help to direct drug delivery but how the triggered release which often modifies the nanomaterial property influence the biological fate of these system is currently unknown the aim of this study wa to investigate how the triggered drug release from peg coated soft nm distensible lipid nanocapsules lnc influenced their diffusion across a mucus barrier the translocation speed of the nontriggered lnc across a microm thick purified gastric mucin pgm barrier wa time faster x cm s compared to equivalentsized negatively charged polystyrene particle x cm s p in a static mucus barrier but when shear wa applied to the barrier the distended lncs diffused more slowly x cm s p compared to the nondistended material x cm s this data suggested the rapid mucus penetration of the distended lncs despite their increased size wa a consequence of their capacity to take a less tortuous path through the barrier ie they experienced less steric hinderance compared to the nondistended lnc,Non-Cancer,1,mucus penetrating property of soft distensible lipid nanocapsules designing nanomaterials to release their drug payload upon exposure to an exogenous trigger can help to direct drug delivery but how the triggered release which often modifies the nanomaterial property influence the biological fate of these system is currently unknown the aim of this study wa to investigate how the triggered drug release from peg coated soft nm distensible lipid nanocapsules lnc influenced their diffusion across a mucus barrier the translocation speed of the nontriggered lnc across a microm thick purified gastric mucin pgm barrier wa time faster x cm s compared to equivalentsized negatively charged polystyrene particle x cm s p in a static mucus barrier but when shear wa applied to the barrier the distended lncs diffused more slowly x cm s p compared to the nondistended material x cm s this data suggested the rapid mucus penetration of the distended lncs despite their increased size wa a consequence of their capacity to take a less tortuous path through the barrier ie they experienced less steric hinderance compared to the nondistended lnc
30820047,genetic metaanalysis of diagnosed alzheimers disease identifies new risk locus and implicates abeta tau immunity and lipid processing,risk for lateonset alzheimers disease load the most prevalent dementia is partially driven by genetics to identify load risk locus we performed a large genomewide association metaanalysis of clinically diagnosed load individual we confirm previous load risk locus and identify five new genomewide locus iqck ace adam adamts and wwox two of which adam ace were identified in a recent genomewide association gwasbyfamilialproxy of alzheimers or dementia finemapping of the human leukocyte antigen hla region confirms the neurological and immunemediated disease haplotype hladr a a risk factor for load pathway analysis implicates immunity lipid metabolism tau binding protein and amyloid precursor protein app metabolism showing that genetic variant affecting app and abeta processing are associated not only with earlyonset autosomal dominant alzheimers disease but also with load analysis of risk gene and pathway show enrichment for rare variant p x indicating that additional rare variant remain to be identified we also identify important genetic correlation between load and trait such a family history of dementia and education,Non-Cancer,1,genetic metaanalysis of diagnosed alzheimers disease identifies new risk locus and implicates abeta tau immunity and lipid processing risk for lateonset alzheimers disease load the most prevalent dementia is partially driven by genetics to identify load risk locus we performed a large genomewide association metaanalysis of clinically diagnosed load individual we confirm previous load risk locus and identify five new genomewide locus iqck ace adam adamts and wwox two of which adam ace were identified in a recent genomewide association gwasbyfamilialproxy of alzheimers or dementia finemapping of the human leukocyte antigen hla region confirms the neurological and immunemediated disease haplotype hladr a a risk factor for load pathway analysis implicates immunity lipid metabolism tau binding protein and amyloid precursor protein app metabolism showing that genetic variant affecting app and abeta processing are associated not only with earlyonset autosomal dominant alzheimers disease but also with load analysis of risk gene and pathway show enrichment for rare variant p x indicating that additional rare variant remain to be identified we also identify important genetic correlation between load and trait such a family history of dementia and education
30904793,giant cerebral aneurysm in a patient with cowden syndrome treated with surgical clipping,background cowden syndrome is characterized by multiple hamartoma and accompanied by a germline mutation of the phosphatase and tensin homolog gene cowden syndrome ha been described to be associated with vascular anomaly such a arteriovenous malformation and developmental venous anomaly with high frequency however the association of cerebral aneurysm with this syndrome ha not been reported yet case description a yearold japanese man presented with a subarachnoid hemorrhage due to a ruptured giant fusiform middle cerebral artery aneurysm we diagnosed him with cowden syndrome by clinical presentation a outlined in the national comprehensive cancer network criterion a the ruptured fusiform aneurysm involved a middle cerebral artery bifurcation we prepared for extracranialintracranial bypass surgery we successfully performed a surgical clipping using multiple tandem clipping technique and suction decompression technique bypass surgery wa not performed a reconstruction of the m trunk wa successfully completed conclusion we present this rare case that potentially indicates an association between cerebral aneurysm and cowden syndrome because vascular anomaly are not included in the diagnostic criterion for cowden syndrome intracranial vascular anomaly may be underestimated we therefore recommended a careful search of vascular disease including cerebral aneurysm in case of cowden syndrome,Non-Cancer,1,giant cerebral aneurysm in a patient with cowden syndrome treated with surgical clipping background cowden syndrome is characterized by multiple hamartoma and accompanied by a germline mutation of the phosphatase and tensin homolog gene cowden syndrome ha been described to be associated with vascular anomaly such a arteriovenous malformation and developmental venous anomaly with high frequency however the association of cerebral aneurysm with this syndrome ha not been reported yet case description a yearold japanese man presented with a subarachnoid hemorrhage due to a ruptured giant fusiform middle cerebral artery aneurysm we diagnosed him with cowden syndrome by clinical presentation a outlined in the national comprehensive cancer network criterion a the ruptured fusiform aneurysm involved a middle cerebral artery bifurcation we prepared for extracranialintracranial bypass surgery we successfully performed a surgical clipping using multiple tandem clipping technique and suction decompression technique bypass surgery wa not performed a reconstruction of the m trunk wa successfully completed conclusion we present this rare case that potentially indicates an association between cerebral aneurysm and cowden syndrome because vascular anomaly are not included in the diagnostic criterion for cowden syndrome intracranial vascular anomaly may be underestimated we therefore recommended a careful search of vascular disease including cerebral aneurysm in case of cowden syndrome
30950529,n mri of slicsabre hyperpolarized nlabelled pyridine and nicotinamide,magnetic resonance imaging mri is a powerful noninvasive diagnostic method extensively used in biomedical study a significant limitation of mri is it relatively low signaltonoise ratio which can be increased by hyperpolarizing nuclear spin one promising method is signal amplification by reversible exchange sabre which employ parahydrogen a a source of hyperpolarization recent study demonstrated the feasibility to improve mri sensitivity with this hyperpolarization technique hyperpolarized n nucleus in biomolecules can potentially retain their spin alignment for ten of minute providing an extended time window for the utilization of the hyperpolarized compound in this work we demonstrate for the first time that radiofrequencybased sabre hyperpolarization technique can be used to obtain n mri of biomolecule nnicotinamide two image acquisition strategy were utilized and compared single point imaging spi and fast low angle shot flash these method demonstrated opportunity of highfield sabre for biomedical application,Non-Cancer,1,n mri of slicsabre hyperpolarized nlabelled pyridine and nicotinamide magnetic resonance imaging mri is a powerful noninvasive diagnostic method extensively used in biomedical study a significant limitation of mri is it relatively low signaltonoise ratio which can be increased by hyperpolarizing nuclear spin one promising method is signal amplification by reversible exchange sabre which employ parahydrogen a a source of hyperpolarization recent study demonstrated the feasibility to improve mri sensitivity with this hyperpolarization technique hyperpolarized n nucleus in biomolecules can potentially retain their spin alignment for ten of minute providing an extended time window for the utilization of the hyperpolarized compound in this work we demonstrate for the first time that radiofrequencybased sabre hyperpolarization technique can be used to obtain n mri of biomolecule nnicotinamide two image acquisition strategy were utilized and compared single point imaging spi and fast low angle shot flash these method demonstrated opportunity of highfield sabre for biomedical application
30988224,tuberous sclerosis complex,tuberous sclerosis complex tsc is an autosomal dominant inherited disorder that is characterized by the systemic hamartoma along with epilepsy cognitive impairment and hypopigmented macule it is caused by genetic mutation in either tsc or tsc gene which encodes hamartin and tuberin respectively a the hamartintuberincomplex downregulates the mechanisticmammalian target of the rapamycin complex mtorc dysfunction in either hamartin or tuberin induces the constitutive activation of mtorc in fact almost all the symptom in tsc are derived from the activation of mtorc therefore mtorc inhibitor improves all the symptom including skin lesion and neural symptom among the many symptom skin lesion appear earlier than renal or pulmonary lesion and are more specific than neuronal symptom therefore skin lesion are useful for the diagnosis of tsc this chapter focus on the feature of skin lesion and mechanistic their potential role in differential diagnosis and therapy including the therapeutic use of mtorc inhibitor,Non-Cancer,1,tuberous sclerosis complex tuberous sclerosis complex tsc is an autosomal dominant inherited disorder that is characterized by the systemic hamartoma along with epilepsy cognitive impairment and hypopigmented macule it is caused by genetic mutation in either tsc or tsc gene which encodes hamartin and tuberin respectively a the hamartintuberincomplex downregulates the mechanisticmammalian target of the rapamycin complex mtorc dysfunction in either hamartin or tuberin induces the constitutive activation of mtorc in fact almost all the symptom in tsc are derived from the activation of mtorc therefore mtorc inhibitor improves all the symptom including skin lesion and neural symptom among the many symptom skin lesion appear earlier than renal or pulmonary lesion and are more specific than neuronal symptom therefore skin lesion are useful for the diagnosis of tsc this chapter focus on the feature of skin lesion and mechanistic their potential role in differential diagnosis and therapy including the therapeutic use of mtorc inhibitor
31005870,hereditary segmental neurofibromatosis a report of three case in a family,hereditary segmental neurofibromatosis snf is an extremely rare form of snf with nine family reported till date snf is considered to be a result of mosaicism and hereditary transmission is possibly explained by increased susceptibility of mutation at neurofibromatosis gene locus we report here three member of an indian family with snf our index case a yearold woman had multiple soft to firm papule and nodule over right shoulder associated with severe intermittent pain her father had three similar nodule over left upper arm and elder sister had two such nodule over right upper arm the father and elder sister were incidentally diagnosed and they had never sought medical advice considering their lesion to be a familial trait in the absence of symptom many familial case of snf are missed thus making any systematic analysis to ascertain it genetic basis difficult,Non-Cancer,1,hereditary segmental neurofibromatosis a report of three case in a family hereditary segmental neurofibromatosis snf is an extremely rare form of snf with nine family reported till date snf is considered to be a result of mosaicism and hereditary transmission is possibly explained by increased susceptibility of mutation at neurofibromatosis gene locus we report here three member of an indian family with snf our index case a yearold woman had multiple soft to firm papule and nodule over right shoulder associated with severe intermittent pain her father had three similar nodule over left upper arm and elder sister had two such nodule over right upper arm the father and elder sister were incidentally diagnosed and they had never sought medical advice considering their lesion to be a familial trait in the absence of symptom many familial case of snf are missed thus making any systematic analysis to ascertain it genetic basis difficult
31009132,frequency of isolated cutaneous involvement in adult mastocytosis a cohort study,background mastocytosis is characterized by the accumulationproliferation of abnormal mast cell the frequency of isolated cutaneous involvement in adult with mastocytosis ha not been fully determined the main objective of our study wa to assess the frequency of isolated cutaneous mastocytosis cm in adult with mastocytosis skin lesion the second objective wa to compare the clinical histological biological and imaging feature in patient with isolated cm and patient with systemic mastocytosis sm method we included all patient with histologyproven mastocytosis skin lesion between january and december the mastocytosis diagnosis wa made according to the international diagnostic criterion all data were collected from a dedicated specific case report result among patient with mastocytosis skin lesion patient had isolated cm had sm and patient had undetermined mastocytosis skin kit mutation or ci p and high bone marrow tryptase or ci p were strong predictor of sm the prevalence of osteoporosis wa higher in the sm population than in the isolated cm population moreover a decrease in bone mineral density over a short period of followup year wa associated with sm there were no difference between the two group regarding the frequency of mast cell activation symptom the presentation of skin lesion the number of mast cell in the dermis and the level of serum tryptase we propose considering the kit mutation status and bone marrow tryptase level to aid the diagnosis of isolated cm in adult mastocytosis patient conclusion only a small minority of adult with mastocytosis skin lesion ha isolated cutaneous involvement in of mastocytosis case even complete workup doe not allow for a precise classification of patient,Non-Cancer,1,frequency of isolated cutaneous involvement in adult mastocytosis a cohort study background mastocytosis is characterized by the accumulationproliferation of abnormal mast cell the frequency of isolated cutaneous involvement in adult with mastocytosis ha not been fully determined the main objective of our study wa to assess the frequency of isolated cutaneous mastocytosis cm in adult with mastocytosis skin lesion the second objective wa to compare the clinical histological biological and imaging feature in patient with isolated cm and patient with systemic mastocytosis sm method we included all patient with histologyproven mastocytosis skin lesion between january and december the mastocytosis diagnosis wa made according to the international diagnostic criterion all data were collected from a dedicated specific case report result among patient with mastocytosis skin lesion patient had isolated cm had sm and patient had undetermined mastocytosis skin kit mutation or ci p and high bone marrow tryptase or ci p were strong predictor of sm the prevalence of osteoporosis wa higher in the sm population than in the isolated cm population moreover a decrease in bone mineral density over a short period of followup year wa associated with sm there were no difference between the two group regarding the frequency of mast cell activation symptom the presentation of skin lesion the number of mast cell in the dermis and the level of serum tryptase we propose considering the kit mutation status and bone marrow tryptase level to aid the diagnosis of isolated cm in adult mastocytosis patient conclusion only a small minority of adult with mastocytosis skin lesion ha isolated cutaneous involvement in of mastocytosis case even complete workup doe not allow for a precise classification of patient
31026806,transcription factor stat serf a a negative regulator controlling ige class switching in mouse,a mutation in stat ha been linked to the incidence of autosomal dominant hyper ige syndrome a disease characterized by elevated serum ige ab however how this genetic mutation lead to the phenotype ha not been fully understood we investigated the specific role of stat in the germinal center gc b cell and plasma cell for ige class switching through the use of stat conditional knockout cko mouse in a thtype immunization model we demonstrated that cdcredriven stat cko mouse showed elevated ige and decreased igg in the serum and a reduction in gc formation within the gc igg gc b cell were decreased whereas ige gc b cell were more prevalent additionally these mouse exhibited reduced igg and elevated ige population of abproducing plasma cell subsequent experiment using a cdcre cko mouse established this effect to be b cellintrinsic transcription factor critical for gc and plasma cell differentiation including bcl and aicda were shown to function a downstream signal of stat regulation chromatin immunoprecipitation sequencing analysis revealed that many gene including bcl and crtc were among the direct stat regulated target mouse with stat deficiency in b cell also demonstrated an increase in lung inflammation when used in an asthmalike disease model this model suggests a negative role for stat in regulating class switching of the gc b cell from the igg to the ige producing state which may serve a a therapeutic target for treatment of autosomal dominant hyper ige syndrome and other immune disorder,Non-Cancer,1,transcription factor stat serf a a negative regulator controlling ige class switching in mouse a mutation in stat ha been linked to the incidence of autosomal dominant hyper ige syndrome a disease characterized by elevated serum ige ab however how this genetic mutation lead to the phenotype ha not been fully understood we investigated the specific role of stat in the germinal center gc b cell and plasma cell for ige class switching through the use of stat conditional knockout cko mouse in a thtype immunization model we demonstrated that cdcredriven stat cko mouse showed elevated ige and decreased igg in the serum and a reduction in gc formation within the gc igg gc b cell were decreased whereas ige gc b cell were more prevalent additionally these mouse exhibited reduced igg and elevated ige population of abproducing plasma cell subsequent experiment using a cdcre cko mouse established this effect to be b cellintrinsic transcription factor critical for gc and plasma cell differentiation including bcl and aicda were shown to function a downstream signal of stat regulation chromatin immunoprecipitation sequencing analysis revealed that many gene including bcl and crtc were among the direct stat regulated target mouse with stat deficiency in b cell also demonstrated an increase in lung inflammation when used in an asthmalike disease model this model suggests a negative role for stat in regulating class switching of the gc b cell from the igg to the ige producing state which may serve a a therapeutic target for treatment of autosomal dominant hyper ige syndrome and other immune disorder
31030808,rare hereditary hemolytic anemia diagnostic approach and consideration in management,hereditary hemolytic anemia hhas comprise a heterogeneous group of anemia caused by mutation in gene coding the globin red blood cell rbc membrane protein and rbc enzyme congenital dyserythropoietic anemia cdas are rare disorder of erythropoiesis characterized by binucleated and multinucleated erythroblast in bone marrow cdas typically present with a hemolytic phenotype a the produced rbc have structural defect and decreased survival and should be considered in the differential of hhas this article discusses the clinical presentation laboratory finding and management consideration for rare hhas arising from unstable hemoglobin rbc hydration defect the less common rbc enzymopathies and cdas,Non-Cancer,1,rare hereditary hemolytic anemia diagnostic approach and consideration in management hereditary hemolytic anemia hhas comprise a heterogeneous group of anemia caused by mutation in gene coding the globin red blood cell rbc membrane protein and rbc enzyme congenital dyserythropoietic anemia cdas are rare disorder of erythropoiesis characterized by binucleated and multinucleated erythroblast in bone marrow cdas typically present with a hemolytic phenotype a the produced rbc have structural defect and decreased survival and should be considered in the differential of hhas this article discusses the clinical presentation laboratory finding and management consideration for rare hhas arising from unstable hemoglobin rbc hydration defect the less common rbc enzymopathies and cdas
31079897,heterozygous variant in kmte cause a spectrum of neurodevelopmental disorder and epilepsy,we delineate a kmterelated neurodevelopmental disorder on the basis of individual in family this study includes distinct heterozygous variant in kmte ascertained from matchmaker exchange and three previously reported and four individual with chromosome q microdeletions encompassing kmte one previously reported almost all variant occurred de novo and most were truncating most affected individual with proteintruncating variant presented with mild intellectual disability onequarter of individual met criterion for autism additional common feature include macrocephaly hypotonia functional gastrointestinal abnormality and a subtle facial gestalt epilepsy wa present in about onefifth of individual with truncating variant and wa responsive to treatment with antiepileptic medication in almost all more than of the individual were male and expressivity wa variable by sex epilepsy wa more common in female and autism more common in male the four individual with microdeletions encompassing kmte generally presented similarly to those with truncating variant but the degree of developmental delay wa greater the group of four individual with missense variant in kmte presented with the most severe developmental delay epilepsy wa present in all individual with missense variant often manifesting a treatmentresistant infantile epileptic encephalopathy microcephaly wa also common in this group haploinsufficiency versus gainoffunction or dominantnegative effect specific to these missense variant in kmte might explain this divergence in phenotype but requires independent validation disruptive variant in kmte are an underrecognized cause of neurodevelopmental abnormality,Non-Cancer,1,heterozygous variant in kmte cause a spectrum of neurodevelopmental disorder and epilepsy we delineate a kmterelated neurodevelopmental disorder on the basis of individual in family this study includes distinct heterozygous variant in kmte ascertained from matchmaker exchange and three previously reported and four individual with chromosome q microdeletions encompassing kmte one previously reported almost all variant occurred de novo and most were truncating most affected individual with proteintruncating variant presented with mild intellectual disability onequarter of individual met criterion for autism additional common feature include macrocephaly hypotonia functional gastrointestinal abnormality and a subtle facial gestalt epilepsy wa present in about onefifth of individual with truncating variant and wa responsive to treatment with antiepileptic medication in almost all more than of the individual were male and expressivity wa variable by sex epilepsy wa more common in female and autism more common in male the four individual with microdeletions encompassing kmte generally presented similarly to those with truncating variant but the degree of developmental delay wa greater the group of four individual with missense variant in kmte presented with the most severe developmental delay epilepsy wa present in all individual with missense variant often manifesting a treatmentresistant infantile epileptic encephalopathy microcephaly wa also common in this group haploinsufficiency versus gainoffunction or dominantnegative effect specific to these missense variant in kmte might explain this divergence in phenotype but requires independent validation disruptive variant in kmte are an underrecognized cause of neurodevelopmental abnormality
31127102,atomic resolution cryoem structure of a nativelike cenpa nucleosome aided by an antibody fragment,genomic dna in eukaryote is organized into chromatin through association with core histone to form nucleosomes each distinguished by their dna sequence and histone variant here we used a singlechain antibody fragment scfv derived from the antinucleosome antibody mab pl to stabilize human cenpa nucleosome containing a native alphasatellite dna and solved it structure by the cryoelectron microscopy cryoem to a resolution in comparison the corresponding cryoem structure of the free cenpa nucleosome could only reach a resolution we find that scfv bind to a conserved acidic patch on the histone hahb dimer without perturbing the nucleosome structure our result provide an atomic resolution cryoem structure of a nucleosome and insight into the structure and function of the cenpa nucleosome the scfv approach is applicable to the structural determination of other nativelike nucleosomes with distinct dna sequence,Non-Cancer,1,atomic resolution cryoem structure of a nativelike cenpa nucleosome aided by an antibody fragment genomic dna in eukaryote is organized into chromatin through association with core histone to form nucleosomes each distinguished by their dna sequence and histone variant here we used a singlechain antibody fragment scfv derived from the antinucleosome antibody mab pl to stabilize human cenpa nucleosome containing a native alphasatellite dna and solved it structure by the cryoelectron microscopy cryoem to a resolution in comparison the corresponding cryoem structure of the free cenpa nucleosome could only reach a resolution we find that scfv bind to a conserved acidic patch on the histone hahb dimer without perturbing the nucleosome structure our result provide an atomic resolution cryoem structure of a nucleosome and insight into the structure and function of the cenpa nucleosome the scfv approach is applicable to the structural determination of other nativelike nucleosomes with distinct dna sequence
31141729,facile spectroscopy and atomic force microscopy for the discrimination of alpha and beta thalassemia trait and disease a photodiagnosis approach,thalassemia thal is an inherited blood disorder endemic to the mediterranean and middle east eg ksa and uae this disease is caused by defect in the synthesis of one or more hemoglobin chain in red blood cell rbc alpha alpha thal is caused by a reduced or absent alpha globin segment similarly beta beta thal is caused by a defect in the beta globin segment we divided the disease into four group alpha thal trait alpha thal disease beta thal trait and beta thal disease the alpha or beta thal trait are milder variant of these disease and do not require treatment but beta thal disease and to a lesser extent alpha thal cause hemolytic anemia splenomegaly and bone deformity and requires repeated lifelong blood transfusion this paper present result regarding the identification of thal variant using fluorescence spectroscopy of blood biomolecules and atomic force microscopy analysis of the morphologic feature of red blood cell the combined result provide new insight into the characteristic of these disease furthermore this study show why beta thal disease subject are often transfusiondependent and alpha thal disease subject are only occasionally transfusion dependent,Non-Cancer,1,facile spectroscopy and atomic force microscopy for the discrimination of alpha and beta thalassemia trait and disease a photodiagnosis approach thalassemia thal is an inherited blood disorder endemic to the mediterranean and middle east eg ksa and uae this disease is caused by defect in the synthesis of one or more hemoglobin chain in red blood cell rbc alpha alpha thal is caused by a reduced or absent alpha globin segment similarly beta beta thal is caused by a defect in the beta globin segment we divided the disease into four group alpha thal trait alpha thal disease beta thal trait and beta thal disease the alpha or beta thal trait are milder variant of these disease and do not require treatment but beta thal disease and to a lesser extent alpha thal cause hemolytic anemia splenomegaly and bone deformity and requires repeated lifelong blood transfusion this paper present result regarding the identification of thal variant using fluorescence spectroscopy of blood biomolecules and atomic force microscopy analysis of the morphologic feature of red blood cell the combined result provide new insight into the characteristic of these disease furthermore this study show why beta thal disease subject are often transfusiondependent and alpha thal disease subject are only occasionally transfusion dependent
31164752,pedia prioritization of exome data by image analysis,purpose phenotype information is crucial for the interpretation of genomic variant so far it ha only been accessible for bioinformatics workflow after encoding into clinical term by expert dysmorphologists method here we introduce an approach driven by artificial intelligence that us portrait photograph for the interpretation of clinical exome data we measured the value added by computerassisted image analysis to the diagnostic yield on a cohort consisting of individual with different monogenic disorder for each case in the cohort we compiled frontal photo clinical feature and the diseasecausing variant and simulated multiple exomes of different ethnic background result the additional use of similarity score from computerassisted analysis of frontal photo improved the top accuracy rate by more than and the top accuracy rate by more than for the diseasecausing gene conclusion image analysis by deeplearning algorithm can be used to quantify the phenotypic similarity pp criterion of the american college of medical genetics and genomics guideline and to advance the performance of bioinformatics pipeline for exome analysis,Non-Cancer,1,pedia prioritization of exome data by image analysis purpose phenotype information is crucial for the interpretation of genomic variant so far it ha only been accessible for bioinformatics workflow after encoding into clinical term by expert dysmorphologists method here we introduce an approach driven by artificial intelligence that us portrait photograph for the interpretation of clinical exome data we measured the value added by computerassisted image analysis to the diagnostic yield on a cohort consisting of individual with different monogenic disorder for each case in the cohort we compiled frontal photo clinical feature and the diseasecausing variant and simulated multiple exomes of different ethnic background result the additional use of similarity score from computerassisted analysis of frontal photo improved the top accuracy rate by more than and the top accuracy rate by more than for the diseasecausing gene conclusion image analysis by deeplearning algorithm can be used to quantify the phenotypic similarity pp criterion of the american college of medical genetics and genomics guideline and to advance the performance of bioinformatics pipeline for exome analysis
31168756,highresolution pharyngeal manometry and impedance protocol and metricsrecommendations of a highresolution pharyngeal manometry international working group,highresolution manometry ha traditionally been utilized in gastroenterology diagnostic clinical and research application recently it is also finding new and important application in speech pathology and laryngology practice a highresolution pharyngeal manometry international working group wa formed a a grass root effort to establish a consensus on methodology protocol and outcome metric for highresolution pharyngeal manometry hrpm with consideration of impedance a an adjunct modality the working group undertook three task survey what expert were currently doing in their clinical andor research practice perform a review of the literature underpinning the value of particular hrpm metric for understanding swallowing physiology and pathophysiology and establish a core outcome set of hrpm metric via a delphi consensus process expert survey result were used to create a recommended hrpm protocol addressing system configuration catheter insertion and bolus administration ninety two article were included in the final literature review resulting in categorization of hrpmimpedance metric into three class pharyngeal lumen occlusive pressure hypopharyngeal intrabolus pressure and upper esophageal sphincter ues function a stable delphi consensus wa achieved for hrpmimpedance metric pharyngeal contractile integral ci velopharyngeal ci hypopharyngeal ci hypopharyngeal pressure at nadir impedance ues integrated relaxation pressure relaxation time and maximum admittance while some important unanswered question remain our work represents the first step in standardization of highresolution pharyngeal manometry acquisition measurement and reporting this could potentially inform future proposal for an hrpmbased classification system specifically for pharyngeal swallowing disorder,Non-Cancer,1,highresolution pharyngeal manometry and impedance protocol and metricsrecommendations of a highresolution pharyngeal manometry international working group highresolution manometry ha traditionally been utilized in gastroenterology diagnostic clinical and research application recently it is also finding new and important application in speech pathology and laryngology practice a highresolution pharyngeal manometry international working group wa formed a a grass root effort to establish a consensus on methodology protocol and outcome metric for highresolution pharyngeal manometry hrpm with consideration of impedance a an adjunct modality the working group undertook three task survey what expert were currently doing in their clinical andor research practice perform a review of the literature underpinning the value of particular hrpm metric for understanding swallowing physiology and pathophysiology and establish a core outcome set of hrpm metric via a delphi consensus process expert survey result were used to create a recommended hrpm protocol addressing system configuration catheter insertion and bolus administration ninety two article were included in the final literature review resulting in categorization of hrpmimpedance metric into three class pharyngeal lumen occlusive pressure hypopharyngeal intrabolus pressure and upper esophageal sphincter ues function a stable delphi consensus wa achieved for hrpmimpedance metric pharyngeal contractile integral ci velopharyngeal ci hypopharyngeal ci hypopharyngeal pressure at nadir impedance ues integrated relaxation pressure relaxation time and maximum admittance while some important unanswered question remain our work represents the first step in standardization of highresolution pharyngeal manometry acquisition measurement and reporting this could potentially inform future proposal for an hrpmbased classification system specifically for pharyngeal swallowing disorder
31186072,triglyceride deposit cardiomyovasculopathy a rare cardiovascular disorder,triglyceride deposit cardiomyovasculopathy tgcv is a phenotype primarily reported in patient carrying genetic mutation in pnpla encoding adipose triglyceride lipase atgl which release long chain fatty acid lcfa a a major energy source by the intracellular tg hydrolysis these patient suffered from intractable heart failure requiring cardiac transplantation moreover we identified tgcv patient without pnpla mutation based on pathological and clinical study we provided the diagnostic criterion in which tgcv with and without pnpla mutation were designated a primary tgcv ptgcv and idiopathic tgcv itgcv respectively we hereby report clinical profile of tgcv patient between and ptgcv and itgcv japanese patient have been registered in the international registry patient with itgcv of which etiology and cause are not known yet suffered from adultonset severe heart disease including heart failure and coronary artery disease associated with a marked reduction in atgl activity and myocardial washout rate of lcfa tracer a similar to those with ptgcv the present first registrybased study showed that tgcv is an intractable at least at the moment and heterogeneous cardiovascular disorder,Non-Cancer,1,triglyceride deposit cardiomyovasculopathy a rare cardiovascular disorder triglyceride deposit cardiomyovasculopathy tgcv is a phenotype primarily reported in patient carrying genetic mutation in pnpla encoding adipose triglyceride lipase atgl which release long chain fatty acid lcfa a a major energy source by the intracellular tg hydrolysis these patient suffered from intractable heart failure requiring cardiac transplantation moreover we identified tgcv patient without pnpla mutation based on pathological and clinical study we provided the diagnostic criterion in which tgcv with and without pnpla mutation were designated a primary tgcv ptgcv and idiopathic tgcv itgcv respectively we hereby report clinical profile of tgcv patient between and ptgcv and itgcv japanese patient have been registered in the international registry patient with itgcv of which etiology and cause are not known yet suffered from adultonset severe heart disease including heart failure and coronary artery disease associated with a marked reduction in atgl activity and myocardial washout rate of lcfa tracer a similar to those with ptgcv the present first registrybased study showed that tgcv is an intractable at least at the moment and heterogeneous cardiovascular disorder
31189917,feedback inhibition of camp effector signaling by a chaperoneassisted ubiquitin system,activation of gprotein coupled receptor elevates camp level promoting dissociation of protein kinase a pka holoenzymes and release of catalytic subunit pkac this result in pkacmediated phosphorylation of compartmentalized substrate that control central aspect of cell physiology the mechanism of pkac activation and signaling have been largely characterized however the mode of pkac inactivation by regulated proteolysis were unknown here we identify a regulatory mechanism that precisely tune pkac stability and downstream signaling following agonist stimulation the recruitment of the chaperonebound e ligase chip promotes ubiquitylation and proteolysis of pkac thus attenuating camp signaling genetic inactivation of chip or pharmacological inhibition of hsp enhances pkac signaling and sustains hippocampal longterm potentiation interestingly primary fibroblast from autosomal recessive spinocerebellar ataxia scar patient carrying germline inactivating mutation of chip show a dramatic dysregulation of pka signaling this suggests the existence of a negative feedback mechanism for restricting hormonally controlled pka activity,Non-Cancer,1,feedback inhibition of camp effector signaling by a chaperoneassisted ubiquitin system activation of gprotein coupled receptor elevates camp level promoting dissociation of protein kinase a pka holoenzymes and release of catalytic subunit pkac this result in pkacmediated phosphorylation of compartmentalized substrate that control central aspect of cell physiology the mechanism of pkac activation and signaling have been largely characterized however the mode of pkac inactivation by regulated proteolysis were unknown here we identify a regulatory mechanism that precisely tune pkac stability and downstream signaling following agonist stimulation the recruitment of the chaperonebound e ligase chip promotes ubiquitylation and proteolysis of pkac thus attenuating camp signaling genetic inactivation of chip or pharmacological inhibition of hsp enhances pkac signaling and sustains hippocampal longterm potentiation interestingly primary fibroblast from autosomal recessive spinocerebellar ataxia scar patient carrying germline inactivating mutation of chip show a dramatic dysregulation of pka signaling this suggests the existence of a negative feedback mechanism for restricting hormonally controlled pka activity
31199508,identification of driver gene and somatic mutation in cellfree dna of patient with pulmonary lymphangioleiomyomatosis,nextgeneration sequencing of cellfree circulating dna cfdna ha emerged a promising technique for identifying minimally invasive genomic profiling of tumor cell recently however it remains relatively unknown in lam disease in our study paired cfdna and genomic dna gdna in blood sample were obtained from lam patient and seven healthy control to explore mutation profile of targeted cancerrelated gene a result logbased allele frequency of mutation in cfdna were significantly different from those of gdna by comparing the mutual mutation identified both in cfdna and gdna a significant correlation wa also observed after removing mutation in gdna distinct somatic mutation profile of cfdna were observed in lam patient forty of targeted gene had recurrent mutation of which atm brca and apc showed the highest frequency based on the mutation correlation network constructed of mutated gene hub gene bearing intensive interaction were highlighted including brca brca rad rb nf apc mlh atm pdgfra palb and blm expression of the hub gene showed significant cluster between lam patient and control and that rad and brca had the strongest association with subject phenotype myogenesis and estrogen response were confirmed to be positively regulated in lam patient collectively our study provided a landscape of genomic alteration in lam and discovered several potential driver gene that is brca and rad which shed a substantial light on the clinical application of key molecular marker and potential therapy target for precision diagnosis and treatment in the future,Non-Cancer,1,identification of driver gene and somatic mutation in cellfree dna of patient with pulmonary lymphangioleiomyomatosis nextgeneration sequencing of cellfree circulating dna cfdna ha emerged a promising technique for identifying minimally invasive genomic profiling of tumor cell recently however it remains relatively unknown in lam disease in our study paired cfdna and genomic dna gdna in blood sample were obtained from lam patient and seven healthy control to explore mutation profile of targeted cancerrelated gene a result logbased allele frequency of mutation in cfdna were significantly different from those of gdna by comparing the mutual mutation identified both in cfdna and gdna a significant correlation wa also observed after removing mutation in gdna distinct somatic mutation profile of cfdna were observed in lam patient forty of targeted gene had recurrent mutation of which atm brca and apc showed the highest frequency based on the mutation correlation network constructed of mutated gene hub gene bearing intensive interaction were highlighted including brca brca rad rb nf apc mlh atm pdgfra palb and blm expression of the hub gene showed significant cluster between lam patient and control and that rad and brca had the strongest association with subject phenotype myogenesis and estrogen response were confirmed to be positively regulated in lam patient collectively our study provided a landscape of genomic alteration in lam and discovered several potential driver gene that is brca and rad which shed a substantial light on the clinical application of key molecular marker and potential therapy target for precision diagnosis and treatment in the future
31203817,exome sequencing in routine diagnostics a generic test for patient with primary immunodeficiency,background diagnosis of primary immunodeficiency pid is complex and cumbersome yet important for the clinical management of the disease exome sequencing may provide a genetic diagnosis in a significant number of patient in a single genetic test method in may we implemented exome sequencing in routine diagnostics for patient suffering from pid this study report the clinical utility and diagnostic yield for a heterogeneous group of consecutively referred pid patient from family for the majority of patient the clinical diagnosis wa based on clinical criterion including rare andor unusual severe bacterial viral or fungal infection sometimes accompanied by autoimmune manifestation functional immune defect were interpreted in the context of aberrant immune cell population aberrant antibody level or combination of these factor result for patient exome sequencing identified pathogenic variant in wellestablished pid gene an exomewide analysis diagnosed additional patient providing diagnosis for patient from family altogether the genetic diagnosis directly indicated novel treatment option for patient that received a diagnosis conclusion exome sequencing a a firsttier test for pid granted a diagnosis for of patient importantly molecularly defined diagnosis indicated altered therapeutic option in of case in addition exome sequencing harbor advantage over gene panel a a truly generic test for all genetic disease including in silico extension of existing gene list and reanalysis of existing data,Non-Cancer,1,exome sequencing in routine diagnostics a generic test for patient with primary immunodeficiency background diagnosis of primary immunodeficiency pid is complex and cumbersome yet important for the clinical management of the disease exome sequencing may provide a genetic diagnosis in a significant number of patient in a single genetic test method in may we implemented exome sequencing in routine diagnostics for patient suffering from pid this study report the clinical utility and diagnostic yield for a heterogeneous group of consecutively referred pid patient from family for the majority of patient the clinical diagnosis wa based on clinical criterion including rare andor unusual severe bacterial viral or fungal infection sometimes accompanied by autoimmune manifestation functional immune defect were interpreted in the context of aberrant immune cell population aberrant antibody level or combination of these factor result for patient exome sequencing identified pathogenic variant in wellestablished pid gene an exomewide analysis diagnosed additional patient providing diagnosis for patient from family altogether the genetic diagnosis directly indicated novel treatment option for patient that received a diagnosis conclusion exome sequencing a a firsttier test for pid granted a diagnosis for of patient importantly molecularly defined diagnosis indicated altered therapeutic option in of case in addition exome sequencing harbor advantage over gene panel a a truly generic test for all genetic disease including in silico extension of existing gene list and reanalysis of existing data
31239192,moxifloxacin resistance and genotyping of mycobacterium avium and mycobacterium intracellulare isolates in japan,background although fluoroquinolones are considered a alternative therapy of pulmonary mycobacterium avium complex mac disease the association between fluoroquinolone resistance and mac genotype in clinical isolates from individual not previously treated for mac infection is not fully clear method total of m avium isolates and mycobacterium intracellulare isolates were obtained from treatmentnaive patient with pulmonary mac disease at the diagnosis of mac infection at hospital in japan their susceptibility of moxifloxacin were determined by broth microdilution method moxifloxacinresistant isolates were examined for mutation of gyra and gyrb variable number of tandem repeat vntr assay wa performed using m avium vntr locus and m intracellulare vntr locus result moxifloxacin susceptibility wa categorized a resistant and intermediate for and respectively of m avium isolates and and of m intracellulare isolates although the isolates of both specie had amino acid substitution of thr and thr at the site corresponding to ser in the m tuberculosis gyra and gly in the m tuberculosis gyrb respectively these substitution were observed irrespective of susceptibility and did not confer resistance the vntr assay showed revealed three cluster among m avium isolates and two cluster among m intracellulare isolates no significant difference in moxifloxacin resistance were observed among these cluster conclusion although resistance or intermediate resistance to moxifloxacin wa observed in approximately onefourth of m avium and m intracellulare isolates this resistance wa not associated with mutation in gyra and gyrb or with vntr genotype,Non-Cancer,1,moxifloxacin resistance and genotyping of mycobacterium avium and mycobacterium intracellulare isolates in japan background although fluoroquinolones are considered a alternative therapy of pulmonary mycobacterium avium complex mac disease the association between fluoroquinolone resistance and mac genotype in clinical isolates from individual not previously treated for mac infection is not fully clear method total of m avium isolates and mycobacterium intracellulare isolates were obtained from treatmentnaive patient with pulmonary mac disease at the diagnosis of mac infection at hospital in japan their susceptibility of moxifloxacin were determined by broth microdilution method moxifloxacinresistant isolates were examined for mutation of gyra and gyrb variable number of tandem repeat vntr assay wa performed using m avium vntr locus and m intracellulare vntr locus result moxifloxacin susceptibility wa categorized a resistant and intermediate for and respectively of m avium isolates and and of m intracellulare isolates although the isolates of both specie had amino acid substitution of thr and thr at the site corresponding to ser in the m tuberculosis gyra and gly in the m tuberculosis gyrb respectively these substitution were observed irrespective of susceptibility and did not confer resistance the vntr assay showed revealed three cluster among m avium isolates and two cluster among m intracellulare isolates no significant difference in moxifloxacin resistance were observed among these cluster conclusion although resistance or intermediate resistance to moxifloxacin wa observed in approximately onefourth of m avium and m intracellulare isolates this resistance wa not associated with mutation in gyra and gyrb or with vntr genotype
31242855,using imputed wholegenome sequence data to improve the accuracy of genomic prediction for parasite resistance in australian sheep,background this study aimed at comparing the accuracy of genomic prediction for parasite resistance in sheep based on wholegenome sequence wgs data to those based on k and highdensity hd single nucleotide polymorphism snp panel investigating whether the use of variant within quantitative trait locus qtl region that were selected from regional heritability mapping rhm in an independent dataset improved the accuracy more than variant selected from genomewide association study gwas and comparing the prediction accuracy between variant selected from wgs data to variant selected from the hd snp panel result the accuracy of genomic prediction improved marginally from and when using all the variant from k and hd genotype respectively to when using all the variant from wgs data fitting a grm from the selected variant alongside a grm from the k snp genotype improved the prediction accuracy substantially compared to fitting the k snp genotype alone the gain in prediction accuracy wa slightly more pronounced when variant were selected from wgs data compared to when variant were selected from the hd panel when sequence variant that passed the gwas formula see text threshold of across the entire genome were selected the prediction accuracy improved by up to whereas when selection wa limited to sequence variant that passed the same gwas formula see text threshold of in region identified by rhm the accuracy improved by up to conclusion our result show that through careful selection of sequence variant from the qtl region the accuracy of genomic prediction for parasite resistance in sheep can be improved these finding have important implication for genomic prediction in sheep,Non-Cancer,1,using imputed wholegenome sequence data to improve the accuracy of genomic prediction for parasite resistance in australian sheep background this study aimed at comparing the accuracy of genomic prediction for parasite resistance in sheep based on wholegenome sequence wgs data to those based on k and highdensity hd single nucleotide polymorphism snp panel investigating whether the use of variant within quantitative trait locus qtl region that were selected from regional heritability mapping rhm in an independent dataset improved the accuracy more than variant selected from genomewide association study gwas and comparing the prediction accuracy between variant selected from wgs data to variant selected from the hd snp panel result the accuracy of genomic prediction improved marginally from and when using all the variant from k and hd genotype respectively to when using all the variant from wgs data fitting a grm from the selected variant alongside a grm from the k snp genotype improved the prediction accuracy substantially compared to fitting the k snp genotype alone the gain in prediction accuracy wa slightly more pronounced when variant were selected from wgs data compared to when variant were selected from the hd panel when sequence variant that passed the gwas formula see text threshold of across the entire genome were selected the prediction accuracy improved by up to whereas when selection wa limited to sequence variant that passed the same gwas formula see text threshold of in region identified by rhm the accuracy improved by up to conclusion our result show that through careful selection of sequence variant from the qtl region the accuracy of genomic prediction for parasite resistance in sheep can be improved these finding have important implication for genomic prediction in sheep
31269567,a clinical study of proteus syndrome caused by a mosaic somatic mutation in akt gene,objective proteus syndrome is a rare disease the aim of the present study wa to analyze the clinical characteristic and gene mutation of proteus syndrome with a case report and relevant literature review method clinical data of the patient with proteus syndrome were collected in detail and biochemical measurement and radiological examination were conducted tissue from phalanx with lesion were obtained to extract dna and sanger sequencing of akt gene wa carried on the pathogenic mutation wa further tested in peripheral blood sample of the patient his parent and healthy volunteer orthopaedic surgery wa performed on the affected limb of the patient result the patient wa presented with progressive overgrowth of the right extremity scoliosis cerebral connective tissue nevus and lower extremity venous a heterozygous mutation of akt gene c ga wa identified in dna extracted from the affected bone tissue of the patient but not be found in genomic dna of peripheral blood sample from the patient his parent and healthy volunteer movement function of the affected limb improved significantly after the operation conclusion the prominent feature of proteus syndrome are overgrowth of one extremity and cerebral connective tissue nevus a mosaic somatic mutation of akt gene is one of the pathogenic mutation for proteus syndrome and orthopedic surgery may be a good way to improve symptom of the disease,Non-Cancer,1,a clinical study of proteus syndrome caused by a mosaic somatic mutation in akt gene objective proteus syndrome is a rare disease the aim of the present study wa to analyze the clinical characteristic and gene mutation of proteus syndrome with a case report and relevant literature review method clinical data of the patient with proteus syndrome were collected in detail and biochemical measurement and radiological examination were conducted tissue from phalanx with lesion were obtained to extract dna and sanger sequencing of akt gene wa carried on the pathogenic mutation wa further tested in peripheral blood sample of the patient his parent and healthy volunteer orthopaedic surgery wa performed on the affected limb of the patient result the patient wa presented with progressive overgrowth of the right extremity scoliosis cerebral connective tissue nevus and lower extremity venous a heterozygous mutation of akt gene c ga wa identified in dna extracted from the affected bone tissue of the patient but not be found in genomic dna of peripheral blood sample from the patient his parent and healthy volunteer movement function of the affected limb improved significantly after the operation conclusion the prominent feature of proteus syndrome are overgrowth of one extremity and cerebral connective tissue nevus a mosaic somatic mutation of akt gene is one of the pathogenic mutation for proteus syndrome and orthopedic surgery may be a good way to improve symptom of the disease
31294066,prediction of functional consequence of the five newly discovered gpd variation in taiwan,glucosephosphate dehydrogenase deficiency gpd deficiency omim is the most common inborn error disorder worldwide while the gpd is the key enzyme of removing oxidative stress in erythrocyte the early diagnosis is utmost vital to prevent chronic and drug food or infectioninduced hemolytic anemia the characterization of the mutation is also important for the subsequent genetic counseling especially for female carrier with ambiguous enzyme activity and male with mild mutation while multiplex snapshot assay and sanger sequencing were performed on gpd deficient male five newly discovered variation namely cg a pek cg c pqh ca t pif cg a pgd and cg a pvi were detected in the other six patient these variant were previously named a the pingtung tainan changhua chiayi and tainan variant respectively the in silico analysis a well a the prediction of the structure of the resultant mutant gpd protein indicated that these five newly discovered variant might be disease causing mutation,Non-Cancer,1,prediction of functional consequence of the five newly discovered gpd variation in taiwan glucosephosphate dehydrogenase deficiency gpd deficiency omim is the most common inborn error disorder worldwide while the gpd is the key enzyme of removing oxidative stress in erythrocyte the early diagnosis is utmost vital to prevent chronic and drug food or infectioninduced hemolytic anemia the characterization of the mutation is also important for the subsequent genetic counseling especially for female carrier with ambiguous enzyme activity and male with mild mutation while multiplex snapshot assay and sanger sequencing were performed on gpd deficient male five newly discovered variation namely cg a pek cg c pqh ca t pif cg a pgd and cg a pvi were detected in the other six patient these variant were previously named a the pingtung tainan changhua chiayi and tainan variant respectively the in silico analysis a well a the prediction of the structure of the resultant mutant gpd protein indicated that these five newly discovered variant might be disease causing mutation
31350329,a pilot study of sirolimus in subject with cowden syndrome or other syndrome characterized by germline mutation in pten,lesson learned this is the first human interventional study in patient with cowden syndrome that is driven by inactivation of germline pten genesingleagent sirolimus a mtor inhibitor suppressed mtor signaling in surrogate human tissue without significant toxicity background cowden syndrome is characterized by inactivating germline pten mutation which can lead to activation of the pikaktmtor pathway method adult subject with germline pten mutation who met international diagnostic criterion for cowden syndrome and who had eastern cooperative oncology group ecog performance status and adequate organ function were enrolled subject were treated with a day course of daily oral sirolimus in addition to symptom assessment and physical examination dermatologic endoscopic neurologic cerebellar and radiographic assessment were conducted inhibition of the mtor pathway in benign skin and gastrointestinal gi lesion wa assessed by immunohistochemistry result a total of patient and family were enrolled pten mutation were located at exon regression of skin and gi lesion wa observed by dermoscopy or endoscopy neurological evaluation showed improvement in cerebellar function score at month immunohistochemistry ihc analysis in skin and gi benign lesion showed a decrease in the ratio of phosphorylated p to total s in response to sirolimus ratio of psk to total s at day and were significantly lower than at baseline p p respectively a day course of sirolimus wa well tolerated conclusion a day course of sirolimus wa well tolerated in subject with cowden syndrome and wa associated with some evidence of improvement in symptom skin and gi lesion cerebellar function and decreased mtor signaling,Non-Cancer,1,a pilot study of sirolimus in subject with cowden syndrome or other syndrome characterized by germline mutation in pten lesson learned this is the first human interventional study in patient with cowden syndrome that is driven by inactivation of germline pten genesingleagent sirolimus a mtor inhibitor suppressed mtor signaling in surrogate human tissue without significant toxicity background cowden syndrome is characterized by inactivating germline pten mutation which can lead to activation of the pikaktmtor pathway method adult subject with germline pten mutation who met international diagnostic criterion for cowden syndrome and who had eastern cooperative oncology group ecog performance status and adequate organ function were enrolled subject were treated with a day course of daily oral sirolimus in addition to symptom assessment and physical examination dermatologic endoscopic neurologic cerebellar and radiographic assessment were conducted inhibition of the mtor pathway in benign skin and gastrointestinal gi lesion wa assessed by immunohistochemistry result a total of patient and family were enrolled pten mutation were located at exon regression of skin and gi lesion wa observed by dermoscopy or endoscopy neurological evaluation showed improvement in cerebellar function score at month immunohistochemistry ihc analysis in skin and gi benign lesion showed a decrease in the ratio of phosphorylated p to total s in response to sirolimus ratio of psk to total s at day and were significantly lower than at baseline p p respectively a day course of sirolimus wa well tolerated conclusion a day course of sirolimus wa well tolerated in subject with cowden syndrome and wa associated with some evidence of improvement in symptom skin and gi lesion cerebellar function and decreased mtor signaling
31399819,use of mammographic measurement to predict complication after nipplesparing mastectomy in brca mutation carrier,background there is limited data evaluating mastectomy skin flap complication of nipplesparing mastectomy nsm in patient with brca gene mutation the purpose of this study wa to identify factor associated with postoperative complication in brca mutation carrier undergoing nsm method following institutional review board approval we interrogated a prospectively collected institutional database for patient undergoing nsm who tested positive for brca mutation patient characteristic preoperative detail and complication were evaluated digital mammogram wa used to estimate the breast volume result from august to december patient male with brca mutation underwent nsms ninetytwo were riskreduction surgery thirtytwo underwent singlestage reconstruction autologous the overall complication rate wa n and n underwent unanticipated reoperation n had fullthickness skin flap necrosis n nipple necrosis and n fullthickness nipple necrosis these complication were associated with larger breast volume cc v cc p and greater body mass index v p by univariate analysis body mass index and breast volume greater than cc were associated with significantly higher complication rate odds ratio and respectively p conclusion this study confirms that nsm in brca mutation carrier is associated with complication in one in four patient utilizing the preoperative mammogram to estimate breast size may be more helpful than breast cup size in counseling preoperatively the risk of complication,Non-Cancer,1,use of mammographic measurement to predict complication after nipplesparing mastectomy in brca mutation carrier background there is limited data evaluating mastectomy skin flap complication of nipplesparing mastectomy nsm in patient with brca gene mutation the purpose of this study wa to identify factor associated with postoperative complication in brca mutation carrier undergoing nsm method following institutional review board approval we interrogated a prospectively collected institutional database for patient undergoing nsm who tested positive for brca mutation patient characteristic preoperative detail and complication were evaluated digital mammogram wa used to estimate the breast volume result from august to december patient male with brca mutation underwent nsms ninetytwo were riskreduction surgery thirtytwo underwent singlestage reconstruction autologous the overall complication rate wa n and n underwent unanticipated reoperation n had fullthickness skin flap necrosis n nipple necrosis and n fullthickness nipple necrosis these complication were associated with larger breast volume cc v cc p and greater body mass index v p by univariate analysis body mass index and breast volume greater than cc were associated with significantly higher complication rate odds ratio and respectively p conclusion this study confirms that nsm in brca mutation carrier is associated with complication in one in four patient utilizing the preoperative mammogram to estimate breast size may be more helpful than breast cup size in counseling preoperatively the risk of complication
31432761,a review on protein marker of exosome from different bioresources and the antibody used for characterization,exosomes are small membrane vesicle ranging from nm to nm secreted by different cell type upon fusion of multivesicular body mvb to the cell plasma membrane under a variety of normal and pathological condition through transferring their cargo such a protein lipid and nucleic acid from donor cell to recipient cell exosomes play a crucial role in celltocell communication due to their presence in most body fluid such a blood breast milk saliva urine bile pancreatic juice cerebrospinal and peritoneal fluid and their role in carrying bioactive molecule from the cell of origin exosomes have attracted great interest in their diagnostic and prognostic value for various disease and therapeutic approach although a large body of literature ha documented the importance of exosomes over the past decade there is no article systematically summarizing protein marker of exosome from different resource and the antibody that are suited to characterize exosomes in this review we briefly summarize the exosome marker protein exosomal biomarkers for different disease and the antibody suitable for different bioresources exosomes characterization,Non-Cancer,1,a review on protein marker of exosome from different bioresources and the antibody used for characterization exosomes are small membrane vesicle ranging from nm to nm secreted by different cell type upon fusion of multivesicular body mvb to the cell plasma membrane under a variety of normal and pathological condition through transferring their cargo such a protein lipid and nucleic acid from donor cell to recipient cell exosomes play a crucial role in celltocell communication due to their presence in most body fluid such a blood breast milk saliva urine bile pancreatic juice cerebrospinal and peritoneal fluid and their role in carrying bioactive molecule from the cell of origin exosomes have attracted great interest in their diagnostic and prognostic value for various disease and therapeutic approach although a large body of literature ha documented the importance of exosomes over the past decade there is no article systematically summarizing protein marker of exosome from different resource and the antibody that are suited to characterize exosomes in this review we briefly summarize the exosome marker protein exosomal biomarkers for different disease and the antibody suitable for different bioresources exosomes characterization
31672142,probable progressive multifocal leukoencephalopathyimmune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation a case report and literature review,background progressive multifocal leukoencephalopathy pml is a rapidly developing demyelinating disease in the cerebral white matter and is often caused by jc polyomavirus jcv pml after lung transplantation is rare and ha a poor prognosis with no established therapy reducing the patient immunosuppressant dos thereby restoring immunity could be used to treat pml however some patient develop immune reconstitution inflammatory syndrome iris with this treatment an immuneinduced inflammatory response to jcv that result in serious neuronal damage we herein report a case of a yearold female who suffered from pml year after lung transplantation had worsened brain lesion thought to be related to pmliris at the time of immunosuppressant reduction and missed treatment opportunity case presentation a yearold female developed pml year after lung transplantation fluidattenuated inversion recovery and diffusionweighted brain magnetic resonance imaging mri revealed multiple highsignal lesion mainly in the cerebral white matter polymerase chain reaction found million copiesml of jcv in the cerebrospinal fluid thus she wa given a diagnosis of pml mycophenolate mofetil and tacrolimus dosage were reduced and cdpositive cell count and the blood concentration of each immunosuppressant were monitored mefloquine wa also orally administered at a daily dose of mg for day and wa then administered at a dose of mg per week although the patient cdpositive cell count increased and her immune system recovered her symptom and brain mri finding worsened we suspected pml progression or a transition to pmliris steroid pulse therapy to suppress the inflammatory lesion wa not possible but wa retrospectively indicated the patient rapidly began to exhibit akinetic mutism and died month after the onset of neurologic symptom conclusion when neurologic symptom and abnormal brain mri finding are noted during immune recovery it is often difficult to distinguish between progressed pml and pmliris however the pathogenesis of brain lesion usually involves inflammation and immunereactive mechanism for jcv steroid pulse therapy which can reduce inflammation should thus be administered in organ transplantation case with differential diagnosis including pmliris,Non-Cancer,1,probable progressive multifocal leukoencephalopathyimmune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation a case report and literature review background progressive multifocal leukoencephalopathy pml is a rapidly developing demyelinating disease in the cerebral white matter and is often caused by jc polyomavirus jcv pml after lung transplantation is rare and ha a poor prognosis with no established therapy reducing the patient immunosuppressant dos thereby restoring immunity could be used to treat pml however some patient develop immune reconstitution inflammatory syndrome iris with this treatment an immuneinduced inflammatory response to jcv that result in serious neuronal damage we herein report a case of a yearold female who suffered from pml year after lung transplantation had worsened brain lesion thought to be related to pmliris at the time of immunosuppressant reduction and missed treatment opportunity case presentation a yearold female developed pml year after lung transplantation fluidattenuated inversion recovery and diffusionweighted brain magnetic resonance imaging mri revealed multiple highsignal lesion mainly in the cerebral white matter polymerase chain reaction found million copiesml of jcv in the cerebrospinal fluid thus she wa given a diagnosis of pml mycophenolate mofetil and tacrolimus dosage were reduced and cdpositive cell count and the blood concentration of each immunosuppressant were monitored mefloquine wa also orally administered at a daily dose of mg for day and wa then administered at a dose of mg per week although the patient cdpositive cell count increased and her immune system recovered her symptom and brain mri finding worsened we suspected pml progression or a transition to pmliris steroid pulse therapy to suppress the inflammatory lesion wa not possible but wa retrospectively indicated the patient rapidly began to exhibit akinetic mutism and died month after the onset of neurologic symptom conclusion when neurologic symptom and abnormal brain mri finding are noted during immune recovery it is often difficult to distinguish between progressed pml and pmliris however the pathogenesis of brain lesion usually involves inflammation and immunereactive mechanism for jcv steroid pulse therapy which can reduce inflammation should thus be administered in organ transplantation case with differential diagnosis including pmliris
36437532,novel genetic determinant of dental maturation in child,dental occlusion requires harmonious development of teeth jaw and other element of the craniofacial complex which are regulated by environmental and genetic factor we performed the first genomewide association study gwas on dental development dd using the demirjian radiographic method radiographic assessment from participant of the generation r study primary study population n mean age of y were correlated with million genetic variant while adjusting for age sex and genomic principal component proxy for population stratification variant associated with dd at genomewide significant level p mapped to q irx lead variant r b p  we used fisher combined probability test weighted by sample size to perform a metaanalysis n combining radiographic dd at a mean age of y from generation r with data from a previous gwas n on number of teeth nt in infant used a proxy of dd at a mean age of y including the alspac and nfbc this gwas metaanalysis revealed novel locus mapping to p igfbp p  q pax p  and q irx p  and validated previously reported nt locus a polygenic allele score constructed from these locus wa associated with radiographic dd in an independent generation r set of child n b p furthermore profiling of the identified gene across an atlas of murine and human stem cell observed expression in the cell involved in the formation of bone andor dental tissue frequency per kilobase of transcript per million mapped read likely reflecting functional specialization our finding provide biological insight into the polygenic architecture of the pediatric dental maturation process,Non-Cancer,1,novel genetic determinant of dental maturation in child dental occlusion requires harmonious development of teeth jaw and other element of the craniofacial complex which are regulated by environmental and genetic factor we performed the first genomewide association study gwas on dental development dd using the demirjian radiographic method radiographic assessment from participant of the generation r study primary study population n mean age of y were correlated with million genetic variant while adjusting for age sex and genomic principal component proxy for population stratification variant associated with dd at genomewide significant level p mapped to q irx lead variant r b p  we used fisher combined probability test weighted by sample size to perform a metaanalysis n combining radiographic dd at a mean age of y from generation r with data from a previous gwas n on number of teeth nt in infant used a proxy of dd at a mean age of y including the alspac and nfbc this gwas metaanalysis revealed novel locus mapping to p igfbp p  q pax p  and q irx p  and validated previously reported nt locus a polygenic allele score constructed from these locus wa associated with radiographic dd in an independent generation r set of child n b p furthermore profiling of the identified gene across an atlas of murine and human stem cell observed expression in the cell involved in the formation of bone andor dental tissue frequency per kilobase of transcript per million mapped read likely reflecting functional specialization our finding provide biological insight into the polygenic architecture of the pediatric dental maturation process
36623684,identification of novel genetic risk factor for focal segmental glomerulosclerosis in child result from the chronic kidney disease in child ckid cohort,focal segmental glomerulosclerosis fsgs is a major cause of pediatric nephrotic syndrome and african american exhibit an increased risk for developing fsgs compared with other population predisposing genetic factor have previously been described in adult here we performed genomic screening of primary fsgs in a pediatric african american population,Non-Cancer,1,identification of novel genetic risk factor for focal segmental glomerulosclerosis in child result from the chronic kidney disease in child ckid cohort focal segmental glomerulosclerosis fsgs is a major cause of pediatric nephrotic syndrome and african american exhibit an increased risk for developing fsgs compared with other population predisposing genetic factor have previously been described in adult here we performed genomic screening of primary fsgs in a pediatric african american population
36632975,effectiveness of elbasvirgrazoprevir plus ribavirin for hepatitis c virus genotype a infection and baseline nsa resistance,in clinical trial patient with hepatitis c virus hcv genotype gta infection and baseline resistanceassociated substitution ras at amino acid position or receiving elbasvirgrazoprevir for week achieved lower rate of sustained virologic response svr than those without baseline ras svr rate in patient with ras were improved when elbasvirgrazoprevir treatment duration wa extended from to week and administered concomitantly with ribavirin,Non-Cancer,1,effectiveness of elbasvirgrazoprevir plus ribavirin for hepatitis c virus genotype a infection and baseline nsa resistance in clinical trial patient with hepatitis c virus hcv genotype gta infection and baseline resistanceassociated substitution ras at amino acid position or receiving elbasvirgrazoprevir for week achieved lower rate of sustained virologic response svr than those without baseline ras svr rate in patient with ras were improved when elbasvirgrazoprevir treatment duration wa extended from to week and administered concomitantly with ribavirin
36695213,toward a realistic in silico abdominal phantom for qsm,qsm outside the brain ha recently gained interest particularly in the abdominal region however the absence of reliable ground truth make difficult to assess reconstruction algorithm whose quality is already compromised by additional signal contribution from fat gas and different kind of motion this work present a realistic in silico phantom for the development evaluation and comparison of abdominal qsm reconstruction algorithm,Non-Cancer,1,toward a realistic in silico abdominal phantom for qsm qsm outside the brain ha recently gained interest particularly in the abdominal region however the absence of reliable ground truth make difficult to assess reconstruction algorithm whose quality is already compromised by additional signal contribution from fat gas and different kind of motion this work present a realistic in silico phantom for the development evaluation and comparison of abdominal qsm reconstruction algorithm
36752347,adsynnet systematic identification of alzheimers diseaseassociated mutation and comutation vulnerability via deep learning,alzheimers disease ad is one of the most challenging neurodegenerative disease because of it complicated and progressive mechanism and multiple risk factor increasing research evidence demonstrates that genetics may be a key factor responsible for the occurrence of the disease although previous report identified quite a few adassociated gene they were mostly limited owing to patient sample size and selection bias there is a lack of comprehensive research aimed to identify adassociated risk mutation systematically to address this challenge we hereby construct a largescale ad mutation and comutation framework adsynnet and propose deep learning model named deepsmci and deepcmci configured with fully connected layer that are capable of predicting cognitive impairment of subject effectively based on genetic mutation and comutation profile next we apply the customized framework to data set to evaluate the importance score of the mutation and identified mutation effector and comutation combination vulnerability contributing to cognitive impairment furthermore we evaluate the influence of mutation pair on the network architecture to dissect the genetic organization of ad and identify novel comutations that could be responsible for dementia laying a solid foundation for proposing future targeted therapy for ad precision medicine our deep learning model code are available open access here httpsgithubcompanbioadmutationeffectors,Non-Cancer,1,adsynnet systematic identification of alzheimers diseaseassociated mutation and comutation vulnerability via deep learning alzheimers disease ad is one of the most challenging neurodegenerative disease because of it complicated and progressive mechanism and multiple risk factor increasing research evidence demonstrates that genetics may be a key factor responsible for the occurrence of the disease although previous report identified quite a few adassociated gene they were mostly limited owing to patient sample size and selection bias there is a lack of comprehensive research aimed to identify adassociated risk mutation systematically to address this challenge we hereby construct a largescale ad mutation and comutation framework adsynnet and propose deep learning model named deepsmci and deepcmci configured with fully connected layer that are capable of predicting cognitive impairment of subject effectively based on genetic mutation and comutation profile next we apply the customized framework to data set to evaluate the importance score of the mutation and identified mutation effector and comutation combination vulnerability contributing to cognitive impairment furthermore we evaluate the influence of mutation pair on the network architecture to dissect the genetic organization of ad and identify novel comutations that could be responsible for dementia laying a solid foundation for proposing future targeted therapy for ad precision medicine our deep learning model code are available open access here httpsgithubcompanbioadmutationeffectors
36802176,multiple infliximab biosimilar switch appear to be safe and effective in a realworld inflammatory bowel disease cohort,switching from originator infliximab ifx to biosimilar ifx is effective and safe however data on multiple switching are scarce the edinburgh inflammatory bowel disease ibd unit ha undertaken three switch programme remicade to ctp ctp to sb and sb to ctp,Non-Cancer,1,multiple infliximab biosimilar switch appear to be safe and effective in a realworld inflammatory bowel disease cohort switching from originator infliximab ifx to biosimilar ifx is effective and safe however data on multiple switching are scarce the edinburgh inflammatory bowel disease ibd unit ha undertaken three switch programme remicade to ctp ctp to sb and sb to ctp
36867021,fzd regulates limb development by mediating catenindependent and independent wnt signaling pathway,human robinow syndrome r and dominant omodysplasia type omod characterized by skeletal limb and craniofacial defect are associated with heterozygous mutation in the wnt receptor fzd however a fzd can activate both canonical and noncanonical wnt pathway it precise function and mechanism of action in limb development are unclear to address these question we generated mouse harboring a singlenucleotide insertion in fzd fzdemsmill causing a frameshift mutation in the final dishevelledinteracting domain fzdemsmill mutant mouse had shortened limb resembling those of r and omod patient indicating that fzd mutation are causative fzdemsmill mutant embryo displayed decreased canonical wnt signaling in developing limb mesenchyme and disruption of digit chondrocyte elongation and orientation which is controlled by the cateninindependent wntaplanar cell polarity pcp pathway in line with these observation we found that disruption of fzd function in limb mesenchyme caused formation of shortened bone element and defect in wntcatenin and wntapcp signaling these finding indicate that fzd control limb development by mediating both canonical and noncanonical wnt pathway and reveal causality of pathogenic fzd mutation in r and omod patient,Non-Cancer,1,fzd regulates limb development by mediating catenindependent and independent wnt signaling pathway human robinow syndrome r and dominant omodysplasia type omod characterized by skeletal limb and craniofacial defect are associated with heterozygous mutation in the wnt receptor fzd however a fzd can activate both canonical and noncanonical wnt pathway it precise function and mechanism of action in limb development are unclear to address these question we generated mouse harboring a singlenucleotide insertion in fzd fzdemsmill causing a frameshift mutation in the final dishevelledinteracting domain fzdemsmill mutant mouse had shortened limb resembling those of r and omod patient indicating that fzd mutation are causative fzdemsmill mutant embryo displayed decreased canonical wnt signaling in developing limb mesenchyme and disruption of digit chondrocyte elongation and orientation which is controlled by the cateninindependent wntaplanar cell polarity pcp pathway in line with these observation we found that disruption of fzd function in limb mesenchyme caused formation of shortened bone element and defect in wntcatenin and wntapcp signaling these finding indicate that fzd control limb development by mediating both canonical and noncanonical wnt pathway and reveal causality of pathogenic fzd mutation in r and omod patient
36897142,initiation and treatment discontinuation of medication for opioid use disorder in pregnant people compared with nonpregnant people,to examine the association between pregnancy and medication for opioid use disorder moud initiation and discontinuation among reproductiveaged people receiving treatment for opioid use disorder oud in the united state,Non-Cancer,1,initiation and treatment discontinuation of medication for opioid use disorder in pregnant people compared with nonpregnant people to examine the association between pregnancy and medication for opioid use disorder moud initiation and discontinuation among reproductiveaged people receiving treatment for opioid use disorder oud in the united state
36914876,the genetic basis of endometriosis and comorbidity with other pain and inflammatory condition,endometriosis is a common condition associated with debilitating pelvic pain and infertility a genomewide association study metaanalysis including case and control of european and east asian descent identified genomewide significant locus comprising distinct association signal effect size were largest for stage disease driven by ovarian endometriosis identified signal explained up to of disease variance and regulated expression or methylation of gene in endometrium and blood many of which were associated with pain perceptionmaintenance srpbmf gdap mllt bsn and ngf we observed significant genetic correlation between endometriosis and pain condition including migraine back and multisite chronic pain mcp a well a inflammatory condition including asthma and osteoarthritis multitrait genetic analysis identified substantial sharing of variant associated with endometriosis and mcpmigraine targeted investigation of genetically regulated mechanism shared between endometriosis and other pain condition are needed to aid the development of new treatment and facilitate early symptomatic intervention,Non-Cancer,1,the genetic basis of endometriosis and comorbidity with other pain and inflammatory condition endometriosis is a common condition associated with debilitating pelvic pain and infertility a genomewide association study metaanalysis including case and control of european and east asian descent identified genomewide significant locus comprising distinct association signal effect size were largest for stage disease driven by ovarian endometriosis identified signal explained up to of disease variance and regulated expression or methylation of gene in endometrium and blood many of which were associated with pain perceptionmaintenance srpbmf gdap mllt bsn and ngf we observed significant genetic correlation between endometriosis and pain condition including migraine back and multisite chronic pain mcp a well a inflammatory condition including asthma and osteoarthritis multitrait genetic analysis identified substantial sharing of variant associated with endometriosis and mcpmigraine targeted investigation of genetically regulated mechanism shared between endometriosis and other pain condition are needed to aid the development of new treatment and facilitate early symptomatic intervention
36928568,prognostic value of deep learningbased fibrosis quantification on chest ct in idiopathic pulmonary fibrosis,to investigate the prognostic value of deep learning dldriven ct fibrosis quantification in idiopathic pulmonary fibrosis ipf,Non-Cancer,1,prognostic value of deep learningbased fibrosis quantification on chest ct in idiopathic pulmonary fibrosis to investigate the prognostic value of deep learning dldriven ct fibrosis quantification in idiopathic pulmonary fibrosis ipf
36928589,synthetic multiantigen mva vaccine cohs and variantspecific derivative protect syrian hamster from sarscov omicron subvariants,emerging sarscov omicron subvariants continue to disrupt covid vaccine efficacy through multiple immune mechanism including neutralizing antibody evasion we developed cohs a synthetic modified vaccinia ankara vector that coexpresses wuhanhubased spike and nucleocapsid antigen cohs demonstrated efficacy against ancestral virus and beta and delta variant in animal model and wa safe and immunogenic in a phase clinical trial here we report efficacy of cohs and analogous omicron ba and betaspecific vaccine to protect syrian hamster from omicron subvariants despite eliciting strainspecific antibody response all three vaccine protect hamster from weight loss lower respiratory tract infection and lung pathology following challenge with omicron ba or ba while the baspecifc vaccine affords consistently improved efficacy compared to cohs to protect against homologous challenge with ba all three vaccine confer similar protection against heterologous challenge with ba these result demonstrate efficacy of cohs and variantspecific derivative to confer crossprotective immunity against sarscov omicron subvariants,Non-Cancer,1,synthetic multiantigen mva vaccine cohs and variantspecific derivative protect syrian hamster from sarscov omicron subvariants emerging sarscov omicron subvariants continue to disrupt covid vaccine efficacy through multiple immune mechanism including neutralizing antibody evasion we developed cohs a synthetic modified vaccinia ankara vector that coexpresses wuhanhubased spike and nucleocapsid antigen cohs demonstrated efficacy against ancestral virus and beta and delta variant in animal model and wa safe and immunogenic in a phase clinical trial here we report efficacy of cohs and analogous omicron ba and betaspecific vaccine to protect syrian hamster from omicron subvariants despite eliciting strainspecific antibody response all three vaccine protect hamster from weight loss lower respiratory tract infection and lung pathology following challenge with omicron ba or ba while the baspecifc vaccine affords consistently improved efficacy compared to cohs to protect against homologous challenge with ba all three vaccine confer similar protection against heterologous challenge with ba these result demonstrate efficacy of cohs and variantspecific derivative to confer crossprotective immunity against sarscov omicron subvariants
36932063,structural basis for antibody recognition of vulnerable epitope on nipah virus f protein,nipah virus niv is a pathogenic paramyxovirus that cause fatal encephalitis in human two envelope glycoprotein the attachment protein grbp and fusion protein f facilitate entry into host cell due to it vital role niv f present an attractive target for developing vaccine and therapeutic several neutralizationsensitive epitope on the niv f apex have been described however the antigenicity of most of the f protein surface remains uncharacterized here we immunize mouse with prefusionstabilized niv f and isolate ten monoclonal antibody that neutralize pseudotyped virus cryoelectron microscopy reveals eight neutralizationsensitive epitope on niv f four of which have not previously been described novel site span the lateral and basal face of niv f expanding the known library of vulnerable epitope seven of ten antibody bind the hendra virus hev f protein multiple sequence alignment suggests that some of these newly identified neutralizing antibody may also bind f protein across the henipavirus genus this work identifies new epitope a target for therapeutic provides a molecular basis for niv neutralization and lay a foundation for development of new crossreactive antibody targeting henipavirus f protein,Non-Cancer,1,structural basis for antibody recognition of vulnerable epitope on nipah virus f protein nipah virus niv is a pathogenic paramyxovirus that cause fatal encephalitis in human two envelope glycoprotein the attachment protein grbp and fusion protein f facilitate entry into host cell due to it vital role niv f present an attractive target for developing vaccine and therapeutic several neutralizationsensitive epitope on the niv f apex have been described however the antigenicity of most of the f protein surface remains uncharacterized here we immunize mouse with prefusionstabilized niv f and isolate ten monoclonal antibody that neutralize pseudotyped virus cryoelectron microscopy reveals eight neutralizationsensitive epitope on niv f four of which have not previously been described novel site span the lateral and basal face of niv f expanding the known library of vulnerable epitope seven of ten antibody bind the hendra virus hev f protein multiple sequence alignment suggests that some of these newly identified neutralizing antibody may also bind f protein across the henipavirus genus this work identifies new epitope a target for therapeutic provides a molecular basis for niv neutralization and lay a foundation for development of new crossreactive antibody targeting henipavirus f protein
36941031,genomewide association study identifies genetic variant which predict the response of bone mineral density to teriparatide therapy,teriparatide tptd is an effective treatment for osteoporosis but the individual response to therapy is variable for reason that are unclear this study aimed to determine whether the response to tptd might be influenced by genetic factor,Non-Cancer,1,genomewide association study identifies genetic variant which predict the response of bone mineral density to teriparatide therapy teriparatide tptd is an effective treatment for osteoporosis but the individual response to therapy is variable for reason that are unclear this study aimed to determine whether the response to tptd might be influenced by genetic factor
36951170,scalable rtlampbased sarscov testing for infection surveillance with application in pandemic preparedness,throughout the sarscov pandemic limited diagnostic capacity prevented sentinel testing demonstrating the need for novel testing infrastructure here we describe the setup of a costeffective platform that can be employed in a highthroughput manner which allows surveillance testing a an acute pandemic control and preparedness tool exemplified by sarscov diagnostics in an academic environment the strategy involves selfsampling based on gargling saline pseudonymized sample handling automated rna extraction and viral rna detection using a semiquantitative multiplexed colorimetric reverse transcription loopmediated isothermal amplification rtlamp assay with an analytical sensitivity comparable with rtqpcr we provide standard operating procedure and an integrated software solution for all workflow including sample logistics analysis by colorimetry or sequencing and communication of result we evaluated factor affecting the viral load and the stability of gargling sample a well a the diagnostic sensitivity of the rtlamp assay in parallel we estimated the economic cost of setting up and running the test station we performed test with an average turnover time of h from sample arrival to result announcement altogether our work provides a blueprint for fast sensitive scalable cost and laborefficient rtlamp diagnostics which is independent of potentially limiting clinical diagnostics supply chain,Non-Cancer,1,scalable rtlampbased sarscov testing for infection surveillance with application in pandemic preparedness throughout the sarscov pandemic limited diagnostic capacity prevented sentinel testing demonstrating the need for novel testing infrastructure here we describe the setup of a costeffective platform that can be employed in a highthroughput manner which allows surveillance testing a an acute pandemic control and preparedness tool exemplified by sarscov diagnostics in an academic environment the strategy involves selfsampling based on gargling saline pseudonymized sample handling automated rna extraction and viral rna detection using a semiquantitative multiplexed colorimetric reverse transcription loopmediated isothermal amplification rtlamp assay with an analytical sensitivity comparable with rtqpcr we provide standard operating procedure and an integrated software solution for all workflow including sample logistics analysis by colorimetry or sequencing and communication of result we evaluated factor affecting the viral load and the stability of gargling sample a well a the diagnostic sensitivity of the rtlamp assay in parallel we estimated the economic cost of setting up and running the test station we performed test with an average turnover time of h from sample arrival to result announcement altogether our work provides a blueprint for fast sensitive scalable cost and laborefficient rtlamp diagnostics which is independent of potentially limiting clinical diagnostics supply chain
36958777,the pyruvate kinase deficiency global longitudinal peak registry rationale and study design,pyruvate kinase pk deficiency is a rare underrecognised hereditary condition that lead to chronic haemolytic anaemia and potentially serious secondary complication such a iron overload cholecystitis pulmonary hypertension and extramedullary haematopoiesis it is an autosomal recessive disease caused by homozygous or compound heterozygous mutation in the pklr gene due to it rarity and clinical heterogeneity information on the natural history and longterm clinical course of pk deficiency is limited presenting major challenge to patient management the development of new therapy and establishing diseasespecific treatment recommendation the pyruvate kinase deficiency global longitudinal peak registry is an initiative to address the gap in the knowledge of pk deficiency this manuscript describes the objective study design and methodology for the peak registry,Non-Cancer,1,the pyruvate kinase deficiency global longitudinal peak registry rationale and study design pyruvate kinase pk deficiency is a rare underrecognised hereditary condition that lead to chronic haemolytic anaemia and potentially serious secondary complication such a iron overload cholecystitis pulmonary hypertension and extramedullary haematopoiesis it is an autosomal recessive disease caused by homozygous or compound heterozygous mutation in the pklr gene due to it rarity and clinical heterogeneity information on the natural history and longterm clinical course of pk deficiency is limited presenting major challenge to patient management the development of new therapy and establishing diseasespecific treatment recommendation the pyruvate kinase deficiency global longitudinal peak registry is an initiative to address the gap in the knowledge of pk deficiency this manuscript describes the objective study design and methodology for the peak registry
36960434,pediatric nemaline myopathy a systematic review using individual patient data,nemaline myopathy is a skeletal muscle disease that affect in live birth the objective of this study wa to develop a narrative synthesis of the finding of a systematic review of the latest case description of patient with nm a systematic search of medline embase cinahl web of science and scopus wa performed using preferred reporting item for systematic review and metaanalyses prisma guideline using the keywords pediatric child nm nemaline rod and rod myopathy case study focused on pediatric nm and published in english between january and december in order to represent the most recent finding information wa collected about the age of first sign earliest presenting neuromuscular sign and symptom system affected progression death pathologic description and genetic change of a total of record case report or series were reviewed covering pediatric patient from country we review varying presentation in child ranging in severity despite being caused by the same mutation in addition to current and future clinical consideration relevant to the care of patient with nm this review synthesizes genetic histopathologic and disease presentation finding from pediatric nm case report these data strengthen our understanding of the wide spectrum of disease seen in nm future study are needed to identify the underlying molecular mechanism of pathology to improve diagnostics and to develop better method to improve the quality of life for these patient,Non-Cancer,1,pediatric nemaline myopathy a systematic review using individual patient data nemaline myopathy is a skeletal muscle disease that affect in live birth the objective of this study wa to develop a narrative synthesis of the finding of a systematic review of the latest case description of patient with nm a systematic search of medline embase cinahl web of science and scopus wa performed using preferred reporting item for systematic review and metaanalyses prisma guideline using the keywords pediatric child nm nemaline rod and rod myopathy case study focused on pediatric nm and published in english between january and december in order to represent the most recent finding information wa collected about the age of first sign earliest presenting neuromuscular sign and symptom system affected progression death pathologic description and genetic change of a total of record case report or series were reviewed covering pediatric patient from country we review varying presentation in child ranging in severity despite being caused by the same mutation in addition to current and future clinical consideration relevant to the care of patient with nm this review synthesizes genetic histopathologic and disease presentation finding from pediatric nm case report these data strengthen our understanding of the wide spectrum of disease seen in nm future study are needed to identify the underlying molecular mechanism of pathology to improve diagnostics and to develop better method to improve the quality of life for these patient
36966905,persistent sarscovspecific immune defect in kidney transplant recipient following third mrna vaccine dos,kidney transplant recipient ktrs show poorer response to sarscov mrna vaccination yet response pattern and mechanistic driver following third dos are illdefined we administered third monovalent mrna vaccine to n ktrs with negative or lowtiter antireceptor binding domain rbd antibody n antirbdneg n antirbdlo compared to healthy control hc n measuring antirbd omicron neutralization spikespecific cd and sarscovreactive t cell receptor tcr repertoire by day antirbdneg remained seronegative ktrs developed ba neutralization versus hcs p day sarscovreactive tcr repertoire were detected in ktrs versus hcs p spikespecific cd tcr expansion wa similar between ktrs and hcs yet ktr cd tcr depth wa fold lower p global negative response wa seen in ktrs associated with highdose mycophenolate p showed global positive response ktrs experienced breakthrough infection with hospitalization prebreakthrough variant neutralization wa poor absent neutralizing and cd response in ktrs indicate vulnerability to covid despite threedose mrna vaccination lack of neutralization despite cd expansion suggests b cell dysfunction andor ineffective t cell help development of more effective ktr vaccine strategy is criticalnct,Non-Cancer,1,persistent sarscovspecific immune defect in kidney transplant recipient following third mrna vaccine dos kidney transplant recipient ktrs show poorer response to sarscov mrna vaccination yet response pattern and mechanistic driver following third dos are illdefined we administered third monovalent mrna vaccine to n ktrs with negative or lowtiter antireceptor binding domain rbd antibody n antirbdneg n antirbdlo compared to healthy control hc n measuring antirbd omicron neutralization spikespecific cd and sarscovreactive t cell receptor tcr repertoire by day antirbdneg remained seronegative ktrs developed ba neutralization versus hcs p day sarscovreactive tcr repertoire were detected in ktrs versus hcs p spikespecific cd tcr expansion wa similar between ktrs and hcs yet ktr cd tcr depth wa fold lower p global negative response wa seen in ktrs associated with highdose mycophenolate p showed global positive response ktrs experienced breakthrough infection with hospitalization prebreakthrough variant neutralization wa poor absent neutralizing and cd response in ktrs indicate vulnerability to covid despite threedose mrna vaccination lack of neutralization despite cd expansion suggests b cell dysfunction andor ineffective t cell help development of more effective ktr vaccine strategy is criticalnct
36989883,implementation of dihydropyrimidine dehydrogenase deficiency testing in europe,the main cause for fluoropyrimidinerelated toxicity is deficiency of the metabolizing enzyme dihydropyrimidine dehydrogenase dpd in the european medicine agency ema recommended two method for pretreatment dpd deficiency testing in clinical practice phenotyping using endogenous uracil concentration or genotyping for dpyd risk variant allele this study assessed the dpd testing implementation status in europe and the release of the ema recommendation,Non-Cancer,1,implementation of dihydropyrimidine dehydrogenase deficiency testing in europe the main cause for fluoropyrimidinerelated toxicity is deficiency of the metabolizing enzyme dihydropyrimidine dehydrogenase dpd in the european medicine agency ema recommended two method for pretreatment dpd deficiency testing in clinical practice phenotyping using endogenous uracil concentration or genotyping for dpyd risk variant allele this study assessed the dpd testing implementation status in europe and the release of the ema recommendation
37148359,the power of topmed imputation for the discovery of latinoenriched rare variant associated with type diabetes,the latino population ha been systematically underrepresented in largescale genetic analysis and previous study have relied on the imputation of ungenotyped variant based on the genome g imputation panel which result in suboptimal capture of lowfrequency or latinoenriched variant the national heart lung and blood institute nhlbi transomics for precision medicine topmed released the largest multiancestry genotype reference panel representing a unique opportunity to analyse rare genetic variation in the latino population we hypothesise that a more comprehensive analysis of lowrare variation using the topmed panel would improve our knowledge of the genetics of type diabetes in the latino population,Non-Cancer,1,the power of topmed imputation for the discovery of latinoenriched rare variant associated with type diabetes the latino population ha been systematically underrepresented in largescale genetic analysis and previous study have relied on the imputation of ungenotyped variant based on the genome g imputation panel which result in suboptimal capture of lowfrequency or latinoenriched variant the national heart lung and blood institute nhlbi transomics for precision medicine topmed released the largest multiancestry genotype reference panel representing a unique opportunity to analyse rare genetic variation in the latino population we hypothesise that a more comprehensive analysis of lowrare variation using the topmed panel would improve our knowledge of the genetics of type diabetes in the latino population
37218474,management of anastomotic leak after oesophagectomy and gastric pullup,to evaluate the effectiveness of endoscopic and surgical intervention in treating anastomotic leak after oesophagectomy,Non-Cancer,1,management of anastomotic leak after oesophagectomy and gastric pullup to evaluate the effectiveness of endoscopic and surgical intervention in treating anastomotic leak after oesophagectomy
37322115,clonal hematopoiesis is associated with protection from alzheimers disease,clonal hematopoiesis of indeterminate potential chip is a premalignant expansion of mutated hematopoietic stem cell a chipassociated mutation are known to alter the development and function of myeloid cell we hypothesized that chip may also be associated with the risk of alzheimers disease ad a disease in which brainresident myeloid cell are thought to have a major role to perform association test between chip and ad dementia we analyzed blood dna sequencing data from individual with ad and individual without ad individual with chip had a lower risk of ad dementia metaanalysis odds ratio or p  and mendelian randomization analysis supported a potential causal association we observed that the same mutation found in blood were also detected in microgliaenriched fraction of the brain in seven of eight chip carrier singlenucleus chromatin accessibility profiling of brainderived nucleus in six chip carrier revealed that the mutated cell comprised a large proportion of the microglial pool in the sample examined while additional study are required to validate the mechanistic finding these result suggest that chip may have a role in attenuating the risk of ad,Non-Cancer,1,clonal hematopoiesis is associated with protection from alzheimers disease clonal hematopoiesis of indeterminate potential chip is a premalignant expansion of mutated hematopoietic stem cell a chipassociated mutation are known to alter the development and function of myeloid cell we hypothesized that chip may also be associated with the risk of alzheimers disease ad a disease in which brainresident myeloid cell are thought to have a major role to perform association test between chip and ad dementia we analyzed blood dna sequencing data from individual with ad and individual without ad individual with chip had a lower risk of ad dementia metaanalysis odds ratio or p  and mendelian randomization analysis supported a potential causal association we observed that the same mutation found in blood were also detected in microgliaenriched fraction of the brain in seven of eight chip carrier singlenucleus chromatin accessibility profiling of brainderived nucleus in six chip carrier revealed that the mutated cell comprised a large proportion of the microglial pool in the sample examined while additional study are required to validate the mechanistic finding these result suggest that chip may have a role in attenuating the risk of ad
37356622,an integral approach to the molecular diagnosis of tuberous sclerosis complex the role of mosaicism and splicing variant,tuberous sclerosis complex tsc is an autosomal dominant genetic disorder characterized by the presence of hamartoma in multiple organ at the molecular level the disease is caused by pathogenic variant in the tsc and tsc gene and only to of clinically diagnosed patient remain negative after multiplex ligationdependent probe amplification and exon sequencing of both gene here to improve the molecular diagnosis of tsc we developed an integral approach that includes multiplex ligationdependent probe amplification and deepcoverage nextgeneration sequencing of the entire tsc and tsc gene along with an adapted bioinformatic pipeline to detect variant at low allele frequency using this workflow the molecular cause wa identified in of patient with tsc describing here for the first time novel pathogenic variant in tsc gene these variant included seven splicing variant five of which were studied at the cdna level determining their effect on splicing in addition of the pathogenic variant were detected in mosaicism including four patient with previous negative study result who presented extremely low mosaic variant allele frequency we demonstrate that this integral approach allows the molecular diagnosis of patient with tsc and improves the conventional one by adapting the technology to the detection of lowfrequency mosaic,Non-Cancer,1,an integral approach to the molecular diagnosis of tuberous sclerosis complex the role of mosaicism and splicing variant tuberous sclerosis complex tsc is an autosomal dominant genetic disorder characterized by the presence of hamartoma in multiple organ at the molecular level the disease is caused by pathogenic variant in the tsc and tsc gene and only to of clinically diagnosed patient remain negative after multiplex ligationdependent probe amplification and exon sequencing of both gene here to improve the molecular diagnosis of tsc we developed an integral approach that includes multiplex ligationdependent probe amplification and deepcoverage nextgeneration sequencing of the entire tsc and tsc gene along with an adapted bioinformatic pipeline to detect variant at low allele frequency using this workflow the molecular cause wa identified in of patient with tsc describing here for the first time novel pathogenic variant in tsc gene these variant included seven splicing variant five of which were studied at the cdna level determining their effect on splicing in addition of the pathogenic variant were detected in mosaicism including four patient with previous negative study result who presented extremely low mosaic variant allele frequency we demonstrate that this integral approach allows the molecular diagnosis of patient with tsc and improves the conventional one by adapting the technology to the detection of lowfrequency mosaic
37387099,radiogenomics in nfassociated schwannomatosis neurofibromatosis type ii exploratory data analysis,our pilot study aimed at exploratory radiogenomic data analysis in patient with nfassociated schwannomatosis formerly neurofibromatosis type ii to assume the potential of image biomarkers in this pathology fiftythree unrelated patient woman avg age  yo were enrolled in the study firstorder graylevel cooccurrence matrix glcm graylevel run length matrix glrlm and geometrybased statistic were calculated feature per region of interest we demonstrated imaging pattern and statistically significant difference in radiomic feature potentially related to the genotype and clinical phenotype of the disease however the clinical utility of these pattern should be further evaluated the study wa supported by the russian science foundation grant,Non-Cancer,1,radiogenomics in nfassociated schwannomatosis neurofibromatosis type ii exploratory data analysis our pilot study aimed at exploratory radiogenomic data analysis in patient with nfassociated schwannomatosis formerly neurofibromatosis type ii to assume the potential of image biomarkers in this pathology fiftythree unrelated patient woman avg age  yo were enrolled in the study firstorder graylevel cooccurrence matrix glcm graylevel run length matrix glrlm and geometrybased statistic were calculated feature per region of interest we demonstrated imaging pattern and statistically significant difference in radiomic feature potentially related to the genotype and clinical phenotype of the disease however the clinical utility of these pattern should be further evaluated the study wa supported by the russian science foundation grant
37389864,ulk phosphorylation of stx control autophagosome maturation via flna,autophagy is a conserved and tightly regulated intracellular quality control pathway ulk is a key kinase in autophagy initiation but whether ulk kinase activity also participates in the late stage of autophagy remains unknown here we found that the autophagosomal snare protein stx is phosphorylated by ulk at residue s beyond which it localizes specifically to autophagosomes inhibition of stx phosphorylation prevents such autophagosome localization flna wa then identified a a linker between atg family protein atgs and stx with essential involvement in stx recruitment to autophagosomes phosphorylation of stx s promotes it interaction with flna activating it recruitment to autophagosomes and facilitating autophagosomelysosome fusion diseasecausative mutation around the atgs and stxbinding region of flna disrupt it interaction with atgs and stx inhibiting stx recruitment and autophagosomelysosome fusion cumulatively our study reveals an unexpected role of ulk in autophagosome maturation uncovers it regulatory mechanism in stx recruitment and highlight a potential association between autophagy and flna,Non-Cancer,1,ulk phosphorylation of stx control autophagosome maturation via flna autophagy is a conserved and tightly regulated intracellular quality control pathway ulk is a key kinase in autophagy initiation but whether ulk kinase activity also participates in the late stage of autophagy remains unknown here we found that the autophagosomal snare protein stx is phosphorylated by ulk at residue s beyond which it localizes specifically to autophagosomes inhibition of stx phosphorylation prevents such autophagosome localization flna wa then identified a a linker between atg family protein atgs and stx with essential involvement in stx recruitment to autophagosomes phosphorylation of stx s promotes it interaction with flna activating it recruitment to autophagosomes and facilitating autophagosomelysosome fusion diseasecausative mutation around the atgs and stxbinding region of flna disrupt it interaction with atgs and stx inhibiting stx recruitment and autophagosomelysosome fusion cumulatively our study reveals an unexpected role of ulk in autophagosome maturation uncovers it regulatory mechanism in stx recruitment and highlight a potential association between autophagy and flna
37394163,an improved recombinase polymerase amplification assay for the visual detection of staphylococcus epidermidis with lateral flow strip,staphylococcus epidermidis is an opportunistic pathogenic microorganism that is an important cause of crossinfection in hospital the development of rapid and effective detection technique is important for it control the application of traditional identification and pcrbased method is limited by their requirement for both laboratory instrumentation and trained personnel to overcome this issue we developed a fast detection approach for s epidermidis that wa based on recombinase polymerase amplification rpa and lateral flow strip lf first five pair of primer were designed for molecular diagnosis using the sesb gene a the target and were screened for their amplification performance and the formation of primer dimer specific probe were then designed based on the best primer pair screened which were susceptible to primerdependent artifact and generated falsepositive signal when used for lf detection this weakness of the lf assay wa overcome by modifying the sequence of the primer and probe the efficacy of these measure wa rigorously tested and improved the rpalfs system standardized system completed the amplification process within min at a constant temperature of c followed by visualization of the lf within min the approach wa very sensitive with a detection limit of cful with very good interspecies specificity in the analysis of clinical sample the approach produced result consistent with pcr and consistent with the culturebiochemical method with a kappa index of our method wa rapid accurate and less dependent on equipment and trained personnel than traditional method and provided information for the timely development of rational antimicrobial treatment plan it ha high potential utility in clinical setting particularly in resourceconstrained location,Non-Cancer,1,an improved recombinase polymerase amplification assay for the visual detection of staphylococcus epidermidis with lateral flow strip staphylococcus epidermidis is an opportunistic pathogenic microorganism that is an important cause of crossinfection in hospital the development of rapid and effective detection technique is important for it control the application of traditional identification and pcrbased method is limited by their requirement for both laboratory instrumentation and trained personnel to overcome this issue we developed a fast detection approach for s epidermidis that wa based on recombinase polymerase amplification rpa and lateral flow strip lf first five pair of primer were designed for molecular diagnosis using the sesb gene a the target and were screened for their amplification performance and the formation of primer dimer specific probe were then designed based on the best primer pair screened which were susceptible to primerdependent artifact and generated falsepositive signal when used for lf detection this weakness of the lf assay wa overcome by modifying the sequence of the primer and probe the efficacy of these measure wa rigorously tested and improved the rpalfs system standardized system completed the amplification process within min at a constant temperature of c followed by visualization of the lf within min the approach wa very sensitive with a detection limit of cful with very good interspecies specificity in the analysis of clinical sample the approach produced result consistent with pcr and consistent with the culturebiochemical method with a kappa index of our method wa rapid accurate and less dependent on equipment and trained personnel than traditional method and provided information for the timely development of rational antimicrobial treatment plan it ha high potential utility in clinical setting particularly in resourceconstrained location
37400446,a rapid cellfree expression and screening platform for antibody discovery,antibody discovery is bottlenecked by the individual expression and evaluation of antigenspecific hit here we address this bottleneck by developing a workflow combining cellfree dna template generation cellfree protein synthesis and binding measurement of antibody fragment in a process that take hour rather than week we apply this workflow to evaluate previously published antibody targeting the severe acute respiratory syndrome coronavirus sarscov including all antibody previously granted emergency use authorization for coronavirus disease covid and demonstrate identification of the most potent antibody we also evaluate antisarscov antibody from a mouse immunized with the sarscov spike protein and identify neutralizing antibody candidate including the antibody sc which bind the sarscov spike protein of all tested variant of concern we expect that our cellfree workflow will accelerate the discovery and characterization of antibody for future pandemic and for research diagnostic and therapeutic application more broadly,Non-Cancer,1,a rapid cellfree expression and screening platform for antibody discovery antibody discovery is bottlenecked by the individual expression and evaluation of antigenspecific hit here we address this bottleneck by developing a workflow combining cellfree dna template generation cellfree protein synthesis and binding measurement of antibody fragment in a process that take hour rather than week we apply this workflow to evaluate previously published antibody targeting the severe acute respiratory syndrome coronavirus sarscov including all antibody previously granted emergency use authorization for coronavirus disease covid and demonstrate identification of the most potent antibody we also evaluate antisarscov antibody from a mouse immunized with the sarscov spike protein and identify neutralizing antibody candidate including the antibody sc which bind the sarscov spike protein of all tested variant of concern we expect that our cellfree workflow will accelerate the discovery and characterization of antibody for future pandemic and for research diagnostic and therapeutic application more broadly
37402998,inhibition of tmema improves cisplatininduced acute kidney injury via preventing drpmediated mitochondrial fission,acute kidney injury aki is associated with high morbidity and mortality our previous study ha demonstrated that tmema a caactivated chloride channel contributes to renal fibrosis progression in chronic kidney disease however whether tmema is involved in aki is still unknown in this study we established cisplatin aki mouse model and found that tmema expression wa upregulated in the injured kidney in vivo knockdown of tmema effectively prevented cisplatininduced tubular cell apoptosis inflammation and kidney function loss western blot and transmission electron microscopy tem revealed that tmema knockdown inhibited drp translocation from the cytoplasm to mitochondrion and prevented mitochondrial fission in tubular cell consistently in cultured hk cell knockdown or inhibition of tmema by shrna or it specific inhibitor suppressed cisplatininduced mitochondrial fission and it associated energy dysfunction ro accumulation and cell apoptosis via inhibiting drp activation further investigation showed that genetic knockdown or pharmacological inhibition of tmema inhibited cisplatininduced drp ser site phosphorylation through erk signaling pathway whereas overexpression of tmema promoted this effect treatment with drp or erk inhibitor could efficiently prevent cisplatininduced mitochondrial fission collectively our data suggest that tmema inhibition alleviated cisplatininduced aki by preventing tubular cell mitochondrial fission through the erk drp pathway inhibition of tmema may be a novel therapeutic strategy for aki,Non-Cancer,1,inhibition of tmema improves cisplatininduced acute kidney injury via preventing drpmediated mitochondrial fission acute kidney injury aki is associated with high morbidity and mortality our previous study ha demonstrated that tmema a caactivated chloride channel contributes to renal fibrosis progression in chronic kidney disease however whether tmema is involved in aki is still unknown in this study we established cisplatin aki mouse model and found that tmema expression wa upregulated in the injured kidney in vivo knockdown of tmema effectively prevented cisplatininduced tubular cell apoptosis inflammation and kidney function loss western blot and transmission electron microscopy tem revealed that tmema knockdown inhibited drp translocation from the cytoplasm to mitochondrion and prevented mitochondrial fission in tubular cell consistently in cultured hk cell knockdown or inhibition of tmema by shrna or it specific inhibitor suppressed cisplatininduced mitochondrial fission and it associated energy dysfunction ro accumulation and cell apoptosis via inhibiting drp activation further investigation showed that genetic knockdown or pharmacological inhibition of tmema inhibited cisplatininduced drp ser site phosphorylation through erk signaling pathway whereas overexpression of tmema promoted this effect treatment with drp or erk inhibitor could efficiently prevent cisplatininduced mitochondrial fission collectively our data suggest that tmema inhibition alleviated cisplatininduced aki by preventing tubular cell mitochondrial fission through the erk drp pathway inhibition of tmema may be a novel therapeutic strategy for aki
37404298,dynamic rod construct a the preventive strategy against adjacent segment disease in degenerative lumbar spinal disorder a retrospective comparative cohort study,adjacent segment degeneration asde and adjacent segment disease asdi are potential longterm complication after lumbar fusion with rigid instrumentation dynamic fixation technique toppingoff adjacent to the fused segment have been developed to curtail the risk of asde and asdi the current study sought to investigate whether the addition of dynamic rod construct drc in patient with preoperative degeneration in the adjacent disc wa effective in reducing the risk of asdi,Non-Cancer,1,dynamic rod construct a the preventive strategy against adjacent segment disease in degenerative lumbar spinal disorder a retrospective comparative cohort study adjacent segment degeneration asde and adjacent segment disease asdi are potential longterm complication after lumbar fusion with rigid instrumentation dynamic fixation technique toppingoff adjacent to the fused segment have been developed to curtail the risk of asde and asdi the current study sought to investigate whether the addition of dynamic rod construct drc in patient with preoperative degeneration in the adjacent disc wa effective in reducing the risk of asdi
37404832,corrigendum genetic diagnosis of inborn error of immunity using clinical exome sequencing,this corrects the article doi fimmu,Non-Cancer,1,corrigendum genetic diagnosis of inborn error of immunity using clinical exome sequencing this corrects the article doi fimmu
37405741,novel association of the notch pathway regulator mib gene with the development of bicuspid aortic valve,nonsyndromic bicuspid aortic valve nsbav is the most common congenital heart valve malformation bav ha a heritable component yet only a few causative gene have been identified understanding bav genetics is a key point in developing personalized medicine,Non-Cancer,1,novel association of the notch pathway regulator mib gene with the development of bicuspid aortic valve nonsyndromic bicuspid aortic valve nsbav is the most common congenital heart valve malformation bav ha a heritable component yet only a few causative gene have been identified understanding bav genetics is a key point in developing personalized medicine
37407995,protocadherin maintains intestinal barrier function to protect against crohn disease by targeting atf,intestinal barrier dysfunction play a central role in the pathological onset of crohn disease we identify the cadherin superfamily member protocadherin pcdh a a crucial factor in crohn disease here we describe the function of pcdh and it mechanism in gut homeostasis barrier integrity and crohn disease development,Non-Cancer,1,protocadherin maintains intestinal barrier function to protect against crohn disease by targeting atf intestinal barrier dysfunction play a central role in the pathological onset of crohn disease we identify the cadherin superfamily member protocadherin pcdh a a crucial factor in crohn disease here we describe the function of pcdh and it mechanism in gut homeostasis barrier integrity and crohn disease development
37460897,mechanistic and evolutionary insight into a type vm crisprcas effector enzyme,rnaguided type v crisprcas effector provide adaptive immunity against mobile genetic element mges in bacteria and archaea among diverse ca enzyme the recently identified casm crisprcas type vm is highly compact and ha a unique ruvc active site although the noncanonical ruvc triad doe not permit dsdna cleavage casm still protects against invading mges through transcriptional silencing by strong dna binding however the molecular mechanism of rnaguided genome inactivation by casm remains unknown here we report cryoelectron microscopy structure of two state of casmcrispr rna crrnatarget dna ternary complex and the casmcrrna binary complex revealing structural dynamic during crrnatarget dna heteroduplex formation the structure indicate that the nontarget dna strand is tightly bound to a unique argininerich cluster in the recognition rec domain and the noncanonical active site in the ruvc domain ensuring strong dnabinding affinity of casm furthermore a structural comparison of casm with tnpb a putative ancestor of ca enzyme suggests that the interaction of the characteristic coiledcoil rec insertion with the protospaceradjacent motifdistal region of the heteroduplex is crucial for casm to engage in adaptive immunity collectively our finding improve mechanistic understanding of diverse type v crisprcas effector and provide insight into the evolution of tnpb to ca enzyme,Non-Cancer,1,mechanistic and evolutionary insight into a type vm crisprcas effector enzyme rnaguided type v crisprcas effector provide adaptive immunity against mobile genetic element mges in bacteria and archaea among diverse ca enzyme the recently identified casm crisprcas type vm is highly compact and ha a unique ruvc active site although the noncanonical ruvc triad doe not permit dsdna cleavage casm still protects against invading mges through transcriptional silencing by strong dna binding however the molecular mechanism of rnaguided genome inactivation by casm remains unknown here we report cryoelectron microscopy structure of two state of casmcrispr rna crrnatarget dna ternary complex and the casmcrrna binary complex revealing structural dynamic during crrnatarget dna heteroduplex formation the structure indicate that the nontarget dna strand is tightly bound to a unique argininerich cluster in the recognition rec domain and the noncanonical active site in the ruvc domain ensuring strong dnabinding affinity of casm furthermore a structural comparison of casm with tnpb a putative ancestor of ca enzyme suggests that the interaction of the characteristic coiledcoil rec insertion with the protospaceradjacent motifdistal region of the heteroduplex is crucial for casm to engage in adaptive immunity collectively our finding improve mechanistic understanding of diverse type v crisprcas effector and provide insight into the evolution of tnpb to ca enzyme
37532168,chromosomal gestational and neonatal outcome of embryo classified a a mosaic by preimplantation genetic testing for aneuploidy,to understand the clinical risk associated with the transfer of embryo classified a a mosaic using preimplantation genetic testing for aneuploidy,Non-Cancer,1,chromosomal gestational and neonatal outcome of embryo classified a a mosaic by preimplantation genetic testing for aneuploidy to understand the clinical risk associated with the transfer of embryo classified a a mosaic using preimplantation genetic testing for aneuploidy
37567924,elevated binding and functional antibody response to sarscov in infant versus mother,infant antibody response to viral infection can differ from those in adult however data on the specificity and function of severe acute respiratory syndrome coronavirus sarscov antibody in infant and direct comparison between infant and adult are limited here we characterize antibody binding and functionality against wuhanhu b lineage strain sarscov in convalescent plasma from postpartum woman and of their infant infected with sarscov from a vaccinenave prospective cohort in nairobi kenya we find significantly higher antibody titer against sarscov spike receptor binding domain and nterminal domain and spikeexpressing cellsurface staining level in infant versus mother plasma antibody from mother and infant bind to similar region of the spike s subunit including the fusion peptide fp and stem helixheptad repeat however infant display higher antibody level and more consistent antibody escape pathway in the fp region compared to mother finally infant have significantly higher level of antibodydependent cellular cytotoxicity adcc though surprisingly spike pseudovirus neutralization titer between infant and mother are similar these result suggest infant develop distinct sarscov binding and functional antibody activity and reveal agerelated difference in humoral immunity to sarscov infection that could be relevant to protection and covid disease outcome,Non-Cancer,1,elevated binding and functional antibody response to sarscov in infant versus mother infant antibody response to viral infection can differ from those in adult however data on the specificity and function of severe acute respiratory syndrome coronavirus sarscov antibody in infant and direct comparison between infant and adult are limited here we characterize antibody binding and functionality against wuhanhu b lineage strain sarscov in convalescent plasma from postpartum woman and of their infant infected with sarscov from a vaccinenave prospective cohort in nairobi kenya we find significantly higher antibody titer against sarscov spike receptor binding domain and nterminal domain and spikeexpressing cellsurface staining level in infant versus mother plasma antibody from mother and infant bind to similar region of the spike s subunit including the fusion peptide fp and stem helixheptad repeat however infant display higher antibody level and more consistent antibody escape pathway in the fp region compared to mother finally infant have significantly higher level of antibodydependent cellular cytotoxicity adcc though surprisingly spike pseudovirus neutralization titer between infant and mother are similar these result suggest infant develop distinct sarscov binding and functional antibody activity and reveal agerelated difference in humoral immunity to sarscov infection that could be relevant to protection and covid disease outcome
37569542,detection of primary dna lesion by transient change in mating behavior in yeast saccharomyces cerevisiae using the alphatest,spontaneous or induced dna lesion can result in stable gene mutation and chromosomal aberration due to their inaccurate repair ultimately resulting in phenotype change some dna lesion per se may interfere with transcription leading to temporary phenocopies of mutation the direct impact of primary dna lesion on phenotype before their removal by repair is not well understood to address this question we used the alphatest which allows for detecting various genetic event leading to temporary or hereditary change in mating type a in heterothallic strain of yeast saccharomyces cerevisiae here we compared yeast strain carrying mutation in dna repair gene mismatch repair pm base excision repair ogg and homologous recombination repair rad a well a mutagen causing specific dna lesion uv light and camptothecin we found that doublestrand break and uvinduced lesion have a stronger effect on the phenotype than mismatch and oxoguanine moreover the loss of the entire chromosome iii lead to an immediate mating type switch a and doe not prevent hybridization we also evaluated the ability of primary dna lesion to persist through the cell cycle by assessing the frequency of uvinduced inherited and noninherited genetic change in asynchronous culture of a wildtype wt strain and in a cdc mutant arrested in the g phase our finding suggest that the phenotypic manifestation of primary dna lesion depends on their type and the stage of the cell cycle in which it occurred,Non-Cancer,1,detection of primary dna lesion by transient change in mating behavior in yeast saccharomyces cerevisiae using the alphatest spontaneous or induced dna lesion can result in stable gene mutation and chromosomal aberration due to their inaccurate repair ultimately resulting in phenotype change some dna lesion per se may interfere with transcription leading to temporary phenocopies of mutation the direct impact of primary dna lesion on phenotype before their removal by repair is not well understood to address this question we used the alphatest which allows for detecting various genetic event leading to temporary or hereditary change in mating type a in heterothallic strain of yeast saccharomyces cerevisiae here we compared yeast strain carrying mutation in dna repair gene mismatch repair pm base excision repair ogg and homologous recombination repair rad a well a mutagen causing specific dna lesion uv light and camptothecin we found that doublestrand break and uvinduced lesion have a stronger effect on the phenotype than mismatch and oxoguanine moreover the loss of the entire chromosome iii lead to an immediate mating type switch a and doe not prevent hybridization we also evaluated the ability of primary dna lesion to persist through the cell cycle by assessing the frequency of uvinduced inherited and noninherited genetic change in asynchronous culture of a wildtype wt strain and in a cdc mutant arrested in the g phase our finding suggest that the phenotypic manifestation of primary dna lesion depends on their type and the stage of the cell cycle in which it occurred
37581253,diagnosis and management of patient with left ventricular hypertrophy role of multimodality cardiac imaging a scientific statement of the heart failure association of the esc,left ventricular lv hypertrophy consists in an increased lv wall thickness lv hypertrophy can be either secondary in response to pressure or volume overload or primary ie not explained solely by abnormal loading condition primary lv hypertrophy may be due to gene mutation or to the deposition or storage of abnormal substance in the extracellular space or within the cardiomyocytes more appropriately defined a pseudohypertrophy lv hypertrophy is often a precursor to subsequent development of heart failure cardiovascular imaging play a key role in the assessment of lv hypertrophy echocardiography the firstline imaging technique allows a comprehensive assessment of lv systolic and diastolic function cardiovascular magnetic resonance provides added value a it measure accurately lv and right ventricular volume and mass and characterizes myocardial tissue property which may provide important clue to the final diagnosis additionally scintigraphy with bone tracer is included in the diagnostic algorithm of cardiac amyloidosis once the diagnosis is established imaging finding may help predict future disease evolution and inform therapy and followup this consensus document by the heart failure association of the european society of cardiology provides an overview of the role of different cardiac imaging technique for the differential diagnosis and management of patient with lv hypertrophy this article is protected by copyright all right reserved,Non-Cancer,1,diagnosis and management of patient with left ventricular hypertrophy role of multimodality cardiac imaging a scientific statement of the heart failure association of the esc left ventricular lv hypertrophy consists in an increased lv wall thickness lv hypertrophy can be either secondary in response to pressure or volume overload or primary ie not explained solely by abnormal loading condition primary lv hypertrophy may be due to gene mutation or to the deposition or storage of abnormal substance in the extracellular space or within the cardiomyocytes more appropriately defined a pseudohypertrophy lv hypertrophy is often a precursor to subsequent development of heart failure cardiovascular imaging play a key role in the assessment of lv hypertrophy echocardiography the firstline imaging technique allows a comprehensive assessment of lv systolic and diastolic function cardiovascular magnetic resonance provides added value a it measure accurately lv and right ventricular volume and mass and characterizes myocardial tissue property which may provide important clue to the final diagnosis additionally scintigraphy with bone tracer is included in the diagnostic algorithm of cardiac amyloidosis once the diagnosis is established imaging finding may help predict future disease evolution and inform therapy and followup this consensus document by the heart failure association of the european society of cardiology provides an overview of the role of different cardiac imaging technique for the differential diagnosis and management of patient with lv hypertrophy this article is protected by copyright all right reserved
37587458,rare disease variant curation from literature assessing gap with creatine transport deficiency in focus,approximately of the world suffers from a rare disease rare disease are often difficult to diagnose and many do not have approved therapy genetic sequencing ha the potential to shorten the current diagnostic process increase mechanistic understanding and facilitate research on therapeutic approach but is limited by the difficulty of novel variant pathogenicity interpretation and the communication of known causative variant it is unknown how many published rare disease variant are currently accessible in the public domain,Non-Cancer,1,rare disease variant curation from literature assessing gap with creatine transport deficiency in focus approximately of the world suffers from a rare disease rare disease are often difficult to diagnose and many do not have approved therapy genetic sequencing ha the potential to shorten the current diagnostic process increase mechanistic understanding and facilitate research on therapeutic approach but is limited by the difficulty of novel variant pathogenicity interpretation and the communication of known causative variant it is unknown how many published rare disease variant are currently accessible in the public domain
37589160,endothelial fis desumoylation protects against hypoxic pulmonary hypertension,hypoxia is a major cause and promoter of pulmonary hypertension ph a representative vascular remodeling disease with poor prognosis and high mortality however the mechanism underlying how pulmonary arterial system responds to hypoxic stress during ph remains unclear endothelial mitochondrion are considered signaling organelle on oxygen tension result from previous clinical research and our study suggested a potential role of posttranslational sumoylation in endothelial mitochondrion in hypoxiarelated vasculopathy,Non-Cancer,1,endothelial fis desumoylation protects against hypoxic pulmonary hypertension hypoxia is a major cause and promoter of pulmonary hypertension ph a representative vascular remodeling disease with poor prognosis and high mortality however the mechanism underlying how pulmonary arterial system responds to hypoxic stress during ph remains unclear endothelial mitochondrion are considered signaling organelle on oxygen tension result from previous clinical research and our study suggested a potential role of posttranslational sumoylation in endothelial mitochondrion in hypoxiarelated vasculopathy
37590348,myodfamily inhibitor protein act a auxiliary subunit of piezo channel,piezo channel are critical cellular sensor of mechanical force despite their large size ubiquitous expression and irreplaceable role in an evergrowing list of physiological process few piezo channelbinding protein have emerged in this work we found that myod myoblast determinationfamily inhibitor protein mdfic and mdfi are piezo interacting partner these transcriptional regulator bind to piezo channel regulating channel inactivation using singleparticle cryogenic electron microscopy we mapped the interaction site in mdfic to a lipidated cterminal helix that insert laterally into the piezo pore module these piezointeracting protein fit all the criterion for auxiliary subunit contribute to explaining the vastly different gating kinetics of endogenous piezo channel observed in many cell type and elucidate mechanism potentially involved in human lymphatic vascular disease,Non-Cancer,1,myodfamily inhibitor protein act a auxiliary subunit of piezo channel piezo channel are critical cellular sensor of mechanical force despite their large size ubiquitous expression and irreplaceable role in an evergrowing list of physiological process few piezo channelbinding protein have emerged in this work we found that myod myoblast determinationfamily inhibitor protein mdfic and mdfi are piezo interacting partner these transcriptional regulator bind to piezo channel regulating channel inactivation using singleparticle cryogenic electron microscopy we mapped the interaction site in mdfic to a lipidated cterminal helix that insert laterally into the piezo pore module these piezointeracting protein fit all the criterion for auxiliary subunit contribute to explaining the vastly different gating kinetics of endogenous piezo channel observed in many cell type and elucidate mechanism potentially involved in human lymphatic vascular disease
37595758,gene editing of hematopoietic stem cell restores t cell response in familial hemophagocytic lymphohistiocytosis,hemophagocytic lymphohistiocytosis hlh is a hyperinflammatory disorder characterized by a lifethreatening cytokine storm and immunopathology familial hlh type fhl account for  of all inborn hlh case worldwide it is caused by mutation in the uncd gene which result in impaired degranulation of cytotoxic vesicle and hence compromised t and nk cellmediated killing current treatment protocol including allogeneic hematopoietic stem cell hsc transplantation still show high mortality,Non-Cancer,1,gene editing of hematopoietic stem cell restores t cell response in familial hemophagocytic lymphohistiocytosis hemophagocytic lymphohistiocytosis hlh is a hyperinflammatory disorder characterized by a lifethreatening cytokine storm and immunopathology familial hlh type fhl account for  of all inborn hlh case worldwide it is caused by mutation in the uncd gene which result in impaired degranulation of cytotoxic vesicle and hence compromised t and nk cellmediated killing current treatment protocol including allogeneic hematopoietic stem cell hsc transplantation still show high mortality
37615951,rare variant in complement gene in c glomerulopathy and immunoglobulinmediated membranoproliferative glomerulonephritis,c glomerulopathy and idiopathic immunoglobulinmediated membranoproliferative glomerulonephritis igmpgn are rare complement mediated kidney disease inherited form of c glomerulopathyigmpgn are rarely described,Non-Cancer,1,rare variant in complement gene in c glomerulopathy and immunoglobulinmediated membranoproliferative glomerulonephritis c glomerulopathy and idiopathic immunoglobulinmediated membranoproliferative glomerulonephritis igmpgn are rare complement mediated kidney disease inherited form of c glomerulopathyigmpgn are rarely described
37704779,brjesonforssmanlehmann syndrome delineating the clinical and allelic spectrum in new family,brjesonforssmanlehmann syndrome bfls is an xlinked intellectual disability syndrome caused by variant in the phf gene we ascertained individual from family with likely pathogenic or pathogenic phf variant male and female one family had previously been reported six variant were novel we analysed the clinical and genetic finding in our series and compared them with reported bfls patient affected male had classic feature of bfls including intellectual disability distinctive facies large ear gynaecomastia hypogonadism and truncal obesity carrier female relative of affected male were unaffected or had only mild symptom the phenotype of affected female with de novo variant overlapped with the male but included linear skin hyperpigmentation and a higher frequency of dental retinal and cortical brain anomaly complication observed in our series included keloid scarring digital fibroma absent vaginal orifice neuropathy umbilical hernia and talipes our analysis highlighted sexspecific difference in phf variant type and location affected male often have missense variant or small inframe deletion while affected female tend to have truncating variant or large deletionsduplications missense variant were found in a minority of affected female and clustered in the highly constrained phd domain of phf we propose recommendation for the evaluation and management of bfls patient these result further delineate and extend the genetic and phenotypic spectrum of bfls,Non-Cancer,1,brjesonforssmanlehmann syndrome delineating the clinical and allelic spectrum in new family brjesonforssmanlehmann syndrome bfls is an xlinked intellectual disability syndrome caused by variant in the phf gene we ascertained individual from family with likely pathogenic or pathogenic phf variant male and female one family had previously been reported six variant were novel we analysed the clinical and genetic finding in our series and compared them with reported bfls patient affected male had classic feature of bfls including intellectual disability distinctive facies large ear gynaecomastia hypogonadism and truncal obesity carrier female relative of affected male were unaffected or had only mild symptom the phenotype of affected female with de novo variant overlapped with the male but included linear skin hyperpigmentation and a higher frequency of dental retinal and cortical brain anomaly complication observed in our series included keloid scarring digital fibroma absent vaginal orifice neuropathy umbilical hernia and talipes our analysis highlighted sexspecific difference in phf variant type and location affected male often have missense variant or small inframe deletion while affected female tend to have truncating variant or large deletionsduplications missense variant were found in a minority of affected female and clustered in the highly constrained phd domain of phf we propose recommendation for the evaluation and management of bfls patient these result further delineate and extend the genetic and phenotypic spectrum of bfls
37740653,hippocampal and neocortical braf mutant nonexpansive lesion in focal epilepsy,mesial temporal lobe epilepsyassociated hippocampal sclerosis mtlehs is a syndrome associated with various aetiology we previously identified cdpositive extravascular stellate cell cd cell possibly related to brafve oncogenic variant in a subset of mtlehs we aimed to identify the brafve oncogenic variant and characterise the cd cell,Non-Cancer,1,hippocampal and neocortical braf mutant nonexpansive lesion in focal epilepsy mesial temporal lobe epilepsyassociated hippocampal sclerosis mtlehs is a syndrome associated with various aetiology we previously identified cdpositive extravascular stellate cell cd cell possibly related to brafve oncogenic variant in a subset of mtlehs we aimed to identify the brafve oncogenic variant and characterise the cd cell
37751797,reassessment of the nf variant of unknown significance found during the year activity of a genetics diagnostic laboratory,the finding of variant of uncertain significance vus in the activity of a diagnostic genetic laboratory is a common issue which is however provisional and need to be periodically reevaluated due to the continuous advancement in our knowledge of the genetic disease neurofibromatosis type caused by the occurrence of heterozygous pathogenic nf variant is a good model for studying the evolution of vus due to the widespread use of genetic testing for the disease the constant enrichment of the international database with nf variant and the full adult penetrance of the disease which make genotyping the parent a crucial step in the diagnostic workflow the present study retrospectively reviewed and reinterpreted the genetic test result of nf in a diagnostic genetic laboratory in the period from january to december all the vus were reinterpreted using the consensus standard and guideline for the interpretation out of nf genetic test which were performed in the period a total of vus were found and reinterpreted in case were reclassified a benignlikely benign whereas were recoded a pathogeniclikely pathogenic with a significant trend distribution chi square test for trend p synonymous vus have mainly been reclassified a class and whereas missense variant have been attributed to class and in out of the case these finding underline an improvement in the classification of variant over time suggesting that a reinterpretation of the genetic test should be routinely performed to support the physician in the clinical diagnosis of genetic disease,Non-Cancer,1,reassessment of the nf variant of unknown significance found during the year activity of a genetics diagnostic laboratory the finding of variant of uncertain significance vus in the activity of a diagnostic genetic laboratory is a common issue which is however provisional and need to be periodically reevaluated due to the continuous advancement in our knowledge of the genetic disease neurofibromatosis type caused by the occurrence of heterozygous pathogenic nf variant is a good model for studying the evolution of vus due to the widespread use of genetic testing for the disease the constant enrichment of the international database with nf variant and the full adult penetrance of the disease which make genotyping the parent a crucial step in the diagnostic workflow the present study retrospectively reviewed and reinterpreted the genetic test result of nf in a diagnostic genetic laboratory in the period from january to december all the vus were reinterpreted using the consensus standard and guideline for the interpretation out of nf genetic test which were performed in the period a total of vus were found and reinterpreted in case were reclassified a benignlikely benign whereas were recoded a pathogeniclikely pathogenic with a significant trend distribution chi square test for trend p synonymous vus have mainly been reclassified a class and whereas missense variant have been attributed to class and in out of the case these finding underline an improvement in the classification of variant over time suggesting that a reinterpretation of the genetic test should be routinely performed to support the physician in the clinical diagnosis of genetic disease
37801091,symptomatic intraventricular choroid plexus cyst illustrative case and systematic review,although choroid plexus cyst are a frequent incidental neuroimaging finding symptomatic one are rarea series of more than five case are hard to find in the absence of highvolume study there are no generally accepted algorithm for diagnosis and treatment for this pathology proposed surgical technique include microsurgical excision or fenestration and endoscopic excision or fenestration with or without additional shunting no definitive conclusion exist about the superiority of a certain technique here we introduce an illustrative case of a patient with a symptomatic choroid plexus cyst in the trigone of the lateral ventricle and a systematic review of additional published case with the aim of identifying epidemiological feature variant of localization of the cyst their symptom persistence of concomitant obstructive hydrocephalus and treatment modality a prismabased literature search wa performed on the pubmed medline scopus and web of knowledge database we include in the review case report and case series of symptomatic choroid plexus cyst with full text or valuable abstract available online in english and published by april all abstract of retrieved study were assessed by two independent researcher to avoid bias only descriptive statistic were used for the presentation of the result a total of study case report and case series with depicted case met the eligibility criterion the review showed a slight predominance of choroid plexus cyst in men the most common localization of cyst were the trigone and the body of the lateral ventricle obstructive hydrocephalus is often present in patient with choroid plexus cyst the most common symptom of cyst were sign of increased icp headache and vomiting the main treatment approach for symptomatic choroid plexus cyst were microsurgical excision microsurgical fenestration endoscopic fenestration and total endoscopic excision the tendency ha been noted to shift from microsurgical to endoscopic procedure over the past two decade some data on the classification of cyst of the central nervous system and the underlying mechanism of the pathogenesis of choroid plexus cyst are also presentedalthough symptomatic case of choroid plexus cyst are rare by summarizing currently available data one could clarify their common feature and identify a preferable treatment modality,Non-Cancer,1,symptomatic intraventricular choroid plexus cyst illustrative case and systematic review although choroid plexus cyst are a frequent incidental neuroimaging finding symptomatic one are rarea series of more than five case are hard to find in the absence of highvolume study there are no generally accepted algorithm for diagnosis and treatment for this pathology proposed surgical technique include microsurgical excision or fenestration and endoscopic excision or fenestration with or without additional shunting no definitive conclusion exist about the superiority of a certain technique here we introduce an illustrative case of a patient with a symptomatic choroid plexus cyst in the trigone of the lateral ventricle and a systematic review of additional published case with the aim of identifying epidemiological feature variant of localization of the cyst their symptom persistence of concomitant obstructive hydrocephalus and treatment modality a prismabased literature search wa performed on the pubmed medline scopus and web of knowledge database we include in the review case report and case series of symptomatic choroid plexus cyst with full text or valuable abstract available online in english and published by april all abstract of retrieved study were assessed by two independent researcher to avoid bias only descriptive statistic were used for the presentation of the result a total of study case report and case series with depicted case met the eligibility criterion the review showed a slight predominance of choroid plexus cyst in men the most common localization of cyst were the trigone and the body of the lateral ventricle obstructive hydrocephalus is often present in patient with choroid plexus cyst the most common symptom of cyst were sign of increased icp headache and vomiting the main treatment approach for symptomatic choroid plexus cyst were microsurgical excision microsurgical fenestration endoscopic fenestration and total endoscopic excision the tendency ha been noted to shift from microsurgical to endoscopic procedure over the past two decade some data on the classification of cyst of the central nervous system and the underlying mechanism of the pathogenesis of choroid plexus cyst are also presentedalthough symptomatic case of choroid plexus cyst are rare by summarizing currently available data one could clarify their common feature and identify a preferable treatment modality
37864100,risk factor for early mortality in elderly patient with unstable isolated c odontoid fracture treated with halovest or surgery,the aim of this study wa to compare inhospital mortality of three procedure halovest immobilization anterior spinal fixation asf and posterior spinal fixation psf in the treatment of elderly patient with isolated c odontoid fracture we extracted data for elderly patient who were admitted with c odontoid fracture and treated with at least one of the three procedure halovest immobilization asf or psf during hospitalization we conducted a generalized propensity scorebased matching weight analysis to compare inhospital mortality among the three procedure we further investigated independent risk factor for inhospital death the study involved patient halovest n asf n and psf n with a mean age of year inhospital death occurred in patient treatment type wa not significantly associated with inhospital mortality male sex odds ratio confidence interval p and a charlson comorbidity index of  odds ratio confidence interval p were independent risk factor for inhospital mortality in conclusion treatment type wa not significantly associated with inhospital mortality in elderly patient with isolated c odontoid fracture halovest immobilization can help to avoid adverse event in patient with c odontoid fracture who are considered less suitable for surgical treatment,Non-Cancer,1,risk factor for early mortality in elderly patient with unstable isolated c odontoid fracture treated with halovest or surgery the aim of this study wa to compare inhospital mortality of three procedure halovest immobilization anterior spinal fixation asf and posterior spinal fixation psf in the treatment of elderly patient with isolated c odontoid fracture we extracted data for elderly patient who were admitted with c odontoid fracture and treated with at least one of the three procedure halovest immobilization asf or psf during hospitalization we conducted a generalized propensity scorebased matching weight analysis to compare inhospital mortality among the three procedure we further investigated independent risk factor for inhospital death the study involved patient halovest n asf n and psf n with a mean age of year inhospital death occurred in patient treatment type wa not significantly associated with inhospital mortality male sex odds ratio confidence interval p and a charlson comorbidity index of  odds ratio confidence interval p were independent risk factor for inhospital mortality in conclusion treatment type wa not significantly associated with inhospital mortality in elderly patient with isolated c odontoid fracture halovest immobilization can help to avoid adverse event in patient with c odontoid fracture who are considered less suitable for surgical treatment
37869874,retrospective pharmacogenetic study in a cohort of pediatric tuberous sclerosis complex patient using everolimus,aim tuberous sclerosis complex tsc is a rare disease that produce multisystemic disorder everolimus evr is the only immunosuppressive drug approved to control the symptom and progression of the disease the aim wa to evaluate the genotypephenotype association to improve the pediatric tsc pharmacotherapeutic outcome patient method ten pediatric tsc patient were recruited concomitant treatment and main metabolic enzyme and transporter coding gene variant of evr were analyzed result significant association were found between cypa allele and concomitant treatment with valproic acid cypainhibitor with a poor metabolizer phenotype and the presence of pneumonia conclusion this is the first pharmacogenetic study of evr in pediatric tsc patient the author propose to consider concomitant treatment and pharmacogenetics due to their multifactorial status,Non-Cancer,1,retrospective pharmacogenetic study in a cohort of pediatric tuberous sclerosis complex patient using everolimus aim tuberous sclerosis complex tsc is a rare disease that produce multisystemic disorder everolimus evr is the only immunosuppressive drug approved to control the symptom and progression of the disease the aim wa to evaluate the genotypephenotype association to improve the pediatric tsc pharmacotherapeutic outcome patient method ten pediatric tsc patient were recruited concomitant treatment and main metabolic enzyme and transporter coding gene variant of evr were analyzed result significant association were found between cypa allele and concomitant treatment with valproic acid cypainhibitor with a poor metabolizer phenotype and the presence of pneumonia conclusion this is the first pharmacogenetic study of evr in pediatric tsc patient the author propose to consider concomitant treatment and pharmacogenetics due to their multifactorial status
37873196,exome copy number variant detection analysis and classification in a large cohort of family with undiagnosed rare genetic disease,copy number variant cnvs are significant contributor to the pathogenicity of rare genetic disease and with new innovative method can now reliably be identified from exome sequencing challenge still remain in accurate classification of cnv pathogenicity cnv calling using gatkgcnv wa performed on exomes from a cohort of family individual with heterogeneous phenotype and variable prior genetic testing collected at the broad institute center for mendelian genomics of the gregor consortium each family cnv data wa analyzed using the seqr platform and candidate cnvs classified using the acmgclingen cnv interpretation standard we developed additional evidence criterion to address situation not covered by the current standard the addition of cnv calling to exome analysis identified causal cnvs for family the estimated size of cnvs ranged from bp to mb with estimate that would not have been detected by standard chromosomal microarrays the causal cnvs consisted of deletion duplication suspected complex structural variant svs insertion and complex svs the latter two group being identified by orthogonal validation method we interpreted cnvs a likely pathogenicpathogenic and cnvs a high interest variant of uncertain significance calling cnvs from existing exome data increase the diagnostic yield for individual undiagnosed after standard testing approach providing a higher resolution alternative to array at a fraction of the cost of genome sequencing our improvement to the classification approach advance the systematic framework to assess the pathogenicity of cnvs,Non-Cancer,1,exome copy number variant detection analysis and classification in a large cohort of family with undiagnosed rare genetic disease copy number variant cnvs are significant contributor to the pathogenicity of rare genetic disease and with new innovative method can now reliably be identified from exome sequencing challenge still remain in accurate classification of cnv pathogenicity cnv calling using gatkgcnv wa performed on exomes from a cohort of family individual with heterogeneous phenotype and variable prior genetic testing collected at the broad institute center for mendelian genomics of the gregor consortium each family cnv data wa analyzed using the seqr platform and candidate cnvs classified using the acmgclingen cnv interpretation standard we developed additional evidence criterion to address situation not covered by the current standard the addition of cnv calling to exome analysis identified causal cnvs for family the estimated size of cnvs ranged from bp to mb with estimate that would not have been detected by standard chromosomal microarrays the causal cnvs consisted of deletion duplication suspected complex structural variant svs insertion and complex svs the latter two group being identified by orthogonal validation method we interpreted cnvs a likely pathogenicpathogenic and cnvs a high interest variant of uncertain significance calling cnvs from existing exome data increase the diagnostic yield for individual undiagnosed after standard testing approach providing a higher resolution alternative to array at a fraction of the cost of genome sequencing our improvement to the classification approach advance the systematic framework to assess the pathogenicity of cnvs
37888959,candida albicans exhibit heterogeneous and adaptive cytoprotective response to antifungal compound,candida albicans an opportunistic human pathogen pose a significant threat to human health and is associated with significant socioeconomic burden current antifungal treatment fail at least in part because c albicans can initiate a strong drug tolerance response that allows some cell to grow at drug concentration above their minimal inhibitory concentration to better characterize this cytoprotective tolerance program at the molecular singlecell level we used a nanoliter dropletbased transcriptomics platform to profile thousand of individual fungal cell and establish their subpopulation characteristic in the absence and presence of antifungal drug profile of untreated cell exhibit heterogeneous expression that correlate with cell cycle stage with distinct metabolic and stress response at day postfluconazole exposure a time when tolerance is measurable surviving cell bifurcate into two major subpopulation one characterized by the upregulation of gene encoding ribosomal protein rrna processing machinery and mitochondrial cellular respiration capacity termed the ribodominant rd state and the other enriched for gene encoding stress response and related process termed the stressdominant sd state this bifurcation persists at and day posttreatment we provide evidence that the ribosome assembly stress response rastr is activated in these subpopulation and may facilitate cell survival,Non-Cancer,1,candida albicans exhibit heterogeneous and adaptive cytoprotective response to antifungal compound candida albicans an opportunistic human pathogen pose a significant threat to human health and is associated with significant socioeconomic burden current antifungal treatment fail at least in part because c albicans can initiate a strong drug tolerance response that allows some cell to grow at drug concentration above their minimal inhibitory concentration to better characterize this cytoprotective tolerance program at the molecular singlecell level we used a nanoliter dropletbased transcriptomics platform to profile thousand of individual fungal cell and establish their subpopulation characteristic in the absence and presence of antifungal drug profile of untreated cell exhibit heterogeneous expression that correlate with cell cycle stage with distinct metabolic and stress response at day postfluconazole exposure a time when tolerance is measurable surviving cell bifurcate into two major subpopulation one characterized by the upregulation of gene encoding ribosomal protein rrna processing machinery and mitochondrial cellular respiration capacity termed the ribodominant rd state and the other enriched for gene encoding stress response and related process termed the stressdominant sd state this bifurcation persists at and day posttreatment we provide evidence that the ribosome assembly stress response rastr is activated in these subpopulation and may facilitate cell survival
37888995,crisprbased diagnostics detects invasive insect pest,rapid identification of organism is essential for many biological and medical discipline from understanding basic ecosystem process disease diagnosis to the detection of invasive pest crisprbased diagnostics offer a novel and rapid alternative to other identification method and can revolutionize our ability to detect organism with high accuracy here we describe a crisprbased diagnostic developed with the universal cytochromeoxidase gene co the co gene is the most sequenced gene among animalia and therefore our approach can be adopted to detect nearly any animal we tested the approach on three difficulttoidentify moth specie keiferia lycopersicella phthorimaea absoluta and scrobipalpa atriplicella that are major invasive pest globally we designed an assay that combine recombinase polymerase amplification rpa with crispr for signal generation our approach ha a much higher sensitivity than realtime pcr assay and achieved accuracy for identification of all three specie with a detection limit of up to fm for p absoluta and fm for the other two specie our approach doe not require a sophisticated laboratory reduces the risk of crosscontamination and can be completed in less than h this work serf a a proof of concept that ha the potential to revolutionize animal detection and monitoring,Non-Cancer,1,crisprbased diagnostics detects invasive insect pest rapid identification of organism is essential for many biological and medical discipline from understanding basic ecosystem process disease diagnosis to the detection of invasive pest crisprbased diagnostics offer a novel and rapid alternative to other identification method and can revolutionize our ability to detect organism with high accuracy here we describe a crisprbased diagnostic developed with the universal cytochromeoxidase gene co the co gene is the most sequenced gene among animalia and therefore our approach can be adopted to detect nearly any animal we tested the approach on three difficulttoidentify moth specie keiferia lycopersicella phthorimaea absoluta and scrobipalpa atriplicella that are major invasive pest globally we designed an assay that combine recombinase polymerase amplification rpa with crispr for signal generation our approach ha a much higher sensitivity than realtime pcr assay and achieved accuracy for identification of all three specie with a detection limit of up to fm for p absoluta and fm for the other two specie our approach doe not require a sophisticated laboratory reduces the risk of crosscontamination and can be completed in less than h this work serf a a proof of concept that ha the potential to revolutionize animal detection and monitoring
37892108,characterization of new alpha zero  thalassaemia deletion gb among malay in malaysian population,malaysia is a multicultural and multiethnic country comprising numerous ethnic group from the total population of million malay form the bulk of the bumiputera in malaysia comprise about followed by chinese indian and others the heterogeneous population and increasing number of noncitizen in this country affect the heterogeneity of genetic disease diversity and heterogeneity of thalassaemia mutation alpha thalassaemia is an inherited haemoglobin disorder characterized by hypochromic microcytic anaemia caused by a quantitative reduction in the globin chain a majority of the thalassaemia are caused by deletion in the globin gene cluster among malay the most common deletional alpha thalassaemia is  deletion followed by sea deletion we described the molecular characterization of a new gb deletion in our population involving both alpha gene in ci interestingly we found that this mutation is unique among malay ethnicity it is important to diagnose this deletion because of the risk of hb bart with hydrops fetalis in the offspring when in combination with another  thalassaemia allele mlpa is a suitable method to detect unknown and uncommon deletion and to characterize those case which remain unresolved after a standard diagnostic approach,Non-Cancer,1,characterization of new alpha zero  thalassaemia deletion gb among malay in malaysian population malaysia is a multicultural and multiethnic country comprising numerous ethnic group from the total population of million malay form the bulk of the bumiputera in malaysia comprise about followed by chinese indian and others the heterogeneous population and increasing number of noncitizen in this country affect the heterogeneity of genetic disease diversity and heterogeneity of thalassaemia mutation alpha thalassaemia is an inherited haemoglobin disorder characterized by hypochromic microcytic anaemia caused by a quantitative reduction in the globin chain a majority of the thalassaemia are caused by deletion in the globin gene cluster among malay the most common deletional alpha thalassaemia is  deletion followed by sea deletion we described the molecular characterization of a new gb deletion in our population involving both alpha gene in ci interestingly we found that this mutation is unique among malay ethnicity it is important to diagnose this deletion because of the risk of hb bart with hydrops fetalis in the offspring when in combination with another  thalassaemia allele mlpa is a suitable method to detect unknown and uncommon deletion and to characterize those case which remain unresolved after a standard diagnostic approach
37901227,significance of hlae and it two nkg receptor in development of complication after allogeneic transplantation of hematopoietic stem cell,transplantation of hematopoietic stem cell hsct is a procedure commonly used in treatment of various haematological disorder which is associated with significantly improved survival rate however one of it drawback is the possibility of development of posttransplant complication including acute and chronic graftversushost disease gvhd or cmv infection various study suggested that nk cell and their receptor may affect the transplant outcome in the present study patient and donor were found to significantly differ in the distribution of the nkga r genetic variant recipient carried the c allele more often than their donor v pnkgc deletion characterized with decreased frequency of nkgc nk cell p our study confirms the importance of nk cell in the development of posttransplant complication and highlight the effect of hlae and nkgc genetic variant shlae serum concentration a well a nkgc surface expression on transplant outcome,Non-Cancer,1,significance of hlae and it two nkg receptor in development of complication after allogeneic transplantation of hematopoietic stem cell transplantation of hematopoietic stem cell hsct is a procedure commonly used in treatment of various haematological disorder which is associated with significantly improved survival rate however one of it drawback is the possibility of development of posttransplant complication including acute and chronic graftversushost disease gvhd or cmv infection various study suggested that nk cell and their receptor may affect the transplant outcome in the present study patient and donor were found to significantly differ in the distribution of the nkga r genetic variant recipient carried the c allele more often than their donor v pnkgc deletion characterized with decreased frequency of nkgc nk cell p our study confirms the importance of nk cell in the development of posttransplant complication and highlight the effect of hlae and nkgc genetic variant shlae serum concentration a well a nkgc surface expression on transplant outcome
37904051,mosaic chromosomal alteration in blood across ancestry using wholegenome sequencing,megabasescale mosaic chromosomal alteration mcas in blood are prognostic marker for a host of human disease here to gain a better understanding of mca rate in genetically diverse population we analyzed wholegenome sequencing data from individual from the national heart lung and blood institute transomics for precision medicine program we observed higher sensitivity with wholegenome sequencing data compared with arraybased data in uncovering mcas at low mutant cell fraction and found that individual of european ancestry have the highest rate of autosomal mcas and the lowest rate of chromosome x mcas compared with individual of african or hispanic ancestry although further study in diverse population will be needed to replicate our finding we report three locus associated with loss of chromosome x association between autosomal mcas and rare variant in dcps adm ppprb and tet and ancestryspecific variant in atm and mpl with mcas in ci,Non-Cancer,1,mosaic chromosomal alteration in blood across ancestry using wholegenome sequencing megabasescale mosaic chromosomal alteration mcas in blood are prognostic marker for a host of human disease here to gain a better understanding of mca rate in genetically diverse population we analyzed wholegenome sequencing data from individual from the national heart lung and blood institute transomics for precision medicine program we observed higher sensitivity with wholegenome sequencing data compared with arraybased data in uncovering mcas at low mutant cell fraction and found that individual of european ancestry have the highest rate of autosomal mcas and the lowest rate of chromosome x mcas compared with individual of african or hispanic ancestry although further study in diverse population will be needed to replicate our finding we report three locus associated with loss of chromosome x association between autosomal mcas and rare variant in dcps adm ppprb and tet and ancestryspecific variant in atm and mpl with mcas in ci
37907381,variant classification for pompe disease acmgamp specification from the clingen lysosomal disease variant curation expert panel,accurate determination of the clinical significance of genetic variant is critical to the integration of genomics in medicine to facilitate this process the nihfunded clinical genome resource clingen ha assembled variant curation expert panel vceps group of expert and biocurators which provide gene and disease specification to the american college of medical genetics genomics and association for molecular pathology acmgamp variation classification guideline with the goal of classifying the clinical significance of gaa variant in pompe disease glycogen storage disease type ii the clingen lysosomal disease ld vcep ha specified the acmgamp criterion for gaa variant classification can play an important role in confirming the diagnosis of pompe disease a well a in the identification of carrier furthermore since the inclusion of pompe disease on the recommended uniform screening panel rusp for newborn in the usa in the addition of molecular genetic testing ha become an important component in the interpretation of newborn screening result particularly for asymptomatic individual to date the ld vcep ha submitted classification and supporting data on gaa variant to public database specifically clinvar and the clingen evidence repository here we describe the acmgamp criterion specification process for gaa an update of the gaaspecific variant classification guideline and comparison of the clingen ld vceps gaa variant classification with variant classification submitted to clinvar the ld vcep ha added to the publicly available knowledge on the pathogenicity of variant in gaa by increasing the number of expertcurated gaa variant present in clinvar and aid in resolving conflicting classification and variant of uncertain clinical significance,Non-Cancer,1,variant classification for pompe disease acmgamp specification from the clingen lysosomal disease variant curation expert panel accurate determination of the clinical significance of genetic variant is critical to the integration of genomics in medicine to facilitate this process the nihfunded clinical genome resource clingen ha assembled variant curation expert panel vceps group of expert and biocurators which provide gene and disease specification to the american college of medical genetics genomics and association for molecular pathology acmgamp variation classification guideline with the goal of classifying the clinical significance of gaa variant in pompe disease glycogen storage disease type ii the clingen lysosomal disease ld vcep ha specified the acmgamp criterion for gaa variant classification can play an important role in confirming the diagnosis of pompe disease a well a in the identification of carrier furthermore since the inclusion of pompe disease on the recommended uniform screening panel rusp for newborn in the usa in the addition of molecular genetic testing ha become an important component in the interpretation of newborn screening result particularly for asymptomatic individual to date the ld vcep ha submitted classification and supporting data on gaa variant to public database specifically clinvar and the clingen evidence repository here we describe the acmgamp criterion specification process for gaa an update of the gaaspecific variant classification guideline and comparison of the clingen ld vceps gaa variant classification with variant classification submitted to clinvar the ld vcep ha added to the publicly available knowledge on the pathogenicity of variant in gaa by increasing the number of expertcurated gaa variant present in clinvar and aid in resolving conflicting classification and variant of uncertain clinical significance
37909662,smurf control the pppcalcineurin complex and tfeb at a regulatory node for lysosomal biogenesis,macroautophagyautophagy is a homeostatic process in response to multiple signaling such a the lysosomedependent recycling process of cellular component starvationinduced mtor inactivation and pppcalcineurin activation were shown to promote the nuclear translocation of tfeb however the mechanism via which signal from endomembrane damage are transmitted to activate pppcalcineurin and orchestrate autophagic response remain unknown this study aimed to show that autophagy regulator smurf controlled tfeb nuclear import for transcriptional activation of the lysosomal biogenesis we showed that blocking smurf affected lysosomal biogenesis in response to lysosomal damage by preventing tfeb nuclear translocation it revealed galectins recognized endolysosomal damage and led to recruitment of smurf and the pppcalcineurin apparatus on lysosome smurf interacts with both lgals and pppcb to form the lgalssmurfpppcalcineurin complex importantly this complex further stabilizes tfeb thereby activating tfeb for lysosomal biogenesis we determined that llomemediated tfeb nuclear import is dependent on smurf under the condition of mtorc inhibition in addition smurf is required for pppcalcineurin activity a a positive regulator of tfeb smurf controlled the phosphatase activity of the pppcb by promoting the dissociation of it autoinhibitory domain aid from it catalytic domain cd overexpression of smurf showed similar effect a the constitutive activation of pppcb thus smurf which bridge environmental stress with the core autophagosomal and autolysosomal machinery interacted with endomembrane sensor lgals and phosphatase pppcb to control tfeb activationabbreviations atg autophagyrelated llome lleucyllleucine methyl ester mlsa mucolipin synthetic agonist mtor mechanistic target of rapamycin kinase pppcb protein phosphatase catalytic subunit beta rpskbpsk ribosomal protein s kinase b smurf smad specific e ubiquitin protein ligase tfeb transcription factor eb,Non-Cancer,1,smurf control the pppcalcineurin complex and tfeb at a regulatory node for lysosomal biogenesis macroautophagyautophagy is a homeostatic process in response to multiple signaling such a the lysosomedependent recycling process of cellular component starvationinduced mtor inactivation and pppcalcineurin activation were shown to promote the nuclear translocation of tfeb however the mechanism via which signal from endomembrane damage are transmitted to activate pppcalcineurin and orchestrate autophagic response remain unknown this study aimed to show that autophagy regulator smurf controlled tfeb nuclear import for transcriptional activation of the lysosomal biogenesis we showed that blocking smurf affected lysosomal biogenesis in response to lysosomal damage by preventing tfeb nuclear translocation it revealed galectins recognized endolysosomal damage and led to recruitment of smurf and the pppcalcineurin apparatus on lysosome smurf interacts with both lgals and pppcb to form the lgalssmurfpppcalcineurin complex importantly this complex further stabilizes tfeb thereby activating tfeb for lysosomal biogenesis we determined that llomemediated tfeb nuclear import is dependent on smurf under the condition of mtorc inhibition in addition smurf is required for pppcalcineurin activity a a positive regulator of tfeb smurf controlled the phosphatase activity of the pppcb by promoting the dissociation of it autoinhibitory domain aid from it catalytic domain cd overexpression of smurf showed similar effect a the constitutive activation of pppcb thus smurf which bridge environmental stress with the core autophagosomal and autolysosomal machinery interacted with endomembrane sensor lgals and phosphatase pppcb to control tfeb activationabbreviations atg autophagyrelated llome lleucyllleucine methyl ester mlsa mucolipin synthetic agonist mtor mechanistic target of rapamycin kinase pppcb protein phosphatase catalytic subunit beta rpskbpsk ribosomal protein s kinase b smurf smad specific e ubiquitin protein ligase tfeb transcription factor eb
37931130,sequence basis for selectivity of ephrinb ligand for eph receptor and pathogenic henipavirus g glycoprotein,ephrinb efnb is a ligand for six eph receptor in human and function a a cell entry receptor for several henipaviruses including the nipah virus niv a pathogenic zoonotic virus with pandemic potential to understand the sequence basis of promiscuity for efnb binding to the attachment glycoprotein of niv nivg and eph receptor we performed deep mutagenesis on efnb to identify mutation that enhance binding to nivg over ephb one of the highest affinity eph receptor the mutation highlight how different efnb conformation are selected by nivg versus ephb specificity mutation are enriched at the base of the gh binding loop of efnb especially surrounding a phenylalanine hinge upon which the gh loop pivot and at a phenylalanine hook that rotates away from the efnb core to engage eph receptor one efnb mutant dq possesses panspecificity to the attachment glycoprotein of closely related henipaviruses and ha markedly diminished binding to the six eph receptor however efnbdq ha high residual binding to ephb and ephb a second deep mutational scan of efnb identified combinatorial mutation to further enhance specificity to nivg a triple mutant of soluble efnb dqqlvl ha minimal binding to eph receptor but maintains binding albeit reduced to nivg soluble efnb decoy receptor carrying the specificity mutation were potent neutralizers of chimeric henipaviruses these finding demonstrate how specific residue change at the shared binding interface of a promiscuous ligand efnb can influence selectivity for multiple receptor and may also offer insight toward the development of henipavirus therapeutic and diagnostics importance ephrinb efnb is a ligand for six eph receptor in human and regulates multiple cell developmental and signaling process it also function a the cell entry receptor for nipah virus and hendra virus zoonotic virus that can cause respiratory andor neurological symptom in human with high mortality here we investigate the sequence basis of efnb specificity for binding the nipah virus attachment g glycoprotein over eph receptor we then use this information to engineer efnb a a soluble decoy receptor that specifically bind the attachment glycoprotein of the nipah virus and other related henipaviruses to neutralize infection these finding further mechanistic understanding of protein selectivity and may facilitate the development of diagnostics or therapeutic against henipavirus infection,Non-Cancer,1,sequence basis for selectivity of ephrinb ligand for eph receptor and pathogenic henipavirus g glycoprotein ephrinb efnb is a ligand for six eph receptor in human and function a a cell entry receptor for several henipaviruses including the nipah virus niv a pathogenic zoonotic virus with pandemic potential to understand the sequence basis of promiscuity for efnb binding to the attachment glycoprotein of niv nivg and eph receptor we performed deep mutagenesis on efnb to identify mutation that enhance binding to nivg over ephb one of the highest affinity eph receptor the mutation highlight how different efnb conformation are selected by nivg versus ephb specificity mutation are enriched at the base of the gh binding loop of efnb especially surrounding a phenylalanine hinge upon which the gh loop pivot and at a phenylalanine hook that rotates away from the efnb core to engage eph receptor one efnb mutant dq possesses panspecificity to the attachment glycoprotein of closely related henipaviruses and ha markedly diminished binding to the six eph receptor however efnbdq ha high residual binding to ephb and ephb a second deep mutational scan of efnb identified combinatorial mutation to further enhance specificity to nivg a triple mutant of soluble efnb dqqlvl ha minimal binding to eph receptor but maintains binding albeit reduced to nivg soluble efnb decoy receptor carrying the specificity mutation were potent neutralizers of chimeric henipaviruses these finding demonstrate how specific residue change at the shared binding interface of a promiscuous ligand efnb can influence selectivity for multiple receptor and may also offer insight toward the development of henipavirus therapeutic and diagnostics importance ephrinb efnb is a ligand for six eph receptor in human and regulates multiple cell developmental and signaling process it also function a the cell entry receptor for nipah virus and hendra virus zoonotic virus that can cause respiratory andor neurological symptom in human with high mortality here we investigate the sequence basis of efnb specificity for binding the nipah virus attachment g glycoprotein over eph receptor we then use this information to engineer efnb a a soluble decoy receptor that specifically bind the attachment glycoprotein of the nipah virus and other related henipaviruses to neutralize infection these finding further mechanistic understanding of protein selectivity and may facilitate the development of diagnostics or therapeutic against henipavirus infection
37938781,autoantibody against type i ifns in human with alternative nfb pathway deficiency,patient with autoimmune polyendocrinopathy syndrome type aps caused by autosomal recessive aire deficiency produce autoantibody that neutralize type i interferon ifns conferring a predisposition to lifethreatening covid pneumonia here we report that patient with autosomal recessive nik or relb deficiency or a specific type of autosomaldominant nfb deficiency also have neutralizing autoantibody against type i ifns and are at higher risk of getting lifethreatening covid pneumonia in patient with autosomaldominant nfb deficiency these autoantibody are found only in individual who are heterozygous for variant associated with both transcription p activity loss of function lof due to impaired p processing to generate p and regulatory ib activity gain of function gof due to the accumulation of unprocessed p therefore increasing the inhibitory activity of ib hereafter plofibgof by contrast neutralizing autoantibody against type i ifns are not found in individual who are heterozygous for nfkb variant causing haploinsufficiency of p and p hereafter plofiblof or gainoffunction of p hereafter pgofiblof in contrast to patient with aps patient with disorder of nik relb or nfb have very few tissuespecific autoantibody however their thymus have an abnormal structure with few aireexpressing medullary thymic epithelial cell human inborn error of the alternative nfb pathway impair the development of aireexpressing medullary thymic epithelial cell thereby underlying the production of autoantibody against type i ifns and predisposition to viral disease,Non-Cancer,1,autoantibody against type i ifns in human with alternative nfb pathway deficiency patient with autoimmune polyendocrinopathy syndrome type aps caused by autosomal recessive aire deficiency produce autoantibody that neutralize type i interferon ifns conferring a predisposition to lifethreatening covid pneumonia here we report that patient with autosomal recessive nik or relb deficiency or a specific type of autosomaldominant nfb deficiency also have neutralizing autoantibody against type i ifns and are at higher risk of getting lifethreatening covid pneumonia in patient with autosomaldominant nfb deficiency these autoantibody are found only in individual who are heterozygous for variant associated with both transcription p activity loss of function lof due to impaired p processing to generate p and regulatory ib activity gain of function gof due to the accumulation of unprocessed p therefore increasing the inhibitory activity of ib hereafter plofibgof by contrast neutralizing autoantibody against type i ifns are not found in individual who are heterozygous for nfkb variant causing haploinsufficiency of p and p hereafter plofiblof or gainoffunction of p hereafter pgofiblof in contrast to patient with aps patient with disorder of nik relb or nfb have very few tissuespecific autoantibody however their thymus have an abnormal structure with few aireexpressing medullary thymic epithelial cell human inborn error of the alternative nfb pathway impair the development of aireexpressing medullary thymic epithelial cell thereby underlying the production of autoantibody against type i ifns and predisposition to viral disease
37957372,prediction of mortality and overt hepatic encephalopathy undergoing transjugular intrahepatic portosystemic shunt a retrospective cohort study,data on medium and longterm efficacy and safety of transjugular intrahepatic portosystemic shunt tip using viatorr stent in chinese patient are limited this study aimed to evaluate the year mortality and the incidence of overt hepatic encephalopathy ohe after viatorr stent insertion and construct a model to predict posttips ohe preoperatively,Non-Cancer,1,prediction of mortality and overt hepatic encephalopathy undergoing transjugular intrahepatic portosystemic shunt a retrospective cohort study data on medium and longterm efficacy and safety of transjugular intrahepatic portosystemic shunt tip using viatorr stent in chinese patient are limited this study aimed to evaluate the year mortality and the incidence of overt hepatic encephalopathy ohe after viatorr stent insertion and construct a model to predict posttips ohe preoperatively
37994469,investigation of bak bax and madl gene expression in human aneuploid blastocyst,maintaining genomic stability is crucial for normal development at earlier stage of preimplantation development a the embryonic genome activation is not fully completed the embryo may be more prone to abnormality aneuploidy are one of the most common genetic cause of implantation failure or firsttrimester miscarriage apoptosis is a crucial mechanism to eliminate damaged or abnormal cell from the organism to enable healthy growth therefore this study aimed to determine the relationship between the expression level of gene involved in apoptosis in human aneuploid and euploid blastocyst in total human embryo obtained from patient were used for this study trophectoderm biopsy were performed and nextgeneration screening wa carried out for aneuploidy screening total rna wa extracted from each blastocyst separately and cdna wa synthesized gene expression level were evaluated using rtpcr the statistical analysis wa performed to evaluate the gene expression level variation in the euploid and aneuploid embryo respectively the expression level of the bax gene wa significantly different between the aneuploid and euploid sample bax expression level were found to be fold lower in aneuploid cell however the expression level of bak and madl gene were similar in each group this study aimed to investigate the possible role of gene involved in apoptosis and aneuploidy mechanism the finding of this investigation revealed that the bax gene wa expressed significantly differently between aneuploid and euploid embryo therefore it is possible that the gene involved in the apoptotic pathway have a role in the aneuploidy mechanism,Non-Cancer,1,investigation of bak bax and madl gene expression in human aneuploid blastocyst maintaining genomic stability is crucial for normal development at earlier stage of preimplantation development a the embryonic genome activation is not fully completed the embryo may be more prone to abnormality aneuploidy are one of the most common genetic cause of implantation failure or firsttrimester miscarriage apoptosis is a crucial mechanism to eliminate damaged or abnormal cell from the organism to enable healthy growth therefore this study aimed to determine the relationship between the expression level of gene involved in apoptosis in human aneuploid and euploid blastocyst in total human embryo obtained from patient were used for this study trophectoderm biopsy were performed and nextgeneration screening wa carried out for aneuploidy screening total rna wa extracted from each blastocyst separately and cdna wa synthesized gene expression level were evaluated using rtpcr the statistical analysis wa performed to evaluate the gene expression level variation in the euploid and aneuploid embryo respectively the expression level of the bax gene wa significantly different between the aneuploid and euploid sample bax expression level were found to be fold lower in aneuploid cell however the expression level of bak and madl gene were similar in each group this study aimed to investigate the possible role of gene involved in apoptosis and aneuploidy mechanism the finding of this investigation revealed that the bax gene wa expressed significantly differently between aneuploid and euploid embryo therefore it is possible that the gene involved in the apoptotic pathway have a role in the aneuploidy mechanism
38027110,polycystic ovary syndrome and recurrent pregnancy loss a review of literature,pcos is a syndrome of ovarian dysfunction associated with recurrent pregnancy loss several correlating factor have been investigated that influence the risk of pregnancy loss in pcos however uncertainty remains about their contribution to pregnancy loss and prognosis this review of literature aim to identify what is known and what requires further investigation on the relationship between pcos and recurrent pregnancy loss to guide future research and optimize medical guidance throughout pregnancy,Non-Cancer,1,polycystic ovary syndrome and recurrent pregnancy loss a review of literature pcos is a syndrome of ovarian dysfunction associated with recurrent pregnancy loss several correlating factor have been investigated that influence the risk of pregnancy loss in pcos however uncertainty remains about their contribution to pregnancy loss and prognosis this review of literature aim to identify what is known and what requires further investigation on the relationship between pcos and recurrent pregnancy loss to guide future research and optimize medical guidance throughout pregnancy
38036954,change of gut microbiota and short chain fatty acid in patient with peutzjeghers syndrome,peutzjeghers syndromeis a rare autosomal dominant genetic disease characterized by gastrointestinal hamartomatous polyp and skin and mucous membrane pigmentation the pathogenesis of pjs remains unclear however it may be associated with mutation in the stk gene and there is currently no effective treatment available the gut microbiota play an important role in maintaining intestinal homeostasis in the human body and an increasing number of study have reported a relationship between gut microbiota and human health and disease however relatively few study have been conducted on the gut microbiota characteristic of patient with pjs in this study we analyzed the characteristic of the gut microbiota of patient with pjs using s sequencing and measured the level of shortchain fatty acid in the intestine the result showed dysbiosis in the gut microbiota of patient with pjs and decreased synthesis of shortchain fatty acid bacteroides wa positively correlated with maximum polyp length while agathobacter wa negatively correlated with age of onset in addition acetic acid propionic acid and butyric acid were positively correlated with the age of onset but negatively correlated with the number of polyp furthermore the butyric acid level wa negatively correlated with the frequency of endoscopic surgery in contrast we compared the gut microbiota of stkpositive and stknegative patient with pjs for the first time but s sequencing analysis revealed no significant difference finally we established a random forest prediction model based on the gut microbiota characteristic of patient to provide a basis for the targeted diagnosis and treatment of pjs in the future,Non-Cancer,1,change of gut microbiota and short chain fatty acid in patient with peutzjeghers syndrome peutzjeghers syndromeis a rare autosomal dominant genetic disease characterized by gastrointestinal hamartomatous polyp and skin and mucous membrane pigmentation the pathogenesis of pjs remains unclear however it may be associated with mutation in the stk gene and there is currently no effective treatment available the gut microbiota play an important role in maintaining intestinal homeostasis in the human body and an increasing number of study have reported a relationship between gut microbiota and human health and disease however relatively few study have been conducted on the gut microbiota characteristic of patient with pjs in this study we analyzed the characteristic of the gut microbiota of patient with pjs using s sequencing and measured the level of shortchain fatty acid in the intestine the result showed dysbiosis in the gut microbiota of patient with pjs and decreased synthesis of shortchain fatty acid bacteroides wa positively correlated with maximum polyp length while agathobacter wa negatively correlated with age of onset in addition acetic acid propionic acid and butyric acid were positively correlated with the age of onset but negatively correlated with the number of polyp furthermore the butyric acid level wa negatively correlated with the frequency of endoscopic surgery in contrast we compared the gut microbiota of stkpositive and stknegative patient with pjs for the first time but s sequencing analysis revealed no significant difference finally we established a random forest prediction model based on the gut microbiota characteristic of patient to provide a basis for the targeted diagnosis and treatment of pjs in the future
38040034,neurological disease in xeroderma pigmentosum prospective cohort study of it feature and progression,xeroderma pigmentosum xp result from biallelic mutation in any of eight gene involved in dna repair system thus defining eight different genotype xpa xpb xpc xpd xpe xpf xpg and xp variant or xpv in addition to cutaneous and ophthalmological feature some patient present with xp neurological disease it is unknown whether the different neurological sign and their progression differ among group therefore we aim to characterize the xp neurological disease and it evolution in the heterogeneous uk xp cohort patient with xp were followed in the uk national xp service from to age of onset for different event wa recorded cerebellar ataxia and additional neurological sign and symptom were rated with the scale for the assessment and rating of ataxia sara the inventory of nonataxia sign inas and the activity of daily living questionnaire adl patient mutation received score based on their predicted effect data from available ancillary test were collected ninetythree xp patient were recruited thirtysix reported neurological symptom especially in the xpa xpd and xpg group with earlyonset and lateonset form and typically appearing after cutaneous and ophthalmological symptom xpa xpd and xpg patient showed higher sara score compared to xpc xpe and xpv sara total score significantly increased over time in xpd pointsyear confidence interval and xpa pointsyear confidence interval hyporeflexia hypopallesthaesia upper motor neuron sign chorea dystonia oculomotor sign and cognitive impairment were frequent finding in xpa xpd and xpg cerebellar and global brain atrophy axonal sensory and sensorimotor neuropathy and sensorineural hearing loss were common finding in patient some xpc xpe and xpv case presented with abnormality on examination andor ancillary test suggesting underlying neurological involvement more severe mutation were associated with a faster progression in sara total score in xpa pointsyear per unit increase in severity score and xpd pointsyear per unit increase and in adl total score in xpa pointsyear per unit increase symptomatic and asymptomatic form of neurological disease are frequent in xp patient and neurological symptom can be an important cause of disability typically the neurological disease will be preceded by cutaneous and ophthalmological feature and these should be actively searched in patient with idiopathic lateonset neurological syndrome scale assessing cerebellar function especially walking and speech and disability can show progression in some of the group mutation severity can be used a a prognostic biomarker for stratification purpose in clinical trial,Non-Cancer,1,neurological disease in xeroderma pigmentosum prospective cohort study of it feature and progression xeroderma pigmentosum xp result from biallelic mutation in any of eight gene involved in dna repair system thus defining eight different genotype xpa xpb xpc xpd xpe xpf xpg and xp variant or xpv in addition to cutaneous and ophthalmological feature some patient present with xp neurological disease it is unknown whether the different neurological sign and their progression differ among group therefore we aim to characterize the xp neurological disease and it evolution in the heterogeneous uk xp cohort patient with xp were followed in the uk national xp service from to age of onset for different event wa recorded cerebellar ataxia and additional neurological sign and symptom were rated with the scale for the assessment and rating of ataxia sara the inventory of nonataxia sign inas and the activity of daily living questionnaire adl patient mutation received score based on their predicted effect data from available ancillary test were collected ninetythree xp patient were recruited thirtysix reported neurological symptom especially in the xpa xpd and xpg group with earlyonset and lateonset form and typically appearing after cutaneous and ophthalmological symptom xpa xpd and xpg patient showed higher sara score compared to xpc xpe and xpv sara total score significantly increased over time in xpd pointsyear confidence interval and xpa pointsyear confidence interval hyporeflexia hypopallesthaesia upper motor neuron sign chorea dystonia oculomotor sign and cognitive impairment were frequent finding in xpa xpd and xpg cerebellar and global brain atrophy axonal sensory and sensorimotor neuropathy and sensorineural hearing loss were common finding in patient some xpc xpe and xpv case presented with abnormality on examination andor ancillary test suggesting underlying neurological involvement more severe mutation were associated with a faster progression in sara total score in xpa pointsyear per unit increase in severity score and xpd pointsyear per unit increase and in adl total score in xpa pointsyear per unit increase symptomatic and asymptomatic form of neurological disease are frequent in xp patient and neurological symptom can be an important cause of disability typically the neurological disease will be preceded by cutaneous and ophthalmological feature and these should be actively searched in patient with idiopathic lateonset neurological syndrome scale assessing cerebellar function especially walking and speech and disability can show progression in some of the group mutation severity can be used a a prognostic biomarker for stratification purpose in clinical trial
38041113,development of a neutralization monoclonal antibody with a broad neutralizing effect against sarscov variant,the emergence of severe acute respiratory syndrome coronavirus sarscov variant ha challenged the effectiveness of current therapeutic regimen here we aimed to develop a potent sarscov antibody with broad neutralizing effect by screening a scfv library with the spike protein receptorbinding domain rbd via phage display,Non-Cancer,1,development of a neutralization monoclonal antibody with a broad neutralizing effect against sarscov variant the emergence of severe acute respiratory syndrome coronavirus sarscov variant ha challenged the effectiveness of current therapeutic regimen here we aimed to develop a potent sarscov antibody with broad neutralizing effect by screening a scfv library with the spike protein receptorbinding domain rbd via phage display
38052076,discriminative fusion of momentsaligned latent representation of multimodality medical data,fusion of multimodal medical data provides multifaceted diseaserelevant information for diagnosis or prognosis prediction modeling traditional fusion strategy such a feature concatenation often fail to learn hidden complementary and discriminative manifestation from highdimensional multimodal data to this end we proposed a methodology for the integration of multimodality medical data by matching their moment in a latent space where the hidden shared information of multimodal data is gradually learned by optimization with multiple feature collinearity and correlation constrains we first obtained the multimodal hidden representation by learning mapping between the original domain and shared latent space within this shared space we utilized several relational regularization including data attribute preservation feature collinearity and featuretask correlation to encourage learning of the underlying association inherent in multimodal data the fused multimodal latent feature were finally fed to a logistic regression classifier for diagnostic prediction extensive evaluation on three independent clinical datasets have demonstrated the effectiveness of the proposed method in fusing multimodal data for medical prediction modelingxd,Non-Cancer,1,discriminative fusion of momentsaligned latent representation of multimodality medical data fusion of multimodal medical data provides multifaceted diseaserelevant information for diagnosis or prognosis prediction modeling traditional fusion strategy such a feature concatenation often fail to learn hidden complementary and discriminative manifestation from highdimensional multimodal data to this end we proposed a methodology for the integration of multimodality medical data by matching their moment in a latent space where the hidden shared information of multimodal data is gradually learned by optimization with multiple feature collinearity and correlation constrains we first obtained the multimodal hidden representation by learning mapping between the original domain and shared latent space within this shared space we utilized several relational regularization including data attribute preservation feature collinearity and featuretask correlation to encourage learning of the underlying association inherent in multimodal data the fused multimodal latent feature were finally fed to a logistic regression classifier for diagnostic prediction extensive evaluation on three independent clinical datasets have demonstrated the effectiveness of the proposed method in fusing multimodal data for medical prediction modelingxd
38057384,mutational spectrum and phenotypic variability of duchenne muscular dystrophy and related disorder in a bangladeshi population,duchenne muscular dystrophy dmd is a severe rare neuromuscular disorder caused by mutation in the xlinked dystrophin gene several mutation have been identified yet the full mutational spectrum and their phenotypic consequence will require genotyping across different population to this end we undertook the first detailed genotype and phenotype characterization of dmd in the bangladeshi population we investigated the rare mutational and phenotypic spectrum of the dmd gene in dmdsuspected bangladeshi participant using an economically affordable diagnostic strategy involving initial screening for exonic deletion in the dmd gene via multiplex pcr followed by testing pcrnegative patient for mutation using whole exome sequencing the deletion mapping identified two critical dmd gene hotspot region near proximal and distal end spanning exon and exon respectively that comprised of the deletion for this population cohort from our exome analysis we detected two novel pathogenic hemizygous mutation in exon and of the dmd gene and novel pathogenic recessive and loss of function variant in four additional gene sgcd dysf cola and dok our phenotypic analysis showed that dmd suspected participant presented diverse phenotype according to the location of the mutation and which gene wa impacted our study provides ethnicity specific new insight into both clinical and genetic aspect of dmd,Non-Cancer,1,mutational spectrum and phenotypic variability of duchenne muscular dystrophy and related disorder in a bangladeshi population duchenne muscular dystrophy dmd is a severe rare neuromuscular disorder caused by mutation in the xlinked dystrophin gene several mutation have been identified yet the full mutational spectrum and their phenotypic consequence will require genotyping across different population to this end we undertook the first detailed genotype and phenotype characterization of dmd in the bangladeshi population we investigated the rare mutational and phenotypic spectrum of the dmd gene in dmdsuspected bangladeshi participant using an economically affordable diagnostic strategy involving initial screening for exonic deletion in the dmd gene via multiplex pcr followed by testing pcrnegative patient for mutation using whole exome sequencing the deletion mapping identified two critical dmd gene hotspot region near proximal and distal end spanning exon and exon respectively that comprised of the deletion for this population cohort from our exome analysis we detected two novel pathogenic hemizygous mutation in exon and of the dmd gene and novel pathogenic recessive and loss of function variant in four additional gene sgcd dysf cola and dok our phenotypic analysis showed that dmd suspected participant presented diverse phenotype according to the location of the mutation and which gene wa impacted our study provides ethnicity specific new insight into both clinical and genetic aspect of dmd
38101549,sex genotype and liver volume progression a risk of hospitalization determinant in autosomal dominant polycystic liver disease,autosomal dominant polycystic liver disease is a rare condition with a female preponderance based mainly on pathogenic variant in gene prkcsh and sec clinically autosomal dominant polycystic liver disease is characterized by vast heterogeneity ranging from asymptomatic to highly symptomatic hepatomegaly to date little is known about the prediction of disease progression at early stage hindering clinical management genetic counseling and the design of randomized controlled trial to improve disease prognostication we built a consortium of european and u center to recruit the largest cohort of patient with prkcsh and sec liver disease,Non-Cancer,1,sex genotype and liver volume progression a risk of hospitalization determinant in autosomal dominant polycystic liver disease autosomal dominant polycystic liver disease is a rare condition with a female preponderance based mainly on pathogenic variant in gene prkcsh and sec clinically autosomal dominant polycystic liver disease is characterized by vast heterogeneity ranging from asymptomatic to highly symptomatic hepatomegaly to date little is known about the prediction of disease progression at early stage hindering clinical management genetic counseling and the design of randomized controlled trial to improve disease prognostication we built a consortium of european and u center to recruit the largest cohort of patient with prkcsh and sec liver disease
38103548,clingen guidance for use of the ppbs cosegregation and pp phenotype specificity criterion for sequence variant pathogenicity classification,the american college of medical genetics and genomics and the association for molecular pathology variant classification publication established a standard employed internationally to guide laboratory in variant assessment those recommendation included both pathogenic pp and benign b criterion for evaluating the inheritance pattern of variant but detail of how to apply those criterion at appropriate evidence level were sparse several publication have since attempted to provide additional guidance but anecdotally this issue is still challenging additionally it is not clear that those prior effort fully distinguished diseasegene identification consideration from variant pathogenicity consideration nor did they address autosomalrecessive and xlinked inheritance here we have taken a mixed inductive and deductive approach to this problem using real disease a example we have developed a practical heuristic for genetic cosegregation evidence and have also determined that the specific phenotype criterion pp is inseparably coupled to the cosegregation criterion we have also determined that negative evidence at one locus constitutes positive evidence for other locus for disorder with locus heterogeneity finally we provide a pointsbased system for evaluating phenotype and cosegregation a evidence type to support or refute a locus and show how that can be integrated into the bayesian framework now used for variant classification and consistent with the guideline,Non-Cancer,1,clingen guidance for use of the ppbs cosegregation and pp phenotype specificity criterion for sequence variant pathogenicity classification the american college of medical genetics and genomics and the association for molecular pathology variant classification publication established a standard employed internationally to guide laboratory in variant assessment those recommendation included both pathogenic pp and benign b criterion for evaluating the inheritance pattern of variant but detail of how to apply those criterion at appropriate evidence level were sparse several publication have since attempted to provide additional guidance but anecdotally this issue is still challenging additionally it is not clear that those prior effort fully distinguished diseasegene identification consideration from variant pathogenicity consideration nor did they address autosomalrecessive and xlinked inheritance here we have taken a mixed inductive and deductive approach to this problem using real disease a example we have developed a practical heuristic for genetic cosegregation evidence and have also determined that the specific phenotype criterion pp is inseparably coupled to the cosegregation criterion we have also determined that negative evidence at one locus constitutes positive evidence for other locus for disorder with locus heterogeneity finally we provide a pointsbased system for evaluating phenotype and cosegregation a evidence type to support or refute a locus and show how that can be integrated into the bayesian framework now used for variant classification and consistent with the guideline
38168382,unravelling the complexity of dnapk activation by structurebased mutagenesis,it ha been known for decade that the dnadependent protein kinase dnapk is only an active serinethreonine protein kinase when it is bound to a dna doublestranded end still the molecular detail of how this activation is achieved have remained elusive the recent surge in structural information for dnapk complex ha provided valuable insight into the process of dna end recognition by dnapk a particularly intriguing feature of this kinase is a region of the protein that can transition from a seemingly structurally disordered state to a single alphahelix that traverse down the dna binding cradle the dnapk bound dna end of the dna substrate engages with and appears to split around this helix which ha been named the dna end blocking helix deb here a mutational approach is utilized to clarify the role of the deb and how dna end activate the enzyme our data suggest two distinct method of kinase activation that is dependent on the dna end chemistry if the dna end can split around the helix and stabilize the interaction between the dna end and the deb with a recently defined helixhairpinhelix hhh motif the kinase form an endprotection monomer that is active towards dnapks many substrate but if the dna end can not stably interact with the deb because of the dna end structure for instance hairpin or because the deb ha been disrupted by mutation the kinase is only partially activated resulting in specific autophosphorylations of the dnapk monomer that allows nucleolytic endprocessing we posit that mutant that disrupt the capacity to stably generate the debhhh dna endinteraction are inefficient in generating the dimer complex that is requisite for nhej in support of this idea mutation that promote formation of this dimer partially rescue the severe cellular phenotype associated with mutation of the deb helix,Non-Cancer,1,unravelling the complexity of dnapk activation by structurebased mutagenesis it ha been known for decade that the dnadependent protein kinase dnapk is only an active serinethreonine protein kinase when it is bound to a dna doublestranded end still the molecular detail of how this activation is achieved have remained elusive the recent surge in structural information for dnapk complex ha provided valuable insight into the process of dna end recognition by dnapk a particularly intriguing feature of this kinase is a region of the protein that can transition from a seemingly structurally disordered state to a single alphahelix that traverse down the dna binding cradle the dnapk bound dna end of the dna substrate engages with and appears to split around this helix which ha been named the dna end blocking helix deb here a mutational approach is utilized to clarify the role of the deb and how dna end activate the enzyme our data suggest two distinct method of kinase activation that is dependent on the dna end chemistry if the dna end can split around the helix and stabilize the interaction between the dna end and the deb with a recently defined helixhairpinhelix hhh motif the kinase form an endprotection monomer that is active towards dnapks many substrate but if the dna end can not stably interact with the deb because of the dna end structure for instance hairpin or because the deb ha been disrupted by mutation the kinase is only partially activated resulting in specific autophosphorylations of the dnapk monomer that allows nucleolytic endprocessing we posit that mutant that disrupt the capacity to stably generate the debhhh dna endinteraction are inefficient in generating the dimer complex that is requisite for nhej in support of this idea mutation that promote formation of this dimer partially rescue the severe cellular phenotype associated with mutation of the deb helix
38181108,treatment and outcome of unicameral bone cyst a systematic review and metaanalysis, unicameral bone cyst ubcs can increase the risk of pathologic fracture of both long and short bone although multiple treatment exist data are conflicting regarding optimal management  we sought to analyze treatment strategy for ubcs and their rate of successful treatment  success rate were analyzed according to treatment modality with emphasis on filling technique andor decompression associated with curettage and injection compound  curettage with bone substitute and cyst decompression wa identified a a highly successful technique for ubc treatment  decompressing the cyst wall after injection regardless of the specific compound used had a greater potential to enhance healing rate  the management decision should be individually guided within the patient context,Non-Cancer,1,treatment and outcome of unicameral bone cyst a systematic review and metaanalysis  unicameral bone cyst ubcs can increase the risk of pathologic fracture of both long and short bone although multiple treatment exist data are conflicting regarding optimal management  we sought to analyze treatment strategy for ubcs and their rate of successful treatment  success rate were analyzed according to treatment modality with emphasis on filling technique andor decompression associated with curettage and injection compound  curettage with bone substitute and cyst decompression wa identified a a highly successful technique for ubc treatment  decompressing the cyst wall after injection regardless of the specific compound used had a greater potential to enhance healing rate  the management decision should be individually guided within the patient context
38182630,biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis aattrv,early identification of attrv amyloidosis disease onset is still often delayed due to the lack of validated biomarkers of this disease light chain neurofilament nfl have shown promising result in early diagnosis in this disease but data is still needed including with alternative measuring method our aim wa to study the level of nfl measured by elisa furthermore interstitial matrix metalloproteinase type mmp serum level were measured a a potential new biomarker in attrv serum nfl and mmp were measured using elisa assay in participant attrvm patient asymptomatic vmttr variant carrier and healthy control median nfl level among attrv amyloidosis patient were significantly higher pgml v pgml in both comparison group the auc comparing attrv amyloidosis patient and asymptomatic carrier wa and the nfl concentration of pgml yielded a sensitivity of and a specificity of nfl level had a significant positive correlation with ni value among patient we found a negative significant correlation between egfr and nfl level finally mmp level were not different between group evidence of nfl use for early diagnosis of attrpn amyloidosis is growing elisa seems a reliable and available technique for it quantification decreased gfr could influence nfl plasma level,Non-Cancer,1,biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis aattrv early identification of attrv amyloidosis disease onset is still often delayed due to the lack of validated biomarkers of this disease light chain neurofilament nfl have shown promising result in early diagnosis in this disease but data is still needed including with alternative measuring method our aim wa to study the level of nfl measured by elisa furthermore interstitial matrix metalloproteinase type mmp serum level were measured a a potential new biomarker in attrv serum nfl and mmp were measured using elisa assay in participant attrvm patient asymptomatic vmttr variant carrier and healthy control median nfl level among attrv amyloidosis patient were significantly higher pgml v pgml in both comparison group the auc comparing attrv amyloidosis patient and asymptomatic carrier wa and the nfl concentration of pgml yielded a sensitivity of and a specificity of nfl level had a significant positive correlation with ni value among patient we found a negative significant correlation between egfr and nfl level finally mmp level were not different between group evidence of nfl use for early diagnosis of attrpn amyloidosis is growing elisa seems a reliable and available technique for it quantification decreased gfr could influence nfl plasma level
38186869,dkk a a potential novel biomarker in patient with autosomal polycystic kidney disease,autosomal dominant polycystic kidney disease adpkd is the most common inherited kidney disease and lead to a steady loss of kidney function in adulthood the variable course of the disease make it necessary to identify the patient with rapid disease progression who will benefit the most from targeted therapy and intervention currently magnetic resonance imagingbased volumetry of the kidney is the most commonly used tool for this purpose biomarkers that can be easily and quantitatively determined which allow a prediction of the loss of kidney function have not yet been established in clinical practice the glycoprotein dickkopf dkk which is secreted in the renal tubular epithelium upon stress and contributes to tubulointerstitial fibrosis via the wnt signaling pathway wa recently described a a biomarker for estimating risk of kidney function loss but ha not been investigated for adpkd this study aimed to obtain a first insight into whether dkk may indeed improve outcome prediction in adpkd in the future,Non-Cancer,1,dkk a a potential novel biomarker in patient with autosomal polycystic kidney disease autosomal dominant polycystic kidney disease adpkd is the most common inherited kidney disease and lead to a steady loss of kidney function in adulthood the variable course of the disease make it necessary to identify the patient with rapid disease progression who will benefit the most from targeted therapy and intervention currently magnetic resonance imagingbased volumetry of the kidney is the most commonly used tool for this purpose biomarkers that can be easily and quantitatively determined which allow a prediction of the loss of kidney function have not yet been established in clinical practice the glycoprotein dickkopf dkk which is secreted in the renal tubular epithelium upon stress and contributes to tubulointerstitial fibrosis via the wnt signaling pathway wa recently described a a biomarker for estimating risk of kidney function loss but ha not been investigated for adpkd this study aimed to obtain a first insight into whether dkk may indeed improve outcome prediction in adpkd in the future
38189053,causal association of immune cell and polycystic ovarian syndrome a mendelian randomization study,polycystic ovarian syndrome pcos is a common reproductive disorder that affect a considerable number of woman worldwide it is accompanied by irregular menstruation hyperandrogenism metabolic abnormality reproductive disorder and other clinical symptom which seriously endangers womens physical and mental health the etiology and pathogenesis of pcos are not completely clear but it is hypothesized that immune system may play a key role in it however previous study investigating the connection between immune cell and pcos have produced conflicting result,Non-Cancer,1,causal association of immune cell and polycystic ovarian syndrome a mendelian randomization study polycystic ovarian syndrome pcos is a common reproductive disorder that affect a considerable number of woman worldwide it is accompanied by irregular menstruation hyperandrogenism metabolic abnormality reproductive disorder and other clinical symptom which seriously endangers womens physical and mental health the etiology and pathogenesis of pcos are not completely clear but it is hypothesized that immune system may play a key role in it however previous study investigating the connection between immune cell and pcos have produced conflicting result
38193064,vaccineinduced immune thrombotic thrombocytopenia post covid booster vaccination in brazil a case series,the emergence of new variant of sarscov ha led to the administration of different booster vaccine to mitigate covid vaccine with adenoviral vector have been rarely associated with vaccineinduced immune thrombotic thrombocytopenia vitt,Non-Cancer,1,vaccineinduced immune thrombotic thrombocytopenia post covid booster vaccination in brazil a case series the emergence of new variant of sarscov ha led to the administration of different booster vaccine to mitigate covid vaccine with adenoviral vector have been rarely associated with vaccineinduced immune thrombotic thrombocytopenia vitt
38211722,detection of constitutional structural variant by optical genome mapping a multisite study of postnatal sample,optical genome mapping is a high resolution technology that can detect all type of structural variation in the genome this second phase of a multisite study compare the performance of optical genome mapping and current standard of care method for diagnostic testing of individual with constitutional disorder including neurodevelopmental impairment and congenital anomaly among the analysis in phase were of retrospective sample supplied by five diagnostic center in the united state and were prospective sample collected over month by two diagnostic center june october additional sample represented a family cohort to determine inheritance n and control n full concordance of result between optical genome mapping and one or more standard of care diagnostic test wa with partial concordance in an additional,Non-Cancer,1,detection of constitutional structural variant by optical genome mapping a multisite study of postnatal sample optical genome mapping is a high resolution technology that can detect all type of structural variation in the genome this second phase of a multisite study compare the performance of optical genome mapping and current standard of care method for diagnostic testing of individual with constitutional disorder including neurodevelopmental impairment and congenital anomaly among the analysis in phase were of retrospective sample supplied by five diagnostic center in the united state and were prospective sample collected over month by two diagnostic center june october additional sample represented a family cohort to determine inheritance n and control n full concordance of result between optical genome mapping and one or more standard of care diagnostic test wa with partial concordance in an additional
38243854,prior male sling doe not affect outcome of artificial urinary sphincter,to investigate the outcome of artificial urinary sphincter au placement in patient with postprostatectomy urinary incontinence ppui with or without a prior male sling,Non-Cancer,1,prior male sling doe not affect outcome of artificial urinary sphincter to investigate the outcome of artificial urinary sphincter au placement in patient with postprostatectomy urinary incontinence ppui with or without a prior male sling
38265426,identification of a complex intrachromosomal inverted insertion in the long arm of chromosome a a cause of tuberous sclerosis complex in a korean family,tuberous sclerosis complex tsc is an autosomal dominant multisystem disorder caused by a lossoffunction of either tsc or tsc gene however in tsc patient there is no pathogenic variant identified in either tsc or tsc gene based on standard clinical testing,Non-Cancer,1,identification of a complex intrachromosomal inverted insertion in the long arm of chromosome a a cause of tuberous sclerosis complex in a korean family tuberous sclerosis complex tsc is an autosomal dominant multisystem disorder caused by a lossoffunction of either tsc or tsc gene however in tsc patient there is no pathogenic variant identified in either tsc or tsc gene based on standard clinical testing
38281420,automatic detection of myocardial ischaemia using generalisable spatiotemporal hierarchical bayesian modelling of dcemri,dynamic contrast enhanced magnetic resonance imaging dcemri can be used a a noninvasive method for the assessment of myocardial perfusion the acquired image can be utilised to analyse the spatial extent and severity of myocardial ischaemia region with impaired microvascular blood flow in the present paper we propose a novel generalisable spatiotemporal hierarchical bayesian model gsthbm to automate the detection of ischaemic lesion and improve the in silico prediction accuracy by systematically integrating spatiotemporal context information we present a computational inference procedure with an adequate tradeoff between accuracy and computational efficiency whereby model parameter are sampled from the posterior distribution with gibbs sampling while lowerlevel hyperparameters are selected using model selection strategy based on the watanabe akaike information criterion waic we have assessed our method on both synthetic in silico data with known goldstandard and set of clinical firstpass myocardial perfusion dcemri datasets we have also carried out a comparative performance evaluation with four established alternative method gaussian mixture model gmm opening and closing operation based on gaussian mixture model gmmcomax markov random field constrained gaussian mixture model gmmmrf and modelbased hierarchical bayesian model mhbm our result show that the proposed gsthbm method achieves much higher in silico prediction accuracy than the established alternative method furthermore this method appears to provide a more robust delineation of ischaemic lesion in datasets affected by spatially variant noise,Non-Cancer,1,automatic detection of myocardial ischaemia using generalisable spatiotemporal hierarchical bayesian modelling of dcemri dynamic contrast enhanced magnetic resonance imaging dcemri can be used a a noninvasive method for the assessment of myocardial perfusion the acquired image can be utilised to analyse the spatial extent and severity of myocardial ischaemia region with impaired microvascular blood flow in the present paper we propose a novel generalisable spatiotemporal hierarchical bayesian model gsthbm to automate the detection of ischaemic lesion and improve the in silico prediction accuracy by systematically integrating spatiotemporal context information we present a computational inference procedure with an adequate tradeoff between accuracy and computational efficiency whereby model parameter are sampled from the posterior distribution with gibbs sampling while lowerlevel hyperparameters are selected using model selection strategy based on the watanabe akaike information criterion waic we have assessed our method on both synthetic in silico data with known goldstandard and set of clinical firstpass myocardial perfusion dcemri datasets we have also carried out a comparative performance evaluation with four established alternative method gaussian mixture model gmm opening and closing operation based on gaussian mixture model gmmcomax markov random field constrained gaussian mixture model gmmmrf and modelbased hierarchical bayesian model mhbm our result show that the proposed gsthbm method achieves much higher in silico prediction accuracy than the established alternative method furthermore this method appears to provide a more robust delineation of ischaemic lesion in datasets affected by spatially variant noise
38324982,targeted macrophage phagocytosis by irgitaconate axis improves the prognosis of intracerebral hemorrhagic stroke and peritonitis,macrophage are innate immune cell whose phagocytosis function is critical to the prognosis of stroke and peritonitis cisaconitic decarboxylase immuneresponsive gene irg and it metabolic product itaconate inhibit bacterial infection intracellular viral replication and inflammation in macrophage here we explore whether itaconate regulates phagocytosis,Non-Cancer,1,targeted macrophage phagocytosis by irgitaconate axis improves the prognosis of intracerebral hemorrhagic stroke and peritonitis macrophage are innate immune cell whose phagocytosis function is critical to the prognosis of stroke and peritonitis cisaconitic decarboxylase immuneresponsive gene irg and it metabolic product itaconate inhibit bacterial infection intracellular viral replication and inflammation in macrophage here we explore whether itaconate regulates phagocytosis
38326571,genomewide association study identifies human genetic variant associated with fatal outcome from lassa fever,infection with lassa virus lasv can cause lassa fever a haemorrhagic illness with an estimated fatality rate of but cause no or mild symptom in many individual here to investigate whether human genetic variation underlies the heterogeneity of lasv infection we carried out genomewide association study gwas a well a seroprevalence survey human leukocyte antigen typing and highthroughput variant functional characterization assay we analysed lassa fever susceptibility and fatal outcome in case of lassa fever and population control recruited over a year period in nigeria and sierra leone we detected genomewide significant variant association with lassa fever fatal outcome near grm and lif in the nigerian cohort we also show that a haplotype bearing signature of positive selection and overlapping large a required lasv entry factor is associated with decreased risk of lassa fever in the nigerian cohort but not in the sierra leone cohort overall we identified variant and gene that may impact the risk of severe lassa fever demonstrating how gwas can provide insight into viral pathogenesis,Non-Cancer,1,genomewide association study identifies human genetic variant associated with fatal outcome from lassa fever infection with lassa virus lasv can cause lassa fever a haemorrhagic illness with an estimated fatality rate of but cause no or mild symptom in many individual here to investigate whether human genetic variation underlies the heterogeneity of lasv infection we carried out genomewide association study gwas a well a seroprevalence survey human leukocyte antigen typing and highthroughput variant functional characterization assay we analysed lassa fever susceptibility and fatal outcome in case of lassa fever and population control recruited over a year period in nigeria and sierra leone we detected genomewide significant variant association with lassa fever fatal outcome near grm and lif in the nigerian cohort we also show that a haplotype bearing signature of positive selection and overlapping large a required lasv entry factor is associated with decreased risk of lassa fever in the nigerian cohort but not in the sierra leone cohort overall we identified variant and gene that may impact the risk of severe lassa fever demonstrating how gwas can provide insight into viral pathogenesis
38341624,the adaptability of the pulsta valve to the diverse main pulmonary artery shape of native right ventricular outflow tract disease,pulsta valve is increasingly used for percutaneous pulmonary valve implantation ppvi in patient with a large native right ventricular outflow tract rvot this study aim to elucidate the outcome of pulsta valve implantation within the native rvot and assess it adaptability to various native main pulmonary artery pa anatomy,Non-Cancer,1,the adaptability of the pulsta valve to the diverse main pulmonary artery shape of native right ventricular outflow tract disease pulsta valve is increasingly used for percutaneous pulmonary valve implantation ppvi in patient with a large native right ventricular outflow tract rvot this study aim to elucidate the outcome of pulsta valve implantation within the native rvot and assess it adaptability to various native main pulmonary artery pa anatomy
38345107,similarity and difference of interstitial lung disease associated with pathogenic variant in sftpc and abca in adult,variant in surfactant gene sftpc or abca are responsible for interstitial lung disease ild in child and adult with few study in adult,Non-Cancer,1,similarity and difference of interstitial lung disease associated with pathogenic variant in sftpc and abca in adult variant in surfactant gene sftpc or abca are responsible for interstitial lung disease ild in child and adult with few study in adult
38352583,a unifying model to explain high nirmatrelvir therapeutic efficacy against sarscov despite low postexposure prophylaxis efficacy and frequent viral rebound,in a pivotal trial epichr a day course of oral ritonavirboosted nirmatrelvir given early during symptomatic sarscov infection within three day of symptom onset decreased hospitalization and death by and nasal viral load by log relative to placebo in highrisk individual yet nirmatrelvirritonavir failed a postexposure prophylaxis in a trial and frequent viral rebound ha been observed in subsequent cohort we developed a mathematical model capturing viralimmune dynamic and nirmatrelvir pharmacokinetics that recapitulated viral load from this and another clinical trial platcov our result suggest that nirmatrelvirs in vivo potency is significantly lower than in vitro assay predict according to our model a maximally potent agent would reduce the viral load by approximately log relative to placebo at day the model identifies that earlier initiation and shorter treatment duration are key predictor of posttreatment rebound extension of treatment to day for omicron variant infection in vaccinated individual rather than increasing dose or dosing frequency is predicted to lower the incidence of viral rebound significantly,Non-Cancer,1,a unifying model to explain high nirmatrelvir therapeutic efficacy against sarscov despite low postexposure prophylaxis efficacy and frequent viral rebound in a pivotal trial epichr a day course of oral ritonavirboosted nirmatrelvir given early during symptomatic sarscov infection within three day of symptom onset decreased hospitalization and death by and nasal viral load by log relative to placebo in highrisk individual yet nirmatrelvirritonavir failed a postexposure prophylaxis in a trial and frequent viral rebound ha been observed in subsequent cohort we developed a mathematical model capturing viralimmune dynamic and nirmatrelvir pharmacokinetics that recapitulated viral load from this and another clinical trial platcov our result suggest that nirmatrelvirs in vivo potency is significantly lower than in vitro assay predict according to our model a maximally potent agent would reduce the viral load by approximately log relative to placebo at day the model identifies that earlier initiation and shorter treatment duration are key predictor of posttreatment rebound extension of treatment to day for omicron variant infection in vaccinated individual rather than increasing dose or dosing frequency is predicted to lower the incidence of viral rebound significantly
38416462,novel polygenic risk score and established clinical risk factor for risk estimation of aortic stenosis,polygenic risk score prss have proven to be a strong a or stronger than established clinical risk factor for many cardiovascular phenotype whether this is true for aortic stenosis remains unknown,Non-Cancer,1,novel polygenic risk score and established clinical risk factor for risk estimation of aortic stenosis polygenic risk score prss have proven to be a strong a or stronger than established clinical risk factor for many cardiovascular phenotype whether this is true for aortic stenosis remains unknown
38418145,contribution of matrix metalloproteinase genotype to taiwan pterygium risk,in the literature the study about the role of matrix metalloproteinase mmp in pterygium diagnosis are mainly based on it protein expression the role of mmp variant ha never been examined the aim of this study wa to examine the association of mmp genotype with pterygium risk,Non-Cancer,1,contribution of matrix metalloproteinase genotype to taiwan pterygium risk in the literature the study about the role of matrix metalloproteinase mmp in pterygium diagnosis are mainly based on it protein expression the role of mmp variant ha never been examined the aim of this study wa to examine the association of mmp genotype with pterygium risk
38418684,cold snare polypectomy with or without submucosal injection for endoscopic resection of colorectal polyp a metaanalysis of randomized controlled trial,the impact of submucosal injection during cold snare polypectomy csp remains uncertain we conducted an evidencebased comparison of conventional csp ccsp and csp with submucosal injection sicsp for colorectal polyp resection,Non-Cancer,1,cold snare polypectomy with or without submucosal injection for endoscopic resection of colorectal polyp a metaanalysis of randomized controlled trial the impact of submucosal injection during cold snare polypectomy csp remains uncertain we conducted an evidencebased comparison of conventional csp ccsp and csp with submucosal injection sicsp for colorectal polyp resection
38429495,digenic inheritance involving a musclespecific protein kinase and the giant titin protein cause a skeletal muscle myopathy,in digenic inheritance pathogenic variant in two gene must be inherited together to cause disease only very few example of digenic inheritance have been described in the neuromuscular disease field here we show that predicted deleterious variant in srpk encoding the xlinked serineargenine protein kinase lead to a progressive early onset skeletal muscle myopathy only when in combination with heterozygous variant in the ttn gene the cooccurrence of predicted deleterious srpkttn variant wa not seen among healthy male individual and statistical modeling strongly supported digenic inheritance a the bestfitting model furthermore doublemutant zebrafish srpk ttn replicated the myopathic phenotype and showed myofibrillar disorganization transcriptome data suggest that the interaction of srpk and ttn in zebrafish occurs at a posttranscriptional level we propose that digenic inheritance of deleterious change impacting both the protein kinase srpk and the giant muscle protein titin cause a skeletal myopathy and might serve a a model for other genetic disease,Non-Cancer,1,digenic inheritance involving a musclespecific protein kinase and the giant titin protein cause a skeletal muscle myopathy in digenic inheritance pathogenic variant in two gene must be inherited together to cause disease only very few example of digenic inheritance have been described in the neuromuscular disease field here we show that predicted deleterious variant in srpk encoding the xlinked serineargenine protein kinase lead to a progressive early onset skeletal muscle myopathy only when in combination with heterozygous variant in the ttn gene the cooccurrence of predicted deleterious srpkttn variant wa not seen among healthy male individual and statistical modeling strongly supported digenic inheritance a the bestfitting model furthermore doublemutant zebrafish srpk ttn replicated the myopathic phenotype and showed myofibrillar disorganization transcriptome data suggest that the interaction of srpk and ttn in zebrafish occurs at a posttranscriptional level we propose that digenic inheritance of deleterious change impacting both the protein kinase srpk and the giant muscle protein titin cause a skeletal myopathy and might serve a a model for other genetic disease
38432242,haemoglobin threshold to define anaemia from age month to year estimate from international data source,detection of anaemia is crucial for clinical medicine and public health current who anaemia definition are based on statistical threshold fifth centile set more than year ago we sought to establish evidence for the statistical haemoglobin threshold for anaemia that can be applied globally and inform who and clinical guideline,Non-Cancer,1,haemoglobin threshold to define anaemia from age month to year estimate from international data source detection of anaemia is crucial for clinical medicine and public health current who anaemia definition are based on statistical threshold fifth centile set more than year ago we sought to establish evidence for the statistical haemoglobin threshold for anaemia that can be applied globally and inform who and clinical guideline
38438086,microrna attenuates secondary brain injury following experimental intracerebral hemorrhage via inhibition of nlrp,the pathophysiological mechanism underlying brain injury resulting from intracerebral hemorrhage ich remain incompletely elucidated and efficacious therapeutic intervention to enhance the prognosis of ich patient are currently lacking previous research indicates that microrna mir can suppress the expression of nodlike receptor protein nlrp thereby modulating neuroinflammation in parkinson disease pathogenesis however the potential regulatory effect mir on nlrp inflammasome after ich are yet to be established this study aim to ascertain whether mir mitigates secondary brain injury following experimental ich by inhibiting nlrp and to investigate the underlying mechanism,Non-Cancer,1,microrna attenuates secondary brain injury following experimental intracerebral hemorrhage via inhibition of nlrp the pathophysiological mechanism underlying brain injury resulting from intracerebral hemorrhage ich remain incompletely elucidated and efficacious therapeutic intervention to enhance the prognosis of ich patient are currently lacking previous research indicates that microrna mir can suppress the expression of nodlike receptor protein nlrp thereby modulating neuroinflammation in parkinson disease pathogenesis however the potential regulatory effect mir on nlrp inflammasome after ich are yet to be established this study aim to ascertain whether mir mitigates secondary brain injury following experimental ich by inhibiting nlrp and to investigate the underlying mechanism
38441724,assessment of autophagy in leishmania parasite,leishmaniasis is a neglected tropical disease caused by numerous specie of leishmania parasite including leishmania major the parasite is transmitted by several specie of sandfly vector and infects myeloid cell leading to a myriad of inflammatory response immune dysregulations and disease manifestation every cell undergoes autophagy a selfregulated degradative process that permit the cell to recycle damaged or wornout organelle in order to maintain cellular health and homeostasis study have shown that leishmania modulates their host cell autophagic machinery and there are indication that the parasitespecific autophagic process may be valuable for parasite virulence and survival however the role of autophagy in leishmania is inconclusive because of the limited tool available to study the leishmaniaspecific autophagic machinery here we describe method to study and definitively confirm autophagy in leishmania major transmission electron microscopy tem allowed u to visualize leishmania autophagosomes especially those containing damaged mitochondrial content a well a dividing mitochondrion with ongoing fusionfission process flow cytometry enabled u to identify the amount of acridine orange dye accumulating in the acidic vacuolar compartment in leishmania major by detecting fluorescence in the red laser when autophagic inhibitor or enhancer were included these method will advance study that aim to understand autophagic regulation in leishmania parasite that could provide insight into developing improved therapeutic target against leishmaniasis,Non-Cancer,1,assessment of autophagy in leishmania parasite leishmaniasis is a neglected tropical disease caused by numerous specie of leishmania parasite including leishmania major the parasite is transmitted by several specie of sandfly vector and infects myeloid cell leading to a myriad of inflammatory response immune dysregulations and disease manifestation every cell undergoes autophagy a selfregulated degradative process that permit the cell to recycle damaged or wornout organelle in order to maintain cellular health and homeostasis study have shown that leishmania modulates their host cell autophagic machinery and there are indication that the parasitespecific autophagic process may be valuable for parasite virulence and survival however the role of autophagy in leishmania is inconclusive because of the limited tool available to study the leishmaniaspecific autophagic machinery here we describe method to study and definitively confirm autophagy in leishmania major transmission electron microscopy tem allowed u to visualize leishmania autophagosomes especially those containing damaged mitochondrial content a well a dividing mitochondrion with ongoing fusionfission process flow cytometry enabled u to identify the amount of acridine orange dye accumulating in the acidic vacuolar compartment in leishmania major by detecting fluorescence in the red laser when autophagic inhibitor or enhancer were included these method will advance study that aim to understand autophagic regulation in leishmania parasite that could provide insight into developing improved therapeutic target against leishmaniasis
38463005,impaired polyamine metabolism cause behavioral and neuroanatomical defect in a mouse model of snyderrobinson syndrome,snyderrobinson syndrome sr is a rare xlinked recessive disorder caused by a mutation in the sm gene which encodes spermine synthase and aberrant polyamine metabolism sr is characterized by intellectual disability thin habitus seizure low muscle tonehypotonia and osteoporosis progress towards understanding and treating sr requires a model that recapitulates human gene variant and disease presentation here we evaluated molecular and neurological presentation in the g mouse model which carry a missense mutation in the sm gene the lack of sm protein in the g mouse resulted in increased spermidinespermine ratio failure to thrive short stature and reduced bone density they showed impaired learning capacity increased anxiety reduced mobility and heightened fear response accompanied by reduced total and regional brain volume furthermore impaired mitochondrial oxidative phosphorylation wa evident in g cerebral cortex g fibroblast and smsnull hippocampal cell indicating that sm may serve a a future therapeutic target collectively our study establishes the suitability of the g mouse a a preclinical model for sr and provides a set of molecular and functional outcome measure that can be used to evaluate therapeutic intervention for sr,Non-Cancer,1,impaired polyamine metabolism cause behavioral and neuroanatomical defect in a mouse model of snyderrobinson syndrome snyderrobinson syndrome sr is a rare xlinked recessive disorder caused by a mutation in the sm gene which encodes spermine synthase and aberrant polyamine metabolism sr is characterized by intellectual disability thin habitus seizure low muscle tonehypotonia and osteoporosis progress towards understanding and treating sr requires a model that recapitulates human gene variant and disease presentation here we evaluated molecular and neurological presentation in the g mouse model which carry a missense mutation in the sm gene the lack of sm protein in the g mouse resulted in increased spermidinespermine ratio failure to thrive short stature and reduced bone density they showed impaired learning capacity increased anxiety reduced mobility and heightened fear response accompanied by reduced total and regional brain volume furthermore impaired mitochondrial oxidative phosphorylation wa evident in g cerebral cortex g fibroblast and smsnull hippocampal cell indicating that sm may serve a a future therapeutic target collectively our study establishes the suitability of the g mouse a a preclinical model for sr and provides a set of molecular and functional outcome measure that can be used to evaluate therapeutic intervention for sr
38480682,biallelic naa variant with impaired nterminal acetylation capacity cause autosomal recessive primary familial brain calcification,primary familial brain calcification pfbc is characterized by calcium deposition in the brain causing progressive movement disorder psychiatric symptom and cognitive decline pfbc is a heterogeneous disorder currently linked to variant in six different gene but most patient remain genetically undiagnosed here we identify biallelic naa variant in ten individual from seven family with autosomal recessive pfbc the naa variant lead to lossoffunction with lack of protein nterminal ntacetylation activity we show that the phosphate importer slca is a substrate of naa in vitro in cell loss of naa caused reduced surface level of slca and a reduction in extracellular phosphate uptake this study establishes naa a a causal gene for pfbc provides a possible biochemical explanation of it diseasecausing mechanism and underscore naamediated ntacetylation of transmembrane protein a a fundamental process for healthy neurobiological functioning,Non-Cancer,1,biallelic naa variant with impaired nterminal acetylation capacity cause autosomal recessive primary familial brain calcification primary familial brain calcification pfbc is characterized by calcium deposition in the brain causing progressive movement disorder psychiatric symptom and cognitive decline pfbc is a heterogeneous disorder currently linked to variant in six different gene but most patient remain genetically undiagnosed here we identify biallelic naa variant in ten individual from seven family with autosomal recessive pfbc the naa variant lead to lossoffunction with lack of protein nterminal ntacetylation activity we show that the phosphate importer slca is a substrate of naa in vitro in cell loss of naa caused reduced surface level of slca and a reduction in extracellular phosphate uptake this study establishes naa a a causal gene for pfbc provides a possible biochemical explanation of it diseasecausing mechanism and underscore naamediated ntacetylation of transmembrane protein a a fundamental process for healthy neurobiological functioning
38496508,deep sequencing of proteotoxicity modifier gene uncovers a presenilinbetaamyloidactin genetic risk module shared among alphasynucleinopathies,whether neurodegenerative disease linked to misfolding of the same protein share genetic risk driver or whether different proteinaggregation pathology in neurodegeneration are mechanistically related remains uncertain conventional genetic analysis are underpowered to address these question through careful selection of patient based on protein aggregation phenotype rather than clinical diagnosis we can increase statistical power to detect associated variant in a targeted set of gene that modify proteotoxicities genetic modifier of alphasynuclein s and betaamyloid a cytotoxicity in yeast are enriched in risk factor for parkinson disease pd and alzheimers disease ad respectively here along with known adpd risk gene we deeply sequenced exomes of sa modifier gene in patient across alphasynucleinopathies pd lewy body dementia and multiple system atrophy beyond known pd gene gba and lrrk rare variant ad gene cd cr and psen and a toxicity modifier involved in rhoaactin cytoskeleton regulation arghef arhgef mical pask pkn psen were shared risk factor across synucleinopathies actin pathology occurred in ipsc synucleinopathy model and rhoa downregulation exacerbated s pathology even in sporadic pd the expression of these gene wa altered across cns cell type genomewide crispr screen revealed the essentiality of psen in both human cortical and dopaminergic neuron and psen mutation carrier exhibited diffuse brainstem and cortical synucleinopathy independent of ad pathology psen contributes to a commonrisk signal in pd gwas and regulates s expression in neuron our result identify convergent mechanism across synucleinopathies some shared with ad,Non-Cancer,1,deep sequencing of proteotoxicity modifier gene uncovers a presenilinbetaamyloidactin genetic risk module shared among alphasynucleinopathies whether neurodegenerative disease linked to misfolding of the same protein share genetic risk driver or whether different proteinaggregation pathology in neurodegeneration are mechanistically related remains uncertain conventional genetic analysis are underpowered to address these question through careful selection of patient based on protein aggregation phenotype rather than clinical diagnosis we can increase statistical power to detect associated variant in a targeted set of gene that modify proteotoxicities genetic modifier of alphasynuclein s and betaamyloid a cytotoxicity in yeast are enriched in risk factor for parkinson disease pd and alzheimers disease ad respectively here along with known adpd risk gene we deeply sequenced exomes of sa modifier gene in patient across alphasynucleinopathies pd lewy body dementia and multiple system atrophy beyond known pd gene gba and lrrk rare variant ad gene cd cr and psen and a toxicity modifier involved in rhoaactin cytoskeleton regulation arghef arhgef mical pask pkn psen were shared risk factor across synucleinopathies actin pathology occurred in ipsc synucleinopathy model and rhoa downregulation exacerbated s pathology even in sporadic pd the expression of these gene wa altered across cns cell type genomewide crispr screen revealed the essentiality of psen in both human cortical and dopaminergic neuron and psen mutation carrier exhibited diffuse brainstem and cortical synucleinopathy independent of ad pathology psen contributes to a commonrisk signal in pd gwas and regulates s expression in neuron our result identify convergent mechanism across synucleinopathies some shared with ad
38500996,comparison of rtpcr and antigen test sensitivity across nasopharyngeal naris and oropharyngeal swab and saliva sample type during the sarscov omicron variant,limited data highlight the need to understand difference in sarscov omicron b variant viral load between the gold standard nasopharyngeal np swab midturbinate mtanterior nasal swab oropharyngeal op swab and saliva mt op and saliva sample from symptomatic individual in atlanta ga in january and longitudinal sample from a small familial cohort were tested by both rtpcr and ultrasensitive antigen assay higher concentration in the naris were observed in the familial cohort but a dominant sample type wa not found among case in the crosssectional cohort the composite of positive mt or op assay for both rtpcr and antigen assay trended toward higher diagnostic yield but did not achieve significant difference our data did not identify a singular preferred sample type for sarscov testing but higher level of saliva nucleocapsid a trend toward higher yield of composite opmt result and association of apparent mt or op predominance with symptom warrant further study,Non-Cancer,1,comparison of rtpcr and antigen test sensitivity across nasopharyngeal naris and oropharyngeal swab and saliva sample type during the sarscov omicron variant limited data highlight the need to understand difference in sarscov omicron b variant viral load between the gold standard nasopharyngeal np swab midturbinate mtanterior nasal swab oropharyngeal op swab and saliva mt op and saliva sample from symptomatic individual in atlanta ga in january and longitudinal sample from a small familial cohort were tested by both rtpcr and ultrasensitive antigen assay higher concentration in the naris were observed in the familial cohort but a dominant sample type wa not found among case in the crosssectional cohort the composite of positive mt or op assay for both rtpcr and antigen assay trended toward higher diagnostic yield but did not achieve significant difference our data did not identify a singular preferred sample type for sarscov testing but higher level of saliva nucleocapsid a trend toward higher yield of composite opmt result and association of apparent mt or op predominance with symptom warrant further study
38501195,rapid measurement of hemoglobinoxygen dissociation by leveraging bohr effect and soret band bathochromic shift,oxygen o bind to hemoglobin hb in the lung and is then released dissociated in the tissue the bohr effect is a physiological mechanism that governs the affinity of hb for o based on ph where a lower ph result in a lower hbo affinity and higher hbo dissociation hbo affinity and dissociation are crucial for maintaining aerobic metabolism in cell and tissue despite it vital role in human physiology hbo dissociation measurement is underutilized in basic research and in clinical laboratory primarily due to the technical complexity and limited throughput of existing method we present a rapid hbo dissociation measurement approach by leveraging the bohr effect and detecting the optical shift in the soret band that corresponds to the light absorption by the heme group in hb this new method reduces hbo dissociation measurement time from hour to minute we show that hb deoxygenation can be accelerated chemically at the optimal ph of we show that time and phcontrolled deoxygenation of hb result in rapid and distinct conformational change in it tertiary structure these molecular conformational change are manifested a significant detectable shift in hb optical absorption spectrum particularly in the characteristic soret band nm we extensively validated the method by testing human blood sample containing normal hb and hb variant we show that rapid hbo dissociation can be used to screen for and detect hbo affinity disorder and to evaluate the function and efficacy of hbmodifying therapy the ubiquity of optical absorption spectrophotometer position this approach a an accessible rapid and accurate hbo dissociation measurement method for basic research and clinical use we anticipate this method broad adoption will democratize the diagnosis and prognosis of hb disorder such a sickle cell disease further this method ha the potential to transform the research and development of new targeted and genomeeditingbased therapy that aim to modify or improve hbo affinity,Non-Cancer,1,rapid measurement of hemoglobinoxygen dissociation by leveraging bohr effect and soret band bathochromic shift oxygen o bind to hemoglobin hb in the lung and is then released dissociated in the tissue the bohr effect is a physiological mechanism that governs the affinity of hb for o based on ph where a lower ph result in a lower hbo affinity and higher hbo dissociation hbo affinity and dissociation are crucial for maintaining aerobic metabolism in cell and tissue despite it vital role in human physiology hbo dissociation measurement is underutilized in basic research and in clinical laboratory primarily due to the technical complexity and limited throughput of existing method we present a rapid hbo dissociation measurement approach by leveraging the bohr effect and detecting the optical shift in the soret band that corresponds to the light absorption by the heme group in hb this new method reduces hbo dissociation measurement time from hour to minute we show that hb deoxygenation can be accelerated chemically at the optimal ph of we show that time and phcontrolled deoxygenation of hb result in rapid and distinct conformational change in it tertiary structure these molecular conformational change are manifested a significant detectable shift in hb optical absorption spectrum particularly in the characteristic soret band nm we extensively validated the method by testing human blood sample containing normal hb and hb variant we show that rapid hbo dissociation can be used to screen for and detect hbo affinity disorder and to evaluate the function and efficacy of hbmodifying therapy the ubiquity of optical absorption spectrophotometer position this approach a an accessible rapid and accurate hbo dissociation measurement method for basic research and clinical use we anticipate this method broad adoption will democratize the diagnosis and prognosis of hb disorder such a sickle cell disease further this method ha the potential to transform the research and development of new targeted and genomeeditingbased therapy that aim to modify or improve hbo affinity
38502483,highthroughput rnahcrfish detection of endogenous premrna splice variant,rnafluorescence in situ hybridization rnafish is an essential and widely used tool for visualizing rna molecule in intact cell recent advance have increased rnafish sensitivity signal detection efficiency and throughput however detection of endogenous mrna splice variant ha been challenging due to the limit of visualization of rnafish fluorescence signal and due to the limited number of rnafish probe per target hifens highthroughput fish detection of endogenous premrna splicing isoforms is a method that enables visualization and relative quantification of mrna splice variant at singlecell resolution in an automated highthroughput manner hifens incorporates hcr hybridization chain reaction signal amplification strategy to enhance the fluorescence signal generated by low abundance transcript or a small number of fish probe targeting short stretch of rna such a single exon the technique offer a significant advance in highthroughput fishbased rna detection and provides a powerful tool that can be used a a readout in functional genomics screen to discover and dissect cellular pathway regulating gene expression and alternative premrna splicing event,Non-Cancer,1,highthroughput rnahcrfish detection of endogenous premrna splice variant rnafluorescence in situ hybridization rnafish is an essential and widely used tool for visualizing rna molecule in intact cell recent advance have increased rnafish sensitivity signal detection efficiency and throughput however detection of endogenous mrna splice variant ha been challenging due to the limit of visualization of rnafish fluorescence signal and due to the limited number of rnafish probe per target hifens highthroughput fish detection of endogenous premrna splicing isoforms is a method that enables visualization and relative quantification of mrna splice variant at singlecell resolution in an automated highthroughput manner hifens incorporates hcr hybridization chain reaction signal amplification strategy to enhance the fluorescence signal generated by low abundance transcript or a small number of fish probe targeting short stretch of rna such a single exon the technique offer a significant advance in highthroughput fishbased rna detection and provides a powerful tool that can be used a a readout in functional genomics screen to discover and dissect cellular pathway regulating gene expression and alternative premrna splicing event
38505014,more attention should be paid to omicronassociated sepsis a multicenter retrospective study in south china,the omicron variant of severe acute respiratory syndrome coronavirus sarscov is highly transmissible but cause less severe disease compared to other variant however it association with sepsis incidence and outcome is unclear this study aimed to investigate the incidence of omicronassociated sepsis a per the sepsis definition in hospitalized patient and to explore it relationship with clinical characteristic and prognosis,Non-Cancer,1,more attention should be paid to omicronassociated sepsis a multicenter retrospective study in south china the omicron variant of severe acute respiratory syndrome coronavirus sarscov is highly transmissible but cause less severe disease compared to other variant however it association with sepsis incidence and outcome is unclear this study aimed to investigate the incidence of omicronassociated sepsis a per the sepsis definition in hospitalized patient and to explore it relationship with clinical characteristic and prognosis
38530241,functional diversity of nlrp gainoffunction mutant associated with cap autoinflammation,nlrpassociated autoinflammatory disease is a heterogenous group of monogenic condition caused by nlrp gainoffunction mutation the poor functional characterization of most nlrp variant hinders diagnosis despite efficient antiil treatment additionally while nlrp is controlled by priming and activation signal gainoffunctions have only been investigated in response to priming here we characterize nlrp variant in vitro evaluating their activity upon induction priming andor activation signal and their sensitivity to four inhibitor we highlight the functional diversity of the gainoffunction mutant and describe four group based on the signal governing their activation correlating partly with the symptom severity we identify a new group of nlrp mutant responding to the activation signal without priming associated with frequent misdiagnoses our result identify key nlrp residue controlling inflammasome activity and sensitivity to inhibitor and antagonistic mechanism with broader efficacy for therapeutic strategy they provide new insight into nlrp activation an explanatory mechanism for nlrpaid heterogeneity and original tool for nlrpaid diagnosis and drug development,Non-Cancer,1,functional diversity of nlrp gainoffunction mutant associated with cap autoinflammation nlrpassociated autoinflammatory disease is a heterogenous group of monogenic condition caused by nlrp gainoffunction mutation the poor functional characterization of most nlrp variant hinders diagnosis despite efficient antiil treatment additionally while nlrp is controlled by priming and activation signal gainoffunctions have only been investigated in response to priming here we characterize nlrp variant in vitro evaluating their activity upon induction priming andor activation signal and their sensitivity to four inhibitor we highlight the functional diversity of the gainoffunction mutant and describe four group based on the signal governing their activation correlating partly with the symptom severity we identify a new group of nlrp mutant responding to the activation signal without priming associated with frequent misdiagnoses our result identify key nlrp residue controlling inflammasome activity and sensitivity to inhibitor and antagonistic mechanism with broader efficacy for therapeutic strategy they provide new insight into nlrp activation an explanatory mechanism for nlrpaid heterogeneity and original tool for nlrpaid diagnosis and drug development
38539243,a systematic review of progranulin concentration in biofluids in over peopleassessing the pathogenicity of grn mutation and other influencing factor,pathogenic heterozygous mutation in the progranulin gene grn are a key cause of frontotemporal dementia ftd leading to significantly reduced biofluid concentration of the progranulin protein pgrn this ha led to a number of ongoing therapeutic trial aiming to treat this form of ftd by increasing pgrn level in mutation carrier however we currently lack a complete understanding of factor that affect pgrn level and potential variation in measurement method here we aimed to address this gap in knowledge by systematically reviewing published literature on biofluid pgrn concentration,Non-Cancer,1,a systematic review of progranulin concentration in biofluids in over peopleassessing the pathogenicity of grn mutation and other influencing factor pathogenic heterozygous mutation in the progranulin gene grn are a key cause of frontotemporal dementia ftd leading to significantly reduced biofluid concentration of the progranulin protein pgrn this ha led to a number of ongoing therapeutic trial aiming to treat this form of ftd by increasing pgrn level in mutation carrier however we currently lack a complete understanding of factor that affect pgrn level and potential variation in measurement method here we aimed to address this gap in knowledge by systematically reviewing published literature on biofluid pgrn concentration
38540177,telomere dysfunction in pediatric patient with differencesdisorders of sexual development,differencesdisorders of sex development dsds are condition in which the development of chromosomal gonadal and anatomical sex is atypical dsds are relatively rare but their incidence is becoming alarmingly common in subsaharan africa ssa their etiology and mechanism are poorly understood therefore we have investigated cytogenetic profile including telomere dysfunction in a retrospective cohort of senegalese dsd patient,Non-Cancer,1,telomere dysfunction in pediatric patient with differencesdisorders of sexual development differencesdisorders of sex development dsds are condition in which the development of chromosomal gonadal and anatomical sex is atypical dsds are relatively rare but their incidence is becoming alarmingly common in subsaharan africa ssa their etiology and mechanism are poorly understood therefore we have investigated cytogenetic profile including telomere dysfunction in a retrospective cohort of senegalese dsd patient
38558419,prenatal detection of mosaicism for a genome wide uniparental disomy cell line in a cohort of patient implication and outcome,to investigate the prenatal detection rate of mosaicism by snp microarray analysis in which an individual ha not one but two complete genome set of dna in their body a normal biparental line with a genome wide uniparental disomy gwupd cell line wa used,Non-Cancer,1,prenatal detection of mosaicism for a genome wide uniparental disomy cell line in a cohort of patient implication and outcome to investigate the prenatal detection rate of mosaicism by snp microarray analysis in which an individual ha not one but two complete genome set of dna in their body a normal biparental line with a genome wide uniparental disomy gwupd cell line wa used
38583503,transcriptome and metabolome analysis reveal hfpota induced disorder of hepatic glucose and lipid metabolism in rat by interfering with ppar signaling pathway,pfoa is one of the most representative compound in the family of perfluorinated organic compound due to it varying toxicity alternative to pfoa are beginning to emerge hfpota is an alternative for pfoa it is currently unclear whether hfpota affect glucose and lipid metabolism in this study rat were used a an animal model to investigate the effect of hfpota on liver glucose and lipid metabolism we found that hfpota can affect glucose tolerance through omics analysis and molecular detection it wa found that hfpota mainly affect the ppar signaling pathway in the liver of rat inhibiting liver glycolysis while promoting glucose production hfpota not only promotes the synthesis of fatty acid in the liver but also promotes the breakdown of fatty acid which ultimately lead to the disruption of hepatic glucose and lipid metabolism the effect of hfpota on metabolism are discussed in this paper to provide a reference for the risk assessment of this pfoa substitute,Non-Cancer,1,transcriptome and metabolome analysis reveal hfpota induced disorder of hepatic glucose and lipid metabolism in rat by interfering with ppar signaling pathway pfoa is one of the most representative compound in the family of perfluorinated organic compound due to it varying toxicity alternative to pfoa are beginning to emerge hfpota is an alternative for pfoa it is currently unclear whether hfpota affect glucose and lipid metabolism in this study rat were used a an animal model to investigate the effect of hfpota on liver glucose and lipid metabolism we found that hfpota can affect glucose tolerance through omics analysis and molecular detection it wa found that hfpota mainly affect the ppar signaling pathway in the liver of rat inhibiting liver glycolysis while promoting glucose production hfpota not only promotes the synthesis of fatty acid in the liver but also promotes the breakdown of fatty acid which ultimately lead to the disruption of hepatic glucose and lipid metabolism the effect of hfpota on metabolism are discussed in this paper to provide a reference for the risk assessment of this pfoa substitute
38593120,early antiretroviral therapy in sivinfected rhesus macaque reveals a multiphasic saturable dynamic accumulation of the rebound competent viral reservoir,the rebound competent viral reservoir rcvrvirus that persists during antiretroviral treatment art and can reignite systemic infection when treatment is stoppedis the primary barrier to eradicating hiv we used time to initiation of art during primary infection of rhesus macaque rms after intravenous challenge with barcoded sivmac a a mean to elucidate the dynamic of rcvr establishment in group of rms by creating a multilog range of preart viral load and then assessed viral timetorebound and reactivation rate resulting from the discontinuation of art after one year rms started on art on day or postinfection showed a nearly fold difference in preart viral measurement for successive artinitiation timepoints only of rms initiating art on day and rebounded after art interruption despite measurable preart plasma viremia rebounding plasma from the rebounding rm contained only a single barcode lineage detected at day postart all rms starting art on day and rebounded between and day postart with rebounding variant each rms starting art on day and had similar timetomeasurable plasma rebound kinetics despite multiple log difference in preart plasma viral load pvl with all rms rebounding between and day postart with rebounding lineage calculated reactivation rate per preart pvl were highest for rms starting art on day and after which the rate of accumulation of the rcvr markedly decreased for rms treated on day and consistent with multiphasic establishment and near saturation of the rcvr within week post infection taken together these data highlight the heterogeneity of the rcvr between rms the stochastic establishment of the very early rcvr and the saturability of the rcvr prior to peak viral infection,Non-Cancer,1,early antiretroviral therapy in sivinfected rhesus macaque reveals a multiphasic saturable dynamic accumulation of the rebound competent viral reservoir the rebound competent viral reservoir rcvrvirus that persists during antiretroviral treatment art and can reignite systemic infection when treatment is stoppedis the primary barrier to eradicating hiv we used time to initiation of art during primary infection of rhesus macaque rms after intravenous challenge with barcoded sivmac a a mean to elucidate the dynamic of rcvr establishment in group of rms by creating a multilog range of preart viral load and then assessed viral timetorebound and reactivation rate resulting from the discontinuation of art after one year rms started on art on day or postinfection showed a nearly fold difference in preart viral measurement for successive artinitiation timepoints only of rms initiating art on day and rebounded after art interruption despite measurable preart plasma viremia rebounding plasma from the rebounding rm contained only a single barcode lineage detected at day postart all rms starting art on day and rebounded between and day postart with rebounding variant each rms starting art on day and had similar timetomeasurable plasma rebound kinetics despite multiple log difference in preart plasma viral load pvl with all rms rebounding between and day postart with rebounding lineage calculated reactivation rate per preart pvl were highest for rms starting art on day and after which the rate of accumulation of the rcvr markedly decreased for rms treated on day and consistent with multiphasic establishment and near saturation of the rcvr within week post infection taken together these data highlight the heterogeneity of the rcvr between rms the stochastic establishment of the very early rcvr and the saturability of the rcvr prior to peak viral infection
38623902,not available,effective longitudinal biomarkers that track disease progression are needed to characterize the presymptomatic phase of genetic frontotemporal dementia ftd we investigate the utility of cerebral perfusion a one such biomarker in presymptomatic ftd mutation carrier,Non-Cancer,1,not available effective longitudinal biomarkers that track disease progression are needed to characterize the presymptomatic phase of genetic frontotemporal dementia ftd we investigate the utility of cerebral perfusion a one such biomarker in presymptomatic ftd mutation carrier
38640937,mechanism and management of loss of response to antitnf therapy for patient with crohn disease year data from the prospective multicentre pant cohort study,we sought to report the effectiveness of infliximab and adalimumab over the first year of treatment and to define the factor that predict antitnf treatment failure and the strategy that prevent or mitigate loss of response,Non-Cancer,1,mechanism and management of loss of response to antitnf therapy for patient with crohn disease year data from the prospective multicentre pant cohort study we sought to report the effectiveness of infliximab and adalimumab over the first year of treatment and to define the factor that predict antitnf treatment failure and the strategy that prevent or mitigate loss of response
38642556,modification of coronary artery disease clinical risk factor by coronary artery disease polygenic risk score,the extent to which the relationship between clinical risk factor and coronary artery disease cad are altered by cad polygenic risk score pr is not well understood here we determine whether the interaction between clinical risk factor and cad pr further explain risk for incident cad,Non-Cancer,1,modification of coronary artery disease clinical risk factor by coronary artery disease polygenic risk score the extent to which the relationship between clinical risk factor and coronary artery disease cad are altered by cad polygenic risk score pr is not well understood here we determine whether the interaction between clinical risk factor and cad pr further explain risk for incident cad
38650020,metaanalysis of the global distribution of clinically relevant cypc allele and their inferred functional consequence,cypc is responsible for the metabolism of of clinically prescribed drug including antimalarial anticancer and antiinflammatory drug genetic variability is an important factor that influence cypc activity and modulates the pharmacokinetics efficacy and safety of it substrate,Non-Cancer,1,metaanalysis of the global distribution of clinically relevant cypc allele and their inferred functional consequence cypc is responsible for the metabolism of of clinically prescribed drug including antimalarial anticancer and antiinflammatory drug genetic variability is an important factor that influence cypc activity and modulates the pharmacokinetics efficacy and safety of it substrate
38701783,fltl governs the development of partially overlapping hematopoietic lineage in human and mouse,fmsrelated tyrosine kinase ligand fltl encoded by fltlg is a hematopoietic factor essential for the development of natural killer nk cell b cell and dendritic cell dc in mouse we describe three human homozygous for a lossoffunction fltlg variant with a history of various recurrent infection including severe cutaneous wart the patient bone marrow bm wa hypoplastic with low level of hematopoietic progenitor particularly myeloid and b cell precursor count of b cell monocyte and dc were low in the patient blood whereas the other blood subset including nk cell were affected only moderately if at all the patient had normal count of langerhans cell lcs and dermal macrophage in the skin but lacked dermal dc thus fltl is required for b cell and dc development in mouse and human however unlike it murine counterpart human fltl is required for the development of monocyte but not nk cell,Non-Cancer,1,fltl governs the development of partially overlapping hematopoietic lineage in human and mouse fmsrelated tyrosine kinase ligand fltl encoded by fltlg is a hematopoietic factor essential for the development of natural killer nk cell b cell and dendritic cell dc in mouse we describe three human homozygous for a lossoffunction fltlg variant with a history of various recurrent infection including severe cutaneous wart the patient bone marrow bm wa hypoplastic with low level of hematopoietic progenitor particularly myeloid and b cell precursor count of b cell monocyte and dc were low in the patient blood whereas the other blood subset including nk cell were affected only moderately if at all the patient had normal count of langerhans cell lcs and dermal macrophage in the skin but lacked dermal dc thus fltl is required for b cell and dc development in mouse and human however unlike it murine counterpart human fltl is required for the development of monocyte but not nk cell
